<SEC-DOCUMENT>0001047469-16-013724.txt : 20160609
<SEC-HEADER>0001047469-16-013724.hdr.sgml : 20160609
<ACCEPTANCE-DATETIME>20160609070123
ACCESSION NUMBER:		0001047469-16-013724
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		42
FILED AS OF DATE:		20160609
DATE AS OF CHANGE:		20160609

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TACTILE SYSTEMS TECHNOLOGY INC
		CENTRAL INDEX KEY:			0001027838
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-209115
		FILM NUMBER:		161704887

	BUSINESS ADDRESS:	
		STREET 1:		1331 TYLER STREET NE STE 200
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55413
		BUSINESS PHONE:		866-435-3948

	MAIL ADDRESS:	
		STREET 1:		1331 TYLER STREET NE STE 200
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55413
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>a2228882zs-1a.htm
<DESCRIPTION>S-1/A
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<P><FONT SIZE=3 >
Use these links to rapidly review the document<BR>
<A HREF="#bg12201_table_of_contents">  TABLE OF CONTENTS</A> <BR>
<A HREF="#fa12201_tactile_systems_technology,_inc.">  TACTILE SYSTEMS TECHNOLOGY, INC.</A><BR></font>
</P>

<P style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=1><B>As filed with the Securities and Exchange Commission on June&nbsp;9, 2016.

 </B></FONT>

</P>

<P ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B> Registration No.&nbsp;333-209115  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B><BR>  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B> <div style="width:100%;border-top:solid #3B5A6F 3.0pt;padding:0in 0in 0in 0in;font-size:3.0pt;"></div>
<div style="width:100%;border-top:solid #3B5A6F 1.0pt;padding:0in 0in 0in 0in;font-size:4.0pt;"></div>  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>  </B></FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Washington, D.C. 20549  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" >


  </I></FONT><FONT COLOR="#3B5A6F" SIZE=1><B>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR>  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>


AMENDMENT NO.&nbsp;3<BR>
TO<BR>  </B></FONT><FONT COLOR="#3B5A6F" SIZE=4><B>FORM S-1<BR>  </B></FONT><FONT COLOR="#3B5A6F" SIZE=1><B>REGISTRATION STATEMENT<BR>
UNDER<BR>
THE SECURITIES ACT OF&nbsp;1933

  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><I>


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" >


 </I></FONT><FONT COLOR="#3B5A6F" SIZE=1><B>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR>  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.<BR>  </B></FONT><FONT COLOR="#3B5A6F" SIZE=1>(Exact name of registrant as specified in its charter) </FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>Delaware</B></FONT><FONT COLOR="#3B5A6F" SIZE=1><BR>
(State or other jurisdiction of<BR>
incorporation or organization)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B> 3841</B></FONT><FONT COLOR="#3B5A6F" SIZE=1><BR>
(Primary Standard Industrial<BR>
Classification Code Number)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B> 41-1801204</B></FONT><FONT COLOR="#3B5A6F" SIZE=1><BR>
(I.R.S. Employer<BR>
Identification No.)</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>Tactile Systems Technology,&nbsp;Inc.<BR>
1331 Tyler Street NE, Suite&nbsp;200<BR>
Minneapolis, MN 55413<BR>
(612)&nbsp;355-5100</B></FONT><FONT COLOR="#3B5A6F" SIZE=1><BR>
(Address, including zip code, and telephone number, including<BR>
area code, of registrant's principal executive offices) </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>Gerald R. Mattys<BR>
Chief Executive Officer<BR>
Tactile Systems Technology,&nbsp;Inc.<BR>
1331 Tyler Street NE, Suite&nbsp;200<BR>
Minneapolis, MN 55413<BR>
(612)&nbsp;355-5100<BR>  </B></FONT><FONT COLOR="#3B5A6F" SIZE=1>(Name, address, including zip code, and telephone number, including area code, of agent for service) </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" >


  </I></FONT><FONT COLOR="#3B5A6F" SIZE=1>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR></FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="46%" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="46%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD COLSPAN=3 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>Copies to:</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=1><B>Jonathan R. Zimmerman<BR>
Faegre Baker Daniels&nbsp;LLP<BR>
2200 Wells Fargo Center<BR>
90 South Seventh Street<BR>
Minneapolis, MN 55402-1425<BR>
(612)&nbsp;766-7000</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=1><B> Jonathan B. Abram<BR>
Dorsey&nbsp;&amp; Whitney&nbsp;LLP<BR>
50 South Sixth Street<BR>
Suite&nbsp;1500<BR>
Minneapolis, MN 55402-1498<BR>
(612)&nbsp;340-2868</B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" >


  </I></FONT><FONT COLOR="#3B5A6F" SIZE=1>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>Approximate date of commencement of proposed sale to the public: </B></FONT><FONT COLOR="#3B5A6F" SIZE=1>As soon as practicable after the effective date of this registration statement. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&nbsp;415 under the Securities Act of 1933, as amended, check the following
box.&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>If this Form is filed to register additional securities for an offering pursuant to Rule&nbsp;462(b) under the Securities Act, check the following box and list the Securities
Act registration number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>If this Form is a post-effective amendment filed pursuant to Rule&nbsp;462(c) under the Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>If this Form is a post-effective amendment filed pursuant to Rule&nbsp;462(d) under the Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of
"large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule&nbsp;12b-2 of the Exchange Act. (Check one): </FONT></P>
 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="115pt" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="88pt" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="136pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Large&nbsp;accelerated filer&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Accelerated&nbsp;filer&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Non-accelerated filer&nbsp;<FONT FACE="WINGDINGS">&#253;</FONT><BR></FONT> <FONT COLOR="#3B5A6F" SIZE=1>(Do not check if a<BR>
smaller reporting company)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Smaller&nbsp;reporting&nbsp;company&nbsp;<FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="18%" ALIGN="CENTER" >


  </I></FONT><FONT COLOR="#3B5A6F" SIZE=1>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR></FONT></P>

<P ALIGN="CENTER" style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=1><B>CALCULATION OF REGISTRATION FEE

 </B></FONT>

</P>




<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="65%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="96" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="96" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:4pt;text-indent:-4pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=5 VALIGN="BOTTOM" style="font-family:times;border-bottom:double #3B5A6F 2.25pt;">&nbsp;</TD>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>Title of Each Class of Securities<BR>
To Be Registered</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>Proposed Maximum<BR>
Aggregate Offering<BR>
Price<SUP>(1)</SUP></B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>Amount of<BR>
Registration Fee<SUP>(2)</SUP></B></FONT><BR></TH>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=5 VALIGN="BOTTOM" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;">&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:4pt;text-indent:-4pt;"><FONT COLOR="#3B5A6F" SIZE=1><B> </B></FONT><FONT COLOR="#3B5A6F" SIZE=1>Common Stock, $0.001 par value per share</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>$73,600,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>$7,411.52</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=5 VALIGN="BOTTOM" style="font-family:times;border-bottom:double #3B5A6F 2.25pt;"><p style="font-family:times;margin-left:4pt;text-indent:-4pt;"> &nbsp;</TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->


<DL compact>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Estimated
solely for the purpose of calculating the registration fee pursuant to Rule&nbsp;457(o) under the Securities Act of 1933, as amended. Includes
offering price of any additional shares that the underwriters have the option to purchase.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Calculated
pursuant to Rule&nbsp;457(o) based on an estimate of the proposed maximum aggregate offering price. The Registrant previously paid a
registration fee of $8,685.38.

</FONT></DD>

</DL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file&nbsp;a further
amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section&nbsp;8(a) of the Securities Act of 1933, as amended, or until the
registration statement shall become effective on such date as the Commission, acting pursuant to said Section&nbsp;8(a), may determine</B></FONT><FONT COLOR="#3B5A6F" SIZE=1>. </FONT></P>
 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT COLOR="#3B5A6F" SIZE=1>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><div
style="width:100%;border-top:solid #3B5A6F 1.0pt;padding:0in 0in 0in 0in;font-size:3.0pt;"></div>
<div style="width:100%;border-top:solid #3B5A6F 3.0pt;padding:0in 0in 0in 0in;font-size:4.0pt;"></div> </FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=382724,FOLIO='blank',FILE='DISK131:[15ZBY1.15ZBY12201]BA12201A.;48',USER='SSTALKE',CD=';7-JUN-2016;17:11' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=ADD_TXTHEX,"PMS193" -->


</B></FONT><FONT COLOR="#D90026" SIZE=2><B>The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration
statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state
where the offer or sale is not permitted. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>




<!-- COMMAND=ADD_TXTHEX,"PMS193" -->


 </B></FONT><FONT COLOR="#D90026" SIZE=2><B>Subject to Completion, dated June&nbsp;9, 2016</B></FONT>

</P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=4><B>4,000,000 Shares

 </B></FONT>

</P>
 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="406pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B><BR>
 <IMG SRC="g202980.jpg" ALT="LOGO" WIDTH="174" HEIGHT="75">
<BR> </B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>Common Stock  </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share  </B></FONT></P>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="100%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="100%" ALIGN="LEFT" >



<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'>

<FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Tactile Systems Technology,&nbsp;Inc. is offering 4,000,000&nbsp;shares.


</FONT>

<FONT COLOR="#3B5A6F" SIZE=2>

<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'>

<FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We anticipate that the initial public offering price will be between $14.00 and $16.00 per share.

</FONT>

<FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> This is our initial public offering and no public market currently exists for our shares.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We have applied to have our common stock approved for quotation on The NASDAQ Global Market under the symbol "TCMD." </FONT></DD></DL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="19%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="19%" ALIGN="CENTER" >


 </I></FONT><FONT COLOR="#3B5A6F" SIZE=2>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>This investment involves risk. See "Risk Factors" beginning on page&nbsp;14.  </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are an "emerging growth company" as defined in the Jumpstart Our Business Startups Act of 2012, and as such, have elected to comply with certain reduced public company
reporting requirements in this prospectus and in future filings. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=7 VALIGN="BOTTOM" style="font-family:times;border-bottom:double #3B5A6F 2.25pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="font-family:times;">&nbsp;</TD>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B><BR>&nbsp;</B></FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B><BR>
Per Share </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B><BR>&nbsp;</B></FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B><BR>
Total </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B><BR>&nbsp;</B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT COLOR="#3B5A6F" SIZE=1><B> </B></FONT><FONT COLOR="#3B5A6F" SIZE=2>Initial public offering price</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Underwriting discounts and commissions<SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Proceeds to Tactile Systems Technology,&nbsp;Inc., before expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR style="font-size:1.5pt;" VALIGN="TOP">
<TD COLSPAN=7 VALIGN="BOTTOM" style="font-family:times;border-bottom:double #3B5A6F 2.25pt;">&nbsp;</TD>
<TD VALIGN="BOTTOM" style="font-family:times;">&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>See
"Underwriting" for additional information regarding underwriting compensation.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2><I>The underwriters have the option to purchase up to 600,000 additional shares from us at the initial public offering price, less the underwriting discounts and commissions, for
30&nbsp;days after the date of this prospectus.</I></FONT>

</P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful
or complete. Any representation to the contrary is a criminal offense.</B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
underwriters expect to deliver the shares of our common stock to investors on or about&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2016. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="34%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="25%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="34%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B>Piper Jaffray</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B>William Blair</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B>Canaccord Genuity</B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="19%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="19%" ALIGN="CENTER" >


 </I></FONT><FONT COLOR="#3B5A6F" SIZE=2>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>BTIG  </B></FONT></P>
 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT COLOR="#3B5A6F" SIZE=2><B>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</b></font></p><p align=center style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>The date of this prospectus
is&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016.</B></FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=2,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=640826,FOLIO='blank',FILE='DISK131:[15ZBY1.15ZBY12201]BC12201A.;49',USER='CHE105948',CD=';7-JUN-2016;11:31' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g981962.jpg" ALT="GRAPHIC" WIDTH="684" HEIGHT="889">
  </B></FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=3,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=306042,FOLIO='blank',FILE='DISK131:[15ZBY1.15ZBY12201]BE12201A.;4',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_bg12201_1_1"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="BG12201A_main_toc"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="bg12201_table_of_contents"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  TABLE OF CONTENTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<A NAME="BG12201_TOC"></A> </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->
<!-- COMMAND=ADD_START_LINKTABLE -->

<!-- User-specified TAGGED TABLE -->

<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Page </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ca12201_prospectus_summary"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2> Prospectus Summary</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ca12201_prospectus_summary"><FONT COLOR="#3B5A6F" SIZE=2> 1</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#da12201_risk_factors"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Risk Factors</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#da12201_risk_factors"><FONT COLOR="#3B5A6F" SIZE=2> 14</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dk12201_special_note_regarding_forward-looking_statements"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Special Note Regarding Forward-Looking
Statements</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk12201_special_note_regarding_forward-looking_statements"><FONT COLOR="#3B5A6F" SIZE=2> 59</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dk12201_use_of_proceeds"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Use of Proceeds</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk12201_use_of_proceeds"><FONT COLOR="#3B5A6F" SIZE=2> 61</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dk12201_dividend_policy"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Dividend Policy</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk12201_dividend_policy"><FONT COLOR="#3B5A6F" SIZE=2> 62</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dm12201_capitalization"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Capitalization</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dm12201_capitalization"><FONT COLOR="#3B5A6F" SIZE=2> 63</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#do12201_dilution"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Dilution</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#do12201_dilution"><FONT COLOR="#3B5A6F" SIZE=2> 65</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dq12201_selected_consolidated_financial_data"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Selected Consolidated Financial Data</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dq12201_selected_consolidated_financial_data"><FONT COLOR="#3B5A6F" SIZE=2> 68</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ds12201_management_s_discussion_and_an__man03466"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Management's Discussion and Analysis of Financial Condition
and Results of Operations</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ds12201_management_s_discussion_and_an__man03466"><FONT COLOR="#3B5A6F" SIZE=2> 70</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#dy12201_business"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Business</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dy12201_business"><FONT COLOR="#3B5A6F" SIZE=2> 89</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ei12201_management"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Management</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ei12201_management"><FONT COLOR="#3B5A6F" SIZE=2> 123</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ek12201_executive_compensation"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Executive Compensation</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ek12201_executive_compensation"><FONT COLOR="#3B5A6F" SIZE=2> 131</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#eo12201_certain_relationships_and_related_party_transactions"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Certain Relationships and Related Party
Transactions</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#eo12201_certain_relationships_and_related_party_transactions"><FONT COLOR="#3B5A6F" SIZE=2> 147</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#eo12201_principal_stockholders"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Principal Stockholders</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#eo12201_principal_stockholders"><FONT COLOR="#3B5A6F" SIZE=2> 149</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#eq12201_description_of_capital_stock"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Description of Capital Stock</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#eq12201_description_of_capital_stock"><FONT COLOR="#3B5A6F" SIZE=2> 151</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#es12201_shares_eligible_for_future_sale"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Shares Eligible for Future Sale</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#es12201_shares_eligible_for_future_sale"><FONT COLOR="#3B5A6F" SIZE=2> 158</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#eu12201_material_u.s._federal_income_t__mat02369"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Material U.S. Federal Income Tax Consequences to Non-U.S.
Holders</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#eu12201_material_u.s._federal_income_t__mat02369"><FONT COLOR="#3B5A6F" SIZE=2> 160</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ew12201_underwriting"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Underwriting</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ew12201_underwriting"><FONT COLOR="#3B5A6F" SIZE=2> 165</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ey12201_legal_matters"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Legal Matters</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ey12201_legal_matters"><FONT COLOR="#3B5A6F" SIZE=2> 174</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ey12201_experts"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Experts</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ey12201_experts"><FONT COLOR="#3B5A6F" SIZE=2> 174</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#ey12201_where_you_can_find_additional_information"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Where You Can Find Additional Information</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#ey12201_where_you_can_find_additional_information"><FONT COLOR="#3B5A6F" SIZE=2> 174</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><A HREF="#fa12201_index_to_consolidated_financial_statements"><p style="font-family:times;margin-left:36pt;text-indent:-36pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Index to Consolidated Financial Statements</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#fa12201_index_to_consolidated_financial_statements"><FONT COLOR="#3B5A6F" SIZE=2> F-1</FONT></A></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>


<!-- end of user-specified TAGGED TABLE -->
<!-- COMMAND=ADD_END_LINKTABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="CENTER" >


  </I></FONT><FONT COLOR="#3B5A6F" SIZE=2>

<!-- COMMAND=ADDING_LINEBREAK -->

<BR></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>Until&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016, all dealers that effect transactions in
these securities, whether or not participating in this offering, may be required to deliver a prospectus.
This is in addition to the dealers' obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotment or subscriptions.  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>You should rely only on the information contained in this prospectus or any related free writing prospectus we may authorize to be delivered to you. We have not, and the
underwriters have not, authorized anyone to provide you with any information other than that contained or incorporated by reference in this prospectus or in any free writing prospectus prepared by or
on behalf of us or to which we have referred you. Neither we nor the underwriters take responsibility for, and can provide no assurance as to the reliability of, any other information that others may
give you. This prospectus is an offer to sell only the shares offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this
prospectus is current only as of its date, regardless of the time of delivery of this prospectus or any sale of shares of our common stock. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>i</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=4,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=934024,FOLIO='i',FILE='DISK131:[15ZBY1.15ZBY12201]BG12201A.;35',USER='DSCHWAR',CD=';8-JUN-2016;18:58' -->
<A NAME="page_bg12201_1_2"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="bg12201_investors_outside_of_the_united_states"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  Investors Outside of the United States    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Neither we nor any of the underwriters have done anything that would permit this offering or possession or distribution of this prospectus in any
jurisdiction where action for that purpose is required, other than the United States. You are required to inform yourselves about and to observe any restrictions relating to this offering and the
distribution of this prospectus outside the United States. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="bg12201_trademarks"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  Trademarks    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Flexitouch, the Flexitouch and design, ACTitouch, Entr&eacute; and our logo are our trademarks and are used in this prospectus. We have a
pending trademark application for Tactile Medical, which is also used in this prospectus. Trade names, trademarks and service marks of other companies appearing in this prospectus are the property of
their respective owners. Solely for convenience, our trademarks and trade names referred to in this prospectus appear without the &reg; and <SUP>TM</SUP> symbols, but those references are
not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights, or the right of the applicable licensor to these trademarks and trade names.
Additionally, we do not intend for our use or display of other companies' trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us, by these other
companies. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="bg12201_industry_and_market_data"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  Industry and Market Data    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Certain market and industry data and forecasts included in this prospectus were obtained from independent market research, industry publications and
surveys, governmental agencies and publicly available information. Industry surveys, publications and forecasts generally state that the information contained therein has been obtained from sources
believed to be reliable, although they do not guarantee the accuracy or completeness of such information. We believe the data from such third-party sources to be reliable. However, we have not
independently verified any of such data and cannot guarantee its accuracy or completeness. Similarly, internal market research and industry forecasts, which we believe to be reliable based upon our
management's knowledge of the market and the industry, have not been verified by any independent sources. While we are not aware of any misstatements regarding the market or industry data presented
herein, our estimates involve risks and uncertainties and are subject to change based on various factors, including those discussed under the heading "Risk Factors," "Special Note Regarding
Forward-Looking Statements" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in this prospectus. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>ii</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=5,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=745247,FOLIO='ii',FILE='DISK131:[15ZBY1.15ZBY12201]BG12201A.;35',USER='DSCHWAR',CD=';8-JUN-2016;18:58' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ca12201_1_1"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ca12201_prospectus_summary"> </A>
<A NAME="toc_ca12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  PROSPECTUS SUMMARY    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>This summary highlights information contained elsewhere in this prospectus and does not contain all of the information you
should consider when making your investment decision. You should read this entire prospectus carefully, including the sections titled "Risk Factors" and "Management's Discussion and Analysis of
Financial Condition and Results of Operations" and our consolidated financial statements and the notes thereto included elsewhere in this prospectus, before making an investment in our common stock.
As used in this prospectus, the terms
"company," "we," "our," and "us" refer to Tactile Systems Technology, Inc., doing business as Tactile Medical, except as otherwise indicated herein or as the context otherwise requires.  </I></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> <A NAME="ca12201_tactile_medical"> </A>
<A NAME="toc_ca12201_2"> </A>
<BR>    </I></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  Tactile Medical    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home. We focus on
advancing the standard of care in treating chronic diseases in the home setting to improve patient outcomes and quality of life and help control rising healthcare expenditures. We possess a unique,
scalable platform to deliver at-home healthcare solutions throughout the United States. This evolving care delivery model is recognized by policy-makers and payers as a key for controlling rising
healthcare expenditures. Our initial area of therapeutic focus is vascular disease, with a goal of advancing the standard of care in treating lymphedema and chronic venous insufficiency. Our
proprietary Flexitouch System is an at-home solution for lymphedema patients. Our proprietary ACTitouch System is a home-based solution for chronic venous insufficiency patients that may be worn
throughout the day. Our products deliver cost-effective, clinically proven, long-term treatment of chronic diseases. We employ a direct-to-patient and -provider model, through which we obtain patient
referrals from clinicians, manage insurance claims on behalf of our patients and their clinicians, deliver our solutions to patients and train them on the proper use of our solutions in their homes.
This model allows us to directly approach patients and clinicians, whereby we disintermediate the traditional durable medical equipment channel and capture both the manufacturer and distributor
margins. For the year ended December&nbsp;31, 2015, we generated revenues of $62.9&nbsp;million and had net income of $1.4&nbsp;million. Our revenues increased 32% during the year ended
December&nbsp;31, 2015 compared to the year ended December&nbsp;31, 2014. For the three months ended March&nbsp;31, 2016, we generated revenues of $13.7 million and had a net loss of $1.0
million. Our revenues increased 35% during the three months ended March&nbsp;31, 2016 compared to the three months ended March&nbsp;31, 2015. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A
traditional treatment for lymphedema is complete decongestive therapy, consisting of manual lymphatic drainage, which is a specialized application of gentle pressure to the skin applied by a
therapist that encourages drainage of lymph fluid, as well as decongestive exercises, skin care and compression with multilayered bandages, compression garments or pumps. Typically, this therapy
begins with clinic visits, but eventually patients transition to self-administered home-based therapy. The standard of care treatment for chronic venous insufficiency is compression therapy. As the
disease progresses, patients may develop a venous leg ulcer, which is commonly treated using multilayered bandages to minimize swelling and enhance blood flow. A clinician applies these non-removable
bandages to patients at a precise pressure and patients wear the bandages between weekly visits to the wound clinic during which the bandages are removed and reapplied. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
advanced at-home Flexitouch System applies a gentle application of pressure to stimulate the movement of lymphatic fluid and direct it toward properly functioning areas of the body.
The Flexitouch System provides an easy-to-use, one-hour daily, self-applied treatment solution. Peer-reviewed, published studies have shown that our Flexitouch System provides improved
quality of life and clinical outcomes and delivers significant cost-savings to payers and patients,
compared to traditional treatments. The predecessor version of our Flexitouch System received 510(k) clearance in </FONT></P>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=6,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=964958,FOLIO='1',FILE='DISK131:[15ZBY1.15ZBY12201]CA12201A.;80',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_ca12201_1_2"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>July
2002 and our current Flexitouch System received 510(k) clearance from the U.S. Food and Drug Administration, or FDA, in October 2006. Our Flexitouch System generated $54.7&nbsp;million, or 87%,
of our revenues in 2015. Our ACTitouch System addresses chronic venous insufficiency and provides precise, sustained and wearable compression that a patient may apply, remove and reapply at home. This
system was developed to provide maximum convenience for patients by providing them with the freedom to remain active while simultaneously receiving the benefits of both sustained and intermittent
pneumatic compression, which we refer to as dual-compression therapy. In a clinical study, our ACTitouch System was shown to have comparable efficacy in healing venous leg ulcers and achieved higher
patient quality of life scores as compared to multilayered bandages. Our ACTitouch System received 510(k) clearance from the FDA in June 2013 and generated $3.2&nbsp;million, or 5%, of our revenues
in 2015. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>To
support the growth of our business, we invest heavily in our commercial infrastructure, consisting of our direct sales force, reimbursement capabilities and clinical expertise. We are a national,
accredited provider of home medical equipment services approved for coverage by private payers, Medicare, the Veterans Administration and certain Medicaid programs in the United States. We market our
products using a direct-to-patient and -provider model. Our direct sales force is focused on increasing clinician awareness of our solutions, and has grown from three people in March 2005 to over
100&nbsp;people as of March&nbsp;31, 2016. We utilize over 300 licensed, independent healthcare practitioners as at-home trainers who educate patients on the proper use of our solutions. Our
experienced reimbursement operations group of over 55&nbsp;people focuses on verifying case-by-case benefits, obtaining prior authorization, billing and collecting payments from payers and providing
customer support services. Our payer relationships group of over 20 people is responsible for developing relationships with payer decision-makers to educate them on our product efficacy, develop
overall payer coverage policies and reimbursement criteria, manage Medicare patient claims and contracts with payers and serve as an advocacy liaison between patients, clinicians and payers throughout
the appeals process. Our clinical team, consisting of a scientific advisory board, in-house therapists and nurses and a medical director, serves as a resource to clinicians and patients and guides our
development of clinical evidence in support of our products. We believe these investments are critical to driving patient adoption of our technologies, and together with our commercial infrastructure,
represent a significant competitive advantage. Health insurance coverage for our
Flexitouch System and our ACTitouch System is in place with private payers, Medicare, the Veterans Administration and certain Medicaid programs. Based on our estimates, we have contracts as an
in-network provider covering over 230&nbsp;million lives in the United States. Over 48,000&nbsp;patients were treated with our Flexitouch System since 2002, and over 11,000 Flexitouch Systems were
shipped in 2015. More than 4,100&nbsp;patients were treated with our ACTitouch System since its launch in 2013, and over 2,200 ACTitouch Systems were shipped in 2015. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview of the Lymphedema and Chronic Venous Insufficiency Markets  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Lymphedema  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The lymphatic system performs a fundamental role in maintaining health through balancing fluids and regulating immunity by removing harmful bacteria,
viruses and waste products. Lymphatic structures are situated throughout the body and are comprised of a series of vessels, lymph nodes and lymphoid organs that act as a drainage system by collecting
protein rich lymph fluid and sending it to the venous system. Lymph nodes are located in several areas of the body with superficial and deep lymph nodes under each arm, at the hip, in the groin, above
the collar bones in the neck, in the abdomen, tonsils and spleen and in bone marrow. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Lymphedema
refers to a type of chronic swelling, or edema, which may occur in the arms, legs, neck, trunk or other body parts and causes severe and debilitating symptoms, including decreased mobility, </FONT></P>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=7,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=992610,FOLIO='2',FILE='DISK131:[15ZBY1.15ZBY12201]CA12201A.;80',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_ca12201_1_3"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>skin
breakdown, pain, increased risk of serious infection and marked psychosocial impairment, resulting in significantly negative implications for a patient's health and quality of life. The disease
occurs when the lymphatic vessels are unable to adequately drain protein-rich lymph fluid from the arms, legs or other regions of the body. Any condition or procedure that damages the lymph nodes or
lymphatic vessels, such as surgery or treatment for breast and other cancers, obesity, infection, scar tissue formation, trauma or chronic venous insufficiency can cause lymphedema. The disease may
also be caused from congenital malformation of the lymphatic system. Lymphedema is progressive in nature, worsens over time, and has no known cure. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Chronic Venous Insufficiency  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Chronic venous insufficiency occurs when the venous wall and/or valves in the veins are not working effectively, making it difficult for blood to
return to the heart. The disease is prevalent among patients who are obese or pregnant and may also be caused by high blood pressure, trauma, lack of exercise, smoking, deep vein thrombosis and
inflammation of the vein walls. As the valves deteriorate, blood leaks or flows backward, leading to increased pressure, stretched and dilated vessels and pooling of blood in the veins. As blood
accumulates, swelling occurs, leading to progressive tissue breakdown and venous leg ulcers. Ulcers develop in areas where blood collects as swelling interferes with the movement of oxygen and
nutrients through tissues, and if left untreated, these ulcers can quickly become infected or even gangrenous. Prolonged or untreated chronic venous insufficiency may damage the lymphatic system. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Market Opportunity  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Lymphedema and chronic venous insufficiency are costly and lifelong conditions with debilitating physical and psychological impacts on patients. We
estimate the addressable market opportunity for our solutions treating lymphedema and chronic venous insufficiency in the United States is approximately $4.7&nbsp;billion. We believe that between
three to five million people in the United States are living with lymphedema. Based on an analysis of claims data commissioned by us, we estimate approximately 700,000&nbsp;patients were diagnosed
with lymphedema during the 12&nbsp;months ended December&nbsp;31, 2014. Based on a separate analysis of claims data commissioned by us, we estimate approximately 820,000 patients were diagnosed
with lymphedema during the 12&nbsp;months ended December&nbsp;31, 2015, representing a 17% growth in the number of patients diagnosed with lymphedema as compared to the immediately preceding
12-month period. We estimate that the addressable market opportunity for our Flexitouch System is approximately $4.1&nbsp;billion in the United States once clinicians, payers and
patients are educated on the benefits of our products. This estimate is based on the number of patients diagnosed with lymphedema
and our average selling price per device. We believe that chronic venous insufficiency afflicts approximately 8% of the U.S. population, and this percentage may rise due to the growing prevalence of
obesity and cancer, as well as an aging population. Based on an analysis of claims data commissioned by us, we estimate there were over 1.5&nbsp;million patients diagnosed with venous leg ulcers in
the United States during the 12&nbsp;months ended June&nbsp;30, 2014. We estimate that our immediately addressable patient population consists of the 30% to 40% of these patients, or approximately
525,000 patients, for whom we believe device reimbursement is available because their venous leg ulcers have not resolved after six months of treatment. We estimate the addressable market opportunity
for our ACTitouch System is approximately $580&nbsp;million in the United States, which is based on the number of patients diagnosed with unresolved venous leg ulcers and our average selling price
per device. These estimates of addressable market opportunities are based on a number of internal and third-party estimates, which in turn are based on projections of current trends in the diagnosis
and treatment of lymphedema and chronic venous insufficiency as well as other estimates of potential patient populations. These projections and estimates involve inherent uncertainties, and the
conditions supporting the projections and estimates may change at any time. </FONT></P>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=8,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=647026,FOLIO='3',FILE='DISK131:[15ZBY1.15ZBY12201]CA12201A.;80',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_ca12201_1_4"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Current Treatment and Limitations  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A traditional treatment for lymphedema is complete decongestive therapy, consisting of manual lymphatic drainage, which is a specialized application
of gentle pressure to the skin applied by a therapist that encourages drainage of lymph fluid, as well as decongestive exercises, skin care and compression with multilayered bandages, compression
garments or pumps. Typically, this therapy begins with clinic visits three to five times per week for four to eight weeks, which is costly and time consuming. At that point, clinical improvement
plateaus or reimbursement for the therapy ends and patients transition to self-administered home-based care. Manual lymphatic drainage is difficult for patients to self-administer due to limited range
of motion and treatment techniques that are difficult to replicate, and traditional pump-based compression is uncomfortable and has not demonstrated the benefits of our advanced pneumatic pump. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
standard of care treatment for chronic venous insufficiency is compression therapy. As the disease progresses, patients may develop a venous leg ulcer, which is commonly treated using multilayered
bandages to minimize swelling and enhance blood flow. A clinician applies these non-removable bandages to patients at a precise pressure and patients wear the bandages between weekly visits to the
wound clinic during which the bandages are removed and reapplied. Treatment typically occurs for several months and impairs patient quality of life by limiting bathing, range of motion and other
activities. Treatment efficacy is inconsistent because bandages can lose their precise pressure between treatments. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Competitive Strengths  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We focus on advancing the standard of care in treating chronic diseases at home to improve patient outcomes and quality of life and help control
rising healthcare expenditures. Our executive team collectively has over 100&nbsp;years of experience in healthcare, developing and commercializing innovative medical technology products and
services. We believe that our commercialization platform and experience, combined with the following competitive strengths, should allow us to continue to grow our revenues and increase our presence
in the market: </FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Established leadership in providing therapies for at-home treatment of
chronic disease.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our strategic focus is developing and providing innovative technologies for the treatment of chronic diseases at home.
Our core competency, which is our direct-to-patient and -provider model, comprises a direct sales force, contract at-home trainers, reimbursement capabilities and medical expertise that we use to
expand awareness, garner referrals and obtain payment for our products.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Proprietary technology with unique advantages over other
treatments.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our solutions leverage patented technological advancements that we believe give us a competitive advantage in the
marketplace. The unique ability of our Flexitouch System to mimic manual lymphatic drainage therapy provides improved quality of life and efficacy and delivers significant cost savings to payers and
patients as compared to traditional treatments. Our ACTitouch System has the unique ability to provide both sustained and intermittent pneumatic compression therapy in one wearable product,
demonstrating comparable efficacy in healing venous leg ulcers, while achieving higher patient quality of life scores as compared to the current standard of care.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Substantial clinical evidence and key opinion leader support for our
Flexitouch System.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We have developed a substantial body of peer-reviewed, published clinical evidence that our Flexitouch System reduces
swelling and improves quality of life for lymphedema patients while reducing healthcare costs. In clinical studies, while using our Flexitouch </FONT></DD></DL>
</UL>
</UL>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=9,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1016544,FOLIO='4',FILE='DISK131:[15ZBY1.15ZBY12201]CA12201A.;80',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_ca12201_1_5"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
 <UL>
<UL>
<UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>System,
patients reported a significant increase in their ability to control their lymphedema along with an increase in activities of daily living, improvement in emotional status and reduction in
limb volume, skin hardening, and pain. Our clinical evidence is primarily based on retrospective studies of a limited number of total subjects, which studies do not compare our Flexitouch System with
other advanced pneumatic compression devices. In addition, we have established strong relationships with key opinion leaders within vascular and lymphedema specialties who promote market awareness of
our solutions and inform our clinical efforts. We have in-house expertise that designs and manages clinical and economic studies in support of the efficacy and cost-effectiveness of our products. </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Significant healthcare system cost
savings.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our solutions offer meaningful cost savings for the healthcare system and patients, as compared to traditional treatments. As
demonstrated by a study published by the American Medical Association in </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>JAMA Dermatology</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>, our Flexitouch System reduces hospitalization occurrences and
length of stays, costly cellulitis infections, outpatient visits and physical therapy visits. In addition, we believe that our ACTitouch System eliminates costly multilayered bandage system supplies
and clinic application time, resulting in cost savings for wound clinics.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Distinctive national third-party payer core
competency.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our specialized reimbursement team is proficient at obtaining reimbursement from payers across the United States. We work
closely with government and private payers to educate them on lymphedema diagnosis and treatment, expand coverage and negotiate competitive rates for our solutions. We also work directly with
clinicians and patients to help them understand payer requirements for our products. We advocate for coverage and submit claims on behalf of our patients through patient-by-patient support and claim
processing. We also engage in broader payer strategic initiatives to gain general preauthorization for our products. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Strategy  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our goal is to become a leader in the at-home treatment of chronic diseases. We intend to leverage our established platform to be a global provider
of clinically proven, easy-to-use and cost-effective solutions. The key elements of our strategy include: </FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Increase awareness of our solutions and establish them as the
standards of care.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We believe that many patients with lymphedema and chronic venous insufficiency are undiagnosed or undertreated, and
we intend to further educate physicians, wound nurses and lymphedema therapists, patients and payers to raise awareness of these diseases, the associated health burdens of such diseases on patients
and society and the clinical and economic benefits of using our products.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Expand our direct sales and customer support
teams.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We plan to expand our direct sales and marketing organization to drive greater product adoption by patients and their clinicians.
We intend to strengthen our distribution network by continuing to recruit, train and retain talented sales representatives and increasing the number of licensed home trainers. With an expanded sales
force, we believe we could target additional clinical call points.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Introduce new features and products to grow our technology
platform.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We intend to pursue new features for our products, and introduce new solutions to expand the number of patients using our
products and allow us to enter new clinical adjacencies. We pursue </FONT></DD></DL>
</UL>
</UL>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=10,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=274315,FOLIO='5',FILE='DISK131:[15ZBY1.15ZBY12201]CA12201A.;80',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_ca12201_1_6"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
 <UL>
<UL>
<UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>internal
research, design and development, and work with external collaborators to expand our product offerings. In addition, we evaluate opportunities to license or acquire additional technologies
and products to expand our total addressable market opportunity.  </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Continue the development of clinical and economic outcome
data.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;A key part of our success is our ability to demonstrate the effectiveness of our products through clinical and economic outcome
data. We intend to invest in additional studies to support peer-reviewed, published studies that evidence the clinical and economic benefits of our solutions as compared to traditional treatments. We
intend to use these data to continue to educate clinicians, payers and patients on the proven advantages of our products compared to other therapies and expand our network of key opinion leader
advocates.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Expand third-party
reimbursement.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our products are covered under existing reimbursement codes, and we have secured coverage for our solutions with private
payers, Medicare, the Veterans Administration and certain Medicaid programs. Our team has experienced significant success in obtaining positive coverage policies from payers by developing direct
relationships with payer decision-makers, leveraging our relationships with physician societies and key opinion leaders, providing clinical data, demonstrating the efficacy of our products and
educating payers on the limitations of traditional lymphedema and venous leg ulcer treatments. We believe that reimbursement for our products could be expanded by obtaining preferred contracts with
payers.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Introduce our solutions outside the United
States.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We currently sell our products only within the United States. While our plan is to continue to focus our direct sales efforts on
penetrating the U.S. market, we plan to pursue future international expansion. We have European CE Mark approval for our Flexitouch System and plan to seek CE Mark approval for our ACTitouch System.
We also have a Medical Device License in Canada for our Flexitouch System. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to Our Business  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our ability to successfully operate our business is subject to numerous risks, including those that are generally associated with operating in the
medical device industry. Some of the principal risks relating to our business and our ability to execute our business strategy include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Our revenues are primarily generated from our Flexitouch System and we are therefore highly dependent on only one product. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Our long-term growth depends on increasing awareness and adoption of our current products and our ability to develop and commercialize
additional products. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> If we are unable to achieve and maintain adequate levels of coverage or reimbursement for our products, our business and results of
operations will be adversely affected. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Our U.S. patents for our Flexitouch System will expire in 2017, which may subject us to increased competition and reduce our
opportunity to increase or maintain our revenues from our Flexitouch System. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> A recent change to the criteria for Medicare coverage for our products could have an adverse effect on our business and results of
operations. </FONT></DD></DL>
</UL>
</UL>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=11,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=311796,FOLIO='6',FILE='DISK131:[15ZBY1.15ZBY12201]CA12201A.;80',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_ca12201_1_7"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> If we are unable to expand, manage and maintain our direct sales and marketing organizations, we may not be able to generate
anticipated revenues. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Increases in our operating costs could have an adverse effect on our financial condition and results of operations. </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We compete and may compete in the future against other companies, some of which have longer operating histories, more established
products or greater resources than we do, which may harm our business. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Physicians and payers may require additional clinical studies prior to prescribing our products or to providing or maintaining
coverage and reimbursement for our products, particularly if the payers and physicians take issue with the design and results of the clinical studies. Any subsequent clinical studies that are
conducted and published may not be positive or consistent with our existing data, which would adversely affect the rate of adoption of our products. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We are subject to extensive federal and state regulation, and if we fail to comply with applicable regulations, we could suffer severe
criminal or civil sanctions or be required to make significant changes to our operations that could adversely affect our business, financial condition and operating results. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> If we are unable to protect our intellectual property, or operate our business without infringing on the intellectual property rights
of third parties, our business will be negatively affected. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Implications of Being an Emerging Growth Company  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As a company with less than $1&nbsp;billion in revenues during our last fiscal year, we qualify as an "emerging growth company" as defined in the
Jumpstart Our Business Startups Act of 2012, or the JOBS Act. For so long as we remain an emerging growth company, we are permitted and intend to rely on exemptions from specified disclosure and other
requirements that are applicable to other public companies that are not emerging growth companies. These exemptions include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> being permitted to provide only two years of audited financial statements, in addition to any required unaudited interim financial
statements, with correspondingly reduced "Management's Discussion and Analysis of Financial Condition and Results of Operations" disclosure; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> not being required to comply with the auditor attestation requirements in the assessment of our internal control over financial
reporting; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding
mandatory audit firm rotation or a supplement to the auditor's report providing additional information about the audit and the financial statements; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> reduced disclosure obligations regarding executive compensation; and </FONT></DD></DL>
</UL>
</UL>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=12,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=617786,FOLIO='7',FILE='DISK131:[15ZBY1.15ZBY12201]CA12201A.;80',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_ca12201_1_8"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
 <UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any
golden parachute payments not previously approved. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
may take advantage of these provisions for up to five years or such earlier time that we are no longer an emerging growth company. We would cease to be an emerging growth company if we have more
than $1&nbsp;billion in annual revenues, have more than $700&nbsp;million in market value of our capital stock held by non-affiliates or issue more than $1&nbsp;billion of non-convertible debt
over a three-year period. We may choose to take advantage of some, but not all, of the available exemptions. We have
taken advantage of some reduced reporting burdens in this prospectus. Accordingly, the information contained herein may be different than the information you receive from other public companies in
which you hold stock. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This provision allows an
emerging growth company to delay the adoption of some accounting standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this exemption and,
as a result, our financial statements may not be comparable to the financial statements of issuers that are required to comply with the effective dates for new or revised accounting standards that are
applicable to public companies. Section&nbsp;107 of the JOBS Act provides that we can elect to opt out of the extended transition period at any time, which election is irrevocable. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Corporate Information  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We were incorporated in Minnesota in January 1995 and reincorporated in Delaware as Tactile Systems Technology, Inc., through a merger with a
wholly-owned subsidiary in July 2006, but have been doing business as Tactile Medical. Our principal executive offices are located at 1331 Tyler Street NE, Suite&nbsp;200, Minneapolis, Minnesota
55413. Our telephone number is (612)&nbsp;355-5100. Our website address is </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>www.tactilemedical.com</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>. Information contained on, or that can be accessed
through, our website is not incorporated by reference into this prospectus, and should not be considered to be part of this prospectus. </FONT></P>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=13,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=929987,FOLIO='8',FILE='DISK131:[15ZBY1.15ZBY12201]CA12201A.;80',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_cc12201_1_9"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;<BR></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="cc12201_the_offering"> </A>
<A NAME="toc_cc12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  THE OFFERING    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="24%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="73%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Issuer</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Tactile Systems Technology,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Common stock offered by us</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2> 4,000,000&nbsp;shares</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Common stock to be outstanding immediately after this offering</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2> 15,752,290&nbsp;shares (or 16,352,290&nbsp;shares, if the underwriters exercise their option in full to purchase additional shares)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Option to purchase additional shares</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2> The underwriters have the option to purchase up to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares from us. The underwriters can exercise
this option at any time within 30&nbsp;days of this prospectus.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Use of proceeds</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2> We intend to use the net proceeds from this offering primarily to expand our sales, marketing, reimbursement, clinical, regulatory and product development activities, and the remainder
for working capital, general and administrative expenses and other general corporate purposes. We will also use a portion of the net proceeds to pay the approximately $8.1&nbsp;million of cumulative accrued dividends to our Series&nbsp;A preferred
stockholders as described in "Dividend Policy." We may also use a portion of our net proceeds to acquire or invest in complementary products, technologies or businesses, although we have no present commitments to complete any such transaction. See
"Use of Proceeds" on page&nbsp;61 for a more complete description of the intended use of proceeds from this offering.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Risk Factors</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2> Investing in our common stock involves risks. See "Risk Factors" beginning on page 14 and the other information included in this prospectus for a discussion of factors you should
carefully consider before deciding to invest in our common stock.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Dividend Policy</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2> The terms of our current certificate of incorporation provide that, upon conversion of our preferred stock into our common stock in connection with this offering, the holders of
Series&nbsp;A and Series&nbsp;B preferred stock will receive a cumulative accrued dividend calculated at a rate of 6% per annum. As of March&nbsp;31, 2016, we had $10.1&nbsp;million of cumulative accrued dividends payable to our Series&nbsp;A and
Series&nbsp;B preferred stockholders. Dividends payable to our Series&nbsp;A and Series&nbsp;B preferred stockholders have continued to accrue subsequent to March&nbsp;31, 2016. Based on an assumed closing date of June&nbsp;27, 2016, we expect to pay
approximately $8.1&nbsp;million of cumulative accrued dividends in cash to our Series&nbsp;A preferred stockholders and issue 844,782&nbsp;shares of our common stock for cumulative accrued dividends to our Series&nbsp;B preferred stockholders. The
cash dividends will be paid from the net proceeds of this offering and neither the cash nor the stock dividends will be paid on any shares of our common stock purchased in this offering. We do not pay dividends on our common stock and do not
anticipate paying any dividends on our common stock for the foreseeable</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<p style="font-family:times;"><font size=1></FONT><FONT COLOR="#3B5A6F" SIZE=2>
</font></p><p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=14,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=542264,FOLIO='9',FILE='DISK131:[15ZBY1.15ZBY12201]CC12201A.;70',USER='GPEARMO',CD=';8-JUN-2016;22:42' -->
<A NAME="page_cc12201_1_10"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="24%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="73%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> future. Any future determinations relating to our dividend policy will be made at the discretion of our board of directors and will depend on various factors. See "Dividend
Policy."</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Proposed NASDAQ Global Market symbol</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2> "TCMD."</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Shares Outstanding  </B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>The information in this prospectus reflects a 1-for-2.82 reverse stock split of our common stock, which became effective on June&nbsp;8, 2016. The
number of shares of common stock to be outstanding after this offering is based on 11,752,920&nbsp;shares of our common stock outstanding as of June&nbsp;8, 2016, including preferred stock on an
as-converted basis and additional shares that our Series&nbsp;A and Series&nbsp;B preferred stockholders are entitled to receive in connection with the initial public offering, and excludes the
following:</FONT>

</P>


<UL>
<UL>
<DL compact>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,631,280&nbsp;shares of our common stock issuable upon the exercise of outstanding options, with a weighted-average exercise price
of $1.18 per share; </FONT><FONT COLOR="#3B5A6F" SIZE=2>



<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5,800&nbsp;shares of our common stock issuable upon the exercise of outstanding warrants, with a weighted-average exercise price of
$4.23 per share; </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,600,000&nbsp;shares of our common stock reserved under our Employee Stock Purchase Plan, which will become effective prior to the
completion of this offering, as well as shares of our common stock that become available pursuant to provisions in our Employee Stock Purchase Plan that automatically increase the share reserve under
the Employee Stock Purchase Plan on January&nbsp;1 of each calendar year as described in "Executive Compensation&nbsp;&#151; Stock Option and Other Equity Compensation Plans;" </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<BR><BR></FONT></DD>

<DT style='font-family:times;margin-bottom:-11pt;'>

<FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 4,800,000&nbsp;shares of our common stock reserved for future issuance under our stock-based compensative plans, consisting
of:

 </FONT>

<FONT COLOR="#3B5A6F" SIZE=2>

<BR><BR></FONT>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'>

<FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> no&nbsp;shares of our common stock reserved for future issuance under our 2003 Stock Option Plan;


</FONT>

<FONT COLOR="#3B5A6F" SIZE=2>

<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'>

<FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> no&nbsp;shares of our common stock reserved for future issuance under our 2007 Omnibus Stock Plan; and

 </FONT>

<FONT COLOR="#3B5A6F" SIZE=2>

<BR><BR></FONT></DD>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 4,800,000&nbsp;shares of our common stock reserved for future issuance under our 2016 Equity Incentive Plan, which will
become effective prior to the completion of this offering, as well as shares of our common stock that become available pursuant to provisions in our 2016 Equity Incentive Plan that automatically
increase the share reserve under the 2016 Equity Incentive Plan on January&nbsp;1 of each calendar year as described in "Executive Compensation&nbsp;&#151; Stock Option and Other Equity
Compensation Plans."

</FONT></DD></DL>
</DD>

</DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


The number of shares of common stock to be outstanding after this offering does not include shares subject to equity-based awards that we expect to grant in connection with this offering. Upon the
effectiveness of this registration statement, we expect to grant (i)&nbsp;stock options to our employees to purchase an aggregate of 173,630&nbsp;shares of our common stock, which options will
have an exercise price per share equal to the price to the public of our common stock in connection with this offering; (ii)&nbsp;restricted stock units ("RSUs") to our employees with a value of
$3,186,012 in the aggregate,

</FONT></P>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=15,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=332287,FOLIO='10',FILE='DISK131:[15ZBY1.15ZBY12201]CC12201A.;70',USER='GPEARMO',CD=';8-JUN-2016;22:42' -->
<A NAME="page_cc12201_1_11"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


(iii)&nbsp;non-statutory stock options to our non-employee directors to purchase the number of shares equal to an aggregate $350,000; (iv)&nbsp;restricted stock units to our non-employee directors
with a value of $350,000 in the aggregate; and (v)&nbsp;additional restricted stock units with a value of $25,000 to one of our non-employee directors who joined our board of directors in 2015. See
"Management&nbsp;&#151; Non-Employee Director Compensation" and "Executive Compensation&nbsp;&#151; IPO Equity Grants" for a more complete description of the terms of such equity
grants.

</FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Pro Forma Adjustments  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Except as otherwise noted, the information in this prospectus reflects and assumes the following:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the filing and effectiveness of our amended and restated certificate of incorporation and the adoption of our amended and restated
bylaws upon completion of this offering; </FONT><FONT COLOR="#3B5A6F" SIZE=2>

<BR><BR></FONT></DD>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the conversion of all shares of our preferred stock outstanding into an aggregate of 5,924,452&nbsp;shares of our common stock
immediately prior to the completion of this offering; </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the issuance of 1,569,549 additional shares of our common stock immediately prior to the completion of this offering that our
Series&nbsp;A and B preferred stockholders are entitled to receive in connection with this initial public offering, assuming an initial offering price of $15.00 per share, which is the midpoint of
the estimated offering price range set forth on the cover page of this prospectus. A $1.00 decrease in the assumed initial public offering price of $15.00 per share would increase the number of
additional shares of our common stock issuable in connection with this initial public offering by 112,111&nbsp;shares. A $1.00 increase in the assumed initial public offering price of $15.00 per
share would decrease the number of additional shares of our common stock issuable in connection with this initial public offering by 98,097 shares; </FONT><FONT COLOR="#3B5A6F" SIZE=2>



<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the issuance of 844,782&nbsp;shares of our common stock immediately prior to the completion of this offering to pay accrued
dividends on our Series&nbsp;B preferred stock, assuming a closing date of June&nbsp;27, 2016 and an initial offering price of $15.00 per share, which is the midpoint of the estimated offering
price range set forth on the cover page of this prospectus. A $1.00 decrease in the assumed initial public offering price of $15.00 per share would increase the number of additional shares of our
common stock issuable in connection with paying the accrued dividends on our Series&nbsp;B preferred stock by 12,209&nbsp;shares. A $1.00 increase in the assumed initial public offering price of
$15.00 per share would decrease the number of additional shares of our common stock issuable in connection with paying the accrued dividends on our Series B preferred stock by 10,683 shares; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the cash payment of a portion of the proceeds from this offering to pay the approximately $8.1&nbsp;million of cumulative accrued
dividends to our Series&nbsp;A preferred stockholders as described in "Dividend Policy;" </FONT><FONT COLOR="#3B5A6F" SIZE=2>



<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> no exercise of our outstanding options or warrants subsequent to March&nbsp;31, 2016; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> no exercise by the underwriters of their over-allotment option.

 </FONT></DD>

</DL>
</UL>
</UL>
 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>11</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=16,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=862248,FOLIO='11',FILE='DISK131:[15ZBY1.15ZBY12201]CC12201A.;70',USER='GPEARMO',CD=';8-JUN-2016;22:42' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ce12201_1_12"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;<BR></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ce12201_summary_consolidated_financial_data"> </A>
<A NAME="toc_ce12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  SUMMARY CONSOLIDATED FINANCIAL DATA    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following tables set forth a summary of our historical consolidated financial data as of and for the periods indicated. The summary consolidated
statements of operations data for the years ended December&nbsp;31, 2014 and 2015 have been derived from our audited consolidated financial statements included elsewhere in this prospectus. Our
summary consolidated statements of operations data for the three months ended March&nbsp;31, 2015 and 2016, and the summary consolidated balance sheet data as of March&nbsp;31, 2016, have been
derived from our unaudited interim
consolidated financial statements included elsewhere in this prospectus. We have prepared the unaudited interim consolidated financial statements on the same basis as the audited consolidated
financial statements and have included, in our opinion, all adjustments, consisting only of normal recurring adjustments that we consider necessary for a fair statement of financial statements set
forth in those statements. Our historical results are not indicative of the results to be expected in the future and our interim results are not necessarily indicative of results to be expected for
the full year ended December&nbsp;31, 2016, or any other period. The following summary financial data should be read in conjunction with, and are qualified in their entirety by reference to, "Use of
Proceeds," "Capitalization," "Selected Consolidated Financial Data," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and our financial statements and the
related notes included elsewhere in this prospectus. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Three Months Ended<BR>
March&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands, except share and per share data)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Consolidated Statements of Operations Data:</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Revenues, net</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>47,736</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>62,872</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>10,121</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>13,700</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Cost of goods sold</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>12,715</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>16,908</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,972</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,811 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:22pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Gross profit</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>35,021</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>45,964</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>7,149</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>9,889 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Operating expenses:</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:22pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Sales and marketing</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>18,154</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>24,485</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>5,169</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>7,281</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:22pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F"
SIZE=1>Research&nbsp;and&nbsp;development&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,843</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>4,312</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>817</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>980</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:22pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Reimbursement, general and administrative</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>10,225</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>13,716</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,647</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,414 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:37pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Total operating expenses</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>31,222</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>42,513</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>8,633</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>11,675 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Income (loss) from operations</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
3,799</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
3,451</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
(1,484</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
(1,786</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Other&nbsp;income (expense)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
(4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
(194</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
12</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
5 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:22pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Income&nbsp;(loss)
&nbsp;before&nbsp;income&nbsp;taxes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,795</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,257</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(1,472</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(1,781</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Income tax expense (benefit)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
1,725</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
1,864</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
(592</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
(801</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Net income (loss)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
2,070</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
1,393</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
(880</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
(980</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Convertible preferred stock dividends</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>1,761</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>1,845</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>460</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>514</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Allocation of undistributed earnings to preferred stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>216</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Net income (loss) attributable to common stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>93</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(452</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(1,340</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(1,494</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Net income (loss) per common share attributable to common stockholders<SUP>(1)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>0.04</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(0.15</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(0.51</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(0.45</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>0.02</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(0.15</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(0.51</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(0.45</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Weighted-average common shares outstanding used to compute net income (loss) per common share attributable
to common stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,491,108</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,929,438</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,640,807</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,293,326</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,797,688</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,929,438</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,640,807</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,293,326</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Pro forma net income (loss) per common share attributable to common stockholders (unaudited)<SUP>(2)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>0.12</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(0.08</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>0.10</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(0.08</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Weighted-average common shares used to compute pro forma net income (loss) per common share attributable to common
stockholders (unaudited)<SUP>(2)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>11,807,560</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>12,171,448</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>13,507,390</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>12,171,448</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=17,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=923876,FOLIO='12',FILE='DISK131:[15ZBY1.15ZBY12201]CE12201A.;105',USER='GPEARMO',CD=';8-JUN-2016;22:43' -->
<A NAME="page_ce12201_1_13"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> </i></font></p>
<DIV style="width:100%;border:#3B5A6F solid 1pt;border-bottom:#3B5A6F solid 1pt;padding-top:12pt;padding-right:12pt;padding-bottom:1pt;padding-left:12pt;">

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="74pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of March&nbsp;31, 2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Actual </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Pro forma<SUP>(3)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Pro forma as<BR>
adjusted<SUP>(4)(5)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands; unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Consolidated Balance Sheet Data:</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Cash and cash equivalents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,787</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,787</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>52,827</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Working capital</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>19,209</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>11,414</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>66,249</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>33,268</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>33,268</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>78,773</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total debt</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Convertible preferred stock</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>33,441</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accumulated deficit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,949</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,949</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,949</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total stockholders' equity (deficit)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,940</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>18,706</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>72,006</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Net
income (loss) per common share attributable to common stockholders is calculated under the two-class method, as our convertible preferred stock
participates in the undistributed earnings of the company. The two-class method requires earnings for the period to be allocated based upon their respective rights to receive distributed and
undistributed earnings. No adjustment is made during periods with a net loss, as the holders of the convertible preferred stock have no obligation to fund losses.

<BR><BR></FONT></DD>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Pro
forma net income (loss) per common share attributable to common stockholders and the number of weighted-average common shares used to compute pro forma
net income (loss) per common share attributable to common stockholders reflect the adjustments set forth in "Summary&nbsp;&#151;&nbsp;The Offering &#151; Pro Forma Adjustments,"
except in lieu of the cash payment of a portion of the proceeds to pay cumulative accrued dividends to our Series&nbsp;A preferred stockholders, reflects the additional 519,671 shares of common
stock that would have been required to be issued to generate sufficient proceeds to fund the cash payment of the Series&nbsp;A convertible preferred stock dividends that are payable from the net
proceeds of this offering.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Reflects
the adjustments set forth in "Summary&nbsp;&#151; The Offering&nbsp;&#151; Pro Forma Adjustments," except in lieu of the cash
payment of approximately $7.8&nbsp;million of cumulative accrued dividends to our Series&nbsp;A preferred stockholders, reflects a pro forma adjustment to accrued dividends payable for this
amount. Dividends payable to our Series&nbsp;A and Series&nbsp;B preferred stockholders have continued to accrue subsequent to March&nbsp;31, 2016. Assuming a closing date of June&nbsp;27,
2016 and an initial offering price of $15.00 per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, immediately prior to the completion
of this offering, we expect to pay an additional approximately aggregate $0.3&nbsp;million of cumulative accrued dividends to our Series&nbsp;A preferred stockholders and issue an additional
59,041 aggregate shares of common stock to our Series&nbsp;B preferred stockholders, in payment of approximately $179,000 of cumulative accrued dividends to our Series&nbsp;B preferred
stockholders.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(4)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Reflects
(a)&nbsp;the pro forma adjustments described in footnote (3)&nbsp;above; (b)&nbsp;the cash payment of accrued dividends as of
March&nbsp;31, 2016 to our Series&nbsp;A preferred stockholders described in footnote (3)&nbsp;above; and (c)&nbsp;our sale and issuance of 4,000,000 shares of common stock in this offering,
at an assumed initial public offering price of $15.00 per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, after deducting the
estimated underwriting discounts and commissions and estimated offering expenses payable by us.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(5)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>A
$1.00 increase (decrease) in the assumed initial public offering price of $15.00 per share, which is the midpoint of the estimated offering price range
set forth on the cover page of this prospectus, would increase (decrease) the pro forma as adjusted amount of each of our cash and cash equivalents, working capital, total assets and total
stockholders' equity (deficit), by approximately $3.7&nbsp;million, assuming the assumed initial public offering price per share remains the same and after deducting the estimated underwriting
discounts and commissions and estimated offering expenses payable by us. Similarly, each increase (decrease) of 1,000,000 shares in the number of shares offered by us would increase (decrease) the pro
forma as adjusted amount of each of our cash and cash equivalents, working capital, total assets and total stockholders' equity (deficit) by approximately $14.0&nbsp;million, assuming the assumed
initial public offering price remains the same and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. </FONT>

</DD>

</DL>
 </DIV>

 <p style="font-family:times;"><font style="font-size:1pt;line-height:1pt;">&nbsp;</font></p>
</DIV>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>13</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=18,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=973908,FOLIO='13',FILE='DISK131:[15ZBY1.15ZBY12201]CE12201A.;105',USER='GPEARMO',CD=';8-JUN-2016;22:43' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_da12201_1_14"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="da12201_risk_factors"> </A>
<A NAME="toc_da12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  RISK FACTORS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>An investment in our common stock involves a high degree of risk. You should carefully consider the following risk factors
and all the other information in this prospectus before you decide to buy our common stock. If any of the following risks and uncertainties described below, together with all the other information
related to our business, actually occurs, our business, financial condition, operating results, and prospects would be adversely affected. In that event, the market price of our common stock could
decline and you could lose part or all of your investment.  </I></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to Our Business  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our revenues are primarily generated from our Flexitouch System and we are therefore highly
dependent on only one product.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our Flexitouch System accounted for 87% of our revenues for the year ended December&nbsp;31, 2015, and 85% of our revenues for the three months
ended March&nbsp;31, 2016. We expect that sales of this product will continue to account for the substantial majority of our revenues going forward. Therefore, our ability to execute our growth
strategy will depend not only upon increasing awareness of lymphedema, but also on the adoption of our Flexitouch System to treat this condition. Many physicians and clinicians may have experience
with, and/or invested substantial resources in, developing expertise in traditional treatments for lymphedema, which may make them less willing to adopt our Flexitouch System. If our Flexitouch System
fails to achieve wide market acceptance for any reason, our business, financial condition and results of operations could be adversely affected. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our long-term growth depends on awareness and adoption of our products.  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A primary growth strategy is to establish our products as the standard of care for the treatment of lymphedema and chronic venous insufficiency. In
order to achieve this growth strategy, we must:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> increase clinician and consumer awareness of these diseases, which are often undertreated; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> introduce the clinical and economic benefits of our solutions to physicians, therapists and other clinicians across several
specialties and in various clinical settings; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> demonstrate consistent coverage and reimbursement for our solutions by private payers, Medicare, the Veterans Administration and
certain Medicaid programs. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Clinicians
may not adopt our solutions as the standard of care for lymphedema and chronic venous insufficiency or may not prescribe our products for a number of reasons,
including:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our inability to educate a sufficient number of clinicians on these diseases or our products; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the unavailability or inadequacy of insurance coverage or reimbursement for our products; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> failure of evidence supporting clinical benefits or cost-effectiveness of our products over existing alternatives to convince
clinicians to change their treatment methods; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> resistance from clinicians to replace traditional treatments with our solutions. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
believe recommendations and support of our products by key opinion leaders can influence market acceptance and adoption. If these key opinion leaders choose to not support our products, our ability
to achieve broad market acceptance for our products may be impaired. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>14</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=19,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=94753,FOLIO='14',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;77',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_da12201_1_15"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we are unable to achieve and maintain adequate levels of coverage or reimbursement for our
products, our business and results of operations will be adversely affected.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any decline in the amount payers are willing to reimburse patients for our products could cause difficulty for patients to purchase our products and
could create pricing pressure for us. If we are forced to lower the price we charge for our products, our gross margins will decrease, which will adversely affect our business, financial condition and
results of operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Third-party
payers, whether foreign or domestic, or governmental or commercial, are developing increasingly sophisticated methods of controlling healthcare costs. In the United States, no uniform
policy of coverage and reimbursement for our products exists among third-party payers. Therefore, reimbursement for our products can differ significantly from payer to payer and our products are not
universally covered by third-party commercial payers. In addition, payers, including Medicare, continually review existing technologies for continued coverage and can, without notice, deny or reverse
coverage for existing products. We believe a reduction or elimination of coverage or reimbursement of our products by Medicare would likely cause commercial third-party payers to implement similar
reductions in their coverage or reimbursement of our products. If we are unable to expand coverage of our products by additional commercial payers, or if third-party payers that currently cover or
reimburse for our products reverse or limit their coverage in the future, our business and results of operations could be adversely affected. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Further,
we believe that future coverage and reimbursement may be subject to increased restrictions, such as additional preauthorization requirements, both in the United States and in international
markets. If we are unable to satisfy any new preauthorization requirements or adjust to any future new restrictions on our products, third-party coverage and reimbursement may be limited in the
future, which could have an adverse impact on our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


A recent change to the criteria for Medicare coverage for our products could have an adverse effect
on our business and results of operations.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Medicare Administrative Contractors, or MACs, responsible for processing Medicare claims for durable medical equipment recently approved a Local Coverage Determination, or LCD, document that may
limit Medicare coverage of our products for certain patients. This LCD, released by the MACs on December&nbsp;17, 2015, is retroactively effective, beginning December&nbsp;1, 2015. The LCD
increases the severity of lymphedema symptoms that a patient must exhibit before such patient is eligible for Medicare reimbursement for a pneumatic compression device. The LCD also inserts more
restrictive criteria that require a patient to potentially endure a longer period of conservative therapy
to prove that it fails to control their lymphedema, instead of requiring completion of just one 4-week round of conservative therapy as stated in the National Coverage Determination, or NCD. The LCD
requires four consecutive weeks of conservative therapy with no significant improvement in symptoms during any of those four weeks. Further, the LCD does not cover use of an advanced pneumatic
compression device, such as our Flexitouch System, unless the patient's lymphedema is present in the chest, trunk or abdomen. Although many patients with lymphedema likely do have some level of chest,
trunk or abdominal involvement, this criteria in the LCD means that patients with lymphedema that is confined to the limb will not have access to advanced pneumatic compression devices until the
lymphedema progresses to impact the trunk, chest or abdomen. There is no similar requirement in the NCD that the lymphedema is present in the chest, trunk or abdomen. We are working through a
coalition of device manufacturers and healthcare providers to have the LCD revised to mirror the NCD. If our efforts and the efforts of other stakeholders to overturn the LCD are unsuccessful, it may
have a negative impact on certain Medicare patients' access to our Flexitouch System and our Entr&eacute; System, which in turn could have an adverse effect on our business and results of
operations. The LCD pneumatic compression device coverage criteria for chronic venous insufficiency with venous stasis ulcers largely track existing NCD criteria, while defining the elements of a
required conservative </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>15</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=20,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=884900,FOLIO='15',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;77',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_da12201_1_16"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>therapy
trial. Under the new LCD, advanced pneumatic compression devices like our Flexitouch System are no longer covered at all for the treatment of venous stasis ulcers. Private payers often follow
Medicare's lead in setting reimbursement criteria and, if the LCD is not overturned, private payers may adopt the same or similar coverage standards as set forth in the LCD. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The U.S. patent protection for our Flexitouch System will expire in 2017, which may subject us to
increased competition and reduce or eliminate our opportunity to generate product revenues.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The four U.S. patents for our Flexitouch System will expire in 2017. Upon expiration of such patents, our Flexitouch System could be subject to
increased competition for products attempting to replicate our technology and our opportunity to increase or maintain revenues from our Flexitouch System could be substantially reduced. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we are unable to expand, manage and maintain our direct sales and marketing organizations, we may
not be able to generate anticipated revenues.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our operating results are directly dependent upon the sales and marketing efforts of our employees. If our direct sales force fails to adequately
promote, market and sell our products, our sales may suffer. Our direct sales force has grown from three people in March 2005 to over 100&nbsp;people as of March&nbsp;31, 2016. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
order to generate future sales growth, we will need to expand the size and geographic scope of our direct sales organization. Accordingly, our future success will depend largely on our ability to
continue to hire, train, retain and motivate skilled sales personnel with significant technical knowledge of lymphedema and chronic venous insufficiency. Because the competition for their services is
high, we cannot assure you we will be able to hire and retain additional personnel on favorable or commercially reasonable terms, if at all. Failure to hire or retain qualified sales personnel would
prevent us from building awareness of our solutions, expanding our business and generating additional sales. If we are unable to expand our sales and marketing capabilities, we may not be able to
effectively commercialize our products, which could have an adverse impact on our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Increases in our operating costs could have an adverse effect on our financial condition and results
of operations.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Reimbursement rates are established by fee schedules mandated by private payers, Medicare, the Veterans Administration and certain Medicaid programs
and are likely to remain constant or decrease due, in part, to federal and state government budgetary constraints. As a result, with respect to Medicare and Medicaid related revenues, we may not be
able to offset the effects of general inflation on our operating costs through increases in prices for our products. In particular, labor and related costs account for a significant portion of our
operating costs and we compete with other healthcare providers to attract and retain qualified or skilled personnel and with various industries for administrative and service employees. This
competitive environment could result in increased labor costs. As such, we must control our operating costs, particularly labor and related costs, and failing to do so could adversely affect our
financial conditions and results of operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
operating costs may fluctuate significantly in the future as a result of a variety of factors, many of which are outside of our control. These factors
include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> increased sales and marketing costs to increase awareness of our products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> costs to develop new and enhanced features for current products and research and development costs for new products; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>16</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=21,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=492188,FOLIO='16',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;77',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_da12201_1_17"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the time, resources, and expense required to develop and conduct clinical trials and seek additional regulatory clearances and
approvals for additional treatment indications for our products and for any additional products we develop; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the costs of preparing, filing, prosecuting, defending, and enforcing patent claims and other patent related costs, including
litigation costs and the results of such litigation; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> any product liability or other lawsuits related to our products and the costs associated with defending them or the costs related to
the results of such lawsuits; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the costs to attract and retain personnel with the skills required for effective operations; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the costs associated with being a public company; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> costs associated with entering international markets. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
failure to anticipate and minimize the impact of these costs could adversely affect our business and results of operations. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We compete and may compete in the future against other companies, some of which have longer
operating histories, more established products or greater resources than we do, which may harm our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The medical device industry is highly competitive. Our success depends, in part, upon our ability to maintain a competitive position in the
development of technologies and solutions for the at-home treatment of lymphedema and chronic venous insufficiency or for market adjacencies. Any product we develop will have to compete for market
acceptance and market share. We face significant competition in the United States, and we expect the intensity of competition will increase over time. Our primary competitors include Bio Compression
Systems, Inc., Lympha Press USA and Wright Therapy Products (which was recently acquired by BSN Medical GmbH). If we expand internationally, we expect that ArjoHuntleigh, an affiliate of the Getinge
Group, would become a competitor. Many of the companies developing or marketing competing products enjoy several competitive advantages, including:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> significantly greater name recognition; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> established relations with healthcare professionals, customers, and third-party payers; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> established distribution networks; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> additional lines of products, and the ability to offer rebates or bundle products to offer higher discounts or other incentives to
gain a competitive advantage; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> greater history in conducting research and development, manufacturing, marketing, and obtaining regulatory approval for homecare
devices; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> greater financial and human resources for product development, sales and marketing, patent litigation and customer financing. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
competitors may develop and patent processes or products earlier than us, obtain regulatory clearance or approvals for competing devices more rapidly than us or develop more effective or less
expensive products or technologies that render our technology or products obsolete or less competitive. We also face fierce competition in recruiting and retaining qualified sales, scientific,
reimbursement and </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>17</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=22,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=71930,FOLIO='17',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;77',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_da12201_1_18"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>management
personnel, particularly those with direct-to-patient and -provider experience. If our competitors are more successful than us in these matters, our business may be harmed. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Physicians and payers may require additional clinical studies prior to prescribing our products or
to providing or maintaining coverage and reimbursement for our products. Any subsequent clinical studies that are conducted and published may not be positive or consistent with our existing data,
which would adversely affect the rate of adoption of our products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our success depends in large part on the medical and third-party payer community's acceptance of our products as being useful in treating patients
with lymphedema or chronic venous insufficiency. We have sponsored 13 clinical studies in which a total of 682&nbsp;patients were treated with our products to track outcomes of treatment with our
products. While the results of our studies collectively indicate a favorable safety and efficacy profile, the study designs and results may not be viewed as compelling to physicians and insurers. In
particular, payers and physicians may see limitations in the design and results of the studies because certain studies were not specifically based on our products, involved a limited number of total
subjects or subjects outside the control group and made "quality of life" conclusions based upon criteria contained in patient questionnaires that required subjective conclusions. Certain physicians
and insurers may also prefer to see longer-term efficacy data than we have produced. If physicians or insurers do not find our data compelling or wish to wait for additional or independently-performed
studies, they may choose not to prescribe or to provide coverage and reimbursement for our products. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
cannot assure you that any data that we or others generate will be consistent with that observed in the existing studies or that results will be maintained beyond the time points studied. We also
cannot assure you that any data that may be collected will be compelling to the medical community because the data may not be scientifically meaningful or may not demonstrate that our products are
attractive alternatives to traditional treatments. If subsequent studies are not positive or consistent with our existing data, adoption of our products may suffer and, accordingly, our business could
be adversely impacted. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our long-term growth depends on our ability to develop and commercialize additional products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The medical device industry is highly competitive and subject to rapid change and technological advancements. Therefore, it is important to our
business that we continue to enhance our product offerings and introduce new products. Developing products is expensive and time-consuming and could divert management's attention away from our
business. We may not be successful in developing new products or enhancements to existing products. Our ability to develop and commercialize additional products or enhancements to existing products
will depend on several factors, including our ability to:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> properly identify and anticipate physician and patient needs; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> develop and introduce new products or product enhancements in a timely manner; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> avoid infringing upon the intellectual property rights of third-parties; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> demonstrate the safety and efficacy of new products with data from clinical studies; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> obtain the necessary regulatory clearances or approvals for new products or product enhancements; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> be fully FDA-compliant with the development, manufacturing and marketing of new devices or modified products; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> provide adequate training to potential users of our products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> secure adequate coverage and reimbursement for our products; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> develop an effective and dedicated sales and marketing team. </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>18</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=23,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=52813,FOLIO='18',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;77',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_da12201_1_19"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
we are unsuccessful in developing and commercializing new products, our ability to increase our revenues may be impaired. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


It is difficult to forecast future performance and our financial results may vary from forecasts and
may fluctuate from quarter to quarter.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our limited operating history and commercial experience make it difficult for us to predict future performance. A number of factors over which we
have limited control, such as seasonal variations in revenues, may contribute to fluctuations in our financial results. In the first and second quarters, our results of operations have been negatively
impacted by resetting of annual patient healthcare insurance plan deductibles, which may cause patients to delay purchase of elective products. In the third and fourth quarters, our revenues have been
higher because patients often spend the remaining balances in their flexible-spending accounts or because of lower out-of-pocket costs to patients who have met their annual deductibles under their
health insurance plans. To the extent that the prevalence of high deductible insurance plans and higher copay and coinsurance plans continue to grow in the private payer market, the seasonal
variations in our revenues could become even more pronounced. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Other
factors that may cause fluctuation in our quarterly results or variations from our forecasts include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> physician adoption of our products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> timing of new product offerings, acquisitions, licenses or other significant events by us or our competitors; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> unanticipated pricing pressure; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the hiring, retention and continued productivity of our sales representatives; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our ability to expand the geographic reach of our sales and marketing efforts; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our ability to obtain regulatory clearance or approval for our products in development or for our current products outside the United
States; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the impact of results from clinical research and trials on our existing products and products in development; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> delays in receipt of anticipated purchase orders; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> delays in, or failure of, component deliveries from our suppliers; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> positive or negative coverage in the media or clinical publications of our products or products of our competitors or our industry.
</FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
the event our actual revenues and operating results do not meet our forecasts or the forecasts or estimates of the research analysts that cover us for a particular period, the market price of our
common stock may decline substantially. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We utilize third-party, single-source suppliers for some components and materials used in our
products, and the loss of any of these suppliers could have an adverse impact on our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We rely on third-party manufacturers and suppliers to supply all components and materials used in our Flexitouch, ACTitouch and Entr&eacute;
Systems. We rely on a single-source supplier for the controller in our </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>19</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=24,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=773143,FOLIO='19',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;77',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_da12201_1_20"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>ACTitouch
System. Our ability to supply our products commercially depends, in part, on our ability to obtain components and materials in accordance with our specifications and with regulatory
requirements and in sufficient quantities to meet demand for our products. Our ability to obtain components and materials may be affected by matters outside our control, including that our suppliers
may cancel our arrangements on short notice, we may be relatively less important as a customer to certain suppliers and our suppliers may have disruptions to their operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
we are required to establish additional or replacement suppliers for any of our components or materials, it may not be accomplished quickly and our operations could be disrupted. Even if we are
able to find replacement suppliers, the replacement suppliers would need to be qualified and may require additional regulatory authority approval, which could result in further delay. In the event of
a supply disruption, our product inventories may be insufficient to supply our patients. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
our third-party suppliers fail to deliver the required commercial quantities of materials on a timely basis and at commercially reasonable prices, and we are unable to find one or more replacement
suppliers capable of production at a substantially equivalent cost in substantially equivalent volumes and quality on a timely basis, the continued commercialization of our products, the supply of our
products to customers and the development of any future products would be delayed, limited or prevented, which could have an adverse impact on our business. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Consolidation in the healthcare industry could lead to demands for price concessions, which may
impact our ability to sell our products at prices necessary to support our current business strategies.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Healthcare costs have risen significantly over the past decade, which has resulted in or led to numerous cost reform initiatives by legislators,
regulators and third-party payers. Cost reform has triggered a consolidation trend in the healthcare industry to aggregate purchasing power, which may create more requests for pricing concessions in
the future. We expect that market demand, government regulation, third-party coverage and reimbursement policies and societal pressures will continue to change the healthcare industry worldwide,
resulting in further business consolidations and alliances among our payers, which may exert downward pressure on the prices of our products in the future. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may be unable to collect all of our Medicare accounts receivable.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>At March&nbsp;31, 2016, we had approximately $4.4&nbsp;million of accounts receivable for shipments of products to patients covered by Medicare.
A portion of our submitted claims to Medicare are initially denied and enter the appeals process, where many are ultimately reviewed by an Administrative Law Judge. The appeal process can be lengthy,
lasting more than a year in most cases. At March&nbsp;31, 2016, we have classified $1.8&nbsp;million as Medicare accounts receivable&nbsp;&#151; long term due to the estimated amount of
receivables that will be paid more than one year from March&nbsp;31, 2016, as a result of delays with the Administrative Law Judge appeal process. A significant increase in Medicare denial of
submitted claims or an increase in the proportion of Medicare denials that are upheld by an Administrative Law Judge would adversely affect our results of operations or cause us to recognize a write
off of Medicare accounts receivables. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As
an alternative to individual appeals, Medicare may seek to settle a number of outstanding appeals at one time through a settlement conference. On September&nbsp;3, 2015, we entered into a
settlement agreement with the Centers for Medicare and Medicaid Services, or CMS, for 247&nbsp;claims, representing approximately $1.46&nbsp;million of original claims based on the Medicare
allowable rates, in which we had submitted a request for an Administrative Law Judge hearing in 2013. The settlement entitled us to receive a payment of approximately $0.85&nbsp;million. We received
this full amount during the fourth quarter of 2015. The settlement resulted in a reduction in the fourth quarter of 2015 of $0.82&nbsp;million in our accounts receivable for shipment of products to
patients covered by Medicare. The settlement was part of a pilot program, facilitated by the Office of Medicare Hearings and Appeals, to address a </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>20</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=25,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=695441,FOLIO='20',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;77',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_da12201_1_21"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>backlog
of overdue claims awaiting Administrative Law Judge adjudication. Because the settlement is part of a pilot program, we cannot predict whether we will be able to conclude future settlements
with Medicare or achieve settlements on similar terms. Any future settlement of claims for amounts less than the corresponding amounts receivable would result in a write off. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Changes to the level of Medicare coverage for our products could have an adverse effect on our
business and results of operations.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Determinations of which products or services will be reimbursed under Medicare can be developed at the national level through an NCD, by CMS, or at
the local level through an LCD, by one or all of the four regional Medicare Administrative Contractors, which are private contractors that process and pay claims on behalf of CMS for different
regions. These NCDs and LCDs may be subject to review and revision from time to time, which revisions may not be favorable for coverage of our products, and the NCDs and LCDs may not always be
consistent. We have in the past been required to respond to potential changes in LCDs for our products, which, if enacted, would have had adverse effects on our business. Further, we believe that a
reduction in coverage by Medicare would likely cause some commercial third-party payers to implement similar reductions in their coverage or reimbursement of our products. Given the evolving nature of
the healthcare industry and on-going healthcare cost reforms, we are and will continue to be subject to changes in the level of Medicare coverage for our products, and unfavorable coverage
determinations at the national or local level could adversely affect our business and results of operations. See also "</FONT><FONT COLOR="#3B5A6F" SIZE=2><I>A recent change to the criteria for Medicare coverage for
our products could have an adverse effect on our business and results of operations."</I></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The size of the market for our products is an estimate, and may be smaller than we believe.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our estimate of the annual total addressable market for our products is based on a number of internal and third-party estimates. In addition, our
internal estimates are based in large part on current trends in diagnosing lymphedema and chronic venous insufficiency. While we believe these factors have historically provided and may continue to
provide us with effective tools in estimating the total market for lymphedema, chronic venous insufficiency and our products, these estimates may not be correct and the conditions supporting our
estimates may change at any time, thereby reducing the predictive accuracy of these underlying factors. As a result, our estimates of the annual total addressable market for our products may prove to
be incorrect. If the actual number of
patients who would benefit from our products and the annual total addressable market for our products is smaller than we have estimated, our future growth could be adversely impacted. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may be unable to manage our growth effectively.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our past growth has provided, and our future growth may create, challenges to our organization. For instance, from March 2005 to March&nbsp;31,
2016, the number of our employees increased from 10 to over 270. We intend to continue to grow and may experience periods of rapid growth and expansion. Future growth will impose significant added
responsibilities on management, including the need to identify, recruit, train, integrate, retain and motivate additional employees. In addition, rapid and significant growth will place a strain on
our administrative personnel, information technology systems and other operational infrastructure. Any failure by us to manage our growth effectively could have an adverse effect on our ability to
achieve our development and commercialization goals. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Successful
growth is also dependent upon our ability to implement appropriate financial and management controls, systems and procedures. In order to manage our operations and growth, we will need to
continue to improve our operational and management controls, reporting and information technology systems and financial internal control procedures. If we are unable to manage our growth effectively,
it may be difficult for us to execute our business strategy and there could be an adverse impact on our business. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=26,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=24043,FOLIO='21',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;77',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_da12201_1_22"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our ability to maintain our competitive position depends on our ability to attract, integrate and
retain key executives and highly qualified personnel.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We believe that our continued success depends to a significant extent upon the efforts and abilities of our executive officers and other key
personnel. Our executive officers and other key personnel are critical to the strategic direction and overall management of our company as well as our research and development process. Some key
personnel have only joined us in the last year as part of our investment in the expansion of our business, including a new Chief Financial Officer who joined us in late April 2016. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
future success also depends on our ability to continue to attract and retain additional executive officers and other key employees. We invest significant time and expense in training our
employees, which increases their value to competitors who may seek to recruit them. Many of our competitors have greater resources than we have that allows them to offer more competitive remuneration,
which could adversely impact our ability to attract and retain experienced executives and other key employees. We carry a "key person" insurance policy on only our Chief Executive Officer. The
replacement of any of our key personnel likely would involve significant time and costs and may significantly delay or prevent the achievement of our business objectives and would harm our business.
Our productivity may be adversely affected if we do not integrate and train our new employees quickly and effectively </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Many
of our employees have become or will soon become vested in a substantial amount of our common stock or a number of common stock options. Our employees may be more likely to leave us if the shares
they own have significantly appreciated in value relative to the original purchase prices of the shares, or if the exercise prices of the options that they hold are significantly below the market
price of our common stock, particularly after the expiration of the lock-up agreements described herein. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We face the risk of product liability claims that could be expensive, divert management's attention
and harm our reputation and business. We may not be able to maintain adequate product liability insurance.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our business exposes us to the risk of product liability claims that are inherent in the testing, manufacturing and marketing of medical devices.
This risk exists even if a device is cleared or approved for commercial sale by the FDA and manufactured in facilities licensed and regulated by the FDA or an applicable foreign regulatory authority.
Our products are designed to affect, and any future products will be designed to affect, important bodily functions and processes. Any side effects, manufacturing defects, misuse or abuse associated
with our products or our products in development could result in patient injury or death. The medical device industry has historically been subject to extensive litigation over product liability
claims, and we cannot offer any assurance that we will not face product liability suits. We may be subject to product liability claims if our products cause, or merely appear to have caused, patient
injury or death. In addition, an injury that is caused by the activities of our suppliers, such as those who provide us with components and materials, may be the basis for a claim against us. Product
liability claims may be brought against us by patients, clinicians or others selling or otherwise coming into contact with our products, among others. If we cannot successfully defend ourselves
against product liability claims, we will incur substantial liabilities and reputational harm. In addition, regardless of merit or eventual outcome, product liability claims may result
in:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> costs of litigation; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> distraction of management's attention from our primary business; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>22</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=27,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=408665,FOLIO='22',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;77',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_da12201_1_23"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the inability to commercialize our existing or new products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> decreased demand for our products or, if cleared or approved, products in development; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> damage to our business reputation; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> product recalls or withdrawals from the market; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> withdrawal of clinical trial participants; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> substantial monetary awards to patients or other claimants; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> loss of revenues. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>While
we may attempt to manage our product liability exposure by proactively recalling or withdrawing from the market any defective products, any recall or market withdrawal of our products would
delay the supply of those products to our clinicians and patients and may impact our reputation. We can provide no assurance that we will be successful in initiating appropriate market recall or
market withdrawal efforts that may be required in the future or that these efforts will have the intended effect of preventing product malfunctions and the accompanying product liability that may
result. Such recalls and withdrawals may also be used by our competitors to harm our reputation for safety or be perceived by patients as a safety risk when considering the use of our products, either
of which could have an adverse impact on our business. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, our product liability insurance is subject to deductibles and coverage limitations. Our current product liability insurance may not continue to be available to us on acceptable terms, if
at all, and, if available, coverage may not be adequate to protect us against any future product liability claims. If we are unable to obtain insurance at an acceptable cost or on acceptable terms or
otherwise protect against potential product liability claims, we could be exposed to significant liabilities. A product liability claim, recall or other claim with respect to uninsured liabilities or
for amounts in excess of insured liabilities could have an adverse impact on our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Changes in reimbursement coding could impair our ability to receive reimbursement for our products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The International Statistical Classification of Diseases and Related Health Problems 9th Revision, or ICD-9, is a coding of diseases, signs and
symptoms, abnormal findings, complaints, social circumstances and external causes of injury or diseases, as classified by the World Health Organization that permits the tracking of many diagnoses.
Current health plan systems and health care providers are required by the Health Insurance Portability and Accountability Act of 1996, or HIPAA, to use a standard code set to indicate diagnoses and
procedures on transactions. For diagnoses, CMS created a derivation of the ICD-9 code for use. For other types of procedures, health plans and providers use Current Procedural Terminology, or CPT, or
Healthcare Common Procedure Coding System, or HCPCS, codes. The International Statistical Classification of Diseases and Related Health Problems 10th Revision, or ICD-10, was recently released and a
modified version of ICD-10 was adopted by CMS and use of the updated diagnosis codes is now required. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>23</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=28,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=390979,FOLIO='23',FILE='DISK131:[15ZBY1.15ZBY12201]DA12201A.;77',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dc12201_1_24"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The ICD-10 codes are markedly different from their predecessors and because ICD-9 codes are used in almost every clinical and administrative process in a healthcare setting,
substantial system and procedural changes will be necessary to implement and correctly use the new codes. The updated code sets will require significant changes in the way health plans reimburse
services, and in the way coverage of services is determined. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
Flexitouch System is reimbursed under HCPCS code E0652, our ACTitouch System is reimbursed under HCPCS code E0651, and our Entr&eacute; System is reimbursed under HCPCS code E0651.
Garments that cover various parts of the body are used with these systems and billed using HCPCS codes E0651, E0652, E0667, E0668 and E0669. These are tied to specific existing ICD-9 diagnoses. Many
private payers have paid for our products using these codes as well. These contracts allow us to be an in-network provider for these payers, and eases our administrative burden in processing at both
prior authorization and billing levels. With the change to ICD-10, it is possible the we or our patients may have difficulty properly submitting claims for reimbursement and, even if the claims are
properly submitted, private payers, Medicare and Medicaid may have problems processing the claims. This could have an adverse impact on our reimbursement rates, results of operations and cash flows. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If the quality of our products does not meet the expectations of physicians or patients, then our
brand and reputation could suffer and our business could be adversely impacted.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In the course of conducting our business, we must adequately address quality issues that may arise with our products, as well as defects in
third-party components included in our products. There can be no assurance that our internal procedures to minimize risks that may arise from quality issues will be able to eliminate or mitigate
occurrences of these issues and associated liabilities. If the quality of our products does not meet the expectations of physicians or patients, then our brand and reputation could suffer with those
physicians or patients and our business could be adversely impacted. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If our facilities are damaged or become inoperable, we will be unable to continue to research,
develop, manufacture and commercialize our products and, as a result, there will be an adverse impact on our business until we are able to secure a new facility.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We do not have redundant facilities. We perform substantially all of our research and development, assembly and back office activity and maintain all
our finished goods inventory in a single location in Minneapolis, Minnesota. Our facility and equipment would be costly to replace and could require substantial lead time to repair or replace. The
facility may be harmed or rendered inoperable by natural or man-made disasters, including, but not limited to, tornadoes, flooding, fire and power outages, which may render it difficult or impossible
for us to perform our research, development, manufacturing and commercialization activities for some period of time. The inability to perform those activities, combined with our limited inventory of
reserve raw materials and finished product, may result in the inability to continue manufacturing our products during such periods and the loss of customers or harm to our reputation. Our insurance
for damage to our property and the disruption of our business may not be sufficient to cover all of our potential losses, and this insurance may not continue to be available to us on acceptable terms,
or at all. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we choose to acquire new and complementary businesses, products or technologies, we may be unable
to complete these acquisitions or to successfully integrate them in a cost-effective and non-disruptive manner.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our success depends on our ability to continually enhance and broaden our product offerings in response to changing customer demands, competitive
pressures and advances in technologies. Accordingly, although we have no current commitments with respect to any acquisition or investment, we may in the future pursue the acquisition of, or joint
ventures relating to, complementary businesses, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>24</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=29,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=156494,FOLIO='24',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;44',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_dc12201_1_25"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>products
or technologies instead of developing them ourselves. We do not know if we will be able to successfully complete any future acquisitions or joint ventures, or whether we will be able to
successfully integrate any acquired business, product or technology or retain any key employees related thereto. Integrating any business, product or technology we acquire could be expensive and
time-consuming, disrupt our ongoing business and distract our management. If we are unable to integrate any acquired businesses, products or technologies effectively, our business will suffer. In
addition, any amortization or charges resulting from the costs of acquisitions could increase our expenses. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Failure to protect our information technology infrastructure against cyber-based attacks, network
security breaches, service interruptions or data corruption could significantly disrupt our operations and adversely affect our business and operating results.  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We rely extensively on information technology systems and telephone networks and systems, including the Internet, to process and transmit sensitive
electronic information and to manage or support a variety of business processes and activities, including sales, billing, customer service, procurement and supply chain, manufacturing, and
distribution. We use enterprise information technology systems to record, process, and summarize financial information and results of operations for internal reporting purposes and to comply with
regulatory financial reporting, legal, and tax requirements. Our information technology systems, some of which are managed by third-parties, may be susceptible to damage, disruptions or shutdowns due
to computer viruses, attacks by computer hackers, failures during the process of upgrading or replacing software, databases or components thereof, power outages, hardware failures, telecommunication
failures, user errors or catastrophic events. Despite the precautionary measures we have taken to prevent breakdowns in our information technology and telephone systems, if our systems suffer severe
damage or disruption or shutdown and we are unable to effectively resolve the issues in a timely manner, our business and operating results may suffer. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, we accept payments for many of our sales through credit and debit card transactions, which are handled through a third-party payment processor. As a result, we are subject to a number of
risks related to credit and debit card payments, including that we pay interchange and other fees, which may increase over time and could require us to either increase the prices we charge for our
products or experience an increase in our costs and expenses. In addition, as part of the payment processing process, we transmit our patients' and clinicians' credit and debit card information to our
third-party payment processor. We may in the future become subject to lawsuits or other proceedings for purportedly fraudulent transactions arising out of the actual or alleged theft of our patients'
credit or debit card information if the security of our third-party credit card payment processor is breached. We and our third-party credit card payment processor are also subject to payment card
association operating rules, certification requirements and rules governing electronic funds transfers, which could
change or be reinterpreted to make it difficult or impossible for us to comply. If we or our third-party credit card payment processor fail to comply with these rules or requirements, we may be
subject to fines and higher transaction fees and lose our ability to accept credit and debit card payments from our patients, and there may be an adverse impact on our business. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We have no experience selling our products outside of the United States and cannot predict if we
will be successful in achieving adoption of our products and revenue growth outside of the United States in a timely manner or at all. If we commercialize any products outside of the United States, a
variety of risks associated with international operations could impact our strategy and adversely affect our future growth.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We expect that we would be subject to additional risks related to entering into international markets,
including:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> difficulty successfully training patients and physicians on using our products; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>25</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=30,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=24672,FOLIO='25',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;44',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_dc12201_1_26"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> difficulty hiring a qualified direct-sales force or finding and entering into commercially-acceptable agreements with suitable
third-parties to market our products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> reduced protection for intellectual property rights; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> unexpected changes in tariffs, trade barriers and regulatory requirements; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> economic weakness, including inflation, or political instability in particular foreign economies and markets; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> compliance with tax, employment, immigration and labor laws for employees living or traveling abroad; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> foreign taxes, including withholding of payroll taxes; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> foreign currency fluctuations, which could result in increased operating expenses and reduced revenues, and other obligations incident
to doing business in another country; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> workforce uncertainty in countries where labor unrest is more common than in the United States; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> international regulators and third-party payers may require additional clinical studies prior to approving or allowing reimbursement
for our products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> disadvantages of competing against companies from countries that are not subject to U.S. laws and regulations, including the U.S.
Foreign Corrupt Practices Act, regulations of the U.S. Office of Foreign Assets Controls, and U.S. anti-money laundering regulations, as well as exposure of our foreign operations to liability under
these regulatory regimes; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> business interruptions resulting from geopolitical actions, including war and terrorism, or natural disasters including earthquakes,
typhoons, floods and fires. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
we experience any of these risks, our strategy to expand internationally could be impacted and our future growth could be adversely affected. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our employees, independent contractors, consultants, collaborators and suppliers may engage in
misconduct or other improper activities, including noncompliance with regulatory standards and requirements and insider trading.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are exposed to the risk that our employees and other third parties may engage in fraudulent conduct or other illegal activity. Misconduct by
employees and other third parties could include intentional, reckless and/or negligent conduct or disclosure of unauthorized activities to us that violate FDA regulations, including those laws
requiring the reporting of true, complete and accurate information to the FDA, manufacturing standards, federal and state healthcare fraud and abuse laws and regulations, or laws that require the
reporting of financial information or data accurately. In particular, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws intended to prevent fraud,
kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer
incentive programs and other business arrangements. Activities subject to these laws also involve the improper use of information obtained in the course of clinical trials, which could result in
regulatory sanctions and serious harm to our reputation. It is not always </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>26</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=31,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=389209,FOLIO='26',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;44',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_dc12201_1_27"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>possible
to identify and deter employee and other third-party misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks
or
losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws. If any such actions are instituted against us, and
we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant civil, criminal and
administrative penalties, damages, monetary fines, disgorgement, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational
harm, diminished profits and future earnings and curtailment or restructuring of our operations, any of which could adversely affect our ability to operate. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


A reclassification of our independent contractor home trainers by tax authorities could require us
to pay retroactive taxes and penalties, which could have a material adverse effect on our business, financial condition and operating results.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We contract with over 300 licensed healthcare practitioners as home trainers, who educate our patients on the proper use of our solutions. Because we
consider these licensed practitioners to be independent contractors, as opposed to employees, we do not withhold federal or state income or other employment related taxes or make federal or state
unemployment tax or Federal Insurance Contributions Act payments. Our contracts with these independent contractors obligate them to pay these taxes. The classification of healthcare practitioners as
independent contractors depends on the facts and circumstances of the relationship. In the event federal or state taxing authorities determine that the healthcare practitioners are employees, our
business may be adversely affected and subject to retroactive taxes and penalties. Under current federal tax law, a safe harbor from reclassification, and consequently retroactive taxes and penalties,
is available if our current treatment is consistent with a long-standing practice of a significant segment of our industry and if we meet certain other requirements. If challenged, we may not prevail
in demonstrating the applicability of the safe harbor to our operations. Further, interested persons have recently proposed to eliminate the safe harbor and may do so again in the future. If such
proposals are reintroduced and passed by Congress, they could impact our classification of healthcare practitioners as independent contractors, which could have a material adverse effect on our
business, financial condition and results of operations. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Relating to Government Regulation  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We are subject to extensive federal and state regulation, and if we fail to comply with applicable
regulations, we could suffer severe criminal or civil sanctions or be required to make significant changes to our operations that could adversely affect our business, financial condition and operating
results.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The federal government and all states in which we currently operate regulate various aspects of our business. Our operations also are subject to
state laws governing, among other things, distribution of medical equipment and certain types of home health activities, and we are required to obtain and maintain licenses in each state to act as a
durable medical equipment supplier. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As
a healthcare provider participating in governmental healthcare programs, we are subject to laws directed at preventing fraud and abuse, which subject our marketing, billing, documentation and other
practices to government scrutiny. To ensure compliance with Medicare, Medicaid and other regulations, government agencies or their contractors often conduct routine audits and request customer records
and other documents to support our claims submitted for payment of services rendered. Government agencies or their contractors also periodically open investigations and obtain information from
healthcare providers. Violations of federal and state regulations can result in severe criminal, civil and administrative penalties and sanctions, including debarment, suspension or exclusion </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>27</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=32,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=168599,FOLIO='27',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;44',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_dc12201_1_28"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>from
Medicare, Medicaid and other government reimbursement programs, any of which would have a material adverse effect on our business. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Changes
in healthcare laws and regulations and new interpretations of existing laws and regulations may affect permissible activities, the relative costs associated with doing business, and
reimbursement amounts paid by federal, state and other third-party payers. There have been and will continue to be regulatory initiatives affecting our business and we cannot predict the extent to
which future legislation and regulatory changes could have a material adverse effect on our business, financial condition and results of operations. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We are subject to significant regulation by numerous government agencies, including the FDA. We
cannot market or commercially distribute our products without obtaining and maintaining necessary regulatory clearances or approvals.  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our products are medical devices subject to extensive regulation in the United States. The FDA and other U.S. and foreign governmental agencies
regulate, among other things, with respect to medical devices:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> design, development and manufacturing; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> testing, labeling, content and language of instructions for use and storage; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> clinical trials; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> product safety; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> marketing, sales and distribution; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> unique device identifiers; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> premarket clearance and approval; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> record keeping procedures; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> advertising and promotion; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> recalls and field safety corrective actions; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> post-market surveillance, including reporting of deaths or serious injuries and malfunctions that, if they were to recur, could lead
to death or serious injury; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> post-market approval studies; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> product import and export. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Unless
an exemption applies, each medical device we seek to distribute commercially in the United States requires marketing authorization from the FDA prior to distribution. The two primary types of
FDA marketing authorization applicable to a device are premarket notification, also called 510(k) clearance, and premarket approval. The type of marketing authorization is generally linked to the
classification of the device. When a 510(k) clearance is required, we must submit a premarket notification to the FDA demonstrating that our proposed device is "substantially equivalent" to a </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>28</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=33,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=917516,FOLIO='28',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;44',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_dc12201_1_29"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>previously
cleared and legally marketed 510(k) device or a device that was in commercial distribution before May&nbsp;28, 1976 for which the FDA has not yet called for the submission of a premarket
approval application, which is commonly known as the "predicate device." The FDA may require further information, including clinical data, to make a determination regarding substantial equivalence. A
premarket approval application must be submitted to the FDA if the device cannot be cleared through the 510(k) process. The premarket approval application process is much more demanding than the
510(k) premarket notification process and requires the payment of significant user fees. A premarket approval application must be supported by valid scientific evidence, which typically requires
extensive data to demonstrate the reasonable assurance of safety and effectiveness of the device. The approval process involves FDA review of information, including but not limited to, technical,
preclinical (bench and/or animal), clinical trials, manufacturing and labeling. The FDA clearance and approval process frequently takes longer than anticipated due to increasing FDA demands for
clarification of data or new data requirements. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
there is no predicate device that would permit the device to be cleared through the 510(k) path, then the FDA will automatically classify the device as a Class&nbsp;III high risk premarket
approval device. In the event of this possibility, the sponsor can request a risk-based classification determination for the device in accordance with the de novo process, which is a route to market
for novel medical devices that are low to moderate risk and are not substantially equivalent to a predicate device. A company files a de novo request when it does not have a predicate to which it can
claim substantial equivalence. The FDA reviews the request for a de novo decision and grants or denies the request. If the request is granted, the FDA issues an order indicating that the device may
legally be marketed and the device is classified as a Class&nbsp;I or II device, depending on risk. Once a device is classified through the de novo process, future devices from the company or a
competitor may use that device as a 510(k) predicate. The advantage of the de novo process is that it generally requires less data than a premarket approval. The disadvantage is that it may require
more data than a 510(k) and most often will include human clinical data. The FDA is increasingly moving devices with slightly different proposed indication statements or different technological
features off the 510(k) path and on to the de novo path resulting in more time and expense for the company. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Both
the 510(k) and premarket approval processes can be expensive and lengthy and require the payment of significant fees, unless an exemption applies. The FDA's 510(k) clearance process usually takes
from approximately three to 12&nbsp;months, but may take longer. The process of obtaining a premarket approval is much more costly and uncertain than the 510(k) clearance process and generally takes
from approximately one to five years, or longer, from the time the application is submitted to the FDA until an approval is obtained. The process of obtaining regulatory clearances or approvals to
market a medical device can be costly and time consuming, and we may not be able to obtain these clearances or approvals on a timely basis, if at all. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
the United States, our currently commercialized products are marketed pursuant to premarket clearance under Section&nbsp;510(k) of the Federal Food, Drug and Cosmetic Act, or FDCA. If the FDA
requires us to go through a lengthier, more rigorous examination for future products or modifications to existing products than we had expected, our product introductions or modifications could be
delayed or canceled, which could cause our sales to decline. In addition, the FDA may determine that future products will require the more costly, lengthy and uncertain premarket approval process.
Although we do not currently market any devices under a premarket approval, the FDA may demand that we obtain a premarket approval prior to marketing certain of our future products. In addition, if
the FDA disagrees with our determination that a product we currently market is subject to an exemption from premarket review, the FDA may require us to submit a 510(k) or premarket approval
application in order to continue marketing the product. Further, even with respect to those future </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>29</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=34,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1047886,FOLIO='29',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;44',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_dc12201_1_30"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>products
where a premarket approval is not required, we cannot assure you that we will be able to obtain the 510(k) clearances required with respect to those products. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
FDA can delay, limit or deny clearance or approval of a device for many reasons, including:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> for non-premarket approval devices, failure of the applicant to demonstrate to the FDA's satisfaction that its products meet the
definition of "substantial equivalence" or meet the standard for the FDA to grant a petition for de novo classification; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> failure of the applicant to demonstrate that there is reasonable assurance that the medical device is safe or effective under the
conditions of use prescribed, recommended or suggested in the proposed labeling; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> insufficient data from the preclinical studies and clinical trials; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the manufacturing processes, methods, controls or facilities used for the manufacture, processing, packing or installation of the
device do not meet applicable requirements. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any
delay in, or failure to receive or maintain, clearances or approvals for our products could prevent us from generating revenue from these products or achieving profitability. Additionally, the FDA
and other governmental authorities have broad enforcement powers. Our failure to comply with applicable regulatory requirements could lead governmental authorities or a court to take action against
us, including, but not limited to:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> issuing untitled (notice of violation) letters or public warning letters to us; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> imposing fines and penalties on us; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> obtaining an injunction or administrative detention preventing us from manufacturing or selling our products; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> seizing products to prevent sale or transport or export; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> bringing civil or criminal charges against us; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> recalling our products or mandating a product correction; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> detaining our products at U.S. Customs; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> delaying the introduction of our products into the market; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> delaying pending requests for clearance or approval of new uses or modifications to our existing products; and </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> withdrawing or denying approvals or clearances for our products. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
we fail to obtain and maintain regulatory clearances or approvals, our ability to sell our products and generate revenue will be materially harmed. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, the FDA may change its clearance and approval policies, adopt additional regulations or revise existing regulations, or take other actions which may prevent or delay approval or clearance
of </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>30</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=35,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=296963,FOLIO='30',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;44',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_dc12201_1_31"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>our
products under development or impact our ability to modify our currently approved or cleared products on a timely basis. For example, in response to industry and healthcare provider concerns
regarding the predictability, consistency and rigor of the 510(k) regulatory pathway, the FDA published new guidance on the 510(k) regulatory pathway in 2014, which alters the manner in which the
510(k)
regulatory pathway is administered and interpreted. The FDA intends these reform actions to improve the efficiency and transparency of the clearance process, as well as bolster patient safety. This
new guidance could impose additional regulatory requirements upon us which could delay our ability to obtain new 510(k) clearances, increase the costs of compliance or restrict our ability to maintain
our current clearances. In addition, as part of the Food and Drug Administration Safety and Innovation Act, Congress reauthorized the Medical Device User Fee Amendments with various FDA performance
goal commitments and enacted several "Medical Device Regulatory Improvements" and miscellaneous reforms which are further intended to clarify and improve medical device regulation both pre- and
post-market. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Medical
devices may only be promoted and sold for the indications for which they are approved or cleared. In addition, even if the FDA has approved or cleared a product, it can take action affecting
such product approvals or clearances if serious safety or other problems develop in the marketplace. Delays in obtaining clearances or approvals could adversely affect our ability to introduce new
products or modifications to our existing products in a timely manner, which would delay or prevent commercial sales of our products. Additionally, the FDA and other regulatory authorities have broad
enforcement powers. Regulatory enforcement or inquiries, or other increased scrutiny on us, could affect the perceived safety and efficacy of our products and dissuade patients and clinicians from
using our products. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we modify our FDA cleared devices, we may need to seek additional clearances or approvals, which,
if not granted, would prevent us from selling our modified products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The FDA regulations require the submission and clearance of a new 510(k) premarket notification, or possibly, premarket approval, for significant
changes or modifications made in the design, components, method of manufacturer and intended use of a device including changes or modifications to a 510(k)-cleared device that could significantly
affect the device's safety or effectiveness, or would constitute a major change or modification in the device's intended use. The FDA requires each manufacturer to make this determination, but the FDA
may review any manufacturer's decision. The FDA may not agree with our decisions regarding whether new clearances or approvals are necessary. We have modified some of our 510(k) cleared products, and
have determined based on our review of the applicable FDA guidance that in certain instances new 510(k) clearances or premarket approval are not required. If the FDA disagrees with our determination
and requires us to submit new 510(k) notifications or premarket approval for modifications to our previously cleared products for which we have concluded that new clearances or approvals are
unnecessary, we may be required to cease marketing or to recall the modified product until we obtain clearance or approval, and we may be subject to significant regulatory fines or penalties. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Furthermore,
the FDA's ongoing review of the 510(k) program may make it more difficult for us to make modifications to our previously cleared products, either by imposing more strict requirements on
when a manufacturer must submit a new 510(k) for a modification to a previously cleared product, or by applying more onerous review criteria to such submissions. If the FDA requires us to cease
marketing a modified device until we obtain a new 510(k) clearance or premarket approval, our business, financial condition, operating results and future growth prospects could be materially
adversely affected. Further in this situation, our products could be subject to recall. Any recall or FDA requirement that we seek additional approvals or clearances could result in significant
delays, fines, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>31</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=36,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=183,FOLIO='31',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;44',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_dc12201_1_32"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>increased
costs associated with modification of a product, loss of revenue and potential operating restrictions imposed by the FDA. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The misuse or off-label use of our products may harm our image in the marketplace, result in
injuries that lead to product liability suits or result in costly investigations, fines or sanctions by regulatory bodies if we are deemed to have engaged in the promotion of these uses, any of which
could be costly to our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The products we currently market have been cleared by the FDA for specific treatments. We train our marketing and direct sales force to not promote
our products for uses outside of the FDA-cleared indications for use, known as "off-label uses." We cannot, however, prevent a physician from using our products off-label, when in the physician's
independent professional medical judgment he or she deems it appropriate. The FDA does not restrict or regulate a physician's choice of treatment. There may be increased risk of injury to patients if
physicians use our products off-label. Furthermore, the use of our products for indications other than those cleared by the governing regulatory body may not effectively treat such conditions, which
could harm our reputation in the marketplace among physicians and patients. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
the FDA determines that our promotional materials or training constitute promotion of an off-label use, it could request that we modify our training or promotional materials or subject us to
regulatory or enforcement actions, including the issuance of an untitled letter, a warning letter, injunction, seizure, civil fine or criminal penalties. It is also possible that other federal, state
or foreign enforcement authorities might take action if they consider our business activities to constitute promotion of an off-label use, which could result in significant penalties, including, but
not limited to, criminal, civil and administrative penalties, damages, fines, disgorgement, exclusion from participation in government healthcare programs, and the curtailment of our operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, physicians may misuse our products or use improper techniques, potentially leading to injury and an increased risk of product liability. If our products are misused or used with improper
technique, we may become subject to costly litigation by our clinicians or their patients. As noted above, we can be subject to lawsuits, whether or not our product is proven to be defective and
whether or not our employees have adequately trained the physicians. Similarly, in an effort to decrease costs, physicians may also reuse those of our products that are intended for a single use or
may purchase reprocessed products from third-party reprocessors in lieu of purchasing new products from us, which could result in product failure and liability. As described immediately above, product
liability claims could divert management's attention from our core business, be expensive to defend and result in sizeable damage awards against us that may not be covered by insurance. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our products may cause or contribute to adverse medical events that we are required to report to the
FDA, and if we fail to do so, we would be subject to sanctions that would materially harm our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our marketed products are subject to Medical Device Reporting, or MDR, obligations, which require that we report to the FDA any incident in which our
products may have caused or contributed to a death or serious injury, or in which our products malfunctioned and, if the malfunction were to recur, it could likely cause or contribute to a death or
serious injury. The timing of our obligation to report under the MDR regulations is triggered by the date we become aware of the adverse event as well as the nature of the event. We may fail to report
adverse events of which we become aware within the prescribed timeframe. We may also fail to recognize that we have become aware of a reportable adverse event, especially if it is not reported to us
as an adverse event or if it is an adverse event that is unexpected or removed in time from the use of our products. If we fail to comply with our reporting obligations, the FDA could take action
including warning letters, untitled letters, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>32</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=37,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=349113,FOLIO='32',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;44',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<A NAME="page_dc12201_1_33"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>administrative
actions, criminal prosecution, imposition of civil monetary penalties, revocation of our device clearances, seizure of our products, or delay in clearance of future products. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our products may in the future be subject to product recalls. A recall of our products, either
voluntarily or at the direction of the FDA or another governmental authority, or the discovery of serious safety issues with our products, could have a significant adverse impact on us.  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The FDA and similar foreign governmental authorities have the authority to require the recall of commercialized products in the event of material
deficiencies or defects in their design or manufacture. The FDA's authority to require a recall must be based on a finding that there is reasonable probability that the device would cause serious,
adverse health consequences or death. We may also choose to voluntarily recall a product if any material deficiency is found. A government-mandated or voluntary recall could occur as a result of an
unacceptable risk to health,
component failures, malfunctions, manufacturing errors, design or labeling defects or other deficiencies and issues. Recalls of any of our products would divert managerial and financial resources and
have an adverse effect on our reputation and business, which could impair our ability to produce our products in a cost-effective and timely manner in order to meet our patients' demands. We may also
be subject to liability claims, be required to bear other costs, or take other actions that may have a negative impact on our future sales and our ability to generate profits. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Companies
are required to maintain certain records of recalls and corrections, even if they are not reportable to the FDA. We may initiate voluntary recalls or corrections for our products in the
future that we determine do not require notification of the FDA. If the FDA disagrees with our determinations, they could require us to report those actions as recalls and we may be subject to
enforcement action. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we or our component manufacturers fail to comply with the FDA's Quality System Regulation, our
manufacturing operations could be interrupted, and our product sales and operating results could suffer.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We and many of our component manufacturers are required to comply with the FDA's Quality System Regulation, or QSR, which covers the procedures and
documentation of the design, testing, production, control, quality assurance, labeling, packaging, sterilization, storage and shipping of our devices. The FDA audits compliance with the QSR through
periodic announced and unannounced inspections of manufacturing and other facilities. We and our component manufacturers have been, and anticipate in the future being, subject to such inspections. We
cannot provide assurance that any future inspection will not result in adverse findings with respect to our QSR compliance. If our manufacturing facilities or those of any of our component
manufacturers or suppliers are found to be in violation of applicable laws and regulations, or we or our manufacturers or suppliers fail to take satisfactory corrective action in response to an
adverse inspection, the FDA could take enforcement action, including any of the following sanctions:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> untitled letters, warning letters, fines, injunctions, consent decrees and civil penalties; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> customer notifications or repair, replacement, refunds, recall, detention or seizure of our products; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> operating restrictions or partial suspension or total shutdown of production; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> refusing or delaying our requests for 510(k) clearance or premarket approval of new products or modified products; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> withdrawing 510(k) clearances or premarket approvals that have already been granted; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> refusal to grant export approval for our products; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> criminal prosecution. </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>33</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=38,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=102661,FOLIO='33',FILE='DISK131:[15ZBY1.15ZBY12201]DC12201A.;44',USER='CHE105948',CD=';7-JUN-2016;13:48' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_de12201_1_34"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any of these sanctions could adversely affect our business, financial condition and results of operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
we begin selling our products outside the United States, our products and operations would also be required to comply with standards set by industrial standards bodies, such as the International
Organization for Standardization, or ISO. Foreign regulatory bodies may evaluate our products or the testing that our products undergo against these standards. The specific standards, types of
evaluation and scope of review differ among foreign regulatory bodies. If we fail to adequately comply with any of these standards, a foreign regulatory body may take adverse actions similar to those
within the power of the FDA. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any
of these actions could prevent us from marketing, distributing or selling our products and would likely harm our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If clinical studies of our future products do not produce results necessary to support regulatory
clearance or approval in the United States or, with respect to our current or future products, elsewhere, we will be unable to expand the indications for or commercialize these products.  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We will likely need to conduct additional clinical studies in the future to support new indications for our products or for clearances of new product
lines, or for the approval of the use of our products in some foreign countries. Clinical testing can take many years, can be expensive and carries uncertain outcomes. The initiation and completion of
any of these studies may be prevented, delayed, or halted for numerous reasons. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Clinical
failure can occur at any stage of testing. Our clinical studies may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical
and non-clinical testing in addition to those we have planned. Our failure to adequately demonstrate the safety and efficacy of any of our devices would prevent receipt of regulatory clearance or
approval and, ultimately, the commercialization of that device or indication for use. Even if our future products are cleared in the United States, commercialization of our products in foreign
countries would require approval by regulatory authorities in those countries. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different
from, and greater than, those in the United States, including additional preclinical studies or clinical trials. Any of these occurrences could have an adverse impact on our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If the third parties on which we rely to conduct our clinical trials and to assist us with
pre-clinical development do not perform as contractually required or expected, we may not be able to obtain regulatory clearance or approval for or commercialize our products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We often must rely on third parties, such as contract research organizations, medical institutions, clinical investigators and contract laboratories
to conduct our clinical trials. If these third parties do not successfully carry out their contractual duties or regulatory obligations or meet expected deadlines, if these third parties need to be
replaced, or if the quality or accuracy of the data they obtain is compromised due to the failure to adhere to our clinical protocols or regulatory requirements or for other reasons, our pre-clinical
development activities or clinical trials may be extended, delayed, suspended or terminated, and we may not be able to obtain regulatory approval for, or successfully commercialize, our products on a
timely basis, if at all, and our business, operating results and prospects may be adversely affected. Furthermore, our third-party clinical trial investigators may be delayed in conducting our
clinical trials for reasons outside of their control. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>34</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=39,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=894396,FOLIO='34',FILE='DISK131:[15ZBY1.15ZBY12201]DE12201A.;32',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_de12201_1_35"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Future regulatory actions may adversely affect our ability to sell our products profitably.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>From time to time, legislation is drafted and introduced that could significantly change the statutory provisions governing the clearance or
approval, manufacture and marketing of a medical device. In addition, FDA and other regulations and guidance are often revised or reinterpreted in ways that may significantly affect our business and
our products. It is impossible to predict whether legislative changes will be enacted or regulations, guidance or interpretations changed, and what the impact of such changes, if any, may be. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Healthcare regulatory reform may affect our ability to sell our products
profitably</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>.  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In the United States, the legislative landscape, particularly as it relates to healthcare regulation and reimbursement coverage, continues to evolve.
In March 2010, the Patient Protection and Affordable Care Act and Health Care and Education Reconciliation Act, which we refer to as the Patient Protection and Affordable Care Act, was passed, which
has the potential to substantially change healthcare financing by both governmental and private insurers, and significantly impact the U.S. medical device industry. The Patient Protection and
Affordable Care Act, among other things, imposes a new excise tax, which began in 2013, on entities that manufacture, produce or import medical devices in an amount equal to 2.3% of the price for
which such devices are sold in the United States. While we believe that our current products are exempt from this tax under an exemption for retail products, if our belief is determined to be
incorrect, we could be subject to significant tax liabilities and penalties, which could have a material adverse effect on our results of operations and cash position. Moreover, products that we
introduce in the future could be subject to this tax. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, the Patient Protection and Affordable Care Act also expands the round two of competitive bidding to a total of 91 competitive bidding areas, and by 2016, the process must be nationalized
or prices in non-competitive bidding areas must be adjusted to match competitive bidding prices. Other legislative changes have been proposed and adopted in the United States since the Patient
Protection and Affordable Care Act was enacted. On August&nbsp;2, 2011, the Budget Control Act of 2011 among other things, created measures for spending reductions by Congress. A Joint Select
Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering
the legislation's automatic reduction to several government programs. This includes aggregate reductions of Medicare
payments to providers up to 2% per fiscal year, which went into effect on April&nbsp;1, 2013. On January&nbsp;2, 2013, President Obama signed into law the American Taxpayer Relief Act of 2012
which, among other things, further reduced Medicare payments to certain providers, including physicians, hospitals, imaging centers and cancer treatment centers, and increased the statute of
limitations period for the government to recover overpayments to providers from three to five years. We expect that additional state and federal healthcare reform measures will be adopted in the
future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for our products or additional
pricing pressures. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


While our products are not currently subject to the competitive bidding process under Medicare, if
our products were to become subject to such process in the future, it could negatively affect our business and financial condition.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 required the Secretary of Health and Human Services to establish and
implement programs under which competitive acquisition areas are established throughout the United States for purposes of awarding contracts for the furnishing of competitively priced items of durable
medical equipment. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=40,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1036734,FOLIO='35',FILE='DISK131:[15ZBY1.15ZBY12201]DE12201A.;32',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_de12201_1_36"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>CMS,
the agency responsible for administering the Medicare program, conducts a competition for each competitive acquisition area under which providers submit bids to supply certain covered items of
durable medical equipment. Successful bidders must meet certain program quality standards in order to be awarded a contract and only successful bidders can supply the covered items to Medicare
beneficiaries in the acquisition area. There are, however, regulations in place that allow non-contracted providers to continue to provide products and services to their existing customers at the new
competitive bidding payment amounts. The contracts are expected to be re-bid every three years. CMS is required to award contracts to multiple entities submitting bids in each area for an item or
service, but has the authority to limit the number of contractors in a competitive acquisition area to the number it determines to be necessary to meet projected demand. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Although
CMS concluded the bidding process for the first round of Metropolitan Statistical Areas in September 2007, in July 2008, Congress enacted Medicare Improvements for Patients and Providers Act
of 2008, which retroactively delayed the implementation of competitive bidding. Medicare Improvements for Patients and Providers Act of 2008 also reduced Medicare prices nationwide by 9.5% beginning
in 2009 for the product categories that were initially included in competitive bidding. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Patient Protection and Affordable Care Act legislation requires CMS to expand competitive bidding further to additional geographic markets or to use competitive bid pricing information to adjust
the payment amounts otherwise in effect for areas that are not competitive acquisition areas by January&nbsp;1, 2016. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Although
we continue to monitor developments regarding the implementation of the competitive bidding program, we cannot predict the outcome of the competitive bidding program on our business when
fully implemented, nor the Medicare payment rates that will be in effect in future years for the items subjected to competitive bidding, including our products. We expect that payment rates will
continue to fluctuate, and a large negative payment adjustment could adversely affect our business, financial conditions and results of operations. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We are subject to additional federal, state and foreign laws and regulations relating to our
healthcare business; our failure to comply with those laws could have an adverse impact on our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are subject to healthcare fraud and abuse regulation and enforcement by federal and state governments, which could adversely impact our business.
Healthcare fraud and abuse and health information privacy and security laws potentially applicable to our operations include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the federal Anti-Kickback Statute, which applies to our marketing practices, educational programs, pricing policies and relationships
with healthcare providers, by prohibiting, among other things, soliciting, receiving, offering or providing remuneration, whether directly or indirectly and overtly or covertly, intended to induce the
referral of an individual for (i)&nbsp;the furnishing or the arranging for the furnishing of items or services reimbursable under a federal healthcare program, such as Medicare or Medicaid; or
(ii)&nbsp;the purchase, lease or order of, or the arrangement or recommendation of the purchasing, leasing or ordering of, of an item or service reimbursable under a federal healthcare program. A
person or entity does not need to have actual knowledge of this statute or specific intent to violate it to have committed a violation; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> federal civil and criminal false claims laws and civil monetary penalty laws, including civil whistleblower or qui tam actions that
prohibit, among other things, knowingly presenting, or causing to be presented, claims for payment or approval to the federal government that are false or fraudulent, knowingly making a false
statement material to an obligation to </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>36</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=41,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=797948,FOLIO='36',FILE='DISK131:[15ZBY1.15ZBY12201]DE12201A.;32',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_de12201_1_37"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>pay
or transmit money or property to the federal government, knowingly concealing or knowingly and improperly avoiding or decreasing an obligation to pay or transmit money or property to the federal
government or knowingly offering remuneration to influence a Medicare or Medicaid beneficiary's selection of health care providers. The government may assert that a claim, including items or services
resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the false claims statutes; </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> HIPAA and its implementing regulations, which created federal criminal laws that prohibit, among other things, executing a scheme to
defraud any healthcare benefit program or making false statements relating to healthcare matters; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, also imposes certain regulatory and
contractual requirements regarding the privacy, security and transmission of individually identifiable health information; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> federal Open Payments (the Physician Payments Sunshine Act) requirements imposed by the Patient Protection and Affordable Care Act on
device manufacturers regarding certain "transfers of value" made or distributed to physicians and teaching hospitals. Failure to submit required information may result in civil monetary penalties of
up to an aggregate of $150,000 per year (or up to an aggregate of $1.0&nbsp;million per year for "knowing failures"), for all payments, transfers of value or ownership or investment interests that
are not timely, accurately, and completely reported in an annual submission. The period between August&nbsp;1, 2013 and December&nbsp;31, 2013 was the first reporting period, and manufacturers
were required to report aggregate payment data by March&nbsp;31, 2014, and to report detailed payment data and submit legal attestation to the accuracy of such data by June&nbsp;30, 2014.
Thereafter, manufacturers must submit reports by the 90th&nbsp;day of each subsequent calendar year; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially
harm consumers; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> state law equivalents of each of the above federal laws, such as anti-kickback and false claims laws that may apply to items or
services reimbursed by any third-party payer, including commercial insurers; state laws that require device companies to comply with the industry's voluntary compliance guidelines and the relevant
compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to healthcare providers; state laws that require device manufacturers to report information
related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures; and state laws governing the privacy and security of certain health
information, many of which differ from each other in significant ways and often are not preempted by HIPAA. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
risk of our being found in violation of these laws and regulations is increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, and their
provisions are open to a variety of interpretations. We are unable to predict what additional federal or state legislation or regulatory initiatives may be enacted in the future regarding our business
or the healthcare industry in general, or what effect such legislation or regulations may have on us. Federal or state governments may impose additional restrictions or adopt interpretations of
existing laws that could have a material adverse effect on us. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>37</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=42,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=691094,FOLIO='37',FILE='DISK131:[15ZBY1.15ZBY12201]DE12201A.;32',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_de12201_1_38"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Because
of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available under such laws, it is possible that some of our business activities, including certain
sales and marketing practices and financial arrangements, including the provision of stock options as partial compensation for consulting services, with physicians, some of whom use or purchase our
products, and other customers, could be subject to challenge under one or more of such laws. Any action against us for violation of these laws, even if we successfully defend against it, could cause
us to incur significant legal expenses and divert our management's attention from the operation of our business. If our operations are found to be in violation of any of the laws described above or
any other governmental regulations that apply to us, we may be subject to penalties, including civil and criminal penalties, damages, fines, exclusion from governmental healthcare programs,
disgorgement, contractual damages, reputational harm, diminished profits and future earnings, and the curtailment or restructuring of our operations, any of which could adversely impact our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Failure to comply with regulations affecting the transmission, security and privacy of health
information could result in significant penalties.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Numerous federal and state laws and regulations, including HIPAA and the Health Information Technology for Economic and Clinical Health Act, or the
HITECH Act, govern the collection, dissemination, security, use and confidentiality of patient-identifiable health information. HIPAA and the HITECH Act require us to comply with standards for the use
and disclosure of health information within our company and with third parties. The Privacy Standards and Security Standards under HIPAA establish a set of basic national privacy and security
standards for the protection of individually identifiable health information by health plans, healthcare clearinghouses and certain healthcare providers, referred to as covered entities, and the
business associates with whom such covered entities contract for services. Notably, whereas HIPAA previously directly regulated only these covered entities, the HITECH Act, which was signed into law
as part of the stimulus package in February 2009, makes certain of HIPAA's privacy and security standards also directly applicable to covered entities' business associates. As a result, both covered
entities and business associates are now subject to significant civil and criminal penalties for failure to comply with Privacy Standards and Security Standards. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>HIPAA
and the HITECH Act also include standards for common healthcare electronic transactions and code sets, such as claims information, plan eligibility, payment information and the use of electronic
signatures, and privacy and electronic security of individually identifiable health information. Covered entities, such as healthcare providers, are required to conform to such transaction set
standards pursuant to HIPAA. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>HIPAA
requires healthcare providers like us to develop and maintain policies and procedures with respect to protected health information that is used or disclosed, including the adoption of
administrative, physical and technical safeguards to protect such information. The HITECH Act expands the notification requirement for breaches of patient-identifiable health information, restricts
certain disclosures and sales of patient-identifiable health information and provides a tiered system for civil monetary penalties for HIPAA violations. The HITECH Act also increased the civil and
criminal penalties that may be imposed against covered entities, business associates and possibly other persons and gave state attorneys general new authority to file civil actions for damages or
injunctions in federal courts to enforce the federal HIPAA laws and seek attorney fees and costs associated with pursuing federal civil actions. Additionally, certain states have adopted comparable
privacy and security laws and regulations, some of which may be more stringent than HIPAA. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
we do not comply with existing or new laws and regulations related to patient health information, we could be subject to criminal or civil sanctions. New health information standards, whether </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>38</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=43,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1034353,FOLIO='38',FILE='DISK131:[15ZBY1.15ZBY12201]DE12201A.;32',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_de12201_1_39"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>implemented
pursuant to HIPAA, the HITECH Act, congressional action or otherwise, could have a significant effect on the manner in which we handle healthcare related data and communicate with payors,
and the cost of complying with these standards could be significant. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
2013 final HITECH omnibus rule modifies the breach reporting standard in a manner that will likely make more data security incidents qualify as reportable breaches. Any liability from a failure to
comply with the requirements of HIPAA or the HITECH Act could adversely affect our financial condition. The costs of complying with privacy and security related legal and regulatory requirements are
burdensome and could have a material adverse effect on our results of operations. These new provisions, as modified, will be subject to interpretation by various courts and other governmental
authorities, thus creating potentially complex compliance issues for us, as well as our clients and strategic partners. In addition, we are unable to predict what changes to the HIPAA Privacy
Standards and Security Standards might be made in the future or how those changes could affect our business. Any new legislation or regulation in the area of privacy and security of personal
information, including personal health information, could also adversely affect our business operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Additionally,
the Federal Trade Commission has issued and several states have issued or are considering new regulations to require holders of certain types of personally identifiable information to
implement formal policies and programs to prevent, detect and mitigate the risk of identity theft and other unauthorized access to or use of such information. Further, the U.S. Congress and a number
of states have considered or are considering prohibitions or limitations on the disclosure of medical or other information to individuals or entities located outside of the United States. If we begin
selling our products outside the United States, we will need to comply with applicable laws in those jurisdictions that regulate the use and disclosure of individually identifiable information. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we fail to comply with state and federal fraud and abuse laws, including anti-kickback, false
claims and anti-inducement laws, we could face substantial penalties and our business, operations, and financial condition could be adversely affected.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The federal anti-kickback statute prohibits, among other things, knowingly and willfully offering, paying, soliciting or receiving remuneration,
whether directly or indirectly and overtly or covertly, to induce or in return for purchasing, leasing, ordering, or arranging for the purchase, lease or order of any healthcare item or service
reimbursable under Medicare, Medicaid, or other federal financed healthcare programs. The statutory exceptions and regulatory safe harbors protecting certain common activities from prosecution are
drawn narrowly, and any remuneration to or from a prescriber or purchaser of healthcare products or services may be subject to scrutiny if they do not qualify for an exception or safe harbor. Our
practices may not in all cases meet all of the criteria for safe harbor protection from anti-kickback liability. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Federal
false claims laws prohibit, in part, any person from knowingly presenting or causing to be presented a false claim for payment to the federal government, or knowingly making or causing to be
made a false statement to get a false claim paid. The majority of states also have statutes or regulations similar to the federal anti-kickback law and false claims laws, which apply to items or
services reimbursed under Medicaid and other state programs, or, in several states, apply regardless of payer. These false claims statutes allow any person to bring suit in the name of the government
alleging false and fraudulent claims presented to or paid by the government (or other violations of the statutes) and to share in any amounts paid by the entity to the government in fines or
settlement. Such suits, known as </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>qui tam</I></FONT><FONT COLOR="#3B5A6F" SIZE=2> actions, have increased significantly in the healthcare industry in recent years. Sanctions under these federal
and state laws may include civil monetary penalties, exclusion of a manufacturer's products from reimbursement under government programs, criminal fines and imprisonment. In addition, the recently
enacted Patient Protection and Affordable Care Act, among </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>39</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=44,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=341000,FOLIO='39',FILE='DISK131:[15ZBY1.15ZBY12201]DE12201A.;32',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_de12201_1_40"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>other
things, amends the intent requirement of the federal anti-kickback and criminal healthcare fraud statutes. A person or entity no longer needs to have actual knowledge of this statute or specific
intent to violate it. In addition, the Patient Protection and Affordable Care Act provides that the government may assert that a claim, including items or services resulting from a violation of the
federal anti-kickback statute constitutes a false or fraudulent claim for purposes of the false claims statutes. Because of the breadth of these laws and the narrowness of the safe harbors and
exceptions, it is possible that some of our business activities could be subject to challenge under one or more of such laws. Such a challenge, regardless of the outcome, could have a material adverse
effect on our business, business relationships, reputation, financial condition and results of operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, there has been a recent trend of increased federal and state regulation of payments made to physicians. The Patient Protection and Affordable Care Act imposes new reporting and disclosure
requirements on device and drug manufacturers for any "transfer of value" made or distributed to prescribers and other healthcare providers. Device and drug manufacturers will also be required to
report and disclose any investment interests held by physicians and their immediate family members during the preceding calendar year. Failure to submit required information may result in civil
monetary penalties of up to an aggregate of $150,000 per year (and up to an aggregate of $1.0&nbsp;million per year for "knowing failures to report"), for all payments, transfers of value or
ownership or investment interests not reported in an annual submission. As of August&nbsp;1, 2013, manufacturers are required to collect data and are required to submit their data reports to CMS by
the 90th&nbsp;day of each calendar year. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Certain
states mandate implementation of compliance programs and/or the tracking and reporting of gifts, compensation and other remuneration to physicians. The shifting compliance environment and the
need to build and maintain robust and expandable systems to comply with different compliance and/or reporting requirements in multiple jurisdictions increase the possibility that a healthcare company
many violate one or more of the requirements. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Federal Civil Monetary Penalties Law prohibits, in part, the offering or giving of remuneration to a Medicare or Medicaid beneficiary that the person knows or should know is likely to influence
the beneficiary's selection of a particular supplier of items or services reimbursable by a Federal or state governmental program. We sometimes offer customers various discounts and other financial
incentives in connection with the sales of our products. While it is our intent to comply with all applicable laws, the government may find that our marketing activities violate the Civil Monetary
Penalties Law. If we are found to be in noncompliance, we could be subject to civil money penalties of up to $10,000 for each wrongful act, assessment of three times the amount claimed for each item
or service and exclusion from the Federal healthcare programs. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform, especially in light of the lack of applicable precedent and
regulations. If our operations are found to be in violation of any of the laws described above or any other government regulations that apply to us, we may be subject to penalties, including civil and
criminal penalties, damages, fines and the curtailment, restructuring, or restricting of our operations. Any penalties, damages, fines, curtailment or restructuring or our operations could harm our
ability to operate our business and our financial results. Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal
expenses and divert our management's attention from operation of our business. Moreover, achieving and sustaining compliance with applicable federal and state fraud laws may prove costly. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>40</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=45,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=407257,FOLIO='40',FILE='DISK131:[15ZBY1.15ZBY12201]DE12201A.;32',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dg12201_1_41"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Failure to maintain the licenses and accreditations necessary to operate under our direct-to-patient
and -provider model would adversely affect our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>To continue operating our business under our direct-to-patient and -provider model, we must maintain our Durable Medical Equipment license and
certification from the Accreditation Commission for Health Care. In May 2008, we became a Durable, Medical Equipment, Prosthetics, Orthotics, and Supplies accredited Medicare supplier by the
Accreditation Commission for Health Care for our solutions and our Medicare accreditation must be renewed every three years through passage of an on-site inspection. Our current accreditation with
Medicare is due to expire in May 2017. In addition to maintaining our Durable Medical Equipment license and certification from the Accreditation Commission for Health Care, we also must maintain
certain state-required licenses. If we were found to be noncompliant, we could lose our licensure in that state. Losing our licensure could prohibit us from selling our current or future products to
patients in such state and our business, financial condition and results of operations could be adversely affected as a result of any such prohibition. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our products are currently made available to authorized users of the Department of Veterans Affairs
Federal Supply Schedule and if we were no longer eligible to sell our products through such channel, our business may be adversely affected.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For our products to be eligible for reimbursement by the Veterans Administration, we must participate in the Department of Veterans Affairs Federal
Supply Schedule pricing program, established by Section&nbsp;603 of the Veterans Health Care Act of 1992. To be eligible for this program, we must comply with additional laws and requirements
applicable to our operations and manufacturing processes. If we were to lose eligibility for reimbursement by the Veterans Administration, our business, financial condition and results of operations
could be adversely affected. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may be unable to obtain or maintain international regulatory registrations or approvals for our
current or future products and indications, which could adversely impact our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any future sales of our devices outside the United States are subject to foreign regulatory requirements that vary widely from country to country. In
addition, the FDA regulates exports of medical devices from the United States. Complying with international regulatory requirements can be an expensive and time-consuming process and approval is not
certain. The time required to obtain registration or approvals, if required by other countries, may be longer than that required for FDA clearance, and requirements for such registrations or approvals
may significantly differ from FDA requirements. In certain countries we intend to rely upon third-party distributors to obtain all required regulatory registrations and approvals, and these
distributors may be unable to obtain or maintain such registrations or approvals. Our distributors in these countries may also incur significant costs in attempting to obtain and in maintaining
foreign regulatory approvals or registrations, which could increase the difficulty of attracting and retaining qualified distributors. If these distributors experience delays in receiving necessary
registrations or approvals to market our products outside the United States, or if they fail to receive those registrations or approvals, we may be unable to market our products or enhancements in
certain international markets effectively, or at all. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our operations involve the use of hazardous and toxic materials, and we must comply with
environmental, health and safety laws and regulations, which can be expensive, and could have an adverse impact on our business.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our operations use or generate small volumes of hazardous or toxic materials. We are therefore subject to a variety of federal, state and local
regulations relating to the use, handling, storage, disposal and human exposure to hazardous and toxic materials. Liability under environmental laws can be joint and several and without regard to
comparative fault, and
environmental laws could become more stringent over time, imposing greater compliance costs and increasing risks and penalties </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>41</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=46,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=965425,FOLIO='41',FILE='DISK131:[15ZBY1.15ZBY12201]DG12201A.;27',USER='CHE108975',CD=';7-JUN-2016;11:53' -->
<A NAME="page_dg12201_1_42"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>associated
with violations, which could have an adverse impact on our business. There can be no assurance that violations of environmental, health and safety laws will not occur in the future as a
result of human error, accident, equipment failure or other causes. The failure to comply with past, present or future laws could result in the imposition of fines, third-party property damage and
personal injury claims, investigation and remediation costs, the suspension of production or a cessation of operations. We also expect that our operations will be affected by other new environmental
and health and safety laws and regulations on an ongoing basis. Although we cannot predict the ultimate impact of any such new laws and regulations, they will likely result in additional costs, and
may require us to change how we manufacture our products, which could have an adverse impact on our business. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to Our Financial Condition  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may need substantial additional funding beyond the proceeds of this offering and may be unable to
raise capital when needed, which could force us to delay or reduce our commercialization efforts or product development programs.  </I></B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>We believe the net proceeds from this offering, together with our existing cash and cash equivalents and revenues, will be sufficient to meet our
capital requirements and fund our operations indefinitely. However, we have based these estimates on assumptions that may prove to be incorrect, and we could spend our available financial resources
much faster than we currently expect. Any future funding requirements will depend on many factors, including:</FONT>

</P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> market acceptance of our products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the scope, rate of progress and cost of our clinical studies; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the cost of our research and development activities; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the cost of filing and prosecuting patent applications and defending and enforcing our patent or other intellectual property rights; </FONT>
<FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the cost of defending, in litigation or otherwise, any claims that we infringe third-party patents or other intellectual property
rights; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the cost and timing of additional regulatory clearances or approvals; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the cost and timing of establishing additional sales, marketing and distribution capabilities; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> costs associated with any product recall that may occur; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the effect of competing technological and market developments; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the extent to which we acquire or invest in products, technologies and businesses, although we currently have no commitments or
agreements relating to any of these types of transactions; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the costs of operating as a public company. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
we raise additional funds by issuing equity securities, our stockholders may experience dilution. Any future debt financing into which we enter may impose upon us covenants that restrict our
operations, including limitations on our ability to incur liens or additional debt, pay dividends, repurchase our </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>42</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=47,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=286466,FOLIO='42',FILE='DISK131:[15ZBY1.15ZBY12201]DG12201A.;27',USER='CHE108975',CD=';7-JUN-2016;11:53' -->
<A NAME="page_dg12201_1_43"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>common
stock, make certain investments and engage in certain merger, consolidation or asset sale transactions. Any debt financing or additional equity that we raise may contain terms that are not
favorable to us or our stockholders. If we raise additional funds through collaboration and licensing arrangements with third parties, it may be necessary to relinquish some rights to our technologies
or our products, or grant licenses on terms that are not favorable to us. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Furthermore,
we cannot be certain that additional funding will be available on acceptable terms, if at all. If we do not have, or are not able to obtain, sufficient funds, we may have to delay
development or commercialization of our products or license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize. We also may have to
reduce marketing, customer support or other resources devoted to our products or cease operations. Any of these factors could harm our operating results. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to Our Intellectual Property  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may not be able to protect our intellectual property rights throughout the world.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Filing, prosecuting and defending patents on products in all countries throughout the world would be prohibitively expensive, and our intellectual
property rights in some countries outside the United States may be less extensive than those in the United States. In addition, the laws of some foreign countries do not protect intellectual property
rights to the same extent as federal and state laws in the United States. For example, many foreign countries have compulsory licensing laws, under which a patent owner must grant licenses to third
parties. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our
inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products, and
further, competitors may export otherwise infringing products to territories where we have patent protection but enforcement rights are not as strong as those in the United States. These products may
compete with our products in jurisdictions where we do not have any issued patents, and our patent claims or other intellectual rights may not be effective or sufficient to prevent them from so
competing. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Many
companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries do not favor the
enforcement of patents and other intellectual property protection, which could make it difficult for us to stop the infringement of our patents generally. Proceedings to enforce our patent rights in
foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted
narrowly and our patent applications at risk of not issuing, and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other
remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial
advantage from the intellectual property that we develop or license. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The patent protection for our products may expire before we are able to maximize their commercial
value, which may subject us to increased competition and reduce or eliminate our opportunity to generate product revenues.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The patents for our products have varying expiration dates and, if these patents expire, we may be subject to increased competition and we may not be
able to recover our development costs or market any of our approved products profitably. For instance, our patents for our Flexitouch System will expire in 2017. Upon expiration of our patents, we may
be subject to increased competition and our </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>43</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=48,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=265260,FOLIO='43',FILE='DISK131:[15ZBY1.15ZBY12201]DG12201A.;27',USER='CHE108975',CD=';7-JUN-2016;11:53' -->
<A NAME="page_dg12201_1_44"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>opportunity
to establish or maintain product revenues could be substantially reduced or eliminated. Further, we may not have sufficient time to recover our development costs prior to the expiration of
our U.S. and foreign patents. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may not identify relevant patents or may incorrectly interpret the relevance, scope or expiration
of a patent, which may adversely affect our ability to develop and market our products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We cannot guarantee that any of our patent searches or analyses, including but not limited to the identification of relevant patents, the scope of
patent claims or the expiration of relevant patents, are complete or thorough, nor can we be certain that we have identified each and every patent and pending application in the United States and
abroad that is relevant to or necessary for the commercialization of our products in any jurisdiction. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
scope of a patent claim is determined by an interpretation of the law, the written disclosure in a patent and the patent family's prosecution history. Our interpretation of the relevance or the
scope of a patent or a pending application may be incorrect, which may negatively impact our ability to market our products. We may incorrectly determine that our products are not covered by a
third-party patent. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Many
patents may cover a marketed product, including but not limited to patents covering the product or portions thereof, methods of use or methods relating to the product, and production processes of
or for the product. The identification of all patents and their expiration dates relevant to the production and sale of a therapeutic product is extraordinarily complex and requires sophisticated
legal knowledge
in the relevant jurisdiction. It may be impossible to identify all patents in all jurisdictions relevant to a marketed product. Our determination of the expiration date of any patent in the United
States or abroad that we consider relevant may be incorrect, which may negatively impact our ability to develop and market our products. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Obtaining and maintaining our patent protection depends on compliance with various procedural,
documentary, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The United States Patent and Trademark Office, or USPTO, and various foreign governmental patent agencies require compliance with a number of
procedural, documentary, fee payment and other similar provisions during the patent prosecution process. Periodic maintenance fees, renewal fees, annuity fees and various other governmental fees on
any issued patent and/or pending patent applications are due to be paid to the USPTO and foreign patent agencies in several stages over the lifetime of a patent or patent application. We have systems
in place to remind us to pay these fees, and we employ an outside firm and rely on our outside counsel to pay these fees. While an inadvertent lapse may sometimes be cured by payment of a late fee or
by other means in accordance with the applicable rules, there are many situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or
complete loss of patent rights in the relevant jurisdiction. If we fail to maintain the patents and patent applications directed to our products, our competitors might be able to enter the market
earlier than should otherwise have been the case, which would have a material adverse effect on our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may become involved in lawsuits to protect our patents or other intellectual property rights,
which could be expensive, time-consuming and ultimately unsuccessful.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Competitors may infringe our patents or other intellectual property rights. To counter infringement or unauthorized use, we may be required to file
infringement claims, which can be expensive and time consuming. In addition, in an infringement proceeding, a court may decide that a patent of ours is not valid or is unenforceable, or may refuse to
stop the other party from using the technology at issue on </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>44</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=49,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=896191,FOLIO='44',FILE='DISK131:[15ZBY1.15ZBY12201]DG12201A.;27',USER='CHE108975',CD=';7-JUN-2016;11:53' -->
<A NAME="page_dg12201_1_45"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>the
grounds that our patents do not cover the technology in question. An adverse result in any litigation or defense proceedings could put one or more of our patents at risk of being invalidated or
interpreted narrowly and could put our patent applications at risk of not issuing. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Various
proceedings brought before the USPTO may be necessary to determine the priority of inventions with respect to our patents and patent applications or those of our current or future
collaborators. An unfavorable outcome could require us to cease using the technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if a prevailing party
does not offer us a license on terms that are acceptable to us. Litigation or other proceedings may fail and, even if successful, may result in substantial costs and distraction of our management and
other employees. We may not be able to prevent misappropriation of our proprietary rights, particularly in countries where the laws may not protect those rights as fully as in the United States. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Furthermore,
because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential and proprietary information
could be compromised by disclosure during this type of litigation. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If
securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Third-party claims of intellectual property infringement or misappropriation may adversely affect
our business and could prevent us from developing or commercializing our products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our commercial success depends in part on us not infringing the patents and proprietary rights of third parties. There is a substantial amount of
litigation, both within and outside the United States, involving patent and other intellectual property rights in the medical device industry, including patent infringement lawsuits, interferences,
oppositions, </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>ex-parte</I></FONT><FONT COLOR="#3B5A6F" SIZE=2> review and </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>inter partes</I></FONT><FONT COLOR="#3B5A6F" SIZE=2> reexamination and post-grant review
proceedings before the
USPTO and corresponding foreign patent offices. Numerous U.S. and foreign issued patents and pending patent applications owned by third parties exist in the fields in which we are developing and may
develop our products. As the medical device industry expands and more patents are issued, the risk increases that our products may be subject to claims of infringement of the patent rights of third
parties. If a third party claims that we infringe on their products or technology, we could face a number of issues, including:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> infringement and other intellectual property claims which, with or without merit, can be expensive and time-consuming to litigate and
can divert management's attention from our core business; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> substantial damages for past infringement, which we may have to pay if a court decides that our product infringes on a competitor's
patent; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> a court prohibiting us from selling or licensing our product, unless the patent holder licenses the patent to us; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> if a license is available from a patent holder, we may have to pay substantial royalties or grant cross licenses to our patents; and </FONT>
<FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> redesigning our processes so they do not infringe, which may not be possible or could require substantial funds and time. </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>45</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=50,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=112449,FOLIO='45',FILE='DISK131:[15ZBY1.15ZBY12201]DG12201A.;27',USER='CHE108975',CD=';7-JUN-2016;11:53' -->
<A NAME="page_dg12201_1_46"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Third
parties may assert that we are employing their proprietary technology without authorization. There may be third-party patents or patent applications with claims to products, materials,
formulations, methods of manufacture or methods for treatment related to the use or manufacture of our products, that we failed to identify. For example, applications filed before November&nbsp;29,
2000 and certain applications filed after that date that will not be filed outside the United States remain confidential until issued as patents. Except for the preceding exceptions, patent
applications in the United States and elsewhere are generally published only after a waiting period of approximately 18&nbsp;months after the earliest filing. Therefore, patent applications covering
our technology or our products could have been filed by others without our knowledge. Additionally, pending patent applications that have been published can, subject to certain limitations, be later
amended in a manner that could cover our technologies, our products or the use or manufacture of our products. We may
also face a claim of misappropriation, if a third party believes that we inappropriately obtained and used trade secrets of such third parties. If we are found to have misappropriated a third party's
trade secrets, we may be prevented from further using such trade secrets, limiting our ability to develop our products, and we may be required to pay damages. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
any third-party patents were held by a court of competent jurisdiction to cover aspects of our products, materials, formulations, methods of manufacture or methods for treatment, the holders of any
such patents would be able to block our ability to develop and commercialize the applicable product candidate until such patent expired or unless we obtain a license. These licenses may not be
available on acceptable terms, if at all. Even if we were able to obtain a license, the rights may be nonexclusive, which could result in our competitors gaining access to the same intellectual
property. Ultimately, we could be prevented from commercializing a product, or be forced to cease some aspect of our business operations, if, as a result of actual or threatened patent infringement
claims, we are unable to enter into licenses on acceptable terms. In addition, during the course of any patent or other intellectual property litigation, there could be public announcements of the
results of hearings, rulings on motions, and other interim proceedings in the litigation. If securities analysts or investors regard these announcements as negative, the perceived value of our
products, programs, or intellectual property could be diminished. Accordingly, the market price of our common stock may decline. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Parties
making claims against us may obtain injunctive or other equitable relief, which could effectively block our ability to further develop and commercialize one or more of our products. Defending
against claims of patent infringement or misappropriation of trade secrets could be costly and time-consuming, regardless of the outcome. Thus, even if we were to ultimately prevail, or to settle at
an early stage, such litigation could burden us with substantial unanticipated costs. In addition, litigation or threatened litigation could result in significant demands on the time and attention of
our management team, distracting them from the pursuit of other company business. In the event of a successful claim of infringement against us, we may have to pay substantial damages, including
treble damages and attorneys' fees for willful infringement, pay royalties, redesign our infringing products or obtain one or more licenses from third parties, which may be impossible or require
substantial time and monetary expenditure. In addition, the uncertainties associated with litigation could have a material adverse effect on our ability to raise the funds necessary to continue our
clinical trials, continue our research programs, license necessary technology from third parties, or enter into development collaborations that would help us bring our products to market. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Changes in U.S. patent law could diminish the value of patents in general, thereby impairing our
ability to protect our products.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As is the case with other medical device companies, our success is heavily dependent on intellectual property, particularly on obtaining and
enforcing patents. Obtaining and enforcing patents in the medical device industry involves both technological and legal complexity, and therefore is costly, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>46</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=51,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=881870,FOLIO='46',FILE='DISK131:[15ZBY1.15ZBY12201]DG12201A.;27',USER='CHE108975',CD=';7-JUN-2016;11:53' -->
<A NAME="page_dg12201_1_47"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>time-consuming
and inherently uncertain. In addition, the United States has recently enacted and is currently implementing wide-ranging patent reform legislation. Further, several recent judicial
rulings have either narrowed the scope of patent protection available in certain circumstances or weakened the rights of patent owners in certain situations. In addition to increasing uncertainty with
regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
our U.S. patent applications containing a claim not entitled to priority before March&nbsp;16, 2013, there is a greater level of uncertainty in the patent law. In September 2011, the Leahy-Smith
America Invents Act, or the American Invents Act, or AIA, was signed into law. The AIA includes a number of significant changes to U.S. patent law, including provisions that affect the way patent
applications will be prosecuted, reviewed after issuance, and may also affect patent litigation. The USPTO is currently developing regulations and procedures to govern administration of the AIA and
many of the substantive changes to patent law associated with the AIA. It is not clear what other, if any, impact the AIA will have on the operation of our business. Moreover, the AIA and its
implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a
material adverse effect on our business and financial condition. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>An
important change introduced by the AIA is that, as of March&nbsp;16, 2013, the United States transitioned to a "first-inventor-to-file" system for deciding which party should be granted a patent
when two or more patent applications are filed by different parties claiming the same invention. A third party that files&nbsp;a patent application in the USPTO after that date but before us could
therefore be awarded a patent covering an invention of ours, even if we had made the invention before it was made by the third party. This will require us to be cognizant, going forward, of the time
from invention to filing of a patent application, but early filing of patent applications may not always be possible. Furthermore, our ability to obtain and maintain valid and enforceable patents
depends on whether the differences between our technology and the prior art allow our technology to be patentable over the prior art. Since patent applications in the United States and most other
countries are confidential for a period of time after filing, we cannot be certain that we were the first to either (a)&nbsp;file any patent application related to our products or (b)&nbsp;invent
any of the inventions claimed in our patents or patent applications. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Among
some of the other changes introduced by the AIA are changes that limit where a patentee may file&nbsp;a patent infringement suit and provide opportunities for third parties to challenge any
issued patent in the USPTO. This applies to all of our U.S. patents, even those issued before March&nbsp;16, 2013. Because of a lower evidentiary standard in USPTO proceedings compared to the
evidentiary standard in United States federal court necessary to invalidate a patent claim, a third party could potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold a
claim invalid as unpatentable, even though the same evidence may be insufficient to invalidate the claim if first presented in a district court action. Accordingly, a third party may attempt to use
the USPTO procedures to invalidate our patent claims that would not have been invalidated if first challenged by the third party as a defendant in a district court action. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Depending
on decisions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain
new patents or to enforce our existing patents and patents that we might obtain in the future. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>47</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=52,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=455373,FOLIO='47',FILE='DISK131:[15ZBY1.15ZBY12201]DG12201A.;27',USER='CHE108975',CD=';7-JUN-2016;11:53' -->
<A NAME="page_dg12201_1_48"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Because of the expense and uncertainty of litigation, we may not be in a position to enforce our
intellectual property rights against third parties.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have become aware from time to time that third parties may be infringing on our patents or other intellectual property rights. Because of the
expense and uncertainty of litigation, we have concluded in the past and may conclude in the future that even if a third party is infringing our patents or other intellectual property rights, the
risk-adjusted cost of bringing and enforcing such a claim or action may be too high or not in the best interest of our company or our stockholders. In such cases, we may decide that the more prudent
course of action is to simply monitor the situation or initiate or seek some other non-litigious action or solution. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Intellectual property rights do not address all potential threats to our competitive advantage.  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The degree of future protection afforded by our intellectual property rights is uncertain, because intellectual property rights have limitations and
may not adequately protect our business or permit us to maintain our competitive advantage. The following examples are illustrative:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Others may be able to make products that are similar to our products but that are not covered by the claims of the patents that we own
or license from others. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Others may independently develop similar or alternative technologies or otherwise circumvent any of our technologies without
infringing our intellectual property rights. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We might not have been the first to conceive and reduce to practice the inventions covered by the patents or patent applications that
we own, license or will own or license. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We might not have been the first to file patent applications covering certain subject matter of the patents or patent applications
that we own or for which we have obtained a license, or will own or for which we will obtain a license. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> It is possible that our pending patent applications will not lead to issued patents. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Issued patents that we own may not provide us with any competitive advantage, or may be held invalid or unenforceable, as a result of
legal challenges by our competitors. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Our competitors might conduct research and development activities in countries where we do not have patent rights, or in countries
where research and development safe harbor laws exist, and then use the information learned from such activities to develop competitive products for sale in our major commercial markets. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Ownership of our patents or patent applications may be challenged by third parties. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> The patents of third parties or pending or future applications of third parties, if issued, may have an adverse effect on our
business. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Confidentiality agreements with employees and others may not adequately prevent disclosure of trade
secrets and protect other proprietary information.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We consider proprietary trade secrets and/or confidential know-how and unpatented know-how to be important to our business. We may rely on trade
secrets and/or confidential know-how to protect our technology, especially where patent protection is believed by us to be of limited value. However, trade secrets and/or confidential know-how can be
difficult to maintain as confidential. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>48</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=53,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=928457,FOLIO='48',FILE='DISK131:[15ZBY1.15ZBY12201]DG12201A.;27',USER='CHE108975',CD=';7-JUN-2016;11:53' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_di12201_1_49"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>To protect this type of information against disclosure or appropriation by competitors, our policy is to require our employees, consultants, contractors and advisors to enter
into confidentiality agreements with us. However, current or former employees, consultants, contractors and advisers may unintentionally or willfully disclose our confidential information to
competitors, and confidentiality agreements may not provide an adequate remedy in the event of unauthorized disclosure of confidential information. Enforcing a claim that a third party obtained
illegally and is using trade secrets and/or confidential know-how is expensive, time consuming and unpredictable. The enforceability of confidentiality agreements may vary from jurisdiction to
jurisdiction. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Failure
to obtain or maintain trade secrets and/or confidential know-how trade protection could adversely affect our competitive position. Moreover, our competitors may independently develop
substantially equivalent proprietary information and may even apply for patent protection in respect of the same. If successful in obtaining such patent protection, our competitors could limit our use
of our trade secrets and/or confidential know-how. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may need to license certain intellectual property from third parties, and such licenses may not
be available or may not be available on commercially reasonable terms.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A third party may hold intellectual property, including patent rights that are important or necessary to the development or commercialization of any
future products. It may be necessary for us to use the patented or proprietary technology of third parties to commercialize our products, in which case we would be required to obtain a license from
these third parties. Such a license may not be available on commercially reasonable terms or at all, which could materially harm our business. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may be subject to claims that our employees, consultants or independent contractors have
wrongfully used or disclosed confidential information of third parties.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have received confidential and proprietary information from third parties. In addition, we employ individuals who were previously employed at
other medical device companies. We may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise improperly used or disclosed confidential
information of these third parties or our employees' former employers. Further, we may be subject to ownership disputes in the future, arising, for example, from conflicting obligations of consultants
or others who are involved in developing our products. We may also be subject to claims that former employees, consultants, independent contractors, collaborators or other third parties have an
ownership interest in our patents or other intellectual property. Litigation may be necessary to defend against these and other claims challenging our right to and use of confidential and proprietary
information. If we fail in defending any such claims, in addition to paying monetary damages, we may lose our rights therein. Such an outcome could have a material adverse effect on our business. Even
if we are successful in defending against these claims, litigation could result in substantial cost and be a distraction to our management and employees. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may be subject to claims challenging the inventorship or ownership of our patents and other
intellectual property.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We may also be subject to claims that former employees, collaborators or other third parties have an ownership interest in our patents or other
intellectual property. We may be subject to ownership disputes in the future, arising, for example, from conflicting obligations of consultants or others who are involved in developing our products.
Litigation may be necessary to defend against these and other claims challenging inventorship or ownership. If we fail in defending any such claims, in addition to paying monetary damages, we may lose
valuable intellectual property
rights, such as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could have a material </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>49</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=54,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=388733,FOLIO='49',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;38',USER='JFUSS',CD=';8-JUN-2016;14:22' -->
<A NAME="page_di12201_1_50"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>adverse
effect on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Our reliance on third parties requires us to share our trade secrets, which increases the
possibility that a competitor will discover them or that our trade secrets will be misappropriated or disclosed.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Because we rely on third parties to assist with research and development and to manufacture our products, we must, at times, share trade secrets with
them. We seek to protect our proprietary technology in part by entering into confidentiality agreements and, if applicable, material transfer agreements, consulting agreements or other similar
agreements with our advisors, employees, third-party contractors and consultants, prior to beginning research or disclosing proprietary information. These agreements typically limit the rights of the
third parties to use or disclose our confidential information, including our trade secrets. Despite the contractual provisions employed when working with third parties, the need to share trade secrets
and other confidential information increases the risk that such trade secrets become known by our competitors, are inadvertently incorporated into the technology of others, or are disclosed or used in
violation of these agreements. Given that our proprietary position is based, in part, on our know-how and trade secrets, a competitor's discovery of our trade secrets or other unauthorized use or
disclosure would impair our competitive position and may have a material adverse effect on our business. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, these agreements typically restrict the ability of our advisors, employees, third-party contractors and consultants to publish data potentially relating to our trade secrets, although our
agreements may contain certain limited publication rights. For example, any academic institution that we may collaborate with in the future will usually expect to be granted rights to publish data
arising out of such collaboration, provided that we are notified in advance and given the opportunity to delay publication for a limited time period in order for us to secure patent protection of
intellectual property rights arising from the collaboration, in addition to the opportunity to remove confidential or trade secret information from any such publication. In the future, we may also
conduct joint research and development programs that may require us to share trade secrets under the terms of our research and development or similar agreements. Despite our efforts to protect our
trade secrets, our competitors may discover our trade secrets, either through breach of our agreements with third parties, independent development or publication of information by any of our
third-party collaborators. A competitor's discovery of our trade secrets would impair our competitive position and have an adverse impact on our business. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If our trademarks and trade names are not adequately protected, then we may not be able to build
name recognition in our markets of interest and our business may be adversely affected.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest, and our
business may be adversely affected. We currently have registered and unregistered trademarks in the United States. Our trademarks or trade names may be challenged, infringed, circumvented or declared
generic or determined to be infringing on other marks. We may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition among potential
collaborators or customers in our markets of interest. At times, competitors may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly
leading to market confusion. Further, there could be potential trade name or trademark infringement claims brought by owners of other trademarks or trade names that incorporate variations of our
trademarks or trade names. In addition, we have not registered our trademarks internationally, and the laws of certain foreign countries may not protect proprietary rights to the same extent as do the
laws of the United States. Over the long term, if we are unable to successfully register our trademarks and trade names and/or establish name recognition based on our trademarks and trade names, then
we may not be able to compete effectively and our business may be </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>50</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=55,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=419650,FOLIO='50',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;38',USER='JFUSS',CD=';8-JUN-2016;14:22' -->
<A NAME="page_di12201_1_51"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>adversely
affected. Our efforts to enforce or protect our proprietary rights related to trademarks, trade secrets, domain names, copyrights or other intellectual property may be ineffective and could
result in substantial costs and diversion of resources and could adversely impact our financial condition or results of operations. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risks Related to This Offering and Ownership of Our Common Stock  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


An active trading market for our common stock may not develop.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Prior to this offering, there has been no public market for our common stock. Although we expect our common stock to be approved for listing on The
NASDAQ Global Market, an active trading market for our shares may never develop or be sustained following this offering. If the market does not develop or is not sustained, it may be difficult for you
to sell your shares of our common stock at a price that is attractive to you or at all. In addition, an inactive market may impair our ability to raise capital by selling shares and may impair our
ability to acquire other companies or technologies by using our shares as consideration, which, in turn, could adversely affect our business. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


The trading price of the shares of our common stock could be highly volatile, and purchasers of our
common stock may not be able to resell the shares of our common stock at or above the initial public offering price and could incur substantial losses.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our stock price is likely to be volatile. The stock market in general has experienced extreme volatility that has often been unrelated to the
operating performance of particular companies. As a result of this volatility, investors may not be able to sell their shares of our common stock at or above the initial public offering price. The
market price for our common stock may be influenced by many factors, including:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the passage of legislation or other regulatory developments in the United States and foreign countries; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> actual or anticipated variations in our financial results or those of companies that are perceived to be similar to us; </FONT> <FONT
COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> changes in the structure of healthcare payment systems, especially in light of current reforms to the U.S. healthcare system; </FONT> <FONT
COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our ability to develop and commercialize additional products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> announcements by us or our competitors of significant acquisitions, strategic collaborations, joint ventures or capital commitments; </FONT>
<FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> market conditions in medical device sectors and issuance of securities analysts' research reports or recommendations; </FONT> <FONT
COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> sales of our stock by us, our insiders and our other stockholders; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the trading volume of our common stock; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> speculation in the press or investment community; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> general economic, industry and market conditions, or other events or factors, many of which are beyond our control; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>51</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=56,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=533320,FOLIO='51',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;38',USER='JFUSS',CD=';8-JUN-2016;14:22' -->
<A NAME="page_di12201_1_52"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> additions or departures of key personnel; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> intellectual property, product liability or other litigation against us. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, the stock market has recently experienced significant volatility with respect to medical device and other life sciences company stocks. The volatility of medical device and other medical
technology company stocks often does not relate to the operating performance of the companies represented by the stock. As we operate in a single industry, we are especially vulnerable to these
factors to the extent that they affect our industry or our products, or to a lesser extent our markets. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We are an "emerging growth company," and the reduced disclosure requirements applicable to emerging
growth companies may make our common stock less attractive to investors.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are an "emerging growth company," as defined in the JOBS Act and may remain an emerging growth company for up to five years. For so long as we
remain an emerging growth company, we are permitted and intend to rely on exemptions from certain disclosure requirements that are applicable to other public companies that are not emerging growth
companies. These exemptions include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> being permitted to provide only two years of audited financial statements, in addition to any required unaudited interim financial
statements, with correspondingly reduced "Management's Discussion and Analysis of Financial Condition and Results of Operations" in this prospectus; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> not being required to comply with the auditor attestation requirements in the assessment of our internal control over financial
reporting; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding
mandatory audit firm rotation or a supplement to the auditor's report providing additional information about the audit and the financial statements; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> reduced disclosure obligations regarding executive compensation; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any
golden parachute payments not previously approved. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
have taken advantage of reduced reporting burdens in this prospectus. In particular, in this prospectus, we have provided only two years of audited financial statements and have not included all of
the executive compensation related information that would be required if we were not an emerging growth company. We cannot predict whether investors will find our common stock less attractive if we
rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be reduced or more
volatile. In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This allows an
emerging growth company to delay the adoption of these accounting standards until they would otherwise apply to private companies. We have elected to avail ourselves of this exemption and, as a
result, our financial statements may not be comparable to the financial statements of issuers that are required to comply with the effective dates for new or revised accounting standards that are
applicable to public companies. We cannot predict whether investors will find our common stock less attractive if we rely on these exemptions. If some investors find our common stock less attractive
as a </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>52</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=57,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1023824,FOLIO='52',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;38',USER='JFUSS',CD=';8-JUN-2016;14:22' -->
<A NAME="page_di12201_1_53"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>result,
there may be a less active trading market for our common stock and our stock price may be reduced or more volatile. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Sales of a substantial number of shares of our common stock by our existing stockholders in the
public market could cause our stock price to fall.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Sales of a substantial number of shares of our common stock in the public market, or the perception that these sales might occur, could significantly
reduce the market price of our common stock and impair our ability to raise adequate capital through the sale of additional equity securities. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


Assuming no exercise of the underwriters' option to purchase additional shares and no exercise of outstanding options and warrants and based on the number of shares outstanding as of March&nbsp;31,
2016 and the adjustments set forth in "Summary&nbsp;&#151; The Offering&nbsp;&#151; Pro Forma Adjustments," upon completion of this offering, we will have outstanding a total of
15,752,920&nbsp;shares of common stock.

</FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Of
these shares, only the shares of common stock sold in this offering by us, plus any shares sold upon exercise of the underwriters' option to purchase additional shares, will be freely tradable
without restriction in the public market immediately following this offering, unless they are purchased by one of our affiliates. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We,
our directors and officers and other holders of substantially all of our outstanding common stock, preferred stock, options and warrants have agreed, subject to certain exceptions, not to engage
in sales or dispositions of, or other transactions relating to, our common stock or securities convertible into or exercisable or exchangeable for our common stock or warrants or other rights to
acquire shares of our common stock. These "lock-up" restrictions end 180&nbsp;days after the date of this prospectus. However, Piper Jaffray&nbsp;&amp;&nbsp;Co. and William Blair&nbsp;&amp; Company,
L.L.C., in their sole discretion, may permit persons who are subject to these lock-up agreements to sell shares prior to the expiration of the lock-up agreements. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


After the lock-up agreements expire, up to an additional 11,195,133&nbsp;shares of our common stock will be eligible for sale in the public market, of which 7,042,232&nbsp;shares are held by
directors, executive officers and other affiliates and will be subject to volume limitations under Rule&nbsp;144 under the Securities Act of 1933, as amended, or the Securities Act. In addition,
shares of our common stock
that are subject to outstanding options, outstanding warrants or reserved for future issuance under our employee benefit plans will become eligible for sale in the public market to the extent
permitted by the provisions of various vesting schedules, the lock-up agreements and Rule&nbsp;144 and Rule&nbsp;701 under the Securities Act. If these additional shares of our common stock are
sold, or if it is perceived that they will be sold, in the public market, the trading price of our common stock could decline.

 </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


Following completion of this offering, the holders of 8,440,399&nbsp;shares of our outstanding common stock, or approximately 54% of our total outstanding common stock, will be entitled to rights
with respect to the registration of their shares under the Securities Act, subject to the 180-day lock-up agreements described above. See "Description of Capital Stock&nbsp;&#151;
Registration Rights." Registration of these shares under the Securities Act would result in the shares becoming freely tradable without restriction under the Securities Act, except for shares held by
affiliates, as defined in Rule&nbsp;144 under the Securities Act. Any sales of securities by these stockholders could have a material adverse effect on the trading price of our common stock.

 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>53</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=58,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=594339,FOLIO='53',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;38',USER='JFUSS',CD=';8-JUN-2016;14:22' -->
<A NAME="page_di12201_1_54"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We may use the net proceeds from this offering in ways that you and other stockholders may not
approve.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our management will have broad discretion in the application of the net proceeds from this offering, including for any of the purposes described in
the section entitled "Use of Proceeds," and you will not have the opportunity as part of your investment decision to assess whether the net proceeds are being used appropriately. Because of the number
and variability of factors that will determine our use of the net proceeds from this offering, their ultimate use may vary substantially from their currently intended use. Our management might not
apply our net proceeds in ways that ultimately increase the value of your investment. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


We intend to use the net proceeds from this offering primarily to expand our sales, marketing, reimbursement, clinical, regulatory and product development activities, and the remainder for working
capital, general and administrative expenses and other general corporate purposes, as well as to pay the approximately $8.1&nbsp;million of cumulative accrued dividends to our Series&nbsp;A
preferred stockholders as described in "Dividend Policy." We may also use a portion of our net proceeds to acquire or invest in complementary products, technologies or businesses, although we have no
present commitments to complete any such transaction. The amounts and timing of our expenditures will depend on numerous factors, including the rate of adoption of our devices, the expenses we incur
in sales and marketing our devices, the scope of research and development efforts, the timing and success of any clinical trials we may commence in the future, and the timing of regulatory
submissions. Accordingly, our management will have broad discretion over the use of the net proceeds from this offering. The failure by our
management to apply the net proceeds from this offering effectively could harm our business. Pending the uses described above, we intend to invest the net proceeds in short-term, interest-bearing,
investment-grade securities, certificates of deposit or governmental securities. These investments may not yield a favorable return to our stockholders.


</FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


You will suffer immediate and substantial dilution in the net tangible book value of the common
stock you purchase.  </I></B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>The initial public offering price of our common stock is substantially higher than the pro forma as adjusted net tangible book value per share of our
outstanding common stock immediately after the completion of this offering. Purchasers of our common stock in this offering will experience immediate dilution of approximately $10.57&nbsp;per share,
based on the assumed initial public offering price of $15.00&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus. In the past,
we issued options and warrants to acquire common stock at prices significantly below the assumed initial public offering price. To the extent these outstanding options and warrants are ultimately
exercised, investors purchasing common stock in this offering will sustain further dilution. For a further description of the dilution that you will experience immediately after this offering, see
"Dilution."

 </FONT>

</P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We do not intend to pay dividends on our common stock, and, consequently, your ability to achieve a
return on your investment will depend on appreciation, if any, in the price of our common stock.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have never declared or paid any cash dividend on our common stock and do not currently intend to do so for the foreseeable future. We currently
anticipate that we will retain future earnings for the development, operation and expansion of our business. In addition, any future debt financing arrangement may contain terms prohibiting or
limiting the amount of dividends that may be declared or paid on our common stock. Any return to stockholders will therefore be limited to any appreciation of their stock. Therefore, the success of an
investment in shares of our common stock will depend upon any future appreciation in their value. There is no guarantee that shares of our common stock will appreciate in value or even maintain the
price at which our stockholders purchased their shares. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>54</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=59,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=363979,FOLIO='54',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;38',USER='JFUSS',CD=';8-JUN-2016;14:22' -->
<A NAME="page_di12201_1_55"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


We will incur significant increased costs as a result of operating as a public company, and our
management will be required to devote substantial time to new compliance initiatives.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As a public company, we will incur significant legal, accounting and other expenses that we did not incur as a private company. We will be subject to
the reporting requirements of the Securities Exchange Act of 1934, or the Exchange Act, which will require, among other things, that we file with the Securities and Exchange Commission, or the SEC,
annual, quarterly and current reports with respect to our business and financial condition. In addition, the Sarbanes-Oxley Act of 2002, as well as rules subsequently adopted by the SEC and the stock
market to implement provisions of the Sarbanes-Oxley Act, imposes significant requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial
controls and changes in corporate governance practices. Further, pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, the SEC has adopted additional rules and regulations
in these areas, such as mandatory "say on pay" voting requirements that will apply to us when we cease to be an emerging growth company. Stockholder activism, the current political environment and the
current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and may impact the
manner in which we operate our business in ways we cannot currently anticipate. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
expect the rules and regulations applicable to public companies to substantially increase our legal and financial compliance costs and to make some activities more time-consuming and costly. If
these requirements divert the attention of our management and personnel from other business concerns, they could have a material adverse effect on our business, financial condition, results of
operations, and prospects. The increased costs will decrease our net income or increase our net loss, and may require us to reduce costs in other areas of our business or increase the prices of our
products or services. For example, we expect these rules and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance, and we may be required
to incur substantial costs to maintain the same or similar coverage. We are evaluating these rules and regulations, and cannot predict or estimate the amount of additional costs we may incur or the
timing of such costs. These rules and regulations are often subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may
evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing
revisions to disclosure and governance practices. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors,
our board committees or as executive officers. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If we fail to maintain proper and effective internal control over financial reporting in the future,
our ability to produce accurate and timely financial statements could be impaired, which could harm our operating results, investors' views of us and, as a result, the value of our common stock.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Pursuant to Section&nbsp;404 of the Sarbanes-Oxley Act, our management will be required to report upon the effectiveness of our internal control
over financial reporting beginning with the annual report for our fiscal year ending December&nbsp;31, 2015. When and if we are a "large accelerated filer" or an "accelerated filer" and are no
longer an "emerging growth company," each as defined in the Exchange Act, our independent registered public accounting firm will be required to attest to the effectiveness of our internal control over
financial reporting. However, for so long as we remain an emerging growth company, we intend to take advantage of an exemption available to emerging growth companies from these auditor attestation
requirements. We could be an "emerging growth company" for up to five years. The rules governing the standards that must be met for management to assess our internal control over financial reporting
are complex and require significant documentation, testing, and possible remediation. To comply with the requirements of being a reporting company under the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>55</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=60,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=829838,FOLIO='55',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;38',USER='JFUSS',CD=';8-JUN-2016;14:22' -->
<A NAME="page_di12201_1_56"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Exchange
Act, we will need to upgrade our systems, including information technology; implement additional financial and management controls, reporting systems, and procedures; and hire additional
accounting and finance staff. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any
failure to implement required new or improved controls, or difficulties encountered in their implementation, could cause us to fail to meet our reporting obligations. In addition, any testing by
us conducted in connection with Section&nbsp;404 of the Sarbanes-Oxley Act, or any subsequent testing by our independent registered public accounting firm, may reveal deficiencies in our internal
control over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further
attention or improvement. Inferior internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our
common stock. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, we may encounter problems or delays in implementing any changes necessary to make a favorable assessment of our internal control over financial reporting. Further, once we are no longer
an emerging growth company, we may encounter problems or delays in completing the implementation of any requested improvements and receiving a favorable attestation in connection with the attestation
provided by our independent registered public accounting firm. If we cannot favorably assess the effectiveness of our internal control over financial reporting, or if our independent registered public
accounting firm is unable to provide an unqualified attestation report on our internal controls,
investors could lose confidence in our financial information and the trading price of our common stock could decline. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
connection with our future evaluation of our internal control over financial reporting, we may need to upgrade our systems or create new systems, implement additional financial and management
controls, update our reporting systems and procedures, create or outsource an internal audit function or hire additional accounting and finance staff. If we are unable to accomplish these objectives
in a timely and effective fashion, our ability to comply with the financial reporting requirements and other rules that apply to reporting companies could be impaired. Any failure to maintain
effective internal control over financial reporting could have a material adverse effect on our business, financial condition and results of operations and the trading price of our common stock. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition
of us, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Provisions in our amended and restated certificate of incorporation and amended and restated bylaws to become effective upon completion of this
offering, as well as provisions of Delaware law, may delay or prevent an acquisition of us or a change in our management. These provisions include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> authorizing the issuance of "blank check" preferred stock, the terms of which may be established and shares of which may be issued
without stockholder approval; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> limiting the removal of directors by the stockholders; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> prohibiting cumulative voting in the election of directors, which would otherwise allow for less than a majority of stockholders to
elect director candidates; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> prohibiting stockholder action by written consent, thereby requiring all stockholder actions to be taken at a meeting of our
stockholders; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>56</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=61,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=306827,FOLIO='56',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;38',USER='JFUSS',CD=';8-JUN-2016;14:22' -->
<A NAME="page_di12201_1_57"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> eliminating the ability of stockholders to call a special meeting of stockholders; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> establishing advance notice requirements for nominations for election to the board of directors or for proposing matters that can be
acted upon at stockholder meetings. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>These
provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of
directors, who are responsible for appointing the members of our management. In addition, because we are incorporated in Delaware, we are governed by the provisions of Section&nbsp;203 of the
Delaware General Corporation Law, which limits the ability of stockholders owning in excess of 15% of our outstanding voting stock to merge or combine with us. These provisions would apply even if an
offer rejected by our board were considered beneficial by some stockholders. Any provision of our amended and restated certificate of incorporation or our amended and restated bylaws or Delaware law
that has the effect of delaying or deterring a change of control could limit the opportunity for our stockholders to receive a premium for their shares of our common stock, and could also affect the
price that some investors are willing to pay for our common stock. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


After this offering, our executive officers, directors and principal stockholders will maintain the
ability to control all matters submitted to stockholders for approval and may take actions that may not be in the best interests of our other stockholders.  </I></B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>Assuming the sale of 4,000,000&nbsp;shares of common stock in this offering (or 4,600,000&nbsp;shares if the underwriters exercise their option
to purchase additional shares in full), our executive officers, directors and stockholders who owned more than 5% of our outstanding common stock before this offering will, in the aggregate,
beneficially own shares representing approximately 48.4% of our capital stock (or 44.9% if the underwriters exercise their option to purchase additional shares in full). As a result, if these
stockholders were to act together, they would be able to control all matters submitted to our stockholders for approval, as well as our management and affairs. For example, these persons, if they act
together, would control the election of directors and decisions on any merger, consolidation or sale of all or substantially all of our assets. This concentration of voting power could delay or
prevent an acquisition of our company on terms that other stockholders may desire or result in management of our company that our public stockholders disagree with. See "Principal Stockholders" for
further information regarding the stock ownership of our directors, executive officers and principal stockholders.

 </FONT>

</P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


If securities or industry analysts do not publish research, or publish inaccurate or unfavorable
research, about our business, the price of our common stock and our trading volume could decline.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The trading market for our common stock will depend in part on the research and reports that securities or industry analysts publish about us or our
business. Securities and industry analysts do not currently, and may never, publish research on our company. If no or too few securities or industry analysts commence coverage of our company, the
trading price for our common stock would likely be negatively affected. In the event securities or industry analysts initiate coverage, if one or more of the analysts who cover us downgrade our common
stock or publish inaccurate or unfavorable research about our business, the price of our common stock would likely decline. If one or more of these analysts cease coverage of our company or fail to
publish reports on us regularly, demand for our common stock could decrease, which might cause the price of our shares and trading volume to decline. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>57</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=62,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=293743,FOLIO='57',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;38',USER='JFUSS',CD=';8-JUN-2016;14:22' -->
<A NAME="page_di12201_1_58"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


Claims for indemnification by our directors and officers may reduce our available funds to satisfy
successful third-party claims against us and may reduce the amount of money available to us.  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our amended and restated certificate of incorporation and amended and restated bylaws that will become effective upon completion of this offering
provide that we will indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, as permitted by Section&nbsp;145 of the Delaware General Corporation Law, our amended and restated bylaws and our indemnification agreements that we intend to enter into with our
directors and officers provide that:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We will indemnify our directors and officers for serving us in those capacities or for serving other business enterprises at our
request, to the fullest extent permitted by Delaware law. Delaware law provides that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably
believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal proceeding, had no reasonable cause to believe such person's conduct was unlawful. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We may, in our discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law. </FONT>
<FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We are required to advance expenses, as incurred, to our directors and officers in connection with defending a proceeding, except that
such directors or officers shall undertake to repay such advances if it is ultimately determined that such person is not entitled to indemnification. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We will not be obligated pursuant to our amended and restated bylaws to indemnify a person with respect to proceedings initiated by
that person against us or our other indemnitees, except with respect to proceedings authorized by our board of directors or brought to enforce a right to indemnification. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> The rights conferred in our amended and restated bylaws are not exclusive, and we are authorized to enter into indemnification
agreements with our directors, officers, employees and agents and to obtain insurance to indemnify such persons. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> We may not retroactively amend our bylaw provisions to reduce our indemnification obligations to directors, officers, employees and
agents. </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>58</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=63,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=892092,FOLIO='58',FILE='DISK131:[15ZBY1.15ZBY12201]DI12201A.;38',USER='JFUSS',CD=';8-JUN-2016;14:22' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dk12201_1_59"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="dk12201_special_note_regarding_forward-looking_statements"> </A>
<A NAME="toc_dk12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>This prospectus contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of
historical facts, contained in this prospectus, including statements regarding our business, operations and financial performance and condition, as well as our plans, objectives and expectations for
our business, operations and financial performance and condition, are forward-looking statements. In some cases, you can identify forward-looking statements by the following words: "anticipate,"
"believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "target," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these
terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements involve known and unknown risks, uncertainties and other factors that
may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this prospectus. The
forward-looking statements in this prospectus include, among other things, statements relating to:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our expectations regarding the potential market size and widespread adoption of our products; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our ability to increase awareness of lymphedema and chronic venous insufficiency and to demonstrate the clinical and economic benefits
of our solutions to clinicians and patients; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> developments and projections relating to our competitors or our industry; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the expected growth in our business and our organization, including outside of the United States; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our ability to achieve and maintain adequate levels of coverage or reimbursement for our products and the effect of a recent change to
the level of Medicare coverage; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our financial performance, our estimates of our expenses, future revenues, capital requirements and our needs for, or ability to
obtain, additional financing; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our ability to retain and recruit key personnel, including the continued development and expansion of our sales and marketing
organization; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our ability to obtain an adequate supply of components for our products from our third-party suppliers; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our ability to obtain and maintain intellectual property protection for our products or avoid claims of infringement; </FONT> <FONT
COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our ability to identify and develop new products; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our compliance with extensive government regulation; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our expected uses of the net proceeds from this offering; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the volatility of our stock price; and </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>59</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=64,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=497329,FOLIO='59',FILE='DISK131:[15ZBY1.15ZBY12201]DK12201A.;41',USER='JFUSS',CD=';8-JUN-2016;14:22' -->
<A NAME="page_dk12201_1_60"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our expectations regarding the time during which we will be an emerging growth company under the JOBS Act. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>You
should read the matters described in "Risk Factors" and the other cautionary statements made in this prospectus as being applicable to all related forward-looking statements wherever they appear
in this prospectus. We cannot assure you that the forward-looking statements in this prospectus will prove to be accurate and therefore prospective investors are encouraged not to place undue reliance
on forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. You should read this
prospectus, the documents that we reference in this prospectus and the documents that we have filed as exhibits to the registration statement, of which this prospectus is a part, completely. Other
than as required by law, we undertake no obligation to update or revise these forward-looking statements, even though our situation may change in the future. Our forward-looking statements do not
reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments that we may make. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>60</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=65,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=185586,FOLIO='60',FILE='DISK131:[15ZBY1.15ZBY12201]DK12201A.;41',USER='JFUSS',CD=';8-JUN-2016;14:22' -->
<A NAME="page_dk12201_1_61"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="dk12201_use_of_proceeds"> </A>
<A NAME="toc_dk12201_2"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  USE OF PROCEEDS    <BR>    </B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>We estimate that the net proceeds that we will receive from the sale of 4,000,000 shares of our common stock in this initial public offering will be
approximately $53.3&nbsp;million, or approximately $61.7&nbsp;million if the underwriters exercise their option in full to purchase additional shares from us. This estimate is based upon an
assumed initial public offering price of $15.00&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, after the underwriting
discounts and commissions and estimated offering expenses payable by us.

 </FONT>

</P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


A $1.00 increase (decrease) in the assumed initial public offering price of $15.00&nbsp;per share would increase (decrease) the net proceeds to us from this offering by approximately
$3.7&nbsp;million, assuming the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts and commissions and
estimated offering expenses payable by us. We may also increase or decrease the number of shares we are offering. Each increase (decrease) of 1,000,000 in the number of shares we are offering would
increase (decrease) the net proceeds to us from this offering, after the underwriting discounts and commissions and estimated offering expenses payable by us, by approximately $14.0&nbsp;million,
assuming the assumed initial public offering price stays the same.

 </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
intend to use the net proceeds from this offering primarily as follows:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> approximately $5.0&nbsp;million to expand our sales and marketing activities; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> approximately $5.0&nbsp;million to expand our product development activities; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> approximately $3.0&nbsp;million to expand our reimbursement and clinical activities; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<BR><BR></FONT></DD>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> approximately $8.1&nbsp;million to pay the cumulative accrued dividends to our Series&nbsp;A preferred stockholders (assuming a
closing date of June&nbsp;27,&nbsp;2016 and an initial public offering price of $15.00&nbsp;per share) as described in "Dividend Policy"; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>

<BR><BR></FONT></DD>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the remainder for working capital, general and administrative expenses and other general corporate purposes. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
may also use a portion of our net proceeds to acquire or invest in complementary products, technologies or businesses, although we have no present commitments to complete any such transaction. The
amounts and timing of our expenditures will depend on numerous factors, including the rate of adoption of our devices, the expenses we incur in sales and marketing our devices, the scope of research
and development efforts, the timing and success of any clinical trials we may commence in the future, and the timing of regulatory submissions. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Accordingly,
our management will have broad discretion over the use of the net proceeds from this offering. Pending the uses described above, we intend to invest the net proceeds in short-term,
interest-bearing, investment-grade securities, certificates of deposit or governmental securities. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>61</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=66,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=945892,FOLIO='61',FILE='DISK131:[15ZBY1.15ZBY12201]DK12201A.;41',USER='JFUSS',CD=';8-JUN-2016;14:22' -->
<A NAME="page_dk12201_1_62"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="dk12201_dividend_policy"> </A>
<A NAME="toc_dk12201_3"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  DIVIDEND POLICY    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have never declared or paid any cash dividends on our common stock. Following the completion of this offering, we intend to retain our future
earnings, if any, to finance the operation and expansion of our business. We do not expect to pay cash dividends on our common stock in the foreseeable future. Payment of future cash dividends, if
any, will be at the discretion of our board of directors after taking into account various factors, including our financial condition, operating results, current and anticipated cash needs,
outstanding indebtedness and plans for expansion and restrictions imposed by lenders, if any. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Holders
of our Series&nbsp;A and Series&nbsp;B preferred stock are entitled to dividends upon the conversion of such shares of preferred stock to our common stock in connection with this initial
public offering, which will occur immediately prior to the completion of this offering. Each Series&nbsp;A and Series&nbsp;B preferred stockholder is entitled to a cumulative accrued dividend
calculated at a rate of 6% per annum of the original issue price of such series of preferred stock. Series&nbsp;B preferred stockholders may elect to receive payment of such dividend in additional
shares of Series&nbsp;B preferred stock. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


As of March 31, 2016, we had $10.1 million of cumulative accrued dividends payable to our Series&nbsp;A and Series&nbsp;B preferred stockholders. These dividends have continued to accrue
subsequent to March&nbsp;31, 2016. As such, we anticipate that the Series&nbsp;B preferred stockholders will elect to receive payment of such cumulative accrued dividends in additional shares of
Series&nbsp;B preferred stock rather than cash. Assuming a closing date of June&nbsp;27, 2016, we expect to pay approximately $8.1&nbsp;million of cumulative accrued dividends in cash to our
Series&nbsp;A preferred stockholders and issue 844,782&nbsp;shares of our common stock in payment of approximately $2.6&nbsp;million of cumulative accrued dividends to our Series&nbsp;B
preferred stockholders. The cash dividend will be paid from the net proceeds of this offering and neither cash nor stock dividends will be paid on any shares purchased in this offering.

 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>62</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=67,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=338931,FOLIO='62',FILE='DISK131:[15ZBY1.15ZBY12201]DK12201A.;41',USER='JFUSS',CD=';8-JUN-2016;14:22' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dm12201_1_63"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="dm12201_capitalization"> </A>
<A NAME="toc_dm12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  CAPITALIZATION    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following table sets forth our cash and cash equivalents and capitalization as of March&nbsp;31,
2016:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> on an actual basis; </FONT><FONT COLOR="#3B5A6F" SIZE=2>

<BR><BR></FONT></DD>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> on a pro forma basis to give effect to: (a)&nbsp;the conversion of all outstanding preferred stock into an aggregate of
5,924,452&nbsp;shares of our common stock immediately prior to the completion of this offering; (b)&nbsp;the issuance of 1,569,549 additional shares of our common stock immediately prior to the
completion of this offering that our Series&nbsp;A and Series&nbsp;B preferred stockholders are entitled to receive in connection with this initial public offering, assuming an initial offering
price of $15.00 per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus; (c)&nbsp;the accrual for the payment of $7.8&nbsp;million in
cumulative accrued dividends to our Series&nbsp;A preferred stockholders as of March&nbsp;31, 2016; (d)&nbsp;the issuance of 785,742&nbsp;shares of common stock immediately prior to the
completion of this offering to pay accrued dividends on our Series&nbsp;B preferred stock (assuming a closing date of March&nbsp;31, 2016 and an initial offering price of $15.00 per share, which
is the midpoint of the estimated offering price range set forth on the cover page of this prospectus); and (e)&nbsp;the effectiveness of our amended and restated certificate of incorporation and the
adoption of our amended and restated bylaws; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> on a pro forma as adjusted basis to give effect to (a)&nbsp;the pro forma adjustments described in the preceding bullet;
(b)&nbsp;the cash payment of accrued dividends as of March&nbsp;31, 2016 to our Series&nbsp;A preferred stockholders described in the preceding bullet; and (c)&nbsp;our issuance and sale of
4,000,000&nbsp;shares of common stock in this offering at an assumed initial public offering price of $15.00 per share, which is the midpoint of the estimated offering price range set forth on the
cover page of this prospectus, after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.

 </FONT></DD>

</DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>You
should read this information in conjunction with "Management's Discussion and Analysis of Financial Condition and Results of Operations" and our financial statements and the related notes included
elsewhere in this prospectus. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>63</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=68,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=333366,FOLIO='63',FILE='DISK131:[15ZBY1.15ZBY12201]DM12201A.;59',USER='GPEARMO',CD=';8-JUN-2016;23:26' -->
<A NAME="page_dm12201_1_64"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="58pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of March&nbsp;31, 2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Actual </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Pro<BR>
Forma </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Pro Forma<BR>
As Adjusted </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands, except for share and<BR>
per share data; unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2> Cash and cash equivalents</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,787</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,787</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>52,827</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Convertible preferred stock</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Series&nbsp;B preferred stock, $0.001 par value per share, 5,319,066&nbsp;shares authorized, 2,733,468&nbsp;shares issued
and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12,796</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Series&nbsp;A preferred stock, $0.001 par value per share, 3,112,152&nbsp;shares authorized, 3,108,589&nbsp;shares issued
and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>20,645</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Stockholders' equity (deficit):</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Preferred stock $0.001 par value per share, no shares authorized, issued and outstanding, actual; 50,000,000&nbsp;shares
authorized, no shares issued and outstanding, pro forma and pro forma as adjusted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Common stock $0.001 par value per share, 14,184,172&nbsp;shares authorized, 3,341,285&nbsp;shares issued and outstanding,
actual; 300,000,000&nbsp;shares authorized, 11,621,028&nbsp;shares issued and outstanding, pro forma; 300,000,000&nbsp;shares authorized, 15,621,028&nbsp;shares issued and outstanding, pro forma as adjusted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>16</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Additional paid-in capital</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>25,643</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>78,939</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accumulated deficit</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,949</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,949</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,949</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total stockholders' equity (deficit)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,940</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>18,706</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>72,006</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total capitalization</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>26,501</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>18,706</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>72,006</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


Each $1.00 increase (decrease) in the assumed initial public offering price of $15.00 per share, which is the midpoint of the estimated offering price range set forth on the cover page of this
prospectus, would increase (decrease) our pro forma as adjusted cash and cash equivalents, additional paid-in capital, total stockholders' equity and total capitalization by approximately
$3.7&nbsp;million, assuming that the number of shares of our common stock offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting
discounts and commissions and estimated offering expenses payable by us. Each increase (decrease) of 1,000,000&nbsp;shares in the number of shares offered by us would increase (decrease) the amount
of our pro forma as adjusted cash and cash equivalents, additional paid-in capital, total stockholders' equity and total capitalization by approximately $14.0&nbsp;million, assuming an initial
public offering price of $15.00 per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, after deducting underwriting discounts and
commissions and estimated offering expenses payable by us.

</FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
table and calculations above are based on the adjustments set forth in "Summary&nbsp;&#151; The Offering&nbsp;&#151; Pro Forma Adjustments." </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>64</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=69,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=302469,FOLIO='64',FILE='DISK131:[15ZBY1.15ZBY12201]DM12201A.;59',USER='GPEARMO',CD=';8-JUN-2016;23:26' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_do12201_1_65"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="do12201_dilution"> </A>
<A NAME="toc_do12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  DILUTION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If you invest in our common stock, your ownership interest will be diluted to the extent of the difference between the initial public offering price
per share of our common stock and the pro forma as adjusted net tangible book value per share of our common stock immediately after completion of this offering. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


As of March&nbsp;31, 2016, our net tangible book value was approximately $24.1&nbsp;million, or approximately $7.21&nbsp;per share. Our net tangible book value represents total tangible assets
less total liabilities. Our net tangible book value per share is our net tangible book value divided by the number of shares of common stock outstanding as of March&nbsp;31, 2016.

 </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


As of March&nbsp;31, 2016, our pro forma net tangible book value of our common stock was approximately $16.3&nbsp;million, or approximately $1.40&nbsp;per share. Our pro forma net tangible book
value represents total tangible assets less total liabilities. Our pro forma net tangible book value per share is our pro forma net tangible book value divided by the number of shares of common stock
outstanding as of March&nbsp;31, 2016, after giving effect to (a)&nbsp;the conversion of all outstanding preferred stock into an
aggregate of 5,924,452&nbsp;shares of our common stock immediately prior to the completion of this offering; (b)&nbsp;the issuance of 1,569,549&nbsp;additional shares of common stock immediately
prior to the completion of this offering that our Series&nbsp;A and B preferred stockholders are entitled to receive in connection with this initial public offering, assuming an initial offering
price of $15.00&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus; (c)&nbsp;the accrual for the payment of
$7.8&nbsp;million in cumulative accrued dividends to our Series&nbsp;A preferred stockholders as of March&nbsp;31, 2016; (d)&nbsp;the issuance of 785,742&nbsp;shares of common stock
immediately prior to the completion of this offering to pay accrued dividends on our Series&nbsp;B preferred stock (assuming a closing date of March&nbsp;31, 2016 and an initial offering price of
$15.00&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus); and (e)&nbsp;the effectiveness of our amended and restated
certificate of incorporation and adoption of our amended and restated bylaws.

 </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


After giving effect to (a)&nbsp;the pro forma adjustments described above; (b)&nbsp;the payment of accrued dividends as of March&nbsp;31, 2016 to our Series&nbsp;A preferred stockholders
described above; and (c)&nbsp;our issuance and sale of 4,000,000&nbsp;shares of our common stock in this offering at an assumed initial public offering price of $15.00&nbsp;per share, which is
the midpoint of the estimated offering price range set forth on the cover page of this prospectus, after deducting the estimated underwriting discounts and commissions and estimated offering expenses,
as of March&nbsp;31, 2016, the pro forma as adjusted net tangible book value of our common stock would have been approximately $69.6&nbsp;million, or approximately $4.43&nbsp;per share. This
amount represents an immediate increase in pro forma net tangible book value to our existing stockholders of $3.03&nbsp;per share and an immediate dilution to new investors purchasing shares in this
offering of $10.57&nbsp;per share. We determine dilution by subtracting the pro forma as adjusted net tangible book value per share after this offering from the amount of

</FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>65</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=70,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=424021,FOLIO='65',FILE='DISK131:[15ZBY1.15ZBY12201]DO12201A.;39',USER='GPEARMO',CD=';8-JUN-2016;22:45' -->
<A NAME="page_do12201_1_66"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


cash that a new investor paid for a share of common stock. The following table illustrates this per share dilution:

</FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="40pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2> Assumed initial public offering price per share</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>15.00</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Historical net tangible book value per share as of March&nbsp;31, 2016</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7.21</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma increase in net tangible book value per share</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(5.81</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma net tangible book value per share as of March&nbsp;31, 2016</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.40</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Increase in pro forma net tangible book value per share attributable to investors purchasing shares in this
offering</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3.03</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma as adjusted net tangible book value per share, after giving effect to this offering</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4.43</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Dilution in pro forma as adjusted net tangible book value per share to investors purchasing shares in this
offering</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10.57</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


A $1.00 increase in the assumed initial public offering price of $15.00&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus,
would increase the pro forma as adjusted net tangible book value per share after this offering by approximately $0.24, and dilution in pro forma net tangible book value per share to new investors by
approximately $0.76, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting the estimated underwriting discounts and
commissions and estimated offering expenses payable by us. A $1.00 decrease in the assumed initial public offering price of $15.00 per share, which is the midpoint of the estimated offering price
range set forth on the cover page of this prospectus, would decrease the pro forma as adjusted net tangible book value per share after this offering by approximately $0.24, and dilution in pro forma
net tangible book value per share to new investors by approximately $0.76, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and
after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.


</FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


If the underwriters exercise their option to purchase additional shares in full, there will be an increase in pro forma as adjusted net tangible book value to existing stockholders of $0.35&nbsp;per
share and an immediate dilution in pro forma as adjusted net tangible book value to new investors of $10.22&nbsp;per share, assuming that the number of shares offered by us, as set forth on the
cover page of this prospectus, remains the same and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.

 </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table summarizes, on a pro forma as adjusted basis described above, the difference between existing stockholders and new investors with respect to number of shares of common stock
purchased from us, the total consideration paid to us, and the average price per share paid, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus,
remains the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>66</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=71,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1015096,FOLIO='66',FILE='DISK131:[15ZBY1.15ZBY12201]DO12201A.;39',USER='GPEARMO',CD=';8-JUN-2016;22:45' -->
<A NAME="page_do12201_1_67"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>same
and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="74pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Shares<BR>
Purchased </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Total Consideration </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Average Price<BR>
Per Share </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Percent </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Amount </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Percent </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2> Existing stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
11,693,880</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
74.5</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>31,372,634</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
34.3</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2.68</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Investors purchasing shares in this offering</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,000,000</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>25.5</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>60,000,000</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>65.7</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>15.00 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>15,693,880</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>100</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>91,372,634</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>100</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5.82</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


A $1.00 increase (decrease) in the assumed initial public offering price of $15.00&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this
prospectus, would
increase (decrease) the total consideration paid by new investors by $4.0&nbsp;million, and increase (decrease) the percentage of total consideration paid by investors purchasing shares in this
offering by approximately 1.4%, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and before deducting estimated underwriting
discounts and commissions and estimated offering expenses payable by us. Similarly, each increase (decrease) of 1,000,000 shares in the number of shares offered by us would increase (decrease) the
total consideration paid by investors purchasing shares in this offering by $15.0&nbsp;million, and increase (decrease) the percentage of total consideration paid by new investors by approximately
4.8%, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and before deducting estimated underwriting discounts and commissions and
estimated offering expenses payable by us.

</FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
the underwriters exercise their option to purchase additional shares in full:</FONT></P>


<UL>
<UL>
<DL compact>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the percentage of shares of common stock held by existing stockholders will decrease to approximately 71.8% of the total number of
shares of our common stock outstanding after completion of this offering; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>



<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the number of shares held by new investors will increase to 4,600,000, or approximately 28.2% of the total number of shares of our
common stock outstanding after completion of this offering.

</FONT></DD>

</DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


The table and calculations above are based on 11,693,880&nbsp;shares outstanding as of March&nbsp;31, 2016 and the adjustments set forth in "Summary&nbsp;&#151; The
Offering&nbsp;&#151; Pro Forma Adjustments."

 </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


To the extent any of the outstanding options to purchase shares of our common stock or warrants to purchase shares of our common stock are exercised or new awards are granted under our equity
compensation plans, there will be further dilution to investors participating in this offering. To the extent all of such outstanding options and warrants had been exercised as of March&nbsp;31,
2016, the pro forma as adjusted net tangible book value per share after this offering would be $71.5&nbsp;million, and total dilution per share to new investors would be&nbsp;$3.08.

 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>67</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=72,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1037250,FOLIO='67',FILE='DISK131:[15ZBY1.15ZBY12201]DO12201A.;39',USER='GPEARMO',CD=';8-JUN-2016;22:45' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dq12201_1_68"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="dq12201_selected_consolidated_financial_data"> </A>
<A NAME="toc_dq12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  SELECTED CONSOLIDATED FINANCIAL DATA    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following tables set forth our selected historical consolidated financial data as of and for the periods indicated. The selected consolidated
statements of operations data for the years ended December&nbsp;31, 2014 and 2015, and the selected consolidated balance sheet data as of December&nbsp;31, 2014 and 2015, have been derived from
our audited consolidated financial statements included elsewhere in this prospectus. Our selected consolidated statements of operations data for the three months ended March&nbsp;31, 2015 and 2016,
and the selected consolidated balance sheet data as of March&nbsp;31, 2016, have been derived from our unaudited interim consolidated financial statements included elsewhere in this prospectus. We
have prepared the unaudited interim consolidated financial statements on the same basis as the audited consolidated financial statements and have included, in our opinion, all adjustments, consisting
only of normal recurring adjustments that we consider necessary for a fair statement of financial statements set forth in those statements. Our historical results are not indicative of the results to
be expected in the future and our interim results are not necessarily indicative of results to be expected for the full year ended December&nbsp;31, 2016, or any other period. The following
financial data should be read in conjunction with, and are qualified in their entirety by reference to, "Use of Proceeds," "Capitalization," "Management's Discussion and Analysis of Financial
Condition and Results of Operations" and our financial statements and the related notes included elsewhere in this prospectus. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Three Months Ended<BR>
March&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands, except share and per share data)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Consolidated Statements of Operations Data:</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Revenues, net</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>47,736</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>62,872</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>10,121</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>13,700</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Cost of goods sold</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>12,715</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>16,908</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,972</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,811 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:22pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Gross profit</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>35,021</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>45,964</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>7,149</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>9,889 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Operating expenses:</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:22pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Sales and marketing</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>18,154</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>24,485</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>5,169</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>7,281</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:22pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Research and development</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,843</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>4,312</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>817</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>980</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:22pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Reimbursement, general and administrative</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>10,225</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>13,716</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,647</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,414 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:37pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Total operating expenses</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>31,222</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>42,513</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>8,633</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>11,675 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Income (loss) from operations</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
3,799</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
3,451</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
(1,484</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
(1,786</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Other income (expense)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
(4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
(194</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
12</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
5 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:22pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Income (loss) before income
taxes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,795</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,257</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(1,472</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(1,781</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Income tax expense (benefit)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
1,725</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
1,864</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
(592</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
(801</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Net income (loss)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
2,070</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
1,393</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
(880</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
(980</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Convertible preferred stock dividends</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>1,761</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>1,845</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>460</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>514</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Allocation of undistributed earnings to preferred stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>216</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Net income (loss) attributable to common stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>93</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(452</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(1,340</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(1,494</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Net income (loss) per common share attributable to common stockholders<SUP>(1)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>0.04</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(0.15</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(0.51</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(0.45</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>0.02</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(0.15</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(0.51</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(0.45</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Weighted-average shares outstanding used to compute net income (loss) per common share attributable to
common stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,491,108</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,929,438</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,640,807</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,293,326</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,797,688</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,929,438</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,640,807</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,293,326</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Pro forma net income (loss) per common share attributable to common stockholders (unaudited)<SUP>(2)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>0.12</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(0.08</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>0.10</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(0.08</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Weighted-average shares used to compute pro forma net income (loss) per common share attributable to common stockholders
(unaudited)<SUP>(2)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>11,807,560</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>12,171,448</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>13,507,390</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>12,171,448</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>68</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=73,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=488685,FOLIO='68',FILE='DISK131:[15ZBY1.15ZBY12201]DQ12201A.;96',USER='GPEARMO',CD=';8-JUN-2016;23:04' -->
<A NAME="page_dq12201_1_69"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
March&nbsp;31,<BR>
2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Consolidated Balance Sheet Data</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Cash and cash equivalents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>5,416</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>7,060</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>5,787</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Working capital</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>18,927</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>19,858</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>19,209</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Total assets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>31,494</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>36,973</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>33,268</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Total debt</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>13</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Convertible preferred stock</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>31,082</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>32,927</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>33,441</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Accumulated deficit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(6,872</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(5,658</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(6,949</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Total stockholders' equity (deficit)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(6,427</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(5,649</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(6,940</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Net
income (loss) per common share attributable to common stockholders is calculated under the two-class method, as our convertible preferred stock
participates in the undistributed earnings of the company. The two-class method requires earnings for the period to be allocated based upon their respective rights to receive distributed and
undistributed earnings. No adjustment is made during periods with a net loss, as the holders of the convertible preferred stock have no obligation to fund losses.

<BR><BR></FONT></DD>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Pro
forma net income (loss) per common share attributable to common stockholders and the number of weighted-average common shares used to compute pro forma
net income (loss) per common share attributable to common stockholders reflect the adjustments set forth in "Summary&nbsp;&#151;&nbsp;The Offering &#151; Pro Forma Adjustments,"
except in lieu of the cash payment of a portion of the proceeds to pay cumulative accrued dividends to our Series A preferred stockholders, reflects the additional 539,338 shares of common stock that
would have been required to be issued to generate sufficient proceeds to fund the cash payment of the Series&nbsp;A convertible preferred stock dividends that are payable from the net proceeds of
this offering. </FONT>

</DD>

</DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>69</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=74,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=900947,FOLIO='69',FILE='DISK131:[15ZBY1.15ZBY12201]DQ12201A.;96',USER='GPEARMO',CD=';8-JUN-2016;23:04' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ds12201_1_70"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ds12201_management_s_discussion_and_an__man03466"> </A>
<A NAME="toc_ds12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  MANAGEMENT'S DISCUSSION AND ANALYSIS OF<BR>  FINANCIAL CONDITION AND RESULTS OF OPERATIONS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>The following discussion and analysis of our financial condition and results of operations should be read in conjunction with
the Selected Consolidated Financial Data and our consolidated financial statements and the accompanying notes thereto included elsewhere in this prospectus. Our actual results could differ materially
from those anticipated in the forward-looking statements included in this discussion as a result of certain factors, including, but not limited to, those discussed in "Risk Factors" and "Special Note
Regarding Forward-Looking Statements" included elsewhere in this prospectus.  </I></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home. We focus on
advancing the
standard of care in treating chronic diseases in the home setting to improve patient outcomes and quality of life and help control rising healthcare expenditures. We possess a unique, scalable
platform to deliver at-home healthcare solutions throughout the United States. This evolving care delivery model is recognized by policy-makers and payers as a key for controlling rising healthcare
expenditures. Our initial area of therapeutic focus is vascular disease, with a goal of advancing the standard of care in treating lymphedema and chronic venous insufficiency. Our solutions deliver
cost-effective, clinically proven, long-term treatment for these chronic diseases. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
two proprietary products are the Flexitouch System and the ACTitouch System. A predecessor to our Flexitouch System received 510(k) clearance from the FDA in July 2002, and we introduced the
system to address the many limitations of self-administered home-based manual lymphatic drainage therapy. We began selling our more-advanced Flexitouch System after receiving 510(k) clearance from the
FDA in October 2006. Historically, we derived substantially all of our revenues from our Flexitouch System. For the years ended December&nbsp;31, 2014 and 2015, and for the three months ended
March&nbsp;31, 2016, our Flexitouch System represented 92%, 87% and 85% of our revenues, respectively. In September 2012, we acquired our second proprietary product, the ACTitouch System. The system
received 510(k) clearance from the FDA in June 2013, and we began selling the product in September 2013 to address the many limitations of non-removable multilayered bandages that are worn by patients
suffering from venous leg&nbsp;ulcers. For the years ended December&nbsp;31, 2014 and 2015, and for the three months ended March&nbsp;31, 2016, our ACTitouch System represented 5%, 5% and 4% of
our revenues, respectively. We also began selling our Entr&eacute; System, a 510(k) cleared basic pneumatic compression device, in February 2013. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>To
support the growth of our business, we invest heavily in our commercial infrastructure, consisting of our direct sales force, home training resources, reimbursement capabilities and clinical
expertise. We market our products in the United States using a direct-to-patient and -provider model. Our direct sales force has grown from three representatives in March 2005 to a team of over
100&nbsp;people as of March&nbsp;31, 2016. This model allows us to directly approach patients and clinicians, whereby we disintermediate the traditional durable medical equipment channel, allowing
us to capture both the manufacturer and distributor margins. We also utilize over 300 licensed, independent healthcare practitioners as home trainers who educate patients on the proper use of our
solutions. We invest substantial resources in our reimbursement operations group of over 55&nbsp;people that focuses on verifying case-by-case benefits, obtaining prior authorization, billing and
collecting payments from payers and providing customer support services. Our payer relationships group of over 20&nbsp;people is responsible for developing relationships with payer decision-makers
to educate them on our product efficacy, develop overall payer coverage policies and reimbursement criteria, manage Medicare patient claims and contracts with payers and serve as an advocacy liaison
between patients, clinicians and payers throughout the appeals process. We also have a clinical team, consisting of a scientific advisory </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>70</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=75,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=591959,FOLIO='70',FILE='DISK131:[15ZBY1.15ZBY12201]DS12201A.;113',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_ds12201_1_71"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>board,
in-house therapists and nurses, and a medical director, that serves as a resource to clinicians and patients and guides our development of clinical evidence in support of our products. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
patients are reimbursed by government and private payers for the purchase of our products pursuant to established rates with each payer. We rely on third-party contract manufacturers for the
sourcing of parts, the assembly of our controllers and the manufacturing of the garments used with our systems. We conduct final assembly of the garments used with our Flexitouch System at, and
perform quality assurance and ship our products from, our facility in Minneapolis, Minnesota. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
the year ended December&nbsp;31, 2015, we generated revenues of $62.9&nbsp;million and had net income of $1.4&nbsp;million, compared to revenues of $47.7&nbsp;million and net income of
$2.1&nbsp;million for the year ended December&nbsp;31, 2014. For the three months ended March&nbsp;31, 2016, we generated revenues of $13.7&nbsp;million and had a net loss of
$1.0&nbsp;million, compared to revenues of $10.1&nbsp;million and a net loss of $0.9&nbsp;million for the three months ended March&nbsp;31, 2015. Due to seasonality of our product sales,
during the first quarter of each year, we typically experience reduced revenues compared to our other quarters and a net loss. As of March&nbsp;31, 2016, we had an accumulated deficit of
$6.9&nbsp;million. Our primary sources of capital to date have been from operating income and private placements of our capital stock. We operate in one segment. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Components of our Results of Operations  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Revenues  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We derive our revenues from the sale of our Flexitouch, ACTitouch and Entr&eacute; systems to patients in the United States. Revenue growth
has been driven by increased clinician, patient and payer awareness of lymphedema and the clinical efficacy of our Flexitouch System, and launch of our ACTitouch and Entr&eacute; systems in
2013. We have expanded our direct sales force that helps us drive and support our revenue growth and intend to continue this expansion. However, any reversal in these recent trends could have a
negative impact on our future revenues. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
revenues have fluctuated, and we expect our revenues to continue to fluctuate, from quarter to quarter due to a variety of factors. For instance, our fourth quarter tends to be our strongest
quarter of the year. See "&#151;&nbsp;Seasonality" for a further discussion of factors contributing to seasonality. Further, our revenues are impacted by fluctuations in the mix of products
being sold during each period and changes in the mix of our payers. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
sell our products directly to patients, who are referred to us by physicians, therapists or nurses. We bill payers, such as private insurers, Medicare, the Veterans Administration or Medicaid, on
behalf of our patients and bill patients directly for their cost-sharing amounts, including any portion of an unsatisfied deductible and any copayments or co-insurance. Approximately 15% of our
revenues in 2015 and 12% of our revenues in the three months ended March&nbsp;31, 2016, came from Medicare patients. A recent change to the level of Medicare coverage for our products could reduce
the number of Medicare patients who have access to our products, and we are seeking to have the coverage determination overturned. Our products currently are not subject to the competitive bidding
process for supplying covered items to Medicare recipients. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
expect our revenues to continue to increase in the future as a result of increased awareness of our solutions, expansion of our direct sales force, marketing and customer support efforts, continued
focus on developing clinical and economic outcome data, expanded third-party reimbursement and introduction of our solutions outside the United States. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>71</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=76,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=393506,FOLIO='71',FILE='DISK131:[15ZBY1.15ZBY12201]DS12201A.;113',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_ds12201_1_72"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Cost of Goods Sold and Gross Margin  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Cost of goods sold consists primarily of component costs, direct labor, overhead costs, product warranties, provisions for slow-moving and obsolete
inventory and delivery costs for items sold. A significant portion of our cost of goods sold consists of manufacturing overhead costs. These overhead costs include the cost of quality assurance,
material procurement, inventory control, facilities, equipment and operations supervision and management. We expect overhead costs as a percentage of revenues to decrease as a result of expected
increases in production volume and yields. Cost of goods sold also includes depreciation expense for product tooling, production equipment and shipping costs. See Note&nbsp;5 to our financial
statements included elsewhere in this prospectus for a description of our royalty payments. We expect cost of goods sold to increase in absolute dollars primarily if, and to the extent, our revenues
grow. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
provide a warranty on our devices ranging from one to two years for the controller, and one year for the garment. We establish a reserve for warranty repairs based on historical warranty repair
costs incurred. Provisions for warranty obligations, which are included in cost of goods sold, are recorded at the time of shipment. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
calculate gross margin as gross profit divided by revenues. Our gross margin has been and will continue to be affected by a variety of factors, including product and payer mix, production volumes,
manufacturing costs and cost-reduction strategies. We expect our gross margin to decrease slightly over the near term as we increase the percentage of total revenues from our ACTitouch and
Entr&eacute; systems. However, our gross margin will likely fluctuate from quarter to quarter. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Sales and Marketing Expenses  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our sales and marketing expenses support our direct-to-patient and -provider model. These expenses consist primarily of personnel-related expenses,
including salaries, bonuses, commissions and benefits for employees. They also include expenses for patient home training, social media and advertising, informational kits, public relations and other
promotional and marketing activities, field sales travel and entertainment expenses, trade shows and conferences, stock-based compensation, as well as customer service. We expect sales and marketing
expenses to continue to increase in absolute dollars as we expand our commercial infrastructure to drive and support our planned revenue growth. To the extent our revenues grow, we expect sales and
marketing expenses to decrease as a percentage of revenues over time. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Research and Development Expenses  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Research and development, or R&amp;D, expenses consist primarily of personnel-related expenses, third-party product development costs, laboratory
supplies, consulting fees and related costs, clinical research expenses, expenses related to clinical and regulatory affairs, patent amortization costs, stock-based compensation and patent legal fees,
including defense costs and testing costs for new product launches. Clinical research expenses include clinical trial management and monitoring, payment to clinical investigators, consulting fees,
data management, stock-based compensation, travel expenses and the cost of manufacturing products for clinical trials. We have made substantial investments in R&amp;D since our inception. Our R&amp;D efforts
have focused primarily on activities designed to enhance our technologies and to support development and commercialization of new and existing products. We expect R&amp;D expenses to increase in absolute
dollars for the foreseeable future as we continue to develop, enhance and commercialize new products and expand clinical trial efforts. We expect R&amp;D expenses as a percentage of our revenues to vary
over time depending on the level and timing of initiating new product development efforts, as well as our clinical trial activities. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>72</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=77,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=420318,FOLIO='72',FILE='DISK131:[15ZBY1.15ZBY12201]DS12201A.;113',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_ds12201_1_73"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Reimbursement, General and Administrative Expenses  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Reimbursement, general and administrative expenses consist primarily of compensation, including salaries, bonuses and benefits for employees in our
patient services and advocacy, billing and collections, case management, payer relations and governmental affairs and reimbursement authorization departments, as well as finance, human resources and
administration, information technology, business development and general management functions, and facilities costs. Our experienced reimbursement authorization department of over 55&nbsp;people
focuses on verifying case-by-case benefits, obtaining prior authorization, billing and collecting payments from payers and providing customer support services. Reimbursement authorization department
expenses also include consulting, travel to payer case manager seminars, professional development and training and certification expenses. General and administrative expenses also include professional
services, such as legal, consulting and accounting services, stock-based compensation, travel expenses and insurance costs. We expect to incur additional legal, accounting, insurance and other
professional service fees associated with being a public company, which may increase further when we are no longer able to rely on the "emerging growth company" exemption we are afforded under the
JOBS Act. We expect our reimbursement, general and administrative expenses to increase in absolute dollars, but decrease as a percentage of our revenues, to the extent our revenues grow. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Income (Expense), Net  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Other income (expense), net consists primarily of interest expense related to our notes payable and interest income driven by the interest accruing
on cash and past due insurance balances. We do not accrue interest on a majority of past due customer accounts receivable balances. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Income Tax Expense (Benefit)  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our income tax expense (benefit) consists primarily of deferred income taxes resulting from temporary differences between the reporting of amounts
for financial statement purposes and income tax purposes. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>73</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=78,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=760257,FOLIO='73',FILE='DISK131:[15ZBY1.15ZBY12201]DS12201A.;113',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_ds12201_1_74"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Results of Operations  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Comparison of the Three Months Ended March&nbsp;31, 2015 and 2016  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following table sets forth our results of operations for the three months ended March&nbsp;31, 2015 and 2016: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Three Months Ended<BR>
March&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>% Change </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands, except percentages)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Consolidated Statement of Operations Data:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Revenues</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,121</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>13,700</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Cost of goods sold</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,972</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,811</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>28 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Gross profit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,149</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9,889</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>38 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Operating expenses:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Sales and marketing</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,169</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,281</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>41</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Research and development</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>817</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>980</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Reimbursement, general and administrative</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,647</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,414</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>29 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total operating expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8,633</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>11,675</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Loss from operations</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,484</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,786</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Other income:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>* </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Loss before income taxes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,472</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,781</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income tax benefit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(592</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(801</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net loss</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(880</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(980</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>11 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*Not
meaningful. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Revenues  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Revenues increased $3.6&nbsp;million, or 35%, to $13.7&nbsp;million during the three months ended March&nbsp;31, 2016 compared to
$10.1&nbsp;million during the three months ended March&nbsp;31, 2015. The growth in revenues was primarily attributable to an increase of approximately $2.8&nbsp;million, or 32%, in sales of our
Flexitouch System, a decrease of approximately $0.1&nbsp;million, or 24%, in sales of our ACTitouch System, and an increase of approximately $0.9&nbsp;million, or 156%, in sales of our
Entr&eacute; System. The increase in unit sales of our Flexitouch and Entr&eacute; Systems was driven by expansion of our sales force and increased physician and patient awareness. The
decrease in unit sales of our ACTitouch System was due to product mix, particularly within the Veterans Administration hospitals in favor of the Flexitouch System. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>74</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=79,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=173306,FOLIO='74',FILE='DISK131:[15ZBY1.15ZBY12201]DS12201A.;113',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_ds12201_1_75"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table summarizes our revenues by product for the three months ended March&nbsp;31, 2015 and 2016 both in dollars and percentage of total revenues: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Three Months<BR>
Ended March&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>% Change </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands, except percentages)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Revenues</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Flexitouch System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8,885</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>11,709</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>32</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>ACTitouch System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>651</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>496</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(24</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Entr&eacute; System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>585</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,495</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>156 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,121</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>13,700</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Percentage of total revenues</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Flexitouch System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>88</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>85</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>ACTitouch System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Entr&eacute; System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>11</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Cost of Goods Sold and Gross Margin  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Cost of goods sold increased $0.8&nbsp;million, or 28%, to $3.8&nbsp;million during the three months ended March&nbsp;31, 2016, compared to
$3.0&nbsp;million during the three months ended March&nbsp;31, 2015. The increase in cost of goods sold was primarily attributable to an increase in the number of systems sold. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Gross
margin for the three months ended March&nbsp;31, 2016 increased slightly to 72.2% compared to 70.6% for the three months ended March&nbsp;31, 2015. The increase in gross margin was primarily
due to the growth in sales of our Flexitouch and Entr&eacute; Systems, which have higher gross margins than our ACTitouch System. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Sales and Marketing Expenses  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Sales and marketing expenses increased $2.1&nbsp;million, or 41%, to $7.3&nbsp;million during the three months ended March&nbsp;31, 2016,
compared to $5.2&nbsp;million during the three months ended March&nbsp;31, 2015. The increase was primarily attributable to a $1.2&nbsp;million increase in compensation expenses as a result of
increased sales and marketing headcount. In addition, other sales and marketing expenses increased $0.9&nbsp;million due to increased field sales meeting, travel and entertainment, consulting and
field sales training expenses. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Research and Development Expenses  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>R&amp;D expenses increased $0.2&nbsp;million, or 20%, to $1.0&nbsp;million during the three months ended March&nbsp;31, 2016, compared to
$0.8&nbsp;million during the three months ended March&nbsp;31, 2015. The increase in R&amp;D expenses was primarily attributable to increases in product development and clinical study costs. In
addition, compensation and other personnel-related expenses increased. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Reimbursement, General and Administrative Expenses  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Reimbursement, general and administrative expenses increased $0.8&nbsp;million, or 29%, to $3.4&nbsp;million during the three months ended
March&nbsp;31, 2016, compared to $2.6&nbsp;million during the three months ended March&nbsp;31, 2015. The increase in reimbursement, general and administrative expenses was primarily
attributable to an increase in personnel-related expenses as a result of increased headcount on our patient services, contracting, case management, billing and collections, advocacy, reimbursement and
administrative teams, as well as higher facility costs for rent, utilities, property taxes and maintenance. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>75</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=80,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=81769,FOLIO='75',FILE='DISK131:[15ZBY1.15ZBY12201]DS12201A.;113',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_du12201_1_76"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Income (Expense), Net  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Other income (expense), net, was less than $20,000 during the three months ended March&nbsp;31, 2016 and 2015. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Comparison of the Years Ended December&nbsp;31, 2014 and 2015  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following table sets forth our results of operations for the years ended December&nbsp;31, 2014 and 2015: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>% Change </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands, except percentages)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Consolidated Statement of Operations Data:</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Revenues</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>47,736</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>62,872</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>32</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Cost of goods sold</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12,715</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>16,908</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>33 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Gross profit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35,021</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>45,964</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>31 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Operating expenses:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Sales and marketing</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>18,154</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>24,485</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Research and development</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,843</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,312</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>52</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Reimbursement, general and administrative</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,225</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>13,716</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>34 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total operating expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>31,222</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>42,513</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>36 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income from operations</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,799</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,451</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(9</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Other expense</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(194</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>* </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income before income taxes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,795</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,257</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(14</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income tax expense</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,725</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,864</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,070</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,393</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(33</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*Not
meaningful. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Revenues  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Revenues increased $15.1&nbsp;million, or 32%, to $62.9&nbsp;million during the year ended December&nbsp;31, 2015, compared to
$47.7&nbsp;million during the year ended December&nbsp;31, 2014. The growth in revenues was primarily attributable to an increase of approximately $11.0&nbsp;million, or 25%, in sales of our
Flexitouch System, an increase of approximately $0.9&nbsp;million, or 37%, in sales of our ACTitouch System, and an increase of approximately $3.2&nbsp;million, or 198%, in sales of our
Entr&eacute; System. The increase in unit sales of our Flexitouch System was driven by expansion of our sales force and increased physician and patient awareness. The increase in unit sales of
our ACTitouch System was due to continued penetration of wound clinics, particularly within Veterans Administration hospitals. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>76</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=81,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=104545,FOLIO='76',FILE='DISK131:[15ZBY1.15ZBY12201]DU12201A.;132',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_du12201_1_77"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table summarizes our revenues by product for the years ended December&nbsp;31, 2014 and 2015 both in dollars and percentage of total revenues: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>% Change </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands, except percentages)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Revenues</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Flexitouch System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>43,738</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>54,748</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>25</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>ACTitouch System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,357</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,234</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>37</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Entr&eacute; System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,641</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,890</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>198 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>47,736</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>62,872</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>32 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Percentage of total revenues</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Flexitouch System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>92</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>87</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>ACTitouch System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Entr&eacute; System</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Cost of Goods Sold and Gross Margin  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Cost of goods sold increased $4.2&nbsp;million, or 33%, to $16.9&nbsp;million during the year ended December&nbsp;31, 2015, compared to
$12.7&nbsp;million during the year ended December&nbsp;31, 2014. The increase in cost of goods sold was primarily attributable to an increase in the number of systems sold, partially offset by
reduced material and labor costs for our products associated with better sourcing and increased volumes. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Gross
margin for the year ended December&nbsp;31, 2015 of 73.1% was essentially flat compared to gross margin of 73.4% for the year ended December&nbsp;31, 2014. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Sales and Marketing Expenses  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Sales and marketing expenses increased $6.3&nbsp;million, or 35%, to $24.5&nbsp;million during the year ended December&nbsp;31, 2015, compared
to $18.2&nbsp;million during the year ended December&nbsp;31, 2014. The increase was primarily attributable to a $4.7&nbsp;million increase in personnel-related compensation expenses as a result
of increased sales and marketing headcount. In addition, other sales and marketing expenses increased $1.6&nbsp;million due to increased field sales travel expenses, trade show and conference
expenses and patient training costs. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Research and Development Expenses  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>R&amp;D expenses increased $1.5&nbsp;million, or 52%, to $4.3&nbsp;million during the year ended December&nbsp;31, 2015, compared to
$2.8&nbsp;million during the year ended December&nbsp;31, 2014. The increase in R&amp;D expenses was primarily attributable to increases in product development and consulting costs of
$1.2&nbsp;million and clinical study costs of $0.2&nbsp;million. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Reimbursement, General and Administrative Expenses  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Reimbursement, general and administrative expenses increased $3.5&nbsp;million, or 34%, to $13.7&nbsp;million during the year ended
December&nbsp;31, 2015, compared to $10.2&nbsp;million during the year ended December&nbsp;31, 2014. The increase in reimbursement, general and administrative expenses was primarily attributable
to a $1.7&nbsp;million increase in personnel-related expenses as a result of increased headcount on our patient services, contracting, case management, billing and collections, advocacy,
reimbursement </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>77</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=82,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=495834,FOLIO='77',FILE='DISK131:[15ZBY1.15ZBY12201]DU12201A.;132',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_du12201_1_78"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>and
administrative teams, an increase of $1.0&nbsp;million in professional, legal, accounting and information technology costs, and higher facility costs of $0.2&nbsp;million for new office space,
utilities, property taxes and maintenance. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Expense  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Other expense increased to $0.2&nbsp;million during the year ended December&nbsp;31, 2015 due primarily to interest expense recognized on minimum
royalty payments. Other expense was less than $5,000 during the year ended December&nbsp;31, 2014. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Quarterly Results of Operations Data </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table sets forth our unaudited quarterly statements of consolidated operations data and other data for each of the eight most recent quarters in the period
ended March&nbsp;31, 2016. We have prepared the quarterly results of operations data on a consistent basis with the audited consolidated financial statements included elsewhere in this prospectus.
In the opinion of management, the quarterly results of operations data reflect all necessary adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of this data.
The statements of consolidated operations data should be read in conjunction with the consolidated financial statements and related notes included elsewhere in this prospectus. The results of
historical periods are not necessarily indicative of results for a full year or for any future period. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="65pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="65pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=23 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Three Months Ended </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>June&nbsp;30,<BR>
2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>September&nbsp;30,<BR>
2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>December&nbsp;31,<BR>
2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>March&nbsp;31,<BR>
2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>June&nbsp;30,<BR>
2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>September&nbsp;30,<BR>
2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>December&nbsp;31,<BR>
2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>March&nbsp;31,<BR>
2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=23 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands, except percentages)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Revenues</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,965</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>11,898</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>18,110</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,121</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>14,771</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>16,820</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21,160</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>13,700</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Cost of goods sold</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,963</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,310</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,431</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,972</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,401</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,466</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,069</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,811 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:16pt;text-indent:-8pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Gross profit</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8,002</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8,588</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>13,679</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,149</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,370</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12,354</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>16,091</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9,889 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:16pt;text-indent:-8pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>Gross margin </I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>73.0</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>%</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>72.2</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>%</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>75.5</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>%</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>70.6</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>%</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>70.2</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>%</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>73.4</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>%</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>76.0</I></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>72.2</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Operating expenses:</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:16pt;text-indent:-8pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Sales and marketing</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,134</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,499</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,697</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,169</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,929</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,199</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,188</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,281</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:16pt;text-indent:-8pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Research and development</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>686</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>700</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>912</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>817</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,011</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,094</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,390</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>980</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:16pt;text-indent:-8pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Reimbursement, general and administrative</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,504</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,783</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,806</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,647</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,202</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,599</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,268</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,414 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total operating expenses</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,324</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,982</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9,415</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8,633</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,142</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,892</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12,846</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>11,675 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income (loss) from operations</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>678</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>606</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,264</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,484</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>228</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,462</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,245</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,786</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Other income (expense)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(16</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(212</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income (loss) before income taxes</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>683</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>610</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,248</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,472</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>231</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,465</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,033</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,781</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income tax expense (benefit)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>260</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>232</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,896</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(592</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>93</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>589</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,774</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(801</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>423</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>378</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,352</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(880</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>138</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>876</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,259</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(980</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>78</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=83,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=477643,FOLIO='78',FILE='DISK131:[15ZBY1.15ZBY12201]DU12201A.;132',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_du12201_1_79"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Seasonality  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our business may be affected by seasonality. In the first quarter of each year, when most patients have started a new insurance year and have not
paid their annual insurance deductibles, we experience substantially reduced demand for our products. We typically experience higher sales in the third and fourth quarters as a result of patients
having paid their annual insurance deductibles in full, thereby reducing their out-of-pocket costs for our products, or because patients often spend the remaining balances in their flexible-spending
accounts. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Liquidity and Capital Resources  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As of March&nbsp;31, 2016, we had cash and cash equivalents of $5.8&nbsp;million and an accumulated deficit of $6.9&nbsp;million, compared to
cash and cash equivalents of $7.1&nbsp;million and an accumulated deficit of $5.7&nbsp;million as of December&nbsp;31, 2015. Our primary sources of capital have
been from operating income and private placements of our capital stock. As of March&nbsp;31, 2016, we had raised net proceeds of $31.2&nbsp;million from private placements of our capital stock. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Cash Flows  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following table summarizes our cash flows for the periods indicated: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Three Months Ended<BR>
March&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(In thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net cash provided by (used in):</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Operating activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(991</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,358</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(438</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,236</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Investing activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(353</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(615</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(150</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(165</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Financing activities</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>221</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>901</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>128 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net increase (decrease) in cash and cash equivalents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,123</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,644</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(584</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,273</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Net Cash Provided By (Used in) Operating Activities  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Net cash used in operating activities during the three months ended March&nbsp;31, 2016 was $1.2&nbsp;million, consisting primarily of our net
loss of $1.0&nbsp;million and an increase of
$0.8&nbsp;million in deferred income taxes asset, offset by a non-cash expense of $0.3&nbsp;million. The cash used in operations was primarily due to the ongoing commercialization of our products.
The non-cash expense items primarily consisted of depreciation and amortization of equipment and leasehold improvements and patents and stock-based compensation. Our net operating assets and
liabilities decreased $0.3&nbsp;million. The decrease in our net operating assets and liabilities was primarily due to decreases in inventory, increased collections on accounts receivable and
decreases in accrued compensation and expenses and increases accounts payable. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Net
cash used in operating activities during the three months ended March&nbsp;31, 2015 was $0.4&nbsp;million, consisting primarily of our net loss of $0.9&nbsp;million and an increase of
$0.6&nbsp;million in deferred income taxes asset, offset by a non-cash expense of $0.3&nbsp;million. The cash used in operations was primarily due to the ongoing commercialization of our products.
The non-cash expense items primarily consisted of depreciation and amortization of equipment and leasehold improvements and patents and stock-based compensation. Our net operating assets and
liabilities decreased $0.8&nbsp;million. The decrease in our net operating assets and liabilities was primarily due to increased collections on accounts </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>79</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=84,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=124643,FOLIO='79',FILE='DISK131:[15ZBY1.15ZBY12201]DU12201A.;132',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_du12201_1_80"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>receivable
and an increase in accrued payroll offset by increased inventory and a decrease in accrued expenses. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Net
cash provided by operating activities during the year ended December&nbsp;31, 2015 was $1.4&nbsp;million, consisting primarily of our net income of $1.4&nbsp;million, a decrease of
$0.9&nbsp;million in deferred income tax assets, a $0.1&nbsp;million provision for doubtful accounts and a non-cash expense of $1.1&nbsp;million. The cash provided by operations was primarily
due to the ongoing commercialization of our products, as well as increased accounts receivable, inventory, prepaid expenses and other non-current assets, offset by increased accounts payable, accrued
compensation and accrued expenses. The non-cash expense items primarily consisted of depreciation and amortization of equipment and leasehold improvements and patents and stock-based compensation. Our
net operating assets and liabilities increased $2.1&nbsp;million. The increase in our net operating assets and liabilities was primarily due to increased accounts receivable, inventory, and other
non-current assets. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Net
cash used in operating activities during the year ended December&nbsp;31, 2014 was $1.0&nbsp;million, consisting primarily of our net income of $2.1&nbsp;million, a decrease of
$1.6&nbsp;million in deferred income tax assets, a $0.5&nbsp;million provision for doubtful accounts and a non-cash expense of $0.8&nbsp;million. The cash used in operations was primarily due to
the ongoing commercialization of our products, as well as increased accounts receivable and inventory and decreased accrued compensation, offset by increased accounts payable. The non-cash expense
items primarily consisted of depreciation and amortization of equipment and leasehold improvements and patents and stock-based compensation. Our net operating assets and liabilities increased
$6.0&nbsp;million. The increase in our net operating assets and liabilities was primarily due to increased accounts receivable and inventory. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Net Cash Used in Investing Activities  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Net cash used in investing activities during the three months ended March&nbsp;31, 2016, was $0.2&nbsp;million, consisting of product tooling and
computer and manufacturing equipment. Net cash used in investing activities during the three months ended March&nbsp;31, 2015 was $0.2&nbsp;million, consisting of product tooling and computer and
manufacturing equipment. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Net
cash used in investing activities during the year ended December&nbsp;31, 2015, was $0.6&nbsp;million, consisting of product tooling and computer and manufacturing equipment. Net cash used in
investing activities during the year ended December&nbsp;31, 2014 was $0.4&nbsp;million, consisting of product tooling and computer and manufacturing equipment. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Net Cash Provided by Financing Activities  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Historically, we have funded our operations through the issuance of capital stock. Net cash provided by financing activities during the three months
ended March&nbsp;31, 2016, was $0.1&nbsp;million, consisting of proceeds from exercise of stock options. Net cash provided by financing activities during the three months ended March&nbsp;31,
2015 was minimal, consisting of proceeds from exercise of stock options, partially offset by minimal repayments of borrowings. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Net
cash provided by financing activities during the year ended December&nbsp;31, 2015, was $0.9&nbsp;million, consisting of proceeds from exercise of common stock options and warrants partially
offset by minimal repayments of borrowings. Net cash provided by financing activities during the year ended December&nbsp;31, 2014 was $0.2&nbsp;million, consisting of proceeds from exercise of
stock options, partially offset by minimal repayments of borrowings. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>80</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=85,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=733966,FOLIO='80',FILE='DISK131:[15ZBY1.15ZBY12201]DU12201A.;132',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dw12201_1_81"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Credit Line  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As of March&nbsp;31, 2016, we had a credit line with Venture Bank with borrowing availability of $2.0&nbsp;million, which we refer to as our
credit line. As of March&nbsp;31, 2016, we did not have any outstanding borrowings under our credit line. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


Our credit line bears interest based on the prime rate, which was 3.50% as of March&nbsp;31, 2016. On May&nbsp;11, 2016, we extended our credit line until May&nbsp;11, 2017. Our credit line is
secured by substantially all our assets, including property and equipment, accounts receivable and inventory. Our credit line contains customary conditions to borrowing, events of default and
covenants, including covenants that restrict our ability to dispose of assets, merge with or acquire other entities, incur indebtedness and encumbrances. In addition, we complied with certain
financial covenants relating to liquidity and leverage ratios until the renewal in May 2015 that released us from our covenant obligations.


</FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Off-Balance Sheet Arrangements  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements, as defined under the applicable
regulations. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Contractual Obligations  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following table summarizes our contractual obligations as of December&nbsp;31, 2015. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Payments Due by Period </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Less Than<BR>
1&nbsp;Year </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2-3<BR>
Years </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>4-5<BR>
Years </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>More Than<BR>
5&nbsp;Years </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Total </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>(In thousands)</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Operating lease obligations<SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>507</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,002</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,035</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>308</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,852</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Future product royalties<SUP>(2)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>991</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>991</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Purchase commitments<SUP>(3)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8,937</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,811</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>13,748 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,435</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,813</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,035</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>308</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>17,591 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>We
currently lease approximately 52,000 square feet of office and assembly space at our corporate headquarters in Minneapolis, Minnesota under
a lease that expires in July 2021.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>We
are required to make royalty payments to a third-party for our ACTitouch System through 2023. We are required to make quarterly payments
through 2023, with guaranteed payments through the third quarter of 2016, and for the remaining period equal to 6% of our quarterly revenues attributable to our ACTitouch System. In any year that
these revenues exceed $40&nbsp;million, we are required to pay 7% on revenues over $40&nbsp;million and 6% on revenues $40&nbsp;million and under.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Represents
purchase orders issued in March&nbsp;2015 to vendors for inventory expected to be received in 2016 and purchase orders issued in
February&nbsp;2016 to vendors for inventory expected to be received in 2016 and 2017. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Quantitative and Qualitative Disclosures about Market Risk  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Interest Rate Risk  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are exposed to market risk from changes in interest rates, primarily related to our investment activities. The principal objectives of our
investment activities are to preserve principal, provide liquidity and maximize income consistent with minimizing risk of material loss. The
recorded carrying amounts of cash and cash equivalents approximate fair value due to their short maturities. Our interest income is sensitive to changes in the general level of interest rates in the
United States, particularly since our investments are generally short-term in nature. Due to the nature of our short-term investments, an immediate 100 basis point change in interest rates would not
have a material effect on the fair market value of our portfolio. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>81</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=86,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=873823,FOLIO='81',FILE='DISK131:[15ZBY1.15ZBY12201]DW12201A.;110',USER='DSCHWAR',CD=';8-JUN-2016;19:29' -->
<A NAME="page_dw12201_1_82"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Additionally,
the interest rates for our credit line have both fixed and variable components. If overall interest rates had increased by 100 basis points during the periods presented, our interest
expense would not have been materially affected. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Inflation  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Inflationary factors, such as increases in our cost of goods sold, sales and marketing expenses and reimbursement expenses, may adversely affect our
operating results. Although we do not believe that inflation has had a material impact on our financial condition or results of operations to date, a high rate of inflation in the future may have an
adverse effect on our ability to maintain and increase our gross margin, and on our sales and marketing and reimbursement expenses as a percentage of our revenues if the selling prices of our products
do not increase as much or more than these increased costs. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Credit Risk  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As of December&nbsp;31, 2014 and 2015 and March&nbsp;31, 2016, our cash and cash equivalents were maintained with one financial institution in
the United states and our current deposits are likely in excess of insured limits. We have reviewed the financial statements of this institution and believe it has sufficient assets and liquidity to
conduct its operations in the ordinary course of business with little or no credit risk to us. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
accounts receivable primarily relate to revenues from the sale of our products to patients in the United States. For the year ended December&nbsp;31, 2014 and 2015 and for the three months ended
March&nbsp;31, 2016, our accounts receivable were $15.0&nbsp;million, $16.2&nbsp;million and $13.5&nbsp;million, respectively. We had accounts receivable from three insurance companies
representing approximately 21%, 16% and 4% of accounts receivable as of March&nbsp;31, 2016 and we had accounts receivable from two insurance companies representing approximately 25% and 20% of
accounts receivable as of March&nbsp;31, 2015. We had accounts receivable from three insurance companies representing approximately 26%, 18% and 7% of accounts receivable as of December&nbsp;31,
2015 and we had accounts receivable from three insurance companies representing approximately 25%, 24% and 5% of accounts receivable as of December&nbsp;31, 2014. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Foreign Currency Risk  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our business is conducted in U.S. dollars and foreign transactions have been minimal. As we begin building relationships to commercialize our
products internationally, our results of operations and cash flows may become increasingly subject to changes in foreign exchange rates. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Critical Accounting Policies and Significant Estimates  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our discussion and analysis of our financial condition and results of operations are based upon our financial statements which have been prepared in
accordance with generally accepted accounting principles in the United States, or GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the
reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities, revenues and expenses at the date of the financial statements. Generally, we base our estimates
on historical experience and on various other assumptions in accordance with GAAP that we believe to be reasonable under the circumstances. Actual results may differ from these estimates and such
differences could be material to our financial position and results of operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>While
our significant accounting policies are more fully described in Note&nbsp;1 to our consolidated financial statements included elsewhere in this prospectus, we believe the following discussion
addresses our most critical accounting policies, which are those that are most important to the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>82</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=87,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=495985,FOLIO='82',FILE='DISK131:[15ZBY1.15ZBY12201]DW12201A.;110',USER='DSCHWAR',CD=';8-JUN-2016;19:29' -->
<A NAME="page_dw12201_1_83"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>portrayal
of our financial condition and results of operations and require our most difficult, subjective and complex judgments. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Revenue Recognition  </I></B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We recognize revenue when persuasive evidence of a sale arrangement exists, delivery of product has occurred through the transfer of title and risks
of reward of ownership, the selling price is fixed or determinable and collectability is reasonably assessed. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
distribute our products directly to patients. For any of our products sold to patients covered by private payers, such as commercial insurance companies, we recognize revenues from such sales upon
shipment of our products. A product is not shipped until we have received a prescription from a physician for our products and, as applicable, receipt of prior authorization from payers. At shipment,
we invoice the payer for their portion of the total product cost and we recognize revenue as a percentage of the payer's invoice based on the polices and payment history of the applicable payer. The
payment history of the applicable payer is drawn from our actual payment experience over the last three years. Any differences in payments received as compared to our estimates are recognized in the
period for which we actually receive payment for the product. Over time, we adjust the applicable estimates used for each payer to reflect any such differences. We separately invoice the patient for
their payment obligation with respect to the shipped product, such as copayments and deductibles, and recognize revenue upon sending such invoice. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
any of our products sold to Medicare patients, we recognize revenues from such sales upon shipment of our products, which can occur only after we have received a prescription from a physician and
all applicable Medicare documentation. We estimate the revenue on each shipment to a Medicare patient as a percentage of the total invoice based on the payment history of each regional administrative
contractor. While we have contracted rates with Medicare, to the extent any claims for reimbursement are denied, we will recognize any necessary adjustments in the period for which the adjustment is
made. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Accounts Receivable  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The majority of our accounts receivable and revenues are from commercial insurance payers and government payers, such as Medicare, Veterans
Administration and Medicaid. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Accounts
receivable are carried net of allowances for estimated non-receipt of patient co-payment and deductible obligations and allowances for uncollectible accounts. We believe all accounts
receivable in excess of the allowance are fully collectible. We do not accrue interest on a majority of the past due accounts receivable. We determine when accounts become past due on a customer by
customer basis. If accounts receivables in excess of the provided allowance are determined uncollectible, they are charged to expense in the quarter that determination is made and accounts receivable
are written off after all collection efforts have failed. A portion of our claims to Medicare are initially denied, and enter the appeals process, where many are ultimately reviewed by an
Administrative Law Judge. After final adjudication of all claims, approximately 90% of the claims submitted are approved (this is on a number of claims, not a dollars claimed, basis). Historically, we
successfully appealed 90% of our initial Medicare claims denials. The appeal process can be lengthy, lasting more than a year in most cases. Accordingly, we classify a portion of our Medicare accounts
receivable as non-current based on our experience with Medicare. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As
an alternative to individual appeals, Medicare may seek to settle a number of outstanding appeals at one time through a settlement conference. On September&nbsp;3, 2015, we entered into a
settlement agreement with the Centers for Medicare and Medicaid Services, or CMS, for 247&nbsp;claims, representing approximately $1.46&nbsp;million of original claims based on the Medicare
allowable rates, in which we </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>83</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=88,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=200880,FOLIO='83',FILE='DISK131:[15ZBY1.15ZBY12201]DW12201A.;110',USER='DSCHWAR',CD=';8-JUN-2016;19:29' -->
<A NAME="page_dw12201_1_84"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>had
submitted a request for an Administrative Law Judge hearing in 2013. The settlement entitled us to receive a payment of approximately $0.85&nbsp;million. We received this full amount during the
fourth quarter of 2015. The settlement resulted in a reduction in the fourth quarter of 2015 of $0.82&nbsp;million in our accounts receivable for shipment of products to patients covered by
Medicare. The settlement was part of a pilot program, facilitated by the Office of Medicare Hearings and Appeals, to address a backlog of overdue claims awaiting Administrative Law Judge adjudication.
Because the settlement is part of a pilot program, we cannot predict whether we will be able to conclude future settlements with Medicare or achieve settlements on similar terms. Any future settlement
of claims for amounts less than the corresponding amounts receivable would result in a write off. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock-Based Compensation  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We account for stock-based compensation awards at the fair value on the date of grant expensed over the applicable vesting period. The fair value of
options on the grant date is estimated using the Black-Scholes option-pricing model. We recognize the fair value of each award as an expense on a straight-line basis over the requisite service period,
which is generally the vesting period of the equity grant. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Black-Scholes option-pricing model requires the input of highly subjective assumptions, including the expected term of the option, the expected volatility of the price of our common stock, the
risk-free interest rate and the expected dividend yield. These estimates involve inherent uncertainties and the significant application of management's judgment. If factors change and different
assumptions are used, our stock-based compensation expense could be materially different in the future. We determined weighted-average valuation assumptions as follows: </FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Expected term.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We use the "simplified method" to
determine the expected term of the stock option.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Expected volatility.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our expected volatility is derived
using the historical volatility of a public company of similar size and industry because we believe the expected volatility will approximate historical volatility, due to the fact that we have no
trading history.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Risk-free interest rate.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;The risk free interest rate is
based on the yields of U.S. Treasury securities with maturities similar to the expected term of the options for each option group.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Expected dividend yield.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We have never declared or paid
any cash dividends on our common stock and do not presently plan to pay cash dividends on our common stock in the foreseeable future. Consequently, we use an expected dividend yield of zero. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table summarizes the assumptions relating to our stock options for the years ended December&nbsp;31, 2014 and 2015 and the three months ended March&nbsp;31, 2015 and 2016: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Three Months<BR>
Ended<BR>
March&nbsp;31, </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2016 </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Expected term</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6&nbsp;years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6&nbsp;years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6&nbsp;years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Expected volatility</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>60%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>60%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>60%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Risk-free interest rate</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Expected dividend yield</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >


<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1>*</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>No
stock options were granted in the three month period ended March&nbsp;31, 2016. </FONT></DD></DL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>84</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=89,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=24582,FOLIO='84',FILE='DISK131:[15ZBY1.15ZBY12201]DW12201A.;110',USER='DSCHWAR',CD=';8-JUN-2016;19:29' -->
<A NAME="page_dw12201_1_85"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If in the future we determine that another method is more reasonable, or if another method for calculating these input assumptions is prescribed by
authoritative guidance, and, therefore, should be used to estimate volatility or expected life, the fair value calculated for our stock options could change significantly. Higher volatility and longer
expected lives result in an increase to stock-based compensation expense determined at the date of grant. Stock-based compensation expense affects our reimbursement, general and administrative
expenses. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
estimate our forfeiture rate based on an analysis of our actual forfeitures and will continue to evaluate the appropriateness of the forfeiture rate based on actual forfeiture experience, analysis
of employee turnover behavior and other factors. Quarterly changes in the estimated forfeiture rate can have a significant effect on reported stock-based compensation expense, as the cumulative effect
of adjusting the rate for all expense amortization is recognized in the period the forfeiture estimate is changed. If a revised forfeiture rate is higher than the previously estimated forfeiture rate,
an adjustment is made that will result in a decrease to the stock-based compensation expense recognized in the consolidated financial statements. If a revised forfeiture rate is lower than the
previously estimated forfeiture rate, an adjustment is made that will result in an increase to the stock-based compensation expense recognized in the consolidated financial statements. The effect of
forfeiture adjustments was insignificant for the years ended December&nbsp;31, 2014 and 2015 and the three months ended March&nbsp;31, 2015 and 2016. We will continue to use significant judgment
in evaluating the expected term, volatility and forfeiture rate related to our stock-based compensation. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
fair value of the common stock underlying our equity compensation awards was historically determined by our board of directors, with input from management and third-party valuations on an annual
basis. We believe that our board of directors has the relevant experience and expertise to determine the fair value of our common stock. However, the fair value of our common stock may vary
significantly in the future and from the estimates previously made. Given the absence of a public trading market for our common stock, our board of directors exercised reasonable judgment and
considered numerous objective and subjective factors to determine the best estimate of the fair value of our common stock using methodologies, approaches and assumptions consistent with the American
Institute of Certified Public Accountants, or AICPA, Audit and Accounting Practice Aid Series: </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>Valuation of Privately Held Company Equity Securities Issued as
Compensation</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>, known as the AICPA Accounting and Valuation Guide. The following factors, among others, were considered:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our results of operations, history of losses and other financial metrics; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our capital resources and financial condition; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the contemporaneous valuations of our common stock by an unrelated third-party valuation firm; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the prices of our convertible redeemable preferred stock sold to outside investors in arms-length transactions; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the rights, preferences and privileges of our preferred stock relative to those of our common stock; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the rights of freestanding warrants and other similar instruments related to our securities that are redeemable; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the hiring of key personnel; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the introduction of new products; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>85</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=90,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=160747,FOLIO='85',FILE='DISK131:[15ZBY1.15ZBY12201]DW12201A.;110',USER='DSCHWAR',CD=';8-JUN-2016;19:29' -->
<A NAME="page_dw12201_1_86"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the fact that the common stock underlying the option grants involves illiquid securities in a private company; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the risks inherent in the development and expansion of our products and services; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the likelihood of achieving a liquidity event, such as an initial public offering or sale of our company given prevailing market
conditions. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
valuing our common stock, since January&nbsp;1, 2014, our board of directors determined the equity value of our business using the market approach valuation method and the income approach
valuation method to determine the enterprise value. For 2014, our board of directors exclusively used the market approach valuation method. For 2015, these two approaches were initially weighted
equally. During 2015, we received a summary valuation from the lead underwriters for this offering. In the second half of 2015 we reviewed our fair value determinations for 2015, effectively modifying
our valuation approach for 2015 to include this summary valuation as a third factor in determining fair value, along with the other approaches previously considered. Our board of directors then
considered the factors set forth above in reaching its determination of the fair value. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
market approach consists of both a comparable publicly traded company methodology and an M&amp;A transaction methodology to determine our enterprise value. The comparable publicly traded company
methodology analyzes publicly traded companies similar in industry and/or business model to our company. This methodology uses these guideline companies to develop relevant market multiples and
ratios, using metrics such as revenue, earnings before interest and taxes (EBIT), earnings before interest, taxes, depreciation and amortization (EBITDA), net income and/or tangible book value. These
multiples and values are then applied to our corresponding financial metrics. Since no two companies are perfectly comparable, premiums or discounts may be applied to the subject company's metrics if
its position in its industry is significantly different from the position of the guideline companies, or if its intangible attributes are significantly different. Our peer group of publicly traded
companies used for determination of the market trading multiples consists of six companies for 2015 and five companies for 2014 that focus primarily on providing lymphedema or wound care treatment
solutions or that are comparable based on our business model. There are, however, significant size and risk differences between our selected peer group of guideline public companies and us. The M&amp;A
transaction methodology uses actual prices paid in merger and acquisition transactions for companies similar to our company. Exit multiples of total purchase price paid to revenues, earnings before
interest and taxes (EBIT), earnings before interest, taxes, depreciation and amortization (EBITDA), net income and/or book value may be developed for each comparable transaction, if the data is
available. These multiples are then applied to our corresponding latest 12-month and projected financial metrics. The transactions used for determination of the multiples consisted of seven
transactions for 2015 and seven transactions for 2014. The transactions consisted of acquired companies that were similar to our company in terms of industry, size and/or developmental stage and
further refined that search to transactions in which the target company competed in an industry or supplied a service that was similar to that of our company. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
income approach determines our enterprise value on the basis of the estimated present value of our projected future cash flows and a residual value based on an exit or steady state terminal
multiple, which represents the future cash flows of our company beyond the discrete projection period. The estimates for future cash flows and the residual value are considered highly complex and
subjective. These future cash flows and residual are discounted to their present values using a discount rate derived from an analysis of the cost of capital of comparable publicly traded companies in
our industry or similar lines of business as of each valuation date and this discount rate is adjusted to reflect the risks inherent in our cash flows. The cost of capital is calculated based on
venture capital rates of return for our company's stage of development and risk profile. A venture capital rate of return of 25.0% is consistent with required returns identified in the AICPA
Accounting and Valuation Guide for companies at a similar stage. Once calculated, the results of the income approach were relied upon to determine an estimated enterprise value. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>86</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=91,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=179001,FOLIO='86',FILE='DISK131:[15ZBY1.15ZBY12201]DW12201A.;110',USER='DSCHWAR',CD=';8-JUN-2016;19:29' -->
<A NAME="page_dw12201_1_87"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Following
the closing of this offering, our board of directors will determine the fair value of our common stock based on the closing market price on The NASDAQ Global Market on the date of grant. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Recent Accounting Pronouncements  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Section&nbsp;107 of the JOBS Act provides that an "emerging growth company" can take advantage of the extended transition period provided in
Section&nbsp;7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an "emerging growth company" can delay the adoption of certain accounting
standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this exemption and, as a result, our financial statements may not be comparable to the
financial statements of issuers who are required to comply with the effective dates for new or revised accounting standards that are applicable to public companies. Section&nbsp;107 of the JOBS Act
provides that we can elect to opt out of the extended transition period at any time, which election is irrevocable. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
May 2014, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, No.&nbsp;2014-09, </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>Revenue from Contracts with
Customers</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>. The new section will replace Section&nbsp;605, </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>Revenue Recognition</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>, and creates modifications to various other
revenue accounting standards for specialized transactions and industries. The section is intended to conform revenue accounting principles with a concurrently issued International Financial Reporting
Standards to reconcile previously differing treatment between U.S. practices and those of the rest of the world and to enhance disclosures related to disaggregated revenue information. The updated
guidance is effective for annual reporting periods beginning on or after December&nbsp;15, 2017, and interim periods within those annual periods. We will adopt the new provisions of this accounting
standard at the beginning of fiscal year 2018, because early adoption is not allowed. We will further study the implications of this statement to evaluate the expected impact on our consolidated
financial statements. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
November 2015, the FASB issued ASU 2015-l7, Income Taxes: Balance Sheet Classification of Deferred Taxes, which requires entities to present deferred tax assets and deferred tax liabilities as
noncurrent in a classified balance sheet. The ASU is effective for annual periods beginning after December l5, 20l7, and interim periods within annual periods beginning after December&nbsp;15, 2018.
Early adoption is permitted for all entities. We are currently evaluating the impact of this new standard on our consolidated financial statements. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes the existing guidance for lease accounting, Leases (Topic 840), ASU 2016-02 requires lessees to recognize a lease
liability and a right-of-use asset for all leases. Lessor accounting remains largely unchanged. The amendments in this ASU are effective for fiscal years beginning after December&nbsp;15, 2018 and
interim periods within those fiscal years. Early adoption is permitted for all entities. ASU 2016-02 requires a modified retrospective approach for all leases existing at, or entered into after the
date of initial adoption, with an option to elect to use certain transition relief. We are currently evaluating the impact of this new standard on our consolidated financial statements. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


JOBS Act  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As an "emerging growth company" under the JOBS Act, we can take advantage of an extended transition period for complying with new or revised
accounting standards. This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to
avail ourselves of this exemption and, as a result, our financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective dates for new or
revised accounting standards that are applicable </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>87</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=92,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=633105,FOLIO='87',FILE='DISK131:[15ZBY1.15ZBY12201]DW12201A.;110',USER='DSCHWAR',CD=';8-JUN-2016;19:29' -->
<A NAME="page_dw12201_1_88"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>to
public companies. Section&nbsp;107 of the JOBS Act provides that we can elect to opt out of the extended transition period at any time, which election is irrevocable. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
are in the process of evaluating the benefits of relying on other exemptions and reduced reporting requirements under the JOBS Act. Subject to certain conditions, as an emerging growth company, we
intend to rely on certain of these exemptions, including without limitation (i)&nbsp;reduced financial statement reporting periods, (ii)&nbsp;providing an auditor's attestation report on our
system of internal controls over financial reporting pursuant to Section&nbsp;404(b) of the Sarbanes-Oxley Act of 2002 and (iii)&nbsp;complying with any requirement that may be adopted by the
Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor's report providing additional information about the audit and the financial statements,
known as the auditor discussion and analysis. We will remain an emerging growth company until the earliest of: (a)&nbsp;the last day of the fiscal year in which we have total annual gross revenues
of $1&nbsp;billion or more; (b)&nbsp;the last day of the fiscal year following the fifth anniversary of the date of the completion of this offering; (c)&nbsp;the date on which we have issued
more than $1&nbsp;billion in nonconvertible debt during the previous three years; and (d)&nbsp;the date on which we are deemed to be a large accelerated filer under the rules of the SEC. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>88</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=93,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=714266,FOLIO='88',FILE='DISK131:[15ZBY1.15ZBY12201]DW12201A.;110',USER='DSCHWAR',CD=';8-JUN-2016;19:29' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dy12201_1_89"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="dy12201_business"> </A>
<A NAME="toc_dy12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  BUSINESS    <BR>    </B></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home. We focus on
advancing the standard of care in treating chronic diseases in the home setting to improve patient outcomes and quality of life and help control rising healthcare expenditures. We possess a unique,
scalable platform to deliver at-home healthcare solutions throughout the United States. This evolving care delivery model is recognized by policy-makers and payers as a key for controlling rising
healthcare expenditures. Our initial area of therapeutic focus is vascular disease, with a goal of advancing the standard of care in treating lymphedema and chronic venous insufficiency. Our
proprietary Flexitouch System is an at-home solution for lymphedema patients. Our proprietary ACTitouch System is a home-based solution for chronic venous insufficiency patients that may be worn
throughout the day. Our products
deliver cost-effective, clinically proven, long-term treatment of chronic diseases. We employ a direct-to-patient and -provider model, through which we obtain patient referrals from clinicians, manage
insurance claims on behalf of our patients and their clinicians, deliver our solutions to patients and train them on the proper use of our solutions in their homes. This model allows us to directly
approach patients and clinicians, whereby we disintermediate the traditional durable medical equipment channel and capture both the manufacturer and distributor margins. For the year ended
December&nbsp;31, 2015, we generated revenues of $62.9&nbsp;million and had net income of $1.4&nbsp;million. Our revenues increased 32% during the year ended December&nbsp;31, 2015 compared to
the year ended December&nbsp;31, 2014. For the three months ended March&nbsp;31, 2016, we generated revenues of $13.7 million and had a net loss of $1.0 million. Our revenues increased 35% during
the three months ended March&nbsp;31, 2016 compared to the three months ended March&nbsp;31, 2015. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Lymphedema
is a type of chronic swelling, or edema, which occurs in the arms, legs, neck, trunk or other body parts when the lymphatic vessels are unable to adequately drain protein-rich lymph fluid
from these regions. Lymphedema is progressive in nature, worsens over time, and has no known cure. Chronic venous insufficiency is a condition that occurs when the venous wall and/or valves in the
veins are not working effectively, making it difficult for blood to return to the heart from the affected region. This pooling or collecting of blood in the veins can result in painful, slow-healing
wounds on the lower leg, called venous leg ulcers. Patients with lymphedema or chronic venous insufficiency are typically treated by vascular surgeons, vascular medicine physicians, wound physicians,
wound nurses and lymphedema therapists. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Lymphedema
and chronic venous insufficiency are costly and lifelong conditions with debilitating physical and psychological impacts on patients. We estimate the addressable market opportunity for our
solutions treating lymphedema and chronic venous insufficiency in the United States is approximately $4.7&nbsp;billion. We believe that between three to five million people in the United States are
living with lymphedema. Based on an analysis of claims data commissioned by us, we estimate approximately 700,000&nbsp;patients were diagnosed with lymphedema during the 12&nbsp;months ended
December&nbsp;31, 2014. Based on a separate analysis of claims data commissioned by us, we estimate approximately 820,000&nbsp;patients were diagnosed with lymphedema during the 12&nbsp;months
ended December&nbsp;31, 2015, representing a 17% growth in the number of patients diagnosed with lymphedema as compared to the immediately preceding 12-month period. We estimate that the
addressable market opportunity for our Flexitouch System is approximately $4.1&nbsp;billion in the United States, which is based on the number of patients diagnosed with lymphedema and our average
selling price per device. We believe that chronic venous insufficiency afflicts approximately 8% of the U.S. population, and this percentage may rise due to the growing prevalence of obesity and
cancer, as well as an aging population. Based on an analysis of claims data commissioned by us, we estimate there were over 1.5&nbsp;million patients diagnosed with venous leg ulcers in the United
States during the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>89</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=94,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=647690,FOLIO='89',FILE='DISK131:[15ZBY1.15ZBY12201]DY12201A.;88',USER='JFUSS',CD=';8-JUN-2016;14:25' -->
<A NAME="page_dy12201_1_90"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>12&nbsp;months
ended June&nbsp;30, 2014. We estimate that our immediately addressable patient population consists of the 30% to 40% of these patients, or approximately 525,000 patients, for whom
we believe reimbursement is available because their venous leg ulcers have not resolved after six months of
treatment. We estimate the addressable market opportunity for our ACTitouch System is approximately $580&nbsp;million in the United States, which is based on the number of patients diagnosed with
unresolved venous leg ulcers and our average selling price per device. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A
traditional treatment for lymphedema is complete decongestive therapy, consisting of manual lymphatic drainage, which is a specialized application of gentle pressure to the skin applied by a
therapist that encourages drainage of lymph fluid, as well as decongestive exercises, skin care and compression with multilayered bandages, compression garments or pumps. Typically, this therapy
begins with clinic visits three to five times per week for four to eight weeks, which is costly, inconvenient and time consuming. At that point, clinical improvement plateaus or reimbursement for the
therapy ends and patients transition to self-administered home-based therapy. Manual lymphatic drainage is difficult for patients to self-administer due to limited range of motion and treatment
techniques that are difficult to replicate, and basic pump-based compression is uncomfortable and has not demonstrated the benefits of our advanced pneumatic pump. To address these limitations, our
advanced at-home Flexitouch System mimics the clinic-based manual lymphatic drainage therapy through an easy-to-use, one-hour daily, self-applied system. Peer-reviewed, published studies have shown
that our Flexitouch System provides improved quality of life and clinical outcomes and delivers significant cost-savings to payers and patients. The predecessor version to our Flexitouch System
received 510(k) clearance from the FDA in July 2002 and our current Flexitouch System received 510(k) clearance from the FDA in October 2006. Our Flexitouch System generated $54.7&nbsp;million, or
87%, of our revenues in 2015. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
standard of care treatment for chronic venous insufficiency is compression therapy. As the disease progresses, patients may develop a venous leg&nbsp;ulcer, which is commonly treated using
multilayered bandages to minimize swelling and enhance blood flow. A clinician applies these non-removable bandages to patients at a precise pressure and patients wear the bandages between weekly
visits to the wound clinic during which the bandages are removed and reapplied. Treatment typically occurs for several months and impairs patient quality of life by limiting bathing, range of motion
and other activities. Treatment efficacy is inconsistent because bandages can lose their precise pressure between treatments. Our ACTitouch System provides precise, consistent and wearable compression
that a patient may apply, remove and reapply at home. This system was developed to provide maximum convenience for patients by providing them with the freedom to remain active while simultaneously
receiving the benefits of sustained and intermittent pneumatic compression, which we refer to as dual-compression. In a clinical study, our ACTitouch System was shown to have comparable efficacy in
healing venous leg&nbsp;ulcers and achieved higher patient quality of life scores, as compared to multilayered bandages. Our ACTitouch System received 510(k) clearance from the FDA in June 2013 and
generated $3.2&nbsp;million, or 5%, of our revenues in 2015. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>To
support the growth of our business, we invest heavily in our commercial infrastructure, consisting of our direct sales force, reimbursement capabilities and clinical expertise. We are a national,
accredited provider of home medical equipment services approved for coverage by private payers, Medicare, the Veterans Administration and certain Medicaid programs in the United States. We market our
products using a direct-to-patient and -provider model. Our direct sales force is focused on increasing clinician awareness of our solutions, and has grown from three representatives in March 2005 to
over 100&nbsp;people as of March&nbsp;31, 2016. We also utilize over 300 licensed, independent healthcare practitioners as home trainers who educate patients on the proper use of our solutions.
Our experienced reimbursement operations group of over 55&nbsp;people focuses on verifying case-by-case benefits, obtaining prior authorization, billing and collecting payments from payers and
providing </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>90</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=95,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=595962,FOLIO='90',FILE='DISK131:[15ZBY1.15ZBY12201]DY12201A.;88',USER='JFUSS',CD=';8-JUN-2016;14:25' -->
<A NAME="page_dy12201_1_91"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>customer
support services. Our payer relationships group of over 20&nbsp;people is responsible for developing relationships with payer decision-makers to educate them on our product efficacy,
develop overall payer coverage policies and reimbursement criteria, manage Medicare patient claims and contracts with payers and serve as an advocacy liaison between patients, clinicians and payers
throughout the appeals process. Our clinical team, consisting of a scientific advisory board, in-house therapists and nurses, and a medical director, serves as a resource to clinicians and patients
and guides our development of clinical evidence in support of our products. We believe these investments are critical to driving patient adoption of our technologies, and together with our commercial
infrastructure represents a significant competitive advantage. Health insurance coverage for our Flexitouch System and our ACTitouch System is in place with private payers, Medicare, the Veterans
Administration and certain Medicaid programs. Based on our estimates, we have contracts as an in-network provider covering over 230&nbsp;million lives in the United States. Over
48,000&nbsp;patients have been treated with our Flexitouch System since its launch in 2002, and over 11,000 Flexitouch Systems were shipped in 2015. More than 4,100&nbsp;patients were treated with
our ACTitouch System since its launch in 2013, and over 2,200 ACTitouch Systems were shipped in 2015. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview of the Lymphedema and Chronic Venous Insufficiency Markets  </B></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Lymphedema  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The lymphatic system performs a fundamental role in maintaining health through balancing fluids and regulating immunity by removing harmful bacteria,
viruses and waste products. Lymphatic structures are situated throughout the body and are comprised of a series of vessels, lymph nodes and lymphoid organs that act as a drainage system by collecting
protein rich lymph fluid and sending it to the venous system. Lymph nodes are located in several areas of the body
with superficial and deep lymph nodes under each arm, at the hip, in the groin, above the collar bones in the neck, in the abdomen, tonsils and spleen, and in bone marrow. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g865608.jpg" ALT="GRAPHIC" WIDTH="277" HEIGHT="400">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>91</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=96,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=768962,FOLIO='91',FILE='DISK131:[15ZBY1.15ZBY12201]DY12201A.;88',USER='JFUSS',CD=';8-JUN-2016;14:25' -->
<A NAME="page_dy12201_1_92"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Lymphedema
refers to a type of chronic swelling, or edema, which may occur in the arms, legs, neck, trunk or other body parts and causes severe and debilitating symptoms, including decreased mobility,
skin breakdown, pain, increased risk of serious infection and marked psychosocial impairment, resulting in significantly negative implications for a patient's health and quality of life. The disease
occurs when the lymphatic vessels are unable to adequately drain protein-rich lymph fluid from the arms, legs or other regions of the body. Any condition or procedure that damages the lymph nodes or
lymphatic vessels, such as surgery or treatment for breast and other cancers, obesity, infection, scar tissue formation, trauma or chronic venous insufficiency can cause lymphedema. The disease may
also be caused from congenital malformation of the lymphatic system. Lymphedema is progressive in nature, worsens over time, and has no known cure. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Misdiagnosis
of lymphedema is fairly common, as many conditions that cause swelling are not related to lymphedema. Correct diagnosis of lymphedema may require evaluation by a physician or other
healthcare provider with knowledge of lymphedema who may choose to perform diagnostic testing. Diagnostic tests for lymphedema include history and physical examination, soft tissue and vascular
imaging, lymph node imaging, volume measurements, changes in electrical conductance, changes in biomechanical properties, genetic testing, and blood tests for other conditions that have similar
symptoms to lymphedema. The International Society of Lymphology categorizes the progression of lymphedema from Stage&nbsp;0, the least severe stage, to Stage&nbsp;3, the most severe stage. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Chronic Venous Insufficiency  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Chronic venous insufficiency occurs when the venous wall and/or valves in the veins are not working effectively, making it difficult for blood to
return to the heart. The disease is prevalent among patients who are obese or pregnant and may also be caused by high blood pressure, trauma, lack of exercise, smoking, deep vein thrombosis and
inflammation of the vein walls. As the valves deteriorate, blood leaks or flows backward, leading to increased pressure in veins, stretched and dilated vessels and pooling of blood in the veins. As
blood accumulates, swelling occurs, leading to progressive tissue breakdown and venous&nbsp;leg ulcers.&nbsp;Ulcers develop in areas where blood collects as swelling interferes with the movement
of oxygen and nutrients through tissues, and if left untreated, these&nbsp;ulcers can quickly become infected or even gangrenous. Prolonged or untreated chronic venous insufficiency may damage the
lymphatic system. Physicians diagnose chronic venous insufficiency based on appearance, symptoms and imaging techniques and classify it based upon a scale endorsed by the Society for Vascular Surgery. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Market Opportunity  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Lymphedema and chronic venous insufficiency are costly and lifelong conditions with debilitating physical and psychological impacts on patients. We
estimate the addressable market opportunity for our solutions treating lymphedema and chronic venous insufficiency in the United States is approximately $4.7&nbsp;billion. We believe that between
three to five million people in the United States are living with lymphedema. Based on an analysis of claims data commissioned by us, we estimate approximately 700,000&nbsp;patients were diagnosed
with lymphedema during the 12&nbsp;months ended December&nbsp;31, 2014. Based on a separate analysis of claims data commissioned by us, we estimate approximately 820,000&nbsp;patients were
diagnosed with lymphedema during the 12&nbsp;months ended December&nbsp;31, 2015, representing a 17% growth in the number of patients diagnosed with lymphedema as compared to the immediately
preceding 12-month period. We estimate that the addressable market opportunity for our Flexitouch System is approximately $4.1&nbsp;billion in the United States, which is based on the
number of patients diagnosed with lymphedema and our average selling price per device. We believe that chronic venous insufficiency afflicts approximately 8% of the U.S. population, and this
percentage may rise due to the growing prevalence of obesity and cancer, as well as an aging population. Based on an analysis of claims data commissioned by us, we estimate there </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>92</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=97,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=918532,FOLIO='92',FILE='DISK131:[15ZBY1.15ZBY12201]DY12201A.;88',USER='JFUSS',CD=';8-JUN-2016;14:25' -->
<A NAME="page_dy12201_1_93"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>were
over 1.5&nbsp;million patients diagnosed with venous leg&nbsp;ulcers in the United States during the 12&nbsp;months ended June&nbsp;30, 2014. We estimate that our immediately addressable
patient population consists of the 30% to 40% of these patients, or approximately 525,000 patients, for whom we believe device reimbursement is available because their venous leg&nbsp;ulcers have
not resolved after six months of treatment. We estimate the addressable market opportunity for our ACTitouch System is approximately $580&nbsp;million in the United States, which is based on the
number of patients diagnosed with unresolved leg venous ulcers and our average selling price per device. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Current Treatment and Limitations  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A traditional treatment for lymphedema is complete decongestive therapy consisting of manual lymphatic drainage, which is a specialized application
of gentle pressure to the skin applied by a therapist that encourages drainage of lymph fluid, as well as decongestive exercises, skin care and compression with multilayered bandages, compression
garments or pumps. Typically, this therapy begins with clinic visits three to five times per week for four to eight weeks, which is costly and time consuming. At that point, clinical improvement
plateaus or reimbursement for the therapy ends and patients transition to self-administered home-based care. Manual lymphatic drainage is difficult for patients to self-administer due to limited range
of motion and treatment techniques that are difficult to replicate, and basic pump-based compression is uncomfortable and has not demonstrated the benefits of our advanced pneumatic pump. To address
these limitations, our at-home Flexitouch System mimics the clinic-based manual lymphatic drainage therapy through an advanced, easy-to-use, self-applied system. Peer-reviewed, published studies have
shown that our Flexitouch System provides improved quality of life and clinical outcomes and delivers significant cost-savings to payers and patients. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
standard of care treatment for chronic venous insufficiency is compression therapy. As the disease progresses, patients may develop a venous leg&nbsp;ulcer, which is commonly treated using
multilayered bandages to minimize swelling and enhance blood flow. A clinician applies these non-removable bandages to patients at a precise pressure and patients wear the bandages between weekly
visits to the wound clinic during which they are then removed and reapplied. Treatment typically occurs for several months and impairs patient quality of life by limiting bathing, range of motion and
other activities. Treatment efficacy is inconsistent because bandages can lose their precise pressure between treatments. Patients also use our ACTitouch System to administer intermittent pneumatic
compression therapy to assist with the circulation of blood through affected veins. Our ACTitouch System provides precise, sustained and wearable compression that a patient may apply, remove and
reapply at home, allowing patients to bathe, improve sleep and increase mobility. In a clinical study, our ACTitouch System was shown to have comparable efficacy in healing venous leg&nbsp;ulcers
and achieved higher patient quality of life scores as compared to multilayered bandages. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Competitive Strengths  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We focus on advancing the standard of care in treating chronic diseases at home to improve patient outcomes and quality of life and help control
rising healthcare expenditures. Our executive team collectively has over 100&nbsp;years of experience in healthcare, developing and commercializing innovative medical technology products. We believe
that our commercialization platform and experience, combined with the following competitive strengths, should allow us to continue to grow our revenues and increase our presence in the
market: </FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Established leadership in providing therapies for at-home treatment of
chronic disease.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our strategic focus is developing and providing innovative technologies for the treatment of chronic diseases at home.
Our core competency, which is our direct-to-patient and -provider model, comprises a direct sales force, contract at-home trainers, reimbursement capabilities and medical expertise that we
use to expand awareness, garner referrals and </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>93</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=98,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=123280,FOLIO='93',FILE='DISK131:[15ZBY1.15ZBY12201]DY12201A.;88',USER='JFUSS',CD=';8-JUN-2016;14:25' -->
<A NAME="page_dy12201_1_94"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>obtain
payment for our products. We believe this platform is scalable and can be leveraged to expand our business into market adjacencies.  </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Proprietary technology with unique advantages over other
treatments.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our solutions leverage patented technological advancements that we believe give us a competitive advantage in the
marketplace. The unique ability of our Flexitouch System to mimic manual lymphatic drainage therapy, provides improved quality of life and efficacy and delivers significant cost savings to payers and
patients as compared to traditional treatments. Our ACTitouch System has the unique ability to provide both sustained and intermittent pneumatic compression therapy in one wearable product,
demonstrating comparable efficacy in healing venous leg&nbsp;ulcers, while achieving higher patient quality of life scores as compared to the current standard of care.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Substantial clinical evidence and key opinion leader support for our
Flexitouch System.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We have developed a substantial body of peer-reviewed, published clinical evidence that our Flexitouch System reduces
swelling and improves quality of life for lymphedema patients while reducing healthcare costs. In clinical studies, patients reported a significant increase in their ability to control their
lymphedema along with an increase in activities of daily living, improvement in emotional status and reduction in limb volume, skin hardening and pain, while using our Flexitouch System. In a study of
lymphedema affecting the lower extremities published in the </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>European Journal of Vascular and Endovascular Surgery</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>, 88% of patients experienced reduced
lower extremity limb volume, 86% showed a reduction in skin hardening and 85% demonstrated increased ability to perform daily life activities, while substantially all of the patients who responded
reported being "very satisfied" or "satisfied" with our Flexitouch System. In addition, we have established strong relationships with key opinion leaders within vascular and lymphedema specialties who
promote market awareness of our solutions and inform our clinical efforts. We have in-house expertise that designs and manages clinical and economic studies in support of the efficacy and
cost-effectiveness of our products.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Significant healthcare system cost
savings.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our solutions offer meaningful cost savings for the healthcare system and patients, as compared to traditional treatments. As
demonstrated by a study published by the American Medical Association in </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>JAMA Dermatology</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>, our Flexitouch System reduces hospitalization occurrences and
length of stays, costly cellulitis infections, outpatient visits and physical therapy visits. In addition, we believe that our ACTitouch System eliminates costly multilayered bandage system supplies
and clinic application time, resulting in cost savings for wound clinics.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Distinctive national third-party payer core
competency.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our specialized reimbursement team is proficient at obtaining reimbursement from payers across the United States. We work
closely with government and private payers to educate them on lymphedema diagnosis and treatment, expand coverage and negotiate competitive rates for our solutions. We also work directly with
clinicians and patients to help them understand payer requirements for our products. Our experienced reimbursement team of over 50 people focuses on coding, coverage, contracting, prior authorization,
in-house billing and payment collection. We advocate for coverage and submit claims on behalf of our patients through patient-by-patient support and claim processing. We also engage in broader payer
strategic initiatives to gain general preauthorization for our products. Based on our estimates, we have contracts in place as an in-network provider covering over 230&nbsp;million lives in the
United States. We have established payer relationships with large private payers </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>94</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=99,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=443450,FOLIO='94',FILE='DISK131:[15ZBY1.15ZBY12201]DY12201A.;88',USER='JFUSS',CD=';8-JUN-2016;14:25' -->
<A NAME="page_dy12201_1_95"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>and
Medicare. In 2015, our reimbursement team obtained insurance reimbursement approvals for over 80% of submitted claims. </FONT></P>

</UL>
</UL>
</UL>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Strategy  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our goal is to become a leader in the at-home treatment of chronic diseases. We intend to leverage our established platform to be a global provider
of clinically proven, easy-to-use and cost-effective solutions. The key elements of our strategy include: </FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Increase awareness of our solutions and establish them as the
standards of care.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We believe that many patients with lymphedema and chronic venous insufficiency are undiagnosed or undertreated, and
we intend to further educate physicians, wound nurses and lymphedema therapists, patients and payers to raise awareness of these diseases, the associated health burdens of such diseases on patients
and society and the clinical and economic benefits of using our products. We intend to continue promoting this awareness through advertising campaigns, exhibiting at tradeshows and physician
societies, training and educating clinicians and publishing additional clinical and economic outcome data demonstrating the benefits of our solutions. Our ongoing marketing initiatives focus on
increasing referrals to physicians trained in venous and lymphatic diseases. In addition, we plan to launch more extensive direct-to-patient and -provider marketing programs that we believe will
further increase awareness of our solutions. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Expand our direct sales and customer support
teams.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We plan to expand our direct sales and marketing organization to drive greater product adoption by patients and their clinicians.
We intend to strengthen our distribution network by continuing to recruit, train and retain talented sales representatives and increasing the number of licensed home trainers. With an expanded sales
force, we believe we could target additional clinical call points. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>

<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'>

<FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Introduce new features and products to grow our technology
platform.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We intend to pursue new features for our products, and introduce new solutions to expand the number of patients using our
products and allow us to enter new clinical adjacencies. We pursue internal research, design and development, and work with external collaborators to expand our product offerings. For example, we are
developing new garment offerings for our Flexitouch System that we intend to release in the first half of 2017 and we are developing controller improvements for our Flexitouch System to launch in the
first half of 2017. In addition, we evaluate opportunities to license or acquire additional technologies and products to expand our total addressable market opportunity.


</FONT>

<FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Continue the development of clinical and economic outcome
data.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;A key part of our success is our ability to demonstrate the effectiveness of our products through clinical and economic outcome
data. We intend to invest in additional studies to support peer-reviewed, published studies that evidence the clinical and economic benefits of our solutions as compared to traditional treatments. We
intend to use these data to continue to educate clinicians, payers and patients on the proven advantages of our products compared to other therapies and expand our network of key opinion leader
advocates. </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>95</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=100,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=763037,FOLIO='95',FILE='DISK131:[15ZBY1.15ZBY12201]DY12201A.;88',USER='JFUSS',CD=';8-JUN-2016;14:25' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ea12201_1_96"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Expand third-party
reimbursement.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Our products are covered under existing reimbursement codes, and we have secured coverage for our solutions with private
payers, Medicare, the Veterans Administration and certain Medicaid programs. Our team has experienced significant success in obtaining positive coverage policies from payers by developing direct
relationships with payer decision-makers, leveraging our relationships with physician societies and key opinion leaders, providing clinical data, demonstrating the efficacy of our products and
educating payers on the limitations of traditional treatments. We intend to continue this strategic approach to further expand coverage for our solutions, as well as to meet payer-specific
requirements on behalf of patients. We also believe that reimbursement for our products could be expanded by obtaining preferred contracts with payers.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Introduce our solutions outside the United
States.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;We currently sell our products only within the United States. While our plan is to continue to focus our direct sales efforts on
penetrating the U.S. market, we plan to pursue future international expansion. We have European CE Mark approval for our Flexitouch System and plan to seek CE Mark approval for our ACTitouch System.
We also have a Medical Device License in Canada for our Flexitouch System. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Our Products  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We market our Flexitouch, ACTitouch and Entr&eacute; systems, as at-home therapies for the treatment of lymphedema and chronic venous
insufficiency. These products have received 510(k) clearance from the FDA to be marketed in the United States. We believe our products have unique features and benefits that address the shortcomings
of traditional treatments, are more cost-effective and enable more consistent and effective therapy, leading to improved patient quality of life. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Flexitouch System  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We introduced a predecessor to our Flexitouch System in the United States in 2003 and our Flexitouch System in 2006. Our Flexitouch System is a
fully-automated, programmable, advanced pneumatic compression device designed for treatment of lymphedema in the home setting. Our Flexitouch System has received 510(k) clearance for the treatment of
lymphedema, certain types of edema, venous insufficiencies and certain types of leg&nbsp;ulcers. The mechanism of action of our patented Flexitouch System is designed to mimic manual lymphatic
drainage therapy, the current standard of care in patient treatment. By automating this technique, we believe our system offers an effective, cost-efficient, convenient and accessible treatment for
patients. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>96</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=101,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=626207,FOLIO='96',FILE='DISK131:[15ZBY1.15ZBY12201]EA12201A.;57',USER='CHE105613',CD=';7-JUN-2016;13:56' -->
<A NAME="page_ea12201_1_97"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g71132.jpg" ALT="GRAPHIC" WIDTH="508" HEIGHT="265">
  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
Flexitouch System consists of an electronic controller unit that offers 15 treatment settings and multiple contoured garment configurations for the trunk and the arm or leg. Our Flexitouch System
offers flexibility for treating upper and lower extremities, as well as the trunk and chest. The electronic
controller is a pneumatic compressor with four connector outlets. Each connector has eight outflow ports into which the garment hoses are connected. Our unique garments contain 32 air chambers, are
made of a soft, pliable fabric and are designed with hook-and-loop fasteners to fit snugly around affected areas for maximum comfort and optimum pressure delivery. The garments come in a variety of
sizes that can be easily adjusted to patients of all sizes. When our system is activated, air passes through the hoses delivering sequential inflation and deflation to the garments, applying gentle
pressure to the skin. The inflation sequence is designed to stimulate the lymphatic system moving lymph fluid from the impaired areas towards healthy regions of the body to be processed. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g804100.jpg" ALT="GRAPHIC" WIDTH="460" HEIGHT="144">
  </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
electronic controller unit adjusts the amount of pressure and the timing of the pressure and release cycles. This unit is lightweight and easily portable, providing maximum convenience for at-home
treatment. A typical therapy session using our Flexitouch System lasts one hour for upper extremity </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>97</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=102,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=466738,FOLIO='97',FILE='DISK131:[15ZBY1.15ZBY12201]EA12201A.;57',USER='CHE105613',CD=';7-JUN-2016;13:56' -->
<A NAME="page_ea12201_1_98"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>treatment
and full leg and core treatment and 45 minutes for lower extremity treatment, with additional treatment options available if prescribed by a clinician. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="31%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="30%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="31%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD ALIGN="CENTER" style="font-family:times;"><BR>
<FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g556508.jpg" ALT="GRAPHIC" WIDTH="205" HEIGHT="355">
 </B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR>
<FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g801727.jpg" ALT="GRAPHIC" WIDTH="186" HEIGHT="342">
 </B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><BR>
<FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g654163.jpg" ALT="GRAPHIC" WIDTH="193" HEIGHT="342">
 </B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


ACTitouch System  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We introduced our ACTitouch System in the United States in September 2013. Our wearable ACTitouch System combines intermittent pneumatic compression
with sustained gradient compression to the lower leg, ankle and foot to improve and accelerate healing, as compared to the current standard of care, which involves sustained compression applied with
compression wraps. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g618561.jpg" ALT="GRAPHIC" WIDTH="637" HEIGHT="303">
  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
ACTitouch System consists of a compression sleeve, a control unit, an undersock and a power adapter/charger. The compression sleeve has four chambers that inflate to apply pressure to the leg, is
designed with hook and loop fasteners to accommodate a wide range of leg shapes and sizes and may </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>98</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=103,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=920054,FOLIO='98',FILE='DISK131:[15ZBY1.15ZBY12201]EA12201A.;57',USER='CHE105613',CD=';7-JUN-2016;13:56' -->
<A NAME="page_ea12201_1_99"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>be
worn under clothing and with most shoes. The control unit is concealed within the compression sleeve and monitors and adjusts the air pressure to ensure the correct level of compression is applied
to the leg. It offers a therapy tracker that monitors and displays average daily use to reinforce therapy goals. The undersock is designed to draw perspiration and moisture away from the skin and has
padding in key areas to provide additional comfort. The system comes with a power adapter/charger that is used to power the device directly during intermittent pneumatic compression mode or to charge
the battery for ambulatory use. The battery life allows the patient to wear the system all day without recharging. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
ACTitouch System operates in sustained compression mode or intermittent pneumatic compression mode. In sustained compression mode, the system provides sustained, graduated compression to the leg
at preset pressures, and the compact, lightweight design gives patients the freedom to stay active while experiencing the benefits of a more comfortable compression therapy. The system ensures
consistent compression regardless of variations in sleeve application, and throughout the day monitors and adjusts pressure automatically every 30 minutes in response to changes in leg circumference.
In intermittent pneumatic compression mode, the system performs cyclic inflation/deflation sequences to preset gradient pressures. Standard daily treatment involves two hours of intermittent
compression while seated or reclining and 10&nbsp;hours of sustained compression while active. The system is worn throughout the day and has the advantage of being removable for bathing or showering
and when driving or operating machinery. The patient removes the system for sleep, allowing the battery to be recharged overnight. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Entr&eacute; System  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We introduced our Entr&eacute; System in the United States in February 2013 to offer a lightweight, portable pneumatic compression solution
for patients who need a basic pump or who do not yet qualify for insurance coverage of an advanced compression device such as our Flexitouch System. Our Entr&eacute; System is a basic
pneumatic compression device used for the at-home treatment of venous disorders including lymphedema and chronic venous insufficiency, including venous leg&nbsp;ulcers. Our Entr&eacute;
System is a pump with garments covering the arm or leg with eight chambers that inflate in sequence and remain inflated for a preset time period. All chambers deflate at once. Our Entr&eacute;
System moves fluid from fingers or toes toward areas closer to the trunk. The system can be programmed to a variety of pressures delivering a prescribed treatment customized to meet the patient's
needs. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Clinical Results and Studies  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Overview  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have developed a significant body of clinical data supporting the safety and effectiveness of our products. We have sponsored 13 clinical studies
in which a total of 682 patients were treated with our products and followed to assess safety, and 286 patients were followed for an extended period of six to 22&nbsp;months to assess long-term
efficacy. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A
key part of our success is our ability to demonstrate the effectiveness of our products through funding studies that generate clinical and economic outcome data supporting our products. We intend to
continue to invest in additional studies to support peer-reviewed, published articles that evidence the clinical and economic benefits of our solutions as compared to traditional treatments. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Impact on Clinical Outcomes and Healthcare Costs with Use of our Flexitouch System  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A retrospective study published by the American Medical Association in </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>JAMA Dermatology</I></FONT><FONT COLOR="#3B5A6F" SIZE=2> demonstrated
significant improvement in key clinical endpoints and immediate cost reductions for individuals with lymphedema following receipt of our Flexitouch System. The study was conducted in </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>99</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=104,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=179145,FOLIO='99',FILE='DISK131:[15ZBY1.15ZBY12201]EA12201A.;57',USER='CHE105613',CD=';7-JUN-2016;13:56' -->
<A NAME="page_ea12201_1_100"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>the
United States and included 718 patients with a lymphedema diagnosis who had continuous insurance coverage during the 12&nbsp;months prior to and the 12&nbsp;months after receiving our
Flexitouch System. Patients were excluded from the study if they had a claim for a pneumatic compression device during the prior 12 month period. The patients in the study included 374 patients with
cancer-related lymphedema and 344 patients with non-cancer-related lymphedema. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
study evaluated a broad, clinically relevant set of healthcare use outcomes for each patient for the 12&nbsp;months before and the 12&nbsp;months after receipt of our Flexitouch System,
including cellulitis infections, inpatient hospitalizations, manual therapy and outpatient hospital visits. Receipt of our Flexitouch System was associated with a significant decline in the rate of
cellulitis diagnosis in the cancer-related lymphedema patients of 79% (from 21.1% to 4.5%; p&lt;.001) and in the non-cancer-related lymphedema patients of 75% (from 28.8% to 7.3%;
p&lt;.001). The inpatient hospitalization rate declined 22% in the cancer-related group (from 2.7% to 2.1%; p=.63) and declined 54% in the non-cancer-related group (from 7.0% to 3.2%; p=.02).
The manual therapy rate decreased 30% in the cancer-related lymphedema patients (from 35.6% to 24.9%; p=.001) and decreased 34% in the non-cancer-related lymphedema patients (from 32.3% to 21.2%;
p=.001). In addition, outpatient hospital visits declined 29% in the cancer-related patients (from 58.6% to 41.4%; p&lt;.001) and 40% in the non-cancer-related patients (from 52.6% to 31.4%;
p&lt;.001). </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
study also reviewed lymphedema-related healthcare costs for each patient in the study for the 12&nbsp;months before and the 12&nbsp;months after receipt of our Flexitouch System. Among the
cancer-related lymphedema patients, total costs per patient, excluding durable medical equipment costs, were reduced by 37%, from $2,597 to $1,642 (p=.002) following receipt of our Flexitouch System.
The greatest contributor to this change was a 54% reduction in outpatient hospital costs from $1,517 to $694 (p&lt;.001). Total costs per non-cancer-related lymphedema patients, excluding
durable medical equipment costs, were reduced by 36% from $2,937 to $1,883 (p=.007). Outpatient hospital costs for the non-cancer patients declined by 65% from $1,726 to $606 (p&lt;.001). </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Impact on Health Outcomes and Costs with Use of Pneumatic Compression Devices  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A retrospective study published in the </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>Public Library of Science Journal</I></FONT><FONT COLOR="#3B5A6F" SIZE=2> demonstrated a significant
improvement in health outcomes for patients who were prescribed a pneumatic compression device, as well as a substantial decrease in the patient's and payer's total healthcare costs. The study was the
first to evaluate overall healthcare costs of lymphedema patients and the impact of available therapeutic intervention in a large, representative national population. The study analyzed U.S. claims
data from a large national insurer for 2007 through 2013 to assess the impact of using a pneumatic compression device. The study included 1,065 patients with cancer-related lymphedema. The claims data
used in the study demonstrated that the prevalence of lymphedema diagnoses among cancer survivors increased from 0.95% in 2007 to&nbsp;1.24% in 2013. The study population included lymphedema
patients who had a claim for a simple or advanced pneumatic compression device during the time period of January&nbsp;1, 2008 through November&nbsp;31, 2012. Each patient in the study had at least
12&nbsp;months of continuous medical and pharmacy insurance eligibility prior to and after receiving the pneumatic compression device. The below diagram depicts the selection strategy for patients
included in the analysis: </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g122410.jpg" ALT="GRAPHIC" WIDTH="619" HEIGHT="106">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>100</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=105,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=234806,FOLIO='100',FILE='DISK131:[15ZBY1.15ZBY12201]EA12201A.;57',USER='CHE105613',CD=';7-JUN-2016;13:56' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ec12201_1_101"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The objective of the study was to analyze the impact of using a pneumatic compression device on the health and cost outcomes of patients with cancer-related lymphedema. The
study did not differentiate between the health outcomes and costs of patients who received our Flexitouch System and those who received a different pneumatic compression device. An analysis of health
outcomes and costs was conducted by comparing a pre-specified set of health outcomes and costs for the 12&nbsp;months before and after receipt of a pneumatic compression device. The health outcomes
measured before and after receipt of a pneumatic compression device included the number of hospitalizations, the proportion of patients with hospitalizations, the proportion of patients with
outpatient hospital visits, the proportion of patients with cellulitis and the proportion of patients using physical therapy. The cost outcomes measured before and after receipt of a pneumatic
compression device included costs associated with the device, home health, emergency services, inpatient services, outpatient services, outpatient physical therapy, other outpatient services, office,
lab, other service location and pharmacy related. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>With
respect to health outcomes, use of a pneumatic compression device was associated with a significant decline in the rate of hospitalizations (45% to 32%, p&lt;0.0001). Use of a pneumatic
compression device was also associated with a reduction in the rate of outpatient hospital visits (95% to 90%, p&lt;0.0001). The percentage of patients with a lymphedema-related clinic visit
decreased from 47% in the baseline period to 32% in the post-pneumatic compression device period (p&lt;0.0001). The proportion of patients with cellulitis also declined in the post-pneumatic
compression device period (28% to 22%, p&lt;0.0003). Finally, the proportion of patients using physical therapy declined (50% to 41%, p&lt;0.0001), primarily driven by a reduction in
the use of lymphedema-related physical therapy (29% to 21%, &lt;0.0001). </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>With
respect to overall healthcare costs of treatment, use of a pneumatic compression device was associated with a decrease in total costs of $11,833 in the 12&nbsp;months after device prescription.
The largest cost decreases were achieved by a diminution of office visit costs by 36% (p&lt;0.0001), and outpatient hospital costs by 30% (p&lt;0.0001). Reductions were observed in
lymphedema-related costs for outpatient physical therapy ($276 to $135, p&lt;0.0001) and other outpatient services ($879 to $563, p&lt;0.0001). </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A
summary of the findings of the study is presented below: </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g700946.jpg" ALT="GRAPHIC" WIDTH="585" HEIGHT="138">
  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Flexitouch System Impact on Limb Volume and Patient-Reported Outcomes  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A prospective study published in the </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>European Journal of Vascular and Endovascular Surgery</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>
demonstrated that use of our Flexitouch System is associated with consistent lower extremity limb volume and pain reduction while achieving improvement in patient health outcomes. The study was
conducted in the United States and collected data from a patient registry required by a third-party payer for 196 patients with lower extremity lymphedema who were prescribed our Flexitouch System
from January 2009 to May 2012. The primary objective of the study was to examine the effectiveness of our Flexitouch System in reducing lower extremity limb volume, with a secondary objective of
evaluating clinician-assessed and patient-reported outcomes. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>101</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=106,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=401039,FOLIO='101',FILE='DISK131:[15ZBY1.15ZBY12201]EC12201A.;82',USER='GPEARMO',CD=';8-JUN-2016;22:47' -->
<A NAME="page_ec12201_1_102"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Use
of our Flexitouch System was associated with a reduction in limb volume, with 88% of patients experiencing a reduction in limb volume and with 35% enjoying a reduction in limb volume of greater
than 10%. Twelve percent of patients experienced an increase in limb volume. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Clinician
assessment indicated that the majority of patients experienced improvement in the condition of their skin. In 168, or 86%, of the patients, a reduction in skin hardening or fibrosis was
reported based on manual assessment of the skin. Based on clinical observation of function, all but three of these patients demonstrated an increased ability to perform activities of daily living.
Additionally, 149, or 77%, of the patients demonstrated improved range of motion. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Patients
reported a significant increase in their ability to control lymphedema through treatment with our Flexitouch System, with an increase in function and a reduction in pain. Of the
98&nbsp;patients who responded, 66% reported being "very satisfied" with the treatment by our Flexitouch System and 29, or 30%, of patients reported being "satisfied" with the treatment by our
Flexitouch System. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Comparison of our Flexitouch System with Pneumatic Compression Devices  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A prospective, randomized controlled study published in </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>Supportive Care in Cancer</I></FONT><FONT COLOR="#3B5A6F" SIZE=2> demonstrated that
our Flexitouch System provides better clinical outcomes as compared to those achieved with a basic pneumatic compression device for home-based treatment of breast cancer-related lymphedema. The study
was conducted in the United States and involved 36&nbsp;patients. This number of participants in the study is considered to be a small sample size and a limitation of the study. The patients were
randomized to our Flexitouch System or a basic pneumatic compression device used for home treatment of one-hour per day for 12&nbsp;weeks. The basic pneumatic compression device used in the study
was a Bio Compression 2004 Sequential Circulator pneumatic compression device. The material difference between our Flexitouch System and the Bio Compression 2004 Sequential Circulator is the ability
of our Flexitouch System to apply calibrated gradient pressure. The Bio Compression 2004 Sequential Circulator is considered a segmented device without calibrated gradient pressure, which is billed
under HCPCS Code E0651. Our Flexitouch System is considered a segmented device with calibrated gradient pressure, which is billed under HCPCS Code E0652. A segmented device with calibrated gradient
pressure for purposes of HCPCS Codes is distinguished by a manual control on at least three outflow ports which can deliver an individually determined pressure to each segmental unit. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
primary objective of the study was to determine whether our Flexitouch System provides better outcomes, as measured by arm edema and tissue water reductions, compared to a basic pneumatic
compression device in patients with arm lymphedema. The study does not reflect a comparison of our Flexitouch System to a product that is billed under the same HCPCS Code as our Flexitouch System. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Thirty-six
patients with unilateral upper extremity lymphedema with at least 5% arm edema volume at the time of enrollment completed treatments over the 12-week period, with 26&nbsp;patients being
evaluated for edema volume change and 28&nbsp;patients being evaluated for changes in arm tissue water content. Arm edema volumes were determined from arm girth measurements and suitable model
calculations, and tissue water was determined based on measurements of the arm tissue. The patients were randomized
into two groups of 18&nbsp;patients each, with one group receiving treatment with our Flexitouch System and the other group receiving treatment using a basic pneumatic compression device. The group
using our Flexitouch System experienced an average of 29% reduction in edema compared to a 16% increase in the group using a basic pneumatic compression device. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Study of Patient-Reported Satisfaction with Use of our Flexitouch System  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A retrospective study published in the </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>Oncology Nursing Forum</I></FONT><FONT COLOR="#3B5A6F" SIZE=2> demonstrated that patients using our
Flexitouch System were "satisfied" with the device and perceived it to be beneficial in managing their lymphedema. The study was conducted in the United States and involved 155&nbsp;patients with </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>102</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=107,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=175422,FOLIO='102',FILE='DISK131:[15ZBY1.15ZBY12201]EC12201A.;82',USER='GPEARMO',CD=';8-JUN-2016;22:47' -->
<A NAME="page_ec12201_1_103"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>lymphedema.
The primary objective of the study was to compare treatment protocol adherence, satisfaction and perceived changes in emotional and functional status between patients with cancer-related
lymphedema and non-cancer-related lymphedema using our Flexitouch System. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Ninety
percent of the 155 study patients reported being "satisfied" with our Flexitouch System. Of these patients, more than 65% reported being "extremely satisfied." The study was conducted by having
patients complete a pre- and post-therapy questionnaire. Of the 286 individuals with lymphedema receiving a pre-therapy questionnaire with our Flexitouch System, 155&nbsp;patients completed
information in the pre- and post-therapy questionnaires required for the analyses. Of these 155&nbsp;patients, 93 had cancer-related lymphedema and 62 had non-cancer-related lymphedema. Patients who
acknowledged using the device as prescribed reported statistically higher levels of satisfaction (p=0.008), a pattern repeated in both lymphedema groups. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Further,
95% of patients reported a positive limb volume outcome, which was defined as a patient perceiving that limb volume had been maintained or reduced with device use. Of these patients, 42%
reported limb volume decreases as much as 20%, and an additional 20% reported decreases of less than 20%. In addition, clinically and statistically significant improvements occurred in all areas of
physical and emotional health (p&nbsp;&lt;&nbsp;0.006). </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Flexitouch System Impact on Patient-Reported Improved Quality-of-Life  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A prospective observational study published in </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>Annals of Vascular Surgery</I></FONT><FONT COLOR="#3B5A6F" SIZE=2> demonstrated that use of
our Flexitouch System is associated with patient-reported overall improvement in quality-of-life and lower extremity-related symptoms. The study was conducted in the United States and collected data
from patients presenting for treatment of lower-extremity lymphedema from March 2011 to September 2014. Inclusion criteria were as follows: age 18 or greater and the presence of lymphedema in the
lower-extremity for at least 14&nbsp;days. Patients were excluded if they were pregnant, had previously used any pneumatic compression device, or had class&nbsp;IV congestive heart failure. A
total of 100 consecutive patients with lower-extremity lymphedema met inclusion criteria and were included in the study. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
primary objective of the study was to demonstrate improved quality-of-life in patients with lower-extremity lymphedema with Flexitouch System treatment. The secondary objective was to demonstrate
reduced infectious complications of lymphedema with Flexitouch System treatment, and to determine the incidence of concomitant venous insufficiency in patients with lymphedema. All patients in the
study were required to use our Flexitouch System for a minimum of three months, with three treatments per week. Quality-of-life questionnaires were completed by all patients, both prior to and
following treatment with our Flexitouch System. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Use
of our Flexitouch System was associated with overall improvement in lower extremity-related symptoms, with 54% of patients reporting greatly improved symptom control after use of our Flexitouch
System, 35% moderately improved and 11% mildly improved. In the year before use of our Flexitouch System, 15% of the patients reported 26 episodes of cellulitis, which decreased to five episodes after
initiation of the Flexitouch System (</FONT><FONT COLOR="#3B5A6F" SIZE=2><I>P</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;= 0.002) in subsequent median follow-up of 12.7&nbsp;months. Eight percent of patients reported
skin&nbsp;ulceration of the affected extremity in the year before presentation for treatment. The number of lower-extremity&nbsp;ulcers pre- and post-Flexitouch System use decreased from seven to
two (</FONT><FONT COLOR="#3B5A6F" SIZE=2><I>P</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;= 0.007). Overall, 46% of the patients had complete limb girth measurements at the ankle and calf, and there was a statistically
significant decreased overall limb girth after Flexitouch System treatment in pre- and post-ankle (28.3 cm vs. 27.5 cm, </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>P</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;= 0.01), and calf mean
girths (44.7 cm vs. 43.8 cm, </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>P</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;= 0.018). In addition, venous reflux was present in 18% of patients, 14% and 4% within the superficial and deep
venous system respectively. In patients with venous reflux, moderate to great improvement in symptoms was reported in 7% and 11%, respectively compared with 28% and 43% in patients without venous
reflux (</FONT><FONT COLOR="#3B5A6F" SIZE=2><I>P</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;= 0.257). </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>103</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=108,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=786618,FOLIO='103',FILE='DISK131:[15ZBY1.15ZBY12201]EC12201A.;82',USER='GPEARMO',CD=';8-JUN-2016;22:47' -->
<A NAME="page_ec12201_1_104"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Comparison of Conventional Treatment for Venous Leg&nbsp;Ulcers with our ACTitouch System  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A prospective, randomized study published in the </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>International Wound Journal</I></FONT><FONT COLOR="#3B5A6F" SIZE=2> demonstrated that our
ACTitouch System provides a comparable degree of effectiveness in venous leg&nbsp;ulcer healing to conventional treatment and an improved quality of life for patients. The study was conducted in the
United States and Europe, involving a total of 90&nbsp;patients over a 12-week period. The primary objective of the study was to evaluate the efficacy, functionality, safety, patient perceptions and
impact on patient quality of life of two compression methods for venous leg&nbsp;ulcers, including our ACTitouch System and a traditional four-layer bandage system. Of the 90&nbsp;patients,
38&nbsp;patients used our ACTitouch System and 52&nbsp;patients used a traditional four-layer bandage system. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
study demonstrated a comparable degree of effectiveness in venous leg&nbsp;ulcer healing, with healing rate differences not reaching statistical significance. The type and frequency of adverse
events reported were similar between the treatment groups and there were no serious adverse events related to treatment in either group. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition to demonstrating a comparable degree of effectiveness in venous leg&nbsp;ulcer healing, this study also demonstrated that using our ACTitouch System yielded greater improvements in
quality of life as compared to those using the bandage system. We believe our ACTitouch System achieved better patient acceptance because it allows greater control over therapy and gives patients the
ability to remove the device as needed for key activities of daily living and personal hygiene, such as bathing and sleeping. The only area that our ACTitouch System did not rate higher than the
bandage system was discreteness under clothing. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Sales and Marketing  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Unlike many of our competitors, we utilize a direct-to-patient and -provider model to market our solutions directly to patients and clinics, whereby
we disintermediate the traditional durable medical equipment channel and capture both the manufacturer and distributor margins. The below chart shows this disintermediation: </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g953521.jpg" ALT="GRAPHIC" WIDTH="675" HEIGHT="145">
  </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
direct-to-patient and -provider model is comprised of a direct sales force, contract at-home trainers, reimbursement capabilities and medical expertise to expand awareness, garner referrals and
obtain payment for our products. As of March&nbsp;31, 2016, we employed 10 sales managers and 95&nbsp;full-time sales representatives who provide coverage throughout the United States. The below
chart describes our U.S. direct-to-patient and -provider model. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>104</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=109,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=890498,FOLIO='104',FILE='DISK131:[15ZBY1.15ZBY12201]EC12201A.;82',USER='GPEARMO',CD=';8-JUN-2016;22:47' -->
<A NAME="page_ec12201_1_105"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g341538.jpg" ALT="GRAPHIC" WIDTH="652" HEIGHT="264">
  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
marketing team leads our efforts in brand development, tradeshow attendance, educational forums, product messaging, website development, social media and advertising. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Reimbursement, Payer Relations and Customer Support Process  </B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>Private insurance payers represented approximately 74% of our revenues in 2015 and 71% of our revenues in the three months ended March&nbsp;31,
2016, while Medicare represented approximately 13% of our revenues in 2015 and 12% of our revenues in the three months ended March&nbsp;31, 2016. Other payers, including the Veterans Administration,
represented the remainder of our revenues. When we sell our solutions directly to patients, we bill third-party payers, such as private insurance or Medicare, on behalf of our patients and bill the
patient for their co-payment obligations and deductibles. A recent change to the level of Medicare coverage for our products could reduce the number of Medicare patients who have access to our
products, and we are seeking to have the coverage determination overturned.

 </FONT>

</P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As
a nationwide provider, we have developed a broad expertise in obtaining billing codes, developing coverage policies, overcoming payer barriers, and obtaining authorization and payment from payers
across all regions of the United States. Our model utilizes our strategic and operational reimbursement proficiency to meet the varying requirements of hundreds of payers across the country. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>To
achieve ongoing success in both the strategic and operational reimbursement arenas, we have developed two teams with specialized focus on these respective competencies. Our payer relations group is
comprised of over 20&nbsp;employees and is responsible for developing relationships with payer decision-makers. Specifically, this group educates payers of our product efficacy, develops overall
payer coverage policies and reimbursement criteria, manages our Medicare strategy and patient claims, codes, and contracts with payers. Our payer relations team is also the advocacy liaison between
patients, clinicians and payers through the appeals process. Our reimbursement operations group is comprised of over 55&nbsp;employees and is responsible for verifying case-by-case benefits,
obtaining prior authorization, billing and collecting payments from payers, analyzing payer data to help understand trends, developing processes and patient programs and providing customer support
services. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
have strong and established payer relationships, including some of the largest private payers in the United States. Based on our estimates, we are contracted or enrolled as an in-network provider
with payers covering over 230&nbsp;million lives. These contracts allow us to be an in-network provider for patients, enabling them to access our systems at a competitive rate and copay comparable
to other suppliers, and easing our administrative burden in processing at both authorization and when billing. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>105</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=110,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1001803,FOLIO='105',FILE='DISK131:[15ZBY1.15ZBY12201]EC12201A.;82',USER='GPEARMO',CD=';8-JUN-2016;22:47' -->
<A NAME="page_ec12201_1_106"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
have enjoyed a consistent commercial payer approval rate of greater than 80% for the last eight years, and greater than 90% Medicare claims submitted approval rate (post-arbitration and based on
the number of claims, not dollar amount of claims, submitted) since we began doing business with Medicare in 2007. We have an in-depth understanding of specific payer coverage criteria, and our
submission materials are tailored to address individual payer's distinct requirements. Our dedicated customer service team is available to answer patient questions regarding reimbursement, account
status, device operation and troubleshooting during normal business hours. If necessary, we will dispatch a trainer for a second time to assist patients with their training needs. We receive no
additional reimbursement for patient support, but provide high-quality customer service to enhance patient comfort, satisfaction, compliance and safety with our products. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
Flexitouch System is reimbursed under HCPCS code E0652, and our ACTitouch System and Entr&eacute; System are reimbursed under HCPCS code E0651. Garments that cover various parts of the
body are used with these systems and billed using HCPCS codes E0651, E0652, E0667, E0668 and E0669. As of March&nbsp;31, 2016, over 600&nbsp;payers have paid for our products. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Research and Clinical Operations  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are committed to ongoing research and development as part of our efforts to be at the forefront of patient preference in the area of chronic
disease, especially lymphedema and chronic venous insufficiency. As of March&nbsp;31, 2016 our research and development and clinical operations staff included more than 10&nbsp;engineers,
scientists and project managers with expertise in pneumatics, electronics, garment design, embedded software, mechanical design, sensors and manufacturing technologies. Our research and development
expenses, including spending on our clinical evidence development efforts, totaled $2.8&nbsp;million and $4.3&nbsp;million for the years ended December&nbsp;31, 2014 and 2015, respectively, and
$0.8 million and $1.0 million for the three months ended March&nbsp;31, 2015 and 2016, respectively. Our current research and development efforts are focused primarily on increasing efficacy,
improving design for ease-of-use, enhancing clinical functionality and reducing production costs of our solutions. Our clinical development efforts are focused on further differentiating our products
from our competitors. We coordinate our development efforts with our intellectual property strategies in order to enhance our ability to obtain patent and other intellectual property protection. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Manufacturing and Quality Assurance  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our manufacturing and quality assurance model combines our internal manufacturing resources and expertise, including assembly, quality assurance,
material procurement and inventory control, with approved third-party manufacturers and suppliers of system components. Our internal manufacturing activities, located in Minneapolis, Minnesota,
include quality inspection, assembly, packaging, warehousing and shipping of our products. We outsource the manufacture of components, which are produced to our specifications and shipped to our
facilities for inspection and final assembly. We use third-party manufacturers and suppliers worldwide to source our components, maintaining dual-source vendors of critical components whenever
possible, and leveraging competitive bids among third-party manufacturers and suppliers to control costs. We have elected to source certain key components from single sources of supply, including our
ACTitouch controller. While we believe alternate sources exist for the ACTitouch controller, we have not yet qualified an alternate supplier. Quality control, risk management, efficiency and the
ability to respond quickly to changing requirements are the primary goals of our manufacturing operations. We believe our manufacturing model permits us to operate with low capital expenditure
requirements. We carefully manage our supply chain in an effort to take costs out of the manufacturing process, as demonstrated by a 58% reduction in controller costs for our Flexitouch System since
2008. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>106</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=111,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=736423,FOLIO='106',FILE='DISK131:[15ZBY1.15ZBY12201]EC12201A.;82',USER='GPEARMO',CD=';8-JUN-2016;22:47' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ee12201_1_107"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We manage our arrangements with our third-party manufacturers and suppliers to adjust delivery schedules and quantities of components to match our changing manufacturing
requirements. We forecast our component needs based on historical trends, current utilization patterns and sales forecasts of future demand. We establish our relationships with our third-party
manufacturers and suppliers through supplier contracts and purchase orders. In most cases, these supplier relationships may be terminated by either party upon short notice. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
order to mitigate against the risks related to a single-source of supply, we qualify alternative suppliers, when possible, and develop contingency plans for responding to disruptions, including
maintaining adequate inventory of any single source components, along with requiring each supplier to maintain specified quantities of inventory. To date, we have not experienced material delays in
obtaining any of our components, nor has the ready supply of finished products to our patients or clinicians been adversely affected by component supply issues. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
have implemented a quality management system designed to comply with FDA regulations and International Standards Organization, or ISO, standards governing medical device products. In the United
States, we and certain of our manufacturers are required to manufacture our products in compliance with the FDA's Quality System Regulation, which covers the methods and documentation of the design,
testing, control, manufacturing, labeling, quality assurance, packaging, storage, and shipping for our products. We maintain a quality management system to control compliance with such requirements
and have procedures in place designed to ensure that all products and materials
purchased by us conform to our requirements and FDA regulations. As of March&nbsp;31, 2016, we had over 17&nbsp;employees in operations, manufacturing and quality assurance. Our quality management
system has been certified to ISO in 2012 and 2014, including ISO&nbsp;13485:2003. Our manufactures' quality management systems also have been certified to ISO. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Order Fulfillment and Patient Training  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Once we have a complete order and prior authorization from the payer, we package and ship a system, configured to their physician's prescription,
directly to the patient. Our primary logistics partner is United Parcel Service, which we use for delivery and pick up of our devices. After delivery, we coordinate a visit from one of our over 300
licensed, independent contract trainers that go to our patients' homes to provide individualized training to our patients, when requested. These trainers are healthcare professionals, licensed in
their state of residence, who we have identified through our sales and marketing interest and instructed on proper use of our products. Training visits are coordinated from our offices in Minneapolis
and training sessions assigned by our staff. Upon completion of training, the independent contractor submits an invoice to us for payment for the patient's training and their travel. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Competition  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The pneumatic compression pump market is a competitive industry, and we compete with a number of manufacturers and distributors of pneumatic
compression pumps. Our significant manufacturing competitors are Bio Compression Systems, Inc., Lympha Press USA and Wright Therapy Products (which was recently acquired by BSN Medical GmbH). If we
expand internationally, we expect that ArjoHuntleigh, an affiliate of Getinge Group, would become a competitor. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Given
the growth of the pneumatic compression pump market, we expect that the industry will become increasingly competitive in the future. Manufacturing companies compete for sales to patients
primarily based on product features and service. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>107</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=112,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=497504,FOLIO='107',FILE='DISK131:[15ZBY1.15ZBY12201]EE12201A.;51',USER='ABEAULI',CD=';8-JUN-2016;16:04' -->
<A NAME="page_ee12201_1_108"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
believe we are the only pneumatic compression home-therapy device company with a meaningful U.S. market position supported by a direct sales force. We believe our manufacturing competitors'
complete reliance on home medical equipment distribution intermediaries compresses their margins and limits their ability to invest in product features that address consumer preferences. To pursue a
direct-to-patient and -provider sales model, our manufacturing competitors would need to meet national accreditation and state-by-state licensing requirements and secure Medicare billing privileges,
as well as compete directly with the home medical equipment providers that many rely on across their entire home care businesses. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Some
of our competitors and potential competitors are large, well-capitalized companies with greater resources than we have. As a consequence, they are able to spend more aggressively on product
development, marketing, sales and other product initiatives than we can. Some of these competitors have:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> significantly greater name recognition; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> established relations with healthcare professionals, customers, and third-party payers; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> established distribution networks; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> additional lines of products, and the ability to offer rebates or bundle products to offer higher discounts or other incentives to
gain a competitive advantage; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> greater history in conducting research and development, manufacturing, marketing, and obtaining regulatory approval for homecare
devices; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> greater financial and human resources for product development, sales and marketing, patent litigation and customer financing. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As
a result, our competitors may be able to respond more quickly and effectively than we can to new or changing opportunities, technologies, standards or customer requirements. In light of our
competitors' advantages, even if our technology and direct-to-patient and -provider marketing strategy is more effective than the technology and marketing strategy of our competitors, current or
potential customers might accept competitor products and services in lieu of purchasing our products. We anticipate that we will face increased competition in the future as existing companies and
competitors develop new or improved products and distribution strategies and as new companies enter the market with new technologies and distribution strategies. We may not be able to compete
effectively against these organizations. Our ability to compete successfully and to increase our market share is dependent upon our reputation for providing responsive, professional and high-quality
products and services and achieving strong customer satisfaction. Increased competition in the future could adversely affect our revenues, revenues growth rate, if any, margins and market share. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Government Regulation  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our systems are medical devices subject to extensive and ongoing regulation by numerous governmental authorities, principally the FDA, and
corresponding state and foreign regulatory agencies. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


FDA Regulation  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In the United States, the FDA regulates medical devices, including the following activities that we perform, or that are performed on our behalf with
respect to our devices: product design and </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>108</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=113,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=948750,FOLIO='108',FILE='DISK131:[15ZBY1.15ZBY12201]EE12201A.;51',USER='ABEAULI',CD=';8-JUN-2016;16:04' -->
<A NAME="page_ee12201_1_109"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>development,
pre-clinical and clinical testing, manufacturing, labeling, storage, premarket clearance or approval, record keeping, product marketing, advertising and promotion, sales and distribution,
and post-marketing surveillance. Failure to comply with applicable U.S. requirements may subject us to a variety of administrative or judicial sanctions, such as warning letters, product recalls,
product seizures, total or partial suspension of production or distribution, injunctions, fines, civil penalties, and criminal prosecution. The FDA can also refuse to approve pending applications. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Unless
an exemption applies, each medical device we seek to distribute commercially in the United States requires marketing authorization from the FDA prior to distribution. The two primary types of
FDA marketing authorization applicable to a device are premarket notification, also called 510(k) clearance, and premarket approval. The type of marketing authorization is generally linked to the
classification of the device. The FDA classifies medical devices into one of three classes&nbsp;&#151; Class&nbsp;I, Class&nbsp;II or Class&nbsp;III&nbsp;&#151; based on the
degree of risk the FDA determines to be associated with a device and the level of regulatory control deemed necessary to ensure the device's safety and effectiveness. Devices requiring fewer controls
because they are deemed to pose lower risk are placed in Class&nbsp;I or II. Class&nbsp;I devices are deemed to pose the least risk and are subject only to general controls applicable to all
devices, such as requirements for device labeling, premarket notification, and adherence to the FDA's Good Manufacturing Practices. Class&nbsp;II devices are intermediate risk devices that are
subject to general controls and may also be subject to special controls such as performance standards, product-specific guidance documents, special labeling requirements, patient registries, or
post-market surveillance. Class&nbsp;III devices are those for which insufficient information exists to assure safety and effectiveness solely through general controls or if the device is a
life-sustaining, life-supporting or a device of substantial importance in preventing impairment of human health, or which presents a potential, unreasonable risk of illness or injury and special
controls are not adequate to assure safety and effectiveness. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Most
Class&nbsp;I devices and some Class&nbsp;II devices are exempted by regulation from the 510(k) clearance requirement and can be marketed without prior authorization from the FDA. Most
Class&nbsp;II devices (and certain Class&nbsp;I devices that are not exempt) are eligible for marketing through the 510(k) clearance pathway. By contrast, devices placed in Class&nbsp;III
generally require premarket approval or 510(k) de novo clearance prior to commercial marketing. The premarket approval process is more stringent, time-consuming, and expensive than the 510(k)
clearance process. However, the 510(k) clearance process has also become increasingly stringent and expensive. </FONT></P>


<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2><B><I> 510(k) Clearance Pathway.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;When a 510(k) clearance is required, we must submit a premarket notification to the FDA demonstrating that our proposed
device is
"substantially equivalent" to a previously cleared and legally marketed 510(k) device or a device that was in commercial distribution before May&nbsp;28, 1976 for which the FDA has not yet called
for the submission of a premarket approval application, which is commonly known as the "predicate device." A device is substantially equivalent
if, with respect to the predicate device, it has the same intended use and has either (i)&nbsp;the same technological characteristics or (ii)&nbsp;different technological characteristics and the
information submitted demonstrates that the device is as safe and effective as a legally marked device and does not raise different questions of safety or effectiveness. By law, the FDA is required to
clear or deny a 510(k) premarket notification within 90&nbsp;days of submission of the application. As a practical matter, clearance often takes significantly longer. The FDA may require further
information, including clinical data, to make a determination regarding substantial equivalence. If the FDA determines that the device, or its intended use, is not substantially equivalent to a
previously-cleared device or use, the FDA will issue a not substantially equivalent decision. This means the device cannot be cleared through the 510k process and will require marketing authorization
through the premarket approval pathway. We obtained 510(k) clearance for our Flexitouch System in October 2006 and for a discontinued predecessor system in July 2002. We currently have a 510(k)
premarket notification

</FONT>

</P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>109</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=114,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=431211,FOLIO='109',FILE='DISK131:[15ZBY1.15ZBY12201]EE12201A.;51',USER='ABEAULI',CD=';8-JUN-2016;16:04' -->
<A NAME="page_ee12201_1_110"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


before the FDA regarding new garment offerings for our Flexitouch System and such notification is subject to the uncertainties of FDA review, including the potential for delays or denial of clearance.
We obtained 510(k) clearance for our ACTitouch System in June 2013 and our Entr&eacute; System in May 2015.

</FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Premarket Approval Pathway.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;A premarket approval application must be submitted to the FDA if the device cannot be cleared through the 510(k)
process. The premarket
approval application process is much more demanding than the 510(k) premarket notification process and requires the payment of significant user fees. A premarket approval application must be supported
by valid scientific evidence, which typically requires extensive data, including but not limited to technical, preclinical, clinical trials, manufacturing and labeling to demonstrate to the FDA's
satisfaction reasonable evidence of safety and effectiveness of the device. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
FDA has 45&nbsp;days from its receipt of a premarket approval application to determine whether the application will be accepted for filing based on the FDA's threshold determination that it is
sufficiently complete to permit substantive review. After the FDA determines that the application is sufficiently complete to permit a substantive review, the FDA will accept the application and begin
its in-depth review. The FDA has 180&nbsp;days to review an "accepted" premarket approval application, although this process typically takes significantly longer and may require several years to
complete. During this review period, the FDA may request additional information or clarification of the information already provided. Also, an advisory panel of experts from outside the FDA may be
convened to review and evaluate the application and provide recommendations to the FDA as to the approvability of the device. In addition, the FDA will conduct a preapproval inspection of the
manufacturing facility to ensure compliance with quality system regulations. The FDA may delay, limit or deny approval of a premarket approval application for many reasons,
including:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> failure of the applicant to demonstrate that there is reasonable assurance that the medical device is safe or effective under the
conditions of use prescribed, recommended or suggested in the proposed labeling; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> insufficient data from the preclinical studies and clinical trials; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the manufacturing processes, methods, controls or facilities used for the manufacture, processing, packing or installation of the
device do not meet applicable requirements. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
the FDA evaluations of both the premarket approval application and the manufacturing facilities are favorable, the FDA will either issue an approval order or an approvable letter, which usually
contains a number of conditions that must be met in order to secure final approval of the premarket approval application. If the FDA's evaluation of the premarket approval application or manufacturing
facilities is not favorable, the FDA will deny approval of the premarket approval application or issue a not approvable letter. A not approvable letter will outline the deficiencies in the application
and, where practical, will identify what is necessary to make the premarket approval application. The FDA may also determine that additional clinical trials are necessary, in which case the premarket
approval application may be delayed for several months or years while the trials are conducted and then the data submitted in an amendment to the premarket approval application. Once granted,
premarket approval application may be withdrawn by the FDA if compliance with post approval requirements, conditions of approval or other regulatory standards is not maintained or problems are
identified following initial marketing. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Clinical Trials.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Clinical trials are almost always required to support premarket approval and are sometimes required for 510(k) clearance. In
the United States,
these trials generally require submission </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>110</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=115,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=212654,FOLIO='110',FILE='DISK131:[15ZBY1.15ZBY12201]EE12201A.;51',USER='ABEAULI',CD=';8-JUN-2016;16:04' -->
<A NAME="page_ee12201_1_111"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>of
an application for an Investigational Device Exemption, or IDE, to the FDA. The IDE application must be supported by appropriate data, such as animal and laboratory testing results, showing it is
safe to test the device in humans and that the testing protocol is scientifically sound. The FDA must approve the IDE in advance of trials for a specific number of patients unless the product is
deemed a non-significant risk device eligible for more abbreviated IDE requirements or the clinical investigation is exempt from the IDE regulations. Clinical trials for significant risk devices may
not begin until the IDE application is approved by the FDA and the appropriate institutional review boards, or IRBs, at the clinical trial sites. We, the FDA or the IRB at each site at which a
clinical trial is being performed may suspend a clinical trial at any time for various reasons, including a belief that the risks to study subjects outweigh the benefits. Even if a trial is completed,
the results of clinical testing may not demonstrate the safety and efficacy of the device, may be equivocal or may otherwise not be sufficient to obtain approval or clearance of the product. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> FDA Ongoing Regulation.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Even after a device receives clearance or approval by the FDA and is placed on the market, numerous regulatory
requirements apply. These
include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> establishment registration and device listing; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> quality system regulation, which requires manufacturers, including third-party manufacturers, to follow stringent design, testing,
control, documentation and other quality assurance procedures during all aspects of the manufacturing process; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> labeling regulations and the FDA prohibitions against the promotion of products for un-cleared, unapproved or "off-label" uses, and
other requirements related to promotional activities; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> medical device reporting regulations, which require that manufacturers report to the FDA if their device may have caused or
contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if the malfunction were to recur; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> corrections and removals reporting regulations, which require that manufacturers report to the FDA field corrections and product
recalls or removals if undertaken to reduce a risk to health posed by the device or to remedy a violation that may present a risk to health; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> post-market surveillance regulations, which apply when necessary to protect the public health or to provide additional safety and
effectiveness data for the device. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>After
a device receives 510(k) clearance or a premarket approval, in general any modification that could significantly affect its safety or effectiveness, or that would constitute a major change in
its intended use, will require a new clearance or approval. The FDA requires each manufacturer to make this determination, but the FDA can review any such decision and can disagree with a
manufacturer's determination. We have modified various aspects of our systems since receiving regulatory clearance, but we believe that new 510(k) clearances are not required for these modifications.
If the FDA disagrees with our determination not to seek a new 510(k) clearance, the FDA may retroactively require us to seek 510(k) clearance or premarket approval. The FDA could also require us to
cease marketing and distribution and/or recall the modified device until 510(k) clearance or premarket approval is obtained. Also, in these circumstances, we may be subject to significant regulatory
fines and penalties. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>111</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=116,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=188349,FOLIO='111',FILE='DISK131:[15ZBY1.15ZBY12201]EE12201A.;51',USER='ABEAULI',CD=';8-JUN-2016;16:04' -->
<A NAME="page_ee12201_1_112"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Failure
to comply with applicable regulatory requirements can result in enforcement action by the FDA, which may include any of the following sanctions: Warning Letters, fines, injunctions, civil or
criminal penalties, recall or seizure of our products, operating restrictions, partial suspension or total shutdown of production, refusing our request for 510(k) clearance or premarket approval of
new products, rescinding previously granted 510(k) clearances or withdrawing previously granted premarket approvals. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
are also subject to announced and unannounced inspections by the FDA, and these inspections may include the manufacturing facilities of our subcontractors. We were audited two times since January
2010 by the FDA and found to be in compliance with the Quality System Regulation. We cannot assure you that we can maintain a comparable level of regulatory compliance in the future at our facility. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


FTC Regulation  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Device advertising and promotional activity in certain circumstances is also subject to scrutiny by the Federal Trade Commission, as well as similar
state consumer protection agencies, which enforce laws related to false and deceptive trade practices. A company that is found to have advertised its product in violation of these laws may be subject
to liability, including monetary penalties. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Centers for Medicare and Medicaid Services  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Centers for Medicare and Medicaid Services, or CMS, requires providers of product or services to attain and maintain accreditation. To attain and
maintain accreditation, companies are required to institute policies and procedures that, among other things, formalize the interaction of the company with patients. Accrediting bodies that are
approved by CMS will perform audits of these policies and procedures every three years. Should a company fall out of compliance with the requirements of the Accrediting body, expulsion from the
Medicare program could follow. In May 2008, we became a Durable, Medical Equipment, Prosthetics, Orthotics, and Supplies accredited Medicare supplier by the Accreditation Commission for Health Care
for our solutions. Our Medicare accreditation must be renewed every three years through passage of an on-site inspection. Our current accreditation with Medicare is due to expire in May
2017.&nbsp;Maintaining our accreditation and Medicare enrollment requires that we comply with numerous business and customer support standards. If we are found to be out of compliance with
accreditation standards, our enrollment status in the Medicare program could be jeopardized, up to and including termination. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Licensure  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Several states require that durable medical equipment providers be licensed in order to sell products to patients in that state. Certain of these
states require that durable medical equipment providers maintain an in-state location. Most of our state licenses are renewed on an annual or bi-annual basis. Although we believe we are in compliance
with all applicable state regulations regarding licensure requirements, if we were found to be noncompliant, we could lose our licensure in that state, which could prohibit us from selling our current
or future products to patients in that state. In addition, we are subject to certain state laws regarding professional licensure. We believe that our certified clinicians are in compliance with all
such state laws. If our clinicians were to be found non-compliant in a given state, we would need to modify our approach to providing education, clinical support and customer service in such state. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Fraud and Abuse Regulations  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Federal Anti-Kickback and Self-Referral Laws.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Federal Anti-Kickback Statute, among other things, prohibits the knowing and willful offer,
payment, solicitation
or receipt of any form of </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>112</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=117,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=771948,FOLIO='112',FILE='DISK131:[15ZBY1.15ZBY12201]EE12201A.;51',USER='ABEAULI',CD=';8-JUN-2016;16:04' -->
<A NAME="page_ee12201_1_113"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>remuneration,
whether directly or indirectly and overtly or covertly, in return for, or to induce the referral of an individual for the:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> furnishing or arranging for the furnishing of items or services reimbursable in whole or in part under Medicare, Medicaid or other
federal healthcare programs; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> purchase, lease, or order of, or the arrangement or recommendation of the purchasing, leasing, or ordering of any item or service
reimbursable in whole or in part under Medicare, Medicaid or other federal healthcare programs. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>There
are a number of safe harbors to the Federal Anti-Kickback Statute. Such safe harbors permit certain payments and business practices that, although they would otherwise potentially implicate the
Federal Anti-Kickback Statute, are not treated as an offense under the same if the requirements of the specific applicable safe harbor are met. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Federal Anti-Kickback Statute applies to certain arrangements with healthcare providers, product end users, and other parties, including marketing arrangements and discounts and other financial
incentives offered to our clinicians in connection with the sales of our products. Although we believe that we have structured such arrangements to be in compliance with the Anti-Kickback Statute and
other applicable laws, regulatory authorities may determine that our marketing, pricing, or other activities violate the Federal Anti-Kickback Statute or other applicable laws. Noncompliance with the
Federal Anti-Kickback Statute can result in civil, administrative, and criminal penalties, restrictions on our ability to operate in certain jurisdictions, and exclusion from participation in
Medicare, Medicaid or other federal healthcare programs. In addition, to the extent we are found to not be in compliance, we may be required to curtail or restructure our operations. Any penalties,
damages, fines, exclusions, curtailment or restructuring of our operations could adversely affect our ability to operate our business, our financial condition, and our results of operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Ethics in Patient Referrals Act, commonly known as the "Stark Law," prohibits a physician from making referrals for certain "designated health services" payable by Medicare to an entity, including
a company that furnishes durable medical equipment, in which the physician or an immediate family member of such physician has an ownership or investment interest or with which the physician has
entered into a compensation arrangement unless an exception applies. Violation of the Stark Law could result in denial of payment, disgorgement of reimbursements received under a noncompliant
arrangement, civil penalties, and exclusion from Medicare or other governmental programs. Although we believe that we have structured our provider arrangements to comply with current Stark Law
requirements, these requirements are highly technical and there can be no guarantee that regulatory authorities will not determine or assert that our arrangements do not meet applicable Stark Law
exceptions. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Additionally,
because some of these laws continue to evolve, we lack definitive guidance as to the application of certain key aspects of these laws as they relate to our arrangements with providers
with respect to patient training. We cannot predict the final form that these regulations will take or the effect that the final regulations will have on us. As a result, our provider arrangements may
ultimately be found to be non-compliant with applicable federal law. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> False statements.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The federal false statements statute prohibits knowingly and willfully falsifying, concealing, or omitting a material fact or
making any
materially false statement in connection with the delivery of healthcare benefits, items, or services. In addition to criminal penalties, violation of this statute may result in collateral
administrative sanctions, including exclusion from participation in Medicare, Medicaid, and other federal health care programs. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>113</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=118,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=938716,FOLIO='113',FILE='DISK131:[15ZBY1.15ZBY12201]EE12201A.;51',USER='ABEAULI',CD=';8-JUN-2016;16:04' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_eg12201_1_114"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Federal False Claims Act and Civil Monetary Penalties Law.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Federal False Claims Act provides, in part, that the federal government may bring
a lawsuit against
any person whom it believes has knowingly presented, or caused to be presented, a false or fraudulent request for payment from the federal government, or who has made a false statement or used a false
record to get a claim paid or to avoid, decrease or conceal an obligation to pay money to the federal government or who has knowingly retained an overpayment. In addition, amendments in 1986 to the
Federal False Claims Act have made it easier for private parties to bring "qui tam" whistleblower lawsuits against companies. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Civil Monetary Penalties Law provides, in part, that the federal government may seek civil monetary penalties against any person that, like under the False Claims Act, presents or causes to be
presented claims to a Federal health care program that the person knows or should know is for an item or services that was not provided as claimed or is false or fraudulent or that has made a false
statement or used a false record to get a claim paid. The federal government may also seek civil monetary penalties for a wide variety of other conduct, including offering remuneration to influence a
Medicare or Medicaid beneficiary's selection of providers and violations of the Federal Anti-Kickback Statute. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Although
we believe that we are in compliance with the Federal False Claims Act as well as the Civil Monetary Penalties laws, if we are found in violation of the same, penalties include fines ranging
from
$5,500 to $11,000 for each false claim violation of the Federal False Claims Act and varying amounts based on the type of violation of the Civil Monetary Penalties Law), plus up to three times the
amount of damages that the federal government sustained because of the act of that person. In addition, the federal government may also seek exclusion from participation in all federal health care
programs. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>To
the extent we are found to not be in compliance, we may be required to curtail or restructure our operations. Any penalties, damages, fines, exclusions, curtailment or restructuring of our
operations could adversely affect our ability to operate our business, our financial condition, and our results of operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> The U.S. Foreign Corrupt Practices Act and Other Anti-Corruption Laws.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;We may be subject to a variety of domestic and foreign anti-corruption
laws with respect to
our regulatory compliance efforts and operations. The U.S. Foreign Corrupt Practices Act, commonly known as the FCPA, is a criminal statute that prohibits an individual or business from paying,
offering, promising or authorizing the provision of money (such as a bribe or kickback) or anything else of value (such as an improper gift, hospitality, or favor), directly or indirectly, to any
foreign official, political party or candidate for the purpose of influencing any act or decision in order to assist the individual or business in obtaining, retaining, or directing business or other
advantages (such as favorable regulatory rulings). The FCPA also obligates companies with securities listed in the United States to comply with certain accounting provisions. Those provisions require
a company such as ours to (i)&nbsp;maintain books and records that accurately and fairly reflect all transactions, expenses, and asset dispositions, and (ii)&nbsp;devise and maintain an adequate
system of internal accounting controls sufficient to provide reasonable assurances that transactions are properly authorized, executed and recorded. The FCPA is subject to broad interpretation by the
U.S. government. The past decade has seen a significant increase in enforcement activity. In addition to the FCPA, there are a number of other federal and state anti-corruption laws to which we may be
subject, including, the U.S. domestic bribery statute contained in 18 USC </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>&sect;</B></FONT><FONT COLOR="#3B5A6F" SIZE=2> 201 (which prohibits bribing U.S. government officials) and the
U.S. Travel Act (which in some instances addresses private-sector or commercial bribery both within and outside the United States). Also, a number of the countries in which we conduct activities have
their own domestic and international anti-corruption laws, such as the UK Bribery Act 2010. There have been cases where companies have faced multi-jurisdictional liability under the FCPA and the
anti-corruption laws of other countries for the same illegal act. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>114</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=119,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=517477,FOLIO='114',FILE='DISK131:[15ZBY1.15ZBY12201]EG12201A.;64',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_eg12201_1_115"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
could be held liable under the FCPA and other anti-corruption laws for the illegal activities of our employees, representatives, contractors, collaborators, agents, subsidiaries, or affiliates,
even if we did not explicitly authorize such activity. Although we will seek to comply with anti-corruption laws, there can be no assurance that all of our employees, representatives, contractors,
collaborators, agents, subsidiaries or affiliates will comply with these laws at all times. Violation of these laws could subject us to whistleblower complaints, investigations, sanctions,
settlements, prosecution, other enforcement
actions, disgorgement of profits, significant fines, damages, other civil and criminal penalties or injunctions, suspension and/or debarment from contracting with certain governments or other persons,
the loss of export privileges, reputational harm, adverse media coverage, and other collateral consequences. In addition, our directors, officers, employees, and other representatives who engage in
violations of the FCPA and certain other anti-corruption statutes may face imprisonment, fines, and penalties. If any subpoenas or investigations are launched, or governmental or other sanctions are
imposed, or if we do not prevail in any possible civil or criminal litigation, our business, financial condition, and results of operations could be materially harmed. In addition, responding to any
action will likely result in a materially significant diversion of management's attention and resources and significant defense costs and other professional fees. Enforcement actions and sanctions
could further harm our business, financial condition, and results of operations. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> State fraud and abuse provisions.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Many states have also adopted some form of anti-kickback and anti-referral laws and false claims acts that
apply regardless of
payer, in addition to items and services reimbursed under Medicaid and other state programs. In some states, these laws apply and we believe that we are in compliance with such laws. Nevertheless, a
determination of liability under such laws could result in fines and penalties and restrictions on our ability to operate in these jurisdictions. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> State and federal transparency/reporting requirements.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;As part of the Patient Protection and Affordable Care Act, the Federal government has
created a transparency
program known as Open Payments (the Physician Payments Sunshine Act) which requires manufacturers of drugs, devices, biologicals and medical supplies to report annually to the Centers for
Medicare&nbsp;&amp; Medicaid Services, or CMS, an agency within the U.S. Department of Health and Human Services, or HHS, information related to payments and other transfers of value provided to
physicians and teaching hospitals and certain ownership and investment interests held by physicians and their immediate family members. Failure to submit timely, accurate and complete information may
result in civil monetary penalties of up to an aggregate of $150,000 per year and up to an aggregate of $1.0&nbsp;million per year for "knowing failures to report." Certain states require
implementation of commercial compliance programs and compliance with the device industry's voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government,
impose restrictions on marketing practices, and/or prohibition and tracking and reporting of gifts, compensation and other remuneration or items of value provided to physicians and other healthcare
professionals and entities. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
laws described above impact the kinds of financial arrangements we may have with hospitals, healthcare professionals or other potential purchasers of our products. If our operations are found to
be in violation of any of the laws or regulations described above or others that apply to us, we may be subject to penalties, including potentially significant criminal, civil and/or administrative
penalties, damages, fines, disgorgement, exclusion from participation in government healthcare programs, contractual damages, reputational harm, administrative burdens, diminished profits and future
earnings, and the curtailment or restructuring of our operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> HIPAA.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Health Insurance Portability and Accountability Act of 1996, or HIPAA, established uniform standards governing the conduct of certain
electronic
healthcare transactions and protecting the security and privacy of individually identifiable health information maintained or transmitted by </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>115</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=120,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=530763,FOLIO='115',FILE='DISK131:[15ZBY1.15ZBY12201]EG12201A.;64',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_eg12201_1_116"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>healthcare
providers, health plans and healthcare clearinghouses, which are referred to as covered entities. The following standards have been promulgated under HIPAA's
regulations:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the Standards for Privacy of Individually Identifiable Health Information, which restrict the use and disclosure of individually
identifiable health information, or "protected health information"; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the Standards for Electronic Transactions, which establish standards for common healthcare transactions, such as claims information,
plan eligibility, payment information and the use of electronic signatures; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the Security Standards, which require covered entities to implement and maintain certain security measures to safeguard certain
electronic health information, including the adoption of administrative, physical and technical safeguards to protect such information; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the breach notification rules, which require covered entitles to provide notification to affected individuals, the Department of
Health and Human Services, and the media in the event of a breach of unsecured protected health information. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
2009, Congress passed the American Recovery and Reinvestment Act of 2009, or ARRA, which included sweeping changes to HIPAA, including an expansion of HIPAA's privacy and security standards. ARRA
includes the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, which, among other things, made HIPAA's privacy and security standards directly applicable to
business associates of covered entities. A business associate is a person or entity that performs certain functions or activities on behalf of a covered entity that involve the use or disclosure of
protected health information. As a result, business associates are now subject to significant civil and criminal penalties for failure to comply with applicable standards. Moreover, HITECH creates a
new requirement to report certain breaches of unsecured, individually identifiable health information and imposes penalties on entities that fail to do so. HITECH also increased the civil and criminal
penalties that may be imposed against covered entities, business associates and possibly other persons and gave state attorneys general new authority to file civil actions for damages or injunctions
in federal courts to enforce the federal HIPAA laws and seek attorney fees and costs associated with pursuing federal civil actions. The 2013 final HITECH omnibus rule modifies the breach reporting
standard in a manner that will likely make more data security incidents qualify as reportable breaches. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition to federal regulations issued under HIPAA, some states have enacted privacy and security statutes or regulations that, in certain cases, are more stringent than those issued under HIPAA.
In those cases, it may be necessary to modify our planned operations and procedures to comply with the more stringent state laws. Most states have also adopted breach notification laws that require
notification to affected individuals and certain state agencies if there is a security breach of certain individually-identifiable information. If we suffer a privacy or security breach, we could be
required to expend significant resources to provide notification to the affected individuals and address the breach, as well as reputational harm associated with the breach. If we fail to comply with
applicable state laws and regulations, we could be subject to additional sanctions. Any liability from failure to comply with the requirements of HIPAA, HITECH or state privacy and security statutes
or regulations could adversely affect our financial condition. The costs of complying with privacy and security related legal and regulatory requirements are burdensome and could have a material
adverse effect on our business, financial condition and results of operations. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>116</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=121,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=334036,FOLIO='116',FILE='DISK131:[15ZBY1.15ZBY12201]EG12201A.;64',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_eg12201_1_117"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Environmental Regulation  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our research and development and manufacturing processes and operations involve the controlled use of hazardous materials, including flammables,
toxics, and corrosives and produce hazardous chemical waste products. We are subject to numerous foreign, federal, state, and local environmental, health and safety laws and regulations relating to,
among other
matters, safe working conditions, product stewardship and end-of-life handling or disposition of products, and environmental protection, including those governing the generation, storage, handling,
use, transportation and disposal of hazardous or potentially hazardous materials. Some of these laws and regulations require us to obtain licenses or permits to conduct our operations. Environmental
laws and regulations are complex, change frequently and have tended to become more stringent over time. Although the costs to comply with applicable laws and regulations, including requirements in the
European Union relating to the restriction of use of hazardous substances in products, have not been material, we cannot predict the impact on our business of new or amended laws or regulations or any
changes in the way existing and future laws and regulations are interpreted or enforced, nor can we ensure we will be able to obtain or maintain any required licenses or permits. Also, we cannot
eliminate the risk of accidental contamination or discharge and any resultant injury from these materials. We do not currently maintain separate environmental liability coverage and any such
contamination or discharge could result in significant cost to us in penalties, damages, and suspension of our operations. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Foreign Government Regulation  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>International sales of medical devices are subject to foreign governmental regulations, which vary substantially from country to country. The time
required to obtain clearance or approval by a foreign country may be longer or shorter than that required for FDA clearance or approval, and the requirements may be different. Many countries also
impose product standards, packaging requirements, environmental requirements, labeling requirements, and import restrictions on medical devices. Each country has its own tariff regulations, duties,
and tax requirements. Failure to comply with applicable foreign regulatory requirements may subject a company to fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of
products, operating restrictions, criminal prosecution or other consequences. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
European Union is the primary regulator in Europe, which has adopted numerous directives and has promulgated voluntary standards regulating the design, manufacture, clinical trials, labeling and
adverse event reporting for medical devices. Medical devices that comply with the requirements of applicable directives will be entitled to bear the CE conformity marking, indicating that the device
conforms with the essential requirements of the applicable directives and, accordingly, can be commercially distributed throughout the member states of the European Union, and other countries that
comply with or mirror these directives. The method of assessing conformity varies depending on the type and class of the product, but typically involves a combination of self-assessment by the
manufacturer and a third-party assessment by a notified body, an independent and neutral institution appointed by a country to conduct the conformity assessment. This third-party assessment may
consist of an audit of the manufacturer's quality system, technical or design file and specific testing of the manufacturer's device. Such an assessment may be required in order for a manufacturer to
commercially distribute the product throughout these countries. Compliance establishes the presumption of conformity with the essential requirements for a CE Marking. We have the authorization to
affix the CE Mark to our products and to commercialize our devices in the European Union. The notified body who inspected us, issued our ISO&nbsp;13485 certification in October 2014 and our
EC-Certificate in December 2014. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
March 2012, we received our Medical Device License in Canada for our Flexitouch System. Before we are permitted to sell our devices in Canada, we must submit and obtain clearance of a license </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>117</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=122,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=259694,FOLIO='117',FILE='DISK131:[15ZBY1.15ZBY12201]EG12201A.;64',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_eg12201_1_118"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>application,
implement and comply with ISO Standard 13485, and undergo an audit by a registrar accredited by Health Canada. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


General Regulatory Compliance and Health Care Reform  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The evolving regulatory and compliance environment and the need to build and maintain robust systems to comply with different compliance or reporting
requirements in multiple jurisdictions increase the possibility that a healthcare company may fail to comply fully with one or more of these requirements. If our operations are found to be in
violation of any of the health regulatory laws described above or any other laws that apply to us, we may be subject to penalties, including potentially significant criminal and civil and
administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government healthcare programs, contractual damages, reputational harm, administrative burdens,
diminished profits and future earnings, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business, financial condition, and our
results of operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
March 2010, the Patient Protection and Affordable Care Act and Health Care and Education Reconciliation Act, which we refer to as the Patient Protection and Affordable Care Act was enacted into law
in the United States. This healthcare reform, which included a number of provisions aimed at improving the quality and decreasing the cost of healthcare, has resulted in significant reimbursement cuts
in Medicare payments to hospitals and other healthcare providers and in the healthcare reimbursement system evolving toward value- and outcomes-based reimbursement methodologies. It is uncertain what
long-term consequences these provisions will have on patient access to new technologies and what impacts these provisions will have on Medicare reimbursement rates. Other elements of the Patient
Protection and Affordable Care Act, including comparative effectiveness research, an independent payment advisory board, and payment systems reform, including shared savings pilots and other reforms,
may result in fundamental changes to federal healthcare reimbursement programs. These and additional legislative or administrative reforms to the U.S. healthcare reimbursement systems may
significantly reduce reimbursement or deny coverage for our medical devices, or adverse decisions relating to our products by administrators of such systems in coverage or reimbursement issues, any of
which could have an adverse impact on our financial condition and results of operations. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Third-Party Reimbursement  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In the United States and elsewhere, sales of medical devices depend in significant part on the availability of coverage and reimbursement to
providers and patients from third-party payers. Third-party payers include private insurance plans and governmental programs. As with other medical devices, reimbursement for our products can differ
significantly from payer to payer and our products are not universally covered by third-party commercial payers. Further, third-party payers continually review existing technologies for continued
coverage and can, without notice, deny or reverse coverage for existing products. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Two
principal governmental third-party payers in the United States are Medicaid and Medicare. Medicare is a federal program that provides certain hospital and medical insurance benefits to persons
age&nbsp;65 and over, certain disabled persons and others. In contrast, Medicaid is a medical assistance program jointly funded by federal and state governments and administered by each state
pursuant to which benefits are available to certain individuals and families with low incomes and resources and who meet other eligibility requirements. The Medicare and Medicaid statutory framework
is subject to administrative rulings, interpretations and discretion that affect the amount and timing of reimbursement made under Medicare and Medicaid. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>118</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=123,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=34341,FOLIO='118',FILE='DISK131:[15ZBY1.15ZBY12201]EG12201A.;64',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_eg12201_1_119"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>CMS,
which is the agency within the Department of Health and Human Services that administers both Medicare and Medicaid, has the authority to decline to cover particular products or services if it
determines that they are not "reasonable and necessary" for the treatment of Medicare beneficiaries. A coverage determination for a product, which establishes the indications that will be covered, and
any restrictions or limitations, can be developed at the national level by CMS through a National Coverage Determination, or NCD, or at the local level through a Local Coverage Determination, or LCD,
by a regional Medicare administrative contractor, which is a private contractor that processes and pays claims on behalf of CMS for the geographic area where the services were rendered. Obtaining a
coverage determination, whether an NCD or LCD, is a time-consuming, expensive and highly uncertain proposition, especially for a new device. Under an NCD that has been effective since
January&nbsp;14, 2002, pneumatic devices, including our products, are covered for the treatment of lymphedema or for the treatment of chronic venous insufficiency with venous stasis ulcers. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
four Medicare Administrative Contractors responsible for processing Medicare claims for durable medical equipment recently approved an LCD that significantly limits Medicare coverage of our
Flexitouch System and our Entr&eacute; System for certain patients. This LCD, released by the MACs on
December&nbsp;17, 2015, is retroactively effective, beginning December&nbsp;1, 2015. The LCD increases the severity of lymphedema symptoms that a patient must exhibit before such patient is
eligible for Medicare reimbursement for a pneumatic compression device. The LCD also inserts more restrictive criteria that require a patient to potentially endure a longer period of conservative
therapy to prove that it fails to control their lymphedema, instead of requiring completion of just one 4-week round of conservative therapy as stated in the NCD. The LCD requires four consecutive
weeks of conservative therapy with no significant improvement in symptoms during any of those four weeks. Further, the LCD does not cover use of an advanced pneumatic compression device, such as our
Flexitouch System, unless the patient's lymphedema is present in the chest, trunk or abdomen. Although many patients with lymphedema likely do have some level of chest, trunk or abdominal involvement,
this criteria in the LCD means that patients with lymphedema that is confined to the limb will not have access to advanced pneumatic compression devices until the lymphedema progresses to impact the
trunk, chest or abdomen. The LCD pneumatic compression device coverage criteria for chronic venous insufficiency with venous stasis ulcers largely track existing NCD criteria, while defining the
elements of a required conservative therapy trial. Under the new LCD, advanced pneumatic compression devices like our Flexitouch System are no longer covered at all for the treatment of venous stasis
ulcers. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
are attempting to overturn the LCD by raising awareness among stakeholders, including physicians, patients and advocacy groups, of the negative consequences to patients that the LCD will cause. We
believe that future expenses related to our efforts to overturn the LCD will not be material, and that we will use cash on hand to fund such expenses. Our goal is to have the Medicare Administrative
Contractors rescind or revise the LCD in light of physician and patient concerns, as well as what we believe are flaws with the LCD and the process by which it was approved. If the new LCD is not
overturned, it could have a negative impact on certain Medicare patients' access to our products, which in turn could have an adverse effect on our business and results of operations. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Private
payers that reimburse for our products do so in a variety of ways, depending on the insurance plan's policies, employer and benefit manager input and contracts with their physician network.
Moreover, Medicaid programs and private insurance plans are frequently influenced by Medicare coverage determinations, and we believe a reduction or elimination of coverage or reimbursement of our
products by Medicare, such as the LCD discussed above or other unfavorable NCD or LCD that may go into effect in the future, would likely cause some commercial third-party payers to implement similar
reductions in their coverage or reimbursement of our products. If we are unable to expand coverage of our products by additional commercial payers, or if third-party payers that currently cover </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>119</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=124,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=962768,FOLIO='119',FILE='DISK131:[15ZBY1.15ZBY12201]EG12201A.;64',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_eg12201_1_120"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>or
reimburse for our products reverse or limit their coverage in the future, our business and results of operations could be adversely affected. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Intellectual Property  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our intellectual property consists of patented designs and methods and proprietary know-how. In addition to the patented designs and methods
discussed below, we have made significant investments in proprietary know-how, including the manufacture of fabrics and garments used in our systems and the algorithms used to manage the inflation and
deflation of our systems and other functions of the controllers. To maintain and protect our proprietary technologies and products, we rely on a combination of patent, copyright, trademark, trade
secret and other intellectual property laws, and confidentiality provisions in our contracts. We have a policy to enter into confidentiality agreements with employees, consultants, third parties and
our advisors to protect our intellectual property and maintain our competitive position. We also require our employees and consultants to sign agreements requiring that they assign to us their
interest in intellectual property such as patents and copyrights arising from their work for us. We also require all employees to sign an agreement not to compete unfairly with us during their
employment and upon termination of their employment through the misuse of confidential information, soliciting employees, and soliciting customers. Despite any measures taken to protect our
intellectual property, unauthorized parties may attempt to copy aspects of our systems or to obtain and use information that we regard as proprietary. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>On
September&nbsp;14, 2012, we completed an acquisition of certain assets, including inventory, equipment and tooling and patents for the ACTitouch System and a technology known as SMM from
ConvaTec,&nbsp;Inc. and ConvaTec Technologies,&nbsp;Inc., or the Sellers. The purchase price of this acquisition included $3.0&nbsp;million at closing and $2.0&nbsp;million at the earliest of
the commercialization date or the first anniversary of the closing date. In addition, we are required to pay quarterly payments to the Sellers following the commercialization date, which was
September&nbsp;1, 2013, through the following sixteen quarterly calculation periods equal to 9% of sales for the ACTitouch System and 7% of sales of SMM with a guaranteed minimum amount of $45,000
for each of the first four quarterly calculation periods (year 1); $148,500 for each of next four quarterly calculation periods (year 2); and $247,750 for each of the next four quarterly calculation
periods (year&nbsp;3)&nbsp;(total of $1,765,000). For each quarterly calculation period beginning with the seventeenth quarterly calculation period and ending on the tenth anniversary of the
commercialization date, we will make quarterly payments to the Sellers equal to 6% of the sale of the ACTitouch System and 5% on the sale of SMM. If ACTitouch System and SMM sales in any calendar year
in years five through ten exceed $40.0&nbsp;million, the sales percentage amount relating to ACTitouch System sales shall equal 6% of the sales of the ACTitouch System up to $40.0&nbsp;million and
7% on the sales of the ACTitouch System over $40.0&nbsp;million. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Patents  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our patent portfolio consists of three sets of patents, including patents relating to our Flexitouch System, our ACTitouch System and other
compression-related technologies, each of which is described in further detail below. As of March&nbsp;31, 2016, we owned more than 70 issued patents globally, of which 17 were issued U.S. patents.
As of March&nbsp;31, 2016, we owned 19
patent applications pending globally, of which 12 were patent applications pending in the United States. Our U.S. issued patents have varying patent terms expiring between 2017 and through at least
2029, subject to payment of required maintenance fees, annuities and other charges. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Flexitouch System Patent Family.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The following is a summary of patents relating to our Flexitouch System:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On January&nbsp;30, 2001, our first patent, directed to our unique wrap structure, was issued (U.S. Pat. No.&nbsp;6,179,796). This
patent is specifically directed to an arcuate design and </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>120</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=125,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=610338,FOLIO='120',FILE='DISK131:[15ZBY1.15ZBY12201]EG12201A.;64',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_eg12201_1_121"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>other
features of a garment for wrapping about a patient. This arcuate design is one of the keys to the success of our Flexitouch System, as it facilitates the movement of the lymph fluid from the
damaged lymph node area to other functioning lymph node areas. Similar patents have been issued in Europe and Canada. </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On November&nbsp;11, 2003, a patent directed to our preparation and drainage methodology was issued (U.S. Pat.
No.&nbsp;6,645,165). This second patent is directed to body preparation for receipt of lymph fluid via pressurization and depressurization of chambers, and the subsequent lymph drainage from a body
extremity via select pressurization and depressurization of chambers. This preparation and subsequent drainage of the lymph fluid is another key to our Flexitouch System, as it allows stimulation of
the lymphatic system to promote reabsorption of the lymph fluid. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On March&nbsp;1, 2005, a patent directed to our wrap structure and fabrication was issued (U.S. Pat. No.&nbsp;6,860,862). This
third patent is directed to the unique aspects of the fabrication of our wrap. In particular, a "four way stretch" and "axial stretch" of our garment allow us to stretch the patient's skin in the same
manner as manual lymphatic drainage therapy. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On November&nbsp;22, 2005, a patent directed to our preparation and drainage methodology was issued (U.S. Pat.
No.&nbsp;6,966,884). This fourth patent is directed to a lymphedema treatment methodology, entailing optimum sequencing of air chamber inflation/deflation. Correct sequencing of the chambers is
important to proper therapy. The subject method of sequencing of treatment, called 2-Phase Lymph Preparation and Drainage, prepares the trunk and extremity regions of the body prior to draining the
extremity of lymph fluid. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> ACTitouch System Patents.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The following is a summary of our patent families relating to our ACTitouch System:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On October&nbsp;14, 2008, a "Medical Compress" patent directed to the ornamental aspects of the compression sleeve was issued (U.S.
Design Pat. No.&nbsp;D578,652). Similar patents have been issued in Europe, Japan, Canada, Mexico, Australia, China and Taiwan. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On June&nbsp;22, 2010, a "Proximity Detection Apparatus" patent directed to control unit proximity detection allowing a different
mode of operation was issued (U.S. Pat. No.&nbsp;7,741,966). Similar patents have been issued in Japan, Canada, Mexico, China and Taiwan, and an application is pending in Europe. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On March&nbsp;22, 2011, a "Compression Device for the Limb" patent directed to the storage of data related to duration of use was
issued (U.S. Pat. No.&nbsp;7,909,786). Similar patents have been issued in Japan, Canada, Mexico, China, the United Kingdom, Germany, France, Ireland, Italy, Sweden and Taiwan. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On May&nbsp;24, 2011, a "Pressurized Medical Device" patent directed to the detection of malfunctioning pressure sensors was issued
(U.S. Pat. No.&nbsp;7,947,003). Similar patents have been issued in Japan, Canada, Mexico, China and Taiwan and an application is pending in Europe. </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On December&nbsp;13, 2011, a "Relating to Socks" patent directed to a sock and compression device kit was issued (U.S. Pat.
No.&nbsp;8,075,507). Similar patents have been issued in Japan, Canada, Mexico, China, the United Kingdom, Germany, France, Ireland, Italy and Sweden. </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>121</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=126,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=379750,FOLIO='121',FILE='DISK131:[15ZBY1.15ZBY12201]EG12201A.;64',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_eg12201_1_122"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On July&nbsp;23, 2013, a "Medical Compress" patent directed to the ornamental aspects of the compression sleeve and control unit was
issued (U.S. Design Pat. No.&nbsp;D686,738). Similar patents have been issued in Europe, Canada, Mexico, Australia, China and Taiwan. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On November&nbsp;5, 2013, a "Compression Device for the Foot" patent directed to a Y-shaped foot wrap was issued (U.S. Pat.
No.&nbsp;8,574,180). Similar patents have been issued in Japan, Canada, China, the United Kingdom, Germany, France, Ireland, Sweden and Taiwan. A continuation application (U.S. Pub.
No.&nbsp;2014/0058302) directed to the subject matter of this patent family is pending in the United States. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On January&nbsp;28, 2014, a "Compression Device for the Limb" patent directed to the compression sleeve configuration was issued
(U.S. Pat. No.&nbsp;8,636,679). Similar patents have been issued in Japan, Canada, Mexico and Taiwan, an application for similar subject matter is pending in Europe, and a continuation application
(U.S. Pub. No.&nbsp;2014/0128787) is pending in the United States. </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> On March 8, 2016, a "Cuff for Providing Compression to a Limb" patent directed to a compression cuff including an abutting spacer
configuration was issued (U.S. Patent No.&nbsp;9,278,043). Similar patents have been issued in Japan, Canada, China, the United Kingdom, Germany, France, Ireland, Sweden and Taiwan. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Trademarks  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have registered the trademarks Flexitouch, the Flexitouch and design and ACTitouch with the United States Patent and Trademark Office on the
Principal Register. We rely in the United States on common law rights to the Entr&eacute;, Tactile Medical and Tactile Medical design trademarks. We have not sought to register any of our
trademarks in jurisdictions outside of the United States. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Employees  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As of March&nbsp;31, 2016, we had 275 employees, including 141 in sales and marketing, 85 in reimbursement and payer relations, 17 in manufacturing
and quality assurance, 19 in general administration, finance, information technology and human resources and 13 in research and development. None of our employees are represented by a collective
bargaining agreement. We believe that our employee relations are positive, as evidenced by our being selected as a Top Workplace in Minnesota by our employees for the last six years. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Facilities  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We lease approximately 52,000 square feet of office and assembly space at our corporate headquarters in Minneapolis, Minnesota under a lease that
expires in July 2021. We believe that our existing facilities are adequate to meet our business requirements for the near term and that additional space will be available on commercially reasonable
terms, if required. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Legal Proceedings  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>From time to time, we may be subject to various claims and legal proceedings arising in the ordinary course of business. We are not currently a party
to any legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on us
because of defense and settlement costs, diversion of management resources, and other factors. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>122</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=127,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=641766,FOLIO='122',FILE='DISK131:[15ZBY1.15ZBY12201]EG12201A.;64',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ei12201_1_123"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ei12201_management"> </A>
<A NAME="toc_ei12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  MANAGEMENT    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Executive Officers and Directors  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table sets forth information concerning our directors and executive officers as of the date of this prospectus: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="30%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="21pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="61%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:21pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,21pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Age </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Position </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B><I>Executive Officers</I></B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Gerald R. Mattys</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>57</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Chief Executive Officer, Director</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Lynn L. Blake</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>49</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Chief Financial Officer</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Robert J. Folkes</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>54</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Chief Operating Officer</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Mary E. Anderson</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>53</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Vice President, Reimbursement</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Bryan F. Rishe</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>60</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Vice President, Sales</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Mary M. Thompson</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>58</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Vice President, Payer Relations and Government Affairs</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B><I>Non-Employee Directors</I></B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Peter H. Soderberg</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>70</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Chairman of the Board</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>William W. Burke</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>57</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Jordan S. Davis</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>54</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Richard Nigon</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>68</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Kevin H. Roche</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>65</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Stephen I. Shapiro</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>71</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Zubeen Shroff</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>51</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following is a brief description of the education and business experience of our directors and executive officers: </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Executive Officers  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Gerald R. Mattys</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as our Chief Executive Officer and as a member of our board of directors
since 2005. From 2002 to 2004, he served as the Chief Executive Officer of Medisyn Technologies,&nbsp;Inc., a development stage biotechnology company. From 2000 to 2002, he was the President and
Chief Executive Officer of Timm Medical Technologies,&nbsp;Inc., a medical device company. During the period from 1998 to 2000, he was Vice President and General Manager of Alternate Care for
Mallinckrodt,&nbsp;Inc., a pharmaceutical and medical device company. Prior to that, he served 18&nbsp;years in various roles in product management, sales, marketing and management at several
medical device companies. He currently serves as an advisor to Augustine Biomedical and Design,&nbsp;LLC. We believe Mr.&nbsp;Mattys is qualified to serve on our board of directors because of his
extensive industry, leadership and product development experience. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Lynn L. Blake</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as our Chief Financial Officer since joining the company in April 2016. Prior to joining our company, Ms.&nbsp;Blake served
as Chief Financial Officer and Secretary of Taylor-Wharton International&nbsp;LLC, a global industrial products manufacturer, from September 2014 through December
2015. Prior to joining Taylor-Wharton International&nbsp;LLC, Ms.&nbsp;Blake served as Chief Financial Officer and Treasurer of Analysts International Corporation, a leading national information
technology services firm, from July 2012 until its sale in October 2013. Prior to these roles, Ms.&nbsp;Blake held a variety of senior financial leadership positions at companies including
Entegris,&nbsp;Inc., MTS Systems Corporation, and Honeywell International&nbsp;Inc. </FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2><B><I>Robert J. Folkes</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as our Chief Operating Officer since February 2015. He served as our Chief Financial Officer from 2005 until April 2016.
Prior to joining our company in 2004, Mr.&nbsp;Folkes was the Chief Financial Officer for Advanced Respiratory, a medical device company, from 1997 until

 </FONT>

</P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>123</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=128,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=406406,FOLIO='123',FILE='DISK131:[15ZBY1.15ZBY12201]EI12201A.;93',USER='JFUSS',CD=';8-JUN-2016;14:38' -->
<A NAME="page_ei12201_1_124"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>its
sale in 2003. Prior to joining Advanced Respiratory, Mr.&nbsp;Folkes was an Audit Senior Manager for Ernst&nbsp;&amp; Young&nbsp;LLP. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Mary E. Anderson</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> serves as our Vice President, Reimbursement and started with our company in 2005 as our Director of Reimbursement. Prior to joining our
company, Ms.&nbsp;Anderson served in various roles at Advanced Respiratory, a medical device company, from 1990 until its sale in 2003, including Controller, Chief Financial Officer and Vice
President of Internal Operations. Ms.&nbsp;Anderson began her career as an auditor with Ernst&nbsp;&amp; Young&nbsp;LLP. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Bryan F. Rishe</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as our Vice President, Sales since 2008. From 2004 to 2008, he served as the Vice President, Sales for BSN Medical, a medical
soft goods manufacturer. Mr.&nbsp;Rishe also served as the Vice President, Sales and Marketing for TFX Medical, a surgical equipment manufacturer. Prior to that, Mr.&nbsp;Rishe was the Western
Area Manager with Surgical Laser Technologies, a specialty laser company. Mr.&nbsp;Rishe has held other sales leadership and business development roles with Becton Dickinson, Baxter Travenol and
American Hospital Supply. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Mary M. "Maggie" Thompson</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as our Vice President, Payer Relations and Government Affairs since 2006. Prior to joining our company,
Ms.&nbsp;Thompson served as Director of Reimbursement for Uroplasty, Inc., a medical device company, from 2005-2006. From 1998 until 2005, Ms.&nbsp;Thompson served as Director of Payer Relations
at Advanced Respiratory, a medical device company, from 1998 until 2009. A registered nurse, Ms.&nbsp;Thompson first practiced nursing at Gillette Children's Hospital and at a grant-funded community
clinic in St.&nbsp;Paul. She then worked for the Minnesota Attorney General's Office as a nurse consultant until she joined a large health plan as the Government Programs Quality Regulatory Manager
working closely with the Centers for Medicare and Medicaid Services and Minnesota's Medicaid program. Ms.&nbsp;Thompson is active in the Alliance for Wound Care Stakeholders and is a member of
Women's Business Leaders in Healthcare. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Non-Employee Directors  </I></B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Peter H. Soderberg</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as a member of our board of directors since September 2012.
Mr.&nbsp;Soderberg currently is the Managing Partner of Worthy Venture Resources,&nbsp;LLC., a company that seeks to add intellectual and financial capital to post start-up companies transitioning
to an established national market presence. Beginning in 2006, Mr.&nbsp;Soderberg served as the President and Chief Executive Officer of both Hillenbrand Industries and Hill-Rom. In 2008,
Hillenbrand Industries separated its two subsidiaries creating two, separately traded, public companies. Mr.&nbsp;Soderberg continued his role as President and Chief Executive Officer of the medical
technology company, Hill-Rom Holdings,&nbsp;Inc. until 2010. Mr.&nbsp;Soderberg served on the board of Hillenbrand Industries/Hill-Rom from 2002 until his semi-retirement in 2011. Previously, he
was President and Chief Executive Officer at Welch Allyn, a manufacturer of medical diagnostic equipment, for six years, and served as Group Vice President and Chief Operating Officer from 1993 to
1999. Prior to his role at Welch Allyn Mr.&nbsp;Soderberg's served 23&nbsp;years at Johnson&nbsp;&amp; Johnson, in a variety of operations, marketing and management positions, including President of
Johnson&nbsp;&amp; Johnson Health Management. His career also includes roles as President and Chief Executive Officer of an industrial technology company and the founder and President of a venture
capital business. Mr.&nbsp;Soderberg currently serves on the board of directors of Greatbatch,&nbsp;Inc., a medical technology company. Mr.&nbsp;Soderberg previously served on the boards of
Constellation Brands,&nbsp;Inc. and the Advanced Medical Technology Association. We believe he is qualified to serve on our board of directors because of his extensive industry, leadership and
investment development experience. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>William W. Burke</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as a member of our board of directors since September 2015. Since January 2014, he has been a consultant to companies in the
medical device industry. Since November </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>124</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=129,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1015564,FOLIO='124',FILE='DISK131:[15ZBY1.15ZBY12201]EI12201A.;93',USER='JFUSS',CD=';8-JUN-2016;14:38' -->
<A NAME="page_ei12201_1_125"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


2015, Mr.&nbsp;Burke has served as President of Austin Highlands Advisors, LLC, a provider of strategic advisory services to emerging growth medical technology companies. He served as Executive Vice
President&nbsp;&amp; Chief Financial Officer of IDEV Technologies, a peripheral vascular devices company, from November 2009 until the company was acquired by Abbott Laboratories in August 2013. He was
retained by Abbott through December 2013 to assist with post-acquisition integration. From August 2004 to December 2007, he served as Executive Vice President&nbsp;&amp; Chief Financial Officer of
ReAble Therapeutics, a diversified orthopedic device company which was sold to The Blackstone Group in a going private transaction in 2006 and subsequently merged with DJO Incorporated in late 2007.
Mr.&nbsp;Burke remained with ReAble until June 2008. From 2001 to 2004, he served as Chief Financial Officer of Cholestech Corporation, a publicly traded medical diagnostic products company.
Mr.&nbsp;Burke has served on the board of directors of LDR Holdings, a publicly traded developer of innovative spinal implants, since October 2013, and Invuity,&nbsp;Inc., a publicly traded
developer of advanced surgical photonics devices, since May 2015. He also served as a member of the board of directors of Medical
Action Industries, a publicly traded manufacturer of disposable medical products, from August 2004 to October 2014, when the company was acquired by Owens&nbsp;&amp; Minor. Mr.&nbsp;Burke was selected
to serve on our board of directors because of his business experience with other medical technology companies, and his experience as the chief financial officer of other companies, including other
publicly traded companies.

 </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Jordan S. Davis</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as a member of our board of directors since September 2012. Mr.&nbsp;Davis is a Managing Partner of Radius Ventures, a
venture capital firm focused on growth equity and expansion-stage health and life sciences companies, which he co-founded in 1997. Mr.&nbsp;Davis has served on numerous public and private company
boards and currently serves on the board of directors of Endogastric Solutions,&nbsp;Inc. and Healthsense,&nbsp;Inc., both Radius portfolio companies. In addition, Mr.&nbsp;Davis serves on the
board of directors of HealthCorps, a non-profit organization engaged in educating youth on nutrition, fitness and mental resilience. Mr.&nbsp;Davis was a co-founder of Cambridge Heart,&nbsp;Inc.,
a medical technology company that developed and commercialized a device to non-invasively identify patients at risk of sudden cardiac death, and Voxware,&nbsp;Inc., a speech technology company and
early entrant in the VoIP market, both of which completed initial public offerings in 1996. We believe Mr.&nbsp;Davis is qualified to serve on our board of directors because of his extensive
industry, investment and capital markets experience. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Richard Nigon</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as a member of our board of directors since September 2012. Mr.&nbsp;Nigon is currently Senior Vice President of Cedar Point
Capital,&nbsp;Inc., a private company that raises capital for early stage companies, where he has served since 2007. From February 2001 until December 2006, Mr.&nbsp;Nigon was a Director of Equity
Corporate Finance for Miller Johnson Steichen Kinnard, a privately held investment firm, which was acquired in December 2006 by Stifel Nicolaus, a brokerage and investment banking firm. After that
acquisition, Mr.&nbsp;Nigon became a Managing Director of Private Placements until May 2007. From February 2000 to February 2001, Mr.&nbsp;Nigon served as the Chief Financial Officer of
Dantis,&nbsp;Inc., a web hosting company. Prior to joining Dantis, Mr.&nbsp;Nigon was employed by Ernst&nbsp;&amp; Young&nbsp;LLP from 1970 to 2000, where he was a partner from 1981 to 2000. While
at Ernst&nbsp;&amp; Young, Mr.&nbsp;Nigon served as the Director of Ernst&nbsp;&amp; Young's Twin Cities Entrepreneurial Services Group and was the coordinating partner on several publicly-traded
companies in the consumer retailing and manufacturing sectors. Mr.&nbsp;Nigon is a Director of Northern Technologies International Corporation and Vascular Solutions,&nbsp;Inc. Mr.&nbsp;Nigon
also serves as a director of several private companies. We believe Mr.&nbsp;Nigon is qualified to serve on our board of directors because of his extensive public accounting and auditing experience,
including particular experience with emerging growth companies. </FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2><B><I>Kevin H. Roche</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as a member of our board of directors since October 2004. Mr.&nbsp;Roche was General Counsel of UnitedHealth Group, a health
insurance provider, from 1989 to 1996, at which

 </FONT>

</P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>125</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=130,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=635786,FOLIO='125',FILE='DISK131:[15ZBY1.15ZBY12201]EI12201A.;93',USER='JFUSS',CD=';8-JUN-2016;14:38' -->
<A NAME="page_ei12201_1_126"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


time he founded and operated as the Chief Executive Officer of the Ingenix division of UnitedHealth Group where he served until 2001. Following his retirement from UnitedHealth Group, Mr.&nbsp;Roche
has spent several years assisting emerging growth companies as an investor, advisor and board member. He also serves as a Senior Advisor for Triple Tree,&nbsp;LLC. He currently serves as a director
for several private healthcare companies. We believe that Mr.&nbsp;Roche is qualified to serve on our board of directors because of his extensive industry and leadership experience and his
experience as a board member.

</FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Stephen I. Shapiro</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as a member of our board of directors since June 2010. From 1983 through 1999, Mr.&nbsp;Shapiro was a Managing Director
of The Wilkerson Group, a leading medical products management consulting firm, with a client base including pharmaceutical, diagnostic, device and biotech companies, where he led the medical devices
practice. Prior to joining The Wilkerson Group, he was Director of Advanced Research and Development and New Business Development for Becton, Dickinson and Company, and spent eight years at Union
Carbide Clinical Diagnostics, becoming engineering group leader. Mr.&nbsp;Shapiro also serves on the board of directors of Pacific Diagnostic Laboratories, LLC, PolyRemedy, Inc., and Cambrooke
Therapeutics,&nbsp;Inc. Mr.&nbsp;Shapiro was a Venture Partner with Advanced Technology Ventures (a venture capital firm focused on investments in healthcare companies) from January&nbsp;2000
through January&nbsp;2015. Mr.&nbsp;Shapiro served as a consultant to Galen Partners (a venture capital firm focused on investments in healthcare companies) as a Venture Partner from
January&nbsp;2000 through December&nbsp;2013. We believe that Mr.&nbsp;Shapiro is qualified to serve on our board of directors because of his deep industry and medical science background. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I>Zubeen Shroff</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2> has served as a member of our board of directors since September 2007. Mr.&nbsp;Shroff is a Managing Director of Galen Partners, a
healthcare growth equity investment firm which he joined in 1996. Prior to joining Galen, Mr. Shroff was a Principal with The Wilkerson Group, where his client base included pharmaceutical,
diagnostics, device and biotech companies, plus a select number of venture capital firms. Prior to joining The Wilkerson Group, Mr. Shroff worked at Schering-Plough France, a manufacturer of
healthcare products and medicines, where he helped launch their biotech product, alpha-Interferon, in several new indications. Currently, Mr. Shroff is Treasurer and on the Executive Committee of the
Board for The Westchester Medical Center Public Benefit Corporation, as well as Chairman of its Foundation. Since 2004, he has served on the Advisory Committees to Boston University Medical School and
School of Public Health. Mr. Shroff is also on the Advisory Board of the Joslin Diabetes Center. In addition to the above positions, Mr. Shroff has served on the board of directors of numerous
privately held Galen portfolio companies. Mr. Shroff currently serves on the board of directors of Quotient Biodiagnostics and served on the board of directors of Pet DRx Corporation until July 2010
and Encore Medical until June 2006. We believe Mr. Shroff is qualified to serve on our board of directors because of his extensive experience in providing strategic guidance to companies in the
healthcare industry, particularly in the areas of medical devices, diagnostics, and capital equipment. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Board Composition  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Director Independence.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors has determined that seven of our eight directors are independent directors, as defined under the
applicable rules of
the NASDAQ stock market. The independent directors are Peter H. Soderberg, William W. Burke, Jordan S. Davis, Richard Nigon, Kevin H. Roche, Stephen&nbsp;I. Shapiro and Zubeen Shroff. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
making such determination, our board of directors considered the independence of its members in light of the beneficial ownership of these individuals and, notwithstanding their beneficial
ownership, determined that it would not interfere with their exercise of independent judgment in carrying out the responsibilities of a director. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>126</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=131,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=652809,FOLIO='126',FILE='DISK131:[15ZBY1.15ZBY12201]EI12201A.;93',USER='JFUSS',CD=';8-JUN-2016;14:38' -->
<A NAME="page_ei12201_1_127"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Familial Relationships.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;There is no family relationship between any director, executive officer or person nominated to become a director or
executive officer. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Board Structure.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors currently is authorized to have eight members. In accordance with the terms of our amended and restated
certificate of
incorporation and amended and restated bylaws that will become effective upon completion of this offering, our board of directors is not classified and each director serves for a one-year term until
the next annual meetings of stockholders. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
accordance with the terms of our amended and restated certificate of incorporation that will become effective upon completion of this offering, our directors may be removed only for cause by the
affirmative vote of the holders of at least 75% of the votes that all our stockholders would be entitled to cast in an election of directors. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Compensation Committee Interlocks and Insider Participation  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>No member of our compensation and organization committee is or has been our current or former officer or employee. None of our executive officers
served as a director or a member of a compensation committee (or other committee serving an equivalent function) of any other entity, one of whose executive officers served as a director or member of
our compensation and organization committee during 2015. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Board Committees  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our board has established four standing committees&nbsp;&#151; audit, nominating and corporate governance, compensation and organization and
compliance and reimbursement committee&nbsp;&#151; each of which operates under a charter that has been approved by our board. Upon completion of this offering, each committee's charter will
be available under the Corporate Governance section of our website at </FONT><FONT COLOR="#3B5A6F" SIZE=2><I>www.tactilemedical.com</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>. The reference to our website address does not constitute
incorporation by reference of the information contained at or available through our website, and you should not consider it to be a part of this prospectus. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following sets forth the membership of each of our committees upon completion of this offering. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="130pt" style="font-family:times;"></TD>
<TD WIDTH="2%" style="font-family:times;"></TD>
<TD WIDTH="128pt" style="font-family:times;"></TD>
<TD WIDTH="2%" style="font-family:times;"></TD>
<TD WIDTH="153pt" style="font-family:times;"></TD>
<TD WIDTH="2%" style="font-family:times;"></TD>
<TD WIDTH="136pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Audit Committee </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Nominating&nbsp;and&nbsp;Corporate<BR>
Governance Committee </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Compensation and<BR>
Organization Committee </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Compliance and<BR>
Reimbursement Committee </B></FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Richard&nbsp;Nigon&nbsp;(Chair)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Zubeen&nbsp;Shroff&nbsp;(Chair)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Peter&nbsp;H.&nbsp;Soderberg&nbsp;(Chair)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Kevin&nbsp;H.&nbsp;Roche&nbsp;(Chair)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>William W. Burke</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>William W. Burke</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Jordan S. Davis</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Jordan S. Davis</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Kevin H. Roche</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Richard Nigon</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Zubeen Shroff</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Stephen Shapiro</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Peter H. Soderberg</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Audit Committee.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The audit committee's responsibilities will include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> appointing, compensating, retaining, replacing and overseeing our independent auditor; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> pre-approving all audit and permitted non-audit services to be provided by our independent auditor; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> assisting our board of directors in its oversight of our financial statements and other financial information to be provided by us; </FONT> <FONT
COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> overseeing our compliance with legal and regulatory matters and aspects of our risk management processes; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>127</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=132,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1007724,FOLIO='127',FILE='DISK131:[15ZBY1.15ZBY12201]EI12201A.;93',USER='JFUSS',CD=';8-JUN-2016;14:38' -->
<A NAME="page_ei12201_1_128"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> discussing with management and our independent auditors any major issues as to the adequacy of our internal controls, any actions to
be taken in light of significant or material control deficiencies and the adequacy of disclosures about changes in internal control over financial reporting; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> establishing procedures for the receipt, retention and treatment of complaints regarding accounting, internal accounting controls or
auditing matters and the confidential, anonymous submission by employees of concerns regarding questionable accounting or auditing matters. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Each
of the members of our audit committee upon completion of this offering meets the requirements for financial literacy and possesses the financial qualifications required under the applicable rules
and regulations of the SEC and the NASDAQ stock market. Our board of directors has determined that Richard Nigon is an audit committee financial expert, as defined under the applicable rules of the
SEC. Each member of our audit committee upon completion of this offering satisfies the NASDAQ stock market independence standards and the independence standards of Rule&nbsp;10A-3(b)(1) of the
Exchange Act. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Nominating and Corporate Governance Committee.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The nominating and corporate governance committee's responsibilities will include assisting our
board
in:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> identifying qualified individuals to become board members; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> determining the composition of the board and its committees; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> assessing and enhancing the effectiveness of the board and individual directors; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> developing and implementing our corporate governance guidelines. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Compensation and Organization Committee.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The compensation and organization committee's responsibilities will
include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> determining the compensation of our chief executive officer and other executive officers; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> providing oversight of our compensation policies, plans and benefit programs; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> administering our equity compensation plans; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> recommending to our board the compensation arrangements for our non-employee directors; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> overseeing and reviewing our executive team and management succession. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Compliance and Reimbursement Committee.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The compliance and reimbursement committee's responsibilities will
include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> assisting the Board in overseeing our regulatory compliance activities; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> monitoring and evaluating our compliance with regulatory requirements to which we are subject. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Code of Business Conduct and Ethics  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We expect to adopt a code of business conduct and ethics upon completion of this offering relating to the conduct of our business by our employees,
officers and directors, which will be posted on our </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>128</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=133,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=561864,FOLIO='128',FILE='DISK131:[15ZBY1.15ZBY12201]EI12201A.;93',USER='JFUSS',CD=';8-JUN-2016;14:38' -->
<A NAME="page_ei12201_1_129"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>website.
We intend to disclose any amendments to the code, or any waivers of its requirements, as required by stock exchange or SEC rules, on our website. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Non-Employee Director Compensation  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Prior to this offering, we did not have a formal policy for compensating our non-employee directors. However, in 2015, we reimbursed the members of
our board of directors for their reasonable out-of-pocket travel expenses incurred in connection with attending meetings of our board of directors. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
board of directors has approved a new compensation program for our non-employee directors to be effective upon completion of this offering. Under the program, our non-employee directors will
receive cash compensation as follows:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> each non-employee director will receive an annual cash retainer of $35,000 per year; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the chairman of our board of directors will receive an additional cash retainer of $35,000 per year; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the chairman of the audit committee will receive an additional cash retainer of $16,000 per year; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> each member of the audit committee (other than the chairman) will receive an additional cash retainer of $8,000 per year; </FONT> <FONT
COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the chairman of the compensation and organization committee will receive an additional cash retainer of $12,000 per year; </FONT> <FONT
COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> each member of the compensation and organization committee (other than the chairman) will receive an additional cash retainer of
$6,000 per year; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the chairman of the nominating and corporate governance committee will receive an additional cash retainer of $8,000 per year; </FONT> <FONT
COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> each member of the nominating and corporate governance committee (other than the chairman) will receive an additional cash retainer of
$4,000 per year; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the chairman of the compliance and reimbursement committee will receive an additional cash retainer of $8,000 per year; and </FONT> <FONT
COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> each member of the compliance and reimbursement committee (other than the chairman) will receive an additional cash retainer of $4,000
per year. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Non-employee
directors may elect to receive between 10% and 100% of their aggregate annual cash retainers in the form of RSUs, with the number of RSUs calculated by dividing the amount of the
retainer payable on a certain date by the closing sale price per share of our common stock on the date of grant. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
also reimburse our directors for their reasonable out-of-pocket expenses incurred in connection with attending our board and committee meetings. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, upon the effectiveness of this registration statement and in future years as annual equity award grants, we expect to grant each of our non-employee directors: </FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> a non-statutory stock option to purchase up to $50,000 of shares of our common stock calculated as the grant date fair value of the
stock-based awards computed in accordance </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>129</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=134,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=527141,FOLIO='129',FILE='DISK131:[15ZBY1.15ZBY12201]EI12201A.;93',USER='JFUSS',CD=';8-JUN-2016;14:38' -->
<A NAME="page_ei12201_1_130"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>with
FASB Topic ASC&nbsp;718 on the date of grant using, for purposes of awards granted upon effectiveness of this registration statement, the price per share to the public of our common stock in
this offering, and for purposes of annual equity awards, the closing sale price per share of our common stock on the date of grant, which will be the date of the annual meeting of stockholders in each
year; and </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> RSUs that have a value of $50,000, with the number of RSUs calculated by dividing $50,000 by, for purposes of awards granted upon the
effectiveness of this registration statement, the price per share to the public of our common stock in this offering, and for purposes of annual equity awards, the closing sale price per share of our
common stock on the date of grant, which will be the date of the annual meeting of stockholders in each year. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Each
option will have an exercise price per share equal to the fair market value on the date of grant, which, for purposes of awards granted upon effectiveness of this registration statement, will be
the
price per share to the public of our common stock in this offering, and for purposes of annual equity awards, will be the closing sale price per share of our common stock on the date of the annual
meeting of stockholders in each year. Each stock option and RSU award will vest in full on the earlier of (a)&nbsp;one year from the date of grant or (b)&nbsp;immediately prior to the next annual
meeting of stockholders following the date of such grant, subject to such director's continued service on our board of directors as of such date. Each stock option will have a term of seven years from
the date of grant. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


Further, upon the effectiveness of this registration statement, we will grant to Mr.&nbsp;Burke RSUs in the amount calculated by dividing $25,000 by the price to the public in this offering, which
will vest in full on the six month anniversary of the date of grant. These RSUs will be granted to Mr.&nbsp;Burke because he joined our board of directors in September 2015 and has not yet received
an equity-based grant similar to grants that other directors had previously received.

 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>130</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=135,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=41192,FOLIO='130',FILE='DISK131:[15ZBY1.15ZBY12201]EI12201A.;93',USER='JFUSS',CD=';8-JUN-2016;14:38' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ek12201_1_131"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ek12201_executive_compensation"> </A>
<A NAME="toc_ek12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  EXECUTIVE COMPENSATION    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Summary Compensation Table  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following table provides information regarding the total compensation for services rendered in all capacities that was earned in 2015 and 2014 by
our principal executive officer and our two other most highly compensated executive officers during 2015, whom we collectively refer to as our "named executive officers." </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:101pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Name and Principal Position

<!-- COMMAND=ADD_SCROPPEDRULE,101pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Salary<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Non-Equity<BR>
Incentive Plan<BR>
Compensation<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>All Other<BR>
Compensation<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Total<BR>
($) </B></FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Gerald R. Mattys</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2015</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>340,000</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>224,978</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>564,978</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><I>Chief Executive Officer</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2014</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>314,673</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>157,337</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>472,010</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2> Robert J. Folkes</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>2015</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>240,000</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>90,712</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>330,712</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>Chief Operating Officer and Former Chief Financial Officer</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2014</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>210,115</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>76,320</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>286,435</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


  Bryan F. Rishe</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>2015</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>237,500</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>128,668</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>9,000</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR><SUP>(1)</SUP></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>375,168</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><I>Vice President, Sales</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2014</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>225,481</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>105,000</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9,000</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><SUP>(1)</SUP></FONT></TD>
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>339,481</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Represents
amounts paid to the named executive officer for a car allowance. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Employment Agreements  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have entered into employment agreements with each of our executive officers. The employment agreements will continue in effect until the executive
officer's employment is terminated by us, the executive or upon his or her disability or death. The employment agreements provide for certain payments upon various employment termination scenarios.
The terms and amounts of potential payments upon the termination of the executive officers' employment are summarized below under "&#151;&nbsp;Potential Payments Upon Termination or
Change-in-Control." </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


The employment agreements provide for the following for the executive officers: (i)&nbsp;a specified annual base salary, which after the first year, may be reviewed and increased in the compensation
committee's sole discretion; (ii)&nbsp;for each calendar year that the executive officer is employed by us, he or she will be eligible for an annual target bonus in an amount that is a specified
percentage of his or her base salary, based upon and subject to criteria set by the compensation committee from time to time; (iii)&nbsp;being eligible to receive equity awards as determined in the
compensation committee's discretion; (iv)&nbsp;being entitled to participate in all of our employee benefit plans and programs, to the extent eligible; (v)&nbsp;business expense reimbursement;
(vi)&nbsp;specified paid time off per year. The employment agreements currently contain the following specified annual base salary amount for the first year: Mr.&nbsp;Mattys: $390,000;
Ms.&nbsp;Blake: $300,000; Mr.&nbsp;Folkes: $260,000; and Mr.&nbsp;Rishe: $257,500. The employment agreements contain, the following percentages of base salary for which the officer is eligible
under the annual target bonus: Mr.&nbsp;Mattys: 75%; Ms.&nbsp;Blake: 50%; Mr.&nbsp;Folkes: 45% and Mr.&nbsp;Rishe: 45%.

 </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


Pursuant to the employment agreements, each executive officer agrees to not at any time disclose our confidential, proprietary or secret information. The employment agreements contain non-competition
provisions that are in effect during the executive's employment with us, and (i)&nbsp;(A) in the case of Mr.&nbsp;Mattys, if his employment is terminated by us without cause, by Mr.&nbsp;Mattys
for good reason, due to Mr.&nbsp;Mattys' disability or as the result of a qualifying termination after a change in control, for an additional 15&nbsp;months following the termination of
Mr.&nbsp;Mattys' employment, (B)&nbsp;in the case of

 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>131</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=136,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=343408,FOLIO='131',FILE='DISK131:[15ZBY1.15ZBY12201]EK12201A.;83',USER='JFUSS',CD=';8-JUN-2016;14:42' -->
<A NAME="page_ek12201_1_132"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


Mr.&nbsp;Rishe, if his employment is terminated by us without cause, by Mr.&nbsp;Rishe for good reason, due to Mr.&nbsp;Rishe's disability or as the result of a qualifying termination after a
change in control, for an additional nine months following the termination of Mr.&nbsp;Rishe's employment, (C)&nbsp;in the case of the other executive officers, if the executive's employment is
terminated by us without cause or by the executive for good reason, for an additional nine months following the executive's termination of employment, provided that in each case we may elect to extend
that period by an additional six months by making additional payments to the executive, and (ii)&nbsp;(A)&nbsp;in the case of Mr.&nbsp;Mattys and Mr.&nbsp;Rishe, if the executive's employment
is terminated for any reason other than by us without cause, by the executive for good reason, due to the executive's disability or as the result of a qualifying termination after a change in control,
an additional 12&nbsp;months following the executive's termination of employment, and (B)&nbsp;in the case of the other executive officers, if the executive's employment is terminated for any
reason other than by us without cause or by the executive for good reason, an additional 12&nbsp;months following the executive's termination of&nbsp;employment. The employment agreements also
provide that, during the executive officer's employment with us and for a period of 12&nbsp;months after termination of his or her employment for any reason, the executive officer will not solicit
or hire our employees and contractors and will not solicit or induce any customer, supplier or other business contact of ours to cancel, curtail or otherwise adversely change its relationship with us.

</FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Equity Awards  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We did not grant any stock option or other equity-based awards to any of our named executive officers during 2015. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Non-Equity Incentive Plan Compensation  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The non-equity incentive plan compensation earned by each of our named executive officers other than Mr.&nbsp;Rishe during 2015 reflected their
participation in our 2015 Bonus Plan. As Vice President, Sales, Mr.&nbsp;Rishe's 2015 bonus opportunity was subject to a separate bonus arrangement described below. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
2015 Bonus Plan incorporated both company financial objectives and company and departmental operational objectives. The company's performance against objectives based on 2015 revenue and 2015
operating income excluding specific board approved expenditures would determine the degree to which a bonus pool would be funded, with payouts from the bonus pool dependent upon the degree to which
financial and operational objectives were achieved. The bonus pool would not be funded if operating income excluding specific board approved expenditures for 2015 was less than $4.5&nbsp;million.
Threshold, target and maximum funding levels of $1.2&nbsp;million, $2.0&nbsp;million and $2.5&nbsp;million respectively, were prescribed depending on the degree to which the financial objectives
were achieved. The bonus pool would be funded at the target level if 2015 revenues were $63.0&nbsp;million and 2015 operating income excluding specific board approved expenditures was
$6.5&nbsp;million, with those metrics assigned relative weightings of 80% and 20%, respectively. Operational objectives generally involved measures to increase efficiencies and reimbursements and
advance clinical studies and submissions. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Individual
payouts from the bonus pool for more senior bonus plan participants, including the named executive officers, were based 80% on achievement of financial objectives and 20% on achievement of
operational objectives. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>132</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=137,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=448226,FOLIO='132',FILE='DISK131:[15ZBY1.15ZBY12201]EK12201A.;83',USER='JFUSS',CD=';8-JUN-2016;14:42' -->
<A NAME="page_ek12201_1_133"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Target
level and actual payouts for 2015 for each named executive officer participating in the 2015 Bonus Plan expressed as a percentage of annual base salary were as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="102pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="102pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:21pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,21pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Target Bonus as % of<BR>
Base Salary </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Actual Bonus as % of<BR>
Base Salary </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Gerald R. Mattys</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>65%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>66.2%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Robert J. Folkes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>37.8%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Mr.&nbsp;Rishe's
2015 bonus opportunity was a function of the degree to which our company achieved monthly and quarterly sales objectives and quarterly sales department expense management goals.
These bonus amounts were payable to Mr.&nbsp;Rishe following the close of the applicable month or quarter during 2015. Mr.&nbsp;Rishe's maximum bonus opportunity for 2015 was approximately 69% of
his base salary, and his actual payout was approximately 54% of his base salary. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Outstanding Equity Awards at Fiscal Year-End  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following table sets forth certain information regarding equity awards that have been granted to our named executive officers and that were
outstanding as of December&nbsp;31, 2015: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="58pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="65pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="41pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="53pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="73pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="84pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Option Awards<SUP>(1)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Stock Awards<SUP>(2)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:21pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,21pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Options (#)<BR>
Exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Options (#)<BR>
Unexercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Option<BR>
Exercise<BR>
Price ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Option<BR>
Expiration<BR>
Date </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number of<BR>
Shares or Units<BR>
of Stock that<BR>
Have Not<BR>
Vested (#) </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Market Value of<BR>
Shares or Units of<BR>
Stock That Have<BR>
Not Vested ($)<SUP>(3)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Gerald R. Mattys</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>138,295</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.51</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2/26/18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35,649</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><SUP>(5)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>534,735</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35,460</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.51</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6/4/19</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>46,098</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.73</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3/8/20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>78,367</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4/20/21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>96,039</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>81,263</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><SUP>(4)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.96</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10/13/23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Robert J. Folkes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
6,106</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR><SUP>(5)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
91,590</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>17,730</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.51</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6/4/19</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>24,822</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.73</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3/8/20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>36,524</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4/20/21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>28,811</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>24,379</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><SUP>(4)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.96</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10/13/23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Bryan F. Rishe</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
17,730</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
0.73</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
3/8/20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>43,261</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4/20/21</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>17,287</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>14,627</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><SUP>(4)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.96</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10/13/23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Option
awards provide a recipient the right to acquire shares of our common stock. All options vested as to 25% of the shares on the first anniversary of
the grant date, with the remaining 75% of the shares vesting in 36&nbsp;monthly installments.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Stock
awards consist of restricted shares of our Series&nbsp;A preferred stock as converted into common stock in connection with this offering.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>The
market value of restricted shares of our Series&nbsp;A preferred stock that have not vested is based on a fair market value of $15.00 per share as of
December&nbsp;31, 2015, as determined by our board of directors.


<BR><BR></FONT></DD>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(4)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>The
unvested shares of common stock subject to this option will vest in 22 equal installments on the 9<SUP>th</SUP> day of each month from January 2016
through October 2017.

<BR><BR></FONT></DD>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(5)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>The
unvested restricted shares of our Series&nbsp;A preferred stock will vest upon the earlier of a change in control of our company or the nine month
anniversary of the closing of this offering. </FONT>

</DD>

</DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>133</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=138,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=266901,FOLIO='133',FILE='DISK131:[15ZBY1.15ZBY12201]EK12201A.;83',USER='JFUSS',CD=';8-JUN-2016;14:42' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_em12201_1_134"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


IPO Equity Grants  </B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>Upon the effectiveness of this registration statement, we expect to grant RSUs to our named executive officers calculated by dividing the following
amounts by the price to the public in this offering: Mr.&nbsp;Mattys: $600,000 RSUs; Mr.&nbsp;Folkes: $348,000 RSUs; and Mr.&nbsp;Rishe: $270,000 RSUs. These RSUs will vest as to 50% of the
shares on January&nbsp;1, 2018 and as to 50% of the shares on January&nbsp;1, 2019, subject to continued employment on each vesting date.

 </FONT>

</P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Pension Benefits for 2015  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We do not offer pension benefits to our named executive officers. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Non-Qualified Deferred Compensation for 2015  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We do not offer non-qualified deferred compensation to our named executive officers. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Potential Payments Upon Termination or Change-in-Control  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our 2003 Stock Option Plan, which we refer to as the 2003 Plan, our 2007 Omnibus Stock Plan, which we refer to as the 2007 Plan, our restricted stock
award agreements, pursuant to which restricted shares of our Series&nbsp;A preferred stock were granted to certain employees, which we refer to as the Series&nbsp;A Restricted Stock, and our 2016
Equity Incentive Plan, which we refer to as the 2016 Plan, address the effect of a grantee's termination of service or a change in control of our company on outstanding awards granted under those
plans and agreements. See "&#151;&nbsp;Stock Option and Other Equity Compensation Plans" below. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Employment Agreements.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;We have entered into an employment agreement with our executive officers. The employment agreements provide for the
following:</FONT></P>


<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'>

<FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> if we terminate the executive officer's employment without cause, or if the executive terminates his or her employment for good
reason, or in the case of Mr. Mattys and Mr.&nbsp;Rishe, if we terminate their employment for death, disability or as the result of a qualifying termination after a change in control as defined
under the 2016&nbsp;Plan, we will pay, in addition to amounts that have been earned prior to the termination date, the following severance benefits:

 </FONT>

<FONT COLOR="#3B5A6F" SIZE=2>

<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'>

<FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> as to Mr.&nbsp;Mattys, an amount equal to 125% of his then-current annualized base salary, and as to the other
executive officers, an amount equal to 75% of the executive officer's then-current annualized base salary;


</FONT>

<FONT COLOR="#3B5A6F" SIZE=2>

<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'>

<FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> as to Mr.&nbsp;Mattys, an amount equal to 125% of his then-current annual target bonus, and as to the other executive
officers, an amount equal to 75% of the executive officer's then-current annual target bonus;

 </FONT>

<FONT COLOR="#3B5A6F" SIZE=2>

<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'>

<FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> payment of the portion of the premium costs for group health insurance coverage that we would pay if he or she remained
employed by us at the same level of coverage, for a period of 15&nbsp;months in the case of Mr.&nbsp;Mattys and nine months in the case of the other executive officers, after his or her employment
termination date or until he or she receives group health or dental coverage from another employer, if earlier;

</FONT>

<FONT COLOR="#3B5A6F" SIZE=2>

<BR><BR></FONT></DD>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> payment of the value of the executive officer's accrued and unused paid time&nbsp;off,

 </FONT></DD>

</DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>134</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=139,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=637064,FOLIO='134',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;84',USER='DBEMBEN',CD=';9-JUN-2016;00:44' -->
<A NAME="page_em12201_1_135"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<UL>
<UL>
<DL compact>

<DT style='font-family:times;margin-bottom:-11pt;'><BR></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>payable,
in the case of the first three bullets above, in equal installments in accordance with our customary payroll practices over the course
of nine months (15 months for Mr.&nbsp;Mattys), subject to potential 409A limitations; </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> if we terminate the executive officer's employment without cause or the executive terminates his or her employment for good reason,
then any of the executive's unvested equity awards will vest in an amount equal to the pro rata portion of the total number of securities issuable pursuant to the awards based on the number of days
served in the vesting period less any amount already vested; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> if we terminate the executive officer's employment for cause, if he or she terminates his or her employment for any reason other than
good reason, or in the event of his or her death or disability (except for Mr. Mattys and Mr. Rishe who also have severance rights if employment is terminated as the result of a qualifying termination
after a change in control), no amounts other than what he or she has earned prior to the termination date is payable.


</FONT></DD>

</DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


If we elect to extend the time during which the non-competition provisions continue following our termination of the executive officer's employment without cause, or following his or her termination
of employment for good reason, or in the case of Mr.&nbsp;Mattys and Mr.&nbsp;Rishe, if we terminate their employment for disability or as the result of a qualifying termination after a change in
control, we will pay to him or her an additional amount equal to the monthly amount payable under those termination circumstances as described above for an additional six&nbsp;months and extend for
an additional six months (three&nbsp;months for Mr.&nbsp;Mattys) the period during which we will pay a portion of the premium costs for group health insurance coverage as described above.


</FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>"Cause"
is defined under the employment agreements as: (i)&nbsp;an act or acts of dishonesty undertaken by the executive officer and intended to result in personal gain or enrichment of the
executive or others at our expense; (ii)&nbsp;unlawful conduct or gross misconduct by the executive officer that, in either event, is injurious to us; (iii)&nbsp;the conviction of the executive
officer of a felony; or (iv)&nbsp;material breach of any terms or conditions of the employment agreement by the executive officer which breach has not been cured by the executive officer within
15&nbsp;days after written notice thereof from us. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


The employment agreements provide that "good reason" means the occurrence of any of the following events without the executive officer's consent: (i)&nbsp;the assignment of the executive officer to
a position with responsibilities or duties of a materially lesser status or degree than the position specified in his or her employment agreement; (ii)&nbsp;a material breach of any terms or
conditions of the employment agreement by us not caused by the executive officer; or (iii)&nbsp;the requirement by us that the executive officer relocate out of the current metropolitan area where
that executive officer&nbsp;resides.

 </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock Option and Other Equity Compensation Plans  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In this section we describe our 2003 Plan, our 2007 Plan, our Series&nbsp;A Restricted Stock agreements, our 2016 Plan and our Employee Stock
Purchase Plan, which we refer to as the ESPP. Prior to this offering, we granted stock option awards to eligible participants under the 2003 Plan and the 2007 Plan and awards of Series&nbsp;A
Restricted Stock. Following the closing of this offering, we expect to grant awards to eligible participants under the 2016 Plan. </FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2><B><I> 2003 Stock Option Plan.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our 2003 Plan was originally approved by our board of directors and our stockholders in 2003, amended in 2005 and amended
and restated in
August 2006. As of June&nbsp;8, 2016, there were 32,269 shares of our common stock subject to outstanding stock options under the


</FONT>

</P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>135</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=140,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=549177,FOLIO='135',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;84',USER='DBEMBEN',CD=';9-JUN-2016;00:44' -->
<A NAME="page_em12201_1_136"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2003
Plan. Since the 2007 Plan became effective, no additional awards have been granted under the 2003 Plan and no additional awards will be granted under the 2003 Plan in the future. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>All
shares subject to awards outstanding under the 2003 Plan as of the effective date of the 2016 Plan that thereafter are forfeited, expire, are cancelled or otherwise do not result in the issuance
of shares will become available for grant under the 2016 Plan in accordance with its terms. All awards outstanding under the 2003 Plan will remain outstanding in accordance with their terms and will
continue to be governed by their existing terms after the completion of this offering. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Eligibility.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The 2003 Plan provides for the grant of stock options to any person who provides services to us, whether as an employee, director,
consultant or
advisor. Incentive and nonqualified stock options could be granted to employees, but only nonqualified stock options could be granted to other eligible participants. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Administration.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our compensation and organization committee administers the 2003 Plan and the awards granted under it, except for awards to our
non-employee
directors which are administered by our board of directors. The plan administrator (compensation and organization committee or the board, as applicable) has the authority to, among other things, make
decisions and determinations related to the 2003 Plan and awards thereunder, including determining who shall receive awards, the types of awards granted and the terms and conditions of the awards and
to adopt rules for the administration of the 2003 Plan. To the extent permitted by law, the plan administrator may delegate all or part of its authority under the 2003 Plan to our chief executive
officer. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Stock Options.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Stock options granted under the 2003 Plan are evidenced by stock option award agreements, containing such provisions as the plan
administrator deems
advisable. All options still outstanding under the 2003 Plan expire not more than ten years after the date of the grant, have a per
share exercise price that is equal to the fair market value of a share of our common stock as of the date the option was granted, and are fully vested and exercisable. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Upon
the termination of an optionee's employment or other service relationship with us: (i)&nbsp;if the termination is due to death or disability, options shall immediately vest and become
exercisable in full and shall remain exercisable for one year after such termination; (ii)&nbsp;if the termination is for "cause," outstanding options shall immediately expire upon such termination;
and (iii)&nbsp;if the termination is for any reason other than death, disability or cause, then to the extent any outstanding options are not then vested and exercisable, they shall immediately
terminate, but to the extent they are already vested and exercisable, they shall remain exercisable for three months following such termination. In no event, however, will an option remain exercisable
past its originally scheduled expiration date. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Change in Control.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In the event of a change in control of our company, the plan administrator may, in its discretion, cause any outstanding option to
immediately
become vested and exercisable in full. The plan administrator may also cause outstanding options to be assumed or replaced by an acquirer in a merger, consolidation or sale of substantially all of the
company's assets, or provide for outstanding options to be cancelled upon a change in control in exchange for a cash payment reflecting the intrinsic value of the options. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
purposes of the 2003 Plan, a "change in control" generally refers to a person acquiring beneficial ownership of 30% or more of the combined voting power of the company's voting securities; the
approval by the company's stockholders of a merger, consolidation or statutory share exchange involving the company, of the sale of all or substantially all of the company's assets or of the
liquidation or dissolution of the company; or a majority of the members of the company's board ceasing to be "continuing" directors. Under the 2003 Plan, "cause" is generally defined to include a </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>136</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=141,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=339315,FOLIO='136',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;84',USER='DBEMBEN',CD=';9-JUN-2016;00:44' -->
<A NAME="page_em12201_1_137"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>material
breach of any agreement between the company and the optionee, gross negligence or willful misconduct by the optionee, the optionee's conviction of a felony or crime involving moral turpitude,
the optionee's willful violation of specific and lawful work-related instructions or prolonged or frequent unexcused absences from work, or fraud, theft or proven dishonesty by the optionee against
the company. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Registration.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;We intend to file with the SEC a registration statement on Form&nbsp;S-8 covering the shares of our common stock issuable under the 2003
Plan. </FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2><B><I> 2007 Omnibus Stock Plan.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our 2007 Plan was approved by our board of directors and our stockholders in 2007, was amended and restated in 2008 and
was further
amended in 2012 and 2014. As of June&nbsp;8, 2016, there were 1,599,011 shares subject to outstanding awards under the 2007 Plan, and 84,895 shares remaining available for the grant of awards under
the 2007 Plan.

 </FONT>

</P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>On
and after the effective date of the 2016 Plan, no additional awards will be granted under the 2007 Plan. On the effective date of the 2016 Plan, any shares remaining available for the grant of
awards under the 2007 Plan will be carried over into the 2016 Plan, and all shares subject to awards outstanding under the 2007 Plan on the effective date of the 2016 Plan that thereafter are
forfeited, expire, are cancelled or otherwise do not result in the issuance of shares will become available for grant under the 2016 Plan in accordance with its terms. All awards outstanding under the
2007 Plan will remain outstanding in accordance with their terms and will continue to be governed by their existing terms after the completion of this offering. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Eligibility.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The 2007 Plan provides for the grant of equity-based awards to any person that provides services to us, whether as an employee, director,
consultant
or advisor. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Administration.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our compensation and organization committee administers the 2007 Plan and the awards granted under it, except for awards to our
non-employee
directors which are administered by our board. The plan administrator (compensation and organization committee or the board, as applicable) has the authority to, among other things, make decisions and
determinations related to the 2007 Plan and awards thereunder, including determining who shall receive awards, the types of awards granted and the terms and conditions of the awards, adopt rules for
the administration of the 2007 Plan, interpret the 2007 Plan and amend the terms of awards thereunder. To the extent permitted by law, the plan administrator may delegate all or part of its authority
under the 2007 Plan with respect to awards to persons who are not officers or directors of the company to one or more persons who are not non-employee directors. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Types of Awards.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Awards under the 2007 Plan may be in the form of stock options, stock appreciation rights, or SARs, restricted stock, performance
units or other
stock-based awards. Each award is to be evidenced by an award agreement containing the terms and conditions of the award. Only stock options have been granted under the 2007 Plan. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any
stock option granted under the 2007 Plan shall have a term as specified by the plan administrator, not to exceed ten years after the date of the grant in the case of an incentive stock option, and
have a per share exercise price, which is determined by the plan administrator and which may not be less than the fair market value of a share of our common stock as of the date the option is granted. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Upon
the termination of an optionee's employment with us: (i)&nbsp;options that are not then vested and exercisable shall immediately terminate; (ii)&nbsp;if the termination is due to death or
disability, options shall remain exercisable for one year after such termination to the extent they were exercisable immediately before such termination; (iii)&nbsp;if the termination is for
"cause," outstanding options shall </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>137</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=142,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=224607,FOLIO='137',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;84',USER='DBEMBEN',CD=';9-JUN-2016;00:44' -->
<A NAME="page_em12201_1_138"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>immediately
terminate upon such termination; and (iv)&nbsp;if the termination is for any reason other than death, disability or cause, then they shall remain exercisable for three months following
such termination to the extent they were exercisable immediately before such termination. In no event, however, will an option remain exercisable past its originally scheduled expiration date. If a
non-employee director's service relationship with the company terminates, any stock option will remain exercisable for the remainder of its scheduled term to the extent it was exercisable immediately
before such termination. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Change in Control.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In the event of a change in control of our company, the plan administrator may, in its discretion, cause any outstanding option to
immediately
become vested and exercisable in full and to remain exercisable during its scheduled term. The plan administrator may also cause outstanding options to be assumed or replaced by an acquirer in a
merger, consolidation or sale of substantially all of the company's assets, or provide for outstanding options to be cancelled upon a change in control in exchange for a cash payment reflecting the
intrinsic value of the options. Unless otherwise provided in an agreement with our company, if the accelerated vesting of an award or payment of cash in exchange for an award that would otherwise
occur in connection with a change in control would, together with any other payments to the same individual that are deemed contingent on a change in control, be characterized as a "parachute payment"
under Code Section&nbsp;280G, then accelerated vesting or payment of cash in exchange for an award shall be reduced to the extent necessary to avoid the imposition of the excise tax on "excess
parachute payments" required by Code Section&nbsp;4999. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
purposes of the 2007 Plan, "change in control" is defined in the same manner as in the 2003 Plan, except that a person must acquire beneficial ownership of 50% or more of the company's voting
securities, rather than 30% or more, and a merger, consolidation or statutory share exchange involving the company, a sale of all or substantially all of the company's assets or the liquidation or
dissolution of the company will constitute a change in control only upon consummation of the transaction, rather than upon stockholder approval of the transaction. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Registration.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;We intend to file with the SEC a registration statement on Form&nbsp;S-8 covering the shares of our common stock issuable under the 2007
Plan. </FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2><B><I> Series&nbsp;A Restricted Stock.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In March 2009, we issued awards to certain of our employees of restricted shares of our Series&nbsp;A preferred
stock. As of
June&nbsp;8, 2016, there were 45,523 shares of Series&nbsp;A Restricted Stock subject to these outstanding awards after applying a 1-for-2.82 reverse stock split of our Series A preferred stock,
which became effective on June&nbsp;8, 2016.

</FONT>

</P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


The award agreements provide that until the shares of Series&nbsp;A Restricted Stock vest, they may not be sold, transferred or encumbered in any manner, and will be subject to forfeiture if the
award recipient's employment with us terminates for any reason. The award agreements provide that shares of the Series&nbsp;A Restricted Stock will vest upon the earlier of a change in control of
our company if the holder of the Series&nbsp;A Restricted Stock is employed by our company on the date of the change in control or the nine month anniversary of the closing of this offering. The
award agreements generally define a "change in control" as involving (i)&nbsp;the acquisition by a person of beneficial ownership of 50% or more of the combined voting power of the company's voting
securities; (ii)&nbsp;the consummation of a merger, consolidation, statutory share exchange or reorganization involving the company; (iii)&nbsp;the consummation of the sale of all or substantially
all of the company's assets; (iv)&nbsp;a majority of the members of the company's board ceasing to be "continuing directors"; or (v)&nbsp;the consummation of a complete liquidation or dissolution
of the company. Unless otherwise provided in a separate agreement with the company, if the vesting of Series&nbsp;A Restricted Stock upon a change in control would, together with any other payments
to the same individual that are deemed contingent on a change in control, be

</FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>138</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=143,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=213470,FOLIO='138',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;84',USER='DBEMBEN',CD=';9-JUN-2016;00:44' -->
<A NAME="page_em12201_1_139"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>characterized
as a "parachute payment" under Code Section&nbsp;280G, then such vesting and other payments are to be reduced to the extent necessary to avoid the imposition of the excise tax on
"excess parachute payments" required by Code Section&nbsp;4999. Mr.&nbsp;Mattys' Series&nbsp;A Restricted Stock also vests 45&nbsp;days following his termination of employment so long as he
provides a release of claims in favor of our company. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> 2016 Equity Incentive Plan.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors adopted the 2016 Plan in 2016 and our stockholders approved the 2016 Plan in 2016. The
purposes of the 2016 Plan
are to attract and retain the best available personnel, to provide them with additional incentives and to align their interests with those of our stockholders. The material terms of the 2016 Plan are
summarized below. </FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2><I> Share Reserve.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;As of June&nbsp;8, 2016, there were no stock options or other equity-based awards outstanding under the 2016 Plan. The 2016 Plan provides
that
4,800,000 shares may be the subject of awards and issued under the plan. We intend to use up to 173,630&nbsp;shares for grants of stock options and restricted stock units equal to $3,211,012 divided
by the price to the public in this offering (214,068 RSUs, assuming an initial offering price of $15.00 per share, which is the midpoint of the estimated offering price range set forth on the cover
page of this prospectus) to our employees and directors effective upon completion of this offering with an exercise price for stock options equal to the offering price. We also intend to use the
number of shares equal to (a) an aggregate $350,000 for grants of non-statutory stock options to our directors and (b) an aggregate $350,000 for grants of restricted stock units to our directors as
described under "Management &#151; Non-Employee Director Compensation", upon the effectiveness of the registration statement on the terms described above, the amount of which will be calculated
as the grant date fair value of the stock-based awards computed in accordance with FASB Topic ASC&nbsp;718 on the date of grant based on the per share price to the public of our common stock in
connection with this offering. The 2016 Plan's share reserve will increase on January&nbsp;1 of each year beginning in 2017 and ending on&nbsp;January&nbsp;1, 2026 in an amount equal to the
least of: (i)&nbsp;5% of the total number of shares outstanding as of December&nbsp;31 of the immediately preceding calendar year; (ii)&nbsp;2,500,000 shares; or (iii)&nbsp;a number of shares
determined by our board of directors. Shares subject to awards under the 2016 Plan, the 2007 Plan or the 2003 Plan that expire unexercised, are cancelled or forfeited, are settled for cash or
otherwise do not result in the issuance of all or a portion of the shares subject to the award will replenish the 2016 Plan's share reserve. If the payment of the exercise price of any award under the
2016 Plan, the 2007 Plan or the 2003 Plan is made by the tendering or withholding of shares or if any applicable tax withholding obligation arising from an award under any of those plans is satisfied
by the tendering or withholding of shares, the shares tendered or withheld also will replenish the 2016 Plan's share reserve.

 </FONT>

</P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Awards
granted or shares of our common stock issued under the 2016 Plan upon the assumption of, or in substitution or exchange for, outstanding equity awards previously granted by an entity acquired
by us or any of our subsidiaries (referred to as "substitute awards") will not reduce the share reserve under the 2016 Plan. Additionally, if a company acquired by us or any of our subsidiaries has
shares available under a pre-existing plan approved by its stockholders and not adopted in contemplation of such acquisition, the unused shares under that pre-existing plan may be used for awards
under the 2016 Plan and will not reduce the share reserve under the 2016 Plan, but only if the awards are made to individuals who were not employed by or providing services to us or any of our
subsidiaries immediately prior to such acquisition. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Administration of Plan.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The compensation and organization committee of our board of directors will administer the 2016 Plan, other than with respect to
awards to
our non-employee directors, which will be administered by the full board of directors. We refer to the compensation and organization committee or the board of directors, as applicable, as the plan
administrator in this section. Subject to the terms of the 2016 Plan, the plan administrator has the authority to, among other things, determine </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>139</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=144,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=129435,FOLIO='139',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;84',USER='DBEMBEN',CD=';9-JUN-2016;00:44' -->
<A NAME="page_em12201_1_140"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>the
persons to whom awards will be granted, the timing, type and number of shares covered by each award, and the terms and conditions of the awards. The plan administrator may also require or permit
the deferral of the settlement of an award, establish and modify rules to administer the plan, interpret the plan and any related award agreement, cancel or suspend an award, accelerate the vesting of
an award, and otherwise modify or amend the terms of outstanding awards to the extent permitted under the plan. Unless an amendment to the terms of an award is necessary to comply with applicable
laws, stock exchange rules or compensation recovery policy, a participant whose rights would be materially impaired by such an amendment must consent to it. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Except
in connection with changes in the Company's capitalization in which share adjustments are specifically authorized, the 2016 Plan prohibits the plan administrator from repricing any outstanding
"underwater" option or SAR awards without the prior approval of our stockholders. For these purposes, a "repricing" includes amending the terms of an option or SAR award to lower the exercise price,
canceling an option or SAR award in exchange for replacement option or SAR awards having a lower exercise price, or canceling an underwater option or SAR award in exchange for cash, other property or
a "full value award," which is an equity-based award other than an option or SAR award. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>To
the extent permitted by law and stock exchange rules, the 2016 Plan permits the plan administrator to delegate its duties, power and authority under the plan to any of its members, to our executive
officers or non-employee directors with respect to awards to participants who are not themselves our directors or executive officers, or to one or more agents or advisors with respect to
non-discretionary administrative duties. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Eligibility.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our employees, non-employee directors and certain consultants and advisors who provide services to us are eligible to receive awards under
the 2016
Plan. Incentive stock options may be granted only to our employees. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Equity Awards.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The 2016 Plan allows us to grant stock options, SARs, restricted stock, stock units and other stock-based awards. Each award will be
evidenced by an
agreement with the award recipient setting forth the terms and conditions of the award, including vesting conditions. Awards under the 2016 Plan will have a maximum term of ten years from the date of
grant. The plan administrator may provide that the vesting or payment of any award will be subject to the attainment of certain performance measures established by the plan administrator, and the plan
administrator will determine whether such measures have been achieved.  </FONT></P>



<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Stock Options.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;Stock options permit the holder to
purchase a specified number of shares of our common stock at a set price. Options granted under the 2016 Plan may be either incentive or nonqualified stock options. The per share exercise price of
options granted under the plan may not be less than the fair market value of a share of our common stock on the date of grant, except in the case of substitute awards. Incentive stock options granted
to employees who hold more than 10% of the total combined voting power of our stock will have an exercise price not less than 110% of the fair market value of our common stock on the date of grant and
will have a maximum term of five&nbsp;years. The maximum number of shares that may be issued upon the exercise of incentive stock options under the 2016 Plan is 4,800,000. The total purchase price
of the shares to be purchased upon exercise of an option will be paid by the participant in cash unless the plan administrator allows exercise payments to be made (i)&nbsp;by means of a
broker-assisted sale and remittance program, (ii)&nbsp;by delivery to us of shares of common stock already owned by the participant, or (iii)&nbsp;by a "net exercise" of the option in which a
portion of the shares otherwise issuable upon exercise of the option are withheld by us.

 </FONT></DD></DL>
</UL>
</UL>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>140</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=145,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=471678,FOLIO='140',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;84',USER='DBEMBEN',CD=';9-JUN-2016;00:44' -->
<A NAME="page_em12201_1_141"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> SARs.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;SARs provide for payment to the holder of all or a
portion of the excess of the fair market value of a specified number of shares of our common stock on the date of exercise over the aggregate exercise price for that number of shares. Payment may be
made in cash or shares of our common stock or a combination of both, as determined by the plan administrator. The exercise price per share of a SAR award will be determined by the plan administrator,
but may not be less than 100% of the fair market value of one share of our common stock on the date of grant, unless the SAR is granted as a substitute award.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Restricted Stock.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;A restricted stock award is an award of
our common stock that vests at such times and in such installments as is determined by the plan administrator. Until it vests, the shares subject to the award are subject to restrictions on
transferability and the possibility of forfeiture. The plan administrator may impose such restrictions or conditions to the vesting of restricted stock awards as it deems appropriate, including that
the participant remain continuously in our service for a certain period or that we, or any of our subsidiaries or business units, satisfy specified performance goals. Participants are entitled to vote
shares of restricted stock prior to the time they vest.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Stock Units.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;The grant of a stock unit provides the right
to receive the fair market value of a share of our common stock, payable in cash, shares, or a combination of both as determined by the plan administrator. A stock unit award vests at such times and
in such installments as is determined by the plan administrator. Until it vests, a stock unit award is subject to restrictions on transferability and the possibility of forfeiture. The plan
administrator may impose such restrictions or conditions to the vesting of stock unit awards as it deems appropriate.  </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Other Stock-Based Awards.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;The plan administrator, in its
discretion, may grant awards of common stock and other awards that are valued by reference to and/or payable in shares of our common stock under the 2016 Plan. The administrator will set the terms and
conditions of such awards. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2><I> Maximum Awards to Individual Participants.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The number of shares of our common stock subject to options or SARs that may be granted to any participant
other than a
non-employee director during a calendar year under the 2016 Plan may not exceed 1,000,000. The aggregate grant date fair value of all awards granted during any calendar year under the 2016 Plan to any
non-employee director (other than awards granted at the election of the director in lieu of cash retainers or fees otherwise payable to the director) may not exceed $500,000. The maximum number of our
shares that may be the subject of full value awards that are intended to qualify as performance-based compensation for purposes of Section&nbsp;162(m) of the Internal Revenue Code, that are
denominated in shares or share equivalents and that are granted to any participant during any calendar year may not exceed 1,000,000 shares. The maximum amount payable with respect to any full value
awards that are intended to qualify as performance-based compensation for purposes of Section&nbsp;162(m), that are denominated other than in shares or share equivalents and that are granted to any
participant during any calendar year shall not exceed $5,000,000.

 </FONT>

</P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Dividend and Dividend Equivalents.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;No dividends, dividend equivalents or distributions will be paid with respect to stock options or SARs granted under
the 2016
Plan. Other than regular cash dividends, any dividends or distributions paid with respect to the unvested portion of a restricted stock award will be subject to the same restrictions as the shares to
which such dividends or distributions relate. The plan administrator may provide the holder of a stock unit award or any other stock-based award with the right to receive dividend equivalents with
respect to the shares subject to the award. Any shares issued as the result of the reinvestment of dividends or the deemed reinvestment of dividend </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>141</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=146,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=483156,FOLIO='141',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;84',USER='DBEMBEN',CD=';9-JUN-2016;00:44' -->
<A NAME="page_em12201_1_142"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>equivalents
in connection with an award will be counted against, and replenish upon any subsequent forfeiture, the 2016 Plan's share reserve. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Transferability.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise determined by the plan administrator, awards granted under the 2016 Plan generally are not transferable except by
will or the
laws of descent and distribution. The plan administrator may permit the transfer of awards other than incentive stock options pursuant to a domestic relations order or by way of gift to a family
member. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Termination of Service.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise provided in an award agreement (and except with respect to terminations following certain corporate
transactions described
below under "&#151;&nbsp;Change-in-Control; Corporate Transaction"), upon termination of an award recipient's service with our company, all unvested and unexercisable portions of the
recipient's outstanding awards will immediately be forfeited. If an award recipient's service with our company terminates other than for cause (as defined in the 2016 Plan), death or disability, the
vested and exercisable portions of the recipient's outstanding options and SARs generally will remain exercisable for three months after termination. If a recipient's service terminates due to death
or disability (or if a recipient dies during the three-month period after termination of service other than for cause), the vested and exercisable portions of the recipient's outstanding options and
SARs generally will remain exercisable for one year after termination. Upon termination for cause, all unexercised stock options and SARs will also be forfeited. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Change in Control.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise provided in an award agreement, in the event of a change in control that is a corporate transaction, the surviving
or successor
entity may continue, assume or replace some or all of the outstanding awards under the 2016 Plan. Our award agreements with our executive officers will typically provide that if awards granted to the
executive officer under the 2016 Plan are continued, assumed or replaced in connection with such a transaction and if within one year after the transaction the executive officer experiences an
involuntary termination of service other than for cause, or terminates his or her employment for good reason, the executive officer's outstanding awards will vest in full, will immediately become
fully exercisable and will remain exercisable for one year following termination. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
awards granted to any participant are not continued, assumed or replaced, then (i)&nbsp;any outstanding stock option or SAR will become fully exercisable for a period of time prior to the
transaction and terminate at the time of the transaction; and (ii)&nbsp;any outstanding full value awards will vest immediately prior to the transaction. Alternatively, the plan administrator may
provide for the
cancellation of any outstanding award in exchange for payment to the holder of the amount of the consideration that would have been received in the transaction for the number of shares subject to the
award less the aggregate exercise price (if any) of the award. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
the event of a change in control that does not involve a corporate transaction, the plan administrator, in its discretion may take such action as it deems appropriate with respect to outstanding
awards, which may include providing for the cancellation of any award in exchange for payment to the holder of the amount of the consideration that would have been received in the change in control
for the number of shares subject to the award less the aggregate exercise price (if any) of the award, or making adjustments to any award to reflect the change in control, including the acceleration
of vesting in full or in part. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
purposes of the 2016 Plan, a "change in control" generally refers to a corporate transaction (as defined in the next sentence), the acquisition by a person or group of more than 50% of the
combined voting power of our stock, or our "continuing directors" ceasing to constitute a majority of the members of the board of directors. A "corporate transaction" generally refers to (i)&nbsp;a
sale or other disposition of all or substantially all of the assets of our company, or (ii)&nbsp;a merger, consolidation, share </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>142</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=147,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=467308,FOLIO='142',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;84',USER='DBEMBEN',CD=';9-JUN-2016;00:44' -->
<A NAME="page_em12201_1_143"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>exchange
or similar transaction involving our company, regardless of whether or company is the surviving corporation. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Performance-Based Compensation.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The 2016 Plan provides that the plan administrator may grant full value awards under the 2016 Plan that are intended to
qualify as
"performance-based compensation" within the meaning of Section&nbsp;162(m) of the Internal Revenue Code in order to preserve the deductibility of those awards for federal income tax purposes, and
contains certain provisions intended to enable our company to comply with the requirements of Section&nbsp;162(m). However, the deduction limitations imposed by Section&nbsp;162(m) do not, for a
period of time following a company's initial public offering, apply to compensation paid by the company pursuant to a compensation plan (such as the 2016 Plan) that existed during the period in which
the company was not publicly held, provided satisfactory disclosure about the compensation plan is included in the initial public offering prospectus. This period of non-applicability continues until
the earliest of (i)&nbsp;the expiration of the compensation plan, (ii)&nbsp;the material modification of the plan, (iii)&nbsp;the issuance of all company stock allocated under the plan, or
(iv)&nbsp;the first annual meeting of the company's shareholders that occurs after the close of the third calendar year following the calendar year in which the initial public offering occurs. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Adjustment of Awards.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In the event of an equity restructuring that affects the per share value of our common stock, including a stock dividend, stock
split,
spinoff, rights offering or recapitalization through an extraordinary dividend, the plan administrator will make appropriate adjustment to: (i)&nbsp;the number and kind of securities reserved for
issuance under the 2016 Plan, (ii)&nbsp;the number and kind of securities subject to outstanding awards under the 2016 Plan, (iii)&nbsp;the exercise price of outstanding options and SARs, and
(iv)&nbsp;any maximum limitations prescribed by the 2016 Plan as to grants of certain types of awards. The administrator may also make similar adjustments in the event of any other change in our
company's capitalization, including a merger, consolidation, reorganization or liquidation. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Amendment and Termination.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The 2016 Plan will remain in effect until the tenth anniversary of the effective date of the 2016 Plan, or until terminated
by our board
of directors, whichever occurs first. Our board of directors may terminate, suspend or amend the plan at any time, but, in general, no termination, suspension or amendment may materially impair the
rights of any participant with respect to outstanding awards without the participant's consent, unless such action is necessary to comply with applicable law or stock exchange rules. Awards that are
outstanding on the 2016 Plan's termination date will remain in effect in accordance with the terms of the plan and the applicable award agreements. Stockholder approval of any amendment of the 2016
Plan will be obtained if required by applicable law or the rules of the applicable stock exchange. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Registration.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;We intend to file with the SEC a registration statement on Form&nbsp;S-8 covering the shares of our common stock issuable under the 2016
Plan. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Employee Stock Purchase Plan.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Prior to the completion of this offering, we expect to adopt and our stockholders to approve our Employee Stock
Purchase Plan, or
ESPP, intended to be a qualified employee stock purchase plan under Section&nbsp;423 of the Internal Revenue Code. Assuming such actions occur as expected, the ESPP will terminate on the earlier of
(i)&nbsp;the date on which all shares subject to the ESPP are issued or (ii)&nbsp;the date our board of directors terminates the ESPP. The purpose of the ESPP is to provide our employees with a
convenient means of purchasing shares of our common stock at a discount to market prices through the use of payroll deductions. The material terms of the ESPP are summarized below. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>143</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=148,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=114213,FOLIO='143',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;84',USER='DBEMBEN',CD=';9-JUN-2016;00:44' -->
<A NAME="page_em12201_1_144"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2><I> Share Reserve.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;A total of 1,600,000 shares of our common stock will initially be made available for sale under the ESPP. In addition, the ESPP provides
for annual
increases in the number of shares available for issuance under the ESPP on January&nbsp;1 of each year beginning in 2017 and ending on January&nbsp;1, 2026 in an amount equal to the least of:
(i)&nbsp;1% of the total number of shares outstanding as of December&nbsp;31 of the immediately preceding calendar year; (ii)&nbsp;500,000 shares; or (iii)&nbsp;a number of shares determined
by our board of directors. If there is any change to our outstanding common stock, such as a recapitalization, stock dividend, stock split or similar event, appropriate adjustments will be made to the
number and class of shares available under the ESPP, the limit on the number of shares that a participant may purchase during any purchase period, and the number, class and purchase price of shares
subject to purchase under any pending offering.

 </FONT>

</P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Administration.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our compensation and organization committee will administer the ESPP. The compensation and organization committee will have full
authority to adopt
rules and procedures to administer the ESPP, to interpret the provisions of the ESPP, to determine the terms and conditions of offerings under the ESPP and to designate any subsidiaries to participate
in the ESPP. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Eligibility and Participation.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;All of our employees (including those of any participating subsidiary) other than those subject to the 5% ownership
limitation
described below are eligible to participate in the ESPP. Our compensation and organization committee may, consistent with the requirements of Section&nbsp;423, impose additional eligibility
requirements for individual offerings under the ESPP. Eligible employees may enroll in the ESPP and begin participating at the start of any purchase period. </FONT></P>


<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2><I> Purchase Periods.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Shares of our common stock will be offered under the ESPP through a series of offerings, each of which consists of a single purchase
period of
six months, or such other duration (up to 27&nbsp;months) as the compensation and organization committee may prescribe. We expect that our shares will be offered under the ESPP through an initial
purchase period commencing on the effective date of this registration statement and in which all of our then-eligible employees will be automatically enrolled, followed thereafter by a series of
successive six-month purchase periods that are expected to commence on May&nbsp;1 and November&nbsp;1 each year. Purchases under the ESPP are expected to occur on the last trading day of each
purchase period.

</FONT>

</P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Purchase Price.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The purchase price of our common stock acquired on each purchase date will be no less than 85% of the lower of (i)&nbsp;the closing
market price
per share of our common stock on the first trading day of the applicable purchase period or (ii)&nbsp;the closing market price per share of our common stock on the last trading day of the applicable
purchase period. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Payroll Deductions and Stock Purchases.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Each participant may elect to have a percentage of eligible compensation between 1% and 15% withheld as a
payroll deduction
per pay period. The accumulated deductions will automatically be applied on each purchase date (the last trading day of a purchase period) to the purchase of shares of our common stock at the purchase
price in effect for that purchase date. No more than 5,000 shares of our common stock may be purchased by an ESPP participant on any purchase date. For purposes of the ESPP, eligible compensation
means the total cash compensation paid to a participant, including base salary, bonuses, commissions and overtime pay, but excludes company 401(k) contributions and income with respect to equity-based
awards. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Special Limitations.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The ESPP imposes certain limitations upon a participant's right to acquire our common stock, including the
following:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> purchase rights may not be granted to any individual who owns stock (including stock purchasable under any outstanding purchase
rights) possessing 5% or more of the total combined voting power or value of all classes of our stock or the stock of any of our subsidiaries; and </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>144</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=149,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=609422,FOLIO='144',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;84',USER='DBEMBEN',CD=';9-JUN-2016;00:44' -->
<A NAME="page_em12201_1_145"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> a participant accrues the right to purchase no more than $25,000 worth of our common stock (valued at the time each purchase right is
granted) for each calendar year during which a purchase period occurs under the ESPP. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Withdrawal or Termination of Purchase Rights.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;A participant may withdraw from the ESPP at any time, and his or her accumulated payroll deductions will
be promptly
refunded. A participant's purchase right will immediately terminate upon his or her cessation of employment for any reason. Any payroll deductions that the participant may have made for the purchase
period in which such
cessation of employment occurs will be refunded and will not be applied to the purchase of common stock. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Transferability.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;No purchase rights will be assignable or transferable by the participant, except by will or the laws of descent and distribution.
</FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Corporate Transactions.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;If our company is acquired by merger, consolidation or other reorganization, or sells all or substantially all its assets, each
right to
acquire shares on any purchase date scheduled to occur after the date of the consummation of the acquisition transaction shall be continued or assumed or an equivalent right shall be substituted by
the surviving or successor corporation or its parent or subsidiary. If those rights are not continued, assumed or substituted, then our board of directors may terminate the ESPP or shorten the
purchase period then in progress by setting a new purchase date to occur prior to the transaction. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Share Proration.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Should the total number of shares of common stock to be purchased pursuant to outstanding purchase rights on any particular purchase
date exceed
the number of shares remaining available for issuance under the ESPP at that time, then the compensation and organization committee will make a pro-rata allocation of the available shares on a uniform
and nondiscriminatory basis. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Amendment.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors may at any time amend or suspend the ESPP. However, our board of directors may not, without stockholder approval,
amend the ESPP
to (i)&nbsp;increase the number of shares issuable under the ESPP outside of the automatic share increase feature, or (ii)&nbsp;effect any other change in the ESPP that would require stockholder
approval under applicable law or to maintain compliance with Code Section&nbsp;423. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


401(k) Retirement Plan  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We maintain a 401(k) retirement plan that is intended to be a tax-qualified defined contribution plan under Section&nbsp;401(k) of the Internal
Revenue Code. All of our eligible employees can participate, beginning on the first day of the month following commencement of their employment. The 401(k) plan includes a salary deferral arrangement
pursuant to which
participants may elect to reduce their current compensation by up to the statutorily prescribed limit, equal to $18,000 in 2016, and have the amount of the reduction contributed to the 401(k) plan.
Participants who are at least 50&nbsp;years old also can make "catch-up" contributions, which in 2016 may be up to an additional $6,000 above the statutory limit. We also make discretionary matching
contributions to our 401(k) plan equal to 3% of the employee contributions up to 3% of the employee's salary, subject to the statutorily prescribed limit, equal to $18,000 in 2016 for all employees
who have been employed at least one year, other than our named executive officers, commissioned field sales representatives and certain highly compensated employees. The match immediately vests in
full. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Limitation of Liability and Indemnification  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our amended and restated certificate of incorporation, which will become effective upon completion of this offering, limits the personal liability of
directors for breach of fiduciary duty to the maximum extent permitted by the DGCL and provides that no director will have personal liability to us or to </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>145</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=12,SEQ=150,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=718350,FOLIO='145',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;84',USER='DBEMBEN',CD=';9-JUN-2016;00:44' -->
<A NAME="page_em12201_1_146"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>our
stockholders for monetary damages for breach of fiduciary duty or other duty as a director. However, these provisions do not eliminate or limit the liability of any of our
directors:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> for any breach of the director's duty of loyalty to us or our stockholders; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law; </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> for voting or assenting to unlawful payments of dividends, stock repurchases or other distributions; or </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> for any transaction from which the director derived an improper personal benefit. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any
amendment to, or repeal of, these provisions will not eliminate or reduce the effect of these provisions in respect of any act, omission or claim that occurred or arose prior to such amendment or
repeal. If the DGCL is amended to provide for further limitations on the personal liability of directors of corporations, then the personal liability of our directors will be further limited to the
greatest extent permitted by the DGCL. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, our amended and restated certificate of incorporation, which will become effective upon completion of this offering, provides that we must indemnify our directors and officers and we must
advance expenses, including attorneys' fees, to our directors and officers in connection with legal proceedings, subject to very limited exceptions. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
maintain a general liability insurance policy that covers certain liabilities of our directors and executive officers arising out of claims based on acts or omissions in their capacities as
directors or executive officers. In addition, we intend to enter into indemnification agreements with each of our directors and executive officers. These indemnification agreements may require us,
among other things, to indemnify each such director or executive officer for some expenses, including attorneys' fees, judgments, fines and settlement amounts incurred by him or her in any action or
proceeding arising out of his or her service as one of our directors or executive officers. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Certain
of our non-employee directors may, through their relationships with their employers, be insured and/or indemnified against certain liabilities incurred in their capacity as members of our
board of directors. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, executive officers or persons controlling us, in the opinion of the SEC, such indemnification
is against public policy as expressed in the Securities Act and is therefore unenforceable. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Rule&nbsp;10b5-1 Sales Plans  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our directors and executive officers may adopt written plans, known as Rule&nbsp;10b5-1 plans, in which they will contract with a broker to buy or
sell shares of our common stock on a periodic basis. Under a Rule&nbsp;10b5-1 plan, a broker executes trades pursuant to parameters established by the director or officer when entering into the
plan, without further direction from the director or officer. It also is possible that the director or officer could amend or terminate the plan when not in possession of material, nonpublic
information. In addition, our directors and executive officers may buy or sell additional shares outside of a Rule&nbsp;10b5-1 plan when they are not in possession of material, nonpublic
information. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>146</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=13,SEQ=151,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1037277,FOLIO='146',FILE='DISK131:[15ZBY1.15ZBY12201]EM12201A.;84',USER='DBEMBEN',CD=';9-JUN-2016;00:44' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_eo12201_1_147"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="eo12201_certain_relationships_and_related_party_transactions"> </A>
<A NAME="toc_eo12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In addition to the director and executive compensation arrangements discussed above under "Executive Compensation," we have been a party to the
following transactions since January&nbsp;1, 2013, in which the amount exceeded or will exceed $120,000, and in which any director, executive officer or holder of more than 5% of any class of our
voting stock, or any member of the immediate family of or entities affiliated with any of them, had or will have a material interest. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Series&nbsp;B Preferred Stock Financing  </B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>In September and October 2012, we issued 2,733,468&nbsp;shares of our Series&nbsp;B preferred stock at an issuance price of $3.80 per share for
aggregate consideration of approximately $10.4&nbsp;million to a total of 18 investors, including Galen Partners and affiliated entities
and Radius Ventures III&nbsp;LP and affiliated entities, each of which holds 5% or more of our capital stock and is represented on our board of directors, as well as certain of our directors or
their affiliates, including Worthy Ventures Resources LLC (an affiliate of Peter Soderberg), Richard Nigon and Kevin Roche. In connection with the closing of the offering contemplated by this
prospectus, such shares of Series&nbsp;B preferred stock will convert to common stock at a ratio of 1-to-1 plus the holders will receive additional shares of common stock in lieu of payment of the
liquidation preference and accrued dividends on the Series B preferred stock. The following table summarizes purchases of Series&nbsp;B preferred stock by such investors:

</FONT>

</P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="83pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="134pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:66pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Stockholder Name

<!-- COMMAND=ADD_SCROPPEDRULE,66pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Shares of Series&nbsp;B </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Series&nbsp;B Total Purchase Price </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2> Galen Partners</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
1,156,467</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,400,131</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Radius Ventures</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
1,156,467</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,400,131</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Worthy Ventures Resources LLC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
78,850</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>300,010</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Richard Nigon (IRA)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
5,719</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21,761</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Kevin Roche</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
5,719</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>21,761</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Amended and Restated Investors' Rights Agreement  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In September 2012, in connection with the closing of our Series&nbsp;B preferred stock financing, we entered into an amended and restated
investors' rights agreement with certain holders of our preferred stock, including entities with which certain of our directors are affiliated. Pursuant to this agreement, holders of our preferred
stock, including certain holders of 5% of our capital stock and entities affiliated with certain of our directors, were granted certain registration rights, including the right to demand that we
file&nbsp;a registration statement or request that their shares be covered by a registration statement that we are otherwise filing. The investors' rights agreement also provides for a right of
first offer in favor of certain holders of our stock with regard to certain issuances of our capital stock. The rights of first offer will not apply to, and will terminate upon, the completion of this
offering. For a more detailed description of these registration rights, see "Description of Capital Stock&nbsp;&#151; Registration Rights." </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Voting Agreement  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are party to a voting agreement under which certain holders of our capital stock, including entities with which certain of our directors are
affiliated, have agreed to vote their shares in a certain way on certain matters, including with respect to the election of directors. The voting agreement also provides for drag-along rights
requiring the stockholders party to this agreement to participate in a sale of our company or a deemed liquidation event under this agreement if any such matter is approved by a certain percentage of
the stockholders party to the agreement. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>147</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=152,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=35714,FOLIO='147',FILE='DISK131:[15ZBY1.15ZBY12201]EO12201A.;71',USER='ABEAULI',CD=';8-JUN-2016;14:41' -->
<A NAME="page_eo12201_1_148"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Upon
the completion of this offering, the voting agreement will terminate in its entirety and none of our stockholders will have any special rights regarding the election or designation of members of
our board of directors or the other rights granted under this agreement. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Right of First Refusal and Co-Sale Agreement  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are party to a right of first refusal and co-sale agreement pursuant to which our preferred stockholders, including certain holders of 5% of our
capital stock and entities affiliated with certain of our directors, are granted a right of first refusal to purchase shares of our capital stock held by the stockholders party to this agreement and
rights of co-sale in the event of a sale of our capital stock held by the stockholders party to this agreement. The right of first offer and co-sale agreement, and the associated rights described
therein, will not apply to, and will terminate upon, the completion of this offering. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Indemnification Agreements  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our amended and restated certificate of incorporation, which will be effective upon the completion of this offering, will contain provisions limiting
the liability of directors, and our amended and restated certificate of incorporation and our amended and restated bylaws will provide that we will indemnify each of our directors to the fullest
extent permitted under Delaware law. Our amended and restated certificate of incorporation and amended and restated bylaws will also provide our board of directors with discretion to indemnify our
employees and agents when determined appropriate by the board. In addition, we intend to enter into agreements to indemnify our directors and executive officers. For more information regarding these
agreements, see "Executive Compensation&nbsp;&#151; Limitation of Liability and Indemnification." </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Change in Control Agreements  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Certain of our executive officers will be entitled to change in control benefits pursuant to the terms of our equity incentive plans and pursuant to
the terms of their employment agreements that we intend to enter into prior to the completion of this offering, as described in greater detail in "Executive Compensation&nbsp;&#151; Potential
Payments Upon Termination or Change-In-Control." </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Executive Compensation Awards  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have approved equity compensation awards for our officers and directors to be made upon the completion of this offering. These are described in
greater detail in "Executive Compensation&nbsp;&#151; Stock Option and Other Equity Compensation Plans." </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Policy for Approval of Related Party Transactions  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Prior to the completion of this offering, our board of directors will adopt a written statement of policy regarding transactions with related
persons, which we refer to as our related person policy. Our related person policy will cover any transaction, arrangement or relationship, or any series of similar transactions, arrangements or
relationships in which we were or are to be a participant, the amount involved exceeds $120,000 and a related person had or will have a direct or indirect material interest, including, without
limitation, purchases of goods or services by or from the related person or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness or employment by us
of a related person. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>148</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=153,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=300074,FOLIO='148',FILE='DISK131:[15ZBY1.15ZBY12201]EO12201A.;71',USER='ABEAULI',CD=';8-JUN-2016;14:41' -->
<A NAME="page_eo12201_1_149"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="eo12201_principal_stockholders"> </A>
<A NAME="toc_eo12201_2"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  PRINCIPAL STOCKHOLDERS    <BR>    </B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>The following table sets forth information with respect to the beneficial ownership of our common stock, as of June&nbsp;8, 2016 by each person
known by us to beneficially own more than 5% of our common stock, each of our directors, each of our named executive officers and all of our current directors and executive officers as a group.


</FONT>

</P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


The column entitled "Percentage of Shares Beneficially Owned&#151;Before Offering" is based on 9,338,589&nbsp;shares of our common stock outstanding as of June&nbsp;8, 2016, assuming the
conversion of all outstanding shares of our preferred stock into an aggregate of 5,924,452 shares of common stock immediately prior to the completion of this offering. The column entitled "Percentage
of Shares Beneficially Owned&#151;After Offering" is based on 15,752,920&nbsp;shares of our common stock to be outstanding after this offering, assuming (a)&nbsp;the conversion of all
outstanding shares of our preferred stock into an aggregate 5,924,452&nbsp;shares of common stock immediately prior to the completion of this offering; (b)&nbsp;the issuance of 1,569,549
additional shares of common stock to which our Series&nbsp;A and Series&nbsp;B preferred stockholders are entitled immediately prior to the completion of this offering issuable in connection with
the initial public offering, assuming an initial offering price of $15.00 per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus; and
(c)&nbsp;the issuance of 844,782&nbsp;shares of common stock immediately prior to the completion of this offering to pay accrued dividends on our Series&nbsp;B preferred stock (assuming a
closing date of June&nbsp;27, 2016 and an initial offering price of $15.00 per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus).

 </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


The number of shares beneficially owned by each stockholder is determined under rules issued by the SEC and includes voting or investment power with respect to securities. Under these rules,
beneficial ownership includes any shares as to which the individual or entity has sole or shared voting power or investment power. In computing the number of shares beneficially owned by an individual
or entity and the percentage ownership of that person, shares of common stock subject to options, warrants or other rights held by such person that are currently exercisable, or will become
exercisable within 60&nbsp;days of June&nbsp;8, 2016, are considered outstanding, although these shares are not considered outstanding for purposes of computing the percentage ownership of any
other person. Except as indicated by the footnotes below, we believe, based on information furnished to us, that the persons and entities named in the table below have sole voting and sole investment
power with respect to all shares of common stock that they beneficially owned, subject to applicable community property laws.

</FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>149</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=154,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=304732,FOLIO='149',FILE='DISK131:[15ZBY1.15ZBY12201]EO12201A.;71',USER='ABEAULI',CD=';8-JUN-2016;14:41' -->
<A NAME="page_eo12201_1_150"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Unless
otherwise indicated, the address of all listed stockholders is c/o Tactile Systems Technology,&nbsp;Inc., 1331 Tyler Street NE, Suite&nbsp;200, Minneapolis, MN 55413. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:57%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"140%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="140%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="91pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="94pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="91pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="94pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Before Offering </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>After Offering </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number of Shares<BR>
Beneficially Owned </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Percentage of Shares<BR>
Beneficially Owned </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number of Shares<BR>
Beneficially Owned </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Percentage of Shares<BR>
Beneficially Owned </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B><I>5% Stockholders</I></B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Galen Partners V&nbsp;L.P.<SUP>(1)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,160,858</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>33.8</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,344,940</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>27.6</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Radius Ventures III QP&nbsp;LP<SUP>(2)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,037,150</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>11.1</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,807,210</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>11.5</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B><I>Named Executive Officers and Directors</I></B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Peter H. Soderberg<SUP>(3)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>131,671</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>176,039</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.1</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Gerald R. Mattys<SUP>(4)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>649,183</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6.7</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>656,863</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4.1</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>William W. Burke</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Jordan S. Davis<SUP>(5)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,037,150</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>11.1</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,807,210</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>11.5</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Richard Nigon<SUP>(6)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>78,281</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>81,497</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Kevin H. Roche<SUP>(7)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>198,070</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2.1</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>201,286</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.3</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Stephen I Shapiro<SUP>(8)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35,460</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>35,460</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Zubeen Shroff<SUP>(9)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,160,858</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>33.8</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,344,940</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>27.6</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Robert J. Folkes<SUP>(10)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>203,324</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2.2</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>204,639</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.3</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Bryan F. Rishe<SUP>(11)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>134,793</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>134,793</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>All executive officers and directors as a group (13&nbsp;persons)<SUP>(12)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,039,095</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>64.7</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,933,912</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>48.4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1>*</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Less
than 1%.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Galen
Partners V,&nbsp;L.P. has one general partner, Galen Partners V,&nbsp;LLC, which has sole voting and investment control over the shares of our
common stock held by Galen Partners&nbsp;V, L.P. and is the beneficial owner of the shares held by Galen Partners&nbsp;V, L.P. Galen Partners V,&nbsp;LLC has three voting partners, including
Zubeen Shroff, one of our directors, David&nbsp;W. Jahns and L.&nbsp;John Wilkerson.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Jordan
Davis, one of our directors, and Dan Lubin are the Managing Members of Radius Ventures III QP&nbsp;LP and hold the shared voting and/or dispositive
power with respect to the shares of our common stock held by Radius Ventures III QP&nbsp;LP.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Includes
78,850 shares before the offering and 123,218 shares after the offering held by Worthy Ventures Resources&nbsp;LLC, of which Mr.&nbsp;Soderberg
serves as manager, and 52,821 shares subject to options that are exercisable within 60&nbsp;days of June&nbsp;8, 2016.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(4)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Includes
27,969 shares before the offering and 35,649 shares after the offering of restricted stock that vest on the earlier of a change of control of our
company or nine months following the closing of this offering and 394,259 shares subject to options that are exercisable within 60&nbsp;days of June&nbsp;8, 2016.



<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(5)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Consists
of the shares beneficially owned by Radius Ventures III QP&nbsp;LP set forth above. Mr.&nbsp;Davis disclaims beneficial ownership of these
shares, except to the extent of his pecuniary interest therein.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(6)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Includes
2,769 shares subject to options that are exercisable within 60&nbsp;days of June&nbsp;8, 2016.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(7)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Includes
2,769 shares subject to options that are exercisable within 60&nbsp;days of June&nbsp;8, 2016.



<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(8)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Consists
entirely of shares subject to options that are exercisable within 60&nbsp;days of June&nbsp;8, 2016.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(9)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Includes
the shares beneficially owned by Galen Partners V, L.P set forth above. Mr.&nbsp;Shroff disclaims beneficial ownership of these shares, except to
the extent of his pecuniary interest therein.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(10)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Includes
4,790 shares before the offering and 6,105 shares after the offering of restricted stock that vest on the earlier of a change of control of our
company or nine months following the closing of this offering and 107,887 shares subject to options that are exercisable within 60&nbsp;days of June&nbsp;8, 2016.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(11)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Includes
52,747 shares subject to options that are exercisable within 60&nbsp;days of June&nbsp;8, 2016.


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1><SUP>(12)</SUP></FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>Includes
40,479 shares before the offering and 51,593 shares after the offering of restricted stock that vest on the earlier of a change of control of our
company or nine months following the closing of this offering and 891,688 shares subject to options that are exercisable within 60&nbsp;days of June&nbsp;8, 2016. </FONT>

</DD>

</DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>150</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=155,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=894486,FOLIO='150',FILE='DISK131:[15ZBY1.15ZBY12201]EO12201A.;71',USER='ABEAULI',CD=';8-JUN-2016;14:41' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_eq12201_1_151"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="eq12201_description_of_capital_stock"> </A>
<A NAME="toc_eq12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  DESCRIPTION OF CAPITAL STOCK    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I>The following is a description of the material provisions of our capital stock, as well as other material terms of our
amended and restated certificate of incorporation and amended and restated bylaws as they will be in effect as of the consummation of the offering. We refer you to the form of our amended and restated
certificate of incorporation and to the form of our amended and restated bylaws, copies of which have been filed as exhibits to the registration statement of which this prospectus forms&nbsp;a
part.</I></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Authorized Capital  </B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>Immediately prior to the completion of this offering and the following the filing of the amended and restated certificate of incorporation, our
authorized capital stock will
consist of (i)&nbsp;300,000,00&nbsp;shares of common stock, par value $0.001 per share, and (ii)&nbsp;50,000,00&nbsp;shares of undesignated preferred stock, par value $0.001 per share.

 </FONT>

</P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


As of June 7, 2016, there were issued and outstanding:</FONT>

</P>


<UL>
<UL>
<DL compact>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3,414,137 shares of our common stock held of record by 297&nbsp;stockholders; </FONT><FONT COLOR="#3B5A6F" SIZE=2>



<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3,190,984 shares of our Series&nbsp;A preferred stock held of record by 100&nbsp;stockholders; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,733,468 shares of our Series&nbsp;B preferred stock held of record by 21&nbsp;stockholders; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> options to purchase 1,631,280 shares of our common stock held of record by 119&nbsp;option holders; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>



<BR><BR></FONT></DD>



<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> warrants to purchase 5,800 shares of our common stock held of record by two&nbsp;warrant holders.

 </FONT></DD>

</DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


Immediately prior to the completion of this offering, all currently outstanding shares of our Series&nbsp;A and Series&nbsp;B preferred stock will be converted into shares of a single class of
common stock. Our Series&nbsp;A preferred stock will convert to common stock at a ratio of 1-for-1.03 and our Series&nbsp;B preferred stock will convert to common stock at a ratio of 1-for-1. In
addition, upon completion of this offering, (a)&nbsp;each Series&nbsp;A preferred stockholder is entitled to receive the number of common shares equal to the Series&nbsp;A original issue price
divided by the initial public offering price per share in this offering; and (b)&nbsp;each Series&nbsp;B preferred stockholder is entitled to receive the number of common shares equal to the
Series&nbsp;B preferred stock original issue price divided by the initial public offering price per share in this offering. Therefore, we expect to issue 1,569,549 additional shares of common stock
immediately prior
to the completion of this offering that our Series&nbsp;A and Series&nbsp;B preferred stockholders are entitled to receive in connection with this initial public offering, assuming an initial
offering price of $15.00 per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus. Finally, immediately prior to the completion of this
offering, each Series&nbsp;B preferred stockholder is entitled to receive the number of common shares equal to (1)&nbsp;the accrued dividends on the shares of Series&nbsp;B preferred stock
divided by the original issue price of the Series&nbsp;B preferred stock and (2)&nbsp;the accrued dividends on the shares of Series&nbsp;B preferred stock divided by the initial public offering
price per share in this offering. Therefore, we expect to issue 844,782 additional shares of common stock to pay accrued dividends on our Series&nbsp;B preferred stock (assuming a closing date of
June&nbsp;27, 2016 and an initial offering price of $15.00 per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus).

 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>151</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=156,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=100348,FOLIO='151',FILE='DISK131:[15ZBY1.15ZBY12201]EQ12201A.;53',USER='DBEMBEN',CD=';9-JUN-2016;00:24' -->
<A NAME="page_eq12201_1_152"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


Assuming the conversion of all outstanding shares of our preferred stock into shares of common stock, assuming a closing date of June&nbsp;27, 2016 and an initial offering price of $15.00 per share,
which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, immediately following the completion of this offering, we expect to have
15,752,920&nbsp;shares of common stock and no shares of preferred stock outstanding (or 16,352,980&nbsp;shares of common stock and no shares of preferred stock outstanding if the underwriters
exercise in full their option to purchase additional shares). A $1.00 decrease in the assumed initial public offering price of $15.00 per share would increase the number of additional shares of common
stock issuable in connection with the conversion of our preferred stock by 112,111&nbsp;shares. A $1.00 increase in the assumed initial public offering price of $15.00 per share would decrease the
number of additional shares of common stock issuable in connection with the conversion of our preferred stock by 98,097 shares. A $1.00 decrease in the assumed initial public offering price of $15.00
per share would increase the number of additional shares of common stock issuable in connection with paying the accrued dividends on our Series&nbsp;B preferred stock by 12,209 shares. A $1.00
increase in the assumed initial public offering price of $15.00 per share would decrease the number of additional shares of common stock issuable in connection with paying the accrued dividends on our
Series B preferred stock by 10,683 shares.

 </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Common Stock  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Pursuant to our amended and restated certificate of incorporation, holders of our common stock will be entitled to one vote on all matters submitted
to a vote of stockholders, except as otherwise expressly provided in our amended and restated certificate of incorporation or as required by applicable law. We have not provided for cumulative voting
for the election of directors. As a result, the holders of a majority of the voting shares will be able to elect all of the directors then standing for election, if they should so choose. Subject to
the rights, if any, of the holders of any outstanding series of preferred stock, holders of our common stock shall be entitled to
receive dividends out of any of our funds legally available when, as and if declared by the board of directors. Upon our liquidation, dissolution or winding-up, the holders of common stock would be
entitled to share ratably in all assets remaining after payment of all debts and other liabilities and the satisfaction of any liquidation preferences granted to the holders of outstanding shares of
preferred stock. Holders of common stock have no preemptive or conversion rights or other subscription rights. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Preferred Stock  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Immediately prior to the completion of this offering, all currently outstanding shares of our Series&nbsp;A and Series&nbsp;B preferred stock
will be converted into shares of a single class of common stock. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


Following this offering, our amended and restated certificate of incorporation provides that we may issue up to 50,000,000 shares of preferred stock in one or more series as may be determined by our
board of directors. Our board of directors has broad discretionary authority with respect to the rights of any new series of preferred stock and may establish the following with respect to the shares
in each series, without any vote or action of the stockholders:</FONT>

</P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the number of shares; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the designations, preferences and relative rights, including voting rights, dividend rights, conversion rights, redemption privileges
and liquidation preferences; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> any qualifications, limitations or restrictions. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
believe that the ability of our board of directors to issue one or more series of preferred stock will provide us with flexibility in structuring possible future financings and acquisitions, and in
meeting </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>152</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=157,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=700840,FOLIO='152',FILE='DISK131:[15ZBY1.15ZBY12201]EQ12201A.;53',USER='DBEMBEN',CD=';9-JUN-2016;00:24' -->
<A NAME="page_eq12201_1_153"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>other
corporate needs that may arise. The authorized shares of preferred stock, as well as authorized and unissued shares of common stock, will be available for issuance without action by our
stockholders, unless such action is required by applicable law or the rules of any stock exchange or automated quotation system on which our securities may be listed or traded. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
board of directors may authorize, without stockholder approval, the issuance of preferred stock with voting and conversion rights that could adversely affect the voting power and other rights of
holders of common stock. Although our board of directors has no current intention of doing so, it could issue a series of preferred stock that could, depending on the terms of such series, impede the
completion of a merger, tender offer or other takeover attempt of our company. Our board of directors could also issue preferred stock having terms that could discourage an acquisition attempt through
which an acquiror may be able to change the composition of our board of directors, including a tender offer or other transaction that some, or a majority, of our stockholders might believe to be in
their best interests or in which stockholders might receive a premium for their stock over the then-current market price. Any issuance of preferred stock therefore could have the effect of decreasing
the market price of our common stock. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
board of directors will make any determination to issue such shares based on its judgment as to the best interests of our company and stockholders. We have no current plan to issue any preferred
stock after this offering. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Registration Rights  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Following the completion of this offering, the holders of our common stock issued upon conversion of our preferred stock or their permitted
transferees are entitled to certain rights with respect to registration of these shares under the Securities Act. These rights are provided under the terms of an investors' rights agreement between us
and the holders of these shares, which was entered into in connection with our preferred stock financings, and include demand registration rights, piggyback registration rights and Form&nbsp;S-3
registration rights, subject to certain exceptions. In any registration made pursuant to such investors' rights agreement, all fees, costs and expenses of underwritten registrations will be borne by
us, and all selling expenses, including underwriting discounts and commissions, will be borne by the holders of the shares being registered, subject to certain exceptions. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
registration rights terminate three years following the completion of this offering or, with respect to any particular stockholder, at such time that the stockholder can sell all of its shares
during any three-month period pursuant to Rule&nbsp;144 of the Securities Act. </FONT></P>


<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2><B><I> Demand Registration Rights.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Following the completion of this offering, the holders of an aggregate of 8,440,399 shares of our common stock, or
their permitted
transferees, are entitled to certain demand registration rights. Under the terms of the investors' rights agreement, we will be required, upon the written request at any time more than 180&nbsp;days
after the effective date of the registration statement of which this prospectus forms&nbsp;a part of holders of at least a majority of the shares that are entitled to registration rights under the
investors' rights agreement and so long as the anticipated aggregate offering price of the shares to be offered and sold under such registration statement on Form&nbsp;S-1 is at least
$10&nbsp;million (net of underwriting discounts and commissions, stock transfer taxes and any other expenses of the such stockholders), to register, within 60&nbsp;days after receiving such
request, all of these shares plus any additional shares requested to be included in such registration requested by any other stockholders within 20&nbsp;days after notice of such registration is
mailed by us. We are required to effect only three registrations pursuant to this provision of the investors' rights agreement. We will not be required to effect a demand registration during the
period from 60&nbsp;days prior to the filing to 90&nbsp;days following the effectiveness of a registration statement relating to a public


</FONT>

</P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>153</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=158,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=140866,FOLIO='153',FILE='DISK131:[15ZBY1.15ZBY12201]EQ12201A.;53',USER='DBEMBEN',CD=';9-JUN-2016;00:24' -->
<A NAME="page_eq12201_1_154"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


offering of our securities. These registration rights are subject to specified conditions and limitations, including our ability to defer the filing of a registration statement with respect to an
exercise of such Form&nbsp;S-3 registration rights for up to 90&nbsp;days under certain circumstances.


</FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2><B><I> Piggyback Registration Rights.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Following the completion of this offering, the holders of an aggregate of 8,440,399&nbsp;shares of our common stock
or their
permitted transferees are entitled to certain piggyback registration rights. If we register any of our securities for our own account after the completion of this offering, the holders of these shares
are entitled to include their shares in the registration upon written request made within 20&nbsp;days after notice of such registration is mailed by us. Both we and the underwriters of any
underwritten offering have the right to limit the number of shares registered by these holders for marketing reasons, subject to limitations set forth in the investors' rights agreement.


</FONT>

</P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2><B><I> Form&nbsp;S-3 Registration Rights.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Following the completion of this offering, the holders of an aggregate of 8,440,399&nbsp;shares of our common
stock, or
their permitted transferees, are entitled to certain Form&nbsp;S-3 registration rights, upon the written request of the holders of at least 20% of the shares that are
entitled to registration rights under the investors' rights agreement and so long as the aggregate amount of shares to be offered and sold under such registration statement on Form&nbsp;S-3 is at
least $2.5&nbsp;million (net of underwriting discounts and commissions, stock transfer taxes and any other expenses of the such stockholders). We are only obligated to file up to two registration
statements on Form&nbsp;S-3 within a 12-month period. We will not be required to effect a demand registration during the period from 60&nbsp;days prior to the filing to 90&nbsp;days following
the effectiveness of a registration statement relating to a public offering of our securities. These registration rights are subject to specified conditions and limitations, including our ability to
defer the filing of a registration statement with respect to an exercise of such Form&nbsp;S-3 registration rights for up to 90&nbsp;days under certain circumstances.

 </FONT>

</P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Anti-Takeover Effects of Delaware Law and Our Certificate of Incorporation and Bylaws  </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Delaware Law.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;We are subject to Section&nbsp;203 of the Delaware General Corporation Law. Section&nbsp;203 generally prohibits a public Delaware
corporation
from engaging in a "business combination" with an "interested stockholder" for a period of three years after the date of the transaction in which the person became an interested stockholder,
unless:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the
transaction which resulted in the stockholder becoming an interested stockholder; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction
commenced, excluding for purposes of determining the number of shares outstanding (a)&nbsp;shares owned by persons who are directors and also officers and (b)&nbsp;shares owned by employee stock
plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> on or subsequent to the date of the transaction, the business combination is approved by the board and authorized at an annual or
special meeting of stockholders, and not by written consent, by the affirmative vote of at least two-thirds of the outstanding voting stock which is not owned by the interested stockholder. </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>154</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=159,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=602164,FOLIO='154',FILE='DISK131:[15ZBY1.15ZBY12201]EQ12201A.;53',USER='DBEMBEN',CD=';9-JUN-2016;00:24' -->
<A NAME="page_eq12201_1_155"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Section&nbsp;203
defines a business combination to include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> any merger or consolidation involving the corporation and the interested stockholder; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> any sale, transfer, pledge or other disposition involving the interested stockholder of 10% or more of the assets of the corporation; </FONT>
<FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to
the interested stockholder; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits
provided by or through the corporation. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
general, Section&nbsp;203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation or any entity or person
affiliated with or controlling or controlled by the entity or person. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A
Delaware corporation may opt out of this provision by express provision in its original certificate of incorporation or by amendment to its certificate of incorporation or bylaws approved by its
stockholders. However, we have not opted out of, and do not currently intend to opt out of, this provision. The statute could prohibit or delay mergers or other takeover or change in control attempts
and, accordingly, may discourage attempts to acquire us. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Provisions of our amended and restated certificate of
incorporation and amended
and restated bylaws, each of which will become effective upon completion of this offering, may delay or discourage transactions involving an actual or potential change in control of our company or
change in our management, including transactions in which stockholders might otherwise receive a premium for their shares, or transactions that our stockholders might otherwise deem to be in their
best interests. Therefore, these provisions could adversely affect the price of our common stock. Among other things, our amended and restated certificate of incorporation and amended and restated
bylaws:</FONT></P>


<UL>
<UL>
<DL compact>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> permit our board of directors to issue up to 50,000,000&nbsp;shares of preferred stock, with any rights, preferences and privileges
as they may designate, including the right to approve an acquisition or other change in our control; </FONT><FONT COLOR="#3B5A6F" SIZE=2>


<BR><BR></FONT></DD>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> provide that the authorized number of directors may be changed by resolution of the board of directors; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> provide that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the
affirmative vote of a majority of directors then in office, even if less than a quorum; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> provide that directors may only be removed for cause by the holders of at least three-fourths of the voting power of the shares
eligible to vote for directors; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> provide that a special meeting of stockholders may be called only by our chief executive officer, the chairman of our board of
directors or by a resolution adopted by a majority of our board of directors; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>155</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=160,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=661050,FOLIO='155',FILE='DISK131:[15ZBY1.15ZBY12201]EQ12201A.;53',USER='DBEMBEN',CD=';9-JUN-2016;00:24' -->
<A NAME="page_eq12201_1_156"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> require that any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders
and not be taken by written consent; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> provide that our by-laws may be amended or repealed by a majority vote of our board of directors or the affirmative vote of the
holders of at least two-thirds of the votes that all our stockholders would be entitled to cast in an election of directors; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> provide that stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as
directors at a meeting of stockholders must provide notice in writing in a timely manner, and also specify requirements as to the form and content of a stockholder's notice; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> do not provide for cumulative voting rights (therefore allowing the holders of a majority of the shares of common stock entitled to
vote in any election of directors to elect all of the directors standing for election, if they should so choose). </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
amended and restated certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, any or all internal corporate claims, which shall include
claims, including claims in the right of our company, (i)&nbsp;that are based upon a violation of a duty by a current
or former director or officer or stockholder in such capacity, or (ii)&nbsp;as to which Title 8 of the Delaware General Corporation Law confers jurisdiction upon the Delaware Court of Chancery,
shall be brought solely and exclusively in a state court located within the State of Delaware (or, if no state court located in the State of Delaware has jurisdiction, the federal district court for
the District of Delaware). It is possible that a court of law could rule that the choice of forum provision contained in our certificate of incorporation is inapplicable or unenforceable if it is
challenged in a proceeding or otherwise. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
amendment of any of the above provisions, except for the provision making it possible for our board of directors to issue preferred stock and the provision prohibiting cumulative voting, would
require approval by holders of at least two-thirds in voting power of the outstanding shares of stock entitled to vote thereon. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Limitation on Liability of Directors and Indemnification.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Our amended and restated certificate of incorporation limits the liability of our
directors to the
fullest extent permitted by Delaware law. Delaware law provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors,
except for liability for any:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> breach of their duty of loyalty to us or our stockholders; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> unlawful payment of dividends or unlawful stock repurchases or redemption of shares as provided in Section&nbsp;174 of the Delaware
General Corporation Law; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> transaction from which the directors derived an improper personal benefit. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>These
limitations of liability do not apply to liabilities arising under federal securities laws and do not affect the availability of equitable remedies such as injunctive relief or rescission. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


Our amended and restated bylaws, in the form that will become effective upon the completion of this offering, provide that we will indemnify and advance expenses to our directors and officers to the

 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>156</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=161,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=808467,FOLIO='156',FILE='DISK131:[15ZBY1.15ZBY12201]EQ12201A.;53',USER='DBEMBEN',CD=';9-JUN-2016;00:24' -->
<A NAME="page_eq12201_1_157"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


fullest extent permitted by law or, if applicable, pursuant to indemnification agreements. They further provide that we may choose to indemnify other employees or agents of the corporation from time
to time. Section&nbsp;145(g) of the Delaware General Corporation Law, our amended and restated certificate of incorporation and our bylaws also permit us to secure insurance on behalf of any
officer, director, employee or other agent for any liability arising out of his or her actions in connection with their services to us, regardless of whether the Delaware General Corporation Law
permits indemnification. We intend to obtain a directors' and officers' liability insurance policy prior to the completion of this offering.

 </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


We will enter into separate indemnification agreements with our directors and officers, in addition to the indemnification provisions set forth in our amended and restated certificate of incorporation
and bylaws. These agreements, among other things, will require us to indemnify our directors and officers for certain expenses, including attorneys' fees, judgments, fines and settlement amounts
incurred by a director or officer in any action or proceeding arising out of his or her services as one of our directors or officers, including services provided to any subsidiary or any other company
or enterprise to which the person provides services at our request.

 </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>At
present, there is no pending litigation or proceeding involving any of our directors or officers as to which indemnification is required or permitted, and we are not aware of any threatened
litigation or proceeding that may result in a claim for indemnification. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of ours pursuant to the foregoing provisions, or otherwise,
in the opinion of the SEC, this indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Transfer Agent and Registrar  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The transfer agent and registrar for our common stock is Computershare Trust Company, N.A. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock Exchange Listing  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have applied to have our common stock listed on The NASDAQ Global Market under the symbol "TCMD." </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>157</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=162,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=55775,FOLIO='157',FILE='DISK131:[15ZBY1.15ZBY12201]EQ12201A.;53',USER='DBEMBEN',CD=';9-JUN-2016;00:24' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_es12201_1_158"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="es12201_shares_eligible_for_future_sale"> </A>
<A NAME="toc_es12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  SHARES ELIGIBLE FOR FUTURE SALE    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Prior to this offering, there was no public market for our common stock. We cannot predict the effect, if any, that market sales of shares of our
common stock or the availability of shares of our common stock for sale will have on the market price of our common stock. Sales of substantial amounts of our common stock in the public market could
adversely affect the market prices of our common stock and could impair our future ability to raise capital through the sale of our equity securities. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


Based on our outstanding shares as of June&nbsp;8, 2016, and assuming (a)&nbsp;the issuance of 4,000,000 shares of common stock in this offering; (b)&nbsp;the conversion of all outstanding
shares of our preferred stock into an aggregate 5,924,452 shares of common stock immediately prior to the completion of this offering; (c)&nbsp;the issuance of 1,569,549 additional shares of common
stock immediately prior to the completion of this offering issuable in connection with the conversion of our preferred stock; and (d)&nbsp;the issuance of 844,782 shares of common stock immediately
prior to the completion of this offering to pay accrued dividends on our Series&nbsp;B preferred stock (assuming a closing date of June&nbsp;27, 2016), upon completion of this offering, we will
have outstanding a total of 15,752,920 shares of our common stock (or 16,352,920 shares if the underwriters' option to purchase additional shares is exercised in full). Of these shares, all of the
shares sold in this offering (plus any shares sold as a result
of the underwriters' exercise of their option) will be freely tradable without restriction or further registration under the Securities Act, unless those shares are purchased by our affiliates as that
term is defined in Rule&nbsp;144 under the Securities Act.

 </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


The remaining 11,752,920 shares of common stock to be outstanding after this offering will be "restricted securities" under Rule&nbsp;144. Of these restricted securities, 11,195,133 shares will be
subject to transfer restrictions for 180&nbsp;days from the date of this prospectus pursuant to lock-up agreements. Restricted securities may be sold in the public market only if they have been
registered or if they qualify for an exemption from registration under Rules&nbsp;144 or 701 or otherwise under the Securities Act.

 </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Lock-up Agreements  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our officers and directors and other holders of substantially all of our outstanding common stock, preferred stock, options and warrants are subject
to lock-up agreements pursuant to which they have agreed, subject to limited exceptions, not to offer, sell, or otherwise transfer or dispose of, directly or indirectly, any shares of common stock or
securities convertible into or exchangeable or exercisable for shares of common stock for a period of 180&nbsp;days from the date of this prospectus without the prior written consent of Piper
Jaffray&nbsp;&amp;&nbsp;Co. and William Blair&nbsp;&amp; Company, L.L.C. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Rule&nbsp;144  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Affiliate resales of restricted securities.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In general, beginning 90&nbsp;days after the effective date of the registration statement of which
this prospectus is
a part, a person who is an affiliate of ours, or who was an affiliate at any time during the three months before a sale, who has beneficially owned shares of our common stock for at least six months
would be entitled to sell in "broker's transactions" or certain "riskless principal transactions" or to market makers, a number of shares within any three-month period that does not exceed the greater
of:</FONT></P>



<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1% of the number of shares of our common stock then outstanding, which will equal approximately 157,530 shares immediately after this
offering; or

</FONT></DD></DL>
</UL>
</UL>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>158</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=163,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1042103,FOLIO='158',FILE='DISK131:[15ZBY1.15ZBY12201]ES12201A.;40',USER='JFUSS',CD=';8-JUN-2016;14:32' -->
<A NAME="page_es12201_1_159"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>



<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the average weekly trading volume in our common stock on the NASDAQ Global Market during the four calendar weeks preceding the filing
of a notice on Form&nbsp;144 with respect to such sale.

</FONT></DD></DL>
</UL>
</UL>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Affiliate
resales under Rule&nbsp;144 also are subject to the availability of current public information about us. In addition, if the number of shares being sold under Rule&nbsp;144 by an
affiliate during any three-month period exceeds 5,000 shares or has an aggregate sale price in excess of $50,000, the seller must file&nbsp;a notice on Form&nbsp;144 with the SEC and NASDAQ
concurrently with either the placing of a sale order with the broker or the execution directly with a market maker. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Non-affiliate resales of restricted securities.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In general, beginning 90&nbsp;days after the effective date of the registration statement of
which this
prospectus is a part, a person who is not an affiliate of ours at the time of sale, and has not been an affiliate at any time during the three months preceding a sale, and who has beneficially owned
shares of our common stock for at least six months but less than a year, is entitled to sell such shares subject only to the availability of current public information about us. If such person has
held our shares for at least one year, such person can resell under Rule&nbsp;144(b)(1) without regard to any Rule&nbsp;144 restrictions, including the 90-day public company requirement and the
current public information requirement. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Non-affiliate
resales are not subject to the manner of sale, volume limitation or notice filing provisions of Rule&nbsp;144. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Rule&nbsp;701  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In general, under Rule&nbsp;701, any of an issuer's employees, directors, officers, consultants or advisors who purchases shares from the issuer in
connection with a compensatory stock or option plan or other written agreement before the effective date of a registration statement under the Securities Act is entitled to sell such shares
90&nbsp;days after such effective date in reliance on Rule&nbsp;144. An affiliate of the issuer can resell shares in reliance on Rule&nbsp;144 without having to comply with the holding period
requirement, and non-affiliates of the issuer can resell shares in reliance on Rule&nbsp;144 without having to comply with the current public information and holding period requirements. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
SEC has indicated that Rule&nbsp;701 will apply to typical stock options granted by an issuer before it becomes subject to the reporting requirements of the Exchange Act, along with the shares
acquired upon exercise of such options, including exercises after an issuer becomes subject to the reporting requirements of the Exchange Act. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Equity Plans  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We intend to file one or more registration statements on Form&nbsp;S-8 under the Securities Act to register all shares of common stock subject to
outstanding stock options and shares of common stock issued or issuable under our stock plans. We expect to file the registration statement covering shares offered pursuant to our stock plans on or
shortly after the date of this prospectus, permitting the resale of such shares by non-affiliates in the public market without restriction under the Securities Act and the sale by affiliates in the
public market, subject to compliance with the resale provisions of Rule&nbsp;144. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Registration Rights  </B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>After the completion of this offering, holders of 8,440,399 shares of common stock will be entitled to specific rights to register those shares for
sale in the public market. See "Description of Capital Stock&nbsp;&#151; Registration Rights." Registration of these shares under the Securities Act would result in the shares becoming freely
tradable without restriction under the Securities Act, except for shares purchased by affiliates, immediately upon the effectiveness of the registration statement relating to such shares.

 </FONT>

</P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>159</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=164,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=959534,FOLIO='159',FILE='DISK131:[15ZBY1.15ZBY12201]ES12201A.;40',USER='JFUSS',CD=';8-JUN-2016;14:32' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_eu12201_1_160"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="eu12201_material_u.s._federal_income_t__mat02369"> </A>
<A NAME="toc_eu12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following discussion is a summary of the material U.S. federal income tax consequences to non-U.S. holders (as defined below) of the purchase,
ownership and disposition of our common stock issued pursuant to this offering, but does not purport to be a complete analysis of all potential tax effects. The effects of other U.S. federal tax laws,
such as estate and gift tax laws, and any applicable state, local or foreign tax laws are not discussed. This discussion is based on the U.S. Internal Revenue Code of 1986, as amended, or the Code,
Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the U.S. Internal Revenue Service, or the IRS, in effect as of the date of
this offering. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect
a non-U.S. holder of our common stock. We have not sought and will not seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a
contrary position regarding the tax consequences of the purchase, ownership and disposition of our common stock. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>This
discussion is limited to non-U.S. holders that hold our common stock as a "capital asset" within the meaning of Section&nbsp;1221 of the Code (generally, property held for investment). This
discussion does not address all U.S. federal income tax consequences relevant to a non-U.S. holder's particular circumstances, including the impact of the Medicare contribution tax on net investment
income. In addition, it does not address consequences relevant to non-U.S. holders subject to particular rules, including, without limitation:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> U.S. expatriates and certain former citizens or long-term residents of the United States; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> persons subject to the alternative minimum tax; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> persons holding our common stock as part of a hedge, straddle or other risk reduction strategy or as part of a conversion transaction
or other integrated investment; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> banks, insurance companies, and other financial institutions; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> real estate investment trusts or regulated investment companies; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> brokers, dealers or traders in securities or currencies; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> "controlled foreign corporations," "passive foreign investment companies" and corporations that accumulate earnings to avoid U.S.
federal income tax; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> S corporations, partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes, or
investors in any such entities; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> tax-exempt organizations or governmental organizations; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> persons for whom our common stock constitutes "qualified small business stock" within the meaning of Section&nbsp;1202 of the Code; </FONT> <FONT
COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> persons who hold or receive our common stock pursuant to the exercise of any employee stock option or otherwise as compensation;
</FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>160</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=165,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=623070,FOLIO='160',FILE='DISK131:[15ZBY1.15ZBY12201]EU12201A.;27',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_eu12201_1_161"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> persons deemed to sell our common stock under the constructive sale provisions of the Code; and </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> tax-qualified retirement plans. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>If
a partnership (or other entity treated as a partnership for U.S. federal income tax purposes) holds our common stock, the tax treatment of a partner in the partnership will depend on the status of
the partner, the activities of the partnership and certain determinations made at the partner level. Accordingly, partnerships holding our common stock and the partners in such partnerships should
consult their tax advisors regarding the U.S. federal income tax consequences to them of the purchase, ownership and disposition of our common stock. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>THIS DISCUSSION IS FOR INFORMATION PURPOSES ONLY AND IS NOT INTENDED AS TAX ADVICE. INVESTORS SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S.
FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR COMMON STOCK ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX
LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Definition of a Non-U.S. Holder  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For purposes of this discussion, a "non-U.S. holder" is any beneficial owner of our common stock that is not a "U.S. person," a partnership, or an
entity disregarded as separate from its owner, each for United States federal income tax purposes. A U.S. person is any of the following:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> an individual who is a citizen or resident of the United States; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) created or organized under the laws of
the United States, any state thereof, or the District of Columbia; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> an estate, the income of which is subject to U.S. federal income tax regardless of its source; or </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> a trust that (i)&nbsp;is subject to the primary supervision of a U.S. court and the control of one or more United States persons
(within the meaning of Section&nbsp;7701(a)(30) of the Code), or (ii)&nbsp;has made a valid election under applicable Treasury Regulations to continue to be treated as a United States person. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Distributions  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As described in "Dividend Policy," we do not anticipate declaring or paying dividends to holders of our common stock in the foreseeable future.
However, if we do make distributions on our common stock, such distributions of cash or property on our common stock will constitute dividends for U.S. federal income tax purposes to the extent paid
from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Amounts not treated as dividends for U.S. federal income tax purposes will constitute a
return of capital and first be applied against and reduce a non-U.S. holder's adjusted tax basis in its common stock, but not below zero. Any excess will be treated as capital gain and will be treated
as described below in "&#151;&nbsp;Sale or Other Taxable Disposition." </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>161</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=166,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=645284,FOLIO='161',FILE='DISK131:[15ZBY1.15ZBY12201]EU12201A.;27',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_eu12201_1_162"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Subject
to the discussion below on backup withholding and foreign accounts, dividends paid to a non-U.S. holder of our common stock that are not effectively connected with the non-U.S. holder's
conduct of a trade or business within the United States will be subject to U.S. federal withholding tax at a rate of 30% of the gross amount of the dividends (or such lower rate specified by an
applicable income tax treaty). </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Non-U.S.
holders may be entitled to a reduction in or an exemption from withholding on dividends as a result of either (a)&nbsp;an applicable income tax treaty or (b)&nbsp;the non-U.S. holder
holding our common stock in connection with the conduct of a trade or business within the United States and dividends being paid in connection with that trade or business. To claim such a reduction in
or exemption from withholding, the non-U.S. holder must provide the applicable withholding agent with a properly executed (a)&nbsp;IRS Form&nbsp;W-8BEN or W-8BEN-E claiming an exemption from or
reduction of the
withholding tax under the benefit of an income tax treaty between the United States and the country in which the non-U.S. holder resides or is established, or (b)&nbsp;IRS Form&nbsp;W-8ECI stating
that the dividends are not subject to withholding tax because they are effectively connected with the conduct by the non-U.S. holder of a trade or business within the United States, as may be
applicable. These certifications must be provided to the applicable withholding agent prior to the payment of dividends and must be updated periodically. Non-U.S. holders that do not timely provide
the applicable withholding agent with the required certification, but that qualify for a reduced rate under an applicable income tax treaty, may obtain a refund of any excess amounts withheld by
timely filing an appropriate claim for refund with the IRS. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Subject
to the discussions below on backup withholding and foreign accounts, if dividends paid to a non-U.S. holder are effectively connected with the non-U.S. holder's conduct of a trade or business
within the United States (and, if required by an applicable income tax treaty, the non-U.S. holder maintains a permanent establishment in the United States to which such dividends are attributable),
then, although exempt from U.S. federal withholding tax (provided the non-U.S. holder provides appropriate certification, as described above), the non-U.S. holder will be subject to U.S. federal
income tax on such dividends on a net income basis at the regular graduated U.S. federal income tax rates. In addition, a non-U.S. holder that is a corporation may be subject to a branch profits tax
at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on its effectively connected earnings and profits for the taxable year that are attributable to such dividends, as
adjusted for certain items. Non-U.S. holders should consult their tax advisors regarding their entitlement to benefits under any applicable income tax treaty. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Sale or Other Taxable Disposition  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Subject to the discussions below on backup withholding and foreign accounts, a non-U.S. holder will not be subject to U.S. federal income tax on any
gain realized upon the sale or other disposition of our common stock unless:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the gain is effectively connected with the non-U.S. holder's conduct of a trade or business within the United States (and, if required
by an applicable income tax treaty, the non-U.S. holder maintains a permanent establishment in the United States to which such gain is attributable); </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the non-U.S. holder is a nonresident alien individual present in the United States for 183&nbsp;days or more during the taxable year
of the disposition and certain other requirements are met; or </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>162</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=167,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=807452,FOLIO='162',FILE='DISK131:[15ZBY1.15ZBY12201]EU12201A.;27',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_eu12201_1_163"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our common stock constitutes a United States real property interest, or USRPI, by reason of our status as a United States real
property holding corporation, or a USRPHC, for U.S. federal income tax purposes. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Gain
described in the first bullet point above will generally be subject to U.S. federal income tax on a net income basis at the regular graduated U.S. federal income tax rates. A non-U.S. holder that
is a foreign corporation may also be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) of a portion of its effectively connected
earnings and profits for the taxable year, as adjusted for certain items. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A
non-U.S. holder described in the second bullet point above will be subject to U.S. federal income tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on any gain
derived from the disposition, which may be offset by certain U.S. source capital losses of the non-U.S. holder (even though the individual is not considered a resident of the United States) provided
the non-U.S. holder has timely filed U.S. federal income tax returns with respect to such losses. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>With
respect to the third bullet point above, we believe we are not currently and do not anticipate becoming a USRPHC. Because the determination of whether we are a USRPHC depends on the fair market
value of our USRPIs relative to the fair market value of our other business assets and our non-U.S. real property interests, however, there can be no assurance we are not a USRPHC or will not become
one in the future. Even if we are or were to become a USRPHC, gain arising from the sale or other taxable disposition by a non-U.S. holder of our common stock will not be subject to U.S. federal
income tax if such class of stock is "regularly traded," as defined by applicable Treasury Regulations, on an established securities market, and such non-U.S. holder owned, actually or constructively,
5% or less of such class of our stock throughout the shorter of the five-year period ending on the date of the sale or other disposition or the non-U.S. holder's holding period for such stock. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Non-U.S.
holders should consult their tax advisors regarding potentially applicable income tax treaties that may provide for different rules. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Information Reporting and Backup Withholding  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Subject to the discussion below on foreign accounts, a non-U.S. holder will not be subject to backup withholding with respect to payments of
dividends on our common stock we make to the non-U.S. holder, provided the applicable withholding agent does not have actual knowledge or reason to know such holder is a United States person and the
holder certifies its non-U.S. status, such as by providing a valid IRS Form&nbsp;W-8BEN, W-8BEN-E or W-8ECI, or other applicable certification. However, information returns will be filed with the
IRS in connection with any dividends on our common stock paid to the non-U.S. holder, regardless of whether any tax was actually withheld. Copies of these information returns may also be made
available under the provisions of a specific treaty or agreement to the tax authorities of the country in which the non-U.S. holder resides or is established. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Information
reporting and backup withholding may apply to the proceeds of a sale of our common stock within the United States, and information reporting may (although backup withholding generally will
not) apply to the proceeds of a sale of our common stock outside the United States conducted through certain U.S.-related financial intermediaries, in each case, unless the beneficial owner certifies
under penalty of perjury that it is a non-U.S. holder on IRS Form&nbsp;W-8BEN, W-8BEN-E or other applicable form (and the payer does not have actual knowledge or reason to know that the beneficial
owner is a U.S. person) or such owner otherwise establishes an exemption. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>163</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=168,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=161131,FOLIO='163',FILE='DISK131:[15ZBY1.15ZBY12201]EU12201A.;27',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_eu12201_1_164"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Backup
withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit against a non-U.S. holder's U.S. federal income tax
liability, provided the required information is timely furnished to the IRS. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Additional Withholding Tax on Payments Made to Foreign Accounts  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Withholding taxes may be imposed under the Foreign Account Tax Compliance Act, or FATCA, on certain types of payments made to non-U.S. financial
institutions and certain other non-U.S. entities. Specifically, a 30% withholding tax may be imposed on dividends on, or gross proceeds from the sale or other disposition of, our common stock paid to
a "foreign financial
institution" or a "non-financial foreign entity" (each as defined in the Code), unless (i)&nbsp;the foreign financial institution undertakes certain diligence and reporting obligations,
(ii)&nbsp;the non-financial foreign entity either certifies it does not have any "substantial United States owners" (as defined in the Code) or furnishes identifying information regarding each
substantial United States owner, or (iii)&nbsp;the foreign financial institution or non-financial foreign entity otherwise qualifies for an exemption from these rules. If the payee is a foreign
financial institution and is subject to the diligence and reporting requirements in (i)&nbsp;above, it must enter into an agreement with the U.S. Department of the Treasury requiring, among other
things, that it undertake to identify accounts held by certain "specified United States persons" or "United States-owned foreign entities" (each as defined in the Code), annually report certain
information about such accounts, and withhold 30% on certain payments to non-compliant foreign financial institutions and certain other account holders. Foreign financial institutions located in
jurisdictions that have an intergovernmental agreement with the United States governing FATCA may be subject to different rules. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
withholding provisions described above will generally apply to payments of dividends made any time and to payments of gross proceeds from a sale or other disposition of stock on or after
January&nbsp;1, 2019. Because we may not know the extent to which a distribution is a dividend for U.S. federal income tax purposes at the time it is made, for purposes of these withholding rules we
may treat the entire distribution as a dividend. Prospective investors should consult their tax advisors regarding these withholding provisions. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>164</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=169,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=403321,FOLIO='164',FILE='DISK131:[15ZBY1.15ZBY12201]EU12201A.;27',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ew12201_1_165"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ew12201_underwriting"> </A>
<A NAME="toc_ew12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  UNDERWRITING    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Piper Jaffray&nbsp;&amp;&nbsp;Co. and William Blair&nbsp;&amp; Company, L.L.C. are acting as representatives of each of the underwriters named below.
Subject to the terms and conditions set forth in an underwriting agreement among us and the underwriters, we have agreed to sell to the underwriters, and each of the underwriters has agreed, severally
and not jointly, to purchase from us, the number of shares of our common stock set forth opposite its name below. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:65%;margin-left:17%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:46pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Underwriters

<!-- COMMAND=ADD_SCROPPEDRULE,46pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number<BR>
of Shares </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2> Piper Jaffray&nbsp;&amp;&nbsp;Co.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>William Blair&nbsp;&amp; Company, L.L.C.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Canaccord Genuity Inc.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>BTIG, LLC</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 </TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,000,000</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 <font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 <font></FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Subject
to the terms and conditions set forth in the underwriting agreement, the underwriters have agreed, severally and not jointly, to purchase all of the shares sold under the underwriting
agreement if any of these shares are purchased. If an underwriter defaults, the underwriting agreement provides that the purchase commitments of the non-defaulting underwriters may be increased or the
underwriting agreement may be terminated. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
have agreed to indemnify the several underwriters against certain liabilities, including liabilities under the Securities Act relating to losses or claims resulting from material misstatements in
or omissions from this prospectus, the registration statement of which this prospectus is a part, certain free writing prospectuses that may be used in the offering and in any marketing materials used
in connection with this offering and to contribute to payments the underwriters may be required to make in respect of those liabilities. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
underwriters are offering the shares, subject to prior sale, when, as and if issued to and accepted by them, subject to approval of legal matters by their counsel, including the validity of the
shares, and
other conditions contained in the underwriting agreement, such as the receipt by the underwriters of officers' certificates and legal opinions. The underwriters reserve the right to withdraw, cancel
or modify offers to the public and to reject orders in whole or in part. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Commissions and Discounts  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The representatives have advised us that the underwriters propose initially to offer the shares to the public at the public offering price set forth
on the cover page of this prospectus and to dealers at that price less a concession not in excess of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. After the initial offering, the public offering price,
concession or
any other term of this offering may be changed. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table shows the public offering price, underwriting discounts and commissions and proceeds before expenses to us. The information assumes either no exercise or full exercise by the
underwriters of their option to purchase additional shares to cover overallotments, if any. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:65%;margin-left:17%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="75pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Per Share </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Without Option </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>With Option </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Public offering price</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Underwriting discounts and commissions</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Proceeds, before expenses, to us</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>165</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=170,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=850707,FOLIO='165',FILE='DISK131:[15ZBY1.15ZBY12201]EW12201A.;55',USER='DSCHWAR',CD=';8-JUN-2016;17:15' -->
<A NAME="page_ew12201_1_166"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


The estimated offering expenses payable by us, exclusive of the underwriting discounts and commissions, are approximately $2.5&nbsp;million, which includes legal, accounting and printing costs and
various other fees associated with the registration and listing of our common stock. We have also agreed to reimburse the underwriters for certain expenses, including an amount not to exceed $50,000
in connection with the clearance of this offering with the Financial Industry Regulatory Authority, as set forth in the underwriting agreement.

 </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Option to Purchase Additional Shares  </B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>The underwriters have an option, exercisable for 30&nbsp;days from the date of this prospectus, to purchase up to 600,000 additional shares of
common stock from us at the public offering price listed on the cover page of this prospectus, less the underwriting discounts and commissions. The underwriters may exercise this option solely for the
purpose of covering
over-allotments, if any, made in connection with the offering of the shares of common stock offered by this prospectus. To the extent the option is exercised, each underwriter will become obligated,
subject to certain conditions, to purchase about the same percentage of the additional shares of common stock as the number listed next to the underwriter's name in the preceding table bears to the
total number of shares of common stock listed next to the names of all underwriters in the preceding table.

 </FONT>

</P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


No Sales of Similar Securities  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We, our executive officers and directors and substantially all of our other stockholders, optionholders and warrantholders have agreed not to sell or
transfer any shares of our common stock or securities convertible into, exchangeable or exercisable for, or that represent the right to receive shares of our common stock, for 180&nbsp;days after
the date of the prospectus used to sell our common stock without first obtaining the written consent of Piper Jaffray&nbsp;&amp;&nbsp;Co. and William Blair&nbsp;&amp; Company, L.L.C. Specifically, we
and these other persons have agreed, with certain limited exceptions, not to directly or indirectly:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> offer, pledge, announce the intention to sell, sell or contract to sell any shares of our common stock; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> sell any option or contract to purchase any shares of our common stock; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> purchase any option or contract to sell any shares of our common stock; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> grant any option, right or warrant to purchase any shares of our common stock; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> make any short sale or otherwise transfer or dispose of any shares of our common stock; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> enter into any swap or other agreement that transfers, in whole or in part, the economic consequences of ownership of any shares of
our common stock whether any such swap or transaction is to be settled by delivery of shares or other securities, in cash or otherwise; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> demand that we file&nbsp;a registration statement related to our common stock. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
restrictions in the preceding paragraph do not apply to transfers of securities:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> as a bona fide gift or gifts; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>166</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=171,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=957856,FOLIO='166',FILE='DISK131:[15ZBY1.15ZBY12201]EW12201A.;55',USER='DSCHWAR',CD=';8-JUN-2016;17:15' -->
<A NAME="page_ew12201_1_167"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> to an immediate family member or any trust for the direct or indirect benefit of the stockholder or an immediate family member of the
stockholder; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> if the stockholder is a corporation, partnership, limited liability company, trust or other business entity (i)&nbsp;transfers to
another corporation, partnership, limited liability company, trust or other business entity that is a direct or indirect affiliate of the stockholder or (ii)&nbsp;distributions of shares of our
common stock to limited partners, limited liability company members or stockholders of the stockholder; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> if the stockholder is a trust, to the beneficiary of such trust; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> by testate succession or intestate succession; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> pursuant to the underwriting agreement; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> pursuant to a "change of control" of our company; </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>provided,
in the case of a transfer described in bullets one through five above, that such transfer does not involve a disposition for value, and each transferee agrees to be subject to the
restrictions described in the immediately preceding paragraph and that no filing by any party under Section&nbsp;16(a) of the Exchange Act, shall be required or shall be made voluntarily in
connection with such transfer. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
addition, the transfer restrictions described above do not apply to:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the exercise of stock options granted pursuant to our equity incentive plans or warrants described in this prospectus, provided that
the exercise does not require a filing under Section&nbsp;16(a) of the Exchange Act; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the establishment of any 10b5-1 plan, provided that no sales of the stockholders' common stock will be made under such plans for
180&nbsp;days after the date of this prospectus; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> any transfers to our company in a transaction exemption from Section&nbsp;16(b) of the Exchange Act to satisfy tax withholding
obligations pursuant to our equity incentive plans or arrangements, provided that any such transfer does not require a filing under Section&nbsp;16(a) of the Exchange Act. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Listing  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have applied to list our common stock on The NASDAQ Global Market under the symbol "TCMD." In order to meet the requirements for listing on that
exchange, the underwriters have undertaken to sell a minimum number of shares to a minimum number of beneficial owners as required by that exchange. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Before
this offering, there has been no public market for our common stock. The initial public offering price will be determined through negotiations among us and the representatives. In addition to
prevailing market conditions, the factors to be considered in determining the initial public offering price include:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> our financial information; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the history of, and the prospects for, our company and the industry in which we compete; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>167</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=172,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=412837,FOLIO='167',FILE='DISK131:[15ZBY1.15ZBY12201]EW12201A.;55',USER='DSCHWAR',CD=';8-JUN-2016;17:15' -->
<A NAME="page_ew12201_1_168"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> an assessment of our management, its past and present operations and the prospects for, and timing of, our future revenues; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the present state of our development; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the valuation multiples of publicly traded companies that the representatives believe to be comparable to us; and </FONT> <FONT COLOR="#3B5A6F"
SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the above factors in relation to market values and various valuation measures of other companies engaged in activities similar to
ours. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>An
active trading market for the shares may not develop. It is also possible that after this offering the shares will not trade in the public market at or above the initial public offering price. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
underwriters have informed us that they do not intend sales to discretionary accounts to exceed 5% of the total number of shares of common stock offered by them. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Price Stabilization, Short Positions and Penalty Bids  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Until the distribution of the shares is completed, SEC rules may limit underwriters and selling group members from bidding for and purchasing shares
of our common stock. However, the representatives may engage in transactions that stabilize the price of our common stock, such as bids or purchases to peg, fix or maintain that price. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
connection with this offering, the underwriters may purchase and sell shares of our common stock in the open market. These transactions may include short sales, purchases on the open market to
cover positions created by short sales and stabilizing transactions. Short sales involve the sale by the underwriters of a greater number of shares than they are required to purchase in this offering.
"Covered" short sales are sales made in an amount not greater than the underwriters' overallotment option described above. The underwriters may close out any covered short position by either
exercising their overallotment option or purchasing shares in the open market. In determining the source of shares to close out the covered short position, the underwriters will consider, among other
things, the price of shares available for purchase in the open market as compared to the price at which they may purchase shares through the overallotment option. "Naked" short sales are sales in
excess of the overallotment option. The underwriters must close out any naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the
underwriters are concerned that there may be downward pressure on the price of our common stock in the open market after pricing that could adversely affect investors who purchase in this offering.
Stabilizing transactions consist of various bids for or purchases of shares of our common stock made by the underwriters in the open market prior to the completion of this offering. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
underwriters may also impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discounts and commissions received by it because the
representatives have repurchased shares sold by or for the account of such underwriter in stabilizing or short covering transactions. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Similar
to other purchase transactions, the underwriters' purchases to cover the syndicate short sales may have the effect of raising or maintaining the market price of our common stock or preventing
or retarding a decline in the market price of our common stock. As a result, the price of our common stock may be higher than the price that might otherwise exist in the open market. The underwriters </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>168</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=173,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=295833,FOLIO='168',FILE='DISK131:[15ZBY1.15ZBY12201]EW12201A.;55',USER='DSCHWAR',CD=';8-JUN-2016;17:15' -->
<A NAME="page_ew12201_1_169"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>may
conduct these transactions on The NASDAQ Global Market, in the over-the-counter market or otherwise. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Neither
we nor any of the underwriters make any representation or prediction as to the direction or magnitude of any effect that the transactions described above may have on the price of our common
stock. In addition, neither we nor any of the underwriters make any representation that the representatives will engage in these transactions or that these transactions, once commenced, will not be
discontinued without notice. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Electronic Offer, Sale and Distribution of Shares  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In connection with this offering, certain of the underwriters or securities dealers may distribute prospectuses by electronic means, such as e-mail.
In addition, one or more of the underwriters may facilitate Internet distribution for this offering to certain of their Internet subscription customers. Any such underwriter may allocate a limited
number of shares for sale to its online brokerage customers. An electronic prospectus is available on the Internet websites maintained by any such underwriter. Other than the prospectus in electronic
format, the information on the websites of any such underwriter is not part of this prospectus. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Relationships  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include securities
trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. Certain of the
underwriters and their affiliates have engaged in, and may in the future engage in, investment banking and other commercial dealings in the ordinary course of business with us or our affiliates. They
have received, or may in the future receive, customary fees and commissions for these transactions. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
the ordinary course of their various business activities, the underwriters and their respective affiliates may make or hold a broad array of investments and actively trade debt and equity
securities
(or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers, and such investment and securities activities may
involve securities and/or instruments of the issuer. The underwriters and their respective affiliates may also make investment recommendations and/or publish or express independent research views in
respect of such securities or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Selling Restrictions  </B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2><B><I> Canada.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in
National
Instrument&nbsp;45&nbsp;106 Prospectus Exemptions or subsection&nbsp;73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument&nbsp;31&nbsp;103
Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the shares must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus
requirements of applicable securities laws.

 </FONT>

</P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a
misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser's province or
territory. The

</FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>169</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=174,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=203836,FOLIO='169',FILE='DISK131:[15ZBY1.15ZBY12201]EW12201A.;55',USER='DSCHWAR',CD=';8-JUN-2016;17:15' -->
<A NAME="page_ew12201_1_170"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


purchaser should refer to any applicable provisions of the securities legislation of the purchaser's province or territory for particulars of these rights or consult with a legal advisor.


</FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


Pursuant to section&nbsp;3A.3 of National Instrument&nbsp;33&nbsp;105 Underwriting Conflicts (NI&nbsp;33&nbsp;105), the underwriters are not required to comply with the disclosure
requirements of NI&nbsp;33&nbsp;105 regarding underwriter conflicts of interest in connection with this offering.

 </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> European Economic Area.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (each, a
"Relevant Member
State") an offer to the public of any shares of our common stock may not be made in that Relevant Member State, except that an offer to the public in that Relevant Member State of any shares of our
common stock may be made at any time under the following exemptions under the Prospectus Directive, if they have been implemented in that Relevant Member
State:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> to any legal entity which is a qualified investor as defined in the Prospectus Directive; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> to fewer than 100 or, if the Relevant Member State has implemented the relevant provision of the 2010 PD Amending Directive, 150,
natural or legal persons (other than qualified investors as defined in the Prospectus Directive), as permitted under the Prospectus Directive, subject to obtaining the prior consent of the
representatives for any such offer; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> in any other circumstances falling within Article&nbsp;3(2) of the Prospectus Directive, provided that no such offer of shares of
our common stock shall result in a requirement for the publication by us or any underwriter of a prospectus pursuant to Article&nbsp;3 of the Prospectus Directive. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
the purposes of this provision, the expression an "offer to the public" in relation to any shares of our common stock in any Relevant Member State means the communication in any form and by any
means of sufficient information on the terms of the offer and any shares of our common stock to be offered so as to enable an investor to decide to purchase any shares of our common stock, as the same
may be varied in that Member State by any measure implementing the Prospectus Directive in that Member State, the expression "Prospectus Directive" means Directive 2003/71/EC (and amendments thereto,
including the 2010 PD Amending Directive, to the extent implemented in the Relevant Member State), and includes any relevant implementing measure in the Relevant Member State, and the expression "2010
PD Amending Directive" means Directive 2010/73/EU. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> United Kingdom.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Each underwriter has represented and agreed that:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> it has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or
inducement to engage in investment activity (within the meaning of Section&nbsp;21 of the Financial Services and Markets Act 2000 (the "FSMA")) received by it in connection with the issue or sale of
the shares of our common stock in circumstances in which Section&nbsp;21(1) of the FSMA does not apply to us; and </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the
shares of our common stock in, from or otherwise involving the United Kingdom. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Hong Kong.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The common shares may not be offered or sold in Hong Kong by means of any document other than (i)&nbsp;in circumstances which do not
constitute an
offer to the public within the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>170</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=175,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1016077,FOLIO='170',FILE='DISK131:[15ZBY1.15ZBY12201]EW12201A.;55',USER='DSCHWAR',CD=';8-JUN-2016;17:15' -->
<A NAME="page_ew12201_1_171"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>meaning
of the Companies Ordinance (Cap. 32, Laws of Hong Kong), or (ii)&nbsp;to "professional investors" within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and
any rules made thereunder, or (iii)&nbsp;in other circumstances which do not result in the document being a "prospectus" within the meaning of the Companies Ordinance (Cap. 32, Laws of Hong Kong)
and no advertisement, invitation or document relating to the shares may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere),
which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the laws of Hong Kong) other than with respect to
common shares which are or are intended to be disposed of only to persons outside Hong Kong or only to "professional investors" within the meaning of the Securities and Futures Ordinance (Cap. 571,
Laws of Hong Kong) and any rules made thereunder. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Singapore.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and
any other document or
material in connection with the offer or sale, or invitation for subscription or purchase, of the common shares may not be circulated or distributed, nor may the common shares be offered or sold, or
be made the subject of an invitation
for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i)&nbsp;to an institutional investor under Section&nbsp;274 of the Securities and Futures Act,
Chapter&nbsp;289 of Singapore (the "SFA"), (ii)&nbsp;to a relevant person pursuant to Section&nbsp;275(1), or any person pursuant to Section&nbsp;275(1A), and in accordance with the conditions
specified in Section&nbsp;275 of the SFA or (iii)&nbsp;otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA, in each case subject to
compliance with conditions set forth in the SFA. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Where
the common shares are subscribed or purchased under Section&nbsp;275 of the SFA by a relevant person which is:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> a corporation (which is not an accredited investor (as defined in Section&nbsp;4A of the SFA)) the sole business of which is to hold
investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust
is an individual who is an accredited investor, </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>shares,
debentures and units of shares and debentures of that corporation or the beneficiaries' rights and interest (howsoever described) in that trust shall not be transferred within six months after
that corporation or that trust has acquired the common shares pursuant to an offer made under Section&nbsp;275 of the SFA except:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> to an institutional investor (for corporations, under Section&nbsp;274 of the SFA) or to a relevant person defined in
Section&nbsp;275(2) of the SFA, or to any person pursuant to an offer that is made on terms that such shares, debentures and units of shares and debentures of that corporation or such rights and
interest in that trust are acquired at a consideration of not less than $200,000 (or its equivalent in a foreign currency) for each transaction, whether such amount is to be paid for in cash or by
exchange of securities or other assets, and further for corporations, in accordance with the conditions specified in Section&nbsp;275 of the SFA; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> where no consideration is or will be given for the transfer; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> where the transfer is by operation of law. </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>171</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=176,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=324013,FOLIO='171',FILE='DISK131:[15ZBY1.15ZBY12201]EW12201A.;55',USER='DSCHWAR',CD=';8-JUN-2016;17:15' -->
<A NAME="page_ew12201_1_172"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> Switzerland.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The common shares may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (the "SIX") or on any
other stock
exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss
Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in
Switzerland. Neither this document nor any other offering or marketing material relating to the common shares or the offering may be publicly distributed or otherwise made publicly available in
Switzerland. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Neither
this document nor any other offering or marketing material relating to the offering, or the common shares have been or will be filed with or approved by any Swiss regulatory authority. In
particular, this document will not be filed with, and the offer of common shares will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA, and the offer of common shares has
not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes ("CISA"). Accordingly, no public distribution, offering or advertising, as defined in CISA, its
implementing ordinances and notices, and no distribution to any non-qualified investor, as defined in CISA, its implementing ordinances and notices, shall be undertaken in or from Switzerland, and the
investor protection afforded to acquirers of interests in collective investment schemes under CISA does not extend to acquirers of common shares. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> United Arab Emirates.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;This offering has not been approved or licensed by the Central Bank of the United Arab Emirates (the "UAE"), Securities
and Commodities
Authority of the UAE and/or any other relevant licensing authority in the UAE, including any licensing authority incorporated under the laws and regulations of any of the free zones established and
operating in the territory of the UAE, in particular the Dubai Financial Services Authority ("DFSA"), a regulatory authority of the Dubai International Financial Centre ("DIFC"). The offering does not
constitute a public offer of securities in the UAE, DIFC and/or any other free zone in accordance with the Commercial Companies Law, Federal Law No 8 of 1984 (as amended), DFSA Offered Securities
Rules and Dubai Listing Rules,
accordingly, or otherwise. The common shares may not be offered to the public in the UAE and/or any of the free zones. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
common shares may be offered and issued only to a limited number of investors in the UAE or any of its free zones who qualify as sophisticated investors under the relevant laws and regulations of
the UAE or the free zone concerned. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><I> France.</I></B></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;This prospectus (including any amendment, supplement or replacement thereto) is not being distributed in the context of a public
offering in France within
the meaning of Article&nbsp;L. 411-1 of the French Monetary and Financial Code (Code mon&eacute;taire et financier). </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>This
prospectus has not been and will not be submitted to the French Autorit&eacute; des march&eacute;s financiers (the "AMF") for approval in France and accordingly may not and will
not be distributed to the public in France. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Pursuant
to Article&nbsp;211-3 of the AMF General Regulation, French residents are hereby informed that:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the transaction does not require a prospectus to be submitted for approval to the AMF; </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> persons or entities referred to in Point 2&deg;, Section&nbsp;II of Article&nbsp;L.411-2 of the Monetary and Financial
Code may take part in the transaction solely for their own account, as provided in Articles&nbsp;D. 411-1, D. 734-1, D. 744-1, D. 754-1 and D. 764-1 of the Monetary and Financial Code; and </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>172</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=177,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=299630,FOLIO='172',FILE='DISK131:[15ZBY1.15ZBY12201]EW12201A.;55',USER='DSCHWAR',CD=';8-JUN-2016;17:15' -->
<A NAME="page_ew12201_1_173"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> the financial instruments thus acquired cannot be distributed directly or indirectly to the public otherwise than in accordance with
Articles&nbsp;L. 411-1, L. 411-2, L. 412-1 and L. 621-8 to L. 621-8-3 of the Monetary and Financial Code. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>This
prospectus is not to be further distributed or reproduced (in whole or in part) in France by the recipients of this prospectus. This prospectus has been distributed on the understanding that such
recipients will only participate in the issue or sale of our common stock for their own account and undertake not to transfer, directly or indirectly, our common stock to the public in France, other
than in compliance with all applicable laws and regulations and in particular with Articles&nbsp;L. 411-1 and L. 411-2 of the French Monetary and Financial Code. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>173</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=178,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=722538,FOLIO='173',FILE='DISK131:[15ZBY1.15ZBY12201]EW12201A.;55',USER='DSCHWAR',CD=';8-JUN-2016;17:15' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ey12201_1_174"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ey12201_legal_matters"> </A>
<A NAME="toc_ey12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  LEGAL MATTERS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The validity of the shares of common stock offered hereby and certain other legal matters will be passed upon for us by Faegre Baker
Daniels&nbsp;LLP, Minneapolis, Minnesota. Certain legal matters will be passed upon on behalf of the underwriters by Dorsey&nbsp;&amp; Whitney&nbsp;LLP, Minneapolis, Minnesota. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ey12201_experts"> </A>
<A NAME="toc_ey12201_2"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  EXPERTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The audited financial statements included in this prospectus and elsewhere in the registration statement have been so included in reliance upon the
report of Grant Thornton&nbsp;LLP, independent registered public accountants, upon the authority of said firm as experts in accounting and auditing. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ey12201_where_you_can_find_additional_information"> </A>
<A NAME="toc_ey12201_3"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  WHERE YOU CAN FIND ADDITIONAL INFORMATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We have filed with the SEC a registration statement on Form&nbsp;S-1 under the Securities Act with respect to the shares of common stock offered by
this prospectus. This prospectus does not contain all of the information included in the registration statement, as permitted by the rules and regulations of the SEC. For further information
pertaining to us and the common stock to be sold in this offering, you should refer to the registration statement and its exhibits. Whenever we make reference in this prospectus to any of our
contracts, agreements or other documents, the references are not necessarily complete, and you should refer to the exhibits attached to the registration statement for copies of the actual contract,
agreement or other document filed as an exhibit to the registration statement or such other document, each such statement being qualified in all respects by such reference. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Upon
completion of this offering, we will be subject to the information and reporting requirements of the Exchange Act and will file annual, quarterly and current reports, proxy statements and other
information with the SEC. We anticipate making these documents publicly available, free of charge, on our website as soon as reasonably practicable after filing such documents with the SEC. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>You
can read the registration statement and our future filings with the SEC over the Internet at the SEC's website at www.sec.gov. You may also read and copy any document we file with the SEC at its
public reference facility at 100&nbsp;F Street, N.E., Room&nbsp;1580, Washington, D.C. 20549. You may also obtain copies of the documents at prescribed rates by writing to the Public Reference
Section of the SEC at the foregoing address. Please call the SEC at 1-800-SEC-0330 for further information on the operation of the public reference facilities. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>174</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=179,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=690441,FOLIO='174',FILE='DISK131:[15ZBY1.15ZBY12201]EY12201A.;28',USER='DSCHWAR',CD=';8-JUN-2016;17:16' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fa12201_1_1"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="fa12201_tactile_systems_technology,_inc."> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="fa12201_index_to_consolidated_financial_statements"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B>  Index to Consolidated Financial Statements    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="fa12201_as_of_and_for_the_years_ended___as_04480"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B>  As of and for the years ended December&nbsp;31, 2014 and 2015 (audited) and as of<BR>  March&nbsp;31, 2016 and for the three month periods ended
March&nbsp;31, 2015 and 2016 (unaudited)    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<A NAME="FA12201_TOC"></A> </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->
<!-- COMMAND=ADD_START_LINKTABLE -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#aa1"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Report of Independent Registered Public Accounting
Firm</B></FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#aa1"><FONT COLOR="#3B5A6F" SIZE=2>F-2</FONT></A></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Consolidated Financial Statements</B></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#aa2"><p style="font-family:times;margin-top:12pt;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Consolidated Balance Sheets</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#aa2"><FONT COLOR="#3B5A6F" SIZE=2><BR>
F-3</FONT></A></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#aa3"><p style="font-family:times;margin-top:12pt;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Consolidated Statements of Operations</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#aa3"><FONT COLOR="#3B5A6F" SIZE=2><BR>
F-4</FONT></A></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#aa4"><p style="font-family:times;margin-top:12pt;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Consolidated Statements of Stockholders' Equity (Deficit)</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#aa4"><FONT COLOR="#3B5A6F" SIZE=2><BR>
F-5</FONT></A></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#aa5"><p style="font-family:times;margin-top:12pt;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Consolidated Statements of Cash Flows</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#aa5"><FONT COLOR="#3B5A6F" SIZE=2><BR>
F-6</FONT></A></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#aa6"><p style="font-family:times;margin-top:12pt;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Notes to the Consolidated Financial Statements</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#aa6"><FONT COLOR="#3B5A6F" SIZE=2><BR>
F-7&nbsp;- F-31</FONT></A></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
<!-- COMMAND=ADD_END_LINKTABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-1</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=180,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=692787,FOLIO='F-1',FILE='DISK131:[15ZBY1.15ZBY12201]FA12201A.;25',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fc12201_1_2"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="fc12201_report_of_independent___fc102270"> </A>
<A NAME="toc_fc12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  <A NAME="aa1"></A>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Board
of Directors and Stockholders<BR>
Tactile Systems Technology,&nbsp;Inc. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
have audited the accompanying consolidated balance sheets of Tactile Systems Technology,&nbsp;Inc. and its subsidiary (the "Company") as of December&nbsp;31, 2015 and 2014, and the related
consolidated statements of operations, stockholders' equity (deficit), and cash flows for each of the two years in the period ended December&nbsp;31, 2015. These financial statements are the
responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We
conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the Company's internal control over financial reporting. Our
audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an
opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement
presentation. We believe that our audits provide a reasonable basis for our opinion. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Tactile Systems Technology, Inc. and subsidiary as of
December&nbsp;31, 2015 and 2014, and the results of their operations and their cash flows for each of the two years in the period ended December&nbsp;31, 2015 in conformity with accounting
principles generally accepted in the United States of America. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>/s/
Grant Thornton LLP </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


Minneapolis, Minnesota<BR>
March&nbsp;25, 2016 (Except for note&nbsp;13 and the effects thereof, which is as of June&nbsp;8, 2016)

 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-2</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=181,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=64591,FOLIO='F-2',FILE='DISK131:[15ZBY1.15ZBY12201]FC12201A.;34',USER='DBEMBEN',CD=';9-JUN-2016;00:44' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fe12201_1_3"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="aa2"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="fe12201_tactile_systems_technology,_in__tac03507"> </A>
<A NAME="toc_fe12201_1"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B><BR>  TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.    <BR>    <BR>    Consolidated Balance Sheets    <BR>    <BR>    (in thousands, except share data)    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="73pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="73pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
March&nbsp;31,&nbsp;2016 </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Pro Forma as of<BR>
March&nbsp;31,&nbsp;2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B><I>Assets</I></B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:8pt;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Current assets</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Cash and cash equivalents</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>5,416</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>7,060</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>5,787</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>5,787</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Accounts receivable, net</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 13,742</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 14,151</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 11,658</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 11,658</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Inventories</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 3,521</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 5,781</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 5,228</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 5,228</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Deferred income taxes</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 2,015</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 1,766</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 2,641</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 2,641</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Prepaid expenses</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 423</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 602</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 469</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 469</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:22pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Total current assets</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 25,117</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 29,360</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 25,783</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 25,783</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Property and equipment, net  </B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 1,303</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 1,346</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 1,369</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 1,369</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Other assets</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Patent costs, net</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 2,744</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 2,489</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 2,419</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 2,419</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Medicare accounts receivable&nbsp;&#151; long term</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 1,302</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 2,039</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 1,811</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 1,811</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Deferred income taxes</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 1,005</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 402</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 328</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 328</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Other non-current assets</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 23</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 1,337</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 1,558</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 1,558</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:22pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Total other assets</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 5,074</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 6,267</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 6,116</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 6,116</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:29pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Total assets  </B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>31,494</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>36,973</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>33,268</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 33,268</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B><I>Liabilities and Stockholders' Equity (Deficit)</I></B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:8pt;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Current liabilities</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Accounts payable</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>2,507</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,336</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,058</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>3,058</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Current portion of notes payable</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 9</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Accrued payroll and related taxes</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 2,003</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 3,355</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 1,821</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 1,821</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Accrued expenses</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 647</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 916</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 952</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 8,747</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Future product royalties&nbsp;&#151; current</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 924</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 991</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 743</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 743</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Income taxes payable</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 100</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 904</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:22pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Total current liabilities</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 6,190</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 9,502</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 6,574</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 14,369</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Long-term liabilities</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Notes payable, net of current portion</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Deferred compensation</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 199</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 193</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 193</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 193</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Future product royalties</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 446</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:22pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Total long-term liabilities, net of current
portion&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 649</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 193</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 193</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 193</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:22pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Total liabilities</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 6,839</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 9,695</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 6,767</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 14,562</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Convertible preferred stock</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Series&nbsp;B&nbsp;convertible&nbsp;preferred&nbsp;stock,&nbsp;$.001&nbsp;par&nbsp;value:<BR>
5,319,066&nbsp;shares authorized, 2,733,468&nbsp;shares issued and outstanding as of December&nbsp;31, 2014 and 2015, and March&nbsp;31, 2016 (unaudited), and no shares authorized, issued or outstanding as of March&nbsp;31, 2016 (pro forma)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 11,894</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 12,599</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 12,796</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Series&nbsp;A&nbsp;convertible&nbsp;preferred&nbsp;stock,&nbsp;$.001&nbsp;par&nbsp;value:<BR>
3,112,152&nbsp;shares authorized, 3,108,589&nbsp;shares issued and 3,061,488&nbsp;shares outstanding as of December&nbsp;31, 2014 and 2015, and March&nbsp;31, 2016, and no shares authorized, issued or outstanding as of March&nbsp;31, 2016 (pro forma)
(unaudited)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 19,188</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 20,328</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 20,645</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:8pt;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Stockholders' equity (deficit)</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Common stock, $.001 par value:<BR>
14,184,175&nbsp;shares authorized, 2,626,620 and 3,222,902&nbsp;shares issued and outstanding as of December&nbsp;31, 2014 and 2015, respectively, and 3,341,285 as of March&nbsp;31, 2016 (unaudited), and 300,000,000 shares authorized, 11,693,880
shares issued and outstanding as of March&nbsp;31, 2016 (pro forma)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 7</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 9</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 9</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 12</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Additional paid-in capital</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 438</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 25,643</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Accumulated deficit</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> (6,872</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> (5,658</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> (6,949</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> (6,949</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:22pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1>Total stockholders' equity (deficit)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> (6,427</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> (5,649</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> (6,940</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> 18,706</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT COLOR="#3B5A6F" SIZE=1> </FONT><FONT COLOR="#3B5A6F" SIZE=1><B>Total liabilities and stockholders' equity (deficit)  </B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>31,494</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>36,973</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>33,268</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>33,268</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT COLOR="#3B5A6F" SIZE=2>

<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"> <FONT COLOR="#3B5A6F" SIZE=2>
See accompanying notes to the consolidated financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-3</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=182,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=512715,FOLIO='F-3',FILE='DISK131:[15ZBY1.15ZBY12201]FE12201A.;72',USER='GPEARMO',CD=';8-JUN-2016;22:51' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fg12201_1_4"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="aa3"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="fg12201_tactile_systems_technology,_in__tac03991"> </A>
<A NAME="toc_fg12201_1"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B><BR>  TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.    <BR>    <BR>    Consolidated Statements of Operations    <BR>    <BR>    (in thousands, except share data)    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Three Months<BR>
Ended March&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Revenues, net  </B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>47,736</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>62,872</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,121</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>13,700</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:11pt;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Cost of goods sold  </B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
12,715</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
16,908</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
2,972</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
3,811 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Gross profit</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 35,021</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 45,964</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 7,149</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 9,889 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Operating expenses</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Sales and marketing</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 18,154</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 24,485</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5,169</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 7,281</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Research and development</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,843</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 4,312</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 817</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 980</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Reimbursement, general and administrative&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10,225</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 13,716</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,647</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3,414 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:27pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total operating expenses</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 31,222</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 42,513</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 8,633</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 11,675 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:36pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income (loss) from
operations&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3,799</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3,451</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (1,484</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (1,786</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:11pt;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Other income (expense)  </B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(194</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
12</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
5 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:36pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Income (loss) before income
taxes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3,795</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3,257</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (1,472</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (1,781</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:11pt;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Income tax expense (benefit)  </B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
1,725</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
1,864</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(592</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(801</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Net income (loss)  </B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,070</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,393</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (880</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (980</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Convertible preferred stock dividends  </B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,761</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,845</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 460</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 514</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Allocation of undistributed earnings to preferred stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 216</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Net income (loss) attributable to common stockholders  </B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>93</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(452</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,340</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,494</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Net income (loss) per common share attributable to common stockholders</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.04</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.15</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.51</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.45</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.02</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.15</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.51</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.45</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:11pt;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Weighted-average common shares used to compute net income (loss) per common share attributable to common
stockholders</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,491,108</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,929,438</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,640,807</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3,293,326</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3,797,688</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,929,438</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,640,807</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3,293,326</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:11pt;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Pro forma net income (loss) per common share attributable to common stockholders (unaudited)
</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.12</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.08</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.10</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.08</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:11pt;margin-left:9pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Weighted-average shares used to compute pro forma net income (loss) per common share attributable to
common stockholders (unaudited)</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 11,807,560</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 12,171,448</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 13,507,390</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 12,171,448</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT COLOR="#3B5A6F" SIZE=2>

<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"> <FONT COLOR="#3B5A6F" SIZE=2>
See accompanying notes to the consolidated financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-4</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=183,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=832656,FOLIO='F-4',FILE='DISK131:[15ZBY1.15ZBY12201]FG12201A.;96',USER='GPEARMO',CD=';8-JUN-2016;22:52' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fi12201_1_5"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<!-- COMMAND=ROTATED_TABLE WIDTH="150%" -->

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><A NAME="aa4"></A>TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> Consolidated Statements of Stockholders' Equity (Deficit)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except share data)  </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:73%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"110%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="110%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Common Stock </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Additional<BR>
Paid-In<BR>
Capital </B></FONT></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Accumulated<BR>
Deficit </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Par Value </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Total </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Balances, December&nbsp;31, 2013  </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
2,226,716</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,822</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(8,942</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(7,114</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Stock-based compensation</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 148</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 148</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Exercise of common stock options</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 399,903</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 229</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 230</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Preferred stock dividends</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (1,761</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (1,761</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,070</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,070 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Balances, December&nbsp;31, 2014  </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,626,619</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 438</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (6,872</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (6,427</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Stock-based compensation</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 316</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 316</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Exercise of common stock options and warrants</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 596,283</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 912</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 914</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Preferred stock dividends</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (1,666</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (179</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (1,845</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,393</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,393 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Balances, December&nbsp;31, 2015  </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
3,222,902</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(5,658</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(5,649</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Stock-based compensation (unaudited)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 75</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 75</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Exercise of common stock options (unaudited)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 118,383</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 128</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 128</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Preferred stock dividends (unaudited)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (203</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (311</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (514</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net loss (unaudited)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (980</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (980</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Balances, March&nbsp;31, 2016 (unaudited)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
3,341,285</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>9</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,949</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(6,940</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
See accompanying notes to the consolidated financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-5</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=184,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=829655,FOLIO='F-5',FILE='DISK131:[15ZBY1.15ZBY12201]FI12201A.;42',USER='CHE105613',CD=';7-JUN-2016;12:48' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fk12201_1_6"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="aa5"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="fk12201_tactile_systems_technology,_in__tac03280"> </A>
<A NAME="toc_fk12201_1"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B><BR>  TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.    <BR>    <BR>    Consolidated Statements of Cash Flows    <BR>    <BR>    (in thousands)    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Three Months<BR>
Ended March&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Cash flows from operating activities</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,070</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,393</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(880</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(980</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Adjustments to reconcile net income (loss) to net cash flows used in operating activities</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Depreciation and amortization</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 706</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 827</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 201</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 211</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Deferred income taxes</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,558</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 852</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (592</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (801</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Stock-based compensation expense</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 148</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 316</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 62</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 75</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Deferred compensation</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (6</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Change in allowance for doubtful accounts</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 500</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 100</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Changes in assets and liabilities</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accounts receivable</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (4,671</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (509</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,340</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,493</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Inventories</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (608</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (2,260</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (375</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 553</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F"
SIZE=2>Prepaid&nbsp;expenses&nbsp;and&nbsp;other&nbsp;non-current&nbsp;assets&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (142</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (1,493</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 15</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (87</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Medicare accounts receivable&nbsp;&#151; long term</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (381</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (737</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 228</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accounts payable</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 547</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 829</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (148</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (278</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accrued payroll and related taxes</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (601</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,352</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 720</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (1,534</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accrued expenses and income taxes payable</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 44</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,073</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (1,632</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (868</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Future product royalties</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (161</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (379</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (149</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (248</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:50pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net cash flows (used in) from operating
activities&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (991</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,358</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (438</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (1,236</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Cash flows from investing activities</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Purchases of property and equipment</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (353</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (592</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (150</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (165</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Patent costs</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (23</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:50pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net cash flows used in investing activities</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (353</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (615</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (150</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (165</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Cash flows from financing activities</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Payments on notes payable</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (9</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (13</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (2</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Proceeds from exercise of common stock options and warrants</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 230</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 914</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 6</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 128 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F"
SIZE=2>Net&nbsp;cash&nbsp;flows&nbsp;from&nbsp;financing&nbsp;activities&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 221</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 901</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 4</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 128 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:40pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net change in cash and cash equivalents</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (1,123</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,644</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (584</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (1,273</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Cash and cash equivalents&nbsp;&#151; beginning of year  </B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 6,539</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5,416</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5,416</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 7,060 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Cash and cash equivalents&nbsp;&#151; end of period  </B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,416</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>7,060</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,832</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,787 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2><B>Supplemental cash flow disclosure</B></FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Cash paid for interest</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Cash paid for taxes</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>238</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>240</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>131</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>951 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT COLOR="#3B5A6F" SIZE=2>

<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"> <FONT COLOR="#3B5A6F" SIZE=2>
See accompanying notes to the consolidated financial statements. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-6</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=185,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=727928,FOLIO='F-6',FILE='DISK131:[15ZBY1.15ZBY12201]FK12201A.;45',USER='CHE105613',CD=';7-JUN-2016;14:04' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fm12201_1_7"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="aa6"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="fm12201_tactile_systems_technology,_in__tac07851"> </A>
<A NAME="toc_fm12201_1"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B><BR>  TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.    <BR>    <BR>    NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS    <BR>    <BR>    (Information as of March&nbsp;31, 2016 and for the
three months ended<BR>  March&nbsp;31, 2015 and 2016 is unaudited)    <BR>    <BR>    (in thousands, except percentages and share data)    <BR>
</B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Nature of Operations  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Tactile Systems Technology, Inc. (the "Company") (doing business as Tactile Medical) is the sole manufacturer and distributor of the Flexitouch and
Entr&eacute; Systems, medical devices to help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the
ACTitouch System, a medical device to treat venous leg ulcers and chronic venous insufficiency. The Company provides its products for use both in the home and in health care institutions, including
hospitals and vascular, wound and lymphedema clinics throughout the United States. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Basis of Presentation  </I></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>The Company was originally incorporated in Minnesota under the name Tactile Systems Technology, Inc. on January&nbsp;30, 1995. During 2006, the
Company set up a merger corporation and subsequently, on July&nbsp;21, 2006, merged with and into this merger corporation. The resulting corporation assumed the name Tactile Systems Technology, Inc.
The purpose of this merger was to reincorporate the Company in Delaware, increase the number of authorized common shares to 8.9&nbsp;million and assign a par value of $.001 to its common stock. In
September 2013, the Company began doing business as Tactile Medical.

 </FONT>

</P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Basis of Consolidation  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Swelling Solutions, Inc., after
elimination of intercompany accounts and transactions. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


JOBS Act Accounting Election  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As an emerging growth company under the Jumpstart Our Business Startups Act, the Company is eligible to take advantage of certain exemptions from
various reporting requirements that are applicable to other public companies that are not emerging growth companies. The Company has elected to take advantage of the extended transition period for
adopting new or revised accounting standards that have different effective dates for public and private companies until such time as those standards apply to private companies. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Unaudited Interim Consolidated Financial Statements  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The accompanying balance sheet as of March&nbsp;31, 2016, the consolidated statements of operations and cash flows for the three months ended
March&nbsp;31, 2015 and 2016, and the consolidated statements of stockholders' equity as of March&nbsp;31, 2016, are unaudited. The consolidated financial data and other information disclosed in
these notes to the consolidated financial statements related to March&nbsp;31, 2016, and the three months ended March&nbsp;31, 2015 and 2016, are also unaudited. The unaudited interim consolidated
financial statements have been prepared on the same basis as the annual consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal
recurring adjustments, necessary to state fairly the Company's financial position as of March&nbsp;31, 2016, and the results of its operations and cash flows for the three months ended </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-7</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=186,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=508703,FOLIO='F-7',FILE='DISK131:[15ZBY1.15ZBY12201]FM12201A.;97',USER='GPEARMO',CD=';8-JUN-2016;22:54' -->
<A NAME="page_fm12201_1_8"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March&nbsp;31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>March&nbsp;31,
2015 and 2016, respectively. The results for the three months ended March&nbsp;31, 2016 are not necessarily indicative of results to be expected for the year ending
December&nbsp;31, 2016, or for any other interim period or for any future year. Our business may be affected by seasonality. In the first quarter of each year, when most patients have started a new
insurance year and have not paid their annual deductibles, we experience substantially reduced demand for our products. We typically experience higher sales in the third and fourth quarters as a
result of patients having paid their annual insurance deductibles in full, thereby reducing their out-of-pocket costs for our products, or because patients often spend the remaining balances in their
flexible spending accounts. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Unaudited Pro Forma Consolidated Balance Sheet  </I></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>The unaudited pro forma consolidated balance sheet as of March&nbsp;31, 2016 reflects: (i)&nbsp;the automatic conversion of all outstanding
shares of the Company's convertible preferred stock into an aggregate of 5,924,452&nbsp;shares of common stock immediately prior to the completion of this offering; (ii)&nbsp;the accrual for the
payment of $7.8 in cumulative accrued dividends to the Company's Series&nbsp;A convertible preferred stockholders; and (iii)&nbsp;the issuance of 785,742&nbsp;shares of common stock to pay
accrued dividends on the Company's Series&nbsp;B convertible preferred stock.

</FONT>

</P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Unaudited Pro Forma Net Income (Loss) Per Share Attributable to Common Stockholders  </I></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>Unaudited pro forma basic and diluted net income (loss) per share has been computed to give effect to: (1)&nbsp;the conversion of all outstanding
convertible preferred stock into an aggregate of 5,924,452&nbsp;shares of common stock immediately prior to the completion of this offering; (2)&nbsp;the issuance of 1,569,549 additional shares of
common stock immediately prior to the completion of this offering that the Company's Series&nbsp;A and Series&nbsp;B preferred stockholders are entitled to receive in connection with this initial
public offering, assuming an initial offering price of $15.00 per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus; (3)&nbsp;the
additional 539,338&nbsp;shares of common stock that would have been required to be issued to generate sufficient proceeds to fund the cash payment of Series&nbsp;A convertible preferred stock
dividends; (4)&nbsp;the issuance of 844,782 shares of common stock immediately prior to the completion of this offering to pay accrued dividends on the Company's Series&nbsp;B convertible
preferred stock (assuming a closing date of June&nbsp;27, 2016 and an initial offering price of $15.00 per share, which is the midpoint of the estimated offering price range set forth on the cover
page of this prospectus); and (5)&nbsp;the effectiveness of the Company's amended and restated certificate of incorporation and adoption of the Company's amended and restated bylaws.

</FONT>

</P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Cash and Cash Equivalents  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company considers all highly liquid investments purchased with an initial maturity date of 90&nbsp;days or less to be cash equivalents. As of
December&nbsp;31, 2014 and 2015 and March&nbsp;31, 2016, cash equivalents consisted of money market funds, which are stated at cost and approximate fair value. The Company maintains cash in bank
accounts which, at times, may exceed the Federal Depository Insurance Corporation ("FDIC") limits. The Company has not experienced any losses from maintaining balances in excess of FDIC limits. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-8</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=187,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=250888,FOLIO='F-8',FILE='DISK131:[15ZBY1.15ZBY12201]FM12201A.;97',USER='GPEARMO',CD=';8-JUN-2016;22:54' -->
<A NAME="page_fm12201_1_9"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March&nbsp;31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Accounts Receivable  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The majority of the Company's accounts receivable and revenues are from commercial insurance payers and government payers, such as Medicare, Veterans
Administration and Medicaid. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Accounts
receivable are carried net of allowances for estimated non-receipt of patient co-payment and deductible obligations and allowances for uncollectible accounts. The allowance for estimated
nonreceipt of co-payment reimbursements and for uncollectible accounts was $1,900 and $2,000 as of December&nbsp;31, 2014 and 2015, respectively, and $2,000 as of March&nbsp;31, 2016. The Company
believes all accounts receivable in excess of the allowance are fully collectible. The Company does not accrue interest on a majority of the past due accounts receivable. The Company determines when
accounts become past due on a customer by customer basis. If accounts receivables in excess of the provided allowance are determined uncollectible, they are charged to expense in the quarter that
determination is made and accounts receivable are written off after all collection efforts have failed. A portion of the Company's claims to Medicare are initially denied, and enter the appeals
process, where many are ultimately reviewed by an Administrative Law Judge. After final adjudication of all claims, approximately 90% of the claims submitted are approved (this is on a number of
claims, not a dollars claimed, basis). The appeals process can be lengthy, lasting more than a year in most cases. Accordingly, the Company classifies a portion of its Medicare accounts receivable as
non-current based on its experience with Medicare. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Company had accounts receivable from three insurance companies representing approximately 25%, 24% and 5% as of December&nbsp;31, 2014. The Company had accounts receivable from three insurance
companies representing approximately 26%, 18% and 7% of accounts receivable as of December&nbsp;31, 2015. Revenues from these insurance companies accounted for 31%, 15%, and 12% of the Company's
total revenues for the year ended December&nbsp;31, 2014 and 28%, 13% and 11% for the year ended December&nbsp;31, 2015. The Company had accounts receivable from three insurance companies
representing approximately 21%, 16% and 4% of accounts receivable as of March&nbsp;31, 2016. Revenues from these insurance companies accounted for 28%, 12% and 10% of the Company's total revenues
for the three months ended March&nbsp;31, 2016. The Company had accounts receivable from two insurance companies representing approximately 25% and 20% of accounts receivable as of March&nbsp;31,
2015. Revenues from these insurance companies accounted for 13% and 27% of the Company's total revenues for the three months ended March&nbsp;31, 2015. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Accounts
receivable include amounts due from Medicare totaling $4,088, $4,275 and $4,368 relating to devices shipped to patients as of December&nbsp;31, 2014 and 2015, and March&nbsp;31, 2016,
respectively, that are waiting insurance approval. The Company estimates the devices for which it expects to receive authorization and payment based on its reimbursement history from Medicare. The
Company classified $1,302, $2,039 and $1,811 of this receivable as of December&nbsp;31, 2014 and 2015, and March&nbsp;31, 2016, respectively, as noncurrent as the Company does not expect these
claims will be paid within one year of shipment of the device due to delays with the Administrative Law Judge appeal process. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-9</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=188,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=415701,FOLIO='F-9',FILE='DISK131:[15ZBY1.15ZBY12201]FM12201A.;97',USER='GPEARMO',CD=';8-JUN-2016;22:54' -->
<A NAME="page_fm12201_1_10"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March&nbsp;31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>On
September&nbsp;3, 2015, the Company entered into a settlement agreement with the Centers for Medicare and Medicaid Services for 247 claims, representing approximately $1,457 of original claims
based on the Medicare allowable rates, in which the Company had submitted a request for an Administrative Law Judge hearing in 2013. The settlement entitled the Company to receive a payment of
approximately $851. The Company received this full amount during the fourth quarter of 2015. The settlement resulted in a reduction in the fourth quarter of 2015 of $815 in accounts receivable for
shipment of products to patients covered by Medicare. The settlement was part of a pilot program, facilitated by the Office of Medicare Hearings and Appeals, to address a backlog of overdue claims
awaiting Administrative Law Judge adjudication. Because the settlement is part of a pilot program, the Company cannot predict whether it will be able to conclude future settlements with Medicare or
achieve settlements on similar terms. Any future settlement of claims for amounts less than the corresponding amounts receivable would result in a write off. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
reserve for uncollectible co-payment reimbursements and doubtful accounts were as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="98pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December 31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Three Months Ended<BR>
March&nbsp;31, 2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Beginning balance</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,400</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,900</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,000</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Provision charged against revenues</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3,285</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5,973</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,286</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Write-offs</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (2,785</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (5,873</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (1,286</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Ending balance</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,900</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,000</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,000 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Advertising  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Advertising costs are charged to operations when incurred. Advertising expense was $23 and $52 for the years ended December&nbsp;31, 2014 and 2015,
respectively, and $1 and $11 for the three month periods ended March&nbsp;31, 2015 and 2016, respectively. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Research and Development Costs  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company expenses research and development costs as incurred. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Shipping and Handling Costs  </I></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company does not charge any shipping and handling costs to its customers and the shipping and handling costs incurred are included in cost of
goods sold. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Product Warranty  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company provides a warranty for its products against defects in material and workmanship for a period up to one year on garments and one to two
years on controllers. The Company records a liability for future warranty claims at the time of sale for the warranty period offered to a customer. If the assumptions used in calculating the provision
were to materially change, resulting in more defects than anticipated, an additional provision may be required. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-10</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=189,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=968886,FOLIO='F-10',FILE='DISK131:[15ZBY1.15ZBY12201]FM12201A.;97',USER='GPEARMO',CD=';8-JUN-2016;22:54' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fo12201_1_11"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March&nbsp;31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data)  </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies (Continued)  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
The warranty reserve was as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="77pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Three Months<BR>
Ended<BR>
March&nbsp;31, 2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Beginning balance</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>250</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>360</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Warranty provision</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>142</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>196</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>81</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Processed warranty claims</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(92</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(86</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(31</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Ending balance</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>250</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>360</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>410 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Inventories  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Inventories are valued at the lower of cost (first-in, first-out method) or market, and consisted of the following: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="77pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
March&nbsp;31, 2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Finished goods</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,628</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,796</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,422</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Component parts and work-in-process</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,893</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,985</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,806 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Ending balance</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,521</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,781</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,228 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Property and Equipment  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Property and equipment are stated at cost and are being depreciated using the straight-line method over their estimated useful lives of three to five
years and leasehold improvements are depreciated over the remaining life of the building lease agreement. Property and equipment consisted of the following: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="77pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
March&nbsp;31, 2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,645</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,797</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,839</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Leasehold improvements</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>306</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>439</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>462</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Tooling</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>719</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>960</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,059</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Furniture and fixtures</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>237</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>303</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>303 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,907</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,499</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,663</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Less: accumulated depreciation</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,604</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(2,153</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(2,294</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Property and equipment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,303</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,346</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,369 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Major
expenditures for property and equipment are capitalized. Maintenance, repairs, and minor renewals are expensed as incurred. When assets are retired or otherwise disposed of, their costs and </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-11</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=190,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=933164,FOLIO='F-11',FILE='DISK131:[15ZBY1.15ZBY12201]FO12201A.;132',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_fo12201_1_12"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March&nbsp;31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>related
accumulated depreciation are removed from the accounts and resulting gains or losses are included in income. Depreciation expense was $428 and $549 for the years ended December&nbsp;31, 2014
and 2015, respectively, and $132 and $141 for the three month periods ended March&nbsp;31, 2015 and 2016, respectively. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Deferred Offering Costs  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Deferred offering costs, primarily consisting of legal, accounting and other direct fees and costs relating to the initial public offering, are
capitalized. The deferred offering costs will be offset against the Company's planned initial public offering proceeds upon the closing of the offering. In the event the offering is terminated, all of
the deferred offering costs will be expensed within income from operations. There were $1,314 and $1,534 in deferred offering costs capitalized as of December&nbsp;31, 2015 and March&nbsp;31,
2016, respectively, in other non-current assets on the balance sheet. There were no deferred offering costs capitalized as of December&nbsp;31, 2014. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Impairment of Long-Lived Assets  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company reviews long-lived assets, including property and equipment and patents, for impairment whenever events or changes in business
circumstances indicate that the carrying amount of an asset may not be fully recoverable. The Company will record impairment losses on long-lived assets used in operations when indicators of
impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets' carrying amount. To date, the Company has recorded no such losses other than
the write-off of various assets acquired in the ACTitouch transaction (see Note&nbsp;5). </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Revenue Recognition  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company recognizes revenue when persuasive evidence of a sales arrangement exists, delivery of product has occured through the transfer of title
and risks of reward of ownership, the selling price is fixed or determinable and collectibility is reasonably assured. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Company distributes its products directly to patients. For any of its products sold to patients covered by private payers, such as commercial insurance companies, the Company recognizes revenues
from such sales upon shipment of its products. A product is not shipped until the Company has received a prescription from a physician for its products and, as applicable, receipt of prior
authorization from payers. At shipment, the Company invoices the payer for their portion of the total product cost and the Company recognizes revenue as a percentage of the payer's invoice based on
the polices and payment history of the applicable payer. The payment history of the applicable payer is drawn from the Company's actual payment experience over the last three years. Any differences in
payments received as compared to the Company's estimates are recognized in the period for which it actually receives payment for the product. Over time, the Company adjusts the applicable estimates
used for each payer to reflect any such differences. The Company separately invoices the patient for their payment obligation with respect to the shipped product, such as copayments and deductibles,
and recognizes revenue upon sending such invoice. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-12</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=191,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=829559,FOLIO='F-12',FILE='DISK131:[15ZBY1.15ZBY12201]FO12201A.;132',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_fo12201_1_13"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March&nbsp;31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
any of the its products sold to Medicare patients, the Company recognizes revenues from such sales upon shipment of its products, which can occur only after the Company has received a prescription
from a physician and all applicable Medicare documentation. The Company estimates the revenue on each shipment to a Medicare patient as a percentage of the total invoice based on the payment history
of each regional administrative contractor. While the Company has contracted rates with Medicare, to the extent any claims for reimbursement are denied, the Company will recognize any necessary
adjustments in the period for which the adjustment is made. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Net Income (Loss) per Share Attributable to Common Stockholders  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company uses the two-class method to compute net income (loss) per common share attributable to common stockholders because the Company has
issued securities, other than common stock, that contractually entitle the holders to participate in dividends and earnings of the Company. The two-class method requires earnings for the period to be
allocated between common stock and participating securities based upon their respective rights to receive distributed and undistributed earnings. All series of the Company's convertible preferred
stock are considered participating securities. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Under
the two-class method, for periods with net income, basic net income per share attributable to common stockholders is computed by dividing the net income attributable to common stockholders by
the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share attributable to common stockholders is computed by dividing the net income
attributable to common stockholders by the weighted-average number of shares of common stock and dilutive potential shares of common stock outstanding during the period. Net income attributable to
common stockholders is computed by subtracting from net income the portion of current year earnings that the participating securities would have been entitled to receive pursuant to their dividend
rights had all of the year's earnings been distributed. No such adjustment to earnings is made during periods with a net loss, as the holders of the participating securities have no obligation to fund
losses. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Income Taxes  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Income taxes are accounted for under the liability method. Deferred income taxes are provided for temporary differences between the financial
reporting and the tax bases of assets and liabilities. If the Company determines in the future that it is more likely than not that the Company will realize all or a portion of the deferred tax
assets, the Company will record a valuation allowance in the period the determination is made (Note&nbsp;9). </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock-Based Compensation  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company accounted for all share-based payments to employees, including grants of employee stock options, based on the fair value on the date of
grant expensed over the applicable vesting period. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
fair value of each option grant is determined as of grant date, utilizing the Black Scholes option pricing model. The Company uses the "simplified method" to determine the expected term of the
stock option. The Company calculates expected volatility for stock options using the historical volatility of a </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-13</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=192,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=846043,FOLIO='F-13',FILE='DISK131:[15ZBY1.15ZBY12201]FO12201A.;132',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_fo12201_1_14"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March&nbsp;31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>public
company of similar size and industry as the Company believes the expected volatility will approximate historical volatility. The risk-free rate for periods within the expected term of the
option is based on the U.S. Treasury rate at the time of grant. The Company estimates the forfeiture rate to be 10-15% based on management's estimate of future employee turnover. Based on these
valuations, the Company recognized compensation expense of $148 and $316 for the years ended December&nbsp;31, 2014 and 2015, respectively, and $62 and $75 for the three month periods ended
March&nbsp;31, 2015 and 2016, respectively, and the expense is included in reimbursement, general and administrative expenses.
The amortization of each grant will continue over the remainder of the vesting period of each option grant. Stock-based compensation expense of outstanding options as of December&nbsp;31, 2015 is
expected to approximate $323, $300, $256 and $40 in each of the next four years, respectively. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
estimated fair value of each option grant is estimated on the date of grant using the Black Scholes pricing model with the following weighted-average assumptions used for options granted: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Three Months<BR>
Ended March&nbsp;31, </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2016 </B></FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=3 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Expected term</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6 years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6 years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6 years</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Expected volatility</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>60%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>60%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>60%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Risk-free interest rate</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Expected dividend yield</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>No
stock options were granted in the three month period ended March&nbsp;31, 2016. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Financial Instruments and Fair Value  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The carrying amounts for all financial instruments approximate fair value. The carrying amounts for cash and cash equivalents, accounts receivable
and accounts payable approximate fair value because of the short maturity of these instruments. The fair value of short- and long-term debt (including future product royalties) approximates carrying
value and has been estimated based on discounted cash flows using interest rates being offered for similar debt having the same or similar remaining maturities and collateral requirements. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Recent Accounting Pronouncement  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In May 2014, the Financial Accounting Standards Board ("FASB") issued guidance creating Accounting Standards Codification ("ASC") Section&nbsp;606,
"Revenue from Contracts with Customers." The new section will replace Section&nbsp;605, "Revenue Recognition," and creates modifications to various other revenue accounting standards for specialized
transactions and industries. The section is intended to conform revenue accounting principles with a concurrently issued International Financial Reporting Standards to reconcile previously differing
treatment between United States practices and those of the rest of the world and to enhance disclosures related to disaggregated revenue information. The updated guidance, which was amended
July&nbsp;9, 2015, is effective for annual reporting periods beginning on or </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-14</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=193,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=991563,FOLIO='F-14',FILE='DISK131:[15ZBY1.15ZBY12201]FO12201A.;132',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<A NAME="page_fo12201_1_15"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March&nbsp;31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 1&nbsp;&#151; Summary of Significant Accounting Policies (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>after
December&nbsp;15, 2017, and interim periods within those annual periods. The Company will adopt the new provisions of this accounting standard at the beginning of fiscal year 2018, because
early adoption is not allowed. The Company will further study the implications of this statement to evaluate the expected impact on its consolidated financial statements. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
November 2015, the FASB issued Accounting Standards Update ("ASU") 2015-l7, Income Taxes: Balance Sheet Classification of Deferred Taxes, which requires entities to present deferred tax assets and
deferred tax liabilities as noncurrent in a classified balance sheet. The ASU is effective for annual periods beginning after December l5, 20l7, and interim periods within annual periods beginning
after December&nbsp;15, 2018. Early adoption is permitted for all entities. The Company is currently evaluating the impact of this new standard on its consolidated financial statements. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes the existing guidance for lease accounting, Leases (Topic 840), ASU 2016-02 requires lessees to recognize a lease
liability and a right-of-use asset for all leases. Lessor accounting remains largely unchanged. The amendments in this ASU are effective for fiscal years beginning after December&nbsp;15, 2018 and
interim periods within those fiscal years. Early adoption is permitted for all entities. ASU 2016-02 requires a modified retrospective approach for all leases existing at, or entered into after the
date of initial adoption, with an option to elect to use certain transition relief. The Company is currently evaluating the impact of this new standard on its consolidated financial statements. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Estimates  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated
financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Company continues to refine its estimate of the Medicare and other accounts receivable and related revenue recognition based on information available to it related to historical approval rates. </FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 2&nbsp;&#151; Patent Costs, Net  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
The Company's patents, all of which are subject to amortization, are summarized as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="77pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
March&nbsp;31, 2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Patents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,380</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,403</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,403</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Less: accumulated amortization</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(636</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(914</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(984</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net patents</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,744</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,489</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,419 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-15</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=194,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=495745,FOLIO='F-15',FILE='DISK131:[15ZBY1.15ZBY12201]FO12201A.;132',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fq12201_1_16"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March 31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data)  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 2&nbsp;&#151; Patent Costs, Net (Continued)  </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
Amortization expense was $278 for the years ended December&nbsp;31, 2014 and 2015, and $70 and $70 for the three month periods ended March&nbsp;31, 2015 and 2016, respectively. Future amortization
expenses are expected as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2016 (remaining)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>209</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2017</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 279</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2018</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 279</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2019</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 279</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2020</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 279</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Thereafter</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,094 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,419 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 3&nbsp;&#151; Notes Payable  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
On August&nbsp;8, 2008, the Company entered into four promissory note agreements with a bank totaling $230 which were used to help fund the Company's relocation to its new corporate headquarters.
The notes have interest rates ranging from 2% to the greater of prime plus 1.5% or 7% (7% as of both December&nbsp;31, 2014 and 2015). There was no outstanding balance on the notes at
March&nbsp;31, 2016. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 4&nbsp;&#151; Accrued Expenses  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
Accrued expenses consisted of the following: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="77pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
March&nbsp;31, 2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accrued warranty</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>250</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>360</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>410</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accrued clinical</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>160</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>130</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>183</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Other</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>237</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>426</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>359 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>647</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>916</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>952 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 5&nbsp;&#151; Asset Purchase Agreement  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
On September&nbsp;14, 2012, the Company completed an acquisition of certain assets, including inventory, equipment and tooling and patents for the ACTitouch System and a technology known as SMM. The
purchase price of this acquisition included $3,000 at closing and $2,000 at the earliest of the commercialization date or the first anniversary of the closing date. In addition, the Company is
required to pay quarterly payments following the commercialization date, which was September&nbsp;1, 2013, through the following sixteen quarterly calculation periods equal to 9% of sales for the
ACTitouch System and 7% of sales of SMM with a guaranteed minimum amount of $45 for each of the first four quarterly calculation periods (year 1); $148 for each of next four quarterly calculation
periods (year 2);&nbsp;and $248 for each of the next four quarterly calculation periods (year 3)&nbsp;(total of $1,765). For each quarterly calculation period beginning with the seventeenth
quarterly calculation period and ending on the tenth </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-16</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=195,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=385742,FOLIO='F-16',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;215',USER='DBEMBEN',CD=';9-JUN-2016;00:07' -->
<A NAME="page_fq12201_1_17"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March 31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE 5&nbsp;&#151; Asset Purchase Agreement (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>anniversary
of the commercialization date, the Company will make quarterly payments equal to 6% of the sale of the ACTitouch product and 5% on the sale of SMM. If ACTitouch System and SMM sales in any
calendar year in years five through ten exceed $40,000, the sales percentage amount shall equal 6% of the sales of product up to $40,000 and 7% on the sales of product over $40,000. The Company
determined the transaction did not qualify as a purchase of a business acquisition and as such, recorded the transaction as an asset purchase which requires the Company to record the transaction at
cost, including transaction costs of $285. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Company allocated the assets acquired as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Inventory (included in prepaid expenses)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>327</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Equipment and tooling</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 997</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Patents</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3,363</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>In-process research and development (IPR&amp;D)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,125 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6,812 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->

 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
net present value of the guaranteed quarterly minimum payments of $1,765 discounted at 7% (or $1,527) in the first three years from the commercialization date have been included in the acquisition
price as this portion of the contingent consideration is reasonably estimated and probable. The Company allocated the cost of the technology for the SMM to IPR&amp;D as it does not have an alternative
future use and requires considerable research and development in the future to bring any potential product to market. This was charged to expense. In addition, the Company recorded a loss on
impairment of assets acquired of $264 for the year ended December&nbsp;31, 2012. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;6&nbsp;&#151; Line of Credit&nbsp;&#151; Bank  </B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>
The Company had a $2,000 line of credit with a bank that bore interest at prime (3.25% as of December&nbsp;31, 2014), which expired on May&nbsp;11, 2015. In May 2015, the Company renewed its
credit line with Venture Bank. This transaction did not result in any debt extinguishment losses or gains. The Company's credit line bears interest based on the prime rate, which was 3.50% as of
December&nbsp;31, 2015, and expires on May&nbsp;11, 2016. The Company's credit line is secured by substantially all its assets, including property and equipment, accounts receivable and inventory.
The Company's credit line contains customary conditions to borrowing, events of default and covenants, including covenants that restrict the Company's ability to dispose of assets, merge with or
acquire other entities, incur indebtedness and encumbrances. In addition, the Company complied with certain financial covenants relating to liquidity and leverage ratios until the renewal in May 2015
that released the Company from its covenant obligations. There was no outstanding balance on the line of credit as of December&nbsp;31, 2014 or&nbsp;2015 or as of March&nbsp;31, 2016.


</FONT>

</P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-17</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=196,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=919530,FOLIO='F-17',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;215',USER='DBEMBEN',CD=';9-JUN-2016;00:07' -->
<A NAME="page_fq12201_1_18"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March 31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;7&nbsp;&#151; Commitments and Contingencies  </B></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Lease Obligation  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In March 2008, the Company entered into a non-cancelable operating lease agreement for building space for its corporate headquarters which provides
for monthly rent, real estate taxes and operating expenses that expired July&nbsp;31, 2015. In December 2012, the Company extended its lease to July&nbsp;31, 2020. In June 2013, the Company
extended the lease to July&nbsp;31, 2021. Rent expense was $750 and $866 for the years ended December&nbsp;31, 2014 and 2015, respectively, and $197 and $226 for the three month periods ended
March&nbsp;31, 2015 and 2016, respectively. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Company also has operating lease agreements for certain computer and office equipment that expire in 2016. The leases provide an option to purchase the related equipment at fair market value at
the end of the lease. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Future
base minimum lease payments for all lease obligations are expected to be as follows for the years ending December&nbsp;31: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="79pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Building </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Computer/Office </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Total </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2016 (remaining)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>347</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>30</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>377</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 475</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 495</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2018</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 489</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 507</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2019</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 504</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 11</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 515</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>2020</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 519</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 520</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Thereafter</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 308</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 308 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,642</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>80</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,722 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Major Vendors  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>During the year ended December&nbsp;31, 2014, the Company had purchases from one vendor that accounted for 27% of total purchases. The Company had
purchases from two vendors that accounted for 14% and 13% of total purchases during the year ended December&nbsp;31, 2015. The Company had purchases from two vendors that accounted for 18% and 14%
of total purchases for the three months ended March&nbsp;31, 2015, and 12% and 11% of total purchases for the three months ended March&nbsp;31, 2016. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Purchase Commitments  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company issued purchase orders in 2015 totalling $3,658 for inventory that it expects to receive between April and August 2016. The Company also
issued purchase orders in February 2016 totaling $8,098 for inventory that it expects to receive between September 2016 and July 2017. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-18</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=197,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=412550,FOLIO='F-18',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;215',USER='DBEMBEN',CD=';9-JUN-2016;00:07' -->
<A NAME="page_fq12201_1_19"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March 31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;7&nbsp;&#151; Commitments and Contingencies (Continued) </B></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Employment Agreements  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company has entered into employment agreements with certain officers of the Company. The agreements require severance ranging from six to twelve
months as defined in the agreements for termination without cause. One severance agreement also requires an amount equal to one year of the annual bonus payable for the calendar year preceding the
termination date as defined in the agreement for termination without cause. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Deferred Compensation  </I></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>Deferred compensation consists of 47,100&nbsp;shares of Restricted Series&nbsp;A Preferred Stock as of December&nbsp;31, 2014, and 45,523 as of
December&nbsp;31, 2015 and March&nbsp;31, 2016. The restricted shares were valued at $4.23 per share and vest upon a Change in Control as defined in the Restricted Stock Agreement.

 </FONT>

</P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
March 2016, the Company's Board of Directors approved the grant of 312,000 stock options and 357,500&nbsp;shares of restricted common stock. These grants are subject to shareholder approval of a
2016 equity incentive plan and the execution of an initial public offering. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Retirement Plan  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company maintains a 401(k) retirement plan for its employees in which eligible employees can contribute a percentage of their compensation. The
Company may also make discretionary contributions. The Company made contributions of $82 and $137 for the years ended December&nbsp;31, 2014 and 2015, respectively, and $31 and $36 for the three
month periods ended March&nbsp;31, 2015 and 2016, respectively. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;8&nbsp;&#151; Stockholders' Equity  </B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>
In September and October 2012, the Company received gross proceeds of $10,400 for issuance of 2,733,468&nbsp;shares of its Series&nbsp;B Preferred Stock at $3.80 per share. The Series&nbsp;B
Preferred Stock includes a liquidation preference of the original investment plus an accruing dividend at a rate of 6%, compounded annually, whether or not declared. The accruing dividend is payable
upon a voluntary or involuntary liquidation or dissolution of the Company, upon conversion of the Series&nbsp;B Preferred Stock to common stock, upon redemption of the Series&nbsp;B Preferred
Stock or at such time as the Company pays a dividend on other shares of its capital stock. The accruing dividend may be paid in cash or, at the option of the stockholder, additional shares of
Series&nbsp;B Preferred Stock determined by dividing the amount of the accruing dividend by the Series&nbsp;B Preferred Stock purchase price as adjusted. There were $1,494 and $2,199 of undeclared
cumulative preferred dividends as of December&nbsp;31, 2014 and 2015, respectively, and $2,396 as of March&nbsp;31, 2016. Holders of shares of Series&nbsp;B Preferred Stock are entitled to votes
equal to the number of shares of common stock into which such Series&nbsp;B Preferred Stock could be converted. Purchasers of the Series&nbsp;B Preferred Stock received anti-dilution rights
whereby if the Company issues or sells additional shares of preferred or common shares at a purchase

</FONT>

</P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-19</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=198,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=256813,FOLIO='F-19',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;215',USER='DBEMBEN',CD=';9-JUN-2016;00:07' -->
<A NAME="page_fq12201_1_20"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March 31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;8&nbsp;&#151; Stockholders' Equity (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


price below $3.80 per share, the Company will issue additional shares to these purchasers of Series&nbsp;B Preferred Stock to effectively reduce their purchase price.


</FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


Each share of Series&nbsp;B Preferred Stock can be converted into equal shares of common stock at the option of the Series&nbsp;B Preferred Stock holder at any time. In addition, the
Series&nbsp;B Preferred Stock shares are automatically convertible into common shares upon the sale of shares of common stock to the public at a price per share of at least $11.42 in a firm
commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, resulting in at least $30,000 of proceeds to the Company, net of
underwriting discounts and commissions and after which the common stock is listed on an United States national securities exchange. Each Series&nbsp;B
Preferred stockholder is also entitled to receive the number of common shares equal to the Series&nbsp;B Preferred Stock original issue price divided by the initial public offering price per share.
In addition, each Series&nbsp;B Preferred stockholder is entitled to receive the number of common shares equal to (1)&nbsp;the accrued dividends on the shares of Series&nbsp;B preferred stock
divided by the original issue price of the Series&nbsp;B preferred stock and (2)&nbsp;the accrued dividends on the shares of Series&nbsp;B preferred stock divided by the initial public offering
price per share in this offering.

 </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


From 2007 through 2009, the Company received gross proceeds of $12,950 for the issuance of 3,061,488&nbsp;shares of its Series&nbsp;A Preferred Stock at $4.23 per share. The Series&nbsp;A
Preferred Stock includes a liquidation preference of the original investment plus an accruing dividend at a rate of 6%, compounded annually, whether or not declared. The accruing dividend is payable
upon a voluntary or involuntary liquidation or dissolution of the Company or upon conversion of the Series&nbsp;A Preferred Stock to common stock, upon redemption of the Series&nbsp;A Preferred
Stock or at such time as the Company pays a dividend on other shares of its capital stock. The accruing dividend will be paid in cash. There were $6,256 and $7,396 of undeclared cumulative preferred
dividends as of December&nbsp;31, 2014 and 2015, respectively, and $7,713 as of March&nbsp;31, 2016. Holders of shares of Series&nbsp;A Preferred Stock are entitled to votes equal to the number
of shares of common stock into which such Series&nbsp;A Preferred Stock could be converted. Purchasers of the Series&nbsp;A Preferred Stock received anti-dilution rights whereby if the Company
issues or sells additional shares of preferred or common shares at a purchase price below $4.23 per share, the Company will issue additional shares to these purchasers of Series&nbsp;A Preferred
Stock to effectively reduce their purchase price. The Series&nbsp;B Preferred Stock was sold at a price less than the Series&nbsp;A Preferred Stock. As a result, the Company will issue
83,972&nbsp;shares of Common Stock for this anti-dilution provision once a liquidation event or other conversion (including an initial public offering) has been declared.

 </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


Each share of Series&nbsp;A Preferred Stock can be converted into equal shares of common stock at the option of the Series&nbsp;A Preferred Stock holder at any time. In addition, the
Series&nbsp;A Preferred Stock shares are automatically convertible into common shares upon the sale of shares of common stock to the public at a minimum price of $11.42 per share in a firm
commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, resulting in at least $30,000 of proceeds to the Company, net of
underwriting discounts and commissions. Each

 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-20</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=199,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=39012,FOLIO='F-20',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;215',USER='DBEMBEN',CD=';9-JUN-2016;00:07' -->
<A NAME="page_fq12201_1_21"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March 31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;8&nbsp;&#151; Stockholders' Equity (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Series&nbsp;A
Preferred stockholder is also entitled to receive the number of common shares equal to the Series&nbsp;A Preferred Stock original issue price divided by the initial public offering
price per share. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>All
shares of preferred stock shall be redeemed by the Company in either a lump sum or three equal annual installments any time after the Company receives notice from one of its two largest preferred
stockholders after September&nbsp;14, 2017. Each share of preferred stock shall be repurchased at its purchase price, as adjusted, plus all unpaid accruing dividends. The Company recorded its
convertible preferred stock at fair value on the dates of issuance, net of issuance costs. As the redemption event is
outside the control of the Company, all shares of convertible preferred stock have been presented outside of permanent equity. The Company has elected to recognize changes in the redemption value
immediately as they occur and adjust the carrying amount of the convertible preferred stock to equal the redemption value at the end of each reporting period. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>At
the time of its issuance, the Company determined that the Series&nbsp;B and Series&nbsp;A preferred stock contained two embedded features: (1)&nbsp;optional redemption by the holder and
(2)&nbsp;optional conversion by the holder. The Company determined that each of the embedded features met the definition of a derivative and that the Series&nbsp;B and Series&nbsp;A preferred
stock should be considered an equity host for the purposes of assessing the embedded derivatives for potential bifurcation. The following was noted regarding these embedded features: </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Optional Redemption by the Holder.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Company determined that the redemption feature was not clearly and closely related to the equity host instrument
but does
not meet the definition of a derivative. As such, the redemption feature did not require bifurcation under the guidance for derivatives. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><I> Optional Conversion by the Holder.</I></FONT><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The optional conversion feature was determined to be clearly and closely related to the Series&nbsp;B and
Series&nbsp;A
preferred stock host. As such the conversion feature did not require bifurcation under ASC&nbsp;815. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Series&nbsp;B and Series&nbsp;A preferred stock was assessed under ASC&nbsp;470, "Debt," to determine if there was a beneficial conversion feature, or BCF. The Company determined there was
no BCF. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following are the preferred stock per share amounts of undeclared cumulative preferred dividends: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
March&nbsp;31,<BR>
2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2> Series&nbsp;A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2.03</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2.43</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2.51</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Series&nbsp;B</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.54</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.82</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.87</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-21</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=200,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=948604,FOLIO='F-21',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;215',USER='DBEMBEN',CD=';9-JUN-2016;00:07' -->
<A NAME="page_fq12201_1_22"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March 31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;8&nbsp;&#151; Stockholders' Equity (Continued) </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock Option Plans  </I></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>During 2003, the Company adopted the 2003 Plan, pursuant to which stock options to acquire an aggregate of 248,223&nbsp;shares of the Company's
common stock may be granted to employees, directors and consultants. In 2003, in connection with the adoption of the 2003 Stock Option Plan (the "2003 Plan"), the board of directors decided they would
no longer grant any options under the 2001 Plan. On March&nbsp;31, 2005, the Company increased the number of authorized shares to 496,446&nbsp;shares. In September 2006, the Company increased the
number of authorized shares to 638,288&nbsp;shares. In general, options vest over a four-year period and expire five to ten years from the date of grant.

 </FONT>

</P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


During 2007, the Company adopted the 2007 Omnibus Stock Option Plan (the "2007 Plan") pursuant to which stock options to acquire an aggregate of 567,367&nbsp;shares of the Company's common stock may
be granted to employees, directors, and consultants. In October 2008, the Company increased the number of authorized shares to 1,010,622. In March 2011, the Company increased the number of authorized
shares to 1,719,831. In September 2012, the Company increased the number of authorized shares to 2,304,928. In October 2014, the Company increased the number of authorized shares to 2,429,039. In
February 2015, the Company increased the number of authorized shares to 2,553,151. With the adoption of the 2007 Plan, the board of directors decided the Company would no longer grant any options
under the 2003 Plan. In general, options granted under the 2007 Plan vest over a four-year period and expire ten years from the date of grant. The Company issues new shares upon the exercise of
options.

</FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-22</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=201,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=264232,FOLIO='F-22',FILE='DISK131:[15ZBY1.15ZBY12201]FQ12201A.;215',USER='DBEMBEN',CD=';9-JUN-2016;00:07' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fs12201_1_23"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March 31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data)  </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;8&nbsp;&#151; Stockholders' Equity (Continued)  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
Information regarding the Company's stock options is summarized below: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="82pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Shares<BR>
available&nbsp;for<BR>
grant </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number<BR>
outstanding </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-average<BR>
exercise<BR>
price </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Aggregate<BR>
intrinsic<BR>
value </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2> Options outstanding&nbsp;&#151; December&nbsp;31, 2013</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
23,402</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
2,467,834</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.79</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Shares reserved</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 124,112</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Granted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (156,558</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 156,558</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1.35</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Exercised</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (399,903</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 0.56</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>161</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Forfeited</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 67,191</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (67,191</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 0.85</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Options outstanding&nbsp;&#151; December&nbsp;31, 2014</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 58,147</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,157,298</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 0.87</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>5,912</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Shares reserved</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 124,112</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Granted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 169,501</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 169,501</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 4.23</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Exercised</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (429,666</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 0.65</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4,569</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Forfeited</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 54,911</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (56,685</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2.26</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Options outstanding&nbsp;&#151; December&nbsp;31, 2015</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
67,669</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
1,840,448</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.18</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>18,573</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Granted (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Exercised (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (118,383</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1.07</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,215</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Forfeited (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 14,243</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (17,934</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3.16</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Options outstanding&nbsp;&#151; March&nbsp;31, 2016 (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
81,912</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
1,704,131</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.18</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>17,218 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Options exercisable&nbsp;&#151; March&nbsp;31, 2016 (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
1,361,442</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.99</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>14,029 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Weighted-average fair value of options granted during the year ended December&nbsp;31, 2014</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.45</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Weighted-average fair value of options granted during the year ended December&nbsp;31, 2015</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8.15</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Weighted-average fair value of options granted during the three month period ended March&nbsp;31, 2016 (unaudited)
</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-23</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=202,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=60650,FOLIO='F-23',FILE='DISK131:[15ZBY1.15ZBY12201]FS12201A.;8',USER='JFUSS',CD=';8-JUN-2016;14:56' -->
<A NAME="page_fs12201_1_24"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March 31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;8&nbsp;&#151; Stockholders' Equity (Continued) </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table summarizes information about stock options outstanding as of December&nbsp;31, 2014: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="97pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Options outstanding </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Options exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Exercise prices </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number<BR>
outstanding </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-<BR>
average remaining<BR>
contractual life-years </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-<BR>
average<BR>
exercise price </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number<BR>
exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-<BR>
average<BR>
exercise price </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> $0.51</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 718,560</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3.18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.51</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
718,560</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.51</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.68</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 376,699</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 8.07</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.68</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
191,439</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.68</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.73</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 190,422</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5.23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.73</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
190,422</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.73</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.96</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 354,604</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 8.79</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.96</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
104,976</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.96</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$1.35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 150,884</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 9.32</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$1.55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 364,356</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 6.48</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
326,984</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$4.23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,773</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 0.07</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4.23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
1,773</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4.23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.51&nbsp;-&nbsp;$4.23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,157,298</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 6.12</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.87</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
1,534,154</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.82</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table summarizes information about stock options outstanding as of December&nbsp;31, 2015: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="97pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Options outstanding </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Options exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Exercise prices </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number<BR>
outstanding </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-<BR>
average remaining<BR>
contractual life-years </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-<BR>
average<BR>
exercise price </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number<BR>
exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-<BR>
average<BR>
exercise price </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> $0.51</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 436,029</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2.54</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.51</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
436,029</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.51</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.68</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 266,961</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 6.99</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.68</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
180,562</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.68</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.73</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 174,465</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 4.24</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.73</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
174,465</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.73</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.96</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 352,978</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 6.95</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.96</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
194,501</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.96</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$1.35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 135,193</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 8.35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
56,955</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$1.55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 325,534</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5.44</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
325,534</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$4.23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 149,288</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 9.16</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4.23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4.23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.51&nbsp;-&nbsp;$4.23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,840,448</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 6.05</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.18</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
1,368,046</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.90 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-24</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=203,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=575704,FOLIO='F-24',FILE='DISK131:[15ZBY1.15ZBY12201]FS12201A.;8',USER='JFUSS',CD=';8-JUN-2016;14:56' -->
<A NAME="page_fs12201_1_25"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March 31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;8&nbsp;&#151; Stockholders' Equity (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following table summarizes information about stock options outstanding as of March&nbsp;31, 2016 (unaudited): </FONT></P>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"150%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="97pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="60pt" style="font-family:times;"></TD>
<TD WIDTH="6%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Options outstanding </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Options exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Exercise prices </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number<BR>
outstanding </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-<BR>
average remaining<BR>
contractual life-years </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-<BR>
average<BR>
exercise price </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number<BR>
exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-<BR>
average<BR>
exercise price </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> $0.51</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 414,178</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2.27</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.51</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
414,178</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.51</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.68</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 213,885</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 6.85</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.68</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
167,634</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.68</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.73</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 170,033</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3.97</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.73</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
170,033</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.73</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.96</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 351,058</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 7.54</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.96</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
214,188</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.96</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$1.35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 115,400</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 8.10</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
59,281</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$1.55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 308,868</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5.20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
308,868</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1.55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$4.23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 130,709</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 8.90</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4.23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
27,260</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4.23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>$0.51&nbsp;-&nbsp;$4.23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,704,131</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,361,442</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following summarizes additional information about the Company's stock options: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
December 31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
March&nbsp;31,<BR>
2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:42pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number of:

<!-- COMMAND=ADD_SCROPPEDRULE,42pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2> Non-vested options beginning of the year</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 794,786</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 623,143</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 472,401</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Non-vested options end of the year</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 623,143</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 472,401</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 342,689</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Vested options</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 322,456</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 304,995</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 129,712</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;<BR></FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
December 31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
March&nbsp;31,<BR>
2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:148pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-average grant date fair value of:

<!-- COMMAND=ADD_SCROPPEDRULE,148pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2> Non-vested options beginning of the year</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.59</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.45</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2.85</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Non-vested options end of the year</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.45</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2.85</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2.74</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Vested options</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.54</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.54</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.68</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Forfeited options</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.45</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3.30</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>6.03</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As
of March&nbsp;31, 2016, there was approximately $755 of unrecognized compensation expense related to stock options not yet vested, which is expected to be recognized over a weighted-average
period of 3.5&nbsp;years. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-25</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=204,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=35357,FOLIO='F-25',FILE='DISK131:[15ZBY1.15ZBY12201]FS12201A.;8',USER='JFUSS',CD=';8-JUN-2016;14:56' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_fu12201_1_26"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March 31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited)  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data)  </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;8&nbsp;&#151; Stockholders' Equity (Continued)  </B></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock Warrants  </I></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The Company has also issued warrants to purchase shares of common stock which are summarized below: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="82pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Number<BR>
outstanding </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-average<BR>
exercise<BR>
price </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2> Warrants outstanding&nbsp;&#151; December&nbsp;31, 2013</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
172,817</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3.84</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Exercised</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Expired</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Warrants outstanding&nbsp;&#151; December&nbsp;31, 2014</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 172,817</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 4.43</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Exercised</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 166,617</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3.81</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Expired</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 400</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Warrants outstanding&nbsp;&#151; December&nbsp;31, 2015</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
5,800</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4.23</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Exercised (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Expired (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Warrants outstanding&nbsp;&#151; March&nbsp;31, 2016 (unaudited)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
5,800</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>4.23</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Information
regarding the warrants outstanding is as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:57%;text-align:center;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"140%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="140%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="7%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="7%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="129pt" style="font-family:times;"></TD>
<TD WIDTH="7%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="7%" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="129pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of December&nbsp;31, 2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of March&nbsp;31, 2016 (unaudited) </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Range of<BR>
exercise&nbsp;prices </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Warrants </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-average remaining<BR>
contractual<BR>
life-years </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Warrants </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Weighted-average remaining<BR>
contractual<BR>
life-years </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> $4.23</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5,800</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1.56</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5,800</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1.32 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;9&nbsp;&#151; Income Taxes  </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
The provision for income tax expense (benefit) consisted of the following: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Three Months Ended<BR>
March&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Current income taxes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>167</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,012</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Deferred income taxes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,558</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 852</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (592</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (801</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total provision for income taxes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,725</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,864</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(592</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(801</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-26</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=205,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=480331,FOLIO='F-26',FILE='DISK131:[15ZBY1.15ZBY12201]FU12201A.;13',USER='DBEMBEN',CD=';9-JUN-2016;00:13' -->
<A NAME="page_fu12201_1_27"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March 31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;9&nbsp;&#151; Income Taxes (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Deferred
income taxes result from temporary differences between the reporting of amounts for financial statement purposes and income tax purposes. These differences relate primarily to different
methods used for income tax purposes including depreciation and amortization, vacation accruals, deductions related to allowances for doubtful accounts, and net operating loss carryforwards. </FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
components of the Company's deferred tax assets are as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>As of<BR>
March&nbsp;31,<BR>
2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Deferred tax assets:</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net operating loss carryforwards</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>874</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>966</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accounts receivable and inventory reserves</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 977</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,253</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,008</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Intangible assets</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 886</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 810</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 736</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Depreciation</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (219</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (243</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (243</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accrued liabilities</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 462</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 309</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 410</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Other</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 40</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 39</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 92 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net deferred tax assets</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,020</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,168</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,969 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net deferred tax assets&nbsp;&#151; current</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,015</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,766</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,641</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net deferred tax assets&nbsp;&#151; long term</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,005</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 402</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 328 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net deferred tax assets</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>3,020</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,168</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,969 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>A
reconciliation of income tax expense (benefit) to the statutory federal tax rate of 34% is as follows: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="28pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="24pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="32pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Three Months Ended<BR>
March&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Tax benefit at statutory rate</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 34.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 34.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (34.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (34.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>State income taxes, net of federal benefit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3.6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (3.1</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (3.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Permanent differences</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3.9</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 8.4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (2.6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (6.2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>State tax rate adjustment</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 9.2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Other and uncertain tax positions</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 4.5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (0.5</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (1.8</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net effective rate</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 45.4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 57.2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (40.2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (45.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)% </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Company adjusted its deferred tax assets by $297 for the year ended December&nbsp;31, 2015 related to a reduction in the state income tax rate used to calculate its deferred tax assets. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-27</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=206,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=611377,FOLIO='F-27',FILE='DISK131:[15ZBY1.15ZBY12201]FU12201A.;13',USER='DBEMBEN',CD=';9-JUN-2016;00:13' -->
<A NAME="page_fu12201_1_28"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March 31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;9&nbsp;&#151; Income Taxes (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For
tax positions meeting the more likely than not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized
upon ultimate settlement with the relevant tax authority. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>With
few exceptions, the Company is no longer subject to U.S. federal, state or local income tax examinations by tax authorities for the years before 2011. The Company is not currently under
examination by any taxing jurisdiction. In the event of any future tax assessments, the Company has elected to record the income taxes and any related interest and penalties as income tax expense on
the Company's statement of operations. </FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;10&nbsp;&#151; Net Income (Loss) Per Share Attributable to Common Stockholders  </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
The following table sets forth the computation of the Company's basic and diluted net income (loss) per share attributable to common stockholders. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:73%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"110%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="110%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Three Months Ended<BR>
March&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2> Net income (loss)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,070</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,393</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(880</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(980</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Preferred stock dividends</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (1,761</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (1,845</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (460</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (514</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Allocation of undistributed earnings to preferred stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (216</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss) attributable to common stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>93</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(452</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,340</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(1,494</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Weighted average shares outstanding</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
2,491,108</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
2,929,438</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
2,640,807</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
3,293,326</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Effect of common stock options</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,306,580</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> &#151; </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Weighted average shares used to compute diluted net income (loss) per share</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3,797,688</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,929,438</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,640,807</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3,293,326</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss) per share&nbsp;&#151; Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
0.04</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(0.15</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(0.51</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
(0.45</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>)</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss) per share&nbsp;&#151; Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.02</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.15</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (0.51</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> (0.45</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
following potentially dilutive securities outstanding were excluded from the computation of weighted shares outstanding for the years ended December&nbsp;31, 2014 and 2015 and for the three </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-28</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=207,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=48125,FOLIO='F-28',FILE='DISK131:[15ZBY1.15ZBY12201]FU12201A.;13',USER='DBEMBEN',CD=';9-JUN-2016;00:13' -->
<A NAME="page_fu12201_1_29"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March 31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;10&nbsp;&#151; Net Income (Loss) Per Share Attributable to Common Stockholders (Continued) </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>months
ended March&nbsp;31, 2015 and 2016, because such securities have an antidilutive impact due to losses reported: </FONT></P>
 <DIV style="padding:0pt;position:relative;width:73%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"110%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="110%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Three Months Ended<BR>
March&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2014 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2> Convertible preferred stock outstanding</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5,794,957</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5,794,957</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5,794,957</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5,794,957</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Common stock options</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,791</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,840,447</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,264,094</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,704,131</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Common stock warrants</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 172,817</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5,800</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 172,817</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5,800</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5,970,565</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 7,641,204</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 8,231,868</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 7,504,888 </FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;11&nbsp;&#151; Unaudited Pro Forma Net Income Per Share Attributable to Common Stockholders  </B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>
The following table sets forth the computation of the Company's unaudited pro forma basic and diluted net income per share attributable to common stockholders during the year ended December&nbsp;31,
2015 and the three months ended March&nbsp;31, 2016 after giving effect to (a)&nbsp;the conversion of all outstanding preferred stock into an aggregate of 5,924,452&nbsp;shares of common stock
immediately prior to the completion of this offering; (b)&nbsp;the issuance of 1,569,549 additional shares of common stock immediately prior to the completion of the offering that the Company's
Series&nbsp;A and Series&nbsp;B preferred stockholders are entitled to receive in connection with its initial public offering, assuming an initial public offering price of $15.00 per share, which
is the midpoint of the estimated offering price range set forth on the cover page of this prospectus; (c)&nbsp;the additional 539,338&nbsp;shares of common stock that would have been required to
be issued to generate sufficient proceeds to fund the cash payment of Series A convertible preferred stock dividends; (d)&nbsp;the issuance of 844,782&nbsp;shares of common stock immediately prior
to the completion of this offering to pay accrued dividends on Series&nbsp;B preferred stock (assuming a closing date of June&nbsp;27, 2016 and assuming an initial public offering price of $15.00
per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus); and (e)&nbsp;the effectiveness of the Company's amended and restated
certificate of incorporation and adoption of the Company's amended and restated bylaws. Unaudited pro forma net income (loss) per share attributable to common stockholders is computed using the
weighted average number of common shares outstanding after giving effect to the items set forth above as if such events had occurred at the beginning of the period presented.


</FONT>

</P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-29</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=208,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=432898,FOLIO='F-29',FILE='DISK131:[15ZBY1.15ZBY12201]FU12201A.;13',USER='DBEMBEN',CD=';9-JUN-2016;00:13' -->
<A NAME="page_fu12201_1_30"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March 31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>


<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;11&nbsp;&#151; Unaudited Pro Forma Net Income Per Share Attributable to Common Stockholders (Continued) </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="74pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="74pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Year Ended<BR>
December&nbsp;31,<BR>
2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Three<BR>
Months<BR>
Ended<BR>
March&nbsp;31,<BR>
2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1><B>(unaudited)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2> Numerator:</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Net income (loss)</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,393</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(980</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Denominator</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Weighted average shares used in computing net income per share attributable to common stock, basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2,929,438</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3,293,326</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma adjustment to reflect conversion of convertible preferred stock into common stock</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5,924,452</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5,942,452</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma adjustment to reflect the issuance of additional shares of common stock to the Series&nbsp;A and Series&nbsp;B
preferred stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,569,549</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1,569,549</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma adjustment to reflect the additional shares of common stock that would have been issued to generate sufficient
proceeds to fund the cash payment of the Series A convertible preferred stock dividends</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 539,338</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 539,338</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma adjustment to reflect the issuance of additional shares of common stock for the payment of cumulative but
unpaid dividends to the Series&nbsp;B preferred stockholders</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 844,782</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 844,782</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma weighted average shares used in computing net income per share attributable to common stockholders,
basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 11,807,560</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 12,171,448</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Effect of common stock options and warrants</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
1,699,830</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2> </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma weighted average shares used in computing net income per share attributable to common stockholders,
diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 13,507,390</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 12,171,448</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Pro forma net income per common share attributable to common stockholders:</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Basic</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.12</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.08</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:30pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Diluted</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>0.10</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>(0.08</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>)</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-30</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=209,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=189931,FOLIO='F-30',FILE='DISK131:[15ZBY1.15ZBY12201]FU12201A.;13',USER='DBEMBEN',CD=';9-JUN-2016;00:13' -->
<A NAME="page_fu12201_1_31"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B><BR>
TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC. </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (Information as of March 31, 2016 and for the three months ended<BR>
March&nbsp;31, 2015 and 2016 is unaudited) </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> (in thousands, except percentages and share data) </B></FONT></P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;12&nbsp;&#151; Subsequent Events  </B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>
For the audited consolidated financial statements, management has reviewed and evaluated material subsequent events from the consolidated balance sheet date of December&nbsp;31, 2015, through the
consolidated financial statements' issue date of March&nbsp;25, 2016. No subsequent events have been identified for disclosure except as disclosed.

 </FONT>

</P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;">


<FONT COLOR="#3B5A6F" SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Interim (unaudited)

 </I></FONT>

</P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>In preparing the accompanying March&nbsp;31, 2016 unaudited consolidated financial statements, the Company evaluated material subsequent events
requiring recognition as of May&nbsp;5, 2016. The Company evaluated disclosures and has appropriately included the effect of these events in the March&nbsp;31, 2016 unaudited Notes to Consolidated
Financial Statements as of June&nbsp;8, 2016.

 </FONT>

</P>

<P style="font-family:times;;margin-left:0pt;text-indent:-0pt;">


<FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:0pt;text-indent:-0pt;" -->


NOTE&nbsp;13&nbsp;&#151; Subsequent Events

 </B></FONT>

</P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>
In connection with the IPO, the Company's board of directors approved a reverse stock split of the Company's common stock on a 1-for-2.820044 basis. The reverse stock split was approved and became
effective on June&nbsp;8, 2016. The par value of the common stock was not adjusted as a result of the reverse stock split. Accordingly, all shares and per share amounts for all periods presented in
these consolidated financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect the reverse stock split.


</FONT>

</P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>F-31</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=210,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=545610,FOLIO='F-31',FILE='DISK131:[15ZBY1.15ZBY12201]FU12201A.;13',USER='DBEMBEN',CD=';9-JUN-2016;00:13' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B>
<IMG SRC="g1002989.jpg" ALT="GRAPHIC" WIDTH="684" HEIGHT="891">
  </B></FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=211,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=484835,FOLIO='blank',FILE='DISK131:[15ZBY1.15ZBY12201]HE12201A.;4',USER='CHE105948',CD=';7-JUN-2016;13:49' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=4><B>4,000,000 Shares

 </B></FONT>

</P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B>TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>Common Stock  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>
<IMG SRC="g820079.jpg" ALT="LOGO" WIDTH="289" HEIGHT="123">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="23%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="23%" ALIGN="CENTER" >


  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B> PROSPECTUS  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=4><B>

<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="23%" ALIGN="CENTER" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="23%" ALIGN="CENTER" >


 </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B>Piper Jaffray  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B> William Blair  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B> Canaccord Genuity  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=5><B> BTIG  </B></FONT></P>
 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
</font></p><p align=center style="font-family:times;"><font> </FONT> <FONT COLOR="#3B5A6F" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=212,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=784665,FOLIO='blank',FILE='DISK131:[15ZBY1.15ZBY12201]HO12201A.;9',USER='CHE108975',CD=';7-JUN-2016;13:14' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ja12201_1_1"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


 </FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ja12201_part_ii_information_not_required_in_prospectus"> </A>
<A NAME="toc_ja12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  PART II    <BR>    <BR>    INFORMATION NOT REQUIRED IN PROSPECTUS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ja12201_item_13._other_expense__ja101979"> </A>
<A NAME="toc_ja12201_2"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B>  Item&nbsp;13.&nbsp;&nbsp;&nbsp;&nbsp;Other Expenses of Issuance and Distribution.    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The following table sets forth the costs and expenses, other than the underwriting discounts and commissions, payable by us in connection with the
sale of common stock being registered. All amounts shown are estimates, except the SEC registration fee, the Financial Industry Regulatory Authority,&nbsp;Inc. filing fee and stock exchange listing
fee. </FONT></P>
 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="84pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Amount </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2> SEC registration fee</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>8,685.38</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>FINRA fee</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>13,437.50</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Stock exchange initial listing fee</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>125,000.00</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Blue sky fees and expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>10,000.00</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Legal fees and expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>1,100,000.00</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Accounting fees and expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>850,000.00</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Printing and engraving expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>250,000.00</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Transfer agent and registrar fees and expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>30,000.00</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Miscellaneous</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>112,877.12</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #3B5A6F 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT COLOR="#3B5A6F" SIZE=2> </FONT><FONT COLOR="#3B5A6F" SIZE=2>Total expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>2,500,000.00</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=1>*</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>To
be filed by amendment </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ja12201_item_14._indemnification_of_directors_and_officers."> </A>
<A NAME="toc_ja12201_3"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B>  Item&nbsp;14.&nbsp;&nbsp;&nbsp;&nbsp;Indemnification of Directors and Officers.    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>We are a corporation organized under the laws of the State of Delaware. Section&nbsp;145 of the Delaware General Corporation Law provides that a
corporation may indemnify any person who was or is a party or is threatened to be made a party to an action by reason of the fact that he or she was a director, officer, employee or agent of the
corporation or is or was serving at the request of the corporation against expenses (including attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him
or her in connection with such action if he or she acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the corporation and, with
respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful, except that, in the case of an action by or in right of the corporation, no
indemnification may generally be made in respect of any claim as to which such person is adjudged to be liable to the corporation. Our amended and restated bylaws, which will become effective upon
completion of this offering, provide that we will indemnify and advance expenses to our directors and officers (and may choose to indemnify and advance expenses to other employees and other agents) to
the fullest extent permitted by law; provided, however, that if we enter into an indemnification agreement with such directors or officers, such agreement controls. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Section&nbsp;102(b)(7)
of the Delaware General Corporation Law permits a corporation to provide in its certificate of incorporation that a director of the corporation shall not be personally liable
to the corporation or its stockholders for monetary damages for breach of fiduciary duties as a director, except for liability for any:</FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> breach of a director's duty of loyalty to the corporation or its stockholders; </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>II-1</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=213,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=201790,FOLIO='II-1',FILE='DISK131:[15ZBY1.15ZBY12201]JA12201A.;41',USER='ABEAULI',CD=';8-JUN-2016;14:59' -->
<A NAME="page_ja12201_1_2"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> unlawful payment of dividends, stock repurchases or redemption of shares; or </FONT><FONT COLOR="#3B5A6F" SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> transaction from which the director derives an improper personal benefit. </FONT></DD></DL>
</UL>
</UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Our
amended and restated certificate of incorporation, which will become effective upon completion of this offering, provides that our directors are not personally liable for breaches of fiduciary
duties to the fullest extent permitted by the Delaware General Corporation Law. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>These
limitations of liability do not apply to liabilities arising under federal securities laws and do not affect the availability of equitable remedies such as injunctive relief or rescission. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


Section&nbsp;145(g) of the Delaware General Corporation Law permits a corporation to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee, or agent of
the corporation. Our amended and restated bylaws, which will become effective upon completion of this offering, permit us to secure insurance on behalf of any officer, director, employee or other
agent for any liability arising out of his or her actions in connection with their services to us, regardless of
whether the Delaware General Corporation Law permits indemnification. We intend to obtain a directors' and officers' liability insurance policy prior to the completion of this offering.

 </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>As
permitted by the Delaware General Corporation Law, we intend to enter into indemnification agreements with each of our directors and officers that require us to indemnify such persons against
various actions including, but not limited to, third-party actions where such director or officer, by reason of his or her corporate status, is a party or is threatened to be made a party to an
action, or by reason of anything done or not done by such director or officer in any such capacity. We intend to indemnify directors and officers against all costs, judgments, penalties, fines,
liabilities, amounts paid in settlement by or on behalf such directors and officers, and for any expenses actually and reasonably incurred by such directors and officers in connection with such
action, if such directors or officers acted in good faith and in a manner they reasonably believed to be in or not opposed to the best interests of the corporation, and with respect to any criminal
proceeding, had no reasonable cause to believe their conduct was unlawful. We also intend to advance to our directors and officers expenses (including attorney's fees) incurred by such directors or
officers in advance of the final disposition of any action after the receipt by us of a statement or statements from directors or officers requesting such payment or payments from time to time,
provided that such statement or statements are accompanied by an undertaking, by or on behalf of such directors or officers, to repay such amount if it shall ultimately be determined that they are not
entitled to be indemnified against such expenses by us. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
indemnification agreements will also set forth certain procedures that will apply in the event of a claim for indemnification or advancement of expenses, including, among others, provisions about
providing notice to us of any action in connection with which a director or officer seeks indemnification or advancement of expenses from us, and provisions concerning the determination of entitlement
to indemnification or advancement of expenses. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Prior
to the completion of this offering we plan to enter into an underwriting agreement, which will provide that the underwriters are obligated, under some circumstances, to indemnify our directors,
officers and controlling persons against specified liabilities.  </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ja12201_item_15._recent_sales_of_unregistered_securities."> </A>
<A NAME="toc_ja12201_4"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B>  Item&nbsp;15.&nbsp;&nbsp;&nbsp;&nbsp;Recent Sales of Unregistered Securities.    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In the three years preceding the filing of this registration statement, we issued the securities indicated below that were not registered under the
Securities Act. All of the following securities are deemed </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>II-2</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=214,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=217209,FOLIO='II-2',FILE='DISK131:[15ZBY1.15ZBY12201]JA12201A.;41',USER='ABEAULI',CD=';8-JUN-2016;14:59' -->
<A NAME="page_ja12201_1_3"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>restricted
securities for purposes of the Securities Act. All certificates representing the issued shares of capital stock described in this Item&nbsp;15 included appropriate legends setting forth
that the securities have not been registered and the applicable restrictions on transfer. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Issuance of Preferred Stock  </B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>In September and October 2012, we sold 2,733,468&nbsp;shares of our Series&nbsp;B preferred stock at the price of $3.80 per share, for aggregate
consideration of $10.4&nbsp;million. No underwriters were involved in the foregoing sales of securities. We believe the offers, sales and issuances of these securities were exempt from registration
under the Securities Act by virtue of Section&nbsp;4(a)(2) and Regulation&nbsp;D promulgated thereunder relative to transactions by an issuer not involving any public offering, to the extent an
exemption from such registration was required. The purchasers of the securities in each of these transactions represented their intentions to acquire the securities for investment only and not with a
view to or for sale in connection with any distribution thereof, and appropriate legends were placed upon the stock certificates issued in these transactions. All purchasers had general access,
through their relationships with us, to information about us. The sales of these securities were made without any general solicitation or advertising.

 </FONT>

</P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Issuance of Common Stock  </B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>From January&nbsp;1, 2015 through December&nbsp;31, 2015, we issued 166,617&nbsp;shares of our common stock upon the exercise of previously
issued warrants at an exercise price of $3.81 per share for aggregate consideration of $635,423. We believe the offers, sales and issuance of the above securities were exempt from registration under
the Securities Act in reliance on Section&nbsp;4(a)(2) because the transactions were pursuant to outstanding warrants. The purchasers of the securities in each of these transactions represented
their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were placed upon the stock
certificates issued in these transactions. All purchasers had general access, through their relationships with us, to information about us. The sales of these securities were made without any general
solicitation or advertising.

 </FONT>

</P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


From January&nbsp;1, 2015 through December&nbsp;31, 2015, we also issued 429,666&nbsp;shares of our common stock upon the exercise of previously issued options at an exercise price of $0.65 per
share for aggregate
consideration of $277,869. We believe the offers, sales and issuance of the above securities were exempt from registration under the Securities Act in reliance on Rule&nbsp;701 because the
transactions were pursuant to compensatory benefit plans or contracts relating to compensation as provided under such rule. The purchasers of the securities in each of these transactions represented
their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were placed upon the stock
certificates issued in these transactions. All purchasers had general access, through their relationships with us, to information about us. The sales of these securities were made without any general
solicitation or advertising.

 </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT COLOR="#3B5A6F" SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock Option Grants  </B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>From January&nbsp;1, 2012 through June&nbsp;8, 2016, we granted stock options to purchase an aggregate of 1,151,223 shares of our common stock at
a weighted-average exercise price of $1.38 per share, to certain of our employees, directors and consultants in connection with services provided to us by these individuals. We believe the offers,
sales and issuance of the above securities were exempt from registration under the Securities Act in reliance on Rule&nbsp;701 because the transactions were pursuant to compensatory benefit plans or
contracts relating to compensation as provided under such rule or

 </FONT>

</P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>II-3</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=215,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=1005422,FOLIO='II-3',FILE='DISK131:[15ZBY1.15ZBY12201]JA12201A.;41',USER='ABEAULI',CD=';8-JUN-2016;14:59' -->
<A NAME="page_ja12201_1_4"> </A>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


pursuant to Section&nbsp;4(a)(2) under the Securities Act relative to transactions by an issuer not involving any public offering, to the extent an exemption from such registration was
required.

 </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ja12201_item_16._exhibits_and_financial_statement_schedules."> </A>
<A NAME="toc_ja12201_5"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B>  Item&nbsp;16.&nbsp;&nbsp;&nbsp;&nbsp;Exhibits and Financial Statement Schedules.    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>See the Exhibit Index following the signature page.  </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ja12201_item_17._undertakings."> </A>
<A NAME="toc_ja12201_6"> </A></FONT> <FONT COLOR="#3B5A6F" SIZE=2><B>  Item&nbsp;17.&nbsp;&nbsp;&nbsp;&nbsp;Undertakings.    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The undersigned registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement, certificates in
such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or
otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is,
therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or
controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </FONT></P>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
undersigned registrant hereby undertakes that: </FONT></P>

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration
statement in reliance upon Rule&nbsp;430A and contained in a form of prospectus filed by the registrant pursuant to Rule&nbsp;424(b)(1) or (4)&nbsp;or 497(h) under the Securities Act shall be
deemed to be part of this registration statement as of the time it was declared effective.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to
be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>For
the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to Rule&nbsp;424(b) as part of a
registration statement relating to an offering, other than registration statements relying on Rule&nbsp;430B or other than prospectuses filed in reliance on Rule&nbsp;430A, shall be deemed to be
part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part
of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as
to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration
statement or made in any such document immediately prior to such date of first use.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>In
a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to
sell the securities to the purchaser, if </FONT></DD></DL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>II-4</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=216,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=180805,FOLIO='II-4',FILE='DISK131:[15ZBY1.15ZBY12201]JA12201A.;41',USER='ABEAULI',CD=';8-JUN-2016;14:59' -->
<A NAME="page_ja12201_1_5"> </A>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A></FONT></P>

<UL>
<UL>

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>the
securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or
sell such securities to such purchaser: </FONT></P>

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>(i)</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any
preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule&nbsp;424;
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>(ii)</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any
free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned
registrant;
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>(iii)</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>The
portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its
securities provided by or on behalf of the undersigned registrant; and
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>(iv)</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Any
other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </FONT></DD></DL>
</UL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>II-5</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=217,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=583712,FOLIO='II-5',FILE='DISK131:[15ZBY1.15ZBY12201]JA12201A.;41',USER='ABEAULI',CD=';8-JUN-2016;14:59' -->
<UL>
<UL>
</UL>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_jc12201_1_6"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="jc12201_signatures"> </A>
<A NAME="toc_jc12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  SIGNATURES    <BR>    </B></FONT></P>

<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Amendment No. 3 to Registration Statement
on Form&nbsp;S-1 to be signed on its behalf by the undersigned, thereunto duly authorized, in Minneapolis, Minnesota, on this 9th day of June, 2016.

 </FONT>

</P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="49%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="21pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="46%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><B> TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>  By:</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>/s/&nbsp;ROBERT J. FOLKES&nbsp;&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Robert J. Folkes<BR>
Chief Operating Officer</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="jc12201_powers_of_attorney"> </A>
<A NAME="toc_jc12201_2"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  POWERS OF ATTORNEY    <BR>    </B></FONT></P>


<P style="font-family:times;">


<FONT COLOR="#3B5A6F" SIZE=2>Pursuant to the requirements of the Securities Act of 1933, this Amendment No. 3 to Registration Statement has been signed by the following persons
in the capacities held on the dates indicated.

</FONT>

</P>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="28pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="35%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="39%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="83pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  COLSPAN=3 ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:33pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Signature

<!-- COMMAND=ADD_SCROPPEDRULE,33pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:17pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Title

<!-- COMMAND=ADD_SCROPPEDRULE,17pt -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH NOWRAP  ALIGN="CENTER" style="font-family:times;"><DIV style="border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;width:17pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Date

<!-- COMMAND=ADD_SCROPPEDRULE,17pt -->

 </B></FONT></DIV></TH>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>*<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Gerald R. Mattys</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Chief Executive Officer (principal executive officer) and Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>June&nbsp;9, 2016</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
*<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Lynn L. Blake</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Chief Financial Officer (principal financial and accounting officer)</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>June&nbsp;9, 2016</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
*<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Peter H. Soderberg</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Chairman of the Board of Directors</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>June&nbsp;9, 2016</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
*<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> William W. Burke</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>June&nbsp;9, 2016</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
*<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Jordan S. Davis</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>June&nbsp;9, 2016</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
*<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Richard Nigon</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>June&nbsp;9, 2016</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
*<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Kevin H. Roche</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>June&nbsp;9, 2016</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
*<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Stephen I. Shapiro</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>June&nbsp;9, 2016</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=3 ALIGN="CENTER" VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>
*<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Zubeen Shroff</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>Director</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>June&nbsp;9, 2016</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>*By:</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>/s/&nbsp;ROBERT J. FOLKES<BR>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#3B5A6F">

</FONT> <FONT COLOR="#3B5A6F" SIZE=2> Robert J. Folkes<BR>
Agent and Attorney-in-Fact</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="CENTER" style="font-family:times;"><BR><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>II-6</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=218,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=256629,FOLIO='II-6',FILE='DISK131:[15ZBY1.15ZBY12201]JC12201A.;33',USER='SSTALKE',CD=';7-JUN-2016;17:34' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ka12201_1_7"> </A>


<!-- COMMAND=ADD_BASECOLOR,"PMS5405" -->


 </FONT> <FONT COLOR="#3B5A6F" SIZE=2>


<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #3B5A6F 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #3B5A6F 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #3B5A6F 1.0pt;margin-bottom:0pt;" -->





<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #3B5A6F 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A HREF="#bg12201a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2><A
NAME="ka12201_exhibit_index"> </A>
<A NAME="toc_ka12201_1"> </A>
<BR></FONT><FONT COLOR="#3B5A6F" SIZE=2><B>  EXHIBIT INDEX    <BR>    </B></FONT></P>
 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
<p style="font-family:times;"></FONT></P>

<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="4pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Exhibit&nbsp;No. </B></FONT></TH>
<TH style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;border-bottom:solid #3B5A6F 1.0pt;"><FONT COLOR="#3B5A6F" SIZE=1><B>Description </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 1.1&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Form of Underwriting Agreement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2.1&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Asset Sale and Purchase Agreement, dated as of September&nbsp;14, 2012, by and between Tactile Systems Technology, Inc., Swelling Solutions, Inc., ConvaTec Inc. and ConvaTec Technologies,
Inc.^</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3.1</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Certificate of Incorporation (to be effective upon completion of the offering)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3.2&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Bylaws (to be effective upon completion of the offering)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3.3</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Certificate of Incorporation (currently in effect)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 3.4&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Bylaws (currently in effect)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 4.1&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Specimen Certificate representing shares of common stock</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 4.2</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Amended and Restated Investors' Rights Agreement dated September&nbsp;14, 2012</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 5.1</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Opinion of Faegre Baker Daniels&nbsp;LLP</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.1#&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2003 Stock Option Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.2#&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Form of Incentive Stock Option Agreement under 2003 Stock Option Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.3#&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Form of Non-Statutory Stock Option Agreement (Employee) under 2003 Stock Option Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.4#&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Form of Non-Statutory Stock Option Agreement (Director) under 2003 Stock Option Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.5#&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2007 Omnibus Stock Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.6#&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Form of Incentive Stock Option Agreement under 2007 Omnibus Stock Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.7#&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Form of Non-Statutory Stock Option Agreement (Employee) under 2007 Omnibus Stock Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.8#&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Form of Non-Statutory Stock Option Agreement (Directors) under 2007 Omnibus Stock Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.9#&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Form of Non-Statutory Stock Option Agreement (Consultants) under 2007 Omnibus Stock Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.10#&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Form of Restricted Stock Agreement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.11#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 2016 Equity Incentive Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.12#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Form of Non-Qualified Stock Option Agreement under 2016 Equity Incentive Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.13#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Form of Incentive Stock Option Agreement under 2016 Equity Incentive Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.14#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Form of Restricted Stock Agreement under 2016 Equity Incentive Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.15#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Form of Restricted Stock Unit Agreement under 2016 Equity Incentive Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.16#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Form of Restricted Stock Unit Agreement under 2016 Equity Incentive Plan (Director&nbsp;RSUs)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.17#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Employee Stock Purchase Plan</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.18#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Non-Employee Director Compensation Policy</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.19#&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Form of Director and Officer Indemnification Agreement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.20#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Form of Employment Agreement between Tactile Systems Technology, Inc. and its named executive officers</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.21</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Promissory Note, dated as of May&nbsp;11, 2014, as amended May&nbsp;11, 2015, by and between Tactile Systems Technology, Inc. and Venture Bank</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.22#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Employment Agreement between Tactile Systems Technology, Inc. and Gerald Mattys</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.23#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Employment Agreement between Tactile Systems Technology, Inc. and Lynn Blake</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 10.24#</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Employment Agreement between Tactile Systems Technology, Inc. and Bryan Rishe</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 21.1&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Subsidiaries</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 23.1</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Consent of Grant Thornton LLP</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 23.2</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Consent of Faegre Baker Daniels&nbsp;LLP (included in Exhibit&nbsp;5.1)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 24.1&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Power of Attorney (included in signature page)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> 24.2&#134;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2> Power of Attorney for Lynn&nbsp;L. Blake</FONT></TD>
</TR>
</TABLE></DIV>

<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#3B5A6F" SIZE="1.0PT" WIDTH="39%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:0%;">
 <DL compact>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>^</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Schedules
to this exhibit have been omitted pursuant to Item&nbsp;601(b)(2) of Regulation S-K. A copy of any omitted schedule will be furnished
supplementally to the Securities and Exchange Commission upon request.

<BR><BR></FONT></DD>

<DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>#</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Indicates
management contract or compensatory plan or arrangement.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT COLOR="#3B5A6F" SIZE=2>&#134;</FONT></DT><DD style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>Previously
filed. </FONT></DD></DL>
 </DIV>
<P ALIGN="CENTER" style="font-family:times;"><FONT COLOR="#3B5A6F" SIZE=2>II-7</FONT></P>

<HR NOSHADE COLOR="#3B5A6F">
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=219,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="1",CHK=496091,FOLIO='II-7',FILE='DISK131:[15ZBY1.15ZBY12201]KA12201A.;45',USER='GPEARMO',CD=';8-JUN-2016;23:01' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>a2228882zex-3_1.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;3.1</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">FOURTH AMENDED AND RESTATED</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CERTIFICATE OF INCORPORATION</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OF</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">Tactile Systems Technology,&nbsp;Inc.,</font> a corporation organized and existing under the laws of the State of Delaware, hereby certifies as follows:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>That the name of the corporation is Tactile Systems Technology,&nbsp;Inc.&#160; The Corporation&#146;s original Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on July&nbsp;21, 2006 under the name Tactile Systems Technology Merger Sub A,&nbsp;Inc. The original Certificate of Incorporation has been subsequently amended, and amended and restated at various times, most recently on June&nbsp;8, 2016, 2016.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Amended and Restated Certificate of Incorporation was duly adopted in accordance with Sections 242 and 245 of the General Corporation Law of the State of Delaware (&#147;<i>DGCL&#148;</i>) and has been duly approved by the written consent of the stockholders of the Corporation in accordance with Section&nbsp;228 of the DGCL.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">C.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Certificate of Incorporation of the Corporation is hereby amended and restated in its entirety to read as follows:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;1</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">NAME</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The name of the Corporation is Tactile Systems Technology,&nbsp;Inc.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;2</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">REGISTERED OFFICE</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The address of the Corporation&#146;s registered office in the State of Delaware is 2711 Centerville Road, Suite&nbsp;400, Wilmington, Delaware 19808, located in New Castle County.&#160; The name of the Corporation&#146;s registered agent for service of process at such address is Corporation Service Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;3</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">PURPOSE</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Purposes</u>.&#160; The Corporation will have general business purposes in accordance with the laws of the State of Delaware.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Powers</u>.&#160; The Corporation will have and may exercise all the powers granted or available under the laws of the State of Delaware and laws amendatory thereof and supplementary thereto, including all powers necessary or convenient to effect any or all of the business purposes for which the Corporation is incorporated.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=915190,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MA_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;4</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">STOCK</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Authorized Capital Stock</u>.&#160; The Corporation shall be authorized to issue 350,000,000 shares of capital stock, of which 300,000,000 shares shall be shares of common stock, par value $0.001 per share (the &#147;<i>Common Stock</i>&#148;), and 50,000,000 shares shall be shares of preferred stock, par value $0.001 per share (the &#147;<i>Preferred Stock</i>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Common Stock</u>.&#160; Except as otherwise provided by law or by the resolution or resolutions adopted by the board of directors of the Corporation designating the rights, powers and preferences of any series of Preferred Stock, the Common Stock shall have the exclusive right to vote for the election of directors and for all other purposes. All shares of Common Stock will be voting shares and will be entitled to one vote per share.&#160; There shall be no cumulative voting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Preferred Stock Rights</u>.&#160; Shares of Preferred Stock may be issued from time to time in one or more series.&#160; The board of directors of the Corporation is hereby authorized by resolution or resolutions to fix the voting rights, if any, designations, powers, preferences and the relative, participation, optional or other rights, if any, and the qualifications, limitations or restrictions thereof, of any unissued series of Preferred Stock, to fix the number of shares constituting such series, and to increase or decrease the number of shares of any such series (but not below the number of shares thereof then outstanding).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;5</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BOARD OF DIRECTORS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Number of Directors; Vacancies and Removal</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Number</u>.&#160; Except as otherwise provided by the resolution or resolutions adopted by the board of directors of the Corporation designating the rights, powers and preferences of any series of Preferred Stock, the number of directors of the Corporation shall be fixed, and may be increased or decreased from time to time, exclusively by the board of directors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Removal</u>.&#160; Subject to the rights, if any, of any series of Preferred Stock to elect directors and to remove any director whom the holders of any such series have the right to elect, any director (including persons elected by directors to fill vacancies in the board of directors) may be removed from office (i)&nbsp;only with cause and (ii)&nbsp;only by the affirmative vote of the holders of 75% or more of the outstanding shares of capital stock then entitled to vote at an election of directors.&#160; At least 45 days prior to any annual or special meeting of stockholders at which it is proposed that any director be removed from office, written notice of such proposed removal and the alleged grounds thereof shall be sent to the director whose removal will be considered at the meeting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Written Ballot</u>.&#160; Unless and except to the extent that the by-laws of the Corporation shall so require, the election of directors of the Corporation need not be by written ballot.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;6</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BY-LAWS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In furtherance and not in limitation of the powers conferred by law, the Board of Directors is expressly authorized to adopt, amend and repeal the by-laws of the Corporation, subject to the power of the holders of capital stock of the Corporation to adopt, amend or repeal the by-laws; provided, however, that, with respect to the power of holders of the capital stock to adopt, amend and repeal by-laws of the</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-MA_PB_2_232819_5631"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=673601,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MA_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Corporation, notwithstanding any other provision of the by-laws or any provision of law which might otherwise permit a lesser vote or no vote, but in addition to any affirmative vote of the holders of any particular class or series of the capital stock of the Corporation required by law, the by-laws or any Preferred Stock, the affirmative vote of the holders of at least 66.67% of the voting power of all of the then-outstanding shares entitled to vote generally in the election of directors, voting together as a single class, shall be required to adopt, amend or repeal any provision of the by-laws of the Corporation.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;7</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">AMENDING THE CERTIFICATE OF INCORPORATION</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Corporation reserves the right at any time from time to time to amend, alter, change or repeal any provision contained in this Certificate of Incorporation, and any other provisions authorized by the laws of the State of Delaware at the time in force may be added or inserted, in the manner now or hereafter prescribed by law. All rights, preferences and privileges of whatsoever nature conferred upon stockholders, directors or any other persons whomsoever by and pursuant to this Certificate of Incorporation in its present form or as hereafter amended are granted subject to the right reserved in this Article.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;8</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">DIRECTOR LIABILITY; INDEMNIFICATION AND INSURANCE</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Elimination of Certain Liability of Directors</u>.&#160; The personal liability of the directors of the Corporation shall be eliminated to the fullest extent permitted by law.&#160; If the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Corporation shall be eliminated or limited to the fullest extent permitted by the DGCL, as so amended.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Indemnification</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Right to Indemnification</u>.&#160; Each person who was or is made a party or is threatened to be made a party to or is involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (hereinafter a &#147;<i>proceeding</i>&#148;), by reason of the fact that he or she, or a person of whom he or she is the legal representative, is or was a director or officer of the Corporation or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, limited liability company, trust or other enterprise, including service with respect to employee benefit plans maintained or sponsored by the Corporation, whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee or agent or in any other capacity while serving as a director, officer, employee or agent, shall be indemnified and held harmless by the Corporation to the fullest extent authorized by the DGCL, as the same exists or may hereafter be amended (but, in the case of any such amendment, to the fullest extent permitted by law, only to the extent that such amendment permits the Corporation to provide broader indemnification rights than said law permitted the Corporation to provide prior to such amendment), against all expense, liability and loss (including attorneys&#146; fees, judgments, fines, amounts paid or to be paid in settlement, and excise taxes or penalties arising under the Employee Retirement Income Security Act of 1974) reasonably incurred or suffered by such person in connection therewith and such indemnification shall continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of his or her heirs, executors and administrators; <u>provided</u>, <u>however</u>, that, except as provided in</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-MA_PB_3_232833_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=903900,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MA_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">paragraph (b)&nbsp;below, the Corporation shall indemnify any such person seeking indemnification in connection with a proceeding (or part thereof) initiated by such person only if such proceeding (or part thereof) was authorized by the board of directors of the Corporation. The right to indemnification conferred in this Article&nbsp;shall be a contract right and shall include the right to be paid by the Corporation the expenses incurred in defending any such proceeding in advance of its final disposition; <u>provided</u>, <u>however</u>, that, if the DGCL requires, the payment of such expenses incurred by a director or officer in his or her capacity as a director or officer (and not in any other capacity in which service was or is rendered by such person while a director or officer, including, without limitation, service to an employee benefit plan) in advance of the final disposition of a proceeding, shall be made only upon delivery to the Corporation of an undertaking, by or on behalf of such director or officer, to repay all amounts so advanced if it shall ultimately be determined that such director or officer is not entitled to be indemnified under this Article&nbsp;or otherwise. The Corporation may, by action of the board of directors, provide indemnification to employees and agents of the Corporation with the same scope and effect as the foregoing indemnification of directors and officers.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Right of Claimant to Bring Suit</u>. If a claim under paragraph (a)&nbsp;above is not paid in full by the Corporation within 30 days after a written claim has been received by the Corporation, the claimant may at any time thereafter bring suit against the Corporation to recover the unpaid amount of the claim and, if successful in whole or in part, the claimant shall be entitled to be paid also the expense of prosecuting such claim. It shall be a defense to any such action (other than an action brought to enforce a claim for expenses incurred in defending any proceeding in advance of its final disposition where the required undertaking, if any is required, has been tendered to the Corporation) that the claimant has not met the standards of conduct which make it permissible under the DGCL for the Corporation to indemnify the claimant for the amount claimed, but the burden of proving such defense shall be on the Corporation. Neither the failure of the Corporation (including its board of directors, independent legal counsel, or its stockholders) to have made a determination prior to the commencement of such action that indemnification of the claimant is proper in the circumstances because he or she has met the applicable standard of conduct set forth in the DGCL, nor an actual determination by the Corporation (including its board of directors, independent legal counsel, or its stockholders) that the claimant has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that the claimant has not met the applicable standard of conduct.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Non-Exclusivity of Rights</u>. The right to indemnification and the payment of expenses incurred in defending a proceeding in advance of its final disposition conferred in this Article&nbsp;shall not be exclusive of any other right which any person may have or hereafter acquire under any statute, provision of the Certificate of Incorporation (as it may be amended from time to time), by-law, agreement, vote of stockholders or disinterested directors or otherwise.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Insurance</u>.&#160; The Corporation may maintain insurance, at its expense, to protect itself and any director, officer, employee or agent of the Corporation or another corporation, partnership, limited liability company, joint venture, trust or other enterprise against any such expense, liability or loss, whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the DCGL.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Amendment or Repeal</u>.&#160; No amendment, modification or repeal of this Article, adoption of any provision in this Certificate of Incorporation, or change in the law or interpretation of the law</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-MA_PB_4_232845_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=786988,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MA_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">shall adversely affect any right or protection of any person under this Article&nbsp;8 with respect to any act or omission that occurred prior to the time of such amendment, modification, repeal, adoption or change.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;9</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">STOCKHOLDER ACTION</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Consent in Lieu of a Meeting</u>. The stockholders of the Corporation may not act by written consent in lieu of meeting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Right to Call a Special Meeting</u>.&#160; Except as otherwise required by law, special meetings of stockholders of the Corporation for any purpose or purposes may be called only by the Board of Directors, the Chairman of the Board or the Chief Executive Officer of the Corporation.&#160; Special meetings of the stockholders may not be called by any other person or persons.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;10</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">DISPUTE RESOLUTION</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Exclusive Forum</u>.&#160; Unless the Corporation consents in writing to the selection of an alternative forum, any or all internal corporate claims, which shall include claims, including claims in the right of the Corporation, (i)&nbsp;that are based upon a violation of a duty by a current or former director or officer or stockholder in such capacity, or (ii)&nbsp;as to which Title 8 of the DGCL confers jurisdiction upon the Delaware Court of Chancery, shall be brought solely and exclusively in a state court located within the State of Delaware (or, if no state court located in the State of Delaware has jurisdiction, the federal district court for the District of Delaware).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-MA_PB_5_232900_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=1034013,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MA_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">IN WITNESS WHEREOF, </font>Tactile Systems Technology,&nbsp;Inc. has caused this Fourth Amended and Restated Certificate of Incorporation to be signed by the Chief Executive Officer of the Corporation on this ____ day of ______, 2016.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gerald R. Mattys, Chief Executive   Officer</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;text-indent:3.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">[Signature Page&nbsp;to Fourth Amended and Restated Certificate of Incorporation]</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="2",CHK=966806,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MA_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.3
<SEQUENCE>3
<FILENAME>a2228882zex-3_3.htm
<DESCRIPTION>EX-3.3
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;3.3</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">THIRD AMENDED AND RESTATED</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CERTIFICATE OF INCORPORATION</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OF</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Pursuant to Sections&nbsp;242 and 245 of the<br> General Corporation Law of the State of Delaware)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tactile Systems Technology,&nbsp;Inc., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the &#147;<b>General Corporation Law</b>&#148;),</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">DOES HEREBY CERTIFY:</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>That the name of this corporation is Tactile Systems Technology,&nbsp;Inc., and that this corporation was originally incorporated pursuant to the General Corporation Law on July&nbsp;21, 2006 under the name Tactile Systems Technology Merger Sub A,&nbsp;Inc.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>That on September&nbsp;14, 2012, this corporation filed an Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">3.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>That the Board of Directors duly adopted resolutions proposing further to amend and restate the Certificate of Incorporation of this corporation in the form of this Third Amended and Restated Certificate of Incorporation, declaring said Third Amended and Restated Certificate of Incorporation to be advisable and in the best interests of this corporation and its stockholders, and authorizing the appropriate officers of this corporation to solicit the consent of the stockholders therefor, which resolution setting forth the proposed Third Amended and Restated Certificate of Incorporation is as follows:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">RESOLVED</font></b>, that the Amended and Restated Certificate of Incorporation of this corporation be further amended and restated in its entirety to read as follows:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">FIRST</font></b>: The name of this corporation is Tactile Systems Technology,&nbsp;Inc. (the &#147;<b>Corporation</b>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SECOND</font></b>:&#160; The name of the registered agent and the address of the registered office of the Corporation in the State of Delaware are:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">c/o Corporation Service Company<br> 2711 Centerville Road, Suite&nbsp;400<br> Wilmington, Delaware 19808<br> County of New Castle</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">THIRD</font></b>:&#160; The nature of the business or purposes to be conducted or promoted is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">FOURTH</font></b>:&#160; For purposes hereof, the term &#147;<b><u style="font-weight:bold;">Reverse Split Ratio</u></b>&#148; means one (1)&nbsp;divided by 2.820044. Immediately upon the filing of this Amended and Restated Certificate of Incorporation, (i)&nbsp;the number of shares of Common Stock held by each holder of Common Stock will be combined and converted into such number of shares multiplied by the Reverse Split Ratio, (ii)&nbsp;the number of shares of Series&nbsp;A Preferred Stock held by each holder of Series&nbsp;A Preferred Stock will be combined and converted into such number of shares multiplied by the Reverse Split Ratio, and (iii)&nbsp;the number of shares of Series&nbsp;B Preferred Stock held by each holder of Series&nbsp;B Preferred Stock will be combined and converted into such number of shares multiplied by the Reverse Split Ratio (the occurrence of all combinations and conversions set forth in (i)-(iii), the &#147;<b><u style="font-weight:bold;">Reverse Split</u></b>&#148;). No fractional shares shall be issued upon the Reverse Split. In lieu of the issuance of fractional shares and in accordance with Section&nbsp;155 of the General Corporation Law, the corporation shall pay in cash the fair value of such fraction of a share as of </p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=242630,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 23:35 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">the consummation of the Reverse Split as determined by the corporation&#146;s Board of Directors. Each outstanding stock certificate of the corporation, which represented one or more shares of the corporation&#146;s Common Stock, Series&nbsp;A Preferred Stock, or Series&nbsp;B Preferred Stock, as the case may be, shall immediately after the Reverse Split represent that number of shares of Common Stock, Series&nbsp;A Preferred Stock, and Series&nbsp;B Preferred Stock, as applicable, resulting from the Reverse Split (such adjusted shares, the &#147;<b><u style="font-weight:bold;">Reverse Split Shares</u></b>&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The corporation shall, upon the request of a record holder of a certificate representing shares of the Common Stock, Series&nbsp;A Preferred Stock, or Series&nbsp;B Preferred Stock of the corporation issued and outstanding immediately before the date hereof, issue and deliver to such holder in exchange for such certificate a new certificate or certificates representing the Reverse Split Shares.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All further references to share and per share amounts set forth in this Amended and Restated Certificate of Incorporation which would be affected by the Reverse Split have been appropriately adjusted to reflect the Reverse Split.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The total number of shares of all classes of stock which the Corporation shall have authority to issue is (i)&nbsp;14,184,175 shares of Common Stock, $0.001 par value per share (&#147;<b>Common Stock</b>&#148;), and (ii)&nbsp;8,431,219 shares of Preferred Stock, $0.001 par value per share (&#147;<b>Preferred Stock</b>&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following is a statement of the designations and the powers, privileges and rights, and the qualifications, limitations or restrictions thereof, in respect of each class of capital stock of the Corporation.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">A.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>COMMON STOCK</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>General</u>.&#160; The voting, dividend and liquidation rights of the holders of the Common Stock are subject to and qualified by the rights, powers and preferences of the holders of the Preferred Stock set forth herein.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Voting</u>.&#160; The holders of the Common Stock are entitled to one vote for each share of Common Stock held at all meetings of stockholders (and written actions in lieu of meetings); <u>provided</u>, <u>however</u>, that, except as otherwise required by law, holders of Common Stock, as such, shall not be entitled to vote on any amendment to the Certificate of Incorporation that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to the Certificate of Incorporation or pursuant to the General Corporation Law.&#160; There shall be no cumulative voting.&#160; The number of authorized shares of Common Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by (in addition to any vote of the holders of one or more series of Preferred Stock that may be required by the terms of the Certificate of Incorporation) the affirmative vote of the holders of shares of capital stock of the Corporation representing a majority of the votes represented by all outstanding shares of capital stock of the Corporation entitled to vote, irrespective of the provisions of Section&nbsp;242(b)(2)&nbsp;of the General Corporation Law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">B.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>PREFERRED STOCK</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3,112,152 shares of the authorized and unissued Preferred Stock of the Corporation are hereby designated &#147;<b>Series&nbsp;A Preferred Stock</b>&#148; and 5,319,066 shares of the authorized and unissued Preferred Stock of the Corporation are hereby designated &#147;<b>Series&nbsp;B Preferred Stock</b>&#148;.&#160; The shares of Series&nbsp;A Preferred Stock and Series&nbsp;B Preferred Stock shall have the following rights, preferences, powers, privileges, restrictions, qualifications and limitations. Unless otherwise indicated, references to &#147;Sections&#148; or &#147;Subsections&#148; in this Part&nbsp;B of this Article&nbsp;<u>Fourth</u> refer to sections and subsections of Part&nbsp;B of this <u>Article&nbsp;Fourth</u>.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-MC-01_PB_2_233256_839"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=475857,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 23:35 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Dividends</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Dividends on the Series&nbsp;A Preferred Stock</u>.&#160; From and after the date of the issuance of any shares of Series&nbsp;A Preferred Stock, dividends at the rate of 6% of the Series&nbsp;A Original Issue Price per share per annum shall accrue on such shares of Series&nbsp;A Preferred Stock (the &#147;<b>Series&nbsp;A Accruing Dividends</b>&#148;).&#160; Series&nbsp;A Accruing Dividends shall accrue from day to day, whether or not declared, and shall compound on each anniversary of the date on which the first share of Series&nbsp;A Preferred Stock was issued and shall be payable (a)&nbsp;subject to <u>Subsection 1.3.1</u>, when, as and if declared by the Board of Directors of the Corporation (the &#147;<b>Board of Directors</b>&#148;) out of funds legally available therefor, (b)&nbsp;whether or not declared, upon a liquidation, dissolution or winding up of the Corporation (including any Deemed Liquidation Event), (c)&nbsp;whether or not declared, upon conversion of such shares of Series&nbsp;A Preferred Stock or (d)&nbsp;whether or not declared, upon redemption of the shares of Series&nbsp;A Preferred Stock by the Corporation.&#160; If any shares of Series&nbsp;A Preferred Stock are transferred, all accrued but unpaid Series&nbsp;A Accruing Dividends on such shares at the time of such transfer shall be transferred with such shares and the transferee shall be entitled to receive all such accrued but unpaid Series&nbsp;A Accruing Dividends, together with all Series&nbsp;A Accruing Dividends that accrue on and after the time of such transfer, upon any payment event set forth herein occurring after such transfer as if such transferee had held such shares from the Corporation&#146;s original issuance of such shares.&#160; The amount of all such accrued but unpaid Series&nbsp;A Accruing Dividends shall be payable in cash.&#160; The &#147;<b>Series&nbsp;A Original Issue Price</b>&#148; shall mean $4.2301 per share, subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Series&nbsp;A Preferred Stock.</p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Dividends on the Series&nbsp;B Preferred Stock</u>.&#160; From and after the date of the issuance of any shares of Series&nbsp;B Preferred Stock, dividends at the rate of 6% of the Series&nbsp;B Original Issue Price per share per annum shall accrue on such shares of Series&nbsp;B Preferred Stock (the &#147;<b>Series&nbsp;B Accruing Dividends</b>&#148;).&#160; Series&nbsp;B Accruing Dividends shall accrue from day to day, whether or not declared, and shall compound on each anniversary of the Series&nbsp;B Original Issue Date and shall be payable (a)&nbsp;subject to <u>Subsection 1.3.1</u>, when, as and if declared by the Board of Directors out of funds legally available therefor, (b)&nbsp;whether or not declared, upon a liquidation, dissolution or winding up of the Corporation (including any Deemed Liquidation Event), (c)&nbsp;whether or not declared, upon conversion of such shares of Series&nbsp;B Preferred Stock or (d)&nbsp;whether or not declared, upon redemption of the shares of Series&nbsp;B Preferred Stock by the Corporation.&#160; If any shares of Series&nbsp;B Preferred Stock are transferred, all accrued but unpaid Series&nbsp;B Accruing Dividends on such shares at the time of such transfer shall be transferred with such shares and the transferee shall be entitled to receive all such accrued but unpaid Series&nbsp;B Accruing Dividends, together with all Series&nbsp;B Accruing Dividends that accrue on and after the time of such transfer, upon any payment event set forth herein occurring after such transfer as if such transferee had held such shares from the Corporation&#146;s original issuance of such shares.&#160; Notwithstanding any other provision set forth herein, the amount of the accrued but unpaid Series&nbsp;B Accruing Dividends in respect of the shares of Series&nbsp;B Preferred Stock shall be payable in cash or, at the option of the holder of such shares of Series&nbsp;B Preferred Stock, in additional shares of Series&nbsp;B Preferred Stock (such number of shares of Series&nbsp;B Preferred Stock shall be determined by dividing the amount of such accrued but unpaid Series&nbsp;B Accruing Dividends in respect of such shares by the Series&nbsp;B Original Issue Price).&#160; The Corporation shall provide the holders of Series&nbsp;B Preferred Stock with at least 15 days prior written notice of any proposed authorization, declaration, set aside or payment of Series&nbsp;B Accruing Dividends and such holders shall have the right, within such 15 day period, to elect whether to receive such Series&nbsp;B Accruing Dividends in the form of cash or in the form of additional shares of Series&nbsp;B Preferred Stock as set forth herein; <u>provided that</u> such 15 day prior written notice shall not be required in connection with any voluntary conversion of shares of Series&nbsp;B Preferred Stock made by the holder thereof in accordance with <u>Subsection 4</u> (in such case, the holder of such shares of Series&nbsp;B Preferred Stock shall make such election contemporaneously with, or within a reasonable time after, such holder&#146;s election to convert such shares of Series&nbsp;B Preferred Stock into shares of Common Stock in accordance with <u>Subsection 4</u> hereof) but such 15 day prior written notice shall be required in connection with any mandatory conversion of shares of Series&nbsp;B Preferred Stock in accordance with <u>Subsection 5</u>; and <u>provided further</u> that if no such election </p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-MC-01_PB_3_233313_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=233758,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 23:35 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">is made by any such holder then all Series&nbsp;B Accruing Dividends payable in respect of the shares of Series&nbsp;B Preferred Stock held by such holder at such time shall be made in the form of additional shares of Series&nbsp;B Preferred Stock as set forth herein.&#160; At the time of any such payment on the shares of Series&nbsp;B Preferred Stock in the form of additional shares of Series&nbsp;B Preferred Stock, if the number of authorized but unissued shares of Series&nbsp;B Preferred Stock shall not be sufficient to effect such payment in additional shares of Series&nbsp;B Preferred Stock, in addition to such other remedies as shall be available to the holders of Series&nbsp;B Preferred Stock, the Corporation will take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of Series&nbsp;B Preferred Stock to such number of shares as shall be sufficient for such purpose including, without limitation, engaging in best efforts to obtain the requisite stockholder approval of any necessary amendment to the Certificate of Incorporation.&#160; The &#147;<b>Series&nbsp;B Original Issue Price</b>&#148; shall mean $3.8048 per share, subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Series&nbsp;B Preferred Stock; provided that no adjustment to the Series&nbsp;B Original Issue Price shall be made as a result of the payment of the Series&nbsp;B Accruing Dividends in the form of additional shares of Series&nbsp;B Preferred Stock.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Dividend Payments</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.3.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Other than in connection with (a)&nbsp;a liquidation, dissolution or winding up of the Corporation (including any Deemed Liquidation Event), (b)&nbsp;conversion of the shares of Preferred Stock or (c)&nbsp;redemption of the shares of Preferred Stock by the Corporation, the Corporation shall not declare, pay or set aside any dividend or other distribution on any series of Preferred Stock of the Corporation (other than dividends on shares of such series of Preferred Stock payable in shares of the same such series of Preferred Stock) unless and until: (i)&nbsp;all consents required elsewhere in the Certificate of Incorporation have been obtained by the Corporation, (ii)&nbsp;prior to or contemporaneously with the declaration, payment or set aside of such dividend or distribution, all Series&nbsp;A Accruing Dividends on all then outstanding shares of Series&nbsp;A Preferred Stock have been paid in full to the holders thereof and all Series&nbsp;B Accruing Dividends on all then outstanding shares of Series&nbsp;B Preferred Stock have been paid in full to the holders thereof and (iii)&nbsp;except in the case of the declaration, payment or set aside of the Series&nbsp;A Accruing Dividends in respect of the Series&nbsp;A Preferred Stock or the declaration, payment or set aside of the Series&nbsp;B Accruing Dividends in respect of the Series&nbsp;B Preferred Stock, contemporaneously with the declaration, payment or set aside of such dividend or distribution, the Corporation also declares, pays or sets aside, as the case may be, a ratable dividend or distribution on each share of the other series of Preferred Stock, on a pari passu basis, in an amount equal to the product of (A)&nbsp;the amount of the dividend or distribution payable on all outstanding shares of such series of Preferred Stock divided by the number of shares of Common Stock issuable upon conversion of all outstanding shares of such series of Preferred Stock and (B)&nbsp;the number of shares of Common Stock issuable upon conversion of one share of such other series of Preferred Stock, in each case calculated on the record date for determination of holders entitled to receive such dividend.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.3.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Corporation shall not declare, pay or set aside any dividend or other distribution on the Common Stock (other than dividends on shares of Common Stock payable in shares of Common Stock) unless and until: (a)&nbsp;all consents required elsewhere in the Certificate of Incorporation have been obtained by the Corporation, (b)&nbsp;prior to or contemporaneously with the declaration, payment or set aside of such dividend or distribution, all Series&nbsp;A Accruing Dividends on all then outstanding shares of Series&nbsp;A Preferred Stock have been paid in full to the holders thereof and all Series&nbsp;B Accruing Dividends on all then outstanding shares of Series&nbsp;B Preferred Stock have been paid in full to the holders thereof and (c)&nbsp;contemporaneously with the declaration, payment or set aside of such dividend or distribution, the Corporation also declares, pays or sets aside, as the case may be, a ratable dividend or distribution on each share of Preferred Stock, on a pari passu basis, in an amount equal to the product of (i)&nbsp;the amount of the dividend or distribution payable on one share of Common Stock and (ii)&nbsp;the number of shares of Common Stock issuable upon conversion of such share of Preferred Stock, in each case calculated on the record date for determination of holders entitled to receive such dividend.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-MC-01_PB_4_233324_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=502701,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 23:35 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Liquidation, Dissolution or Winding Up; Certain Mergers, Consolidations and Asset Sales</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Preferential Payments to Holders of Preferred Stock</u>.&#160; In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, the holders of shares of Preferred Stock then outstanding shall be entitled to be paid out of the assets of the Corporation available for distribution to its stockholders before any payment shall be made to the holders of Common Stock by reason of their ownership thereof, an amount per share equal to (a)&nbsp;for each share of Series&nbsp;A Preferred Stock, the Series&nbsp;A Original Issue Price plus all Series&nbsp;A Accruing Dividends accrued but unpaid thereon, whether or not declared, together with any other dividends declared but unpaid thereon and (b)&nbsp;for each share of Series&nbsp;B Preferred Stock, the Series&nbsp;B Original Issue Price plus all Series&nbsp;B Accruing Dividends accrued but unpaid thereon, whether or not declared (to be paid, at the election of the holder thereof, either in cash or in the form of additional shares of Series&nbsp;B Preferred Stock in accordance with <u>Subsection 1</u>), together with any other dividends declared but unpaid thereon.&#160; If upon any such liquidation, dissolution or winding up of the Corporation, the assets of the Corporation available for distribution to its stockholders shall be insufficient to pay the holders of shares of Preferred Stock the full amount to which they shall be entitled under this <u>Subsection 2.1</u>, the holders of shares of Preferred Stock shall share ratably in any distribution of the assets available for distribution in proportion to the respective amounts which would otherwise be payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid in full.</p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Distribution of Remaining Assets</u>.&#160; In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, after the payment of all preferential amounts required to be paid to the holders of shares of Preferred Stock under <u>Subsection 2.1</u>, the remaining assets of the Corporation available for distribution to its stockholders shall be distributed among the holders of the shares of Preferred Stock and Common Stock, pro rata based on the number of shares held by each such holder, treating for this purpose all such securities as if they had been converted to Common Stock pursuant to the terms of the Certificate of Incorporation immediately prior to such dissolution, liquidation or winding up of the Corporation.&#160; The aggregate amount which a holder of a share of Series&nbsp;A Preferred Stock is entitled to receive under <u>Subsections 2.1</u> and <u>2.2</u> is hereinafter referred to as the &#147;<b>Series&nbsp;A Liquidation Amount</b>.&#148;&#160; The aggregate amount which a holder of a share of Series&nbsp;B Preferred Stock is entitled to receive under <u>Subsections 2.1</u> and <u>2.2</u> is hereinafter referred to as the &#147;<b>Series&nbsp;B Liquidation Amount</b>.&#148;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Deemed Liquidation Events</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.3.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Definition</u>.&#160; Each of the following events shall constitute a liquidation, dissolution or winding up of the Corporation and shall be considered a &#147;<b>Deemed Liquidation Event</b>&#148; unless the holders of at least a majority of the outstanding shares of Series&nbsp;A Preferred Stock and the holders of at least 66-2/3% of the outstanding shares of Series&nbsp;B Preferred Stock, voting as separate classes (collectively, the &#147;<b>Required Holders</b>&#148;) elect otherwise by written notice sent to the Corporation:&#160; (a)&nbsp;any transaction or series of related transactions (including, without limitation, any reorganization, share exchange, consolidation or merger of the Corporation with or into any other entity but excluding any sale of capital stock by the Corporation for capital raising purposes) (i)&nbsp;in which the holders of the Corporation&#146;s outstanding capital stock immediately before the first such transaction do not, immediately after any other such transaction, retain stock or other equity interests representing at least 50% of the voting power of the surviving entity of such transaction or (ii)&nbsp;in which at least 50% of the Corporation&#146;s outstanding capital stock (calculated on an as-converted to Common Stock basis) is transferred; or (b)&nbsp;the sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions, by the Corporation or any subsidiary of the Corporation of all or substantially all the assets of the Corporation and its subsidiaries taken as a whole or the sale or disposition (whether by merger or otherwise) of one or more subsidiaries of the Corporation if substantially all of the assets of the Corporation and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries, except </p>
<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-MC-01_PB_5_233338_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=138036,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 23:35 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">where such sale, lease, transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Corporation.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.3.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Effecting a Deemed Liquidation Event</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Unless the Required Holders elect otherwise by written notice sent to the Corporation, the Corporation shall not have the power to effect a Deemed Liquidation Event and no stockholder shall enter into any transaction that constitutes a Deemed Liquidation Event unless the consideration payable to the stockholders and/or the Corporation in such Deemed Liquidation Event shall be allocated among the holders of capital stock of the Corporation in accordance with <u>Subsections 2.1</u> and <u>2.2</u>.</p>
<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In the event of a Deemed Liquidation Event referred to in <u>Subsection 2.3.1(b)</u>, if the Corporation does not effect a dissolution of the Corporation under the General Corporation Law within 90 days after such Deemed Liquidation Event, then (i)&nbsp;the Corporation shall send a written notice to each holder of Preferred Stock no later than the 90th day after the Deemed Liquidation Event advising such holders of their right (and the requirements to be met to secure such right) pursuant to the terms of the following <u>clause (ii)</u>&nbsp;to require the redemption of such shares of Preferred Stock and (ii)&nbsp;if the Required Holders so request in a written instrument delivered to the Corporation not later than 120 days after such Deemed Liquidation Event, the Corporation shall use the consideration received by the Corporation for such Deemed Liquidation Event (net of any retained liabilities associated with the assets sold or technology licensed, as determined in good faith by the Board of Directors), together with any other assets of the Corporation available for distribution to its stockholders (the &#147;<b>Available</b><b> Proceeds</b>&#148;), to the extent legally available therefor, on the 150th day after such Deemed Liquidation Event, to redeem all outstanding shares of Preferred Stock at a price per share equal to (x)&nbsp;for each share of Series&nbsp;A Preferred Stock, the Series&nbsp;A Liquidation Amount and (y)&nbsp;for each share of Series&nbsp;B Preferred Stock, the Series&nbsp;B Liquidation Amount.&#160; Notwithstanding the foregoing, in the event of a redemption pursuant to the preceding sentence, if the Available Proceeds are not sufficient to redeem all outstanding shares of Preferred Stock, the Corporation shall redeem a pro rata portion of each holder&#146;s shares of Preferred Stock to the fullest extent of such Available Proceeds, based on the respective amounts which would otherwise be payable in respect of the shares to be redeemed if the Available Proceeds were sufficient to redeem all such shares, and shall redeem the remaining shares to have been redeemed as soon as practicable after the Corporation has funds legally available therefor.&#160; The provisions of <u>Subsections 6.2</u> through <u>6.4</u> shall apply, with such necessary changes in the details thereof as are necessitated by the context, to the redemption of the Preferred Stock pursuant to this <u>Subsection 2.3.2(b)</u>.&#160; Prior to the distribution or redemption provided for in this <u>Subsection 2.3.2(b)</u>, the Corporation shall not expend or dissipate the consideration received for such Deemed Liquidation Event, except to discharge expenses incurred in connection with such Deemed Liquidation Event or incurred in the ordinary course of business.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.3.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Amount Deemed Paid or Distributed</u>.&#160; The amount deemed paid or distributed to the holders of capital stock of the Corporation upon any such merger, consolidation, sale, transfer, exclusive license, other disposition or redemption shall be the cash or the value of the property, rights or securities paid or distributed to such holders by the Corporation or the acquiring person, firm or other entity.&#160; Subject to <u>Subsection 2.3.4</u>, the value of such property, rights or securities shall be determined in good faith by the Board of Directors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.3.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Contingent Consideration</u>. &#160;Notwithstanding any other provision set forth in this Section&nbsp;2, in the event that any consideration payable to the Corporation and/or its stockholders in connection with any Deemed Liquidation Event is contingent upon the occurrence of any event or the passage of time (including, without limitation, any deferred purchase price payments, installment payments, payments made in respect of any promissory note issued in such transaction, payments from escrow, purchase price adjustment payments or payments in respect of &#147;earnouts&#148; or holdbacks) (the &#147;<b>Contingent Consideration</b>&#148;), such Contingent Consideration shall not be deemed received by the </p>
<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">6<a name="16022-2-MC-01_PB_6_233355_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=533276,FOLIO='6',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 23:35 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">Corporation or its stockholders or available for distribution to such stockholders unless and until such Contingent Consideration is indefeasibly received by the Corporation or its stockholders in accordance with the terms of such Deemed Liquidation Event. The definitive agreement with respect to such Deemed Liquidation Event shall provide that (a)&nbsp;the portion of such consideration that is not Contingent Consideration (the &#147;<b>Initial Consideration</b>&#148;) shall be allocated among the stockholders of the Corporation in accordance with</font>  <u>Subsections 2.1</u> and <u>2.2</u> as if the Initial Consideration were the only consideration payable in connection with such Deemed Liquidation Event and (B)&nbsp;any Contingent Consideration which becomes payable to the Corporation or the stockholders of the Corporation upon the release from escrow or the satisfaction of the applicable contingencies shall be allocated among the stockholders of the Corporation in accordance with <u>Subsections 2.1</u> and <u>2.2</u> after taking into account the previous payment of the Initial Consideration as part of the same transaction.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Voting</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>General</u>.&#160; In addition to any class or series voting rights provided to the holders of Preferred Stock under the Certificate of Incorporation, applicable law or otherwise, on any matter presented to the stockholders of the Corporation for their action or consideration at any meeting of stockholders of the Corporation (or by written consent of stockholders in lieu of meeting), each holder of outstanding shares of Preferred Stock shall be entitled to cast the number of votes equal to the number of whole shares of Common Stock into which the shares of Preferred Stock held by such holder are convertible as of the record date for determining stockholders entitled to vote on such matter and shall be entitled, notwithstanding any provision hereof, to notice of any stockholders&#146; meeting in accordance with the bylaws of the Corporation.&#160; Fractional votes shall not, however, be permitted and any fractional voting rights available on an as-converted to Common Stock basis (after aggregating all fractional shares into which shares of Preferred Stock held by each holder could be converted) shall be rounded to the nearest whole share (with one-half being rounded upward).&#160; Except as provided by law or by the other provisions of the Certificate of Incorporation, holders of Preferred Stock shall vote together with the holders of Common Stock as a single class.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Election of Directors</u>.&#160; The holders of record of the shares of Series&nbsp;A Preferred Stock, exclusively and as a separate class, shall be entitled to elect two directors of the Corporation (the &#147;<b>Series&nbsp;A Directors</b>&#148;), the holders of record of the shares of Series&nbsp;B Preferred Stock, exclusively and as a separate class, shall be entitled to elect two directors of the Corporation (the &#147;<b>Series&nbsp;B Directors</b>&#148;) and the holders of record of the shares of Common Stock, exclusively and as a separate class, shall be entitled to elect three directors of the Corporation.&#160; Any director elected as provided in the preceding sentence may be removed without cause by, and only by, the affirmative vote of the holders of the shares of the class or series of capital stock entitled to elect such director or directors, given either at a special meeting of such stockholders duly called for that purpose or pursuant to a written consent of stockholders.&#160; If the holders of shares of Series&nbsp;A Preferred Stock, Series&nbsp;B Preferred Stock or Common Stock, as the case may be, fail to elect a sufficient number of directors to fill all directorships for which they are entitled to elect directors, voting exclusively and as a separate class, pursuant to the first sentence of this <u>Subsection&nbsp;3.2</u>, then any directorship not so filled shall remain vacant until such time as the holders of the Series&nbsp;A Preferred Stock, Series&nbsp;B Preferred Stock or Common Stock, as the case may be, elect a person to fill such directorship by vote or written consent in lieu of a meeting; and no such directorship may be filled by stockholders of the Corporation other than by the stockholders of the Corporation that are entitled to elect a person to fill such directorship, voting exclusively and as a separate class. The holders of record of the shares of Common Stock and of any other class or series of voting stock (including the Preferred Stock), exclusively and voting together as a single class, shall be entitled to elect the balance of the total number of directors of the Corporation.&#160; At any meeting held for the purpose of electing a director, the presence in person or by proxy of the holders of a majority of the outstanding shares of the class or series entitled to elect such director shall constitute a quorum for the purpose of electing such director.&#160; Except as otherwise provided in this <u>Subsection 3.2</u>, a vacancy in any directorship filled by the holders of any class or series shall be filled only by vote or written consent in lieu of a meeting of the </p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">7<a name="16022-2-MC-01_PB_7_233411_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=71246,FOLIO='7',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 23:35 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">holders of such class or series or by any remaining director or directors elected by the holders of such class or series pursuant to this <u>Subsection 3.2</u>.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Preferred Stock Protective Provisions of the Required Holders</u>.&#160; At any time when any shares of Preferred Stock are outstanding, the Corporation shall not, either directly or indirectly by amendment, merger, consolidation or otherwise, do any of the following without (in addition to any other vote required by law or the Certificate of Incorporation) the written consent of the Required Holders:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>liquidate, dissolve or wind-up the business and affairs of the Corporation or consent to any of the foregoing;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>amend, alter or repeal any provision of the Certificate of Incorporation or Bylaws of the Corporation other than to the extent necessary to create the rights, preferences and privileges of the shares of capital stock permitted to be authorized pursuant to Section&nbsp;3.3(c)(i)&nbsp;without the written consent of the Required Holders;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(i)&nbsp;create, or authorize the creation of, or issue or obligate itself to issue shares of, any class or series of capital stock unless the same ranks junior to, or pari passu with, the Series&nbsp;A Preferred Stock and the Series&nbsp;B Preferred Stock with respect to the distribution of assets on the liquidation, dissolution or winding up of the Corporation, the payment of dividends and rights of redemption, (ii)&nbsp;increase the authorized number of shares of Preferred Stock or any series thereof except with respect to an issuance of capital stock permitted to be authorized pursuant to Section&nbsp;3.3(c)(i)&nbsp;without the written consent of the Required Holders or (iii)&nbsp;increase the authorized number of shares of any additional class or series of capital stock unless the same ranks junior to, or pari passu with, the Series&nbsp;A Preferred Stock and the Series&nbsp;B Preferred Stock with respect to the distribution of assets on the liquidation, dissolution or winding up of the Corporation, the payment of dividends and rights of redemption, in each such case, other than other than issuances of (or in connection with issuances of): (A)&nbsp;shares of Series&nbsp;B Preferred Stock pursuant to the terms of that certain Series&nbsp;B Preferred Stock Purchase Agreement, dated as of or around the Series&nbsp;B Original Issue Date, between the Corporation and the other parties thereto (the &#147;<b>Series&nbsp;B Purchase Agreement</b>&#148;) and (B)&nbsp;shares of Series&nbsp;B Preferred Stock issued in respect of the Series&nbsp;B Accruing Dividends in accordance with the Certificate of Incorporation;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(i)&nbsp;reclassify, alter or amend any existing security of the Corporation that is pari passu with the Series&nbsp;A Preferred Stock or the Series&nbsp;B Preferred Stock in respect of the distribution of assets on the liquidation, dissolution or winding up of the Corporation, the payment of dividends or rights of redemption, if such reclassification, alteration or amendment would render such other security senior to the Series&nbsp;A Preferred Stock or the Series&nbsp;B Preferred Stock in respect of any such right, preference or privilege, or (ii)&nbsp;reclassify, alter or amend any existing security of the Corporation that is junior to the Series&nbsp;A Preferred Stock or the Series&nbsp;B Preferred Stock in respect of the distribution of assets on the liquidation, dissolution or winding up of the Corporation, the payment of dividends or rights of redemption, if such reclassification, alteration or amendment would render such other security senior to or pari passu with the Series&nbsp;A Preferred Stock or the Series&nbsp;B Preferred Stock in respect of any such right, preference or privilege;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>purchase or redeem (or permit any subsidiary to purchase or redeem) or pay or declare any dividend or make any distribution on, any shares of capital stock of the Corporation other than (i)&nbsp;redemptions of the Preferred Stock as expressly authorized herein, (ii)&nbsp;dividends or distributions on any shares of Preferred Stock in connection with (A)&nbsp;a liquidation, dissolution or winding up of the Corporation (including any Deemed Liquidation Event), (B)&nbsp;conversion of the shares of Preferred Stock or (C)&nbsp;redemption of the shares of Preferred Stock by the Corporation, (iii)&nbsp;dividends or other distributions payable on the Common Stock solely in the form of additional shares of Common Stock, (iv)&nbsp;repurchases of stock from former employees, officers, directors, consultants or other persons who performed services for the Corporation or any subsidiary in connection with the cessation of such employment or service at the lower of the original purchase price or the then-current fair </p>
<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">8<a name="16022-2-MC-01_PB_8_233427_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=213367,FOLIO='8',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 23:35 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">market value thereof or (v)&nbsp;as approved by a majority of the members of the Board of Directors that are not interested in such purchase, redemption, dividend or distribution, including the approval of at least one Series&nbsp;A Director and at least one Series&nbsp;B Director;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>create, or authorize the creation of, or issue, or authorize the issuance of, any indebtedness or any debt security if the aggregate indebtedness of the Corporation and its subsidiaries for borrowed money following such action would exceed $5,000,000, or permit any subsidiary to take any such action with respect to any debt security;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(i)&nbsp;create, or hold capital stock or other equity interests in, any subsidiary that is not wholly owned (either directly or through one or more other subsidiaries) by the Corporation, (ii)&nbsp;sell, transfer or otherwise dispose of any capital stock or other equity securities of any direct or indirect subsidiary of the Corporation, (iii)&nbsp;permit any direct or indirect subsidiary to (A)&nbsp;sell, lease, transfer, exclusively license or otherwise dispose (in a single transaction or series of related transactions) of all or substantially all of the assets of such subsidiary, (B)&nbsp;merge or consolidate with or into any other entity other than in connection with a Deemed Liquidation Event, (C)&nbsp;effect a reorganization, recapitalization or division or (D)&nbsp;liquidate, dissolve or wind up;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>guaranty, or permit any subsidiary to guaranty, the debt of any other person or entity; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>increase or decrease the authorized number of directors constituting the Board of Directors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Protective Provisions of the Majority Preferred Holders</u>.&#160; At any time when any shares of Preferred Stock are outstanding, the Corporation shall not, either directly or indirectly by amendment, merger, consolidation or otherwise, effect any Deemed Liquidation Event, recapitalization or reorganization, or consent to any of the foregoing without (in addition to any other vote required by law or the Certificate of Incorporation) the written consent of the holders of at least a majority of the shares of Common Stock issuable upon conversion of the Preferred Stock voting together as a single class.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Optional Conversion</u>.&#160; The holders of the Preferred Stock shall have conversion rights as follows (the &#147;<b>Conversion Rights</b>&#148;):</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Right to Convert</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.1.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Conversion Ratio</u>. Each share of Series&nbsp;A Preferred Stock shall be convertible, at the option of the holder thereof, at any time and from time to time, and without the payment of additional consideration by the holder thereof, into such number of fully paid and nonassessable shares of Common Stock as is determined by dividing the Series&nbsp;A Original Issue Price by the Conversion Price (as defined below) of the Series&nbsp;A Preferred Stock in effect at the time of conversion.&#160; Each share of Series&nbsp;B Preferred Stock shall be convertible, at the option of the holder thereof, at any time and from time to time, and without the payment of additional consideration by the holder thereof, into such number of fully paid and nonassessable shares of Common Stock as is determined by dividing the Series&nbsp;B Original Issue Price by the Conversion Price of the Series&nbsp;B Preferred Stock in effect at the time of conversion.&#160; The term <b>&#147;Conversion Price&#148;</b> means (a)&nbsp;with respect to the Series&nbsp;A Preferred Stock, initially $4.11874995, and (b)&nbsp;with respect to the Series&nbsp;B Preferred Stock, initially the Series&nbsp;B Original Issue Price.&#160; Such initial Conversion Prices, and the rate at which shares of each series of Preferred Stock may be converted into shares of Common Stock, shall be subject to adjustment as provided below.&#160; For an initial underwritten public offering of the Corporation&#146;s Common Stock, in addition to the shares of Common Stock otherwise issuable upon conversion of the Preferred Stock pursuant to this Section&nbsp;4, there shall be issued immediately prior to the public offering to the holders of the Preferred Stock, (i)&nbsp;for each share of Series&nbsp;A Preferred Stock held, the number of shares of Common Stock as is determined by dividing the Series&nbsp;A Original Issue Price by the price per share of Common Stock in such public offering and (ii)&nbsp;for each share of Series&nbsp;B Preferred Stock held, </p>
<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">9<a name="16022-2-MC-01_PB_9_233446_7091"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=9,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=1039960,FOLIO='9',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 23:35 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">the number of shares of Common Stock as is determined by dividing the Series&nbsp;B Original Issue Price by the price per share of Common Stock in such public offering.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.1.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Termination of Conversion Rights</u>.&#160; In the event of a notice of redemption of any shares of Preferred Stock pursuant to <u>Section&nbsp;6</u>, the Conversion Rights of the shares designated for redemption shall terminate at the close of business on the last full day preceding the date fixed for redemption, unless the redemption price is not fully paid on such redemption date, in which case the Conversion Rights for such shares shall continue until such price is paid in full.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Fractional Shares</u>.&#160; No fractional shares of Common Stock shall be issued upon conversion of the Preferred Stock.&#160; In lieu of any fractional shares to which the holder would otherwise be entitled, the Corporation shall pay cash equal to such fraction multiplied by the fair market value of a share of Common Stock as determined in good faith by the Board of Directors.&#160; Whether or not fractional shares would be issuable upon such conversion shall be determined on the basis of the total number of shares of Preferred Stock the holder is at the time converting into Common Stock and the aggregate number of shares of Common Stock issuable upon such conversion.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Mechanics of Conversion</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.3.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Notice of Conversion</u>.&#160; In order for a holder of Preferred Stock to voluntarily convert shares of Preferred Stock into shares of Common Stock, such holder shall surrender the certificate or certificates for such shares of Preferred Stock (or, if such registered holder alleges that such certificate has been lost, stolen or destroyed, a lost certificate affidavit and agreement reasonably acceptable to the Corporation to indemnify the Corporation against any claim that may be made against the Corporation on account of the alleged loss, theft or destruction of such certificate), at the office of the transfer agent for the Preferred Stock (or at the principal office of the Corporation if the Corporation serves as its own transfer agent), together with written notice that such holder elects to convert all or any number of the shares of the Preferred Stock represented by such certificate or certificates and, if applicable, any event on which such conversion is contingent and, if such holder is converting shares of Series&nbsp;B Preferred Stock, whether such holder elects to receive the amount of the accrued but unpaid Series&nbsp;B Accruing Dividends in respect of such shares of Series&nbsp;B Preferred Stock in the form of cash or in the form of additional shares of Series&nbsp;B Preferred Stock in accordance with <u>Subsection 1</u>.&#160; Such notice shall state such holder&#146;s name or the names of the nominees in which such holder wishes the certificate or certificates for shares of Common Stock to be issued.&#160; If required by the Corporation, certificates surrendered for conversion shall be endorsed or accompanied by a written instrument or instruments of transfer, in form satisfactory to the Corporation, duly executed by the registered holder or his, her or its attorney duly authorized in writing.&#160; The close of business on the date of receipt by the transfer agent (or by the Corporation if the Corporation serves as its own transfer agent) of such certificates (or lost certificate affidavit and agreement) and notice shall be the time of conversion (the &#147;<b>Conversion Time</b>&#148;), and the shares of Common Stock issuable upon conversion of the shares represented by such certificate and the shares of Series&nbsp;B Preferred Stock, if any, issuable as a dividend in accordance with <u>Subsection 1</u> in respect of the shares represented by such certificate shall be deemed to be outstanding of record as of such date.&#160; The Corporation shall, as soon as practicable after the Conversion Time, (i)&nbsp;issue and deliver to such holder of Preferred Stock, or to his, her or its nominees, a certificate or certificates for the number of full shares of Common Stock issuable upon such conversion in accordance with the provisions hereof and a certificate for the number (if any) of the shares of the applicable series of Preferred Stock represented by the surrendered certificate that were not converted into Common Stock, (ii)&nbsp;pay in cash such amount as provided in <u>Subsection 4.2</u> in lieu of any fraction of a share of Common Stock otherwise issuable upon such conversion and (iii)&nbsp;pay all unpaid Series&nbsp;B Accruing Dividends (in the form of cash or in the form of additional shares of Series&nbsp;B Preferred Stock in accordance with <u>Subsection 1</u>) and Series&nbsp;A Accruing Dividends (in the form of cash), whether or not declared, in accordance with <u>Subsection 1</u>, together with any other dividends declared but unpaid on the shares of Preferred Stock converted.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">10<a name="16022-2-MC-01_PB_10_233457_455"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=10,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=950137,FOLIO='10',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 23:35 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.3.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Reservation of Shares</u>.&#160; The Corporation shall, at all times when the Preferred Stock shall be outstanding, reserve and keep available out of its authorized but unissued capital stock, for the purpose of effecting the conversion of the Preferred Stock, such number of its duly authorized shares of Common Stock as shall from time to time be sufficient to effect the conversion of all outstanding Preferred Stock; and if at any time the number of authorized but unissued shares of Common Stock shall not be sufficient to effect the conversion of all then outstanding shares of the Preferred Stock, the Corporation shall take such corporate action as may be necessary to increase its authorized but unissued shares of Common Stock to such number of shares as shall be sufficient for such purposes, including, without limitation, engaging in best efforts to obtain the requisite stockholder approval of any necessary amendment to the Certificate of Incorporation.&#160; The Corporation shall, at all times when the Series&nbsp;B Preferred Stock shall be outstanding, reserve and keep available out of its authorized but unissued capital stock, for the purpose of effecting the payment of all unpaid Series&nbsp;B Accruing Dividends in the form of additional shares of Series&nbsp;B Preferred Stock in accordance with <u>Subsection 1</u>, such number of its duly authorized shares of Series&nbsp;B Preferred Stock as shall from time to time be sufficient to effect the payment of such Series&nbsp;B Accruing Dividends in the form of additional shares of Series&nbsp;B Preferred Stock in accordance with <u>Subsection 1</u>; and if at any time the number of authorized but unissued shares of Series&nbsp;B Preferred Stock shall not be sufficient to effect the payment of all unpaid Series&nbsp;B Accruing Dividends in the form of additional shares of Series&nbsp;B Preferred Stock in accordance with <u>Subsection 1</u>, the Corporation shall take such corporate action as may be necessary to increase its authorized but unissued shares of Series&nbsp;B Preferred Stock to such number of shares as shall be sufficient for such purposes, including, without limitation, engaging in best efforts to obtain the requisite stockholder approval of any necessary amendment to the Certificate of Incorporation. Before taking any action which would cause an adjustment reducing any Conversion Price below the then par value of the shares of Common Stock issuable upon conversion of the Preferred Stock, the Corporation will take any corporate action which may, in the opinion of its counsel, be necessary in order that the Corporation may validly and legally issue fully paid and nonassessable shares of Common Stock at such adjusted Conversion Price.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.3.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Effect of Conversion</u>.&#160; All shares of Preferred Stock which shall have been surrendered for conversion as herein provided shall no longer be deemed to be outstanding and all rights with respect to such shares shall immediately cease and terminate at the Conversion Time, except only the right of the holders thereof to receive shares of Common Stock in exchange therefor, to receive payment in lieu of any fraction of a share otherwise issuable upon such conversion as provided in <u>Subsection 4.2</u> and to receive payment of all Series&nbsp;B Accruing Dividends (in the form of cash or in the form of additional shares of Series&nbsp;B Preferred Stock in accordance with <u>Subsection 1</u>) and all Series&nbsp;A Accruing Dividends (in the form of cash), whether or not declared, together with all other dividends declared but unpaid on the shares of Preferred Stock converted.&#160; Any shares of Preferred Stock so converted shall be retired and cancelled and may not be reissued as shares of such series, and the Corporation may thereafter take such appropriate action (without the need for stockholder action) as may be necessary to reduce the authorized number of shares of Preferred Stock and the applicable series thereof accordingly.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.3.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Taxes</u>.&#160; The Corporation shall pay any and all issue and other similar taxes that may be payable in respect of any issuance or delivery of shares of Common Stock upon conversion of shares of Preferred Stock pursuant to this <u>Section&nbsp;4</u>.&#160; The Corporation shall not, however, be required to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery of shares of Common Stock in a name other than that in which the shares of Preferred Stock so converted were registered, and no such issuance or delivery shall be made unless and until the person or entity requesting such issuance has paid to the Corporation the amount of any such tax or has established, to the satisfaction of the Corporation, that such tax has been paid.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">11<a name="16022-2-MC-01_PB_11_233503_4141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=11,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=919485,FOLIO='11',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 23:35 2016' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Adjustments to Conversion Prices for Diluting Issues</u>.</p>
<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.4.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Special Definitions</u>.&#160; For purposes of this <u>Article&nbsp;Fourth</u>, the following definitions shall apply:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Option</b>&#148; shall mean rights, options or warrants to subscribe for, purchase or otherwise acquire Common Stock or Convertible Securities.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Series&nbsp;B Original Issue Date</b>&#148; shall mean the date on which the first share of Series&nbsp;B Preferred Stock was issued.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Convertible Securities</b>&#148; shall mean any evidences of indebtedness, shares or other securities directly or indirectly convertible into or exchangeable for Common Stock, but excluding Options.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Additional Shares of Common Stock</b>&#148; shall mean all shares of Common Stock issued (or, pursuant to <u>Subsection 4.4.3</u> below, deemed to be issued) by the Corporation after the Series&nbsp;B Original Issue Date, other than (1)&nbsp;the following shares of Common Stock and (2)&nbsp;shares of Common Stock deemed issued pursuant to the following Options and Convertible Securities (clauses (1)&nbsp;and (2), collectively, &#147;<b>Exempted Securities</b>&#148;):</p>
<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>shares of Common Stock, Options or Convertible Securities issued by reason of a dividend, stock split, split-up or other distribution on shares of Common Stock that is covered by <u>Subsection 4.5</u>, <u>4.6</u>, <u>4.7</u> or <u>4.8</u>;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>shares of Common Stock or Options issued to employees or directors of, or consultants or advisors to, the Corporation or any of its subsidiaries pursuant to a plan, agreement or arrangement approved by the Board of Directors including the approval of at least one Series&nbsp;A Director and at least one Series&nbsp;B Director or in effect at the time this Amended and Restated Certificate of Incorporation is filed with the Delaware Secretary of State;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>shares of Common Stock or Convertible Securities actually issued upon the exercise of Options or shares of Common Stock actually issued upon the conversion or exchange of Convertible Securities, in each case provided such issuance is pursuant to the terms of such Option or Convertible Security;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>shares of Common Stock, Options or Convertible Securities issued to banks, equipment lessors or other financial lending institutions, or to real property lessors, pursuant to a bona fide debt financing, equipment leasing or real property leasing transaction approved by the Board of Directors;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>shares of Common Stock, Options or Convertible Securities issued to third party service providers in connection with the provision of services pursuant to transactions approved by the Board of Directors;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(vi)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>shares of Common Stock, Options or Convertible Securities issued pursuant to the acquisition of another corporation by the Corporation by merger, purchase of substantially all of the assets or other reorganization or </p>
<p style="margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">12<a name="16022-2-MC-03_PB_12_233656_9945"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=12,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=142986,FOLIO='12',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 3.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">to a joint venture agreement, provided, that such issuances are approved by the Board of Directors;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(vii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>shares of Common Stock, Options or Convertible Securities issued in connection with sponsored research, collaboration, technology license, development, OEM, marketing or other similar license agreements or strategic partnerships approved by the Board of Directors;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(viii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>shares of Series&nbsp;B Preferred Stock issued or issuable in respect of the Series&nbsp;B Accruing Dividends in accordance with the Certificate of Incorporation;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ix)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>shares of Series&nbsp;B Preferred Stock issued or issuable pursuant to the Purchase Agreement; or</p>
<p style="margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(x)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>shares of Common Stock, Options or Convertible Securities determined by the Required Holders to be &#147;Excluded Stock.&#148;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.4.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Adjustment of Conversion Prices</u>.&#160; No adjustment in any Conversion Price shall be made as the result of the issuance or deemed issuance of Additional Shares of Common Stock if the Corporation receives written notice from the Required Holders agreeing that no such adjustment shall be made as the result of the issuance or deemed issuance of such Additional Shares of Common Stock.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.4.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Deemed Issue of Additional Shares of Common Stock</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If the Corporation at any time or from time to time after the Series&nbsp;B Original Issue Date shall issue any Options or Convertible Securities (excluding Options or Convertible Securities which are themselves Exempted Securities) or shall fix a record date for the determination of holders of any class of securities entitled to receive any such Options or Convertible Securities, then the maximum number of shares of Common Stock (as set forth in the instrument relating thereto, assuming the satisfaction of any conditions to exercisability, convertibility or exchangeability but without regard to any provision contained therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or, in the case of Convertible Securities and Options therefor, the conversion or exchange of such Convertible Securities, shall be deemed to be Additional Shares of Common Stock issued as of the time of such issue or, in case such a record date shall have been fixed, as of the close of business on such record date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If the terms of any Option or Convertible Security, the issuance of which resulted in an adjustment to any Conversion Price pursuant to the terms of <u>Subsection 4.4.4</u>, are revised as a result of an amendment to such terms or any other adjustment pursuant to the provisions of such Option or Convertible Security (but excluding automatic adjustments to such terms pursuant to anti-dilution provisions of such Option or Convertible Security) to provide for either (1)&nbsp;any increase or decrease in the number of shares of Common Stock issuable upon the exercise, conversion and/or exchange of any such Option or Convertible Security or (2)&nbsp;any increase or decrease in the consideration payable to the Corporation upon such exercise, conversion and/or exchange, then, effective upon such increase or decrease becoming effective, such Conversion Price computed upon the original issue of such Option or Convertible Security (or upon the occurrence of a record date with respect thereto) shall be readjusted to such Conversion Price as would have obtained had such revised terms been in effect upon the original date of issuance of such Option or Convertible Security.&#160; Notwithstanding the foregoing, no readjustment pursuant to this <u>clause&nbsp;(b)</u>&nbsp;shall have the effect of increasing a Conversion Price to an amount which exceeds the lower of (i)&nbsp;such Conversion Price in effect immediately prior to the original adjustment made as a result of the issuance of such Option or Convertible Security, or (ii)&nbsp;such </p>
<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">13<a name="16022-2-MC-03_PB_13_233711_8627"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=13,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=938235,FOLIO='13',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conversion Price that would have resulted from any issuances of Additional Shares of Common Stock (other than deemed issuances of Additional Shares of Common Stock as a result of the issuance of such Option or Convertible Security) between the original adjustment date and such readjustment date.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If the terms of any Option or Convertible Security (excluding Options or Convertible Securities which are themselves Exempted Securities), the issuance of which did not result in an adjustment to the Conversion Price pursuant to the terms of <u>Subsection 4.4.4</u> (either because the consideration per share (determined pursuant to <u>Subsection 4.4.5</u>) of the Additional Shares of Common Stock subject thereto was equal to or greater than such Conversion Price then in effect, or because such Option or Convertible Security was issued before the Series&nbsp;B Original Issue Date), are revised after the Series&nbsp;B Original Issue Date as a result of an amendment to such terms or any other adjustment pursuant to the provisions of such Option or Convertible Security (but excluding automatic adjustments to such terms pursuant to anti-dilution or similar provisions of such Option or Convertible Security) to provide for either (1)&nbsp;any increase in the number of shares of Common Stock issuable upon the exercise, conversion or exchange of any such Option or Convertible Security or (2)&nbsp;any decrease in the consideration payable to the Corporation upon such exercise, conversion or exchange, then such Option or Convertible Security, as so amended or adjusted, and the Additional Shares of Common Stock subject thereto (determined in the manner provided in <u>Subsection 4.4.3(a)</u>) shall be deemed to have been issued effective upon such increase or decrease becoming effective.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Upon the expiration or termination of any unexercised Option or unconverted or unexchanged Convertible Security (or portion thereof) which resulted (either upon its original issuance or upon a revision of its terms) in an adjustment to a Conversion Price pursuant to the terms of <u>Subsection 4.4.4</u>, such Conversion Price shall be readjusted to such Conversion Price as would have obtained had such Option or Convertible Security (or portion thereof) never been issued.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If the number of shares of Common Stock issuable upon the exercise, conversion and/or exchange of any Option or Convertible Security, or the consideration payable to the Corporation upon such exercise, conversion and/or exchange, is calculable at the time such Option or Convertible Security is issued or amended but is subject to adjustment based upon subsequent events, any adjustment to a Conversion Price provided for in this <u>Subsection 4.4.3</u> shall be effected at the time of such issuance or amendment based on such number of shares or amount of consideration without regard to any provisions for subsequent adjustments (and any subsequent adjustments shall be treated as provided in clauses (b)&nbsp;and (c)&nbsp;of this <u>Subsection 4.4.3</u><b>)</b>.&#160; If the number of shares of Common Stock issuable upon the exercise, conversion and/or exchange of any Option or Convertible Security, or the consideration payable to the Corporation upon such exercise, conversion and/or exchange, cannot be calculated at all at the time such Option or Convertible Security is issued or amended, any adjustment to a Conversion Price that would result under the terms of this <u>Subsection 4.4.3</u> at the time of such issuance or amendment shall instead be effected at the time such number of shares and/or amount of consideration is first calculable (even if subject to subsequent adjustments), assuming for purposes of calculating such adjustment to such Conversion Price that such issuance or amendment took place at the time such calculation can first be made.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.4.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Adjustment of Conversion Prices Upon Issuance of Additional Shares of Common Stock</u>.&#160; In the event the Corporation shall at any time after the Series&nbsp;B Original Issue Date issue Additional Shares of Common Stock (including Additional Shares of Common Stock deemed to be issued pursuant to <u>Subsection 4.4.3</u>), without consideration or for a consideration per share less than the Series&nbsp;B Conversion Price in effect immediately prior to such issue, then the Conversion Price for each series of Preferred Stock shall be reduced, concurrently with such issue, to a price (calculated to the nearest one-hundredth of a cent) determined in accordance with the following formula:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CP</font><font size="1" style="font-size:6.5pt;position:relative;top:1.0pt;">2</font>&#160;= CP<font size="1" style="font-size:6.5pt;position:relative;top:1.0pt;">1</font>*&#160; (A + B) &#247; (A + C).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For purposes of the foregoing formula, the following definitions shall apply:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">14<a name="16022-2-MC-03_PB_14_233723_7906"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=14,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=168903,FOLIO='14',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;CP<font size="1" style="font-size:6.5pt;position:relative;top:1.0pt;">2</font>&#148; shall mean the Conversion Price for such series of Preferred Stock in effect immediately after such issue of Additional Shares of Common Stock</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;CP<font size="1" style="font-size:6.5pt;position:relative;top:1.0pt;">1</font>&#148; shall mean the Series&nbsp;B Conversion Price in effect immediately prior to such issue of Additional Shares of Common Stock;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;A&#148; shall mean the number of shares of Common Stock outstanding immediately prior to such issue of Additional Shares of Common Stock, including in the definition of &#145;outstanding&#146; all shares of Common Stock issuable upon exercise of Options outstanding immediately prior to such issue or upon conversion or exchange of Convertible Securities (including the Preferred Stock);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;B&#148; shall mean the number of shares of Common Stock that would have been issued if such Additional Shares of Common Stock had been issued at a price per share equal to CP<font size="1" style="font-size:6.5pt;position:relative;top:1.0pt;">1</font>&#160;(determined by dividing the aggregate consideration received by the Corporation in respect of such issue by CP<font size="1" style="font-size:6.5pt;position:relative;top:1.0pt;">1</font>); and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;C&#148; shall mean the number of such Additional Shares of Common Stock issued in such transaction.</p>
<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.4.5</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Determination of Consideration</u>. For purposes of this <u>Subsection&nbsp;4.4</u>, the consideration received by the Corporation for the issue of any Additional Shares of Common Stock shall be computed as follows:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Cash and Property</u>:&#160; Such consideration shall:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>insofar as it consists of cash, be computed at the aggregate amount of cash received by the Corporation, excluding amounts paid or payable for accrued interest;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>insofar as it consists of property other than cash, be computed at the fair market value thereof at the time of such issue, as determined in good faith by the Board of Directors; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>in the event Additional Shares of Common Stock are issued together with other shares or securities or other assets of the Corporation for consideration which covers both, be the proportion of such consideration so received, computed as provided in <u>clauses (i)</u>&nbsp;and <u>(ii)</u>&nbsp;above, as determined in good faith by the Board of Directors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Options and Convertible Securities</u>.&#160; The consideration per share received by the Corporation for Additional Shares of Common Stock deemed to have been issued pursuant to <u>Subsection 4.4.3</u>, relating to Options and Convertible Securities, shall be determined by dividing</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the total amount, if any, received or receivable by the Corporation as consideration for the issue of such Options or Convertible Securities, plus the minimum aggregate amount of additional consideration (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such consideration) payable to the Corporation upon the exercise of such Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible Securities, the </p>
<p style="margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">15<a name="16022-2-MC-03_PB_15_233736_3736"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=15,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=9121,FOLIO='15',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 3.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities, by</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 3.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the maximum number of shares of Common Stock (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.5</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Adjustment for Stock Splits and Combinations</u>. If the Corporation shall at any time or from time to time after the Series&nbsp;B Original Issue Date effect a subdivision of the outstanding Common Stock, the Conversion Prices for each series of Preferred Stock in effect immediately before that subdivision shall be proportionately decreased so that the number of shares of Common Stock issuable on conversion of each share of such series shall be increased in proportion to such increase in the aggregate number of shares of Common Stock outstanding.&#160; If the Corporation shall at any time or from time to time after the Series&nbsp;B Original Issue Date combine the outstanding shares of Common Stock, the Conversion Prices for each series of Preferred Stock in effect immediately before the combination shall be proportionately increased so that the number of shares of Common Stock issuable on conversion of each share of such series shall be decreased in proportion to such decrease in the aggregate number of shares of Common Stock outstanding.&#160; Any adjustment under this subsection shall become effective at the close of business on the date the subdivision or combination becomes effective.&#160; Notwithstanding the foregoing, no adjustment is to be made under this <u>Section&nbsp;4.5</u> by reason of the Reverse Split.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.6</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Adjustment for Certain Dividends and Distributions</u>.&#160; In the event the Corporation at any time or from time to time after the Series&nbsp;B Original Issue Date shall make or issue, or fix a record date for the determination of holders of Common Stock entitled to receive, a dividend or other distribution payable on the Common Stock in additional shares of Common Stock, then and in each such event the Conversion Prices in effect immediately before such event shall be decreased as of the time of such issuance or, in the event such a record date shall have been fixed, as of the close of business on such record date, by multiplying each Conversion Price then in effect by a fraction:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 2.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the numerator of which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time of such issuance or the close of business on such record date, and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 2.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the denominator of which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time of such issuance or the close of business on such record date plus the number of shares of Common Stock issuable in payment of such dividend or distribution.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding the foregoing, (a)&nbsp;if such record date shall have been fixed and such dividend is not fully paid or if such distribution is not fully made on the date fixed therefor, each Conversion Price shall be recomputed accordingly as of the close of business on such record date and thereafter such Conversion Price shall be adjusted pursuant to this subsection as of the time of actual payment of such dividends or distributions; (b)&nbsp;no such adjustment shall be made to the Conversion Price of the Series&nbsp;A Preferred Stock if the holders of Series&nbsp;A Preferred Stock simultaneously receive a dividend or other distribution of shares of Common Stock in a number equal to the number of shares of Common Stock as they would have received if all outstanding shares of Series&nbsp;A Preferred Stock had been converted into Common </font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">16<a name="16022-2-MC-03_PB_16_233750_9621"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=16,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=95366,FOLIO='16',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stock on the date of such event; and (c)&nbsp;no such adjustment shall be made to the Conversion Price of the Series&nbsp;B Preferred Stock if the holders of Series&nbsp;B Preferred Stock simultaneously receive a dividend or other distribution of shares of Common Stock in a number equal to the number of shares of Common Stock as they would have received if all outstanding shares of Series&nbsp;B Preferred Stock had been converted into Common Stock on the date of such event.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.7</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Adjustments for Other Dividends and Distributions</u>.&#160; In the event the Corporation at any time or from time to time after the Series&nbsp;B Original Issue Date shall make or issue, or fix a record date for the determination of holders of Common Stock entitled to receive, a dividend or other distribution payable in securities of the Corporation (other than a distribution of shares of Common Stock in respect of outstanding shares of Common Stock) or in other property and the provisions of Section&nbsp;1 do not apply to such dividend or distribution, then and in each such event the holders of Preferred Stock shall receive, simultaneously with the distribution to the holders of Common Stock, a dividend or other distribution of such securities or other property in an amount equal to the amount of such securities or other property as they would have received if all outstanding shares of Preferred Stock had been converted into Common Stock on the date of such event.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.8</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Adjustment for Merger or Reorganization,&nbsp;etc</u>.&#160; Subject to the provisions of <u>Subsection 2.3</u>, if there shall occur any reorganization, recapitalization, reclassification, consolidation or merger involving the Corporation in which the Common Stock (but not the Preferred Stock) is converted into or exchanged for securities, cash or other property (other than a transaction covered by <u>Subsections 4.4</u>, <u>4.6</u> or <u>4.7</u>), then, following any such reorganization, recapitalization, reclassification, consolidation or merger, each share of Preferred Stock shall thereafter be convertible in lieu of the Common Stock into which it was convertible prior to such event into the kind and amount of securities, cash or other property which a holder of the number of shares of Common Stock of the Corporation issuable upon conversion of one share of the applicable series of such Preferred Stock immediately prior to such reorganization, recapitalization, reclassification, consolidation or merger would have been entitled to receive pursuant to such transaction; and, in such case, appropriate adjustment (as determined in good faith by the Board of Directors) shall be made in the application of the provisions in this <u>Section&nbsp;4</u> with respect to the rights and interests thereafter of the holders of the Preferred Stock, to the end that the provisions set forth in this <u>Section&nbsp;4</u> (including provisions with respect to changes in and other adjustments of the Conversion Prices) shall thereafter be applicable, as nearly as reasonably may be, in relation to any securities or other property thereafter deliverable upon the conversion of the Preferred Stock.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.9</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Certificate as to Adjustments</u>.&#160; Upon the occurrence of each adjustment or readjustment of any Conversion Price pursuant to this <u>Section&nbsp;4</u>, the Corporation at its expense shall, as promptly as reasonably practicable but in any event not later than 10 days thereafter, compute such adjustment or readjustment in accordance with the terms hereof and furnish to each holder of Preferred Stock a certificate setting forth such adjustment or readjustment (including the kind and amount of securities, cash or other property into which each series of Preferred Stock is convertible) and showing in detail the facts upon which such adjustment or readjustment is based.&#160; The Corporation shall, as promptly as reasonably practicable after the written request at any time of any holder of Preferred Stock (but in any event not later than 10 days thereafter), furnish or cause to be furnished to such holder a certificate setting forth (i)&nbsp;the Conversion Price of such series of Preferred Stock then in effect, and (ii)&nbsp;the number of shares of Common Stock and the amount, if any, of other securities, cash or property which then would be received upon the conversion of such series of Preferred Stock.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.10</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Definition of &#147;Common Stock&#148;</u>.&#160; As used in this <u>Subsection 4</u>, the term &#147;Common Stock&#148; shall mean and include the Corporation&#146;s authorized Common Stock, par value $0.001 per share, as constituted on the Series&nbsp;B Original Issue Date and shall also include any security of the Corporation thereafter authorized which shall not be limited to a fixed sum or percentage in respect of the rights of the holders thereof to participate in dividends or in the distribution of assets upon the voluntary or involuntary liquidation, dissolution or winding up of the Corporation; <u>provided that</u> the shares of Common Stock receivable upon conversion of shares of Preferred Stock shall include only shares </p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">17<a name="16022-2-MC-03_PB_17_233802_8715"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=17,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=982492,FOLIO='17',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">designated as Common Stock of the Corporation on the date of filing of this instrument, or in case of any reorganization, recapitalization, reclassification, consolidation or merger involving the Corporation in which the Common Stock (but not the Preferred Stock) is converted into or exchanged for securities, cash or other property (other than a transaction covered by <u>Subsections 4.4</u>, <u>4.6</u> or <u>4.7</u>), the stock, securities or assets provided for in <u>Subsection 4.8</u>.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.11</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Notice of Record Date</u>.&#160; In the event:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the Corporation shall take a record of the holders of its Common Stock (or other capital stock or securities at the time issuable upon conversion of the Preferred Stock) for the purpose of entitling or enabling them to receive any dividend or other distribution, or to receive any right to subscribe for or purchase any shares of capital stock of any class or any other securities, or to receive any other security; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>of any capital reorganization of the Corporation, any reclassification of the Common Stock of the Corporation, or any Deemed Liquidation Event; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>of the voluntary or involuntary dissolution, liquidation or winding-up of the Corporation,</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">then, and in each such case, unless the Required Holders elect otherwise, the Corporation will send or cause to be sent to the holders of the Preferred Stock a notice specifying, as the case may be, (i)&nbsp;the record date for such dividend, distribution or right, and the amount and character of such dividend, distribution or right, or (ii)&nbsp;the effective date on which such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation or winding-up is proposed to take place, and the time, if any is to be fixed, as of which the holders of record of Common Stock (or such other capital stock or securities at the time issuable upon the conversion of the Preferred Stock) shall be entitled to exchange their shares of Common Stock (or such other capital stock or securities) for securities or other property deliverable upon such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation or winding-up, and the amount per share and character of such exchange applicable to the Preferred Stock and the Common Stock.&#160; Such notice shall be sent at least 10 days prior to the record date or effective date for the event specified in such notice.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Mandatory Conversion</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Trigger Events</u>.&#160; Upon either (a)&nbsp;the closing of the sale of shares of Common Stock to the public at a price of at least $11.42 per share (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Common Stock), in a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, resulting in at least $30,000,000 of aggregate proceeds, net of the underwriting discount and commissions, to the Corporation and after which the Common Stock is listed on a United States national securities exchange or (b)&nbsp;the date and time, or the occurrence of an event, specified by the written consent of the Required Holders (the time of such closing or the date and time specified or the time of the event specified in such written consent is referred to herein as the &#147;<b>Mandatory Conversion Time</b>&#148;), (i)&nbsp;all outstanding shares of Preferred Stock shall automatically be converted into shares of Common Stock at the then effective conversion rate and (ii)&nbsp;such shares may not be reissued by the Corporation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Procedural Requirements</u>.&#160; All holders of record of shares of Preferred Stock shall be sent written notice of the Mandatory Conversion Time and the place designated for mandatory conversion of all such shares of Preferred Stock pursuant to this <u>Section&nbsp;5</u>.&#160; Such notice need not be sent in advance of the occurrence of the Mandatory Conversion Time.&#160; Upon receipt of such notice, each holder of shares of Preferred Stock shall surrender his, her or its certificate or certificates for all such shares (or, if such holder alleges that such certificate has been lost, stolen or destroyed, a lost certificate </p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">18<a name="16022-2-MC-03_PB_18_233840_563"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=18,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=280319,FOLIO='18',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">affidavit and agreement reasonably acceptable to the Corporation to indemnify the Corporation against any claim that may be made against the Corporation on account of the alleged loss, theft or destruction of such certificate) to the Corporation at the place designated in such notice.&#160; If so required by the Corporation, certificates surrendered for conversion shall be endorsed or accompanied by written instrument or instruments of transfer, in form satisfactory to the Corporation, duly executed by the registered holder or by his, her or its attorney duly authorized in writing.&#160; All rights with respect to the Preferred Stock converted pursuant to <u>Section&nbsp;5.1</u>, including the rights, if any, to receive notices and vote (other than as a holder of Common Stock), will terminate at the Mandatory Conversion Time (notwithstanding the failure of the holder or holders thereof to surrender the certificates at or prior to such time), except only the rights of the holders thereof, upon surrender of their certificate or certificates (or lost certificate affidavit and agreement) therefor, to receive the items provided for in the next sentence of this <u>Subsection 5.2</u>.&#160; As soon as practicable after the Mandatory Conversion Time and the surrender of the certificate or certificates (or lost certificate affidavit and agreement) for Preferred Stock, the Corporation shall issue and deliver to such holder, or to his, her or its nominees, a certificate or certificates for the number of full shares of Common Stock issuable on such conversion in accordance with the provisions hereof, together with cash as provided in <u>Subsection 4.2</u> in lieu of any fraction of a share of Common Stock otherwise issuable upon such conversion and the payment of all unpaid Series&nbsp;B Accruing Dividends (in the form of cash or in the form of additional shares of Series&nbsp;B Preferred Stock in accordance with <u>Subsection 1</u>) and Series&nbsp;A Accruing Dividends (in the form of cash), whether or not declared, in accordance with <u>Subsection 1</u>, together with any other dividends declared but unpaid on the shares of Preferred Stock converted.&#160; Such converted Preferred Stock shall be retired and cancelled and may not be reissued as shares of such series, and the Corporation may thereafter take such appropriate action (without the need for stockholder action) as may be necessary to reduce the authorized number of shares of Preferred Stock accordingly.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Redemption</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Redemption</u>.&#160; All shares of Preferred Stock held by Redeeming Holders (as defined below) shall be redeemed by the Corporation out of funds lawfully available therefor at a price equal to (a)&nbsp;with respect to each share of Series&nbsp;A Preferred Stock, the Series&nbsp;A Original Issue Price per share, plus all unpaid Series&nbsp;A Accruing Dividends thereon and (b)&nbsp;with respect to each share of Series&nbsp;B Preferred Stock, the Series&nbsp;B Original Issue Price per share, plus all unpaid Series&nbsp;B Accruing Dividends thereon in accordance with <u>Subsection 1</u> (the &#147;<b>Redemption Price</b>&#148;), all of which may be paid, at the election of the Corporation, (i)&nbsp;as a lump sum or (ii)&nbsp;in three equal annual installments commencing not less than 30 days, and not more than 60 days, after receipt by the Corporation at any time on or after September&nbsp;14, 2017 from Galen Partners V, L.P. (&#147;<b>Galen</b>&#148;) or Radius Venture Partners III, L.P. (&#147;<b>Radius</b>&#148;) (so long as Galen or Radius, respectively, holds at least 35,460 shares of Common Stock calculated on an as-converted to Common Stock basis subject to appropriate adjustment for stock splits, stock dividends, combinations, and other recapitalizations) of written notice requesting redemption of all of the shares of Preferred Stock then held by the Redeeming Holders. The date of each such installment shall be referred to as a &#147;<b>Redemption Date</b>&#148;.&#160; The Corporation shall send written notice of such redemption request to all holders of Preferred Stock within 10 days after it receives such redemption request and each such holder shall have 15 days after it receives such written notice from the Corporation to elect to have the Corporation redeem all, but not less than all, of such holder&#146;s shares of Preferred Stock (each such holder electing to have all of its shares of Preferred Stock redeemed by the Corporation hereunder shall be referred to herein as a &#147;<b>Redeeming Holder</b>&#148;).&#160; In the event that Galen or Radius requests a redemption but the other entity holds at least 35,460 shares of Common Stock calculated on an as-converted to Common Stock basis<b> (</b>subject to appropriate adjustment for stock splits, stock dividends, combinations, and other recapitalizations) and does not elect to be a Redeeming Holder in such redemption, such other entity shall continue to have the right to request that the Corporation redeem all of the shares of Preferred Stock held by such other entity at a later date in accordance with this <u>Section&nbsp;6</u>.&#160; On each Redemption Date, the Corporation shall redeem from each Redeeming Holder such number of shares of each series of Preferred Stock held by such Redeeming Holder determined by dividing (i)&nbsp;the </p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">19<a name="16022-2-MC-03_PB_19_233852_9497"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=19,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=915259,FOLIO='19',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">total number of shares of each such series of Preferred Stock held by such Redeeming Holder immediately prior to such Redemption Date by (ii)&nbsp;the number of remaining Redemption Dates (including the Redemption Date to which such calculation applies).&#160; If the Corporation does not have sufficient funds legally available to redeem on any Redemption Date all shares of Preferred Stock to be redeemed on such Redemption Date, the Corporation shall redeem a pro rata portion of such shares of Preferred Stock held by each Redeeming Holder (ratably between the series of Preferred Stock held by such Redeeming Holder based on the respective redemption amounts of such series of Preferred Stock held by such Redeeming Holder if such Redeeming Holder holds more than one series of Preferred Stock) out of funds legally available therefor, based on the respective amounts which would otherwise be payable in respect of the shares to be redeemed if the legally available funds were sufficient to redeem all such shares, and shall redeem the remaining shares to have been redeemed as soon as practicable after the Corporation has funds legally available therefor, <u>provided that</u> the redemption of any Preferred Stock shall be prior to and in preference to any junior ranking securities.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Redemption Notice</u>.&#160; The Corporation shall send written notice of the redemption (the &#147;<b>Redemption Notice</b>&#148;) to all Redeeming Holders not less than 30 days prior to each Redemption Date.&#160; Each Redemption Notice shall state:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the number of shares of Preferred Stock held by each Redeeming Holder that the Corporation shall redeem on the Redemption Date specified in the Redemption Notice;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the Redemption Date and the Redemption Price;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the date upon which such Redeeming Holder&#146;s right to convert such shares terminates (as determined in accordance with <u>Subsection 6.4</u>); and</p>
<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>that such Redeeming Holder will surrender to the Corporation, in the manner and at the place designated, his, her or its certificate or certificates representing the shares of Preferred Stock to be redeemed.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Surrender of Certificates; Payment</u>.&#160; On or before the applicable Redemption Date, each Redeeming Holder shall surrender the certificate or certificates representing the shares of Preferred Stock to be redeemed by the Corporation on such Redemption Date (or, if such registered holder alleges that such certificate has been lost, stolen or destroyed, a lost certificate affidavit and agreement reasonably acceptable to the Corporation to indemnify the Corporation against any claim that may be made against the Corporation on account of the alleged loss, theft or destruction of such certificate) to the Corporation, in the manner and at the place designated in the Redemption Notice, and thereupon the Redemption Price for such shares shall be payable to the order of the person whose name appears on such certificate or certificates as the owner thereof.&#160; In the event less than all of the shares of Preferred Stock represented by a certificate are redeemed, a new certificate representing the unredeemed shares of Preferred Stock shall promptly be issued to the holder thereof.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Rights Subsequent to Redemption</u>.&#160; If the Redemption Notice shall have been duly given, and if on the applicable Redemption Date the Redemption Price payable upon redemption of the shares of Preferred Stock to be redeemed from the Redeeming Holders on such Redemption Date is paid or tendered for payment or deposited with an independent payment agent so as to be available therefor in a timely manner, then notwithstanding that the certificates evidencing any of the shares of Preferred Stock to be redeemed from the Redeeming Holders shall not have been surrendered, dividends with respect to such shares of Preferred Stock shall cease to accrue after such Redemption Date and all rights with respect to such shares shall forthwith after the Redemption Date terminate, except only the right of the Redeeming Holders to receive the Redemption Price without interest upon surrender of their certificate or certificates therefor.&#160; Notwithstanding anything to the contrary, Redeeming Holders shall retain full rights as holders of Preferred Stock until the Redemption Price for such shares have been paid in full.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">20<a name="16022-2-MC-03_PB_20_233903_3641"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=20,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=591061,FOLIO='20',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Redeemed or Otherwise Acquired Shares</u>.&#160; Any shares of Preferred Stock that are redeemed or otherwise acquired by the Corporation or any of its subsidiaries shall be automatically and immediately cancelled and retired and shall not be reissued, sold or transferred.&#160; Neither the Corporation nor any of its subsidiaries may exercise any voting or other rights granted to the holders of Preferred Stock following redemption.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Notices</u>.&#160; Any notice required or permitted by the provisions of this Article&nbsp;<u>Fourth</u> to be given to a holder of shares of Preferred Stock shall be mailed, postage prepaid, to the post office address last shown on the records of the Corporation, or given by electronic communication in compliance with the provisions of the General Corporation Law, and shall be deemed sent upon such mailing or electronic transmission.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Waiver</u>.&#160; Any of the rights, powers, preferences and other terms of the Series&nbsp;A Preferred Stock set forth herein may be waived on behalf of all holders of Series&nbsp;A Preferred Stock by the written consent or vote of the holders of a majority of the then outstanding shares of Series&nbsp;A Preferred Stock.&#160; Any of the rights, powers, preferences and other terms of the Series&nbsp;B Preferred Stock set forth herein may be waived on behalf of all holders of Series&nbsp;B Preferred Stock by the written consent or vote of the holders of at least 66-2/3% of the then outstanding shares of Series&nbsp;B Preferred Stock.&#160; Any of the rights, powers, preferences and other terms of the Preferred Stock (as a single class) set forth herein may be waived on behalf of all holders of Preferred Stock by the written consent or vote of the holders of a majority of the then outstanding shares of Series&nbsp;A Preferred Stock and the holders of at least 66-2/3% of the then outstanding shares of Series&nbsp;B Preferred Stock.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">FIFTH</font></b>:&#160; Subject to any additional vote required by the Certificate of Incorporation, the number of directors of the Corporation shall be determined in the manner set forth in the Bylaws of the Corporation.</p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIXTH</font></b>:&#160; Elections of directors need not be by written ballot unless the Bylaws of the Corporation shall so provide.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SEVENTH</font></b>:&#160; Meetings of stockholders may be held within or without the State of Delaware, as the Bylaws of the Corporation may provide.&#160; The books of the Corporation may be kept outside the State of Delaware at such place or places as may be designated from time to time by the Board of Directors or in the Bylaws of the Corporation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EIGHTH</font></b>: To the fullest extent permitted by law, a director of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director.&#160; If the General Corporation Law or any other law of the State of Delaware is amended after approval by the stockholders of this Article&nbsp;<u>Eighth</u> to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Corporation shall be eliminated or limited to the fullest extent permitted by the General Corporation Law as so amended.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Any repeal or modification of the foregoing provisions of this Article&nbsp;<u>Eighth</u> by the stockholders of the Corporation shall not adversely affect any right or protection of a director of the Corporation existing at the time of, or increase the liability of any director of the Corporation with respect to any acts or omissions of such director occurring prior to, such repeal or modification.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">NINTH</font></b>: The following indemnification provisions shall apply to the persons enumerated below.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Right to Indemnification of Directors and Officers</u>.&#160; The Corporation shall indemnify and hold harmless, to the fullest extent permitted by applicable law as it presently exists or may hereafter be amended, any person (an &#147;<b>Indemnified Person</b>&#148;) who was or is made or is threatened to be made a party or is otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (a &#147;<b>Proceeding</b>&#148;), by reason of the fact that such person, or a person for whom such person is the legal representative, is or was a director or officer of the Corporation or, while a director or officer of the Corporation, is or was serving at the request of the Corporation as a director, </p>
<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">21<a name="16022-2-MC-03_PB_21_233919_5250"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=21,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=772006,FOLIO='21',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">officer, employee or agent of another corporation or of a partnership, joint venture, limited liability company, trust, enterprise or nonprofit entity, including service with respect to employee benefit plans, against all liability and loss suffered and expenses (including attorneys&#146; fees) reasonably incurred by such Indemnified Person in such Proceeding.&#160; Notwithstanding the preceding sentence, except as otherwise provided in Section&nbsp;3 of this Article&nbsp;<u>Ninth</u>, the Corporation shall be required to indemnify an Indemnified Person in connection with a Proceeding (or part thereof) commenced by such Indemnified Person only if the commencement of such Proceeding (or part thereof) by the Indemnified Person was authorized in advance by the Board of Directors.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Prepayment of Expenses of Directors and Officers</u>.&#160; The Corporation shall pay the expenses (including attorneys&#146; fees) incurred by an Indemnified Person in defending any Proceeding in advance of its final disposition, <u>provided</u>, <u>however</u>, that, to the extent required by law, such payment of expenses in advance of the final disposition of the Proceeding shall be made only upon receipt of an undertaking by the Indemnified Person to repay all amounts advanced if it should be ultimately determined that the Indemnified Person is not entitled to be indemnified under this Article&nbsp;<u>Ninth</u> or otherwise.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Claims by Directors and Officers</u>.&#160; If a claim for indemnification or advancement of expenses under this Article&nbsp;<u>Ninth</u> is not paid in full within 30 days after a written claim therefor by the Indemnified Person has been received by the Corporation, the Indemnified Person may file suit to recover the unpaid amount of such claim and, if successful in whole or in part, shall be entitled to be paid the expense of prosecuting such claim.&#160; In any such action the Corporation shall have the burden of proving that the Indemnified Person is not entitled to the requested indemnification or advancement of expenses under applicable law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Indemnification of Employees and Agents</u>.&#160;&#160; The Corporation may indemnify and advance expenses to any person who was or is made or is threatened to be made or is otherwise involved in any Proceeding by reason of the fact that such person, or a person for whom such person is the legal representative, is or was an employee or agent of the Corporation or, while an employee or agent of the Corporation, is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, limited liability company, trust, enterprise or nonprofit entity, including service with respect to employee benefit plans, against all liability and loss suffered and expenses (including attorney&#146;s fees) reasonably incurred by such person in connection with such Proceeding.&#160; The ultimate determination of entitlement to indemnification of persons who are non-director or officer employees or agents shall be made in such manner as is determined by the Board of Directors in its sole discretion.&#160; Notwithstanding the foregoing sentence, the Corporation shall not be required to indemnify a person in connection with a Proceeding initiated by such person if the Proceeding was not authorized in advance by the Board of Directors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Advancement of Expenses of Employees and Agents</u>.&#160; The Corporation may pay the expenses (including attorney&#146;s fees) incurred by an employee or agent in defending any Proceeding in advance of its final disposition on such terms and conditions as may be determined by the Board of Directors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Non-Exclusivity of Rights</u>.&#160; The rights conferred on any person by this Article&nbsp;<u>Ninth</u> shall not be exclusive of any other rights which such person may have or hereafter acquire under any statute, provision of the certificate of incorporation, these by-laws, agreement, vote of stockholders or disinterested directors or otherwise.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Other Indemnification</u>.&#160; The Corporation&#146;s obligation, if any, to indemnify any person who was or is serving at its request as a director, officer or employee of another corporation, partnership, limited liability company, joint venture, trust, organization or other enterprise shall be reduced by any amount such person may collect as indemnification from such other corporation, partnership, limited liability company, joint venture, trust, organization or other enterprise.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">22<a name="16022-2-MC-03_PB_22_233930_7672"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=22,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=664377,FOLIO='22',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Insurance</u>.&#160; The Board of Directors may, to the full extent permitted by applicable law as it presently exists, or may hereafter be amended from time to time, authorize an appropriate officer or officers to purchase and maintain at the Corporation&#146;s expense insurance:&#160; (a)&nbsp;to indemnify the Corporation for any obligation which it incurs as a result of the indemnification of directors, officers and employees under the provisions of this Article&nbsp;<u>Ninth</u>; and (b)&nbsp;to indemnify or insure directors, officers and employees against liability in instances in which they may not otherwise be indemnified by the Corporation under the provisions of this Article&nbsp;<u>Ninth</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Amendment or Repeal</u>.&#160; Any repeal or modification of the foregoing provisions of this Article&nbsp;<u>Ninth</u> shall not adversely affect any right or protection hereunder of any person in respect of any act or omission occurring prior to the time of such repeal or modification.&#160; The rights provided hereunder shall inure to the benefit of any Indemnified Person and such person&#146;s heirs, executors and administrators.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TENTH</font></b>:&#160; Pursuant to Section&nbsp;122(17) of the General Corporation Law, the Corporation hereby renounces any interest or expectancy of the Corporation or any subsidiary of the Corporation in, or in being offered an opportunity to participate in, any and all business opportunities that are presented to the holders of Preferred Stock or their affiliates other than holders who are employees of the Corporation (including, without limitation, any representative or affiliate of such holders of Preferred Stock serving on the Board of Directors or the board of directors or other governing body of any subsidiary of the Corporation (each a &#147;<b>Board</b>&#148;)) (collectively, the &#147;<b>Investor Parties</b>&#148;).&#160; Without limiting the foregoing renunciation, the Corporation on behalf of itself and its subsidiaries (a)&nbsp;acknowledges that the Investor Parties are in the business of making investments in, and have or may have investments in, other businesses similar to and that may compete with the businesses of the Corporation and its subsidiaries (&#147;<b>Competing Businesses</b>&#148;) and (b)&nbsp;agrees that the Investor Parties shall have the unfettered right to make investments in or have relationships with other Competing Businesses independent of their investments in the Corporation.&#160; By virtue of an Investor Party holding capital stock of the Corporation or by having persons designated by or affiliated with such Investor Party serving on or observing at meetings of any Board of Directors or otherwise, no Investor Party shall have any obligation to the Corporation, any of its subsidiaries or any other holder of capital stock or securities of the Corporation to refrain from competing with the Corporation and any of its subsidiaries, making investments in or having relationships with Competing Businesses, or otherwise engaging in any commercial activity and none of the Corporation, any of its subsidiaries or any other holder of capital stock or securities of the Corporation shall have any right with respect to any investment or activities undertaken by such Investor Party.&#160; Without limitation of the foregoing, each Investor Party may engage in or possess any interest in other business ventures of any nature or description, independently or with others, similar or dissimilar to the business of the Corporation or any of its subsidiaries, and none of the Corporation, any of its subsidiaries or any other holder of capital stock or securities of the Corporation shall have any rights or expectancy by virtue of such Investor Parties&#146; relationships with the Corporation, or otherwise in and to such independent ventures or the income or profits derived therefrom; and the pursuit of any such ventures, even if such investment is in a Competing Business, shall not for any purpose be deemed wrongful or improper.&#160; No Investor Party shall be obligated to present any particular investment opportunity to the Corporation or its subsidiaries even if such opportunity is of a character that, if presented to the Corporation or such subsidiary, could be taken by the Corporation or such subsidiary, and each Investor Party shall continue to have the right for its own respective account or to recommend to others any such particular investment opportunity.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ELEVENTH</font></b>:&#160; Subject to any additional vote required by the Certificate of Incorporation or Bylaws, in furtherance and not in limitation of the powers conferred by statute, the Board of Directors is expressly authorized to make, repeal, alter, amend and rescind any or all of the Bylaws of the Corporation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*&#160;&#160;&#160;&#160; *&#160;&#160;&#160;&#160; *</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">23<a name="16022-2-MC-03_PB_23_233939_536"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=23,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=880946,FOLIO='23',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>That the foregoing amendment and restatement was approved by the holders of the requisite number of shares of this Corporation in accordance with Section&nbsp;228 of the General Corporation Law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>That this Third Amended and Restated Certificate of Incorporation, which restates and integrates and further amends the provisions of this corporation&#146;s Amended and Restated Certificate of Incorporation, has been duly adopted in accordance with Sections 242 and 245 of the General Corporation Law.</p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">24<a name="16022-2-MC-03_PB_24_233941_5926"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=24,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=811560,FOLIO='24',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">IN WITNESS WHEREOF</font></b>, this Third Amended and Restated Certificate of Incorporation has been executed by a duly authorized officer of this Corporation on this 8<font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">th</font>&#160;day of June, 2016.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Robert Folkes</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Robert Folkes, Chief   Operating Officer</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">[Signature Page to Third Amended and Restated Certificate of Incorporation]</font></i></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=25,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="3",CHK=1005805,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MC-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>4
<FILENAME>a2228882zex-4_2.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 4.2</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.<br> AMENDED AND RESTATED INVESTORS&#146; RIGHTS AGREEMENT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">THIS AMENDED AND RESTATED INVESTORS&#146; RIGHTS AGREEMENT</font> is made as of September&nbsp;14, 2012, by and among Tactile Systems Technology,&nbsp;Inc. a Delaware corporation (the &#147;<b>Company</b>&#148;), and each of the Persons listed on <u>Schedule A</u> hereto, each of which is referred to in this Agreement as an &#147;<b>Investor</b>.&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">RECITALS</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company and certain of the Investors are parties to the Investors&#146; Rights Agreement, dated as of October&nbsp;25, 2007 (the &#147;<b>Existing Agreement</b>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Pursuant to that certain Series&nbsp;B Preferred Stock Purchase Agreement, dated as of the date hereof (as amended from time to time, the &#147;<b>Purchase Agreement</b>&#148;), by and between the Company and certain Investors, the Company has agreed to sell and issue shares of its Series&nbsp;B Preferred Stock to such Investors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">C.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To induce such Investors to enter into the Purchase Agreement and to induce such Investors to invest funds in the Company pursuant to the Purchase Agreement, the parties signatory hereto desire to amend and restate the Existing Agreement in its entirety as set forth in this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">NOW, THEREFORE</font></b>, the parties hereby agree as follows:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Definitions</u>.&#160; For purposes of this Agreement:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Affiliate</b>&#148; means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person including, without limitation, any general partner, managing member, officer or director of such Person or any venture capital fund now or hereafter existing that is controlled by one or more general partners or managing members of, or shares the same management company with, such Person.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Certificate of Incorporation</b>&#148; means the Company&#146;s Certificate of Incorporation, as amended from time to time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Common Stock</b>&#148; means shares of the Company&#146;s common stock, par value $0.001 per share.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Damages</b>&#148; means all losses, damages and liabilities (joint or several) to which a Person entitled to indemnification hereunder may become subject under the Securities Act, the Exchange Act, any other federal or state law or otherwise insofar as such losses, damages or liabilities (or any action in respect thereof) arises out of or is based upon (i)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in any registration statement of the Company, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto; (ii)&nbsp;an omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading; or (iii)&nbsp;any violation or alleged violation by the indemnifying party (or any of its agents or Affiliates) of the Securities Act, the Exchange Act, any state securities law, or any rule&nbsp;or regulation promulgated under the Securities Act, the Exchange Act, or any state securities law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.5</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Deemed Liquidation Event</b>&#148; shall have the meaning ascribed to such term in the Certificate of Incorporation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.6</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Derivative Securities</b>&#148; means any securities or rights convertible into, or exercisable or exchangeable for (in each case, directly or indirectly), Common Stock, including options and warrants.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">1<a name="16022-2-KM-01_PB_1_073931_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=451524,FOLIO='1',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-01_ZBY12202.CHC",USER="DBEMBEN",CD='May  6 03:18 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.7</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Exchange Act</b>&#148; means the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations promulgated thereunder.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.8</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Excluded Registration</b>&#148; means (i)&nbsp;a registration relating to the sale of securities to employees of the Company or a subsidiary pursuant to a stock option, stock purchase, or similar plan; (ii)&nbsp;a registration relating to an SEC Rule&nbsp;145 transaction; (iii)&nbsp;a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities; or (iv)&nbsp;a registration in which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.9</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Form&nbsp;S-1</b>&#148; means such form under the Securities Act as in effect on the date hereof or any successor registration form under the Securities Act subsequently adopted by the SEC.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.10</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Form&nbsp;S-3</b>&#148; means such form under the Securities Act as in effect on the date hereof or any registration form under the Securities Act subsequently adopted by the SEC that permits incorporation of substantial information by reference to other documents filed by the Company with the SEC.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.11</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>GAAP</b>&#148; means generally accepted accounting principles in the United States.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.12</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Holder</b>&#148; means any holder of Registrable Securities who is a party to this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.13</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Immediate Family Member</b>&#148; means a child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships, of a natural person referred to herein.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.14</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Initiating Holders</b>&#148; means, collectively, Holders who properly initiate a registration request under this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.15</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>IPO</b>&#148; means the Company&#146;s first underwritten public offering of its Common Stock under the Securities Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.17</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Major Investor</b>&#148; means any Investor that, individually or together with such Investor&#146;s Affiliates, holds at least 300,000 shares of Registrable Securities (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected after the date hereof).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.18</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>New Securities</b>&#148; means (i)&nbsp;all shares of capital stock or other equity securities of the Company, whether or not currently authorized, (ii)&nbsp;all rights, options and warrants to purchase such shares of capital stock or other equity securities, (iii)&nbsp;all Derivative Securities, (iv)&nbsp;all securities entitling the holder thereof to participate in dividends or distributions from the Company or in the distribution of assets upon the liquidation, dissolution or winding up of the Company, (v)&nbsp;all phantom stock or stock appreciation rights and (vi)&nbsp;all other securities of any type whatsoever that are, or may become, convertible or exchangeable into or exercisable for such shares of capital stock or other equity securities, except for shares of the Company&#146;s Series&nbsp;B Preferred Stock issued pursuant to the Purchase Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.19</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Person</b>&#148; means any individual, corporation, partnership, trust, limited liability company, association or other entity.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.20</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Preferred Stock</b>&#148; means shares of the Company&#146;s Series&nbsp;A Preferred Stock and shares of the Company&#146;s Series&nbsp;B Preferred Stock.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.21</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Registrable Securities</b>&#148; means (i)&nbsp;the Common Stock issuable or issued upon conversion of the Preferred Stock; (ii)&nbsp;all shares of Common Stock acquired by any Investor after the date hereof; and (iii)&nbsp;any Common Stock issued as (or issuable upon the conversion or exercise of any warrant,</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-KM-01_PB_2_074141_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=208304,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-01_ZBY12202.CHC",USER="DBEMBEN",CD='May  6 03:18 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">right, or other security that is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of, the shares referenced in clause (i)&nbsp;or clause (ii)&nbsp;above or as a result of a stock split or other similar capital reorganization; excluding in all cases, however, any Registrable Securities sold by a Person in a transaction in which the applicable rights under this Agreement are not assigned pursuant to <u>Section&nbsp;6.1</u>, and excluding for purposes of <u>Section&nbsp;</u>2 any shares for which registration rights have terminated pursuant to <u>Section&nbsp;2.13</u> of this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.22</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Registrable Securities then outstanding</b>&#148; means the number of shares determined by adding the number of shares of outstanding Common Stock that are Registrable Securities and the number of shares of Common Stock issuable (directly or indirectly) pursuant to then exercisable and/or convertible securities that are Registrable Securities.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.23</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Required Holders</b>&#148; means (i)&nbsp;the holders of at least a majority of the then outstanding shares of Series&nbsp;A Preferred Stock and (ii)&nbsp;the holders of at least 66-2/3% of the then outstanding shares of Series&nbsp;B Preferred Stock, voting as separate classes.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.24</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Restricted Securities</b>&#148; means the securities of the Company required to bear the legend set forth in <u>Section&nbsp;2.12(b)</u>&nbsp;hereof.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.25</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>SEC</b>&#148; means the Securities and Exchange Commission.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.26</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>SEC Rule&nbsp;144</b>&#148; means Rule&nbsp;144 promulgated by the SEC under the Securities Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.27</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>SEC Rule&nbsp;145</b>&#148; means Rule&nbsp;145 promulgated by the SEC under the Securities Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.28</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Securities Act</b>&#148; means the Securities Act of 1933, as amended, and the rules&nbsp;and regulations promulgated thereunder.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.29</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Selling Expenses</b>&#148; means all underwriting discounts, selling commissions, and stock transfer taxes applicable to the sale of Registrable Securities, and fees and disbursements of counsel for any Holder, except for the fees and disbursements of the Selling Holder Counsel borne and paid by the Company as provided in <u>Section&nbsp;2.6.</u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.30</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Series&nbsp;A Director</b>&#148; means any director of the Company that the holders of record of the Series&nbsp;A Preferred Stock are entitled to elect pursuant to the Certificate of Incorporation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.31</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Series&nbsp;A Preferred Stock</b>&#148; means shares of the Company&#146;s Series&nbsp;A Preferred Stock, par value $0.001 per share.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.32</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Series&nbsp;B Director</b>&#148; means any director of the Company that the holders of record of the Series&nbsp;B Preferred Stock are entitled to elect pursuant to the Certificate of Incorporation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.33</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<b>Series&nbsp;B Preferred Stock</b>&#148; means shares of the Company&#146;s Series&nbsp;B Preferred Stock, par value $0.001 per share.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Registration Rights</u>.&#160; The Company covenants and agrees as follows:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Demand Registration</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Form&nbsp;S-1 Demand</u>.&#160; If at any time after the earlier of (i)&nbsp;five years after the date of this Agreement or (ii)&nbsp;180 days after the effective date of the registration statement for the IPO, the Company receives a request from Holders of a majority of the Registrable Securities then outstanding that the Company file a Form&nbsp;S-1 registration statement with respect to outstanding Registrable Securities having an anticipated aggregate offering price, net of Selling Expenses, of at least $10,000,000, then the Company shall (i)&nbsp;within ten days after the date such request is given, give notice thereof (the &#147;<b>Demand Notice</b>&#148;) to all Holders other than the Initiating Holders; and (ii)&nbsp;as soon as</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-KM-01_PB_3_074239_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=511572,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-01_ZBY12202.CHC",USER="DBEMBEN",CD='May  6 03:18 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">practicable, and in any event within 60 days after the date such request is given by the Initiating Holders, file a Form&nbsp;S-1 registration statement under the Securities Act covering all Registrable Securities that the Initiating Holders requested to be registered and any additional Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within 20 days of the date the Demand Notice is given, and in each case, subject to the limitations of <u>Section&nbsp;2.1(c)</u>&nbsp;and <u>Section&nbsp;2.3</u>.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Form&nbsp;S-3 Demand</u>.&#160; If at any time when it is eligible to use a Form&nbsp;S-3 registration statement, the Company receives a request from Holders of at least 20% of the Registrable Securities then outstanding that the Company file a Form&nbsp;S-3 registration statement with respect to outstanding Registrable Securities of such Holders having an anticipated aggregate offering price, net of Selling Expenses, of at least $2,500,000, then the Company shall (i)&nbsp;within ten days after the date such request is given, give a Demand Notice to all Holders other than the Initiating Holders; and (ii)&nbsp;as soon as practicable, and in any event within 45 days after the date such request is given by the Initiating Holders, file a Form&nbsp;S-3 registration statement under the Securities Act covering all Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within 20 days of the date the Demand Notice is given, and in each case, subject to the limitations of <u>Section&nbsp;2.1(c)</u>&nbsp;and <u>Section&nbsp;2.3</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding the foregoing obligations, if the Company furnishes to Holders requesting a registration pursuant to this <u>Section&nbsp;2.1</u> a certificate signed by the Company&#146;s chief executive officer stating that in the good faith judgment of the Company&#146;s Board of Directors (the &#147;<b>Board of Directors</b>&#148;) it would be materially detrimental to the Company and its stockholders for such registration statement to either become effective or remain effective for as long as such registration statement otherwise would be required to remain effective, because such action would (i)&nbsp;materially interfere with a significant acquisition, corporate reorganization, or other similar transaction involving the Company; (ii)&nbsp;require premature disclosure of material information that the Company has a bona fide business purpose for preserving as confidential; or (iii)&nbsp;render the Company unable to comply with requirements under the Securities Act or Exchange Act, then the Company shall have the right to defer taking action with respect to such filing, and any time periods with respect to filing or effectiveness thereunder shall be tolled correspondingly, for a period of not more than 90 days after the request of the Initiating Holders is given; <u>provided, however</u>, that the Company may not invoke this right more than once in any 12 month period; and <u>provided further</u> that the Company shall not register any securities for its own account or that of any other stockholder during such 90 day period other than an Excluded Registration.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to <u>Section&nbsp;2.1(a)</u>&nbsp;(i)&nbsp;during the period that is 60 days before the Company&#146;s good faith estimate of the date of filing of, and ending on a date that is 90 days after the effective date of, a Company-initiated registration, <u>provided</u>, that the Company is actively employing in good faith commercially reasonable efforts to cause such registration statement to become effective; (ii)&nbsp;after the Company has effected three registrations pursuant to <u>Section&nbsp;2.1(a)</u>; or (iii)&nbsp;if the Initiating Holders propose to dispose of shares of Registrable Securities that may be immediately registered on Form&nbsp;S-3 pursuant to a request made pursuant to <u>Section&nbsp;2.1(b)</u>.&#160; The Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to <u>Section&nbsp;2.1(b)</u>&nbsp;(i)&nbsp;during the period that is 30 days before the Company&#146;s good faith estimate of the date of filing of, and ending on a date that is 90 days after the effective date of, a Company-initiated registration, <u>provided</u>, that the Company is actively employing in good faith commercially reasonable efforts to cause such registration statement to become effective; or (ii)&nbsp;if the Company has effected two registrations pursuant to <u>Section&nbsp;2.1(b)</u>&nbsp;within the 12 month period immediately preceding the date of such request.&#160; A registration shall not be counted as &#147;effected&#148; for purposes of this <u>Section&nbsp;2.1(d)</u>&nbsp;until such time as the applicable registration statement has been declared effective by the SEC, unless the Initiating Holders withdraw their request for such</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-KM-01_PB_4_074310_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=597647,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-01_ZBY12202.CHC",USER="DBEMBEN",CD='May  6 03:18 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">registration, elect not to pay the registration expenses therefor, and forfeit their right to one demand registration statement pursuant to <u>Section&nbsp;2.6,</u> in which case such withdrawn registration statement shall be counted as &#147;effected&#148; for purposes of this <u>Section&nbsp;2.1(d).</u></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Company Registration</u>.&#160; If the Company proposes to register (including, for this purpose, a registration effected by the Company for stockholders other than the Holders) any of its securities under the Securities Act in connection with the public offering of such securities solely for cash (other than in an Excluded Registration), the Company shall, at such time, promptly give each Holder notice of such registration.&#160; Upon the request of each Holder given within 20 days after such notice is given by the Company, the Company shall, subject to the provisions of <u>Section&nbsp;2.3</u>, cause to be registered all of the Registrable Securities that each such Holder has requested to be included in such registration.&#160; The Company shall have the right to terminate or withdraw any registration initiated by it under this <u>Section&nbsp;2.2</u> before the effective date of such registration, whether or not any Holder has elected to include Registrable Securities in such registration.&#160; The expenses (other than Selling Expenses) of such withdrawn registration shall be borne by the Company in accordance with <u>Section&nbsp;2.6</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Underwriting Requirements</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If, pursuant to <u>Section&nbsp;2.1</u>, the Initiating Holders intend to distribute the Registrable Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to <u>Section&nbsp;2.1,</u> and the Company shall include such information in the Demand Notice.&#160; The underwriter(s)&nbsp;will be selected by the Initiating Holders, subject only to the reasonable approval of the Company.&#160; In such event, the right of any Holder to include such Holder&#146;s Registrable Securities in such registration shall be conditioned upon such Holder&#146;s participation in such underwriting and the inclusion of such Holder&#146;s Registrable Securities in the underwriting to the extent provided herein.&#160; All Holders proposing to distribute their securities through such underwriting shall (together with the Company as provided in <u>Section&nbsp;2.4(e)</u>) enter into an underwriting agreement in customary form with the underwriter(s)&nbsp;selected for such underwriting.&#160; Notwithstanding any other provision of this <u>Section&nbsp;2.3,</u> if the managing underwriter(s)&nbsp;advise(s)&nbsp;the Initiating Holders in writing that marketing factors require a limitation on the number of shares to be underwritten, then the Initiating Holders shall so advise all Holders of Registrable Securities that otherwise would be underwritten pursuant hereto, and the number of Registrable Securities that may be included in the underwriting shall be allocated among such Holders of Registrable Securities, including the Initiating Holders, in proportion (as nearly as practicable) to the number of Registrable Securities owned by each Holder or in such other proportion as shall mutually be agreed to by all such selling Holders; <u>provided, however</u>, that the number of Registrable Securities held by the Holders to be included in such underwriting shall not be reduced unless all other securities are first entirely excluded from the underwriting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In connection with any offering involving an underwriting of shares of the Company&#146;s capital stock pursuant to <u>Section&nbsp;2.2</u>, the Company shall not be required to include any of the Holders&#146; Registrable Securities in such underwriting unless the Holders accept the terms of the underwriting as agreed upon between the Company and its underwriters, and then only in such quantity as the underwriters in their sole discretion determine will not jeopardize the success of the offering by the Company.&#160; If the total number of securities, including Registrable Securities, requested by stockholders to be included in such offering exceeds the number of securities to be sold (other than by the Company) that the underwriters in their reasonable discretion determine is compatible with the success of the offering, then the Company shall be required to include in the offering only that number of such securities, including Registrable Securities, which the underwriters and the Company in their sole discretion determine will not jeopardize the success of the offering.&#160; If the underwriters determine that less than all of the Registrable Securities requested to be registered can be included in such offering, then the Registrable Securities that are included in such offering shall be allocated among the selling Holders in proportion (as nearly as practicable to) the number of Registrable Securities owned by each selling Holder or in such other proportions as shall mutually be agreed to by all such selling Holders.&#160; Notwithstanding</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-KM-01_PB_5_074351_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=502496,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-01_ZBY12202.CHC",USER="DBEMBEN",CD='May  6 03:18 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">the foregoing, in no event shall (i)&nbsp;the number of Registrable Securities included in the offering be reduced unless all other securities (other than securities to be sold by the Company) are first entirely excluded from the offering, or (ii)&nbsp;the number of Registrable Securities included in the offering be reduced below 30% of the total number of securities included in such offering, unless such offering is the IPO, in which case the selling Holders may be excluded further if the underwriters make the determination described above and no other stockholder&#146;s securities are included in such offering.&#160; For purposes of the provision in this <u>Section&nbsp;2.3(b)</u>&nbsp;concerning apportionment, for any selling Holder that is a partnership, limited liability company, or corporation, the partners, members, retired partners, retired members, stockholders, and Affiliates of such Holder, or the estates and Immediate Family Members of any such partners, retired partners, members, and retired members and any trusts for the benefit of any of the foregoing Persons, shall be deemed to be a single &#147;selling Holder,&#148; and any pro rata reduction with respect to such &#147;selling Holder&#148; shall be based upon the aggregate number of Registrable Securities owned by all Persons included in such &#147;selling Holder,&#148; as defined in this sentence.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>For purposes of <u>Section&nbsp;2.1</u>, a registration shall not be counted as &#147;effected&#148; if, as a result of an exercise of the underwriter&#146;s cutback provisions in <u>Section&nbsp;2.3(a)</u>, fewer than 50% of the total number of Registrable Securities that Holders have requested to be included in such registration statement are actually included.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Obligations of the Company</u>.&#160; Whenever required under this <u>Section&nbsp;2</u> to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>prepare and file with the SEC a registration statement with respect to such Registrable Securities and use its commercially reasonable efforts to cause such registration statement to become effective and, upon the request of the Holders of a majority of the Registrable Securities registered thereunder, keep such registration statement effective for a period of up to 120 days or, if earlier, until the distribution contemplated in the registration statement has been completed; <u>provided, however</u>, that (i)&nbsp;such 120 day period shall be extended for a period of time equal to the period the Holder refrains, at the request of an underwriter of Common Stock (or other securities) of the Company, from selling any securities included in such registration, and (ii)&nbsp;in the case of any registration of Registrable Securities on Form&nbsp;S-3 that are intended to be offered on a continuous or delayed basis, subject to compliance with applicable SEC rules, such 120 day period shall be extended for up to one year, if necessary, to keep the registration statement effective until all such Registrable Securities are sold;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>prepare and file with the SEC such amendments and supplements to such registration statement, and the prospectus used in connection with such registration statement, as may be necessary to comply with the Securities Act in order to enable the disposition of all securities covered by such registration statement;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>furnish to the selling Holders such numbers of copies of a prospectus, including a preliminary prospectus, as required by the Securities Act, and such other documents as the Holders may reasonably request in order to facilitate their disposition of their Registrable Securities;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>use its commercially reasonable efforts to register and qualify the securities covered by such registration statement under such other securities or blue-sky laws of such jurisdictions as shall be reasonably requested by the selling Holders; <u>provided that</u> the Company shall not be required to qualify to do business or to file a general consent to service of process in any such states or jurisdictions, unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>in the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and customary form, with the underwriter(s)&nbsp;of such offering;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">6<a name="16022-2-KM-01_PB_6_074436_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=444502,FOLIO='6',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-01_ZBY12202.CHC",USER="DBEMBEN",CD='May  6 03:18 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>use its commercially reasonable efforts to cause all such Registrable Securities covered by such registration statement to be listed on a national securities exchange or trading system and each securities exchange and trading system (if any) on which similar securities issued by the Company are then listed;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>provide a transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and provide a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>promptly make available for inspection by the selling Holders, any managing underwriter(s)&nbsp;participating in any disposition pursuant to such registration statement, and any attorney or accountant or other agent retained by any such underwriter or selected by the selling Holders, all financial and other records, pertinent corporate documents, and properties of the Company, and cause the Company&#146;s officers, directors, employees, and independent accountants to supply all information reasonably requested by any such seller, underwriter, attorney, accountant, or agent, in each case, as necessary or advisable to verify the accuracy of the information in such registration statement and to conduct appropriate due diligence in connection therewith;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>notify each selling Holder, promptly after the Company receives notice thereof, of the time when such registration statement has been declared effective or a supplement to any prospectus forming a part of such registration statement has been filed;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>after such registration statement becomes effective, notify each selling Holder of any request by the SEC that the Company amend or supplement such registration statement or prospectus; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(k)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>furnish, on the date that such Registrable Securities are delivered to the underwriters for sale, if such Registrable Securities are being sold through underwriters, (i)&nbsp;an opinion, dated as of such date, of the counsel representing the Company for the purposes of such registration, in form and substance as is customarily given to underwriters in an underwritten public offering, addressed to the underwriters, if any, and (b)&nbsp;a letter dated as of such date, from the independent certified public accountants of the Company, in form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering addressed to the underwriters.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.5</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Furnish Information</u>.&#160; It shall be a condition precedent to the obligations of the Company to take any action pursuant to this <u>Section&nbsp;2</u> with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method of disposition of such securities as is reasonably required to effect the registration of such Holder&#146;s Registrable Securities.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.6</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Expenses of Registration</u>.&#160; All expenses (other than Selling Expenses) incurred in connection with registrations, filings, or qualifications pursuant to <u>Section&nbsp;2</u>, including all registration, filing, and qualification fees; exchange listing fees; printers&#146; and accounting fees; fees and disbursements of counsel for the Company; and the reasonable fees and disbursements of one counsel for the selling Holders (&#147;<b>Selling Holder Counsel</b>&#148;), shall be borne and paid by the Company; <u>provided, however</u>, that the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to <u>Section&nbsp;2.1</u> if the registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered (in which case all selling Holders shall bear such expenses pro rata based upon the number of Registrable Securities that were to be included in the withdrawn registration), unless the Holders of a majority of the Registrable Securities agree to forfeit their right to one registration pursuant to <u>Section&nbsp;2.1(a)</u>&nbsp;or <u>Section&nbsp;2.1(b)</u>, as the case may be; <u>provided further</u> that if, at the time of such withdrawal, the Holders shall have learned of a material adverse change in the condition, business, or prospects of the Company from that known to the Holders at the time of their request and have withdrawn the request with reasonable promptness after learning of such information</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">7<a name="16022-2-KM-01_PB_7_074550_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=1029309,FOLIO='7',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-01_ZBY12202.CHC",USER="DBEMBEN",CD='May  6 03:18 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">then the Holders shall not be required to pay any of such expenses and shall not forfeit their right to one registration pursuant to <u>Section&nbsp;2.1(a)</u>&nbsp;or <u>Section&nbsp;2.1(b)</u>.&#160; All Selling Expenses relating to Registrable Securities registered pursuant to this <u>Section&nbsp;2</u> shall be borne and paid by the Holders that incurred such Selling Expenses.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.7</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Delay of Registration</u>.&#160; No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any registration pursuant to this Agreement as the result of any controversy that might arise with respect to the interpretation or implementation of this <u>Section&nbsp;2</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.8</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Indemnification</u>.&#160; If any Registrable Securities are included in a registration statement under this <u>Section&nbsp;2</u>:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To the extent permitted by law, the Company will indemnify and hold harmless each selling Holder, and the partners, managers, members, officers, directors, and stockholders of each such Holder; legal counsel and accountants for each such Holder; any underwriter (as defined in the Securities Act) for each such Holder; and each Person, if any, who controls such Holder or underwriter within the meaning of the Securities Act or the Exchange Act against all Damages and the Company will pay to each such Holder, underwriter, controlling Person and other aforementioned Person all legal and other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which Damages may result, as such expenses are incurred; <u>provided, however</u>, that the indemnity agreement contained in this <u>Section&nbsp;2.8(a)</u>&nbsp;shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without the consent of the Company, which consent shall not be unreasonably withheld, conditioned or delayed, nor shall the Company be liable for any Damages to a Holder, underwriter, controlling Person or other aforementioned Person to the extent that they arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of such Holder, underwriter, controlling Person or other aforementioned Person expressly for use in connection with such registration.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To the extent permitted by law, each selling Holder, severally and not jointly, will indemnify and hold harmless the Company, and each of its directors, each of its officers who has signed the registration statement, each Person (if any), who controls the Company within the meaning of the Securities Act, legal counsel and accountants for the Company, any underwriter (as defined in the Securities Act), any other Holder selling securities in such registration statement, and any controlling Person of any such underwriter or other Holder, against all Damages, in each case only to the extent that such Damages arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of such selling Holder expressly for use in connection with such registration; and each such indemnifying Holder will pay to the Company and each other aforementioned Person all legal and other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which Damages may result, as such expenses are incurred; <u>provided, however</u>, that the indemnity agreement contained in this <u>Section&nbsp;2.8(b)</u>&nbsp;shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without the consent of the Holder, which consent shall not be unreasonably withheld, conditioned or delayed; and <u>provided further</u> that in no event shall the aggregate amounts payable by any Holder by way of indemnity or contribution under <u>Sections 2.8(b)</u>&nbsp;and <u>2.8(d)</u>&nbsp;exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such Holder), except in the case of fraud or willful misconduct by such Holder.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Promptly after receipt by an indemnified party under this <u>Section&nbsp;2.8 </u>of notice of the commencement of any action (including any governmental action) for which a party may be entitled to indemnification hereunder, such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this <u>Section&nbsp;2.8</u>, give the indemnifying party notice of the commencement thereof.&#160; The indemnifying party shall have the right to participate in such action and, to the extent the indemnifying party so desires, participate jointly with any other indemnifying party to</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">8<a name="16022-2-KM-01_PB_8_074622_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=969169,FOLIO='8',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-01_ZBY12202.CHC",USER="DBEMBEN",CD='May  6 03:18 2016' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">which notice has been given, and to assume the defense thereof with counsel mutually satisfactory to the parties; <u>provided, however</u>, that an indemnified party (together with all other indemnified parties that may be represented without conflict by one counsel) shall have the right to retain one separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such action. The indemnifying party shall not be entitled to assume or maintain control of the defense of any claim and shall pay the fees and expenses of one counsel retained by the indemnified party if (1)&nbsp;the claim relates to or arises in connection with any criminal proceeding, action, indictment or allegation, (2)&nbsp;the claim seeks an injunction or equitable relief against the indemnified party or any of its affiliates or (3)&nbsp;the indemnifying party has failed or is failing to prosecute or defend the claim.&#160; The failure to give notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than under this <u>Section&nbsp;2.8</u>, except to the extent such failure to give notice materially prejudices the indemnifying party&#146;s ability to defend the action.&#160; No indemnifying party in the defense of any such action shall, except with the consent of each indemnified party, consent to entry of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect of such action.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To provide for just and equitable contribution to joint liability under the Securities Act in any case in which either (i)&nbsp;any party otherwise entitled to indemnification hereunder makes a claim for indemnification pursuant to this <u>Section&nbsp;2.8</u> but it is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case, notwithstanding the fact that this <u>Section&nbsp;2.8</u> provides for indemnification in such case, or (ii)&nbsp;contribution under the Securities Act may be required on the part of any party hereto for which indemnification is provided under this <u>Section&nbsp;2.8</u>, then, and in each such case, such parties will contribute to the aggregate losses, claims, damages, liabilities and expenses to which they may be subject (after contribution from others) in such proportion as is appropriate to reflect the relative fault of each of the indemnifying party and the indemnified party in connection with the statements, omissions, or other actions that resulted in such loss, claim, damage, liability and expense, as well as to reflect any other relevant equitable considerations.&#160; The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or allegedly untrue statement of a material fact, or the omission or alleged omission of a material fact, relates to information supplied by the indemnifying party or by the indemnified party and the parties&#146; relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission; <u>provided, however</u>, that, in any such case, (x)&nbsp;no Holder will be required to contribute any amount in excess of the public offering price of all such Registrable Securities offered and sold by such Holder pursuant to such registration statement, and (y)&nbsp;no Person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f)&nbsp;of the Securities Act) will be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation; and <u>provided further</u> that in no event shall a Holder&#146;s liability pursuant to this <u>Section&nbsp;2.8(d)</u>, when combined with the amounts paid or payable by such Holder pursuant to <u>Section&nbsp;2.8(b)</u>, exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such Holder), except in the case of fraud or willful misconduct by such Holder.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Unless otherwise superseded by an underwriting agreement entered into in connection with the underwritten public offering, the obligations of the Company and Holders under</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">9<a name="16022-2-KM-03_PB_9_075101_1276"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=9,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=787211,FOLIO='9',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:32 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">this <u>Section&nbsp;2.8</u> shall survive the completion of any offering of Registrable Securities in a registration under this <u>Section&nbsp;2</u>, and otherwise shall survive the termination of this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.9</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Reports Under Exchange Act</u>.&#160; With a view to making available to the Holders the benefits of SEC Rule&nbsp;144 and any other rule&nbsp;or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form&nbsp;S-3, the Company shall:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>make and keep available adequate current public information, as those terms are understood and defined in SEC Rule&nbsp;144, at all times after the effective date of the registration statement filed by the Company for the IPO;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>use commercially reasonable efforts to file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act (at any time after the Company has become subject to such reporting requirements); and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request (i)&nbsp;to the extent accurate, a written statement by the Company that it has complied with the reporting requirements of SEC Rule&nbsp;144 (at any time after 90 days after the effective date of the registration statement filed by the Company for the IPO), the Securities Act, and the Exchange Act (at any time after the Company has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form&nbsp;S-3 (at any time after the Company so qualifies); (ii)&nbsp;a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company; and (iii)&nbsp;such other information as may be reasonably requested in availing any Holder of any rule&nbsp;or regulation of the SEC that permits the selling of any such securities without registration (at any time after the Company has become subject to the reporting requirements under the Exchange Act) or pursuant to Form&nbsp;S-3 (at any time after the Company so qualifies to use such form).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.10</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Limitations on Subsequent Registration Rights</u>.&#160; From and after the date of this Agreement, the Company shall not, without the prior written consent of (i)&nbsp;the Holders of a majority of the Registrable Securities then outstanding, (ii)&nbsp;the holders of at least a majority of the then outstanding shares of Series&nbsp;A Preferred Stock (if any) and (iii)&nbsp;the holders of at least 66-2/3% of the then outstanding shares of Series&nbsp;B Preferred Stock (if any), enter into any agreement with any holder or prospective holder of any securities of the Company that would allow such holder or prospective holder to (i)&nbsp;include such securities in any registration unless, under the terms of such agreement, such holder or prospective holder may include such securities in any such registration only to the extent that the inclusion of such securities will not reduce the number of the Registrable Securities of the Holders that are included or (ii)&nbsp;initiate a demand for registration of any securities held by such holder or prospective holder.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.11</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>&#147;Market Stand-off&#148; Agreement</u>.&#160; Each Holder hereby agrees that it will not, without the prior written consent of the managing underwriter, during the period commencing on the date of the final prospectus relating to the registration by the Company of shares of its Common Stock or any other equity securities under the Securities Act on a registration statement on Form&nbsp;S-1 and ending on the date specified by the Company and the managing underwriter, such period not to initially exceed 180 days; provided, however, that if during the last 17 days of the initial lock-up period, the Company releases earnings results or material news or a material event relating to the Company occurs or prior to the expiration of the initial lock-up period, the Company announces that it will release earnings results during the 16-day period beginning on the last day of the initial lock-up period, then in each case the lock-up period will be extended until the expiration of the 18-day period beginning on the date of release of the earnings results or the occurrence of the material news or material event, as applicable, unless the managing underwriter waives, in writing, such extension, (i)&nbsp;lend; offer; pledge; sell; contract to sell; sell any option or contract to purchase; purchase any option or contract to sell; grant any option, right, or warrant to purchase; or otherwise transfer or dispose of, directly or indirectly, any shares of Common</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">10<a name="16022-2-KM-03_PB_10_075250_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=10,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=294245,FOLIO='10',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:32 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stock or any securities convertible into or exercisable or exchangeable (directly or indirectly) for Common Stock held immediately before the effective date of the registration statement for such offering or (ii)&nbsp;enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of such securities, whether any such transaction described in clause (i)&nbsp;or (ii)&nbsp;above is to be settled by delivery of Common Stock or other securities, in cash, or otherwise.&#160; The foregoing provisions of this <u>Section&nbsp;2.11</u> shall apply only to the IPO, shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, and shall be applicable to the Holders only if all officers, directors and stockholders individually owning more than 1% of the Company&#146;s outstanding Common Stock (after giving effect to conversion into Common Stock of all outstanding Preferred Stock) are subject to the same restrictions.&#160; The underwriters in connection with such registration are intended third-party beneficiaries of this <u>Section&nbsp;2.11</u> and shall have the right, power, and authority to enforce the provisions hereof as though they were a party hereto.&#160; Each Holder further agrees to execute such agreements as may be reasonably requested by the underwriters in connection with such registration that are consistent with this <u>Section&nbsp;2.11</u> or that are necessary to give further effect thereto.&#160; Any discretionary waiver or termination of the restrictions of any or all of such agreements by the Company or the underwriters shall apply pro rata to all Holders subject to such agreements, based on the number of shares subject to such agreements.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.12</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Restrictions on Transfer</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Preferred Stock and the Registrable Securities shall not be sold, pledged, or otherwise transferred, and the Company shall not recognize and shall issue stop-transfer instructions to its transfer agent with respect to any such sale, pledge, or transfer, except upon the conditions specified in this Agreement, which conditions are intended to ensure compliance with the provisions of the Securities Act and state securities laws.&#160; A transferring Holder will cause any proposed purchaser, pledgee, or transferee of the Preferred Stock and the Registrable Securities held by such Holder to agree to take and hold such securities subject to the provisions and upon the conditions specified in this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each certificate or instrument representing (i)&nbsp;the Preferred Stock, (ii)&nbsp;the Registrable Securities, and (iii)&nbsp;any other securities issued in respect of the securities referenced in clauses (i)&nbsp;and (ii),&nbsp;upon any stock split, stock dividend, recapitalization, merger, consolidation, or similar event, shall (unless otherwise permitted by the provisions of <u>Section&nbsp;2.12(c)</u>) be stamped or otherwise imprinted with a legend substantially in the following form:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in .5in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">THE SECURITIES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY STATE SECURITIES LAWS.&#160; SUCH SHARES MAY&nbsp;NOT BE SOLD, PLEDGED, OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR A VALID EXEMPTION FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF SAID ACT AND SUCH LAWS.</font></p>
<p style="margin:0in .5in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in .5in .0001pt;text-align:justify;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">THE SECURITIES REPRESENTED HEREBY MAY&nbsp;BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Holders consent to the Company making a notation in its records and giving instructions to any transfer agent of the Restricted Securities in order to implement the restrictions on transfer set forth in this <u>Section&nbsp;2.12.</u></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The holder of each certificate representing Restricted Securities, by acceptance thereof, agrees to comply in all respects with the provisions of this <u>Section&nbsp;2</u>.&#160; Before any proposed sale, pledge, or transfer of any Restricted Securities, unless there is in effect a registration</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">11<a name="16022-2-KM-03_PB_11_075314_7091"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=11,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=365394,FOLIO='11',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:32 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">statement under the Securities Act covering the proposed transaction, the Holder thereof shall give notice to the Company of such Holder&#146;s intention to effect such sale, pledge, or transfer.&#160; Each such notice shall describe the manner and circumstances of the proposed sale, pledge, or transfer in sufficient detail and, if reasonably requested by the Company, shall be accompanied at such Holder&#146;s expense by either (i)&nbsp;a written opinion of legal counsel who shall, and whose legal opinion shall, be reasonably satisfactory to the Company, addressed to the Company, to the effect that the proposed transaction may be effected without registration under the Securities Act and state securities laws; (ii)&nbsp;a &#147;no action&#148; letter from the SEC to the effect that the proposed sale, pledge, or transfer of such Restricted Securities without registration will not result in a recommendation by the staff of the SEC or a state securities regulator that action be taken with respect thereto; or (iii)&nbsp;any other evidence reasonably satisfactory to counsel to the Company to the effect that the proposed sale, pledge, or transfer of the Restricted Securities may be effected without registration under the Securities Act and state securities laws, whereupon the Holder of such Restricted Securities shall be entitled to sell, pledge, or transfer such Restricted Securities in accordance with the terms of the notice given by the Holder to the Company.&#160; The Company will not require such a legal opinion or &#147;no action&#148; letter (x)&nbsp;in any transaction in compliance with SEC Rule&nbsp;144 or (y)&nbsp;in any transaction in which such Holder distributes Restricted Securities to an Affiliate of such Holder for no consideration; provided that each transferee agrees in writing to be subject to the terms of this <u>Section&nbsp;2.12</u>.&#160; Each certificate or instrument evidencing the Restricted Securities transferred as above provided shall bear, except if such transfer is made pursuant to SEC Rule&nbsp;144, the appropriate restrictive legend set forth in <u>Section&nbsp;2.12(b)</u>, except that such certificate shall not bear such restrictive legend if, in the opinion of counsel for such Holder and the Company, such legend is not required in order to establish compliance with any provisions of the Securities Act or state securities laws.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.13</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Termination of Registration Rights</u>.&#160; The right of any Holder to request registration or inclusion of Registrable Securities in any registration pursuant to <u>Section&nbsp;2.1</u> or <u>Section&nbsp;2.2</u> shall terminate upon the earlier to occur of:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the closing of a Deemed Liquidation Event (provided that if the occurrence of a Deemed Liquidation Event was waived under the Certificate of Incorporation, a Deemed Liquidation Event shall not be deemed to occur for purposes of this provision);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the date on which all shares of Registrable Securities held by such Holder may be sold under Rule&nbsp;144; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>that is the third anniversary of the consummation of the IPO.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Information Rights</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Delivery of Financial Statements</u>.&#160; The Company shall deliver to each Major Investor:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>as soon as practicable, but in any event within 150 days after the end of each fiscal year of the Company (i)&nbsp;a balance sheet as of the end of such year, (ii)&nbsp;statements of income and of cash flows for such year, and (iii)&nbsp;a comparison between (x)&nbsp;the actual amounts as of and for such fiscal year and (y)&nbsp;the comparable amounts for the prior year and as included in the Budget (as defined in <u>Section&nbsp;3.1(e)</u>) for such year, with an explanation of any material differences between such amounts and a schedule as to the sources and applications of funds for such year, and (iv)&nbsp;a statement of stockholders&#146; equity as of the end of such year, with the financial statements set forth under (i), (ii)&nbsp;and (iv)&nbsp;above to be audited and certified by independent public accountants of nationally recognized standing selected by the Company;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>as soon as practicable, but in any event within 45 days after the end of each of the first three quarters of each fiscal year of the Company, unaudited statements of income and of cash flows for such fiscal quarter, and an unaudited balance sheet as of the end of such fiscal quarter, all prepared in accordance with GAAP (except that such financial statements may (i)&nbsp;be subject to normal</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">12<a name="16022-2-KM-03_PB_12_075343_455"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=12,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=23882,FOLIO='12',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:32 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">year-end audit adjustments and (ii)&nbsp;not contain all notes thereto that may be required in accordance with GAAP);</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>as soon as practicable, but in any event within 45 days after the end of each quarter of each fiscal year of the Company, a statement showing the number of shares of each class and series of capital stock and securities convertible into or exercisable for shares of capital stock outstanding at the end of the period, the Common Stock issuable upon conversion or exercise of any outstanding securities convertible or exercisable for Common Stock and the exchange ratio or exercise price applicable thereto, and the number of shares subject to issued stock options and stock options not yet issued but reserved for issuance, if any, all in sufficient detail as to permit the Major Investors to calculate their respective percentage equity ownership in the Company, and certified by the chief financial officer or chief executive officer of the Company as being true, complete, and correct;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>as soon as practicable, but in any event within 30 days of the end of each month, an unaudited income statement and statement of cash flows for such month, and an unaudited balance sheet as of the end of such month, all prepared in accordance with GAAP (except that such financial statements may (i)&nbsp;be subject to normal year-end audit adjustments and (ii)&nbsp;not contain all notes thereto that may be required in accordance with GAAP);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>as soon as practicable, but in any event 30 days before the end of each fiscal year, a budget and business plan for the next fiscal year (collectively, the &#147;<b>Budget</b>&#148;), approved by the Board of Directors and prepared on a monthly basis, including balance sheets, income statements, and statements of cash flow for such months and, promptly after prepared, any other budgets or revised budgets prepared by the Company;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>with respect to the financial statements called for in <u>Section&nbsp;3.1(a)</u>, <u>Section&nbsp;3.1(b)</u>&nbsp;and <u>Section&nbsp;3.1(d)</u>, an instrument executed by the chief financial officer or chief executive officer of the Company certifying that such financial statements were prepared in accordance with GAAP consistently applied with prior practice for earlier periods (except as otherwise set forth in <u>Section&nbsp;3.1(b)</u>&nbsp;and <u>Section&nbsp;3.1(d)</u>) and fairly present the financial condition of the Company and its results of operation for the periods specified therein; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>such other information relating to the financial condition, business, prospects, or corporate affairs of the Company as any Major Investor may from time to time reasonably request; provided, that the Company shall not be obligated to provide information the disclosure of which would adversely affect the attorney-client privilege between the Company and its counsel.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If, for any period, the Company has any subsidiary whose accounts are consolidated with those of the Company, then in respect of such period the financial statements delivered pursuant to the foregoing sections shall be the consolidated and consolidating financial statements of the Company and all such consolidated subsidiaries.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding anything else in this <u>Section&nbsp;3.1</u> to the contrary, the Company may cease providing the information set forth in this <u>Section&nbsp;3.1</u> during the period starting with the date 30 days before the Company&#146;s good-faith estimate of the date of filing of a registration statement if it reasonably concludes it must do so to comply with the SEC rules&nbsp;applicable to such registration statement and related offering; provided that the Company&#146;s covenants under this <u>Section&nbsp;3.1</u> shall be reinstated at such time as the Company is no longer actively employing its commercially reasonable efforts to cause such registration statement to become effective.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Inspection</u>.&#160; The Company shall permit each Major Investor and its agents, at such Major Investor&#146;s expense, to visit and inspect the Company&#146;s properties; examine its books of account and records; and discuss the Company&#146;s affairs, finances, and accounts with its officers, during normal business hours of the Company as may be reasonably requested by the Major Investor; provided,</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">13<a name="16022-2-KM-03_PB_13_075417_4141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=13,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=440536,FOLIO='13',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:32 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">that the Company shall not be obligated to provide information the disclosure of which would adversely affect the attorney-client privilege between the Company and its counsel.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Termination of Information Rights</u>.&#160; The covenants set forth in <u>Section&nbsp;3.1</u> and <u>Section&nbsp;3.2</u> shall terminate and be of no further force or effect upon the earlier of (i)&nbsp;the date immediately before the consummation of the IPO or (ii)&nbsp;the date that the Company first becomes subject to the periodic reporting requirements of Section&nbsp;12(g)&nbsp;or 15(d)&nbsp;of the Exchange Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Confidentiality</u>.&#160; Each Investor severally agrees that such Investor will keep confidential and will not disclose, divulge, or use for any purpose (other than to monitor its investment in the Company or to enforce its rights under this Agreement or otherwise) any confidential information obtained from the Company pursuant to the terms of this Agreement (including notice of the Company&#146;s intention to file a registration statement), unless such confidential information (a)&nbsp;is known or becomes known to the public in general (other than as a result of a breach of this <u>Section&nbsp;3.4</u> by such Investor), (b)&nbsp;is or has been independently developed or conceived by such Investor without use of the Company&#146;s confidential information, or (c)&nbsp;is or has been made known or disclosed to such Investor by a third party without a breach of any obligation of confidentiality such third party may have to the Company; <u>provided, however</u>, that an Investor may disclose confidential information (i)&nbsp;to its attorneys, accountants, consultants, and other professionals to the extent necessary to obtain their services in connection with monitoring its investment in the Company or to enforce its rights under this Agreement or otherwise; (ii)&nbsp;to any prospective purchaser of any Registrable Securities from such Investor, if such prospective purchaser agrees to be bound by the provisions of this <u>Section&nbsp;3.4</u>; (iii)&nbsp;to any existing or prospective Affiliate, partner, member, stockholder, or wholly owned subsidiary of such Investor in the ordinary course of business, <u>provided that</u> such Investor informs such Person that such information is confidential and directs such Person to maintain the confidentiality of such information; or (iv)&nbsp;pursuant to a court decree, subpoena, or other judicial or administrative order or process reasonably believed by such Investor to compel disclosure of such confidential information, <u>provided that</u>, to the extent permitted by applicable law, such Investor promptly notifies the Company of such disclosure and takes reasonable steps to minimize the extent of any such required disclosure.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Rights to Future Stock Issuances</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Right of First Offer</u>.&#160; Subject to the terms and conditions of this <u>Section&nbsp;4.1</u>, if the Company proposes to offer or issue any New Securities, the Company shall first offer such New Securities to each Major Investor.&#160; A Major Investor shall be entitled to apportion the right of first offer hereby granted to it among itself and its Affiliates in such proportions as it deems appropriate.&#160; Each Major Investor that desires to exercise his, her or its rights under this Section&nbsp;4 must be an &#147;accredited investor&#148; within the meaning of Regulation D as promulgated under the Securities Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company shall give notice (the &#147;<b>Offer Notice</b>&#148;) to each Major Investor, stating (i)&nbsp;its bona fide intention to offer such New Securities, (ii)&nbsp;the number of such New Securities to be offered, and (iii)&nbsp;the price and terms, if any, upon which it proposes to offer such New Securities.&#160; If the consideration to be paid by others for the New Securities is not cash, the fair market value of the consideration shall be determined in good faith by the Board of Directors and a reasonably detailed explanation of the Board of Director&#146;s determination of such value shall be included in the Offer Notice.&#160; All Major Investors electing to participate in the offering of such New Securities shall pay the cash equivalent thereof as so determined.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By notification to the Company within 20 days after the Offer Notice is given, each Major Investor may elect to purchase or otherwise acquire, at the price and on the terms specified in the Offer Notice, up to that portion of such New Securities which equals the proportion that the sum of the number of shares of Common Stock issued and then held by such Major Investor as a result of the conversion of Preferred Stock and the number of shares of Common Stock issuable upon conversion of the Preferred Stock then held by such Major Investor bears to the sum of the number of</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">14<a name="16022-2-KM-03_PB_14_075441_8627"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=14,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=114404,FOLIO='14',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:32 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">shares of Common Stock issued and outstanding as a result of the conversion of Preferred Stock and the number of shares of Common Stock issuable upon conversion of the then outstanding shares of Preferred Stock.&#160; At the expiration of such 20 day period, the Company shall promptly notify each Major Investor that elects to purchase or acquire its full ratable portion of the New Securities available to it (each, a &#147;<b>Fully Exercising Investor</b>&#148;) of any other Major Investor&#146;s failure to do likewise.&#160; During the ten day period commencing after the Company has given such notice, each Fully Exercising Investor may, by giving notice to the Company, elect to purchase or acquire, in addition to its portion of the New Securities specified above, up to that portion of the New Securities for which Major Investors were entitled to subscribe but that were not subscribed for by the Major Investors which is equal to the proportion that the sum of the number of shares of Common Stock issued and then held by such Fully Exercising Investor who desires to purchase such unsubscribed New Securities as a result of the conversion of Preferred Stock and the number of shares of Common Stock issuable upon conversion of the Preferred Stock then held by such Fully Exercising Investor bears to the sum of the number of shares of Common Stock issued and then held by all Fully Exercising Investors who desire to purchase such unsubscribed New Securities as a result of the conversion of Preferred Stock and the number of shares of Common Stock issuable upon conversion of the Preferred Stock then held by all Fully Exercising Investors who desire to purchase such unsubscribed New Securities.&#160; The closing of any sale pursuant to this <u>Section&nbsp;4.1(b)</u>&nbsp;shall occur within the later of 90 days of the date that the Offer Notice is given and the date of initial sale of New Securities pursuant to <u>Section&nbsp;4.1(c)</u>.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If all New Securities referred to in the Offer Notice are not elected to be purchased or acquired as provided in <u>Section&nbsp;4.1(b)</u>, the Company may, during the 90 day period following the expiration of the periods provided in <u>Section&nbsp;4.1(b)</u>, offer, sell or enter into an agreement to sell the remaining unsubscribed portion of such New Securities to any Person or Persons at a price not less than, and upon terms no more favorable to the offeree than, those specified in the Offer Notice.&#160; If the Company does not enter into an agreement for the sale of the New Securities within such period, or if such agreement is not consummated within the later of such 90 day period or 30 days of the execution thereof, the right provided hereunder shall be deemed to be revived and such New Securities shall not be offered unless first reoffered to the Major Investors in accordance with this <u>Section&nbsp;4.1</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The right of first offer in this <u>Section&nbsp;4.1</u> shall not be applicable to (i)&nbsp;Exempted Securities (as defined in the Certificate of Incorporation) and (ii)&nbsp;shares of Common Stock issued in the IPO.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Termination</u>.&#160; The covenants set forth in <u>Section&nbsp;4.1</u> shall terminate and be of no further force or effect upon the earlier of (i)&nbsp;the date immediately before the consummation of the sale of shares of Common Stock to the public at a price of at least $4.05 per share (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization) in a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, resulting in at least $30,000,000 of aggregate proceeds, net of the underwriting discount and commissions, to the Company and after which the Common Stock is listed on a United States national securities exchange; or (ii)&nbsp;the date of a Deemed Liquidation Event (provided that if the occurrence of a Deemed Liquidation Event was waived under the Certificate of Incorporation, a Deemed Liquidation Event shall not be deemed to occur for purposes of this provision).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Additional Covenants</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Insurance</u>.&#160; The Company shall maintain, with financially sound and reputable insurers, Directors and Officers liability insurance in an amount and on terms and conditions satisfactory to the Board of Directors and the Required Holders and shall not be cancelable by the Company without prior written approval by the Board of Directors and the Required Holders.&#160; The Company shall maintain, with financially sound and reputable insurers, a term &#147;key-person&#148; life insurance on the Chief Executive Officer of the Company in the amount of at least $1,000,000 and on terms and conditions satisfactory to</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">15<a name="16022-2-KM-03_PB_15_075507_7906"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=15,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=601196,FOLIO='15',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:32 2016' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">the Board of Directors and the Required Holders and the policy or binder for such insurance shall name the Company as loss payee and shall not be cancelable by the Company without prior written approval by the Board of Directors and the Required Holders.&#160; Within 60 days after the date hereof, the Company shall increase the amount of its product liability insurance coverage to $5,000,000 and, thereafter, maintain such coverage with financially sound and reputable insurers on terms and conditions satisfactory to the Board of Directors and the Required Holders and the policy or binder for such insurance shall not be cancelable by the Company without prior written approval by the Board of Directors and the Required Holders.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Employee Agreements</u>.&#160; The Company will cause (i)&nbsp;each person now or hereafter employed by it or by any subsidiary (or engaged by the Company or any subsidiary as a consultant/independent contractor) with access to confidential information and/or trade secrets to enter into a nondisclosure and proprietary rights assignment agreement and (ii)&nbsp;its Chief Executive Officer and Vice President of Sales to enter into a one year noncompetition and nonsolicitation agreement, substantially in the form approved by the Board of Directors.&#160; In addition, the Company shall not amend, modify, terminate, waive, or otherwise alter, in whole or in part, any of the above-referenced agreements or any restricted stock agreement between the Company and any employee, without the consent of the Board of Directors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Employee Stock</u>.&#160; Unless otherwise approved by the Board of Directors, all future employees and consultants of the Company who purchase, receive options to purchase, or receive awards of shares of the Company&#146;s capital stock after the date hereof shall be required to execute restricted stock or option agreements, as applicable, providing for (i)&nbsp;vesting of shares over a four year period, with the first 25% of such shares vesting following 12 months of continued employment or service, and the remaining shares vesting in equal monthly installments over the following 36 months, and (ii)&nbsp;a market stand-off provision substantially similar to that in <u>Section&nbsp;2.11</u>.&#160; In addition, unless otherwise approved by the Board of Directors, the Company shall retain for all future employees and consultants of the Company who purchase, receive options to purchase, or receive awards of shares of the Company&#146;s capital stock after the date hereof a &#147;right of first refusal&#148; on employee transfers until the Company&#146;s IPO and shall have the right to repurchase unvested shares at cost upon termination of employment of a holder of restricted stock.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Matters Requiring Investor Director Approval</u>.&#160; So long as the holders of Series&nbsp;A Preferred Stock are entitled to elect two Series&nbsp;A Directors or the holders of Series&nbsp;B Preferred Stock are entitled to elect two Series&nbsp;B Directors, the Company shall not, without approval of the Board of Directors (or a committee thereof), which approval must include the affirmative vote of at least one of the Series&nbsp;A Directors and at least one of the Series&nbsp;B Directors:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>make, or permit any subsidiary to make, any loan or advance to any Person, including, without limitation, any employee or director of the Company or any subsidiary, except advances and similar expenditures in the ordinary course of business or under the terms of an employee stock or option plan approved by the Board of Directors;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>guarantee, directly or indirectly, or permit any subsidiary to guarantee, directly or indirectly, any indebtedness except for trade accounts of the Company or any subsidiary arising in the ordinary course of business;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>make any investment inconsistent with any investment policy approved by the Board of Directors;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>otherwise enter into or be a party to any transaction with any director, officer, or employee of the Company or any &#147;associate&#148; (as defined in Rule&nbsp;12b-2 promulgated under the Exchange Act) of any such Person, except for transactions contemplated by this Agreement, the Purchase Agreement; or transactions made in the ordinary course of business and pursuant to reasonable</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">16<a name="16022-2-KM-05_PB_16_074019_3021"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=16,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=918794,FOLIO='16',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-05_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">requirements of the Company&#146;s business and upon fair and reasonable terms that are approved by a majority of the Board of Directors; or</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(i)&nbsp;issue awards exceeding 2,334,026 shares of Common Stock under the Company&#146;s 2007 Omnibus Stock Plan (provided, that awards that are issued but terminate prior to the actual issuance of shares of Common Stock without restrictions shall not be counted towards the 2,334,026 share limit once the shares are returned for issuance to the Company&#146;s 2007 Omnibus Stock Plan), (ii)&nbsp;amend the 2007 Omnibus Stock Plan to increase the number of shares issuable under the Plan, (iii)&nbsp;otherwise issue any shares of Common Stock, options, warrants or other securities under any other equity incentive plan or arrangement established for the benefit of the employees, officers, directors and/or consultants of the Company or the subsidiary or (iv)&nbsp;adopt any new equity incentive plan or arrangement established for the benefit of the employees, officers, directors and/or consultants of the Company or the subsidiary.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.5</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Board Matters</u>.&#160; Unless otherwise determined by the vote of a majority of the directors then in office, the Board of Directors shall meet at least quarterly in accordance with an agreed-upon schedule.&#160; The Company shall reimburse the nonemployee directors for all reasonable out-of-pocket travel expenses incurred in connection with attending meetings of the Board of Directors or the meetings of the board of directors (or other governing body) of any subsidiary of the Company or in connection with other activities requested by the Company.&#160; The Company shall maintain an audit and compensation committee, each of which shall consist solely of non-management directors.&#160; At least one Series&nbsp;A Director and at least one Series&nbsp;B Director shall be entitled in such person&#146;s discretion to be a member of each committee of the Board of Directors and each committee of the board of directors (or other governing body) of any subsidiary of the Company (if any).&#160; The Company&#146;s board of directors shall be permitted to elect a chair by majority vote.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.6</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Successor Indemnification</u>.&#160; If the Company or any of its successors or assignees consolidates with or merges into any other Person and is not the continuing or surviving corporation or entity of such consolidation or merger, then to the extent necessary, proper provision shall be made so that the successors and assignees of the Company assume the obligations of the Company with respect to indemnification of members of the Board of Directors as in effect immediately before such transaction, whether such obligations are contained in the Company&#146;s Bylaws, the Certificate of Incorporation, or elsewhere, as the case may be.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.7</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Reservation of Capital Stock</u>.&#160; The Company shall at all times reserve and keep available, solely for issuance and delivery upon the conversion of the Preferred Stock, all Common Stock issuable from time to time upon such conversion.&#160; The Company shall at all times reserve and keep available, solely for issuance and delivery upon the payment of accrued dividends on the shares of Series&nbsp;B Preferred Stock in accordance with the terms of the Certificate of Incorporation, such number of shares of Series&nbsp;B Preferred Stock from time to time to ensure that there will be sufficient shares of Series&nbsp;B Preferred Stock available for issuance to the holders of shares of Series&nbsp;B Preferred Stock in connection with the payment of such dividends.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.8</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Directors&#146; Liability and Indemnification</u>.&#160; The Company&#146;s and each of its subsidiaries&#146; certificate of incorporation, bylaws and other organizational documents shall provide (a)&nbsp;for elimination of the liability of directors to the maximum extent permitted by law and (b)&nbsp;for indemnification of directors for acts on behalf of the Company and its subsidiaries to the maximum extent permitted by law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.9</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Proprietary Rights Agreement</u>.&#160; The Company and each of its subsidiaries shall require all employees, officers and consultants hired after the date hereof to execute and deliver an Employee Confidentiality and Assignment of Inventions Agreement that is substantially in the form attached to the Purchase Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">17<a name="16022-2-KM-05_PB_17_074054_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=17,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=576740,FOLIO='17',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-05_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.10</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Chief Clinical Officer Recruitment</u>.&#160; The Company promptly shall recruit a part- or full-time employee or consultant to become the Company&#146;s Chief Clinical Officer or Chief Medical Officer who shall be responsible for, among other things, developing and executing on the Company&#146;s clinical development program (trial strategy, trial administration, key opinion leader relations and publishing) and who shall be acceptable to the Board of Directors including the approval of the Series&nbsp;B Directors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.11</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Convertible Securities</u>.&#160; All securities or obligations that are exercisable for, convertible into or exchangeable for shares of capital stock of the Company, other than shares of the Company&#146;s Preferred Stock, shall, by their terms, terminate in their entirety at the time of a Deemed Liquidation Event if not exercised, converted or exchanged into shares of the Company&#146;s capital stock immediately prior to such Deemed Liquidation Event.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.12</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Termination of Covenants</u>.&#160; The covenants set forth in this <u>Section&nbsp;5</u>, except for <u>Section&nbsp;5.6</u>, shall terminate and be of no further force or effect upon the earlier of (i)&nbsp;the date immediately before the consummation of a Qualified IPO, as such term is defined in the Certificate of Incorporation or (ii)&nbsp;the date of a Deemed Liquidation Event (provided that if the occurrence of a Deemed Liquidation Event was waived under the Certificate of Incorporation, a Deemed Liquidation Event shall not be deemed to occur for purposes of this provision).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Miscellaneous</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Successors and Assigns</u>.&#160; The rights under this Agreement may be assigned (but only with all related obligations) by a Holder to a transferee of Registrable Securities that (i)&nbsp;is an Affiliate of a Holder; (ii)&nbsp;is a Holder&#146;s Immediate Family Member or trust for the benefit of an individual Holder or one or more of such Holder&#146;s Immediate Family Members; or (iii)&nbsp;after such transfer, holds at least 100,000 Registrable Securities (subject to appropriate adjustment for stock splits, stock dividends, combinations, and other recapitalizations); provided, however, that (x)&nbsp;the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of such transferee and the Registrable Securities with respect to which such rights are being transferred; and (y)&nbsp;such transferee agrees in a written instrument delivered to the Company to be bound by and subject to the terms and conditions of this Agreement, including the provisions of <u>Section&nbsp;2.11</u>.&#160; For the purposes of determining the number of shares of Registrable Securities held by a transferee, the holdings of a transferee (1)&nbsp;that is an Affiliate or stockholder of a Holder; (2)&nbsp;who is a Holder&#146;s Immediate Family Member; or (3)&nbsp;that is a trust for the benefit of an individual Holder or such Holder&#146;s Immediate Family Member shall be aggregated together and with those of the transferring Holder; provided further that all transferees who would not qualify individually for assignment of rights shall have a single attorney-in-fact for the purpose of exercising any rights, receiving notices, or taking any action under this Agreement.&#160; The terms and conditions of this Agreement inure to the benefit of and are binding upon the respective successors and permitted assignees of the parties.&#160; Nothing in this Agreement is intended to confer upon any party other than the parties hereto or their respective successors and permitted assignees any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided herein.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Governing Law</u>. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, regardless of the laws that might otherwise govern under applicable principles of conflicts of law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Counterparts; Facsimile</u>.&#160; This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.&#160; This Agreement may also be executed and delivered by facsimile or other electronic signatures and in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">18<a name="16022-2-KM-05_PB_18_074137_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=18,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=391865,FOLIO='18',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-05_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Titles and Subtitles</u>.&#160; The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.5</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Notices</u>.&#160; All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual receipt or: (i)&nbsp;personal delivery to the party to be notified; (ii)&nbsp;when sent, if sent by electronic mail or facsimile during the recipient&#146;s normal business hours, and if not sent during normal business hours, then on the recipient&#146;s next business day; (iii)&nbsp;five days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (iv)&nbsp;one business day after the business day of deposit with a nationally recognized overnight courier, freight prepaid, specifying next-day delivery, with written verification of receipt.&#160; All communications shall be sent to the respective parties at their addresses as set forth on <u>Schedule A</u> hereto, or to the principal office of the Company and to the attention of the Chief Executive Officer, in the case of the Company, or to such email address, facsimile number, or address as subsequently modified by written notice given in accordance with this <u>Section&nbsp;6.5</u>.&#160; If notice is given to the Company, a copy shall also be sent to Faegre Baker Daniels LLP, 2200 Wells Fargo Center, 90 South Seventh Street, Minneapolis, MN 55402-3901, Attention Jonathan R. Zimmerman.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.6</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Amendments and Waivers</u>.&#160; Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance, and either retroactively or prospectively) only with the written consent of the Company, the holders of a majority of the Registrable Securities then outstanding and the Required Holders; <u>provided that</u> the Company may in its sole discretion waive compliance with <u>Section&nbsp;2.12(c)</u>&nbsp;(and the Company&#146;s failure to object promptly in writing after notification of a proposed assignment allegedly in violation of <u>Section&nbsp;2.12(c)</u>&nbsp;shall be deemed to be a waiver); and provided further that any right of any party hereunder may be waived by the waiving party on such party&#146;s own behalf, without the consent of any other party.&#160; Notwithstanding the foregoing, this Agreement may not be amended or terminated and the observance of any term hereof may not be waived with respect to any Investor without the written consent of such Investor, unless such amendment, termination, or waiver applies to all Investors in the same fashion (it being agreed that a waiver of the provisions of <u>Section&nbsp;4</u> with respect to a particular transaction shall be deemed to apply to all Investors in the same fashion if such waiver does so by its terms, notwithstanding the fact that certain Investors may nonetheless, by agreement with the Company, purchase securities in such transaction).&#160; The Company shall give prompt notice of any amendment or termination hereof or waiver hereunder to any party hereto that did not consent in writing to such amendment, termination, or waiver.&#160; Any amendment, termination, or waiver effected in accordance with this <u>Section&nbsp;6.6</u> shall be binding on all parties hereto, regardless of whether any such party has consented thereto.&#160; No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any such term, condition, or provision.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.7</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Severability</u>.&#160; In case any one or more of the provisions contained in this Agreement is for any reason held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of this Agreement, and such invalid, illegal, or unenforceable provision shall be reformed and construed so that it will be valid, legal, and enforceable to the maximum extent permitted by law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.8</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Aggregation of Stock</u>.&#160; All shares of Registrable Securities held or acquired by Affiliates shall be aggregated together for the purpose of determining the availability of any rights under this Agreement and such Affiliated persons may apportion such rights as among themselves in any manner they deem appropriate.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.9</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Entire Agreement</u>.&#160; This Agreement (including any Schedules and Exhibits hereto) constitutes the full and entire understanding and agreement among the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties (including, without limitation, the Existing Agreement) is expressly canceled.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">19<a name="16022-2-KM-05_PB_19_074207_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=19,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=364896,FOLIO='19',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-05_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Existing Agreement is hereby amended in its entirety and restated herein.&#160; All provisions of, rights granted under and covenants made in the Existing Agreement are hereby waived, released and superseded in their entirety and shall have no further force or effect.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.10</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Delays or Omissions</u>.&#160; No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement upon any breach or default of any other party under this Agreement shall impair any such right, power, or remedy of such nonbreaching or nondefaulting party nor shall it be construed to be a waiver of or acquiescence to any such breach or default or to any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring.&#160; All remedies, whether under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.11</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Acknowledgment</u>.&#160; The Company acknowledges that the Investors are in the business of venture capital investing and therefore review the business plans and related proprietary information of many enterprises, including enterprises which may have products or services which compete directly or indirectly with those of the Company.&#160; Nothing in this Agreement shall preclude or in any way restrict the Investors from investing or participating in any particular enterprise whether or not such enterprise has products or services which compete with those of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[Remainder of Page&nbsp;Intentionally Left Blank]</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">20<a name="16022-2-KM-05_PB_20_074231_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=20,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=102224,FOLIO='20',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-05_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE   SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="42%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Gerald R. Mattys</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gerald R. Mattys</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Chief Executive Officer</font></i></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">INVESTORS:</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">GALEN PARTNERS V, L.P.</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By: Galen V, L.L.C.,   its general partner</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="42%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Zubeen Shroff</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Zubeen Shroff</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Managing Partner</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">GALEN PARTNERS   INTERNATIONAL V, L.P.</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By: Galen V, L.L.C.,   its general partner</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="42%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Zubeen Shroff</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Zubeen Shroff</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Managing Partner</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">RADIUS VENTURE PARTNERS III, L.P.</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Radius Venture Partners III, LLC,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">its General Partner</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="42%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Jordan Davis</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jordan Davis</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Managing Partner</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WORTHY VENTURE   RESOURCES, LLC</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="42%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Peter H. Soderberg</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Peter H. Soderberg</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="42%" valign="top" style="padding:0in 0in 0in 0in;width:42.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Managing Partner</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=21,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=446772,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-05_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">INVESTORS:</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">RADIUS VENTURE PARTNERS   III QP, L.P.</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Radius Venture Partners   III, LLC,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">its General Partner</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Jordan Davis</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jordan Davis</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Managing Member</font></i></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">RADIUS VENTURE PARTNERS   III (OHIO), L.P.</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Radius Venture Partners   III (Ohio) LLC,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">its General Partner</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Radius Venture Partners   III LLC,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">its Manager</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Jordan Davis</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jordan Davis</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Managing Member</font></i></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=22,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="4",CHK=724997,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-KM-05_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:03 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>a2228882zex-5_1.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;5.1</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="720" height="91" src="g160222nfi001.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Jonathan R. Zimmerman</font></b><br>    <i>Partner</i></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.04%;">
<p align="right" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Faegre Baker Daniels LLP</font></b><br>   2200 Wells Fargo Center 90 South Seventh Street<br>   Minneapolis Minnesota 55402-3901<br>   Main <b>+1 612 766 7000</b><br>   Fax <b>+1 612 766 1600</b></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">June&nbsp;8, 2016</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tactile Systems Technology,&nbsp;Inc.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1331 Tyler Street NE, Suite&nbsp;200</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Minneapolis, MN 55413</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We have acted as counsel to Tactile Systems Technology,&nbsp;Inc., a Delaware corporation (the &#147;<b>Company</b>&#148;), in connection with the Registration Statement on Form&nbsp;S-1 (File No.&nbsp;333-209115) (the &#147;<b>Registration Statement</b>&#148;) filed by the Company with the Securities and Exchange Commission (the &#147;<b>Commission</b>&#148;) under the Securities Act of 1933, as amended (the &#147;<b>Securities Act</b>&#148;), relating to the issuance by the Company of up to 4,600,000 shares of Common Stock, par value $0.001 per share (the &#147;<b>Common Stock</b>&#148;), of the Company&#160; in connection with the offering described in the Registration Statement (the &#147;<b>Shares</b>&#148;). The term &#147;Shares&#148; also includes any additional shares of Common Stock registered by the Company pursuant to Rule&nbsp;462(b)&nbsp;under the Securities Act in connection with the offering contemplated by the Registration Statement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We have examined the Registration Statement and the form of amended and restated certificate of incorporation of the Company, which has been filed with the Commission as an exhibit to the Registration Statement.&#160; We also have examined the originals, or duplicates or certified or conformed copies, of such corporate and other records, agreements, documents and other instruments and have made such other investigations as we have deemed relevant and necessary in connection with the opinions hereinafter set forth.&#160; As to questions of fact material to this opinion, with your consent we have relied upon certificates or assurances of public officials and of officers and representatives of the Company</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In rendering the opinions set forth below, we have assumed (i)&nbsp;the genuineness of all signatures, (ii)&nbsp;the legal capacity of natural persons, (iii)&nbsp;the authenticity of all documents submitted to us as originals, (iv)&nbsp;the conformity to original documents of all documents submitted to us as duplicates or certified or conformed copies, (v)&nbsp;the authenticity of the originals of such latter documents and (vi)&nbsp;that the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the Delaware General Corporation Law.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="5",CHK=840877,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NF_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 03:59 2016' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Based upon the foregoing, and subject to the qualifications, assumptions and limitations stated herein, we are of the opinion that the Shares have been duly authorized by all necessary corporate action of the Company, and (a)&nbsp;when the Registration Statement becomes effective under the Securities Act, (b)&nbsp;when the pricing committee of the Company&#146;s board of directors (the &#147;<b>Pricing Committee</b>&#148;) has taken all necessary action to approve the issuance and sale of the Shares, including determination of a specific number of Shares to be sold and a specific price for the sale of the Shares (which total number of shares shall not exceed the total number of shares available under the Company&#146;s amended and restated certificate of incorporation), (c)&nbsp;upon payment and delivery for the Shares in accordance with the underwriting agreement in the form most recently filed with the Commission as an exhibit to the Registration Statement and approved by the Pricing Committee, (d)&nbsp;when paid for in cash in an amount equal to or in excess of, on a per share basis, the par value of the shares, and (e)&nbsp;when the Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the purchasers, will be validly issued, fully paid and nonassessable.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We do not express any opinion herein concerning any law other than the Delaware General Corporation Law.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We hereby consent to the filing of this letter as Exhibit&nbsp;5.1 to the Registration Statement and to the use of our name under the caption &#147;Legal Matters&#148; in the Prospectus included in the Registration Statement.&#160; We further consent to the incorporation by reference of this letter and consent into any registration statement filed pursuant to Rule&nbsp;462(b)&nbsp;under the Securities Act with respect to the Shares.&#160; In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules&nbsp;and regulations of the Commission.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This opinion is limited to the specific issues addressed herein, and no opinion may be inferred or implied beyond that expressly stated herein.&#160; This opinion speaks only as of the date the Registration Statement becomes effective under the Securities Act and we assume no obligation to revise or supplement this opinion thereafter.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">FAEGRE BAKER DANIELS LLP</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">/s/ Jonathan R. Zimmerman</font></i></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jonathan R. Zimmerman</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="5",CHK=790250,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NF_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 03:59 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>6
<FILENAME>a2228882zex-10_11.htm
<DESCRIPTION>EX-10.11
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;10.11</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2016 EQUITY INCENTIVE PLAN</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Purpose</u>.</b>&#160; The purpose of the Tactile Systems Technology,&nbsp;Inc. 2016 Equity Incentive Plan (the &#147;Plan&#148;) is to attract and retain the best available personnel for positions of responsibility with the Company, to provide additional incentives to them and align their interests with those of the Company&#146;s stockholders, and to thereby promote the Company&#146;s long-term business success.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Definitions</u>.</b>&#160; In this Plan, the following definitions will apply.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.85pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Affiliate&#148; means any entity that is a Subsidiary or Parent of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Agreement&#148; means the written or electronic agreement, notice or other document containing the terms and conditions applicable to each Award granted under the Plan.&#160; An Agreement is subject to the terms and conditions of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Award&#148; means a grant made under the Plan in the form of Options, Stock Appreciation Rights, Restricted Stock, Stock Units, or an Other Stock-Based Award.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Board&#148; means the Board of Directors of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Cause&#148; means what the term is expressly defined to mean in a then-effective written agreement (including an Agreement) between a Participant and the Company or any Affiliate, or in the absence of any such then-effective agreement or definition, means a Participant&#146;s (i)&nbsp;ongoing failure or refusal to perform satisfactorily the duties reasonably required of the Participant by the Company (other than by reason of Disability); (ii)&nbsp;material violation of any law, rule, regulation, court order or regulatory directive (other than traffic violations, misdemeanors or other minor offenses); (iii)&nbsp;material breach of the Company&#146;s business conduct or ethics code or of any fiduciary duty or nondisclosure, non-solicitation, non-competition or similar obligation owed to the Company or any Affiliate; (iv)&nbsp;engaging in any act or practice that involves personal dishonesty on the part of the Participant or demonstrates a willful and continuing disregard for the best interests of the Company and its Affiliates; or (v)&nbsp;engaging in dishonorable or disruptive behavior, practices or acts which would be reasonably expected to harm or bring disrepute to the Company or any of its Affiliates, their business or any of their customers, employees or vendors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Change in Control&#148; means, unless otherwise provided in an Agreement, one of the following:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>An Exchange Act Person becomes the beneficial owner (within the meaning of Rule&nbsp;13d-3 under the Exchange Act) of securities of the Company representing more than 50% of the combined voting power of the Company&#146;s then outstanding Voting Securities, except that the following will not constitute a Change in Control: (i)&nbsp;any acquisition of securities of the Company by an Exchange Act Person from the Company for the purpose of providing financing to the Company; (ii)&nbsp;any formation of a Group consisting solely of beneficial owners of the Company&#146;s Voting Securities as of the effective date of this Plan; (iii)&nbsp;any repurchase or other acquisition by the Company of its Voting Securities that causes any Exchange Act Person to become the beneficial owner of more than 50% of the Company&#146;s Voting Securities; or (iv)&nbsp;with respect to any particular Participant, any acquisition of securities of the Company by the Participant, any Group including the Participant, or any entity controlled by the Participant or a Group including the Participant.&#160; If, however, an Exchange Act Person or Group </p>
<p style="margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=81294,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:43 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">referenced in clause (i), (ii)&nbsp;or (iii)&nbsp;above acquires beneficial ownership of additional Company Voting Securities after initially becoming the beneficial owner of more than 50% of the combined voting power of the Company&#146;s Voting Securities by one of the means described in those clauses, then a Change in Control will be deemed to have occurred.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Individuals who are Continuing Directors cease for any reason to constitute a majority of the members of the Board.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>A Corporate Transaction is consummated, unless, immediately following such Corporate Transaction, all or substantially all of the individuals and entities who were the beneficial owners of the Company&#146;s Voting Securities immediately prior to such Corporate Transaction beneficially own, directly or indirectly, more than 50% of the combined voting power of the then outstanding Voting Securities of the surviving or acquiring entity resulting from such Corporate Transaction (including beneficial ownership through any Parent of such entity) in substantially the same proportions as their ownership, immediately prior to such Corporate Transaction, of the Company&#146;s Voting Securities.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding the foregoing, to the extent that any Award constitutes a deferral of compensation subject to Code Section&nbsp;409A, and if that Award provides for a change in the time or form of payment upon a Change in Control, then no Change in Control shall be deemed to have occurred upon an event described in this Section&nbsp;2(f)&nbsp;unless the event would also constitute a change in ownership or effective control of, or a change in the ownership of a substantial portion of the assets of, the Company under Code Section&nbsp;409A.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Code&#148; means the Internal Revenue Code of 1986, as amended and in effect from time to time.&#160; For purposes of the Plan, references to sections of the Code shall be deemed to include any applicable regulations thereunder and any successor or similar statutory provisions.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Committee&#148; means two or more Non-Employee Directors designated by the Board to administer the Plan under Section&nbsp;3, each member of which shall be (i)&nbsp;an independent director within the meaning of the rules&nbsp;and regulations of the NASDAQ Stock Market, (ii)&nbsp;a non-employee director within the meaning of Exchange Act Rule&nbsp;16b-3, and (iii)&nbsp;an outside director for purposes of Code Section&nbsp;162(m).&#160; Notwithstanding the foregoing, the &#147;Committee&#148; means the Board with respect to Awards made to Non-Employee Directors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.85pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Company&#148; means Tactile Systems Technology,&nbsp;Inc., a Delaware corporation, or any successor thereto.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.85pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Continuing Director&#148; means an individual (i)&nbsp;who is, as of the effective date of the Plan, a director of the Company, (ii)&nbsp;who is elected as a director of the Company subsequent to the effective date hereof pursuant to a nomination or board representation right of preferred stockholders of the Company, or (iii)&nbsp;who becomes a director of the Company after the effective date hereof and whose initial election, or nomination for election by the Company&#146;s stockholders, was approved by at least a majority of the then Continuing Directors, but excluding, for purposes of this clause (iii), an individual whose initial assumption of office occurs as a result of an actual or threatened proxy contest relating to the election of directors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(k)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Corporate Transaction&#148; means (i)&nbsp;a sale or other disposition of all or substantially all of the assets of the Company, or (ii)&nbsp;a merger, consolidation, share exchange or similar transaction involving the Company, regardless of whether the Company is the surviving corporation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-MQ-01_PB_2_011754_4196"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=318838,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:43 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(l)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Disability&#148; means (A)&nbsp;any permanent and total disability under any long-term disability plan or policy of the Company or its Affiliates that covers the Participant, or (B)&nbsp;if there is no such long-term disability plan or policy, &#147;total and permanent disability&#148; within the meaning of Code Section&nbsp;22(e)(3).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(m)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Employee&#148; means an employee of the Company or an Affiliate.</p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(n)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Exchange Act&#148; means the Securities Exchange Act of 1934, as amended and in effect from time to time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(o)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Exchange Act Person&#148; means any natural person, entity or Group other than (i)&nbsp;the Company or any Affiliate; (ii)&nbsp;any employee benefit plan (or related trust) sponsored or maintained by the Company or any Affiliate; (iii)&nbsp;an underwriter temporarily holding securities in connection with a registered public offering of such securities; or (iv)&nbsp;an entity whose Voting Securities are beneficially owned by the beneficial owners of the Company&#146;s Voting Securities in substantially the same proportions as their beneficial ownership of the Company&#146;s Voting Securities.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(p)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Fair Market Value&#148; means the fair market value of a Share determined as follows:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:71.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If the Shares are readily tradable on an established securities market (as determined under Code Section&nbsp;409A), then Fair Market Value will be the closing sales price for a Share on the principal securities market on which it trades on the date for which it is being determined, or if no sale of Shares occurred on that date, on the next preceding date on which a sale of Shares occurred, as reported in<i> The Wall Street Journal </i>or such other source as the Committee deems reliable; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If the Shares are not then readily tradable on an established securities market (as determined under Code Section&nbsp;409A), then Fair Market Value will be determined by the Committee as the result of a reasonable application of a reasonable valuation method that satisfies the requirements of Code Section&nbsp;409A.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(q)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Full Value Award&#148; means an Award other than an Option Award or Stock Appreciation Right Award.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(r)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Grant Date&#148; means the date on which the Committee approves the grant of an Award under the Plan, or such later date as may be specified by the Committee on the date the Committee approves the Award.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(s)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Group&#148; means two or more persons who act, or agree to act together, as a partnership, limited partnership, syndicate or other group for the purpose of acquiring, holding, voting or disposing of securities of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(t)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Non-Employee Director&#148; means a member of the Board who is not an Employee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(u)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Option&#148; means a right granted under the Plan to purchase a specified number of Shares at a specified price.&#160; An &#147;Incentive Stock Option&#148; or &#147;ISO&#148; means any Option designated as such and granted in accordance with the requirements of Code Section&nbsp;422.&#160; A &#147;Non-Qualified Stock Option&#148; or &#147;NQSO,&#148; means an Option other than an Incentive Stock Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Other Stock-Based Award&#148; means an Award described in Section&nbsp;11 of this Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-MQ-01_PB_3_011826_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=812991,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:43 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(w)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Parent&#148; means a &#147;parent corporation,&#148; as defined in Code Section&nbsp;424(e).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(x)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Participant&#148; means a person to whom a then-outstanding Award has been granted under the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(y)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Performance-Based Compensation&#148; means an Award to a person who is, or is determined by the Committee to likely become, a &#147;covered employee&#148; (as defined in Section&nbsp;162(m)(3)&nbsp;of the Code) and that is intended to constitute &#147;performance-based compensation&#148; within the meaning of Section&nbsp;162(m)(4)(C)&nbsp;of the Code.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.85pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(z)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Plan&#148; means this Tactile Systems Technology,&nbsp;Inc. 2016 Equity Incentive Plan, as amended and in effect from time to time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(aa)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Prior Plans&#148; means the Company&#146;s 2007 Omnibus Stock Plan and the Company&#146;s 2003 Stock Option Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(bb)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Restricted Stock&#148; means Shares issued to a Participant that are subject to such restrictions on transfer, vesting conditions and other restrictions or limitations as may be set forth in this Plan and the applicable Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(cc)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Service&#148; means the provision of services by a Participant to the Company or any Affiliate in any Service Provider capacity.&#160; A Service Provider&#146;s Service shall be deemed to have terminated either upon an actual cessation of providing services to the Company or any Affiliate or upon the entity to which the Service Provider provides services ceasing to be an Affiliate.&#160; Except as otherwise provided in this Plan or any Agreement, Service shall not be deemed terminated in the case of (i)&nbsp;any approved leave of absence; (ii)&nbsp;transfers among the Company and any Affiliates in any Service Provider capacity; or (iii)&nbsp;any change in status so long as the individual remains in the service of the Company or any Affiliate in any Service Provider capacity.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(dd)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Service Provider&#148; means an Employee, a Non-Employee Director, or any consultant or advisor who is a natural person and who provides services (other than in connection with (i)&nbsp;a capital-raising transaction or (ii)&nbsp;promoting or maintaining a market in Company securities) to the Company or any Affiliate.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ee)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Share&#148; means a share of Stock.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ff)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Stock&#148; means the common stock, $0.001 par value per share, of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(gg)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Stock Appreciation Right&#148; or &#147;SAR&#148; means the right to receive, in cash and/or Shares as determined by the Committee, an amount equal to the appreciation in value of a specified number of Shares between the Grant Date of the SAR and its exercise date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(hh)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Stock Unit&#148; means a right to receive, in cash and/or Shares as determined by the Committee, the Fair Market Value of a Share, subject to such restrictions on transfer, vesting conditions and other restrictions or limitations as may be set forth in this Plan and the applicable Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.85pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Subsidiary&#148; means a &#147;subsidiary corporation,&#148; as defined in Code Section&nbsp;424(f), of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-MQ-01_PB_4_011837_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=82752,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:43 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(jj)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Substitute Award&#148; means an Award granted upon the assumption of, or in substitution or exchange for, outstanding awards granted by a company or other entity acquired by the Company or any Affiliate or with which the Company or any Affiliate combines.&#160; The terms and conditions of a Substitute Award may vary from the terms and conditions set forth in the Plan to the extent that the Committee at the time of the grant may deem appropriate to conform, in whole or in part, to the provisions of the award in substitution for which it has been granted.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(kk)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;Voting Securities&#148; of an entity means the outstanding equity securities (or comparable equity interests) entitled to vote generally in the election of directors of such entity.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">3.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Administration of the Plan</u>.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Administration</u>.&#160; The authority to control and manage the operations and administration of the Plan shall be vested in the Committee in accordance with this Section&nbsp;3.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Scope of Authority</u>.&#160; Subject to the terms of the Plan, the Committee shall have the authority, in its discretion, to take such actions as it deems necessary or advisable to administer the Plan, including:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>determining the Service Providers to whom Awards will be granted, the timing of each such Award, the types of Awards and the number of Shares covered by each Award, the terms, conditions, performance criteria, restrictions and other provisions of Awards, and the manner in which Awards are paid or settled;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>cancelling or suspending an Award, accelerating the vesting or extending the exercise period of an Award, or otherwise amending the terms and conditions of any outstanding Award, subject to the requirements of Sections 15(d)&nbsp;and 15(e);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>adopting sub-plans or special provisions applicable to Awards, establishing, amending or rescinding rules&nbsp;to administer the Plan, interpreting the Plan and any Award or Agreement, reconciling any inconsistency, correcting any defect or supplying an omission in the Plan or any Agreement, and making all other determinations necessary or desirable for the administration of the Plan;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>granting Substitute Awards under the Plan;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>taking such actions as are provided in Section&nbsp;3(c)&nbsp;with respect to Awards to foreign Service Providers; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>requiring or permitting the deferral of the settlement of an Award, and establishing the terms and conditions of any such deferral.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Awards to Foreign Service Providers</u>.&#160; The Committee may grant Awards to Service Providers who are foreign nationals, who are located outside of the United States or who are not compensated from a payroll maintained in the United States, or who are otherwise subject to (or could cause the Company to be subject to) legal or regulatory requirements of countries outside of the United States, on such terms and conditions different from those specified in the Plan as may, in the judgment of the Committee, be necessary or desirable to comply with applicable foreign laws and regulatory requirements and to promote achievement of the purposes of the Plan.&#160; In connection therewith, the Committee may establish such subplans and modify exercise procedures and other Plan rules&nbsp;and </p>
<p style="margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-MQ-01_PB_5_011850_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=690013,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:43 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">procedures to the extent such actions are deemed necessary or desirable, and may take any other action that it deems advisable to obtain local regulatory approvals or to comply with any necessary local governmental regulatory exemptions.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Acts of the Committee; Delegation</u>.&#160; A majority of the members of the Committee shall constitute a quorum for any meeting of the Committee, and any act of a majority of the members present at any meeting at which a quorum is present or any act unanimously approved in writing by all members of the Committee shall be the act of the Committee.&#160; Any such action of the Committee shall be valid and effective even if the members of the Committee at the time of such action are later determined not to have satisfied all of the criteria for membership in clauses (i), (ii)&nbsp;and (iii)&nbsp;of Section&nbsp;2(h).&#160; To the extent not inconsistent with applicable law or stock exchange rules, the Committee may delegate all or any portion of its authority under the Plan to any one or more of its members or, as to Awards to Participants who are not subject to Section&nbsp;16 of the Exchange Act, to one or more directors or executive officers of the Company or to a committee of the Board comprised of one or more directors of the Company.&#160; The Committee may also delegate non-discretionary administrative responsibilities in connection with the Plan to such other persons as it deems advisable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Finality of Decisions</u>.&#160; The Committee&#146;s interpretation of the Plan and of any Award or Agreement made under the Plan and all related decisions or resolutions of the Board or Committee shall be final and binding on all parties with an interest therein.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Indemnification</u>.&#160; Each person who is or has been a member of the Committee or of the Board, and any other person to whom the Committee delegates authority under the Plan, shall be indemnified by the Company, to the maximum extent permitted by law, against liabilities and expenses imposed upon or reasonably incurred by such person in connection with or resulting from any claims against such person by reason of the performance of the individual&#146;s duties under the Plan.&#160; This right to indemnification is conditioned upon such person providing the Company an opportunity, at the Company&#146;s expense, to handle and defend the claims before such person undertakes to handle and defend them on such person&#146;s own behalf.&#160; The Company will not be required to indemnify any person for any amount paid in settlement of a claim unless the Company has first consented in writing to the settlement.&#160; The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such person or persons may be entitled under the Company&#146;s Certificate of Incorporation or Bylaws, as a matter of law, or otherwise.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">4.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Shares Available Under the Plan</u>.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Maximum Shares Available</u>.&#160; Subject to Sections 4(b)&nbsp;and 4(c)&nbsp;and to adjustment as provided in Section&nbsp;12(a), the number of Shares that may be the subject of Awards and issued under the Plan shall be 4,800,000, which shall include any Shares of Stock which remain available for future grants under the Company&#146;s 2007 Omnibus Stock Plan on the effective date of this Plan and which shall be rolled over into this Plan&#146;s share reserve.&#160; No further awards shall be made under the 2007 Plan after the effective date of this Plan.&#160; Shares issued under the Plan may come from authorized and unissued shares or treasury shares.&#160; In determining the number of Shares to be counted against this share reserve in connection with any Award, the following rules&nbsp;shall apply:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Where the number of Shares subject to an Award is variable on the Grant Date, the number of Shares to be counted against the share reserve shall be the maximum number of Shares that could be received under that particular Award, until such time as it can be determined that only a lesser number of shares could be received.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">6<a name="16022-2-MQ-01_PB_6_011902_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=742274,FOLIO='6',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:43 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Where two or more types of Awards are granted to a Participant in tandem with each other, such that the exercise of one type of Award with respect to a number of Shares cancels at least an equal number of Shares of the other, the number of Shares to be counted against the share reserve shall be the largest number of Shares that would be counted against the share reserve under either of the Awards.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Shares subject to Substitute Awards shall not be counted against the share reserve, nor shall they reduce the Shares authorized for grant to a Participant in any calendar year.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Awards that will be settled solely in cash shall not be counted against the share reserve, nor shall they reduce the Shares authorized for grant to a Participant in any calendar year.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Automatic Share Reserve Increase</u>. The share reserve specified in Section&nbsp;4(a)&nbsp;will be automatically increased on January&nbsp;1 of each year commencing in 2017 and ending on (and including) January&nbsp;1, 2026 in an amount equal to the lesser of: (i)&nbsp;5% of the total number of Shares outstanding as of December&nbsp;31 of the immediately preceding calendar year, or (ii)&nbsp;2,500,000 Shares; provided, however, that the Board may determine that any annual increase in the share reserve shall be for a number of Shares that is less than the number of Shares as provided by the lesser of clauses (i)&nbsp;and (ii).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Effect of Forfeitures and Other Actions</u>.&#160; Any Shares subject to an Award, or to an award granted under one of the Prior Plans that is outstanding on the effective date of this Plan (a &#147;Prior Plan Award&#148;), that expires, is cancelled or forfeited, is settled for cash or otherwise does not result in the issuance of all of the Shares subject to such Award (including as a result of the settlement in Shares of the exercise of a Stock Appreciation Right) shall, to the extent of such cancellation, forfeiture, expiration, cash settlement or non-issuance, again become available for Awards under this Plan, and the share reserve under Section&nbsp;4(a)&nbsp;shall be correspondingly replenished.&#160; In addition, if (i)&nbsp;payment of the exercise price of any Award or Prior Plan Award is made through the tendering (either actually or by attestation) of Shares by the Participant or by the withholding of Shares by the Company, or (ii)&nbsp;satisfaction of any tax withholding obligations arising from any Award or Prior Plan Award occurs through the tendering (either actually or by attestation) of Shares by the Participant or by the withholding of Shares by the Company, then the Shares so tendered or withheld shall become available for Awards under this Plan and the share reserve under Section&nbsp;4(a)&nbsp;shall be correspondingly replenished.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Effect of Plans Operated by Acquired Companies</u>.&#160; If a company acquired by the Company or any Subsidiary or with which the Company or any Subsidiary combines has shares available under a pre-existing plan approved by its stockholders and not adopted in contemplation of such acquisition or combination, the shares available for grant pursuant to the terms of such pre-existing plan (as adjusted, to the extent appropriate, using the exchange ratio or other adjustment or valuation ratio or formula used in such acquisition or combination to determine the consideration payable to the holders of common stock of the entities party to such acquisition or combination) may be used for Awards under the Plan and shall supplement the Share reserve under Section&nbsp;4(a).&#160; Awards using such available shares shall not be made after the date awards or grants could have been made under the terms of the pre-existing plan absent the acquisition or combination, and shall only be made to individuals who were not Employees or Non-Employee Directors prior to such acquisition or combination.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Fractional Shares</u>.&#160; Unless otherwise determined by the Committee, the number of Shares subject to an Award shall always be a whole number.&#160; No fractional Shares may be issued under the Plan, but the Committee may, in its discretion, pay cash in lieu of any fractional Share in settlement of an Award.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">7<a name="16022-2-MQ-01_PB_7_011910_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=893590,FOLIO='7',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:43 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Individual Option and SAR Limit</u>.&#160; The aggregate number of Shares subject to Option and/or Stock Appreciation Right Awards granted during any calendar year to any one Participant other than a Non-Employee Director shall not exceed 1,000,000 Shares (subject to adjustment as provided in Section&nbsp;12(a)).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Performance-Based Compensation Limit</u>.&#160; With respect to Awards of Performance-Based Compensation, (i)&nbsp;the maximum number of Shares that may be the subject of Full Value Awards that are denominated in Shares or Share equivalents and that are granted to any Participant during any calendar year shall not exceed 1,000,000 Shares (subject to adjustment as provided in Section&nbsp;12(a)); and (ii)&nbsp;the maximum amount payable with respect to Full Value Awards that are denominated other than in Shares or Share equivalents and that are granted to any one Participant during any calendar year shall not exceed $5,000,000.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Limit on Awards to Non-Employee Directors</u>.&#160; The aggregate grant date fair value (as determined in accordance with generally accepted accounting principles applicable in the United States) of all Awards granted during any calendar year to any Non-Employee Director (excluding any Awards granted at the election of a Non-Employee Director in lieu of all or any portion of retainers or fees paid to Non-Employee Directors in cash) shall not exceed $500,000.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">5.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Eligibility</u>.</b>&#160; Participation in the Plan is limited to Service Providers.&#160; Incentive Stock Options may only be granted to Employees.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">6.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">General Terms of Awards</u>.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Award Agreement</u>.&#160; Except for any Award that involves only the immediate issuance of unrestricted Shares, each Award shall be evidenced by an Agreement setting forth the amount of the Award together with such other terms and conditions applicable to the Award (and not inconsistent with the Plan) as determined by the Committee.&#160; An Award to a Participant may be made singly or in combination with any form of Award.&#160; Two types of Awards may be made in tandem with each other such that the exercise of one type of Award with respect to a number of Shares reduces the number of Shares subject to the related Award by at least an equal amount.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Vesting and Term</u>.&#160; Each Agreement shall set forth the period until the applicable Award is scheduled to expire (which shall not be more than ten years from the Grant Date), and the applicable vesting conditions and any applicable performance period.&#160; The Committee may provide in an Agreement for such vesting conditions and timing as it may determine.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Transferability</u>.&#160; Except as provided in this Section&nbsp;6(c), (i)&nbsp;during the lifetime of a Participant, only the Participant or the Participant&#146;s guardian or legal representative may exercise an Option or SAR, or receive payment with respect to any other Award; and (ii)&nbsp;no Award may be sold, assigned, transferred, exchanged or encumbered, voluntarily or involuntarily, other than by will or the laws of descent and distribution.&#160; Any attempted transfer in violation of this Section&nbsp;6(c)&nbsp;shall be of no effect.&#160; The Committee may, however, provide in an Agreement or otherwise that an Award (other than an Incentive Stock Option) may be transferred pursuant to a domestic relations order or may be transferable by gift to any &#147;family member&#148; (as defined in General Instruction A(5)&nbsp;to Form&nbsp;S-8 under the Securities Act of 1933) of the Participant.&#160; Any Award held by a transferee shall continue to be subject to the same terms and conditions that were applicable to that Award immediately before the transfer thereof.&#160; For purposes of any provision of the Plan relating to notice to a Participant or to acceleration or termination of an Award upon the death or termination of Service of a Participant, the references to &#147;Participant&#148; shall mean the original grantee of an Award and not any transferee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">8<a name="16022-2-MQ-01_PB_8_011919_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=133105,FOLIO='8',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:43 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Designation of Beneficiary</u>.&#160; To the extent permitted by the Committee, a Participant may designate a beneficiary or beneficiaries to exercise any Award or receive a payment under any Award that is exercisable or payable on or after the Participant&#146;s death.&#160; Any such designation shall be on a form approved by the Company and shall be effective upon its receipt by the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Termination of Service</u>.&#160; Unless otherwise provided in an applicable Agreement or another then-effective written agreement between a Participant and the Company, and subject to Section&nbsp;12 of this Plan, if a Participant&#146;s Service with the Company and all of its Affiliates terminates, the following provisions shall apply (in all cases subject to the scheduled expiration of an Option or SAR Award, as applicable):</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Upon termination of Service for Cause, all unexercised Option and SAR Awards and all unvested portions of any other outstanding Awards shall be immediately forfeited without consideration.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Upon termination of Service for any other reason, all unvested and unexercisable portions of any outstanding Awards shall be immediately forfeited without consideration.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Upon termination of Service for any reason other than Cause, death or Disability, the currently vested and exercisable portions of Option and SAR Awards may be exercised for a period of three months after the date of such termination.&#160; However, if a Participant thereafter dies during such three-month period, the vested and exercisable portions of the Option and SAR Awards may be exercised for a period of one year after the date of such termination.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:72.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Upon termination of Service due to death or Disability, the currently vested and exercisable portions of Option and SAR Awards may be exercised for a period of one year after the date of such termination.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Rights as Stockholder</u>.&#160; No Participant shall have any rights as a stockholder with respect to any Shares covered by an Award unless and until the date the Participant becomes the holder of record of the Shares, if any, to which the Award relates.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Performance-Based Awards</u>.&#160; Any Award may be granted as a performance-based Award if the Committee establishes one or more measures of corporate, business unit or individual performance which must be attained, and the performance period over which the specified performance is to be attained, as a condition to the grant, vesting, exercisability, lapse of restrictions and/or settlement in cash or Shares of such Award.&#160; In connection with any such Award, the Committee shall determine the extent to which performance measures have been attained and other applicable terms and conditions have been satisfied, and the degree to which vesting, exercisability, lapse of restrictions and/or settlement of such Award has been earned.&#160; Any performance-based Award that is intended by the Committee to qualify as Performance-Based Compensation shall additionally be subject to the requirements of Section&nbsp;16 of this Plan.&#160; Except as provided in Section&nbsp;16 with respect to Performance-Based Compensation, the Committee shall also have the authority to provide, in an Agreement or otherwise, for the modification of a performance period and/or an adjustment or waiver of the achievement of performance measures under specified circumstances such as (i)&nbsp;the occurrence of events that are unusual in nature or infrequently occurring, such as a Change in Control, acquisitions, divestitures, restructuring activities, recapitalizations, or asset write-downs, (ii)&nbsp;a change in applicable tax laws or accounting principles, or (iii)&nbsp;the Participant&#146;s death or Disability.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">9<a name="16022-2-MQ-01_PB_9_011926_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=9,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=80711,FOLIO='9',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:43 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.85pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Dividends and Dividend Equivalents</u>.&#160; No dividends, dividend equivalents or distributions will be paid with respect to Shares subject to an Option or SAR Award.&#160; Other than regular cash dividends, any dividends or distributions paid with respect to Shares that are subject to the unvested portion of a Restricted Stock Award will be subject to the same restrictions as the Shares to which such dividends or distributions relate. In its discretion, the Committee may provide in a Restricted Stock Award Agreement for restrictions on regular cash dividends with respect to unvested restricted Shares, and in an Agreement for a Stock Unit Award or an Other Stock-Based Award that the Participant will be entitled to receive dividend equivalents on the units or other Share equivalents subject to the Award based on dividends actually declared and paid on outstanding Shares. The terms of any dividend equivalents will be as set forth in the applicable Agreement, including the time and form of payment and whether such dividend equivalents will be credited with interest or deemed to be reinvested in additional units or Share equivalents. Any Shares issued or issuable during the term of this Plan as the result of the reinvestment of dividends or the deemed reinvestment of dividend equivalents in connection with an Award or a Prior Plan Award shall be counted against, and replenish upon any subsequent forfeiture, the Plan&#146;s share reserve as provided in Section&nbsp;4.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Deferrals of Full Value Awards</u>.&#160; The Committee may, in its discretion, permit or require the deferral by a Participant of the issuance of Shares or payment of cash in settlement of any Full Value Award, subject to such terms, conditions, rules&nbsp;and procedures as it may establish or prescribe for such purpose and with the intention of complying with the applicable requirements of Code Section&nbsp;409A.&#160; The terms, conditions, rules&nbsp;and procedures for any such deferral shall be set forth in writing in the relevant Agreement or in such other agreement, plan or document as the Committee may determine, or some combination of such documents.&#160; The terms, conditions, rules&nbsp;and procedures for any such deferral shall address, to the extent relevant, matters such as: (i)&nbsp;the amount of compensation that may or must be deferred (or the method for calculating the amount); (ii)&nbsp;the permissible time(s)&nbsp;and form(s)&nbsp;of payment of deferred amounts; (iii)&nbsp;the terms and conditions of any deferral elections by a Participant or of any deferral required by the Company; and (iv)&nbsp;the crediting of interest or dividend equivalents on deferred amounts.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">7.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Stock Option Awards</u>.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Type and Exercise Price</u>.&#160; The Agreement pursuant to which an Option Award is granted shall specify whether the Option is an Incentive Stock Option or a Non-Qualified Stock Option.&#160; The exercise price at which each Share subject to an Option Award may be purchased shall be determined by the Committee and set forth in the Agreement, and shall not be less than the Fair Market Value of a Share on the Grant Date, except in the case of Substitute Awards (to the extent consistent with Code Section&nbsp;409A and, in the case of Incentive Stock Options, Code Section&nbsp;424).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Payment of Exercise Price</u>.&#160; The purchase price of the Shares with respect to which an Option Award is exercised shall be payable in full at the time of exercise.&#160; The purchase price may be paid in cash or in such other manner as the Committee may permit, including by payment under a broker-assisted sale and remittance program, by withholding Shares otherwise issuable to the Participant upon exercise of the Option or by delivery to the Company of Shares (by actual delivery or attestation) already owned by the Participant (in each case, such Shares having a Fair Market Value as of the date the Option is exercised equal to the purchase price of the Shares being purchased).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Exercisability and Expiration</u>.&#160; Each Option Award shall be exercisable in whole or in part on the terms provided in the Agreement.&#160; No Option Award shall be exercisable at any time after its scheduled expiration.&#160; When an Option Award is no longer exercisable, it shall be deemed to have terminated.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">10<a name="16022-2-MQ-01_PB_10_011933_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=10,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=84354,FOLIO='10',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:43 2016' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Incentive Stock Options</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>An Option Award will constitute an Incentive Stock Option Award only if the Participant receiving the Option Award is an Employee, and only to the extent that (i)&nbsp;it is so designated in the applicable Agreement and (ii)&nbsp;the aggregate Fair Market Value (determined as of the Option Award&#146;s Grant Date) of the Shares with respect to which Incentive Stock Options held by the Participant first become exercisable in any calendar year (under the Plan and all other plans of the Company and its Affiliates) does not exceed $100,000 or such other amount specified by the Code.&#160; To the extent an Option granted to a Participant exceeds this limit, the Option shall be treated as a Non-Qualified Stock Option.&#160; The maximum number of Shares that may be issued upon the exercise of Incentive Stock Options shall be equal to 4,800,000 plus the maximum number of Shares by which the Plan&#146;s share reserve may be increased pursuant to Section&nbsp;4(b), subject in each case to adjustment as provided in Section&nbsp;12(a).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No Participant may receive an Incentive Stock Option Award under the Plan if, immediately after the grant of such Award, the Participant would own (after application of the rules&nbsp;contained in Code Section&nbsp;424(d)) Shares possessing more than 10% of the total combined voting power of all classes of stock of the Company or an Affiliate, unless (i)&nbsp;the per Share exercise price for such Award is at least 110% of the Fair Market Value of a Share on the Grant Date and (ii)&nbsp;such Award will expire no later than five years after its Grant Date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:67.9pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>For purposes of continued Service by a Participant who has been granted an Incentive Stock Option Award, no approved leave of absence may exceed three months unless reemployment upon expiration of such leave is provided by statute or contract.&#160; If reemployment is not so provided, then on the date six months following the first day of such leave, any Incentive Stock Option held by the Participant shall cease to be treated as an Incentive Stock Option and shall be treated for tax purposes as a Non-Qualified Stock Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:67.9pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If an Incentive Stock Option Award is exercised after the expiration of the exercise periods that apply for purposes of Code Section&nbsp;422, such Option shall thereafter be treated as a Non-Qualified Stock Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:67.9pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Agreement covering an Incentive Stock Option Award shall contain such other terms and provisions that the Committee determines necessary to qualify the Option Award as an Incentive Stock Option Award.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">8.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Stock Appreciation Right Awards</u>.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Nature of Award</u>.&#160; An Award of Stock Appreciation Rights shall be subject to such terms and conditions as are determined by the Committee, and shall provide a Participant the right to receive upon exercise of the SAR Award all or a portion of the excess of (i)&nbsp;the Fair Market Value as of the date of exercise of the SAR Award of the number of Shares as to which the SAR Award is being exercised, over (ii)&nbsp;the aggregate exercise price for such number of Shares.&#160; The per Share exercise price for any SAR Award shall be determined by the Committee and set forth in the applicable Agreement, and shall not be less than the Fair Market Value of a Share on the Grant Date, except in the case of Substitute Awards (to the extent consistent with Code Section&nbsp;409A).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Exercise of SAR</u>.&#160; Each SAR Award may be exercisable in whole or in part at the times, on the terms and in the manner provided in the Agreement.&#160; No SAR Award shall be exercisable at any time after its scheduled expiration.&#160; When a SAR Award is no longer exercisable, it shall be deemed to </p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">11<a name="16022-2-MQ-03_PB_11_012022_7821"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=11,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=770264,FOLIO='11',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 01:28 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">have terminated.&#160; Upon exercise of a SAR Award, payment to the Participant shall be made at such time or times as shall be provided in the Agreement in the form of cash, Shares or a combination of cash and Shares as determined by the Committee.&#160; The Agreement may provide for a limitation upon the amount or percentage of the total appreciation on which payment (whether in cash and/or Shares) may be made in the event of the exercise of a SAR Award.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">9.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Restricted Stock Awards</u>.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Vesting and Consideration</u>.&#160; Shares subject to a Restricted Stock Award shall be subject to vesting and the lapse of applicable restrictions based on such conditions or factors and occurring over such period of time as the Committee may determine in its discretion.&#160; The Committee may provide whether any consideration other than Services must be received by the Company or any Affiliate as a condition precedent to the grant of a Restricted Stock Award, and may correspondingly provide for Company reacquisition or repurchase rights if such additional consideration has been required and some or all of a Restricted Stock Award does not vest.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:33.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Shares Subject to Restricted Stock Awards</u>.&#160; Unvested Shares subject to a Restricted Stock Award shall be evidenced by a book-entry in the name of the Participant with the Company&#146;s transfer agent or by one or more Stock certificates issued in the name of the Participant.&#160; Any such Stock certificate shall be deposited with the Company or its designee, together with an assignment separate from the certificate, in blank, signed by the Participant, and bear an appropriate legend referring to the restricted nature of the Restricted Stock evidenced thereby.&#160; Any book-entry shall be subject to comparable restrictions and corresponding stop transfer instructions.&#160; Upon the vesting of Shares of Restricted Stock, and the Company&#146;s determination that any necessary conditions precedent to the release of vested Shares (such as satisfaction of tax withholding obligations and compliance with applicable legal requirements) have been satisfied, such vested Shares shall be made available to the Participant in such manner as may be prescribed or permitted by the Committee.&#160; Except as otherwise provided in the Plan or an applicable Agreement, a Participant with a Restricted Stock Award shall have all the rights of a shareholder, including the right to vote the Shares of Restricted Stock.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">10.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Stock Unit Awards</u>.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Vesting and Consideration</u>.&#160; A Stock Unit Award shall be subject to vesting and the lapse of applicable restrictions based on such conditions or factors and occurring over such period of time as the Committee may determine in its discretion.&#160; If vesting of a Stock Unit Award is conditioned on the achievement of specified performance goals, the extent to which they are achieved over the specified performance period shall determine the number of Stock Units that will be earned and eligible to vest, which may be greater or less than the target number of Stock Units stated in the Agreement. The Committee may provide whether any consideration other than Services must be received by the Company or any Affiliate as a condition precedent to the settlement of a Stock Unit Award.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Payment of Award</u>.&#160; Following the vesting of a Stock Unit Award, and the Company&#146;s determination that any necessary conditions precedent to the settlement of the Award (such as satisfaction of tax withholding obligations and compliance with applicable legal requirements) have been satisfied, settlement of the Award and payment to the Participant shall be made at such time or times in the form of cash, Shares (which may themselves be considered Restricted Stock under the Plan) or a combination of cash and Shares as determined by the Committee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">11.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Other Stock-Based Awards</u>.</b>&#160; The Committee may from time to time grant Shares and other Awards that are valued by reference to and/or payable in whole or in part in Shares under the Plan.&#160; The </p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">12<a name="16022-2-MQ-03_PB_12_012044_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=12,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=115189,FOLIO='12',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 01:28 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Committee shall determine the terms and conditions of such Awards, which shall be consistent with the terms and purposes of the Plan.&#160; The Committee may direct the Company to issue Shares subject to restrictive legends and/or stop transfer instructions that are consistent with the terms and conditions of the Award to which the Shares relate.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">12.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Changes in Capitalization, Corporate Transactions, Change in Control</u>.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Adjustments for Changes in Capitalization</u>.&#160; In the event of any equity restructuring (within the meaning of FASB ASC Topic 718) that causes the per share value of Shares to change, such as a stock dividend, stock split, spinoff, rights offering or recapitalization through an extraordinary dividend, the Committee shall make such adjustments as it deems equitable and appropriate to (i)&nbsp;the aggregate number and kind of Shares or other securities issued or reserved for issuance under the Plan, (ii)&nbsp;the number and kind of Shares or other securities subject to outstanding Awards, (iii)&nbsp;the exercise price of outstanding Options and SARs, and (iv)&nbsp;any maximum limitations prescribed by the Plan with respect to certain types of Awards or the grants to individuals of certain types of Awards.&#160; In the event of any other change in corporate capitalization, including a merger, consolidation, reorganization, or partial or complete liquidation of the Company, such equitable adjustments described in the foregoing sentence may be made as determined to be appropriate and equitable by the Committee to prevent dilution or enlargement of rights of Participants.&nbsp; In either case, any such adjustment shall be conclusive and binding for all purposes of the Plan.&nbsp; No adjustment shall be made pursuant to this Section&nbsp;12(a)&nbsp;in connection with the conversion of any convertible securities of the Company, or in a manner that would cause Incentive Stock Options to violate Section&nbsp;422(b)&nbsp;of the Code or cause an&nbsp;Award&nbsp;to be subject to adverse tax consequences&nbsp;under&nbsp;Section&nbsp;409A of the Code.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Corporate Transactions</u>.&#160; Unless otherwise provided in an applicable Agreement or another written agreement between a Participant and the Company, the following provisions shall apply to outstanding Awards in the event of a Change in Control that involves a Corporate Transaction.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Continuation, Assumption or Replacement of Awards</u></i>.&#160; In the event of a Corporate Transaction, then the surviving or successor entity (or its Parent) may continue, assume or replace Awards outstanding as of the date of the Corporate Transaction (with such adjustments as may be required or permitted by Section&nbsp;12(a)), and such Awards or replacements therefor shall remain outstanding and be governed by their respective terms, subject to Section&nbsp;12(b)(4)&nbsp;below.&#160; A surviving or successor entity may elect to continue, assume or replace only some Awards or portions of Awards.&#160; For purposes of this Section&nbsp;12(b)(1), an Award shall be considered assumed or replaced if, in connection with the Corporate Transaction and in a manner consistent with Code Sections 409A and 424, either (i)&nbsp;the contractual obligations represented by the Award are expressly assumed by the surviving or successor entity (or its Parent) with appropriate adjustments to the number and type of securities subject to the Award and the exercise price thereof that preserves the intrinsic value of the Award existing at the time of the Corporate Transaction, or (ii)&nbsp;the Participant has received a comparable equity-based award that preserves the intrinsic value of the Award existing at the time of the Corporate Transaction and contains terms and conditions that are substantially similar to those of the Award.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Acceleration</u></i>.&#160; If and to the extent that outstanding Awards under the Plan are not continued, assumed or replaced in connection with a Corporate Transaction, then (i)&nbsp;all outstanding Option and SAR Awards shall become fully vested and exercisable for such period of time prior to the effective time of the Corporate Transaction as is deemed fair and equitable by the Committee, and shall terminate at the effective time of the Corporate Transaction, and (ii)&nbsp;all outstanding Full Value Awards shall fully vest immediately prior to the effective time of the Corporate Transaction.&#160; The Committee shall provide written notice of the period of accelerated exercisability of Option and SAR Awards to all </p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">13<a name="16022-2-MQ-03_PB_13_012059_7091"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=13,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=480895,FOLIO='13',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 01:28 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">affected Participants.&#160; The exercise of any Option or SAR Award whose exercisability is accelerated as provided in this Section&nbsp;12(b)(2)&nbsp;shall be conditioned upon the consummation of the Corporate Transaction and shall be effective only immediately before such consummation.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Payment for Awards</u></i>.&#160; If and to the extent that outstanding Awards under the Plan are not continued, assumed or replaced in connection with a Corporate Transaction, then the Committee may provide that some or all of such outstanding Awards shall be canceled at or immediately prior to the effective time of the Corporate Transaction in exchange for payments to the holders as provided in this Section&nbsp;12(b)(3).&#160;&#160; The Committee will not be required to treat all Awards similarly for purposes of this Section&nbsp;12(b)(3).&#160; The payment for any Award surrendered shall be in an amount equal to the difference, if any, between (i)&nbsp;the fair market value (as determined in good faith by the Committee) of the consideration that would otherwise be received in the Corporate Transaction for the number of Shares subject to the Award, and (ii)&nbsp;the aggregate exercise price (if any) for the Shares subject to such Award.&#160; If the amount determined pursuant to clause (i)&nbsp;of the preceding sentence is less than or equal to the amount determined pursuant to clause (ii)&nbsp;of the preceding sentence with respect to any Award, such Award may be canceled pursuant to this Section&nbsp;12(b)(3)&nbsp;without payment of any kind to the affected Participant.&#160; Payment of any amount under this Section&nbsp;12(b)(3)&nbsp;shall be made in such form, on such terms and subject to such conditions as the Committee determines in its discretion, which may or may not be the same as the form, terms and conditions applicable to payments to the Company&#146;s stockholders in connection with the Corporate Transaction, and may, in the Committee&#146;s discretion, include subjecting such payments to vesting conditions comparable to those of the Award surrendered, subjecting such payments to escrow or holdback terms comparable to those imposed upon the Company&#146;s stockholders under the Corporate Transaction, or calculating and paying the present value of payments that would otherwise be subject to escrow or holdback terms.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">Termination After a Corporate Transaction</u></i>.&#160; If and to the extent that Awards are continued, assumed or replaced under the circumstances described in Section&nbsp;12(b)(1), and if within twelve months after the Corporate Transaction a Participant experiences an involuntary termination of Service for reasons other than Cause, then (i)&nbsp;outstanding Options and SARs issued to the Participant that are not yet fully exercisable shall immediately become exercisable in full and shall remain exercisable for one year following the Participant&#146;s termination of employment, and (ii)&nbsp;any Full Value Awards that are not yet fully vested shall immediately vest in full.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Other Change in Control</u>.&#160; In the event of a Change in Control that does not involve a Corporate Transaction, the Committee may, in its discretion, take such action as it deems appropriate with respect to outstanding Awards, which may include: (i)&nbsp; providing for the cancellation of any Award in exchange for payments in a manner similar to that provided in Section&nbsp;12(b)(3)&nbsp;or (ii)&nbsp;making such adjustments to the Awards then outstanding as the Committee deems appropriate to reflect such Change in Control, which may include the acceleration of vesting in full or in part. The Committee will not be required to treat all Awards similarly in such circumstances, and may include such further provisions and limitations in any Award Agreement as it may deem equitable and in the best interests of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Dissolution or Liquidation</u>.&#160; Unless otherwise provided in an applicable Agreement, in the event of a proposed dissolution or liquidation of the Company, the Committee will notify each Participant as soon as practicable prior to the effective date of such proposed transaction.&#160; An Award will terminate immediately prior to the consummation of such proposed action.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">13.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Plan Participation and Service Provider Status</u>.</b>&#160; Status as a Service Provider shall not be construed as a commitment that any Award will be made under the Plan to that Service Provider or to </p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">14<a name="16022-2-MQ-03_PB_14_012114_455"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=14,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=827159,FOLIO='14',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 01:28 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">eligible Service Providers generally.&#160; Nothing in the Plan or in any Agreement or related documents shall confer upon any Service Provider or Participant any right to continued Service with the Company or any Affiliate, nor shall it interfere with or limit in any way any right of the Company or any Affiliate to terminate the person&#146;s Service at any time with or without Cause or change such person&#146;s compensation, other benefits, job responsibilities or title.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">14.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Tax Withholding</u>.</b>&#160; The Company or any Affiliate, as applicable, shall have the right to (i)&nbsp;withhold from any cash payment under the Plan or any other compensation owed to a Participant an amount sufficient to cover any required withholding taxes related to the grant, vesting, exercise or settlement of an Award, and (ii)&nbsp;require a Participant or other person receiving Shares under the Plan to pay a cash amount sufficient to cover any required withholding taxes before actual receipt of those Shares.&#160; In lieu of all or any part of a cash payment from a person receiving Shares under the Plan, the Committee may permit the individual to cover all or any part of the required tax withholdings (but not to exceed the minimum statutory amount required to be withheld if such limitation is necessary to avoid an adverse accounting impact) by authorizing the Company to withhold a number of the Shares that would otherwise be delivered to the Participant, or by delivering to the Company Shares already owned by the Participant, with the Shares so withheld or delivered having a Fair Market Value on the date the taxes are required to be withheld equal to the amount of taxes to be withheld.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">15.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Effective Date, Duration, Amendment and Termination of the Plan</u>.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Effective Date</u>.&#160; The Plan shall become effective on the date it is approved by the Company&#146;s stockholders, which shall be considered the date of its adoption for purposes of Treasury Regulation &#167;1.422-2(b)(2)(i).&#160; No Awards shall be made under the Plan prior to its effective date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Duration of the Plan</u>.&#160; The Plan shall remain in effect until all Shares subject to it are distributed, all Awards have expired or terminated, the Plan is terminated pursuant to Section&nbsp;15(c), or the tenth anniversary of the effective date of the Plan, whichever occurs first (the &#147;Termination Date&#148;).&#160; Awards made before the Termination Date shall continue to be outstanding in accordance with their terms and the terms of the Plan unless otherwise provided in the applicable Agreements.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Amendment and Termination of the Plan</u>.&#160; The Board may at any time terminate, suspend or amend the Plan.&#160; The Company shall submit any amendment of the Plan to its stockholders for approval only to the extent required by applicable laws or regulations or the rules&nbsp;of any securities exchange on which the Shares may then be listed.&#160; No termination, suspension, or amendment of the Plan may materially impair the rights of any Participant under a previously granted Award without the Participant&#146;s consent, unless such action is necessary to comply with applicable law or stock exchange rules.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Amendment of Awards</u>.&#160; Subject to Section&nbsp;15(e), the Committee may unilaterally amend the terms of any Agreement evidencing an Award previously granted, except that no such amendment may materially impair the rights of any Participant under the applicable Award without the Participant&#146;s consent, unless such amendment is necessary to comply with applicable law or stock exchange rules&nbsp;or any compensation recovery policy as provided in Section&nbsp;17(h).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Option or SAR Repricing</u>.&#160; Except as provided in Section&nbsp;12(a), no Option or Stock Appreciation Right Award granted under the Plan may be (i)&nbsp;amended to decrease the exercise price thereof, (ii)&nbsp;cancelled in conjunction with the grant of any new Option or Stock Appreciation Right Award with a lower exercise price, (iii)&nbsp;cancelled in exchange for cash, other property or the grant of any Full Value Award at a time when the per share exercise price of the Option or Stock Appreciation Right </p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">15<a name="16022-2-MQ-03_PB_15_012133_4141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=15,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=345143,FOLIO='15',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 01:28 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Award is greater than the current Fair Market Value of a Share, or (iv)&nbsp;otherwise subject to any action that would be treated under accounting rules&nbsp;as a &#147;repricing&#148; of such Option or Stock Appreciation Right Award, unless such action is first approved by the Company&#146;s stockholders.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Performance-Based Compensation</u>.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Designation of Awards</u>.&#160; If the Committee determines at the time a Full Value Award is granted to a Participant that such Participant is, or is likely to be, a &#147;covered employee&#148; for purposes of Code Section&nbsp;162(m)&nbsp;as of the end of the tax year in which the Company would ordinarily claim a tax deduction in connection with such Award, then the Committee may provide that this Section&nbsp;16 will be applicable to such Award, which shall be considered Performance-Based Compensation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Compliance with Code Section&nbsp;162(m)</u>.&#160; If an Award is subject to this Section&nbsp;16, then the grant of the Award, the vesting and lapse of restrictions thereon and/or the distribution of cash, Shares or other property pursuant thereto, as applicable, shall be subject to the achievement over the applicable performance period of one or more performance goals based on one or more of the performance measures specified in Section&nbsp;16(c).&#160; The Committee will select the applicable performance measure(s)&nbsp;and specify the performance goal(s)&nbsp;based on those performance measures for any performance period, specify in terms of an objective formula or standard the method for calculating the amount payable to a Participant if the performance goal(s)&nbsp;are satisfied, and certify the degree to which applicable performance goals have been satisfied and any amount that vests and is payable in connection with an Award subject to this Section&nbsp;16, all within the time periods prescribed by and consistent with the other requirements of Code Section&nbsp;162(m).&#160; In specifying the performance goals applicable to any performance period, the Committee may provide that one or more objectively determinable adjustments shall be made to the performance measures on which the performance goals are based, which may include adjustments that would cause such measures to be considered &#147;non-GAAP financial measures&#148; within the meaning of Rule&nbsp;101 under Regulation G promulgated by the Securities and Exchange Commission, including adjustments for events that are unusual in nature or infrequently occurring, such as a Change in Control, acquisitions, divestitures, restructuring activities or asset write-downs, or for changes in applicable tax laws or accounting principles.&#160; The Committee may also adjust performance measures for a performance period to the extent permitted by Code Section&nbsp;162(m)&nbsp;in connection with an event described in Section&nbsp;12(a)&nbsp;to prevent the dilution or enlargement of a Participant&#146;s rights with respect to Performance-Based Compensation.&#160; The Committee may adjust downward, but not upward, any amount determined to be otherwise payable in connection with an Award subject to this Section&nbsp;16.&#160; The Committee may also provide, in an Agreement or otherwise, that the achievement of specified performance goals in connection with an Award subject to this Section&nbsp;16 may be waived upon the death or Disability of the Participant or under any other circumstance with respect to which the existence of such possible waiver will not cause the Award to fail to qualify as &#147;performance-based compensation&#148; under Code Section&nbsp;162(m).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Performance Measures</u>.&#160; For purposes of any Full Value Award considered Performance-Based Compensation subject to this Section&nbsp;16, the performance measures to be utilized shall be limited to one or a combination of two or more of the following performance measures: (i)&nbsp;net earnings or net income; (ii)&nbsp;earnings before one or more of interest, taxes, depreciation, amortization and share-based compensation expense; (iii)&nbsp;earnings per share (basic or diluted); (iv)&nbsp;revenue; (v)&nbsp;gross profit; (vi)&nbsp;operating income; (vii)&nbsp;profitability as measured by return ratios (including, but not limited to, return on assets, return on equity, return on invested capital and return on revenue) or by the degree to which any of the foregoing earnings measures exceed a percentage of revenue or gross profit; (viii)&nbsp;cash flow (including, but not limited to, operating cash flow, free cash flow and cash flow return on capital); (ix)&nbsp;market share; (x)&nbsp;margins (including, but not limited to, one or more of gross, operating and net earnings margins); (xi)&nbsp;stock </p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">16<a name="16022-2-MQ-03_PB_16_012149_8627"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=16,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=892210,FOLIO='16',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 01:28 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">price; (xii)&nbsp;total stockholder return; (xiii)&nbsp;asset quality; (xiv)&nbsp;non-performing assets; (xv)&nbsp;operating assets; (xvi)&nbsp;balance of cash, cash equivalents and marketable securities; (xvii)&nbsp;product cost and expense management; (xviii)&nbsp;economic value added or similar value added measurements; (xix)&nbsp;improvement in or attainment of working capital levels; (xx)&nbsp;productivity ratios; (xxi)&nbsp;employee retention or satisfaction measures; (xxii)&nbsp;safety record; (xxiii)&nbsp;customer satisfaction; (xxiv)&nbsp;debt, credit or other leverage measures or ratios; (xxv)&nbsp;implementation or completion of critical projects, (xxvi)&nbsp;accounts receivable days outstanding; (xxvii)&nbsp;reimbursement approvals; (xxviii)&nbsp;achievement of specified acquisitions or divestitures; (xxix)&nbsp;acquisition synergies or achievements; (xxx)&nbsp;market penetration goals; (xxxi)&nbsp;geographic business expansion goals; (xxxii)&nbsp;research and development goals, including publication of studies; (xxxiii)&nbsp;new product development and introduction goals; (xxxiv)&nbsp;clinical study goals; (xxxv)&nbsp;regulatory achievements; (xxxvi)&nbsp;compliance measures; (xxxvii)&nbsp;quality measures; (xxxviii)&nbsp;contracts with payers; and (xxxix)&nbsp;analyst coverage.&#160; Any performance goal based on one or more of the foregoing performance measures may be expressed in absolute amounts, on a per share basis (basic or diluted), relative to one or more other performance measures, as a growth rate or change from preceding periods, or as a comparison to the performance of specified companies, indices or other external measures, and may relate to one or any combination of Company, Affiliate, division, business unit, operational unit or individual performance.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">17.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Other Provisions</u>.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Unfunded Plan</u>.&#160; The Plan shall be unfunded and the Company shall not be required to segregate any assets that may at any time be represented by Awards under the Plan.&#160; Neither the Company, its Affiliates, the Committee, nor the Board shall be deemed to be a trustee of any amounts to be paid under the Plan nor shall anything contained in the Plan or any action taken pursuant to its provisions create or be construed to create a fiduciary relationship between the Company and/or its Affiliates, and a Participant.&#160;&#160; To the extent any person has or acquires a right to receive a payment in connection with an Award under the Plan, this right shall be no greater than the right of an unsecured general creditor of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Limits of Liability</u>.&#160; Except as may be required by law, neither the Company nor any member of the Board or of the Committee, nor any other person participating (including participation pursuant to a delegation of authority under Section&nbsp;3(c)&nbsp;of the Plan) in any determination of any question under the Plan, or in the interpretation, administration or application of the Plan, shall have any liability to any party for any action taken, or not taken, in good faith under the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Compliance with Applicable Legal Requirements and Company Policies</u>.&#160; No Shares distributable pursuant to the Plan shall be issued and delivered unless and until the issuance of the Shares complies with all applicable legal requirements, including compliance with the provisions of applicable state and federal securities laws, and the requirements of any securities exchanges on which the Company&#146;s Shares may, at the time, be listed.&#160; During any period in which the offering and issuance of Shares under the Plan is not registered under federal or state securities laws, Participants shall acknowledge that they are acquiring Shares under the Plan for investment purposes and not for resale, and that Shares may not be transferred except pursuant to an effective registration statement under, or an exemption from the registration requirements of, such securities laws.&nbsp; Any stock certificate or book-entry evidencing Shares issued under the Plan that are subject to securities law restrictions shall bear or be accompanied by an appropriate restrictive legend or stop transfer instruction.&#160; Notwithstanding any other provision of this Plan, the acquisition, holding or disposition of Shares acquired pursuant to the Plan shall in all events be subject to compliance with applicable Company policies, including those relating to insider trading, pledging or hedging transactions, stock ownership guidelines, and post-vesting holding periods, and to forfeiture or recovery of compensation as provided in Section&nbsp;17(h).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">17<a name="16022-2-MQ-03_PB_17_012200_7906"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=17,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=188251,FOLIO='17',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 01:28 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Other Benefit and Compensation Programs</u>.&#160; Payments and other benefits received by a Participant under an Award made pursuant to the Plan shall not be deemed a part of a Participant&#146;s regular, recurring compensation for purposes of the termination, indemnity or severance pay laws of any country and shall not be included in, nor have any effect on, the determination of benefits under any other employee benefit plan, contract or similar arrangement provided by the Company or an Affiliate unless expressly so provided by such other plan, contract or arrangement, or unless the Committee expressly determines that an Award or portion of an Award should be included to accurately reflect competitive compensation practices or to recognize that an Award has been made in lieu of a portion of competitive cash compensation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Governing Law</u>.&#160; To the extent that federal laws do not otherwise control, the Plan and all determinations made and actions taken pursuant to the Plan shall be governed by the laws of the State of Delaware without regard to its conflicts-of-law principles and shall be construed accordingly.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Severability</u>.&#160; If any provision of the Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the illegal or invalid provision had not been included.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Code Section&nbsp;409A</u>.&#160; It is intended that (i)&nbsp;all Awards of Options, SARs and Restricted Stock under the Plan will not provide for the deferral of compensation within the meaning of Code Section&nbsp;409A and thereby be exempt from Code Section&nbsp;409A, and (ii)&nbsp;all other Awards under the Plan will either not provide for the deferral of compensation within the meaning of Code Section&nbsp;409A, or will comply with the requirements of Code Section&nbsp;409A, and Awards shall be structured and the Plan administered and interpreted in accordance with this intent.&#160; The Plan and any Agreement may be unilaterally amended by the Company in any manner deemed necessary or advisable by the Committee or Board in order to maintain such exemption from or compliance with Code Section&nbsp;409A, and any such amendment shall conclusively be presumed to be necessary to comply with applicable law.&#160; Notwithstanding anything to the contrary in the Plan or any Agreement, with respect to any Award that constitutes a deferral of compensation subject to Code Section&nbsp;409A:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If any amount is payable under such Award upon a termination of Service, a termination of Service will be deemed to have occurred only at such time as the Participant has experienced a &#147;separation from service&#148; as such term is defined for purposes of Code Section&nbsp;409A;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If any amount shall be payable with respect to any such Award as a result of a Participant&#146;s &#147;separation from service&#148; at such time as the Participant is a &#147;specified employee&#148; within the meaning of Code Section&nbsp;409A, then no payment shall be made, except as permitted under Code Section&nbsp;409A, prior to the first business day after the earlier of (i)&nbsp;the date that is six months after the Participant&#146;s separation from service or (ii)&nbsp;the Participant&#146;s death.&#160; Unless the Committee has adopted a specified employee identification policy as contemplated by Code Section&nbsp;409A, specified employees will be identified in accordance with the default provisions specified under Code Section&nbsp;409A.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">None of the Company, the Board, the Committee nor any other person involved with the administration of this Plan shall (i)&nbsp;in any way be responsible for ensuring the exemption of any Award from, or compliance by any Award with, the requirements of Code Section&nbsp;409A, (ii)&nbsp;have any obligation to design or administer the Plan or Awards granted thereunder in a manner that minimizes a Participant&#146;s tax liabilities, including the avoidance of any additional tax liabilities under Code Section&nbsp;409A, and (iii)&nbsp;shall have any liability to any Participant for any such tax liabilities.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">18<a name="16022-2-MQ-03_PB_18_012209_3736"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=18,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=928468,FOLIO='18',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 01:28 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Forfeiture and Compensation Recovery</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Committee may specify in an Agreement that the Participant&#146;s rights, payments, and benefits with respect to an Award will be subject to reduction, cancellation, forfeiture or recovery by the Company upon the occurrence of certain specified events, in addition to any otherwise applicable vesting or performance conditions of an Award.&#160; Such events may include termination of Service for Cause; violation of any material Company or Affiliate policy; breach of noncompetition, non-solicitation or confidentiality provisions that apply to the Participant; a determination that the payment of the Award was based on an incorrect determination that financial or other criteria were met or other conduct by the Participant that is detrimental to the business or reputation of the Company or its Affiliates.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Awards and any compensation associated therewith may be made subject to forfeiture, recovery by the Company or other action pursuant to any compensation recovery policy adopted by the Board or the Committee at any time, including in response to the requirements of Section&nbsp;10D of the Exchange Act and any implementing rules&nbsp;and regulations thereunder, or as otherwise required by law.&#160; Any Agreement may be unilaterally amended by the Committee to comply with any such compensation recovery policy.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">19<a name="16022-2-MQ-03_PB_19_012212_9621"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=19,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="6",CHK=377054,FOLIO='19',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MQ-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  8 01:28 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.12
<SEQUENCE>7
<FILENAME>a2228882zex-10_12.htm
<DESCRIPTION>EX-10.12
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 10.12</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Non-Qualified Stock Option Agreement</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Under the 2016 Equity Incentive Plan</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:36.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tactile Systems Technology,&nbsp;Inc. (the &#147;Company&#148;), pursuant to its 2016 Equity Incentive Plan (the &#147;Plan&#148;), hereby grants an Option to purchase shares of the Company&#146;s common stock to you, the Participant named below.&#160; The terms and conditions of the Option Award are set forth in this Agreement, consisting of this cover page&nbsp;and the Option Terms and Conditions on the following pages, and in the Plan document, a copy of which has been provided to you.&#160; Any capitalized term that is not defined in this Agreement shall have the meaning set forth in the Plan as it currently exists or as it is amended in the future.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name   of Participant:&nbsp;&nbsp;**[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No.&nbsp;of   Shares Covered:&nbsp;&nbsp;**[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Grant   Date:</font></p>    </td>
<td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.84%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u>, 20<u>&nbsp;&nbsp;&nbsp;&nbsp;</u></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exercise   Price Per Share:&nbsp;&nbsp;$**[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Expiration   Date:</font></p>    </td>
<td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.84%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u>, 20<u>&nbsp;&nbsp;&nbsp;&nbsp;</u></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vesting   and Exercise Schedule:</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="47%" valign="bottom" style="padding:0in 0in 0in 0in;width:47.84%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="49%" valign="bottom" style="padding:0in 0in 0in 0in;width:49.66%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Portion&nbsp;of&nbsp;Shares&nbsp;as&nbsp;to&nbsp;Which</font></b></p>    </td>   </tr>
<tr>
<td width="47%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:47.84%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Dates</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="49%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:49.66%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Option&nbsp;Becomes&nbsp;Vested&nbsp;and&nbsp;Exercisable</font></b></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:47.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:49.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:47.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:49.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By signing below or otherwise evidencing your acceptance of this Agreement in a manner approved by the Company, you agree to all of the terms and conditions contained in this Agreement and in the Plan document.&#160; You acknowledge that you have received and reviewed these documents and that they set forth the entire agreement between you and the Company regarding your right to purchase shares of the Company&#146;s common stock pursuant to this Option.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">PARTICIPANT:</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TACTILE   SYSTEMS TECHNOLOGY,&nbsp;INC.</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr height="0">
<td width="325" style="border:none;"></td>
<td width="29" style="border:none;"></td>
<td width="35" style="border:none;"></td>
<td width="319" style="border:none;"></td>   </tr> </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="7",CHK=594334,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MS_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:46 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Tactile Systems Technology,&nbsp;Inc.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2016 Equity Incentive Plan</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Non-Qualified Stock Option Agreement</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Option Terms and Conditions</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Non-Qualified Stock Option</u></b>.&#160; This Option is <u>not</u> intended to be an &#147;incentive stock option&#148; within the meaning of Section&nbsp;422 of the Internal Revenue Code and will be interpreted accordingly.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Vesting and Exercisability of Option</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Scheduled Vesting</u>. This Option will vest and become exercisable as to the number of Shares and on the dates specified in the Vesting and Exercise Schedule on the cover page&nbsp;to this Agreement, so long as your Service to the Company does not end.&#160; The Vesting and Exercise Schedule is cumulative, meaning that to the extent the Option has not already been exercised and has not expired or been terminated or cancelled, you or the person otherwise entitled to exercise the Option as provided in this Agreement may at any time purchase all or any portion of the Shares subject to the vested portion of the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Accelerated Vesting</u>. Notwithstanding Section&nbsp;2(a):</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Death or Disability</i>.&#160; If your Service terminates prior to the final scheduled vesting date due to your death or Disability, this Option will vest and become exercisable in full as of such termination date, and will remain exercisable for one year thereafter.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Change in Control</i>.&#160; If and to the extent this Award is continued, assumed or replaced in connection with a Change in Control, and if within one year after the Change in Control you experience an involuntary termination of Service for reasons other than Cause, [or you terminate your Service for Good Reason (as defined below),] then this Option shall vest and become exercisable in full as of such termination date, and will remain exercisable for one year thereafter.&#160; In addition, vesting of Option may be accelerated during the term of the Award under the circumstances described in Sections 12(b)&nbsp;and 12(c)&nbsp;of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Definition of &#147;Good Reason</i>.&#148;&#160; &#147;Good Reason&#148; shall, if you have an employment agreement with the Company, have the meaning set forth in your employment agreement.&#160; If you do not have an employment agreement with the Company, &#147;Good Reason&#148; means the existence of one or more of the following conditions without your written consent, so long as you provided written notice to the Company of the existence of the condition not later than 90 days after the initial existence of the condition, the condition has not been remedied by the Company within 30 days after its receipt of such notice and your Service terminates no later than 130 days after the condition&#146;s initial occurrence: (i)&nbsp;any material, adverse change in your duties, responsibilities, or authority; (ii)&nbsp;a material reduction in your base salary or bonus opportunity that is not part of a general reduction applicable to</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-MS_PB_2_000132_6469"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="7",CHK=316744,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MS_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:46 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">employees in the same classification or grade as you; or (iii)&nbsp;a geographical relocation of your principal office location by more than 50 miles.]</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Expiration</u></b>.&#160; This Option will expire and will no longer be exercisable at 5:00&nbsp;p.m.&nbsp;Central Time on the earliest of:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The expiration date specified on the cover page&nbsp;of this Agreement;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Upon your termination of Service for Cause;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Upon the expiration of any applicable period specified in Section&nbsp;6(e)&nbsp;of the Plan or Section&nbsp;2 of this Agreement during which this Option may be exercised after your termination of Service; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The date (if any) fixed for termination or cancellation of this Option pursuant to Section&nbsp;12 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Service Requirement</u></b><b>.</b>&#160; Except as otherwise provided in Section&nbsp;6(e)&nbsp;of the Plan or Section&nbsp;2 of this Agreement, this Option may be exercised only while you continue to provide Service to the Company or any Affiliate, and only if you have continuously provided such Service since the Grant Date of this Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Exercise of Option</u></b>.&#160; Subject to Section&nbsp;4, the vested and exercisable portion of this Option may be exercised in whole or in part at any time during the Option term by delivering a written or electronic notice of exercise to the Company&#146;s Chief Financial Officer or to such other party as may be designated by such officer, and by providing for payment of the exercise price of the Shares being acquired and any related withholding taxes.&#160; The notice of exercise must be in a form approved by the Company and state the number of Shares to be purchased, the method of payment of the aggregate exercise price and the directions for the delivery of the Shares to be acquired, and must be signed or otherwise authenticated by the person exercising the Option.&#160; If you are not the person exercising the Option, the person submitting the notice also must submit appropriate proof of his/her right to exercise the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Payment of Exercise Price</u></b>.&#160; When you submit your notice of exercise, you must include payment of the exercise price of the Shares being purchased through one or a combination of the following methods:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Cash (including personal check, cashier&#146;s check or money order);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By means of a broker-assisted cashless exercise in which you irrevocably instruct your broker to deliver proceeds of a sale of all or a portion of the Shares to be issued pursuant to the exercise to the Company in payment of the exercise price of such Shares; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By delivery to the Company of Shares (by actual delivery or attestation of ownership in a form approved by the Company) already owned by you that are not subject to any security interest and that have an aggregate Fair Market Value on the date of exercise equal to the exercise price of the Shares being purchased; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By authorizing the Company to retain, from the total number of Shares as to which the Option is being exercised, that number of Shares having a Fair Market Value on the date of</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-MS_PB_3_000141_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="7",CHK=106853,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MS_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:46 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">exercise equal to the exercise price for the total number of Shares as to which the Option is being exercised.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">However, if the Committee determines, in any given circumstance, that payment of the exercise price with Shares or by authorizing the Company to retain Shares is undesirable for any reason, you will not be permitted to pay any portion of the exercise price in that manner.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Withholding Taxes</u></b>.&#160; You may not exercise this Option in whole or in part unless you make arrangements acceptable to the Company for payment of any federal, state, local or foreign withholding taxes that may be due as a result of the exercise of this Option.&#160; You hereby authorize the Company (or any Affiliate) to withhold from payroll or other amounts payable to you any sums required to satisfy such withholding tax obligations, and otherwise agree to satisfy such obligations in accordance with the provisions of Section&nbsp;14 of the Plan.&#160; If you wish to satisfy some or all of such withholding tax obligations by delivering Shares you already own or by having the Company retain a portion of the Shares being acquired upon exercise of the Option, you must make such a request which shall be subject to approval by the Company.&#160; Delivery of Shares upon exercise of this Option is subject to the satisfaction of applicable withholding tax obligations.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Delivery of Shares</u></b><b>.</b>&#160;&#160; As soon as practicable after the Company receives the notice of exercise and payment of the exercise price as provided above, and has determined that all other conditions to exercise, including satisfaction of withholding tax obligations and compliance with applicable laws as provided in Section&nbsp;17(c)&nbsp;of the Plan, have been satisfied, it shall deliver to the person exercising the Option, in the name of such person, the Shares being purchased, as evidenced by issuance of a stock certificate or certificates, electronic delivery of such Shares to a brokerage account designated by such person, or book-entry registration of such Shares with the Company&#146;s transfer agent.&#160; The Company shall pay any original issue or transfer taxes with respect to the issue or transfer of the Shares and all fees and expenses incurred by it in connection therewith.&#160; All Shares so issued shall be fully paid and nonassessable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Transfer of Option</u></b>.&#160; During your lifetime, only you (or your guardian or legal representative in the event of legal incapacity) may exercise this Option except in the case of a transfer described below.&#160; You may not assign or transfer this Option except (i)&nbsp;for a transfer upon your death in accordance with your will, by the laws of descent and distribution or pursuant to a beneficiary designation submitted in accordance with Section&nbsp;6(d)&nbsp;of the Plan, (ii)&nbsp;pursuant to a domestic relations order, or (iii)&nbsp;with the prior written approval of the Company, by gift to a &#147;family member&#148; as the term is defined under General Instruction A.1(a)(5)&nbsp;to Form&nbsp;S-8 under the Securities Act.&#160; The Option held by any such transferee will continue to be subject to the same terms and conditions that were applicable to the Option immediately prior to its transfer and may be exercised by such transferee as and to the extent that the Option has become exercisable and has not terminated in accordance with the provisions of the Plan and this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">No Stockholder Rights Before Exercise</u></b>.&#160; Neither you nor any permitted transferee of this Option will have any of the rights of a stockholder of the Company with respect to any Shares subject to this Option until a certificate evidencing such Shares has been issued, electronic delivery of such Shares has been made to your designated brokerage account, or an appropriate book entry in the Company&#146;s stock register has been made.&#160; No adjustments shall be made for dividends or other rights if the applicable record date occurs before your stock certificate has been issued, electronic delivery of your Shares has been made to your designated brokerage account, or an appropriate book entry in the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-MS_PB_4_000149_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="7",CHK=577643,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MS_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:46 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company&#146;s stock register has been made, except as otherwise described in the Plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Governing Plan Document</u></b>.&#160; This Agreement and Option are subject to all the provisions of the Plan, and to all interpretations, rules&nbsp;and regulations which may, from time to time, be adopted and promulgated by the Committee pursuant to the Plan.&#160; If there is any conflict between the provisions of this Agreement and the Plan, the provisions of the Plan will govern.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Choice of Law</u></b>.&#160; This Agreement will be interpreted and enforced under the laws of the state of Delaware (without regard to its conflicts or choice of law principles).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Binding Effect</u></b>.&#160; This Agreement will be binding in all respects on your heirs, representatives, successors and assigns, and on the successors and assigns of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Other Agreements</u></b><b>.</b>&#160; You agree that in connection with the exercise of this Option, you will execute such documents as may be necessary to become a party to any stockholder, voting or similar agreements as the Company may require.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Restrictive Legends</u></b><b>.</b>&#160; The Company may place a legend or legends on any certificate representing Shares issued upon the exercise of this Option summarizing transfer and other restrictions to which the Shares may be subject under applicable securities laws, other provisions of this Agreement, or other agreements contemplated by Section&nbsp;14 of this Agreement.&#160; You agree that in order to ensure compliance with the restrictions referred to in this Agreement, the Company may issue appropriate &#147;stop transfer&#148; instructions to its transfer agent.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Compensation Recovery Policy</u></b>.&#160; To the extent that any compensation paid or payable pursuant to this Agreement is considered &#147;incentive-based compensation&#148; within the meaning and subject to the requirements of Section&nbsp;10D of the Exchange Act, such compensation shall be subject to potential forfeiture or recovery by the Company in accordance with any compensation recovery policy adopted by the Board of Directors of the Company or any committee thereof in response to the requirements of Section&nbsp;10D of the Exchange Act and any implementing rules&nbsp;and regulations thereunder adopted by the Securities and Exchange Commission or any national securities exchange on which the Company&#146;s common stock is then listed.&nbsp; This Agreement may be unilaterally amended by the Company to comply with any such compensation recovery policy.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Electronic Delivery and Acceptance</u></b>.&#160; The Company may deliver any documents related to this Option Award by electronic means and request your acceptance of this Agreement by electronic means.&#160; You hereby consent to receive all applicable documentation by electronic delivery and to participate in the Plan through an on-line (and/or voice activated) system established and maintained by the Company or the Company&#146;s third-party stock plan administrator.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">By signing the cover page&nbsp;of this Agreement or otherwise accepting this Agreement in a manner approved by the Company, you agree to all the terms and conditions described above and in the Plan document.</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-MS_PB_5_000158_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="7",CHK=373377,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MS_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:46 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>8
<FILENAME>a2228882zex-10_13.htm
<DESCRIPTION>EX-10.13
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 10.13</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Incentive Stock Option Agreement</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Under the 2016 Equity Incentive Plan</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tactile Systems Technology,&nbsp;Inc. (the &#147;Company&#148;), pursuant to its 2016 Equity Incentive Plan (the &#147;Plan&#148;), hereby grants an Option to purchase shares of the Company&#146;s common stock to you, the Participant named below.&#160; The terms and conditions of the Option Award are set forth in this Agreement, consisting of this cover page&nbsp;and the Option Terms and Conditions on the following pages, and in the Plan document, a copy of which has been provided to you.&#160; Any capitalized term that is not defined in this Agreement shall have the meaning set forth in the Plan as it currently exists or as it is amended in the future.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name   of   Participant:&nbsp;&nbsp;**[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No.&nbsp;of   Shares   Covered:&nbsp;&nbsp;**[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Grant   Date:</font></p>    </td>
<td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.84%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u>, 20<u>&nbsp;&nbsp;&nbsp;&nbsp;</u></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exercise   Price Per   Share:&nbsp;&nbsp;$**[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Expiration   Date:</font></p>    </td>
<td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.84%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u>, 20<u>&nbsp;&nbsp;&nbsp;&nbsp;</u></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vesting   and Exercise Schedule:</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="47%" valign="bottom" style="padding:0in 0in 0in 0in;width:47.84%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="49%" valign="bottom" style="padding:0in 0in 0in 0in;width:49.66%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Portion&nbsp;of&nbsp;Shares&nbsp;as&nbsp;to&nbsp;Which</font></b></p>    </td>   </tr>
<tr>
<td width="47%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:47.84%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Dates</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="49%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:49.66%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Option&nbsp;Becomes&nbsp;Vested&nbsp;and&nbsp;Exercisable</font></b></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:47.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:49.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:47.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:49.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By signing below or otherwise evidencing your acceptance of this Agreement in a manner approved by the Company, you agree to all of the terms and conditions contained in this Agreement and in the Plan document.&#160; You acknowledge that you have received and reviewed these documents and that they set forth the entire agreement between you and the Company regarding your right to purchase shares of the Company&#146;s common stock pursuant to this Option.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">PARTICIPANT:</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TACTILE   SYSTEMS TECHNOLOGY,&nbsp;INC.</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr height="0">
<td width="325" style="border:none;"></td>
<td width="29" style="border:none;"></td>
<td width="35" style="border:none;"></td>
<td width="319" style="border:none;"></td>   </tr> </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=549681,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MU_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Tactile Systems Technology,&nbsp;Inc.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2016 Equity Incentive Plan</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Incentive Stock Option Agreement</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Option Terms and Conditions</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Incentive Stock Option</u></b>.&#160; This Option is intended to be an &#147;incentive stock option&#148; within the meaning of Section&nbsp;422 of the Internal Revenue Code (the &#147;Code&#148;) and will be interpreted accordingly.&#160; To the extent that, for any reason, the Option does not qualify as an incentive stock option under Code Section&nbsp;422, the Option will be treated as a non-statutory stock option, subject to the tax consequences applicable to such options.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Vesting and Exercisability of Option</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Scheduled Vesting</u>.&#160; This Option will vest and become exercisable as to the number of Shares and on the dates specified in the Vesting and Exercise Schedule on the cover page&nbsp;to this Agreement, so long as your Service to the Company does not end.&#160; The Vesting and Exercise Schedule is cumulative, meaning that to the extent the Option has not already been exercised and has not expired or been terminated or cancelled, you or the person otherwise entitled to exercise the Option as provided in this Agreement may at any time purchase all or any portion of the Shares subject to the vested portion of the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Accelerated Vesting</u>.&#160; Notwithstanding Section&nbsp;2(a):</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Death or Disability</i>.&#160; If your Service terminates prior to the final scheduled vesting date due to your death or Disability, this Option will vest and become exercisable in full as of such termination date, and will remain exercisable for one year thereafter.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Change in Control</i>.&#160; If and to the extent this Award is continued, assumed or replaced in connection with a Change in Control, and if within one year after the Change in Control you experience an involuntary termination of Service for reasons other than Cause, [or you terminate your Service for Good Reason (as defined below),] then this Option shall vest and become exercisable in full as of such termination date, and will remain exercisable for one year thereafter. &#160;In addition, vesting of the Option may be accelerated during the term of the Award under the circumstances described in Sections 12(b) and 12(c) of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Definition of &#147;Good Reason</i>.&#148;&#160; &#147;Good Reason&#148; shall, if you have an employment agreement with the Company, have the meaning set forth in your employment agreement.&#160; If you do not have an employment agreement with the Company, &#147;Good Reason&#148; means the existence of one or more of the following conditions without your written consent, so long as you provided written notice to the Company of the existence of the condition not later than 90 days after the initial existence of the condition, the condition has not been remedied by the Company within 30 days after its receipt of such notice and your Service terminates no later than 130 days after the condition&#146;s initial occurrence: (i)&nbsp;any material, adverse </p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-MU_PB_2_001423_3014"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=350355,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MU_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">change in your duties, responsibilities, or authority; (ii)&nbsp;a material reduction in your base salary or bonus opportunity that is not part of a general reduction applicable to employees in the</font>  </font>same classification or grade as you; or (iii)&nbsp;a geographical relocation of your principal office location by more than 50 miles.]</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Expiration</u></b>.&#160; This Option will expire and will no longer be exercisable at 5:00&nbsp;p.m.&nbsp;Central Time on the earliest of:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The expiration date specified on the cover page&nbsp;of this Agreement;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Upon your termination of Service for Cause;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Upon the expiration of any applicable period specified in Section&nbsp;6(e)&nbsp;of the Plan or Section&nbsp;2 of this Agreement during which this Option may be exercised after your termination of Service; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The date (if any) fixed for termination or cancellation of this Option pursuant to Section&nbsp;12 of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Service Requirement</u></b><b>.</b>&#160; Except as otherwise provided in Section&nbsp;6(e)&nbsp;of the Plan or Section&nbsp;2 of this Agreement, this Option may be exercised only while you continue to provide Service to the Company or any Affiliate, and only if you have continuously provided such Service since the Grant Date of this Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Exercise of Option</u></b>.&#160; Subject to Section&nbsp;4, the vested and exercisable portion of this Option may be exercised in whole or in part at any time during the Option term by delivering a written or electronic notice of exercise to the Company&#146;s Chief Financial Officer or to such other party as may be designated by such officer, and by providing for payment of the exercise price of the Shares being acquired and any related withholding taxes.&#160; The notice of exercise must be in a form approved by the Company and state the number of Shares to be purchased, the method of payment of the aggregate exercise price and the directions for the delivery of the Shares to be acquired, and must be signed or otherwise authenticated by the person exercising the Option.&#160; If you are not the person exercising the Option, the person submitting the notice also must submit appropriate proof of his/her right to exercise the Option.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Payment of Exercise Price</u></b>.&#160; When you submit your notice of exercise, you must include payment of the exercise price of the Shares being purchased through one or a combination of the following methods:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Cash (including personal check, cashier&#146;s check or money order);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By means of a broker-assisted cashless exercise in which you irrevocably instruct your broker to deliver proceeds of a sale of all or a portion of the Shares to be issued pursuant to the exercise to the Company in payment of the exercise price of such Shares; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>By delivery to the Company of Shares (by actual delivery or attestation of ownership in a form approved by the Company) already owned by you that are not subject to any security interest and that have an aggregate Fair Market Value on the date of exercise equal to the exercise price of the Shares being purchased.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-MU_PB_3_001440_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=207647,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MU_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">However, if the Committee determines, in any given circumstance, that payment of the exercise price with Shares is undesirable for any reason, you will not be permitted to pay any portion of the exercise price in that manner.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Tax Consequences</u></b>.&#160; You hereby acknowledge that if any Shares received pursuant to the exercise of any portion of this Option are sold within two years from the Grant Date or within one year from the effective date of exercise of this Option, or if certain other requirements of the Code are not satisfied, such Shares will be deemed under the Code not to have been acquired by you pursuant to an &#147;incentive stock option&#148; as defined in the Code.&#160; You agree to promptly notify the Company if you sell any Shares received upon the exercise of this Option within the time periods specified in the previous sentence.&#160; The Company shall not be liable to you if this Option for any reason is deemed not to be an &#147;incentive stock option&#148; within the meaning of the Code.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Delivery of Shares</u></b><b>.</b>&#160; As soon as practicable after the Company receives the notice of exercise and payment of the exercise price as provided above, and has determined that all other conditions to exercise, including compliance with applicable laws as provided in Section&nbsp;17(c)&nbsp;of the Plan, have been satisfied, it shall deliver to the person exercising the Option, in the name of such person, the Shares being purchased, as evidenced by issuance of a stock certificate or certificates, electronic delivery of such Shares to a brokerage account designated by such person, or book-entry registration of such Shares with the Company&#146;s transfer agent.&#160; The Company shall pay any original issue or transfer taxes with respect to the issue or transfer of the Shares and all fees and expenses incurred by it in connection therewith.&#160; All Shares so issued shall be fully paid and nonassessable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Transfer of Option</u></b>.&#160; During your lifetime, only you (or your guardian or legal representative in the event of legal incapacity) may exercise this Option.&#160; You may not assign or transfer this Option except for a transfer upon your death in accordance with your will, by the laws of descent and distribution or pursuant to a beneficiary designation submitted in accordance with Section&nbsp;6(d)&nbsp;of the Plan.&#160; The Option held by any such transferee will continue to be subject to the same terms and conditions that were applicable to the Option immediately prior to its transfer and may be exercised by such transferee as and to the extent that the Option has become exercisable and has not terminated in accordance with the provisions of the Plan and this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">No Stockholder Rights Before Exercise</u></b>.&#160; Neither you nor any permitted transferee of this Option will have any of the rights of a stockholder of the Company with respect to any Shares subject to this Option until a certificate evidencing such Shares has been issued, electronic delivery of such Shares has been made to your designated brokerage account, or an appropriate book entry in the Company&#146;s stock register has been made.&#160; No adjustments shall be made for dividends or other rights if the applicable record date occurs before your stock certificate has been issued, electronic delivery of your Shares has been made to your designated brokerage account, or an appropriate book entry in the Company&#146;s stock register has been made, except as otherwise described in the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Governing Plan Document</u></b>.&#160; This Agreement and Option are subject to all the provisions of the Plan, and to all interpretations, rules&nbsp;and regulations which may, from time to time, be adopted and promulgated by the Committee pursuant to the Plan.&#160; If there is any conflict between the provisions of this Agreement and the Plan, the provisions of the Plan will govern.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Choice of Law</u></b>.&#160; This Agreement will be interpreted and enforced under the laws of the state of Delaware (without regard to its conflicts or choice of law principles).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-MU_PB_4_001454_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=708926,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MU_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Binding Effect</u></b>.&#160; This Agreement will be binding in all respects on your heirs, representatives, successors and assigns , and on the successors and assigns of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Other Agreements</u>.</b>&#160; You agree that in connection with the exercise of this Option, you will execute such documents as may be necessary to become a party to any stockholder, voting or similar agreements as the Company may require.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Restrictive Legends</u></b><b>.</b>&#160; The Company may place a legend or legends on any certificate representing Shares issued upon the exercise of this Option summarizing transfer and other restrictions to which the Shares may be subject under applicable securities laws, other provisions of this Agreement, or other agreements contemplated by Section&nbsp;14 of this Agreement.&#160; You agree that in order to ensure compliance with the restrictions referred to in this Agreement, the Company may issue appropriate &#147;stop transfer&#148; instructions to its transfer agent.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Compensation Recovery Policy</u></b>.&#160; To the extent that any compensation paid or payable pursuant to this Agreement is considered &#147;incentive-based compensation&#148; within the meaning and subject to the requirements of Section&nbsp;10D of the Exchange Act, such compensation shall be subject to potential forfeiture or recovery by the Company in accordance with any compensation recovery policy adopted by the Board of Directors of the Company or any committee thereof in response to the requirements of Section&nbsp;10D of the Exchange Act and any implementing rules&nbsp;and regulations thereunder adopted by the Securities and Exchange Commission or any national securities exchange on which the Company&#146;s common stock is then listed.&nbsp; This Agreement may be unilaterally amended by the Company to comply with any such compensation recovery policy.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Electronic Delivery and Acceptance</u></b>.&#160; The Company may deliver any documents related to this Option Award by electronic means and request your acceptance of this Agreement by electronic means.&#160; You hereby consent to receive all applicable documentation by electronic delivery and to participate in the Plan through an on-line (and/or voice activated) system established and maintained by the Company or the Company&#146;s third-party stock plan administrator.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">By signing the cover page&nbsp;of this Agreement or otherwise accepting this Agreement in a manner approved by the Company, you agree to all the terms and conditions described above and in the Plan document.</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-MU_PB_5_001504_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="8",CHK=41960,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MU_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.14
<SEQUENCE>9
<FILENAME>a2228882zex-10_14.htm
<DESCRIPTION>EX-10.14
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 10.14</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Restricted Stock Award Agreement</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Under the 2016 Equity Incentive Plan</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tactile Systems Technology,&nbsp;Inc. (the &#147;Company&#148;), pursuant to its 2016 Equity Incentive Plan (the &#147;Plan&#148;), hereby grants an award of Restricted Stock to you, the Participant named below.&#160; The terms and conditions of this Restricted Stock Award are set forth in this Restricted Stock Award Agreement (the &#147;Agreement&#148;), consisting of this cover page&nbsp;and the Terms and Conditions on the following pages, and in the Plan document, a copy of which has been provided to you.&#160; Any capitalized term that is not defined in this Agreement shall have the meaning set forth in the Plan as it currently exists or as it is amended in the future.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name   of   Participant:&nbsp;&nbsp;**[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Number   of Shares of Restricted Stock:&nbsp;&nbsp;**[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Grant   Date:</font></p>    </td>
<td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,   20&nbsp;&nbsp;&nbsp;&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vesting   Schedule:</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="47%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:47.84%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Vesting Dates</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="49%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:49.66%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Number of Restricted Shares that Vest</font></b></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:47.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:49.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:47.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:49.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By signing below or otherwise evidencing your acceptance of this Agreement in a manner approved by the Company, you agree to all of the terms and conditions contained in this Agreement and in the Plan document.&#160; You acknowledge that you have received and reviewed these documents and that they set forth the entire agreement between you and the Company regarding the grant to you of the number of Shares of Restricted Stock specified in the table above.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">PARTICIPANT:</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TACTILE   SYSTEMS TECHNOLOGY,&nbsp;INC.</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr height="0">
<td width="325" style="border:none;"></td>
<td width="29" style="border:none;"></td>
<td width="35" style="border:none;"></td>
<td width="319" style="border:none;"></td>   </tr> </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="9",CHK=874456,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MW_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  7 01:50 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Tactile Systems Technology,&nbsp;Inc.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2016 Equity Incentive Plan</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Restricted Stock Award Agreement</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Terms and Conditions</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Grant of Restricted Stock</u></b>.&#160; The Company hereby grants to you, as of the Grant Date specified on the cover page&nbsp;of this Agreement and subject to the terms and conditions in this Agreement and the Plan, an Award of the number of Shares of Restricted Stock specified on the cover page&nbsp;of this Agreement.&#160; Unless and until these Shares vest as provided in Section&nbsp;4 below, they are subject to the restrictions provided for in Section&nbsp;3 of this Agreement and are referred to as &#147;Restricted Shares.&#148;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Issuance of Restricted Shares</u></b>.&#160; Until the Restricted Shares vest as provided in Section&nbsp;4, the Restricted Shares will be evidenced either by a book-entry in your name with the Company&#146;s transfer agent or by one or more stock certificates issued in your name.&#160; Any such stock certificate(s)&nbsp;will be deposited with the Company or its designee and will bear the following legend:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;This Certificate and the shares of stock evidenced hereby are subject to the terms and conditions (including possible forfeiture and restrictions on transfer) contained in the Restricted Stock Award Agreement (the &#147;Agreement&#148;) between the registered owner of the shares evidenced hereby and the Company.&#160; Release from such terms and conditions shall be made only in accordance with the provisions of the Agreement, a copy of which is on file in the office of the Company&#146;s Secretary.&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Any book-entry will be accompanied by a similar legend and shall be subject to such stop-transfer orders and other restrictions as the Company may deem advisable.&#160; Simultaneously with the execution and delivery of this Agreement, you shall deliver to the Company one or more stock powers endorsed in blank relating to the Restricted Shares.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Transfer Restrictions, Possible Forfeiture and Rights as Shareholder</u></b>.&#160; Until the Restricted Shares vest as provided in Section&nbsp;4, you are not entitled to sell, transfer, assign, pledge or otherwise encumber or dispose of the Restricted Shares, and the Restricted Shares remain subject to possible forfeiture as provided in Section&nbsp;5.&#160; Except as otherwise provided in this Agreement or the Plan, you are entitled at all times on and after the Grant Date specified on the cover page&nbsp;of this Agreement to all the rights of a shareholder with respect to the Restricted Shares, including the right to vote the Restricted Shares and the right to receive regular cash dividends thereon (subject to applicable tax withholding).&#160; Any Shares distributed as a stock dividend or in a stock split or otherwise with respect to the Restricted Shares before they vest shall be considered additional Restricted Shares subject to the same transfer restrictions and risk of forfeiture as the underlying Restricted Shares and shall be held as prescribed in Section&nbsp;2.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Vesting of Restricted Shares</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Scheduled Vesting</u>.&#160; If you remain a Service Provider continuously from the Grant Date specified on the cover page&nbsp;of this Agreement, then the Restricted Shares will vest in the number(s)&nbsp;and on the date(s)&nbsp;specified in the Vesting Schedule on the cover page&nbsp;of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-MW_PB_2_002433_6084"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="9",CHK=294110,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MW_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  7 01:50 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Accelerated Vesting</u>.&#160; Notwithstanding Section&nbsp;4(a):</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Death or Disability</i>.&#160; If your Service terminates prior to the final scheduled vesting date due to your death or Disability, all of the Restricted Shares shall vest as of such termination date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Change in Control</i>.&#160; If and to the extent this Award is continued, assumed or replaced in connection with a Change in Control, and if within one year after the Change in Control you experience an involuntary termination of Service for reasons other than Cause, [or you terminate your Service for Good Reason (as defined below),] then all of the Restricted Shares shall vest as of such termination date.&#160; In addition, vesting of the Restricted Shares may be accelerated during the term of the Award under the circumstances described in Sections 12(b)&nbsp;and 12(c)&nbsp;of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Definition of &#147;Good Reason</i>.&#148;&#160; &#147;Good Reason&#148; shall, if you have an employment agreement with the Company, have the meaning set forth in your employment agreement. &#160;If you do not have an employment agreement with the Company, &#147;Good Reason&#148; means the existence of one or more of the following conditions without your written consent, so long as you provided written notice to the Company of the existence of the condition not later than 90 days after the initial existence of the condition, the condition has not been remedied by the Company within 30 days after its receipt of such notice and your Service terminates no later than 130 days after the condition&#146;s initial occurrence: (i)&nbsp;any material, adverse change in your duties, responsibilities, or authority; (ii)&nbsp;a material reduction in your base salary or bonus opportunity that is not part of a general reduction applicable to employees in the same classification or grade as you; or (iii)&nbsp;a geographical relocation of your principal office location by more than 50 miles.]</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Effect of Termination of Service</u></b>.&#160; Except as otherwise provided in accordance with Section&nbsp;4(b), if you cease to be a Service Provider, you will immediately forfeit all unvested Restricted Shares.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Delivery of Unrestricted Shares</u></b>.&#160; After any Restricted Shares vest pursuant to Section&nbsp;4, the Company shall, as soon as practicable, cause to be delivered to you, or to your designated beneficiary or estate in the event of your death, the applicable number of unrestricted Shares.&#160; Delivery of the unrestricted Shares shall be effected by the removal of restrictions on the book-entry in the stock register maintained by the Company&#146;s transfer agent with a corresponding notice provided to you, by the electronic delivery of the Shares to a brokerage account you designate, or by delivery to you of a stock certificate without restrictive legend, and shall be subject to the tax withholding provisions of Section&nbsp;7 and compliance with all applicable legal requirements as provided in Section&nbsp;17(c)&nbsp;of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Tax Consequences and Withholding</u></b><b>.</b>&#160; You acknowledge that unless you make a proper and timely Section 83(b) election as described below, then at the time the Restricted Shares vest, you will be obligated to recognize ordinary income in an amount equal to the Fair Market Value as of the date of vesting of the Restricted Shares then vesting.&#160; No unrestricted Shares will be delivered to you</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-MW_PB_3_002444_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="9",CHK=1020731,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MW_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  7 01:50 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">unless you have made arrangements acceptable to the Company for payment of any federal, state, local or foreign withholding taxes that may be due as a result of the vesting of the Restricted Shares.&#160; You hereby authorize the Company (or any Affiliate) to withhold from payroll or other amounts payable to you any sums required to satisfy such withholding tax obligations, and otherwise agree to satisfy such obligations in accordance with the provisions of Section&nbsp;14 of the Plan.&#160; If you wish to satisfy some or all of such withholding tax obligations by delivering Shares you already own or by having the Company retain a number of unrestricted Shares otherwise deliverable to you, you must make such a request which shall be subject to approval by the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">You understand that, with respect to the grant of this Restricted Stock Award, you may file an election with the Internal Revenue Service, within 30 days of the Grant Date, electing pursuant to Section&nbsp;83(b)&nbsp;of the Internal Revenue Code to be taxed on the Fair Market Value of the Restricted Shares as of the Grant Date.&#160; You acknowledge that it is your sole responsibility to timely file an election under Section&nbsp;83(b)&nbsp;of the Code.&#160; If you make such an election, you must promptly provide the Company with a copy, and make arrangements acceptable to the Company for the payment of withholding taxes as described above.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Governing Plan Document</u></b>.&#160; This Agreement and the Award are subject to all the provisions of the Plan, and to all interpretations, rules&nbsp;and regulations which may, from time to time, be adopted and promulgated by the Board or the Committee pursuant to the Plan.&#160; If there is any conflict between the provisions of this Agreement and the Plan, the provisions of the Plan will govern.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Choice of Law</u></b>.&#160; This Agreement will be interpreted and enforced under the laws of the state of Delaware (without regard to its conflicts or choice of law principles).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Binding Effect</u></b>.&#160; This Agreement will be binding in all respects on your heirs, representatives, successors and assigns, and on the successors and assigns of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Compensation Recovery Policy</u></b>.&#160; To the extent that any compensation paid or payable pursuant to this Agreement is considered &#147;incentive-based compensation&#148; within the meaning and subject to the requirements of Section&nbsp;10D of the Exchange Act, such compensation shall be subject to potential forfeiture or recovery by the Company in accordance with any compensation recovery policy adopted by the Board or any committee thereof in response to the requirements of Section&nbsp;10D of the Exchange Act and any implementing rules&nbsp;and regulations thereunder adopted by the Securities and Exchange Commission or any national securities exchange on which the Company&#146;s common stock is then listed.&nbsp; This Agreement may be unilaterally amended by the Company to comply with any such compensation recovery policy.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Other Agreements</u></b><b>.</b>&#160; You agree that in connection with this award of Restricted Shares or the delivery of unrestricted Shares, you will execute such documents as may be necessary to become a party to any stockholder, voting or similar agreements as the Company may require.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Electronic Delivery and Acceptance</u></b>.&#160; The Company may deliver any documents related to this Restricted Stock Award by electronic means and request your acceptance of this Agreement by electronic means.&#160; You hereby consent to receive all applicable documentation by electronic delivery and to participate in the Plan through an on-line (and/or voice activated) system established and maintained by the Company or the Company&#146;s third-party stock plan administrator.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-MW_PB_4_002452_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="9",CHK=954537,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MW_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  7 01:50 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">By signing the cover page&nbsp;of this Agreement or otherwise accepting this Agreement in a manner approved by the Company, you agree to all the terms and conditions described above and in the Plan document.</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-MW_PB_5_002456_7091"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="9",CHK=842339,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MW_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  7 01:50 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.15
<SEQUENCE>10
<FILENAME>a2228882zex-10_15.htm
<DESCRIPTION>EX-10.15
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 10.15</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2016 EQUITY INCENTIVE PLAN</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Restricted Stock Unit Award Agreement</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tactile Systems Technology,&nbsp;Inc. (the &#147;Company&#148;), pursuant to its 2016 Equity Incentive Plan (the &#147;Plan&#148;), hereby grants an award of Restricted Stock Units to you, the Participant named below.&#160; The terms and conditions of this Award are set forth in this Restricted Stock Unit Award Agreement (the &#147;Agreement&#148;), consisting of this cover page&nbsp;and the Terms and Conditions on the following pages, and in the Plan document, a copy of which has been provided to you.&#160; Any capitalized term that is not defined in this Agreement shall have the meaning set forth in the Plan as it currently exists or as it is amended in the future.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name   of Participant:&nbsp;&nbsp;**[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Number   of Restricted Stock Units:&nbsp;&nbsp;**[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Grant   Date:</font></p>    </td>
<td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.84%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u>, 20<u>&nbsp;&nbsp;&nbsp;&nbsp;</u></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vesting   Schedule:</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="top" style="padding:0in 0in 0in 0in;width:16.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="47%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:47.84%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Vesting&nbsp;Dates</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="49%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:49.66%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Number&nbsp;of&nbsp;Restricted&nbsp;Stock&nbsp;Units&nbsp;that&nbsp;Vest</font></b></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:47.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:49.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:47.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:49.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By signing below or otherwise evidencing your acceptance of this Agreement in a manner approved by the Company, you agree to all of the terms and conditions contained in this Agreement and in the Plan document.&#160; You acknowledge that you have received and reviewed these documents and that they set forth the entire agreement between you and the Company regarding the grant to you of the number of Restricted Stock Units specified in the table above.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">PARTICIPANT:</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TACTILE   SYSTEMS TECHNOLOGY,&nbsp;INC.</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr height="0">
<td width="325" style="border:none;"></td>
<td width="29" style="border:none;"></td>
<td width="35" style="border:none;"></td>
<td width="319" style="border:none;"></td>   </tr> </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="10",CHK=693038,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MY_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Tactile Systems Technology,&nbsp;Inc.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2016 Equity Incentive Plan</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Restricted Stock Unit Award Agreement</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Terms and Conditions</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Grant of Restricted Stock Units</u></b>.&#160; The Company hereby confirms the grant to you, as of the Grant Date and subject to the terms and conditions in this Agreement and the Plan, of the number of Restricted Stock Units specified on the cover page&nbsp;of this Agreement (the &#147;Units&#148;).&#160; Each Unit represents the right to receive one Share of the Company&#146;s common stock.&#160; The Units granted to you will be credited to an account in your name maintained by the Company.&#160; This account shall be unfunded and maintained for book-keeping purposes only, with the Units simply representing an unfunded and unsecured obligation of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Restrictions Applicable to Units</u></b>.&#160; Neither this Award nor the Units subject to this Award may be sold, assigned, transferred, exchanged or encumbered other than by will or the laws of descent and distribution.&#160; Any attempted transfer in violation of this Section&nbsp;2 shall be of no effect and shall result in the forfeiture of all Units.&#160; The Units and your right to receive Shares in settlement of the Units under this Agreement shall be subject to forfeiture as provided in Section&nbsp;4 until satisfaction of the vesting conditions set forth in Section&nbsp;3.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Vesting of Units</u></b>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Scheduled Vesting</u>.&#160; If you remain a Service Provider continuously from the Grant Date specified on the cover page&nbsp;of this Agreement, then the Units will vest in the numbers and on the dates specified in the Vesting Schedule on the cover page&nbsp;of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Accelerated Vesting</u>.&#160; Notwithstanding Section&nbsp;3(a):</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Death or Disability</i>.&#160; If your Service terminates prior to the final scheduled vesting date due to your death or Disability, all of the unvested Units shall vest as of such termination date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Change in Control</i>.&#160; If and to the extent this Award is continued, assumed or replaced in connection with a Change in Control, and if within one year after the Change in Control you experience an involuntary termination of Service for reasons other than Cause, [or you terminate your Service for Good Reason (as defined below),] then all of the unvested Units shall vest as of such termination date.&#160; In addition, vesting of the Units may be accelerated during the term of the Award under the circumstances described in Sections 12(b)&nbsp;and 12(c)&nbsp;of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Definition of &#147;Good Reason</i>.&#148;&#160; &#147;Good Reason&#148; shall, if you have an employment agreement with the Company, have the meaning set forth in your employment agreement.&#160; If you do not have an employment agreement with the Company, &#147;Good Reason&#148; means the existence of one or more of the following conditions without your written consent, so long as you provided written notice to the Company of the existence of the condition not later than 90 days after the initial </p>
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-MY_PB_2_003011_2421"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="10",CHK=692608,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MY_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">existence of the condition, the condition has not been remedied by the Company within</font>  </font>30 days after its receipt of such notice and your Service terminates no later than 130 days after the condition&#146;s initial occurrence: (i)&nbsp;any material, adverse change in your duties, responsibilities, or authority; (ii)&nbsp;a material reduction in your base salary or bonus opportunity that is not part of a general reduction applicable to employees in the same classification or grade as you; or (iii)&nbsp;a geographical relocation of your principal office location by more than 50 miles.]</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Effect of Termination of Service</u></b>.&#160; Except as otherwise provided in accordance with Section&nbsp;3(b), if you cease to be a Service Provider, you will forfeit all unvested Units.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Settlement of Units</u></b>.&#160; After any Units vest pursuant to Section&nbsp;3, the Company shall, as soon as practicable (but no later than March&nbsp;15 of the year following the calendar year in which such Units vest), cause to be issued and delivered to you, or to your designated beneficiary or estate in the event of your death, one Share in payment and settlement of each vested Unit.&#160; Delivery of the Shares shall be effected by the issuance of a stock certificate to you, by an appropriate entry in the stock register maintained by the Company&#146;s transfer agent with a notice of issuance provided to you, or by the electronic delivery of the Shares to a brokerage account you designate, and shall be subject to the tax withholding provisions of Section&nbsp;6 and compliance with all applicable legal requirements as provided in Section&nbsp;17(c)&nbsp;of the Plan, and shall be in complete satisfaction and settlement of such vested Units.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Tax Consequences and Withholding</u></b>.&#160; No Shares will be delivered to you in settlement of vested Units unless you have made arrangements acceptable to the Company for payment of any federal, state, local or foreign withholding taxes that may be due as a result of the delivery of the Shares.&#160; You hereby authorize the Company (or any Affiliate) to withhold from payroll or other amounts payable to you any sums required to satisfy such withholding tax obligations, and otherwise agree to satisfy such obligations in accordance with the provisions of Section&nbsp;14 of the Plan.&#160; If you wish to satisfy some or all of such withholding tax obligations by delivering Shares you already own or by having the Company retain a number of Shares upon settlement of the Units, you must make such a request which shall be subject to approval by the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">No Shareholder Rights</u></b>.&#160; The Units subject to this Award do not entitle you to any rights of a shareholder of the Company&#146;s common stock.&#160; You will not have any of the rights of a shareholder of the Company in connection with the grant of Units subject to this Agreement unless and until Shares are issued to you upon settlement of the Units as provided in Section&nbsp;5.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Governing Plan Document</u></b>.&#160; This Agreement and the Award are subject to all the provisions of the Plan, and to all interpretations, rules&nbsp;and regulations which may, from time to time, be adopted and promulgated by the Committee pursuant to the Plan.&#160; If there is any conflict between the provisions of this Agreement and the Plan, the provisions of the Plan will govern.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Choice of Law</u></b>.&#160; This Agreement will be interpreted and enforced under the laws of the state of Delaware (without regard to its conflicts or choice of law principles).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Binding Effect</u></b>.&#160; This Agreement will be binding in all respects on your heirs, representatives, successors and assigns, and on the successors and assigns of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-MY_PB_3_003026_4141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="10",CHK=545313,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MY_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Section&nbsp;409A of the Code</u></b>.&#160; The award of Units as provided in this Agreement and any issuance of Shares or payment pursuant to this Agreement are intended to be exempt from Section&nbsp;409A of the Code under the short-term deferral exception specified in Treas. Reg. &#167; 1.409A-l(b)(4).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Compensation Recovery Policy</u></b>.&#160; To the extent that any compensation paid or payable pursuant to this Agreement is considered &#147;incentive-based compensation&#148; within the meaning and subject to the requirements of Section&nbsp;10D of the Exchange Act, such compensation shall be subject to potential forfeiture or recovery by the Company in accordance with any compensation recovery policy adopted by the Board or any committee thereof in response to the requirements of Section&nbsp;10D of the Exchange Act and any implementing rules&nbsp;and regulations thereunder adopted by the Securities and Exchange Commission or any national securities exchange on which the Company&#146;s common stock is then listed.&nbsp; This Agreement may be unilaterally amended by the Company to comply with any such compensation recovery policy.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Other Agreements</u></b><b>.</b>&#160; You agree that in connection with the settlement of vested Units, you will execute such documents as may be necessary to become a party to any stockholder, voting or similar agreements as the Company may require.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Restrictive Legends</u></b><b>.</b>&#160; The Company may place a legend or legends on any certificate representing Shares issued in settlement of vested Units summarizing transfer and other restrictions to which the Shares may be subject under applicable securities laws, other provisions of this Agreement, or other agreements contemplated by Section&nbsp;13 of this Agreement.&#160; You agree that in order to ensure compliance with the restrictions referred to in this Agreement, the Company may issue appropriate &#147;stop transfer&#148; instructions to its transfer agent.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Electronic Delivery and Acceptance</u></b>.&#160; The Company may deliver any documents related to this Restricted Stock Unit Award by electronic means and request your acceptance of this Agreement by electronic means.&#160; You hereby consent to receive all applicable documentation by electronic delivery and to participate in the Plan through an on-line (and/or voice activated) system established and maintained by the Company or the Company&#146;s third-party stock plan administrator.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">By signing the cover page&nbsp;of this Agreement or otherwise accepting this Agreement in a manner approved by the Company, you agree to all the terms and conditions described above and in the Plan document.</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-MY_PB_4_003039_8627"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="10",CHK=670283,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-MY_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.16
<SEQUENCE>11
<FILENAME>a2228882zex-10_16.htm
<DESCRIPTION>EX-10.16
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;10.16</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Tactile Systems Technology,&nbsp;Inc.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2016 Equity Incentive Plan</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Restricted Stock Unit Agreement</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(Quarterly Awards)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Restricted Stock Unit Agreement (the &#147;<b>Agreement</b>&#148;), effective as of <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>, 20<u>&nbsp;&nbsp;</u>, is between Tactile Systems Technology,&nbsp;Inc., a Delaware corporation (the &#147;<b>Company</b>&#148;), and you, <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>.&#160; Any capitalized term used but not defined in this Agreement shall have the meaning set forth in the Company&#146;s 2016 Equity Incentive Plan as it currently exists or as it is amended in the future (the &#147;Plan&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Background</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A.&#160; Under the Plan, the Board has the authority to determine Awards and administer the Plan with respect to Awards involving Non-Employee Directors.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B.&#160; The Board has determined that Non-Employee Directors may elect to receive their annual cash retainers for service as a member of the Board in the form of restricted stock units (&#147;RSUs&#148;).&#160; Settlement and payment of RSUs will be effected in Shares as provided in Section&nbsp;5 hereof.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">C.&#160; In accordance with the Company&#146;s Non-Employee Director Compensation Policy (the &#147;Policy&#148;), such annual cash retainers to Non-Employee Directors are payable in quarterly installments, in arrears, on the last business day of each calendar quarter.&#160; If a Non-Employee Director has elected to receive payment of such retainer amounts in the form of RSUs, the resulting RSUs will be granted as of the last business day of each calendar quarter with respect to the annual cash retainer installment that would otherwise have been payable on such date.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">D.&#160; You have elected to receive the annual cash retainer quarterly installments to which you would otherwise be entitled for service as a Non-Employee Director in the form of RSUs, each of which represents the right to receive one share of the Company&#146;s common stock.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">E.&#160; Each quarterly RSU grant hereunder will be evidenced by a Grant Notification in the form attached hereto as <u>Exhibit&nbsp;A</u>, and each such Grant Notification when issued by the Company will be incorporated into and made a part of this Agreement.&#160; The terms and conditions of each quarterly RSU grant are set forth in this Agreement, including the applicable Grant Notification, and in the Plan document.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Terms and Conditions of Quarterly RSU Grants</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><u style="font-weight:bold;">Grant</u></b>.&#160; Subject to Sections 7 and 8 below, on the last business day of each calendar quarter commencing with the [third] calendar quarter of 2016, you will be granted the number of RSUs specified in the applicable Grant Notification.&#160; The number of RSUs that will be subject to each of these quarterly RSU grants (the &#147;RSU Grants&#148;) will be determined by dividing the dollar amount of the annual cash retainer installment otherwise payable for that calendar quarter by the Fair Market Value of a share of the Company&#146;s common stock on the applicable RSU Grant Date.&#160; Each RSU will represent the right to receive one Share of the Company&#146;s common stock.&#160; The RSUs granted to you will be credited to an account in your name maintained by the Company.&#160; This account shall be unfunded and maintained for book-keeping purposes only, with the RSUs simply representing an unfunded and unsecured obligation of the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="11",CHK=62358,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NA_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><u style="font-weight:bold;">Restrictions on RSUs</u></b>.&#160; Prior to settlement of the RSUs in accordance with Section&nbsp;5, the RSUs subject to this Agreement may not be sold, assigned, transferred, exchanged or encumbered other than by will or the laws of descent and distribution.&#160; Any attempted transfer in violation of this Section&nbsp;2 shall be of no effect.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><u style="font-weight:bold;">No Stockholder Rights</u></b>.&#160; The RSUs subject to this Agreement do not entitle you to any rights of a stockholder of the Company&#146;s common stock.&#160; You will not have any of the rights of a stockholder of the Company in connection with the grant of RSUs subject to this Agreement unless and until Shares are issued to you upon settlement of the RSUs as provided in Section&nbsp;5.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><u style="font-weight:bold;">Vesting of RSUs</u></b>.&#160; The RSUs subject to this Agreement are 100% vested as of their respective Grant Dates.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><u style="font-weight:bold;">Settlement of RSUs</u></b>.&#160; The Company shall cause to be issued and delivered to you, or to your designated beneficiary or estate in the event of your death, one Share in payment and settlement of each RSU subject to this Agreement upon the earlier of (i)&nbsp;a termination of your Service to the Company and its Affiliates that constitutes a &#147;separation from service&#148; as such term is defined for purposes of Code Section&nbsp;409A, or (ii)&nbsp;a Change in Control within the meaning of Section&nbsp;2(f)(3)&nbsp;of the Plan.&#160; Delivery of Shares in settlement of a RSU Grant subject to this Agreement shall be effected by an appropriate entry in the stock register maintained by the Company&#146;s transfer agent with a notice of issuance provided to you, or by the electronic delivery of the Shares to a brokerage account you designate, and shall be subject to compliance with all applicable legal requirements, including compliance with the requirements of applicable federal and state securities laws.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><u style="font-weight:bold;">Dividend Equivalents</u></b>.&#160; If cash dividends are declared and paid by the Company with respect to its common stock, then the Company will credit to your account, as of each dividend payment date, a number of additional RSUs (the &#147;Dividend RSUs&#148;).&#160; The number of Dividend RSUs so credited as of any dividend payment date will be equal to (i)&nbsp;the total cash dividends you would have received on that dividend payment date if your outstanding RSUs as of the record date for such dividend payment (including any previously credited Dividend RSUs) had been actual Shares, divided by (ii)&nbsp;the Fair Market Value of a Share on the dividend payment date (with the quotient rounded down to the nearest whole number).&#160; Once credited to your account, Dividend RSUs will be considered RSUs for all purposes of this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><u style="font-weight:bold;">Termination of Future Awards</u></b>.&#160; You will no longer be entitled to receive any additional quarterly RSU Grants pursuant to this Agreement upon the earliest to occur of (i)&nbsp;the termination of your Service with the Company and all Affiliates, (ii)&nbsp;the beginning of the calendar year immediately following the Company&#146;s receipt of written notice from you that you are terminating your election to receive RSUs in lieu of annual cash retainer installments, or (iii)&nbsp;a Change in Control within the meaning Section&nbsp;2(f)(3)&nbsp;of the Plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><u style="font-weight:bold;">Changes in Capitalization</u></b>.&#160; If an &#147;equity restructuring&#148; (as defined in Section&nbsp;12(a)&nbsp;of the Plan) occurs that causes the per share value of the Shares to change, the Board shall make such equitable adjustments to any RSUs subject to this Agreement as are contemplated by Section&nbsp;12(a)&nbsp;of the Plan in order to avoid dilution or enlargement of your rights hereunder.&#160; The Board may make such equitable adjustments to any RSUs subject to this Agreement as and to the extent provided in Section&nbsp;12(a)&nbsp;of the Plan in connection with other changes in the Company&#146;s capitalization contemplated by Section&nbsp;12(a)&nbsp;of the Plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><u style="font-weight:bold;">Interpretation of This Agreement</u></b>.&#160; All decisions and interpretations made by the Board with regard to any question arising hereunder or under the Plan shall be binding and conclusive upon you and the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-NA_PB_2_034737_7474"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="11",CHK=562702,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NA_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><u style="font-weight:bold;">Governing Plan Document</u></b>.&#160; The RSU Grants evidenced by this Agreement (including any Grant Notifications issued hereunder) are granted pursuant to the Plan, the terms of which are hereby made a part of this Agreement.&#160; This Agreement (including any Grant Notifications issued hereunder) shall in all respects be interpreted in accordance with the terms of the Plan.&#160; If any terms of this Agreement or any Grant Notification issued hereunder conflict with the terms of the Plan, the terms of the Plan shall control, except as the Plan may specifically provide otherwise.&#160; This Agreement (including any Grant Notifications issued hereunder) and the Plan constitute the entire agreement of the parties with respect to the quarterly RSU Grants and supersede all prior oral or written negotiations, commitments, representations and agreements with respect thereto.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><u style="font-weight:bold;">Discontinuance of Service</u></b>.&#160; Neither this Agreement nor any RSU Grant subject to this Agreement shall confer on you any right with respect to continued Service with the Company or any of its Affiliates, nor limit or interfere in any way with the right of the Company or any Affiliate to terminate such Service or otherwise deal with you without regard to the effect it may have upon you under this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><u style="font-weight:bold;">Binding Effect</u></b>.&#160; This Agreement shall be binding in all respects on your heirs, representatives, successors and assigns, and on the successors and assigns of the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b><u style="font-weight:bold;">Choice of Law</u></b>.&#160; This Agreement will be interpreted and enforced under the laws of the state of Delaware (without regard to its conflicts or choice of law principles).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">You and the Company have executed this Agreement as of the date specified at the beginning of this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">PARTICIPANT</font></p>    </td>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TACTILE SYSTEMS   TECHNOLOGY,&nbsp;INC.</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="47%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:47.66%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By</font></p>    </td>
<td width="46%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:5.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp;&nbsp;Its</font></p>    </td>
<td width="44%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:44.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr height="0">
<td width="337" style="border:none;"></td>
<td width="17" style="border:none;"></td>
<td width="27" style="border:none;"></td>
<td width="13" style="border:none;"></td>
<td width="314" style="border:none;"></td>   </tr> </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-NA_PB_3_034852_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="11",CHK=202509,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NA_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;A</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Tactile Systems Technology,&nbsp;Inc.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2016 Equity Incentive Plan</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Restricted Stock Unit Agreement</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(Quarterly Awards)</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Grant Notification</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tactile Systems Technology,&nbsp;Inc. (the &#147;Company&#148;), pursuant to its 2016 Equity Incentive Plan (the &#147;Plan&#148;) and a Restricted Stock Unit Agreement (Quarterly Awards) dated <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>, 20<u>&nbsp;&nbsp;</u> (the &#147;Agreement&#148;) between the Company and you, the Participant named below, hereby grants to you an award of Deferred Stock Units (&#147;RSUs&#148;), each such RSU representing the right to receive one share of the Company&#146;s common stock.&#160; The terms and conditions of this RSU Award are set forth in this Grant Notification, the Agreement, and the Plan document, and these documents set forth the entire agreement between you and the Company regarding the grant to you of the number of RSUs shown in the table below.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name of Participant:</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Number of RSUs:</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Grant Date:</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.02%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vesting Schedule:</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt 6.55pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="73%" style="border-collapse:collapse;margin-left:1.0in;">
<tr>
<td width="61%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:61.14%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Vesting&nbsp;Date</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.4%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="34%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:34.1%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Percentage&nbsp;of&nbsp;Units&nbsp;That&nbsp;Vest</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.36%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="61%" valign="top" style="padding:0in 0in 0in 0in;width:61.14%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="34%" valign="bottom" style="padding:0in 0in 0in 0in;width:34.1%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.36%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="61%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:61.14%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[Grant Date]</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="34%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:34.1%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.36%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="11",CHK=485389,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NA_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.17
<SEQUENCE>12
<FILENAME>a2228882zex-10_17.htm
<DESCRIPTION>EX-10.17
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;10.17</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EMPLOYEE STOCK PURCHASE PLAN</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Purpose of the Plan</i></b><i>.</i>&#160; The purpose of this Tactile Systems Technology,&nbsp;Inc. Employee Stock Purchase Plan (the &#147;Plan&#148;) is to provide the employees of Tactile Systems Technology,&nbsp;Inc. (the &#147;Company&#148;) and its participating subsidiaries with a convenient means of purchasing shares of the Company&#146;s common stock from time to time at a discount to market prices through the use of payroll deductions.&#160; The Company intends that the Plan shall qualify as an &#147;employee stock purchase plan&#148; under Section&nbsp;423 of the Code.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Definitions</i></b><i>.</i>&#160; The terms defined in this section are used (and capitalized) elsewhere in this Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Affiliate</i>&#148; means each domestic or foreign entity that is a &#147;parent corporation&#148; or &#147;subsidiary corporation&#148; of the Company, as defined in Code Sections 424(e)&nbsp;and 424(f)&nbsp;or any successor provisions.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Board</i>&#148; means the Board of Directors of the Company.</p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Code</i>&#148; means the Internal Revenue Code of 1986, as amended and in effect from time to time.&#160; For purposes of the Plan, references to sections of the Code shall be deemed to include any applicable regulations thereunder and any successor or similar statutory provisions.</p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Committee</i>&#148; means the Compensation Committee of the Board or such other committee of non-employee directors appointed by the Board to administer the Plan as provided in Section&nbsp;13.</p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.5</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Common Stock</i>&#148; means the common stock, par value $0.001 per share, of the Company.</p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.6</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Company</i>&#148; means Tactile Systems Technology,&nbsp;Inc., a Delaware corporation.</p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.7</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Corporate Transaction</i>&#148; means (i)&nbsp;a merger, consolidation or other reorganization of the Company with or into another corporation, or (ii)&nbsp;the sale of all or substantially all of the assets of the Company.</p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.8</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Designated Affiliate</i>&#148; means any Affiliate which has been expressly designated by the Board or Committee as a corporation whose Eligible Employees may participate in the Plan.</p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.9</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Eligible Compensation</i>&#148; means the total cash compensation (including wages, salary, commission, bonus, and overtime earnings) paid by the Company or any Affiliate to a Participant in accordance with the Participant&#146;s terms of employment, but shall not include any employer contributions to a 401(k)&nbsp;or other retirement plan, any expense reimbursements or allowances, or any income (whether paid in Shares or cash) realized by the Participant as a result of participation in any equity-based compensation plan of the Company or any Affiliate.</p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.10</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Eligible Employee</i>&#148; means any employee of the Company or a Designated Affiliate, except for any employee who, immediately after a right to purchase is granted under the Plan, would be deemed, for purposes of Code Section&nbsp;423(b)(3), to own stock possessing 5% or more of the total combined voting power or value of all classes of stock of the Company or any Affiliate.&#160; Notwithstanding the foregoing, with respect to any Offering, the Committee may provide for the exclusion of certain employees within the limitations described in Treasury Regulations &#167;1.423-2(e)(1), (2)&nbsp;and (3).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=226237,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NC_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 01:16 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.11</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Exchange Act</i>&#148; means the Securities Exchange Act of 1934, as amended from time to time, and the regulations promulgated thereunder.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.12</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Fair Market Value</i>&#148; of a Share of Common Stock as of any date means (i)&nbsp;if the Company&#146;s Common Stock is then listed on a national securities exchange, the closing sale price for a Share on such exchange on said date, or, if no sale has been made on such exchange on said date, on the last preceding day on which any sale shall have been made; (ii)&nbsp;if the Company&#146;s Common Stock is not then listed on a national securities exchange, such value as the Committee in its discretion may in good faith determine, <i>provided that</i>, for the IPO Purchase Period, the Fair Market Value of a Share on the applicable Offering Date will be the price per share at which Shares are first sold to the public in the Company&#146;s initial public offering as specified in the final prospectus for that initial public offering.&#160; The determination of Fair Market Value shall be subject to adjustment as provided in Section&nbsp;14.1.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.13</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>IPO Date</i>&#148; means the effective date of the Company&#146;s registration statement on Form&nbsp;S-1 for the initial public offering of the Common Stock.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.14</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>IPO Purchase Period</i>&#148; means the initial Purchase Period under the Plan which begins on the IPO Date and ends on the next May&nbsp;15 or November&nbsp;15 to occur at least six months thereafter.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.15</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Offering</i>&#148; means the right provided to Participants to purchase Shares under the Plan with respect to a Purchase Period.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.16</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Offering Date</i>&#148; means the first Trading Day of a Purchase Period, which shall be the IPO Date for the IPO Purchase Period.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.17</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Participant</i>&#148; means an Eligible Employee who has elected to participate in the Plan in the manner set forth in Section&nbsp;4 and whose participation has not ended pursuant to Section&nbsp;8.1 or Section&nbsp;9.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.18</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Plan</i>&#148; means this Tactile Systems Technology,&nbsp;Inc. Employee Stock Purchase Plan, as it may be amended from time to time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.19</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Purchase Date</i>&#148; means the last Trading Day of a Purchase Period.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.20</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Purchase Period</i>&#148; means a period of six months beginning either (i)&nbsp;on May&nbsp;16 of each calendar year and ending on the next November&nbsp;15, or (ii)&nbsp;on November&nbsp;16 in each calendar year and ending on the next May&nbsp;15, such other period of time (but not to exceed 27 months or such longer period as may be permitted under Code Section&nbsp;423) commencing on such date as may be established by the Committee, or the IPO Purchase Period.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.21</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Recordkeeping Account</i>&#148; means the account maintained in the books and records of the Company recording the amount contributed to the Plan by each Participant through payroll deductions<i>.</i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.22</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Shares</i>&#148; means shares of Common Stock.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.23</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Trading Day</i>&#148; means a day on which the national stock exchanges in the United States are open for trading.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Shares Available</i></b><i>.</i>&#160; Subject to adjustment as provided in Section&nbsp;14.1, the maximum number of Shares that may be sold by the Company to Eligible Employees under the Plan shall be 1,600,000 Shares, plus an automatic annual increase in such amount on January&nbsp;1 of each year beginning in 2017 and ending on (and including) January&nbsp;1, 2026 equal to the lesser of: (i)&nbsp;1% of the total number of Shares outstanding</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-NC_PB_2_011412_8471"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=30422,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NC_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 01:16 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">as of December&nbsp;31 of the immediately preceding calendar year, or (ii)&nbsp;500,000 Shares, <i>provided, however</i>, that the Board may determine that any annual increase shall be for a number of Shares that is less than the number of Shares determined by the application of clauses (i)&nbsp;and (ii).&#160; If the purchases by all Participants in an Offering would otherwise cause the aggregate number of Shares to be sold under the Plan to exceed the number specified in this Section&nbsp;3, each Participant in that Offering shall be allocated a ratable portion of the remaining number of Shares which may be sold under the Plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Eligibility and Participation</i></b><i>.</i>&#160; To be eligible to participate in the Plan for a given Purchase Period, an employee must be an Eligible Employee on the first day of such Purchase Period.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Enrollment for IPO Purchase Period. </i>&#160;Each individual who, on the IPO Date, qualifies as an Eligible Employee shall automatically become a Participant on such day and shall be deemed to have been granted the right to participate in the Offering occurring during the IPO Purchase Period at the maximum applicable participation rate.&#160; Adoption of the Plan by the Board constitutes the approval of the grant of such a right to all Eligible Employees as of the IPO Date.&#160; Each Participant who was automatically enrolled in the Plan on the IPO Date shall file a payroll deduction election form in the manner prescribed by Section&nbsp;6.2 below within 30 calendar days after the IPO Date.&#160; If a Participant who was automatically enrolled on the IPO Date fails to file such election form in a timely manner, then such Participant shall be deemed to have withdrawn from the Plan in accordance with Section&nbsp;8.1 below.&#160; A former Participant who is deemed to have withdrawn from the Plan pursuant to this Section&nbsp;4.1 shall not again be a Participant in the Plan until he or she reenters the Plan for a subsequent Purchase Period through the enrollment process described in Sections 4.2 and 6.2 below.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Enrollment After the IPO Purchase Period</i>.&#160; An Eligible Employee may elect to participate in the Plan by filing an election form with the Company before the Offering Date for a Purchase Period occurring after the IPO Purchase Period that authorizes regular payroll deductions from Eligible Compensation beginning with the first payday in such Purchase Period and continuing until the Plan is terminated or the Eligible Employee withdraws from the Plan, modifies his or her authorization, or ceases to be an Eligible Employee, as hereinafter provided.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Amount of Common Stock Each Eligible Employee May&nbsp;Purchase</i></b><i>.</i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Purchase Amounts and Limitations</i>.&#160; Subject to the provisions of this Plan, each Participant shall be offered the right to purchase on the Purchase Date the maximum number of Shares (including fractional Shares) that can be purchased with the entire balance in the Participant&#146;s Recordkeeping Account at the per Share price specified in Section&nbsp;5.2.&#160; Notwithstanding the foregoing, no Participant shall be entitled to:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the right to purchase Shares under this Plan and all other employee stock purchase plans (within the meaning of Code Section&nbsp;423(b)), if any, of the Company and its Affiliates that accrues at a rate which in the aggregate exceeds $25,000 of Fair Market Value (determined on the Offering Date of a Purchase Period when the right is granted) for each calendar year in which such right is outstanding at any time; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>purchase more than 5,000 Shares in any Offering under this Plan, such limit subject to adjustment from time to time as provided in Section&nbsp;14.1.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Purchase Price</i>.&#160; Unless a greater purchase price is established by the Committee for an Offering prior to the commencement of the applicable Purchase Period, the purchase price of each Share sold pursuant to this Plan will be the lesser of (i)&nbsp;85% of the Fair Market Value of such Share on the Offering Date of the applicable Purchase Period, or (ii)&nbsp;85% of the Fair Market Value of such Share on the Purchase Date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-NC_PB_3_011425_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=664985,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NC_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 01:16 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Method of Participation</i></b><i>.</i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Notice and Date of Grant</i>.&#160; The Company shall give notice to each Eligible Employee of the opportunity to purchase Shares pursuant to this Plan and the terms and conditions of such Offering.&#160; The Company contemplates that for tax purposes the Offering Date for a Purchase Period will be considered the date of the grant of the right to purchase such Shares.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Contribution Elections</i>.&#160; Each Eligible Employee who desires to participate in the Plan for a Purchase Period shall signify his or her election to do so by signing and filing with the Company an election form approved by the Committee.&#160; An Eligible Employee may elect to have any whole percent of Eligible Compensation (that is, 1%, 2%, 3%,&nbsp;etc.) withheld as a payroll deduction, but not exceeding 15% per pay period (or such other maximum percentage as the Committee may establish from time to time prior to the commencement of an Offering).&#160; Except with respect to the IPO Purchase Period, an election to participate in the Plan and to authorize payroll deductions as described herein must be made before the Offering Date of a Purchase Period, and shall be effective beginning with the first payday in the Purchase Period immediately following the filing of such election form.&#160; With respect to the IPO Purchase Period, an election to authorize payroll deductions (which may be in an amount less than the maximum participation percentage) is to be submitted following the IPO Date, but no later than 30 days thereafter, by any Participant who was automatically enrolled in the Plan.&#160; Any election form submitted shall remain in effect until the Plan is terminated or such Participant withdraws from the Plan, modifies his or her authorization, or ceases to be an Eligible Employee, as hereinafter provided.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Additional Contributions</i>.&#160; If specifically provided by the Committee in connection with an Offering (including for purposes of complying with applicable local law), or in connection with the IPO Purchase Period as provided below, in addition to or instead of making contributions by payroll deductions, a Participant may make additional contributions to his or her Recordkeeping Account through the payment by cash or check prior to a Purchase Date.&#160; A Participant may make such additional contributions into his or her Recordkeeping Account only if the Participant has not already had the maximum permitted amount withheld during the Offering through payroll deductions, subject to the limitations set forth in Section&nbsp;5.1.&#160; Subject to the preceding sentence, a Participant will be permitted to make such an additional contribution into his or her Recordkeeping Account in connection with the IPO Purchase Period only if the Participant made a timely election as provided in Section&nbsp;6.2 above to authorize payroll deductions for the IPO Purchase Period at the maximum participation percentage, and such additional contribution is limited in amount to the maximum contribution percentage applied to Eligible Compensation received on paydays occurring during the IPO Purchase Period before the Participant&#146;s initial payroll deduction election became effective.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Offering Terms and Conditions</i>.&#160; Each Offering shall consist of a single Purchase Period and shall be in such form and shall contain such terms and conditions as the Committee shall deem appropriate, consistent with the terms of the Plan.&#160; The Committee may provide for separate Offerings for different Designated Affiliates, and the terms and conditions of the separate Offerings, including the applicable Purchase Period, need not be consistent.&#160; Any Offering shall comply with the requirement of Code Section&nbsp;423 that all Participants shall have the same rights and privileges for such Offering.&#160; The terms and conditions of any Offering shall be incorporated by reference into the Plan and treated as part of the Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Recordkeeping Accounts</i></b><i>.</i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Crediting Payroll Deduction Contributions</i>.&#160; The Company shall maintain a Recordkeeping Account for each Participant.&#160; Payroll deductions pursuant to Section&nbsp;6 will be credited to such Recordkeeping Accounts on each payday.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-NC_PB_4_011441_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=624076,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NC_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 01:16 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>No Interest Payable</i>.&#160; No interest will be credited to a Participant&#146;s Recordkeeping Account (unless required under local law).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>No Segregation of Accounts</i>.&#160; The Recordkeeping Account is established solely for accounting purposes, and all amounts credited to the Recordkeeping Account will remain part of the general assets of the Company and need not be segregated from other corporate funds (unless required under local law).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Additional Contributions</i>.&#160; A Participant may not make any separate cash payment into a Recordkeeping Account, except as may be permitted in accordance with Section&nbsp;6.3, and any such additional contributions will be credited to the Recordkeeping Accounts when received by the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Right to Adjust Participation; Withdrawals from Recordkeeping Account</i></b><i>.</i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Withdrawal from Plan</i>.&#160; A Participant may at any time withdraw from the Plan.&#160; If a Participant withdraws from the Plan, the Company will pay to the Participant in cash the entire balance in such Participant&#146;s Recordkeeping Account and no further deductions will be made from the Participant&#146;s Eligible Compensation during such Purchase Period.&#160; A Participant who withdraws from the Plan will not be eligible to reenter the Plan until the next succeeding Purchase Period, and any such reentry shall be through the enrollment process described in Section&nbsp;6.2.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Adjusting Level of Participation</i>.&#160; A Participant may adjust his or her rate of payroll deduction contributions to the Plan as follows:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>A Participant may, by written notice, direct the Company to increase or decrease his or her rate of payroll deduction contributions, with such change to be effective as of the first day of the next Purchase Period.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>A Participant may, by written notice, direct the Company to decrease his or her rate of payroll deduction contributions for a Purchase Period (including a decrease to 0%) one time during the applicable Purchase Period, with such change to become effective as soon as reasonably practicable.&#160; Any Participant who has decreased his or her rate of payroll deductions to 0% and does not increase such rate of payroll deductions from 0% to at least 1% in accordance with Section&nbsp;8.2(a)&nbsp;prior to the start of the next Purchase Period will be withdrawn from the Plan effective as of the first day of that next Purchase Period.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Submission of Notices</i>.&#160; Notification of a Participant&#146;s election to withdraw from the Plan as provided in Section&nbsp;8.1 or to change his or her rate of payroll deductions as provided in Section&nbsp;8.2 shall be made by signing and submitting to the Company an appropriate form for that purpose approved by the Committee.&#160; The Committee may promulgate rules&nbsp;regarding the time and manner for submitting any such written notice, which may include a requirement that the notice be on file with the Company&#146;s designated office for a reasonable period before it will be effective.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Adjustments by Company</i>.&#160; To the extent necessary to comply with Section&nbsp;423(b)(8)&nbsp;of the Code or Section&nbsp;5.1 of the Plan, a Participant&#146;s payroll deduction contributions to the Plan may be decreased by the Company to 0% at any time during a Purchase Period.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Termination of Employment</i></b><i>.</i>&#160; If the employment of a Participant is terminated for any reason, including death, disability, or retirement, the entire balance in the Participant&#146;s Recordkeeping Account will be refunded in cash to the Participant within 30 days after the date of termination of employment.&#160; For purposes of the Plan, a Participant will not be deemed to have terminated employment while the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-NC_PB_5_011451_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=81363,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NC_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 01:16 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Participant is on sick leave, military leave or other leave of absence approved by the Company.&#160; Where the period of leave exceeds 90 days and the Participant&#146;s right to reemployment is not guaranteed either by statute or by contract, the employment relationship shall be deemed to have terminated on the ninety-first day of such leave.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Purchase of Shares</i></b><i>.</i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Number of Shares Purchased</i>.&#160; As of each Purchase Date, the entire balance in each Participant&#146;s Recordkeeping Account will be used to purchase the maximum number of Shares (including fractional Shares) (subject to the limitations of Section&nbsp;5.1) at the purchase price determined in accordance with Section&nbsp;5.2, unless the Participant has filed an appropriate form with the Company in advance of that date to withdraw from the Plan in accordance with Section&nbsp;8.1.&#160; Any amount in a Participant&#146;s Recordkeeping Account that, for any reason, is not used to purchase Shares pursuant to this Section&nbsp;10.1 will be refunded to the Participant.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Conversion of Foreign Currency</i>.&#160; In circumstances where payroll deductions have been taken from a Participant&#146;s Eligible Compensation in a currency other than United States dollars, Shares shall be purchased by converting the balance in the Participant&#146;s Recordkeeping Account to United States dollars at the exchange rate in effect at the end of the fifth Trading Day preceding the Purchase Date, as published by Bloomberg.com if available or otherwise as determined with respect to a particular jurisdiction by the Committee or its delegate for this purpose, and such dollar amount shall be used to purchase Shares as of the Purchase Date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Crediting of Shares</i>.&#160; Promptly after the end of each Purchase Period, the number of Shares purchased by all Participants as of the applicable Purchase Date shall be issued and delivered to an agent selected by the Company.&#160; Delivery of the shares to the agent shall be effected by an appropriate book-entry in the stock register maintained by the Company&#146;s transfer agent or delivery of a certificate.&#160; The agent will hold the Shares for the benefit of all Participants who have purchased Shares and will maintain a Share subaccount for each Participant reflecting the number of Shares (including fractional Shares) credited to each Participant.&#160; Each Participant will be entitled to direct the voting by the agent of all Shares credited to such Participant&#146;s Share subaccount, and the agent may reinvest any dividends paid on Shares credited to a Participant&#146;s Share subaccount in additional Shares in accordance with such rules&nbsp;as the Committee may prescribe.&#160; Each Participant may also direct the agent to sell any or all of the Shares credited to the Participant&#146;s Share subaccount and distribute the net proceeds of such sale to the Participant.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Withdrawal of Shares From Share Subaccount</i>.&#160; Except for sales through the agent as provided in Section&nbsp;10.3, a Participant may not withdraw Shares from the Participant&#146;s Share subaccount until after the Participant has satisfied the minimum holding period requirements established by Code Section&nbsp;423(a)(1).&#160; Once these holding period requirements have been satisfied with respect to Shares credited to a Participant&#146;s Share subaccount, the Participant may request that the agent transfer any or all of those Shares directly to the Participant or to a brokerage account maintained by the Participant.&#160; The agent shall deliver the requested number of whole Shares by the issuance of a stock certificate, the electronic delivery of the Shares to a brokerage account designated by the Participant, or an appropriate book-entry in the stock register maintained by the Company&#146;s transfer agent with a notice of issuance provided to the Participant, and will pay the Participant a cash amount representing the Fair Market Value of any applicable fractional Share withdrawn.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Rights as a Shareholder</i></b><i>.</i>&#160; A Participant shall not be entitled to any of the rights or privileges of a shareholder of the Company with respect to Shares, including the right to vote or direct the voting or to receive any dividends that may be declared by the Company, until (i)&nbsp;the Participant actually has paid the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">6<a name="16022-2-NC_PB_6_011502_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=178563,FOLIO='6',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NC_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 01:16 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">purchase price for such Shares and (ii)&nbsp;certificates for such Shares have been issued either to the agent or to the Participant, as provided in Section&nbsp;10.3.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Rights Not Transferable</i></b><i>.</i>&#160; A Participant&#146;s rights under this Plan are exercisable only by the Participant during his or her lifetime, and may not be sold, pledged, assigned, transferred or disposed of in any manner other than by will or the laws of descent and distribution.&#160; Any attempt to sell, pledge, assign, transfer or dispose of the same shall be void and without effect.&#160; The amounts credited to a Recordkeeping Account may not be sold, pledged, assigned, transferred or disposed of in any way, and any attempted sale, pledge, assignment, transfer or other disposition of such amounts will be void and without effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Administration of the Plan</i></b><i>.</i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Authority of the Committee</i>.&#160; This Plan shall be administered by the Committee.&#160; Subject to the express provisions of the Plan and applicable law, and in addition to other express powers and authorizations conferred on the Committee by the Plan, the Committee shall have full power and authority to:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Determine when each Purchase Period under this Plan shall occur, and the terms and conditions of each related Offering (which need not be identical);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Designate from time to time which Affiliates of the Company shall be eligible to participate in the Plan;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Construe and interpret the Plan and establish, amend and revoke rules, regulations and procedures for the administration of the Plan.&#160; The Committee may, in the exercise of this power, correct any defect, omission or inconsistency in the Plan, in such manner and to the extent it may deem necessary, desirable or appropriate to make the Plan fully effective;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Exercise such powers and perform such acts as the Committee may deem necessary, desirable or appropriate to promote the best interests of the Company and its Designated Affiliates and to carry out the intent that the Offerings made under the Plan are treated as qualifying under Code Section&nbsp;423(b);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>As more fully described in Section&nbsp;18, to adopt such rules, procedures and sub-plans as may be necessary, desirable or appropriate to permit participation in the Plan by employees who are foreign nationals or employed outside the United States by a non-U.S. Designated Affiliate, and to achieve tax, securities law and other compliance objectives in particular locations outside the United States; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Adopt and amend as the Committee deems appropriate a Plan rule&nbsp;specifying that Shares purchased by a Participant during a Purchase Period may not be sold by the Participant for a specified period of time after the Purchase Date on which the Shares were purchased by the Participant, and establish such procedures as the Committee may deem necessary to implement such rule.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Interpretations and Decisions by the Committee</i>.&#160; Unless otherwise expressly provided in the Plan, all designations, determinations, interpretations, and other decisions under or with respect to the Plan shall be within the sole discretion of the Committee, may be made at any time and shall be final, conclusive, and binding upon all persons, including the Company, any Affiliate, any Participant and any Eligible Employee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">7<a name="16022-2-NC_PB_7_011515_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=55026,FOLIO='7',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NC_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 01:16 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Delegation by the Committee</i>.&#160; Subject to the terms of the Plan and applicable law, the Committee may delegate ministerial duties associated with the administration of the Plan to such of the Company&#146;s officers, employees or agents as the Committee may determine.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Indemnification</i>.&#160; No member of the Board or Committee shall be liable for any action taken or determination made in good faith with respect to the Plan.&#160; In addition to such other rights of indemnification as they may have as members of the Board or officers or employees of the Company or a Designated Affiliate, members of the Board and Committee and any officers or employees of the Company or Designated Affiliate to whom authority to act for the Committee is delegated shall be indemnified by the Company from and against any and all liabilities, costs and expenses incurred by such persons as a result of any act or omission to act in connection with the performance of such person&#146;s duties, responsibilities and obligations under the Plan if such person has acted in good faith and in a manner that he or she reasonably believes to be in, or not opposed to, the best interests of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Changes in Capitalization and Corporate Transactions</i></b><i>.</i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14.1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Adjustments</i>.&#160; In the event of any change in the Common Stock of the Company by reason of a stock dividend, stock split, reverse stock split, corporate separation, recapitalization, merger, consolidation, combination, exchange of shares and the like, the Committee shall make such equitable adjustments as it deems appropriate in the aggregate number and class of Shares or other securities available under this Plan, the Share limitation expressed in Section&nbsp;5.1(b)&nbsp;of the Plan, and the number, class and purchase price of Shares or other securities subject to purchase under any pending Offering.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14.2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Corporate Transactions</i>.&#160; In the event of a Corporate Transaction, each right to acquire Shares on any Purchase Date that is scheduled to occur after the date of the consummation of the Corporate Transaction may be continued or assumed or an equivalent right may be substituted by the surviving or successor corporation or a parent or subsidiary of such corporation.&#160; If such surviving or successor corporation or parent or subsidiary thereof refuses to continue, assume or substitute for such outstanding rights, then the Board may, in its discretion, either terminate the Plan or shorten the Purchase Period then in progress by setting a new Purchase Date for a specified date before the date of the consummation of the Corporate Transaction.&#160; Each Participant shall be notified in writing, prior to any new Purchase Date, that the Purchase Date for the existing Offering has been changed to the new Purchase Date and that the Participant&#146;s right to acquire Shares will be exercised automatically on the new Purchase Date unless prior to such date the Participant&#146;s employment has been terminated or the Participant has withdrawn from the Plan.&#160; In the event of a dissolution or liquidation of the Company, any Offering and Purchase Period then in progress will terminate immediately prior to the consummation of such action, unless otherwise provided by the Board.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Amendment or Suspension of Plan</i></b>.&#160; The Board may at any time suspend this Plan or amend it in any respect, but no such amendment may, without shareholder approval, increase the number of shares reserved under this Plan, increase the rate of automatic annual increase in the number of shares reserved as provided in Section&nbsp;3, or effect any other change in the Plan that would require shareholder approval under applicable law or regulations or the rules&nbsp;of any securities exchange on which the Shares may then be listed, or to maintain compliance with Code Section&nbsp;423.&#160; No such amendment or suspension shall adversely affect the rights of Participants pursuant to Shares previously acquired under the Plan.&#160; During any suspension of the Plan, no new Offering or Purchase Period shall begin and no Eligible Employee shall be offered any new right to purchase Shares under the Plan or any opportunity to elect to participate in the Plan, and any existing payroll deduction authorizations shall be suspended, but any such right to purchase Shares previously granted for a Purchase Period that began prior to the Plan suspension shall remain</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">8<a name="16022-2-NC_PB_8_011529_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=245381,FOLIO='8',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NC_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 01:16 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">subject to the other provisions of this Plan and the discretion of the Board and the Committee with respect thereto.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Effective Date and Term of Plan</i></b><i>.&#160; </i>The Plan will become effective on the IPO Date.&#160; No rights to purchase Shares granted under this Plan will be exercised unless and until the Plan has been approved by the shareholders of the Company, which approval must be within 12 months before or after the date the Plan is adopted by the Board of Directors.&#160; The Plan and all rights of Participants hereunder shall terminate (i)&nbsp;at any time, at the discretion of the Board of Directors, or (ii)&nbsp;upon the completion of any Offering under which the limitation on the total number of shares to be issued during the entire term of the Plan, as determined in accordance with Section&nbsp;3 and including the annual increased provided thereby, has been reached.&#160; Except as otherwise determined by the Board, upon termination of this Plan, the Company shall pay to each Participant cash in an amount equal to the entire remaining balance in such Participant&#146;s Recordkeeping Account.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Governmental Regulations and Listing</i></b><i>.</i>&#160; All rights granted or to be granted to Eligible Employees under this Plan are expressly subject to all applicable laws and regulations and to the approval of all governmental authorities required in connection with the authorization, issuance, sale or transfer of the Shares reserved for this Plan, including, without limitation, there being a current registration statement of the Company under the Securities Act of 1933, as amended, covering the Shares purchasable on the Purchase Date applicable to such Shares, and if such a registration statement shall not then be effective, the term of such Purchase Period shall be extended until the first Trading Day after the effective date of such a registration statement, or post-effective amendment thereto.&#160; If applicable, all such rights hereunder are also similarly subject to effectiveness of an appropriate listing application to a national securities exchange covering the Shares issuable under the Plan upon official notice of issuance.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Rules&nbsp;for Foreign Jurisdictions</i></b>.&#160; The Committee may adopt rules, procedures or subplans relating to the operation and administration of the Plan to accommodate the specific requirements of local laws and procedures.&#160; Without limiting the generality of the foregoing, the Committee is specifically authorized to adopt rules&nbsp;and procedures regarding handling of payroll deductions, payment of interest, conversion of local currency, payroll tax, the definition of Eligible Compensation, withholding procedures and handling of stock certificates that vary with local requirements.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><i style="font-weight:bold;">Miscellaneous</i></b><i>.</i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19.1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Effect on Employment Status</i>.&#160; This Plan shall not be deemed to constitute a contract of employment between the Company and any Participant, nor shall it interfere with the right of the Company to terminate the employment of any Participant and treat him or her without regard to the effect that such treatment might have upon him or her under this Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19.2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Governing Law</i>.&#160; This Plan, and all agreements hereunder, shall be construed in accordance with and governed by the laws of the State of Delaware.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19.3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Electronic Documentation and Signatures</i>.&#160; Any reference in the Plan to election or enrollment forms, notices, authorizations or any other document to be provided in writing shall include the provision of any such form, notice, authorization or document by electronic means, including through the Company&#146;s intranet, and any reference in the Plan to the signing of any document shall include the authentication of any such document provided in electronic form, in each case in accordance with procedures established by the Committee.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19.4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Book-Entry and Electronic Transfer of Shares.</i>&#160; Any reference in this Plan to the issuance or transfer of a stock certificate evidencing Shares shall be deemed to include, in the Committee&#146;s discretion, the issuance or transfer of such Shares in book-entry or electronic form.&#160; Uncertificated Shares shall be deemed</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">9<a name="16022-2-NC_PB_9_011542_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=9,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=354212,FOLIO='9',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NC_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 01:16 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">delivered for all purposes of this Plan when the Company or its agent shall have provided to the recipient of the Shares a notice of issuance or transfer by electronic mail (with proof of receipt) or by United States mail, and have recorded the issuance or transfer in its records.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19.5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Registration of Share Accounts and Certificates.</i>&#160; Any Share account contemplated by Section&nbsp;10.3 and certificate to be issued to a Participant shall be registered in the name of the Participant, or jointly in the name of the Participant and another person, as the Participant may direct on an appropriate form filed with the Company or the agent.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">10<a name="16022-2-NC_PB_10_011550_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=10,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="12",CHK=765187,FOLIO='10',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NC_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 01:16 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.18
<SEQUENCE>13
<FILENAME>a2228882zex-10_18.htm
<DESCRIPTION>EX-10.18
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 10.18</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">NON-EMPLOYEE DIRECTOR COMPENSATION POLICY</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Adopted [<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>], 2016</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .35in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Each non-management director of Tactile Systems Technology,&nbsp;Inc. (the &#147;<i>Company</i>&#148;) will receive:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .35in;text-indent:-.25in;"><b><font size="2" face="Symbol" style="font-size:10.0pt;font-weight:bold;">&#183;</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>An annual stock option grant on the date of each annual meeting of stockholders at which the director is elected to the board or continues to serve as a director with a grant date fair value of $50,000 computed in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 718, <i>Stock Compensation</i>.&#160; Each grant will vest in full on the earlier of one year after the date of grant or the date of the next year&#146;s annual meeting of stockholders, provided the director remains a member of the board as of the vesting date, and will have a term of ten years.&#160; The exercise price shall be the closing sale price for a share of the Company&#146;s common stock on the Company&#146;s principal stock exchange on the date of the Company&#146;s grant.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .35in;text-indent:-.25in;"><b><font size="2" face="Symbol" style="font-size:10.0pt;font-weight:bold;">&#183;</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>An annual restricted stock unit (RSU) grant on the date of each annual meeting of stockholders at which the director is elected to the board or continues to serve as a director, the number of RSUs calculated by dividing $50,000 by the closing sale price for a share of the Company&#146;s common stock on the Company&#146;s principal stock exchange on the date of grant. Each grant will vest in full on the earlier of one year after the date of grant or the date of the next year&#146;s annual meeting of stockholders, provided the director remains a member of the board as of the vesting date.&#160; RSUs will settle in shares no later than March&nbsp;15 of the calendar year following the date of vesting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .35in;text-indent:-.25in;"><b><font size="2" face="Symbol" style="font-size:10.0pt;font-weight:bold;">&#183;</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>An annual retainer of $35,000, payable in quarterly installments, in arrears, on the last business day of each calendar quarter.&#160; A non-management director may elect to receive a grant of fully-vested RSUs in lieu of each such annual retainer installment, with the grant date being the last business day of each calendar quarter and the number of RSUs equal to the amount of the annual retainer installment divided by the closing sale price for a share of the Company&#146;s common stock on the Company&#146;s principal stock exchange on the date of grant.&#160; Each RSU will represent the right to receive one share of the Company&#146;s common stock upon the earlier of the director&#146;s separation from service as a director of the Company or the occurrence of a change in control of the Company.&#160; Any election to receive RSUs in lieu of cash, and the settlement of such RSUs shall be made in accordance with the requirements with Section&nbsp;409A of the Internal Revenue Code.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Each non-management director of the Company that chairs of a committee will receive an annual fee as follows:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="79%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:79.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Committee&nbsp;Chair</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="17%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Annual&nbsp;Cash&nbsp;Fee</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="79%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:79.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Audit</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$16,000</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Compensation and   Organization</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="bottom" style="padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$12,000</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="79%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:79.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Nominating and   Corporate Governance</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$&nbsp;&nbsp;8,000</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Compliance and   Reimbursement</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="bottom" style="padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$&nbsp;&nbsp;8,000</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Each non-management director of the Company, other than the chair, that serves on a committee will receive an annual fee as follows:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="79%" valign="bottom" style="padding:0in 0in 0in 0in;width:79.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Non-Chair</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="17%" valign="bottom" style="padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="79%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:79.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Committee&nbsp;Members</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="17%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Annual&nbsp;Cash&nbsp;Fee</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="79%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:79.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Audit</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$8,000</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Compensation and   Organization</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="bottom" style="padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$6,000</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="79%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:79.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Nominating and   Corporate Governance</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$4,000</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Compliance and   Reimbursement</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="17%" valign="bottom" style="padding:0in 0in 0in 0in;width:17.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$4,000</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The chairman of the Company&#146;s board of directors will receive an additional annual fee of $35,000.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="13",CHK=511047,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NE_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 08:04 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company will reimburse a director&#146;s reasonable expenses in connection with attending board and committee meetings.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">For directors joining the Company during a period between annual meetings, all amounts will be prorated based on the percentage of the year until the next annual meeting.&#160; All directors will receive the equity awards set forth above in granted upon pricing of the Company&#146;s initial public offering.</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-NE_PB_2_005236_5084"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="13",CHK=890545,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NE_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 08:04 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.20
<SEQUENCE>14
<FILENAME>a2228882zex-10_20.htm
<DESCRIPTION>EX-10.20
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;10.20</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EMPLOYMENT AGREEMENT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">This Employment Agreement (this &#147;<i>Agreement</i>&#148;) is entered into effective </font><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></font>, <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> (the &#147;<i>Effective Date</i>&#148;) by and between <b>TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</b>, a Delaware corporation (the &#147;<i>Company</i>&#148;), and <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>, a resident of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(&#147;<i>Executive</i>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BACKGROUND</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company and Executive have been parties to an Employment Agreement, dated <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> (the &#147;<i>Prior Agreement</i>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company desires to employ Executive on the terms and conditions set forth in this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">C.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Executive desires to be employed by the Company on the terms and conditions set forth in this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">D.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Agreement shall govern the employment relationship between the Executive and the Company from and after the Effective Date hereof, and supersedes and negates any previous agreements or understandings, whether written or oral, with respect to such relationship, including without limitation the Prior Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">AGREEMENT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In consideration of the foregoing premises and the respective agreements of the Company and Executive set forth below, the Company and Executive, intending to be legally bound, agree as follows:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>EMPLOYMENT</u>. The term of Executive&#146;s employment under this Agreement shall commence as of the Effective Date and continue until terminated in accordance with Section&nbsp;10 hereof (the &#147;<i>Term</i>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>POSITION AND DUTIES</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Position with the Company</u>.&#160; During the Term, Executive will serve as the Company&#146;s <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> and will perform such duties and responsibilities as the Company&#146;s Chief Executive Officer will assign to Executive from time to time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Performance of Duties and Responsibilities</u>.&#160; Executive will serve the Company faithfully and to the best of Executive&#146;s ability and will devote Executive&#146;s full time, attention and efforts to the business of the Company during Executive&#146;s employment with the Company.&#160; Executive will report to the Company&#146;s Chief Executive Officer.&#160; During Executive&#146;s employment hereunder, Executive will not accept other employment or engage in other material business activity, except as approved in writing by the Company&#146;s Board of Directors (the &#147;<i>Board</i>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="14",CHK=100350,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NI-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 08:05 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>COMPENSATION</u>.&#160; While Executive is employed by the Company during the Term, and in exchange for Executive fulfilling Executive&#146;s duties and responsibilities as set forth in this Agreement, the Company will provide Executive the compensation and benefits set forth in this Section&nbsp;3.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Base Salary</u>.&#160; The Company will pay to Executive an annual base salary of <b>$</b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>, less deductions and withholdings, which base salary will be paid in accordance with the Company&#146;s normal payroll policies and procedures.&#160; During each year after the first year of Executive&#146;s employment hereunder, the Compensation Committee of the Board (the &#147;<i>Committee</i>&#148;) may review and increase Executive&#146;s base salary in its sole discretion.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Bonus.</u>&#160; For each calendar year Executive is employed by the Company, Executive shall be eligible for an annual target bonus in an amount of <u>&nbsp;&nbsp;&nbsp;</u><b>%</b> of Executive&#146;s base salary earned during such calendar year, based upon and subject to criteria set by the Committee from time to time.&#160; In order to earn and receive payment of an annual bonus, Executive must be an employee of the Company on the date the bonus is paid by the Company, provided, however, that if Executive&#146;s employment is terminated by the Company other than for Cause (as herein defined) or by Executive for Good Reason (as herein defined) and the Termination Date (as defined herein) is after the completion of a calendar year but before the annual bonus for such calendar year has been paid to Executive, then Executive will earn and receive payment of an annual bonus for such prior calendar year in accordance with the bonus plan in effect for such year. In any case, any annual bonus earned under this Section&nbsp;3(b)&nbsp;will be paid not later than March&nbsp;15 immediately following the calendar year to which the bonus relates.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Equity Awards</u>.&#160; During the Term, Executive shall be eligible to receive one or more equity-based incentive awards at the discretion of the Committee.&#160; The terms of such awards, if any, shall be determined in the sole discretion of the Committee, including the types of awards, the number of securities covered by each award, the vesting conditions applicable to each award, and the manner in which awards are to be paid or settled.&#160; Nothing herein shall obligate the Company to make an equity award to Executive at any time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Employee Benefits</u>.&#160; Executive shall be entitled to participate in all employee benefit plans and programs of the Company to the extent that Executive meets the eligibility requirements for each individual plan or program.&#160; The Company provides no assurance as to the adoption or continuance of any particular employee benefit plan or program, and Executive&#146;s participation in any such plan or program will be subject to the provisions, rules&nbsp;and regulations applicable thereto.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Expenses</u>.&#160; The Company will reimburse Executive for all reasonable and necessary out-of-pocket business, travel and entertainment expenses incurred by Executive in the performance of the duties and responsibilities hereunder, subject to the Company&#146;s normal policies and procedures for expense verification and documentation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Paid Time Off</u>.&#160; Executive shall be entitled to paid time off (&#147;<i>PTO</i>&#148;) of <u>&nbsp;&nbsp;</u>&nbsp;days per year.&#160; PTO days shall be taken at such times so as not to disrupt the operations of the Company, as approved by the Company&#146;s Chief Executive Officer.&#160; Any accrued and unused</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="14",CHK=971482,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NI-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 08:05 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">PTO upon termination of employment will not be paid out pursuant to the Company&#146;s standard policies addressing PTO.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>AFFILIATED ENTITIES</u>.&#160; As used in this Agreement, &#147;<i>Affiliates</i>&#148; includes the Company and each corporation, partnership, or other entity which controls the Company, is controlled by the Company, <u>OR</u> is under common control with the Company (in each case &#147;<i>control</i>&#148; meaning the direct or indirect ownership of 50% or more of all outstanding equity interests).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>CONFIDENTIAL INFORMATION</u>.&#160; Except as permitted by the Company, Executive will not at any time divulge, furnish or make accessible to anyone or use in any way other than in the ordinary course of the business of the Company or its Affiliates, any confidential, proprietary or secret knowledge or information of the Company or its Affiliates that Executive has acquired or will acquire about the Company or its Affiliates, whether developed by Executive or by others, concerning (i)&nbsp;any trade secrets, (ii)&nbsp;any confidential, proprietary or secret designs, programs, processes, formulae, plans, devices or material (whether or not patented or patentable) directly or indirectly useful in any aspect of the business of the Company or of its Affiliates, (iii)&nbsp;any customer or supplier lists, (iv)&nbsp;any confidential, proprietary or secret development or research work, (v)&nbsp;any strategic or other business, marketing or sales plans, (vi)&nbsp;any financial data or plans, or (viii)&nbsp;any other confidential or proprietary information or secret aspects of the business of the Company or of its Affiliates.&#160; Executive acknowledges that the above-described knowledge and information constitutes a unique and valuable asset of the Company and represents a substantial investment of time and expense by the Company, and that any disclosure or other use of such knowledge or information other than for the sole benefit of the Company or its Affiliates would be wrongful and would cause irreparable harm to the Company.&#160; Executive will refrain from intentionally committing any acts that would materially reduce the value of such knowledge or information to the Company or its Affiliates.&#160; The foregoing obligations of confidentiality shall not apply to any knowledge or information that (i)&nbsp;is now or subsequently becomes generally publicly known, other than as a direct or indirect result of the breach of this Agreement, (ii)&nbsp;is independently made available to Executive in good faith by a third party who has not violated a confidential relationship with the Company or its Affiliates, or (iii)&nbsp;is required to be disclosed by law or legal process.&#160; Executive understands and agrees that Executive&#146;s obligations under this Agreement to maintain the confidentiality of the Company&#146;s confidential information are in addition to any obligations of Executive under applicable statutory or common law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>VENTURES</u>.&#160; If, during Executive&#146;s employment with the Company, Executive is engaged in or provides input into the planning or implementing of any project, program or venture involving the Company, all rights in such project, program or venture belong to the Company.&#160; Except as approved in writing by the Board, Executive will not be entitled to any interest in any such project, program or venture or to any commission, finder&#146;s fee or other compensation in connection therewith.&#160; Executive will have no interest, direct or indirect, in any customer or supplier that conducts business with the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>NONCOMPETITION AND NONSOLICITATION COVENANTS</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Agreement Not to Compete</u>.&#160; During the Restricted Period (defined below), Executive will not, directly or indirectly, engage in any business, in the United States or in any</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="14",CHK=22697,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NI-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 08:05 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">other location in which the Company is then doing business, for the development, sale, service, or distribution of medical devices to treat lymphedema patients or any other business that is competitive with the then-current businesses of the Company or its Affiliates, including without limitation as a proprietor, principal, agent, partner, officer, director, stockholder, employee, member of any association, consultant or otherwise.&#160; Ownership by Executive, as a passive investment, of less than 2.5% of the outstanding shares of capital stock of any corporation listed on a national securities exchange or publicly traded in the over-the-counter market shall not constitute a breach of this Section&nbsp;7(a).&#160; Notwithstanding the foregoing, Executive&#146;s direct or indirect engagement in a business whose sole purpose is the development, sale, service, or distribution of compression garments (but not pumps or other devices) to treat lymphedema patients or other patients shall not constitute a breach of this Section&nbsp;7(a).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Agreement Not to Solicit or Hire Employees or Contractors</u>. During Executive&#146;s employment with the Company or any Affiliates and for a period of twelve (12) consecutive months from and after the termination of Executive&#146;s employment, whether such termination is with or without cause, or whether such termination is at the instance of Executive or the Company, Executive will not, directly or indirectly, solicit, hire or engage any person who is then an employee or contractor of the Company or who was an employee of the Company at any time during the six (6)&nbsp;month period immediately preceding Executive&#146;s termination of employment, in any manner or capacity, including without limitation as a proprietor, principal, agent, partner, officer, director, stockholder, employee, member of any association, consultant or otherwise, or otherwise directly or indirectly request, advise or induce any then current employee or contractor of the Company to terminate or otherwise adversely change its relationship with the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Agreement Not to Solicit Others</u>. During Executive&#146;s employment with the Company or any Affiliates and for a period of twelve (12) consecutive months from and after the termination of Executive&#146;s employment, whether such termination is with or without cause, or whether such termination is at the instance of Executive or the Company, Executive will not, directly or indirectly, solicit, request, advise or induce any then current customer, supplier or other business contact of the Company to cancel, curtail or otherwise adversely change its relationship with the Company, in any manner or capacity, including without limitation as a proprietor, principal, agent, partner, officer, director, stockholder, employee, member of any association, consultant or otherwise.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Restricted Period</u>.&#160; For purposes of this Agreement &#147;<i>Restricted Period</i>&#148; is defined as follows.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If (x)&nbsp;Executive&#146;s employment is terminated by the Company without Cause (defined below) or by Executive for Good Reason (defined below), <i>and</i> (y)&nbsp;Executive signs a release of claims as provided for in Section&nbsp;11(g), then the Restricted Period shall be the period during Executive&#146;s employment with the Company or any Affiliates and for a period of <b><u style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</u> (&nbsp;&nbsp;)</b> consecutive months from and after the termination of Executive&#146;s employment; provided that the Company may in its sole discretion elect to extend the Restricted Period by an additional six (6)&nbsp;months by providing Executive at least thirty (30) days&#146; notice of such extension and the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="14",CHK=353357,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NI-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 08:05 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">payments and reimbursements provided for in Section&nbsp;11(a)(iii)&nbsp;of this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If Executive&#146;s employment is terminated by the Company or by Executive under any conditions other than as provided for in Section&nbsp;7(d)(i), then the Restricted Period shall be the period during Executive&#146;s employment with the Company or any Affiliates and for a period of twelve (12) consecutive months from and after the termination of Executive&#146;s employment.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Acknowledgment</u>.&#160; Executive hereby acknowledges that the provisions of this Section&nbsp;7 are reasonable and necessary to protect the legitimate interests of the Company and that any violation of this Section&nbsp;7 by Executive will cause substantial and irreparable harm to the Company to such an extent that monetary damages alone would be an inadequate remedy therefor.&#160; Executive represents and warrants that Executive is not subject to any other agreements prohibiting the performance of Executive&#146;s obligations under this Agreement, including any non-competition agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Blue Pencil Doctrine</u>.&#160; If the duration of, the scope of or any business activity covered by any provision of this Section&nbsp;7 is in excess of what is determined to be valid and enforceable under applicable law, such provision will be construed to cover only that duration, scope or activity that is determined to be valid and enforceable.&#160; Executive hereby acknowledges that this Section&nbsp;7 will be given the construction which renders its provisions valid and enforceable to the maximum extent, not exceeding its express terms, possible under applicable law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>PATENTS, COPYRIGHTS AND RELATED MATTERS</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Disclosure and Assignment</u>.&#160; Executive must immediately disclose to the Company any and all improvements and inventions that Executive may conceive and/or reduce to practice individually or jointly or commonly with others while Executive is employed with the Company or any of its Affiliates with respect to (i)&nbsp;any methods, processes or apparatus concerned with the development, use or production of any type of products, goods or services sold or used by the Company or its Affiliates, and (ii)&nbsp;any type of products, goods or services sold or used by the Company or its Affiliates.&#160; Any such improvements and inventions will be the sole and exclusive property of the Company and Executive hereby immediately assigns, transfers and sets over to the Company Executive&#146;s entire right, title and interest in and to any and all of such improvement and inventions as are specified in this Section&nbsp;8(a), and in and to any and all applications for letters patent that may be filed on such inventions, and in and to any and all letters patent that may issue, or be issued, upon such applications.&#160; In connection therewith and for no additional compensation therefor, but at no expense to Executive, Executive will sign any and all instruments deemed necessary by the Company for:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the filing and prosecution of any applications for letters patent of the United States or of any foreign country that the Company may desire to file upon such inventions as are specified in this Section&nbsp;8(a);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="14",CHK=775556,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NI-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 08:05 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the filing and prosecution of any divisional, continuation, continuation-in-part or reissue applications that the Company may desire to file upon such applications for letters patent; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the reviving, re-examining or renewing of any of such applications for letters patent.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Section&nbsp;8(a)&nbsp;will not apply to any invention for which no equipment, supplies, facilities, confidential, proprietary or secret knowledge or information, or other trade secret information of the Company was used and that was developed entirely on Executive&#146;s own time, and (i)&nbsp;that does not relate (A)&nbsp;directly to the business of the Company, or (B)&nbsp;to the Company&#146;s actual or demonstrably anticipated research or development, or (ii)&nbsp;that does not result from any work performed by Executive for the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Copyrightable Material</u>.&#160; All right, title and interest in all copyrightable material that Executive shall conceive or originate individually or jointly or commonly with others, and that arise in connection with Executive&#146;s services hereunder or knowledge of confidential and proprietary information of the Company, will be the property of the Company and are hereby assigned by Executive to the Company of its Affiliates, along with ownership of any and all copyrights in the copyrightable material. Where applicable, works of authorship created by Executive relating to the Company or its Affiliates and arising out of Executive&#146;s knowledge of confidential and proprietary information of the Company shall be considered &#147;works made for hire,&#148; as defined in the U.S. Copyright Act, as amended.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Remedies</u>.<font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive acknowledges that it would be difficult to fully compensate the Company for monetary damages resulting from any breach by Executive of this Section&nbsp;8.&#160; Accordingly, in the event of any actual or threatened breach of any such provisions, the Company will, in addition to any other remedies it may have, be entitled to injunctive and other equitable relief to enforce such provisions, and such relief may be granted without the necessity of proving actual monetary damages.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>RETURN OF RECORDS AND PROPERTY</u>.&#160; Upon termination of Executive&#146;s employment or at any time upon the Company&#146;s request, Executive will promptly deliver to the Company any and all Company and Affiliate records and any and all Company and Affiliate property in Executive&#146;s possession or under Executive&#146;s control, including without limitation manuals, books, blank forms, documents, letters, memoranda, notes, notebooks, reports, printouts, computer disks, computer tapes, source codes, data, tables or calculations and all copies thereof, documents that in whole or in part contain any trade secrets or confidential, proprietary or other secret information of the Company or its Affiliates and all copies thereof, and keys, access cards, access codes, passwords, credit cards, personal computers, telephones and other electronic equipment belonging to the Company or its Affiliates.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>TERMINATION OF EMPLOYMENT</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s employment with the Company will terminate immediately upon:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="14",CHK=975340,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NI-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 08:05 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s receipt of written notice from the Company of the termination of Executive&#146;s employment, effective as of the date indicated in such notice;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the Company&#146;s receipt of Executive&#146;s written resignation from the Company, effective as of the date indicated in such resignation;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s Disability (as defined below); or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s death.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The date upon which Executive&#146;s termination of employment with the Company occurs is the &#147;<i>Termination Date</i>.&#148; For purposes of Section&nbsp;11(a)&nbsp;of this Agreement only, the Termination Date shall mean the date on which a &#147;separation from service&#148; has occurred for purposes of Section&nbsp;409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance thereunder (the &#147;<i>Code</i>.&#148;)</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Immediately upon termination of Executive&#146;s employment with the Company for any reason, Executive shall resign all positions then held as an Executive of the Company and any Affiliates of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Following termination of Executive&#146;s employment with the Company for any reason, Executive shall cooperate with the Company in the transition of Executive&#146;s duties and responsibilities hereunder to the extent reasonably requested by the Board; provided that Executive will be fairly compensated to the extent such cooperation requires more than an incidental amount of time and effort on Executive&#146;s part, and further that Executive will not be required to incur any out-of-pocket expenses in doing so.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>PAYMENTS UPON TERMINATION OF EMPLOYMENT</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Subject to Section&nbsp;11(g)&nbsp;of this Agreement, if Executive&#146;s employment with the Company is terminated by the Company without Cause or by Executive for Good Reason, then, in addition to paying Executive&#146;s earned and accrued base salary, accrued but unpaid expense reimbursements and benefits through the Termination Date, the Company will provide to Executive the following payments:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Separation Pay</u>.&#160; The Company will pay to Executive an amount equal to Executive&#146;s then current base salary for a period of <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><b> (</b><u>&nbsp;&nbsp;</u><b>)</b> months plus an amount equal to <u>&nbsp;&nbsp;&nbsp;</u><b>%</b> of Executive&#146;s then current target bonus, with such sum, less applicable withholdings, payable in equal installments in accordance with the Company&#146;s regular payroll schedule commencing with the first normal payroll date of the Company following the Termination Date and continuing for <b><u style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> (</b><u>&nbsp;&nbsp;</u><b>)</b> months thereafter, provided that any installments that would have been paid during the sixty (60) day period immediately following the Termination Date shall be held by the Company until the first payroll date occurring more than sixty (60) days after the Termination Date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="14",CHK=813158,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NI-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 08:05 2016' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Value of Accrued and Unused PTO</u>.&#160; The Company will pay to Executive the value of Executive&#146;s accrued and unused PTO as of the Termination Date (based on Executive&#146;s base salary as of the Termination Date), less applicable withholdings, payable in a lump sum on the Company&#146;s first payroll date occurring more than sixty (60) days after the Termination Date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Continued Benefits</u>. If Executive is eligible for and takes all steps necessary to continue Executive&#146;s group health insurance coverage with the Company following the Termination Date, the Company will pay for the portion of the premium costs for such coverage that the Company would pay if Executive remained employed by the Company, at the same level of coverage that was in effect as of the Termination Date, for a period of <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><b> (</b><u>&nbsp;&nbsp;</u><b>) </b>consecutive months after the Termination Date (or until Executive receives group health or dental coverage from another employer, if earlier).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Restricted Period Extension Payments</u>.&#160; If the Company elects to extend the Restricted Period for six (6)&nbsp;additional months as provided for in Section&nbsp;7(d)(i), then the Company will (A)&nbsp;pay to Executive an amount equal to the monthly amount payable to Executive under Section&nbsp;11(a)(i), with such additional amounts payable to Executive in installments in accordance with the Company&#146;s regular payroll schedule commencing on the first normal payroll date of the Company following the nine (9)&nbsp;month anniversary of the Termination Date and continuing for six (6)&nbsp;months thereafter, and (B)&nbsp;extend for six (6)&nbsp;additional months (after the end of the nine (9)&nbsp;month period identified in Section&nbsp;11(a)(iii)) the period during which it will pay a portion of the premium costs for group health insurance coverage as provided in, and subject to the same conditions of, Section&nbsp;11(a)(iii).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Accelerated Vesting of Equity</u>.&#160; In addition to the payments identified above in Sections 11(a)(i)-(iv), if Executive&#146;s employment with the Company is terminated by the Company without Cause or by Executive for Good Reason, then, subject to Section&nbsp;11(g)&nbsp;of this Agreement and notwithstanding any language in any equity plan or applicable equity award agreement to the contrary, upon the expiration of the all rescission periods provided by law with respect to the release of claims described in Section&nbsp;11(g), any equity awards issued to Executive that have any portion of such award unvested as of the Termination Date (each an &#147;<i>Award</i>&#148;) will vest as to the number of shares, options or other securities (the &#147;<i>Securities</i>&#148;) &nbsp;calculated as follows (rounded up to the nearest whole share):</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Additional Securities Vested = (Number of Securities Issued Under Award x ((Number of Days between Date of Grant of Award and Termination Date) / (Number of Days between Date of Grant of Award and Final</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="14",CHK=101316,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NI-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:44 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vesting Date of Award))) &#151; Number of Securities Vested Under Award as of the Termination Date.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; If Executive&#146;s employment with the Company is terminated for any of the following reasons:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s abandonment of Executive&#146;s employment or Executive&#146;s resignation for any reason other than Good Reason;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>termination of Executive&#146;s employment by the Company for Cause; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Executive&#146;s death or Disability.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">then the Company will pay Executive or Executive&#146;s estate, as the case may be, Executive&#146;s earned and accrued base salary, accrued but unpaid expense reimbursements and benefits through the Termination Date.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#147;<i>Cause</i>&#148; hereunder means:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>an act or acts of dishonesty undertaken by Executive and intended to result in personal gain or enrichment of Executive or others at the expense of the Company;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>unlawful conduct or gross misconduct by Executive that, in either event, is injurious to the Company;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the conviction of Executive of a felony; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>material breach of any terms or conditions of this Agreement by Executive which breach has not been cured by Executive within 15 days after written notice thereof to Executive from the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For the purposes of Sections 11(c)(ii)&nbsp;and (iv), no act or failure to act on Executive&#146;s part shall be considered &#147;Cause&#148; if done by Executive pursuant to specific authorization evidenced by a resolution duly adopted by the Board or pursuant to specific advice given by counsel for the Company, unless such specific authorization or advice results in whole or in part from material misrepresentations or omissions of Executive.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#147;<i>Disability</i>&#148; hereunder means the inability of Executive to perform on a full-time basis the duties and responsibilities of Executive&#146;s employment with the Company by reason of Executive&#146;s illness or other physical or mental impairment or condition, if such inability continues for an uninterrupted period of 90 days or more during any 180-day period.&#160; A period of inability is &#147;uninterrupted&#148; unless and until Executive returns to full-time work for a continuous period of at least 30 days.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#147;<i>Good Reason</i>&#148; hereunder means the occurrence of any of the following events without Executive&#146;s consent:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=9,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="14",CHK=511574,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NI-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:44 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the assignment of Executive to a position with responsibilities or duties of a materially lesser status or degree than the position specified in Section&nbsp;2(a);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>material breach of any terms or conditions of this Agreement by the Company not caused by Executive;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the requirement by the Company that Executive relocate out of the Minneapolis/St. Paul Metropolitan area.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For the purposes of Section&nbsp;11(e), &#147;Good Reason&#148; shall not exist unless Executive has first provided written notice to the Company of the occurrence of one or more of the conditions under clauses (i)&nbsp;through (iii)&nbsp;above within ninety (90) days of the condition&#146;s initial occurrence,&#160; such condition is not fully remedied by the Company within thirty (30) days after the Company&#146;s receipt of written notice from Executive, and the Termination Date occurs no later than one hundred and thirty (130) days after the condition&#146;s initial occurrence.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; In the event of termination of Executive&#146;s employment, the sole obligation of the Company to pay post-termination severance and benefits under this Agreement will be its obligation to make the payments called for by Sections 11(a)&nbsp;or 11(b)&nbsp;hereof, as the case may be, and the Company will have no other obligation to Executive, except as otherwise provided by law, under the terms of any other applicable agreement between Executive and the Company or under the terms of any employee benefit plans or programs then maintained by the Company in which Executive participates.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Notwithstanding the foregoing provisions of this Section&nbsp;11, the Company will not be obligated to make any payments under Section&nbsp;11(a)&nbsp;hereof unless Executive has signed a release of claims in favor of the Company and its Affiliates in a form to be prescribed by the Company, all applicable consideration and rescission periods provided by law shall have expired, and Executive is in strict compliance with the terms of this Agreement as of the dates of such payments.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>MISCELLANEOUS</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Governing Law</u>.&#160; All matters relating to the interpretation, construction, application, validity and enforcement of this Agreement will be governed by the laws of the State of Minnesota without giving effect to any choice or conflict of law provision or rule, whether of the State of Minnesota or any other jurisdiction, that would cause the application of laws of any jurisdiction other than the State of Minnesota.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Jurisdiction and Venue</u>.&#160; Executive and the Company consent to jurisdiction of the courts of the State of Minnesota and/or the federal courts, District of Minnesota, for the purpose of resolving all issues of law, equity, or fact, arising out of or in connection with this Agreement.&#160; Any action involving claims of a breach of this Agreement must be brought in such courts.&#160; Each party consents to personal jurisdiction over such party in the state and/or federal courts of Minnesota and hereby waives any defense of lack of personal jurisdiction.&#160; Venue, for the purpose of all such suits, will be in Hennepin County, State of Minnesota.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=10,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="14",CHK=224316,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NI-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:44 2016' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Entire Agreement</u>.&#160; This Agreement contains the entire agreement of the parties relating to Executive&#146;s employment with the Company and supersedes all prior agreements and understandings with respect to such subject matter, including without limitation the Prior Agreement, and the parties hereto have made no agreements, representations or warranties relating to the subject matter of this Agreement that are not set forth herein; provided, however, that nothing in this Agreement is intended to supersede, replace or modify the terms of the Company&#146;s 2016 Equity Incentive Plan or any equity award agreements issued to Executive under the Company&#146;s 2016 Equity Incentive Plan, each of which shall remain in full force and effect in accordance with their terms.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Code Section&nbsp;409A</u>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; This Agreement is intended to be exempt from or comply with the requirements of Section&nbsp;409A(a)(2), (3)&nbsp;and (4)&nbsp;of the Code, including current and future guidance and regulations interpreting such provisions, and should be interpreted accordingly.&#160;&#160; To the extent such potential payments or benefits could become subject to additional tax under such Code Section&nbsp;409A, the parties shall cooperate to amend this Agreement with the goal of giving Executive the economic benefits described herein in a manner that does not result in such tax being imposed.&#160; Each payment or benefit made pursuant to Section&nbsp;11(a)&nbsp;of this Agreement shall be deemed to be a separate payment for purposes of Code Section&nbsp;409A.&#160; In addition, payments or benefits pursuant to Section&nbsp;11(a)&nbsp;shall be exempt from the requirements of Code Section&nbsp;409A to the maximum extent possible as &#147;short-term deferrals&#148; pursuant to Treasury Regulation Section&nbsp;1.409A-1(b)(4), as involuntary separation pay pursuant to Treasury Regulation Section&nbsp;1.409A-1(b)(9)(iii), and/or under any other exemption that may be applicable, and this Agreement shall be construed accordingly.&#160; To the extent that any amounts payable under this Agreement are required to be delayed under Code Section&nbsp;409A, such amounts are intended to be and should be considered for purposes of Code Section&nbsp;409A as separate payments from the amounts that are not required to be delayed.&#160; Notwithstanding anything herein to the contrary, if Executive is considered a &#147;specified employee&#148; (as defined in Treasury Regulation Section&nbsp;1.409A-1(i)) as of the Termination Date, then no payments of deferred compensation subject to Code Section&nbsp;409A and payable due to Executive&#146;s separation from service shall be made under this Agreement before the first business day that is six (6)&nbsp;months after the Termination Date (or upon Executive&#146;s death, if earlier) (the &#147;<i>Specified Period</i>&#148;).&#160; Any deferred compensation payments that would otherwise be required to be made to Executive during the Specified Period will be accumulated by the Company and paid to Executive on the first day after the end of the Specified Period.&#160; The foregoing restriction on the payment of amounts to Executive during the Specified Period will not apply to the payment of employment taxes.&#160; In the event that the interpretation or requirements of Code Section&nbsp;409A change during the Term, the parties agree to amend this Agreement, only as necessary, to comply with any such change, if and to the extent such an amendment is permitted by Code Section&nbsp;409A.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Code Section&nbsp;280G</u>.&#160; Notwithstanding anything in this Agreement to the contrary, if any payment or other benefit hereunder, together with any other payments or benefits that Executive has the right to receive from the Company or any corporation which is a member of an &#147;affiliated group&#148; (as defined in Section&nbsp;1504(a)&nbsp;of the Code without regard to Section&nbsp;1504(b)&nbsp;of the Code) of which the Company is a member, would constitute a &#147;parachute payment&#148; (as defined in Section&nbsp;280G(b)(2)&nbsp;of the Code), then, such payments and benefits will be reduced to</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=11,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="14",CHK=716351,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NI-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:44 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">the largest amount as, in the sole judgment of the Company, will result in no portion of such payments or benefits being subject to the excise tax imposed by Section&nbsp;4999 of the Code.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Amendments</u>.&#160; No amendment or modification of this Agreement will be deemed effective unless made in writing and signed by the parties hereto.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Waiver</u>.&#160; No term or condition of this Agreement will be deemed to have been waived, except by a statement in writing signed by the party against whom enforcement of the waiver is sought.&#160; Any written waiver will not be deemed a continuing waiver unless specifically stated, will operate only as to the specific term or condition waived and will not constitute a waiver of such term or condition for the future or as to any act other than that specifically waived.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Assignment</u>.&#160; This Agreement will not be assignable, in whole or in part, by either party without the prior written consent of the other party, except that the Company may, without the consent of Executive, assign its rights and obligations under this Agreement (1)&nbsp;to an Affiliate or (2)&nbsp;to any corporation or other person or business entity to which the Company may sell or transfer all or substantially all of its assets; </font>provided, however, that the Company&#146;s&#160; assignment of rights may only take place if the assignee accepts and agrees to all of the obligations to Executive&#160; under this Agreement.&#160; &#160;After any such assignment by the Company, the Company will be discharged from all further liability hereunder and such assignee will thereafter be deemed to be &#147;the Company&#148; for purposes of all terms and conditions of this Agreement, including this Section&nbsp;12. For the avoidance of doubt, in the event of Executive&#146;s death, all payments and obligations to Executive shall be paid to Executive&#146;s estate.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Counterparts</u>.&#160; This Agreement may be executed by facsimile signature and in any number of counterparts, and such counterparts executed and delivered, each as an original, will constitute but one and the same instrument.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Severability</u>.&#160; Subject to Section&nbsp;7(f)&nbsp;hereof, to the extent that any portion of any provision of this Agreement is held invalid or unenforceable, it will be considered deleted herefrom and the remainder of such provision and of this Agreement will be unaffected and will continue in full force and effect.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Captions and Headings</u>.&#160; The captions and paragraph headings used in this Agreement are for convenience of reference only and will not affect the construction or interpretation of this Agreement or any of the provisions hereof.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=12,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="14",CHK=444616,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NI-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:44 2016' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Executive and the Company have executed this Agreement effective as of the Effective Date set forth in the first paragraph.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE   SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Its:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">[NAME]</font></b></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=13,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="14",CHK=419036,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NI-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:44 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.21
<SEQUENCE>15
<FILENAME>a2228882zex-10_21.htm
<DESCRIPTION>EX-10.21
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>

<div>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 10.21</font></b></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="103%" style="border-collapse:collapse;width:103.46%;">
 <tr style="page-break-inside:avoid;">
  <td width="96%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:96.62%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" color="white" face="Times New Roman" style="color:white;"><img width="720" height="931" src="g160222nk01i001.gif" alt="GRAPHIC"></font></p>
  </td>
  <td width="3%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:3.38%;">
  <p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">*002800000014248*
  CORPORATE RESOLUTION TO BORROW / GRANT COLLATERAL Principal $2,000,000.00
  Loan Date 05-11-2016 Maturity 05-11-2017 Loan No 14248 Call / Coll 5200
  Account 102727-1 Officer 120 Initials References in the boxes above are for
  Lender's use only and do not limit the applicability of this document to any
  particular loan or item. Any item above containing &quot;'&quot; has been
  omitted due to text length limitations. Lender: Venture Bank Corporation:
  Tactile Systems Technology, Inc. Bloomington Office 1331 Tyler Street
  Northeast, Suite 200 4470 W. 78th Street Circle, Suite #100 Minneapolis, MN
  55413 Bloomington, MN 55435 I, THE UNDERSIGNED, DO HEREBY CERTIFY THAT: THE
  CORPORATION'S EXISTENCE. The complete and correct name of the Corporation is
  Tactile Systems Technology, Inc. (&quot;Corporation&quot;). The Corporation
  is a corporation for profit which is, and at all times shall be, duly
  organized, validly existing, and in good standing under and by virtue of the
  laws of the State of Delaware. The Corporation is duly authorized to transact
  business in the State of Minnesota and all other states in which the
  Corporation is doing business, having obtained all necessary filings,
  governmental licenses and approvals for each state in which the Corporation
  is doing business. Specifically, the Corporation is, and at all times shall
  be, duly qualified as a foreign corporation in all states in which the
  failure to so qualify would have a material adverse effect on its business or
  financial condition. The Corporation has the full power and authority to own
  its properties and to transact the business in which it is presently engaged
  or presently proposes to engage. The Corporation maintains an office at 1331
  Tyler Street Northeast, Suite 200, Minneapolis, MN 55413. Unless the
  Corporation has designated otherwise in writing, the principal office is the
  office at which the Corporation keeps its books and records. The Corporation
  will notify Lender prior to any change in the location of the Corporation's
  state of organization or any change in the Corporation's name. The
  Corporation shall do all things necessary to preserve and to keep in full
  force and effect its existence, rights and privileges, and shall comply with
  all regulations, rules, ordinances, statutes, orders and decrees of any
  governmental or quasi-governmental authority or court applicable to the
  Corporation and the Corporation's business activities. RESOLUTIONS ADOPTED.
  At a meeting of the Directors of the Corporation, or if the Corporation is a
  close corporation having no Board of Directors then at a meeting of the
  Corporation's shareholders, duly called and held on May 11, 2016, at which a
  quorum was present and voting, or by other duly authorized action in lieu of
  a meeting, the resolutions set forth in this Resolution were adopted.
  OFFICER. The following named person is an officer of Tactile Systems
  Technology, Inc.: NAMES TITLES AUTHORIZED ACTUAL SIGNATURES Robert Folkes COO
  Y X (Seal) ACTIONS AUTHORIZED. The authorized person listed above may enter
  into any agreements of any nature with Lender, and those agreements will bind
  the Corporation. Specifically, but without limitation, the authorized person
  is authorized, empowered, and directed to do the following for and on behalf
  of the Corporation: Borrow Money. To borrow, as a cosigner or otherwise, from
  time to time from Lender, on such terms as may be agreed upon between the
  Corporation and Lender, such sum or sums of money as in his or her judgment
  should be borrowed, without limitation. Execute Notes. To execute and deliver
  to Lender the promissory note or notes, or other evidence of the
  Corporation's credit accommodations, on Lender's forms, at such rates of
  interest and on such terms as may be agreed upon, evidencing the sums of
  money so borrowed or any of the Corporation's indebtedness to Lender, and
  also to execute and deliver to Lender one or more renewals, extensions,
  modifications, refinancings, consolidations, or substitutions for one or more
  of the notes, any portion of the notes, or any other evidence of credit
  accommodations. Grant Security. To mortgage, pledge, transfer, endorse,
  hypothecate, or otherwise encumber and deliver to Lender any property now or
  hereafter belonging to the Corporation or in which the Corporation now or
  hereafter may have an interest, including without limitation all of the
  Corporation's real property and all of the Corporation's personal property
  (tangible or intangible), as security for the payment of any loans or credit
  accommodations so obtained, any promissory notes so executed (including any
  amendments to or modifications, renewals, and extensions of such promissory
  notes), or any other or further indebtedness of the Corporation to Lender at
  any time owing, however the same may be evidenced. Such property may be
  mortgaged, pledged, transferred, endorsed, hypothecated or encumbered at the
  time such loans are obtained or such indebtedness is incurred, or at any
  other time or times, and may be either in addition to or in lieu of any
  property theretofore mortgaged, pledged, transferred, endorsed, hypothecated
  or encumbered. Execute Security Documents. To execute and deliver to Lender
  the forms of mortgage, deed of trust, pledge agreement, hypothecation agreement,
  and other security agreements and financing statements which Lender may
  require and which shall evidence the terms and conditions under and pursuant
  to which such liens and encumbrances, or any of them, are given; and also to
  execute and deliver to Lender any other written instruments, any chattel
  paper, or any other collateral, of any kind or nature, which Lender may deem
  necessary or proper in connection with or pertaining to the giving of the
  liens and encumbrances. Negotiate Items. To draw, endorse, and discount with
  Lender all drafts, trade acceptances, promissory notes, or other evidences of
  indebtedness payable to or belonging to the Corporation or in which the
  Corporation may have an interest, and either to receive cash for the same or
  to cause such proceeds to be credited to the Corporation's account with
  Lender, or to cause such other disposition of the proceeds derived therefrom
  as he or she may deem advisable. Further Acts. In the case of lines of
  credit, to designate additional or alternate individuals as being authorized
  to request advances under such lines, and in all cases, to do and perform
  such other acts and things, to pay any and all fees and costs, and to execute
  and deliver such other documents and agreements as the officer may in his or
  her discretion deem reasonably necessary or proper in order to carry into
  effect the provisions of this Resolution.</font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

</div>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="15",CHK=462553,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NK-01_ZBY12202.CHC",USER="DBEMBEN",CD='May  7 01:29 2016' -->


<br clear="all" style="page-break-before:always;">


<div>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="92%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" color="white" face="Times New Roman" style="color:white;"><img width="720" height="931" src="g160222nk01i002.gif" alt="GRAPHIC"></font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:4.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">CORPORATE
  RESOLUTION TO BORROW / GRANT COLLATERAL Loan No: 14248 (Continued) Page 2
  ASSUMED BUSINESS NAMES. The Corporation has filed or recorded all documents
  or filings required by law relating to all assumed business names used by the
  Corporation. Excluding the name of the Corporation, the following is a
  complete list of all assumed business names under which the Corporation does
  business: Assumed Business Name Filing Location Date Tactile Systems MN
  Secretary of State 01-30-1995 NOTICES TO LENDER. The Corporation will
  promptly notify Lender in writing at Lender's address shown above (or such
  other addresses as Lender may designate from time to time) prior to any (A)
  change in the Corporation's name; (B) change in the Corporation's assumed
  business name(s); (C) change in the management of the Corporation; (D) change
  in the authorized signer(s); (E) change in the Corporation's principal office
  address; (F) change in the Corporation's state of organization; (G)
  conversion of the Corporation to a new or different type of business entity;
  or (H) change in any other aspect of the Corporation that directly or
  indirectly relates to any agreements between the Corporation and Lender. No
  change in the Corporation's name or state of organization will take effect
  until after Lender has received notice. CERTIFICATION CONCERNING OFFICERS AND
  RESOLUTIONS. The officer named above is duly elected, appointed, or employed
  by or for the Corporation, as the case may be, and occupies the position set
  opposite his or her respective name. This Resolution now stands of record on
  the books of the Corporation, is in full force and effect, and has not been
  modified or revoked in any manner whatsoever. NO CORPORATE SEAL. The
  Corporation has no corporate seal, and therefore, no seal is affixed to this
  Resolution. CONTINUING VALIDITY. Any and all acts authorized pursuant to this
  Resolution and performed prior to the passage of this Resolution are hereby
  ratified and approved. This Resolution shall be continuing, shall remain in
  full force and effect and Lender may rely on it until written notice of its
  revocation shall have been delivered to and received by Lender at Lender's
  address shown above (or such addresses as Lender may designate from time to
  time). Any such notice shall not affect any of the Corporation's agreements
  or commitments in effect at the time notice is given. IN TESTIMONY WHEREOF, I
  have hereunto set my hand and attest that the signature set opposite the name
  listed above is his or her genuine signature. I have read all the provisions
  of this Resolution, and I personally and on behalf of the Corporation certify
  that all statements and representations made in this Resolution are true and
  correct. This Corporate Resolution to Borrow / Grant Collateral is dated May
  11, 2016. THIS RESOLUTION IS DELIVERED UNDER SEAL AND IT IS INTENDED THAT THIS
  RESOLUTION IS AND SHALL CONSTITUTE AND HAVE THE EFFECT OF A SEALED INSTRUMENT
  ACCORDING TO LAW. CERTIFIED TO AND ATTESTED BY: X Robert Folkes, COO of
  Tactile Systems Technology, Inc. (Seal) NOTE: If the officer signing this
  Resolution is designated by the foregoing document as one of the officers
  authorized to act on the Corporation's behalf, it is advisable to have this
  Resolution signed by at least one non-authorized officer of the Corporation.
  LaserPro, Ver. 16.1.10.003 Cop, D+H USA Corporation 1997, 2016. All Rights
  Reserved. - DE/MN C:\APPS\CFI\CFI\LPL\C10.FC TR-7313 PR-72 </font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

</div>
<!-- ZEQ.=1,SEQ=2,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="15",CHK=966020,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NK-01_ZBY12202.CHC",USER="DBEMBEN",CD='May  7 01:29 2016' -->



<div>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="92%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" color="white" face="Times New Roman" style="color:white;"><img width="720" height="931" src="g160222nk03i001.gif" alt="GRAPHIC"></font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:4.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">*09600000014248*
  CHANGE IN TERMS AGREEMENT Principal $2,000,000.00 Loan Date 05-11-2016
  Maturity 05-11-2017 Loan No 14248 Call / Coll 5200 Account 102727-1 Officer
  120 Initials References in the boxes above are for Lender's use only and do
  not limit the applicability of this document to any particular loan or item.
  Any item above containing &quot;m&quot; has been omitted due to text length
  limitations. Borrower: Tactile Systems Technology, Inc. 1331 Tyler Street
  Northeast, Suite 200 Minneapolis, MN 55413 Lender: Venture Bank Bloomington
  Office 4470 W. 78th Street Circle, Suite #100 Bloomington, MN 55435 Principal
  Amount: $2,000,000.00 Date of Agreement: May 11, 2016 DESCRIPTION OF EXISTING
  INDEBTEDNESS. Promissory Note #14248 dated 5/11/2014 in the original amount
  of $2,000,000.00 from Borrower to Lender. DESCRIPTION OF COLLATERAL. All
  Business Assets per Commercial Security Agreement dated 5/11/2014.
  DESCRIPTION OF CHANGE IN TERMS. Extend maturity date to 5/11/2017. PROMISE TO
  PAY. Tactile Systems Technology, Inc. (&quot;Borrower&quot;) promises to pay
  to Venture Bank (&quot;Lender&quot;), or order, in lawful money of the United
  States of America, the principal amount of Two Million &amp; 00/100 Dollars
  ($2,000,000.00) or so much as may be outstanding, together with interest on
  the unpaid outstanding principal balance of each advance. Interest shall be
  calculated from the date of each advance until repayment of each advance.
  PAYMENT. Borrower will pay this loan in one payment of all outstanding
  principal plus all accrued unpaid interest on May 11, 2017. In addition,
  Borrower will pay regular monthly payments of all accrued unpaid interest due
  as of each payment date, beginning June 11, 2016, with all subsequent
  interest payments to be due on the same day of each month after that. Unless
  otherwise agreed or required by applicable law, payments will be applied
  first to any accrued unpaid interest; then to principal; then to any unpaid
  collection costs; and then to any late charges. Borrower will pay Lender at
  Lender's address shown above or at such other place as Lender may designate
  in writing. VARIABLE INTEREST RATE. The interest rate on this loan is subject
  to change from time to time based on changes in an independent index which is
  the Prime rate of interest as published each business day by the Wall Street
  Journal (the &quot;Index&quot;). The Index is not necessarily the lowest rate
  charged by Lender on its loans. If the Index becomes unavailable during the
  term of this loan, Lender may designate a substitute index after notifying
  Borrower. Lender will tell Borrower the current Index rate upon Borrower's
  request. The interest rate change will not occur more often than each day.
  Borrower understands that Lender may make loans based on other rates as well.
  The Index currently is 3.500% per annum. Interest on the unpaid principal
  balance of this loan will be calculated as described in the &quot;INTEREST
  CALCULATION METHOD&quot; paragraph using a rate equal to the Index, rounded
  to the nearest percent, adjusted if necessary for any minimum and maximum
  rate limitations described below, resulting in an initial rate of 3.500% per
  annum based on a year of 360 days. NOTICE: Under no circumstances will the
  interest rate on this loan be less than 3.250% per annum or more than the
  maximum rate allowed by applicable law. INTEREST CALCULATION METHOD. Interest
  on this loan is computed on a 365/360 basis; that is, by applying the ratio
  of the interest rate over a year of 360 days, multiplied by the outstanding
  principal balance, multiplied by the actual number of days the principal
  balance is outstanding. All interest payable under this loan is computed
  using this method. This calculation method results in a higher effective
  interest rate than the numeric interest rate stated in the loan documents.
  PREPAYMENT. Borrower agrees that all loan fees and other prepaid finance
  charges are earned fully as of the date of the loan and will not be subject
  to refund upon early payment (whether voluntary or as a result of default),
  except as otherwise required by law. Except for the foregoing, Borrower may
  pay without penalty all or a portion of the amount owed earlier than it is
  due. Early payments will not, unless agreed to by Lender in writing, relieve
  Borrower of Borrower's obligation to continue to make payments of accrued
  unpaid interest. Rather, early payments will reduce the principal balance
  due. Borrower agrees not to send Lender payments marked &quot;paid in
  full&quot;, &quot;without recourse&quot;, or similar language. If Borrower
  sends such a payment, Lender may accept it without losing any of Lender's
  rights under this Agreement, and Borrower will remain obligated to pay any
  further amount owed to Lender. All written communications concerning disputed
  amounts, including any check or other payment instrument that indicates that
  the payment constitutes &quot;payment in full&quot; of the amount owed or
  that is tendered with other conditions or limitations or as full satisfaction
  of a disputed amount must be mailed or delivered to: Venture Bank, P.O. Box
  9180 Minneapolis, MN 55480-9180. LATE CHARGE. If a payment is 10 days or more
  late, Borrower will be charged 5.000% of the unpaid portion of the regularly
  scheduled payment or $50.00, whichever is greater. INTEREST AFTER DEFAULT.
  Upon default, including failure to pay upon final maturity, the interest rate
  on this loan shall be increased by adding an additional 6.000 percentage
  point margin (&quot;Default Rate Margin&quot;). The Default Rate Margin shall
  also apply to each succeeding interest rate change that would have applied
  had there been no default. However, in no event will the interest rate exceed
  the maximum interest rate limitations under applicable law. DEFAULT. Each of
  the following shall constitute an Event of Default under this Agreement:
  Payment Default. Borrower fails to make any payment when due under the
  Indebtedness. Other Defaults. Borrower fails to comply with or to perform any
  other term, obligation, covenant or condition contained in this Agreement or
  in any of the Related Documents or to comply with or to perform any term,
  obligation, covenant or condition contained in any other agreement between
  Lender and Borrower. False Statements. Any warranty, representation or
  statement made or furnished to Lender by Borrower or on Borrower's behalf
  under this Agreement or the Related Documents is false or misleading in any
  material respect, either now or at the time made or furnished or becomes
  false or misleading at any time thereafter. Insolvency. The dissolution or
  termination of Borrower's existence as a going business, the insolvency of
  Borrower, the appointment of a receiver for any part of Borrower's property,
  any assignment for the benefit of creditors, any type of creditor workout, or
  the commencement of any proceeding under any bankruptcy or insolvency laws by
  or against Borrower.</font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

</div>
<!-- ZEQ.=1,SEQ=3,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="15",CHK=211660,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NK-03_ZBY12202.CHC",USER="DBEMBEN",CD='May  7 01:31 2016' -->


<br clear="all" style="page-break-before:always;">


<div>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="92%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" color="white" face="Times New Roman" style="color:white;"><img width="720" height="931" src="g160222nk03i002.gif" alt="GRAPHIC"></font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:4.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">CHANGE IN TERMS
  AGREEMENT Loan No: 14248 (Continued) Page 2 Creditor or Forfeiture
  Proceedings. Commencement of foreclosure or forfeiture proceedings, whether
  by judicial proceeding, self-help, repossession or any other method, by any
  creditor of Borrower or by any governmental agency against any collateral
  securing the Indebtedness. This includes a garnishment of any of Borrower's
  accounts, including deposit accounts, with Lender. However, this Event of
  Default shall not apply if there is a good faith dispute by Borrower as to
  the validity or reasonableness of the claim which is the basis of the
  creditor or forfeiture proceeding and if Borrower gives Lender written notice
  of the creditor or forfeiture proceeding and deposits with Lender monies or a
  surety bond for the creditor or forfeiture proceeding, in an amount
  determined by Lender, in its sole discretion, as being an adequate reserve or
  bond for the dispute. Events Affecting Guarantor. Any of the preceding events
  occurs with respect to any guarantor, endorser, surety, or accommodation
  party of any of the Indebtedness or any guarantor, endorser, surety, or
  accommodation party dies or becomes incompetent, or revokes or disputes the
  validity of, or liability under, any Guaranty of the Indebtedness evidenced
  by this Note. Change In Ownership. Any change in ownership of twenty-five
  percent (25%) or more of the common stock of Borrower. Adverse Change. A material
  adverse change occurs in Borrower's financial condition, or Lender believes
  the prospect of payment or performance of the Indebtedness is impaired.
  Insecurity. Lender in good faith believes itself insecure. Cure Provisions.
  If any default, other than a default in payment, is curable and if Borrower
  has not been given a notice of a breach of the same provision of this
  Agreement within the preceding twelve (12) months, it may be cured if
  Borrower, after Lender sends written notice to Borrower demanding cure of
  such default: (1) cures the default within fifteen (15) days; or (2) if the
  cure requires more than fifteen (15) days, immediately initiates steps which
  Lender deems in Lender's sole discretion to be sufficient to cure the default
  and thereafter continues and completes all reasonable and necessary steps
  sufficient to produce compliance as soon as reasonably practical. LENDER'S
  RIGHTS. Upon default, Lender may declare the entire unpaid principal balance
  under this Agreement and all accrued unpaid interest immediately due, and
  then Borrower will pay that amount. ATTORNEYS' FEES; EXPENSES. Lender may
  hire or pay someone else to help collect this Agreement if Borrower does not
  pay. Borrower will pay Lender that amount. This includes, subject to any limits
  under applicable law, Lender's reasonable attorneys' fees and Lender's legal
  expenses, whether or not there is a lawsuit, including reasonable attorneys'
  fees, expenses for bankruptcy proceedings (including efforts to modify or
  vacate any automatic stay or injunction), and appeals. If not prohibited by
  applicable law, Borrower also will pay any court costs, in addition to all
  other sums provided by law. GOVERNING LAW. This Agreement will be governed by
  federal law applicable to Lender and, to the extent not preempted by federal
  law, the laws of the State of Minnesota without regard to its conflicts of
  law provisions. This Agreement has been accepted by Lender in the State of
  Minnesota. DISHONORED ITEM FEE. Borrower will pay a fee to Lender of $32.00
  if Borrower makes a payment on Borrower's loan and the check or preauthorized
  charge with which Borrower pays is later dishonored. RIGHT OF SETOFF. To the
  extent permitted by applicable law, Lender reserves a right of setoff in all
  Borrower's accounts with Lender (whether checking, savings, or some other
  account). This includes all accounts Borrower holds jointly with someone else
  and all accounts Borrower may open in the future. However, this does not
  include any IRA or Keogh accounts, or any trust accounts for which setoff
  would be prohibited by law. Borrower authorizes Lender, to the extent
  permitted by applicable law, to charge or setoff all sums owing on the
  indebtedness against any and all such accounts, and, at Lender's option, to
  administratively freeze all such accounts to allow Lender to protect Lender's
  charge and setoff rights provided in this paragraph. COLLATERAL. Borrower
  acknowledges this Agreement is secured by All Business Assets per Commercial
  Security Agreement dated 5/11/2014. LINE OF CREDIT. This Agreement evidences
  a revolving line of credit. Advances under this Agreement, as well as
  directions for payment from Borrower's accounts, may be requested orally or
  in writing by Borrower or by an authorized person. Lender may, but need not,
  require that all oral requests be confirmed in writing. Borrower agrees to be
  liable for all sums either: (A) advanced in accordance with the instructions
  of an authorized person or (B) credited to any of Borrower's accounts with
  Lender. The unpaid principal balance owing on this Agreement at any time may
  be evidenced by endorsements on this Agreement or by Lender's internal
  records, including daily computer print-outs. Lender will have no obligation
  to advance funds under this Agreement if: (A) Borrower or any guarantor is in
  default under the terms of this Agreement or any agreement that Borrower or
  any guarantor has with Lender, including any agreement made in connection
  with the signing of this Agreement; (B) Borrower or any guarantor ceases
  doing business or is insolvent; (C) any guarantor seeks, claims or otherwise
  attempts to limit, modify or revoke such guarantor's guarantee of this
  Agreement or any other loan with Lender; (D) Borrower has applied funds
  provided pursuant to this Agreement for purposes other than those authorized
  by Lender; or (E) Lender in good faith believes itself insecure. CONTINUING
  VALIDITY. Except as expressly changed by this Agreement, the terms of the
  original obligation or obligations, including all agreements evidenced or
  securing the obligation(s), remain unchanged and in full force and effect.
  Consent by Lender to this Agreement does not waive Lender's right to strict
  performance of the obligation(s) as changed, nor obligate Lender to make any
  future change in terms. Nothing in this Agreement will constitute a
  satisfaction of the obligation(s). It is the intention of Lender to retain as
  liable parties all makers and endorsers of the original obligation(s),
  including accommodation parties, unless a party is expressly released by Lender
  in writing. Any maker or endorser, including accommodation makers, will not
  be released by virtue of this Agreement. If any person who signed the
  original obligation does not sign this Agreement below, then all persons
  signing below acknowledge that this Agreement is given conditionally, based
  on the representation to Lender that the non-signing party consents to the
  changes and provisions of this Agreement or otherwise will not be released by
  it. This waiver applies not only to any initial extension, modification or
  release, but also to all such subsequent actions. LOAN AGREEMENT. A document
  titled, &quot;Business Loan Agreement (Asset Based)&quot;, is attached to
  this Promissory Note. SUCCESSORS AND ASSIGNS. Subject to any limitations
  stated in this Agreement on transfer of Borrower's interest, this Agreement
  shall be binding upon and inure to the benefit of the parties, their
  successors and assigns. If ownership of the Collateral becomes vested in a
  person other than Borrower, Lender, without notice to Borrower, may deal with
  Borrower's successors with reference to this Agreement and the Indebtedness
  by way of forbearance or extension without releasing Borrower from the
  obligations of this Agreement or liability under the Indebtedness.
  MISCELLANEOUS PROVISIONS. If any part of this Agreement cannot be enforced,
  this fact will not affect the rest of the Agreement. Lender may delay or
  forgo enforcing any of its rights or remedies under this Agreement without
  losing them. In addition, Lender shall have all the rights and remedies
  provided in the related documents or available at law, in equity, or
  otherwise. Except as may be prohibited by applicable law, all of Lender's
  rights and remedies shall be cumulative and may be exercised singularly or
  concurrently. Election by Lender to pursue any remedy shall not exclude
  pursuit of any other remedy, and an election to make expenditures or to take
  action to perform an obligation of Borrower shall not affect Lender's right
  to declare a default and to exercise its rights and remedies. Borrower and
  any other person who signs, guarantees or</font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

</div>
<!-- ZEQ.=1,SEQ=4,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="15",CHK=850869,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NK-03_ZBY12202.CHC",USER="DBEMBEN",CD='May  7 01:31 2016' -->


<br clear="all" style="page-break-before:always;">


<div>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="92%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" color="white" face="Times New Roman" style="color:white;"><img width="720" height="931" src="g160222nk03i003.gif" alt="GRAPHIC"></font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:4.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">CHANGE IN TERMS
  AGREEMENT Loan No: 14248 (Continued) Page 3 endorses this Agreement, to the
  extent allowed by law, waive presentment, demand for payment, and notice of
  dishonor. Upon any change in the terms of this Agreement, and unless
  otherwise expressly stated in writing, no party who signs this Agreement,
  whether as maker, guarantor, accommodation maker or endorser, shall be
  released from liability. All such parties agree that Lender may renew or
  extend (repeatedly and for any length of time) this loan or release any party
  or guarantor or collateral; or impair, fail to realize upon or perfect
  Lender's security interest in the collateral; and take any other action
  deemed necessary by Lender without the consent of or notice to anyone. All
  such parties also agree that Lender may modify this loan without the consent
  of or notice to anyone other than the party with whom the modification is
  made. The obligations under this Agreement are joint and several. SECTION
  DISCLOSURE. To the extent not preempted by federal law, this loan is made
  under Minnesota Statutes, Section 334.01. PRIOR TO SIGNING THIS AGREEMENT,
  BORROWER READ AND UNDERSTOOD ALL THE PROVISIONS OF THIS AGREEMENT, INCLUDING
  THE VARIABLE INTEREST RATE PROVISIONS. BORROWER AGREES TO THE TERMS OF THE
  AGREEMENT. BORROWER: TACTILE SYSTEM TECHNOLOGY, INC. By: Robert Folkes, COO
  of Tactile Systems Technology, Inc. LENDER: VENTURE BANK X Authorized Signer
  LaserPro, Ver. 16.1.10.003 Copr, D+H USA Corporation 1997, 2016. All Rights
  Reserved. - MN C:\APPS\CFI\CFI\LPL\D20C.FC TR-7313 PR-72 </font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

</div>
<!-- ZEQ.=1,SEQ=5,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="15",CHK=4596,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NK-03_ZBY12202.CHC",USER="DBEMBEN",CD='May  7 01:31 2016' -->



<div>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="92%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" color="white" face="Times New Roman" style="color:white;"><img width="720" height="931" src="g160222nk05i001.gif" alt="GRAPHIC"></font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:4.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">*003450000014248*
  DISBURSEMENT REQUEST AND AUTHORIZATION Principal $2,000,000.00 Loan Date
  05-11-2016 Maturity 05-11-2017 Loan No 14248 Call / Coll 5200 Account
  102727-1 Officer 120 Initials References in the boxes above are for Lender's
  use only and do not limit the applicability of this document to any
  particular loan or item. Any item above containing &quot;***&quot; has been
  omitted due to text length limitations. Borrower: Tactile Systems Technology,
  Inc. 1331 Tyler Street Northeast, Suite 200 Minneapolis, MN 55413 Lender:
  Venture Bank Bloomington Office 4470 W. 78th Street Circle, Suite #100
  Bloomington, MN 55435 LOAN TYPE. This is a Variable Rate Nondisclosable
  Revolving Line of Credit Loan to a Corporation for $2,000,000.00 due on May
  11, 2017. This is a secured renewal loan. PRIMARY PURPOSE OF LOAN. The
  primary purpose of this loan is for: Maintenance of Borrower's Primary
  Residence. Personal, Family or Household Purposes or Personal Investment.
  Agricultural Purposes. Business Purposes. SPECIFIC PURPOSE. The specific
  purpose of this loan is: Working Capital. DISBURSEMENT INSTRUCTIONS. Borrower
  understands that no loan proceeds will be disbursed until all of Lender's
  conditions for making the loan have been satisfied. Please disburse the loan
  proceeds of $2,000,000.00 as follows: Undisbursed Funds: $2,000,000.00 Note
  Principal: $2,000,000.00 CHARGES PAID IN CASH. Borrower has paid or will pay
  in cash as agreed the following charges: Prepaid Finance Charges Paid in
  Cash: $7,500.00 Loan Origination Fee $7,500.00 Other Charges Paid in Cash:
  $921.00 $521.00 Capital Lien Fee $400.00 Loan Documentation Fee Total Charges
  Paid in Cash: $8,421.00 AUTOMATIC PAYMENTS. Borrower hereby authorizes Lender
  automatically to deduct from Borrower's Demand Deposit - Checking account,
  numbered 013193, the amount of any loan payment. If the funds in the account
  are insufficient to cover any payment, Lender shall not be obligated to
  advance funds to cover the payment. At any time and for any reason, Borrower
  or Lender may voluntarily terminate Automatic Payments. FINANCIAL CONDITION.
  BY SIGNING THIS AUTHORIZATION, BORROWER REPRESENTS AND WARRANTS TO LENDER
  THAT THE INFORMATION PROVIDED ABOVE IS TRUE AND CORRECT AND THAT THERE HAS
  BEEN NO MATERIAL ADVERSE CHANGE IN BORROWER'S FINANCIAL CONDITION AS
  DISCLOSED IN BORROWER'S MOST RECENT FINANCIAL STATEMENT TO LENDER. THIS
  AUTHORIZATION IS DATED MAY 11, 2016. BORROWER: TACTILE SYSTEMS TECHNOLOGY,
  INC. By: Robert Folkes, COO of Tactile Systems Technology, Inc. LaserPro,
  Ver. 16.1.10.003 Copr, D+H USA Corporation 1997, 2016. All Rights Reserved. -
  MN C:\APPS\CFI\CFI\LPL\120.FC TR-7313 PR-72 </font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

</div>
<!-- ZEQ.=1,SEQ=6,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="15",CHK=213134,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NK-05_ZBY12202.CHC",USER="DBEMBEN",CD='May  7 01:32 2016' -->



<div>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="92%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" color="white" face="Times New Roman" style="color:white;"><img width="720" height="931" src="g160222nk07i001.gif" alt="GRAPHIC"></font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:4.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">*012550000014248*
  ERRORS AND OMISSIONS AGREEMENT Principal $2,000,000.00 Loan Date 05-11-2016
  Maturity 05-11-2017 Loan No 14248 Call / Coll 5200 Account 102727-1 Officer
  120 Initials References in the boxes above are for Lender's use only and do
  not limit the applicability of this document to any particular loan or item.
  Any item above containing &quot;&quot;&quot;&quot;&quot; has been omitted due
  to text length limitations. Borrower: Tactile Systems Technology, Inc. 1331
  Tyler Street Northeast, Suite 200 Minneapolis, MN 55413 Lender: Venture Bank
  Bloomington Office 4470 W. 78th Street Circle, Suite #100 Bloomington, MN
  55435 LOAN NO.: 14248 The undersigned Borrower for and in consideration of
  the above-referenced Lender funding the closing of this loan agrees, if
  requested by Lender or Closing Agent for Lender, to fully cooperate and
  adjust for clerical errors, any or all loan closing documentation if deemed
  necessary or desirable in the reasonable discretion of Lender to enable
  Lender to sell, convey, seek guaranty or market said loan to any entity,
  including but not limited to an investor, Federal National Mortgage
  Association, Federal Home Loan Mortgage Corporation, Government National
  Mortgage Association, Federal Housing Authority or the Department of Veterans
  Affairs. The undersigned Borrower does hereby so agree and covenant in order
  to assure that this loan documentation executed this date will conform and be
  acceptable in the marketplace in the instance of transfer, sale or conveyance
  by Lender of its interest in and to said loan documentation. DATED effective
  this May 11, 2016 BORROWER: TACTILE SYSTEMS TECHNOLOGY, INC. By: Robert
  Folkes, COO of Tactile Systems Technology, Inc. Sworn to and subscribed before
  me this 5th day of May, 2016 Misty Exkert Notary Public Minnesota My
  commission Expires January 31, 2017 X (Notary Public) My Commission Expires
  January 31, 2017 LaserPro, Ver. 16.1.10.003 Copr, D+H USA Corporation 1997,
  2016. All Rights Reserved. - MN c:\APPS\CFI\CFI\LPL\126.FC TR-7313 PR-72</font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

</div>
<!-- ZEQ.=1,SEQ=7,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="15",CHK=118983,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NK-07_ZBY12202.CHC",USER="DBEMBEN",CD='May  7 01:33 2016' -->


<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.22
<SEQUENCE>16
<FILENAME>a2228882zex-10_22.htm
<DESCRIPTION>EX-10.22
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;10.22</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EMPLOYMENT AGREEMENT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:36.45pt;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">This Employment Agreement (this &#147;<i>Agreement</i>&#148;) is entered into effective </font><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></font>, 2016 (the &#147;<i>Effective Date</i>&#148;) by and between <b>TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</b>, a Delaware corporation (the &#147;<i>Company</i>&#148;), and <b>GERALD MATTYS</b>, a resident of <b>Minnesota</b> (&#147;<i>Executive</i>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BACKGROUND</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company and Executive have been parties to an Amended and Restated Employment Agreement entered into effective March&nbsp;1, 2008 (the &#147;<i>Prior Agreement</i>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company desires to employ Executive on the terms and conditions set forth in this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">C.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Executive desires to be employed by the Company on the terms and conditions set forth in this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">D.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Agreement shall govern the employment relationship between the Executive and the Company from and after the Effective Date hereof, and supersedes and negates any previous agreements or understandings, whether written or oral, with respect to such relationship, including without limitation the Prior Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">AGREEMENT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In consideration of the foregoing premises and the respective agreements of the Company and Executive set forth below, the Company and Executive, intending to be legally bound, agree as follows:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>EMPLOYMENT</u>. The term of Executive&#146;s employment under this Agreement shall commence as of the Effective Date and continue until terminated in accordance with Section&nbsp;10 hereof (the &#147;<i>Term</i>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>POSITION AND DUTIES</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Position with the Company</u>.&#160; During the Term, Executive will serve as the Company&#146;s <b>CHIEF EXECUTIVE OFFICER</b> and will perform such duties and responsibilities as the Company&#146;s Board of Directors will assign to Executive from time to time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Performance of Duties and Responsibilities</u>.&#160; Executive will serve the Company faithfully and to the best of Executive&#146;s ability and will devote Executive&#146;s full time, attention and efforts to the business of the Company during Executive&#146;s employment with the Company.&#160; Executive will report to the Company&#146;s Board of Directors.&#160; During Executive&#146;s employment hereunder, Executive will not accept other employment or engage in other material business activity, except as approved in writing by the Company&#146;s Board of Directors (the &#147;<i>Board</i>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>COMPENSATION</u>.&#160; While Executive is employed by the Company during the Term, and in exchange for Executive fulfilling Executive&#146;s duties and responsibilities as set forth in this</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="16",CHK=412813,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NM-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Agreement, the Company will provide Executive the compensation and benefits set forth in this Section&nbsp;3.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Base Salary</u>.&#160; The Company will pay to Executive an annual base salary of <b>$390,000</b>, less deductions and withholdings, which base salary will be paid in accordance with the Company&#146;s normal payroll policies and procedures.&#160; During each year after the first year of Executive&#146;s employment hereunder, the Compensation Committee of the Board (the &#147;<i>Committee</i>&#148;) may review and increase Executive&#146;s base salary in its sole discretion.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Bonus.</u>&#160; For each calendar year Executive is employed by the Company, Executive shall be eligible for an annual target bonus in an amount of <b>75%</b> of Executive&#146;s base salary earned during such calendar year, based upon and subject to criteria set by the Committee from time to time.&#160; In order to earn and receive payment of an annual bonus, Executive must be an employee of the Company on the date the bonus is paid by the Company, provided, however, that if Executive&#146;s employment is terminated by the Company other than for Cause (as herein defined) or by Executive for Good Reason (as herein defined) and the Termination Date (as defined herein) is after the completion of a calendar year but before the annual bonus for such calendar year has been paid to Executive, then Executive will earn and receive payment of an annual bonus for such prior calendar year in accordance with the bonus plan in effect for such year. In any case, any annual bonus earned under this Section&nbsp;3(b)&nbsp;will be paid not later than March&nbsp;15 immediately following the calendar year to which the bonus relates.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Equity Awards</u>.&#160; During the Term, Executive shall be eligible to receive one or more equity-based incentive awards at the discretion of the Committee.&#160; The terms of such awards, if any, shall be determined in the sole discretion of the Committee, including the types of awards, the number of securities covered by each award, the vesting conditions applicable to each award, and the manner in which awards are to be paid or settled.&#160; Nothing herein shall obligate the Company to make an equity award to Executive at any time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Employee Benefits</u>.&#160; Executive shall be entitled to participate in all employee benefit plans and programs of the Company to the extent that Executive meets the eligibility requirements for each individual plan or program.&#160; The Company provides no assurance as to the adoption or continuance of any particular employee benefit plan or program, and Executive&#146;s participation in any such plan or program will be subject to the provisions, rules&nbsp;and regulations applicable thereto.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Expenses</u>.&#160; The Company will reimburse Executive for all reasonable and necessary out-of-pocket business, travel and entertainment expenses incurred by Executive in the performance of the duties and responsibilities hereunder, subject to the Company&#146;s normal policies and procedures for expense verification and documentation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Paid Time Off</u>.&#160; Executive shall be entitled to paid time off (&#147;<i>PTO</i>&#148;) of 27 days per year.&#160; PTO days shall be taken at such times so as not to disrupt the operations of the Company.&#160; Any accrued and unused PTO upon termination of employment will not be paid out pursuant to the Company&#146;s standard policies addressing PTO.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="16",CHK=656558,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NM-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>AFFILIATED ENTITIES</u>.&#160; As used in this Agreement, &#147;<i>Affiliates</i>&#148; includes the Company and each corporation, partnership, or other entity which controls the Company, is controlled by the Company, <u>OR</u> is under common control with the Company (in each case &#147;<i>control</i>&#148; meaning the direct or indirect ownership of 50% or more of all outstanding equity interests).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>CONFIDENTIAL INFORMATION</u>.&#160; Except as permitted by the Company, Executive will not at any time divulge, furnish or make accessible to anyone or use in any way other than in the ordinary course of the business of the Company or its Affiliates, any confidential, proprietary or secret knowledge or information of the Company or its Affiliates that Executive has acquired or will acquire about the Company or its Affiliates, whether developed by Executive or by others, concerning (i)&nbsp;any trade secrets, (ii)&nbsp;any confidential, proprietary or secret designs, programs, processes, formulae, plans, devices or material (whether or not patented or patentable) directly or indirectly useful in any aspect of the business of the Company or of its Affiliates, (iii)&nbsp;any customer or supplier lists, (iv)&nbsp;any confidential, proprietary or secret development or research work, (v)&nbsp;any strategic or other business, marketing or sales plans, (vi)&nbsp;any financial data or plans, or (viii)&nbsp;any other confidential or proprietary information or secret aspects of the business of the Company or of its Affiliates.&#160; Executive acknowledges that the above-described knowledge and information constitutes a unique and valuable asset of the Company and represents a substantial investment of time and expense by the Company, and that any disclosure or other use of such knowledge or information other than for the sole benefit of the Company or its Affiliates would be wrongful and would cause irreparable harm to the Company.&#160; Executive will refrain from intentionally committing any acts that would materially reduce the value of such knowledge or information to the Company or its Affiliates.&#160; The foregoing obligations of confidentiality shall not apply to any knowledge or information that (i)&nbsp;is now or subsequently becomes generally publicly known, other than as a direct or indirect result of the breach of this Agreement, (ii)&nbsp;is independently made available to Executive in good faith by a third party who has not violated a confidential relationship with the Company or its Affiliates, or (iii)&nbsp;is required to be disclosed by law or legal process.&#160; Executive understands and agrees that Executive&#146;s obligations under this Agreement to maintain the confidentiality of the Company&#146;s confidential information are in addition to any obligations of Executive under applicable statutory or common law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>VENTURES</u>.&#160; If, during Executive&#146;s employment with the Company, Executive is engaged in or provides input into the planning or implementing of any project, program or venture involving the Company, all rights in such project, program or venture belong to the Company.&#160; Except as approved in writing by the Board, Executive will not be entitled to any interest in any such project, program or venture or to any commission, finder&#146;s fee or other compensation in connection therewith.&#160; Executive will have no interest, direct or indirect, in any customer or supplier that conducts business with the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>NONCOMPETITION AND NONSOLICITATION COVENANTS</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Agreement Not to Compete</u>.&#160; During the Restricted Period (defined below), Executive will not, directly or indirectly, engage in any business, in the United States or in any other location in which the Company is then doing business, for the development, sale, service, or distribution of medical devices to treat lymphedema patients or any other business that is competitive with the then-current businesses of the Company or its Affiliates, including without</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="16",CHK=477751,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NM-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">limitation as a proprietor, principal, agent, partner, officer, director, stockholder, employee, member of any association, consultant or otherwise.&#160; Ownership by Executive, as a passive investment, of less than 2.5% of the outstanding shares of capital stock of any corporation listed on a national securities exchange or publicly traded in the over-the-counter market shall not constitute a breach of this Section&nbsp;7(a).&#160; Notwithstanding the foregoing, Executive&#146;s direct or indirect engagement in a business whose sole purpose is the development, sale, service, or distribution of compression garments (but not pumps or other devices) to treat lymphedema patients or other patients shall not constitute a breach of this Section&nbsp;7(a).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Agreement Not to Solicit or Hire Employees or Contractors</u>. During Executive&#146;s employment with the Company or any Affiliates and for a period of twelve (12) consecutive months from and after the termination of Executive&#146;s employment, whether such termination is with or without cause, or whether such termination is at the instance of Executive or the Company, Executive will not, directly or indirectly, solicit, hire or engage any person who is then an employee or contractor of the Company or who was an employee of the Company at any time during the six (6)&nbsp;month period immediately preceding Executive&#146;s termination of employment, in any manner or capacity, including without limitation as a proprietor, principal, agent, partner, officer, director, stockholder, employee, member of any association, consultant or otherwise, or otherwise directly or indirectly request, advise or induce any then current employee or contractor of the Company to terminate or otherwise adversely change its relationship with the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Agreement Not to Solicit Others</u>. During Executive&#146;s employment with the Company or any Affiliates and for a period of twelve (12) consecutive months from and after the termination of Executive&#146;s employment, whether such termination is with or without cause, or whether such termination is at the instance of Executive or the Company, Executive will not, directly or indirectly, solicit, request, advise or induce any then current customer, supplier or other business contact of the Company to cancel, curtail or otherwise adversely change its relationship with the Company, in any manner or capacity, including without limitation as a proprietor, principal, agent, partner, officer, director, stockholder, employee, member of any association, consultant or otherwise.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Restricted Period</u>.&#160; For purposes of this Agreement &#147;<i>Restricted Period</i>&#148; is defined as follows.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If (x)&nbsp;Executive&#146;s employment is terminated by the Company without Cause (defined below), by Executive for Good Reason (defined below), by Executive for CIC Reason (as defined below), or if Executive&#146;s employment with the Company is terminated due to Disability (as defined below)<i> and</i> (y)&nbsp;Executive signs a release of claims as provided for in Section&nbsp;11(i), then the Restricted Period shall be the period during Executive&#146;s employment with the Company or any Affiliates and for a period of <b>fifteen (15)</b> consecutive months from and after the termination of Executive&#146;s employment; provided that the Company may in its sole discretion elect to extend the Restricted Period by an additional six (6)&nbsp;months by providing Executive at least thirty (30) days&#146; notice of such</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="16",CHK=684801,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NM-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><a name="16022-2-NM-01_PB_1_011927_7056"></a><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">extension and the payments and reimbursements provided for in Section&nbsp;11(a)(vi)&nbsp;or 11(b)(iv)&nbsp;of this Agreement (as applicable).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If Executive&#146;s employment is terminated by the Company or by Executive under any conditions other than as provided for in Section&nbsp;7(d)(i), then the Restricted Period shall be the period during Executive&#146;s employment with the Company or any Affiliates and for a period of twelve (12) consecutive months from and after the termination of Executive&#146;s employment.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Acknowledgment</u>.&#160; Executive hereby acknowledges that the provisions of this Section&nbsp;7 are reasonable and necessary to protect the legitimate interests of the Company and that any violation of this Section&nbsp;7 by Executive will cause substantial and irreparable harm to the Company to such an extent that monetary damages alone would be an inadequate remedy therefor.&#160; Executive represents and warrants that Executive is not subject to any other agreements prohibiting the performance of Executive&#146;s obligations under this Agreement, including any non-competition agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Blue Pencil Doctrine</u>.&#160; If the duration of, the scope of or any business activity covered by any provision of this Section&nbsp;7 is in excess of what is determined to be valid and enforceable under applicable law, such provision will be construed to cover only that duration, scope or activity that is determined to be valid and enforceable.&#160; Executive hereby acknowledges that this Section&nbsp;7 will be given the construction which renders its provisions valid and enforceable to the maximum extent, not exceeding its express terms, possible under applicable law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>PATENTS, COPYRIGHTS AND RELATED MATTERS</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Disclosure and Assignment</u>.&#160; Executive must immediately disclose to the Company any and all improvements and inventions that Executive may conceive and/or reduce to practice individually or jointly or commonly with others while Executive is employed with the Company or any of its Affiliates with respect to (i)&nbsp;any methods, processes or apparatus concerned with the development, use or production of any type of products, goods or services sold or used by the Company or its Affiliates, and (ii)&nbsp;any type of products, goods or services sold or used by the Company or its Affiliates.&#160; Any such improvements and inventions will be the sole and exclusive property of the Company and Executive hereby immediately assigns, transfers and sets over to the Company Executive&#146;s entire right, title and interest in and to any and all of such improvement and inventions as are specified in this Section&nbsp;8(a), and in and to any and all applications for letters patent that may be filed on such inventions, and in and to any and all letters patent that may issue, or be issued, upon such applications.&#160; In connection therewith and for no additional compensation therefor, but at no expense to Executive, Executive will sign any and all instruments deemed necessary by the Company for:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the filing and prosecution of any applications for letters patent of the United States or of any foreign country that the Company may desire to file upon such inventions as are specified in this Section&nbsp;8(a);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="16",CHK=70142,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NM-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the filing and prosecution of any divisional, continuation, continuation-in-part or reissue applications that the Company may desire to file upon such applications for letters patent; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the reviving, re-examining or renewing of any of such applications for letters patent.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Section&nbsp;8(a)&nbsp;will not apply to any invention for which no equipment, supplies, facilities, confidential, proprietary or secret knowledge or information, or other trade secret information of the Company was used and that was developed entirely on Executive&#146;s own time, and (i)&nbsp;that does not relate (A)&nbsp;directly to the business of the Company, or (B)&nbsp;to the Company&#146;s actual or demonstrably anticipated research or development, or (ii)&nbsp;that does not result from any work performed by Executive for the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Copyrightable Material</u>.&#160; All right, title and interest in all copyrightable material that Executive shall conceive or originate individually or jointly or commonly with others, and that arise in connection with Executive&#146;s services hereunder or knowledge of confidential and proprietary information of the Company, will be the property of the Company and are hereby assigned by Executive to the Company of its Affiliates, along with ownership of any and all copyrights in the copyrightable material. Where applicable, works of authorship created by Executive relating to the Company or its Affiliates and arising out of Executive&#146;s knowledge of confidential and proprietary information of the Company shall be considered &#147;works made for hire,&#148; as defined in the U.S. Copyright Act, as amended.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Remedies</u>.<font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive acknowledges that it would be difficult to fully compensate the Company for monetary damages resulting from any breach by Executive of this Section&nbsp;8.&#160; Accordingly, in the event of any actual or threatened breach of any such provisions, the Company will, in addition to any other remedies it may have, be entitled to injunctive and other equitable relief to enforce such provisions, and such relief may be granted without the necessity of proving actual monetary damages.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>RETURN OF RECORDS AND PROPERTY</u>.&#160; Upon termination of Executive&#146;s employment or at any time upon the Company&#146;s request, Executive will promptly deliver to the Company any and all Company and Affiliate records and any and all Company and Affiliate property in Executive&#146;s possession or under Executive&#146;s control, including without limitation manuals, books, blank forms, documents, letters, memoranda, notes, notebooks, reports, printouts, computer disks, computer tapes, source codes, data, tables or calculations and all copies thereof, documents that in whole or in part contain any trade secrets or confidential, proprietary or other secret information of the Company or its Affiliates and all copies thereof, and keys, access cards, access codes, passwords, credit cards, personal computers, telephones and other electronic equipment belonging to the Company or its Affiliates.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>TERMINATION OF EMPLOYMENT</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s employment with the Company will terminate immediately upon:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="16",CHK=975340,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NM-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s receipt of written notice from the Company of the termination of Executive&#146;s employment, effective as of the date indicated in such notice;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the Company&#146;s receipt of Executive&#146;s written resignation from the Company, effective as of the date indicated in such resignation;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s Disability (as defined below); or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s death.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The date upon which Executive&#146;s termination of employment with the Company occurs is the &#147;<i>Termination Date</i>.&#148; For purposes of Section&nbsp;11(a)&nbsp;and 11(b)&nbsp;of this Agreement only, the Termination Date shall mean the date on which a &#147;separation from service&#148; has occurred for purposes of Section&nbsp;409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance thereunder (the &#147;<i>Code</i>.&#148;)</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Immediately upon termination of Executive&#146;s employment with the Company for any reason, Executive shall resign all positions then held as an Executive of the Company and any Affiliates of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Following termination of Executive&#146;s employment with the Company for any reason, Executive shall cooperate with the Company in the transition of Executive&#146;s duties and responsibilities hereunder to the extent reasonably requested by the Board; provided that Executive will be fairly compensated to the extent such cooperation requires more than an incidental amount of time and effort on Executive&#146;s part, and further that Executive will not be required to incur any out-of-pocket expenses in doing so.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>PAYMENTS UPON TERMINATION OF EMPLOYMENT</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Subject to Section&nbsp;11(i)&nbsp;of this Agreement, if Executive&#146;s employment with the Company is terminated by the Company without Cause or by Executive for Good Reason, then, in addition to paying Executive&#146;s earned and accrued base salary, accrued but unpaid expense reimbursements and benefits through the Termination Date, the Company will provide to Executive the following payments:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Separation Pay</u>.&#160; The Company will pay to Executive an amount equal to <b>fifty percent (50%) of Executive&#146;s annualized base salary as of the Termination Date plus an amount equal to fifty percent (50%) of Executive&#146;s target bonus as of the Termination Date</b>, with such sum, less applicable withholdings, payable in equal installments in accordance with the Company&#146;s regular payroll schedule commencing with the first normal payroll date of the Company following the Termination Date and continuing for <b>six (6)&nbsp;months</b> thereafter, provided that any installments that would have been paid during the sixty (60) day period immediately following the Termination Date shall be held by the Company until the first payroll date occurring more than sixty (60) days after the Termination Date; but in no event shall such amount paid under this Section&nbsp;11(a)(i)</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="16",CHK=1045181,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NM-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">exceed the lesser of: (A)&nbsp;two (2)&nbsp;times Executive &#145;s annualized compensation based upon the annual rate of pay for services to the Company for the calendar year prior to the calendar year in which the Termination Date occurs (adjusted for any increase during that year that was expected to continue indefinitely if Executive had not separated from service); or (B)&nbsp;two (2)&nbsp;times the limit of compensation set forth in Code Section&nbsp;401(a)(17) as in effect for the year in which the Termination Date occurs.&#160; The Company and Executive intend the payments under this Section&nbsp;11(a)(i)&nbsp;to be a &#147;separation pay plan due to involuntary separation from service&#148; under Treas. Reg. &#167;&nbsp;1.409A-1(b)(9)(iii).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Make-up Payment</u>.&#160; If Executive&#146;s separation pay under Section&nbsp;11(a)(i)&nbsp;above is limited by application of clause (A)&nbsp;or (B)&nbsp;thereof, then the Company shall make an additional lump sum payment to Executive equal to the difference between (x)&nbsp;the amount that equals the amount calculated under Section&nbsp;11(a)(i)&nbsp;above prior to application of clause (A)&nbsp;or (B)&nbsp;thereof, minus (y)&nbsp;the amount to be paid to Executive under Section&nbsp;11(a)(i)&nbsp;above as a result of the application of clause (A)&nbsp;or (B)&nbsp;thereof, less applicable withholdings.&#160; Such amount will paid to Executive in a lump sum on the first regular payroll date of the Company to occur following the date that is six (6)&nbsp;months after the Termination Date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Supplemental Separation Pay</u>.&#160; The Company will pay to Executive an amount equal to <b>seventy-five percent (75%) of Executive&#146;s annualized base salary as of the Termination Date plus an amount equal to seventy-five percent (75%) of Executive&#146;s target bonus as of the Termination Date</b>, with such sum, less applicable withholdings, payable in equal installments in accordance with the Company&#146;s regular payroll schedule commencing with the first normal payroll date of the Company following the six (6)&nbsp;month anniversary of the Termination Date and continuing for <b>9 months</b> thereafter.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Value of Accrued and Unused PTO</u>.&#160; The Company will pay to Executive the value of Executive&#146;s accrued and unused PTO as of the Termination Date (based on Executive&#146;s base salary as of the Termination Date), less applicable withholdings, payable in a lump sum on the Company&#146;s first payroll date occurring more than sixty (60) days after the Termination Date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Continued Benefits</u>. If Executive is eligible for and takes all steps necessary to continue Executive&#146;s group health insurance coverage with the Company following the Termination Date, the Company will pay for the portion of the premium costs for such coverage that the Company would pay if Executive remained employed by the Company, at the same level of coverage that was in effect as of the Termination Date, for a period of <b>15 consecutive months</b> after the Termination Date (or until</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="16",CHK=647070,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NM-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Executive receives group health or dental coverage from another employer, if earlier).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(vi)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Restricted Period Extension Payments</u>.&#160; If the Company elects to extend the Restricted Period for six (6)&nbsp;additional months as provided for in Section&nbsp;7(d)(i), then the Company will (A)&nbsp;pay to Executive an amount equal to that payable under Section&nbsp;11(a)(i)&nbsp;(prior to any application of clause (A)&nbsp;or (B)&nbsp;thereof), with such additional amount payable in equal installments in accordance with the Company&#146;s regular payroll schedule commencing on the first normal payroll date of the Company following the 15 month anniversary of the Termination Date and continuing for six (6)&nbsp;months thereafter, and (B)&nbsp;extend for three (3)&nbsp;additional months (after the end of the 15 month period identified in Section&nbsp;11(a)(v)) the period during which it will pay a portion of the premium costs for group health insurance coverage as provided in, and subject to the same conditions of, Section&nbsp;11(a)(v).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(vii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Accelerated Vesting of Equity</u>.&#160; In addition to the payments identified above in Sections 11(a)(i)-(vi), if Executive&#146;s employment with the Company is terminated by the Company without Cause or by Executive for Good Reason, then, subject to Section&nbsp;11(i)&nbsp;of this Agreement and notwithstanding any language in any equity plan or applicable equity award agreement to the contrary, upon the expiration of the all rescission periods provided by law with respect to the release of claims described in Section&nbsp;11(i), any equity awards issued to Executive that have any portion of such award unvested as of the Termination Date (each an &#147;<i>Award</i>&#148;) will vest as to the number of shares, options or other securities (the &#147;<i>Securities</i>&#148;) &nbsp;calculated as follows (rounded up to the nearest whole share):</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Additional Securities Vested = (Number of Securities Issued Under Award x ((Number of Days between Date of Grant of Award and Termination Date) / (Number of Days between Date of Grant of Award and Final Vesting Date of Award))) &#151; Number of Securities Vested Under Award as of the Termination Date.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Subject to Section&nbsp;11(i)&nbsp;of this Agreement, if Executive&#146;s employment with the Company is terminated by Executive for CIC Reason, or if Executive&#146;s employment with the Company is terminated due to death or Disability, then, in addition to paying Executive&#146;s earned and accrued base salary, accrued but unpaid expense reimbursements and benefits through the Termination Date, the Company will provide to Executive the following payments:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Separation Pay</u>.&#160; The Company will pay to Executive an amount equal to Executive&#146;s <b>125% of Executive&#146;s annualized base salary as of the Termination Date plus an amount equal to 125% of Executive&#146;s target bonus as of the Termination Date,</b> with such sum, less applicable withholdings, payable in equal installments in accordance with the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=9,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="16",CHK=331745,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NM-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company&#146;s regular payroll schedule commencing with the first normal payroll date of the Company following the Termination Date and continuing for <b>15 months</b> thereafter, provided that any installments that would have been paid during the sixty (60) day period immediately following the Termination Date shall be held by the Company until the first payroll date occurring more than sixty (60) days after the Termination Date.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Value of Accrued and Unused PTO</u>.&#160; The Company will pay to Executive the value of Executive&#146;s accrued and unused PTO as of the Termination Date (based on Executive&#146;s base salary as of the Termination Date), less applicable withholdings, payable in a lump sum on the Company&#146;s first payroll date occurring more than sixty (60) days after the Termination Date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Continued Benefits</u>. If Executive is eligible for and takes all steps necessary to continue Executive&#146;s group health insurance coverage with the Company following the Termination Date, pay for the portion of the premium costs for such coverage that the Company would pay if Executive remained employed by the Company, at the same level of coverage that was in effect as of the Termination Date, for a period of <b>15 consecutive months</b> after the Termination Date (or until Executive receives group health or dental coverage from another employer, if earlier).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Restricted Period Extension Payments</u>.&#160; If the Company elects to extend the Restricted Period for six (6)&nbsp;additional months as provided for in Section&nbsp;7(d)(i), then the Company will (A)&nbsp;pay to Executive an amount equal to that payable under Section&nbsp;11(a)(i)&nbsp;(prior to any application of clause (A)&nbsp;or (B)&nbsp;thereof), with such additional amount payable in equal installments in accordance with the Company&#146;s regular payroll schedule commencing on the first normal payroll date of the Company following the 15-month anniversary of the Termination Date and continuing for six (6)&nbsp;months thereafter, and (B)&nbsp;extend for three (3)&nbsp;additional months (after the end of the 15-month period identified in Section&nbsp;11(b)(iii)) the period during which it will pay a portion of the premium costs for group health insurance coverage as provided in, and subject to the same conditions of, Section&nbsp;11(b)(iii).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If Executive&#146;s employment with the Company is terminated for any of the following reasons:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s abandonment of Executive&#146;s employment or Executive&#146;s resignation for any reason other than Good Reason or CIC Reason; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>termination of Executive&#146;s employment by the Company for Cause;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=10,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="16",CHK=996027,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NM-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:04 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">then the Company will pay Executive or Executive&#146;s estate, as the case may be, Executive&#146;s earned and accrued base salary, accrued but unpaid expense reimbursements and benefits through the Termination Date.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Cause</i>&#148; hereunder means:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>an act or acts of dishonesty undertaken by Executive and intended to result in personal gain or enrichment of Executive or others at the expense of the Company;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>unlawful conduct or gross misconduct by Executive that, in either event, is injurious to the Company;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the conviction of Executive of a felony; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>material breach of any terms or conditions of this Agreement by Executive which breach has not been cured by Executive within 15 days after written notice thereof to Executive from the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For the purposes of Sections 11(d)(ii)&nbsp;and (iv), no act or failure to act on Executive&#146;s part shall be considered &#147;Cause&#148; if done by Executive pursuant to specific authorization evidenced by a resolution duly adopted by the Board or pursuant to specific advice given by counsel for the Company, unless such specific authorization or advice results in whole or in part from material misrepresentations or omissions of Executive.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>CIC Reason</i>&#148; hereunder means Executive&#146;s separation from service after a Change in Control (as defined in the Tactile Systems Technology,&nbsp;Inc. 2016 Equity Incentive Plan) occurs, provided that, if requested by the Company or any successor of the Company, Executive remains employed by the Company or any successor of the Company for a transition period not to exceed sixty (60) days following such Change in Control and Executive&#146;s Termination Date occurs no later than ten (10)&nbsp;days after the end of any transition period requested by the Company or any successor of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Disability</i>&#148; hereunder means the inability of Executive to perform on a full-time basis the duties and responsibilities of Executive&#146;s employment with the Company by reason of Executive&#146;s illness or other physical or mental impairment or condition, if such inability continues for an uninterrupted period of 90 days or more during any 180-day period.&#160; A period of inability is &#147;uninterrupted&#148; unless and until Executive returns to full-time work for a continuous period of at least 30 days.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Good Reason</i>&#148; hereunder means the occurrence of any of the following events without Executive&#146;s consent:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the assignment of Executive to a position with responsibilities or duties of a materially lesser status or degree than the position specified in Section&nbsp;2(a);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=11,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="16",CHK=255796,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NM-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:04 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>material breach of any terms or conditions of this Agreement by the Company not caused by Executive;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the requirement by the Company that Executive relocate out of the Minneapolis/St. Paul Metropolitan area.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For the purposes of Section&nbsp;11(g), &#147;<i>Good Reason</i>&#148; shall not exist unless Executive has first provided written notice to the Company of the occurrence of one or more of the conditions under clauses (i)&nbsp;through (iii)&nbsp;above within ninety (90) days of the condition&#146;s initial occurrence,&#160; such condition is not fully remedied by the Company within thirty (30) days after the Company&#146;s receipt of written notice from Executive, and the Termination Date occurs no later than one hundred and thirty (130) days after the condition&#146;s initial occurrence.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In the event of termination of Executive&#146;s employment, the sole obligation of the Company to pay post-termination severance and benefits under this Agreement will be its obligation to make the payments called for by Sections 11(a), 11(b)&nbsp;or 11(c)&nbsp;hereof, as the case may be, and the Company will have no other obligation to Executive, except as otherwise provided by law, under the terms of any other applicable agreement between Executive and the Company or under the terms of any employee benefit plans or programs then maintained by the Company in which Executive participates.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding the foregoing provisions of this Section&nbsp;11, the Company will not be obligated to make any payments under Section&nbsp;11(a)&nbsp;or 11(b)&nbsp;hereof unless Executive has signed a release of claims in favor of the Company and its Affiliates in a form to be prescribed by the Company, all applicable consideration and rescission periods provided by law shall have expired, and Executive is in strict compliance with the terms of this Agreement as of the dates of such payments.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>MISCELLANEOUS</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Governing Law</u>.&#160; All matters relating to the interpretation, construction, application, validity and enforcement of this Agreement will be governed by the laws of the State of Minnesota without giving effect to any choice or conflict of law provision or rule, whether of the State of Minnesota or any other jurisdiction, that would cause the application of laws of any jurisdiction other than the State of Minnesota.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Jurisdiction and Venue</u>.&#160; Executive and the Company consent to jurisdiction of the courts of the State of Minnesota and/or the federal courts, District of Minnesota, for the purpose of resolving all issues of law, equity, or fact, arising out of or in connection with this Agreement.&#160; Any action involving claims of a breach of this Agreement must be brought in such courts.&#160; Each party consents to personal jurisdiction over such party in the state and/or federal courts of Minnesota and hereby waives any defense of lack of personal jurisdiction.&#160; Venue, for the purpose of all such suits, will be in Hennepin County, State of Minnesota.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Entire Agreement</u>.&#160; This Agreement contains the entire agreement of the parties relating to Executive&#146;s employment with the Company and supersedes all prior agreements and understandings with respect to such subject matter, including without limitation the Prior Agreement, and the parties hereto have made no agreements, representations or warranties</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=12,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="16",CHK=266884,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NM-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:04 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">relating to the subject matter of this Agreement that are not set forth herein; provided, however, that nothing in this Agreement is intended to supersede, replace or modify the terms of the Company&#146;s 2016 Equity Incentive Plan or any equity award agreements issued to Executive under the Company&#146;s 2016 Equity Incentive Plan, each of which shall remain in full force and effect in accordance with their terms.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Code Section&nbsp;409A</u>.&#160; This Agreement is intended to be exempt from or comply with the requirements of Section&nbsp;409A(a)(2), (3)&nbsp;and (4)&nbsp;of the Code, including current and future guidance and regulations interpreting such provisions, and should be interpreted accordingly.&#160; To the extent such potential payments or benefits could become subject to additional tax under such Code Section&nbsp;409A, the parties shall cooperate to amend this Agreement with the goal of giving Executive the economic benefits described herein in a manner that does not result in such tax being imposed.&#160; Each payment or benefit made pursuant to Section&nbsp;11(a)&nbsp;or 11(b)&nbsp;of this Agreement shall be deemed to be a separate payment for purposes of Code Section&nbsp;409A.&#160; In addition, payments or benefits pursuant to Section&nbsp;11(a)&nbsp;or 11(b)&nbsp;shall be exempt from the requirements of Code Section&nbsp;409A to the maximum extent possible as &#147;short-term deferrals&#148; pursuant to Treasury Regulation Section&nbsp;1.409A-1(b)(4), as involuntary separation pay pursuant to Treasury Regulation Section&nbsp;1.409A-1(b)(9)(iii), and/or under any other exemption that may be applicable, and this Agreement shall be construed accordingly.&#160; To the extent that any amounts payable under this Agreement are required to be delayed under Code Section&nbsp;409A, such amounts are intended to be and should be considered for purposes of Code Section&nbsp;409A as separate payments from the amounts that are not required to be delayed.&#160; Notwithstanding anything herein to the contrary, if Executive is considered a &#147;specified employee&#148; (as defined in Treasury Regulation Section&nbsp;1.409A-1(i)) as of the Termination Date, then no payments of deferred compensation subject to Code Section&nbsp;409A and payable due to Executive&#146;s separation from service shall be made under this Agreement before the first business day that is six (6)&nbsp;months after the Termination Date (or upon Executive&#146;s death, if earlier) (the &#147;<i>Specified Period</i>&#148;).&#160; Any deferred compensation payments that would otherwise be required to be made to Executive during the Specified Period will be accumulated by the Company and paid to Executive on the first day after the end of the Specified Period.&#160; The foregoing restriction on the payment of amounts to Executive during the Specified Period will not apply to the payment of employment taxes.&#160; In the event that the interpretation or requirements of Code Section&nbsp;409A change during the Term, the parties agree to amend this Agreement, only as necessary, to comply with any such change, if and to the extent such an amendment is permitted by Code Section&nbsp;409A.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Code Section&nbsp;280G</u>.&#160; Notwithstanding anything in this Agreement to the contrary, if any payment or other benefit hereunder, together with any other payments or benefits that Executive has the right to receive from the Company or any corporation which is a member of an &#147;affiliated group&#148; (as defined in Section&nbsp;1504(a)&nbsp;of the Code without regard to Section&nbsp;1504(b)&nbsp;of the Code) of which the Company is a member, would constitute a &#147;parachute payment&#148; (as defined in Section&nbsp;280G(b)(2)&nbsp;of the Code), then, such payments and benefits will be reduced to the largest amount as, in the sole judgment of the Company, will result in no portion of such payments or benefits being subject to the excise tax imposed by Section&nbsp;4999 of the Code.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Amendments</u>.&#160; No amendment or modification of this Agreement will be deemed effective unless made in writing and signed by the parties hereto.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=13,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="16",CHK=221173,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NM-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:04 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Waiver</u>.&#160; No term or condition of this Agreement will be deemed to have been waived, except by a statement in writing signed by the party against whom enforcement of the waiver is sought.&#160; Any written waiver will not be deemed a continuing waiver unless specifically stated, will operate only as to the specific term or condition waived and will not constitute a waiver of such term or condition for the future or as to any act other than that specifically waived.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Assignment</u>.&#160; This Agreement will not be assignable, in whole or in part, by either party without the prior written consent of the other party, except that the Company may, without the consent of Executive, assign its rights and obligations under this Agreement (1)&nbsp;to an Affiliate or (2)&nbsp;to any corporation or other person or business entity to which the Company may sell or transfer all or substantially all of its assets; provided, however, that the Company&#146;s assignment of rights may only take place if the assignee accepts and agrees to all of the obligations to Executive under this Agreement.&#160; After any such assignment by the Company, the Company will be discharged from all further liability hereunder and such assignee will thereafter be deemed to be &#147;the Company&#148; for purposes of all terms and conditions of this Agreement, including this Section&nbsp;12. For the avoidance of doubt, in the event of Executive&#146;s death, all payments and obligations to Executive shall be paid to Executive&#146;s estate.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Counterparts</u>.&#160; This Agreement may be executed by facsimile signature and in any number of counterparts, and such counterparts executed and delivered, each as an original, will constitute but one and the same instrument.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Severability</u>.&#160; Subject to Section&nbsp;7(f)&nbsp;hereof, to the extent that any portion of any provision of this Agreement is held invalid or unenforceable, it will be considered deleted herefrom and the remainder of such provision and of this Agreement will be unaffected and will continue in full force and effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(k)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Captions and Headings</u>.&#160; The captions and paragraph headings used in this Agreement are for convenience of reference only and will not affect the construction or interpretation of this Agreement or any of the provisions hereof.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=14,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="16",CHK=110156,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NM-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:04 2016' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Executive and the Company have executed this Agreement effective as of the Effective Date set forth in the first paragraph.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE   SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ROBERT   FOLKES</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Chief   Operating Officer</font></i></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">GERALD   R. MATTYS</font></b></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=15,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="16",CHK=415997,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NM-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:04 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.23
<SEQUENCE>17
<FILENAME>a2228882zex-10_23.htm
<DESCRIPTION>EX-10.23
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;10.23</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EMPLOYMENT AGREEMENT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Employment Agreement (this &#147;<i>Agreement</i>&#148;) is entered into effective April&nbsp;27, 2016 (the &#147;<i>Effective Date</i>&#148;) by and between <b>TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</b>, a Delaware corporation (the &#147;<i>Company</i>&#148;), and <b>LYNN BLAKE</b>, a resident of Minnesota (&#147;<i>Executive</i>&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BACKGROUND</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company desires to employ Executive on the terms and conditions set forth in this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Executive desires to be employed by the Company on the terms and conditions set forth in this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">C.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Agreement shall govern the employment relationship between the Executive and the Company from and after the Effective Date hereof, and supersedes and negates any previous agreements or understandings, whether written or oral, with respect to such relationship.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">AGREEMENT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In consideration of the foregoing premises and the respective agreements of the Company and Executive set forth below, the Company and Executive, intending to be legally bound, agree as follows:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>EMPLOYMENT</u>. The term of Executive&#146;s employment under this Agreement shall commence as of the Effective Date and continue until terminated in accordance with Section&nbsp;10 hereof (the &#147;<i>Term</i>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>POSITION AND DUTIES</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Position with the Company</u>.&#160; During the Term, Executive will serve as the Company&#146;s Chief Financial Officer and will perform such duties and responsibilities as the Company&#146;s Chief Executive Officer will assign to Executive from time to time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Performance of Duties and Responsibilities</u>.&#160; Executive will serve the Company faithfully and to the best of Executive&#146;s ability and will devote Executive&#146;s full time, attention and efforts to the business of the Company during Executive&#146;s employment with the Company.&#160; Executive will report to the Company&#146;s Chief Executive Officer or the Board of Directors if requested by the Board of Directors.&#160; During Executive&#146;s employment hereunder, Executive will not accept other employment or engage in other material business activity, except as approved in writing by the Company&#146;s Board of Directors (the &#147;<i>Board</i>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>COMPENSATION</u>.&#160; While Executive is employed by the Company during the Term, and in exchange for Executive fulfilling Executive&#146;s duties and responsibilities as set forth in this Agreement, the Company will provide Executive the compensation and benefits set forth in this Section&nbsp;3.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">1<a name="16022-2-NO-01_PB_1_020544_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="17",CHK=420988,FOLIO='1',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NO-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:09 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Base Salary</u>.&#160; The Company will pay to Executive an annual base salary of $300,000, less deductions and withholdings, which base salary will be paid in accordance with the Company&#146;s normal payroll policies and procedures. &#160;During each year after the first year of Executive&#146;s employment hereunder, the Compensation Committee of the Board (the &#147;<i>Committee</i>&#148;) may review and increase Executive&#146;s base salary in its sole discretion.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Bonus.</u>&#160; For each calendar year Executive is employed by the Company, Executive shall be eligible for an annual target bonus in an amount of 50% of Executive&#146;s base salary earned during such calendar year, based upon and subject to criteria set by the Committee from time to time. In order to earn and receive payment of an annual bonus, Executive must be an employee of the Company on the date the bonus is paid by the Company; provided, however, that if Executive&#146;s employment is terminated by the Company other than for Cause (as herein defined) or by Executive for Good Reason (as herein defined) and the Termination Date (as defined herein) is after the completion of a calendar year but before the annual bonus for such calendar year has been paid to Executive, then Executive will earn and receive payment of an annual bonus for such prior calendar year in accordance with the bonus plan in effect for such year. In any case, any annual bonus earned under this Section&nbsp;3(b)&nbsp;will be paid not later than March&nbsp;15 immediately following the calendar year to which the bonus relates.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Equity Awards</u>.&#160; During the Term, Executive shall be eligible to receive one or more equity-based incentive awards at the discretion of the Committee.&#160; The terms of such awards, if any, shall be determined in the sole discretion of the Committee, including the types of awards, the number of securities covered by each award, the vesting conditions applicable to each award, and the manner in which awards are to be paid or settled.&#160; Nothing herein shall obligate the Company to make an equity award to Executive at any time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Employee Benefits</u>.&#160; Executive shall be entitled to participate in all employee benefit plans and programs of the Company to the extent that Executive meets the eligibility requirements for each individual plan or program.&#160; The Company provides no assurance as to the adoption or continuance of any particular employee benefit plan or program, and Executive&#146;s participation in any such plan or program will be subject to the provisions, rules&nbsp;and regulations applicable thereto.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Expenses</u>.&#160; The Company will reimburse Executive for all reasonable and necessary out-of-pocket business, travel and entertainment expenses incurred by Executive in the performance of the duties and responsibilities hereunder, subject to the Company&#146;s normal policies and procedures for expense verification and documentation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Paid Time Off</u>.&#160; Executive shall be entitled to paid time off (&#147;<i>PTO</i>&#148;) of 20 days per year.&#160; PTO days shall be taken at such times so as not to disrupt the operations of the Company, as approved by the Company&#146;s Chief Executive Officer.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>AFFILIATED ENTITIES</u>.&#160; As used in this Agreement, &#147;<i>Affiliates</i>&#148; includes the Company and each corporation, partnership, or other entity which controls the Company, is controlled by the Company, <u>OR</u> is under common control with the Company (in each case &#147;<i>control</i>&#148; meaning the direct or indirect ownership of 50% or more of all outstanding equity interests).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="16022-2-NO-01_PB_2_020602_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="17",CHK=822903,FOLIO='2',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NO-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:09 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>CONFIDENTIAL INFORMATION</u>.&#160; Except as permitted by the Company, Executive will not at any time divulge, furnish or make accessible to anyone or use in any way other than in the ordinary course of the business of the Company or its Affiliates, any confidential, proprietary or secret knowledge or information of the Company or its Affiliates that Executive has acquired or will acquire about the Company or its Affiliates, whether developed by Executive or by others, concerning (i)&nbsp;any trade secrets, (ii)&nbsp;any confidential, proprietary or secret designs, programs, processes, formulae, plans, devices or material (whether or not patented or patentable) directly or indirectly useful in any aspect of the business of the Company or of its Affiliates, (iii)&nbsp;any customer or supplier lists, (iv)&nbsp;any confidential, proprietary or secret development or research work, (v)&nbsp;any strategic or other business, marketing or sales plans, (vi)&nbsp;any financial data or plans, or (viii)&nbsp;any other confidential or proprietary information or secret aspects of the business of the Company or of its Affiliates.&#160; Executive acknowledges that the above-described knowledge and information constitutes a unique and valuable asset of the Company and represents a substantial investment of time and expense by the Company, and that any disclosure or other use of such knowledge or information other than for the sole benefit of the Company or its Affiliates would be wrongful and would cause irreparable harm to the Company.&#160; Executive will refrain from intentionally committing any acts that would materially reduce the value of such knowledge or information to the Company or its Affiliates.&#160; The foregoing obligations of confidentiality shall not apply to any knowledge or information that (i)&nbsp;is now or subsequently becomes generally publicly known, other than as a direct or indirect result of the breach of this Agreement, (ii)&nbsp;is independently made available to Executive in good faith by a third party who has not violated a confidential relationship with the Company or its Affiliates, or (iii)&nbsp;is required to be disclosed by law or legal process.&#160; Executive understands and agrees that Executive&#146;s obligations under this Agreement to maintain the confidentiality of the Company&#146;s confidential information are in addition to any obligations of Executive under applicable statutory or common law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>VENTURES</u>.&#160; If, during Executive&#146;s employment with the Company, Executive is engaged in or provides input into the planning or implementing of any project, program or venture involving the Company, all rights in such project, program or venture belong to the Company.&#160; Except as approved in writing by the Board, Executive will not be entitled to any interest in any such project, program or venture or to any commission, finder&#146;s fee or other compensation in connection therewith.&#160; Executive will have no interest, direct or indirect, in any customer or supplier that conducts business with the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>NONCOMPETITION AND NONSOLICITATION COVENANTS</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Agreement Not to Compete</u>.&#160; During the Restricted Period (defined below), Executive will not, directly or indirectly, engage in any business, in the United States or in any other location in which the Company is then doing business, for the development, sale, service, or distribution of medical devices to treat lymphedema patients or any other business that is competitive with the then-current businesses of the Company or its Affiliates, including without limitation as a proprietor, principal, agent, partner, officer, director, stockholder, employee, member of any association, consultant or otherwise.&#160; Ownership by Executive, as a passive investment, of less than 2.5% of the outstanding shares of capital stock of any corporation listed on a national securities exchange or publicly traded in the over-the-counter market shall not constitute a breach of this Section&nbsp;7(a).&#160; Notwithstanding the foregoing, Executive&#146;s direct or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="16022-2-NO-01_PB_3_020622_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="17",CHK=456192,FOLIO='3',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NO-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:09 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">indirect engagement in a business whose sole purpose is the development, sale, service, or distribution of compression garments (but not pumps or other devices) to treat lymphedema patients or other patients shall not constitute a breach of this Section&nbsp;7(a).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Agreement Not to Solicit or Hire Employees or Contractors</u>. During Executive&#146;s employment with the Company or any Affiliates and for a period of twelve (12) consecutive months from and after the termination of Executive&#146;s employment, whether such termination is with or without cause, or whether such termination is at the instance of Executive or the Company, Executive will not, directly or indirectly, solicit, hire or engage any person who is then an employee or contractor of the Company or who was an employee of the Company at any time during the six (6)&nbsp;month period immediately preceding Executive&#146;s termination of employment, in any manner or capacity, including without limitation as a proprietor, principal, agent, partner, officer, director, stockholder, employee, member of any association, consultant or otherwise, or otherwise directly or indirectly request, advise or induce any then current employee or contractor of the Company to terminate or otherwise adversely change its relationship with the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Agreement Not to Solicit Others</u>. During Executive&#146;s employment with the Company or any Affiliates and for a period of twelve (12) consecutive months from and after the termination of Executive&#146;s employment, whether such termination is with or without cause, or whether such termination is at the instance of Executive or the Company, Executive will not, directly or indirectly, solicit, request, advise or induce any then current customer, supplier or other business contact of the Company to cancel, curtail or otherwise adversely change its relationship with the Company, in any manner or capacity, including without limitation as a proprietor, principal, agent, partner, officer, director, stockholder, employee, member of any association, consultant or otherwise.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Restricted Period</u>.&#160; For purposes of this Agreement &#147;<i>Restricted Period</i>&#148; is defined as follows.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If (x)&nbsp;Executive&#146;s employment is terminated by the Company without Cause (defined below) or by Executive for Good Reason (defined below), <i>and</i> (y)&nbsp;Executive signs a release of claims as provided for in Section&nbsp;11(g), then the Restricted Period shall be the period during Executive&#146;s employment with the Company or any Affiliates and for a period of nine (9)&nbsp;consecutive months from and after the termination of Executive&#146;s employment; provided that the Company may in its sole discretion elect to extend the Restricted Period by an additional six (6)&nbsp;months by providing Executive at least thirty (30) days&#146; notice of such extension and the payments and reimbursements provided for in Section&nbsp;11(a)(iii)&nbsp;of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If Executive&#146;s employment is terminated by the Company or by Executive under any conditions other than as provided for in Section&nbsp;7(d)(i), then the Restricted Period shall be the period during Executive&#146;s employment with the Company or any Affiliates and for a period of twelve (12) consecutive months from and after the termination of Executive&#146;s employment.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="16022-2-NO-01_PB_4_020702_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="17",CHK=330788,FOLIO='4',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NO-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:09 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Acknowledgment</u>.&#160; Executive hereby acknowledges that the provisions of this Section&nbsp;7 are reasonable and necessary to protect the legitimate interests of the Company and that any violation of this Section&nbsp;7 by Executive will cause substantial and irreparable harm to the Company to such an extent that monetary damages alone would be an inadequate remedy therefor.&#160; Executive represents and warrants that Executive is not subject to any other agreements prohibiting the performance of Executive&#146;s obligations under this Agreement, including any non-competition agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Blue Pencil Doctrine</u>.&#160; If the duration of, the scope of or any business activity covered by any provision of this Section&nbsp;7 is in excess of what is determined to be valid and enforceable under applicable law, such provision will be construed to cover only that duration, scope or activity that is determined to be valid and enforceable.&#160; Executive hereby acknowledges that this Section&nbsp;7 will be given the construction which renders its provisions valid and enforceable to the maximum extent, not exceeding its express terms, possible under applicable law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>PATENTS, COPYRIGHTS AND RELATED MATTERS</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Disclosure and Assignment</u>.&#160; Executive must immediately disclose to the Company any and all improvements and inventions that Executive may conceive and/or reduce to practice individually or jointly or commonly with others while Executive is employed with the Company or any of its Affiliates with respect to (i)&nbsp;any methods, processes or apparatus concerned with the development, use or production of any type of products, goods or services sold or used by the Company or its Affiliates, and (ii)&nbsp;any type of products, goods or services sold or used by the Company or its Affiliates.&#160; Any such improvements and inventions will be the sole and exclusive property of the Company and Executive hereby immediately assigns, transfers and sets over to the Company Executive&#146;s entire right, title and interest in and to any and all of such improvement and inventions as are specified in this Section&nbsp;8(a), and in and to any and all applications for letters patent that may be filed on such inventions, and in and to any and all letters patent that may issue, or be issued, upon such applications.&#160; In connection therewith and for no additional compensation therefor, but at no expense to Executive, Executive will sign any and all instruments deemed necessary by the Company for:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the filing and prosecution of any applications for letters patent of the United States or of any foreign country that the Company may desire to file upon such inventions as are specified in this Section&nbsp;8(a);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the filing and prosecution of any divisional, continuation, continuation-in-part or reissue applications that the Company may desire to file upon such applications for letters patent; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the reviving, re-examining or renewing of any of such applications for letters patent.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Section&nbsp;8(a)&nbsp;will not apply to any invention for which no equipment, supplies, facilities, confidential, proprietary or secret knowledge or information, or other trade secret information of the Company was used and that was developed entirely on Executive&#146;s own time, and (i)&nbsp;that</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="16022-2-NO-01_PB_5_020727_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="17",CHK=352730,FOLIO='5',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NO-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:09 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">does not relate (A)&nbsp;directly to the business of the Company, or (B)&nbsp;to the Company&#146;s actual or demonstrably anticipated research or development, or (ii)&nbsp;that does not result from any work performed by Executive for the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Copyrightable Material</u>.&#160; All right, title and interest in all copyrightable material that Executive shall conceive or originate individually or jointly or commonly with others, and that arise in connection with Executive&#146;s services hereunder or knowledge of confidential and proprietary information of the Company, will be the property of the Company and are hereby assigned by Executive to the Company of its Affiliates, along with ownership of any and all copyrights in the copyrightable material. Where applicable, works of authorship created by Executive relating to the Company or its Affiliates and arising out of Executive&#146;s knowledge of confidential and proprietary information of the Company shall be considered &#147;works made for hire,&#148; as defined in the U.S. Copyright Act, as amended.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Remedies</u>.<font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive acknowledges that it would be difficult to fully compensate the Company for monetary damages resulting from any breach by Executive of this Section&nbsp;8.&#160; Accordingly, in the event of any actual or threatened breach of any such provisions, the Company will, in addition to any other remedies it may have, be entitled to injunctive and other equitable relief to enforce such provisions, and such relief may be granted without the necessity of proving actual monetary damages.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>RETURN OF RECORDS AND PROPERTY</u>.&#160; Upon termination of Executive&#146;s employment or at any time upon the Company&#146;s request, Executive will promptly deliver to the Company any and all Company and Affiliate records and any and all Company and Affiliate property in Executive&#146;s possession or under Executive&#146;s control, including without limitation manuals, books, blank forms, documents, letters, memoranda, notes, notebooks, reports, printouts, computer disks, computer tapes, source codes, data, tables or calculations and all copies thereof, documents that in whole or in part contain any trade secrets or confidential, proprietary or other secret information of the Company or its Affiliates and all copies thereof, and keys, access cards, access codes, passwords, credit cards, personal computers, telephones and other electronic equipment belonging to the Company or its Affiliates.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>TERMINATION OF EMPLOYMENT</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s employment with the Company will terminate immediately upon:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s receipt of written notice from the Company of the termination of Executive&#146;s employment, effective as of the date indicated in such notice;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the Company&#146;s receipt of Executive&#146;s written resignation from the Company, effective as of the date indicated in such resignation;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s Disability (as defined below); or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s death.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">6<a name="16022-2-NO-01_PB_6_020747_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="17",CHK=821655,FOLIO='6',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NO-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:09 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The date upon which Executive&#146;s termination of employment with the Company occurs is the &#147;<i>Termination Date</i>.&#148; For purposes of Section&nbsp;11(a)&nbsp;of this Agreement only, the Termination Date shall mean the date on which a &#147;separation from service&#148; has occurred for purposes of Section&nbsp;409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance thereunder (the &#147;<i>Code</i>.&#148;)</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Immediately upon termination of Executive&#146;s employment with the Company for any reason, Executive shall resign all positions then held as an Executive of the Company and any Affiliates of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Following termination of Executive&#146;s employment with the Company for any reason, Executive shall cooperate with the Company in the transition of Executive&#146;s duties and responsibilities hereunder to the extent reasonably requested by the Board, provided that Executive will be fairly compensated to the extent such cooperation requires more than an incidental amount of time and effort on Executive&#146;s part, and further that Executive will not be required to incur any out-of-pocket expenses in doing so.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>PAYMENTS UPON TERMINATION OF EMPLOYMENT</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Subject to Section&nbsp;11(g)&nbsp;of this Agreement, if Executive&#146;s employment with the Company is terminated by the Company without Cause (as defined below) or by Executive for Good Reason (as defined below), then, in addition to paying Executive&#146;s earned and accrued base salary, accrued but unpaid expense reimbursements and benefits through the Termination Date, the Company will:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>pay to Executive an amount equal to Executive&#146;s then current base salary for a period of nine (9)&nbsp;months plus an amount equal to 75% of Executive&#146;s then current target bonus, with such sum, less applicable withholdings, payable in equal installments in accordance with the Company&#146;s regular payroll schedule commencing with the first normal payroll date of the Company following the Termination Date and continuing for nine (9)&nbsp;months thereafter, provided that any installments that would have been paid during the sixty (60) day period immediately following the Termination Date shall be held by the Company until the first payroll date occurring more than sixty (60) days after the Termination Date;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>if Executive is eligible for and takes all steps necessary to continue Executive&#146;s group health insurance coverage with the Company following the Termination Date, pay for the portion of the premium costs for such coverage that the Company would pay if Executive remained employed by the Company, at the same level of coverage that was in effect as of the Termination Date, for a period of nine (9)&nbsp;consecutive months after the Termination Date (or until Executive receives group health or dental coverage from another employer, if earlier); and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">7<a name="16022-2-NO-01_PB_7_020806_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="17",CHK=964211,FOLIO='7',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NO-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:09 2016' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>if the Company elects to extend the Restricted Period by six (6)&nbsp;months as provided for in Section&nbsp;7(d)(i), then the Company will (A)&nbsp;pay to Executive an additional amount equal to that two-thirds of that payable under Section&nbsp;11(a)(i), with such additional amount payable to Executive in equal installments in accordance with the Company&#146;s regular payroll schedule commencing on the first normal payroll date of the Company following the nine-month anniversary of the Termination Date and continuing for six (6)&nbsp;months thereafter, and (B)&nbsp;extend for an additional six (6)&nbsp;months the period during which it will pay a portion of the premium costs for group health insurance coverage as provided in, and subject to the conditions of, Section&nbsp;11(a)(ii).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If Executive&#146;s employment with the Company is terminated for any of the following reasons:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s abandonment of Executive&#146;s employment or Executive&#146;s resignation for any reason other than Good Reason (as defined below);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>termination of Executive&#146;s employment by the Company for Cause (as defined below); or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s death or Disability.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">then the Company will pay Executive or Executive&#146;s estate, as the case may be, Executive&#146;s earned and accrued base salary, accrued but unpaid expense reimbursements and benefits through the Termination Date.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Cause</i>&#148; hereunder means:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>an act or acts of dishonesty undertaken by Executive and intended to result in personal gain or enrichment of Executive or others at the expense of the Company;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>unlawful conduct or gross misconduct by Executive that, in either event, is injurious to the Company;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the conviction of Executive of a felony; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>material breach of any terms or conditions of this Agreement by Executive which breach has not been cured by Executive within 15 days after written notice thereof to Executive from the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For the purposes of Sections 11(c)(ii)&nbsp;and (iv), no act or failure to act on Executive&#146;s part shall be considered &#147;Cause&#148; if done by Executive pursuant to specific authorization evidenced by a resolution duly adopted by the Board or pursuant to specific advice given by counsel for the Company, unless such specific authorization or advice results in whole or in part from material misrepresentations or omissions of Executive.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">8<a name="16022-2-NO-03_PB_8_020027_4962"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="17",CHK=742431,FOLIO='8',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NO-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:04 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Disability</i>&#148; hereunder means the inability of Executive to perform on a full-time basis the duties and responsibilities of Executive&#146;s employment with the Company by reason of Executive&#146;s illness or other physical or mental impairment or condition, if such inability continues for an uninterrupted period of 90 days or more during any 180-day period.&#160; A period of inability is &#147;uninterrupted&#148; unless and until Executive returns to full-time work for a continuous period of at least 30 days.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Good Reason</i>&#148; hereunder means the occurrence of any of the following events without Executive&#146;s consent:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the assignment of Executive to a position with responsibilities or duties of a materially lesser status or degree than the position specified in Section&nbsp;2(a);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>material breach of any terms or conditions of this Agreement by the Company not caused by Executive;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the requirement by the Company that Executive relocate out of the Minneapolis/St. Paul Metropolitan area.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For the purposes of Section&nbsp;11(e), &#147;Good Reason&#148; shall not exist unless Executive has first provided written notice to the Company of the occurrence of one or more of the conditions under clauses (i)&nbsp;through (iii)&nbsp;above within ninety (90) days of the condition&#146;s initial occurrence, such condition is not fully remedied by the Company within thirty (30) days after the Company&#146;s receipt of written notice from Executive, and the Termination Date occurs no later than one hundred and thirty (130) days after the condition&#146;s initial occurrence.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In the event of termination of Executive&#146;s employment, the sole obligation of the Company to pay post-termination severance and benefits under this Agreement will be its obligation to make the payments called for by Sections 11(a) or 11(b) hereof, as the case may be, and the Company will have no other obligation to Executive, except as otherwise provided by law, under the terms of any other applicable agreement between Executive and the Company or under the terms of any employee benefit plans or programs then maintained by the Company in which Executive participates.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding the foregoing provisions of this Section&nbsp;11, the Company will not be obligated to make any payments under Section&nbsp;11(a)&nbsp;hereof unless Executive has signed a release of claims in favor of the Company and its Affiliates in substantially the form attached hereto, with such changes as may be necessary to account for changes in circumstances or law following the date hereof, all applicable consideration and rescission periods provided by law shall have expired, and Executive is in strict compliance with the terms of this Agreement as of the dates of such payments.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>MISCELLANEOUS</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Governing Law</u>.&#160; All matters relating to the interpretation, construction, application, validity and enforcement of this Agreement will be governed by the laws of the State of Minnesota without giving effect to any choice or conflict of law provision or rule, whether of</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">9<a name="16022-2-NO-03_PB_9_020053_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=9,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="17",CHK=355243,FOLIO='9',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NO-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:04 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">the State of Minnesota or any other jurisdiction, that would cause the application of laws of any jurisdiction other than the State of Minnesota.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Jurisdiction and Venue</u>.&#160; Executive and the Company consent to jurisdiction of the courts of the State of Minnesota and/or the federal courts, District of Minnesota, for the purpose of resolving all issues of law, equity, or fact, arising out of or in connection with this Agreement.&#160; Any action involving claims of a breach of this Agreement must be brought in such courts.&#160; Each party consents to personal jurisdiction over such party in the state and/or federal courts of Minnesota and hereby waives any defense of lack of personal jurisdiction.&#160; Venue, for the purpose of all such suits, will be in Hennepin County, State of Minnesota.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Entire Agreement</u>.&#160; This Agreement contains the entire agreement of the parties relating to Executive&#146;s employment with the Company and supersedes all prior agreements and understandings with respect to such subject matter, and the parties hereto have made no agreements, representations or warranties relating to the subject matter of this Agreement that are not set forth herein; provided, however, that nothing in this Agreement is intended to supersede, replace or modify the terms of the Company&#146;s 2016 Equity Incentive Plan or any equity award agreements issued to Executive under the Company&#146;s 2016 Equity Incentive Plan, each of which shall remain in full force and effect in accordance with their terms.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Code Section&nbsp;409A</u>.&#160; This Agreement is intended to be exempt from the requirements of Section&nbsp;409A(a)(2), (3) and (4)&nbsp;of the Code, including current and future guidance and regulations interpreting such provisions, and should be interpreted accordingly.&#160; To the extent such potential payments or benefits could become subject to additional tax under such Code Section&nbsp;409A, the parties shall cooperate to amend this Agreement with the goal of giving Executive the economic benefits described herein in a manner that does not result in such tax being imposed and as close as possible to the timing of such benefits proscribed herein.&#160; Each payment or benefit made pursuant to Section&nbsp;11(a)&nbsp;of this Agreement shall be deemed to be a separate payment for purposes of Code Section&nbsp;409A.&#160; In addition, payments or benefits pursuant to Section&nbsp;11(a)&nbsp;shall be exempt from the requirements of Code Section&nbsp;409A to the maximum extent possible as &#147;short-term deferrals&#148; pursuant to Treasury Regulation Section&nbsp;1.409A-1(b)(4), as involuntary separation pay pursuant to Treasury Regulation Section&nbsp;1.409A-1(b)(9)(iii), and/or under any other exemption that may be applicable, and this Agreement shall be construed accordingly.&#160; To the extent that any amounts payable under this Agreement are required to be delayed under Code Section&nbsp;409A, such amounts are intended to be and should be considered for purposes of Code Section&nbsp;409A as separate payments from the amounts that are not required to be delayed.&#160; Notwithstanding anything herein to the contrary, if Executive is considered a &#147;specified employee&#148; (as defined in Treasury Regulation Section&nbsp;1.409A-1(i)) as of the Termination Date, then no payments of deferred compensation subject to Code Section&nbsp;409A and payable due to Executive&#146;s separation from service shall be made under this Agreement before the first business day that is six (6)&nbsp;months after the Termination Date (or upon Executive&#146;s death, if earlier) (the &#147;<i>Specified Period</i>&#148;).&#160; Any deferred compensation payments that would otherwise be required to be made to Executive during the Specified Period will be accumulated by the Company and paid to Executive on the first day after the end of the Specified Period.&#160; The foregoing restriction on the payment of amounts to Executive during the Specified Period will not apply to the payment of employment taxes.&#160; In the event that the interpretation or requirements of Code Section&nbsp;409A change during the Term, the parties agree to amend this</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">10<a name="16022-2-NO-03_PB_10_020140_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=10,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="17",CHK=285723,FOLIO='10',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NO-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:04 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Agreement, only as necessary, to comply with any such change, if and to the extent such an amendment is permitted by Code Section&nbsp;409A.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Amendments</u>.&#160; No amendment or modification of this Agreement will be deemed effective unless made in writing and signed by the parties hereto.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Waiver</u>.&#160; No term or condition of this Agreement will be deemed to have been waived, except by a statement in writing signed by the party against whom enforcement of the waiver is sought.&#160; Any written waiver will not be deemed a continuing waiver unless specifically stated, will operate only as to the specific term or condition waived and will not constitute a waiver of such term or condition for the future or as to any act other than that specifically waived.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Assignment</u>.&#160; This Agreement will not be assignable, in whole or in part, by either party without the prior written consent of the other party, except that the Company may, without the consent of Executive, assign its rights and obligations under this Agreement to any corporation or other person or business entity to which the Company may sell or transfer all or substantially all of its assets; provided, however, that the Company&#146;s assignment of rights may only take place if the assignee accepts and agrees to all of the obligations to Executive under this Agreement.&#160; After any such assignment by the Company, the Company will be discharged from all further liability hereunder and such assignee will thereafter be deemed to be &#147;the Company&#148; for purposes of all terms and conditions of this Agreement, including this Section&nbsp;12. For the avoidance of doubt, in the event of Executive&#146;s death, all payments and obligations to Executive shall be paid to Executive&#146;s estate.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Counterparts</u>.&#160; This Agreement may be executed by facsimile signature and in any number of counterparts, and such counterparts executed and delivered, each as an original, will constitute but one and the same instrument.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Severability</u>.&#160; Subject to Section&nbsp;7(f)&nbsp;hereof, to the extent that any portion of any provision of this Agreement is held invalid or unenforceable, it will be considered deleted herefrom and the remainder of such provision and of this Agreement will be unaffected and will continue in full force and effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Captions and Headings</u>.&#160; The captions and paragraph headings used in this Agreement are for convenience of reference only and will not affect the construction or interpretation of this Agreement or any of the provisions hereof.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(k)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Notices</u>.&#160; All notices, requests, consents and other communications hereunder (i)&nbsp;shall be in writing, (ii)&nbsp;shall be effective upon receipt, and (iii)&nbsp;shall be sufficient if delivered personally, electronically or by mail, in each case addressed to the Company at its principal executive officer and to Executive at Executive&#146;s most recent residential address known by the Company or any other address Executive may provide to the Company in writing.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">11<a name="16022-2-NO-03_PB_11_020151_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=11,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="17",CHK=710595,FOLIO='11',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NO-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:04 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Executive and the Company have executed this Agreement effective as of the Effective Date set forth in the first paragraph.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE   SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.92%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   Gerald R. Mattys</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gerald   R. Mattys</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:1.0pt;font-style:italic;">&nbsp;</font></i></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.92%;">
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:1.0pt;font-style:italic;">&nbsp;</font></i></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.08%;">
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Chief   Executive Officer</font></i></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   Lynn Blake</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">LYNN   BLAKE</font></b></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">12<a name="16022-2-NO-03_PB_12_020249_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=12,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="17",CHK=710136,FOLIO='12',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NO-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:04 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.24
<SEQUENCE>18
<FILENAME>a2228882zex-10_24.htm
<DESCRIPTION>EX-10.24
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;10.24</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EMPLOYMENT AGREEMENT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">This Employment Agreement (this &#147;<i>Agreement</i>&#148;) is entered into effective </font><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></font>, 2016 (the &#147;<i>Effective Date</i>&#148;) by and between <b>TACTILE SYSTEMS TECHNOLOGY,&nbsp;INC.</b>, a Delaware corporation (the &#147;<i>Company</i>&#148;), and <b>BRYAN RISHE</b>, a resident of North Carolina (&#147;<i>Executive</i>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BACKGROUND</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company and Executive have been parties to an Employment Agreement, dated December&nbsp;15, 2008 (the &#147;<i>Prior Agreement</i>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">B.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company desires to employ Executive on the terms and conditions set forth in this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">C.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Executive desires to be employed by the Company on the terms and conditions set forth in this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">D.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>This Agreement shall govern the employment relationship between the Executive and the Company from and after the Effective Date hereof, and supersedes and negates any previous agreements or understandings, whether written or oral, with respect to such relationship, including without limitation the Prior Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">AGREEMENT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In consideration of the foregoing premises and the respective agreements of the Company and Executive set forth below, the Company and Executive, intending to be legally bound, agree as follows:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>EMPLOYMENT</u>. The term of Executive&#146;s employment under this Agreement shall commence as of the Effective Date and continue until terminated in accordance with Section&nbsp;10 hereof (the &#147;<i>Term</i>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>POSITION AND DUTIES</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Position with the Company</u>.&#160; During the Term, Executive will serve as the Company&#146;s <b>VICE PRESIDENT, SALES</b> and will perform such duties and responsibilities as the Company&#146;s Chief Executive Officer will assign to Executive from time to time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Performance of Duties and Responsibilities</u>.&#160; Executive will serve the Company faithfully and to the best of Executive&#146;s ability and will devote Executive&#146;s full time, attention and efforts to the business of the Company during Executive&#146;s employment with the Company.&#160; Executive will report to the Company&#146;s Chief Executive Officer or such other individual or individuals designated by the Chief Executive Officer.&#160; During Executive&#146;s employment hereunder, Executive will not accept other employment or engage in other material business activity, except as approved in writing by the Company&#146;s Board of Directors (the &#147;<i>Board</i>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="18",CHK=673653,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>COMPENSATION</u>.&#160; While Executive is employed by the Company during the Term, and in exchange for Executive fulfilling Executive&#146;s duties and responsibilities as set forth in this Agreement, the Company will provide Executive the compensation and benefits set forth in this Section&nbsp;3.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Base Salary</u>.&#160; The Company will pay to Executive an annual base salary of <b>$257,500</b>, less deductions and withholdings, which base salary will be paid in accordance with the Company&#146;s normal payroll policies and procedures.&#160; During each year after the first year of Executive&#146;s employment hereunder, the Compensation Committee of the Board (the &#147;<i>Committee</i>&#148;) may review and increase Executive&#146;s base salary in its sole discretion.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Bonus.</u>&#160; For each calendar year Executive is employed by the Company, Executive shall be eligible for an annual target bonus in an amount of <b>45%</b> of Executive&#146;s base salary earned during such calendar year, based upon and subject to criteria set by the Committee from time to time.&#160; In order to earn and receive payment of an annual bonus, Executive must be an employee of the Company on the date the bonus is paid by the Company, provided, however, that if Executive&#146;s employment is terminated by the Company other than for Cause (as herein defined) or by Executive for Good Reason (as herein defined) and the Termination Date (as defined herein) is after the completion of a calendar year but before the annual bonus for such calendar year has been paid to Executive, then Executive will earn and receive payment of an annual bonus for such prior calendar year in accordance with the bonus plan in effect for such year. In any case, any annual bonus earned under this Section&nbsp;3(b)&nbsp;will be paid not later than March&nbsp;15 immediately following the calendar year to which the bonus relates.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Equity Awards</u>.&#160; During the Term, Executive shall be eligible to receive one or more equity-based incentive awards at the discretion of the Committee.&#160; The terms of such awards, if any, shall be determined in the sole discretion of the Committee, including the types of awards, the number of securities covered by each award, the vesting conditions applicable to each award, and the manner in which awards are to be paid or settled.&#160; Nothing herein shall obligate the Company to make an equity award to Executive at any time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Employee Benefits</u>.&#160; Executive shall be entitled to participate in all employee benefit plans and programs of the Company to the extent that Executive meets the eligibility requirements for each individual plan or program.&#160; The Company provides no assurance as to the adoption or continuance of any particular employee benefit plan or program, and Executive&#146;s participation in any such plan or program will be subject to the provisions, rules&nbsp;and regulations applicable thereto.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Expenses</u>.&#160; The Company will reimburse Executive for all reasonable and necessary out-of-pocket business, travel and entertainment expenses incurred by Executive in the performance of the duties and responsibilities hereunder, subject to the Company&#146;s normal policies and procedures for expense verification and documentation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Paid Time Off</u>.&#160; Executive shall be entitled to paid time off (&#147;<i>PTO</i>&#148;) of 27 days per year.&#160; PTO days shall be taken at such times so as not to disrupt the operations of the Company, as approved by the Company&#146;s Chief Executive Officer.&#160; Any accrued and unused</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=2,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="18",CHK=394033,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">PTO upon termination of employment will not be paid out pursuant to the Company&#146;s standard policies addressing PTO.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>AFFILIATED ENTITIES</u>.&#160; As used in this Agreement, &#147;<i>Affiliates</i>&#148; includes the Company and each corporation, partnership, or other entity which controls the Company, is controlled by the Company, <u>OR</u> is under common control with the Company (in each case &#147;<i>control</i>&#148; meaning the direct or indirect ownership of 50% or more of all outstanding equity interests).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>CONFIDENTIAL INFORMATION</u>.&#160; Except as permitted by the Company, Executive will not at any time divulge, furnish or make accessible to anyone or use in any way other than in the ordinary course of the business of the Company or its Affiliates, any confidential, proprietary or secret knowledge or information of the Company or its Affiliates that Executive has acquired or will acquire about the Company or its Affiliates, whether developed by Executive or by others, concerning (i)&nbsp;any trade secrets, (ii)&nbsp;any confidential, proprietary or secret designs, programs, processes, formulae, plans, devices or material (whether or not patented or patentable) directly or indirectly useful in any aspect of the business of the Company or of its Affiliates, (iii)&nbsp;any customer or supplier lists, (iv)&nbsp;any confidential, proprietary or secret development or research work, (v)&nbsp;any strategic or other business, marketing or sales plans, (vi)&nbsp;any financial data or plans, or (viii)&nbsp;any other confidential or proprietary information or secret aspects of the business of the Company or of its Affiliates.&#160; Executive acknowledges that the above-described knowledge and information constitutes a unique and valuable asset of the Company and represents a substantial investment of time and expense by the Company, and that any disclosure or other use of such knowledge or information other than for the sole benefit of the Company or its Affiliates would be wrongful and would cause irreparable harm to the Company.&#160; Executive will refrain from intentionally committing any acts that would materially reduce the value of such knowledge or information to the Company or its Affiliates.&#160; The foregoing obligations of confidentiality shall not apply to any knowledge or information that (i)&nbsp;is now or subsequently becomes generally publicly known, other than as a direct or indirect result of the breach of this Agreement, (ii)&nbsp;is independently made available to Executive in good faith by a third party who has not violated a confidential relationship with the Company or its Affiliates, or (iii)&nbsp;is required to be disclosed by law or legal process.&#160; Executive understands and agrees that Executive&#146;s obligations under this Agreement to maintain the confidentiality of the Company&#146;s confidential information are in addition to any obligations of Executive under applicable statutory or common law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>VENTURES</u>.&#160; If, during Executive&#146;s employment with the Company, Executive is engaged in or provides input into the planning or implementing of any project, program or venture involving the Company, all rights in such project, program or venture belong to the Company.&#160; Except as approved in writing by the Board, Executive will not be entitled to any interest in any such project, program or venture or to any commission, finder&#146;s fee or other compensation in connection therewith.&#160; Executive will have no interest, direct or indirect, in any customer or supplier that conducts business with the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>NONCOMPETITION AND NONSOLICITATION COVENANTS</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Agreement Not to Compete</u>.&#160; During the Restricted Period (defined below), Executive will not, directly or indirectly, engage in any business, in the United States or in any</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=3,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="18",CHK=22697,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">other location in which the Company is then doing business, for the development, sale, service, or distribution of medical devices to treat lymphedema patients or any other business that is competitive with the then-current businesses of the Company or its Affiliates, including without limitation as a proprietor, principal, agent, partner, officer, director, stockholder, employee, member of any association, consultant or otherwise.&#160; Ownership by Executive, as a passive investment, of less than 2.5% of the outstanding shares of capital stock of any corporation listed on a national securities exchange or publicly traded in the over-the-counter market shall not constitute a breach of this Section&nbsp;7(a).&#160; Notwithstanding the foregoing, Executive&#146;s direct or indirect engagement in a business whose sole purpose is the development, sale, service, or distribution of compression garments (but not pumps or other devices) to treat lymphedema patients or other patients shall not constitute a breach of this Section&nbsp;7(a).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Agreement Not to Solicit or Hire Employees or Contractors</u>. During Executive&#146;s employment with the Company or any Affiliates and for a period of twelve (12) consecutive months from and after the termination of Executive&#146;s employment, whether such termination is with or without cause, or whether such termination is at the instance of Executive or the Company, Executive will not, directly or indirectly, solicit, hire or engage any person who is then an employee or contractor of the Company or who was an employee of the Company at any time during the six (6)&nbsp;month period immediately preceding Executive&#146;s termination of employment, in any manner or capacity, including without limitation as a proprietor, principal, agent, partner, officer, director, stockholder, employee, member of any association, consultant or otherwise, or otherwise directly or indirectly request, advise or induce any then current employee or contractor of the Company to terminate or otherwise adversely change its relationship with the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Agreement Not to Solicit Others</u>. During Executive&#146;s employment with the Company or any Affiliates and for a period of twelve (12) consecutive months from and after the termination of Executive&#146;s employment, whether such termination is with or without cause, or whether such termination is at the instance of Executive or the Company, Executive will not, directly or indirectly, solicit, request, advise or induce any then current customer, supplier or other business contact of the Company to cancel, curtail or otherwise adversely change its relationship with the Company, in any manner or capacity, including without limitation as a proprietor, principal, agent, partner, officer, director, stockholder, employee, member of any association, consultant or otherwise.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Restricted Period</u>.&#160; For purposes of this Agreement &#147;<i>Restricted Period</i>&#148; is defined as follows.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If (x)&nbsp;Executive&#146;s employment is terminated by the Company without Cause (as defined below), by Executive for Good Reason (as defined below), by Executive for CIC Reason (as defined below), or if Executive&#146;s employment with the Company is terminated due to Disability (as defined below)<i> and</i> (y)&nbsp;Executive signs a release of claims as provided for in Section&nbsp;11(i), then the Restricted Period shall be the period during Executive&#146;s employment with the Company or any Affiliates and for a period of <b>nine (9)</b>&nbsp;consecutive months from and after the termination of Executive&#146;s employment; provided that the Company may in its sole</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=4,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="18",CHK=711915,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">discretion elect to extend the Restricted Period by an additional six (6)&nbsp;months by providing Executive at least thirty (30) days&#146; notice of such extension and the payments and reimbursements provided for in Section&nbsp;11(a)(iv)&nbsp;or 11(b)(iv)&nbsp;of this Agreement (as applicable).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If Executive&#146;s employment is terminated by the Company or by Executive under any conditions other than as provided for in Section&nbsp;7(d)(i), then the Restricted Period shall be the period during Executive&#146;s employment with the Company or any Affiliates and for a period of twelve (12) consecutive months from and after the termination of Executive&#146;s employment.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Acknowledgment</u>.&#160; Executive hereby acknowledges that the provisions of this Section&nbsp;7 are reasonable and necessary to protect the legitimate interests of the Company and that any violation of this Section&nbsp;7 by Executive will cause substantial and irreparable harm to the Company to such an extent that monetary damages alone would be an inadequate remedy therefor.&#160; Executive represents and warrants that Executive is not subject to any other agreements prohibiting the performance of Executive&#146;s obligations under this Agreement, including any non-competition agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Blue Pencil Doctrine</u>.&#160; If the duration of, the scope of or any business activity covered by any provision of this Section&nbsp;7 is in excess of what is determined to be valid and enforceable under applicable law, such provision will be construed to cover only that duration, scope or activity that is determined to be valid and enforceable.&#160; Executive hereby acknowledges that this Section&nbsp;7 will be given the construction which renders its provisions valid and enforceable to the maximum extent, not exceeding its express terms, possible under applicable law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>PATENTS, COPYRIGHTS AND RELATED MATTERS</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Disclosure and Assignment</u>.&#160; Executive must immediately disclose to the Company any and all improvements and inventions that Executive may conceive and/or reduce to practice individually or jointly or commonly with others while Executive is employed with the Company or any of its Affiliates with respect to (i)&nbsp;any methods, processes or apparatus concerned with the development, use or production of any type of products, goods or services sold or used by the Company or its Affiliates, and (ii)&nbsp;any type of products, goods or services sold or used by the Company or its Affiliates.&#160; Any such improvements and inventions will be the sole and exclusive property of the Company and Executive hereby immediately assigns, transfers and sets over to the Company Executive&#146;s entire right, title and interest in and to any and all of such improvement and inventions as are specified in this Section&nbsp;8(a), and in and to any and all applications for letters patent that may be filed on such inventions, and in and to any and all letters patent that may issue, or be issued, upon such applications.&#160; In connection therewith and for no additional compensation therefor, but at no expense to Executive, Executive will sign any and all instruments deemed necessary by the Company for:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the filing and prosecution of any applications for letters patent of the United States or of any foreign country that the Company may desire to file upon such inventions as are specified in this Section&nbsp;8(a);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=5,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="18",CHK=942588,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the filing and prosecution of any divisional, continuation, continuation-in-part or reissue applications that the Company may desire to file upon such applications for letters patent; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the reviving, re-examining or renewing of any of such applications for letters patent.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Section&nbsp;8(a)&nbsp;will not apply to any invention for which no equipment, supplies, facilities, confidential, proprietary or secret knowledge or information, or other trade secret information of the Company was used and that was developed entirely on Executive&#146;s own time, and (i)&nbsp;that does not relate (A)&nbsp;directly to the business of the Company, or (B)&nbsp;to the Company&#146;s actual or demonstrably anticipated research or development, or (ii)&nbsp;that does not result from any work performed by Executive for the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Copyrightable Material</u>.&#160; All right, title and interest in all copyrightable material that Executive shall conceive or originate individually or jointly or commonly with others, and that arise in connection with Executive&#146;s services hereunder or knowledge of confidential and proprietary information of the Company, will be the property of the Company and are hereby assigned by Executive to the Company of its Affiliates, along with ownership of any and all copyrights in the copyrightable material. Where applicable, works of authorship created by Executive relating to the Company or its Affiliates and arising out of Executive&#146;s knowledge of confidential and proprietary information of the Company shall be considered &#147;works made for hire,&#148; as defined in the U.S. Copyright Act, as amended.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Remedies</u>.&#160; Executive acknowledges that it would be difficult to fully compensate the Company for monetary damages resulting from any breach by Executive of this Section&nbsp;8.&#160; Accordingly, in the event of any actual or threatened breach of any such provisions, the Company will, in addition to any other remedies it may have, be entitled to injunctive and other equitable relief to enforce such provisions, and such relief may be granted without the necessity of proving actual monetary damages.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>RETURN OF RECORDS AND PROPERTY</u>.&#160; Upon termination of Executive&#146;s employment or at any time upon the Company&#146;s request, Executive will promptly deliver to the Company any and all Company and Affiliate records and any and all Company and Affiliate property in Executive&#146;s possession or under Executive&#146;s control, including without limitation manuals, books, blank forms, documents, letters, memoranda, notes, notebooks, reports, printouts, computer disks, computer tapes, source codes, data, tables or calculations and all copies thereof, documents that in whole or in part contain any trade secrets or confidential, proprietary or other secret information of the Company or its Affiliates and all copies thereof, and keys, access cards, access codes, passwords, credit cards, personal computers, telephones and other electronic equipment belonging to the Company or its Affiliates.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>TERMINATION OF EMPLOYMENT</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s employment with the Company will terminate immediately upon:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=6,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="18",CHK=941074,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s receipt of written notice from the Company of the termination of Executive&#146;s employment, effective as of the date indicated in such notice;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the Company&#146;s receipt of Executive&#146;s written resignation from the Company, effective as of the date indicated in such resignation;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s Disability (as defined below); or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s death.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The date upon which Executive&#146;s termination of employment with the Company occurs is the &#147;<i>Termination Date</i>.&#148; For purposes of Section&nbsp;11(a)&nbsp;and 11(b)&nbsp;of this Agreement only, the Termination Date shall mean the date on which a &#147;separation from service&#148; has occurred for purposes of Section&nbsp;409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance thereunder (the &#147;<i>Code</i>.&#148;)</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Immediately upon termination of Executive&#146;s employment with the Company for any reason, Executive shall resign all positions then held as an Executive of the Company and any Affiliates of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Following termination of Executive&#146;s employment with the Company for any reason, Executive shall cooperate with the Company in the transition of Executive&#146;s duties and responsibilities hereunder to the extent reasonably requested by the Board; provided that Executive will be fairly compensated to the extent such cooperation requires more than an incidental amount of time and effort on Executive&#146;s part, and further that Executive will not be required to incur any out-of-pocket expenses in doing so.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>PAYMENTS UPON TERMINATION OF EMPLOYMENT</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Subject to Section&nbsp;11(i)&nbsp;of this Agreement, if Executive&#146;s employment with the Company is terminated by the Company without Cause or by Executive for Good Reason, then, in addition to paying Executive&#146;s earned and accrued base salary, accrued but unpaid expense reimbursements and benefits through the Termination Date, the Company will provide to Executive the following payments:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Separation Pay</u>.&#160; The Company will pay to Executive an amount equal to Executive&#146;s then current base salary for a period of <b>nine (9)</b>&nbsp;months plus an amount equal to <b>75%</b> of Executive&#146;s then current target bonus, with such sum, less applicable withholdings, payable in equal installments in accordance with the Company&#146;s regular payroll schedule commencing with the first normal payroll date of the Company following the Termination Date and continuing for <b>nine (9)</b>&nbsp;months thereafter, provided that any installments that would have been paid during the sixty (60) day period immediately following the Termination Date shall be held by the Company until the first payroll date occurring more than sixty (60) days after the Termination Date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=7,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="18",CHK=549046,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Value of Accrued and Unused PTO</u>.&#160; The Company will pay to Executive the value of Executive&#146;s accrued and unused PTO as of the Termination Date (based on Executive&#146;s base salary as of the Termination Date), less applicable withholdings, payable in a lump sum on the Company&#146;s first payroll date occurring more than sixty (60) days after the Termination Date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Continued Benefits</u>. If Executive is eligible for and takes all steps necessary to continue Executive&#146;s group health insurance coverage with the Company following the Termination Date, the Company will pay for the portion of the premium costs for such coverage that the Company would pay if Executive remained employed by the Company, at the same level of coverage that was in effect as of the Termination Date, for a period of <b>nine (9)&nbsp;</b>consecutive months after the Termination Date (or until Executive receives group health or dental coverage from another employer, if earlier).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Restricted Period Extension Payments</u>.&#160; If the Company elects to extend the Restricted Period for six (6)&nbsp;additional months as provided for in Section&nbsp;7(d)(i), then the Company will (A)&nbsp;pay to Executive an amount equal to the monthly amount payable to Executive under Section&nbsp;11(a)(i), with such additional amounts payable to Executive in installments in accordance with the Company&#146;s regular payroll schedule commencing on the first normal payroll date of the Company following the nine (9)&nbsp;month anniversary of the Termination Date and continuing for six (6)&nbsp;months thereafter, and (B)&nbsp;extend for six (6)&nbsp;additional months (after the end of the nine (9)&nbsp;month period identified in Section&nbsp;11(a)(iii)) the period during which it will pay a portion of the premium costs for group health insurance coverage as provided in, and subject to the same conditions of, Section&nbsp;11(a)(iii).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Accelerated Vesting of Equity</u>.&#160; In addition to the payments identified above in Sections 11(a)(i)-(iv), if Executive&#146;s employment with the Company is terminated by the Company without Cause or by Executive for Good Reason, then, subject to Section&nbsp;11(i)&nbsp;of this Agreement and notwithstanding any language in any equity plan or applicable equity award agreement to the contrary, upon the expiration of the all rescission periods provided by law with respect to the release of claims described in Section&nbsp;11(i), any equity awards issued to Executive that have any portion of such award unvested as of the Termination Date (each an &#147;<i>Award</i>&#148;) will vest as to the number of shares, options or other securities (the &#147;<i>Securities</i>&#148;) &nbsp;calculated as follows (rounded up to the nearest whole share):</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Additional Securities Vested = (Number of Securities Issued Under Award x ((Number of Days between Date of Grant of Award and Termination Date) / (Number of Days between Date of Grant of Award and Final</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=8,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="18",CHK=343041,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vesting Date of Award))) &#151; Number of Securities Vested Under Award as of the Termination Date.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Subject to Section&nbsp;11(i)&nbsp;of this Agreement, if Executive&#146;s employment with the Company is terminated by Executive for CIC Reason, or if Executive&#146;s employment with the Company is terminated due to death or Disability, then, in addition to paying Executive&#146;s earned and accrued base salary, accrued but unpaid expense reimbursements and benefits through the Termination Date, the Company will provide to Executive the following payments:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Separation Pay</u>.&#160; The Company will pay an amount equal to Executive&#146;s then current base salary for a period of <b>nine (9)</b>&nbsp;months plus an amount equal to <b>75%</b> of Executive&#146;s then current target bonus, with such sum, less applicable withholdings, payable in equal installments in accordance with the Company&#146;s regular payroll schedule commencing with the first normal payroll date of the Company following the Termination Date and continuing for <b>nine (9)</b>&nbsp;months thereafter, provided that any installments that would have been paid during the sixty (60) day period immediately following the Termination Date shall be held by the Company until the first payroll date occurring more than sixty (60) days after the Termination Date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Value of Accrued and Unused PTO</u>.&#160; The Company will pay to Executive the value of Executive&#146;s accrued and unused PTO as of the Termination Date (based on Executive&#146;s base salary as of the Termination Date), less applicable withholdings, payable in a lump sum on the Company&#146;s first payroll date occurring more than sixty (60) days after the Termination Date.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Continued Benefits</u>. If Executive is eligible for and takes all steps necessary to continue Executive&#146;s group health insurance coverage with the Company following the Termination Date, the Company will pay for the portion of the premium costs for such coverage that the Company would pay if Executive remained employed by the Company, at the same level of coverage that was in effect as of the Termination Date, for a period of <b>nine (9)&nbsp;</b>consecutive months after the Termination Date (or until Executive receives group health or dental coverage from another employer, if earlier).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Restricted Period Extension Payments</u>.&#160; If the Company elects to extend the Restricted Period for six (6)&nbsp;additional months as provided for in Section&nbsp;7(d)(i), then the Company will (A)&nbsp;pay to Executive an amount equal to the monthly amount payable to Executive under Section&nbsp;11(b)(i), with such additional amounts payable to Executive in installments in accordance with the Company&#146;s regular payroll schedule commencing on the first normal payroll date of the Company following the nine (9)&nbsp;month anniversary of the Termination Date and continuing for six (6)&nbsp;months thereafter, and (B)&nbsp;extend for six (6)&nbsp;additional months (after the end of</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=9,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="18",CHK=899207,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NQ-01_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 07:45 2016' -->

<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">the nine month period identified in Section&nbsp;11(b)(iii)) the period during which it will pay a portion of the premium costs for group health insurance coverage as provided in, and subject to the same conditions of, Section&nbsp;11(b)(iii).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If Executive&#146;s employment with the Company is terminated for any of the following reasons:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Executive&#146;s abandonment of Executive&#146;s employment or Executive&#146;s resignation for any reason other than Good Reason or CIC Reason; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>termination of Executive&#146;s employment by the Company for Cause;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">then the Company will pay Executive or Executive&#146;s estate, as the case may be, Executive&#146;s earned and accrued base salary, accrued but unpaid expense reimbursements and benefits through the Termination Date.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Cause</i>&#148; hereunder means:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>an act or acts of dishonesty undertaken by Executive and intended to result in personal gain or enrichment of Executive or others at the expense of the Company;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>unlawful conduct or gross misconduct by Executive that, in either event, is injurious to the Company;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the conviction of Executive of a felony; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>material breach of any terms or conditions of this Agreement by Executive which breach has not been cured by Executive within 15 days after written notice thereof to Executive from the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For the purposes of Sections 11(d)(ii)&nbsp;and (iv), no act or failure to act on Executive&#146;s part shall be considered &#147;Cause&#148; if done by Executive pursuant to specific authorization evidenced by a resolution duly adopted by the Board or pursuant to specific advice given by counsel for the Company, unless such specific authorization or advice results in whole or in part from material misrepresentations or omissions of Executive.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Disability</i>&#148; hereunder means the inability of Executive to perform on a full-time basis the duties and responsibilities of Executive&#146;s employment with the Company by reason of Executive&#146;s illness or other physical or mental impairment or condition, if such inability continues for an uninterrupted period of 90 days or more during any 180-day period.&#160; A period of inability is &#147;uninterrupted&#148; unless and until Executive returns to full-time work for a continuous period of at least 30 days.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>CIC Reason</i>&#148; hereunder means Executive&#146;s separation from service after a Change in Control (as defined in the Tactile Systems Technology,&nbsp;Inc. 2016 Equity Incentive Plan) occurs, provided that, if requested by the Company or any successor of the Company,</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=10,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="18",CHK=77622,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NQ-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:34 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Executive remains employed by the Company or any successor of the Company for a transition period not to exceed sixty (60) days following such Change in Control and Executive&#146;s Termination Date occurs no later than ten (10)&nbsp;days after the end of any transition period requested by the Company or any successor of the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:38.25pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>&#147;<i>Good Reason</i>&#148; hereunder means the occurrence of any of the following events without Executive&#146;s consent:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the assignment of Executive to a position with responsibilities or duties of a materially lesser status or degree than the position specified in Section&nbsp;2(a);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>material breach of any terms or conditions of this Agreement by the Company not caused by Executive;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the requirement by the Company that Executive relocate out of the Charlotte, North Carolina Metropolitan area.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For the purposes of Section&nbsp;11(g), &#147;Good Reason&#148; shall not exist unless Executive has first provided written notice to the Company of the occurrence of one or more of the conditions under clauses (i)&nbsp;through (iii)&nbsp;above within ninety (90) days of the condition&#146;s initial occurrence, such condition is not fully remedied by the Company within thirty (30) days after the Company&#146;s receipt of written notice from Executive, and the Termination Date occurs no later than one hundred and thirty (130) days after the condition&#146;s initial occurrence.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In the event of termination of Executive&#146;s employment, the sole obligation of the Company to pay post-termination severance and benefits under this Agreement will be its obligation to make the payments called for by Sections 11(a), 11(b)&nbsp;or 11(c)&nbsp;hereof, as the case may be, and the Company will have no other obligation to Executive, except as otherwise provided by law, under the terms of any other applicable agreement between Executive and the Company or under the terms of any employee benefit plans or programs then maintained by the Company in which Executive participates.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding the foregoing provisions of this Section&nbsp;11, the Company will not be obligated to make any payments under Section&nbsp;11(a)&nbsp;or 11(b)&nbsp;hereof unless Executive has signed a release of claims in favor of the Company and its Affiliates in a form to be prescribed by the Company, all applicable consideration and rescission periods provided by law shall have expired, and Executive is in strict compliance with the terms of this Agreement as of the dates of such payments.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>MISCELLANEOUS</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Governing Law</u>.&#160; All matters relating to the interpretation, construction, application, validity and enforcement of this Agreement will be governed by the laws of the State of Minnesota without giving effect to any choice or conflict of law provision or rule, whether of the State of Minnesota or any other jurisdiction, that would cause the application of laws of any jurisdiction other than the State of Minnesota.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=11,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="18",CHK=62959,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NQ-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:34 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Jurisdiction and Venue</u>.&#160; Executive and the Company consent to jurisdiction of the courts of the State of Minnesota and/or the federal courts, District of Minnesota, for the purpose of resolving all issues of law, equity, or fact, arising out of or in connection with this Agreement.&#160; Any action involving claims of a breach of this Agreement must be brought in such courts.&#160; Each party consents to personal jurisdiction over such party in the state and/or federal courts of Minnesota and hereby waives any defense of lack of personal jurisdiction.&#160; Venue, for the purpose of all such suits, will be in Hennepin County, State of Minnesota.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Entire Agreement</u>.&#160; This Agreement contains the entire agreement of the parties relating to Executive&#146;s employment with the Company and supersedes all prior agreements and understandings with respect to such subject matter, including without limitation the Prior Agreement, and the parties hereto have made no agreements, representations or warranties relating to the subject matter of this Agreement that are not set forth herein; provided, however, that nothing in this Agreement is intended to supersede, replace or modify the terms of the Company&#146;s 2016 Equity Incentive Plan or any equity award agreements issued to Executive under the Company&#146;s 2016 Equity Incentive Plan, each of which shall remain in full force and effect in accordance with their terms.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Code Section&nbsp;409A</u>.&#160; This Agreement is intended to be exempt from or comply with the requirements of Section&nbsp;409A(a)(2), (3)&nbsp;and (4)&nbsp;of the Code, including current and future guidance and regulations interpreting such provisions, and should be interpreted accordingly.&#160; To the extent such potential payments or benefits could become subject to additional tax under such Code Section&nbsp;409A, the parties shall cooperate to amend this Agreement with the goal of giving Executive the economic benefits described herein in a manner that does not result in such tax being imposed.&#160; Each payment or benefit made pursuant to Section&nbsp;11(a) or 11(b)&nbsp;of this Agreement shall be deemed to be a separate payment for purposes of Code Section&nbsp;409A.&#160; In addition, payments or benefits pursuant to Section&nbsp;11(a)&nbsp;or 11(b)&nbsp;shall be exempt from the requirements of Code Section&nbsp;409A to the maximum extent possible as &#147;short-term deferrals&#148; pursuant to Treasury Regulation Section&nbsp;1.409A-1(b)(4), as involuntary separation pay pursuant to Treasury Regulation Section&nbsp;1.409A-1(b)(9)(iii), and/or under any other exemption that may be applicable, and this Agreement shall be construed accordingly.&#160; To the extent that any amounts payable under this Agreement are required to be delayed under Code Section&nbsp;409A, such amounts are intended to be and should be considered for purposes of Code Section&nbsp;409A as separate payments from the amounts that are not required to be delayed.&#160; Notwithstanding anything herein to the contrary, if Executive is considered a &#147;specified employee&#148; (as defined in Treasury Regulation Section&nbsp;1.409A-1(i)) as of the Termination Date, then no payments of deferred compensation subject to Code Section&nbsp;409A and payable due to Executive&#146;s separation from service shall be made under this Agreement before the first business day that is six (6)&nbsp;months after the Termination Date (or upon Executive&#146;s death, if earlier) (the &#147;<i>Specified Period</i>&#148;).&#160; Any deferred compensation payments that would otherwise be required to be made to Executive during the Specified Period will be accumulated by the Company and paid to Executive on the first day after the end of the Specified Period.&#160; The foregoing restriction on the payment of amounts to Executive during the Specified Period will not apply to the payment of employment taxes.&#160; In the event that the interpretation or requirements of Code Section&nbsp;409A change during the Term, the parties agree to amend this Agreement, only as necessary, to comply with any such change, if and to the extent such an amendment is permitted by Code Section&nbsp;409A.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=12,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="18",CHK=670777,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NQ-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:34 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Code Section&nbsp;280G</u>.&#160; Notwithstanding anything in this Agreement to the contrary, if any payment or other benefit hereunder, together with any other payments or benefits that Executive has the right to receive from the Company or any corporation which is a member of an &#147;affiliated group&#148; (as defined in Section&nbsp;1504(a)&nbsp;of the Code without regard to Section&nbsp;1504(b)&nbsp;of the Code) of which the Company is a member, would constitute a &#147;parachute payment&#148; (as defined in Section&nbsp;280G(b)(2)&nbsp;of the Code), then, such payments and benefits will be reduced to the largest amount as, in the sole judgment of the Company, will result in no portion of such payments or benefits being subject to the excise tax imposed by Section&nbsp;4999 of the Code.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Amendments</u>.&#160; No amendment or modification of this Agreement will be deemed effective unless made in writing and signed by the parties hereto.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Waiver</u>.&#160; No term or condition of this Agreement will be deemed to have been waived, except by a statement in writing signed by the party against whom enforcement of the waiver is sought.&#160; Any written waiver will not be deemed a continuing waiver unless specifically stated, will operate only as to the specific term or condition waived and will not constitute a waiver of such term or condition for the future or as to any act other than that specifically waived.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Assignment</u>.&#160; This Agreement will not be assignable, in whole or in part, by either party without the prior written consent of the other party, except that the Company may, without the consent of Executive, assign its rights and obligations under this Agreement (1)&nbsp;to an Affiliate or (2)&nbsp;to any corporation or other person or business entity to which the Company may sell or transfer all or substantially all of its assets; provided, however, that the Company&#146;s assignment of rights may only take place if the assignee accepts and agrees to all of the obligations to Executive under this Agreement.&#160; After any such assignment by the Company, the Company will be discharged from all further liability hereunder and such assignee will thereafter be deemed to be &#147;the Company&#148; for purposes of all terms and conditions of this Agreement, including this Section&nbsp;12. For the avoidance of doubt, in the event of Executive&#146;s death, all payments and obligations to Executive shall be paid to Executive&#146;s estate.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Counterparts</u>.&#160; This Agreement may be executed by facsimile signature and in any number of counterparts, and such counterparts executed and delivered, each as an original, will constitute but one and the same instrument.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Severability</u>.&#160; Subject to Section&nbsp;7(f)&nbsp;hereof, to the extent that any portion of any provision of this Agreement is held invalid or unenforceable, it will be considered deleted herefrom and the remainder of such provision and of this Agreement will be unaffected and will continue in full force and effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(k)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Captions and Headings</u>.&#160; The captions and paragraph headings used in this Agreement are for convenience of reference only and will not affect the construction or interpretation of this Agreement or any of the provisions hereof.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=13,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="18",CHK=199988,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NQ-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:34 2016' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Executive and the Company have executed this Agreement effective as of the Effective Date set forth in the first paragraph.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TACTILE   SYSTEMS TECHNOLOGY,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gerald   Mattys</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief   Executive Officer</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BRYAN   RISHE</font></b></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;text-indent:3.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=14,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="18",CHK=162741,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NQ-03_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:34 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>19
<FILENAME>a2228882zex-23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<div>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;23.1</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We have issued our report dated March&nbsp;25, 2016 (except for Note 13, and the effects thereof, which is as of June&nbsp;8, 2016) with respect to the consolidated financial statements of Tactile Systems Technology,&nbsp;Inc. contained in the Registration Statement and Prospectus. We consent to the use of the aforementioned report in the Registration Statement and Prospectus, and to the use of our name as it appears under the caption &#147;Experts.&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">/s/ GRANT THORNTON LLP</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Minneapolis, Minnesota</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">June&nbsp;8, 2016</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- ZEQ.=1,SEQ=1,EFW="2228882",CP="TACTILE SYSTEMS TECHNOLOGY INC.",DN="19",CHK=898571,FOLIO='',FILE="DISK112:[15ZBY2.15ZBY12202]16022-2-NY_ZBY12202.CHC",USER="DBEMBEN",CD='Jun  9 02:05 2016' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g202980.jpg
<DESCRIPTION>G202980.JPG
<TEXT>
begin 644 g202980.jpg
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M)ODONCE];=4:_LY$EF@-"DV;O*A"&/ $&U+65*L=)JM5J23!2  Y(T]R;FG
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M>N=]C6?V4\N/V*:5_A/977!4W']4AS6?_<:X?R6W?B]?;[_JZ-K./'B:F:\
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M<7X0)W_79_\ []SKA-*?;CU1Z^WOD4KOG&/_ %%'_+\7RX^/I+K]]=ME7?\
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M62A:S8ZL4B=K6;2R4#8I. DW'QVV++ >UR178%E+>75D-N)=7A2,8[]Q)^"
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M=<+:\A"R<F.;;-6/0L),VR<IP5AC(HPN:K*Y&6BX;$LF,K5]>K^92"FA86:
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CZD/*@A,1[MN;E>F[>:M1K7$X\4(]C!L>]'/8(37(-O\ _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g981962.jpg
<DESCRIPTION>G981962.JPG
<TEXT>
begin 644 g981962.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@ Z1$E32S$S,3I;,35:0EDQ+C$U6D)9
M,3(R,#$N3U544%5473$V,#(R7S%?249#7S1#7U-!1RY%4%/_VP!#  $! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" -Y
M JP# 2(  A$! Q$!_\0 'P !  $$ @,!              <&" D*! 4! PL"
M_\0 =Q    8" 0("! 0,$ H%!@$= 0(#! 4&  <1"!(3(0D4%3$6(D%1&"-7
M87%W@9&7L;35%QHE,C,T-C=8='64EK6VT0HD)D*3E:'3U-89.%+!\#E55G9X
MTB=#4V)R<Z2S\2@U151DMRE(8V5G@X:8H[+"P\37X?_$ !T! 0 !!0$! 0
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M**ME%"$<-S& JZ)C HD80 Y2B/&=GF$I*DDI4DI4#@I4""#Y"#@@_'6<E25
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M>P]P;3W7<6]OVYL*W;'LRCALB$S<9V0GGJ#?QTA!JT4?KK R:%[0[&K0J*!
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MNO6NV2)\.Z2+?"?N=N1(:@7!V,RY-A-RT!N4W$E+07HZ)* $/I:6@.I 2L*
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M_?PN7O\ /F.H/[X?(:>#G]^GY%?]J^D!R'U_O#_=CD/K_>'^[/F__1=]5_\
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MKZ0'(?7^\/\ =CD/K_>'^[/G"(]7O5@50HEZF]^AV@)C?_"[>^0+P)>"B$\
M@8QN.!X'R P<>0#G*^C#ZL_X3G4!^%^^_GS.XZ!Z!KUKRP(U Q>8-JC.RY,:
M.U+BR75OHC%"')"%-E*>KZ\NLC@G>PYSC%?*_2[\U%IKHFU>YHZ5I^XWZ;'M
M\*;,D0)L6.U%<G)6\U#<0^A:^N$7P>23P.KDM<=Y^CCR'U_O#_=CD/K_ 'A_
MNSYQWT8?5G_"<Z@/POWS\^8^C#ZL_P"$YU ?A?OGY\R;>Q3OWPML_P#8)O\
MC],'S9Y?[.W2OP#O_P!E;?\ F/C]#Q]''D/K_>'^['(?7^\/]V?..^C#ZL_X
M3G4!^%^^?GS'T8?5G_"<Z@/POWS\^8]BG?OA;9_[!-_Q^F#YLO9VZ5^ =_\
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M2 EQ*DX!%,8QFOK;4QC&*4S0']*W_P!?WJ+_ /6B,_L]%YO\9H&>EE:N4/2
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M+_Y4M=?&/S</_E=8/KT@_DB\UCAQC&?>5?E;3&,<@ "(^X $QA^8I0$1'[@
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M' J/ZG*.3J0$E%G<*K I"N4"F]GB@<&Y"D,F0B0D,0,H^RJ!U5[UZ5?1XO\
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MUJEK3LW*G/K6XVS9+C&,[;7R]3&,8I3&,8I3*-O%K"IQ!5FX >:DS+-(%%1
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M_LW2"61JA)VG0R=SLVR73I=I0(76JK%M(DOTBY6[73:-,V=I)@P4,5V+P%4
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M;$_$OL6%8@_%1 MWK@9E,RCN:BMRK@U%\,?<MT:Y2)+$1Q:5I2I;;2F^UO\
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M"?RY _V8B<WXLT'?2U?^4!ZA/Y<@?[,1.?2WS+GOXO/ULO\ Y4M=?&/S</\
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M.) ST/';.-;@\DWC2-9B)@!Y(.$F;41((=P$6<&(142\\F*CXIB@ B8H  Y
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M!\Z,9P=P'U9 WKIT0Y#95,$..>0G68__ ->/T=M.>7_PETOSYX_5YEY\>_\
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M';DXP,9KZV'T0>CN.?T6=?"''/(6F*$./GY!QQQ]?/'T0FCA]VVM??TIBO\
MB,T36'CEAF  X="(,D1#ERX 0^+R'/*H?+Y^8<C[\ZMNHX%P'^-.N1,/O<N!
MYXY'GR4_7>_@H\#S]G-2)FH3G]>V< ?0:;GN[O5[TSQYJC9E@@>%)Y_].?\
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M3C('^K'G.#Q^N?C[N[C.>-O$^_M*)E*=3:=$3(?GL.I9(TA#]H\&[#F6 IQ
M?(0*(B ^0^>?I#?>EW11.VVC1G) ]YV]BCUB!]83)*F* _6$><TIIIU;)8&4
M0\E'KB'A#+$B&)UC%08E64,LL*0]X&.HJJ<QCF4$PCR'  &=G L99@D9NVF5
MX]N<Y3J((3"S-%0Y2B *&22<$*8P%$>..>>>1 <LF]7O:V1-M)44@N V68 D
MG;PE0U K(Y/)2G/D'=3ZWY W[I36,^UD,+.X9_; N@ ^9*E8/>>RMT8=]Z7
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MHB4P>WF8\"'O#D#B'WARFZEIQ":6:WG;Y$KG>WJ:;L(Z1*=Q5*8FMPX2@:U
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M^:LS7T0>D?JJ47^D3#_>8^B#TC]52B_TB8?[S,,O@H__ !E#R_\ N=#RY_\
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M]M=*U=A[=Z1C/[7 SBI,4)\-E.)P5I@[59XSEA@H! Q@C:HGMR2<C@"LNO@
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M2UAF8.1[):QMCB!A#D1 %G3?@0#W@(AY^0A[ASLAM]4:D Q[!K1N!1XY/8H
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M> %-W<B(]W&438G=-U]%K/WMTD546P.SG3*?D$DT" =,SEQ).%N?$\Q*! $
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MG!R4C>G&S)*=I&5#%9[3[;[TI3"FU,I>"6.K&T=2XVT^V%<D;E)<2O(2G"5
M8"MPJ@-<&4":N*0 83*A'B/;R(#W"Z1-QSY@(% 3F\@$WEP/=P 2QJ'PR=0E
M50,<QBF;)@ B/)Q4(#L"&, \\&[ODYY[0Y$/+SBS7)>RPVI,...Z-2-W ?GO
M*N[*' D]X?%, CV^7E[Q$>97U8ASU%U(>XPE%5+M P^?:*#LY>/(![2F* ?&
M ! ??\H9Z^/:W?I%\#(/*>\8X/!/)!^2KZ.$-C&/;"._]\HDC^G^CN[*SS(E
M[8]F7CCADWY ?E^EA\GN#GR'C/?%AROP/R (!P/UA$1\P^O]WZWNSR!0]4;
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M&5G & 2#WG [_/P/O]N+B4E12E(Y7C P>SC(SD#SGLR,G@8KN)B6>+F-VE4
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M9))QW]FW/:1CM''=CR\5GCMS@=W8.!G'Q 8SY^?/72R4R5(3'%3M(DF;Q"@
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MW$K2DD9("B "0#C.:Z5[U$Z'*F)7VQ*X("FH50R=I]9, "B<@\%326$2=IA
M![Q "AR'R@%I_3AN?3U!J]S;W*T)Q99>Y+S%<%)P_,+^%['"0.D@:%^GI&4
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M#M1;N%%!?.1Y 0[6S$JZYN0[0[  P<#QE\R]'L#QTH^62;1S9(J8G5D7!43
M"8<G'PB]YB@4 'DRHIE#CCN ?+(H"NFI,P\O%8LU:OUAK*CUVXJ4+'R4XNU(
MX35*JHY]G*$4Y;\@54K=3QBIF%7PS$*)3:][4%KB,/%,R.X\EA8:;0HNA;I2
M2A!6T%I2"H@$J4D#G)36_LE@N5PGPXS<5](D2&FRM3924(*T[UA*\*5L0"K
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MNRK:Y3D*?3'4DJM6HFSV5K+6*/A5OC,6DQ.,&3%.3DDDP$BSE)FU!3DI@13
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M8O*OQ/$5+'J@4A!*JD<14[0$X+%\,#%$"&'*ZA5E'#*GM&Z@BJJHZ.=(3"F
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MG6% )=8<6TX,_MFU;"4_\.Y)VD]Q']%[S>2!0H'./:4 (4 $P<A\WEY_%$
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MYX P\\% !^00Y'.6MZTU>R8JTZFOA7"*E1#ZJ3%&,5M]4LL[WE=45,K6THI
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M^:?2(D6?+7VSSUI< JF0B8?3">"W3'P4TR]C<.P"E* !YB;)SK^@-(TZBO\
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M]31M,VAM%PF27;HRVI\B&VVJUQT2G>M><66L+:ZPI4$*W+0I'!.T542P,'C
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M))K%1ZKZ?=5;)2'H4QC:_&:>BF2W*9>RKVA@A9>!)6D;FRN.4=<$)'5FJO\
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MU6 $[T;O&(!(W(4HJ!P H\+KT+*+"*OA&$@D(;Q/!X7$P* !2"("4$R<B!5
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M=T\,4BB3<IS"EPB*N;.=(2PT7<;6D(4XMU)" $('6*4I9==:VA(*EY!) SE
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MMEG!URP#%,0;HLVK1JT;@!0X;H$%,IN>!#W9O=//07;W$5%=4I2D2-R%HV*
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MZWE*EI'5,WJ%UR&4C"$-[G0SAO! 3N!4M;BE%((QF!W-U0Z)H$U(PMBWUJ6
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MB!&_<<G!5#%.!C#SR=,2#W% 1 0'S#<!,52<-'JUY3G:H ':01XJD[MN04D
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M!T@Z(!@A&8"43H'4[1#CS*<W(?('O$<+1W[-\4$7*35V3L!3L<MF[D ,(]O
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MEAM)2$C:I25(<2XE03JD+O4*](*.S%7;)NI!1 S54ADSLGW</K$:<B@"9)1
M2")"+@!A* $*(J$, 21%62%=)@L_2.JT1(!O#6< V:)$'S4.Y4Y#R,(!W@4.
M>T.P.WD39D0ZX^DZ8D7#K9-"I:3-\=B=Q9JDU;G>JW!B@19TK854VZ8)&L)B
MF$IS,B%4752(5,0<E^/A@?1YS+FC$56BHG[O$J-YFE:9,1BH^9D$EI--NWFD
M0$OA'1=#'/$^ (<5>\V3*S3H.IH;;[;H:D(PB2VE8*FEIP% JRVE.\!10ZM2
M&U@G*T.Y:$E1=78"BIE"'65)"TQG"HN-.'QL;0EYQYHK('M+3KJ$J&YL-HZZ
MKAENH%'@8G6D*RF7J1SH(R"!%4Z^V=B(E/VF,!%GZQ#<%/ZN8"E$IB&6( &R
MIJK,79!VUL6R+TJJ85A]FP;=!%"-0>+$%,$&C!HB9PZ,B4Y@ 3JK$((^(HKP
M \6Y1TTI0FB*:U4>)S#@10AQ2B2^Q7SY<3=K:)?,E%8Y<A [E2MD%A7.D4[@
MP"'>8)&AY,D&T<6RR2B%EM7:5LP@H98K\8Q9V $0C4R)")$'IC'[')$B$*V2
M YU53]ALRI=M99:4W%BI"'3L3(7U<B9*6<((0\M*D1VN<..(2V!DI.Y8-;:!
M>Y4AUIZ=,<6XP.N5';ZR%;H#:4A0+L<+2[+D83EIAU3RR?'3U:0";KW5Z=KM
M58=D=!RXE$#HJJR3-!VR9,4Q*FH^>L'"9R.O#-PFT9B  X=@!1Y33.(5:RG8
MJ.*DX85^KL7K8A5@FBUB 2ER.44RE,_!ZC'D,F\. '.98ABG(=0P)CP Y;37
M'3MBP%Y)KHOI^2.9S+'9K%7:LQ2(8R4<V. &#U2/3/X1#<<+./&7$!,8!"LF
M[]55#N?N@;H&,0_8H()F%N!?$-R(B =QPXY >X! 0 >..!C#L,M!332B$)*@
MHMJ4.N/BI60D8*T^*$HW>*H#>4^,0)Q'EL2MCTAAI;Q2"GKFVE%@)Y0"I05M
M<\8%PI.0KQ 5!()N.C;Y+2!DEWDT^.U1>%<\G=+<=B7:8/"*': G4$.T![>?
MC"/(!YAWSK9\JL9R@E*/DR.DS@"97:GQ.TP]O!A$>/B^1@ P<\>0Y;*:RIN$
MCF0.4K9/L12*F)2#P4!#N$""/'(!R(?*4. ]_.?LDT@?N5!RF!O" A0%0@<#
MY" B F 0[A#@>0'@P 7R\\UAMH)R6@.0 DI!Q\Z>>..?GN!V$9S6U%Q9' 4#
MP#D$ $8&2D9XY' \N.>,FYYOL!4IT@<.UET_#*503*J@8#%*(&$HF[A ?</<
M/F E\N0SEN-FKCXJ:"PJHB7@/&**AN2EX-YF\R^0E^, AY\^7GEKH6(IDA**
MY"B4P 8"J%^-R(#R8W/<)AX$>.0X 3>X.!SUGL1# (@J)3<\B4#@ #Y!\XCR
M(@ >7;\;GD/,.<\]3 3DHQD '('FY/:/N>7MXKSU28&.1Y>>P\CN[B,#(SG
M^/$_NKTY X'!4R9P$3@(&*(@''"G^: B50G'D(B(<" #Y91TA:5#)J#WF,=4
MQ1X 1'D3<CV<AY@')0$0$P<CP'  &14-@*<AA%4!$3)=A0-R// CQQQW#S\X
M\B >8^0\9ZW$\W9(^N.1,X.FH4K=FD8#JO'9B_26R*1>3',8P\FX+P0H"(^[
MG+[=O (P@DDX  /)X(\G>0">?/G&1XJYMG/C!*4C*B<8&-O/!\@X SG( !SF
MJV?2JI$B H84W#H2D*3R$2@(]RA@]_F4@!R "(B/GSQY9^4IA5%R*!C#P*9"
MI" \F.;@PF'RY'N$..X. ^?YPREF .G"P/I%3A1! QU$_,$VR[D1X;(CR)1]
M70 I3&\S&$1$> 'C.IEW*JA':B1S@8C!59$Q!$@)KH%4/WE,40$HE+QS\OOY
M\N,O(C(4H-^*> %'M 4=HPD^0 =^4X[ZLN2U)0'>1D^*E1\8H YW=P*B3QCC
M&*EM.>7*)?C&*4QP+R'/=V\<%-P'N,/ !QP'NX^OG<(V,XCP=0P&  [@$?(
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ME$0\@S&%Z"9X=_Z1'2@E4,V(ML>Y2B[-)V!VRPIJ1A&2JR;<W@*KD*L<Q04
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M<>\*200#FN32 _&6MF2E:2E0"DDDI3M&%DI!\8X4,;3M5N[%)(QUD,:0B14
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MQ26A[A+@W3^,7A0\6Z469.S&\RJ$>%5*!#>0AY\=QO$QN;AHR583G&6E*'(
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MD*<H^?>;PQ\O=QF_RXK[YFDH9I>;"J*@)@NG*-(Q^S3*H @8Q6C9%BLB8@@
M$,#E04BB8YTU!*&>2UJ.41$Z]EM2J_A%,HHA/J-TC"(]P^&BBW!HF5(0$!(F
M'<;GM/P8H\R5?2Q<#@-V:$%%).XR9#B0H8."C:VH[0>%;]Q/.0D"H4CHZMR2
M%+GK6 M)&(C:%GA(&Y944JP=RDG;OW*(4I0 2-+73WH>NO;9$ZD>9UJ34\80
MY2+3NS)1LBW7;+\@HU:P4"O+2RBAN/CIJ-FG"8@<AC")1S)=0_0*0,>9L\W7
MOJ2[VB:9W3"E5QI',D6RA0_Q0D]9')WSD@#W%*X"+1<D#M*8XE*;MV 'E'HZ
MY#NY-.8DCD)\8)*P2JWA(@<#*?M1PS 1$A?%*)NX$>WM P@82YSV-=I$8[3,
MSC >.4R^M1Z4DZ<S3%NV5.(."1Z<@JN#8P%$7 ]QE $Q#"7M 1+FED])&K7P
M41I3%O;<.2W#BMJ6   2ER4)#J5'@DH4WR 1M[]E$T%IB,M#JX[TMYL80Y)>
M<2/&Y"0B.MALCE:?'0KQ5+2=P40;2.G+H^Z;>DN.>M]96&3B7LBX(]EK)(7(
MSZ=F7)4C(M"2*S-9(BC=JF=1-DP(V!JEXJAR%,J/?ESR<M4%U3H.; _L9S*^
M*9)NE*6(B1C@)@6=LT&SQLF0! X&44Y.3XO:4 '*K--1C8%R)L(IJHP,8KM-
M".8(G.0Q?$3= *!!.H5T@(' W//C%,!2E$0 :?6N#,3#'.UTBMCH&,P=)I@G
MXY#B)E4C^&D4@* 4H 7DHJ=O<8Y@'(?-N-QN#CCTZ;+ENN'QG7WUK*CA([2H
M#;A. D8 2 .!@5*(<&##;0S$B1X[: E*$,MMH"  , !*.S.<<DG^FNT2G:JB
M@HW:PD]:DU"@DG'1L )V:Z0!PL1,9GV?$G3#D#JE.MQY"4"\^0TXF,A$D$D1
MK>K5:(>F7. S?@QSI0ZPF.8#153;.F'BG*4ZA15?)**@(B E*81#HR[)81:R
M=?G5UWL8IW(PDFJ)"BBBH'B R5="I].(EW=J0F'@ ]PCP8,Z"0OK>%=&8KG;
MKP;\2>#PL559-8.XZ1"@4PB(B( !#AV%X-P(%#@1U@2D@C"2DJ[P<9R-I4,<
MD)/!^(9P2#L M:3E!4A1 \8*(5CC.TI*<$'M!&,CXC5>Q+\&8IA&6"(KJQCB
M0R,%56RBCD1-WCXKJ?=R"A )P;P@*8J0F^/V@8/+GF;0AG!W+]:1L,@ @<S^
M?<D<F:F( F*#1@BFE%-@ 1[A.T:'56,(%,J/:7MMQL-JKCON31=%36<  "@1
MP0%2B)@X*8XB)DBB')C$-YB8/> &[1CI79TFJ 1ZJS91-$P)H'344!P)!$Q!
M(7XY@[S%]QBIG(//;^N'@0P@;$!L) _:)VI X! 'BCY2<@^;CU76N*4XXMQ2
MSC*G%E3BOG>"M6Y1QG]MV9&._%WDI94!(<2KI"00,EW"<P)>'V"*8%$@"8IB
MD*(>&B(E _Q3   &40O;$U ,<G?ZNH?P2% "=_BE)Q\?@!X,(!YD'N^00#R\
M[7K5M"!IL>,E=K-6Z1$(B)C.+/-MHE3L\,!X;,G2WM%VJH(@55-HR5,(B05"
MI%$HA:+8^M>/FG'L/06N=D[QL*O<BA),X:0@**57N[ 4/+.D".7)"&$"*")V
MJ0I_&1*H  ;,R/%F24[F&%J0."^K#3 &.U<ETH90 ,9!<))X"<UBNNQV"$NN
MI0O;GJQE;O&T^*RV"ZHD9. D@C/<!64A>T,S)R4:Y_QD7<?*M4&*0^(=\*T2
MY3.FF!^T_  H81Y "CYIB(>_,-7H&G/_ .$<T>V22.W.C<K'ZRD<J::B95I2
M/(;Q$DOBIG64 QE>WD#&* ]P\\Y:QUC=0_I#-3U5A/WJ%IVK]9;&4>U5&&I+
M7LG6+A!'UXT?.R[A\XERNG[,QC \:JMT%V_B-A JG/,E_P"#E6'VYZ2K5Y!3
M%)-N^C%T"\G,!5'DJD#E,QCB("<QR%,0"@/(=PB8P^>3Z%9)4/2-^G./QI#4
MB([L\%=\(;;+ =:6%ND)270MPH*4I( 1N#B@H <^U=<V'XDR(F/(;<0T4EQ]
MOJ2<-N/%(2HDX4E#+J 5!3H)(0 T37U>@]WW3?C'(3W;^PZN^W+K_P#+G&38
M'N^Z;\8Y">[?V'5WVY=?_ESC.A:U][%U^DC?CL:H)I3WPVSZJ[^+O5-N,8R4
M)[!\0^]4>IC&,]I3&,"/ "/S!SBE:.GII# 7TBVY#F((@6G:@,8W)1+V#1VY
M $0[@X$@B)@*)1[N!\_( #$ZY.83D$H<E$1(!  0!0#<<D+W"("4P\B4Y>#>
M_G@."Y>+_A 75%JW4GI,MUUVUV%HVE&](TPJI'I&5<ODRN: T=$+ZJV ZJ:B
MZ2B1DRJ@0BA#@8OO$<UZ[5Z0E:9,JQU=KJSSA2G'L?KM3HHJ'/R5,X$0*N[2
M3 0[2)G33$X&[^1  ,/+)%KN,FYSG&HKI:\,DD/+PRSM+ZAD.NE*".P>*K(S
MFNG0IL-F! ;<E,]:8<4!A"NM>)++?B]2R%NA7!&"@$DD=IYR&6E9L[8/6JI"
MD3*F<@^*<B:?83WI%.8>WDJ@B<YAY$HE$H!P/EC5VA(143)N#@N54@G/QQP1
M$!^, &$W  (<\F$P\!P'(<A[J71F.M#<YRMV$6SIS!P*G:5A#R+U\!%"\$!0
MH%?+J"81^(<J*(>(?@X\E#.R3]&%UA7]=![/G33;KF)X\G;9=6/;(-P^FF<!
M%@!WK@Y"]YQ11;E5, >&5,QC 4;K;UHMJR+I?[1#QVMB3UR^.3[GA&[C!2E:
ME@$8SQ5Q35QEMA4"RW.2%?.K5'\'2#QGW;VT @@[E-A! ."3D5^]"5NH;[M&
MQ:@^=%$T)KP).-EVOTU:!FU9Y@U1D$4RF*FN5,AO!<I*\IJ-EU" 4%2D,$2S
MA9R@STG3KVS%%U'.")^*4PF(FW$QB(/F*I0$%H]\@ '15(;Q #O24*!DS=M[
MFI?1D7;5DN%FD=X2<'/>&=HZ::W:F8D>,5!!;U21>RR"Q'#4ZI4Q63,@*R1^
M#HD 2\$ACJ6TAU/$=-Y"5J$%?J]! L5E9:;Z\O;6\&H)SJ,IMB[*@>:;IJ=K
MDI6#4RY5Q44;%,F)@&1Z4Z0K)&O:K?$OL9^VO);0#)ZV*&Y( 1UC"I"6T.H?
M*0'&TGO0XC*@L.Z+4&B;N]:4W!^U26+@RXI6UCJY9=BY*TMR$QBHMEA))0LC
M"25)5A*@6X45!RV;)NV3@SV ,8H=X'(N5J G X=Y3#XO:4X@0YC <Y!,'F %
M 1ZYQ%0<LHHX:)(-7X\F%<$TET3F.'<JH?Q>0X#D2BDH7A(QA$H\#Y10VMLU
M5'!P:M%3F2!5NZ8K-A%PBJD84UV;E@X*F<%43 )5DE"%.0!%,1 PEXD:!M-6
MFA*F^1<U>97(8XE51.W:NA/P0I6X."^KE4, \")C^&!B]@G*)1SOC,Z/)P"
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M1"!W<#[N!X&:KC"[#AXQZTUK$VB..^0*V;NKI.,/8YD%3 5PLWCP!:PIG.@
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M\14XG66,)C<',(J*<% H]H"4I0\@,.6S6HY E%2AV'+X90\A["F*(@'BG[Q
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MQA)!"24KEQD+RKC:4*=0H$*!"@""" GG.:RZK7]%-1%([D2'*<A5")E$P*$
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MOB\ 8,M\:>C\DWS91*\=1>WK6'CF.X;H6V<BVIR  & BA&3UJ F#N QBB!R
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M<E6ZA>K'4==;5>_ZBG+S6(- OAV6DHFD7#1@ B7@Z38#IKHID\TTU$T1*"@
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ME$ .7PBB8HE*'R"&6!GM.TG8)/(JGVUTD"9W@+%KLP(K=X@=(AA-'F(<X'Y
M"@<X@) * >0<]!(36R"&4=2$#)QWB^(HJK+ 6,\(QR_3"*(/UV+=7P@2-V <
MQ! 3 !0 2^?%D0%*X2MKD #"@HYP!^U4,GL/9DG@#BOHLK"<Y"AQSD8&.#WC
M([.3Y\GCMR"CLIL3O%61*403!)(_K0=HBF/Q._GD5/,Q^2E 1[ Y+\<.1ZAS
MM**3*"H+MU^TZ21S 0YS>+W"H':/!.\H '[,<HB < (<^0XW/AE-^K^L2-@J
M$,@0BIQ]MV^L1B!42& PF**LTH<P&$  X@4.2]P@4#!P-$R&WZ&P5.61W?HF
M,<>:@%6V;%R!R]P\ !$(Q%P %'N[NTQCG "E)QR4.<E%EDN$!*'G",Y#;#RR
M./\ A2KR]N"?-V9QUSHK0)<>90,9]L>:1C./WRT\G!QD]@."3D5DW>[G8D Z
M95%2F\5-0!,*)2=IA !42,40X  'L*8.>2B8A@\P'.G<;M3 R@@9,"*#XA4T
MSCV=HF 04Y Y_FX,)C")S%X$I0#,7 []U28Y4W.Z:D^*4X@4]/J-XO1@$ 'D
M&_L^/9(J)J"81,*9^#<!W";@<YI=GE>)D"BN-W7[QS#X1:UT^33)N8.?,HN[
M%*-6Y0 1 3#V" D'N H#R7,@Z>EI ZQEQD9[9+;K*<<<EQQ"4ISR>>W!/8*M
M^JD+)VO(=*0,]2XAU7!QC:V5$\C@8SP1SBLDP[OC0$05%$HD(4QP."YU.Y,@
ME P'(8A1 Y!X Q0[1 WQN2@(AQ7&]&"(*>K+&!18J8\JJ F7Q5 \R)=YRE3*
MD4O<4X"82B7M\_,<QV,ZAU-7 P),=#[)!D[4Y,ZMUQJU,1[#F ?'48-(N4>I
M@B0X@8".B<"(^0#\4)7CNB+<%C32>3DU1J8413!PW>/[=?W7:=,  B:B;V":
M)F3((%,"7!%!(/'!39:5:H+ )DW"&UY0T^B4<[1VHC..+3WY&WCQ<D9)%Q,]
M;V$LQ9*^P^V,KC@YQR%/I;"NP9 /'.?+5RLCO5BD0>ZQ0Z28>:BSF314$ +W
M=OBI)*CW"'ZTA2E$Q>1,;R  RA5NJ&GM4CB]M##Q"@<X R="HN8IC G\5-$5
M5#$ "F^,) ,(&[3 4O!LIN,]&[6E%VZ]EVG,/."'\9&$HD)'129CEY,0C:8>
MS3D@*>8$4.J8P'$WD(!DM1G0CH5@@S;OU+]-HH@0Y0^$(U]JJ8G)2% L Q8=
M@#R/:453%(//(B @.6@G3[9_UJ7).[!+$4H'& 0%/J;SW^?)\IJL.W)1(\%9
M9!Y'6OA1/([0TE6,<]A(Y'DJ&Y7J^UNF"@!.OWG@IF(HFA&/TRB4?C!SZPD4
MRG;QVF,!A$X=@AP4H",<2767#KF*E7JL\EQ(!A\02F*/?\Q$DS^.8 #R HD-
MYF[0 ?(!OT@^D?IHAEDSIZMC))V!TU3*3TE)V%T4$A#N,<LHX<%,H/O\(Q1,
MH0#\" $XR<(NHTFO-TDJ_2J[#&*0@@E%5]A'+\ ( 8XJ)(HJ& P%('AG$!'C
MQ2ASY9:7*L39/5P9KZO_ *\EEGL"0>&4ND\DD9([,$ <54A%Q4!O>C,C ]S:
M6[W@9RM;8 !P"-N>"<X[,13/>.\[>15*L:DD6J1RE(DX/7K(^%8XF$4P2\%L
MW;H H(_&,LN4IN!Y/P&=DC&]<TUW WUG,L2E.8Q554:]')&1#@JABN7T\)&Z
M1CF*(%,B(E'CG_.XS!+2:,254O@D2<NETS 4IS+KF,!P%(! QS<@;D1,4H%'
MM(("40Y /0614=D%("D*3DQ3F.8I2G!,1.)D2'#Q 3*8PBHCR &\SB8 #M"@
MW=A"\,V6$ <8ZY3SZDG@8!#B,DC&>X#D8QDU^"ON ;Y\C)&26TM- @GG.4+Q
MMYVXYSCG/(Q9LM&=<<PNU-8+/&UM@X2*<[5]?V23IJ<@]J:*B=?9O4#)\@'<
MB4_BB7N*)PX ,O&T)IJTT15:6OEI@9V1.AV)^QT998J*9A.!SOG<XNNX?F/Q
MPDBU39L4P$QE4%S&)VW"F<'073(HH4 ( IH).C()$ #ICR8HCP8./$,/A '
M!P4> -W#Z1>'[Q.!4BF*B5%$QC@5(1X\D>U(OTWP"@!2<A[Q$P&^0+,BYNRF
MRWU,1A.>R/&;;) P$Y42M0P3G*5[E;<'(!S4U$#)!+S[IP,]<\5\D^-E(" >
MS&"G:DG(PKLJ#X$:AD(]]'OM5:].FY/ZT\*K3X0ZCU<R11,X=F]3#N,J!A4.
MX$!4 5.#&X#RB4^@.G=9=5TQT5K)J4Z9N'C2LM"'2("A?#,/<7CQSB4X&5(0
M/B&*(#R)>)&,X6.NF4QB+G(85"@B<IB%,8!-WI]INXZQ?$\-1L<!$2E,(CPG
MP/H<."$*8$^WN%,IQ;MD".#%2,(\^&N(%!4P"7GO\P*)1[0  +F*W,E-J44/
MN)!24D N$$*P0,!21N0G@*R>,(.0,DN*PX$A3:5*"DD'Q 00$@X.T^*O()21
MP<\ $)%*,]5:DCN/8^KZ6Q.1, ,J,#'%,0A1^* &\,W<8X^:A^?CE,/F!@'F
MJF\17H\ASQ\-'LD@("8D18-"@'>8"J%0(FF;N6+W J!D@[ )\80$0$<Z]].1
MD,D=U-/FD0P(GR5=^[0C6IT.!$?$,[.C\<X@ "8AA$G'(![@"B'N[]1Q*1W+
MW857;&3*'*+>2]<.(D[O<9OWG,F!1$#&#@HE-W'\BY;W2GR4#KG$Y! 2E2R5
M!0.Y60HE043@+4I.[D@BKQ0TT$KPE) Y)(&U)'*<@I "@!DA*" 3M(-2F5-D
M!1<+IG-W@5,Q2"4@-@!0"% R?'=Y%,4PE3 "\GY$2AY9R .7L*4R/B*%$QB
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M?V]A3" D#W@&M.L]*+P5ZIL*E9S^S4!:N<<DF63D9/G[CY\T:ITJ#A.H["D
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M@/:F8RXE3%,X<@4X@40,0Q0(/'(=K*ZDWJR;=K'5\I*N$N\Z/J5FJ1?CJ&*
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M \5]:MJADA25'/C [?%SG18UM6E)<O-E:2H)2M)ND4O@*P5[2)"6@M&01N!
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M*LW63-[C$51.10HA[RF <Y.8/.GOKGL>I*^SI-V@G5XJT84C:#>,WJ#2P03
M@$(G'\NBBUE(YH0HE9I*G0=H$'P@<+)%(1.[4OI(M." ":K[!(80#DHQ<<;M
M'CS#N)(& >/=R B'W,Y_I3YIWHCU!9H4ZX:GB:=N2V&O5"T75J4R]#E;4AYM
MMX,+CRF.LW%EYAU>]K:7$-.E32>@ZI^9JZ6-/WB9 @Z8FZAM[;S@@7>T%B2Q
M,B[O:G5M)=$B(\4$=:Q):;4AP+2VIUL)<7D.QF//_I(=-?\ HUL'_53#R_\
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ME0!TY03%X^,D "HJOPF#=L0 -[VI4DRG()B 9R;Q2W#1VN?94<C$1Z#%G&H
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M<CKYXZ=MML-ZE)H.+%(1JTC>7DC#1\7;W")4S&B@B5W<:9W6TQ,T7/&*IG4
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M_/UG_*$>K\7_ %F/]79_YB:V;LLF](!_U>)/_P!::M_6&7LY9-Z0#_J\2?\
MZTU;^L,_6?IO_P#*#I(^M"]?B;E?370Y_P":W1U]>-@_*,>L$&,8S\2J_:>F
M,8Q2F,8Q2O<V;.'CENS:(*NG;M=%JT;()F57<NG"A46[=!(@"=59=4Y$DDR
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M:DM/N(B+?1U2I(:2O%NJBL@LJW<(K-W""ADEV[A)1!=!4@B4Z2R*I2*I*IF
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M#S^F1FA*;NEQ4--[0U"G7TGR&RW+!PK/&?F04B 9 F D(Q!$P.Q4\,! PKI
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MEAI^;,0]+4&FU!X*2%5X47A1!+$@^*XDCP,;5!Y"&W2XD,;75.("4J6X%K(
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M,<[%.-)"\<[2<5K:B E$2F*8IBF,4Q3 )3%,4PE.0Q1X$IBF 2F*( )3 ("
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M5!Q7XB0?E,50SI=5PF59%9),IA8G431*02J&A_Z"KJ;^IF?W>?\ E-5?K_\
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M:;NC3VQ)!2)U_M?6MYE4F0R*L93[W5K/()1X'(F+Y1G"2KYR1F"BB9!=&3!
M#G(7Q.XQ0%@>0>GZ!\E*DO&=#-VFLUHO=8K%!0)?9\K+=TU+QT4'LJ#0(ZFI
M+E^Y;A[/B&RJ3B4>\^K1Z"A%G:J*9RF'NDE4G"22Z"J:R"R9%45DCE42524*
M!TU4E""8BB:A# <AR")3%$#%$0$!Q@>0>GZ!\E*]F,9X$0* F,( 4 $1$1
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ME*X8R+!9PS=H&,4Q2JMUE$S"4P 81*/'9B(% 3&$ * "(B(@   !R(B(^0
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M% !DPKNP%Y5YXEB>> +,FT>*20^8IE_6"0/B!SV"(")?UO/8(@ B7]8(@ B
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M0LTN41CE&JQ#N94OKSA5%8BJ[DZJJAS'54$RE87ZK;=R[$V' :SUAOWJBD-
M3>[]5QWZ,$_!OXK87MA_JZ^63<FMVMAL5&CE0IK5U$5!5Q*.(4B%0LDR]@82
M6\<$F[6A&_4!UHQKR\2=2LFY+)OA&A=5CG?FI;/03GUOI(U)6<,^FV:U8S?P
M4;#N)R;8>&]K,?'6.?\ T:3$.[FTF+@2@38?(1-,I"%#@J90*0.!'M*4.T..
M0$0X#RY\A'Y1'SRDK_ TZRTBWP%_CF<K29BMS#"VQ[]-91HZKRK!<)5)<&H
MZ H,_&.4[4P.T3%*JT,1<J9@4K ,E?=T3TS<M6ZGZH^JRPUE_N'T?4 38%DK
M0-[S4(K;!-QN]T$@W<G18]8862&(ABR[^;@!CZF[02BFCTJ<8F 5O8MY[Q@N
MHH[*OWK?*3=6^=0VJ;#2;,SFY^.K5/I6A[NOJ&?>Q$9125VM+W#8<%!3],OZ
MENEIZ].94L?(I$;N2L6V6_IWU1I;7E/^$>FDY:0A]FMJ_;%KC9K5=;Q9K3&D
MAF[:IG?6384G,6D\7$0)D&4!$.W2+:%8F,W:LFAE5RGN \-/N$>PO)NWD1(
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M[%9K%#NM<3C4J4%%H>I&6=6P3SN_M]'[GU30K#O&XQE@J7I"&F]--6'7LU\
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M^I=<C)R[5JF0U!B48>-=QJZ<21FJTFG17S^6="T>@L=(B! R?@!>2CQY@ @
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M(.Y.MW$(.B4FX=-TC +; CJ9*;'M%OA*27<C,S^X0-@L"\O%+/4G+YI&,)0
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MT;V^[-6VI=K%U_)R<?=^E&-&MR]S^&==EM>]/%GD;!(SJZ3/65+B&\D[4?\
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MQ2F,8Q2F,8Q2F,8Q2F,8Q2F0)U"_N9IOVV]7_P!J6N3WD"=0O[F:;]MO5_\
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M_8:QY.V03M?]W^@/MA3']AK'D8UA^PA_G?37_4EIJQ)]R'U6/_SVJG4ON#[
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M9+OU J7#X'55OJYS6D;"8TRA5BJUYZR*\2DS/?"5]5.D 'R0 D )  2
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M5@AWZZI0GFBZ:KLT$:,3,]R[GJ#,4U7IABB!BFVUJ\2F*(" @-H:B @("("
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M8 ,40$,YA?<'V _%GG)&IM#K9;<0AQM:-JT+2%H6DC!2I*@4J21P000>^KY
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M;32;PK50L?*:YL*S.3K"J*1T'KB,;A,H/$E5TC\22Z YRQKR-^N/49<[/O\
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MH\*%%:+TF7*>;CQX[2!E3CSSJDMMH3WJ6H >6KRE)2"I1"4@9*E$  #M))X
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M5K7(N:G]6WY67BI$YG;)K.5%(GB"NIVYM@*4"@4H 4I0 "@4  "@7CM H<<
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M1:O\#XJ^1;21:"W5G(F"(WC$C+\$=1;9*+<]['E(:)TAK[4G1QK74&@HZ=<
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ML$+>856 A#5EM'H-$%8I_L<%(0A"IE(4J9"E(4A2@4A2E  *4I0 "E*4
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M4+M-[4;R,B6?;6>O--A7RKWZ>]G.0>SFYZ^E56UE>G38IPZK4B!T,M(  <<
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MP6KBZ\Q!7(Q[6F4[&:??;9S\^III:\< <Y%U>_:K8$E>#M"R0G=W;B 2!Y2
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MV!:=9KGW[JHM&FW4NO-:_N; '!;*_5,LFYIB4LZK04"?(K+MG$NDZ.U(I63
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ML>NZT_[C4'=^Y/57?CZ"^?TYPZ]'D=_J'OS?G'RU-V,A'X?[9^H@Z_IS _\
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MA\E3MC()^&>]?J-U_P#"0E_RWCX9[U^HW7_PD)?\MX]>]H_@.JN[]Q6L/-]
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>Q2F,8Q2F,8Q2F,8Q2F,8Q2F,8Q2F,8Q2F,8Q2O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g865608.jpg
<DESCRIPTION>G865608.JPG
<TEXT>
begin 644 g865608.jpg
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M,146(D%181<C,G&!D4+P"A@D)3.AL<$94H+1X2<T8I)#4W+_Q  5 0$!
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MPC]XU@&+]!,A"](B0"\@(@'3]P']>!Y$ '@! ?[[RW,\Y#S43EX 1,("/ B
M?KP'(_S#[:#*.44NCJ$.!+W#OW_H(C]_;V'6A7$G^YW9BB40\I01Y#@> #W
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M0 (% 2 7@Q>L!.8P!SWX ./;1,8S+U"^PZ4<Z51!H[:*//+4,!%2+/$&0M5
M 0 4S@\.8P' W)P(!1#@1T%F0" ^P\_Y$/\ MKG7YI\ !BA[%,(=QY'W_P"0
M!VX[\_H'&OTT!HT:- :-&C0&C1HT!HT:- :-&C0&C1HT!HT:- :-&C0&C1HT
M!HT:- :-&C0&C1HT!K!V5B,E RK$O/6Y9.")"'OYQ4S*(=@[CRL1,!#[_?MK
M.:ZG !X_/<"]_N("'V$!$  >1X^V@KB!J(.7SA4#%=2#Q1=7@ *5 YC"<Z()
M]P#@XJ<@( ;J$?OVU,-4?E39I-5@Z0 I3(G !*4#>P )@ ?8  1Y'[C^ XVG
M+%&B(J/5LL>BJW<*RJ R*7FCZ=0'8F( H)"4?**#G@YN@0$QU!Y'I "ETB(3
M\UD  /(D   1  ]@XY^GCV 0$.W'MVYT$WPR9'P 58"F31*)Q*8HF$1XXX(
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MB0DXF77A))V=L$^S;*/8^*44.0&Q)@B(&>-&ZZBAVQGY4E&C4R9/5>0DMYI
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M;GGE0WTCT]^.H.>3!S*B47$T>K,8N'9H1T5$1C6,BF+< (BR8LT2-F;)/@
M"-FR::0" !]) -[B("A.2;Q'5F</8[#)(1E>1*NG+2+MPFV0CV:YQ0%T+@YR
M@F*(J%52$3% RB94_J%0I3 AUIS-NQINURR5+!];J,?7*99,AX3HMXM+%Q8\
M@9E;?.4W$PB6%:=%R;:)%.LT,TO.6"_7IRTC6ZT*J=A$NF[0ZSBUO:;BG%>'
MMN>'\?X1)+#C!E1826ISBQ/%'D[)Q5L9IV?XY/NU>3JS,T>7&1DQ  1276,@
MB4"$(&DYVKT>MVBQ6F+G(ATBTV]HS..Z#&@=_P#!$#Y-CY9Q=LH-CR"G6O;+
MK#.D8Y)JL5=&M10%1C5.J676!I]NMLB:!2H7!%]L$5"7K#L>UI;<LW(,H9.W
M46%(9"B7*N'D'#5.4C'U43BH^0!$3KQMAC96/?I(N4@*<&9<,$C )@( "'/0
M4HCUAWX[ASR(>X?U[\>VL0I#=0\@' "/N!@'J]_8!^_("/''W'CC6-O=TF*L
MPA%ZI19S),K,2":2<-7'<4R(G$)I>H?RR]@F7#6NLDD&QDU&J+V116E3"9"+
M3=.2B0(U97G(^4;%:*G0HD,6,Z.\81=PN%W805KE%+%)1J<J$!5*U7[,]ASN
M8^-7;K3,K/3J'HEW39@6(7<)N2%"1I5")A6*\I-2,;$Q;<$R+R4M(,(N.;G6
M.5-(%WTBNV9H"JH8$TBJ+E%90P)DZCCTZI[WFY%D)3*UF0J.0:A+U#&6'6D;
M"PE>AI*U3E?W(Y!O]/>TG(,K,UIL];LZ3BZO5P+3=GQ9!-&(C3"R?!YCQ=,K
MKY]VQ8TRDNQI.Z!]D++>';6UK<8928OLW5ZY Y,C;$YD8IU,PE /56,6PGTA
MC(Z%F5R+,(R28'C9-<RLXV6.S;[%.-J5A6WXYKL!!4*@!C6S5IVA%LD&+=C
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ME42*PV.:'9"#&BZ6*I,7:P6!Q8["NH=XU;L;Q(>22F(^/E&YBG1?,FKI,2"
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M,2P%#9:W%;?+Y X[?;-\A7'$-WM<],L[OB&TU.\-<2)RI%)B<BIN!4>P4RM
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MR2(5D&E.BB/G=B,V=E9QCW#U#99)(9JR7EC-&Y?+^X&MWXD.,)@F\GB(O"U
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M0135@(&-CWT3,0JY&,O7)1%1J1X+=RUC9)J)T7A"E(N513RU#:71<10%8J^
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M #]29.>>=!N+-3X5.J-1'H1<#YA1Y[#U"8>W/?W,'(_?GV[]H\WL"X>;)=R
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MWF.0F'*DW%1T&3)=JL$,M&NT6K<]DDU8^-J[\DB=JX,$3'3"**153F>.1$A
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MM"R3]L1U90:GAT)5W&QCQXSCG3SUKU% RI>ZA>I]-LAE7>0GBX ;R"UR175
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M3QCGG'@O@ H!),)"-@91HGR(RS"+EK0)B^NX-9/BRV$M-38+*J=<HQ3382Q
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MBG*H41 !$2CP/80Y*)>#?;O[CV_ ??G0>YT_%-Z*91,(\@<1,' ^_;N4>1,
M  &$.W(_2!=;M#K&71$YC\")>  !^X\@ "'W$1]NWM[A^8NFE#-WW5QV.!!'
M[!](]R^WU<\  \<\#P/<.>-GB98A"$*(F#S0*/( /TFX["7CCWY$.![<AW'G
M022?^ W''/ ^_/'_ "[_ -N_.OB?_P!(JQCNIC]\.U/+F+261U#6&0I>/<7O
M(=\JX1;7Y>0=)&J3:/4,+9A+.G*X2:+HA$UWB#HRZCH"M.E/[0R/EUB&%(3'
M 2]Q @@8.>P\!W#D.?N AS]M5>>(^\EOF/9ZE!P3.S3>.L]RNYM[$.6ZCI0U
M.VZ8SMEFL:R!&JA%VKQ\I+Q\3"NS@9$M@7C4%4W(J$;F#IX@.V);<7L%FC7C
M!T1F_<EC7 ]CE,?U]Q*NH^5B<LV#&7RW<'-3EF;UHG\PK)K22<:X5,HD>51;
M&;=*@D7!\]LL_%6;;K@F?A4%F<7*X@QN[9,G3@SIRP1-4(A/X<Z=*&,=R[CS
MIG9NESF$ZJZ)U#"(F$1K0VW[AE<?2GB*6FU9SF,S5R"OT/F'#-0G$_+=1-&R
M?CB!G*I0J2LY74^-I2-XL<31%8]C^X@K.9O"JI-7DHD@-A.W6F2F(=O^(,<3
MQSGFZACNLQ$X(% I$YLL<FZF6J/2)B@@RDG3E@B8!$3I-2&   PE )JF7WE%
M,!>1#J'L(=/' \#P///'N'''\(?;6/BEC+AU H9,/K$!*(@/MW#GGZ@$!^H!
M[#P'5K4K!. 9 _EAP<0X#GW#@![=^P_?CN4>0'V]M9&HG.=F*ZHF .DX_<0X
M$1Z?Q_3@!]@#VYT$5Y((8'I!'I^D!$W @  4!$P<=QXY#ZAX[<C_ '7^QOG+
MQB,>T$_ICGY.4INZIQ'C@W/^'G@/Q[]A[:G#)3D%GABE'W 2<CWX 1$1XX$.
MX\]P 1X^X:B5$K*-;N)*0$"-V::JIA4$  QR@8Q ( _2)SFX "B( 8?Y<B$Z
M;9X,T7!VA14H^H7EVR ]@X @,$5P* @'/!%%C#P'L;GMWU&NWB+)C;==O.QF
MFH*<9?9W&&Z.!:J![KY-JKG&UX.UX 0*B6RX?9.5B@/EG=22S@ %=5P.F P*
M4Z^.XZ8.04U;!(RLNH4X 4P =ZHW:ICQ_P#UMVR20!SP'2/'OJ$\B %*WO;;
MK@4@D:9=Q=FO \LN;A--:;KGRYFNA$,;IZ3JIQM;RF1N@?H4*+I8[<.DRY#
M[6C7 #S]N.P#_?[?S ./[ZYT$$YNIWQR#^.-4@"2@BK*B)0* N(X>#NDS_XC
M&2$@+)#R EZC@4?<-5<V& <P^6WMW@2KGM4-"5O*-=:-N@R\ZPB'"=#S!4C)
M%* ./F>C*UV0:-C#U%G*U&/"*)&4<'-=HX;).D5T%RE427241.0Q>2BFJ42'
M*("/ @8##S[<AP'V#2 Q6+IV<RW2I*)!HBC0I^R-[$LOUID-6I^)<Q+UJ@H4
MAA&4%9I'.6;53]V &7<>80R1>H&^IT.@9!)X41.W,4#$ZA,4IS  !R!0XY
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M-1"GIHGX*)DI1F(&'W*(BJ00'\ )3<&[\"'8> [:",(1X,A%I>9P*B9"@81
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M ."HW<2@DVBHUL3I!-!@T;E#MQP1NF0"_P!0#V[\_KK(&  #G@.PE$?MP!1
M>>>/8..?Z:#3T[W3CM3NT;;6%&Q)9O!>I"PPIFXS#L>EC%"N1\9()1\'0+1@
M80>K@8HIH&_AUYI')5"B)2N0<M>*A%S=PE#P54AY"S0;24LTVDU?O5HFO,%W
MI'4S)(LHJ4>*L8])PY*WC7R@IE!JOY=)5\\#>ES];QK7J+F-/%C2F0F/F%K:
M4_&IHB$R#::] O(.V9?EHN"N<-_]8Y3ST)>CWJ0=2[^ARQ'3E8ED0<(-V<ZT
M/PM6M#RY1LK$R)0;6^J>X&,W BG<<#,IR7CYCY9R!2+!7*#9375)Y1(.1@;A
M'6:)(V3E B,MQ\_D9RC*J6QU#, LYBLJXTG'3IC#9%HDR]96A_27K**MU=?.
MF=RBA*64J#INWD5%T;,P,H0'L$HF64:=28+M2=8&-I4MG/ U(OC#&4KDNA0F
M0K)+.T2516?CR3?Q@8$UD\J:0(J8(-R]KZ)Y",+8%(T9ALF8L09XITIZK!L_
MA"M)K,MKR9%Y#Q-!PUPS-:LF*QI=L[5:]T]K;[]1\DOY7'60V>1(XM2S4TEJ
M>M6V.9"UE^HE1I8*^K5EG<<A*JR9N \+['6X#<==<PV66Q.9A<:Z95U3)G"4
M#8+.%S;XJLN,("[2EL<V=L,RRK"\RQMD"P?5CUD=8H9)=E.MUA;+,0LJL>2Z
M+3ZY?;;8K5#Q\!C&&DK!?GQ79) U3B(F,7FI%Y-1\9ZR2:BWC&J[XK<[/U;A
MLF(MFZHB7J]*60J6M!1MG"V5Y" F(QM+QDH]EF$<U=1[PB*K=T4\@X:B0BA'
M"(#YI4S)**E26236Y2"HK"GA3I8D3W5OWFZ&;N2NY/"MIPA\7D89<I6#ZX%.
M>0O%],\O<FUR)=8>556CZHL0U9<0U.64JBJKPQQDS?J7PE5;/:,=M<OY7QWE
M3#&)IQW)TW$\UM\(8):.EK4K=9N,R%-S.1;!"6\R]B4(:,41IL,Q8Q[9L1W%
M2D@0\DH%N[N]T]BH]1>VVKLEHYBC(OTG5AA4%&+!R!3-WSU-9\F=JT7(8#HN
M5@(W5*8!35, @;6R-G23M)%PV537;N$TUD5D54E4E$52 HFLFJD91-5)0@E,
MF=(YDSE'J(H8.!'YH8'P;LX2.2[M4;1(X-#&T;6G[>I9SN6,X7*&0LFO749B
M2+B87),:O:(:R3-'B#X[D7<'0I"2B&>,TI06M7O%Q</E7<=?OMMQ&\P+@G$V
M%WUC2M[C&-(A*:>R-80:VTE$X5N#9NHQ@32DV>)CT&Q46K)@M,RCANT;HD7?
MO%^M<X3EHT:- :-&C05Z9JV93>:MR#J\2U^LU8Q1/8^QXTL#.AV%_5KH]MV*
M'V76]9C GV2Y'4=6G+3-DS.N2,D'1'TC7RQTFF1N^04%.7WA"9 >(J1P[DZZ
M*;.Y(V^)N+[&N29C(#M"#AB5VJU>TIRFX)UC&38$@&,-$VJSPN-J[>Y]-@Y?
ML++!RTFY?!>CHT%9G^I5GHN9/]:=ON'Q^RW)E@'^-D7C7!LL;#2>&I2'KJ#R
ME*T)WEMS<7<Z2W5B(R"SNB^23/$YAFG .8]U5!-$FB1AX2,<Q92;8V>9Y\XN
M4W:;3E9T]I,:5'*ELD7'S=3K!8HIE.-8MBZHN7)BZY&8I1+=LD_+8(ZJG]+#
MUYH*UQVC04L./"-E([%L95J+N.<TS)43EFI7Y')[7&B;HDC5*RG NB8^GJNK
M=4TY-NUME=BKY6)[XNB\K%G8%%!JZC).P,9>4*_X>&0\,Y:H>4MONX4R:%*H
MM@JAJ?N%K%RS8R<RMB@:+5I"P0<U&Y7QU+5M%2OXYK34E<15=19722CGS *F
MV20M7T:!.*!C/</1MOU9KE*L&+*CEH]JL]TLK2XUNQWO'S4ETM5FM<M2X=.M
MV^G3+-G&.9ULTA9M*2=E:-8_R3Q3PBW)<>:];[J@033^ < 953[@#G%V>++2
M994J9?XQK>4<:_"4#G#D2)%OKLI1#I4< '[P'7UP(<_Y'V^X>X>^@0)QOAG*
MJ\+'92V<;P:,8!$'L[!XQB,O4UB0G)5%5K'BFU6-8J!3 (^:$2)54Q*9+GJZ
M0T3)N_S:K:$8FHM<U52KR;QX@XD(K)(2^*)=J"75Y#->.R;%U-9-VJKR/D@)
MSJ F(HF5(('&S$Y>CK,4I>1 1$>Q3\#[\']P .W8>WX]A'286J)B[]<+$M,Q
M4=.19G96(1\PQ8RS-=I'AY!4E&\BW<)&2,8#*&3,7H,81$0'D3"'Z8MF:]:&
M39Y6;+7[2Q<D+Y+JLSD58&ZW(CT]"T2[=D/U<#QTF-U<A[B/>7+JY=5*%9/H
M^ D[!+R#IM'14.S*+?S7SD#<+2CQP0$(J):)E.M(/W)#$;(%$"HKKF21.KDA
MLKVG61V+Z3V]XM:2AS=1YFK5E#'\X=0P]EU)W':E3F%5RCP*:YWQE43%(9,Q
M3AU:]:^PZ.ATQD\6[H]XN)R(HBJS@(?.+^]4Q)0@@($5JV4XRWIN42I@"0H_
M$T#*)%*550XE$V@].71W3FQW;Y3&2>)5+^A!.W=1JJK2R.$5YAJ*:[:/5GY!
MPV8F!Z!#M"*N:VFW!1QP;R3^6<O@QWN SLW4Q_3KWM>M,=D.R8Y&\2@0^1<;
MEJZ;B&4@V=KAX]Q*/FLG\<AWL]'*G@G3,JOH7:"R+E0H"(8?]GF\>J*@6N[F
M,59(11  ;M\S[>1BY1V0>P).;)AJ^4\B"W ?_>FK3TY^ %1NH/4&HGP%?O$7
MF]_MQIV?=LF$8/;%6\*'2I6Y3'$Y9GZ\[9WC^#DE*Y%$M4HG+$1E'_Q )Z!<
M59BZC"PK)<T\_9(M05"R*E9IHEOCE%?BZ-=E&CUM#R]7N2K>L6ROS;U3R6L)
M.0DDNFX2?NEP%./,V,Z9RP"!HUR[*81"G3Q$\?.KCO&V^9>J&=6\.CA7%EZG
MK9B^NO8Z04L<GC[)F-[C76EI)'R'KF+-*5?-99HWDV:Q"2$0FJT\M8P@+L;^
M?#\KV^J"P9'RN0Y7&3S#.:*?E8\S PC>4E++!UQUZJ0HBKT\C&.HUA,])"^N
M(N[39#YA_AK@QRB2-MYC:C46=QQ2JO%0-:(AB;.7HJ]!1+)@DB>YVO"]+KBA
M&;-LF@928LKTS%(ZI#F<O5!.X\WA0= O%URQ,T[Q L3Q,)C6SWEGE;?WD^#E
MYZ! XL*8GC797CNKIR$V(-7"96#<ETL4FY.*S8Q$HI5(@G,)P3O&>O3D3,0B
M8B8A1 .> *8H!R*QA'@2$ "&, FX I -SP4!U1OMZ2B\'92Q-7\K988RSVI[
MQO$2<6')60)2.JYYJ1?P,:]K!)5W,RQFP/4*9:H*+:%!\L*D?'(@D4B "F2T
M-W8X_<+(%@JB]5?X=B'('NMNC070A\C.VZ@D1HE7F"BA\8K13AZZX3T.HXC7
MJ"36OQ[]P9Q* D&0L5PJ3B9C*ZXN%4;3LRD^<P\$K98-.:DD8E/S91=C%F?@
M^>MX\@@+]9J@LBT 0]09(H".E>S9ONPU@9&J13./OF:;):L@5K&3"GX+K3Z]
M2C>=L!UDS+/I5JG\K(H0[=!P]EFA)Q:0;)I="S5'D3D_*T^'IMFD=T37<1*8
MAJRSZ Q4TH=.BV2#:)ID X5EI)U9'BU&BD(Z.?REA9/8YN,H;K2%FQ>,Y)NZ
M!TF .W4XN/8MXZ(B8]E$1+$I&["+BF36/BV"::?EE39QS1%%HV(0A1(1-%(I
M$R#TDX#GD-4@Y]O>J[(.24_(%2,S,1(R.0:HM5Y%WYI#FZV:"KMWZE%(4Q*H
M<IRBD8Q"FZ@, Z@"R096J@J$(!C)N 5#K*($'R^X 8 #D>X\<"'(\=N.PZ>:
M;*4C00  Y4$PF'MR8>X<\\<" ?KR/?GG[Z6BX,A.FX[=@(8>>.D0 .>0'W[#
MSP/8.0'MSTCP# 8]LI+758N4* E6*EZ-XEU%$$GC+I06 !#CCK,!52=@'H.
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MP+B0Q',U0@)8Q=YQB9,EE2NKNHD-AD,-*1A*1$3:SFT+N&;8&]@/]&0(%#V
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MRD*)M*ZZPNKD!BI<LWQSJS7ER#^7KU+0M]ECZ7C\I&BJD'4V+*%DXME)21%
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MV&8ZW:8HD>JZI\_7\;LK8E)?$TD7L>Y:**L$E%O(.$)9SH=9Q'XQNTW-^/\
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M'3NZ0FOO"1>9*R^$Y015=JME#B(&$4GZ2K8..!^YA(("/;CGCOI]!,  (B'
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MQDS \ RCE\35IY:HBEX_RI)S%A1BX*ZNIJ$DIA.6=1\U,1KA^V\H%0 UDW4
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M@7,-;'+E9&(DR*P[*/E:Y&R30+]$GR3MPV*W7*J@J4JY5B& Z:J9R@)%2&
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MD)+'3Q0BE4KMW<IQ1Y*QIBR>1#!V*C)N%PW67\_?@!X$0'MR/ \<" ![B'(
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MQ-5A(IDR=M'*Z(#)NEY!TJZ;IM6YT!HT:- :-&C0&C1HT!HT:- :-&C0=#\
M4>1 /;N/L \AQ_STL>5'19*YQD6F(F)$,P*M^CAZ<' _^LJ14>P=@ >!_1GC
M!R''ZA_8! 1_Z:@YYC6P/[3*3R[R*!!\Y.JDD55T*I$B\)H$.!FG2 E2(4#
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1' ?@-&C0&C1HT!HT:-!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g71132.jpg
<DESCRIPTION>G71132.JPG
<TEXT>
begin 644 g71132.jpg
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MB[_EZEI!>-V:G5VGV32RY;S;KFI$:%>M,CS&IJ&+:2[$FH9K;K26%.AO*?\
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M2&]1E$K0XE04G&0,$ @YZHZ&E5$29;?R;C&V774ALJ0[NS(*4D@+5PZ05(
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M'$O%UE2@E#;B/&02L*RD(Z>__28 ']%M0N>1_K=;_(__ )C_ +_?I!^_X_\
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M"1US^UELMJ\P ;2H*&TE6X %1!.-V%A1"B=VP\X)QT'\@$R6D,RRTA925(.
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M1(F27'6*:X%.%YN5'?SN.U*=M>&IVVPILNQ5EM;C\-I.U("PM];J7"V1MQM
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MO^;B#':<R_3)<],V*I:=S;,J6MZ.^VGA9:3O4T]])2E>P[OJ( .(4LK4"?\
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M/5-U#F+VMN>5QER ZO"$[T24I#K"0E()2^UM!3DJ)W*,6M-J:8LA+:$N-I*
M4*  'C(&PH . "#N0@@$8/  '2F4ZK_6E2"M1X5G/U8(SDD# W X]?8^N>@E
M;C5".\VA<=]N:@ +:=9D)6S(8.Y!#;@&S=A2-R4[> XI(//734:O2*+,,F.<
MLCZ7F%!"DR(#^$O,E"0D )*L@J.6VTA1*5* ,9UM:C5JWW$.TZH+#*EH2Y$<
MR[%>(45%#C!W(*EDG>X-GZH+R<CIS-J:U4NK-QVJC&%(EJ4O$AP@P7T*'(<R
M2ZP%;<M[P\G!"0 /0) T*IU:@Q&)4@.4FL0$*;<*@7(B$N^ E2DC"9%)J!!<
M )W1Y"59*0<(56(+U&J$^GSE#>VX[D^,%*FSM#CZ5JR4LN9;D-*P,I W*2GD
M?RUKC+YAQX+S50B>1U40-.%:'T/-$/M(<:W-@36D! VA!,AAMP)W\I[^^X":
MM0(%Q(#C\B T8DMQ*?JDT]24?+2G"G"2IMEQGYCE9;VOI4 $\ E*J@RE);^D
M%845+9VX#BBIE2L$GZ5%*702<?TMI<2E0PDRXRD_JT$K!4HX><!5O+9*0K/[
M02\]N.Y(/VQQUJ7)Q;)/(2L\E+:DI"E):6@@>3.-Z7-PYV<@$X.=5)DNX'A=
M"4(VIW(40I*=P02">"%$92#DJ"E*SM& &_,Q!<+?C&Q1"4)44!;8P2HA/.XJ
M^H>FY(().<'KY,E;B4Y*DH"UI!1M"R=J0O(.2!P$[Q])2"1ZG/-JDH]Y"RM2
MU)5^T@M%84E10"?K^I.%<_L9( !ZVB)314AH#>2&U$'=M)45#G'T@D*SCG &
M0,<=!EJPOZD!?T)2I25K(W':,*05$C=E0.,# 3D#=CK5R'EQW%H:(02D;5+.
M>26RHI P%#(4%>Z3M(Y(!V):*$(4M*TG:K&Y) <&[<0@@8 22< +X0I) &,]
M-/[B>YJU=%"W0:/3(5U7_/8#YA/35-TVWXR@#&E5I3"%R')4S!,6F,NLO.QT
M+?>?80IGR YZ(VP0'YU<6K>2I,5@!;JDYVH;05$JW-E6Q*L#;E.\Y(/24:_4
MMM5 M6J..AI='O:U)L=#@+C\1MRK,TI3DF:E9#ZE?BPWH2VAIDH.W<4*/47"
M^\;6V?4%U--PT2F;7%I9A0[<I(B(8W#+2Q*:D27D)&4!3SZG2 DK6M7U=:>]
MNZW6"^H"J-5;CC-P5284I3=)I42G!4B#(1*C.*=2'GE;933,DM!26RMAH[=N
MY)";'2JFB]Y=#LUDE*9E8FS*^XE)_446)($R6MTC]6 \EM#3:5G"5JXR!CIR
M6J=X1E5)^B6RTI%9J--BTF;)82IPTJV(3@1#I#"@E:67JH]MDN!("G"N,-N2
MD(KS:*]]6M6CURUV:F12[PA7!1Y%'DP+@AM@Q77=I9J%.ETU$6;"D!U#?S*&
MBIJ8V"AP)6M+B.^9[U>X^5.=GVQ0X3<^1*3+;?IEB5.L+1);"O$%/5(SF'/E
M]V]ALM*2R\$NH22A( 3:5^.BU+;IVFM,6V*Q6W&ZU><]*0DLM*2%-P'%HRD)
M:;\49OT2E*"K \BB./?61&6RVEIOQ%#+ "DK&S!"1DDD)2K!]P23@E6.H;:3
MW!]Z<BI3K@E-W7579+Z3,35[%BR67?K26VFV7*?$=;0 GZ4L82T/0@I3A3[:
M[VM2+<_%VM5M.JK4U.@N4N32Z"_;KL1U#;I=8G(?9<8?BN+\6QQM;;[25/DK
M?W)V ^ZX:J_3@XE;#[J"XK<J-'^92@JW$**VT[MI*OVO0%) ]"2W+4Z_3 HD
MM,5VIHEO->-D(8=!;6M*0WM24 J^A>5 *4G><#UZCAO3NUURN:>[,8O.=;R9
M<E],6C4),>!3X4=1)$=M#C#DE\M).%R)3RWG%9=60I6U*<C5_6>4Z&Y>I%=6
MF:E36U^1'FK9&T%U]@/QB(ZVPD!+B%)4-PPL'& D:T;NBFV[3$"K.RZ=)J51
MJ<Q]P)2S)FCYL(9:=+J M*6&0,A1 1O41G(/65JIW-P8$"5;UG41F756PXE%
M5<*%18#I3L.UP$OR7BO*U J#0)PHA/ C"CUVJ4S>5W'57Y#KHDR)DRJ/O2GG
ME'<7$!Q;B&T*Y"DAL 9()4<8SV;M2X\2F5E:AD%Q_P @6<D'<=J5@J6=V\#(
MX"DXR0'U6K0J-WU>95J_(=<E3GU2),A9#:W%K/U;&6MK82?0#E20!E9Y/7F-
M)[=0VG<)CB@D<(DN-GC X S@'@8'!XYZW\2YFG-R%K6VM/TJR=R=V/Z!'!)Y
MP4*QC)&>MVB>'4@I<X(P<JRDD<9XQ@G(_+[^G (K<]E&EM+=I[TPLI(.U:RX
M0@#]DE:,@#W'ND>_(Z>EV(]PS>GE6D:?7-4HT.#)J*+DL6JSU%EFEW6T0B;1
MU[2!X+F:4E"DK"4_,-*"%-K<2"B;[;4II33R4K2O.4E(((/H?N"#D^AYZ2"X
M+'F1G#4:4I82RI+NU (6VII0=;<:(42%H6$.(7_14A)5G'068*%J(Y6;OJ^I
MEE.*IEZ5"9 JNJ-F"7XVJM+@QF:='OJV4*4AN541366&JQ':/DFQXK$UK>\V
M\%8-Q=EVA5YZM0]?J+?]:TCOB3*D5VMTJUC19UO5VK3&5(FU1^%(=:>HJJ@M
M8<J\"(IJ/(D$OM1XTA1=5#+IAW>U6E4ZCTV:$4V[Z6ER(:K-6TY3JBRX@,NE
M3#[:AEYKZGX;CR6VY"G%QG0E8"78Z<Z\7%7'/EYU7A5-MQ]+R$1_EX[BXZSM
M+9D;%S$J9SM;84XX@M;4^1S"5=!H?B;4JFVU7](*_1#'J[RZ-<5JU^O1%1G%
M5--'?I]0I+CKD9*/*IEN74E-H<!<CM.B,"I+2,QR4^J19Z$N,.(+I *0#]))
M(^E7.0 5'<?;!]\CJP=<&FFF.OVG\>P[E:1,E376Y\2HPEM1JC:TQ+00BHP9
M3J7 7B@KC2&7][$IHJ2ZT=J5(B2U\[%=8-#9TJN6]&7?UD^1QY%:H,-2IL.*
ME>4FKTEA<AUAUD<.3(X<B.D*4HLG/0-3F53Y.8^R1L=^38<BMJ)4@N*>>9RI
M9/U(02EPYR/&GTS@=>EOL(6J3*\BU%I*-PY_6;%J="!P A2E'S2#R5.K0CC:
M<<37)Q-1A"0VZT\TT\P\TM)2I20XAQ*U))&"<E"P22#D>O774VHQX<9N.91;
M+C06[@**B-Q4\^YM2KQ)024EU>$E1"4A:QM4"@4!*@7IDH_K'SO>6H_2A.06
MV&@KT2VD[G%9(4ZHMG*D$!X':IJ$]I[J0NJHF+A-5*S+EITA:2<O,/LM2VHI
M0 0IQ:H;:6T$$H<4E:3O2!TS"D36)+K31;>\>UOQ>1AUIE#((4C:AP^18<R5
M>1:$EPG./NLVGDC?J!;T&.VN4^XZM:8S:DI(2X'$1RXI60VT9/CWJ5C+04$@
MG'06?M/KA-2AT]'C7YUTZ"].#6TLM/3&VY"::%)^H+8;="I+C8^EX>-1R".G
M;6LTPF. I:$[2 DJ44I2@)&$( SZC]HJY)'K@D=-8T>M5%*MND)<>)(A0R[(
M6,N29!8;6\^7#RXA2B>0,J&P_N<.RE<6/Y6XBW64I)+\F0BFQ48&4J2AR1&D
MOGC(+2OV>"/0=!V]4KL.DQ'"I]3#BE98VK*RK)+8.P-+4I!SL*0G(!!& ,=5
MJ_BL=UD*\JLC0&T[EIZX=*EQ:IJ$EEYI;DVJ1'$R*)0E/I4C":>I1J4EI 4H
M2!$0Z/I ZE4[GM;(>EEDW;<[[JWW*-;U0J;K<!R0$*;8CN.1Z9&<E/2$.5"K
M/I1%:PE(B0Y#\\(44LD4X+CJ5;O>ZZS>%5=#E5N"OSJ]5PV2ZAJ3/F.2W6FE
M@;4,QBL1XZ"?H9:;;)(2G(*E3I#7X?4FU.;"6)*%+4. %QBD@_\ !SN*3D G
M! ^_7ZLO:'L_U*';)XU!;?\ J>]%?&L @+1_-I;&Q0!Y 4G! /.#SU^38XW)
MG4>LLQ7W6)+L6>MAYGZ7$N-05.-J]P<K2 0K(()S]Q^L%V5J<5V==J"GE%3J
MNVG0=3JC@%3ATJM,K40  "59)P ,G@= YGHZ.CH(F/B!*(U)L< ?[QI!_P#U
M%-'[O^?TQR.F#Y_('W]_?^K'\/Z\=/S^(,L)U+L<'_N%?(&<?[XIW3!?,./3
MG^_\/X]!_75820/^G\N/ZCUP-PJR%D^GOSSR?3/ YXP!Z<#KL)4@)0HD^F3_
M  P?X#]W).<_<])U790VJY )*N/7'/!'N??H.'?<"2H?YLD8]_X'^SUZU:Y8
M23CD@GT]<X/W^WW_ '$=?,R0"I9]#^_/M]_O[_8?;TSSLF8$YYYYSSR3CD?G
MSZ'/&/3H-U(JQ;0H!0 VD$D\X/J1GUSG'H1_9UW-O:]4XTRB:<ZF.G]'8DU3
M5IWNM3)D6"_-24[*NZZDNR+9=="&UI\G^)!X^1*F$,N1N L*TI^I-VQ;7ART
M04N-.RY<Y2 _\M&9*$J+;&]!=?<=6TRRA2T-[W=ZCL0L=.X1VRV=;T<MN4%-
MT2G$%$B37PW/2_N20YXX6$Q4,G]D@-+W C((/(<["D5*BUAZV*]"^1J$=+<B
MD5%EU+](K].D[51IE)F [)#3K2PZE(4O<@E*2E:%-=(3W*:BHMRTYU#92A51
MJ,9^"0XD+2&IS07/D%!X6$QCX$XR"MT@<MGIT-0M828])I,D.P:?15(1!IS"
MEQX2(["&PW#;9<5LCM,AIOY7Y=33L=3:/&0$[.H@.YS5(73>]352(4^32J:H
MTZ&Z5QV_-\NKQRY332UI6IMQ]"_&5$*6VE*MB2K'0-CN"9,D*VLRU);0I13'
M0AF.R@< C:AE3@'H -PQZ'CJ8;X=7Q,[1T7LI6A_<7<$^GV_1Y)5IM>#4&3/
M@T6DR?)\[:UPK8\LV/%B2I#C]!JOA<9@QY3]-?+++45:8.KBNWPA9_ ZZZZH
MY4F/%&[W(*?(KQJ5Q_\ &<^FT>W'PJ_&12ZM=%5B3Z?&AM2([;5<A?)$H;1Y
M),EL!]]$B.E!+7F 1E\%"4DIR O8V)W*:*ZLM(JFG-\VY=M.2AT-OV]6:?/:
M2\\6_F"6V)"G&G"TAB&VEP(6VV'1A(<R%+9NRG+D)<CON$-N$%]*]I3ZH26U
MI.XI#H/[)Y2EGZCA6?S/+0FZ\S;SE7_HM)NRQFXDB0NE5^@5F3;C884ZLI4E
M3;\9V5YP-Q:7%?:6@)'UA"27DTWXE7Q,=&8T9-1U=E7-3X24CY.\K:H]>8+:
M, !R8S$I\Q9 2 EPO[D8W#) /077=;NS;LM[G7W)^MW;WIQ>U:7^H3<GX,JB
MWDZAH.1F\W#:S]'KCJ LJ\9FRW6TJ*2DJ*<!G%X_ ^[+JY3T4BP:KJ5HY#H<
M65%;33+J;NJD17"AZ67I,:[F9M04W#><+KJ?QAA!9CJ0/& 737:LC^4']VM#
M4Q$N.Q=,ZQ#0]'5*73%7);\R4AEQ#BT+?;J-1VMNI0I+K:&VQ]:E *]#*'H/
M\;VR-::#5].[ZMZ7IQ<NI%3E4>UJ\S5EURV(E8O:="H2*55*D(L"HTV069=0
M;ASID1R$),F.RJ1'*D* 1OZW=J%W:(UF5+ICLZ[])&:O+C4B]8+2($QZGH=>
M8I[UQTQHR'J":AD3&2E^33WBY':$Q*MK2E*[>)D)4%FG0)4VM5-45R1)HJ8I
M35(K;+[R5OMH'$Y$F.67'S#20XVG<XREP!8E(J*EQW:C0+D%.D6XMMVGRH-8
M@-_A$F$Z@LEMR0Z^64AQD!MV.MD(W)*FR2E/2,Z&Z.6;8U[ZH0J'4(U4HSTZ
MA5N@1&FT^>A,2!56I%%<FK\RW&8*E1ODI4=Y(FPG&2XD.M*R""F>U\T\EL*#
M27UI0A0*'&TI60$+2O"TJ1Z*2M(6DC"N>K=_98H+[3NWU8]%:86TH?N,7/5>
M^LZ5V9=LUZ7/I*69CA*7)U/=>AR'5H(_6**.)#G(!4ME:B/VEDXZL7]JM&CV
M[VX:+T.*X\[&I>G]"AL./E)>6VU'(072@)25D?M$) )]N@I!7=<#;M[W4@R2
MMUNZ*VDA(4C'^N$G8$'<5*&T$I422@%9(VY/3.]?J3%D3W:W3V]DF&6TU-)^
MI;T&6A+T>7E/[349Y:V%XSL;=:)RE"U!8;Y7(%[7<['4TT&KLKZBI&].T&HS
M$^@&=BBDEO 2$Y7NX.>N.K%LW;>12JBTY<Z66OD%H\B&8\B'LPE3KTIQ+"L9
M"4A*B%M8&[Z4Y!D<U3P8$I(/R[!9;#C2E!2%+WD(?2?J0<@):4%8*"4I(4,=
M=)1ZJI;:5()*S@J 5M.\ G 4K&[CT3SD9''7?ZC:)7II[2DUVKHI<RD3EKB5
M6+1YJY[E'VJ:5',])892AMQU20U(:#S$>2WL<=2'&UJ085%=*E-M)2TI#@+D
M=?(9D(R$[6^2"XV=P=9*BM 3@C: 2"O1ZFB.05!UYP)Y8:"E;4J)*BDY W/D
MEM.1DMEQ2<;TGKK8$FKRW?,ZTJ"RC"&@%)^9=6H#8TD$E+;"$_K7?V5!* @G
MGI(HMT,0&3,D.QXJ<*<7)?&5 I&5K9)4<J0@#U1A+8"4@'K0S=3JQ57#$MDR
M V2IE=6F)V))4""(4920IU1X)==\3?"04K"< 'D4746J62&I2;B9I33+C;P3
M(D-M)6ZT<MD;U\N I 04#*#DIP",.ALCN\9>H<F/6*"W4(DJ0MQIR-/4VRMU
MIYYF6I##S3@<CU*,IQ*VMR$I+S;B%%* DQ.TNU$S'C6;IFKGO(PXMRHNJDIB
M-CD[E.$-M@)4"&F$(2V=J4 YSTK=*KD1R'M@,/MT]"&VX\IQM,=A:$)VE3""
MH*\24I)#W"2 5YP,= YJOZSWC&FRET.R:-4Z8],>,)V5=Z:8\S$4ZZ8L68F9
M (1-*7@PI45Z1'?<3N'B\AVX<'5;4N7(8_$M-:72X9<P[/5J#29/@:*TY<7%
M;AJ<6V G:4,MN.*&4;$Y"PWZ)4%U.4Q4WBX8T9;@I$9?+#A +?XL^@_Y1W]M
M,!M60VC=)_:6@IZAVKGQ.+=>7A*-Q!4I0(SD9SC)*ANVGA1X.!C *K6KGOJI
MM+-/NZU;<4DK6E^D6_.K-4)5D(;*JW(C4MHI25%;Z(+ZG-@2$H223S51I>K=
M8@LQCW!5>FQGFMNZEV=1*?*5O& 52XC[+H4H I"VU(Q_1 .".6ASO+N6XI;:
M'MBM^,J#90!@C^B1S@?F/S)V<JO'&UM90AEMMMG!^H)0E0'(&-RL_5CW^_ Z
M#D7]$:M4%*8K.O>HU26"7)"?+)+92OA2D-R:T\@+]U*5N!X&!C/7..]I-BSI
MA?FWO>DEUY96Y*?11Y+LE:AA*GG765+#A^GE2EJ4-J1M]E/:K \GF6HJ4XA(
M41N"0K!SG!Y!S]ASCK8,7 6$D;]R2 DI(R<)SL(*CD'TW*]=HQQQT"7M=GFE
MT9L*5<%YR4;TK6X)-(:)^O+C80W . H_05)5E(!Q@@$;N!VY:+T>0F5^"3ZO
MM4ELQJU6Y4R",JSYG&(YA+25'(2A;CC2?V4M\9/7*N!["BEXH!)4 DGC>22C
M<" 4CUQ@#)SGWZQ'*NXL_P"5QD;2!E(P<'*@<C()/MG)XY/0=9$IME6TM*:!
M:-KTIQM"4IDT^BTR.\H A!/S*8ZI"U!/HZMTJ63N6HGGKT?NR0CZ6'7$!(R2
MVHM@8!X 1M'Y$@'/L3UP#U3R"5*W<_25$# "2,8Y]=O/^CK7-R77E*=/^3!&
M,'&3G[@XPD9SG^!(YZ#MG[GE;TK,AT*6. 7%DE(/!!))! _+D\\8'7JU<LU0
MVB4M2,YVK4I23GZ1N2HE./X>H_+I.42O.^\YR4-E3;1P"D*2$[L#."2HJ!5Z
M'!Z^(\Q:7%-+<)<SO0DG&X(="5%(. "4J' (('N.@4>2J@U/'XM;] J9)*E&
MH46FR5[LA)4EQZ*M0W@D+(5N4G]HYP>N0FZ8Z/U12E2; H#+C@4A3U.1+I+Z
M4DDE++L"4P&TY.X!" ./JR..O$3"4K</[.%'!&0 %>P'&3G!(SP,=9**@!E)
M4#@\$D) "@>#SZ#UR/? QST":5/M4T8J>5PG+LI#JE$^9-9150%*4 E(8J<9
M0V')^G<0,#GG)0G5'M6?M2F/W#9-=1<<""VI^;3JK3$T^KQ66P5//LR*8Z(\
MIIEM)<=0&69 ;WK\:TMK'3T$3P.-Q(S@C<K&0!R2,$<^_P"0QGUZR?GDJ24.
M;74C]I"MJFUH/#B'$#(*5))20>2"0<I)Z")*/#J!0D%#S"QE:4ATRH:B.$[7
M 0^PHI.Y*EIV$'"@H<#;4^NR(BPU(W<C<05$K2,D%22"$NH!'.W!2,%83[[^
M\H:;<NNY:,RLAJ%6:BRTA! 0F.7EN14I X #"VT)^R$I.><#AG2'4[E .'"B
M05$+2X/53:D_LJ6,<C&2,'@GH%3@5QB0D*"@3QD*4.00><#TY'L3DG Y'6^$
MU#J=J0""G*D@G !R ""<D'G//\<^J"QI$AI9>:<*EI&]24_0EXIQN24#Z6Y*
M>-P!"%@93R>NKIEPLO@)4K:Z"0L*"@I"P0,*QC&#CV&#@_?H.RGT*B5#/S$)
ME8(/ 0E)/ &[>D @YSSG/Y\#K3P?QRPIJ:U:K[LEEK"I%'F.N+8=;1NR(C@4
M7(SK:?J26BE)^G>A8..LU,HJ]5JX0!N)Y(&XXS[@9'IZ_P!7647@I.%*6I6S
M:4YPG./88/U<^OH1P1T#S-$NZMN4^V5-S(+L0-MSV&5.R%1%*&%.S&A]?@ "
MB'V@ZPI:5)RA6Y/4LNE.N5(N*+#:0^S5T.M!E;B$E1"W D;#@*5L4D'"2&DC
MZE+(3DBL%<#]6L^L0KKMN8[3IS:\K6UC8LY)4R^R?U+L>0,)>9=26U#) 2LE
M73X= =<X]SJ#%*FQK9O.,@NR:(ZLIIM:;92%.2( RA6%86'(Z@IQ@*2%A3:B
MZ F:U6[,= ]<$N5NH6E3Z76W&DN-U>V&DTBHJ<=RXKYCY4")+&_(4X]'6M2\
MX=&#EF]T?"RHT027;8ONN4]UQ:G$,UNCT^K J;*0P''HSD5]"$N.I;20V5)Y
M4A!6=W2QZ<]PTUE;5,FRG*34?$A*VI+FX.E0R%1G"=BFRH_JT) YR/7!+EX?
M<&$A+=88:2VX6=CF\!) V@K6XD<@;=ZD^J%*2I04,CH(*-4.V7631ZN"DUNV
MZG4:?(;7)IEQVS3I58I%1CL\.*4ZQ'=E09; PJ1"FLMO- %:5+:'DZ[GM3H;
M53U7H$:>E@EKYU]YQ:2E3WRS3B&OF&U;U!^.\M"?$G*MFY6U*D[1.V-1;:K;
M#;T1Z(Y]:5I4M>]S<$D#:H E'"O$5 8+2U)(SZ(U&TILVX]9+=U+MZ*Q2*M"
ME.0;A%.0Q!CU^GRXSC)E/E* RJI07PTI4T)2Y(BEQA];BD,J0$E=D1%HID5M
MEA1#;#* \M(3M2V@)W-H!4K80"H -I4 1P,$'87G66Z%19%1<+2D,M+#?EWM
ME;Z$@A"UJ4POQ8.]XJ2O#*7 C>LA(S66Z3$IK\F+7FHS42,MU^86')#4=#39
M4L+G3IK\-E3>'"?$P=JP1LR,B,G6[6RL:AU:=;5FSJC6Z&R\N+(K38DHAK2E
M:D+A4<.)3\TLIRBHU=3;$8@JCTQA+22\L&K]Z^H*[LTHU2E(D%R)&I,L!XI2
M$S7E2&(ZY"<(26V@MUMF$#D)8!"ADG%=J06OFZ68[P4J1+93(2E:\H6-I(4"
M<8"N!@A*@"<>IZL87IH-+U+LNN6;4ZK)H#-?C,Q7YT1AJ5*C(:E,RSM:=7X7
M4NE@-X<<3N1]1(6>F.W'\,"L1'8\^W-4X,I4=:7O!<=LRX06M) "3,I$R<VU
MN]"7(Q SZ8Y ,5MI@O-RE8*DABJ*4C'!+<,X*C]N#@>Y))XXZ_5T[.!M[1NU
MM.,;>W/0\8^V-+[5&/X>G7YHT#MHKFEPJ$K4146J4:0RNG4Z7956BR@]5)Y6
MQ\A)<FQ [ 6U'*Y9"HJRZ$%I#@<04'],[M58CQ>V'MRC1"X8D?0?1]B,75^1
MTQV=.[<;9+B_&UO<+24[UEIO<K*O&C.T O?1T='01"_$0=*-3[$'.#84DG[?
M]DDT#G!YY_A_'J/E4DCD^H/(../;@#V!]SG[<]/Z^(PLIU0L-(][!D$?F?TE
MGC'H?]&,C/47>H6H5#T[MV5<5=4ZMEM28\*!%*/G*I/="BS"B;_U:5*2E2WG
MW<,QH[;CK@4=K:P[2;+)2K/  .<^O[_3^OC']>>DQKT_=OPK[I3SCGU.#GT]
M>?7'O]M]HK=[>LUI.W0S:=3H;:*K*I2(\QQ509GB*AEPS:=*;983*BJ+WR[I
M#(#4IEYI*EA.0J+5CU-A3JGZ%3EM%1*1,BLI.PD[0"\$J3]../<XR?<@TR5)
MV[MQQGU^_/.$\\DC\O3[#TY.I3_$A2LY6<[1G@?EZ^_&<=/$K%F4Q]M:7Z'!
M8)!'DCE*4>^<!++K:AD<;%#WP0>>F[W'I-)#TB13*T VM2W$PZA'>=0WGG8U
M,BM!Q+8((0EYE[8#CRG Z#;=MM<33K_J,Q;N'44)[9R<_P"V6BK &=R4823N
M! )"L$CF1^VKXC/MM)E+0ZEU1&Y;BG"I).P$*R0CG.[E(2H_4."!%%IS"J-K
M:A0F*FTVE$V)4(29"'B6E>1CRI4RK""5_JL(2XA.2>/?IRM-N.<P\&V9CJ0R
MI:0AM9:((=4VX0D85E(6#](*%;3P< D']ZB4FVH6F=YWS+8;6S;-K5FNNO!W
M#K*H=/?D,H(4 ' \^&&VN 5>0 ''*JHVJM_VO:SKLVZ[CI-'7(\SZD2Y*4S'
MG'E>1U46 @.3)" XM00IF.L$ 8/OU/EWBZR5FW?A]Z\5>VA+F7!!LNE1([B&
M525PT5"YZ-2YE0F,@I\M.IL>2[-G^1(0AAE160R59HQW=7*I7JU4*I6*C-JM
M0E/NNR9T^0N3)?<*CN4MQU2B,GD(3M;0"$(0E("0$F6G%^4K7S6.P=#])Z3<
MU[WOJ-<L&W*&U3:2Y&C,_,%QVH566[47([K=*H5+9G5JIR!&4ENG0)"TI4O8
ME3T?B$:)Z9T"_M)M ]-;5G634K+LL3.X.J-W<F]*=4)T60W!H"6'EQXL.-<-
MVNPYE<GTY,""FDQ9+L673"['0\['/\(]%R_ZOK1ZKVQ5Y%$F6[ O^X9U0CM1
M'G!1J99E754X.R;'E1RBHL.?)NY:*RVZI+:T%6\.,[@>ZVW).IFHMRW=5Y5V
MZ@7C>5>N&\)5*90Z34GYCS$6"Z]N1'::HU*8B4QEAM8::##GC2"ZO 8 ETNW
M8HI5+B,Q(4-&T+P77U.$!*7'7'.7'#C/U#QI2E*&T-MI2VGGIYI5UPGX<T-3
M4\)<2\RA&Y1!]0"6RD Y/*%[MN.3CI#)/<GI]4U.1Y-/JU,"SN\TB*7FR>4I
MWN17)"FT@ X_5+ R2< D]?,>_+.DTR3-I%T0T)4\/.N2\ID12=Z@V\I*5);"
MB 6U.AHN[0$!1!2 ;IK-:EK6Q5)\1E!CUE]+#E*I[+$CY1YEYP)5*,@M)C%I
MA(4"VAY:@\ VO:HGKO-#*#!J%LUBFUB*D2:E/AKHRU EY*Z2XQ49,A):/F::
MBOHC!R6H(0V7D-I=\ZFT'C;DJ#^I6H%-I='E(GTP"%0J=)>"OEUJ=<#TZI N
MI24-(D+<<+JMN^/'"R " 9-KOT6M/3ZBZ6W19=/IWX1<=,5IS6ZU""C\_7:'
M37;@B3)KKKJU/R:IBK+?=:0TP5PV&%)4I".@<-9O=1;2X^E5"U9NJ1)K*ZE4
M;,NN;4VZFU0ZK9)I4IN%6JM5GV7(2:G!/R+3QD.M3)[D=[PY7)4OI\O:=?5B
M7P+WEV76!4*7012J&U46%-2F*S$W2ETB6IY]+:WGH#,>1!,EE+:9 :"UY0IE
M:HEFJ-0(PCK-.9ERTE!0Z\P9CX*22-C2OI; XQXV E/KZCIZG:'=C-I7;.MQ
M#,2E4V\6F6VT".U"4W7*>E]ZG-I)  ;E,.RHC258WOK92EOR$'H)76G$.* 9
M:<*CM05*0XVVL%04-J4!*2=V58)42#]7T^L]O;R@MZ':6(4@(*;,HZ2@# 20
MSZ8R<??@D9Y'4 -OQ*A.FL(/GF)*@0T&G'$I6DC;N6DD9&, 8RD9W)*D\V#-
M"VE,:.::LK:\*V[0I"5-8(\:@P,IPH C!^XST'YSUZZDMQ-3KN$NDUFHT]J]
M:X9;,.E53=(8169 ?2E28B@%+9W%I0.T*1A22'#ER%AU66Y3Y$QJ8_/#[C$B
MG-2XZH)<CU!"FZ8'H):BOTZ,AA2OF&Y"7'(K\9T(*<!2>KU 9JBKTO';$B>/
M])J[A:&G HXJ3Y2L8=2G ..",J)^W7+-QZFB*^\E@.!L1X4M33:D(2S(6ZMC
MRN%P.H"E+>@(<&]2'9D5"=Q((#/J\5JJPW8TF#%KU1>B;'V4NLNP%MN!;*GI
M:GGB'D* 4B/$CM[%%AM12?\ +&-G5K3R38<QYY47YBVI;Y6MDI>:%)DNK4VA
MI#SZ$N-)"1F%+*4I5E+;GD&Q;DM-!+].D."M.1(SSL:'):(B%Q;C;T=* EIU
MGS)$A<414)+BF=ZDN%;S7D++>Y<L>WJRAQR1#@+9FE*DKN)1FLOR'GW(\9D1
M7EO0RVM[:VXY*<\*"M:-@24K;"!)5.E.K2FDM1+F8<61\G-F1Z=6XJ<;TMN,
MR'6(M3;WG"3 ?:=6G"W6BG(&U@ROT?*/QNF3J<ZL*"!*ISK+!4$E0CQ'D(,=
M1"4X2&W05C>X2H$J$H=]]INFM2?>D,V93*'45-!Z0Q!D3**69C382M\)C+D0
M/DI"@74,Q8)0VLE2-A7O+=;E[<*_$B.T:)/A4&#467UR*1=-KU"X6'X21Y(C
ME.J-*FJDO/K(;<9\L6!)05)=8=("BD&NTE52NUX3*A(%+MYMP^-M]8:5*"%;
M0VRQ]*GE$8WONI\8S]"'#R.G?J!JU1%"IV44BGA!K,P*VC8L?J*8P1MW/R2D
M?,%. F.E8203RKD#MQNV1 8D&U16C'2E+<^E+BV^['2VUEIA"94Z,^PX!]:O
MG)<DND%3VY )3JZ?V]:EO24H-FWG0*<VMQQ4RJUVC1(\GR.I2J0PW3PVF22I
M:0B:Y42I.4D)/U-J#5JJ(:*D,JVMLI882@(^A)0W@;0GZ2  4CCT.2  .L]I
M:GFVB^\DI"_(Z@J2E6&DG"2CT"@HI!'I_7CKOVNV;45Q#;M/G@E+A2N-*J](
MJ)9>21@O22RAQM1;<!;W_- CZDK"B ,Q[M4U=G-N+A5>$A#3;CKP6();2$.A
M"TF0J1"0DA2D@<)"DDJ05 #(<$:QY5*0UA+;3*-BMNTJVY23P0 3E)R?N<@Y
MZ\D5!#J WN*25!0!!R5$C(&/3W]>#Q^_KMT=K6N26P80I+C6=BUE<(H*PCR$
MK6*X<-^,!:G%I2@)(*-QZU:^V_78K411Z3-4EK>AN#)"7U!1(0I3:93JVT*(
M/UI#P40K'V :-=1#;W#F$$ D8'TE/'H#^8"AZ'!Y]A_55-*5!PN' 'IDX42.
M?IS_ )@. .O*7H-KY%E"([:<3S.*RAMJN-..**N6FUH^7!:<7D82ZI"@G*MI
MP3US\G2_6^ MWYJTGF5LJ+3J4.R93:' ,;"ZU 6CRX]$[U)4D;DDXZ#?FJHV
M[DN%1R<@@^Y/(YY X'^GKY544;5KWY)2CD9P4EQ(/!Y&!R4G&<>AZXEZUM36
M3XC;3RG -RV@MQI82?Z2D/,,A+:N>?0^HSG ]X]J:I2&/+#LRI3PIW:#%RX?
M( 4EH?1M>4GU*-W&#CD$=!V"):7\D+(_; !.T'C .?895@IQNY^PSUCIJ2Y3
MBXL59$*$%%]\$_KY*!Q'0?38/1S@J.,'CGKXB:4:UR8[SCEDU>,@I(+IA5!U
MQ"%9)2V6H:FTKVI(!2' %>Y(QUQ]^1;[TWBQ6J]2T6A&6VA4;\>MRNLEYQ:"
MX%-2Y9A0Y#Z\;MBB%/ E004#@%(:2(<5I#A"75 *5@[B5N'>H''[*N"?S]^2
M.N=J;KB(TYSR_K8H4XVH%2=B,I<4<C!PH)(!] K&>..FCR=4KMFU-UFGWHW(
ME(>;2B&W2HY:(<P,!*UJ"%HQN5AQ02@$EPKP.EMH=0NAZF/-UEM-8;##B55.
M$A$10:(4IM#]/>"%O%K*BMR(_(!;:+A2 DX!3X=9^8C,X44%8VO<*4,A0"E
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MRMRMU2=!.-F"D!).<8!!.0>F_P!>B_(2GH*'G$1Y[+K++R6E)2RI2@8H4C*
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M!M>]/A81Y%AK/D0AUM0;A D=W\N0L/MPF)3[@"5%MN_Z@E:\*0S^J<D1$)#
M*0C8ELO%.]PJ6I21C1NZBZX4'Y6GT5L*E2A,EOO6/=4V6F4PG=&>>DRIJB^
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M,\D(4H+"=P+2TK.])"$[-@00L %M)Z#BY6G6B$QL(D:<T6K);#7UM:>2YK:
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M2K804E'H1\K8L<?; ]!CCU/7R[\"'M1E;?G]1.X.J%((W5._*;+6K.=VY7X
MV"% X*0D)_+''05_FK*T]IZ-Z:);D3"U/)\D2&PI(3A0*5D,MI&W*T*0I2B0
M$G!ZQ'ZSI32%E#T^T((0I*E(>J5*:6E )\A;RZE2BI*B5.;E#<%8QMP+ @^
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M*L *+2JE.=#:0<CZ"00%*'/5E$?!A[> M*QJ5K6"E(3Q5;''IQZ_H3D93].
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MI53/PB@Z@7A06_(DNQV*C6(T7?G:4H81)6PTV3M#:&4):;4%!QO=M+BPQO\
MWK_XT_\ *$]?R=^VS_\ QO\ BV^@TU5U9ORM,&'5]4*Y6&B\A28\NKUJ0TM
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2J6C0W_<?TX_^ZE+_ .*/0?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g804100.jpg
<DESCRIPTION>G804100.JPG
<TEXT>
begin 644 g804100.jpg
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M,14B05%A%B,R)#-"<:$70U*!D;$*&#1BP271\"9%4W*2_\0 %0$! 0
M              '_Q  9$0$  P$!                 1'P,4'_V@ , P$
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M'Q5J7F6724^Q)?8\.05 )()YYLX[I]J;0LW&]G[)B056+I2<8E9538-3P&G
M5M-?X;=NZUY;++12VAZV;=$I*OD42KCK'@PTO0TV481Y<!Q12FRJWHDVM4L!
M*5)1,@O/UY/!22I#BTDJ'*SSP M?R?ZD=(I+[.%ZRN[(N/#QF9-=0JZ,E".1
MRF!!1-E)4L<*]/(6D_M4GGT&$N>][N!RZ0VQ22L8Q,2Y#4./&J:-B>__ )JP
MA*G;*Z5*=3\23YJ<9995RGD'PY087QHSR#RGD<#GA2O)( ] @#E)X_J.1^..
M/X4%>E312OV'$*:=:4V$AQ#J'$D+1QP%((3PX% CX^3_  . EE=S=E7J/CS+
M;>P,B?3P7(S%^]3U#2R/(MQ6:A$)UQ"/(I#BI'@K_@2GQYZ::VQB.%.+(D25
M$%2G9<F7->/OG_,7*E.>8)_=R1RI1)))Y)65!E2;>,F,X@-626DDM'GP>0@!
M+C\/_P 0/HAKT@$'Q2.3SGO,N+4!P%!0]<@>_7D3_I '\<@?@GCC@= PTFM?
M94X&6_C"!^0VD>A^$\)X]C\^^0!^?8ZUZ)-JP>$J:''X4IDEU1/!]J^0)X'X
M "00.!R?Y>&= :2I96MM!62D))X4"D\\(_N.?Q[''))Z3;E4E3A2A)4H\'E0
M*2>??' /'B/[#G^IY]] C&;B:GT['BNA7I22V_\ N'!]<N.+/\<G@?V]#CI2
M0KS[93;K->[!6CDH<KI;C"^2?:DJ;2RI!_'LN+YY]%/X.[C8NR5!;Q (]%+1
MY"@KU[4L$<_GD<'D\<>^#UO&,>KO)"/A>=//M!6Z4J_IRED'T>>02 3_ ,((
MYZ#6LYG=HE";6[&VWA5GY)4]*QW8-Y ;EA"4AMJ?72GK:CF,H"4\(>IU^0_8
MM1!5T\..=QG<3CZHOV&XL/V"RI7*XVT=<U;4\H!Y#/ZYK*SQJ:VPCC_4YCTM
MX >VE>D])VNP\/KXAX^I9/'"4L?(YZ_\0?3Y 'V>0D'C\'IP*O6.0OOA#&-L
MM^87RM<..TM) Y!X2T'?7H@\@>O8(Z!YZKO4V-618C>1Z0J\I5_F?=S]8[+J
MHZ0A/[PJ#CFR*[%[1U1')6V]:*6#PAH+''+Y8OWH:AMDQXU_'S;7\Y26TO1\
MTQ*UC1&'W!_],;RI:MJ9]:5D(^5F86%<^27"GWU%MO3-\ ')DK'JY+:%**[*
M>TRVKD<*#J9*T,I6$C]JB$J !\5<=8;F.:_J'$IN-Q:Z@N)0E*EQ\AK'90#1
MX*$,P93[R4#@A25I2X0"".?706 V'<1I6FB09MYM/6]%'LFR[!7=YYBU1]XV
MEQ+;BHHL;.*9'P^7+X;Y+!'@]\:B!U%'N:^I?V9]N.,Q\BS;>V"37;BIGRL>
MI<+FG/;R[=@A9CN(@XBQ=RF:E<@K@2+"1'::B+><D1W5+8<*8Z9%C_:9D<:5
M5YIG.N,WAO%1?KI^"(REA7*O(I2F10O._O)()C2FUE2@>2K@B%^R_IX?3%SW
M]7L*-.U=57MK$0EV\UG39>U1-+9#GB]+Q?(J>]I78S07\K<6$JK8<;"DJ6/
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M*0VX&CJ>V"7&S"@@O9?#PG#;NYAU\RUS-RQO*+%:R3(#-G9HMZ1N5<V=15L
MJ;HRPW;M@(;<DH9#CO08VN'-E;IRK&]*8%A5IL_(LPLC!QO#:E[SGS+AALRW
MIE3*E.LQ,=74QFU3+S*3*K8%=6LR'[6:J.E+;G55VN_12P.FQ:EL^X_-IV8Y
M@&H\BTQ;!'5TN-UKJ_%W]+DY38MS<KR0L(/VTFPC.4$*6M#AA,!GQ<5+7Z=O
M9=VJ=N^$0,LT1)KMHW&6T@:M-_OJA6=SE4#Y27*FBDPT?9XCB\&:R QC-/\
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M=RN@>Z?%-6;0V9H+?<S7,7/M*4&4ZOP[)<3G:JU3LBEE.X;E>5;%LZRYB/;
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M:S:L*Z7">2GQ1-0B0?630UEY/4F7!JV3)E%96Q5Q2Z7'"I:9#DMZ*_XO ^2
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MIZ#L^PGXO76<:ED80FXCXBG-Z2\H_P#%ES&KZ2)$9J;JVL(5/D-#8V:_UO\
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MNN[?^ZFGOLAT!L6!LK'L<ET\.PR"GILHA4+[E]5HN*IZDN;ZBJ*W)X,F$O\
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M40UJ02Z[-F+5+="4A ;6/>(Y>)4^'D^)\?\ ( 4L?* GGEP_&7%*\?+@-'A
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M^)/^H'^@   '_/K>1I/S+XC+;3\BU)"5)6@)6H_(0DJX;6XI(*' DCC\*/\
M'2BQZL-O8(:+*0RREZQGNE(2(T"N*5OK45'Q"5+4E*>?]:E<))X) 0D^I)EL
M_">WK7^MZYB5(F9UFL2TLXB4%_Y*7 :Z7;.*60H*#;UYD->TE*/%)7&!62I"
M1UVO_2!P;+]=?38[/L6SJ*] R9G3&/7,^OD)6E^OCY3(L,GI:^0A826Y<.@N
M*MF6UX)#;R2@ ^)4J-/:Q]-+26;XUK/>.]\%3G&Q'80LL:QS*UN.XIC%!*LA
M<TH5C"0Q'E7A989GS)EBIR(XLU[3U<\N.0;J*JM36LAI"&6T!IE"6V $-I*
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M<GA&Z8^,]G>2&#NKN@TEW,8;JC5V]-\M:&S_ 'OISNK702IN-&5"<MY+T'N
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MH3^K-(CH3&CZXV-:N3)#4A]EJNQW*E/5LLQXUM3K9[5,O4M<=WR\BD @?G@
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MM(/DE_S#C:PH $<.!()_"0>#^SD=!+/%,C,93YD/%16M/ 4I0\2E:TJ;XX_
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M=;6II"2M2>"A0'#@4H E'F@<%(2I/B1PH>^ U@I=L/!MMVEQ:O+:4,E-AGD
M!E"5J5\?Q5\*2D-H3^5L,MD^@L@>^LQO#\[<\#+R' X#'"DA4:5?WTDN?P U
M%KXK9X)\4EUQ(('\ ]?MW(DI'@I*D(YX4A+A:4#X'TD<) 4$@$ _\/)(XX/6
M$[DCC12I!\@MMLMN>7@7%#\(6 #XA/()_ 4HD@$$=!LU8/7-E*\@RBSME*4C
MF-41:W'8ZU-%SS9=E/.6MJI"BCE!:;C+))_<A7'&9#G5N/-(1C53!JG'0_\
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M+A)B7,>;&1"DR(B&DQWG&U1!QGZHFMK+(L=Q[.NW_NETG_VCZ;VGO/2MKMW
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M/'X\2>:0I2.5R?E80CD#@J\U*5Z!\?9Y)/'/\@:]75BP[[]-H3XF9W#R3P4
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M*(*TI"/1'O@<) ]<<\\?^6"#PE:@"?%*N D$\D@?M42"E"??!6X4H2"5%7H
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MNK<7\ <A):=M'F7"0ZVF0\E$:%SRI?FRA;K;GH$G]W0,7M#,['+I<G7>&RC
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M]P((/) ' (_J?0')X_@GCK9(45(2H_DCW_'_ $_C_E_'1X(_'BGC\\>(_/\
M7\=?H  <  #^@]#H#HZ.CH#HZ.CH#HZ.CH#HZ.CH#HZ.CH#HZ.CH#HZ.CH#H
MZ.CH#HZ.CH#HZ.CH#HZ.CH#HZ.CH#HZ.CH#HZ.CH#HZ.CH#HZ.CH#HZ.CH#K
M%<CLI2I81XJ'L*1_J!Y'L>_R?_R?Z]977Q20H$'\'_\ !YZ!'W5:W.94HMH#
MG"DJ#8_RR G@<#CD*YY\N?1XY!X)X9JYQV3#<+\9'I1],+2"AX\?NX!')/\
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1 ='1T= ='1T= ='1T=!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g556508.jpg
<DESCRIPTION>G556508.JPG
<TEXT>
begin 644 g556508.jpg
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M$#(0C9J\4=;!T43A6DU$\[BX;)1VI"-*GO\ 8T9\BR^'/"2(*0,3$8/./#-
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MM>QW_!S7(K53_@J+RVB\R$]S%BL;2M$156>O%/5E:2GJCO9(.0R9(&(J>YS
M9 VR>GM(;-$Y\;K*QF&KA*B17'W@T?\ 4&LGEC@%EQD14!.FLR&MG!#E;*0+
M(BME9:M*C;?ME?=M9!'9J.V\!QVW$#(0H(0<RYWN=\;6M(NF,=[?:QK/1!ZV
M=6(LLTKGEV$*_&C!H'K)/W;$EQLZ45?*U)E2%]O+&GN6NK)4>OL14161F6",
M6 2-W[F0NG-1BM@8DF,(W4?0T1UEEDZ@SYE9L[-;"_M7>BSTC]439$9F&J*F
M(?>UR69 1]K!#G2ZH;-3V,983('EO2*7JM*JND SHT$8H,L7I6@-1[65U4^2
MUST8\,DOI\,;1A:U8($:[W*++(Y5^)CEYSKWQ[>J69L3I;#'WH\D[4F61TE3
M=9^V_;[$42.!W]6R_E7?+,L;%A8D4<JK+_'-?'EYX31=Y6']H6 L0*+L=H8X
M5L+;OGCHM8&#$L0*D$CQ$3U5T' C!(+!!R12PXX138(UAA+CUPU7T]/)H^Z9
M 3AL[1I-\0A&CLM7FI!8A(Y'R,2:6H(L[LH2)\DDL(L0,WMDE>YL,;Y)9.;C
M_&3QKS7CCCIZD(O]=UE_(.9KM3(.@RV! \;F"5U<,KY'A4=8DDR C22RD333
MDFERNG(2.');E,=2U#XCX'U=<Z&U*:;91.!$='8&-8/&THZ-85882V,05C9R
M6RS(P8=J/1L,2,^!^<H+4N"PLZ2HL#A1R!!C#JP$PL<4I\<A(T!)(\LT(Y$D
M,3YX(Y&Q3/BC=*Q[F-5.PM-4JUK%K*_V-.(M&M^Q$]K;(MI#2CVM^'T0TEI9
M32"T1")FDD)+*])I4?R/3U0DXQ(M;7CD!US:<2> (6&8:J8^.1E:/+%$R2"O
M;)#"]H43F"M?%&Y(D=&Q4J/'''(VU<ORZ_*5WX])*R^*>JMD]SDF/S-,K$>B
M+&D?QVDRS1N<V61$:L2JUDJ<N.=[8R85>QKFN)E8U?:CGK,Z]!6-B)^51%5'
M/5WIZ,]GO545$]8TCK8]30=G+"V6130(<X+-'(UR2S4=*ZQ= /[O=&L(M_<V
M(DCW^V1Y+"XI$C^)B-OBMO*\YU!;M14K]U2B2PLDC:L3BU!:>-$0GN?&R4D
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M:NGC,KC/B56K+%&3$UA0[9(_NPI"@W2-C(>O.I@Z:USV4J:6YE$E,KHYQF-
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MRJ_X_2;57T15_P!$]>:NNR_*[LJU[YV'4^&T-?U^%C$M:^OEERM1KK'::"F
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M?X(QA*311"/EF=Z),[0T90T XLCD:BQP2:B**56O7Y2F#0?&[UC6.=D_A/\
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M,7\/BFAD?%(Q?PYCE1?YYAS2>!O05%IAK^"OTAE<%:1W8>-LK^8S(PVD*(V
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#<__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g801727.jpg
<DESCRIPTION>G801727.JPG
<TEXT>
begin 644 g801727.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@!!1$E32S$S,3I;,35:0EDQ+C$U6D)9
M,3(R,#$N3U544%5473$V,#(R7S%?3$5'7T%235]&4$]?2U]02%0N15!3_]L
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M%KUC36;$?4U\.7(@VY[-]](KOJ,:;57<2M/02XL.*&M3.JM1THD43*..>KF
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M)A%1%54:L5B28C=UA[='&R.VUWJYTN=-(,*%D02ZC7,A1R'$0IGL9L^MQXT
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MLG:A?":KA!MGZU<(QKE>M'M"QQN>C1^1#.CWE=1E&'UO9W<XI%&,3WYHP'4
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MB1IVP1YLM:/9H(Z2=*E61:+9=?+L (-G,F2)L@]1,@WNNS(\0YY1C$K; EH
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6^/5U1I<*, Q)LR8>S,8QC&,8QC/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g654163.jpg
<DESCRIPTION>G654163.JPG
<TEXT>
begin 644 g654163.jpg
M_]C_X  02D9)1@ ! 0$!K@&N  #__@!"1$E32S$S,3I;,35:0EDQ+C$U6D)9
M,3(R,#$N3U544%5473$V,#(R7S%?05)-7T-/4D5?1E!/7TM?4$A4+D504__;
M $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_   L( 54 P0$!$0#_Q  ?  $  00#
M 0$!            !P4&" D!! H# @O_Q !"$  !!0$  @(! P," P0( PD$
M 0(#!08'  @1$A,)%"$5(C$642-!D1<D87$*&"4R,X&A\!E"P2988I.QT=3A
M\?_:  @! 0  /P#W\>/'CSRP?JK^Z_1N0?JF<V]?-/\ J0]$_3Y]9+KTH'ZD
M?JL+R_F_2GV?7TZWL\[65TH.NY1TFUB_U!G094GE@9 ".W-#MC_;$%S2%;"^
M$>\>$XOE?T\>87/L-U[WWE_4%Z!UNEX_[26V,YS@&SU^3J"MG^;99>EI^<(!
M1UH,,V:I'TV-FN29Q5GMATC>TI^(GOK^K!K[S(:2@]7;+HG%MIZY?J_>L7H[
MV#16==@+(7H6?U5D2;MPLU$6S6?@R>BJIA I"S@*+4#R0N<&\+Y_*_,'].+V
M/[=V?W1_5^YIT_H-EKL+ZZ^U?/,!Q;.FUV?#%P60N.5-T%E25Q-13UUC80%V
M[_WCY[XVW-8YK61$QQ?9CL2_UI_=/W6PO8.?<!_3PU/],Z3POU_ZO[_>SP@M
M/G;UMSQ'DYU/697E%E+=U-RVJ=U0Z/8L0>O96Z(QE56.K;,!A#)",S^O_K"<
M+Y3Q3T2[?4<ZZSVJA_4 M:7/<<IN,U^9T>D;I]!AUUE=G3:NWT5#^ZLYKC_]
MB7C5Y$SJ^^9/+;/"JPCCX(0VWZ[.+YW=]VR6K]'?=0?:^L7-.6=B]@\M6TG$
M[8KC_..CY)NO,O\ ;6H_8&4 Y&0"EB&MJ.EM+RZLYVGE4(9M336]@%D7ZU?J
MT\=]D_8_)>N(G&/8ODUMUGA]A[%^O^U[#B,_F,IW7D-2?7@'ZO(!UNNO=;G6
M._J4%A7UG0L]D[@ZI:IW["!I ##,B/;3V]N/64C"4V5]7/9?V<T^\9I38Z[A
M&2RRYS'TN3"@/M;CH?3>FZ_GW,<8PF*=8Z&KM=6V[T$PYB5E=+&+)+Y@^3^N
M3ZZF<O\ 2GI^%XW[$]+3WCVG7^9<TP&/S6*EZ/2=-XTR<:_PNDIK3<5U(^SL
MKZ!]/56U-I#\M'#\Z&UO:[.Q3V$54K_UMO7B3U\W77[WD/L1F>GX'VDKO2JQ
M]4K#)90[O]M[-WJ#39SF>>#I=E88"SEN@2);&*]_UM!3!AUUDXTF*2$:,R.O
M0'WA[M[-_J?^_G,=U7=?Y9RWDW$O5JQROK;V7,X2CU7(N@Z2MMV]&DF/QLV@
MAT$&E)@#LZ^[K][K<M:5DXAE!.*UY T76[5WCV[]Q/U*>P_I]>KOL0WT[YGZ
MH<0Y[TKN/:LGSC$=1Z[M^B]<6"PQW/LJ'TP2RR&4RM/G9AKFZMF45E;6)32J
MY"!XB WBS;5>T_L'^GAZCW6R_4^U&<[IT8;O2<;X/;^LF'+?TGV9@VUFE?QN
ME(Y6P6ER^;[#JY!K>6SJZC0)D@JD2,TZS%+&.>52)OUG^/YWE'M]K>J\!]B^
M(=C]+.75/9NJ>L?5*7!5'6+CF.CG:)FMQ@K:DW.@YKJ,W;'I/52V,&SA2FMQ
MI*^YA#EE&6;HI^LWD)<UR"8+TW]QCNH>RU[-%ZO<)AS/*(^H]VYU68"FZ'HN
MWT,)/5(,OC>39^HNPQ2KKI6BR5P58RQ1 44\2D2BY^^H/MMS;W.Y)-U7G59L
M<M-0[?9\LZ-SKHU''G>B<JZOSJU6EW'.=S4BFVM8/H<\<L+I9J>WMJ@\$P(^
MNL21R6JW*3QX\>/'CQYK7O/1S66_ZK62_4%_UQF&X7.^E-[ZNS\YFI;:35DZ
M*WZC/O&:J&[_ '']"CI(Z^9U9+72".L7DJZ5LZ#N5BTW]0;T=ZC[,[;TX[GZ
M_=0PW,.X>EG9+WI^#@Z?BKK;<MV%7L\H['Z[+:VGRF@RNF$:36M'FK;.DN!Y
MQ9&E1*C'D1%BZW[+]#_OMWF^U":?V6YEIMAV3]4C@/ZAUWJ6<STV: >%S.L@
M7:8F'-!Z&W;5GW%RXJ/)S16]D#5T<($-T5967[HN79QZ8^D6M]8O9?\ 45[E
M?[G.:>H]T^]X[KV5HJ6JMJ^SQ-;F\&F0(J- 9832AV9Y,R,+@(JF1C1Q-<V1
MJO>C68B?_@=\7[W[1^WOM%[YS-[[I.Y]$H8N.T./W7:>65W(N$8W,CYO.\[M
M"<-N<=+KK&P2)3]!*;#-2,*;^2G%%>;9/)B'DGZ*G:N7!^D7/W>P>(T/(_0O
M]0_I'L[Q:MLL[KI=0/ZY[*NLWT'%SBY3) 7:_*WMU;DQ:5KDHS1#U_[G!/ C
M9I_[!^E=T;I'5_U@>A5_5\-5@_J1^K7-. X"M,S>CG+YE=8;E&AYZ9H=A..<
MR"_JCSKF&R&"H&!FPB02032NG<UZ21@_TY-UDO;ST(]CRNDY(RC]1/0:Y]0M
M-FQZ.]AMMAIK.NR(;=C0FRDO!K*%DF;ED=6V;)K/Z3QL29SFO<WH?J$_IS=6
M]N/8GUS[AD.D\=N<;QS*[S(:/UI]I^7:;M/KMHK';3CO"Z]'SFDVF5J+;I^-
M'C>)2IK!["HG$B&%:16M<5)+BUZY_HM=6X;%^FI4G=OYMH:GT%]HO;+M%B57
M8;1T)?1<9WZ&TCRU15U3+(BKR6BS[[-ZW4#9#,XR"*$6B2.&)J>=S;?HL],T
MJ^T6QH._XS(]@V'ZGV?_ %+?5_5K@;G1Y_GFNRE -GZ_#]2SQ=U73ZNHNZ];
M$*^(S-C5R,BE#(!=]X)H)\J/2GT,]C>)>Z?M;[G>QO<^9]8UWM+S/B.6L:/F
MW.=#SVCQ%MRUMN+)2YP&\TFH(FPX-436@9Z6WM[#5%SQ6=E?FN>7 *+TO9+]
M/;V#C]P;CWS]#/8+GO#>[]&Y11\5[GC^W<IM>M\<ZIE,H;^_QNHDK,SKL5J,
M[T'*K")6"VPEJ6#84P\04XP[4*0Z*K[])+NVT]2*KG_0?>S?;WW"S7N+0>^6
M-]B]=EIM!@,3V_+DE$4>%R/&+/2D"YOA(@]A:U_^C:"\JBDDLR+2*6)8AJV*
MQNG?I$>QGL?@O?\ W'LA[&\MT?M=[E^L5'ZEXZPYSS'4XC@7%>29B]76 @ Y
MBVU&LWVHN+W5DG7E_<V6A1PZN'KZH-@J2^7Q[<?H_']^IO1#:YK2\0LNT>EG
M(H.,GYOOO*+SJ/KUVG$V.(S>:OZG4Y*HU.7UE"36W>?_ -38N^IK=3ZHHJ2(
M\8OZ0NBSN_3X]0"/3'A17.KLCCIVSU.ZTW1MH;PGBE'P7G']9T;A(1JNBQ5.
M?;&%C9^HKP*2'3ZJXM]??C!PDWEA)*R*.+.GQX\>/'CQX\>/'CQX\>/'CQX\
M>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'SYQ\I_X_P#1?G_Y
MI\?Q_P#/SGQX\>/'CQX\>/'CQX\>/'CQX\>4NZN:[/U1]U:D-%KZT:0HJ9R*
MY6QQI_#(XF(LD\\SU9",/$U\Q)$D4$+'RR,:L3NK;37N8_92DQRFDLB#YZ(>
M2/058L\+RHF; ZK=$[2W+01I2SZMQSJ$=\L0< !B0QW)=T'\YY_$"Y),G5_C
MC;&B?M@B5F:]C%AAD1X/R:BP-=_PYV*Z89B*^)S%:BI:T=M8XV%+06PLKO)@
M)-+I:BU*+OKR@KED2-;_ #MT]DMG?4]4Z.1;BKMG&W$0BRE1%P&!I46$T0S0
MDPQ$#RQSP3QLFAFA>V6&:*5J/CEBD8JLDCD8YKXY&*K7L<CFJK51?/KX\>/'
MCQX\>/'CQX\>/'CQX\L?;#!F28X2PG?$)+MJB9\;72(A)->':6E6/(UD<C9(
MWVX(#Y&2HV+ZQ?=7M>QB^?K/PLB6H4DI3CB 2+)&#QHP>!+!S9R;$ISY))92
M"97_ +0:9SVM6)9HQAHXV$.2]O+ M!XXM%6ER125TI1G[/\ R.2!?03M<*0,
M3$C6R#&?MG1DQN<JM)B%2*;\SA8FQ]OGGXDR%1"//^Y$$0X$";Y>JNKJ^T."
MKD7[QQ.16 CCQJW\;$:K%:U/JC56]/'CQX\>1OONO\PY=%!+T'=9G)J4B.%'
MN+0> XJ-7*U91:YBR6!$+7-5KIH17Q-=\(Y[55/GZX+K7-.H#3%<^W&:UK!T
M^Q45+:#E&",^_P"-)#*_[,/#C>_^V.0D:*.145&.<ODA^/'CQX\>/'CQX\C7
M00J?T'*@$.DF$"S>ET8->Z>6 6?0U=IF!:XJ9L<D:$R!#61R01S?EA@<2XET
M2R1QO95L7!'$-8+ LCQE*;$/*0U_[J-D$:,=73.E>^7_ -D2*^O;%_9!"Z"1
ML+$59%6]/+/U9+()\]^6)D@T5K+8%/6.22>".KK32XY!?K)&S\TI"0AHUZ2?
MD_=_BC9^1S53IX<>$";75(4DZU=5I8QZP6:9Y+:Z(K.T%F57CS22S2?@ALCS
M9&CND<T-TSQ8D;#%&U+\\>/'CR$_8GK$?%./[/H+(X";2K C$SP1"_\ !,T=
MN1'6TL,K?EJR#Q&$-,,B8]DCPA26QN1ZM\\L_7^Q5M*'K^Q]KWX58")'/<ZS
M<;"TC&AC9_+F1_GG=]E?*[Z!4E#5Q23$3.%J:.NFFD'&=].(]GFLJ?G'=.1Z
M"XJA]-GL[NL;=_@(J;.6DT( MQ6-M:U\BR-@.!(A9:49SI8I8WR!EQN5%^OJ
MBX-U,?L_)L9T:(:,$B_K%_JM?$_\C*^\KB)JVZ#C555_X([$0AXGY/B1P<@[
MWHCG+Y%/4_>#UPXOT$3EO1=/MZC<V9)(=)2UG#>\ZV/2& Y?_6MB'E+C'<RT
M%%JRZK*MEN[@;.6=I/3A#&.LV"2!%QPY0T]N%>U-7=5RE.K[BN!M 7&5UC5E
MJ'8BPF"J56VHH5E7$K!/&LX-B((<'+]QS!AR(I8F5)7(G^_^?C^&N7_^B?X_
M\?\ 'D>A]7Y\?U*_XH)IA)^HY?!Y/IM]D&CV"'UN%W%_K<OE=%,0\-M:\2XO
ML+K*V"& Z4V&6F(D+%'@E%E(D/QX\>/'CRT=5FR;IU195)\%5H,^<\VJ/)!2
MQ%?$2.\.SJCA?SBRO M@W_@G>.2.2--&,8/)^49K'T_&W;;T.EOH8D$_U-42
M%6M:V1\D=;H*N2 *U':]\<?VF&+4JL,D^D:3R5T4J-^5>YU_>1IMSY/WE2",
M\)#_ .KTH]/!81D3"D7-FZP='.5")..00)45%;;6SPFD"(;,+"UQ438/[[GR
MN=BS-2T%"7GF$E&6EO:20Q#2VMS9D/+LK&0>!/PC_N")%_$-$KHQ1V0C,<]L
M2/=<GCQX\>89>_&-M=CZUZ_^D1/((RQ]%LYQ8HW22SUM =][96-;_P @ZTDF
MQD5?\0A2JB*[ZIYYKMG0U6ASMB):TM;?H&.7;U MG6!VS1=!6UQTE):5XYD!
M#8;FO+E26IL!V-."*>V4*:&96N\B#U&I;?->JGK7G]%5V-#?4/!^5U%Y37(9
M%=:U%K78VI&L:ZS ,9"6"< 1%+ 8*5%%./-$^.9C'M<B>L'T8Q=IB?6O!C7,
M) I]^MQKE")C=%,*'I+.<^L8^-W]S5GK/V9OU<C7L0KZ/:US7)Y;'L;B-CHO
M:GT!U-!F;RXS6#Z;W^SV][7!S$563K[_ -7.F9>C-ORF*D=>-:Z.RKZ.OEE_
MB>T-&&9\23(OFMK7>LF_J.E^Y/M')R#K>@W>8_4O];-OD)*5-=;ZC5>I//JC
MT_UG1(>/8B.W2MTU,_34.^L3JG/UK;747.<OZH9EI80CUA'PPGKCJO9WVLGO
M^Y\'[<!Z]:[OOO3L'YWH\&SQ5-:Y30<7]&L=R>RV-$#=@3#TFN/R/0+S%Y72
M10%5=_1FEGTE+L<Z3$#CGF/7CW#9T3UOZWT+FW9]YS+F'HEZ"9_V<XS>4>B,
MVGL#88/V"]F&V^?*U+[%^DU70/6\'0XGN>BY"?(<WMP$-?G=<193G5U?;>II
MO^$7^?Y_G^4^%_G_ )_"_P I\_Y^%_E/\*B+_'G/CQX\>/"_X7_E_P"/^WD?
M942$2ZT D!*$Q"WM^:C&.^4#DO75%E,++\*K4>TN0]T3&_'UB?\ #VI(BKY(
M/D7FPQG]5HVR$M;%2YZZM(8/R/;));2?T^J<K6_7\4D0E3<ROF:Y_P"6.0X2
M1C4C?(KI0\>/'CQY\IX(2H9AB88B!R(I(9X)HV2PS0RL6.6*6*1',DBD8YS)
M(WM<Q['.:YJM54753U_],NJOK\N\Y!L L<#83RD2Y+15YEC45DDJ_=S**R F
M2P% ^ZJL5<:.:T1J_B&):.V."+M\8_33I<UH!=%U[6!;:&MGB*$R=%7FUU$8
M5#(R2)]Z>=.ZPL@XWL^SJP> $<I41ALI RR"S;3F,9$QL<;&LC8UK&,8U&L8
MQJ(UK6M:B-:UK41K6M1$:B(B(B(B>?KX3_;_ !_C_P /./A/Y3X3X7^53X3^
M5_W7_?PB(G^$1/CY^/A$3X^?\_\ 7_GX^K?]D_Q\?X3_ !_M_P"7_AYSX\>/
M'E*O+VES-18W^BMJZBHZ@24ZTM[8P>OK:X*!JNF*--*DB'&@C1/[I99&,151
M/GY5$7%PWV[RML636<JQ^TZD=#*H[#ZJG,I\P\A&L56I<V8O[LB&-7_DDG!I
MR8WCQRSBO(8UOW[_ "KK.[[173!V]'_V.7E':6F<W&:<5!HMG57==(LL?[$F
M46.DJZ*ZHY*[1T-^0+=3VM'=UTL0E2=(SZY%T&;J,V*T.H'=! C%1ZR$3E33
MRR$$F$%EE$R2DF'F%%D$FG%2S%%S2*^:5WPU$KWEE:W.5EG%#9.CLA[8 J J
MNN*'\:7=22QD@[S@HI(2&&?82:06QKYA38+2M5P901D3(H4Q93VRLJ.[-KY>
M<:OJ>$IG7(Q_9.7#5AM0R?/&5X%M_4<D9:163$#GL6Q*=1&VHUNZNNCJ@!E8
M YR9$<N[7RWLU+%>\VVE+IQ'M>LPP9*1VH3XI9!YH["H(2*R#=$1%-"KY1D@
MD?$]1YIHT2193\>/'CQX\>/'CQX\>/'EGZ_33T, 0E6)#87]S*1!5BDSN% '
MB#'<797-P5''-*+35 C4E+D@AE)((F"K1(U+/'5,?]]BG])R-_3;&Z)O8[NH
MMA1F%54D=$ 07]XJL\'%@E?0IU39_MWB$Z$RV?$5"W\UHTMC@8:)S*\U>GPU
M+8V4,@=JV,RGT%0G]-H/Z3I\\:30Z*J('"#-1J@W=>;&CHG1.>CFDPM1CXT=
M:NQRZY2\%ZJ^L*8'_2R:3JG] LCR-!+G2:ZQJ8MKFYF+ ?)J,56VMB-(L"D'
M%92RL&U%>MW2T?TRBK8Y;X,8[$;:\)I;4=3Q+]A5)>TDH!N<@JZJ>D)L:PR6
MT&@DBBT04X\[PC[:0F>S.L IW5K^O8$6-!>'RZ/J)%+1SP4;:MMO5XJFKU/(
MH;VI-" NSH&OLS)+,4373 .'26N,CA%9.906$E4'B#L+QNDUO_8_S?J]QO<V
M%\V?21*7HE-#K*6I*H75!_/\;+72"RZ8S3"3SZ*X#,*<?SL=W]0J+0,VVRU:
M%S:@8K860/%>:C0XA :L&?I1M'"1C]5C\:VMCI*S+"C3-&LEUFPJ1V4HUH;'
M8ST>.@+MT)D((I'38[>Q5/C^46^4S4-E#G-%=0#MY]=2.#HR*2OJ81ZT_1(7
M0N$TA<F,A>'$&,#&MI>&SU5-!%<"E%)6796^VW2^'66'J[W=9#V:P&OB&CJK
M40P+-]0K18T<,XJVMW"U>2LK.Q+@E%SM%H*W,66RNYEH<_;3V5<3"1M!Y[T#
M+=0Q]+N<;8+94%Z.^8662"8,L>:":04ZNL@"61E5]I6FPS@V5>3&P@,R"6&1
MORU%6]/'CQX\>/'CQX\>/'D,V4=A;[.YG:_[ CI4XZ%GV7ZB-_;_ -=N"V*U
M%D9*=;VV1#,C5$CD J$6"3\BRM6OU[QAZ^M,-@45\L\IQ *JA#PA<_%*+ %$
MK?X(=!8/@?\ =$=)-8FOD:KGR-<V ] VPPG5BFV]O_2LQV5?ZMGZD,5"C:KH
MM'60#W5'$4T4B+[:_+UH^A&BAB:LE]2:*"#]V\IA$ER.J4DD=/&)HC)G*YS9
M;*U%&3^Y_P!FM21Z2V D4?Q]H_VD;%C1RQ_3^5:D9PUG1>0S6A/.Z_/MY[;6
M3[*TY<R];76D!Q:/=:7'-K^Q%"K*,RU)6(VVR-@O]&*G:451V.=L#B4*Q;]E
M>D\]V-?KLE:S9:KM--2Y;-SX[K?-],!.0(299P6UYKA;6B4'1YC*):):PNJU
M+<DSU?06T]G>"R!ZJ^<?II2<UU5_V+U1]QA1+X>8#'XJD$YS(85<ZW3S_)>.
M,AV14<165.#$AMK.UB;-+55(-DXEQ"5PSGY-Z/V ]E/T_J(Z#VBXEZ\]SP<]
MF9<6/5N1=%J<UU"YM[@E6#6%QS+?%-NRHH$<)500YJ!HE72BC0B3Q#BND2Z?
M4[MGJ-[%61W29.DT&\Z%+:10Z3C6['_TT=0T"3K^PN<?D[0UY%[!0SDDDB5E
M>994H=:TXH6L'TRD7EC+>!R.;YSW_KOKX!7TFOY_TV>=*DN>P&M2P)=)C;@^
MRYI?/DG((/;125(=MC)9TF=GCAB2&3 FW9#9,7J?]0'KOKUOND<!]?>;Y?JE
MAEZ^GZ5U[0=0O=%E\_S*R6,# V49 ^3HK>TN;/=3B8K4%_T<69L.JTN@B4 A
M?WA@VVG]/#WKSWOAQZWW(V97$;;#:B;$]$R,=DMU7 748<-@':T%RHPDECG;
MP*92*Z4H48X>6 L(J)SQVSS9^>?E[V1,?)(]K(V-<][WN1K&,:BN<YSG*C6M
M:U%<YSE1&HBJJHB*OFL7L?ZE>.R5V7GN6Y;_ +0GUT\@QFG/M'TN8FGA>^.>
M.F_;AG6-Q Q[?HEC^,$&=6O>&\N!8B']OBOZD6,V]Z#F.FYG_LZ,LR(Q*_1"
MVC[G+.,(E9",-:23!A6-(V>1[8F'3Q%5S)'-_=D!QJLOFS!%1414_P +_*?_
M '_^J?PO_+SGQX\>/'CSA?\ '_G\)_U7X_\ U\ANC9!89A]DA[*PZ^TFRDBC
M2"4]I$I5Z>*@S(A7(5-*,VK"(C*B7[#*,B/C4;[PK!EU[&4F0Z\%S'H=3:88
MV_$J",II]7+7!8W3Z248RUN*;*O<2EJ7^W*#&L4B)BCG(.@EJH1F3?B629-7
ME8NA8VSS;1+4+^I.&*"U/[7\VHK=!5D1F4NH%<;-6"C'5%E# :!$PV>%C(WA
M2AL"FDA=%^-MM+?);4.M9#6[G(%0UFPJF6T\8J3D1234^CJ1JD85JYO6!Q/M
M:213%F&5#:@]JV-25$V]/Z.>,JSU_P#1&F?S])":\QZHBJGRQI2G2DM<YK?J
MZ=&?=[E:KXWHB-7 [W/Z!B>09Z3J79;[!Y^MH;'G450)<8A-#JMA%)?Z"OU6
M-R7X=#!)IVV.9M+92LV$'#+73$065F9%,54R5V 7&/7GV#]N] +T/(AO]1?6
MROMK>'-S:ZCK=CW3I4,=P6P@M*25X8&-K8&M?4AQ7!9)0([)1XI+A[9IEQ^U
M/I_Q'V4]L_87D^<?1'TWKO3YIVU[KL=A+GY[3HIR11%8">-C)@"%82+< &V/
MU<..E64V-/JYC6U\[U'XUM# >+#XKG>8-?;HW([BLOJ*GM<C<6$4[K>PH.CX
MX*H&NX+'^G5$.<J=9$>/7793F?\ %B)+^MV8$O3\$V&C]7>B"1V7L=ZQ%UW1
M>/[3'T+RK+O/+;Z^@N;+8;"Z:/*53V>$J(X1M#-=3L;.%$4(1$0^65#;^[OZ
MP=-MO94/N'!M9SJO(]GLGQZ#=YCHL>_JL;-<'[@G09Z[@TN"N:S6UR9;>Y3,
MUT]?$4R.UFBFAMARZPV>O=MS_3Q](I/2KFNXK='LQ>@]2Z_T"RZ=T_3U5/\
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MGT_UA;NQR7II)ES]=7/MM]J,SDJ++Y0=,]E00SF%CCJ'6Q2V%H:*J3NFBL;
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M;3)U4ZW1G.@75N!.)E2!DT5ABP'N#RQX<@IE$.YT-;./&YS5M;6>E7J3N:/
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M-I0PK/O),V3JZG$8N[V5X1H,C0W4A&?R]@1+94PAQ$X@1V@J+)(S)H7%P3"
MEA20-AFC1',:]JM<KW>6 9ZX8-U@R\R]KM\>0*<1G<XF?V5J;5U@ELZ$'42U
MV>U*Z3/"?O\ \14),8M;"QPX#/QOB1\J/LG5\ MY<[T;+UG7=A!!L+;97U]*
M=F\18GS3W]:!4,@#-@I*V8)Y9D\,($K56,2 >5@D$"0K*ERG<$M705=U8=7V
M1-]E!;.JI4IL_@*$2.6]@HC;"9!US%K(A3H*H6!L[B'.;]"&LC12I4DP'[#R
M'&X'HQ'5SK+3Z#.U^SBZ;H:35'F:(+:1?]K>:Y#T,VY"^$K2:^GSA_\ 7?\
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MVK^K!+><2HFG$(L6>0CL?5WK1?L3T2*3UO(U'3=S[Q<=]A^;>]3+KGTXG*N
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MF8B95:[Y2<P&CK%E8V.7\QD3'N:B*_R</_/SHVE<+;UMA5',_(%9A%5YD?\
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M57QX\>/(IVW&L5O^@<>Z7H8;.33\.O=AHL)(':$! 0V6YP-[S>^=; 1(L-O
M_,Z*RB$@)5&"'.A/C^9H&(L.W_I1Q'0T'=:(H;7AO[_V[-^QFGOJG8V]5I\Q
MV;%T',:'&;CG-Z&L9>+LLLG(<1:5,(/YP4M03ICAC@[>Q!GI_(_1CB'&-^!U
M#+R= L]R+J.Q[8N_U^_O-67=:SO-)R6CZ9=W*VCGM*FN8N+XTH$2)!JS/DI:
MQ4(-=6G1UPEBP?IH>L V>@SP]7N(F5O&^%<7SENS>7#-!D:?UKZAM^R<8U^6
MN&L0FFZ1B^A;Z\O!-I CC2V-"K3X":R&<0K8 U%:U$5RN5$1%<[Z_9R_'\N7
MZM:WY<ORJ_5K6_*K]41/A$_7CQX\>/+!(PBM()DHM1H,T(:678%U5?%G;.MD
ML#I%E+-'@TU#>OK7D2/GDG'K)1 9IB2"'BJ1-)*ZE38336J('H-U*14J]TA4
M-%G@LW;V:K"^#Z6%W <=)$Q[',?++3!TYJ3PPRBEB)&C/)+$%'!%&"$B9 *)
M!"*-!'\HR$<>-L,,3$555&1Q,8QJ*JK\-3Y55\['CQY871P29\ZVVKQG%VV4
MLZ[65D#'K')/+2S_ )3PHW?=C4=9T<MM5*KT>B-.<K8WR(Q/*</#5_T6BLHY
M5L@S18[3]M_\6(RHE%KR#GC.@62*0>.6$.XB'_*L9+8GQ1_E25&^4L"IDQ>Z
MKQJ&9L6=VI-J0?2JD3Q8CX:J6P=?UTC54B ILH,-?:Q.3]C8C6E:5]X[0(A]
MC,7CQX\>/'CQX\>/'CQX\>/'CQX\>183B)Z X2PR%Q'3UZ6<Q!>:LJQUUGV?
MOX)XS'T(T=C4EYV8J6?\Y$ AL]&^1)9FT;#")2UJV4RB@%,T-H>VTNGTP]*(
MX<62OJJ>EBG4K^G5%=,;9$0H40V&>Q+,LCS3GBA1N(C$"$%AOWQX\>/'CQX\
%>/'G_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g618561.jpg
<DESCRIPTION>G618561.JPG
<TEXT>
begin 644 g618561.jpg
M_]C_X  02D9)1@ ! 0$!KP&O  #__@!!1$E32S$S,3I;,35:0EDQ+C$U6D)9
M,3(R,#$N3U544%5473$V,#(R7S%?04-4251/54-(7TM?4$A/5$\N15!3_]L
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M40D5,F$6(W&!%T)2D20SH;'P0V(*&#13P='A)7*2&F-S@O'_Q  4 0$
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M&"/JD<L_*3WD_7K(QT=![]-2L*/N*"7>\*Y9P?&#D93@]G/USG.==F,(1AS
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M=K!K\/RU7J9Z=[:NR;[GYEN+,F7>\2L_+3EN&FT-@C&2E,"%\3C/$KF+5V%
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MG-A;!;@;@4AQUKWDMBI4:N0^FVVW4)+B6):$J7E1 Y8^19"B =4K5?3A?Y:
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M5])7X,WXC]\>J"W:ALCOK.A57=FRZ9'JEOWLI*(L[<FUF1\//?J[#/",J[*
M!'74),9IM-8ISR:@XPU)CRUK#?;J!SI!/76#V<#H@^<'_MJ($* *2"#X(((/
M]".M0N$!"B2 !CL^!V//C_\ ;XT'@RD<2",E7C*<^!X^4G!^O6/Z9T!00C]
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M_,01@I^Q^Z.\?0_0Y ^FN>2,X^0'F,]IR2/OE.1^P(']3UCCDGB@Y2/F2?\
M*/HHYP%$9\#)^^, :%2,=E) <'D(.>E$#/,$D8&,\>L@^1H("4@J!"<8R0"
M?TI^R2,GL?8GHXSJUEU/A*7<92M:3TC'$%7+'' 4,  =9&"#T .[G.XX.=C
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M+SZD)]QRD2'?EFLD]N,I69$97)IQ!P%JR'44E"1\@["ACB 4_*<#KL'SU_7
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M4=0XG)ZQDD=6MEPHKJ_G91R(Z6D<5 $84!@ 'EX4>^NOJ=!ZV#_+?0",*8?
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M!/>O7MP^9FWK/+YU-K<'9!S@DDY&1DD]DGQT1C5,5,+8FI<"N(&",Y!.%DD
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M--- TTTT#3330---- TTTT#3330---- TTTT#3330---- TTTT#3330----
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M!IIIH&FFF@:'P?Z?;/\ T^O]--0.!90H-GBLC"5===]GL$9QG'7G0?.?^,]
M6QNALU4V6D(5+L6JTMYWV\+DF/<"WPE:BD%8@ET 9)XB2<8"L:TAS93;+RFG
MR&59[4KI)/+ZGO!&/[CSUKZB?Q;=FW+PV+A[M4U:!5MFG9-0D0U1U.FK46YI
ME(I$UI+Z<JCNTZ4F%4&U+26%,IE)<*,@GY26Y#5TR5R69"U !3CL=U/LOL+Y
M$K0^UR40 02'$Y:7D*2H(.-!5"2EUT+:4A8/8*%)5D# "L9R 2#Y \]=ZI2=
M&4BLU!8/_JX4,=?K2K /@@=Y_;KQX[I%)4VZRZ'%H2TI*!Q6MI1)/7)2% D!
M.!R/0&0,^1/ZTEMC@VV.W(Z%\W""XE:\E.58Y+ &?F5@J&,C/D*-;>:B^ZVD
M<E?$/*& 1CFZLD9[[[__ #D>->],\%(&#CRH#[X P<=#]S^_>I7#AR9TN8TT
ME2@F6OY^^(]U"%]D '.23^WVSJKHULH:0')SY0C RV#CDK&>/G))\??K/9T%
M"W!%37X@@)]QMKWVI#KB0" VQR4M)7\H2D@G) Y#&?&-66FPUN/BFP$!<F2^
MQ @,L!16Z[-<2Q&2E/2E+<4ZVD#O*E#.<]9,U5V*U"GM0FA'::C.%V0ZD+XE
M*,!(2"2MQS](3D#/1ZU(O2?:?^(/JO\ 3Y;4V-[D2N[S;?1GH[R24NQ&+DAS
M)"7TG(XJ9C*]SHI*,C''(T'WF; [?P]J=E-J]M(+8;CV)85JVN0E'MI7(I-%
MA1YKP1Y!>G"2ZO/?N+7WC&KO:\\9!2A14>16M:N6 G*2?D^5("1\H ZSGSGO
M ]&@:@<_0>R/'8\^1X_?[?;4>NMT9;4 2,X[ !(['@$$?[CKSH/#\Q2D94"2
M?J!V,>3PZ_KD=G['46%<4X"_F"CGSXXG/_+(\X^V,'R!KKRA.#E1[/\ I^PS
M_P"F#@8\ C^GVY^4A&2<\21^CL9'_P#:\=>?M]_.@X+R&&WG75*0AL.+6K(^
M5"5 Y)*<><><^<=GCJS%?NJKQJJ*G3'3PC$LJIKK@$>:AP@J:D#B5-O+2 IN
M4V$J96I*>#C7-)JFZJXA*3!C.CM9]YP%"DE8424)X@!03WDGI2P!@\,ZM=+9
M6%E\%3@05EMQ0RH\CDEW"NR22.P0#\N4J*<A>NV[KI=S1?=AOEJ9' :J%,>6
ME$V$^H9]MYH DH4<^T^@*:>2.:% GBFI.65)P5GLD_MT>_\ E^3V?H.LCQG6
M)$)R2Y7/S2GJEQWJ,I3*9<!(2)$B0C*XKK@R7V(R@/>87S9#BTI6G*"!>FW[
MX6XZU"N%(9=4H(9J2$H:8<4KI*)+2DE,=Q1.$N)/LN*&.+9*3H+C3)!CPWWB
M5 -CEW@DGBK  #8QD?MG./M@Z^_4'NC4HUO7!2Z949$27.#4%+L=U;+Z&'Y+
M8E(96TI*TE;"%-*6DI5P6X$XR-9[5I'.D2@V>RD%!5Q)( < QQ0,YZP$Y/8.
M,>--^_+\R-=+[$DE#"O=7R7E*,M.@I!41T1R.<_;[>0^?W?_ -4^^- WEW"M
MZTK_ )=OV];5>F42EP:=3Z.$I:AHAAQV0_)@2WY,ER0N3SD.N\BG#92GB-6W
MC>M'U,,,I9_Q+]WV2TD.2+9M=^0YS^8J?>52DJ<4HX2I2ADIZ^V*\WE]*^\=
MP[J[A7!;M!I]7HEPW+5:O39YK]'@EZ-49*)"4.QIDEIYIYK+K2BH%"N*7$*(
M6$B@&O1OZ@U>+.I02M;:@57=;('R#BHGE4,@\AG'E0R1C 4H)O']<?J8C*<0
M;[IDI*E+XJF69;#Q2$J*$A&*>WP2>BK(/)0R2>\[<-@KXNN]]E]OKIO%^'4;
MAK]#7/GS44Z'$$GW)TQJ.^6(S+;#*UQFVN892A(5DI2">]-4KTB>HV,%.HVR
MG34EQ](_+:O;\]:L'F%AMFIE00L)3[:ATI0X^2 -SVS-H5BQMH]M[4KL0Q*O
M0;/I,"IQ@ZW(3&J :4_*C%YO+;BF'7U-KX$I#B5(23QY$*YJ\LQH$J4A" MI
MLG 0,#L'].,@YP?/TSKOMRA-5BE0ZC(?DA<E"CA$AQH8!Z^5*NN_J1_<:D%X
M/B-;\YSZ\.(!([)S@'H==8/US]/IJY%F->W;E)22#F,A61D=K&?MC.#XQC(_
MV"0SK8B((_XZK-'EQ2EJ<\@?L<I^G[Y^I_M+T4$I_P"55Z\W\N!FI/G!SUR*
M@ 0.R<\D@]XU6-52I+R>*CDH7UUC/6,8'G!'[C&?!U(3[H\Y!R<CH?7)\#Z?
MW/\ ^0DS] D@<E5F6YW@IE-1IJ?ZX=9)_;'TQ^^-2A=MI<Y"0U19P(.4OT9A
MO/GM3C' ]^#@#'D#56DKQ@] GQT/^_?_ )]L:AS]AY^^#GZ_8?\ F!]!H*%_
MA2F1U%]-LTY3S>%H5$D/,DK3E0_E+..)(_2%9P.B-4E;*[PA0I-'G4"!4&(4
MZ8*:7C*;>%+=><?BQGW9,9U#[D5+GL)>#H*T-M\\JR=7E. #D=8[R1_?/7V^
MA\?74CA5I*ZW"I[+:/;?DJ:6L9SQ"4J"L#/'.<>._I]M!09I=7JE00S^2,4:
M.(_MKCN?!28#RN:W%.%&$NI6OD 1P&. XDC(U/(=G6Q0%R:_7OR[X6F,JFK:
M(5!H<5,8>^[4JJEQ:D2Q&2DO)0X&8;26TJ]EQP!9]$BI+B7'-AO+(++ZDH3R
M&/;SX 5CZ$?3'T![U@KZ[=Y:C2J33=I*(S+AMW5!;K-QU90+34NCL3ELLT"$
MH?\ .$F3&$FJX4"F,F*SC_B'!H,*/4;NR[O-NU<%V-NK=H<4NT*U6B24IH-+
M+B&9B!Q3P-4D.2*BH<4J2E]II?;.=6-/$+9SG@DM@ @E0]I"E=@#)^4Y\@X&
M?/DK 7_5+Y'6,?(#GH?91R#V,Y\ ZZE'"EGOY%N=CH (9=1@GHD?-T<?UZ&-
M!W,H6ZM++2%NO++#;+38*G''GWD>VTTC_.ZZ2$( _4O )R<'=QZ>-F7]EMLX
MC3[+*=PMP2P]4UJ;XO1E/M913R,%7P]!CO.-NJP@+FKF*'+FT=87^A?8L[A7
MV[N%<<$NV983S<B.[(1F/5+I0RE4*.G(X/(I#2D3Y""%MB0[#;4"H%(VP0:B
MY*O#\RJ3:(Z4,8I$99"0S ;=4AMMI) "7WTI$E\?\Q25-9&$KP$KKU.>8<I]
MNTYI:8E&ALQB[Q(]Z0OD]*D*'0R\^XXM1\DJ(/@'4@DTBIH9+)C.NMJRI6$$
MI&"2,D?YL#([ZS]AG5[WJA16'G);X*Y$I8#31"5.+5T$I".\XSDD!8 )R1DZ
MK2!&CO)0I;".)2E2D<0 .NP>O(RD8'G[@#H,3(UB52K.A"*;ADI 4XOW$)0"
M<_/D$$]C(SUT ,ZK252X]O4%-"3(4X%N%QU)<4IMM9RD(;2K/%(.<<>CY/[7
MHNZMLTF$XW'0A">'090G*E#Z C))S@  ''9[^EBR)-2+KSR5%YPD-C&2@'L?
MWQ_MCR>]!4>TE/7!K4Q8_P"6M)!.2!]",=8QY/?CK/G5?;C7.S282RVL*FRD
MAF$T2.0*>EOK!'((; )"N@3@#)ZU35)G0[3HDBHSU\,H",)(]UY1 X,M)\J6
MLCL#Z$D_?5F:O6)M>GO5.<H!;JL-,@_(PPG_ );"0>A@=N*'ZE'R< :#R!;J
MT\%**W7W.:U+.5K6HE2E+./FY9^_0P,XU?79/;&K;@W;1J%3F^3DZ4A*9!;*
MFH$)M8-0K,D!)_DPV>0:Y8]Q[VVTG+B=6IM^D+J<H([#392I]SB5%*3V&FP!
MDO.#P$@D)S@9*<[OO2MLVC;JSV[BJ\0L71=$1AUUEQM"'J314\7J?3>"P5-O
MK^2;-&$J#JVVEY#&-!DA:5L4FS+<H]L42.(U.H\)J*P$IX*>4A/\Z2^5 E<B
M2XI;SZR25.K40>]3U*B'#@+/0).0,)Y# P6\?U(\^,]:["4^<J& ._E'U_\
M\8P?O]L?3K74 D.]*4#Y/Z<#YAY^3)^Z2<_;.@C7GAWRZ)/C[N'.?D)^G7?8
MP>OK$GD0D_,0H9\YZ+BR0?D\@_TS^XR-=;A2I.3S R?\J1G"R2>T$]9[R>O'
M]8T8(1^HX! )"/\ 6HYR4X\]8& ,D8QX"8Z:::!IIIH&FFF@::::!IIIH&FF
MF@::::!IIIH&FFF@::::!IIIH&FFF@::::!IIIH&FFF@LSZA+%=W,V6W1L".
MEE4R[K"N>AP4ODI954)5.=_+^:A\R2F:AA:%C!0X$GL92?A]N6RJ0)\XT^48
M%2C/NQ_B(3GM+9=8667D*( *DH<;4A:5#BHG/$DG'WPO)6<*0ELE&5 K)!20
M0>L ]'&#V#V/&-?&I^(1Z;86SWJ)ONWG8*X]LW34)%]VE-IKC\)3-'NF3)FN
MPVBTI 6FD54S:<I*RI2&V&E9_F@ ,'&9E=H_)JJHA5B*I/ 26W&XK[B,]^^@
MG@I?>$+1P<"B.:5I)(\=9N.F)?7)<0Z(X2VVWX=X!I 2E)+?-!*""I1"L*43
MCKQ2%8V<J+R2[1J_-D)(Y-HDN+=4DJ)ZRI?9 .,]$> 3JA';&ONW75*5,D2&
M3@.174>XRM))&%(65)!!\X'+/6<'057(W?HE'E.0XL*KN/**5/>S3W%EQ82@
M%7,J'$9&4D)XD?7ZZF\3=>)4TA'Y;4ST" ZT6U?7Z9(!R?(./ 'G5+4FF*J:
MUM.L.T^I!(2'$8"5J2"4)RK]03E0 SQP>.1@:G3%,JC*B"[P+?7!Q()(!_4"
MD'/+&?F(QD8/@Z">56I.UJG)0PT]$:4I)6TM!#BSY3^@*.,]$D8^OCQE9^&+
M9+M<]?WIZ@J2I\4>Y*S=$A)!PENW;2K=22XI)R &WQ'5GQG \G6*28DU905.
M+"4\<J;!'(#R.R!]P23_ %&/.V'\&*R7J_ZSZI=R0I<+;K:&ZYJGUX443KEE
MTFW(B>?ZBY[+U0"<9!RK"N@-!];:1A*1]D@?;Z?;7.NMH*"2%'D0M6#G)XE1
M*0HX'8! Q@8P/ZGLT#4*QE"OZ9^WCO[C_OJ+4*_TG^W_ '&=!+<%'%2U])R3
MR4D(Q]S\Q.1D=A."!]#G5+UVNMPXI0U(RI84VM2?U-@)4E0;(/:U@E 4 ..2
MH=@#7-T3),2GNJ9)^5HK5@ =<N..TE6,#O'G]L#.+PW$3&K/Y=5E*0P\ZI$:
M4L<F$2#A"8\@<26PZHX9>[;5R]M90H@D+C2RIU:DNCBE20YE YE/?RA(R<X&
M KL$#)).>K>W%<-13+A4"C);<K-36XE@JP68<1ON1499!4IM+*2>&4Y==6TT
M HKR)[5;B]F$&8C(G5%X+,6*A:4*44_*/>60$LQT*('ODCAT%9Z!YM&@II9>
MFU%U,BI2G5OS). H+<> _P"&:*QR$., EIA!/SX6^0%N'03>G4XTF(S'2KFE
MIH()SA3KJP%NNK2%@*4XL*<4I1)4I:LD$G'O<]EX*9>0I06DJ"4X.,D J<!Q
MA(R 0>\$XZ&=>BHJ]Q"%MK0L$('$)(PCR02!P "AV2"<$) QV?8MM##0)"0\
MXWR=*4Y6 <81E71&/U8&<]:#U4BZ5T-E,"N*<D4=?%+$\)4ZY!024!,E!4%/
M14^$.#+K21\W-"1QL5O;L=&O-"JA#2'V9"%.-.-@/(<;= 6E0*>2"EP'/2RG
MO'6,:NDX1)"6N)=ST\1G*6AD9XDD#BG(\\4]!.>R>ZE5V1:<IV.6W)]LR5)=
M=BC^:[3/E/*3 !)*V@?FDPOERH%;">8*' U>5?TRU.$XX(]-:)Y* )]U0'6<
M)"E$?V( SX((&J*G>G>[$ EJ E(!S\C><$X^A23XQD=CZC!SK>NQ H57C,3H
MK<67&D-H<9DLMI+;K:DDA0XA/S ]*0HA2%A25@*!2!M>C+"PY"9)/).2SX.0
M0H#&0$D9P"<YP,#.0^?>H[/7Q2DE28"E!)QQ]HX&#]%)'US@X [/T.=4DZS=
M= 6?BH,IL-^0E;Q0 ,@D(65I)P.L@8_;'7T.R[!MV8E2%P&22$ *]@ 8'ZN2
MBD]J"N7C.4A(\DFU-U^GVVJNV][$*.2H+[+2<C].5X*>0)\X ^P/?D-#MS5W
M\SH<Q@M*0\$)4IDCBZ5#L\4DD*![RE)*A]0 =7NL6I1)ELTQ;3S1+<5MM:0X
MGD%)3V%=@I7D8(QD>,9SC+2_?23&E)D&'%+:BI904MA/C&..,$$  D_7)QV,
M:QHJVP%W6R%M1(X?82I1"'(Z% C)P4JRES*2,DI7@D^>]!US$L/J^90.,'(6
M._V!Y=^.^\]?7.O J&TLD![HX4$GB0 KZ$Y\CZ><8_?JCJC:=U0#\]O\TC(/
M%R>SR5G)R$/J \X& , ]9^E.+_B&(3[ENRPD''R5">D8_J0K(Z/WQ_MH+I.4
M\!("5)4"K.7 ?'VZ^GGZ$']AJ6O1TI4L$!*ACK.<CSE/CO'W&/H-4&U<56C%
M/.AU()&#Q3,<=0!Y)'NM9R2,<0H9[[!.HY-X/GB409L4XPH28:I(4<#/%;#R
M3G)P>0&<>#UH*BEK]METY.>*@#GO./Z_^'K5 45"D70SG)X,/R@?HDGBVGP?
M [XG/[?;73-N^,GG\74$L!6>(71YB6QR)Z*O<4<)R,G!U/J(J$I3%30_'DHD
MM".S-C.!493A/(M*!PXT]G_TW "D_P#4/3>EK(N*8W5J=),"<6VO?"NVW%H
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MB(!40%+&.L5[HVYO3;>4Y3JQ DL.]B.Y,;$!YY*0>VG@I5(G(<3A:7(DE/+
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M6A1!RPX1DI[*0?&%*^0 Y([.1X)!UH)O]#E1KE90WD_%5>-&) R?;8Y.K.?
MP7$CZ_T!SH+IT_A,886M7RN-A15D']2 ?&!CSWCQD_3SWJMJ'(&4/)"G,X)
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MSU\I\> ,$$XSH+R@@@$=@C(/W!U"L921X_\ /WZ_WZ^^B$);0E"?TH2$CZG
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MNDL*L^KI9&5HA22<$?-AH]@'_*/H/)!([\ZW+[62&Y>VVW[S?:'+,M=P**<
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MF  &   / '0']M-!1%'V[M.A--LTZDQF$-@<$MMI0E/R@'"0,$=9&<D'ZD8
MJ]J+'8XAIEM'$83Q0D$=Y/>.1)(&22?VQKT::!IIIH&FFF@::::!J%?:3_;_
M +C[8_[ZBU"O])_\^O[]:"7!)' @)(23WA7?0[(YG./(Z/[G47$X0H)3TA1
M/(%0..Q\XP1]>N_.@R D^VH')'+I( P/J4CL@#Z@=^,#.@/2,M$D(/$\DXP
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M/WDQRPAZ;$D^V#@<U4-@9P<DG+8)Z/@Y\:^M3?% 7;+WR*2#$?(! R,A0.<
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MEK;+1;J-G0E)Q@I4Q29;P3Q)P$E,@*3WV%9 \$[PHR2(D; 4"&FAY  )0CR
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MLTT'D]A?)2@484",'D.L$ = ?<YUX9M'C5!'MRV6GFPE20VLJX@*QWTD'(
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M!GKQWC/7TT%D]S-ZE;;5RD41.TV]5_"K0A,-7VUL$W71*9F<8/PM7J J]/\
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2YH&FFF@::::!IIIH&FFF@__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>g122410.jpg
<DESCRIPTION>G122410.JPG
<TEXT>
begin 644 g122410.jpg
M_]C_X  02D9)1@ ! 0$!A0&%  #__@!#1$E32S$S,3I;,35:0EDQ+C$U6D)9
M,3(R,#$N3U544%5473$V,#(R7S%?24U004-47TA%3%1(7TM?1DQ/5RY%4%/_
MVP!#  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  +" !I FL! 1$ _\0 '@   04
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M?EY9\_+_ "YVX<.'#SQY^7GCS\O/R_Q\O\_+_+ASCSQZO7CU_1Z_I]7GZO\
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MRMIR)G/Z3'7W]HN_XW_-6-?HQ^K'[N40[C=U\]394"C/DWR=_'>.(G_N^"K
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MV$=&Q[-)%FP8,6B*+5DR:(HMFK9))NW2323TTU]VO]K3_7I_'CF7I9^51/\
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MI@1##@2#HA!?):,Q3Y1]%HR"3]/$?,2+%75-#9PEGW7??7577;.4O3SKG7E
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MVM2!ENNT <1U0&$?("#F=&"0P[! ?95D=NFDH)/(&=G!"Q*[A&4-$249D6E
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>g700946.jpg
<DESCRIPTION>G700946.JPG
<TEXT>
begin 644 g700946.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@!!1$E32S$S,3I;,35:0EDQ+C$U6D)9
M,3(R,#$N3U544%5473$V,#(R7S%?2$5!3%1(7T-/4U\T0U]/4D<N15!3_]L
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M8^C&:>V)\Y?A1;4_.:Q]&<LR-ZQ^,?TYIE:_E;=OMIN7\OM_UVO:[_!YX?\
M[!."_P#=78?[!J\[VQ/G+\*+:GYS6/HSCVQ/G+\*+:GYS6/HSEF.,/E;=OMI
MN7\OM_UVC_!YX?\ [!."_P#=78?[!J\[VQ/G+\*+:GYS6/HSCVQ/G+\*+:GY
MS6/HSEF.,/E;=OMIN7\OM_UVC_!YX?\ [!."_P#=78?[!J\[VQ/G+\*+:GYS
M6/HSCVQ/G+\*+:GYS6/HSEF.,/E;=OMIN7\OM_UVC_!YX?\ [!."_P#=78?[
M!J]%/M$N<@G( \HMJ" F* ]7-8$.@B >KV,Y+EX&7>W;(X?<?KS?+!(6NX6;
M7L=*6"Q2PMS2,O(JO'Z:CQV+5!JW%8Y$DRF\%ND3H0.A R"8G^^)_P <O](,
MG%=FM[A/C%\ET5_GTED@^'=Z[:W2ZEFY;LHM LJ6+,TRJWI$ YE65V ;!(R
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MY#?;$-T#O%$#=THCT!B'+O%R8OSLA#QRQ%2K, D\/0D 9G:090D@ESRL<CL
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M8:-,8QAHTQC&&C5GO:!^XDY4?(7L7]0.<@9&]8_&/Z<GF]H'[B3E1\A>Q?U
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MS6V^:W,EJ99Y#<DAD8.L8C 0PUZX"X'<,K'/?(\M=E:K'55EC9V#,&/.0<$
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M0X&*)S&-T[QC".J:2*(""***(&'O&!%)-(#&_P"48$RE QNGH[QNH].@=>@
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MY*UFNXDAFB8JZ./:"/,$95E.5=258%206NCM&P=&*LIR&!P0?[]B/(CL>VH
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M&C ]P_O_ /0_!KOO95:?[JK5_.BP?M/'LJM/]U-J_G18/VGG0XPZ$'^1C_\
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M4@B B14A%""(#U 1(<#%$0'T@(AU ?2&;/D3'_F++\S;?^5G)QAHUQO(F/\
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ML,Y D[!'/82?!O<_N]C?!L X3L8_ /H$! ! 0$! 0$.H" AZ! 0$! 0Z@("
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M&ZQ#)JIE, AG!R>00P#*05(!!!!!!&001V(([@CL1I=\_+3&  1'H =1'T
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M(+%.DN@ND<Z2R*I#I*IG,FH0Q#"48N?:3=E4[U26?WWQJA%WVKD4W4S?-9,
M</)37A/%.N\GZ<U BKB1H:*9S+24&0ZC^G(I'<L".ZX51&#E*9H8I3@)3  @
M(" @( (" @("'0?1T$!$!#U" B ^@<1M[V.COM0UK:8=0QKV4 ZU:0@>LA/S
MD8A>I$3RR #.&"NLD^&'BEQ/X5<01[UP_/U*TQCCWC9;$CC;MYIHQ/1LHN>G
M8C#.:=Z-3/4D=BO/#)/!-\X\! 0 Q1*8I@ Q3%,!BF*8 $IBF*(E,4Q1 Q3%
M$2F*(" B @.:Y(Z[2KLHSJJ6'D'Q8KACKKJOIW9&FH9%,A#B*9W<A:M91J*9
M.ZZ44*N[FZ,V[Q7RRRCZJI(N@5A7L<7_ /T/\(")3 (#T$!*8!*8H@!BF Q3
M !BB 5_WG9;NQVVJ7$['+03H#T;$8..>-B/,9 =#Z\;$!A@J6]=?#;Q,X8\4
MN'HM^X<L^N@CBW7:IV0;CLUUU+&K=B4GU7Y7-6T@->Y&C/$W,DL<3&,T$0*
MF,8I2E 3&,80*4I0]9C&$0  #\(CB1J0M:_A$1   !$1$0    ZB)A'H %
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MRLS&,NUX5\*]X\\=XP6C-&P174FZ*E*W&XRJ3HM,UC3"NB-I"ZW5^V*)T(]
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MDBF4"D* !G8(ID23*FF0B:9.I"$(4"$(0GV!"%*4 *4I"%*0I0  *4H%
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M.NZ=+G4<NW*BKERJJNJ=0WH,8RW<,,5>**""*."""-(H88D6.***-0D<<<:
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M!F&KL]+U94%'!FZMFM2[84U%UW"B:K2M5=FNG-6R53,RCQ:LVTK+Q7TG^!/
MG1W9[Z.C-.:<C#NGSHS:8V1LB8;-2W/:5S*U!NYLMF<MP$B#= @J,ZU6F:@P
MU3ANY&1A#JGD'\ACP^IR:G5H'LY("9@ZU7X:8M&W]S+V65B8:.CI*Q+P=T=P
M4*M.OF;9%U+*P\(V;0\6H_5<'CXINA'M!1:))HESV9Q;'0AAK1V\<\\Z<W.P
M^IH?\1!DXSCUF\V\NP[:<?BAQ=N>Z[Q;V+/HVU[99,0K1.3Z7/& ?2;+87G(
@)^DPXZ</GZ\F9-,8QB]J*M,8QAHTQC&&C3&,8:-?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>g953521.jpg
<DESCRIPTION>G953521.JPG
<TEXT>
begin 644 g953521.jpg
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M>Q<1F^N-&\>HJ5>1D-OS=U>E+59=IFB'CAG*S^M]?M7#.,84=)1%1-K8+2Z
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MCM8<M+Y)R_&#BK$<0R:;]OS><A[Q'U5F7:K*M6.-.:M:^VFA<N\Y6<G=B%:
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M'DRE2WG"\A+#2 B$X%+D*(8"5HN$,MJXPI<+VR@J6VZE$ ^T20'$^]WDY^]
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M4_00 1Z#TLCVUV0/1.HKU=: ^C-N7B2U>QCI/;<OJS5%MV'5]3LI5F63:J[
ML,&W.QA#!%&"4<-DC/'+-@!EG**0E.0M&NQE*VK;58VAR\V'$JQUQWU+4VK1
M:3SM55T*-HRG1VODBIN"B=$[::V.AL:Q@LV,9-V2214.<XID*G3Z#G-R\2=H
M<UX,>+.W]\);YVO);CT[:M>P$39*A9UK=3XJ%4H>R9AY,,#4II6)2-[P7=2[
M15D>N**J,RK'*BDZ4J06F\GM.7Z^K4&J6499X74FO]W,["FEVE-E]?[/E)6)
MILG$6-=<C-XXDW4.Z,#(")K))';G$1.L"9:Z.9.,9+M&[M^S:N'Q^Y,D'+M!
MNJ\4\0]HU155(=RH'4/V*)%#AU#Q!U#(4+_Q+L6W=J;MG=P<=H1Z<.QPT"M5
M"'K<4M(ZT@]\M%MG/)&I:R,)FJ#J;J;QY#H5M\#-O(1B+Q-Q&*L@DW *VF\C
M]%\A=A:\]BI+CO?Y+9,#PPXX5J@VQ+5<SM"ZV*[P\ A*W>,9WV8MJ5=X[6*C
M61-1O,>UN!1O][<"#D)F0[1!KBE9,"TM%MUBH+R+%%<[A%F5%9XW34,Z7(*B
M+8J2BI3"Y53 3IH%**RA $Q"&* CA:4BVZI$%Y!DBL=RFS325>H)+'=JD!5)
MJ4AUBJ'<*)B"A&Y0,J<@@8J8E$!''ZW+Q'O>PXKLD=_E='6^S[2DZCQIE..5
M@>0[U:SNKE":JK*=LE]<*G=$7;VR-L<<#&;F&G>TRDNW6CEGAFQED5.Q<BN(
MUMV%&=DLOBVDK/:-I2"VBI?C;/!&O'%@7GX+65"1L$YJ]4CL@MI]I/QSJ/FI
MF.!K)+&C@C7+E9FV(B"E3S*R$<D]0CE7K1)^X3,JV8G=(INW"28]#J(M3*E7
M72)X^W,1,Y"=![80$!RG.K-Q4W<'NC>TX\H?W+=J6_3MI]E(Q6-[2XTGV.]F
MR1W=5#]_Q9?9-KWI))]HDZ_;.T3+W,>L&&R>-F[+#R<VO+W"G;?DKE:=\Z7N
M>E-PT33,);9:KT. BZB9FVB][V*_5MCIR"IKEM/16Q*:\8]O9T59*2CF4\]F
M""C*7PKI%PI(<L_;?6IFM^V[FQOF[U?V9:"U]GZ?/C5O82RQ?4Y^^8:5!HY[
MQ=AVH+ @I^P+VN*5>QG%S'_,5?\ 5-_1G*9L.F14AB*%*<A@$#%, " @(=!\
M0_\ ^Y C,$=L95 C/I!Z#G42_)W]VZ_C/_5-G;NQK_Z*W-_M+4O[(D\N9W1Q
MGC-FL7*D).K5V7,0XI$=(>R,.LJ(#VI%DBG2?-BF$0 56ZZI4@ZF!JI^Y'H?
M#;1]^T@;:T3>&;!,LQ.UMY"2<5()OXZ7:-&$BV<+H=2H/6QDE3I@JW?,VRI.
MZ$$H*%$3!8M,N-O@J&:=^2AO'Q5#?VM_;RJ[*TEE:<QM'9W<_P ;/[.U4"/(
MC]_W=?YTKO\ V^]RCN5BY$?O^[K_ #I7?^WWN4=SIV#_ #&%_@XO[ANOFC?/
MZ:O'_E+A_P#EO4S0P=0$/C 0^T,UQEU6+J_IKS'@F53?U]&H3AWR&@-?:UJD
MBJXB@&O;%J-7NU)D[LB=-V"Y(U_6;J^9M42%5>B)!*Y:)B9)=+FGO,/6TC==
MIW(M*O-?E[B\U@ZKEEKQ=?N+E'1M"JL= 2=06E+.PG&E=B+"\8"\5FZRV5FT
MVZPIF*55% "QUXS"'#]L*EKXEP*<&RLAYS)2=N.YLE.ULE)7&:44D$9[9RS6
MJMU3P@XG2AEOE;!0POC&DF'&S0X&;A'#B5AL+2X&KE)0'$J"P R K990!>KM
M7E!5]@)SR;"K6%E[,<HH+?R0R"T.8&\/%TV#K3B .#9TMVTLHZBUG"#@H]X]
MZJI@JJ1;NA"]FEN4NI;B^V.%WH^QUH>9Y!Q'("D(UF9J\;(DE(R C8$:[;E)
M$L@W2CEBQQ71W,(#MV/=>X)+-S)"LK8)C*@L=O"&T)0ZD-#9;4E]T+0,V"<E
MA6T"1';23G\7:'9435%6.<0+>D/N/1752E\9(0Y!C+:>4$S4I"VE-E)2DSY"
MPG++;XLG/82*O:G.4-(G#7!*1U_*S,5:>6D1R%<0DLXBBL7U381ZK%Y3I04U
MG/62>E4'J=-)S%F3ZIK*G()R'J@]YQU./=4I>NUJ_3"=+W8XV8T;6H:!!LRU
MB7JDY4I*E0<;1X]C'U]&'83(G@71D)1=^[35>3#U$RI4B1JXR15@MBP@+96I
M*$J2E)><RR4VEE0^-F"IM(2HI*2H'>20@IJM<(&)V%.K9EL-N.K;<4XF'&"M
MIJ2N8V?Y/94$27"ZA+B5A!S" E+CH<O)INZ>/VJMGZ[M>M=:['"#KRMX/<).
MU6>(=7*<;7.#D8)K&0T:P6+3V#2K-GZBK-VLFE*3*G:EE'71(3..RZQY(Z5I
M<7IUK.TK:4R\T#LB_P!HUZI&S528MI6 O,LF\*-R35(*BL]#M443%9PIF<4^
M?)F*H_29+&32L1QE1VRPW@>-5*6HH"%.*E/EQ20):<BLK)R+<Z4UD,DAMW82
M $HV:$7&EYAJ28J+8RA#JGFX[=JA)CM+*[0Z"AE+00=E^Q6N3M+"EJD1N.<4
MM3KQ<NL/R/9,7O&27AZR\5D>/U@O$Z[0E'+0C.?]MFQ7-P2:,%FXN5V0IQ3H
M\:[=+MRF(\[59!-9 @":N'OT*7%WO75AAHW;LO7JS>K+?9V*M+[7+,Q',S4Y
M^MQL-6XNH1$-&+!%'G3*GLD\Z/-NV:/>BPKB8IDXX\9!VQ6U[9XQE2ME$EO^
M47F42G'W71GGF,G)#RT$$%)7V2  )HN.<1P]KD\Q"-IZV/\ \W9(#MJCP8D5
M03L[)!CVV&T\%)4'$LYD!2W"IT* G$I0*!E%#]"@ !U4.8XB(!XA,(F$3#Y3
M&$1'J(]<8QF7K4.S3-2^4/XP_IS3-2^4/XP_IQ2LD'43%]*=CPBHV,9NI&1D
M>-]I8Q[!B@JZ>OGKNJ3[=HS:-4"G6<NG+A1-!N@B0ZJRQR)IE,<P .'TAQ-Y
M2@@W >-N^@$&Z!3 .H[V E,") $HA[!^(0$! 0\H" AF:OPR_@LZ,_-_$?UG
M&7-] _+]H_XYR9C7"[.(;N^X[+=C&++N"$AMM"POC9)422H@@C8 &7;-?93V
M.?#Q=>!S!S42W6"WWI-]M6&I#JYLJ3&5'5!M9:2EL,)4%AP225%6\%"<NR:P
M$?>G<I/JW;Y^Z2]^@\>].Y2?5NWS]TE[]!YGW= _+]H_XXZ!^7[1_P <T_K:
MP^^DGR#7WZZ&]W!B?P%L/I.X?A5@(^].Y2?5NWS]TE[]!X]Z=RD^K=OG[I+W
MZ#S/NZ!^7[1_QQT#\OVC_CCK:P^^DGR#7WZ>[@Q/X"V'TG</PJ\].]:BVMK!
M.,6V5K._Z^1FE'2,,K=JA/U8DLJQ(BH]2C33;!D5\HS3<MSNB-A5,W(X1,J!
M 5()K_NQU=CJLW+VS)7:[HR-;X^5J2[E.S:?=&<C?Y%FH N:;3W E 2H%, (
M6BRI=LE#HG-'1QE9Q41C<B7FWPB0YGW?CFULTV,-J_6$O?Y[8"+%=5&QV)&:
M9U1K#UF#6*F<D<245C7WLQ-&."\;'(G)')&D7C9PTOFI]/J^OZQ!TNE0,76*
MI6HUM$0,!#-$F,9%QS0G:(-6C9( *0A?V1SG-VRJZQU7"ZBJZJJIZ5NP VU=
MGES'%/VR*IHL)6$I7.<+3;B^,2DD)CM.*4VH9[3JD%.Y(43D<:^S FS^#RVQ
ML.1&;5CF_-7!-W?B+=>C87AMSY<.-R-V0E*GKQ/B,M2FU;*FK>T^EX%3ZF4M
M4MVG6("E<:MBU"J1+*!K-7TM;("OPL<B"#")AHBEOV,;',T0$>YMVC1!)!(H
MF,;M2 )S&.)C#BAD_!I_R:?]0N9;.^_WCMQ_FNOO]UI3,28GX-/^33_J%SJ+
M@Z2E,2XI2 E*7HR4I2 $I2&W   -P &X ;@-PKXQ>R-<<>O.'775K===AW-Q
MQQQ16XXXN3&4M;BU$J6M:B5*4HE2B22236[&,9Z-7.-,N*X][8I&L@VQ%; @
M[;.5S:>M76O'A*6\A6$VQ1?22#MR\0<SP*,4S@V2.F@8S=WVJYBBHW.GU$MN
MN,H28[<MA<=W:XMS8*MA10K-MQ+J2E:<E)(6A)S!!W5?6VXR;5-9GQ"WRA@/
M!''-(>:*7V'8SJ5M. H6E;+SB"%#^MF,B :ORK/*[7E!LVE(JB4&X,-1ZAE;
MQ9G+"=G(:7OUPMEXKTO!NY:0>-TV$ R0CT)06[-DT J1FXK*&!,Y&[<GT2YB
M01JY5H=S39DCYAI"_:ZM;]HZCREL-QL5%KNN*U9"I*O1Z1D+5ZPP0> H5!\H
MLLX%NU6$3**V$XS&JL%L6H+6TXIS)04XIYU2W"I<AQ:G%*42M2W)3JU$GXW%
MD <4V$[(WCW$K3:F6I4=M@K0M##<&(AED--6UAEMAM#00RVRQ:8C+:4 ?!\>
M%%1DOE=]TER%T?;JAK*$N#?D]$2="U;6M;O$-:;"JE;JDP2":*HN)!6*>D=J
MN%7RCA9-11R!#*L 1;+( )#":Q13N?=%.X@<J'=% 0*H)14*AVYNXE4$@ 05
M"I=H"@D ""<#"0 +T -F,O8D%B$' P7=EQ144K<4M*25+6=@*^+FI:B=_:[0
MK"W:^3;T8ZIR8Q<CMAM+K,=MAQQ(;9:3QRD <84H8;"20,CM'LJ-,8QEY6'I
ME_/8U?X4L+_L1=__  C#+!LOY[&K_"EA?]B+O_X1AF&Q%_0=U_P3_P#H-;EP
M>?[\X4_\Y;_WZ:I5V9/1FZMC\KH"?U]J'9UZ@TM,5"-5F:?1+-98I*1;V6\+
M.&"DA#QKMJ1Z@BY;*K-3*@LFDX04.0"JD$T3GO3N4GU;M\_=)>_0>9]W3K\?
MVB'] XZ!^7[1_P <Y"N. HMQG2IR[A(:5)=4Z6TLMJ2@JR]Z%%0) R[)&=?;
M_!/LM\08)PG8<*1<(6:='L5O:@-2W[A-:>D(;*B''&VVRA"CM',)) RK 1]Z
M=RD^K=OG[I+WZ#Q[T[E)]6[?/W27OT'F?=T#\OVC_CCH'Y?M'_'++K:P^^DG
MR#7WZVGW<&)_ 6P^D[A^%6 C[T[E)]6[?/W27OT'FQ7BER?02577XY;V1002
M57765U->4TD4$4S*K+*J&A *FDBD0ZBJAA J:93',(%*(AGX] _+]H_XYP5G
MCW,I7)^-9 0SN0A)9BU*JJ*28N'<<Y;( =40/W,@JJD RG:&[0O4W:CTZ# \
M&T, GVSDG(=CB&MYYA\?G[%3M^S>Q,I:$JP/84I4M(4KVSN'O4D@%6]O+<-^
M_=NKSZ=8ZRO.Y+U6M;:VKSVTW*VOTV$+$,2].Z"( HX?/71@%"-AXUMVSZ7E
MW9B,HU@FHY<'Z 0BF9EP*X'TKA?K]0!5:6?<5P:1WNCWQ-)4J*P-U^^FU4K"
M3CHHQJ4*Y65%N8Z:3Z<>BI,R@$4.U9L?EP$X#T7AAK]$ZP,K3NFT1+!+8>P!
M0ZE*)")+&J-0!9,J\93HYT4# 4W:/K ]2"6F!$Q6#*.D$4_<A_KI_P#$+F1P
MEA)%I0B?/2E=R<3FA!R4B$A0R*4G>%2%))#C@S" 2VV<MM;FE^R(]D/(X19+
M^$<)OO1<#Q'P),@;;+^*)+#@4A]])V5MVAEU"7(,)82M]Q")TQ =$:/#\[G;
M/[Z^U?SH[)_OQ/YT#._[9_?7VK^='9/]^)_.@9]%(O\ -H__ &&?W::\%3V!
MXA]E,8QE>HTQC&*5('Q%Y>LN,6B>6M>AG;ECMS:S/41-6.G%+A+I6$G-0L,R
MXLPV5E9&\C!))'A)95./+(Q,@11V8JB)4'*"*Q.9U1RX@KU;-Z7/ES;9"PWB
M\:QK-,US:9;5,9M;7]6+7K.C+N()_H9A)TZD2T8I'$.-7:R2)J[!SZBTN\9'
M7<*KJQQXS!OX>MC[EP?4T42KDXPX_,0&>5-AAN$VAEAU;*RB.H0&2['<#K3J
ME/!Q*D.; HEALEQ662W"DJ6 G;&R&TA*24G))XM)*3F"=K/,'*I?M]<QN.^Z
M&G,J'1E+Y!,]\:4XMPE#DE];1XJDO''X\O*R%:L,+$2[*.@(V<DEV#)E.0YG
M$%$H+NW;)DJDQ;M'??I_G=QMV+:^0$//N9.LT[8MWX[;+I]PL_'FN[N1)*ZF
MTQ6];V. EM;V&>CO8N2&3AU9*FV]JZ<C'*]LZ412(L9NYA#QF/&#;0&TMA<T
M);;0VT>-85Q1;;M#27$I7&4A2]BR000ZAQD[+I#0+A(DY(UD!FL9  9%.[(,
MIS *2"2&$9Y@I[.[?4G&ZN9-"VA2TXM&0O+V=/S^7Y(/GDY6X2&=2FMV=(I]
M5AY281J1F59"\*+5Q=XXAHMDFDV45(N1V9RHJLI^O?O*C1NWM1<OJ7'2%RB[
M!LGF@3DUJH7-+[O'66 /5&5/&"L+WV526ILHB@I(29G#EM(E,1LT8()'.]64
M9Q>8R[:PS;&#$+/*&^1.AYC9<;R"A(C2=DI+)!1M16D;.0R:*TI(44K1,(S8
MV<MH;!S&_P"<A666667O$C<!NSY]],8QFPU7IC&,4IFT_P"#4_DU/ZALW9M/
M^#4_DU/ZALBGLCQC[:BGLCQC[:S^.&W\$CC%^8'47]PH'&.&W\$CC%^8'47]
MPH'&<5W+^D9_^-E?OW*TES^4<_OJ_P!1JY$2E'R@ _Q@ _TXZ!XO$'B\GB\G
M\7Q9KC+*I*T[4H>0 \74 \0>0?*'\_PXZ!XO$'B\GB#Q?Q?%_-FN,4K3H'C\
M0>/IU\0>/IY.O\7P?%G5KO2*ML>HV*B76';S]3M<6ZA;#"N5'*+>3BWI0(Z:
M+JLEVKHB:Q  IS(.$5>G[E0,[5C%*ZS3:;5=>56OT>CP$75JC58IG"5ZO0K1
M-E%Q,4P2!%JS9MD@ I$TR!U$QA,JJH8ZRRBBRBBANRB #UZ@ ]?+U /'T\G7
M-<8I3H'Q!Y.G\WQ?Q9IVI?\ LA\'P!\'D^SX/BS7&*5IT#Q^(/'Y?$'CZ>3K
M\?3'0/'X@\?E\7E_C^/-<8I6G0/+T#KXAZ] \H>0?YO@^+-0  \@ '4>H]/A
M'X_X\8Q2F,8Q2F.G_E_N\88QBE1^W'L;FA+Q;;/<YB9V6E+6N>E+%)IL;)%(
M,B/I=VH]<D:(J5U8Z3<JJIBHIG65,0G0#*'-U,/6_!9\<_EW:WG3#^K&238S
M,HQ%?&TI0BYRTH0E*4)#A 2E( 2D#+< $@ =H5I3O!S@9]UQ]W#%I<=><6ZZ
MXJ."I;CBMM:U'/>5*))U)[=1L^"SXY_+NUO.F']6,>"SXY_+NUO.F']6,DFQ
MDW5)?N^LSRITTT%4^MI@+P5M'FPTUT]9[=1L^"SXY_+NUO.F']6,>"SXY_+N
MUO.F']6,DFQCJDOW?69Y4Z::"G6TP%X*VCS8::Z>L]NHV?!9\<_EW:WG3#^K
M&/!9\<_EW:WG3#^K&238QU27[OK,\J=--!3K:8"\%;1YL--=/6>W4;/@L^.?
MR[M;SIA_5C'@L^.?R[M;SIA_5C))L8ZI+]WUF>5.FF@IUM,!>"MH\V&FNGK/
M;J-GP6?'/Y=VMYTP_JQCP6?'/Y=VMYTP_JQDDV,=4E^[ZS/*G3304ZVF O!6
MT>;#373UGMU&SX+/CG\N[6\Z8?U8QX+/CG\N[6\Z8?U8R2;&.J2_=]9GE3II
MH*=;3 7@K:/-AIKIZSVZC9\%GQS^7=K>=,/ZL8\%GQS^7=K>=,/ZL9)-C'5)
M?N^LSRITTT%.MI@+P5M'FPTUT]9[=1L^"SXY_+NUO.F']6,U#L6G',! ?9W:
MP]/CM,/_ .58#))<8ZI+]WUF>5.FF@IUM,!>"MH\V&FNGK/;KH^M:!":LH=6
MUY7%9!>"J$0VA8M:5<).I%1HU$_<S/'"*#5)9<>W'MSD;HE'Q="!G>,8S#+6
MMQ:W'%%:W%*6M:CFI2UDJ4HGG*B22>V:W1AAF*PS&CMI:8CM-L,-(&2&F6D!
MMMM YDH0E*4CF %,8QDM5:8QC%*8QC%*Z_;*VPN56LE1E3N4XRT04M7I%1DH
M1%X1C,L%XYT=JL=-8B3@J#A0R*ATE2D4 IC)G !*,?(=BSXY@  $[M;H4H%#
M_.F'\A0Z!U_S8\O0,DFQE_#NEPMZ5IA2WHR7"E3@:7LA93\4J[>69RK7[SA7
M#N(7&';W:(5R<C(6VPN4T'%-(<4E2TH.8R"E(22.?*HV?!9\<_EW:WG3#^K&
M/!9\<_EW:WG3#^K&238R\ZI+]WUF>5.FF@K#=;3 7@K:/-AIKIZSVZC9\%GQ
MS^7=K>=,/ZL8\%GQS^7=K>=,/ZL9)-C'5)?N^LSRITTT%.MI@+P5M'FPTUT]
M9[=1L^"SXY_+NUO.F']6,>"SXY_+NUO.F']6,DFQCJDOW?69Y4Z::"G6TP%X
M*VCS8::Z>L]NHV?!9\<_EW:WG3#^K&/!9\<_EW:WG3#^K&238QU27[OK,\J=
M--!3K:8"\%;1YL--=/6>W4;/@L^.?R[M;SIA_5C'@L^.?R[M;SIA_5C))L8Z
MI+]WUF>5.FF@IUM,!>"MH\V&FNGK/;J-GP6?'/Y=VMYTP_JQE6M*<&=/:&O;
M;8=,E+X[G&L7*1":,_.QS^.%K+II)NC';MH1BJ*Q2HD[B<' %(/;"8A^H=+S
M,93>OUYD-.,/7*4XRZ@MN-K<)2M"@ 4J'."  :N8> ,&6^5'G0L.6R-+BNH?
MCR&F EQEYLA2'$*SW*20"#V\Z8QC,16X4QC&*4QC&*4S00 0Z#\8#_.40,'^
M\,UQBE0XV'L(/$2R3\]8W]FWFF_L4[-6%^1M=J\FV(^G95W+O"-DS4XYDVY'
M+U4J"9U%#$1 A#*',43&XCP$_#KYT[Y\^:[ZEY-+C-G3C/%20$IOUQ 2 $@/
MG(    ;NP  !XA5V)TL=B0X/\QIIH*A:\!/PZ^=.^?/FN^I>/ 3\.OG3OGSY
MKOJ7DTN,CU:XK[_W+RY_AH.BG+YG=#G2---!4+7@)^'7SIWSY\UWU+QX"?AU
M\Z=\^?-=]2\FEQCJUQ7W_N7ES_#0=%.7S.Z'.D:::"H6O 3\.OG3OGSYKOJ7
MCP$_#KYT[Y\^:[ZEY-+C'5KBOO\ W+RY_AH.BG+YG=#G2---!4+7@)^'7SIW
MSY\UWU+QX"?AU\Z=\^?-=]2\FEQCJUQ7W_N7ES_#0=%.7S.Z'.D:::"H6O 3
M\.OG3OGSYKOJ7CP$_#KYT[Y\^:[ZEY-+C'5KBOO_ '+RY_AH.BG+YG=#G2--
M-!4+7@)^'7SIWSY\UWU+QX"?AU\Z=\^?-=]2\FEQCJUQ7W_N7ES_  T'13E\
MSNASI&FF@J%KP$_#KYT[Y\^:[ZEX\!/PZ^=.^?/FN^I>32XQU:XK[_W+RY_A
MH.BG+YG=#G2---!4+7@)^'7SIWSY\UWU+P/8)^'(@(#:=\]! 0'_ #YKGD$!
M ?+2Q^/)I<8ZM<5]_P"X^7.FF@Z*<OF=T.=(TTT%=*UO1(;5VO:-K6NJOUX#
M7]1KM,A%I5=)U)K159B6D-'JR+E%!LBX>G:LTC.EDFR":JPG.1%,H@0&=UQF
MLK6MQ:W%J*EN*4M:CO*EJ)4I1/.222=35J2222<R222>R2=Y)\=,8QDM0IC&
M,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&
M,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&
M,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&
M,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC.INKY265SBM=/+=6VM^G(*2M$-
M2W$U'(VF4KD,Z:,96=CX([@LF[B(YX^:-GD@@V.U;KKD344 W; 7MF3K;<0$
M%:%H#B XV5I4D.-E2DA:"0-I!4E20I.:=I*AGF"!(AUMPN!MQ"RTOBG0A25%
MMP)0OBW "=A>PM"]E62ME:599*!+&,9)4],8QBE,8QBE,8QU\?3X?+BE,8QB
ME,8QBE,8P(]/+BE,999?>R$<3->V:1ILAM$+-9H595O/1.MJI<=GJU]PB<4U
M6\\XH4#/L8ATFH4Z9VCUTFZ(=-0IT2B0W2L>EN26C^0T<]D=/;&K]T]BA(6;
MBF:KAA9*^JH8Q"(V&K2[>/L4$J90ITRDDXUL!SD,4AC" =<F_9+S&BB=(M-R
M8AJ"%"6]!DM1REW+BU<<MI+>RYF.+5M9+S&R3G6/:NUJD23#8N4!Z6"H&,U+
M8<?S1GMCBD.%>:,CM@)S1E[X"JX8QC,960IC&,4IC&,4IC&,4IC&,4IC&,4I
MC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4IC&,4I
MC&,4IC&,4IC&,4IC&,4IC&/)Y<4IC+1-P<[^*>C+,I2+_MN))>D  7=&J<38
M]@W&/*) 4[:6KE%B+!)PQ.YF(H!I5%F(E.7H B8 'MFC>7''3D>K(,M.[4KM
MLG(=#OF:JAP?P%UA4 4!$ZTO3+(SB+,P0(J8B1W"\8#<ISI@*H=T3[:_5:KF
MB,)J[=.3#*0L2E1'TQRA1 2OCBV&]A1("5;6RH[@2:J%ET(VRTX$99[>PK9R
M.61VLLLCF,CGD>:KC\8QEA5.F,8Q2F,8Q2F,8Q2F,8Q2F,8Q2F,8Q2F,8Q2F
M,8Q2F1R]D7[(SJ[@#K DO,%;6_<%P;/F^K=6MWB:;R8=HIG3/9[*8BI7,-0H
M9WW(DK*D*+N1<F)"P::\BLHHSD66 PI*@10$C"F<"JF*!BIF$H@50Q3"4# 0
M>AA*)B@/3H)@ 1'("MV]@MT]R+V;:-P;BY<\A+E?[>[(ZEY=TMJ)!!%%!,$&
M$1#QR%,*SAH"(:E*TB(9@FDS8MBB!"&65<+K;M@./@MR^-/X[N$J)8XFR\Y#
M@Q),B5=70KWD0N, ")%W;4I[;#ZD9,QTI4XJ1'T+A$DX[:L#L;@]MD29?YNT
MRW.GS8L6):&R %2^+D**I<KWV45CBS'2L*>DJ*&TQY&(Y;>7W(VZ<B1Y62^T
M[(CO9&<1G(F\1;@&"];%IW9./@:Y'E[I'QM0CF+A>)0JG<5H5S$.';&3;2!7
M\@=UFR=BW[*;1N=M,)2[B,72N2]0B4UK?34UBMXRZQS4B:+B^Z^375,LO$JK
M"49ZNF.O)5)XL5-4SN&<1TJXLQ7_ .39<66J*CESR&W^@W1(*BJZPZJ2133#
MQB=152DE3(0 \8F,8"@'PY3VS]B X+\,"Q_(2:Y\[DT]):V>%M%;MC6R:=;V
M1"9BB'7;MZM%-Z<YD[),/" =HG7(Z.E#S2*ZT<YCW3)RY1-TIC[%7 KPE6>'
M9;9[90KY;V40\,R;;AJ8I4?()2Q:U18K16_;W3LH$9M!7'4>.C)"^,0[ROP<
MX0X>."V^S;]=C:I]@N3ZYV*XMTQ5!0F0%*VY%V1*EN[$>Y-)S69+BDHD)3Q$
ME6P$+9R*=][*LNG]1W39%0U5<]VV2KLV#J+U;KTB*EQMRKR9C8M9I"$<)K)&
M68M7R\NY Z1_\ACW0E#M^UR'J1[-)LB)V?!:5D^QJ\K6.W+/ .[57-;NGM:1
MN4Y6V R'?D[%P9F'?;N+;>Q,GW9VF44R=X.@$?VDV2V<8-HGW;QWTOMI0SU7
MW1=;U2WD7DVT>SDW2$W%HO&SR5911$HIE*/6YTG<DRBTDHUF]67;,$TVB2)"
MQ-;H /#_ /#_ ,7_ .3C8?\ 1NK/!<%0+&I_$UJQ#AJ-=)EELV)KNF0Y<;O#
M=1(L<%3B("FX,R,RJ.J1'67'%-<H(=6D. )0$]'XYN5^3%PK>,-XF?M4*_7O
M"UG5&1:[3-;7&Q!/0VNX)<G17WDR$QGVPVVESD^;8)02M9,D/%#D1M_D+%V:
M<V5Q/VAQ?C8A=BS@&VVINO*V2VN5>^32:K*KQ*82L5&1)$VA?9*9(T))K/>Y
MQB+E)JY<$N[ 0'R?9Y!#KY.H#XP_GR(;LIEQTI6TM6--R\\]V\4()ZWM9'&L
M./:AAV/N;OI2'0CG;8*_7[!;V#"LND72"JZ3%2)DC20LBJM9%L516P/L8_,F
MQ5CDMRPTRSW9O/D-Q=U_Q[D.0.J9OD QF6&U8F/J2=:<3488]JBHV?.SE"6*
M08H*K-T(A^,/'3L4Q:^R#P%XIP%)Q!8+CB^T1TVR-'CF:FS)M]_$$1F9T>V.
M-0K_ '0/QI\[C'D3'(Z);J>+4\$.MN,JB-TU\(D7#>([;@V]R3<Y$F4F J^*
MN.'C/,M^ _=&7)^';469=O@%MER&W)<B-JXQ+"G&W&WTRW<G7J'7I\/D\74>
MGP^/IY/Y^F6O\DN6FL.,3S2D+>/9>1L^_P#;U1TYKBO0;9)9V_G+++QL>^FG
M[ETJW9Q]=K#221D)EXHL=RH*K./CFCM\^23+"=P^TWRD[*?0)?F)NSF=R(T1
M"6FYVIEH_4_'.S-J+5Z3!UM^>+1DY#JW=%L2J<D1W%%"0:A*R(0ZLK)S:YI%
M!G'4O[*_QJO<!R![&XG/<I]\6J5V5N37&L$7SB5AV+/75DJK#5%2E=MZPC4V
M*_M<OEPDC#<9U=\\EVAK&)5DB=P("8Y*S<'-C&,H^%;UB>*]-C-WD7J!;X=S
MRB3[5:Y,U<!NX*B\3)#+L=QN8ZRE"?\ 9GF8JW%.,O5C+WPFW]6"96+;%A.4
MQ!DNV55CGW*=:PJ9;KK=(D%%P<MR91>C%]J2TY#9>4M13*8>D(0EMYFIT.;7
M(K=_'*CT*R:*XS6WD[/6C9T#39^M5)R_0=5BMR#=\X>65U[&1$TNFD+AJWB6
M[U\@T@8YV^1=SLDS9D_;;39CDOM"H]F>IW&\LP_=:HW#Q*;SS^FR+KOF.K=X
MJ+W85A:VR$334.DRE7T=$N*W.@U4[TEV9X]9PFLM$1ZZ5 ^R/^[9PHXH\8JU
M0N4O(:VVF9YHT>&M&U+G>15V%::O:6]OD'=0F)2%9Q396K-BLV+5M#I-$VXH
MM$SK@HL90YMFTO%_RAWCB(!Y.(UJZ!_%![B\676'\.6T6*3*5%MDYB5A+A/>
MC7)"9XE37;"W;7(,I^--5Q$,Q'E(=@JBM,OD+<Y9FH)JSQ'B:ZJOT2*F7=(#
M\7&G!0Q)M:U6\Q(+.('+DW<(C$N$D/S4S60IJ>F4Z\P%(;Y&$I*C60$(@ ].
MOC^(/&/3R=>@=1Z?E\F.H=.O4.GQ_!]O^[^/Q9BD<EN8]=WIS8Y+ZXY#\V-Q
M\.N.7'"=;:OUM5-#NIV,N^R-FQZKE"Q6VP.:K7K-)OHB$DHV0<F+(M$(HL:Y
MKT6P48R+B47?73=C!V[LWG-IW=>G;SR+V/-S/&K;982@\DJ>+FJ7C8VK;?$6
M%A6Y.7;3L6F9::!O$OW;>2L<8^F&G?D8:106EHX9!QA;EP57>TX>3B&?,2S'
M9CV:9<DFVW0,0HM^0TN IBX*BH@W-]E4F*W<XL%YQV$N0E(Y06I :SEKX7[-
M>,2JPU;X2GY+TB]P[6I-UM)D3I6'G'47!,BV(E+GVJ.^B-+=M<JX,MM3VXRE
M'DX<8+N0EC. JD(M6JQ7JZXEY&P+0,)%PRD[,* M+S!HQB@R]DY58O[%>3?
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MNN:K^DJ@>>E9]*8]US5?TE4#STK/I3/.J[S9_B;/]$;_ *O'>;/\39_HC?\
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MR%L(E/[#*WG%-)^%5\5M2BA/;W)&_?3&,9?5C*8QC%*JWIW0^X.0,_*5;2]
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MU[>;2I1-2=^PH)(! W%1!3&()]]D,N/((WYA.XY[CCA 4P^0!'X/$ ^7XO\
M>'VY^\(F6-&'FRQ4H:%2>DC59HL:^-#)22B7=TXY26!N,<G(J(?MY&!W17AT
M/VXJ I?L\FIN-'XXZ7JDG;*WQCH5M7F^R-3FAHZ(W?'S\C)T36[NBT>9E:.I
M'0=T49.Y.!E928C(*1E):</#%.+WN;J2 01Y'D55H/7?";F?JG7>N:^%0UCV
M2!>M-'"41-S$Q5*D>GMI"-LLE,&E%Q:/81P\9T:%LLJCWFA77;:"<IO)-PC(
M&O4XM;><A(8@2$HF2X\=#LAR.VGBW)$>.\YDAUU86RN4P$MJ2GC25A*@$I4N
M?E0)2 VKWZPD%12!EMI0H[BHYI*QN.69SW[J@UQ@?*/P?D^+&;?5U3&,8I3-
MI_P:G\FI_4-F[-I_P:G\FI_4-D4]D>,?;44]D>,?;6?QPV_@D<8OS ZB_N%
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MF[1VU3E&#A@=RU/U#M'"!7 JH&ZAVJI"#\&6R1_$^'B+%3IR/OMP<$J;]>1
M+&N%MG%UV]OMEUA2L;;/N'E@B$_92WO&%O,BY=.+[78R!@YI=%M& =:Y9Q!=
M9 ==F8FNC+ZEJ7[]4F27B4K6I;CP>V@XMS)'ODJVE+VUK2D%56C^&[1&+#4'
M"EH?CI0A!V6X<4,(2MMM*&V3'V2VVUM*R2I 0E 0VA2BE(X\>$VM   '9_*\
M $0  'F%R3#J(^0  =E>,?B#_#'O)]:>, V?RO\ %Y0#F%R3\77XP#97P_[\
MVT?A]&4-W0GC;:VSK4K2MF*[,55OTXM:',J_<:]6URK#D7[O'>Q<(VB21CB+
MCDDW3-@ZCNZF;.W#QPY#M=ZXOUB]3MHGU[1;8!]:[36;5(K5>25@'9W-5UQ8
M]=,(]>1BUFC]]$+MK$K*R$:]769OW+5)D[16CEW*)ZR[U+2_L)Q9='&.**N/
M#,E)#O'!'%\2J0#D6<W@YMY9@-$!1)%NW8XJF-M>#;0W(XX(X@O0U)XDQ^,+
MW')B$9A_)@M[&>14Z%%( /50X3ZS\@;0Y7^40$ YA<D_* =1 0]TKR@'01_)
MT^,,>\HUH'_XH<L $0$>GOP>2G40Z@'7I[I/7RB ?E$0 /&(9^V/XH,HRS1-
ML9[&MC>6K^QN0&Q(44TFQVJ#_?B)B.TGK-TY=-9!6CK&[M4%CHHL$ (4CR'7
M'ME#_HK_ !$H\/7X^OREIOUN"#U5;=/0$O9+,_6F6-4MDG(/UW3UW'KQR<O9
MH]NZ91T=9':!))DC$LG3)5I('<NE8JO,E(!&+;HO> 4H8D[0S7)3F-N2A! 0
MW&</OP?]H6D))CGC2;'&4=DX-LZ-V84M^)L9!N(HI);A+6%%;DQM.2"G_94+
M*@F2.)XOWD^M>@?^L_E?T$?V/_VPN2?C$0\?0/=)\O0/'TZCT#Q^3-/>3ZT'
MKTVARO'R@/3F'R3'Q@(@)?%LH?& ]0$/* _!E4+KHB%ML9JZ#;3+^OP^L9.&
M=L4&#9J[?.6D&G'=XMV<K("N\@W_ '6):$4GV)E)<6#B69)KIGDU7:=/6G$J
M"2B&,<O?+F1S'L-QQ97,4Y)&M91KMHTR9NK88Y962)+/Z$I/RSRG."N6;>.D
MI!Z[29(E7*W1I-7N<IL*<Q1<FEE2P6]B2X4H =*%%27@C-90V"E)5L<<#M*V
M%Y57;#!0ZI#6$;2\VE#1#NW$;"UJ+ =2E*HVWLMI6\I*U!/&<24[*"XBN/\
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MT[/E4?>IR63W.]Y->FFHKA,9S?M8M'S6M/FS/>CL>UBT?-:T^;,]Z.QRB/\
MIV?*H^]3DLGN=[R:]--17"8SF_:Q:/FM:?-F>]'8]K%H^:UI\V9[T=CE$?\
M3L^51]ZG)9/<[WDUZ::BN$SY+_@%_P"06_X1\[![6+1\UK3YLSWH[/DO6+1W
M!?\ S6M/X!;_ .&9[_Y9_P#]NR*9$?,?#L]D?\5';_O4Y-)_0/>27I\W45GT
M\;XAI8.(VBH)\*Q64UQYUO$NS-U 27*UDM<Q#)P**AB*%36!%<XIG$AP(?M3
M"0P!T&P G8-^&1"$($SO3M4R$(7KL2)ZB4A0*'7I30\?0/&(=.H]1R1;BNFH
MCQCX[HK)J(JI:/U4FJDLF=%5)0E&@BG3525*11)0A@$ITU"%.0P"4Q0, @%>
ML^5V)+7;KC=[@J=#CRRU<)X:+S:5[ 7*65;)/8"BE)/;R!K[)\'^/,9X+LD5
MO"F);QA]%PMUI5.1:YCL42EQH@#!?#9&V60\\$9_%#BP/C&H<? <\,_EG>GW
MB17J;CP'/#/Y9WI]XD5ZFY,=C,!U,X?[T0/((_/,.BM\Z^7#!^L?%OI>1][3
M[>V:AQ\!SPS^6=Z?>)%>IN/ <\,_EG>GWB17J;DQV,=3.'^]$#R"/SS#HIU\
MN&#]8^+?2\C[VGV]LU#CX#GAG\L[T^\2*]3<> YX9_+.]/O$BO4W)CL8ZF</
M]Z('D$?GF'13KY<,'ZQ\6^EY'WM/M[9J''P'/#/Y9WI]XD5ZFX\!SPS^6=Z?
M>)%>IN3'8QU,X?[T0/((_/,.BG7RX8/UCXM]+R/O:?;VS4./@.>&?RSO3[Q(
MKU-QX#GAG\L[T^\2*]3<F.QCJ9P_WH@>01^>8=%.OEPP?K'Q;Z7D?>T^WMFH
M<? <\,_EG>GWB17J;CP'/#/Y9WI]XD5ZFY,=C'4SA_O1 \@C\\PZ*=?+A@_6
M/BWTO(^]I]O;-0X^ YX9_+.]/O$BO4W'@.>&?RSO3[Q(KU-R8[&.IG#_ 'H@
M>01^>8=%.OEPP?K'Q;Z7D?>T^WMFH<? <\,_EG>GWB17J;CP'/#/Y9WI]XD5
MZFY,=C'4SA_O1 \@C\\PZ*=?+A@_6/BWTO(^]I]O;-0X^ YX9_+.]/O$BO4W
M'@.>&?RSO3[Q(KU-R8[&.IG#_>B!Y!'YYAT4Z^7#!^L?%OI>1][3[>V:AQ\!
MSPS^6=Z?>)%>IN/ <\,_EG>GWB17J;DQV,=3.'^]$#R"/SS#HIU\N&#]8^+?
M2\C[VGV]LU#CX#GAG\L[T^\2*]3<> YX9_+.]/O$BO4W)CL8ZF</]Z('D$?G
MF'13KY<,'ZQ\6^EY'WM/M[9J''P'/#/Y9WI]XD5ZFX\!SPS^6=Z?>)%>IN3'
M8QU,X?[T0/((_/,.BG7RX8/UCXM]+R/O:?;VS4./@.>&?RSO3[Q(KU-R)SGY
MV.^M:5W;Q_TKQ@B=@72R[EAK2N2'LDZSG7RTG"S$2T160>)14.VAX9A'/'CZ
M<D7P&9,&B!GKE=%)$05R\<ZXI4:PM:FUW6@HQ6W,H-U66=C4:)*2[2 ?/D)-
M[$-7IP,LV8/7[5JZ>-T#)D=K-6IG'= ;(@G8W+!]GF13'C0XL%Q3K!5)892'
M4-(=0MU+9&X*<;26P3[T;69"@-D[7@OV1_"5AN^MW>]8EOV*HD>%<VVK+=+H
M^Y;I$^3;Y$:WO34$[3D>%,=9F.-ME+KH8XMMQE:P\W8AP!X!4GAK2?9!_P!X
MVG=]LC&Z5]O*9#*-6:(G(Y]I]-!PDFNPJK%P5,SA<Y$Y"ROT"RDIVB2<='1T
MAZG[D/\ 73_XA<WYL/Y _P!=/_B%S884*-;XS42&TEEAE.RA">?G4M:CO6M9
MS4M:B5*422237C>)L37O&%[GXBQ%<'KE=KD\7I,EXZ;+;++:<FX\:.V$LQHS
M*4,L,H0VVA*4@5YW.V?WU]J_G1V3_?B?SH&5:VM6+,?:NTSDK5E.0^S]CG(<
ME<G3$.0]WGC%.0Y8X2G(8H@8IRB)3%$#%$0$!'H7M6M'S8L_FU/>CL[?BNM<
MFC_"M_R#7]=/Z-.M9E*DY#>.P.<=JN"QG.^U:T?-BS^;4]Z.Q[5K1\V+/YM3
MWH[*_'-?I6__ '3_ !J.8[8Z17!8SG?:M:/FQ9_-J>]'8]JUH^;%G\VI[T=C
MCFOTK?\ [I_C3,=L=(KCD)&1;-'K!M(R#9C) @628MG[QNQD2MCBJV+(LT5D
MVK\K=014;@\27!!0141 AQ$V?>*FYN!76=0,W-0+IPU68N'4%,24*Z79..@.
M&2[F+=-%UF:X% %VBJAVZP  *I'Z!T_5[5K1\V+/YM3WH['M6M'S8L_FU/>C
MLE*V"% K9(5O4"I!"CD!FH$[]P W\P YA3-/;'2*V$LMD3,X.G9+&F=W%D@W
M9T[!,D.[@TTQ13@W9RO@,ZA$T1%).'<"I&)I"*9&I2")1^S.VVR.DUIJ/M=J
MCYIRV*R<33"S3S&9<,BID1*R<2S211D7#,J*2216BSD[<B2::94@(F0I=GM6
MM'S8L_FU/>CL>U:T?-BS^;4]Z.R&<;(C-C(C9(S;R*=WO2.<;AN.[<.T*9I[
M:?57'A)20-DV824B#-)^>529^R#WO1*54 I3RB37N_<$Y0X%*!Y(B97QP*4#
M.! I>GZSV&PJ)RZ*E@GU$; H1:?1/.2YTI]9-0%4UIY(ST4YM9-4I54U94KM
M1-4I5"&*<H&#Z^U:T?-BS^;4]Z.Q[5K1\V+/YM3WH[([4?\ YF=QS&]&XYA6
M?9[.T K/M@'L@4S3VQTCQ_;OK@L9SOM6M'S8L_FU/>CL>U:T?-BS^;4]Z.R;
MCFOTK?\ [I_C3,=L=(K@L9SOM6M'S8L_FU/>CL>U:T?-BS^;4]Z.QQS7Z5O_
M -T_QIF.V.D5P6;3_@U/Y-3^H;.?]JUH^;%G\VI[T=FT]6M':*=*O:!_:S^2
MLSX^4@A\$=\>1#S((^%;[(_KI_C44D9C>.R.<=NL]OAM_!(XQ?F!U%_<*!QG
MTX>)*H<3>,R*Z2J"R.A-2)JHKI*(+)*$HD$4Z:J*I2*I*$, E.FH0AR& 2G*
M4P" ,XON6^XSR.QRV5^_<K2G/Y1S^^K_ %&KCL8QEE4E,8QBE,8QBE,8QBE,
M8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,
M8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,
M8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,8QBE,
-8QBE,8QBE,8QBE?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>g341538.jpg
<DESCRIPTION>G341538.JPG
<TEXT>
begin 644 g341538.jpg
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M?_TSQ\WZ]_XR1_\ VT/_ .F>/F_7O_&2/_[:'_\ 3/'S?KW_ (R1_P#VT/\
M^F>/F_7O_&2/_P"VA_\ TSSOCO0-X4V4QCNXI?8_ IO.C!^[CVD?EQ!KY4SM
MJ[8J,HF(4V?):>ZJD8\U40E6>%$V"R3]#&-MFL#/0Y/#QQ /R+66AI9JD]CI
M%DKA9LZ;+8]]%$]\>V<9QG&VBB>^NBJ*NBB*R::R:B>OK>/'CQYKSZ'YXF1:
M9<W72C;*$DAE=Z8AS)#.[>3;[Y^ED).,CTO;"^J^,;*S4*EKC9QMC,K%83D4
MU4G.(@!_#V!#ZR,=MAN];X3TE8K=3&[B.<;X_P!'.-ONRX8N,XVV9O-=<:JZ
MXRFIA-PFHGC.O'CQX\>/'CQX\>/'CQX\>/'CQYQG&,XSC.,9QG&<9QG&,XSC
M.,XVQG7.,XVUVQG.-M<XSKMKG.NV,XSG'E>Y.,+*++,6Q4^?@CM/N*A7/TNT
M:M&[*X5<HK-DL_&K!J[^ZNNR6,NQUWG5ZRV^J_'IILHJ^T F]@G:6B=4'+=R
MAM&$XQ)ZMW+F*<N6^=743+-=L;(N6CE'93+9SA/9E*,MOI4O;.%D4:!7%3I'
MS61KV)7;=Q*U3*N$]"" V445R.955]DVKI3.%-]8S&^_P0,]OC=6-5WUBI79
M5!5%9WG8R31!;#MIN$<X<,W&,Z[:[8QHX:.=,8RLR>H^^<H.V^=L843SG.NV
MN=5D=E$5$U-O?\>/'CQX\>/'CQX\>/'CQX\>/,%/P"&L"'VCI'75!ZAJIO%2
MNB>JB\>NIK[;8SKGV^L,7'MC5ZRVS\"VGLHGG1QHFICV^>.AYD$F6U)W8YRA
M]!E!B'&+Y?*C?+=3.$8^+E)!;.,.(QQC&J,)-K;8V;;8UB9;;39-%9+.NE>:
MGD\\WMRH]-HRQ8S;YA*Q3#X$<%6$=/;=XSTS[(ZDFJ.,I+)*X^K$3;W9O,9>
M_1*K0A65FLSMFHS>)ZQA7&:[:3$/OKNCG?*._P!"L^8HK>RVJ&JV,IO&:F/K
M,6Y]V[C&4\I*[RIX\>/'CQX\>/'CQX\>/'CQX\>="4BX^:CW<5*M$7T>^1V0
M=-5]?B363V^_'WX]MM%--L84163VU505UT52WUWUQG$2 !^4<J%&&+[:0)*5
M))#.54L8RN]'GJ^<?&[::?Z.B<HGIK\3MIK]$T)6J7TZ&$9='./-JD#/0Y/#
MQQ /R+66AI9JD]CI%DKA9LZ;+8]]%$]\>V<9QG&VBB>^NBJ*NBB*R::R:B>O
MK>/'CQYKSZ'YXF1:9<W72C;*$DAE=Z8AS)#.[>3;[Y^ED).,CTO;"^J^,;*S
M4*EKC9QMC,K%83D4U4G.(@!_#V!#ZR,=MAN];X3TE8K=3&[B.<;X_P!'.-ON
MRX8N,XVV9O-=<:JZXRFIA-PFHGC.O'CQX\>/'CQX\>/'CQX\>/'CQYQG&,XS
MC.,9QG&<9QG&,XSC.,XVQG7.,XVUVQG.-M<XSKMKG.NV,XSG'E>Y.,+*++,6
MQ4^?@CM/N*A7/TNT:M&[*X5<HK-DL_&K!J[^ZNNR6,NQUWG5ZRV^J_'IILHJ
M^T F]@G:6B=4'+=RAM&$XQ)ZMW+F*<N6^=743+-=L;(N6CE'93+9SA/9E*,M
MOI4O;.%D4:!7%3I'S61KV)7;=Q*U3*N$]"" V445R.955]DVKI3.%-]8S&^_
MP0,]OC=6-5WUBI795!5%9WG8R31!;#MIN$<X<,W&,Z[:[8QHX:.=,8RLR>H^
M^<H.V^=L843SG.NVN=5D=E$5$U-O?\>/'CQX\>/'CQX\>/'CQX\>/,%/P"&L
M"'VCI'75!ZAJIO%2NB>JB\>NIK[;8SKGV^L,7'MC5ZRVS\"VGLHGG1QHFICV
M^>.AYD$F6U)W8YRA]!E!B'&+Y?*C?+=3.$8^+E)!;.,.(QQC&J,)-K;8V;;8
MUB9;;39-%9+.NE>:GD\\WMRH]-HRQ8S;YA*Q3#X$<%6$=/;=XSTS[(ZDFJ.,
MI+)*X^K$3;W9O,9>_1*K0A65FLSMFHS>)ZQA7&:[:3$/OKNCG?*._P!"L^8H
MK>RVJ&JV,IO&:F/K,6Y]V[C&4\I*[RIX\>/'CQX\>/'CQX\>/'CQX\>="4BX
M^:CW<5*M$7T>^1V0=-5]?B363V^_'WX]MM%--L84163VU505UT52WUWUQG$2
M !^4<J%&&+[:0)*5))#.54L8RN]'GJ^<?&[::?Z.B<HGIK\3MIK]$T)6J7TZ
M&$9='./-JD#/0Y/#QQ /R+66AI9JD]CI%DKA9LZ;+8]]%$]\>V<9QG&VBB>^
MNBJ*NBB*R::R:B>OK>/'CQYKSZ'YXF1:9<W72C;*$DAE=Z8AS)#.[>3;[Y^E
MD).,CTO;"^J^,;*S4*EKC9QMC,K%83D4U4G.(@!_#V!#ZR,=MAN];X3TE8K=
M3&[B.<;X_P!'.-ONRX8N,XVV9O-=<:JZXRFIA-PFHGC.O'CQX\>/'CQX\>/'
MCQX\>/'CQYQG&,XSC.,9QG&<9QG&,XSC.,XVQG7.,XVUVQG.-M<XSKMKG.NV
M,XSG'E>Y.,+*++,6Q4^?@CM/N*A7/TNT:M&[*X5<HK-DL_&K!J[^ZNNR6,NQ
MUWG5ZRV^J_'IILHJ^T F]@G:6B=4'+=RAM&$XQ)ZMW+F*<N6^=743+-=L;(N
M6CE'93+9SA/9E*,MOI4O;.%D4:!7%3I'S61KV)7;=Q*U3*N$]"" V445R.95
M5]DVKI3.%-]8S&^_P0,]OC=6-5WUBI795!5%9WG8R31!;#MIN$<X<,W&,Z[:
M[8QHX:.=,8RLR>H^^<H.V^=L843SG.NVN=5D=E$5$U-O?\>/'CQX\>/'CQX\
M>/'CQX\>/,%/P"&L"'VCI'75!ZAJIO%2NB>JB\>NIK[;8SKGV^L,7'MC5ZRV
MS\"VGLHGG1QHFICV^>.AYD$F6U)W8YRA]!E!B'&+Y?*C?+=3.$8^+E)!;.,.
M(QQC&J,)-K;8V;;8UB9;;39-%9+.NE>:GD\\WMRH]-HRQ8S;YA*Q3#X$<%6$
M=/;=XSTS[(ZDFJ.,I+)*X^K$3;W9O,9>_1*K0A65FLSMFHS>)ZQA7&:[:3$/
MOKNCG?*._P!"L^8HK>RVJ&JV,IO&:F/K,6Y]V[C&4\I*[RIX\_6FFRF^B>F/
MBW4WT3TUQ[8SMNIMC337&<YQC&=MML8QG.<8]\_?G&/O\UWC?JP^G8670TYZ
MA>IPG-OO[%E:C8B<L-V<-MGMG0LL[@7P,T,"4#B -<CS-L7$0Q8Z%.?FLC]7
M:1:CQ9ZRU<7X*9R*"!8B-RYW@>$1$>FRPF(9-N\3C80;&XIY.STT^42;+*X9
M14/'OI)WLBBLKAJU6W225VU^',/ /3-)6F<#%>5V9+&!$:4(*=.B*\.*&FPL
M2T><3>@^(FL,;.QUJ)O=YZ042W9"^DM@PTC%D9EW -HM9-UM/^&;S93*.K)Y
MLMC3"F4=6CC97"><_#A7*6$L[X2SM_HX4SK\'Q?Z/Q?%]WD=F%H5_7Y76 *:
ME4<,F%TDTP&U0.RB,EI)'A3 #;DPFH.!T08.$<OHT79N9QS\P78-\,$=MDUU
M%=DT=ZH](>IAPSR&?-ZPZ/O^)JTZ=P$$4-8*2!+<G]5X,G<2+2 =I3(97I*/
M;KRCF*D$6T7B7^;Y4;9PI'I_3-_IK,T?=%:=(U:.7721(J=U<6YE\#Q<@.%@
M\VD-H&8?0$OKM&&$".S[#9E+QCUGOK)Q++97Z'#EOA9FLW<*]B[;;!N=JM,;
MGMU]-#==@4<WE2>7CP\O+Y%FR=RL;"(;LA<.@YTIFE=I*68([MH:'?N$$5MW
MKA-)BV=.4902:NUDT5DVCO*#C1)1%?+5?1#=-;&-DU/IMT]4]4\XS[[;[;8T
M3QC;Z3.OP;_#%U16X"7O!$9+5LA,$<,)V&=U7/.7(B6C:K(WK2<W'#&,T8D\
M)#R#QC'3":C5G/M&JT!.::;.H.2D&FN5L2CJU=;[[IZ-'>ZB?M](GHV7W42]
M\9SC"B>J>=T\[8QG.N-\:YVQC.<>^,9\_&45\*_5\H+X<?%\'U?**N'&-_;W
M^#*&=/I<;^WW_#\'Q>WW^WM]_GTPS>[;Y2U9/=E==,*;):M'.RFJ>VWP:J93
MPEG?">V_^AA3.N-,[_Z&-OB^[PFS>*K8;IM'2CC.4\?0:MULJZY5VUU3SNG\
M'Q)Z[[;:XUWWQKIGXM<XV]LXSY$5*7?5/1E;PEO4F9Q]@UL1OB6-A"N+9S,>
MRD'P<32X:3-TFL_&0\JGM$DT%+Q"^SB/13679*+--W#3=!PK*OCQYT)2+CYJ
M/=Q4JT1?1[Y'9!TU7U^)-9/;[\??CVVT4TVQA1%9/;55!7715+?7?7&<1( '
MY1RH488OMI DI4DD,Y52QC*[T>>KYQ\;MII_HZ)RB>FOQ.VFOT30E:I?3H81
MET<X\VJ0,]#D\/'$ _(M9:&EFJ3V.D62N%FSILMCWT43WQ[9QG&<;:*)[ZZ*
MHJZ*(K)IK)J)Z^MX\>/'FO#HOGR5$)5[>-,I:,GK/5S(FPFWTUU9/F?MEQ)R
M[%IKG1/=)337=Q.Q&OP85^':6C/HI!)9-SBH >Q%@0VLG'?[.[;_ $24M%[[
M_&M'.E-,[ZXQO[8PX:.-==U&3K7&,+):[:J:Z+I*Z:YSX\>/'G89I:N'K%NI
M[X3<OF;93X<^VV$W#I)%3.N?;/MM\&^?AS[9QC;VS[9_#S^1T;]<SL-_RYV\
M1R8M2VW2-?7L!B/)<>@#R: B35:26M?8$53AI X*-W)!)!$=S-:4A(O&3YDF
MCK\N?.FJJ&NR6M[L>N4 5%4?)A+T-2UP2$G<O//(MJ6?:H-%5P(59!$O3\'"
MKM65;"UA6+!']PMQR1D%7QI'4]#FNM>1NR3*?D<R"#E)+L=,^L<^A*HZ5,*"
MIRPA1CROUP <MV-?M["X<CS](&#;I,0J"VQ(1=1I^K/RDJQ"IUZ<,2.1CX:+
M&XK5NI-IHS&VD7F53;UL.=(04K4P"*>OVR&5^F%W,>;X]M^R&O5KMJF@G&[0
MZZ$@)>T+-%X88J1W)ZY@0#<[<#Q[9,PDKH.@^K/9!VM6<V]:8P,;)D_V#5K(
MMN7R3TE+M[Y$+YEAH)*#86):\=344H52M</K=@&T^&5Z90S^G"VJG";$K([9
M::R\21XJ7=<KQ+)!ZW=55(*.MS:C>G[81IBB.,+@ZAO"MZ\K2(K&NQCKFO0P
MC$CZ7A'EI[3L=J_EBA--V!04=*N8Q7$FVB9:4B8)25<2IT-ZR%+<\G%YP3[G
MWJ6SJWYL/JUI^Z;^K$0!'E3!-RVMM#;B];O'!6?"I$Y>)-9Z,S-D#2(4A8F4
M>,8%7Z1_*16[W;ZJGE)55+;.,[)*J);9Q[^V=DM]D]LX]\8S[9SKG./?&,^W
MM[XQG[O/QX\>/'CQX\XSC&<9QG&,XSC.,XSC&<9QG&<;8SKG&<;:[8SG&VN<
M9UVUSG7;&<9SCRO,K'%5$%6+:JK?"48G[8*Q??*F8Q6-46UW<(KM],^ZD&LK
MMC?39/'UL>>[:.V.WU;.R>FRVK[-#+U!LS42DDY:.TU8<F&Y1-!RO%O56VN7
MT+*MMM=D'3=9NOC=%?&FS228+)KIXUQNHBEK]N2H"#F@D5L.ODU9*JIEV@A.
M#ZJ^VVP^JY6^%NQ644SOOEALKO\ 1#TUG"CA@MOK$R>5D5457=.?4D[%,N8>
M";(ZEHO[+R1@+%-'PD2W-85:<A4$K!O6N:V*&DO"MY**5WDF4$5R?U3X)!/1
MI)ZLWW^U(::I+1V]]7ZF&/13NCU^?^GTQ"&[K0].\DZ)4&0#:DH+I.8>Z-1$
M6W?,SY\;R,>48WT5S*-Q%NJ/-%V3R78?22#1FI5 &]5?HF2Z+Y%IV'K-6X@7
MH3M'U!:#-K 5"Z^J^7'1[F!R^UB!H'A&]T2"+A[440V0/+#-R=LY=6K7SA&.
M$89E9?UN";_H<]<D-J7C;FN^;GK^[+W5M*G#:Y32V0BO:>Y["H\8&[I+:Q0;
M,1RPKFT'I^Q\_)4]D::J@M/S96$8HELHC'(SR2+?8'QOUP7])]=]YU'(:C^U
M24#.\6J4J^C8!Q"E4@)=*<ZQ]QS3DS=KR+W61D?KTDVS%)ILH_:&9[;1R^KY
M1/+G-+:/]84B6J:AT[,H"V;_ .BND;;[W$:LKWED/#&K=\,\;66[A7>9[[>6
M% M8!;0&6CY.1(/K,FT<N8^466:MG3B.8/)-3];&@B,,I NJ&A>I+W<6WS*6
M=@E0?5P:&/2^B.?P<PFZ\)3.T&$T;Q3%\X:G0P303&"!I CD)EM /YF,RL@K
M',WV3P/K'\YS=)W+>&U=W2P@J+XWY_[8,X7,<#/)E[6_1BKQ -%AA3[9,F,F
M<PZK/;[2(2F\"/I)K([1DW(9^EU2P\F]5@;I,GZSE+'A+;MX<!>P^6>6:@K&
MHZA"&E@1Q1TG0;:RQ0:9/W=GI9M;YW-Z.$5IV3T%IR*EWK8=B!N6B=$97,I1
M/JPU"H\E0LNI2_J^O2!ZUY_XQFN>")A6TA:#*U^C0?-C!4TEL.6!)C+NN(L1
M9D$P2E?SALNU9BLZXCX>0239;.\[[Y]1D"X!8#<@:4];]ILIT7/3>0F0-Q6X
MB%BHK7>C':7WF+ N S!!)^9S.7Z?V-JP<?S%BEB#=XZBX'=)-MJ\K7:/K@T'
M7K.9GQ[G;K.VP8.YRYTZTLBPP ,KI$6K2A.EHMG*!A46:DMDQ,ZG.1.LBR9S
M8A'PSQZX=[2"L2_=14+*R;:.._\ UDI6E0GI%ARS2EGG)%SR><[UN8]%D-?1
M$US$'6+<9A7SUU61.FH909QN0*U>3R&S8B;POV:@3IX.C\FX^M2<8H_L%ZO'
M:MF<2#'+DA6]C534,?=/4*M-']HW%4IE=HT!A.M=EI5]H4@$ EH@MF'Z$K!L
M$-T8;=R\6;N%--&V-?C4UI=S?ZWCU"O[;FKQV$^H4VO6(MS%RK9G+0&XY^@^
MFB&7JI"RK 8N!'IHZ&F=4H4=\:$<:FAJ1PT(]WFHQI&M))=/:2<71 O6:Y.-
MH$ *'T/:0./'E&=8W1F<+(L.^4C$MQ-NY6Z'I6;=PQG);/K7%X-ND6PJ(ZA+
MAQ,*2</*LRALI(Z,TH28>LM7HG+])V59K.T&M>CH#Z=<O37/#RJJ\$;@9&W<
M-?%1D'!LA8"]M/!DFGS)C&-B&<R7. @;J"*C'[/YJ2*;+[>9)'>NKS$K$MI"
M>K&XQ)ZV;]=Q)A"RCRLYEP%V?Q]6$5<115*\X(%Y"(%DS9U?S<7,U*4AI%+B
ML_NL[9/7+%:,?92MAQUZBM5=M$ZH[500?1:,9SC2W0I3-DZHWHQ$5KQFBZ''
M*@FVD;(NI'6RH; ,32!%A%',$V:1VVB#M1PIJGC8'X\>8*?@$-8$/M'2.NJ#
MU#53>*E=$]5%X]=37VVQG7/M]88N/;&KUEMGX%M/91/.CC1-3'O<X]"38<0,
MZ)N-??ZRFNTB@LI75V<XWPZSJE$0LD[V]U'+%]C9-(>EU?\ 7)YV3BI/&,ZM
MUT\WZ5YJ>3SS>VZDTVC+%C-_K\K%1_P(X*L(:>V[QGIGV1P2:HXRDJDKCZL1
M-O=F\QEYE)5:$*RLUD=LU&;Q/2,*XO7;28A]]=T<[Y0W^A6>L45O9;5#5;&4
MWC-3'UF+<^[=QC*>4E=Y4\[#3;71XRWWSC731ZTWWVVS[:ZZ:.4MM]MLY^[&
MNNN,[9SG\,8SGS^;'C7TU.B+/B)[3I6\K0K_ )U"/5'Z%ZM%^,G=# @@\-R,
M.O&2,JFL-[><XMO8BE?F[]9H0)1K*&3AY>';Y3CI31H[UD6^J6O^0^L[QN8T
M(S7E'IP:VO*B/4Z#NG@HUKKI-O$/[?D@0V)^7ABQ.@+%MV<%>C9AY8L(#$("
M5U[7M353 RV!(>CE"Z76>)1,EN>8.]HSF6*#N;:,ZOJ.+AO1BY9K0Q OLK8@
M+.R]XB_;",_V()"(Y)%$,Z5MJP0),Q+F<?!SPR5'-;R^K0<=PD:0QL9I(]4<
M<7P7UG4=>"('V)$<EF_JY<VD$I6,I5]\<JJ5_P Y(TS9HWTC-CHP6](79T=7
MU&$Y&\%42R6.S^#CUBE1^_#,;-'NSYI[0#P2;AMC<52MC<FWX<UGS%ZR7:XX
M%,LCEGV#.5MQ/-LX64YCFF*+DCQ-J49'VM\)E&FSUV\9-OE\O+R<F]:[NV$G
MO!]6"M[.M6@:1'*T$BT^FX+OWB*PIR)#HV2G74>(A%RIRQD9NV<8DKNW@1J.
MS\UFYO='1I&,,9>NED&^FRFM6^Q^<K;M/U-[6O/:KKZM,"I+TS')YSC%!EG6
M'6(&6=O"ER60]!X..)!^78C;NVXX9EV[T5Q/M9=*!WDH\B5B)!9E%X;Z#ZUY
MA[NB:([IS3-%]>!>+L].FEMX4;C*7ZBJ-[+=:P/5U1RMC0L-I;MM6>?6+:HX
M"+&3>:MI-Q7J1_#H&#X/ (X-2WD)K9=:O%M[S=]]!=0,:VZ8<76%^M3RI)T"
M21)-<Z$1&\@R36NT[N*0H&CYU,'D*M?Z?,F5B%V@\^8ZL(?Y9(R+6.C'K3/W
M&>..@;RLKCBL>BJRZ.D>?I#U*?6"GN@F#LAN #BMN?S&*9/N=UC<E&9\=GF-
M3FLW&H-@#3,LU@B)GNXCHG96-D'2;JDD=45]C%7\& G9E,]AW0*5GR%WBR#Z
M K2VI8&Z IF]1[I:P\T-TC8@Z]M*NC6*J<*I+0/A1Z[B)>6K^O6C=AF7^LM=
M/L[,;$XEW<YO_P#C?<T(AP/;-WFIY4%,19RQ"I>TI(^6K^4N&9W/3"5CZOFH
MFW[,'8D?9H;%M>!1'$$1T,NUXC2881&'RNM1.:.)^AR2"J&@SZJ.KHKF5SZR
M^A7)P"PAT-S7%MN+#'F!]I,3&HVYML_L&I*3)B[.T;-P,I;TM)Q4K*;P97,,
MC*1>LT^_&\T7/7X;Q^%=)\X]Z6SQ-2_6?J2CNU&4@M<TK:@ZH[+8E7@T^7C8
M N&;*DZUB&J$_P#LM.E"I(<%IEW@A>R&L6_7TE]U/HBU-:-'>F;S]65S@AS6
MMDP,_?CPA#++9.F!U%:$G0EG$L,L2HNTTEEY&5A):.EE9+X,(S&'N)5MG9N\
M2VSM=\>/'G0E(N/FH]W%2K1%]'OD=D'35?7XDUD]OOQ]^/;;133;&%$5D]M5
M4%==%4M]=]<9Q$@ ?E'*A1AB^VD"2E220SE5+&,KO1YZOG'QNVFG^CHG*)Z:
M_$[::_1-"5JE].AA&71SCS:I SL.3P\<0#\BUEH:7:I/8Z19*85;.FRV/?11
M/?'MG&<9]]%$]]=%45==T5DTUD]T]?6\>//BY<MV;==V[71;-6J*KARY<*Z(
MH-T$=-E5EUUE=M4TD4D]=E%55-M4T]-=M]]M==<YQJVNJZR'H@@<5?5[E9A6
MK!;3),3_  JI:$6B:OW+*^WT:N('"B><Q45[Z."!QIJ\>:I1Z2:>F6"HK#!T
M.WA81O\ 1-TO]-==3X=G;]UMC&%7KY;&,?2N%<ZX^['LD@GC1!#71+37'F1^
M/'CQY]6ZVS=PW<Z8QMNV<-W.FNWO\.V[=;1;37;V]L_#MMIC&WMG&?;.?;.,
M_?YI,:^A=S WF:^GE+'N%U)5V(=A"#%538120F4NP'=P/I.8FV:,5JV<2]//
M+Q/G-6*ZI_0Z+2&BDZD[_P!?HM&19_\ CZT.3HN81#I"[840EZAY.JHDB,UY
MSZ4$\KGC8<$QBJ)>%LXO )@YKL>E6@?&RUA5G7+\9&S$EV^:R,ALS;-HC2WI
M+Z55(EG/M^\Y39P?OPSHKMR9[G-GKR-"W[YL?3]IB]KR@!'QKV'6@W=<NI86
M;PRC:89OI=:#?ODG+MPOMIOB"RST0Z;6<1C^I+TLBF78);M^651L3I5U#6_7
MM&BO3:C!_<-)"586X&$ ?,U>](HQJ6@:$\TVFZR)5)*1&7V5)9UG612_T@ZE
M*=!;1O?-_0V8G@RW?3U,W"F:T(Y"U*>N9X1D),2%[^9"_I(L\:'1%]MHUX'I
MP,7AY"0@\HQT&=)6/ENH3>C?0Q15O5=4O+2MU"&ZUY]XNYU-I)NB$_-!D6XA
M%X,5KR=%/I8/=IDA,&4"V<&N)=%Y&Z.5U\0+9@CA/377%WSZ:'7-YWWTL T<
M"V^&T[U5=O,-LDAA ])TVGR/-2]9O!E8YM:^J;*X)GT.PM:+C!3$?%UY5"Q%
M7Q?/[C!NK+:.H!G")_U-N%-57#E73WQHJX<*Z8V]L;8T56WWUQMC&=L8V^';
M'Q8QMMC&WOC&VV/OS\?'CQX\>/'GP<N6[-NN[=KHM6K5%1PY<N%-4D&Z"6N=
MU5EE=\XU333UQG.VV<_\L>^V<8S D1$%_4A?L(B.[F$K*$<H*DQ.JAMC5;3&
MWQI;[I;_  ZN7[K77;:"@MMOA3U_WM+_  )::::[-HB(KVB*\RU;;,A<,%F2
MCM\^=J>^ZN^?A^LR,BY^'ZQ)2\DO\.-ML:*.GKI1)HT1QCZNWTUJ'!T6]6EF
M4T\R S30T_S]39^_T3J6=)^^OUMYC7XDG$^Y1WS]&CG*S(89*YUQ]-(K**.<
M&ZWY KOK[F8IY8+9DB! ,IE*WE5Y0%2A\ST>K6=CBMF1*+/$\S?QRNDE,B;-
MG+K/&RSE5B[>JHJ:/=DEM*^27I<4Y)NREXM8=F)J%GJB"_JL/<)I"7PM;G%%
MXI=E6S3.T3G;]EKG>(0P[46SN7>RBV49?3/P9U\&!]**KA(HH4V$KJN,<*N?
M>L^J>L1B5:Q]</TYV5[$RU:7'61%'S(Q(M/L2['VZXS"RT9JS+XJ.DY!\VDT
MYO$=)1U29;_\>>@7(8#U[!](WA "PURQ.\C$6SJN^>3<F):UE;,.K6;OADH.
MZ\GGU-$WVD/)"/)Y>LDHQ^9#+)M#N9"&4>2;]SM%Y?XS!N6+0O6V!,O+RDAO
MYES&S*V9,W@&T3%?NM4M%4@(+0",(R:N$]B4?B49DF2?+N4DII55.'PTC\:(
M8@FF?2SINDS;F0Y@+%LR9D>6B+MXD#64TB)ZL"-UW9(ZR-C-RCZE%).-6X:I
MIJF$9B56:BFF,YG\O<^V,5?E/1*&:WJ.O1[F+J3HVHC^J.0KEY#?D@WI5:DQ
MT)31\8G=OQ-;'BY(-NH $?-K),7S",L<,8L)V$'I-WJCNU?::3*,6U[Z'\H?
M\QU@&VCTA?'.!387 W/G(_8U05%K3)<-'^]&8=2 BEJ;3T&6.(?0<DW>K>7U
M!9/:-,6;35M\Y:,7\LG(7I(_2KIHF+2<P>V1:"+\I[1Y*[>=M6R0EAJVL/CZ
MO4:Y!1!OLM%*+;!A5%H_7RY13;$[H_WSI"O63?'P;1GMPN:'OK0O.Z2BNFH)
M3U0\_C@J%36MC#Q#O?\ ?>L(5AT%9ZU;PR2<J ;TU5UD'%>-GYGLYDIURG$2
M(\HC&N7"3>3>WO2Z .V[9#K=GKEL&KYH?HNR.<)R/&P.F;&93-76?(K2I$J(
MYN0,-$*BLS+E=5BA;0/'X,T!_?:&C743MMO(;X:AZ/%'I5!>E.;VK;"T+??$
M_,O#)+,99!2,M"5WRU'Z1@48P**<7EA]M)]JDC@F2?I+PF-]-MXQJVRI[:8I
M>_HQ MW3UU-6O6'2%6TOT45TW9]U<_@T;5#P'.;EI%B'Q8S8KB>*!65*XI&8
M;!,-(%8;#NV</-$K9C/+O=M(6$BV&Q"^^:Q;H$^Y@L,D(R8?EN5>@D>BPQJ.
M?+<-"(J1$",-T@R51^W6=)0.6)(Z=Y4B%&LE];;M]<.,([*:YHY>'I!U'<AS
M<%K-;=/@:TK*Z6#>K1DJ2 *=L.'K2S1:I%J7EHU&O[+%2$+LH$/!!71P7#-@
MQKS=<@:,Y5O(XTT=,W?4MKT:: O/E^D>9[1M"XB'%,VP36YM;33(2.'IK(V*
MSF(FV0B0BQP>BPT4JRQAZ72%'@()0S..@1>$@XF/4=8:.%GF3]">DC0O0Q?T
MR>S1N?B95T3-\@&$4Z@(BOY6(I4WXEAR&#IR?!1HJ')>#)8UW&$TI&&8@=M)
M6!FH9PI%-,1B>^%TL/(?1KIBPZ0KVH[=N.T[#FPCJ6+ZM?60S&*JK-><)6<'
ML)2M90]:UJ+#U;US39*(?1C\R&AT2EMMK]:D$G_TKS9LA:?C+@NH.'WO2;^J
MY4IF7/3=]$5[%6Q5\FS]E5)A1^I#5J'_ "ABRV1KT*WF9[889R.74BAM.2&5
MW._QZX\N[X\>1-9MFH!:",3$HXEC*6PFC$Q*26[K9#9UOA%L[=MD<;*K;+*[
M83CHY/&7$FXSKKKKAOC??:P'-/-*XBXUM*T=<RUF2V=WK-H]WT=:BFKO3.-U
M%-L9V15(UDMOHG"Z/^SQ"&<QL;[>SAPM,E[7L,TB,Y?R&4Y(EDDUTQD937PF
MXDG">OMNZ=;X^+9E#,MMM=G[_;7/XZM6NJSQ9)+S7E7P80$A6^N.PML)DTZ]
M7F&,:V;ZQFB"CU'Z+#]XT;XT^BTRTVU18QRVRBNR.,/9;=R[5^^P7CQ[8Q^&
M/;^W_'\_./;&?;WQC/MK\&/?[_;3[_\ 1Q[_ (:_?G_1Q[8^_/W??X^'7_\
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M765VU32123UV4554VU33TUVWWVUUUSG&K6ZKJ(.B"!S5]7N56%:L%=<DY/\
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M9_=Z(OY?/_Y?'S[HS^[T1?R^?_R^/GW1G]WHB_E\_P#Y?'S[HS^[T1?R^?\
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M9_=Z(OY?/_Y?'S[HS^[T1?R^?_R^/GW1G]WHB_E\_P#Y?'S[HS^[T1?R^?\
M\OCY]T9_=Z(OY?/_ .7Q\^Z,_N]$7\OG_P#+X^?=&?W>B+^7S_\ E\?/NC/[
MO1%_+Y__ "^/GW1G]WHB_E\__E\?/NC/[O1%_+Y__+X^?=&?W>B+^7S_ /E\
M?/NC/[O1%_+Y_P#R^/GW1G]WHB_E\_\ Y?'S[HS^[T1?R^?_ ,OCY]T9_=Z(
MOY?/_P"7Q\^Z,_N]$7\OG_\ +X^?=&?W>B+^7S_^7Q\^Z,_N]$7\OG_\OCY]
MT9_=Z(OY?/\ ^7Q\^Z,_N]$7\OG_ /+X^?=&?W>B+^7S_P#E\^2\YTCN@MJA
M0!"W6V24U27S$3CG""F=<XT6^K[XUT7^CV]M\([[8T5SC&FV?ASG&;+<T\TK
MB*^MHVEK\VLN5SL]:-'FVCK44U=:9QLHIMC.Z*Q&LCM]$X<(^[>';Y^6QN<>
MSAPM,-\7T*T<-_7I)5N_)Y--9,8&-72:+F3<)X^'9VZV]\[LX5EOMKE^_P Z
M9^_.K5KJL\622\U'1-I#Q,<25D6_*R)$1JN4]XU@T8MW$.QT1SG=KA-%9^FD
MDSC?BRG%12:>R**F-W[Q1V\5VWVFS]Y.MOSG\YS]^<YCF><YSG[\YSG,I[YS
MG/WYSG\<^/WDJV_.?_ES/_RGC]Y*MOSG_P"7,_\ RGC]Y*MOSG_Y<S_\IX_>
M2K;\Y_\ ES/_ ,IX_>2K;\Y_^7,__*>/WDJV_.?_ )<S_P#*>/WDJV_.?_ES
M/_RGC]Y*MOSG_P"7,_\ RGC]Y*MOSG_Y<S_\IX_>2K;\Y_\ ES/_ ,IX_>2K
M;\Y_^7,__*>/WDJV_.?_ )<S_P#*>/WDJV_.?_ES/_RGC]Y*MOSG_P"7,_\
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M*7SU:23>R@:0GI_:)##BM8TPKXO-%1T3V,H5N2H$#.4 _P!0'CX^OC?F<0O
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MLJK<R<J$24H-D$2RF4XQ\.+0&_\ 2PZ=CQ=<T&@ZHVMU&5K7><SCN#]0[U#
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MN,G[,N"0&..NJ6/<ZET=(SOI]^I#UC8-8+P=&*,N-KK@:AJ=&5#AL)&PEH7
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M9K^H-!AM]J'#%H\#SIB3#MJXDG^C,4T%9::0=R4-NP=NH'D/5ZA[, >RI4,
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MQ.;%#QL/"P_!HR!4JGIHY*7Z,3&LT79(\RGA1W.K)[2:ZF<YW<YQ[8QWOV>
M7VV_:3]BA+]H?R7[-?;O[-PGVS^SOTWUCY!]JOJ/S[Y)]8_U_P I^8?+_IO]
M9]6^/[_.A%U/5\)*D\Y#5R"1,T;/7,D92\8'CC"4+)!ZT4CWC\FD6D8B\GWK
MIBLJR<NY9=XX7:*J-EE-T5-]-NA'4G3D0$/ZSBJHK6,KF59[Q\F!1X$)L@J1
M8*N7#U5B_%&L.E /&:CQVZ=*-7,>JANY<N'&R>5EE-]O8CZTKJ)V"]XL##([
M:MV+^+KW9@*P#/8%C95DE&2<>&[-H]+(LQD(Y!%@^9P.8]L\9))-7*2J">B>
MO$O65<S[DI>3H"%S+LX@&0H9NI44@)%P6B\=L^VCQLG7>1RZI! ,=I.2V9PT
MQN]C6NT@]V0:IY=KY4\8MI\)*:=*Z,;1J(@ %->$E9?+ IE%#Z0^,$PY(##E
M 98H1^\-$[L(Z16S%HZ1:C!JNFCG9DJCKLCOB5:<PTA5E4IT[ UT'/0YX)C0
MD8H3 >(N%K+;# Q&B3:4LM)K LXTTFI")BFVDJ]F8]QJYWRIIHBBVSHWTS%&
ME:>;)M$6]55N@DP<A;UBFD""B2;-W6Z.[>O7371.(UU;N 1!51$-71QHJ+)*
M;I0.\?IMMKGT9BK:T(9(-F9^O@B;EZ[<?6P"4EQ(>DY$'=_"AI]:#WSV-7="
M[G.C9MIE>"5CU?A;H:_%[(I8TRG$+$:_1?#%QVOT,FO-(^S!ICZ*7<Y<9<2B
M?LCCZ.17R[=96?Z>SM7+E?Z1;;Z93XL:3K.N4128 T0(+2"2%6=7GP](5@$Q
M:;6*'KF2)59@=TCM8:34(9%X[?SF[YDOM+O73EU(9<N%U5-_7%!$5 QZ,$@@
M:'P\6A4=V\.-"T+&#T!%-U%E7*B$;"P[5E&,$=W"RR^Z31JBGLLJJKMKE13?
M;;(?'CQX\>/'CQYJJ]0RB+^*+,YUO[EX9L%:T*TAKAK,C+*:MJD:ULQ*MK62
M!9AX&O(;HZL;!J(PK<A+J\&Y,HF]W,+:%52<%!&%819VHX)PV3@*NO1EQ'4;
MSP)2_25I539@MR-3G*O1DS3+"J9QK;(I5V">2C-8 PMVJC WKHQ&WUB6./05
MTUFZ 3^0@"=62=H,)Z*#W0E?IWP?43IN5M,SQ^D@7=DU7VX_T3E83;+6SZA;
MU"T&1QDHN/+*?8)TVI@72FF#W=X1O</9S=(F;*.VN[*J 5Z.-6B8@?U(ZZ!O
MV;H>;H.Z.;JQJ'"5-#D73M;7C#Y&YW5H6BM4PYS;I$#BN<B523=\3]C[@< H
MZVPWF"%ZZ(5,MZT]*.O.K;"L,Z=W;;%5:W'S>UY@MB.!!NC9N5)*\A4SS([J
M,'EHU0?'E5+IKV+/9*V=8SPS%'2"45I/,\/(_21W^1;Z5H^6JFI XZ*M=A8D
MY?XEU(%': 71,FK6]W-.?(OFRTY>-$B6L9T,+0N\:]C=DC:OCN$GX6 ?/EGM
M=KB+QC#.XW-+?XO(X?TR.H.0JS*C2Y+*M'GSI45CR^RYX7AB8]L^ZQPS447=
MNX"*#  !BEB$ETBAJ"$H 4":]&VD/"P$;&1<,CGR"RCT=!ZSHY^37#U/>]JW
MNW4H)O7UQV&)\YD[FMA'G.8,2:OP#%:K4RE4MC0[DEL(M(S:9LL2)R4H*]QT
MI;3,-*A8FO%Y#$>D" 1R:>DCT9?!*Y7M[I"T9V7G(^F$98@8];T:TIF]@9UJ
M-U</0$5 2[ED@=!KH<'H:3 I;1,:B5G 2@W@4O:4])JO(^R(,O![]O4!#G*?
M.VUNUO!-ZB71N*5YB$00  YA_9<Q5[ZX*R6*@:LP0+M=G3!R"19V+CJ3!)K
MN94@?R\\1?I]4S%P%)CFD_83B.HJQNH[+%_II4>36E)KK5E=K"QV,_LU&6Z:
MD1%(7P7?8]O%)13F,V8#_P R=S&K-[K(8L3>G<*&?!=<<)E=M'D_"U/#TU&A
M5JRHS54B58<<]E@X4U&Y+ *1!GU,G4?"Z!XS!D0P55](C)G%1ZZDY&[RCU21
M3\.A?30$:6LZ+MB8O6XK6*(B\9'HQGJ6Q=.C<3I:)/RUKR49;IQ%95B$QK ,
ME:W8#KJ$#(=I&L1*<'&:L8[79/YAK(1T3^D-7VZ"Z53=(]&4:X+JNNFA[DDP
MEQ4<W)6[25VW7:M]R@9+['E6E+ 3F 0YNJS$JOL 'CH0O%H$OF8]V]FW"Z#]
MMD75/#9>3\U</<T\]%1H*17,M]<AOV=DQLX%-+%"JUYUB'40W-&V2R!?!Q,0
M-&\;!:S(V\$)2)*VKV7B5QI:+>.6FDC\\>G97=$GJ%S2-EVC:EY33?H=U:-G
M&NX.P>VF5]*/* W,28@'PL.'!J!W$A[FFK 2MH$.80(Z-AT0Y:2# @F7JLWF
MJPUZ:36/[BX2(VM?2<907IJ\CN:JKJU2JPQV=)NA#>1BQT.K"%**['6$;AHG
MSQ!QMAF>IG/M8A!X<V<SP"P.C9M./&>63_HXUF?&]G%EK]"WS9:)I4]VTL);
M3[*F$#X  K[FH66*XAW=<?5B%NW @+M8".':S:7@6G\8&P:+=7=A,$<=$D,?
MFQ%Z6<$43%M04AU7U"QYYM0@Z;.]^:("=KB# !VQNMA2PQJVR)$G95WBR"P<
MUD;8L0_#ZO/RLGK@=L4DU(E1^6;C@E%P6*&WI#!9%:9?9(KT9<=<HEUD\UW<
M^&QX-YYEE7%P<KXIM&LYV5L,JIV:MJ7!=$*.#'$A3VYTTKY*75G)&%C8A&45
MCM;25EP;455;\N;#L_8#K')6][;5SK+2L"XQ+XZ"VDMC#4PRU'&>TAB,^:+X
M',Q/R79KC1',EF4SC?.]V_'CQX\>5UN[F<&ODIJ,M+I4HCY&FI*T),91'WD6
MU9OE[8IDXH\ATFTY"(DEG"3,5/I=_$:LEV&Z$\WCW+O=ZP2<1SFJYQZ:8^^&
M:#C*6Z.O_F\OHGFMIQZG9M:;U3,E]@\ZI1 I&J"9BUL>M#(3:E#%^'1A0*V(
M(CHX4!Y(\G%HA7,/-/H7?VF/IA\ZPH">UB.2%BCP2=1G%L%B&9$,4\R+0'"*
MP/O2T,.OYF DI#=L[;@$&R,W$^YFY"90W?*,'D0[<:.4IUC>;X2N!+JU.OW,
MU,$'2YK85NSC(C>Q2C%L>EM2A]8IQ$)LC'QFC$;V8U^/*ZHRR\@Z2?/)5PXE
M-VBK=NTUH\V>CYC6B^=XKJZ_;ZLH^J3F3GZF0@5F9.G/E?.S$(,>>;KL8)"B
M ,K9BN>?:>S.>:^$9DY.I(PGUJS$F0^/S#)Q(2Y'+Y7ZDOIUR?1-57I652C!
M!/D_=/1G-Y/;-F/[('@EKRY#4L.UZ,NKDK]-&/;%LW,-06K4QV*$8->7FYLR
M-=U'DE!!>TNM&2_TSZ6M==)NPL?>6[9@#18T,52'ON>(""J0KKI.&IF<S*A3
M^KY.SJ\-3GG@R5C<-!0E-Z*)PDAFH"%&7*;M@4C$*2M.@<>EC 2$M,3].=2]
M+<YSIW']$"=M3M6OJJ<35A5STGT59?392*(2!I69,K7\R#6';]B-:FLNO\0-
MAA8^3O6ZT[-2Z$;,L/B;^DW6$T8!5@@=RVW6IP%7'>-LQY+M"4G;;Y']XB.J
MZ+LB$C$[TJFR&D5*Z-Z@#]A*STVSJU!]10G3<E<TS+I]H\]BLO2JIVO>?[-Y
M[>6?<1@/VCQY \-S!+./@9J5Q](!L_T+*A:T:XB EE%JGT-&=%$T&_*I6,D4
M"!,?&Y:3A<R^9QS,;/&C9-FU;-$L[;)M4$6Z>=\XSOG1!+1+3.^=<:XSMG73
M&=LXUQC.??.,8Q]V.QX\>/'CQX\>/'CQX\>4!]3VFB3H+C,]J$7%IHS?&%B\
MT)20Z/.WD?+O!&&ZCI<B/'#21CG\7)1V(H'AR*8<R$;(LI)BT8.'<>X2>(H;
M8U3W7QQO5E@V)!Z\BFAOZ>$!ZB]37.:\O4O7J16$G-:R7 #(+5+H7G,?5U1M
M2OQ+LE8=L*VJQ'!Y^Z)RJ(7L1\(%[X<?9<1B+^GN;7!6D)!VURP:NJM&>*?5
M%VYFIZW4V\Y*T>[M#J87+^&JUDX7Y])LH"XZZI5+1.M&2[V3(J3:-$!B'(X6
M<&M]D,-MK@R_JOJV<8TQ1!)$@9A5OI&G'5H=%5B[NU:]"JMI#J]OUA(&],?M
M"#)/I6QTI>8Y_*[]&GQBD97:.0*+.=>62\1R)SFX7TB*OL*K>;CJ/,X0S$!L
MFZ$M,QJ,#,*68\W-0FLY?0<:MXT#YY0L*R)6D*UG3"-+S4.K,HF8XB&VA,Y^
MF&!6,>Q0]';4?'CQX\>/'CQX\>/'CQX\>/'CQX\>:PO44Z4O.GY6C*OYT((>
M,LFVE+*G%(V-YPM#K"TGXY6T>*ZJK"=1A!15X9%""9(:#K"Q;3M:Y@.!$F\B
M/#HZP)"@W9NAK5 5^M_U<-T[3A4G45-25HWQRYR7UN#@K*--%&^:VBX.ZBKU
M)&^%]S/"LFZID6I1&8K9XT=;-XE2W0)B1[&>S=1>5DJR/5,ZP.*OA#OGB6J_
M5X?;=F7=3@T&\Q6_TN;&W,M'VOK5_.I>9Q\-:-9UK6%:7&TAR Y,+O,;5'7>
M$)L/$:UKB85;DY5'?=UZJ'94K4=[=.1(W2T=6]65WP5!A=4P]=G1Z<E=X]_5
M!R^31\U/D^MDC2*M=T@6WULZ8AHX/QY5<3'* NX,:\=L$B&6RL [R]00V=B7
M/B<.$@]LEW8P?0+&\+XYM(*Q<Z54;\>WST=+$S[EZ$Z'+Y>%L\!)*87A81M.
M61%!5F"D\/33=M$8WEW2<7%WJE=T*L NIPH9@)>Z:_K[J<UMT^KOE@RN8+L:
M5YU[(N?DD0;)@>O0==.Z(KTUWI64-[-,'QK8KT/4)HB!&4OJL<]FG4VPWJ.]
M8S'1]+/36'#:*YOL%WR?!ZL)FDBZYPN3FNBJDK4G)0HYZ_I>U2L;YVO0?M"R
M&@76 1;=-0E=V' I@\XG8;Y"YQN2&I:].3M3J*\+@G*^ZH=!HB2%%.OKA%*H
M0Y[L&M,QJ$(8#L%-R5%]#M+-N:A>QJ):QAH)ZJV<&EHJ:L9.7%Y^4 H\>L1A
M&"F.K]T]5YMYU9R4Q0Z'->?4G5]-1C0VX;..KHT>[S_[+V=^N[<TM!C&JSJ5
MH;:&[JD$:H1;N>?D]Y1(U:D"^)U",N/;UMWDKT4+ ZS+'H9<]U.'-[W&K)R#
M<W#X(E/BNYID*C9FU)PKLFS)M>+83J368+IZ%E!F,C*^8(0<&.0ZL#O,RDK-
M>T>O*-O7]UF["CG^ZC..Z!X,'7MK@-;$M6,757=E[]#Q$V,NZQ<6S8:PW88"
M3<]2SX=(ERU]&3X.8#*\B+?,V3V1D_3$.U.L[XZP&^>:OE*#!@YE?O?<%81S
M, 9:=D.U6<2V7Q\+1HP)Q;2RAZ#1L$]5OHM$RLHF5W,2(KLVD]'"+R1@5AV9
M[7J3=F=6<V6M ,JIV$!&DA*FG-PV79\GSW8'4S"(EF);--%(2\QBD[.@KBYR
MHG8,&YB54Z*AZDMJ'2DFY(N[0B4*VE84KQ3]^GIZ5M->TD)^B=^6)'U%E_3@
MCJ.CA66=76Y0?/=J]C^@V]T:69K"JSZ]A+)';>H$*C58..?]DB%$NQ.+:RR<
M'\_>H);=.>F^9$>4@N<?\K>D_P"FM?(;,G"A _D3&PK]JH]V)FA]++$S5>:1
M>2H+ M8###>*EUG\F^U>OIAT\;:H1N][/Z$Y_=7/:UT/@[HQW3_=?JKR%9LM
MFUGUXY"P/FWA*UK>A &!5S;I= +,)IT.MQ=O]I1Z?@A*$E2&3BH78F5AYR L
M&7]O=^42D6U(9%?)MTW>55YP5;M5'PO61X"50(H]=]G!G)1N!F8PQN,Y)2P?
M%E2A0SJ6R8H@''AG'QTU'3(^HX@E7[C'++[7]1<#3-:482U>V ?5!U+8U1V'
M>M,<B%UR&#FO8OFSG"_Z\)H?AZ!Z2B+(((_$[T#D!M@HJ\RLIT)1XX,OD EH
M_LIM*#.[WFRU$;QY]I2X$2$**\V75H*:N2*N-"=$"F'Y".1\A)OA!J;1\2:,
M1Y626=_*HTQBHTKC&F$X\C8-)EJ]0TFSQX\>/'GX55313W554T23TQ\6ZBF^
MJ>FFN/QVVWWSKKKC']N=LXQY^45T7">%4%4EDML[8PHBIHKIG.N<Z[8QNGMM
MKG.NV,XSC&?NSC.,^V<>WE:.G>J [EJ(K9Z2A5L6/.6Y9&M5U^#4P#*6"<$)
M7@&-K'=I-H/23B-$X^.#J^*9B0?K/=$FZ,?\'P;[K:8\_'/W75/=%!1N8#;@
MJ!'M5$[L*N("N@0F:BLBH"UI#Q1)\FL41,T6#F#3?C$[!%$ 0H.) 2*1F9C"
M 8(9>*=Z.L2RYMNN6EB!U3KED;BPK "#"QPT:3^LN') $ 4D&1!81,';=NK&
M;,HF0L(.0SJJ]3</<3:2\:@];-9!9IE<<2#\NS=2$5.1$FP9/'D<[>Q\FQ?-
M&LA'J;(OV+ARU<*HH/&*NFR;QHJIHX:J:[:+II[8]O.CL<!NFK/?8K&]=9"&
M=$3#;,]$_"]'V*"3I[.--OKGLYAF;9=%P[E4,J,&R"J2R[A-)33?/DHV)%.B
M^$%6,422+*?")$Y8'D=#*O:U^I,9H?A6\*L;MU5(C0GF\D*,J/P>FRB\S!QT
MS*M%-D(U7XO:2,A)> =%2)./*C++5YN\(DIN+4@FND>KNB_W<S&CO:-0T9+)
MJ(O-U76FK573=-?*>^NVN.F8F;,1!"4_1B"0R8C@O*E:<%7\,N7E9,UC(Q:4
M3C Z C=\N"2<ET4M4(*+8J95EGB[9NVWSE?3;/JZDL#\S90BDM'(3DBR7D6<
M&X?,T9I=DTRGH]<I16Z^'RJ#%55-%ZLDANBT6VPDNIIOG&,_M@1P$HXE6D;-
MQ+]U!/-(Z;;,I)B[<0\@KIHHFQE46ZZBL:\4343WT:/=$'&^F^NVJ><;8SYV
M)&7BHAH[?RLDPC6,>DHN^>/WC9FU9())?3JK.W+E5)%LBFCG"JBJZB>B:7^L
MWVUT_P!+SKH$< ZE)&#;342XFH=NU=RL0C),E9.,:/4\JLW4C'IK[/&+=VEC
M*C5=VBBDXTQ\:.^^OMGPP(H&46E6\;,Q4@X@G/U*:08R+-VM$/,HZN<-)1)N
MNHI'.LMM]''U=[J@M]!OJM\'T6<;>=)0S$4A](L4*!U,77PAE$CWG(K2!6PY
M<ZLFV4IG9WB,4PX>;:M$,Z.ML+.ML-T_B6S\'F0JK)((J.%E-$D$D]U555=L
M)IIIIZYW444WWSKKIIIKKMMOOOG&NFN,[;9QKC.<0!8W3585P_J>+=+SA:_N
MYQ83*LF]>1&37)4^K6K#"WYYC&*0[E1%T[=BH/-H0*391?YQ/_4H5#.KEWIM
MI*T";0DZR'%M]G,#+$HW'%#42)DDX,R8QT@BQWWTEQEVO\S8.XQS(-XN81W2
MWTC9;.\<NKASKC3:$@OK&KR^RG]1.FID!G\<%QI\M 68+K@SE0=GK<LRF1I9
MM\X=:9<NRDGJHBDQIBEKLXFA1Z.D++51M-MDM.I8W6P%5Y.U#200MQ8FFR^P
MPH'AX:N):5>V9,UGSNYZ4G]ZX107U4+H]T',)47@GT=K]',6=#RP$WUUE&*R
MN)4!;GKNQ2$Y$!B>^L&%8R E#V*+/6$A&389.&X)"66.0LTV?MD$L2;P,(HJ
M8408.'VC35=1HZ51>M73=&3TU4U<;;)*:*8UWW3VSIMKOC51/;.JFFV=<Y^'
M?3;&==],^VVNV,Z[8QG&<>?OQX\>/&<8S]V<8SC\L_?^&??'Z9^__KYQG77/
MO[ZXS[YQG/OC&??./PSG\\X]L>WCX=?_ .G'X>WX8_#/XX_Z9_+\/'PZY^[.
MN/;VQCV]L?AC/OC'_3&?OQ^6?P\8QC&/;&,8Q^6,>V/S_P#WYSX\>/'CQX\>
M/'CQX\>/'CQX\>/'CRNM_P#)7.'4OV'ST#4 =:>];R\A,A:I.S<JK0BTTW:M
M""/378O&*ST<)VK%@U+!.34>BI6WCX] CAI1)BTU1\D3XJY/!X>OQ\7Y]JR+
MAJI$[5 JSC]11@[;@ '=\CK)VJ#!^)##O<>"S5?1%"7%(O=M 8C&S2&91[.'
M:-F"6+'7I[<3V5$4V/&_,M1$ [0 NF"5*-NA5N@."5?I(Q".M=IC[%1I#S5=
M;:P$(HL $K*;#G#B)CG;B$5=-$5M<M'.,.5Q2H"V@X6AZV2IT]%(8&-Z^?#R
M,R.F B."D>"C@^3MIO>26G(T>#8B'%H%&2<.-H6!AXB+C-VK6*CTVW7IKBCE
M3GZ%'X&H:+ 0QF,6-)6]#N6D8O)3B-HRP5+5N^L%T33KN6)94P5KR<E 30@E
MY=_(M@UWN,-5T(71%DEBUO\ IY<3WW%CD+;?-55&D8*$%CDT&U?C^6>K:2N(
MG=FEMH.%8=U&N).#M(L?.B*QA>66?"YO,*?7R6&DE]$]M/3E>"^/)J[!KHF0
MYZK7>X!'<.7@2YO"J,/JLA745F"KR9<CT>Z:"<H05_"X0B04BEX!_.AT:QC&
M0Y(QC:*C$VG=HCAWDWF,P*CVA:) JP+#*/<0TO+#+!VALV'WD\J4/!<;9NWS
MR."Q)X1*_/'8F&,Q\;=2B+1ZO%*+L66[?[_N2<GYZ*QUEFA*XST1C?#K]J>8
M+3)#\XP/X$L%/T.5LPWVVP(XP(8._E7VS^R6/LS\^^1_[!Y+$92U2P]7O*3C
MJW"6U0R,&0C,C6>HW%J T@.EJLFL403\87;K1#V((%)J6VF8YTU6:2/S)[AT
MDIJX4QM6J"]-?A<:I<MY]@^9ZSCJG.B:!-"L;082>7DP7B6T7D.*%RQ654-4
M2$)3A(=H#S#,D;/PJ/BV$:++Q$>U2;:R]3O)W-O/S8::TO2==5LF'LSUB-J"
M@XTC7<6C:<D&S5F;I/\ &%'RSNPINO@N;-I!TX</RF:&HJ6FG3V1;_6=\9Z!
MX@Y/ZG(14KZ HL$M B#HYW!PLN1,7F'B@U(2;*9?A\[O&/H[4L"'TM'M9)Z$
M%FLX).GR>[E>%457<;*_K/$/)F>AL]6YH.M_W@\Z9VS:&('36?\ F.1K[%_:
M/"&JV(;4R^Q?_P#)>#C6*P8X#O\ ^5L3N('_ '?YA!YZ;'"-GR%?2![RQ3Q/
MM5U?C-5!,?)#&N8"*KD(46< H6X&F[E =G1T">.'$@!1I'%RZ 1).'$D*XB'
MZZKG>5HWDGFN),2X]9TN!?:HZ/YNTRF4=PNDEK)V&45HO3I47XCY)1Y$L)LL
MK)TZ#"QU&,&7VHA7+E&?TD57"RV^$5#P!QE0HX1"=2<X58$CQ675X<ST9&CN
MKA)^1U#/,"BI7&591Q(.FT?5<_&,96M!]DX;#H"[0PH)Q$1C=;53T;HX9Y*Z
M$;R"-NT2"%SF3/5K/>S.S-_!$RIZZ H*K9 GU*Q>0@R="3EJX%QL&F]FTNBA
M-BD##0<N@^81K-%&Q@:'"M>"0R! H[#"(6%P$0+"0J.QS6(@!P;@6"$7"P<+
M%LDTFD=%Q<<V;LF+)LDF@V;(II)Z8UUQCS)/'CQX\>5)[NY49]O\AW[R?(&S
MRN65ZU_( ;DWCX-$D>#:3]XP>9DD8)>5@T97.F6&$MF:DLPU535W]W&GMC&8
MK]+S@:-]-#CL"Y'B;0E;B9 Q%8Q F>30RW$9"3VL$XF355LM!M9TD1;XC%)C
M:/T7UEELO-4/K6R3?97*&G5[X8V1%EG#=O5_2MFWNPHCK"9/S\,J%$)>'380
MG^4.FJF;SL;''IL 0;]NQ,;'%&\@C@B2>HM'BKQNU=:ME-,:=NL^6NM.@9$\
MZZ><]'8(!V7U1SVY+N8GE3T'T3=3[GOGGG&\*X!K6LZA)4_=U):1%KT#<+4W
MQ4>3XLFA>N D"-6T;,GPLT#H6-(_T].AF-85!(@O/QS WV8<8>KW4-(V*4@%
M+@QKRX2WL= -@\P@Q"YK"8D!_FP1E03'0(_50V,$1)%T0M<KRKG!'%_77GU7
MX4CZ>5GV,.G,"OS3:@;2AG=?IF0I]3QYSIS7Q^*% U3'24H=W9-:4_1IT2ZD
MGV J>23 SZVI,B3_ &RC+ML(#K UB0UM.+VH+_2F&B&PR(G<\=5J^SMZN=.&
MD'(9%:_3^J<+"7.U1U_*C$4EHZ1Q&4/B0'IP<G*6:HMATB;MG:4N"2S!YE1S
M#)_Z;-^R-:1%/#] 2#"M&4-U;7* :.S8V.0T+6!SZZE%=" 0G!HQ!1&J0(^O
MR0+D)6/1T&JQT'1&(U&VFD1-)Q\!MDW77 5L![FZH:A.>M!OD]'U"J9O9W2M
M-452=K"Y-6V.!HNJYHT#^3RPA$JW/FH;U!F&,S(&=-&,M)3,&O:D*-%Y2*P^
MKVT]6<MWO'>B;U!SXU"+":69:M0]L)4W3!K$54 E@K'W"K8[VK:W9!5;3+RL
MZHC'69QJ^&*PCRZ7CZGBB!B!NY[3 YN@RQ!MZ?)2PNA?HIGS[&)7LMZT"UVZ
M7#C085L=ER2_$<ALJYBBY67S-P]7R\*L[;35<Q;UHVEW;V0F)(0>2[YV^7UR
MT_Q?TB"U_>8O7W%5D--!:KJ8GYV;-:4J"I.E"0OH[MNB+M=TMI=%87%%U7Z@
MTS/@P?;A3 W^4U8 FKB<90Z,@<OIJ[B6!C;Y1O+A[VAUFVN*]./3>(YI+>_T
M[C5KSHJ*"\.)>KP?TN=*,$C2Q*LP33^J$-*=!1R3&/K\H9O97#IE!3I,--6N
M^OU.BR/(W5\ST_O9K7C<\K@R?$GJ1U]9DP$TK7\$-R&G1U,=!L*A?&'4Q'=]
M@="]9P9>;(5G*IEQ''P-,50YDAN#P)UHF-# ]"6*.?36/ZHJQ.#HSDQTW%B/
MTZN)0SI>NZPDQ 4(^B2^F^L*J.^BZM,7RQ1$_M,MD\YT;W&$[DAI,.E#AL52
M ?('.4"#?R-[^Y6,R_:OK)I'T\K3H#CUC>W0$_*\U?N\45TA-SQR7T]00@$]
M&[^GY8Y8/U=3XQ)O0FWJU;0XY*3)7&2)%O=<N)BFULETI$7JLSE+J53T3*JY
MRA8BQ)ZUA"'Y_>V)5A+FJ; LTAI<,NT9-[!H9>'5GH"FCV;CZ99+5\G7#HS:
M 1ZS@M:RD2^4AIMS*R5*:MX9Z7=5QF3$*;M&#&9N\^S2T<"#*I*&YA^SL:;^
MEO9//$68#7/=6$CN"IV"MZ\92(B_LT]E52";*$GUJS\"(-3-]LI"2E9#H%9(
M\.W?SKM875 YZE?HZMP'IZ&EZ@)->?*L'VG"\3KR_,$<58JME 9:&MHRW7D]
MSRQ%7?[08L^7Z 0BB 1F9\R'LP/>%CZ(>'SJ_/3:L+JJ4-N1>J:3H:2A1VH[
M'1J:][0]0+M6V0*:<Y*K C<56\F .R*H-XN^8M)-:M8U!5MN3#<P\4BGT\VK
MPAVY,5R<P$X&S5HV.[GKX5FC=H0P"FEA$1-_^/56_'FQTS=S$S&/5$#[J^$(
MP]JYDVL=)+2Z^Y!+,F$,YS+YBWI.D"OCAEVKV,,<],0>]:0NOTZ^NZ5+5X4:
M$8'I.3@Z"">=KHY];6% .%9:;.+!E"6]QF9$%V;J4E"\[@"EBSG),E:/=OZ,
M.'.?Y/F'E:GJ<)9;8C/X0?>$=ME.R^'62Z[;'G96R;K+-7'PZ[J($5J%I=*,
M]5,[[(,'#1K\>VJ&N?+8>/'G&<XUQ[YS[8]\8_QVSC7&/N_/.<8__?W>4-Y'
M]3/BKN@^NFL.7KBWLHWYZ?MHRW(;>O[+#L"KUX0DPJV1UD#D0&XR<PK."$^T
MU5'GDJEA-FF\VWPR>L7#B2.XK_G.5^1.B>BAJ%@B&?INIRT^AH4H>O8X;D)*
M"8_3M$)]_&_[>SAL*[:J2;EGG#A%FFMNEG&VN,XUQ5]ZLN*QMJT@'L:P>0YF
MN0/GV+Z">7YQZ;V+:HD ,GEW!="LP&W1+,.53L 2FY6?PLG63V&DY#[3Q<!8
M.B\$Q2#W$FYMDGZI/)Z9R'5],/;D%YXES530D<%?.MX#X_2I#>SW6/I0*Z.)
MY '3@>>SRT7*\9]E@NV7XN0_0D0DYFV,,W,!A65[]J>HSSF,T>XLP3M,9:2Y
M,-=7JUU@^#;>;P[8IX\'SV2O;2RQX5"):QQ(=J>0KR?8'BNXSI+_ %E!G#C3
M29(" :CI:+;J]5>FP>T RE:Z0(#L[D^PN?>12PC4K.VFM)1M@V@60+2PP"#O
M5(3UJN6N*M0>5<E<G7?VL^:,5FBT-)M_G$?,Q4?8FE>^N;K\LK%7U[/FJDO+
M19?.5V2D]3V<#UK=D%7LK'P9_.4/9Q>*PP-<42(2LM&)RKT&FY5->-?M"6&^
M;"BVL[YYUK>H?S'3%RH4B<SQZB0MR*L0TO+1^G;6+JDJXSNV2C(>G0ZV[>%Q
M&5KRM":RY*<@6PM$%D_'N%L$@LO)?+&I6-KRF3<8]?"W:%6%-I"84?@C$6O"
M[J3=0MAA9R%S#A]3EF$(!M.(,#D0#9+=M.M(9K*OF:,:OD.GG4Q7I ]P7B)$
MS:5%Y7]8'G2XZ-%K+N.2EJ0FE.<S3HLQDRFM;;&J>6%*DD6D/=BU6VJ6![$9
MM36IY67'V!6R"Y2>E$G,_&:1K>5^G4RA+D=ZJ'(CD'G#*7E[A#I(>L>M*ED:
MJ..;[\%+XV/+L9.G]*0[&C96O4K.DF]NH,G2=?33 <<P<](LY.$Q)-IN%FX^
M-^51^JQQS<IO" , 4V0+S,XVM%KJ_M6C+CJ05ASBCHZ0F[KJ0F,K$#!T8&[>
MJ0?BI(A/Z^EY1M,P,)'OY!3"J;%[JWE[G7N6@>H"&6%:S>V)'S[,1BK)@8RT
M*;M:FW%A5//O\Q<%;=8Z6B(BNU@5K*27T3-,I&]7C=DH^AU)9".0((!63K5%
M>KKS<G,7/ &HY=@G/5KUN3\>@@RRH.^R\PO.R!FJH>UUD*S%H:J4Y*8?.H-<
MD7TB&'S--K!#\<7OI=N.F@J[?9 :^JAS"P=6L'C1E,PQ<)@?1\Z!6!95,WS#
M<Y6&3\PBI-.7)$AEQ0U?/X"SM*E<B\UFQ8FK'A*388C9=H'QY'(#LB@VRM3U
M,N7(FV(&B9DJ+G]B*&5,5<:S8G3%T3-0U]:/0 @"%M+B)O;& ;4*#'=O-+%$
MT*Y2))IHM+2,Y'PDAB-F=]VF(O<>K;S!78RGO:YK)DA@R@K8LPK;<_4;TA9T
M"$4;6=^6I24];AJJC6/S00"@"9K22A+2*"!NRA88B82+^$4E0]^.S4E,!QZF
M7(5>W1'T80G):J3/3BHJK<%(Y4%MF%205MWWL.JTY4I3<@H%S%:"]D6!$E@X
M1PHI.DK!\B,SD).2V8UE.0N\AX76/=3;F[IODVAWS".AA6Z(2_;0MFV"X2MB
M1#:WJ/GT7@)8E=;$P:*/@@8?N'12UE)DPL@K@ < %H%X]*=M7!6(?6ND/^K%
MQ9+5I85KS9I8]="U:,Z?G"%M:O/][5L7/@OH(O:@-'6,) )97L>;&M>6F9NT
MQD4+!6!EH_>=T<0\K\LDVRK3%\Z]-&=C XF>1T*8#C O'XLB9P-@"$_7YO$-
MI5JF[1CRP(*V4:3"<^U34U2E!Z?CV,Q$NL*,Y!HW=)*):YCX\>/'CQYQG.-<
M>^<^V/?&/\=LXUQC[OSSG&/_ -_=Y0WD?U,^*NZ#ZZ:PY>N+>RC?GI^VC+<A
MMZ_LL.P*O7A"3"K9'60.1 ;C)S"LX(3[354>>2J6$V:;S;?#)ZQ<.,4]1[KH
MPY+&^<G E8/.%0ZW;T/K3Q#;757SW]D-?0B=(W/:NLE)Y@+ K-;$M-S-8Q A
M"Y>%C1E]<(M<;-W;G+9':,Z]]2<.%:Q!)>S;EIWLBQ+AM@P!:EAO35K2P+4T
M(8P!'!R?L/Z<7;6/;DDFK5<?+8G;%)W)1%0D5'D(9!MXM8JG8:-(/;Y+]46H
M;VYV(KJ.I- >>A=.71TX6LA\0.4V$=SB 7YT15(J9)LIMJM-[$DJ/T%,24Z%
MJZ)E$?-:.FRL'&ZN63!.3Y?U+.9H:YH6FEU;2=;R)35==3EI1U0'CZD "UKQ
M'X$IJ"I[#M1&*^SHI8!Y!%@B\CX=ULLTAE3$+CRV3'9,Q&&4K5^W_6UY\ *B
MO"Q1*J>C"R>K.D97H6M10DHNU:_9]$4_#'8K7,K:%4D#P/F7#RN(4D-Q%0B)
M9<?BWL(.DP^7+P2@S,,)1:T>?4CYZTM6$JY>*NIJC(&->59/V<\I"PF=/5W=
MUKQ Y,@%%6383N)0CA"V)I(Q$HE^//6RK$2+B@> S69'#:;C!]SDO3W>5/\
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ME9<4WD2WXS@MALGML\G5CBX3DS)7A24*DJL$'Q^1^%&!9TA$RKTCN16O+B0
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M>NJPM1I9<+28;5,G,DM/]?$_-^T+>F#"S8TNYN #PT@G'4%1IU,WBJ*';-A
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MY=3EG/E3(\+P\SF"R 3<1,FE\U^0$0[7RNN\NABR!JZ2E+%K&FC_ *B!/2"
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M%@1LUM*\>>S\J@!,CBRX1BB$L]-CA>:F$A FA):>AYP2=OW:\H,2<;-2S5W
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M88@8V!4#Y^@9HW.RD+$D060>:-3QI;CU?N8%K/NG2P!BE[-L&PB_TK/5$Y\
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M#_8I 1^J.=B;GU:JE90FS!Q171;V\\7R,<W:<R"L=2Y];*MFG]*F-_5O]"0
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MV3QSN.3@\C]8&J"6J#LR&16\*5'9R@[=OWF>_+,I\/+Z^Z#K>FIN&AS8]J@
MB+L@#:90BVA!!&,0%VMFDR8UKR;9'(RFZ@$)%RSG9MZG=4.;US3>M/\ 0J0P
MUZ;E>.9GH)T'!S:DX7HMF-.RR* UG6UA;6/*QY!%M,-FAX/5S+@4).O6 Z9$
M0S,KJ-&_UYQ]3FI>F+/KFOA.HNAA0?O2O[+MSG.XCX)%(:J;^J>K)D5@YX_
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M:$44LVE!FQ9A#!3#,7P\;HR[YO%("3%9RWS>ZX.]+C:7>=<NT94]=S%Q;=0
M_.-;$5FFQ)$5VBPDN,F_9=@V2?-1@;D"39$3%T9(2'0L74W?&!$Z@]W4^-1B
MDN^C<>Y<Z5[HL;NXEJOH"OZDJNN(7BP&L"7K4/LU.RY2'N'/15X51(E\ 4Q@
M P;3 F?L:V6DHV'ER=C."@CJ%I$0K"V.[/1^%C(H]4FY@OJZ\*<,:GJ0$&:\
MA^C' &"6,170 7O:<-1]0$EIC%MUG,D-2MZ&N<%L_86>LW /4!Z26%60PZ^V
M)3N[=CAP)C.4WQZII[5X8-RX91 T9EAAQKS-TL.C\S9,B+Q2YAT=TC5'/L<
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MB)V0%\R0$*CY&3(IU>0F0TX1YD-:[NNL%0)V+"]^.*L?GNE?EQ:!R+>5H^
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M[<E\'!(=CW04'58HVONP.5[#G7!094K'VW'U?6U_\L.8>I^AL+C\(9V+%L-
MP-N$+'/FD*<"68B AIU[N5QG&<>^,^^,_?C./PSC\_'CQX\>/'CQX\>/'CQX
M\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>1 96W68?:
ME/5@4.\HV';?[1,UDVQ!/'_UK]GPRT)#;_?*+19K!?5X%TV4_P!K<M/FOO\
M4V_UA73*>)#^1#K9#">(B(0;-HIQ$ZZ:QS%)%"%<9T5=QVN-4-4THM;**:CE
MGCX6:F4]-EDMOAUSC H^FJ0: <C4L75M7-JSE]%G4K6S $$$ 623D7.CQ=Q(
M!C:(T''J<@\;Z.E5G46MJ\<H:+[;JK(Z;Z8U81E1='#8IH41@_ C9D>@'/L
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M\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CQX\>/'CRK'6]Z<OTY6;B!ZIFX;
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%'CQY_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>g1002989.jpg
<DESCRIPTION>G1002989.JPG
<TEXT>
begin 644 g1002989.jpg
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M04MI2VXJZ^Y'<#778:=NC9';]4-:7[L[+5_8.]%CB3"5N+HQ3;W7;^40;*M
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MDW\EZ_@[?L5_19[5_A+6 ^[';O\ ./3Z+/:O\):P'W8[=_G'K\=3N4/K=O\
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M#!OYG;_4F_[G1_J1_P# U^JYV)Z::79>;1B))II$"AI\0(D0J9 S7M5F'!"
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M\UV?SQLO_L+K_P#NYKQ9:_HCY"/_ %8</?IYI_YK68_*'E0_[Y9C_P#T,O\
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MBR;]I*/=D_8GR=&5/(QRX*QDA7MRW]4595#Y$A *1-=06#8' ]V5006+Q&,
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M>W>U="VYJ";JME"5/<9G!R=0T>C4-0 \JDS,JCX&^5'JS./(_4BF@&.Y(@B
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M];Q#QW5Y=0\*U%''E%"W$N7U68M6Y_530Y90K299#F/F3RP\MGJJOG<JG.M
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M _(.F!] _(.K^>_? ?!UV]?:Y6OY\Z>_? ?!UV]?:Y6OY\Z>=U_Y)F_6Z/\
MM?7\'9YCEGY;A_4:W^S\?I[CBP>!] _(.F!] _(.K^>_? ?!UV]?:Y6OY\Z>
M_? ?!UV]?:Y6OY\Z>=U_Y)F_6Z/^U]?P=GF.6?EN']1K?[/Q^GN.+!X'T#\@
MZ8'T#\@ZOY[]\!\'7;U]KE:_GSI[]\!\'7;U]KE:_GSIYW7_ ))F_6Z/^U]?
MP=GF.6?EN']1K?[/Q^GN.*2HJ]5X+;TM7=#T!<RNJ+HVZ$>E$W'I:F:CD8B
MKJ+0*<B$?5<8T5(VFFB)5%"IH/"*$(4YP*  8=413M03U)3L-5%+R\E3U1T]
M),YB"G(=TLPE8>5CU2KL9&->H"59H]9K$*JV<)& Z2A0,40$-7D]^^ ^#KMZ
M^URM?SYT]^^ ^#KMZ^URM?SYU0&F!J&&0@-5D&J(FR\&I(C6(&H(>\Q$2B,&
M35:-5390 +S%2$0 \17%+?S8&ES"U/=^8>3Z/W*\AUG1I].[=;G%,2]\KTS]
MTG%[YJZUPY.\CJ13EG-TW=5S!Z_7DTDB()OEJH(Y)**.2H)IH"<RX@9$A4CE
M,F'#KNZGW+[BJUN'3%VJPOA=:J;H44N@YHZX%0UM.2]74LX:G*HV7I^:>NEG
M,2L@H4BB:C,4C@<A#"83$*(<SW[X#X.NWK[7*U_/G3W[X#X.NWK[7*U_/G5'
M(6\;?6U3ZHJ<TD1OEEXJ5ET-31G5=*<H2AA6T97T2MC87:TLX^NB6TDXJ9!R
M<RL]0&#"=Q:S2AK$2&[ [WVQOQF['=!"W.J"]41N"O'&7?JR,&$J>YS&OJ@;
MUS4$./DPC%3%1)N@?OX_+-KAHX4,B7R='A('!SI&IKY7GK2@H.UE6W1KVI+:
MTU/2U4T]04U4DC(4E"5)/*JKS4[%0:ZAF3*5E55UE'[Q%,JKDZJACCDYLU/[
M]\!\'7;U]KE:_GSI[]\!\'7;U]KE:_GSK"4Z1O%*G#-.DL(A$,B_4M9(A3HT
M4 C<$,@@CDDCATD<M'9$TJ[#&6E5TDC?BF9HY3*94:+,BDAG9&F+J19C*RHT
MFH'45!:^G;HJOW 7VN!0M*6PKJ\-S*QMQ0KE)Y1="U-6,W,TK2CM!L=F@ZI^
M&?.EFL8X0:'.U06;%(HBW,**9BIX*'(K#<7N N%1<7;FO+UW6K.@80B"411E
M3UW4<W3$>FU.51N1O#OWR[0"H*$(HB50B@)J$(<F#% 0[7W[X#X.NWK[7*U_
M/G3W[X#X.NWK[7*U_/G65IT3E:>&:=>1,]1#I^I8Y-1(=4D\5B.7,[79Y4TN
MYW9B3M@O&PD#<43$2Q)!*##F1YD* !(I+CTXU%@JM< 7%K7Q2M!7NO-:R$J^
MFK:74N'0%/7 C3Q%<PE'U9-4_%5=%J(+-E&%0LHYT@A)-CMEUFYR+%R9!51(
MQA(;AU\5W>F\%T']'RMQ[FUY7,I;VGXVE*$DJIJ:5F)"CJ:AES.HB!IEZY7%
MS#1<8Y,9PQ:LE4RMEA%1(2F'.JM]^^ ^#KMZ^URM?SYT]^^ ^#KMZ^URM?SY
MU/EGGM5?6Y%YRY)>HU9;SV+1K$Q:;5S&)B B)+;QJJ'T=A$<D0K3#B:3S=0H
M6#D9CRE"OS5"QVTJ%D/,%@+.2PL;G'3W.W#W\O5&PL/=^\UTKGQ%-E M/Q=>
M5M/5/'0Q03%(/<YG*.UV[<Y4Q$A5"IBH4IC 4X<1L\&J[Z7IKNK:.KVM;J7
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M=,B28 0N-575VX>_=?!0 5O>2YU6#:E%%M;(\_64Y)*V_;MBMRMT:.76="O
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MCZA5)$P2+EO$L0&O*I#N6*+QT]<II9#B$%G2QA.8P\0 (%#\W_Y2TU3+POD
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M+!Z]IV7>0C]>+=+H( _8B]8K @Z1+PG)P"<J9S"0-=:VD:J:A6HB:K2".J:
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MN!,""@N3H%0!-<2'!!05 (N)# B902B .8E[:TOJ"VU"^HVLO7Y1N+#KN._
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M7]<<-;VM+%M2Z0;$ZA8&]K$WL#<@6/;C4Y4NI5Y<FI@"JZ&U,#N"HM<@C<$
M@XXVFN:A&2+I,%6L?(.4A,J4%6S!XY1$R"7?K@"K=!5,3((@*RQ>/B11 5E
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M(;T:PU(9KE9HH]-AOC2R?BRKR=:=8((V-/3U-.KF21'*U-7253-=2+%32B,
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M<IR)>3<[,R+@1!!E%Q,:@X?/WJP@()H-D%5CX'!>0B'./DHRV*0U4F<2Z8X
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M9HV^JA6E*#FV[@&CB(JZH$XLT53DD@Y,#=9E*.FKA-8P)J$*<<:[@FV+<@I
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MS#;G;Z-A'E.Q5167K1HM*3THQ-) XC2Q*Y3QZ;S]U4?N;V!5B-RKD6TK>\5
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M:J:7FI!&"KC=E2#6<:50TK"Z#B(IME-7>-&GEHPE25#"4Q-5BI*-W*440)%
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MLA%E6FJ1.O3KV2IYDS>.WK!<=>5;B-UXASC&<CT]'L]733B-D!XAR 8 <CD
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MO5=V-WU+Q>]>I]T$%O"=6H<[:MG4Y0-=P;#9J2EZK95"Z7E%:BBVU"4<^M[
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M3^(A_#K[#YDOVBB&?HE=P?7ZVH3^(!_EZ-/MA/)I^4,R'_\ R:SP_H>OW>.
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M&>[N'C\QQX(=->^4/F2G:,( /T2NX3G_ .+T'_$'RZU_2E&T;X2NX3['H/\
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M?"3W"?8E!_Q+I^E.=HWPD]PGV)0?\2ZQ]L/Y,ORCF7[(K?[/U_!VS]B;B_\
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MNC\R9[/@#/T36X+E_P"+4)^;^OG]*;;//A-;@_L:A/S?T^V%\FG7ZHYC;O\
MJ36>']#U_-W[/L3<7_ZBBWM_^MB[;?Q]7=?'@DTU[V3_ #)QL\(&?HF-P8A_
MS>A/X@UM?I3W9W\)C<)]CT'_ !!I]L+Y-/RCF/[)K/#^AX_1W[/L3<7_ .IH
M>S_];%VV_C\Q\+^"O37O5#YD\V>#TW+[A/L>@_X@UJ/S)WL] !'Z)?<)R_\
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MG#3333##3333##336TJLFD41,8 P _R'X_C] 9TPQNB(!S$<!Z1UUCUX"9!
MAP*.<"/+T#Z\\_#ESY^C7 =2@* 8B88P Y$.?0>H#GID _EG'39%0XF.(X$<
MCS'T_'X?)X:@S@;#?Q[OXX 7Z=OL^G&JAC+&$XCQ''KS#H CC\6M2@( &?\
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MR]FG$4!\XY1'PR( /CTY^/J]&J45DG*O3D'C@.HXQX=.0\L8Q[<#K9XW*P@
MF$H8SG(@&/3GF/CRU$N.P$^/0=GM[^SLQFW;V>H^'L[>_P#=C?J>F8"J6"S&
M2;-5CJ$.""IBD!5)7A$"&*? F 0''KP& QJR- EGZ"J->GI%95:&66,1H=4Q
ME$R%_P"+X5#& N #D ![/1B\ODZ@&)@PB83"'%D>6<\PY^CESYXY=,ZIFOH]
MPXA#.F6#.V(E6,IU.&!*)O9X\@SR].JG -I +,GI>C^$-M0/S>/9ZLJ?P3T-
MQZCU'QWVM;H;BKRJ*9^ A@-UR(!G ^GQ#'/]_KKB'EP-T >7+(!@!#GZ\^.>
M?QAJCZ2?HS,$V<"/&NF )KFYY Y>7/IG..?+H/ISJI.[1#EPEY<N8"/3\?I'
MQU,.Q (WN 187(&WL^-MK8P18V-]N[V>(O[?FOCZ-)+=0 P#TR/+(<^0]?Y?
M+K;&0<&# !RQCIG'CUP'CSU\F3(H E)D! >?L_\ 6'T^K7R" E#K\N.OQ#ZO
M -8NQ[?G [O$?X^-\ %OO<"VQMOO;UX"]=<LG$,>K]_.OCRMQ_R@ZW"EQG.!
M^_C7R/%S#@#X@_'K-F O<^ W\+>KX]F;"]@1;;?:YO;V^SLZ>O;\I<?\J8?:
M(#]X0'Y?W]:>4+?\H(>S ?'TUJ(@'7EX:TXR^G[P_O:C<GJ2?;B6A1^%;W#X
M[?@;_(JJ#^N$!\1#D(^T0YZT%0X\A.<0] F']_7T/"?Q'E_H](:VS!@<?)[-
M8Q$BWB.P]_?CY,8X!R$W7GC(\OY8UM\2@]<C\7^C6[IIB./@#JAR Q@#Y _%
MK0>\$!](^/+KK<TTPQL&!41R XY>D _!K3A6_JOOAKD::8D&(MTV\/4?W?!M
M;9*)R#DYN0\NOI]GKQSZ<^?AK?*H B &'B .@"(B'HY<P =?)@R&/D]NMH2B
M7&<<],8ON#V_-MMT^/"V.>4R F .'/7/+U#Z_5K[$$C"( !0ST#  ./5Z_#T
M]<>G74FS@!#.0'PUIWJ@#S'V9  ^/H&L@[[@'PL+?X^.)!21UWWV/A;LL;^/
ML]6.W[D #S! 1Y9#.<=>H &0'_3KY$AN8"'J$,A^_KKRO#I\\CSP'+ Y'GS\
M[(?('QZWBO!-@1\1#PZY]..F?4&EU)W!'=;^_P"GO^8"PNO6PZ6)Z[VV]OAU
MQR0*)!X@# ],YSU^,=!,(]1_!KY!<# /0 Z>.M.(H^/WA_>T/<";=QQ)2#U"
M@WVM;'V B'0=:\9O3]X/WM?.FESWGWXE8=P]V-PIA$>8^'J]6MS7'TU(.0-]
M_;B)2YO>WA;^_&^(@'7TXU5#,0,V1$/$F?OCJDR=1]GXPU5K3^=TO['\8ZFI
MU7/C;%3"S6\#O_P]G]^.1IIIJ6&&FFFF&&FFFF&&FFFF&&FFFF&&FFFF&.GE
MN\#R<4S"7SS /,>HE''CZO7\775MJCJV/IDJ /55UG#GB%%HV,!EA3+R,LH)
MS%*FEQ>:!C"(F, @4HX'5S9(,BASY<8_XIM8FW0R%7N2B81 C". N? !1,80
M .@ (B(CCJ//6O,S("P[Q;YK_1X?-BR-0[ $]"2?8 ;=.WYN[?%;C=F)'K'2
MH^U5L/\ ^$T"[,2'2.E0]BK8/_PFK#::U.<^V_3P'AX>!]5]NF+^2O>>[J?#
MQ[[G_#>_GONQH8PPE@QT^F-1Z!@.JGA^]Z-??OPQ_BPE!]IVO^<U8#36>?)U
MOOV]!?IX=MC[_##DK:V_Q:_T?&]\@BWE8$')8^3 <8SQM<X]O>#ZLB ?%K=)
M>MD \XZ2$.?+C:#S'TY,'X=8\::">0?A7Z=?BWS8"%/'W^KX]6,CBWNC0^JB
MY,0\?/:?%@>(!]HYZ?+K=]_"*#_O1*?&HT'\)]8R.7K!B0JLA(1\:D<W 1:1
M?-6")U,9[LBKM5%,Z@AS A3"; ".,:V6TM#/E!1CYN$D5RE%0R$=+QSY<J9<
M 9446KE54$BB( 902 4HB &$!$,UFO59!$T\0E-@(V>(2$D"UD-F).Y%AO?:
MX&+5H97C,RT\[0K?5*L4IA&FVJ\BC0+=#Z0M>VW0Y1#?")$HA[D2@#CJ"C0!
M$?B/R]/Q8\==4XO!%KCSC9/ X$0%1KUSG/)3 _(&<!TU8#T!XCR /2/H#7#"
M2BC$(H67B#)*.CL$EBRC$R*TBF.%(U%4JXIJR*8\E&)#&=$$! R08U)ZPI;7
M)&G<'*+>Q4$V-K@%E'<"Z@[E;P2D+W*1RR6L"45WL2"0#8-8D(Q ZD*QWTDX
MR%&[$+P@ 14GQ=,B=IC'JP?KZ^>/7SS\!=>(R'^I<C^V-OR_O>/I#5A%UVS1
M)1P\<MF39+ K.GKA%HU1 1 H"LX<'312 3"!0%0Y0$P@4.8@&MP! P 8IBG*
M8 ,4Y# 8ARF #%.0Q1$IB&*(&*8HB4Q1 P"(" Z"H.HH&4L%#%?1U!6) 8@;
MA6*, ;6)# '8X<@:0Y5]!)17LP0LH5BJM\DLH96*@D@.I(]($W^]]N$  X8F
M3 P8R(':>CSOU_R9]HZ^@N[#>,5*#UY]XT]/(,<?H\<]?#PU8#34A/(.A^9?
M#^CUV._7?PQ'E*>I)^!V]>_:]M_#&0/OO0W"<ON3)B!RB'ZHT# CX_5CZ _E
MS'B25V8QS%.F3.,D47*R"B22ZIVHD2$Y1 #8(83X 1S@/EU8G36#-(>WLMT'
M;;?IUV._7?KMC')3Q]Y\/'U_'6M;9SL+0@RCMZT?2<K).%%CNTA0*!$SB(]W
ME8W'X\Q# #CT#C5U O-"\0&&(E1'(B/TQIS 0'_P^O3\&L=M-$F= %!V%^P=
MI![K]_AOTQDQ*QN;^\]-MKW[A]'=OD5[\L&(B(Q$MS$1Y*,_'_U_3[.6MT+T
M0/C#RWM!5GZO#C'UCUUCAIJ7G,O>/</X>OX&\33H;7N;>)\/&_8>O?X8R1)>
M>GS& JD3+ID$P *G&T4X"CU,*93@8^.HE*("/0.>KJ,7S239MI!@N5PS=I%6
M06)R Q#!T$H\R'(.2G(;!B& 0$-8-:R:M*Y M*$1.81X9-\!0$<@0H\!@ H>
M "/,0#J(CD,ZN@F=W*L1;3?I8BWJVMZ_#QQ5+"J ,HL0>F^]@.\FUSV]-]][
M8NMKCNW;9@U</7JQ&S1JD99PNH.")IE#F8?2(C@I"AS.<0*7(B&M\!*8!Z#R
MR'RAS^3./$?#5OKI'_UC2H 80$SB.(8N>I?+$Q$!](9*'JY!X]-EVTHS 7L"
M;8I4%RH((!8 ^\=EK[^O;QQTA[T4^FH8$HR75(4?,5 6J(*8Z&[LZ@G( _U)
MO.]( /+5K[M5?&W"IA>&BHU2/DE54S$?2 (F2(F41$X#Y.)U1,/+AP'" ZMY
MIKG-/(X*L18^ QO")%M8$6M;<]A'CX?&V+XT;=*(IFF(B"7C))RO'LDFZZZ1
MVH)*JIAYQTP.H4X%,/3C#.-5+[]\%_6:6_;&?^=UC3IK(GD4  BP%AZ([/9A
MRDZV.YOU/Q_CC)D+XP8  >XTKR_\-I_G=/?RA/ZRRO\ AM/\[K%YR\8L4P6D
M'[".0$P$!>1>MF* J" B"8+.E4DQ4, ")2 83" "(!@!UL-I>%>J]PPG8.0<
M<(G\GCYB.?..[+]4IW#5RJKW9>7$?@X2Y#(@(ZK->%<1-/"LIM:,O&)#?I9"
M=1OV6&]C;H<6K12-&9EIIVA6^J58I6B73;5JD52BV_"NPM?>VV,J/?RA/ZRR
MO^&T_P [I[^4)_665_PVG^=UC-UZ:X02<4)"J!+Q I'="P35"48BDI(AG,:F
MJ"XIJ20" @+ AC.\@/TGD.I/6E+:Y8TO<C646X&D$BY%[%E![M2WZB\4I3)?
MEQ226(!T*[6)N5!T@V+!6(!W(#6^2;93>_E"?UEE?\-I_G=/?RA/ZRRO^&T_
MSNL87#ALS1.X>NFK%LD)05=/G*+-JD8Y@(F55PY.DBF*AQ!-,#G*)U#%(7)A
M -;H" @ @(&*( 8IBB!BF*(9*8I@$0,4P" E, B @(" B ZEYT^HKK34 &*^
MCJ"L2%8KU"L58*2+$JP!)4VCYNND/H;06*A_2T,RA&90WR2RJZ%E!NH=20 R
MXR5->Z"-UAI;KGDHS_SNMH;U0@9X(B6#(CU49AU]BF?5]_6-^FL^<R]K#W#^
M'\<1Y*=Q]Y\/'XOTMB_JMWHM8XF4CI3AR/"4%&H@ #X<U/#X^HZ^278@R@'%
M$R9C9Y^>TX<>H./K[1QUU8(YTTDU%5E$T44B&46664(DBBD0!,HJLJH)4TDD
MR@)E%%#%(0H"8Q@* CKA-9>$?*@WCYZ!D' @(E;1\U&/7)B@&1,5NV=*K&
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M376=)IUT(Q3'_5<AZ5)*"5L D_U*XGAA7S']WYOTK]3\W6-$"F0+>VR "$
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MJLN\_J(,_P#*?5K)-#RQ+*]'DO$O#66PRSW<T],*>,)%1").NW; !MOM?@8
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MR4BPQ1T-!/,\="\$<SUR9A61.HIYL_S[E#,'TTTTU]!Q\LPU7UL! *WBA'D
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MD UT=9V0IRKZI^?AC4E:V_K%6/)%2%14#+)1CV7C2%X"M)--PBNBX^EX1[\
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MZ2D9"4F'=:5W7$U+-T&BTG6DND\%LS;B D;,(]B@UCFH"8I15<%0%PMP^><
M,8!ORSACR@T7$?#D\N?U]1D='E^3C,TJ\WJ:YI:E<OKCG]/6QS9DL-9)5YK4
MQRT56,LK&I:>"EIZ2LRVEI!3U.MG?&7DLS'A7BZGIN&,JI>(:_-<]^HST60T
M66+!1',\K7A:JRZ6FRAJB@CH<CHYX<RHSF] M=5U-;5YA09Q75PK*&X6FFFO
MLF/S]C*^BP$*8A!$!P+$,#CK]-4U=%I_.Z7]C^,=6RHW_>K _P#,"_\ 7+:N
M:T_G=+^Q_&.NK%][3Q1?ZH'[L<]OE_\ %\Q QR----3PPTTTTPPTTTTPPTTT
MTPPTTTTPPTTTTPQT<R<2@VP _5F'(>HHXY8Y]?$=64J^AU:D<IR#)=)J_(D"
M*Y7!3=TY33SW1N,H"*:B?$8,B E.7'0>8WNER\0-^G)00Y^LH_O:Z !$H<NN
M,>K5$@#$AODW%[> 'S]?@XL34-UL#WGV?3V[?OMCV-JJ@#&7<9SS_P :J/3V
M)^O\.M0M5/CC^;8L,CXJJAC_ /MZR!#B#ZH0Q_+U!K00)U''/(YS\OCJGDIX
M^_%FN3O'J('AW7^G]V+ &M34 ='L4/L74_!W>M0M1/B'\^Q73(_3E.7_ -#6
M0 ('4#*2:AP_JB$.</E*!@U]^2.PR'DZ_/K](5_S>G)C[C[_ .[&.9(#8D>N
MP\!WCM([L8^EM//FS_-T2& SS7. =0#KP>O7U[TL_P#UPA_LDWY.L@ :. ^J
M;KX_]"M^0'AG6ODJWUNO^TJ_DZR(8^YCZF_N/;AKD-O24>&WAX'P]_?;&/WO
M25"/U+V(-['!_P / (!\>,^&M/>EJ/Z[B?9Y0?/HZ<&=9"%:+YY-UP].45>8
M>CZD?'\ ZU.@N 8!LXXO2""P^/HX,8''W^FG)CZV:WZ7;MX>/QVN8XZL/</#
MQ'7U7ZV%K8Q["TE1^+R* /\ TZ@_>X,Z^O>CJ(>CR+'_ .=5_P WK((&[G!<
M(KE,.,@*"OCRQ^IC@1Y\L>&OH2.0ZM7'M[A40$>?3!1_[,YQGEGD16WU [=M
MQN+]@VQCFR=A%O$ =W?Z[>W;&/?O1U%D %[% (] %94,X]'F<]<.0ME+Q3)=
M_(2<,U;-R&.HHJX.3S2@)O-R0,B(!R#VZR&DWC>%8J2L@5<B3<O'W0(J"81#
MF  '"&3#RSS# 9YYUB],KU=>F6)'Q[9]'4XU6#R@_<.42JI<6!#B%+A/DHCG
MB' @/CG4'CC38!F8VTJ"1>]MS;?U"XOV['&5DD/4@#M) \!W=?CNQ2E*)N*T
MEEXJ 9NW1&YC%4E3)@2, 0R')<1R(#@1# =/3J[(V=J8H\ /HD1$,B4'"F '
MJ("'!J\U*THRHR(0BXA@8@%3(158K<_&H8 YF,8$^89$P!GF.1SS'EWHHN38
MRBXR YR"*H#\H$S@>@AT'4HZ<%?3^5?>QL!T-NAO[>WL[,8:9B3IL .EQ??O
M["/#?MQCJ-HJC PD%Y%%$ SS64Z>GZCPYY]FOL+/U((9![#_ !N3A^%/Y-9&
M]VN8 R@OD.0B**F1_P#H\_\ MT[E;_D5OVI3\G0PQ@D6)L?QB#U%P;;=EO[L
M8YTG>/=_?Z_?C'+WGJE^O8;[*/\ YO0;/5('_=L/]D'_ !$'61O<K?\ (K?M
M2GY.M027#HBM^TJ?DZ"&+M5O^(]P\>\?/Z[N=)WK_P /]_K^!OCC[S]2C_W;
M#_9*@?A3UH-H*B*.!?0_Q.%!Y?$GK(LPF#S3Y*/7!@X1^00 =:==.3%V*WM8
M^'<?#Y_6,.=)WCW?W^OXZX[IV?J$YR@,C$$)D.,_>K'$I1' B! *43" <P+Q
M!D0 ,\]===1RK35*QM"4RY4,JL<1E7P8(=550Q1<*&( CP 8<@1/C'@*   B
M(".LES""*2SC'FHIG.;F/,I2B8?;C&<:PKK2?)*U,NID ;I+J<89'..+I@#"
M(!@?2'CTU&14C6RW!<6WN3I%NER=CVFY_<<AV<^E8A=^@V)&W\?7X;8R M!3
M<##4V@:-[A635*)WRV"]Z*IAR;BYYQD>O4,\^H:KN<8)3T:\A'PF*B[*!"KI
M@7B053,51%8H8 #<"A"B)1,'&7)!^J 0LM9V0*\E7I&HJ W2;B42B/FB8!*(
M^;D0Z\\YZ>D>6L@>Z  .4,CQ";GSSS'XQ#'[VK(R&B06VW4@; VMU ]=OHQ!
MMGN3<[$'NW'0^SKOOU%^F.RUI9Y-8R:4C%+I\6"+ =5(#%S@#&3$IA3'Q$O$
M(!T >6MLUIZ@*&?+HD1] +J9^3@Z>O61!4 +Q$+D<ASSUYY#P#P_'K4K<2CD
M 'X^(?3ZO7K'(C\=^XDVZ;=#?KW]=O7/G-W]/ ;]/=V[]W9?&/:=HJ@4R 2,
M.4W+ &75 >>>H<'H#KT#Y,\D+,U(/20A1]BZWCTQR]'3.?DY:OPHW-RX0,)L
MX $^(QASZ@ 1\-:D1=D')$G7[4J(!_\ 0]6L<F,=0Q\0WT K]/T8<R0[@BWB
M+;[=W>?7UM?OQ^4M#428X,_B/7]/4  ^,28^_K;-::?*&?="''U NH(YP(^!
M!]&LAQ;N5,@=!QSYY[E4.?\ @?>'EZM?0,#]127'(=!24Y?(4-.3'W'?8$L=
MNE]AU]WJMO?!ED&Q(/C8;]#[O9[<8V^];4'%P@YC1](]ZH  (C@ SP<\^'X-
M<@MI:C, "+N+* ^E97_-ZR/!F<<!W*H 7&<I*<P_P?5XZW1;*B&!24P'_P";
M4_)UD4Z;&S&_7L[M^[U=EM_4YS^'NQC8%I:B$1#RR+#'B*JO/_Z&OKWHJC^O
M(O\ ;5?\WK)$S93 ?2E1_P#FE/Q!ZM.X6  ^DJ^P$E,A[?-T,"=@:XZ[@]>G
M3O[L.<_>/</#X]N,;O>BJ/Z\B_VU7_-ZU]Z2I,</EL9CT=\MC/LX,>'WM9']
MTJ&<H+CRY815Z_X/^C7P*+@QB\*2H  \^)%4.6#>(D\>0>K/LU@0(>P^\_N&
M,<U^\>X?P^+GPMB].VYEZ>BG,Q(/8PK5L3C.4BJ@JG# B()E,0 $V Y (AG/
M7KKKZ7HF7JR."48&;MFIC<)!>F,F8XY$,EX2B AR$<Y]&-7!O ]>/S1M,H(.
MA*X<I=\4C=<>,@F .0@0>+ <O1[1YZNE2\.,53<<P(T73!%$!.04%2GR)A,.
M2\ #G&/#(]1ZZ@(E,C  Z4 U;D^EM?ITZ[[]/FGS7"@DBY/<.GJ[?FZXL>:T
M=1E.!/+(D<AQ9*NH8,9'',$^H^CV^C6OO15']>1?[:K_ )O619$7(AD$5B@(
MB( **@" > #YF?EYZ^NX<_\ )*_M*GY&I\B/U;#8EC^[]Y]>(\V3O'L M^_U
M? .,<O>BJ/Z\B_VU7_-ZT]Z2H?KV*_;E?R-9'=RXXBD%%;S\AGN5,%Y=3#P<
M@YXYZ^?)UA4%,&ZX8ZJ=TKP#CT")<<^6,>OT:R((^YCOU%[=G>,.<_>/</C_
M !/A;&B0MA.QS%U(+.XPR+1(RJI4UE!4$I0$1 A1)S'ERZ!ZPUTE+4;)5:U5
M=QJ[-%-(XD,#M0Q#"8!Q@.$# /0>HA\6K[73ERP%&2#E5,X&62,B4#D,7B.(
M8QS O,<^OEZM=7:*/.UI)!R"8IJ/<. X@ZE4$Q_:(CT#T8ZARU7RDYJH+D:=
M3"Y^;NV]6_KWD)6TWN+WM>WJZ[>OI_#%!!:2HAR/EL5@!$,@LH(<O6!,:KFB
M[?'IQZ,K(O$'3XJ*J#9%J4_<($6 "*J**''*BIBAPE*4I03YFR(B :N<!5 $
MQ. 0*'//@(B.1Y^ ?'UZ:"4X9'A$0#J/+'KY_P OBU>D,:L&WN"+ GMVL;6!
MV/2X'?B#2.18G;U 7!L>SW^TCIMC337SW@!D!*(^'+PZ\Q]73^77< HF#("&
MKM2[[]/ X@01U[<6AJ^VRTQ)+2T2[;(*/#<;QJ[XRE%?  *Z"I ' * 'GI'+
MYHADIL#C5)>]/4/UY%?MZO\ F]9%"4,X,41 /'H CSZ<P'7P<4^0 '3EU'T>
MOT"&.NM=X8]1-B+[@@FUR;GLZ> \,6+(XL 3MX [;6Z].[NL>_&/(6FJ(>0.
MXKT_JZ@?A3UK[TM1_7<5^WJ?YO6090 !SD  0Y!GG@>FM\J2IPR1)4P#T$J1
MS /K 0*("'K#65IHR+G5[^SY\9,SCH0=AO8=WAC',UIZB+@!=Q?/D&%E!^7Z
M7RY:ZM];N?8@83^3+@7Q;G.8!Y>LH#U]6,<\\\:RA%NN/5NO^TJ_DZ"V5$HE
M,U5,4<A@R"H]>O4OX>@ZB:4;V/;M<[@?1[?FPYS^'7N'3^.,2&=*3#YR5LDA
MPG,;AXU.(J9? 1,;'( 'KZ U58VGJ #%+Y;%"(AD?IROF^GB^E\A#KC611&/
M=%$4V1RGYB&&RH#GV@3T:^2H.2\6&R_G=?I"O+V>;J/(5?E:B;]>@MX?Q^GL
MSS7/0@=-C:_9^_U==M^F.PVIGP-CRV*QR\[OE,9SC'ZGU#EGVZ^QM14*?_=\
M6&?ZE97GZ^1.FL@P;.  2@V<8'F/TA7T8Z\&=?9$'!!SY,X$,8P*"H_A+\FL
MB%/Z0\;]/C;M%K[X%W[U.PVL-SZ/AT[?:,8]%M)4)L8>Q7/TK*!\N2!C7PK:
M6I4R"<KB,5QX$7.(]<?U'W]9#F0<F'FW<=1']05#K["!K0&[D.C=R'_S*WY.
MG(C[ _98W]79;?KMOVC&=<EOE+?NMZMMO7[R.HQBN_HBH(XAE%69CD+GSDLF
M <>(<@Y8P.?7KK8J#&6=^0IR+!HZ_P"0>G.B<1S@< )1S@1 !_#X:S"!-8_)
M5FJ<G+(';*&Z^( )!#(>SGZM6WK*W",NB>4AT5F4LB!CD%- Z?>8R80  3R/
M%@ Q@<ATYZ@U/8:E.JVY6^]MNAL/$';;U],"5OPMNX^L @'J.GMQ;T]HZB)C
MB>16!R(&!900'ISR!!Y#GE\6M/>DJ'Z]BOVY7\C5>6\J9\_%:GIQ!RA)L/,$
M5F[@IE0#D  8Z8"/( '(]>>KFF;KI'$HHK*E,.2F(BH..F<X(/,/1SZ9U)8H
MF75Z=M@;$$@]H-]_#?W[[8,L@-KBX[AUO;IM\7VQCM[TE0_7L5^W*_D:>])4
M/U[%?MROY&LB@:N<?J:P#G_D%, 'HSP8$?3][7UY,X_Y)7]J5_(U+D0]I<=.
MI'AW#XN;>&.:_P",/</#P[?X]-L8Z>]'40]'D4/_ ,ZK_F]/>BJ/Z\B_VU7_
M #>LC.Y51 3'26.!L8 J*OF^W!!'U=-:"!N$>8%, \RF#S@YCR$HX$!QZ<:P
M8(QW]G4B_9OMU]F'-D[Q[AX>'O\ 7ZL8Z>]%4?UY%_MJO^;UOM[039U2%=2,
M<@W$0[U5+O5EBESS[I,0(4Q\9QQ"!0' B( '/(8@") $P 4V>>1QX?A\?P#K
M7A_\(ORZSR%%B =[$;^('9;O%NZ_@<8YK]_S#^'Q?U6X#)@WCV;5@V Q4&;=
M)ND!AR82I$ O$8<<S'')S?\ A&''+57->2"8>H?\8=4^(  9$Q?EU4#;]03]
M@_XPZV$OOW;6[NG9[+8KQOZ:::GAAIIIIAAIIIIAAIIIIAAIIIIAAIIIIACI
MY8W"#?UJ#_BFU3?>>K[_ /HU4TH ""&0S],_^Z;6.&X>^5*;<[35-=6JT7$B
ME#D;,8"FHXHJ35959++IL:?I6#:I_3W;^3D%T2G3;E.JDS*NX N" .J7(N?C
ML&WQUOB:AK'2=R0+=;G8=O3XOCXOCN(M+MXIUC4-U*E]R FWI(JEX",9.IRK
M:OFEA$K6'IBFXU)>2DG;E8"-RJE1*S1553!=<@".,4G,YVANXMT!K84K3.SJ
MV#IN55E5US",*XO!,-%RD$CE&DXY12-I=<4QXR,9$ 72*<2K.RK!@M<[5MK<
M_*SJ.ZS=4DC5VXRL6WNA3\%(%,[I:P])/^!W"411<([*=K%ST8T5*C.SJ1"O
MU7@*))G3,191:1L  .@8SS'UCZ1'J(^D1YCHJ%MR;#N'7L.Y[/4._KB195/0
M.PZLP!7U!=KV[S>]NEL1?(=G#5%3!Y5>'>KNAK^34P90T/5+"B(U$X@&2,V,
M8S=F10*/$!"*+JB!1YFR&N4MV8-J6Y!47W!;LD4BAYRJM[W2:9? .(YXDI2^
MK(AGPU)FNL1NBJNH.$T4SJJ&_J4TR&.<V/'!2CR\=6UB&B56BSG)DONBC(B#
MV*B7!5!CHJ'4'RB/4<1YA[I>673(FHX=N@$R"ARH-TRE(?BBZ1K8:=3'INP[
M1OM<];&P]MAOAS)&&[6"]P4=? 6[OW=2,8'-^S/L^Y4%)KN-W5+J@!1%-"^Z
MRIP*8.(@\"<68V#!YQ1 ! 0'(9USOT+RV'[/^[;[MKW^)]2%RE,PSXH<<3'Y
M(BH4JZ2(-7J/FE*46KIKW*R!RER*:B:A3)G HD#'(.!2CUVBL\@'KES(E8I)
M.HN4=B)W;N-5.=N+>15$I>]DXYTBHW<K"4HN$CMUQ#O#*",0L0?ELMF(N+,X
MU !;D GH-A<$[[=N[7)IU!CU .XV[KVZ7(-@=]K^., Q[+NV ];_ .[8?;>U
M[_$^GZ%W;#I[_P#NVQZ/?M>^S^L_HY:DRTU;R8_Q?^9O#Q\!B/,?\8XC-#LN
M[8!TO_NV#V7M>^/7_O/XZ!V7EL '(7_W; /I"]KW/K_[S^/CJ3+33DQ_B]/Z
M3>'CX#XOAS'_ !CB,9?LLK3.@PZOMNO<ESGA7O2[5+GK]2>&$.O/IUU](=EK
M:EJ7@;7XW8-R<O,0O0Z2)RZ>:2& !^/V=-2;Z:SR8^NG?ON?XX<R3\8XC-'L
MN[7CG-_MVO,<C_LV/>O_ /1]:?H75K_V?MVOW;'O\3ZDSTUCDQ?B_.WAX^ P
MYC_C'$9GZ%W:\.E_MVH?_P [7O\ $^M?T+RV'[/^[;[MKW^)]29::<F+\7_F
M;P\? 8<Q_P 8XC-_0O+8?L_[MONVO?XGU\*=EW;;ARWW"[M4%@$!(J-Z7BP$
M, Y >[-$ 4WL$<>K4FNF@AC'1?G;P\? 8<Q_QCB+)ULKW:6T$'VW_?7<)V1H
M<56M$WSA8VNZ8<IE'C\B6D4$4I%N1?A*BHX(V47 IC&(JD;S@V('>_<"R]01
M-O\ ?A:D+-/95T2-@+Y4DZ-45CZI=',!$/+737RV1HQTN8R:9D94YD2JF$QA
M13#G*IJCZ[H"B[G4K,41<"F8>KJ4GFJC.6@IUDB_CWB*A1+YZ*Q# FLGGC0<
MI"1PW4*51%0AR@(#&/P38]@))7LV[Q[.\^R7,U;.H8?C !6'J(%CXW!OTN.R
MGJCGFC:FC2;5TW=,Y!H55H\;+IKMG39TD!T7#9PD*B2Z*J9@.FLF)B'(8!*;
MT8'5&[;-7[A85@XG1S'(&<B/$(CZ/'X_5K':8;UQL-N!"6!JBHYRJ=J-W9Y%
MM8NLZC=KR,G::M72Q2KVRGYI<^ IEXV AH 5^[2344%1'A,1XF&?3_;N\EI"
M!?'<%*BDB0[M(QN8CYO&42B Y$! 0ZY'T\N>I*LCM95/H@"W<3:_=V[^/6]C
M<2554W)&EB2#W@ =>T$$V/[K''?[>(9V@P>2RQ1!-P8Y"F,',V39#F(Y$0#
M8 !  Z=,ZR2 .?(.8ZZN A&=-Q+>*9$(4B)<&,   B?F!C<@\<=?2/J#7;@
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MMRU](&PW^3?\.VYSJ>^G6;^S<FUK V/[_P"CC 3]"]MCC'T0&[?']VY]X_\
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MEG@5BZDA79".HYVDJ4R?$)3-5C!])7$1P%?C?.**<0\G.).8"/"8!QGG^M]
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MWP&',?\ &.(Q#=E?:0ZHKFOINN,N/5<;T.N^''3*GN-Q#CUCKE?H7ML<8^B
MW;8P 8]^U[CETY>X^I,=-.3'^+\[>'CX##FR?C'N^/=B,W]"[M?G/O\ V[;/
MI]^U[G_V/I^A=VO_ &?MVWW;7O\ $^I,M-.3%^+_ ,S>'CX##F/^,<1D*]E[
M;\@%4C-QN[6/=IB)DG0WD<N^[-CD8$58DI#8' X$<#C&NE=;5=]%H/\ 56Q6
M\V3N@RCRBHE;?<13C&:82B*7GEC$JLB@1?,15QW22_=->[XN-9R)2B RHZ:<
ME!T!7U$_OOC/-?8$A@.QE!Z^L7[!V[6%L1J6TWT"QKF(LENVMP_VT7EEU2LJ
M<5DWR4S:NXSDIC) O15:M 48M1=*IG(UC9AT583 5('!U3@34A D HB4PB4P
M#@0$0 0'T"'\@$.8<AU05[;$6OW"T-)V^NG2[&H8.02'R9PHDFG,0+\ABJ-9
MFG)8$S.X688KD37;/69TS<9 36*JB8Z9H_MO=VZYVOW2=;,]S53/*H9^0'F=
MM%ZYOOS.;C4>B947=$U)(NC&[^L:53,U;(@*JJKA$W<]ZHEY&H;!NA&JQ7L8
M]G@1[/'M)-B;-(<$H+,-RM[W'>O;[/=XR>\!!ZCGXP_>UWK; (I@'0 ''LXA
MU:#WUJ'QRDD1](<1 ''7/,WW@Y_CNG#2#25C&D@Q."C5R0QT3AS Q04.4<#Z
MC%$/BU)&4W *GM]$GPW-_9Z\5V/:"/HO]/S#'9Z:::LPPTTTTPPTTTTPPTTT
MTPPTTTTPPTTTTPQU4D #W&1P ''/LP/[WH'4<MP/<>_>^RU-EGI6[^F=L5%N
M=PU7QBOG)R5?5:9:DK>LWB*A1351I]J=S/D3#B SIP@=0H=PF.I')$,B@'I/
MCY0$/QZC,V:LRSF]+M%JY> 920:W&H&@&2B@9%O$T_3BQO)DC"(B5)99-!<R
M8"!0.''PY-RJ< E1VL=^FX%C8@[6V'M [\3CN!(?Q1<>MM*W'3I<[^KN%I1@
M#'+^7K'VCU'UZ:::MQ#'050]48P4@LBBFNLHFFR236,)415D%DV)#K"!3F%)
M(S@%5"%+Q*%(*91*)@$.%3C)>.09Q:K@SL(MDDU.[*B" NW*)"H+K+)%P1(H
MB43-T4P%,$A 0$1#7>RD<WEXY[&.A5*W?-E6RAVZ@HN$@5*)06;K%\Y)=$V%
M45  1(J0IL#C&J3IA]*%=.X67,=P\AG@QPR)B=W[K,/)"NHJ26\XW$_41!1.
M1%,J: NN(R1 (8"EI<6DC;>U[ CQ-B#Z[@CP4^HS4^BPL#MO?KV6(-NS?:XZ
M[7/2NC%*8! P ("&! ?$/1JWC14Z%7QBJ2I#M):(E60)"X,0Z:D:_%V5UY+W
M8E.=<B@HKG,<#% J8@)P-JOUE!2155 HG%-,YP* "(FX2B;  ',1''0.8ZH6
MF&HR[Q2I7 %!NW5DHZ 2*0"B#,7(D>22QQ$3&7?KI'233P4B#1%(@<1S"?6)
M%O+&0!<!B3VV#1WN>ZUQZS@/DM?O&WL/3VV]8OUMM7^FFFK\0PTTTTPPTTTT
MPPTTTTPPTTTTPPTTTTPPTTTTPQCCNQL5![B[#5];270*,@]AG<M1\D!0\I@:
MWAFRSZEYEFI]4DLUE$T2*B3FHU5<(& 2JB&K9[$[S2U[=L5N*EJA01KRFF+B
MW5QDE! %T:XH94L#-G<E "B19V=L1V<! 1$RBF3&-Q"&;0AGY0'Y!SJ*G8.8
M(.\/:$4 D8$XBF-T;N7BD0, )-R5;'.)-ZF4N0*4QWG&J;A(4,FP(F$,ZJ;T
M9$(&[!@>F]K6W]=M^[%B^E&X-_1*LOM8*1;QN/=W[XDW'F.<@.0 >7AZM8S;
MQKT.K!;;+HW+BR@I4<?")0-'-^?$O6%6O$*;I[NP !$QVKZ1(^ O"8#"U !*
M(<0#DH51$<B1=,X%R& .41Y8 >0<\A_V:C8[1PQYIKM,MVMQ&B*_W;6W:RZ0
M#@J[>G5/GC0(H C@Y>_9?4B AD1 0YB.LNQ"DVWMU![RHN-Q^-<;@[8Q$H9T
M! M>]CML-R.G:!TMX8R:V3V 2VX;=J$H)V=5W5[UJI6-Q99SS>3%?U6"<I4C
MIV<%%2G.W=*ECDA(8$Q09)G A3'/G+'6@?C'\(ZUU-0%  [ !Z[=N(L2Q)/4
MF_QZL-4;5HJN58"(1,HD+Z72=JKE(H<H-8<AI%RWRFHGPJNR) @B*@F2R8>,
MA^0:K+5/5+$+RS%(6+DS.4C'2<I%.0#C3*_:IJE21=)<A69.B*J-GB13IG,@
MJ<4U"* 0P1<$H0!>]MN\7%Q[1? =1O;?K:]O''+B"F,W!53'>")D0 IC"F"2
M)S%)P%-TR',XCD1/GGC :WY," S6.8IA,4N4Q+]4"AA*0@AS#D)A*!L\A+D!
MSTUU-+R2DG').5")I&4005512!0"(NC@H5XF0%!$Q4BN4E!2*81.4@AQ"(B
MCS9]Z6/B'SLW" (MU3^>."F,!#=VEG^K74X$$@#SA54(!0$V &E1_FQ7Y5D9
M=][D7&_7M\!;L MB9/W0';Y0-ATZBV.CI5!5C(U2Q.+11):6+-HJML%. 3"!
M5%4'9"Y)WZ"J!@(J0<+HF(<2D$.'5::IJFH8\8V6=/# I,2ZJ;^65*3NTBN!
M0(F1FU3$QS),F*?TALD910P8.<3B)Q *EU=&+(NUNIMW DD ^-COB!-S[!]
MPTTTU/&,----,,----,,----,,----,,----,,!#/\O$.8?(.HEK;-3[9.T-
MN#9",1\@M/NJHZ4OC1\;Q%(PB;KP2QR5RVC4\\#<9M#+M1L02=X(M"I)F!$3
M&EIU&1OY3+3]Y]@5QF^"24/N9C:* Q?-.K&5_'^02"*A@X3&1X&!?,,;@*)S
M#PB)M52[*&_%8=][$@$"Q'6XOX8LBW)0]'4CU$ LI]XMX7OX&0DIBEZC]4(
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M '6Y^CX \<5O+3\/!D(:4D&[0RV0;MSG SMT8! O T:$XG+H_$8I>%!)0<F
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MG!2CR$,C@1P/AG'/'*9[4$5F)5U';INT$(V,<H+W^BN\ H /$4D*L'/(#D0
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M.M!)4#27GR+$615)*/W239RW5'NE3C',5&#1/O$P^EI'(H IX$#<1A'5;5"
MV4,YL3903< @;  D]=MK'L)OC(B8@%CI!]1/N) ^>_?CFSLJVJ9TV@*>4+(.
MFCUK)/95J<31\.1DXX3I&D4N)+W67R=%&/24\I!$ZRRW=HE'BN*4 *4  ,
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MIB-2MF2:I_J@4!9T*JQ^,O(0XC"(Y'A\!YB)$B<E(U8RJ0G^EBNDL<0(0WG
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M*4<#YRAA' 9,81R([8ITYEVDC)_&YKL2UQ<6+>NRZC;8#IC5+,5MI:X[D [
M+DVMT[;7ZD[F^-@%F)2%$%@[DI2EX5VC=1$3I\( 90R0";O38#@#J/+A)@ U
M]&<)F[\H&24(+15PF;!CI)B@8H*%*..,B1L8.BH(' ^>0%'.N6\=*@GD6B(*
M"8O<H'(#IPH80SCNB  )B/(HG,;!0'B$< .L ZXO*5;<BU@64T\E"6T=4K3R
M- 4(J#63J&MK@"H9VI4JIE4VKZ(HN%*Y?2=/I)NA<$.V?*.&JJ)B:U<QS"++
MA"SE6$L\< !NI#LK.Q"L29&6%9)5B6-G<1D >D"-FDI'J^8$%^7&TAW5O14Q
M@ V TAI&1"U[)J);T5-LRGS4D?4-/U,*A6SE<6\!*'.L5,CR,DR+*1J+HO$
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MT"GMN.@UU<@6LQ-B+\M3<6Z @W(ZC<D#NVMCF)'024%%1P]6<8*D9VHS;J"
M&YB519$H$4X>8'$2C@W,0R( /+3\F. F15;G.4@F(HB06[@HB %$3)CA(X\
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MY%ZHRF*O=*4K'I'8?/1(PE0NV9:D 0D&Q6\<9$Y?(B ?AS^]>O=H=5[D=O\
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M'$!0 3 <> 2X'AP3A.'MVYG'Q06>/F3^9DE.,@G=R$@=8I$@6*8P& .-!DV
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MYDX[PC=P47#)H=0IT!X%$5!!$1PDH1(4LG$0*FF;!1#&HWE$R("&1B;7 L5
M0%'!VO>_I 7/W+2+EL 4T'4K:K#MW!'1A<$VZ=2/PA;H<4O1LM!L6<J(F:("
MI553\)UW;;NR=U)"!U3.%D6(-T $Y!!,B:P)"<I0<+\0''LI>KH9J[4;%D%G
MKPX(LCIQ3%Y*F;+.3\?#Q,TEB(&5;F+W8*B4N!%45"\!L=10%+4Q"1LHB,1%
M-LU%/D2(+4ZG\S>7JBB  _0[PV4S#QG*4R2H\RJ+%(0X5>J).\%=!<&R'E:3
M9-$B144P3%(RICD(0""J=PF81#B+Q)\0"4 $1T<ND:FZ LP 1%%E!!N2 5NQ
M%[-V$CLN<2&@N39R+&[,=V8:;"X5MAVCM'4G88ZBCWY)2=JE<8B2C$TFM.-6
M82[9-JY=QXQRK@%$VP'.L1N5==9 Y7 $4\J3<%,F  43<""[^.5>PRB@+F@I
M9RBT5*<JV8]<X24:@KPF*;OV3)X#$Z:_"*12I*@02*)B:HV:!DJR<N3(*)FD
M:;:=X8R@=TF#!^N5!NFD'_' F\.=R<.0""90P !GI4072J.JD1(<4@>-Y'(
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M8;D8F:H;<;8JY<N: H2ZU$5+-E,8I(J.GF1Y!QP<S'9M%%$UGJ8  B)VI%0
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M^_EL1[^F+HNC_P"YZ_OB=/'$A]0%3<Q*D>@("6=>,(,N3G./D\J]2*[.44C
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M6(ACJ&D8E>6O)$TAD422%3$NH2!B&5E(,:D$8O<ZKBCJ8=L4YV=9H3<T0S6
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MXHJT[MPWB85(CL2\(KMW:CYT*0@(>:*"Q1#A' X, X#(:ZZK&8M:HIZ>35=
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M$AT'#"1DTF:AA*<IUYU5NNV6.H(8$R;^2,L %P9 B1$SF*8Y3!I2L$2$GIJ
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MS2!60,#*F\=E/0I(JR*QLP==2M< C*%M@K,-6E&*DJ0C@!EVM<%6TD#8J2"
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MG),],4A0\<Y3D9*EI2YJ3V3D&1?(HZ$@JMDX(DFHV:$0;*APB9)@T:N ,(X
MY#)\1M>JJ(FH\_S*G5JID,N8T\+3K2*'CBJXQ3R(:<*[F2%Y9!)*MS<L^EPP
M/D>:E;D.15FFF223+<HFG6'G QSR4LJ5:,LC-&H6HAL5BMI!5 "%4XR6B&IV
M=7-$UU2 0*;<-F:"A5#*]^A(("LN580X#&.R,@4W/BX2@!1X0$-7)U:NEYTE
M12\(Z;'9/ &FQF7;U))4ABH2ZA6T:*''R3*_*Q5<F2-],(4G"80 @ -U-=.D
M14B*I?2)'M<DF^Q-R>T&XVV%K=F.7.Q9[M:^D7 Z"VUAL-OB^&FFFMK%.&FF
MFF&&FFFF&&FFFF&&FFFF&&H?]HU%,*PW1=H^#Y=5$K/<# D("9S$ P'@7!S<
M?"8,CG %SXZF U%?L<_IH.TJY9_VPU/=>G^]Y?T" Y]/Q:ID4,T8(N+FX\/1
M_?BU"0DI'4*O]=<9L/K)PAF!R,CJ [2XCI&45.8!,&3%+@1P.<=?'ERZZC%W
M:KJMKN;)Z?<IE(O%[KJ<YE* <1?<%RF B(8$>8>(8]>IH"".#9-X&P&<\QY9
M$.8_A]O/G$1OG@PC[\;*9#(G\NW44\7C'ES"%<GP& ]&1#/K^.J6-4T% 0+V
M-MQ;J-B;7[^TB_;C,+7< ]S6O:_0CQ[]]]AB5"O.<7&)@4>-6I(4B2A2IF.B
MH#LQRJD*IYHF+P"4< )RE.8Y XRE'6Q"\,94KQB3S&E1,4II!'&"D?MR(MI'
M@P&13<(&;'XC" ]\@MG F*&N;7"1O<5)\ %,E#RL=,.2BGWAO(V+KB=F3 !
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M6!N D3*:2FJE1CZ>,LN5$B2:Z0B5UD[8X*R[0ATS%(4ZAE%6ZAP)@IBY'!P
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MH^]D U&AVA/.O=A(A\+>FL_:])\OE^7KJ3+A$"B X]/R8'\0ZC,[0<,5YL*
M>H;MZ:_<_)CK,OWMO9_6&$7WQ?;_ %3B3X.GQF_".M=:!T^,WX1UKJS%>*2K
MAJJYIM\=OR78':RJ7U&#&BW2+TQ#<93 !3I(J%,82^: B(8$,AP8QZ#@59 H
M\W#9!R8_(Q0;R#0BZ8<0#D") HT$A@$4^$3<S#GAK-VD5=JY1,!3%5;K)&*<
M ,0042.00.4<@8H@80,40$! 1 0U;^F2%5A.$#*+&)3K1N90V4U.3<J)0( @
M!, 5MQ (#]+ "%$ S@-*I4\V)@>NH:/QV56(]=@6/J%^@QL1,!'(I%]U.KM
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MR<I^(Q#8$ R.!,(8QU$0]'/MS6BE14PNSF%.ZG8]JZ0<(*& #F$C14HB >.
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MK4[41Z?G'S1TD8S5EY'3LIQ/%%$!,X;@"9E"ID-J3TARJ$(<HY*<I3E'TE,
M" _(.L%M^L!$OK5A+RQP;-VK:I8,'?=2SH".ZD@7#6*04CX@JCB1(O*HH$*V
M.DHGWA@/W8F* AI\4P&?)JAD*AX"DT;%M 4@Z->L!B!&KF2UK.4"/="RMT^&
MI$3.:-9%#QS2<F2,B_,5K-R]F0CF,BI<,"NJXW Q#AVD4G:Z0W'[>]T=/7 3
M?4K:6^=GG%PG5.U&#.(94E?5,;22DZ,@Q4*\2G:?A';*5EDFR@ RC(X_EQ"$
M<\>I&[?6"VN;R[#51MNO!1T)=&@J9JJ&JI"*<R51MWT-4I6RR05-3M4(O&-0
MM91&21>/T)F+DB@FA-@R*8&O=HC@)>JPU-5#L.E(VU](EB7E;6:K>V=64U&F
M;KJ2-45!;YW7%#U VD7R2HL:@@[ATJN[9*)&*]30DS1(%\I H)YY=GG<^K[F
MPEE[CST3"Q;"Z>WZF)=,\?(+OG[J12A(!225>)F02:-"&FHZ;$Y45%%R+&1:
MG#"2AQU\JJZAZ/(LW810YC19G4TQDH$J&6.DSI8,SH?-ZQR)$C6NKJ^:0MN)
MXRJ#2B7Z^?T%*L^?Y2 T]'+E>4UA2N\V^ZU.5O5Y)6J],HD661Z&BR8L$D95
MAD#N+NRKG+MIVLV(VA6T:6CV]V^B[>4.UD'DPM'LG$A)R,M-R*G>2$Y4%03+
MM_.U!,O#<(+2,L_=..Z(D@0Q$4B$#(/337K7D>9WEE=Y9)&+O)(S/)(S;EW=
MB69B=RS$DGJ<>'BBB@C2*&-(HHU"QQQHJ1HHZ*B* JJ.P  ##3334,68::::
M88::::88::::88::::88:BSV+?TTG:5?WPE/?N><:E,U%IL5#.Z3M*@#X0E/
M?N=<:J?Y<7K;]V+$^1+^BO\ ]1<2A\\EP&<& <>P!_!J,SM# _V0-AGKW<4T
M(Y\!&GI+4FX%$! ?'/Q8P/W]1D=H:.;@;#?5NYIL/_J]):S+][;V?UAA%]\7
MV_U3B3H.GQF_".M=:!T^,WX1UKJS%>-I<_=H+'P(\"2A\!U'A(8<!ZQQ@/7J
MV]+H&;0,*0G>%!VS20RKDJH<*AUN 4LX3,8A\*<0B "&.8:KF;*4T-+E,1=0
MIHQ^4R;81*X.46BP"1 0Y@L<,E2'P4$HZI2",F6%BR%!4"EC&"[<ZR@"<AV[
M)(W"LIDYSN&Z:1$7*A?-%4QP*(@.=:M0NLKT]$,W;?<J#8BQ'HZAW;]-@1;&
M; [7OMM>^UB.T;7M?;WC'50 F]\%V+E(Q3?.4Q1CE>\ &YDFTT^]TB)(& #@
MY[U9DHZ6* $,DHS3R;NR\-TCE Q#%-S*8HE,'I*(" A\8".K5*B9K4],RI#"
M9-S)R4 L0$S\1D)!EY8W,4>,$TT4W;8O><8G,8#D I.(!Q=<>@^S^732DN(=
M)L=)M?K<%01W7 !T^-O:4ORR>E['U$"QW[3<7/K[,0N7(;FM]>=6%KF3B8:V
MU>0]XK NJE,S71:THQK!!*;IB5J%X\=>2G3;/W7?)I"#1$Z2BYVZN"&(,8U+
M4C;BVN]F1D)ZN%:CI7<-MG\AA7RLU*0[:;G]I]QX2"*R;1L.JW779510\M)3
MU-QK@RBAQB.-!59-TJJ:4?M&:8ILU11P3\($ZK54O;>8:H."S1X7W I:36B*
MT:31VH#',4WS)Y&@,DY%([9N@)?*$Q.&8M;F%J:S ;>:S9';U.EMYWNT@]1,
MH9&';4]0%W JBRM2T\]54:JOE::GG\[2=1('<*F3C2-2 <![Y NOE662"C\H
M,F1-ET<M-GF49_EDE:SR5313JD5=E%%/2@QHL-3-E"U*66659&=5>.G)MZ_-
M66/+^',Y6)^>)J:HJ*E)4IU$>55U.DJZB[DO+E^?YY"\A104I5] G63]=JQ=
MV\,E<#:PPJ*XU_+:=GP-AJO-*5YM]AJS10J;<U#&J:!H6G[BU#1#=.X5*0S%
M5C3,[$L4VHMIDRI63AL)7CE=";?LC*GW15?V?>WF=WBL*@97S<4W((S*U7M0
MCZQF*99SDBVH6?JV/ J8LZ@FZ33BW[XBJ:;I;O4W3XA'JS@A;V;3'50%IVM:
M:JUG%M)> JXG&TBWCM^T(B]AXU4 (I(H(.U@;+)%;*.#I"FHN@*B2AL".LN0
M  # ??YB/,1YC[1$?CU]FHLZ%;PWEE U#!#-3%!)4!.7*33&IA8"+2'C>=I2
MU099IM:P4H01"-A)\^JLADR_BC-J\U\LB3F1%H[AXDYI@D!,P;3*L(CM3".&
M!4$\]]8=0GY['S4W:NLJ7[02V=V*H:R\G:^YEF:5C:;?H&.DV;.*&J"4;5G1
M<>_435;LYD6KU"=(GPG$B<ZF]*FJ"#@$XU.T?W5;=]SU ;(FEB8:MJ8>68LW
M6EMZDMY4:46NRMW#FN=-2=O:%AY"'@XAM4S]M!N4U33C'RDLBR>Q+:0#YY$I
M917],;='M-L#O,M:_LYN+MW#W$H=X[2DVS20!1O(P<VV261:3].S#4R<A"33
M1-PN1!^R6(84U5$5B+(G,F,;.V3YGZ[.#:S=:&O)2- 5M7M8TP^"3I,MWZU4
MKN!I>33 X-I2*@%8N/CU9)GQB9F\DTWZC54J:Z)"+IE4#Z7DW&V54F6Y4M=3
M5K9AD23QT2TSH*6J6:*2$<\.WW-@C@,P1F!0,C$,T>/F6>\!YQ6YEG/U/K,O
M3*^))*63,FJHY#74C4TT4Q\U9!9U=HSI1SH 8AE# 28R;[)&UE<V7[-_9];J
MY"+QE64)9:EG$O$R &*]@1FVXS;. =)F\Y%Q$,9!LR7;FP9NJD=$W,@ZQUWJ
MV'W$79[2_97/V.NM<#;VQIG:UO$B*FO;1]KZ&N;&QKNH:OV[KPM$S32Y4%/4
MC&K5&$0^EHU91J26<&IU=)BJ5$'8A-"  4   P !@ #ER#V:UU\TJ9VJJFHJ
MG 5ZB>6=E7Y(:61I& O?8%B!?LZX^ITT"TM-3TJ$LE/!% K-\HK%&L:DVMN0
MH)MV],><K>G6.[&R-8;A+=HJ[L+T5/<G:ML_IBR5?VMME,.H:K;KTQ?6I&5[
MZG5/;>+)05J*A9TE*P=0UJC(FIF.=4@B080)(Z!VA:TVAVDNE3G:!/JMG;<U
MK"TFI=#M:WJ512=/2#.#%A7NXBP<O0;PL@JD5N#6L8B)E)*EU1,!)AA'/7#(
M5$VZHAZ <?RZ?@TQ_+(ZHQ?B"^REZX7;1VA':4QEUZ)O;&)WXOQMPEK35!3]
MAKP5W1541:6W2B*(?2A*RHBC:@IF+CXFJFJL5,JR\G'F8'(HY73!HFLY3CTI
MB0[4V(J.Z]0-:MN8RW!1=KMV[B_,,ZMW<6!MNYJ1X_DF&WI&D[BW3JL-OJDW
M#0ZL=)61&Q5/IL)MZ1E%W*%JW6DE=>MK'CS^4?P9QJE:ZH:D;F4;5%O:^IZ,
MJNBJU@I.FJIIN9;@[BYJ#F&JK*1CWK<PEXD7+=8Y!,0R:J1^%9%1-9--0K#X
M^/C]]X1>RN>KP^\'>I;.F*IW:S%HJ3L9LKJ>DX+=\]NBI7T%6=P&=ZWUQG3&
M,NTU955%,YJ1B(T\DDHW3BCS[*63IP I]!@ 3RZQKVT;1K";1J<GJ9L71:E,
M-JIDF4K4\K+5'4M9U343J*8$B80LU5E82LU4$@S@(A-.*@F"[\S.)8E.DS13
M,NY.MDIIAAJ,SM&?]W=C_P#?FVK^^$CJ3/49':/+)H3.R)94Q2));R;6J*',
M( 4A"A(9,81Y !<Y$?  SJJ;[VWK3^NN+(OEC_>\/P3V]F)+1'A,/!SXS& P
MA^L$##GH'MZ^/B'76,UXQ&#K:E)EC@'+Y46KI,,?3D>!0! X!D<#DP9QXCZ-
M7L&NZ<3<*MP>H"!%%0.H!R\.2',!AR(@ Y$!$,B'+U:QZ>/5+D7+%VU*9:&I
MQ ZQ% #*7&@18P^<&0'H&1 0'T\N>H3,K*JJ06++IMN1N#?PM_=WX(#<WVV/
M7MZ=/?\ 3Z\6$[)L1-MAGC#R$U][U&$/0)JR="(<O6.I-]1D=DY_2Q5  = O
MU>P SZJT>!^+4F^K8_D+ZL)OOC>SKUZ#KAJ@*J$AZCH] 7"B1U GP!(O%P+)
MG9-T3\8 42G[L5""!#&)R,8P#YH@-?ZHR<*(S\68P-S 2.D.Y3-Q"Z67,LTX
MB-BCA,H 0I3*JF')"X 0X!'5=0+PN.H]&X[UU+J'K*W (W!W&^,)LZG?KL1U
M![#[#[.^PQQ'C]0[)1P0JA?(D'S!(J:9N,KA)@<@+(@8O&J7RCS$S&\P1(!N
M?")B][28(EIF!*W$@I!$L>$4U 5*(B@3C$%"F,4^3\0B8#& 1R("(<]=8Y*D
M!"\"?)=8%!1 1.)U$GATES 4  3^:N)L";'/! $"B([E#B9&%/&*<0JPDG)Q
M)SB4"D4*W=J*-SH@ _J(M5D )DJ?0>$@% N=>EN)7!(-T4[=+@ >XJ!:PM93
M[;) -"D=;D >';T &S=3XCM!Q:[<M R4W;-RM#HQRLK"2\7)M?=8SLL:"*BI
MXN1"0!@8CQ5@9A(K^5-T1^G$ "G 0#E"G4%"TQ>FRB%%5-5+:%K!:$F]I3VE
MB%\FFIJ7=3=2Q<9/Q2[L5.XB"4)54G%J(/&QEC1Z)%O+ [OR@GH KV.5EZ)J
MV,04,DX>TY,MVRI!,!TG)X]<6ZI!*!C =)8"'()2F,!@ 0*(\M>9ZM*!;2UR
M;F71ME4C1K*TE<>W"[2IZ@-)2;P6DI -HQX>6:N6R;61)"UN@Z]VG9P!%6+D
M",T%%%&ZA"_,/*7/+E$M'G=-0"OGI>74"):AH9H4I)!45>84P5D#3T-%3R2W
MD=(@@TR/I8HWILH>(Y)FDLU.]4N524N8<J.-27@DJ(LMK8Y79T40'+<QS"1U
M).K0;C8%;X]FI?IM(63LG5+6K"S=QT+0/K)*PDS4ZKY%W<2TYJIMX2G&<><P
M@@P7JBEJ34C5TDP<&93ZB*BIT$DA&+K8#ONWZ7+WA[8XRI;V7+J>[=P+UU_1
MNZG:_5TK3DW24/;^-2FEZGJVF:+@(5N^L="V:6:HQL>A5#IO,5-(*,P9N))D
MLZSG;M3FW]N+N[P+44G;0S*+C[U4EN@IE8DK3D C3E$7XI& E7R48AW+U9\P
M=7 I:IUH=JV4;D!J"2)E$G)5 #TE0M/TOY4>KXVGH1A,U$S;.7\PTBHM"7?H
MN$4UR$?RK9JF\?%*!BA]/<+%$2@(9# Z^Q9-FM)15?$<,>705%-FXI<WRV1X
M6C\VI\XH9)HT4SQRB5!%54\K"$PNDL,11XW'H^&SW)Z_,J?A2K?,9Z.3*H9,
MKKXT92:RJR*K3+YYG6EFA6&9JB@J%TRBHC>&=Q)$Z-I>J2_4ACIX9SG'@//G
MS#7G][5>V%00MXJ:N\I%NW]#U#34) R$B'>!'L9V#D7IQA7SI,148%F8YR06
MBY@*03BL5 PK@!->@3753<%"U+%O(2H(J/FH>01,W?1DHT0?,72)@$!(NV<$
M424 !\XHB7B(8 ,02F !#Y]Y2>!H?*#PM4Y!)5^8U'/@KJ&L,0FC@K:4MRS-
M"2.;!(CR12J&#!9-:ZBH5H9E0C,*5Z?7RV+*Z/;4%=#<:E[5(NI%P;&X-QCR
MNWJO/%[@*?LG1]&6]D8.LJ:>5K#MZ5BY=S4,>JG5$K$_.K3M(BLFB[6;D18)
M]X1PT;EC51\G*JZ146=AZ4]O5!/[861MA04J<32U-4=#,94!$# E*&;%<R#8
MA@$2F3:O%UFR9BB("1(! 1 =:T+M\LG;.45FZ"MC1U+RZQ> \G%PZ";TI1$1
M$J+E7O56Q1R("5N9(! 1 >0XU>/7E_)GY,LQX1S3-^).(<THLSS[-:*@RH?4
MRE-)04V7Y?#3PQA5*0F2>9:2F,A$$*Q\HA0^LL-7+,LEHY9JFIG6>HFCBB)C
MC$<:I$JJ#I4*"[Z%+65%!'HJ 3B++=+L5'=)O@LI<:NF=;-;,4#MBO31#^H[
M>W<J>UE0-[AUG<&U\E"1+E6AZ@@JHDXQU3L#/N_JUXEL\:H*..[> SX\%-R7
M9PWGE[_U_$6\VV6ZNW!7:>;1TK4[T[B7>.%V-F=+;="P+*2@VC&?:2E>3[^-
M5AI6N:-D:-DSK7!JJMIJ/NN[&-9MUE?1QIK[+CLX\Y<GV=]]Z@W1R47);9;/
M'C5=VER=RDQVAC^NX)[<>N[6US0]10Z-AI>W7N":K%WBZ,TQM--TS).U;0L[
M>1(51!($J8C&.0E;[.>UU962V4;>+0W!MA%V@K.VMOV%%5#0\)(4U*P[.0I]
M=RP/*QC^DU%(=PSJ--).=2$H)/2 ^[J22(^(N&LV<!UQS].FF&&FFFF&&M!Z
M?&7\(:UUH/3XR_A#3#$$>P&KJJHFR]S7L:T6<PTON(OBV,J4!$C9VA5C@J@A
M@!#B,&.H?'J:6V\BM+43 2+@3&6=-53G$_U0B5TN0!'UB! '[^HX.RPB&$WM
MLN4QD4"+HJ;G;^8*< '!@J]< $!P(EP F#XO9J4>*CF\3'MHYJ4"(-2"1,H=
M  3F...0<LF'PUK0(P.O42I4V'<=0_@;>OUXNF8%B+6((W[QI'S]^.PTTTUL
MXIPTTTTPPTTTTPPTTTTPPTTTTPPTTTTPQC-NFJ92#M\$>V,)7<XZ%HD!1$#"
M0J1Q4QCT (9]'H'IK"+LPV7N;<3>]'B&!:7DII(P>'%\ZQSCCXS<]97[MD@6
M);A,<87J-9L8!''F*H% 1'GC'( R/IUCYV?K0K&^W:!,RXX6M^8!$!+]2($I
M0 Y>KG\8:TKDU1OT&E5]U_7V$]V-@6\W>W;8GUZU'T=WCTQ*5IIIK=QKXMPS
M [*<JEFX ARJ/VD\W @&*!D'#=-(045$ZAA4(LW$H%X$TBE#"8#DQM*M1;_.
M_5BJQ0(88Z32*8" <#"(&*AQI%'SR]X(<0" B( 8IO#7*J$?<ZI(F1Y<,Q'/
MZ=P( ('?D(I*10& QN PF%%ZDD4"@8RBH<9A*!>'IJ@*HJR%!RZ50&7E*<;
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MMN'GG2T]5]IB041=]!DLN]/52989VT>,TDQ(+1:7>(+*,TY95%!1=1@DV.Z
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M/[X6 _<XOJM_EI[?I3%B?(E_17_ZBXE)$< (^@,ZC%[0T<W V&#Z=W%-#_\
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MWV%@;@GH0#B>6324^99?/$+RPUM++&-]WCGC90;;V+  CM!QY7J_FJ<G[A[
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M2Z$;=*6(I2547#G%K;VMJVX3:B[;T49D2K*^K)[ LSLH2G80\@T*N0SEQ./
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M%MM/1,E\_5"4R99CY4ZEHBO$E'TJ^LM4"R;SOQJ6#X9.3JVQ\_&.I.G*@HZ
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MBK+.8:F0/(7?O*Z4M59^ :&S(/*MJA T:$PDF7)BM:;;O!E%UQ#NBK$:HJ&
M%LA66U^@Z1VU6#MG9P)5FO)T=3+%K4KUODX2=6N$P=U/)G4 Z@*J/)E9T852
MF$B@ 4Q"E*/"%3,.8H) "@DWMU:P !/0]OCBP;1MMNY '3HINQ/;UMV6QE9J
M,OM.FBD%0%B;R !3M;*;E+559*D-Q 4D1+SC>F9!V<P%$"I,T9 55!$Q>I0
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M*=M1NBA(ZW%W06(9-E2UV8'"=#5.^,<O"5I4!'*\>NX+PE0[PZBYQ(APA-6
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MN;_A/A_$8:#^,G_&O\<2D:^#ID4*8IR@8I@$IBCS*)1 0$!*/(0$!$! 0$!
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M]"EMJ<<(X[Y*]4PF0^.7$":B(G)GKPB(XR 9SK=#]A5P?5MUML>WJ/?C7*;
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MD$J#9))!--,M2ZA%D-]?:"QDD:(>;9]OQ'Y3"0R:=U9Y5,# ;AQWI2 7.?\
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MO;9]VV7_ ,QK7WW.UA\-I>VWX[VRX>W_ +G]N!TUCN;L_!/;:WTC#EG\9/\
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M&-E3ZM+ED1,//H(8#^7+77IB8ICG#]8<?D$<8^/(_P"G78J  F3Z (&SZ\
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M0.0P8-PIB<A '(YS@ 'QYCGU4[0]4&K*.=N5$Q2*W="D0PA]4 &'&<@&0\W
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M3")V@F#(" " B/AGD'Q#JT4?/FIN;+(4NHY;QIE.-:.> 0!$N.92&2$Q.>1
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MZP>:HBH',HE.', R "( (B&!''77?%$"B CC "'7IUUR.'  L3 "&0P <O\
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M$@@;&!SK"2\$<[E-TL8V8VNA;P./>C(I\YT\^91K R23E3CF3.WYTVX+Q7$
M(I\8**>4'%,!P.*R1EJDHBI]OU.1=!P]DT;@5U4[:N*!II6,DV$JC&QZ(1CA
MW(-@<E4672$JH"U6252 P(G$>' ?(X?*+F"9UG\-;EL2Y)DO$B\."6ER_/GK
M)YJG-,HR>BG&934L7#=Q69Q3RU=&N9&O2DCGEBII&55;[U4^2+*WX;X7JLMS
MB5^(N(N$I.+6IZW->&(Z*EIZ+)<]S_,:<Y-3YA/QEH^I^0545%F3Y(,IEKIJ
M>GFKH@SNF6TA(Q\0Q=2DL^:1<8R2%9[(OUTVK)FB @457+E4Q4D4P,( )SF
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M2T$DR-S6RRDI.-AF#J4F)!E%1C%+OGLC(N4F;)HCQ%)WKARN8B21.,Y2\1S
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M8@7&QPTTTU=C7PTTTTPPUF':\X_./#*'/YJ)'X#D1'! >KF .HX I0Y!TQC
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MTQLMW#>02*Y9+$<HB(AWA#E$ X>? /"(@(EZY'F/CX:WS&((Y(<>(, (B
M!UYACU^WP'6>O3&>WW[>[Z/WX=V41* 9 W& &#Q* AG/I ,\LX#U:HFX=<,J
M$@U79Q*=\L04F:/$'&HJ?S2X#F8V!'(  >&JYXBA].$<$3*8RJIA$H"!0SS
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MZEJHUJ-1ENYMQ-VKIB?C+=13Y:7(UM?+04S30MWB2:RKNGFS=JP++',W.#M
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MHL)" *AP(4#&$1 H!RUVFJ^IBW<Q5D4E+QSR-2;K% P).E5BK$ 0SA0$T3E
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M(DZYBQE8ETP01*J9$R+PZI'!3% !$PE234+PCG #Q#S =5<-E*JP(E>PQA\
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M+6GHT:UAZ\8,U(&:AH26I\K>GTV,5$R4=,D53=EE6+=F4KE<I%C%17*9,Q
MF>("@ W^I^BQJ= J\14E.K\6,)&<K%5#/0.'N1R/IP/LSKAUG1TO0[9L]E 2
M=LG"I4C.8T3KE;";_C'!3D3,5,.63!GED0SC6]-PQD=1+/63Y/12SU%?1YK/
M5/ K3R9CEZTT=%5F?[Z):5*2FCA*NJHD*IITE@W-AXPXDIZ>EHH,^S**DH\J
MK\CI:-*F04T.4YI)639C0+3#[B8*V7,*R6H#(S225#N6U:2N.PV1HP;1)V4\
MHG?G.2*W(5QY>B$Z(-IH)Y/+[R44<B^*!3X:AEN(IA@WGZJ)6W%.K5Q 7 .I
M)>[U-T<_H:/3*Z3"./"2+?R5<[IMW(G5?E2_4G!5B$(?SA1-TUDA&6FFYADV
MD8Z5A'#1TD59%0B[@<D.&0 P AR,'0P> @(:YWO*51]?PW[<Y_@^B<*9(@I-
M&34BBA@R>FH],6U/3Y!+-/DL46]@F6S5$\E*/_9M*YN;XLDXVXGE-<9>(,Q<
MYE5<0UM>6J#>JJ^*Z>GI>))YMO2DSJFI*:&O;;G1P1@@:<8VT!0T);6GDJ9I
MQ204CD925ER*2;@CIWY7,/E)!T JD11+W)5U# @3N\D3 ""8V,C:V4VS6VE&
M=0Q1WE;,X*I)96H'%.LJJ<HP#&H%UB+.)IC&&041,]6%/AP\%T@D4YQ22(?A
M.7.7WDZI^OH?]M<_P?3WDZI^OH?]M<_P?557P9P[7T%#E=9D%!4Y?EE-)1Y?
M22TRM%24LL"4TM- #ND$D$<<<D5RCB*)F!>*-DMH>/N+<MS/,<ZR_B;-:/-<
MXJXLPS.N@JGCJ*ZN@J6K(:RH8"SU,-3))-%-I$D;33*K!)I5?%R(MI3T+456
MU2V<2RTM6L!#TY-"Y=(G;>0PC-1BT59H)MT_)W:B*IA<*"<Z9U,&*D0 P-&+
M;=[>JTO15+IKU2P&WJLFK2M214ZI&U2P+,.W#V004E&J! 7;K+N5!*D9 O=%
MQP"!LB.:WO)U3]?0_P"VN?X/I[R=4_7T/^VN?X/K$W!?#M1"U//D%!+"RUJF
M.2G#@?5',:?.*U@6N5>HS6DI<P>12)!5T\4R,KH",T_'W%U+.M33<39I3SJ<
MN*R0U+1M;*<GJ^'\N0A0%:*DR.NK,ICA8&(T%5/32(\<C*<5;>6II2UZE2GI
M<\T8*KD&\G)EF9126.5TW0*@!D7*Z8.CBM@RSA1TLNLJNH<PJ 7A*'#N#9NB
M;DR$5-S1)J*J6$24;Q=44M,N8&=;-E!XA;&=M@-Y0B0V11(J410XU 3$ .8-
M9;>\G5/U]#_MKG^#Z>\G5/U]#_MKG^#ZM/"60MDZ\/MD5 V21R&6/*S2QFCB
ME-2];S88B+0RK5R/41RQ:'BE8O$R&UJ4XWXICS]^*4XDS9>(Y(E@ESI:V9<P
MF@6BCR[D3SA@T\+T,4=)+#-KCG@7ES+(I-\/8FP]KX>C*@H1*!</82K'1)"I
MG,I).GTY,R:8#W$DYF5!!TF\:B)C-#H"0J!S*' IC**";2C['451DF]G&SNJ
MI^=>0CFFTIFK*A<SSV+@W2)VZL?$BX(5-D44E#)BJ4AE3$ "F,(&. YA^\G5
M/U]#_MKG^#Z>\G5/U]#_ +:Y_@^J(^".&8I<NGBX:RJ*7*85@RUXZ"",T<22
M33(L.A !RIJBHGB8@M%45%1/&RS3RN^S+Y0^-)X<VIY^+L^GASV=JG.(YLSJ
MI1F$[QTT$CU!DD8MS:>CHZ:9%*I/34E+32J\%-!''B8QL[0[.V:5I%FTC)T>
MB"PID?/S!*D75D595)VE(M4T#H/&3U4563A%,AT>$H9-YV=ZDK50-(S*E0EF
MJTJ>;&/+$M9"LJJ?U >,BRX_F*/07!-NB4W"0IUS)'<&(7A[P ,;65OO)U3]
M?0_[:Y_@^GO)U3]?0_[:Y_@^KTX2R*.;+:A,CHEGRBFI:/+913)KI*6B5UHH
M8S;=*(22&C#ZC2M)(\!C>1V;6EXVXHG@S>EFXBS.2GSZLK<PSB%JJ0I7UN9/
M$^8U,P[)<P:"$5YCT"L6&%*D2I%&JV=U\G 1*8 ZB40#VB ZO)[R=4_7T/\
MMKG^#ZW4K+3:9%EWDE'@BBBHH4C,5UEU5"D$2$+QI$(0./ &$1,..@:[PAE/
MX#>T8\SS4_&'S_'\.W%YHJ(I^IJ>B'2[!JL52/;%,;NR\8*)HD2/DP  B/$0
M>8@(^D1'.MYK;^E6:I5DHM(3@.0$Y0.'%D>8ACED.7HS@>NK<V0G5EV#VGG:
MG$XBEERE*(AQ%(5<Q>8#YV,"'LST#GJ_&38-Q!C&1 <]<=!^]G\(:WH]#JKZ
M1>UB2.T;'L\.S&H;J;7(MXD>(]_7%(3=#TU.(^3N&:*)P*)2*-RD35)GQ#
M;(8#',.8:M))6BG(<!>4E.+$71,*J23@QSB(!D>#)CB&!P'3GUY"/3('@*J8
M#Y$#9QZN(!\>7I]'WNNMSB,0P H/%GD !CGZ_ !\>0^&LO"C[D6/XR['^_V@
MXP&(]5[V[#_"_0V]^+&4'<R8>2:M*U/&+)2S7"9G@%$J*P@..(H<(!R# Y 1
MY^H,ZO@H;A# \\E$>OAC_3KKEH2+,["0(U1(\ 0,*I2@4Y@Y?5"'/..H^//Q
M'7/4#*@"8/,,0,<_2 <O ?7[-9C5U!#MJW]$GK:W;X_OP)!Z"W2_K[>WIV_
M ^.\(DDHZ4\TB)3F$1Z8X>8Y\0YAGT>O6,L8D>ZE>.7#L#C#0JQD^[$<D.9,
MP@&/#ETY^GTZOA7,D,11LT\*.#%0.4@AX&.8I0Y\L>W.J$L;&>1TPXDU  5Y
M)TJJ)@ .(.+ ]1YXS]X!'4)/3D2,_)'IL.^VP!_A;>^,KL"P(N; ?-<^.Q'?
MT]]JKHV$DJMJV//'N0;0#?!Q;$ <\0"4>$1X@SPX'PZ>//62=(4NPHR"9Q4<
M0J8IIE!<P=3G#ZH>$>8"(CG.?3Z<ZJ8IP3YB &/G(F$,B #GS>OX^> Y:VSF
M$XB80P&>G@'J#^7HSJ20HC,Z]6^8=P\,1:1F4+OMV;V!(!))Z&VW\,;9AQS
M.?0/C_ &/7\>NJFY1"#@Y28=' I6+59< $P (G(0YB]1Y!D \/CQT[7SL@)1
MS@>8>SK][J B&K(;A9<&5%A'-S]VM,G,T P"(" #PE$>N0 !-R'F'MZZE(VA
M&;N&WK.P^<X1K<JI(.XO;U@^'9OWGOQ:6SC!&J:HFKKUNJD;A<.&<$@Z ! J
M13\1#)B; #D"Y#S?0'ASS78.T'S1!TVQW"Q1,GC !P@82] Y!S =1Q+S:S)I
M!T\T5,W;,VZ:S@2")>\5 ,'$V!P.1-G(AD>8B(@&-9Z6[4!6C()0#"<#-E!
MPCD1PY7#KXXQCXN?/6M3-N4%MAJ)_"+'3U]73W8MD Z^( %MM(!M;W=N*TTT
MTUN8JPTTTTPPTTTTPPTTTTPPTTTTPPTTTTPQ96\$U6]/D@)*CVWE:9'3E.50
M\W)D3(@*(X-R'!RB \N6=4O3-^6SM1*/J:-68NC"!%%,>8!P'.<%*(8#P'(
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M/JV6!%B4Y5FS#' )""8!P8@X'(E'K@,XY@/+-:/K.TH\[LH$51X"<)BHJ=V
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M@7A_\'&/5KI3=E#8(ZHKGNAN=.N(B(K'O;+G5$1ZB*AHX3B(^(B.1].L-SR
M$4+;J2P-^G3I;WXP%B!N7)\ I'OOV?%CB^)Y*MJ[6.DS8OQ35#B(<Q![@ Z9
M'H'#PCS <#D1SCQ[V&L,]>%4/4+DJ1E0$131 1#)L\C 7.1 <YYB'//75@T.
MRZLVU##6\^[%J7P*WOW4"(!CP $V1<!GGCIKE_H95JOV==WO_2%J;^"ZJ$#7
MNZLQV_#6W[]NN)$IV26Z?@-_'ICGW+VSO(\J<C"B== JH"J"9#") # \1@$P
MB &Z    >CH :QM""=P%2G8N$%.,R>,BF. ,4Q0Z<^0<\]1SXXU?]7LQ+2+D
M%->^&[A9,>I%=P-2*$'VE.T$-=*IV4-@5E 66NAN=56#D"JE[)8ZH?\ SAHX
M3\_'GS\=5O2LQNJE0>PLI[O$7&WO]>+%E4"QDN.FR$=WOZ;^K;NQF/8\RIJ3
MX!24P3NP\XA@#(E-R#.>>  0#'+GJ\7=*#^L-_@B'X=1TM>R[LVQ*)&-Y]V+
M(@A@2-+^5"V*(!TR5%F0O+V>(ZY/Z&1:C]G/=W_T@ZE_@NMI.8B*O+O86OJ4
M8H98VO\ =#O;\!NRW\,2&=TI_P F?_!'][3NU/\ DS_X)OWM1Y_H8]I_V<]W
M?_2#J7^"ZT-V9-KP 1;7]W@LU@ >[<M]P=0]ZD., 8@+,54Q$.N#)F <<P$,
MAJ>J3_5_\X_A@$C ^^';;Y!\.\CQQ(>4!*(@8!*(] , E$<9SC(!GXOQ:^\\
M\>/H_E[=1C/]FV[>TY32FV[>O74Z=KQ"WH3<>U0N)3CY+!LH+3Q$TY-HL8N$
MTW*; _=#A3!3% 0[6WF^>IZ"K.)M'O?MBI82NY5RG&T[<Z/55DK!UZ^5 O<)
M1=9+"9M3\FN4P&-'RKDR95BJ)G=('(5(7,L0&4J3[1?NN/COM@8[[HP?:Y N
M&'^Z=SU[+XSZK&M(NAXP7\D< .(&%)$!$3*"'+   #^'GS]6L%+Q7$)>>$&(
M8\30L>L*I2#D"G,(E >+(8S@G(!'(9]6N9N%K \U4AV*3H5&;-(HH"BL4[=<
MI\J)*I&3.9)9)8@E4352,9-1,W&4QBB C:FW)F+DLRU>&(B\[DRJ \0%$38.
M/41#.1 ,!C'H\-:$T[2.8P0$N1WW([>ENO9O_&Q$TJ'/RA8CN[.H_=B1*R$>
MO&6\A6;@0%1) A1$O00!,H<NO/E\>-75U8RP-5%GZ869', KQ2XMQQCF0H<.
M>HCX (<@#&KZXP?'7F'/V\];\)!B2QOZ('M&Q^.WKBE@0Q!%C<[>O?'SP<8#
MZN?K\?4.NJJ-D1[ 2;0Q0,"C)8 *.<"8"B(9Z#S'KTUW1N7G9Q@.GIZCCX]8
M37JWNT';RL%[.V]H^M-P5\%62ASVWM3&DFDZ=65*0&OOBU,548JAF:Y505%6
M2%5VF@0QQ9@!B",G( ()M<$>OL[-^WLWP568V47[^P#Q).P'B2,5SMSDB@%1
MPPB!3-7RHE+GE@#@& ]/CZ?1K)X>(#9+G ]0X3#GG[/#U<QS@.FH@Z0VN[^K
MC24K+U_?>F-L%.3:YW*E(6-:#4U7"BN('%E(UG+$:(('(F<4CJ,@=@5=,%T0
M( \.KM-^S.HE9,JE1;F-Y-221P SE\YOW,,BJK"'TPZ31C'))H)F'(D2XE.
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M>;'" @8<\\$$,!R\ 'GU ?5S\-"#PYSS 1\/#F(_'U]6/7K0Y#F. @.2!@0
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MMV[&XE:W.M#)732L_="D+I2GSTUK:NJGLO\ .:G*4[6,BH[E6S>F*F6;?/!
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M['T#3E;OJKD/(T:-J]>1:Q#ZK*6I)V8Y%Y&H+<LJHH]Q63=(%0C"U,P!<$1
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M!*?O .3.0'F.,>( (]0P'+4C&X+^@5=X,\_>SK3&>HX@'N?7[?;JFF4-'*6
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MJ(&>KIH$4(MPF4.!2B9,"FQS\1 >7KZ:^V[A"1;E=-E"*)*!YIB" @(9QGD
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MZ1R(ZRG@X"+IUFFQC&J3=(H 4133*0QQ .IA#'HZ9^_KN"@ !P@ % /J2A@
M OAR#I][0>+/(,A_VZNCB6/?JW:QW/J\!B!8GU=@'3'UIIIJW&,:#T^,OX0U
M&)V7/]#S<3_?;7F_RN,U)V/3XR_A#48G9<_T/-Q/]]M>;_*XS5;??8_T9/\
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MNT4?W]5O]\B_W[W[M.+$ORY;&VR>OY0M;Z<=D_BFE.;DFL1' #=H=,RHMT0
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M65UJ*=4JH8Q;_5EHB>4$9P--I8D"BH0R+&KKC$#<[N;VX[1;4DO-?RZA+?4
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M-]AL?4/$VZ#8XH:Q$8N=)>44(8$CD$J0F 0\W@#AP(ASY> <N>LBQ,!C" =
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MTC"I'.4CT)!)1)+("H! X\FQRP \L9Z#@<:VX&?]V]G=S2G5 ZS"VE:-U R
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MIIAAIIIIAC95,(<!"AS4'A$1Q@ \>O7V<_E$-=!,Q#>>BGD.\*!TED<)&/U
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MGBZ@?J8AW8B&.G00]8X 3<AZXY>%P1 !*8H@ @8,#GT?@^]K8CF#9FJNL0
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M]F)@Z!>]F(]P\=^MO=VC%E:-V[TG2TB215;-7:J+E-P@0R9CD*8A@$.1^0@
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M7UZS(4. >/(,_&(9\0SK#+L[N$VR+;F '#B+1+D1* @(\JCFQ$!#F(<N0YP
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M,X$ @& 0$"*IF5,!. 2YY"/35$KDQ ,!=B8UN=_1)  V(OJ5=@/PKWVOBV,
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M+/88)86T@F9!J9!J +(F+J1V6(DA&NU#B57NB@4Y% $4D3!&*%/QE$1 B8X
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MN<?@UR")F.7) SCJ&,"'LSC/R:OQ D].EM]MNMNO>>GO]VT4HESG'/'X]?8
M(] \<:W"ICU$.F<@/7QZ@/R^.MP,!X!\G+VZ=U]O'&0M]_'IV]1^Z_=V8TP(
M  "'+&/4/+6T8N.8=/#Y-;XG$0P(!C\'L]FO@W0?8/X-9-NPWQ.UQN+'LN;^
MV^-C6\@0#J% 0SYQ?3TSSULZY+?)52"7!@$P9\.@@(!U\1#\>@ZCUC%0!ZCL
MWZVQW;L.%H&?3]X/Y9UV+#^<T/[#_P"\.NO?B -2E']<'X@_?USX\,,VX?\
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MB1(PG(8QBJ.DFQ@(42@*B:9C&P3 VE0\$UO1],Z=KE?06.]K]003;;?;KOB
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M%G+I*0RYDRE, '.8[Q(F!(H!0,*@E+P"<O-< 5=9%00(N=XX4623.8Y?YG2
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M;IMW=.AZ^-[XXVM#=!]@_@UN&*(!Q>!A''RCSUM&$,#SYXZ>//5>+0P(O[_
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M8)B.0\?#ITY<_P"0ZWBIX# \A#V?+\OKUJF XR.<XQ^#^7HUN:8R !TQH'
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MH&]M-KG&9B=0%[@"X/9Z0!)'Z1]*^U[W(OBWM-MBHM7D< HM^XFJBBR))E4
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MXO#&H*@06&Z]?5>U[VZ=?'Z#B18L;G:UK6'=8=_A?U_-Q1*8I0 1$2AD"Y\
MS_+Y.>N.?ZH?B_ &N6H42\L\@Q@/B]H_>Z^/37$/]4/Q?@#0]?=]'QW>H=,2
M_ /3:W3V=?'OQ\Z[)L.5T\>'  _X9==;KLV?ZH/J ,>KS@T4V8>NWOVQ$=&/
MJ^<_W8Y<L8N$^?@(?>-KM8[^<F_]@/\ C&UT,F.3$]6?P@'XM=]'?SDW_L!_
MQC:L'RV]7\,1^/CNQS=---3PPTTTTPPTTTTPPTTTTPPTTTTPPTTTTPQP76.^
M;@8< 83 /R<M=:=(H%<,Q4_52' AL<P 2\L<^> #(9QGF <P#7;.0#*8X 1
M38Y!GIX:Z[B)C)BCWO0HXY_Z.6/BR \L!K!\?B^W[^S?&.WX^-K_ #[XH>D*
M$CZ3=2#YL8#N9%=998_" #]-'(Y'(B(\QZ_?U78@ XR'3IK3//'/IG'AU^7.
MM=8550:5%A\;X@6+,.[;PV-OCNQM.V:$G'O(QP'TMX@H@/+E],(8F?5C.0#'
M,?$-61LRE+4]*5/1DBDH+-J^56C7 \7"9N!C@!"B("4.0EP #\O+5]BE V>8
ME$ Y"'/GK4J+43]Z")4W!B<(K 4 .;H(Y, 9$#>.<\AU%DU.C@V*GWJ>H._N
MZ_/BP$BZFUB-O81;J#ZNN^/LA $Q_24<  @'/'0?4(X#T9'(ARZ?0@(#@=:I
MCR'(_4\A]89$0'KUZ_OZT$<B(AXZLQ@=.[]WQ\V/LRI2XST$<<@'^7K'U!K[
M')3%$H\91YCTY /KY9Y].GAKY!,V!$  P@/(!Z?*/C_+QY;#MZT8(F<2+E%J
MF7)A$Z@% ,9$ Y]1Y<@#E\FA(&Y-AWG&<<L0$Q\@(@8 R)!#D/3D(^OV<N?A
MSU1=6US$4C'+KNU"B],0_D[-,1,HHH(&!/ZD.0"8/;CXLVZJ>[W?F5AJ2;*O
MI)8>Y363*!RE$0P!N6<"/4.8> :X5'6MDWSPL_7BQWB^052:J',8A -@Y0$@
M@&.'.!#'+IT#6NTI8Z81J/:_X*^\6/QUQ+3;=NG=VGIV>W'$HFG92NIHE8U$
MD9)BBY379,5.(0,)39*(@;'+(<Q ,@'+//6+/9;$!.W.X9,H8*GNSO(0H!T
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M.F"U9(MP&3F42F0%4HB=- Q2&XB\6<"; !D/7C5[-P1P&QMXBX$!"V=:#S]
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M-Z0QCX\ZPO4>O$>PD==[B_9M;WD_%L?+]3*HE'G@OLP(\_P\^6JCCOYR;_V
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MT0'D #C/+F//P]&!^4=:KN&C),57;E)(I2\0\1BEY /4,F#/LQ\NK,5%>1!
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M.@*TV9;?I8%56<HZHM9=1=,Q2\:I9^93+^MR( 4A<ATY>CF%YY"WMW* 7[^
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M+GS#'3&.>JY) @':2;*!U)_@.W&42]CV=23T%[>^W[\534EW6C(QF<*@>1=
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MIM*%K+>=:!XF+68IO</,5ZW:F$.(U.W CF2T>X H\Q*=W'/,B43 7B*4W";
M#6Q DC'>'_\ MQ:OWN7;?T#Z@#O?M[1O:WCB5_3335F*L-6SK-%5M4%,R"*!
MEDY('U-OA OF)$>%3=,7*R@@)4R(.6YR<0CQ&[[@(!N(0U<S5N:K46DIV(B6
MJGF0R:E2R9.\*4AA0,",0U6((>?W[CREP0>(O=^2\8Y ,#K5BZJ>11?4P 4+
M\HM<$6V.]QW6 O?%T!TRH3:US>^PL00?IV\;8^XUPJ2KH]L)$4DC4L[3P41
MZIVCV/*0HAD"F,EQ+Y,4OFE$"";H W#U;A I3U9""B43&29S9U%2JB4"("FW
M2X!)S*?O')BK<)1YB8%AYDQJX^E*;Q'I8,0+=+6%K>%CMC$HTL.NZ@F_>;X:
MM0D"83E1H@8PIMYX,'(H5,&0/HU@\<F%, *"AU'*X'2$1.!CJFR(" %U=?5I
MF:7E<A53U(Z)S'J5PFJV "'507BV+%JW[X!. D.LFV\J3*;NPX#)F ! .(:,
MQ^\KWZCZ[:3?]W3<=1OL9TQ D-^A0CMZDC;;P!Z['H=L=Y;I]Y? ++^3HM\3
M4V@!$ ,!#E;/U$"JF X />*E(!U!  *)Q$2A@0U7NK?4H[!C+3<"JH847#@T
M[!',8HI'CG)4D7K-#&# ,=(IJ]XF<!4*1R14QA*;(7!UM4[ZX8VVOI -A87
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MR<)B&:*R!VO?D/P]Z5,2$'ZK$93:*3:_HD6[[BW9OV]F^,)NZ]@U"Y\ ;G%
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M+/AU#5SK77!:U[ )BK])E([#>01/]6!T@*4QC!@!YCD! !$1SCTZRC,&T/\
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MHF)G3L0XE%%,#G)Q#BP CT\==?;NF&U.0B+A5/BEY$G?N7"@94,98 $Q>+P
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MD/'WR1%B?JJ21RUO3TZE-M#B8@M)1D<&TS&*&RO'/P >\2, X,HV4,4RC)T
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MB]1(HFTE*JDQ.)(U;Z8JD1!51/@04#5?;HM]K6D95S8S;)&-[V;EI1)1J,#
MJ@_I^U[1<IT#U;7LH@16/:DC#F!=&'.N*RJB7$^!!N %7HO:#$TQMOAZD/6*
M[^JKP7/F?GKO)=28$1?5;5*QE5#(LTR@";*GHA1RX;Q#1$B)13,*RB91!-,E
M$DBW5-0 )!)[+"Q !\=M^GSVOC5E',M=K'0O;?IJ(/8 21?J;=F^).$D46Z2
M3=NF1%N@DF@@BF4I"(H(D*DBD0I0*4I$TB$(4I0  *4    ,:W-=)#U73=0D
M(K&R2*A3I\7"!ASGVF#P'D(#SY<M5 =(2$[P!XR]0QC(AD?6'@'AUU<"I TD
M$6VL1TQJLIM;M&YN3?Y_?UQLCP_KL8] ^/IY>/LU0-S*X;T#2[N26'B=NR"V
MCT0#)SKJ 8H"!1P(CZ0P/(-5\(\8E,0,   (9YY-[!]?I^+5'571D16PL FT
MS*$C7!7"*?,"BH7IDO$ 8#T\^8!X:B^HH0EM1%@>RQV)OZC<?-C*66VJ]@=Q
M;L)%O?\ O-Q<8MW8:DGT) .JGERB66J50SU4#@('*DH8QBE$#!R''IY &0#5
M[\ 4#"7F541X@](FY#\7+TX^0-:AW:2*#5$@)HMTRI)D+]2!2  !@/#& SZ1
MZ<NOQ@,Y]6-81.6@5=[6!)[]KGLZ[G_'$B2QU7M?L[+6&WA;H-SMWX DDHD9
M%8H':G*8BB0AQ 8# (8YYY9'IR !'/76'@$5L]>$"@BJ--U88G FF4QDTE5E
M1 1$, 0N  !' "/CGGC688YR @(AS#(>& _'Z]=%-TS#U"X:.Y5L1PX8"4S8
MY@YD,41, AS](8SX>G498R^DJ0'1@03TMM?;N\.\=N)(P4M>Y#"Q _<>OTX[
M4YDU4P50Y(J84( \AX3!DH8#(=!Z<N> Y^'%. 8SCGGK\0ZY8HE(4I2@!2D*
M!"%#H   X^37&-@,Y]8>W4@ 05-@>O3ITWOW'V$=.F, V(M?K[2+_&V-@ XC
MIAZ3!Z,<N?XO9Z=<]Z8"H$* CS''M# Y]7I#IT]O/@IF %R>)0-S]0\P#/X^
M>.6N0^-Q%3* 9P(YQ_+U\_1[1U$?):]KD[=]AI_?<XR?2;M!%R.^X![OW8Z[
M59QW\Y-_[ ?\8VJ03)Q'*0>7$..8#Z_C_ET'IJM&B8)-TDPZ$ 0Y_P!D.I(-
MR?9\?';B-K?PQR----688::::88::::88::::88::::88::::88XRYA*9' 9
M 3#GT '+KR$/C\-6^J.EOGBEXQPJIP,8]4%^[ 0\\P9'A !SRR&>@!X=,"-A
M=U6_7:5LK/1R6YV\D+:@]>A+#219:'J:5&8"%!O[J"C\[T-*]P#3RI#C%R*/
M'WH GQ<\8=!V[G9-   &\:CL8P/^M"Y/I_M0#V^.NU2<+<1YG3)54'#V>5U)
M*28ZFCRJOJ:>4QN4;1-! \;Z)%*-I8V=64[@C'/GS?+*25H:C,:"GG4#5%/6
M4\,BA@""4DD5EU*002-QN._$N@&3(!$A*(]V0")>&  ,<@#&   ]'AGUZ^0$
M_!@P8.)N(!Y_$&,!ZNGX^41WZ.[V3)O.'>-1PF#D&:0N2 \LA_\ (_QR/ZX.
MN<AH;MXNR=,)#?1C4>'" @ !1UR>70.?^M+D/+KSUM_65QE^:?$O38#(LTMV
M?[+XBQMVVMBCZO9(3MG.5]G^D*/;I_[Z_0^._< ;R;5A1IJEDXJ4:K&:NH]4
MAE3 /"*B9#<0%' 9$<@(<^7/Q#5?$P"9$3AYP$X14$ $1$  ,CXX'',,AG.
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MW#$X\_R#2->=Y2NE]6^948-K#H#,+[_/[1CT@[<HY6-M73Z2Q1*HJB5<0$!
M?IA"FYYQGKJ^NH7*-[=/LGH:FHB,5W?4:W4:,T43HC2%R"B0Y"%*8!X*0.0>
M8=2C@?#E@=5/^CS]DU\,2C?M2N5^9NMJ/@GC)413PGQ-<* ;Y%F@-]NH\U\1
MX8I;/\C+$G.<JW)/_:%)VD?^^\0,2^:L-N3M'0MY[1U92->4K$53'*QJZ[1"
M3:D668O4Q(=-[&N0+Y2P>IB0!(Y:G(I@.$X*$R08_/T>?LFOAB4;]J5ROS-U
ML..W?[)9T@JV6WA48=)9,R2A1I&Y7,IPP(?[S?'4FX)XQ92OUI\2[BW_ &%F
MG;:Q_P#RO82#X8#/\C!!&<Y5<6(_](4GA_[[Q&+=[;-OFYREZ>=GVR;IW4"T
MB9%P@ZM-?2%7N)1B"88*"D/)-5VL]$)&*":": "X20P*I"<0E ,EE*B[5V$$
M6JEO=H]9< \)92,J&NH8JY0$0!11J_<H&3,?'$)"I@4F>$!'KJ.JSG;.]FM0
MUUJP=K[K*69T=)'4.R>#2]=F27,97C##=*G%%TQ$N!\],!]0X'690]O-V30]
M=X=&\O\ R2N5^9NM>'@?C0H _"?%*,#:WU#S50PN/2 -(/E7&_MMBY^(LBU$
M_5C)W!  O7T9MT%B5F&X/>21[\7'^?WM6?V#=KGV\U1_&&GS^]JS^P;M<^WF
MJ/XPU;C]'G[)KX8E&_:E<K\S=/T>?LFOAB4;]J5ROS-U;]8W&7YK\4]G^A,T
M\/\ 9?'Y_ XA]<60_E3)OVA3>'^T>/S^!Q<?Y_>U9_8-VN?;S5'\8:?/[VK/
M[!NUS[>:H_C#5N/T>?LFOAB4;]J5ROS-T_1Y^R:^&)1OVI7*_,W3ZQN,OS7X
MI[/]"9IX?[+X_/X'#ZXLA_*F3=G^D*;P_P!H\?G\#BX_S^]JS^P;M<^WFJ/X
MPT^?WM6?V#=KGV\U1_&&K<?H\_9-?#$HW[4KE?F;I^CS]DU\,2C?M2N5^9NG
MUC<9?FOQ3V?Z$S3P_P!E\?G\#A]<60_E3)NS_2%-X?[1X_/X'%Q_G][5G]@W
M:Y]O-4?QAI\_O:L_L&[7/MYJC^,-6X_1Y^R:^&)1OVI7*_,W3]'G[)KX8E&_
M:E<K\S=/K&XR_-?BGL_T)FGA_LOC\_@</KBR'\J9-V?Z0IO#_:/'Y_ XN/\
M/[VK/[!NUS[>:H_C#3Y_>U9_8-VN?;S5'\8:MQ^CS]DU\,2C?M2N5^9NGZ//
MV37PQ*-^U*Y7YFZ?6-QE^:_%/9_H3-/#_9?'Y_ X?7%D/Y4R;L_TA3>'^T>/
MS^!Q<?Y_>U9_8-VN?;S5'\8:?/[VK/[!NUS[>:H_C#5N/T>?LFOAB4;]J5RO
MS-UH/;S=DT("'T8E&\__ "1N5^9VGUC<9?FOQ3V?Z$S3P_V7Q^?P.'UQ9#^5
M,F_:%-X?[1X_/X'%R/G][5G]@W:Y]O-4?QAI\_O:L?L&[7/MYJC^,-6T_1Y.
MR:Y_[<6C>?\ Y(W*](#_ /([U:T'MXNR9'KO%HW[4;E_F=I]8W&7YK\4]G^A
M,T\/]E\?G\#A]<60_E7)OVA3^'^T>(Q<\E7=JW)#Y(G:G:93QE.02<E5E:R#
M9 .@F%LQ=K+',&>(H 0P9+@0P.NDF=IF\>^XF8;EMVC6EZ%=%*23MWMEI]W1
MP2K40XE&4C64^=W+B0QRE*=1JU;F43,<N0'@'5$CV\'9-&  '>-1H8#EBD;E
MA_[GCG7R/;P=DWX;QJ-Z?_)"Y7YH!^#3ZQN,.WA7BAAML<DS0@].SS7Q'OQD
M<1Y)^#FV3KXK74A.]CU:9K6V(/K[L2"V-VY66VZ4D>CK5T1'4W&N![Z6?F_F
M^?J%V($ [R?G'(&?RCE04R'$%E>X*<.))$@B.:SJ.V-'U4U.BY8)I+"!C$52
M*4I@'T\B\P^0?5XZC%'MW>R:$.>\>CO9\Z%RL9]GSG_C^/7TEV\'9-)F$?HQ
M:-$.''.D+DA\@A2 ^CICIXZD>".+R-)X1XDL=K?4',_ _P#[7;<@^LXK^N#)
M=5_JSE=R=V^J-)?LM?[KW^ZW@;77C:*JHE<3-+4Q)KM#Q?>N4@XU/IJ93 )2
M8SSXLAG > 9R&KIPE[:OH)\6$N!#N"L&YNY]T 24$A@^IX@4.(EYCD.?AXXU
M&Q(=M=V73&[36JH3=Q2@QKG@)(N"4G<(J92&*0%"F*>ER*J  @(\DO4 #X7A
MJ/MNNQ]JMBJQFMV="NDU2\/&I1EQS*%'J E,-&B/7P$<^L-::<"<:+K*<*\3
M(P;;5D.:Z&6X(M>E&P)'3;IOVXM/$.1&VK-\J((%R,PI+@]#_P"UZ^OH.G?B
M6FG*NIVKV23^&D4#D4P((@JF)PST Q2CGF/3EXCGTZJ P"0YBJX*80\T Y (
MYY  CUZ^&?EUYL:L[8+LV*#J!I)6CW;T_)M!.F9PU"FJ^9MD<"7( 5S3B7$&
M,XP0,XZ=-9=TOV\G9;/(-DK4V[NCV<P5(@+I?.G<502' A1')T:24(<0-D!$
M#!ZQSTV(^#>-3<2<(<3J1^$<AS701L#9O-+ G8V!(N;],5OG>0V!3.LI-R/1
M^J%'J7<6NO.O;IN0+C$QY"X#)@ ##XAZ/#^0\];>HE"]N[V3AO.-O'I#/3 T
M?<@/E *1$!'UY^_SU\F[=OLFL\MXU'_%1UR1#]R/WM6C@OC&P_\ PGQ-^PLT
M_E-[W]M_'$!GV27-\XRO?_\ D*2UMK#[]X[[#>_=B6W6@AD0'H(??#T:B3#M
MV^R:P.=XU'].6:.N2'IZ?ZTN>OC]';[)SPWC4?\ :;<D?_=,-#P7QC^:7$QZ
M?Z"S3PM_^E]6,_5[(_RQE?[0I/#_ -]X_3W8EK,;/+'0?P9#7!<#P@/K'T^D
M!Y_+J)X_;L=DX.!+O&I#.<C_ *SKD\_EI,.OHUQ5NW4[)X_/Z,:D>6 Y49<?
MH&?_ "5]>J_K)XSW)X2XE)('3(LTV-U_V0?-C(S[([_]LY7X?Y_2=>RWW7OM
M?POB69  $3B/@&0$?2 ^OV^W6JB@Y#/,.>.?H\?'KJ);]'3[)\$P -XU(YR/
M_P #+C^OJ'SJ?O\ LZ:^![=+LGQ*&=XM(Y <?[S+C],?VJ^GU:Q]9/&=@!PE
MQ,>W_L'-.VVW_P"5OW=W7NQ(9]D8N1G.5@]!>OI>NUQO+UZCI[>W$NL:D*SD
M!$!$I<CGJ >/CZ S@/3\FJM*'"  '0-0Z,>W<[)EJF)AWB4?GA$3<5'W) 0P
M&1$ +2!QZ!T >8YY".I0;/7AMQ?RV]+7=M'5#2L[=UJR7D*8J9BW?-6LLS;/
M7,<NLBWDFS-ZD5-ZS<H&*X;)'XDA$"B42F'4KN'\]RB&.?-<ES;+(99.5'-F
M&75E'%)*5+\I)*F&-6?0I?0I+%59K6!(OILRR^N9UHZ^CJW0!G6FJ89V138!
MG6-V*@D@7( OMUQ<O3337*QN8::::88::::88::::88::::88::::88\4GS7
M9_/&R_\ L+K_ /NYKQ9:]IOS79_/&R_^PNO_ .[FO%EK^B/D(_\ 5AP]^GFG
M_FM9C\H>5#_OEF'_ /0R_P#\%#AIIIKZ_CY]CE,63R3>LHR.:.'\C)/&D='L
M&:*CEX^?OG";1DR:-TBG5<.G;I9)LV02*959=5-),ICG*4<O5^SNW]M2N3N=
MDVZ]N1F1PJ[.M8&YJ9&R;0AU'2BYC4X )$;$34.N8XE!(J:@G$ (;%AK)?T:
M[,<^'_9@M;S#J'^OVGN8>SKKV%=KK?N%M]N$W7)0';=;A['W%I^GG[JG=G])
MT9<DU*,JB)1W?1%"L:FBH\:>:M:L<"D5Q) Z!!D>246=+ 5(^/G/%W%V;Y+G
MN2Y)E5#2U+9I15M7)-44>=UQB-+5T%*B\K):2LEBC8UNIZBH2."/0 \JEE!]
MSPUPO09QE68YG75LM,M#4QP"-)**$2!Z>2<D25LT"-)]S*K$C,[WNJFQQXWJ
MNMG<:@&%(RE=4'6%&QM?P0U10LA5%.2L$SK*FP='8C4%+N9)JW1G84'J2C3W
M3C3N&GE)#H"J"A1*%$\)LXX1R/0,#GY->P7Z#J@M[M:]CC;BZJTDO;JA.RWN
M!?&MJ?BYZ-I>2K>.H"MD#IT:E4\NHDPIY*H)>89EE9QPJBE'QB#Q59VR3.+U
M#%3<_M@V>V@H#;5O'^A:LW2S]KN-;VAOCL6H?=5"[BZ4N;;"H2HMJ8K^D)^W
M%>RU91-8+A('3-&IU$9M\\$8U[^/".=)%<\W+_*MET\M'05-!4OFM5YX.11/
M2&%94KLVI<OIQYW5P5+R5RY4UYHX)*.EEGA%74TZ2JPVZKR?5B><ST]93K1P
M21HKU(E$SH(:.6JG*P0RQHE/YVIT/(LLRJW(25A8^:I!LX=+HMFR"SARX72;
M-T$$SJK+N%U"HH())D 3J++*G(DDF4!.=0Y2% 3& !N/5-E;Q4/5%1416=J;
MCTG6=(1#.?JRDZBHNHHBHZ7@I!FTD6,U4,,]CTG\-$O(^08O6TC((-V:S1ZU
M736,FND8WHA[6W8MM/[.F*L?;>T]H:HG:\W47S?W8@+R5Z-3Q$G8ZS["HJ5/
M!V$HTK&91A754QIII1O4,E/L)&H&C!LW=@LF],"R<F+*4MM9C?QVV=*3-H8J
M\J4#V?EK+B.9^ZM?W%FZAG:00M79E.7LY,RXSAWZU%STJ_2G#RJ3E&IHE6-9
MQ46^1BP!%+5J?*S%)EU'F^3Y-55E%79?F5=21U3P4E14IE^>Y!DCR)>H=(8N
M=F]0-$ZK,[4JLJK$ZN]T'D^9*IZ',<RAAJ8Z^AHY6IP\T<)K:"OK45M42EY
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M.0# Y'H&!R/L#57T);VO;HU7%T+;2BZJN!6TV#P8:D:,@9*I:EE@CF+F3?\
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M7BRU[3?FNS^>-E_]A=?_ -W->++7]$?(1_ZL.'OT\T_\UK,?E#RH?]\LQ_\
MZ&7_ /@H,----?7\?/L=W3,^^I2I:;JJ,*W-)TM4,'4T:5VF99J:1IZ5:3#
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M>[FS.WZK:\@K>4O753(-ZAFIBH4*;D7T.WPH]IVB'KJ)FVCJX4RF8$J5BWC
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M[BW<B]OUF(*U2]WJRB)-J\1JBYTC&.GKVHWB#A%*250*9JT</&C1PL@LHU0
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M]M%O:@W(1,;![B;NVCL13] WAO7$QSI%[Y%7-9,'[@JR<BZ;IK2QXJ-C5I
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M:B]T7N%N2E9RVE8[?+D1]RZ.>W4,<A5Z#G)=JT9C3\ZR2%5XY!\B+8K!J[=
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MEAZGOC:ZC)E!NX;SE8T&@Q0,T2:D<H!*-FS]PX8'. "58#)F/$[R$ $! 0$
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M:!2D*4I"$"X\   4A  I2E+T*4   # <M2N_I:?M8 SBU%L>?7_9SM_S]O\
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M7-*(M71%P*SF*IJY\TD7C2(C9>AJZB(]VNUBVCV153<2$Q'-\-VBRA!<@<Y
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M3/)[^>?#?[6I/[7Q^GN.'UF<6?F]FWZE-_TX@,TU/G^EI>U?_8GMA]W.W_\
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$#'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>g820079.jpg
<DESCRIPTION>G820079.JPG
<TEXT>
begin 644 g820079.jpg
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M01 LI7Y(4Y6'71<D5(XE)S-Y$X#5."K+I>G3P>=PE-:V+[%!#4O58 2F.R!
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MV!,HT7/M4CZE9;-F)S;H=E'6BOVM)S J4BHPQ':CVNOGS5NH,C%/D?!5U".
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M@W7(SFXF(5>HJ1_A8DJBJ<%[B0FFU( VW)103%.B:4#(^+!@3H+!T%#%EC7
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M@ Q0,4P 8I@ 0 Q3  @/,![0'2+R:V<O<<7]FS;KNW;JDVMLU:MDCKN7+A>
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M7@VS3LK*R%[N>:<0TXLX-RG<+.,K493<,2FU:TS-QIK,)FCLLR8\9PEGF9&
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L#.9HHIT4SB3*PRSK83,F2.3VA[(#S !#N$ 'X=<Z-&N)<2)X-&C1HX./_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>g160222nfi001.jpg
<DESCRIPTION>G160222NFI001.JPG
<TEXT>
begin 644 g160222nfi001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !; M # 2(  A$! Q$!_\0
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MHHH **** "BBB@ HHHH **** .*\.:]J,]D;RZ;4;QRC'RFMHXH<[L960@#
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M?#FFZ^]JVI0&4VK[XL.5VGCTZ]!5TY*,KLF<>:-D9'Q'U[^PO"5QY38N;O\
MT>''7YNI_ 9_'%9MA\/Y7\$:=I:ZC/I\@;[3<F ?,[L.A.1TZ?A74ZKX;TW6
M[NTN-1@,SVC;H07(4'(/0'!Z#K6I34[120N2\FV>'^+/#=WX"N%N8;R6]@U&
M"6VFDE&#EAT/KV(^E=?\.-0T:#P59QWUU81SAI-RS.@;[YQD'FNRUG1+'7[
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M- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '$^(OATVN^(G
MU>'69[&5D5 (H^1@8^]D'FJ/_"J)+C"7_B;4KF#^*,\9_,G^5>B45HJLDK7(
M=.+=['(>$OAY:>%-5N;Z*Y>X:1=D2N@'E+G)YSR>G/M77T45$I.3NRHQ459'
M%ZM\-[;4O%T>NQWK6[K)'*\(B!#LI'.<\9P*[2BBFY-[@HI;',^,/!%EXO@B
M\V0VUU$<)<(N3M[J1W'\JAU/P(FI6N@0F_>/^QMN"(@?-QMZ\\?=_6NLHH4Y
M+J)PB^AQ/B/X=-KOB)]7AUF>QE9%0"*/D8&/O9!YJM;?#2_M[J&9O%FHR"-U
M<H=V&P<X/S5W]%5[65K7%[.-[G$^(OATVN^(GU>'69[&5D5 (H^1@8^]D'FJ
M/_"K;UOED\6:D\9X93NPP[C[]>B44*K)*UP=.+=['G;?"RYM?,@TGQ-?VEE(
M?F@Y( ].& _2NK\,>&++PKI?V.RW,6;?)*_WI&]3_A6S12E4E)6;!0BG=!11
M14%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !16;_ &[9^LG_ 'S1_;MG
MZR?]\T :5%9O]NV?K)_WS1_;UGZR?]\T :5%,AE2>)9(SE6&0:;<7$=M"9)6
MPHH EHK-_MVS]9/^^:/[=L_63_OF@#2HK-_MVS]9/^^:/[=L_63_ +YH TJ*
MS?[=L_63_OFC^W;/UD_[YH TJ*S?[=L_63_OFC^W;/UD_P"^: -*BLW^W;/U
MD_[YH_MVS]9/^^: -*BLW^W;/UD_[YH_MVS]9/\ OF@#2HK-_MVS]9/^^:/[
M=L_63_OF@#2HK-_MVS]9/^^:/[=L_63_ +YH TJ*S?[=L_63_OFC^W;/UD_[
MYH TJ*S?[=L_63_OFC^W;/UD_P"^: -*BLW^W;/UD_[YH_MVS]9/^^: -*BL
MW^W;/UD_[YH_MVS]9/\ OF@#2HK-_MVS]9/^^:/[=L_63_OF@#2HK-_MVS]9
M/^^:/[=L_63_ +YH TJ*S?[=L_63_OFC^W;/UD_[YH TJ*S?[=L_63_OFC^W
M;/UD_P"^: -*BLW^W;/UD_[YH_MVS]9/^^: -*BLW^W;/UD_[YH_MVS]9/\
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M;/UD_P"^: -*BLW^W;/UD_[YH_MVS]9/^^: -*BLW^W;/UD_[YH_MVS]9/\
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=Q?RH\M/[B_E3J* &^6G]Q?RH\M/[J_E3J* /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>g160222nk01i001.gif
<DESCRIPTION>G160222NK01I001.GIF
<TEXT>
begin 644 g160222nk01i001.gif
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M 5Z:)Y:+YJ[7GH318D5M C/C%W#BW.H\8'\(B_NX Q,ZP':Z.%9XM 6*ALO
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M 'Z?MHEC]!G@(B7GQV;I5RPLB'(2B".RIR4057^W%U]EI7_?XR+-P7<<!8"
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M4-(CG=(JO=)8BP&H40)!00X><&*)A0&C9 +:] W+T;\VO2(E,&H\[0#'\M-
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M ,,A,!E?- .[''BV1P)@@GHT 1IP8P*G[<ICG'IE<1K@@&$R(%13*, !>E"
M!8K,!!<Q&.X>Y\)I4K.:J$(3[-2X""!$ZAP#8$, 4.(D%12@2?W2@9,F!$*I
MK#*!U F'WZ $JZH40"E7 9(.&H4 !/2 B;KS@STG\R@.0"#^F8?K 2EG)<9S
MZH!=*RK"NUJPCY85T /QVL(Y?@###P@ 3G*AA<#4J*OI] ])"=A !C8@B1&E
M &DF&*2,X'0. IU 11- 2O$N"L:Q5"0+6"B&+BQ@!)=""9,Z$$*>'G, @_Y
M%P?@0 56 2N&"/,!3YA% #MF!"D"BZNP1,B7*C(!KHSOEDICXS:!T(@+BNJ;
M!I!-U:X&@ 6VC@8<> ()316 ;XJ ++2!!-2L*=C!$C8:&W6!!6PS/J)VLWR,
M1$@4^#"$S54@8?-1'D2O9;@L#D0 )=5$1T^A)R?NDJ?..)9 "(*251P/*!%
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M;S=FT,H%N**)74_:!-PJP; Z<)Y%;<K'I3U ;S0 U;3.H]N^)<LJ&' !SE7
M#I)H0 <R$")((.8"&8@J>_T[EGE3UD8E>FWGKGO &-&K+(VI-P1Z@ ODUKF.
MREM%7LM+$'D#W,Y'9F\#%H ]G]3@(@& @ 484!Z^4 EC3WK^,6^TPI5]9*0!
M:C'8K*P=HJ=M01=AU@%=!*  !K!!#3 #Q!.(0)>T(CE=+0]1*Y?M55C&H"!C
MT)9:!B 5ZC2JH\.@2$_V^G4P/,%2DW)U0S\H AI\!PA.NL !%]B'O4A8!48U
M-M[SKJH*].  .802%39B'DZBBS<*#IR?,VF+/[;[E>?X1+3LB*&!F3OG1VAY
M3KW*7Y%<4054VM,(\EH!IXP@ =()A=W+LI$1/+5V#<LI#350=!$L(% 4KT$,
M?AZW\Y;%CUEP,"X=@4G5("%06,!\(JJPCX?NPS$:\",!TJ2)S(0(GVK.N!DR
MP #2"Z !XL*8M"BPUPDT( !$&(S^SST@?FKS!@$$,(" O_G>'42EHP5P*6S8
M0+DOW55__A< #33 -SG/ "@ "LP")VS  1C IC@ ?>R  G"-!#K  OP  U2@
M#D0  TS& F ?V3  2C& ! K3!NJ="9[@=E1 ,@4  A#5!1C4 #C IDP  ;@4
M!1@ "]P@6Z&,02E 6#E;.\U#2U2  D0&[#R  60&!13 2$4 2R@  AP  R0
MS@%7 C# IG2 UJR2 V"%!-P3!&!2!BC  2#  R14!TQ 2RA FF0 !$S&%\+%
M-E$ %"* !$ -!V!%%NKA#DS  BA !*!-!9QA\4  ]FT!5+ ;%WQA(#8#!ES
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M_$0 !>#$&SY UDS ,/&G _ G?T8 !/PG;O[G!.2G!5  ?B[H!%C @DI !43
M6T!  XPF!91FABYHO94F?HZF:,(%5$1 @)(HHP6H@*;H?PX3BK(H@)[H?P)H
M@,XHH\FHB]KHB[JHCK(HC4Y@ _PHD (IHP4ID19ID&(/D"J  K1$ ?B?DSZI
M_L #E$XIE4ZIE%8IEF:IEE:IU@U EVJ=_X'I_WFIEXZG4R#$APV#*8161Q$
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M '7O<K(2 ]<3?,7?#(%_J' /5' ET<F$C$'/X,5>@!8GQP+@<J41B'*4)4
MR(.MK%R(7*@:S$1A#L$*W( 'J 4$*$  O!0*.T-7?V-$E44*((1M',44C,@P
MA!$BLN!<38!AE'0,$+%U3/$U;-]C.!*#"E=I,M>G !:D%(X -%4#8/,?S&TV
M6, &9T,+ZT\R%*C<H(X1_$0,2,!%H,>3G(._8,  &,)DD[$ P\H46,'TS%4B
M9( 'H($Z&8(03  WS,]:>$ 5*<'^ &" ]9W (AN.2/!4)?EU%T#:)^C;6.<T
M!O3!B%3 *W_P)]-S=2  LT2   0$DM7T7-D* X1#&4R! Q>#8T4/&I1&K#5"
M2FBU- @N)\.!I3# H(',!T0?'(Q5%I R,!,>-3-);)2&QW0! 2BX!%C$(DL!
M!+=R;511K U #CR /-Q !LP$7IL2/20(1F2;8&/!'QB!;0Q BN<3C66#X![)
M#5A!*5, $UC/!["@)TF'#>18^11P2I3!#2@W-<A,AU,#L_@E8+"$@>OSW%Q
M*PEN/HS)+=2&!0@T05.#05M'DT*.*36"MFFQ+TF <%"$+E! =J?$9=@&,GT
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MT*!P8<?P$,  S/#%T.3YQ>%S0@&P\6'=<X3P4##@XBOS<R.. M%Y(%2@X'!
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M8U6R5F0GA_3E?$NABBD<(1;\T<F[AL+ :7"" YPP11P@1XI>L*!S)L2"*&-
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M%_\7BM. #I37,5]',Y>8 A[(>U[$!%_05V\H Y:1@,5"*TWS,+^ &0$@  /
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MZRD# @"8[KDIU"&?!3$V\=(F1,$B<\*?=\*%;A.52>*?40F@!4J@>#.@'-
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MR@!SV[9U^[9T^ZISFZEZ:[=RJQT4$*I].PP*4*D,, $V.:F'VJ>+R[B-Z[B
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M0"Q" !7 W*^(#+?'4\H>@$,1%E@AXHL)E[.^).^0 !BA#!"P6**-"@C0"P6
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M)RD6/CRK\$ "5!/?%F"(D,G"&I92/'00D(% F X/>E!0H.&" P5/BMTI4.*
M+1QGNBJBG(!"A 4EHJC^T( E&X3^E0!,0 R!@H,&'"[P2(3C0@\'(DB8H)![
M0H(."!HP&_" 0H+#"AL@])%)P1H(#34%V- @4TXGS3A$[4"@0@<-+AJ44$ Y
MS ,($E)P($$'H$"!P089#$ -/;:@TT$&&6B&@ T4U.&:0=:14@($AQ@$P3+-
M,)"0 I*(P%!HQ;QBTSX($%)'.E! H-P $Q!@BU'OE("#+ 9X\-8'#E3D@$<C
M>&5$ !@,@Z(B=4#@72X);2;-/PI@,$ ''!!@W2$/1) (!:<0PP 7/C)@##<0
M<, , 8X08A 4_UUI@ 6^O>E)/1\XQ4$ +]47C!%85N!! A!H4  '&9"0@#L&
M:%7!!@'^A%*1#1.<9!!"4JRF 0JP[!&!1Q?$5),THC50$DRE6*< #C@$%,%#
MVCR *$8)F3#!"IU24"8"$TRP9P09K+<.&/"\B<$$E2E 7084M)5 &+X4J)^'
M.)(E@3;M,(#!"AAH\8%F'Z2' :V"D4L! +>1FZZZ==&P[EXQ&7%!6PZXQ*@4
M/RK 00$:0)#)!MM$D */'@"P ;T>3;!(P%CRNT\QOP8V0G *90EM+9MQ$Q\
M8 FP0<)045 E'A9,L !\"B"(P0(C39#" ,0$\, #GBA#P0 ,!H!# PU8L&\;
MQ9D[@625,*J FYH D $>+4SASWL"]%$ !BAPYXF;3%TP  W^S!S00,![V)/+
M"5)#\0 < %2@#P\=],S2!E#,TD ]'O!H"")&") )+-+10.('%HB(0 '10.%
M'@-HT',"!E0H1D,WWY1  8==)U4*G@S 7R(,0("!)Q",980""30@ J+5(*
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M@,J-\ "5HU$$B=  ??Y3**#OYLH7B)@+$!=UW?;EH[D=0@>[3(?7MAA/E-!
M'" S,RS=,0T&<(20YL &E>.A!$AI3$FZ1'0! <!5M\:%!Z 7%\10X&X5V($
M&K   +0&,: *[7_(@B<T0X,99[:!9#G%D(^?(1(7L%UX]E'^^42XZ0#!^8H
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MSQG <P2' 5#**FA%,X#:]RT+"0B?T?6,7FA$%6R( ?S/ $2 %+PA*]+ +#Q
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MP$CZ' #\A %021&0AQ@40%"/0 NB'EN4P +4(.J5S0"<@C;+"X38X@_4U>A
M]6 3-@K;X,=JP08HF !LH_7@\YD-0 ,0P-O,:0 D K?(18@8<5]XA!P@B@3J
MQJ^) !I(4#8*B;@< 0,X#11HA==RT<S\$,QUD 08 ^IH:&'^*Q5NZ_;ZXL#Q
M4L%\"FC_UN]N>S"O$?=Q!_)FXYT$/_!Q(K?R#H28E-"!AE!U//=UXY!,DTN)
MSM.5=.C;U))V8_?X(4 >*]C[]=/WV8+-W+97T9*#M#<NY8"&'DA\WY"#).(4
M<T)$VY2 W!#S3?!XDPM7>FP=@-ISS@$Q3%3QD(L#"-A15P.:E<%U9+6 CY\$
M5+08Y(PF6$ CQ0LAH<D+C14")A(H88!0Y, >O<T_WL%Q'$$ER@4DM7()(;-=
M_",!*%A4L!:RZ=FMX=V\Y;$CT04$#-^ZU%#&PMA<R,U?E(%^_\5"6_@Z>>U#
M%,%_N5(S #<WE:A_:#G<<%.*W<#^?#J"*LW;)1E 5H]#+D1#EQT!NHAWE"M7
M><]#49&$@>'S 01 U"+(OZ*UZ"AL&!C PJK#PR*.  C8Z)V+--CY1D+-PC(#
MMM[%+R7:8-4'%;$"!,2D?8R #53Z.P$ -31/:\Z7)K2F/:$"4#WA,5=8CA!2
M4A&!EK=8*Z]XFMD.VWC !!"3IW10:"'';60F;@9("5 (7?R!29QX39P$'</Y
M73C-P8W*;\Q'#I1W14BE=F@SZ)U,  2'/K5K!CBZ- 3 %#2<.=N/61)%,.2X
M@G%J-)B? !##1?_;LB]ON-,%AMM"RB+&I[,- #!# Q3,D>W7@"G"6ZA%(F1T
M#?&C0/S^(QL$6$Y3,KAX@JGRQ5O^B2);"1XHV%>B&;,H0@1409Y_DCU)2!@4
MY45H04N@7EBC'A$ &36_#/JI'P)8MD4EV'[";'X6@()Q0P  \QV<G\!&0=0V
MF)V50=1J@*7A>&#A<U40^XQQ=0&<RS^6MSK+.UT80!ZCF6-DAF+DC %T1]+\
MXV;<-=*Y0]+TCK<T +,@9#1 P&UI30W9QTCT"&P%A 5\<RX40018R0 0DB@(
M0.B9==6K%!)$13)U:[P%!C"S5<'$3](\@)[E@B5;*P("CYXUERU@.$+BA+D,
M2(7G_%_8'U%LR+XX\X_82F!$0#00P)=$0P$8!"R$W*$WE[#^.0ND>!82> J]
M.7- 2() S%O'Y\-<.$#$0  ):'M BD%(Z)D#I !:V%,'J/8(;+.>L:.*#8>>
M_>,>J$HSSL4?U!5 (X@(5)#@,SM^8'I.]UA"R!RWA$&S:5,D( '=6$LI;%K\
M-]>3@$LF,/_'"6,SF&!_@< 5&1^#E 8F?"P&&$>QL71MWWBN[WSO_\"@<$@L
M&@L #BLC\,!8D\ 'T?Q4 )I/!I!Y %C>CZ$ !DPN <_V\I$ / <"BP+H) :L
M^^_YT3 4 1P*#!\>'Q-X$60$$PH"#@H.-!D5+ H)'P,9"!(?#@ "$1\ %%<)
M" D; !83<@Y2$P !DC4/<A^."0G^&0F2'6TD#P@==1I2!9(0!1=-!ED($ UR
M=!T5!1:W-@,5QH4"& ,-'QU*1N;GZ.GJZT4$HL0;"@T8)!I< A.9$Q.8!!+$
M'@I(X$""0@)B%^Q]:'#@PP$%'Q(LJ+ BPHE"N +9^0(!#\,/"P9L"*1!P)8*
M&1K\8L>RI<N7,&/VL #@6@4">-Q$Z&! 3@P6]A1LW."F II^MZA\B/!FRP,/
ML: "D*!!P9<$=1SFI*7#  E<) QT(=- P96E<A@U.-&@$HNB"TDT$#"@@P@.
M"0QX /  0X -%" 0LR"!1(2_*A\$6,G"P:T'!?!V@"  +X4)9!P<(-9!U0;%
M%PPPV&+^)P&:""XH+  PPP" 9!!J".#VA9B&! 0N$,"4H)S,W\"#!Z=R8("<
M!>(0Q"!#N><'"! -3!@))P*'$Q/8%C @Q0V%#@.09,#6YB*+#E0( *@$08H#
M$@SD(, )4<$  1"%Z]_/O[^ZVP$$H, ,5A0P@#.X8&*% !040(!;$]#%P"\(
MY*>!@\)8$-%Z%@CP"P4$"$  !F#E08("7^F00'X;''"** PXF,$& CQP04,)
MY)/ =B32T& !!V3P@2J$=,"  0F0V$  &+2R3 <$:$!!0Q,T-((!;M' #PL>
M-%#  DH\\-!2DDB@TH#HD2@! 9+$PX$'#"3PP <<2  !!*S^+80%2/DUA@$'
MXA@Y P1R=M"!2OXEJNBB-1C*P9N%_.+!HRN1\XNAXT0ZSJ7C>,"3!!$:HL&E
M'%2JJ0VE,B;IJBP\2H.KC,8JZZRT5K 8K3\80H.N-O#::ZMX9L$E#K[J4*QP
M5SB@' >O$!)1)\?B*NVTU +!0("=5*OMMMQJ>P6!W0H1+4979(N13+Z.ZX.O
M%;BHQ" K8<!8#>J&:^^]OY&#[[[\]LN.&OX&+/# !,,T;Z9 P(KI.+X-D<'!
M-&B00</F=)"!L*/J@ &X.EP @9 W9 "M;\=F,*$#;/0ABI;"CA,!R 7'W._$
M-.A+PP8'5Z#J!1A@8)2O'5A0[R3^% C=:A >\(I!RAMDF<,O/?.0+I<0%Q)!
M DYCE,$"OU!L@P804*#K!@M00$,%6,NLM@X5U#4)&5<,<)\X%Q0P2PVXL8!
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M (QR2.O1#2-40:)C88  OT!B@UP  *$ @ H#\$T'!'  .Q[^ @!12ETP8T"
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MB( I/71<Y)DB WB?7QBP 9& 1Z&((&86*+,! TSP6D+Q1 MGD)<:" +I0EJ
M!AS>*A1IB &5>(\D+N \'#^<[&%,0$B-0@@,I,T!&JW!)"NP8 K,"<?R6$D%
M$'!CIWO>"!QHN6J+@SMK?- 0=4O^W#@^2H,#K$ #!U!"? CA@,O73,!FZ<,
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M>E1/(U1UKD$&$65)>- !<18!BD2,^J@?ZL$SC),!&/  D_/^">+0 %,H %E
MB[^P.,35"E;Q/4B "7X!)1< !]RA4',@-Q[@!:P1"S!68G!H#Y0H)!PPB02R
M)'^!"_:A( Y%!U6WC_W''8" '?^# *]@!7$&8U= *(05 -P@!X#&%$T3 $R1
M1',B&L,U!43)/-JP4X*05EKE?8Z' UZ %2&7404679U$ R4F#BZP-ZD$DV(9
M' 10 !2P4R;!6*K /G5@A".Q$U0W !,@""HF 30!*EP >;_6#=L0$JGF-(;
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M@RP!C,S($?#(D)Q7?:QJUY>KDFP4%J"O/7.MUW=]H/*[!+@HQ2K&R$'#=*P
MJ! ):Q'%"B!BZ"1BP]O"QLO$(:7#= S%R_C&A"D/+UPAAU?'E_ 0<ES'J(JJ
MNH  <MS"#""EM2</8=S"PK7$4CK+R7LGUGS-V)S-VKS-W-S-WOS-UMR[3EQ[
M=T*8N;S$N)R\+[S$#\  $N  A:QJ'SS/]%S/]GS/^/S!"5S^NPJ\=^77P!K@
M,Y3 N4>%$CX'D!80T!*#N0S=T []T! =T1+-T!<ST0[]OYA;T0&] 3U#"0 Y
MT*I[ 9F<1SZ' 2/]T1*CT2F=TA>3 2V]T@O]TBT]TS,=TS(=TPMMTS?]NM>*
M1PS<)'_,P&<YU!Z<ST9]U!9L)Y3\R'/<U,E+B4]MSG,<S2[<S@RP /!FPP$X
M*S/BKA(CP/-*"7K4120MTJV+NB;=N9YKNA8PNJ3[UB+]UD;A,R)M 7;=I&T=
MUP0,P7H=TG']UJ;KNFBMUH1=V(9]V(B=V(K-N11<"HFF1Q,PO-?\R-H\O//4
MR)B]77X,*IK]QYS-V9[=V8PLVIO^O=F?;=K[,-JE#=JEK=FLW=G;!2HA-=O%
M*V+O#$0,$%+K)R?31R@+@!Q7O8Q1+0]0+,/1;,,YC,,UK-S)N]S-7<,ZO-S0
MG</.'=W)7<8ZK-Q07'OHG,*_;0+F_!#0N2*H? E = F\',91?+Q:';S&&\[8
MC+SOG<WN+=_'.]_W?<U$?,3L',6F+-6$"0&1/4\0?*U(?> (?L\7H$&D&\$)
MP=$"O. $/#$N[7.X<BC/O<0T3(FZ8)!2N")?/$\/\+MY-0$C;KQS%E*2)<.0
M@$ZFNL0O/,.GL  280*ZH O.['TK4A8XK@O+Z'V_*Z4P/.+ J[P/D%=V0L-F
M,D\DCN3^C^SD2 [EE\WDCESE5"[)CGSE5#[E4<[E6C[E8 [)E"WF],W([AU2
M=B(!<6U&Y5?2:@V0G OGA"WG'QWGTDKG=Y[G)2WG>F[G?=[1G5OG%?[1A%[A
M_^O2'" QCNG2F'N^#..V _2\YV$(E&ZXEE[IA8#IFG[I*MCIND+IE7ZXG)XI
MH1Z"@WOJJ)[J:].U],+JO':VF*ZV<,NV27.WYQ+KIKXN=BL<?<M/=;LKKBZV
MLSXNN X$QT*W(NBU:5OKRZZWS$[KP7[KK9ZW<,OJQ_XKO:[JVK[MW-[MWO[M
MX![NXC[NY%[NYG[NZ)[NZK[N[-[N[O[N\![O\C[O]%[O]G[^[_@NM=E^[L1N
M#OUNZ[N>@7L[ML:>ZVJ;[^+>LPCOA54CN#/8*-&>N"K(&(MKN S;*37SZ:+N
M*35X'A1_*;>X\")O/M$(A 90(2DG 0A@"!#P/JC<9'U( Y=8 O]K #.P6AY@
M$2["!JNE'"V''LIQ2(7P29'CB8[19U9@\R]$ A"@''X32"FUGCBP%G[3(QW@
M!0QB P>@)BM0&*I* IF:)!I7'$*A;-O1 3'["WY6,\LC37831==D=* 0&P,0
M *DCF76Q&E%DE@7P(2FY(0*0.BT'8[S3=#O) JL1^.8X\HP_1)1J RD1.("G
M&"SPJP @)R-> P66"6WT2SMD!P+^T/18X +</3'9-5QR(":(L&P-L3P2IP$T
M(0E "A+ND+Q3P&S+\UIZ<ZR+DP5Q%,;#R (!H"'X1!F_:S;\J0QXD%)SMN !
MMT<G<$YB0*B?9(40X4J.F=#K,1FL@4W<,!(5E^A6%AL!\$HN'3@873KJE"V+
M\Q42@ZH2 S"-/_]JLP K@ -T9$D%Q&A[45B)<S<@\!$4!P!3!W3(\7T'@@DN
M]VGM)P6?<F!7Y6-(8  8%V53 00PF=U"L<%L7@_7 >=R&1R?3@"2FK@4@ZU'
MX+@H9@]"IJ+Y"((0P$L1[V@ E$S/!T;!P\ <#<"%#9F! @9%Q88?Q@1 AF!
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M00&B<RD-(& .&3" !R1 @"P8('$NN "6#H ]!38B" P(8",LL"H#2(@,'5@
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M9(8"28'  AR@GP 82#<3T!]F)E !!L " A5(0!48@[4;%2$"%!/ )8IP$_V
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MDP ($*"NJP!6!!+<C0$PL0%@(.Q@Q1FCNRHHP18H2 D>, B!\($;#L CU5(
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M]&#[Z!(%6$@%0 *W:4!N3$#S(<K^/>T"^''#!$@+-^2<2T! !%3!U>W/TTW
M#6R3HKB?"RF :9D0$0Q6]WU$!B 2!]A3*5S<;_P?+X""24"C V2+9&A/*0#+
M7IA7/6J,!C!8%:;"%N) 0PR (FQ$2=H#A9$/%VP@HAA<57% 8+A:S33<#7 #
M B!-4ES &\W@.&;6-4U=*9P;-ES!$UV!!-2 90#9?6G0 B1%S@F !4! %1R
M^PF!(ES;'UI12W"= \#"%2KD!3S@*'S$! @=//75M<V! 9 !Y[4$+_$,&N(
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M'A'9 _A-<*4C9I!39W5L5JRE8'*6"L;&+MS@ P#?0V)E;&15(W'30?R! 46
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M&' / 1C^:,)! !WXHD #-E!P@0!4=% $)5(88$< &JC!1@(05 ! )>_XPL$
MB=75Q@T+>,/*&#@DP$  'EAP@ -:V."  88@H  # &B5%X0'I.CE 4R5*<04
M!Y7P   25%#001P L($$ ^B"H& &* " 05+5Y@  CC@0* /3$9I7)@?@I\T!
M:R!PP "=GF!  0G("91/OOX*;+ [J:E" TL00*4 $R#+A@,'3/!  !9T8"L#
M)N"7!R0)."!<!!! E$-*Z0U@1  ^7*#I7A)@$( GG3$@000OH;@".QNQF<<F
M^4B@QPO??! ! ,SQ0P$L ZS;K@4&6!#P!#C&P8$D"E4PV7;^G5TP207P ?I!
M0FQL $ "#8!U3AL'(,!  3J>-@H.!L@Y!0"L;#HD*QVP(A$."G"Y 4<-^N80
M1[$IP,]%;$ ZP 5K<4B& @5,LH(#"=!%0'>R1'W. !H\$P&K%S[P6@2=B/6!
M,W70:L@#!1C@R H-Z$J!.(Z6[=K"$$2 05P= %J (1TXK1^UJZGP;0(' ;0
M(NX=TM(*&:3:@1=Y*1 !?@^@D0 &$'S!@ 7H-A9;)^(L<$DE"D@!+R@1(,C.
M11=([H@T#C#0001T9+ (*!PLL YJ2TR@5P8>2!W?!#IX,$%(&E00>048"-,4
M&[5?H0$&EUR@E08.5  >)3+18$'^9QNHR,%P,LVHPFWOA$(!!K-X!L'Z%EP2
M ?8Z\O(!H>1QX$$'PA.*@0U$X!($ L7K-E <%7 @!1W0  )5L 'L#*X&-.B
M!;<Q!@]LH'_2\X &9@$;F EKA"0LX4V2EQ<54( &^Z&1"IT@008(94A#>4!J
M^L&?%$C@$E6Q'1TH5@$>*L ('3#2! 9');FXD @6,%*]IF&.%#BO#GJX@PK0
M]8Z(V:5]&-#*!3IP@4MDH'WA8<81:\ ,5%C@,N_+7P'RM@0-8,<*S/-,>"[1
M@36R(0.7:$L_4N#!_,T">U,@U .WD19"AL,1,..C!3D PO1=4'J07$T;^[&$
M_HE0.I?^W.0DIW!)4%IHE%/(H$[:V($,(F""I>0D*"SP@I[PJX@5,N$*QF3+
M*QI &;FTR48JH#86W*J7CBL $<1 3!-ZX&0[,TXR;3D&,OWGF=2LIC4/$9=K
M6O,!M=2F3S; '6_V,@/=$^<S-VE-#0)K;\-D@PB']ZGUD;*$_-N)!]!Y$PFL
MTIXEQ$ 1G,D3.=USG1"@0"A9 PI\XG.$<LH <<Q)0H!"=*+0]-4F?Y%08"W4
MHC@9J'1 4;V>;'*D%<T?14^*TI2J=*4L;:E+E6D3#F84@J*TIT3G^=*<ZC2=
M.Y5>3Z7WR'KZJB,;]0DZ 80=DH(B@@C%R0)MHH&B-O4F'*#^05$=.-5Y1I.5
M[LSJ)*6ZSJ6N@2>UR^4#;OJQ'J"$)Q  %#/P!PH7\N0A8W6#4P F!2CF,H@F
M)(5.!@"#^.!D1AV VD]U"DR$?E%8<HI"&]\Q 7GJI"!99>P4%- V!8;$6#W9
M0".6%E*;P-4GF+%,.C#K@ >,=AM7$V<&%C"R43"EL@D]!UV<V$L)1.ZN/)E
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M$ -P V&N %IO@H&SE(T!&Y#G!>K8K(7@0XPJ2D?P,$"!!\S"0$F&P@)3HX$
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MDCP2QTH3$4 *T>(E)<K$304 Y3D,!T4^/)  !8!$;)1@Q5*J$B7ASMLW!"
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MQ@9L@0.31P?P8CN]\%L>X!M .'GN,5:,<PCT]PZQ9'$N-T:+T((Z9TV4UPO
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M$WA!& Q@9;)0$D@""A(W'L8U;EMR">[P-HVP3Q:"/]8E <=@E R0,Y-@+0D
M6VS0CFWP FPF/15R$1$P +0B%"]C.CFR% JQ%!70%;IP<YN9=7G2$YEWBS8C
M#.2":33B:[305G;A()VP#RIP#77A'L%E&$@P"2CP.'*S3+JA%6=U-([0! ,
M5T"X!$I3?.CH.]+EG5&3 'ZI.;F1CHD(&\&%&A+@ /#8'+MW !%0/?[4-N7
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M;KGP*4RW ,,8'HWX*E] ? !# 9@6!49@(CFS#^E63H'Q' O@0A(;K-UX-Q9
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M3 \-:Q#(LO"00),$'!PXD(#"AP U#"@H:)!!90><MC@PB$!A8QU[*61!H/"
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M^9%RTFJ^"@;$%1VY-,$%!]GA0 +^99WC2 (E:=!!,/:F4YYY!>!EYB0 <(
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M&#(;<*H'W'J.Q8#!$W2/#+:?*4LU BP2$RN%$,_A @WJ [BV00<%G.DZ+QD
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MPR'N.I#!RJ.OG=!L$S"K#%CU=3&2Y=*'*%N$L1(A.H> K$$?X[L9I&:0I'A
M8#JES]OB-K?<&T,1*A ]W0(WN,(=+G&+:]S<ZN.X^F314#>DW'T,X;8(2$ #
MB_K<ZZHB RI3W01P2"S;/L*<1&!  40#7NP^5[RE4*\JS'F!_G% %NQM;U[0
MRXKYVC?^O_F<+W]3@5]3J/>_ $8%?O];D:$L2;P*7IV UU $@RRSO0MF4H/I
M^]HZ'-@"E2.P?I6K@0I;N,,B'C&)2XQA$Z,XQ2I>\8A!?.'[<O@4_5T#9)5T
MSU;,-UDO5D4[U5&*#O2OOCMNL 7N*5X9%#573MI2'3J04"?QX +"0(%"S'7>
M?6QTP#&>*@SH>X&&Z==C7E'2! 8GX*#6D<4>#D5%8M!D09:"G1Z8@(NIAE0'
M"WG'0C9G83L@*%90H)<#=@#1XF$E+=<!<:Q@I8Q7%P&667<5_!1%<_#GBG.4
M-A5N-4@KO,* !H3JMI.80*9708]\I@,5#44%!%!3Z@Q, J+^^K3/*0(G-T'T
M]BM+HN8:-J!K[MH1"0*H3I!I'!94Z!C9&L1U)^ZYD=#X;C'1:8(I)-L)&D1V
M S 5[T;NR@D-<")T&;!A8@FW!T%K5!D<"/4:AL*#"&0@#&H&;D684L"*2-FA
MPX.C(_9]"C'@E  ;QB>24+K>^0+3OY3X,^%DD>P71R0O)ZU(9)7AG1IWHG(5
M)]S 38%(@SDBLK!R,E,"VP2[NG$#Q/"Q41N[  H51#Z1*84#P^IDP326>YQ1
MQB:4P60HT:Z=L,+ 6O<1QK1,HEIN]0X%LE"9#31S#4/P0-,?SE<)T'G=Y]D'
M_5*]ALPX8@( $'2$)*!2=X'Y /O^J<:^/*83TDD@E\HXV8;QBAC0/*8(969
M9"L8@,HQQ$,H0$]L3>'K!HRAJF$P" 68^/(U$&A@C"F".3+ @,L_*B<66-R
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M%Q&::AT(#CI,0!XTP(=4A&RF@]ULBLE@1&J0 &0!Q5@^PA'^&2H*>(6$A(C
M)<?'%%!CPN3-%)M!CL M8$8.3*88!!FA#$0$O /E@0M2710RBJ<?*>M"PAIQ
M%*0#5 (&$, WR5*G:$S["08^%DA]<HL5J!R1K,8,:,PT^.<@B0!!V-$^I$,
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M'CV "1 A4K!!"<7#28Q;!'A  -S,)MC#.RA%>'911 &40*($=S3 [.:':"3
M#B#OIZU!1$2"-D*,#@C.AZ0:(4  #5E ,J -!&R"+VQ#.#"&;#! TOA>D@#
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M"0H4GL+ 2]DI8 2CQ)*14PIT1@,$HS3)5M0-R'% ,AK<D@+^ZBO=5PBZ%C#
MLS_P%)$O;P=H(D<"%ZR!P4"H;IKC;+GBD )'#DRH  <[=IKP\N4<X!AI$A#1
MC@/#4\" ,PK .(0S!I!F5H"E[I;# >*8JV.571$1BHS3D1'Q>)@X(.RKY.I
MK;B@HPYT( &G408.WL. 8!DP?0F00RN*D" 9R.84#W!&6;HC%8(@8"( FPK,
M(" 5F<6@'6G1P-I*Z ""C.TQ.J+ GB9#@1)6K501\ BP\H,#8)U@ BB!TPU2
M8 ,4T.IU1RB$!2KPK1',2@ZEFPPJZE  TAA 6]7 0!DX(*\4<* >Q\@::A20
MPQM(H'54Z$UL4G:,G;'E @5@VH_^NK $!@3G6#);0 \\ $0C[&<">JK.I$K
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MHMN -Y';'  "$XM(=U@T(YLT0+"*FF$.IF( (KBB !1RQ@2($!1?#$6+KVO
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MAW>^"6[P)V";X?O&9<0=I.Z-"_SC( ^YR$=.\I*;_.0H3_FU58YO;3_<XB@
M&,??37-ASYLWFUXWW>B]4#*T>^+.]KAY+2WT]Y(+9!?;&KA97NX4\+Q!_V:Q
M@N3PAYK^(T%$O%FZY70.=214H-$+_WF]QV; KXW]"$,YP@;D#>N$,T'FJ.A
M!5[E;94YH6I6;Y "<MX$]Q%QH\[+6Q*^I+,C([3;8TDFNB\C\!=-!NX@MQ&#
M+-UKYXVYUKGF=1-J  $ F&LSL#Z,K)E.^@5]6T$KBM'AER#9M"XA#]5^ *Q_
MP>V!12B^C+]/6)4P@!\L_=8+)7H*-@#X#PR@ L7-_*[1%0#,H\"+ME;#!N3
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M$$TC84?^[I!(4G("*7 ! & RY(&3'! %8;"25P # /$E!6 .)K,AF:$,)[
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M 5R5F/58$2+B8"'R)M2!"060(^V09@&P22E@'-+):C+7.PI0(=3@*]5P-XZ
M&H0R/A@Q,0[P9Z>0+\Y2!'2P,R%1!Q8@9X:"$(QFA+ES GI%!W<S@CF2"CCV
M"U,(+SD0H<C( -94%<,Q/2:%"1:5,#Q0HS3 +9,!&> #0VI0.!X5 XYA*S(D
M#@<D+9YS5'0H +>A-$"D *OG%J:0*6PA&@'  '00.%_Q4C.43&M@%(KG*C"P
M *;J! [!B-V0$1<0$QMV,Y=9-T7^FAZ]\G<44"H!X!<?UE /D"=\:EY?@@PY
M- YZA*@T\!$78#)4D%SY4!DQDB-&HP I,%KU^0$QU0;F<V=&QAHZP@XQ:H"&
M<B^'DQ $& HH$4/OIC0*5)\EH6RSF@KI@J8R("U$,R<!D#E?@'=3R!!D<0CV
MH@S^HG89) #=XPP80*WI 3"H@GR9LHH"@ G'.DM;0 $:< (+ZP8_@"#X>!8_
M-1T.B@/')S9+,0+.$45>E"4R@X&+P%2/93W#^DWU@@#CTQYNT&C"(*T\(AM
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M!Q 4J*!! !4(!!"(.!" 0X(J,P40G%F F(D, 1(DD..*PK<+""8 =8%A  0
M#AHU<$#0@$<%'1;S=?!&P0 )"!C@= "AVX$!&11 \#HB<X#%+%>S;NWZ->S5
M*1HL4%&!"(,"%7L(,J" +XNL!\8,&*#) /(.!P!<:)!#08%N' XL*)!/A08#
M"9@V*"O20 '*%: >J$GJMH$#LC@XV%!@ 0'.'A?@-0%5YX<%SPJKZ'!2J08
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MZC! JP&+B>KE&BTXD >$!03P($LEV@>B"! P< $%$XCHE0;^(AB"@#H/J8#
M!1?4@4$;"1"A0# I+*"%"PF8@6"6*>"(4P8.U)8=&B9,@Q,\G!V@003O["K(
M!S6ID,$ *=S;R@<(Q%.3!@N1YB4K!, !5%=C;!"!!FT4'*T9&IJSP3C%0&-
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MG""UMJ'S70FLX0#.1 @G#8  )7XUB0=<*F><>10$%#O>TEP@ #$ZQH)<\,L
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MYD4I*(<\=($\#"#.A0P/:,+VP ,*78>G$$0O:$($3  @H X1B.,+3(#7%4,
M4, #/-<9F@, &95GH-@@N$K=N,"M6%J@1,5O81W:/<"7]%P _(9#9.4<Y$0^
M6-3+#)V@+0,"H(@*)*>RC$"2!!'^9Z0=(="'.B2 NXQ:"J3)Q[04R=V#=YK
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MU, Y+T[4ABTIA0M<@#H\F+(\A2*PI"A<K0DLEA7,@1QP5T +ABLJ0DB,S@7
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MR,-.Z(0GZ45^E!*;_ 3\(@DV%O,;#<7;'(TU[)'H$D;>P<G_(LYX%DRFD),
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M\@K)"<VU8W<H*7,]3X2\1Q2$A0A@703,Q!IX!9NOPR/, X.%P;@\9VZB, .
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MNG00@4N"B7   @<,,T$!"Q#04U!R;O-  @H@T!,#!T@0 14%NJ&!AEAN,$
MH?T(5!(R)J"< G>N4,T"!/6'9 4&L/C%4B]!P  "0#V @ )X4&!G,APPY4"0
M6$(!0 ,5;#G #)0R2H)3#!# @ G^%C@:1 ,'@*D!  C$2!.1FDB00*=\88!
MJ,$$L  J%@#P@ 8!^/J%!0DTD*@(PXXPP2=I'K % 0=0$"H#!7P29 %[@-@
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M&4GQ30;^&.+2R!X;DL]+0_H@$0+VH%*.>"H!$Y-8[]3V'V @9P2=.A<),&L
M,T !GF L=%,EVK4P7.$!+O(VRO,;+-$BA208^:$.KK,E7G != !(WE136<5#
M)?( "Z 4\,$4&?!65" <[:$QM$-CRG<BZ=$ \I&!^L 3'&%Z7S=+A=03LM4
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M$&8!B1H3B0YQB,7H$*%X Z?E OK@5%51$&K(%8^X")5H">FX#>IE0^AXB3;
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M FE0#+"%!](Y $T@#!Z0%#\B 6T30N574!V2L=:JO*="R<ST%29$#U#-)0H
M:Z=G ,/<0P67"08 /ZQ3PA030D[^9*T+DA#MYRU!LW),P6.>6SX4\R]!HPUB
M0Q,)SX67L2XY8">^\G3;E'(X7&P[%(2<PAYOXBBN( HH7R(C$A>OH"4>)X&N
MTP0*,@5^8)E;7@<]B-CK@F!&2P/#IT8Y- @/HEEN$"4@3W>!$<VPA.#SL  %
M6R)[T@E!$BX#H"$;-@?J>U81<._KYBV.Z3;D,D'A5C!M1R[7R0#T]SS-@@<
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MHCSP#*;^$42 W 42E&H"=W=],$$#,V70@$26/N" 7Q,P\($$L@;'  "Y8K
M0D-5   K!DR 0&NA*H!=!<2] ($)$AA@@"H)G/0  PE,])D!##YK@%X'%.#9
M @!@$(%2"AQ@0 8=+-  MG PP)YA!IB$0!HFD0M@4Q),T(@5JWQP0!$, *HK
M RYU@ZH+%RW P04/4&#@'HDZ % %$4A05 04*/ +!0R8P('#=SRP@*."0'"
M"P8$4$,$#]!9+ -EWG$S 01LL)T"?K6:  ,PM3R1!! DH$$%_1S@0TF .O!
M AR$"A ,%#3 S@<)**=#!@PL($!P%@A-P!,,,-#>!VD/5&'^ 1M$H$ "+D1
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MBX!&,("=@[   VJU/25@0('O+5@&5J"AF$R@ @&(0!L7X $(A HB._@/IQZ
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M:8, XM=  "W81!8:\"\$ $H!H"($38  Q+@$MY_1)F5>CDI"GH X!IA" %#
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M73$ !E*!,C5-'$K1%2A J"%.<UEB4@7 ,<R$D&T16UQ- 62@'!30 >Q!!P2
M2X#8 A@ !-BA6+U,D_E%QKC5UA@ B?B.QUG*>"G&L1G,%7P0F5G*.?S3 M1>
M@7S@&1W/[-7-,X#8%>B0^:3 &I[="[ ;%BR T#!5D!D:@N0*C6'*X"G *["*
M%+)6-84:"5R1X%2!T9"B=H!8NJ0 :QA=:>F H5S8%SQ #^"3(&#-1&" (PU1
M;:4);3$)J4C D3#,"L##=@18!EB 7TT$?:#*+$P 6C1 #5Q  V2$-5C ;YU
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M#4E@&Q#/,_WILC)KLSKKB/XJN[2*H<!'H"3$^<"!2F%5 $Q$!!R0U%A/^ R
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M$@FM#9P] ,$-QCU/P7FP0 &8S;J2S $$P)8"0$:4$BDH!IK^ULN23(%ID4$
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MB$; 4UD)]&G0'9C X5C#N^#S\1(0B44 >FS-?UQ <'\&9=PJA%!10/<J]"E
M1X."@EOAP'3T"0" +\$Z S5?L:\/I^G3ML!"S?['0$/")>T>)Y'SR7U+#EW!
M>RP X70[U+711%C?O0A(TQ@ >_!./['+ 5T!!@B *W+' 4BW#PR $LC-P)G
M 80['+PW(OR,1[:X1ZUHRUB)]O(9 3!(2=2VI0! (RV3O:4I'-;V@5BS=[3'
M ,A \D3^&?,%->,U+CZUQYQ+@/!%P#-OSPBB"?W]Y=N$$@$QR+#-[ZQORAL-
M4#+@C\ZYXD** N^XBBS EN30!F2@R>)T2'?UV/\X&!.YP#59J^.8S'ES$8"M
MCYHH 1Y=HJ68;W])YPL@E6=DY!5\C/7@J).-RB5E8W@\"U.M3:X\0."L*S-P
M#(/ B_CHP/5ACST-YC_MP:EX"THQ'\\1%ZIX!C]HP_ E;5FDY<*65V$<G@;
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MZ]>3%C)VK"EY'Q"'%@R[)@H4">0+3P@AT*!!0@4YE!A,N)#%4K!:'QA0T(!
M@<4/$2XHJ)!!0;45""YTVN-*T@5P'1!44+1QD@,()C"DV+%(0J()!2J0^>*E
MTIH(#4QT.##TS*:C2),J7<JTJ=--$@!@*## ! %P')9UV%  00< -#, 4 ?S
M2M02"83P(%&/$ !P>P!H"+"A =4.63M4:)8-@ ($<K_V I"!054[#\2^9/4!
M0="(1SJ40% GBX"F%@0<.  @Z(,JV124R6#E2JH/^BA(:& @08(&&0XH2*"
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M 1L9U $!SRE0"P(!:#!5G @<B($& #S7E0D7 * &!$(H$, %"D(16  !-$8
M!T%$8Q8J"PC@P%?\2-L!!@ XL($#P39KI!V/,4" =IHD(( $$E2$$9-(%3 !
M7IYV( %$36HRS20+'")!%1-$$,$1ZU*D@2^^J*L;:1)"H( P!70X&Y8#>,"
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M"M5\P5<_,X#0YJ" # 2% 6Z(@!<@L)K#Y"T"!TA 3W80G,UA  )N>, 6*%
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M$@($XO?^535$ 8\%!B%M RUTA(2:T8'6(?X!8RD;!*GA%^)-P %1[(  ,#6
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M9 45+).   _H'7&B BOG(W1X7CQ "*HS"2+83'SQ=U6@ES*!/65"D-!  4)
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M @K\XX!['B 0*TO7QO4#'1@H4P$ IL"6@;,3P&1/!0;496V*"(@G+02G,?
MD1\4@, &+'$P@ 47))@%*!-80*E4VQE\,,()*TP(!P#DIT "!IQFZ0163?)B
M"4P$,($'5PIQ@ (IG:->#4CA( 0 DU%&  (*L!!R!M/$E($&!3"PQ59U/&#
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M8.S0-C_^7$6B><C I5HJV,$.XBH$B!=BI-$+"GB   Y@@ 0\$*X/!  !$PB
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M6,-[+@" HN9Y#P68#$>VY"85 :D#!8A< NI$J22Q)%1#V!3-  "J0''%%XG
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MP$=Q#K5I *@H!YY8P8+4R9U!5>$%!/Y<P 6T74?5VM/4A@TDB4=<8"D8A#M
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M&@! 05Z+QL' @QP<'JB;4:F+PZE92!5;#=@'"["6#<2$V-!$ 00#X,#?!PQ
MYU@!;(02")4D!$1 &!35*OB"!.@#<W@51IJ+$4 B3O['Y&" !:"CQ! $GAQ
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M$Z&-EA1'JW2>58!&$$A '!C+"!T   2K2/U!!PR<'SC%,T0 :*E- 1&M?J#
M#61/,=#$3EH4 ?0/$,C'OK#)$GI  -  A@G;E5CAPN))"TP(_46"(&X VJ
M8]$0 P3 HN($YW4LJ>Z",3#=,41-^\UJE.T"\-%!PK402WDBL D!T 9&F$TF
ME,;"/1S^Z34Y@E-@20%Y(M$V%M-% '_D75$H$!_FUZ!Y RZ8 4KD%PDL2!!<
M8 @)'%-T:=:F!0#<R5^Q $AJ71\Q0 $)B=EB0B@P0PD 1+<80)[1A#T(VU=,
MP&@.A#3"A$#4*X;M[0D SD\E:TLR@-SY EA,3K J0 "@B7'"".-.$L\-@.H
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MRRS7&T48DC019'E$%1L5!L")_ P#*C/9Y/ 'L0V9UD5$ 2B.EH;0FU6'=05
MV_Y!LVD&_27"J?!4KRPA+TR S:$?3\&E?!38'Y[*&M"(!!28H S<$C+!@-!P
MOK%CK^S^I%F@! 1L#8'*[_%"!TVUS@!@*A-4&E'-:N#(@R^G0U3F02CS\4\G
MDEQ6P5)PF0$<YA_^5$E(@=QU#9[]&P,4H"\O7U>/4YL*0%X;@'1/C@!/C@G_
MVP#_&P$P)0(,0&6%@S7A@@ 49  ,  #X#4VAMR^#:0"\]WL[I'FC-P&X]P"
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M'@A<T%F'*3+TGB-,9]!EA;NCC7!&*QS%4_>!I?#4'22\L>5E>3?TUN>]UF_
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M"PUPI $''DP00 8*)"#! 4BL"\ BJ6TP +J8_DN1+>L)L$P 3ZW;2R,!V+;
M ^P-$!H'QHVW*P)4I.9,!@-8@,TM5)D5P!L"-  2P*7\XP+^!QEPT*\+D6[
MI\OYFDSS'&O^]&0 ,]EQP  ?B%.R#5P)%.0/2Q@0Y0L&%G!!!AG@8U=RUD@
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M;@O8QP]!P4!3!%&3#2 @(LO0R;NAL UPHH' PZ;%'U>R#"%"_ 854,S5*/D
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M"0Q0A,/C>Y^ "\F@ &1C Q; 4<E("PI@ 0C'.P;%BI^@(Q4@>-[Q"YI(&PX
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MCH(('E&@E[00+H!1'E&#CY)1+J G-O @YS99WO@ XGA#5,$KL1..+R  60$
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M?OT#O./(42<>6O+M.!(:"#\0BFS6U/ .RT !>=@T]4=12"#^?C==21C4#5Y
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M*T2YP:BB]@'740Q',>$  K3A$2LF(4>L:, "C#0(4-5Q#16P0&GT1B&&I&U
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M AQ &([^HH!K;/" %+2E"#IQP*AF Q?2Z#0. R#8LAAP@#W42@@/  #!!I$
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M=P?E[O6<GSWM:V_[V^,^]XO?2:5KN5(&54 ?2="$$BI,@+.#9(;B&-4J'S0
M \S"X _+INZK;_WK8S_[VM?]?X0O[@]8P#\-[ D%A("<;@\A S'UZ80JP ^O
M[*\(C(&B'[YH@0KDJ_VLT*X!&' ["]P**GE2-W" ;GP?MU5 N?C5_TA4*TQ
M'GA \*E:9^2+!I0.^!G/U1C#-%#:(&3 [+@*_F&!#-C:]IG@":)@"JK@"GY2
M)]"0R<#^Q ,( *?0V_$5Q$QY%FUH"U9\@W=\&$S(@@)@T1 L4D$8PW70TW(8
M@ P2QD\<0&G<1BQ\A =4C +LEP5TA6-T0[T(0 48 "T$R7,0 ;Z4GGZ!!BH0
MP %@!@)X89(-@$;8@ '@2P[HES:]3P+07#$,$4,0%R@X0 FR8" *XB 28B&2
MW3AL0'C<@ 5DQ\^5'PRT .$DD#X4#Q%D0%DT3*>Y"#\@5S_0"W-@0#: 12A8
M0'I-2&300N$\5[-$@ V\TA!0P#^04BT, P; @B<1'XWP1DQLP-.\ 2$H />(
MPSPX!-+0'*=0#0)<HCZTC!:Y2K,88C1*XS128S4V 9'Y38S^>!,B' T')(!.
M5$>S-("\D,($Z)"R>8<&@" /E8H^  86RDS?) CBU NVO _S>1("O!+5O*(,
M_(.]O,#%B-%1')7P$0(TT)+HB,%0\4-,R1= 4$"1A$)>U%$RYLSH)$#2_(LU
M<F1'>N1'GB B)@<KJ,4%JH0-U$/+\(.M0 @4Q$=1#0%/@* :OB0H3(:J\,-X
M91LAL)$8T <^QL>*L-3;^($LD@)4Q0;UO9](_916?!9K5!$ 1 $]#032-$HX
MA0H$P)@R:@2AR- S]D.K@.18DF59FB7B-<YN^4 B"(O@R*%3>- \18$D'%\1
M/%C_#0,IL&$@/"%Q$((Z,$\YCA3^@JG HM%0X S!@QT %PF::33 Z"@. ?A%
MN>A" 1! $^F ,T".. C 1F$!69T8%_@9(?A & Q5!3B &HA(;/R6.I:"3YUE
M;,KF;-+FW=2&PJC>P*7.T(7>Q<D>1@A.;OZ<P #GT,5'O_$<OQU!<1IGU1!>
M<$9<$OP;WK'"4#5GY;6>Z]7F=G)G=WKG=P)>!)P>>))G>9KG>:)G>JKG>K)G
M>[KG>\)G?,KG?-)G?=KG?>)G?NKG?O)G?_KG?P)H@ KH@!+H[8TGU3UGY$%>
M@V@ ?\D= 66G$2@H"<I>U2A(Y/D<\GDGU*C:!4RH@F  ^EW%!!PHW6B FHR
M1"*!!FC^J.V=W-I]Z(*L7'I)J,[UH((P5]WX1X@ XA+ DQ((!EF5J!'D*-W
M)(-D$ME)#VSN0P-$Z.Z-2HPRP=SIQG]=AQ*8DY0F 9L09<]Q9TT00   0'#X
MEP, 0$L! )097 V8Z58D03!8'_Z1G<[$%(.0F@@TB"J<WKT9YTK"!/KM [\5
MW<AY4-6,7,JT2<;U*=X]5S\IJN/97, QZAH<2=IM&W+26WHURV 080L!')^U
MPBN4( 5PP8]>@,0Y#PU9"]Q9AEU1B)FI!L?13 3"B*2E'B.Z7S^L%?MX$RD
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M%Q6;#?#*8A"!->Q**< !D!7.8E=,;40. <P8?'Q.ER0"/-B5Y!R-?LF, A5
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MI=5+8+2"#N2!I_ !,'D&A<D12N3+0$0!&[5"/VX:06F.*'"!0'"!>!*"8U
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M  0->*B*:W1>9D$$"7BG  (8D-$!!VC0(6\2)S!\,80!2N$%:Q:@@0  '$2
MB*2B+%#%!)LR80  Q1YPQ@70,&  !0TLN.\& PS 004'%(" !PS8-8&$#QA0
M #D0*&   2KVJ?;:R_5;3A48B#VT PJ4O0 "7V20@ '$M*9 *088D,$# $10
M0147',#MOA(8(*4+&AR@!&L()! M-@HP  JCZCW HR?1('""!0@\8/6.ETR2
MP "N()0 W?M^\4 51R+ P01^%7!7$@ATT#@*T1J@  $--(#^=CN!CQB!V!Z>
MX<#$.9<SY\D((-!  8#1#3NJ!APP@"X"&% L 94G8/R($A" _0P%&%\#Q Y
M-"?C+Q3P0 2V'] X.2+<P($ #;C8#@;E@ #$@0%QV]!!// Z!$@H?(3Z  'J
M5H"3&* ""2"&ULC2@>\10 J8^( !3*<')20@ !]8P-@F"($!<(9OQ?L ARI
M@ PXH"M/J1O^/G ,"LR) JQ[&@5ZE %0,.%Y%QA )OH7 & T24D56-0( ("&
M!-!@ .[XX/,T0 $!3( N!2/ !A)@!@!4P ,&V$ !,%"!.26A"RHR0$, P 0&
M7"  '7C G&#W.0/00@#N&)$'CLC^!!V8B0 4N   SF27O@1H7\1(D0PUL &T
MW(^&+E@C!!PD@0BR[9.@9$L%/.F)7U!M< E@I*YJ6 "#1&L""O# !;*0A \,
M@ 1R&( U!O !!/P- 1F;@ 0X@$4@W@X"&IA3$9G3J/Z9"0$+Z(#2L"9!"W
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M'BKNED]A0  *4+A**L"+&F!"7Z=P@ 0(( T$.  !)G#<7^A7 (,BC ">+Z$
M=E,0=.(??1$ UEZ:;:AS.DLYS&N!BRG/O P\1A484#D](%"$<Y  &S !!V ]
M\%5H%[0CK;,O'+!G)N$@B5, J(!^FY5.V\=?#<9?$I@ &;#^:!RH Q'  NYB
M7@7F !U8!6M@7DW% -"V&%' &F[ ,=+P$##' 1FP  %T O>F ,2@ 1M& .\R
M67,0$'3Q!)-0 VA"![>R9PJ@ M6 #2U  5;D#3S8-RT0%L %.8=S#;O09NV
M 4U6#@4Q!["" MIQ.U_D$PVA*V" 3CFP$"DS2;<A+JY0$=("<7L@ ]OF%/,2
M RZ A[BR!W<B!1Z@'370$7@(*^TQ D+A%#]Q%4Q!(J8WB6S3 1?P+%: +GJB
M6QNP).E1 YC"1J.R 1/1$77R&.BP&!<0*(,8B18 ";<A+;DR A8P!RLS MH!
M'M;A+(<8#PFP)'LP4CX1*/& +7C^B"G^$@JA4 ,GL24O$ ]'X1#*6!PQXB-%
MD &V4B.@E$3Q80C=%$64"!H>\#CA6([F&(ZI=8X_<$;JF!QO1B:L5C=AP@,6
M< #ZT2?5V([ZN(_\6!:/V(\ &9 ".9 $69 &>9 (F9 *N9 ,V9 .^9 0&9$2
M.9$469$6>9$8F9$:N9$<V9$>^9$=F8\@"4HB.9(F>9(H^4F5@A.!D2<EF9(P
MZ8RGT0,K&1@O:00UZ0=J\1,WJ38]F18UX"V2J!D, @$_^0,8P#H]D#*'4!8:
M$#@8DRC7N!,.4AMTL1<=  J*@ T:F4<2H&&2L!;=R .082H"V -LV")IH4<7
M(V*> 8C^;\&"0%!FG;%DZ\(67C@$+O<5&Z""0: !$@)AB;%?H9%NGK$)HL$!
M[.  80D7OF,54B080N,>9G(![$ 9M6%1(2( =Q F[M$;D!B-#G !YD&33&&9
M+^ ;]&021&$LH="  =" '= 78QF1&@   R V[A*)VL@4RR8$]=0C&P  KC 5
M8S.4B_@5PL0C3#4"OH&':1"(C*@#>M* D$,'E; 30' F-=" :4DG =*-EO@)
MAT@!4C!=9Q(H<=("%O ?,F$E%L6%\/$#0*,#W7(1Z?$:YT(%)N$.+9 ""VA9
M<[( /28#9Z(;/J K/Q8G%R L%' "L/)CEKB&#<%%_^%CON+^'Y!#&#+PCT !
M$TOB#E+0 +9#)TEX&A:PH!E@ 0;1 V@2#I!3)R=  #W" 1:PBGO0H,#H [YS
M:H?#*28A!E\0 7B46H9I#:VU7H#0 UQ$ PQE63WF"1 P 69R(!3 "<)DE.;T
M#;@0 18@93X F-SG 18P +3  X^55T,%,6_#F$"Z+S&%3-A0!VZP:Q40%IX#
M$ RP )GP  Y0<8@0)3*D !935^%&!P>P>Q"!"G^J6C3) ,=@="J' :9@A+ W
M)WE%..18D;=9"/\)"A/ 2SSU0< # )F@2QUT!@"@:P! #+,B &943RI0%T H
M 0"PJK8: .!@  -0:U^Q6196 )?^@Y8*Q8'_] : L0911P&2,U4C\I3$Q X0
MP'^;"CD$H$)L1$=*>3$GY![!5CV\= A%]081L!!/0I<.I%"]1*,N"@#LL"$*
MH&,] #0BT$FW=S4 \"?$X$>9PUL2 !@*<)P\H#E(H*O=Q$,WH =:\G<3 $V]
M9"L^%'2#,P 4$#@/LZ(+4&:8!2XN!U !PJQ,$#X0T&P.IB(.T*H#LR]E4%(.
M8":WIT9ILP91E! ;4RP1MD8%E97N  H)4 52TU#RV(1!8  T % + %;QL6LL
M]F.\U$(9EPF"8UT35!$\\ L9UT'Z- \NA0$7,'?[)$&0X6^K^%(]=C.E(XD>
M<#S]BD/^/6 F'74G?>= )$!;.P!(/% V=-)L P V/=(N+Y>5X<0.XW FO%2N
M&P 8&R=2$0 8&T"R\L1S.ZH)P 81L?EF@U4ZPLE+P?!(&7F; !  ^2I#"#
MY#  <L8.$S0!UQ=P]80;O*0$70ND&^! +R4 &( [*858 +!0Q#D! (!&D<$
M_"$"C.D-<Y)$/M"S4X 6VR0@HG=G$N0&7RF<!F2X0)B5-LN@.^*E<S>M\%8
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M*O+T>/EZM$G&F@&7:*PU(@-@179+EH%,HW;1 )EP31V5'@"P!;J$Q!NSEI)
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M 9P(7($1Z*0P A )1"Q,$-BAPH-Y'" XP&9B)(*2&@" &1$!03\.;3R(+*@
MR $)P&5!B "!@X(#3Q (P$!< 9P/$A9H+%$A00(@"@0 09-!, ,%'G;WBZ!@
MX(<'"OHY6%"< 8,%'"0 L.TS/0<7'"!?.A <H  !)73 4AL,-+#  I6P9( &
M&3"P3!G^'!R01P8%0%! ("-  $ ;#BB@ !((> @! RKJT$D&N5T3!R@%-(
M!_$X(( >:. UX(8=Q/C  1S4-\(B*/"F0(DG]O;!! 4P8  '%1# @  +>"#
M !D\@,")\3&I0@4',!  05 ^(4$; H#9B34(=B#!  X,T,8)"FQ7$@&C./#%
M!V!"D&"9%5#('T8JR)??! D"\$ #"1I(@0 QT1- !@W\8$"#%&A@@#)5_-9!
M 15,4$8%*@0PU !?1,@C _V0@(!J UBPP0 )-<"C P1D0  %UF"0@ IX:4"
M!\I!6:0*QZ)"0%I+&&!7 815=2VV)B"0P(X<;%#  P,T,\#^E!=<0$"O 07P
M)0$+3-M!  PD,, "'GX %0,#=$!! ':VD< #Q'Y ;@4%?'!C P%H$,&Z]H9G
M)HTD=&AG!!D\JD !AM!$XR1R=<+ @-#B&D$!11CPP 2=&#  !,)$,%C&(Y!Z
M(5,%+VCC0A \   $= 9:006BG-! D9!Z0( =VA7@@0)9 >")OA& BH & C2
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MXFL0 ,ZG;E!EHQ"D"E03'Y(\@50IU ,>RQ:,)_0,11S;!<@&IYTGZ;"M7>B
M X9) !\29!)U!1LH%' V4)2AGN*C1PS<-Y>"?$<993I8 ^P4* MPX&$CL  %
M9J*43DR@1;0L 84\\1@PY($$C!F!F2QPDMDH T5.T(E1<\6:0"4D Q28$@@/
MX"DU&H5^?+5,#/C@K0K<*$TSU"O?0/53;RRS<SWITUSIH8&2#HA&R:P<0@IP
MR@SH\0(SI0<%!N#'^'R#'Q9XTA3^@ ;8_Z7 +EZ!JR^!L#\A<6 !"G!F"1:
M@ VP" ;JX-82.+"T%^A+)^E)AS67<0&FY0%.O2LD2$R3@,JH P!/T<@Z/'
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M05"&6T# Z+R :(R"D)1 ,W" "+)>)A4.- '##RU#_(%"0BC$-&1 ,'@"(UB
MZC5&!HC#*&R#@FB@)Y0@"EB21>#"3X7*6*" S)P"#> "6GR"MZB#)R3%$D:,
M'SBA94A7Q%0!+=0 Y(A 8D4,%D@/#L#'[@&>!1P![[55 CC:&KXA'+* .8AA
MME1! WQ@'-X!!C10'O:A'PK!'%Y:*O&A);C (!R E 0B%/C$)Q0B"-G )42B
M((C(GA4B#@2B*52%(IH ,ORA)V;!'*H"'5Z!.6 B#K!"(VRB)I# )@Z#*;:
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M2>3$=_1*WH''/,C'0WI  Q1 9^F,C 7;P;Q2H\1;!@C /55! C#$=D@5#5#
MME A!1"/"DJ-"@'>EDF?,OR&:"X L3S% BB/Q: &F43'$Q#+C5S%<S022+$B
MCB2 N\0;O.&%^&D4>"1 QBQ ?VA(="2/ 2  "IU(G6 (E69ARVU%;CC:BUZ(
MNR@5_EW=P13IJ\7=E;33E0# -  ,E8P;4IB ,SG/ W@  ,A+/^"'G1C"H!Y
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MR? ,%"A!H4'U6 T.07A@),($^"8N.'!0Y\3WKA<:)'B:VP3^N%" @"T</,#
M#A!(0,<$#.#'P@0&)/!8 $Z=H   7#2@ #4?3*!  N1=(8$!"*A 00('_%+
M 2@@P  :%RBP@ )4=,#  L1P4( #"D2@@8M<"#4,C 5T50$G;^1T  , 4 #B
M!PL@4  :'1IPV@D-$&!  \,(8(0)3G:@P $*B,(%! @0N4X#"!!@#@(+.*4!
M '(@ ,$"R33 H3X6%?!  1=<   !J)@0@0$0!.#9 !$,,%X!+0P@2(D,&,!%
M !T\<( # I2 YP-9)%   Y)YL"8$#.14PP$9Z%2EIR@XL($!&5@P78<?,(#
M!04$.<$ZY%% @ 6>=M" K5(MRRS^1 -H8@ #G<)SP )5?O#H @"$1L$#TT7P
M!J]KHJK  *$!0,T!'E10 )4;<&"  H9*R4 "7K*@ 0$%+) ! @XDT(&V$ SL
MP+Y@<G$  BY"X,:%FBP P00(=!!  @BLT8@" 310:P4$_"#% ?Y-P&,"CG
M@,682J"  YA.0( # R + 08(?.  AP%@:VX!$F@0 *V8UAMH!Q)\3 "+.1%Y
MPCH0A,A% 3::H($"&EC2[T"8RNMK!!E0VH #&GP:@4X!*+6$!6L8FC4":][<
M %KV8B  !V67HBZG%0SP,P -/& #ASQ*;  '!U PAW9^AJB! 1-L$, #WG@0
M '/;EAC^"@44"/#!F]TBX,&_*T!0^ 0#<*! >U!P\H&9'20P0>,L27K"L[H
M*<!@_-CVP0#.&%#! :@0!4,%-XOWP9,XAN(, 5[(P  [%XCR5>8I&H8IAQ.X
MR $!'#S8^2\R1$#[ <&&*</FX7]PY(P^G6Y"!@!X@0 F7F(@:8&8JZ8! J_=
MM@("H"<6-[-("5;D/@ODKR/ZZ$ M\# P3!$O 4010 7VACH 4L!W!)H#9=:
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M7)( _$ H1&!"$> <OO)V[\%-)@"3>30!3@DH7/"WRN4EG]8["Q ! F!P:S
M1$R[$M,X:"  L&/#S>!$<:0;NB2C 4!8)K W>[,$ I0/-20*OX((M4(8F"(
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MQ(?'I9(ZQ4 H82.C$P *,Q+::>#67@*YH9 5HO#8TP0[964!\.($\/( V^-
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M3A(8$($!"*Z%P (/+,F-"HNU4Z-5$!Q@FXPM: !4D4_U]"54V475@0$LM(#
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M% 1I0+4 ;94\; D#95SA!585@+R3"!]P M5T%#_U0@4LE+Q8 1T4T+% !4#
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MX#2;NU2 N0=.^82I%AR>I!.Y4T-QO'4 N@V/-P-8#0N8U $+(.5(OGO %X@
M%-.UACB=0Q"T7 <MJ 6@)LF:# FR8P%NU6 GA=%$"S8PC!/:S@S;ZPS4P-$E
M#W+) EH87S#8Y(@^>" "-H$+^;;^4$$E:($@6D"$YBS"PH5 0 N9F<D$&("'
M"P!@.)780 ^REX$&F,LS+!O"!;KP@0><1%,HH9MENOA%,^X$#13P2X,B\ !V
M+,T &\C  QS0!@PLK!X*(  %!&" "UD!%5WXFAHR8H(&. ,E@;!=Q?;5*8 T
M0 %::, "UG&!&B5  Q100 *BQ0%F](,"!'# >S#UC0-D\@L0   [S!&.%1R
M!:3\ 0>\9H ,*("6N\H2!0#AM \L0 $'B$ $EO*&#^RL @-(  \I0($ +*
M:9C *@,0L4RV0VL3D< #L'A' 4"  2+Y@ /"<+0,+&$*IQS FLXP GHN@P$$
M0$@!7+#^$0!<P (&@ #0.@  !EQ@&PV )2<J (!,JJT# X" !-+0O7GUPASH
M>\#XS.?1JA1 #IT( P*&D8 "C( +D2P',[!0@ < ( T(04!><EE!:*YBDYD<
M'@NVPH,M'( !FG1!.BB @7XF( &.($8AEC&$Y!&  S<RQ*<<VH ,$$ 9(]@
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MR$T<T(<D*/<T$_C!C9[=">@-P;DT00 6-A=*IR43F Q"P!]?,&"7E<'&&A!
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MHA;*.(!WN"0O;H$69(09\.!)+("WR!4Y@)E*[ 0&6"&]X4 ;W-A!$$$$GL2
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M"!==C=.][%,HEAF@#^U816 *B  8#H] P \4CU008+)0K?J\"J(JK+S"C>(
M*KZ2JN!2",^<SBX,RAELF88FD!HH!)-P0.8.SU&4!5#D79LJ*X(41;0<C* P
M"Q&P%W;4Q0D!B^ZTJ>V@&+!@P);]A)"*H;)X0!4-0\:4A25\D8M>G(O>!!BQ
MT^<L2%W9 %8AI!#DZ(2$5">0$QY8A*OM1 8 @!28P!T%J77^Z2K>C)P]D-)P
M;)CSA86R28""KMP$0DT52 ,%')3OXA4><!2_F4$B*)4]Y0!HJ,4\7FV1=$
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M AB'>XFA,D'+ &13&H@A8.Q<W,W-H)U?">NJ(JJ#"QP &VM! DC&\RQ A +
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M=&7%G09]MQ(O",#.@4"A*=;G&!\')%_KOG LSW1MWW@>$]%G=!_ 1M'X=!)
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M0B""EY!$9,KY0!X6F/(GD$@"V.@'&TRA(@88#/I"9A0 J('^*AQ$ ($I##Q
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MLA;4H@.34DX2-H"W>@!N&!KR%*N:4">/'2U3H\@#",]CBK+HK )4RY\*86"
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M21$ZL(Z0>*!4!@!+/Q-0LQ8,E '05(#!)"E4;9%S.#0S@GX*@ 4%="$?FV+
M @BI  :XA *8F8A=$)"'FR@ $ LHP@(6H$\(P$9["4C?00S @@EP)@$<.$
M(L(D!A0  ?6 S0!$X0 %[.$%*HGG*0P &IEAX !L#9T EL"' 7BA 55% 1Z4
MTH"E3.8C"I 6 1HP@#+$0"5>S(;^4BYPLA0PP04%(,!.:$D8"<RCJG1@Z@$@
M6PB:F71\)@CK&2(0% +L,0"575"1/,%1_WVA7;H!@/.0!!9D]'5]>#J# N#B
MVTU5! %=0 P ZD&SJ/@  @BP0A$PD(!H5((2V00*) #P1Z[&U <$V!:%W*0C
M013A M(02P4"D &[="  6XUI%0!@IQ8\  +Q *@ XG$J%&A@N#<$GP2$P(
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M !_ V[-3^O8QWDFS=UR2+C%X1S=KB((I#'"!L"JT".QV0 4FP&X^0.8"%/!
M:C"4@2+TPP0M\H'SFG>&N$;AV0#(RAJL 8SU:=MG+* #Z2C^)8"3(<($^RM
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MM<3Y;']T Q9@.(X1 Y54&=:ZN;!3-#@;37<S!11P8S?@D+&0!WSK00HU.1J
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M,20()"-(!15S/B3X=&[UKM>$!0\Y2R#R;#D!(![!$2OG\9XE'<YV%E($(KG
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MZJ?!9>%'PP(T!$D*!Z)2$)@ 84,!'!$6&,. 0(Z0%O(^0$ "H46#'!JN5!C
M@0 '#[0B?'@0(0*7 RA4,%AU0<\5#@*8.+"PP,$^1Q8>=,J(@$*$9PP3H'C
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M"VG9AL R:I"S)9==>OEE#@[(A:4$IL   5YPW,7 395<@,$5"T @!X(3>)"
M'1!X  $##@@T5Y\,<.  21G X0#^58>E0"<8(B@G#S\0/(,(FA]L0)6@$7#@
M0E@NZ,$ !AH$2,$+]3B P@1[ $<!!1LPX%Y9#.R4@08/5" H!XH:D%$.$03!
M 0H6G-I !QR8P0$#1FU@[ -S=-'"D48V.PBQ.2SFIZ 2!,%J"@(,@IT$1C%A
MD(66XL0!7IOY8:V?))6;PZ!2_#5=;G$P$\@*,&" US/Q$6)!!Q-<-D@%#3
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M6QWPTR7(&.A+;+$I( !A!8IX@K63CE/;:JX?3I*T%UI0VX[82@&@P($$<W
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M!9[6%/2A"\B*)/Q#D:A&!<*%Y+! '-2-8K4 ?LG#<FU2;T2$,<9 $-"0R[6
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M$YO2(_3#-4:IE&F?U<4  R!3@(724FA':X$-DB5 >H09=/:G<.+"#,!'7)G
M 0Q HR7([7E  5S.JT98IO$?A!+  7 5%^H; (3GE )"/TC57Z1</CY*1T
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M)"6!QCG:IOK;9*U";P#83].01/ +"GX@#ZS4&B*'\Z% 'XR44=S*MY ;X:<
M,[0MN![^@'4NI4YRNAW$(P,-X*MNB@,@ C^>0 #0%%0*' E(P!-4DI3 QNE?
M"D SS&07Z6=Q'%9-GLMH:6QEFD^PGA=PT-C=X=P)Q!3P1)D0"G@#CL';@A*L
MZ,=@2;Z;4@*< $B08@E+D*^E6RJTTQ- _]RLF00\ RL.SO#5 ?AW) A(3V5@
M5L5]*A6I"=90ZN=]E?(57R-]T_*!0"B(SN9BY&0(D]FL<N!H")G"YH/ '*Z0
MC%-1^0R\B SXDX!\' J'<XU90QRM2F]V\$XPC\;ND_>A(,&@]A'!<=#AY&'0
M<: AZ%;3$1#7,%'X@8&34)-P8<&0<2 X,9'PP4&PH8AVX:3^*>#541"I<J$#
MF#$0YD2@\= "@3.#,4'AL"&PR-"!T)30,H/P\'$1X!&AJ[(QD/*P >%W@?"Q
M5)#RML[>[OX.'R\_+\_1M$& P7!UP,=P#6$"#@VE:.R0,"&,A@04"GBHD,K
M%3 6.G#H9=!!*@P)")T;L"C"%14=!EQAL$""@0\4%+0"](\0J0\"9+QXX.;"
MA0C%;,V84-! .74D(=0X4 '!E0*<U$B0X*"'!%\J$%AP9 H"D <)IM1HP '!
MORH5"'Q@8$V#G50: G  >Y:"P \6'F!04^&!! MKBGUXM$&!!PT.G?CI%Q?5
M!X(62K')D<)!"@5J,#B88 [#@,7^1(.D2DKP#;Y%!R@0=H*91CI0.^H(:#(C
MT5()& 1\( "+!XQS!CQ >B-!QTH':N1^D-"@@P -O(AN>)&K@P(93BJD6]F@
MA00@<SP(J%"!&0('S\ ;4D%B@P, &F9],,"!9ZY;*LX$@)6GP8D :C8 X.O$
M @9 D$Y9$-3DA 0*1#! ,*44<$$"7BP 02M:.0+?&XX$HL _,QBPP 0&1%!+
M! 28TX T &1P@0(= %!! VJ(A8 :!2RB0!P&6;#B! 4@4, T,SA0@ '6$$"5
M"E0\H$8#'JJ 0044I.*C 3B4M0 !=ZC 08=!'E+0D-4LD)<U&7B(@#GTK,EF
MFVZ^^4;^C1DH!=4$LX1U0P2/O33# PMX $8">W25(B 36>   QS1-^4%#2@P
MUQHR)N>$5L1L, $3@P!B!Z0*/)!!*D@)<@$':8 1%I,9SL"  S("LHAA"U#0
M@#@+VJ+!IPIPX$ 8%0"H0@.AIA#!!("VZ 94+770@ $5,! -!=*U% :D#Q0A
MV7%AH(6 !,_0FH$%"+1$W5]^\$0A(STX$ E"DJ0D2 ,'M$#I!(MTZ0 "]#Z:
M2K%O]+% !F^MXV2S8:01FP(--%!&%\?UT $!G;&DP +6"')#),CLP  T.TS\
M2 8.>+"Q3C:T(&X"2=IPP MPK ,M!!Q4T 0&/=BQF (&\,7^0:M-1!#F7Q%
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MBA?,Z8M@ ,5R%8@ (093"G%$P!>N8@ .4"$"%?Q@D39(@";>T   3" #Q+!
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M( -VRH"3-F"+ TT+Q2(SB0(2T*4.?#AB".U-!"2I/2(=1P<)8)TB"%"1 WC
MO)((3Q#,0@$)(/D(S)@7&L;8 MSHV <*6$@13-*6V37 &@O3@#PY-P (8$ B
M!TC6 DZ#20R8@P+[8$\.6**#^]S&5"YYU!3^,@#Q-6A4#'BD;C\-ZE## T*+
MB0(0KK:(,9X2#"UK%@(NL)D<1.)&93#(!58"J4WD@0!VA='"T)#=PM982I(4
MQ@UHXBN7F"-B:2@ B>=P#7/<X QHP$ $(J&G5:B@!!V RB \(@@39:<CA8*K
M$R*0"HS^U3D B5+ K3^*"4,LX&H&0  !&"V##MA6!<;U0;HGX #:5M,-J8Q
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M>*F0."6!;5_E!<]" G_5&#MP: "P=39@%@( "Q*#5<^2"ZI0 %X0!=TB"=K
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M=!,D,XQW6S!:+8*#$^]^3V?5M4 5-4 D?U3A;O8+A8  75+^")[$#*\P!1+
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M@;:HTBL?H'7B&]\& O@($APK517 ;0!_4( &&(09&\'O!0F;A+\F@2&&&E9
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M :"P@?L*X)0 ,* 0'CE  Q@3I@(DX) P<%\ .G4(>:D+ 'W^&H I** ! "S
M ]U!7BL,0,@&). 1&4  !0R @0T,@%,K$(T'#C ! T2J ]=X9;),& "*/$("
M71@ 1XH5R0GP*R^E&A,9GF& !$C $A!0QC6"-\ &O-(!/EI  2HP@'(4P"CJ
M $,%F-'#O C@ ;MZ@ 8L,8%BZ:\ LU*F,E%1@2&D+PX'H (J.ND!5/3R Y.L
MF2(,\ @%]/(!#[7*7 80!%0,8%H!8!0DN?(T@1[4&-(1*/1XQ3 ,"+27'HCG
M(1[# 0)\;(>D&2$$,F )"@CT #5H0&@VD $!,*H"VS."#;RY%P/R( +,.( B
M!#$!2YR/#3M+Q@4(4((B*48I';#^D@@Q*@$=8  R$USK^6KP@ 9PH!O8;(65
M(!"F!\RE@U$;1P(Z   (:$  E_"!1RD0 %D.8A9SJ @"_A93(*#TL'"PP [O
M:0"4S<*GQE $WS PBV4-@ H:-68PX/J("CQ  B@-DR8[=X%G9&8!/B*=1TJW
M0PT(5  R8,!<$A !#%C"&04SR0%*,( /^#88&WD&"H,QDC"!M68F@517VR'4
M9W1@ (PB52P@<$]@2B4+O 3F%3^ 5!A8@+6[/80,'M"J'?1S9FQ8IDD>H B!
M9B"T43M3#4CQ 0UB(8H-5*:T"D8!IO'  !>H   LD%X(/,*O5'O=#HJ4MUTP
MC+N=*8#^!"Q@L.3]]TQ!:( %'$62R\1P!POP@0)J($VY.6H#EC@"P_2X%6I>
M50,B[%-S'WJ(0W3!48]),08:&0 2L"$!&&B #DCR+UT=@!@&V,"KC"&6[JCU
M P&0@3+BP(#R=< "40B5%P[Y".@Q! [9>^M<6GP!=2I@ LP8:]32(9D+A(D"
M NS&#B"9C@0D5; 8C<5E &#GN]D !=2\8 54BZUWT IZ>S/CBSQ(.T K0 ;[
M(7$[:L?6"6[ D76<@ XX(( E=2'*_Z!B<;.W :$0 # !@&EW*#,!13A 50#@
M2Y D\ ! = X&C:X=K7B@@!7\N!LPM:ZBS$B !50W#A& H+O^(C&["% X"1!6
M@D2+X=JYO(F[TD: /, D!(*V @QQGD !WMK7*HN0 !J@G7O!XX-[,D/'<&34
M.$H8@2EM!0$;Q):/N.O(>BYB !Q(SZ\K]@S#:2!O)@C3E&,!280P@RJ&(^TU
MOI!!%*"4 "UA$A>2P=!#E*1S-R7714VBNP,4"@(N. J3'_ ,#@1 2!E@LC@8
MD02AYD7BQZ2 !,:CY!!3<81@6C$$)H!GAI&M%#X0@WTOT-P$I.=%D%P$('-S
MIB[$Q-$_)@;TC*$2# !I P7HDR_;AMPW1^$><5@"!8K C(IS 72 V\$C#;A5
MO:D% 1;0P<T""ZY'Z,JE[]E="DK^P WH94#)$28G3"SP=#T7C H,D, 0/-"W
MR2[5!Q&8,IEBL9S%S,4 +K<Z5OOZ7_$6.2!-G"Q2#Q%Q'$H3!<?Y]%I]:0,'
MG" %.\QT,FJP$0S0;P&D\T$!R$6* @0!^'<YGZZ[%0?)? #8**A !,B7 @+$
MYG1C(BC"%O&(G2;$G3LIW4-[V(5,6> 1@;# 3UD;$-?"20$"X(]S1L( #NR0
M'Z$;.(U$!$24ROR7[)F$ .R2#D  !M#8/3&)(QE##"W "R 'P+7?H@!@P3W"
M40#<F'!#0)1#Q%V1!^R,!YG;<YR/RL 54_& ]UE!P6@ !AE#1QW8E%&9R@2!
MP;R>YWC^GO()$(%=X+P9A$ UC:%)U'%Q4#OLFM/Y%-H!$@(D 8:!RB]0@Q]9
M7@>5'0$,GH(]QT'%"@.\B1P 0BN(WFNE"0((% <,$M1=P/:<CV_%$U"A$,H(
M@%R<6K$<0!"0SS^UB=I1@"RP"1O(PW])$@I0Q03LFF=U0<6ER07,10.8T65Y
ME)9UA<A$F2M<0 G@ELK $?CAS (4R@/,#C @D;E-SR.\ENP<#'2AE/#80"AY
M&@\\BE"@0U)$6:54BU<A5P&HPT(0P4IXSR5 !3!VA)HA$V I !MDRDA,PGOQ
M'KTH@&\9 #,D0 $T@LJ81/S)#C,L@0*0R65TFP<D$CI(TJ[^H,!;)0.@-9":
M^58 %-T*2&(K^,^IS=T%O4 \/,:LC  R*5AH&(]HA$G\(8#JC5 E,)\![)&B
M3$0#$$()3(# . 0HB9($D- U=% *J(*5C- I^$"QM())/(>>,&1I)468+  :
M^0_:I-4#U$/P_5C\,8!(<L(CD!H%O$!<Y<8%=L<%*$):*4&<J< (>5L6- !>
M91P/V!P9CA! '!L[LIL'D,_:!0,;E$XP9 $*C<X&9!PS4-D&A$8XQ(%09$Y"
M;$7I*(\2&(#6( 7P*49+O-7,=!(;'$05L(%.NMU C,?"R4'%)(5, (N@%,T.
MW!!(?,:;\<7@-0 5D #:>8 /V$S^7WS$3DR S.A%%EQ RA0)H[0#&W@ 5FP
M6;P%?+D,5@"+''R+.+3#=/0$8A3%;3B+.&1!QI +9Q@&QKB&K]3!JDSC;TY(
M9'(+!ZQE/W'%='" -.$*T65!3V3%<PY>%F1 4:1,SUQ6'!"%S'! ,7C%5KB+
M9\(7R0"+-TA(!_0,:\J!4Q3&.N!*N(B#8+0#LLB&#609J!C+KJ2 (L3&:/+
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M _##2'1N=51/ J!,YV;9!@W:L4W"?P4!YJB9H\S,*%0& >3<$DB"ME6C22
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MXFB!7D" 1A 8.*CV:056%"1Q$K2$(+5*109X!V7=Q$  :L!1 04=0" !'!)
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M8" &<,(&VG* X  @=^A0@AAL<X-K3& @@#@"[I)0B.CUQ"K.ZX !"B"6%U
M&)688@&(A+O<";(!:1R%ZL:UD7G^.,$ =V%! ECQ@04T  'EF $>B), /Z+/
M  ;X@"&0A8L?J!(%%SA !*@Q@0%,00%??(BW,&$!'GB+ P)  &E"^( !; 0
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M4P XW06#7AM 3ZX1BQ/H: $=0 ;ZX':# BS @SUA@!, 4 $)-/2N2D@0 3B
MP9<X(+/U2>4"6J:W+"A& ";! RW$>(UFE,UV[L!  #PP/8A@@:R2G8 ]\7J;
M:[00!C!Y" ?PZEDE/""G)CA(W!C60QQH0 L/PFXX.I!!9<@C&>0#T&J5@8'+
M?"  E5A !"CPD K0  %A(\$DQ(8L*%Z  5ZCAEF4P4(TQ$W^E?,UIN=>1H"#
M?F$ ;,  +8#P LW)M4=9B$0JV5*",@@CBL L"0,X0 .4 :L7[F) !@BPN08D
M 0,%0-#%^$??#S"Q&K&QYUYA'*\2," T[N#(!B+A 8\V8 ([BX,&LB5(Q "-
M:VT\0.'08!H&C*!4%1B 0"7[!K^DD@-H> 5$*" !W'+$O*W)V0/6J"L%/(!?
M$7! )DWP$#'3)V<H,8!\W1R1$B3   Z8K2"C<)P?C, D#H P\$BPYCR2@*@D
MX")^(^51&[,S"Y69VM3PA;,&2/&Z.4LKQ^I3 05 )<RI_ =%24#BMRS #1\@
M![X<0(&]1F  &CCI"R+ @&9H#J[^;%",,EH1&0%@I0A2),$42E#5,_<9%186
MF8W_" ?M"5(1#\$ ,J:1  %(8*U(!BMRN" !%'51!?]H'S4P>YL"#6X#,9;K
M1A) ;R7D9&H(Z"8$WC#;$OE"$:FT0%ONFPP*J!A[_&@R)KK:2:\883APH;<\
M!.L/";#R&@\@"+Q,,VRQ[;  ;9D"_4BP2SUP,@-(ML W2N/B -0'#0>(G@K_
M#=U$3Y5>%]!JI#F0LDA=LP#?Q8,S#=$ ;?;"E@"!P%3C<$1:5",GUR"IO-A2
M'B ])Y52C(  ZF-,(!Y!%O5]&9:,GA<(0" "5:&,6 S@@2)JI -=6>8!$*,1
M$I12 RO^#'>5<^*54G<%,B(L@1">$XELP$UX0$=PLIKQ+WG<(#1(B,.:=?R<
M4,-:&0_09Z8$KH<)W":(&*C5'+0CR%*CP0:+WDCV*MP2N'6@YR6J-0D6F8";
M0-H-,DL&$P^0C V8(I6BYA@"*.> 4[>ASG,XZ'1=/7AIZYM\*=B  -;$ 7I3
M8*;WKG8E(#=MOS*#90X($NR5,0&#0Z2' 'L%6P+1Y08$ A[PQC9$H%D Q4YP
MK1) @\LU, $/\&-H!;$87Y14'$8%(V=4<3!;E787IM8!*T<6RI \!&$[_48"
M=64""7!(]4 #!Q 2J),$%8$#+J!8)7 %D>9P+T 7,,!%P/?^!A[@!Z1A7ZKC
M-??6$V:W>E=@9SZ6! Y0!B%A 0"&+/%79(MP$%YW1,4U4W$P?0W6 4;G 80U
M52JA,B:%7AXT5"\&<B,$ ]0 1!*P9A[5=K.@6I0T3VIC.YOF9T;P"AF  !Z0
M6!=P&+BD 0608WH0-R2F!CW& 7%$ +1@ 6)A9!,@84"H $Q68M> "OR %CD
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MA^$X?#H-Q!?RH$8_D<.O,=$@VA^,XMV)3!2<B\+"!L>  <0 @H>%@D**W0K
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MH+#Q((0"&1!H<. CV#8U )0"46#  0 +!R3PW$V!0X )L3XD*$A%=TH,$P!
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M+@"G"GR!9X7D&:>,8.R6%6]?D_S"JN@A-2MTA @>ZT A!UF&MI6! @^W% (
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M*AA!XLT>G&3+P<$@UA!-(N*(*\")!U! H3& %[5!BL36%MJ!0"P&G2E=^:U
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M%\U(5M3^Z6QH!>1B3!U8@6A]#8ULSK_T3?Y"W2'D2 "@! U.QLJP:@I,TO-
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M3<WY8>A89R!V>$QX9L)78&)M3(@:>L8.^2G&ZH,+4,VG0"C*S, (H\0U+$
MB.-$& L<8 5Q\ 4@0(PJ?-A*%)D"! ,T1)(&O<0%H(1,@0)<"048DX$^I$(
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M$#.!,='1 ' !L5#1("(SH5!BX0"QT?%PX:#W,?&0$(AQ4M7 L"!#PH&@$/<
MD7 VP@ @\2%AX*6*D7"PH\!PH '[0?%@HJ!PY*#L1I+(4// @-OP44$S44$
M-:&Z@7!P75L!<:! @ 6!L(#,@" 02=(PD%#PH1!FH/QQ@/" @!X'!@I V*.
MAK\- WX-R&*@8(<* A:,4Y6A@(,!$#JD^U;B  $. A X.' D0;-4JEJZ? DS
MILR9-&O^EL @,M4&D34P($B@@,(!%1\"(IA% HH"#QP8$#A(@@*  9F@7%,E
M#(&(>P5>'/C P4&R P<E^+HE(X("!!(X##BBKVB"5 ;F$BUQP4 # D;$5;!
M@, U#@E083O (%"&<0@V<!A'@)(R=24R$!A0H4,"! )5)1B@(,J&! V&J7H@
MSL$$ P0H2 "(#$/%IX\T *"TP($H;)$)#"$! 0 R!0<*L"QA  &' .T*>-!@
M()>?$LO=>(CQH #B#P@*N"J NH8$Q CV"#A008&$!N49&-A@ %L!"0,P6
M 1ZVG1,65+L9P 0-7/.  104P(D!%02PP6H1!&#?5V%] %K^! -D0-]O.3S$
M 0!SM)% !A1M$ $ &$@@P!@D3$)"1D4<%0 #&! PT0$;!.C!>Q(XT $ #,RA
MB@=:<>/1 ""1L* 4!7" 8@O0$( A Q54$\$##2"SG@8$[%'$5X#(0,%!#VP
M 241-.!! !EX-,&6%^ C0W3YP/!5 _@,V($ &PCIT4%(53" !SE^\&,#W\P!
M'C8(9#1" 1HD<$MF\47 @&4>8(9+!!<\!)\J!E4AP$24J/C!@!1B80 &CU0!
MH4VNO@IKK+ R@$P"&T@0AP$1R.;!9A\D0(%0I1Y'2S7-=-!:'"7,]X$!J2B
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M@PKOVA$=&F  @GRB&BA!2184(+(1V&@$&'"/6":G@/S@;00>(<'!CD MV'$
M&8/CSB:6MD (0,!:Q^!.!O &@6@-8#I(PJ3X-J"#G71A PH0@:$F\8(+:"!4
M+JE "D\P0U[@ T&"-%T.\ $$!YR1 @A@P#76XX->1: 1="#E"#* !05$@ )F
MV@3,)$"-*O#,D>BBG07B0[M/0 )F>H@+J22P-!XE '$M2,!C1* !],11 HCX
M0 %P8HQ**8=!2)# ]3JD!KCI83D;<)L,'$ 7*A2@ A0X9*7<!]&(2A1)'3@8
M&P(!$/ %HRAGJL8AM+<D0;32BS+^$$ /:%D!G]&"$DR*P%=0PXTL5&.( [C
M&3F  NWI(0,"D,!(YI2 U-DRA/#BP36@<\*\C  "V"S$:XX@ 0UHI0H76, <
M)D'%?!RQ 0=I314X6 *V$$H"$= #!4A*A?'0 0%7,H9SN(0>;#@B%0#0@+ ^
M$ $7QB&<DRO5TA2@(5SH 4[S0< W2*&*[7Q@ 8WAX #C:C(ZJ"-5W"&A6)2*
M+&-08ESW_ 2P_F, +'2-51?,AU@>9<\Y %)*W"'F-Z"U00]8X&DQR&@*;P*
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M\4&'Z' %K7O,^WX;.S\^YB^0:NMRGF)T>*+T[X___.M___RO6DR0YA+S0A/
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M!CZ1 6*3 1X",!'&4'=Q*58E.FU2%%?D* V0"LO$,O.2%TV0+V7R&(B##PB
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MI4G["0</[=2!"+0ENX/$RY8?D%!E*AJ3%0B'!!^P ).R5QA2S:P[3!BL;HB
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M D3@-CF%$J2)Y[!(G"&9S @!2-B*'!S!P7'B1.1 4MA+3_"-*:8!)=1B@;G
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MW L:.!(>F J3$!9529>K9  C[.S^#B2 00S5<@P5'L3+:-H!!1@ ;M[1S.W
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M24$$6/I!5F2J[O7;L:'H8$0')L:+FH!%LP2)9L1%<""8C\R>OAL3A'4G,S:
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M!1\1> 43;FT(%D >T@U6,A$Q'O#^F_ @1H59&0H@,*-"T8=E#\/HB4'A@(<
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M[:P-)"'"!&]4NQ+R[X0H3*$*5\C"%LKO,G"KB@!E8 D.ZLH_R&-=$3QV-+@
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M8#U * UPV1JE*H+5,< SDPHB'JS^"@20?4IC<TT)#LAS 0Y<X&4)B,!/*L
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;MKO][7"/N]SG3O>ZV_WN>,^[WO?.]YR'   [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>g160222nk01i002.gif
<DESCRIPTION>G160222NK01I002.GIF
<TEXT>
begin 644 g160222nk01i002.gif
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M(*^2(1> *HCR0#S1,#-F(AC#3YGT:8#2'NU 3&)'(5>D>'>0'P2P%1TD'@5
M .LR$V%A AMP  BR)PE((R!(  S $QM0 +%"(%8Q #/R0]#G)0-@%A*@']FA
M5B6  +35&Y-%'_MA(!V0%P"R'1-P -;1 &NR ?61'6DQ 0"" "O8 0>  #!8
M $8D1_61@ L (240 06R E!'@3/!2*C! -3V2OI1  C@ )GA 1#@A NF#E 7
M.19 'AO 2 ## +1!30Q@'2/X&<MA I<12%ES=BM@ =BQ%1*0&U+X.\"!  50
M 9A(9)DS "(P .DE&QMB E 'A)?^Y1U71 &8&$E2910DL1,7\!8DT0 8( $)
M4"P>( $+D" 5H "900&N.!E+413(40';,P$Y$W,-, )3\8H1IH'0&(W2V W)
ML@L/D1"N@HT]4(TYP(U+H!#[D(TXH [Q8!#W(";3F([JN(ZDX(W@@!X\@1=E
M\88Q$!50" 2%,6+!Q8[KZ(X181WK1R&W)RKEN (0D!9VE3$-08Y,\2K,T8'\
MN L.D($XD %/I18*$&DQ (SQ8 %V@1(1(&<=L  )2 $.T!;?$%#F@2D9(2>0
M-0.=,BDFF7@X\&I7DE4160,(T$*VHQXVP %35"%^@"1,9P,!Q86O0H\LH 'Z
M= *(4U[^[)0M0@EM7=(^9 .*X"!2#V9<7%0 /&%='Z$.%0 !') 8-]$^"["2
M72$;&8 !#-  DS(!-Q0>?:$!$ !,(6$!KHA(5&*).6D##.( #((^.= M+1-L
M>G!)B#DO2,$3'8",DW(3%I",,=<@!D(J:Y(!$U ]5\<4:,)"D;8V\@1A'X F
M@-<@0T$E5Z$[WX D!60RZ!,/I,)1A((3XC( "6 CB\$GY/)W'_!ZGPD27((3
M2!(J9"( XO([@.*%H*(Q N"/?[D X_1*'-,!#"  !3 6<@(40R&% 0"$'8 1
M7P5V>H DT'$2C4(:DH=$(F@C/M4C8.1CKS(AO[,Q[L"4W#+^/@E4'-,Y..VP
M-BS! 04 *+^SA9;1==[P)4;R)3/423]" JAR%6:$0A@#30E%&BW$$G("'6A"
MG,8E+B30(\E%?8=2 H"BE'_I H"B 1R@ $P"**?Q(E>B &AB(-;1,BO8')P$
MG6:@F)NE75\6),D8  82  6D(V;3(Q4621($5$$R+.91 6IX IH$7UPSG8I8
M;S!!)6FQ:?'B#0%U%?*3 I9U)1@S8?.B0E\R*<,)5*]S)=#1IDAR%6WB  V@
M<2(C+Z0R(Z0B;2DZ X#B($92,B+Q::A1 @%@)$X4>>Y!G5[9!^8I*@, )R*%
M 8RD*@%P%5>2I"^B(Z@R6>.').7^PP+VB7\Z-@!RPQ-RHJ><!DLXT4=$$5_>
M0#]YYA40<)E3R: (%G J%),-EQOX1"8<^B+ @5PLA !ZL0 ;$",DLJ<ET*=_
M6@-3=$R3 G4#L#$51B("X(9@8@"P2AC4!ZG% U-P<@#8%@!0*  &(@#F$2.<
MRA)X\YA-BB1*5U?)<R5NTJ1W="3-9E9?4ANP] T\)R>Q43F@"ED]$B1HZIJ]
M-BFF"52QX30?("YW%5]4U!,7,#KM]$_RYJ?1:@_2>0)?1BY*ZE9IJC( $!@2
MX+%\%*"0&@#!)0%NV$45UG*!TI>_F2]-FD1 )S$K<R(;T#(@ 0'>97SG@!?[
M]B.A(C+^ _  H.%+^[9A&M!53?&EWN!D,^&>UV-<^_0@04D:"]NK8+(8@W(.
M4SE$'W!S#C H5S$L1K8V?N>U$\*F^_.Q,1"R(2%&$P!6,8*)JH*=+>.7]M,F
MR .5>Q M@X0A&6L  E, &K!/]%%2.,0B44,X(4))C,L2$B!& D BXM0/"2!/
ML/8Z"9 MOU(L81,;$6 [1DJ3UD E+WF"]R, P;8!UR-&,C%%(+%]<#*AH?NJ
ML4$J5Y$!!M!">8$H#? K[>&=ZLJN7R6Z=@L#$$">BB,P$G  ?/4:46,@&( F
M&>DJ&+  H*$ "U"4A<"03) /ZIMB$%%'1<"C!:%+5!6]/"#^9612K_2["U]F
MOOY@!=>9OSZP&1.R  O)O@"\"E;HNEQP &ESP#P OPX<P1(\P11<P19\P1B<
MP1J\P1S<C42PONC8#R+<J.+8J.YPPJZ28NBKD&("PM25PENTP@1I32F,PC"\
MPB_,PC!,PSQ,PCW\P^S[PBZ\PSD<P_@PQ" \PS?<OR6,CO50D$U<P^=H#TX\
MPE/LQ/)PCN%X#^8(P1W\Q6!, QI@,Q@0,F5\QFA\=9Q2-&P,,B+ +]1B 7*,
M+R!3 6E,+7><QV?<EGJ,QFT),GR\QV4<R'U<R(9\R(2,R'(LQV5<-"%32!40
M3&UI 1(@ 5)JR0G33100 1-0-!K^-@%22@%(L6]((0%!,1EP01(U\103$ $/
M@!$/8,JKG!*T+,LD8<H0(,LUT<JP[!'\ILH1X,I!\<K +,P>0<O'G,K$K,K(
MO,RPW,NGW,RJK,S*_!3.3,V3T<S+?,K#S,VK/,W0[,W@S,W)/,S:C,V3$<S!
MK&\CH<[N/,KN_,[QK&_N3,_!#,_WO&^5/!6F_!,0,!6O[,K!_,KT_ !VZA0'
M:= .P  *\!,Z0="N_ #B*[X2X  ( !-C2+X+D  7O0 9O0#D^QK_3,L1C1%W
MV@ .\  -'1H;+81^Q-%_%-/"(1Q_1-,R'=,UG=,PC=,[K=,X;=,</8>LL=%W
MNCI5<#/^$R!,$I#42VW*PL343:W42ZW422W531W5N P!PM3.7'W/^N;4_(81
M6=T189W4#D#//S$!KPS+0/$ G-P1PLQO4YW+ZJS62*'6;IW+O&S*7DW72PW/
ME:S5P=P13SW5A5W)E?S45JUO3+W.]?S5ZUS)C@T4E W/J7S9F$T51]'.FXT4
M7*W9<'$4E<W9HWW/H2W:GOW9E8W:J1W:J;S9I=W5KSW;F7W9G9W:MVW;5-':
MF)W;M>W;F9W;K#W<M=W._<(OSK+4/B/'_N+(U$+'_G(!$;#&SJ(P%H!AC<PO
M%-#&VU(OAPPR96S'X/W'?%?&X'W&]7+<Y@W'('/<CAS=[]W^W-SM,^M=W^?=
MR/U2 3[C+_HM IXLQQ7@WR(0X(L<R0%^X ?NWPBNX J^X 0>R?[=W473EHPX
M!1LPW0:>X1H.R@.NX0CNX9$,RB ^XI$,R1INXAZ.XH9T3(:TXB5^3(4$XR0^
MXS1.XBINX)8,XAV>X1;@3=WDU"+@RJT< <'$U+%LT$CA !&0T@7]SZ"A$PR
M%J AY:#Q%U4.&EA.Y5*.TF^)Y7]AT :-Y5'.G5W>Y2@]%7;ZEDZ;RTY^& M]
MY67NY7)NYG0>YU;^%W<^YW@.YV6^YW9^Y7D.YWANY7_.YX1^Z'->Z(J.Z(:N
MYX+>YXY.Z(;AYJCL%"E]IW8*RSK^D=(C =# #,TIO=D8T=:8C>0>T8R=SNG_
MK!-_P>HCO>H'B=*GKM!17KY'=A@;3=2OP0!_Y-$*(.:R+NLCC188<>GERP (
MT  >S0#$T0#(6KX7'>TN'>VW).W6?NW8GNW:CNP@;13;DP4<D.,WWN(E;N#C
M/NXU/N*6#,G=5.1+W>,B[DT20,D20 %\'<ST+DP,!AJ<[-:@7,DA#LKM;N!)
M#>_[EN'VCO 9[DTB/N(J_O T;N+HGNXHSN+EGN[DCO$97^X3G^(G_O$S#O$7
M;^X@3_(*?_(FG_(CO_(;K_(1K_$=7_(:W_(B7P$:D"N<<@$;0'<;H/,9H %S
MC&%TETK^/X]!&% R'+#S=5=W-\_S29_T+*I<=:=<RK7S5'_U6)_U@Y/U6)]<
M6K\RRK7U@[/U*S/V9A_V7L_U7R_V99]<8]_V9A_W<C_W=%_W=G_V2:_ 8;SW
M?)\%VAC%5VS#,JS#4%P0!<S$6&R4,)#$/OP"5@S$@*\"6QSY!FS$\4OYF/_$
M\8N-?V^.C0_$G@_Y*KS#FH_X?7_ZJ)_ZJK_ZK-_ZKO_ZL!_[LC_[M%_[MG_[
MN)_[NK_[O-_[OO_[P!_\PC_\Q%_\QG_\R)_\RK_\S-_\SO_\T!_]TC_]U%_]
MUG_]V)_]VK_]W-_]WF_[X&CZ67SY Z'XHJ\#_NC%W[_^AJ#^_I)_!#S!<%?
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M/0G%A4-%./C+,:9# !;[BABH,*+^ @(@&-PMK&CQ8@D% +!]0"! P@$ &S
MB+   !P 4RH \" ! *"7 3X\  #A@0(.+QV$+$@!P((( @Q\"&#J [(- "P!
MR'!!P <!"3\,J+"S 0$*/^\!X+"! $X E$0@$/LAP=$+  #0\#   !:-- (0
MN&:JP4<&<'5X<Y"APX$?."P$H+#!0;0<+L*)<V'2C$(4X(*4J(!%<A!>F%44
ML#"EGXH2$W*%X\5X<HMPF#UL7EQCT D3-,N4B T!PI<4'3BH:;%9\F9P*#QH
MWD7Y X=H'(*3:SU" X$.%3!L>. !"X\.FILM?P$<\PGMW3F0#W-"H<(1ZRJ5
M0=%!L-?^$1((D.N^ <7]($V0>^5!WH4#S'CPWUEX4- !"QSPLIQ@(E#06Q#,
MB<%"!@D@U" Y^8EA@P<6)-B$!@AV8,& %=""P10B8*#!([5<D  '<'C0E@V&
M(#=%B!5(EH$P%Z3X04 8"3FD"!P,@)4+J011!P4!.#;% #2HQ0@ ])T$50,1
MC3!! "@LX.26(GU  50"<$3  C_] ,$.!7A  %!46055)^YX4(<$ O  P2HB
M)   40GD$H@"!&#S)DQ1L?6!322DXH($/\:@0#0'+*" *1PTL$ #/(QPP" <
MX(&!H!)TH "F#Z"U  H4(*# (@H@L( &"2B0@ =_9N  #:W^6,@!6A"Z<$$!
MA4X1 1F+3"!KGQ\X $ F&]QD!@,*M-5 *T>-$,$!@&AP0 +1B5 K 1$\D0 6
M'K2RAP6O8"/H !XP  LS[2+ #&\)# #(<Y(8("INM(W 4[ACHE'- Y=VL(!#
M$D@@!P-9>8)"! D@@ 6GDG0 00 90("  05] ($! X0!RS=_0D !!!MC8,H!
M$9-6:+@=(&M 8D :4$ %&=PZQ2$+1!?!'A1HL0 'EEJH0 .X?L  &CD+M8 J
M'?26P%@"/4#&OPU,40 G$)#FQ0!@2< I( Y$P$%=")ABU$$"=&O*!@9 3=0(
M#=B4M +=.H. )0L<-%7>!S2R@07^J.;"]"/MML"$(Z-D"0@#M@)"@0%?-IA!
M %AA0< *]#%0[06DOND)%JXRD$L#"BQ E ,&)% -D;7ODR55>&P0DJ%> C
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ML@$D#0NRB  G$K<!!'2 B4]#P+>6 0@+<((6%QAB!P2P 08P0V!><,</O<&
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MZDK;,CA A;G%FX, L0%T3<"/T2JP X;8  HT5GII:A%Z1Z"\D34!<+70 *I
MXD9Y\N, 2,1&! S@K09 <<4,_-8T4;"RK'AVPRCPRPC^>99-3I,UW *( L)X
M@NZ"0;II758![E-9?I&TRT5XR::^A($ <**6;*0(+J*RB)>,;'D <"T NAD1
MUIAAB-#^,>>8 /"##01 C\ LC ,$X + 8:!,<( 3,9R$($+,60 44!6#\6$
M3IQD#]D;7;&*@@&]96 !4UA*A*+"KWU=1Q>;8/ 0&)8 H.5L 4?1@*?QEDB_
MULMA_%I>80M @T]2(!>/\":0 MP%'XO ,@,4Y0>^=9B9[J>%(^M 1O?J$JL-
MX3&=*)H6\"&&+FR8"F.(%;=<0*EUSM4+',0;!2KP5PEPF2I3V%]Q@^N"1#JA
MA+?>-#8R4>X'I-M^L(M Q:C HB$D%@-K*^H47+  ]XT90X[] -'6\<_V1H"9
MG/B*!; 1QO2X,=FC=4#=X- IZXY, ;5Z^*FU(H$RX+:^P!S^7B!865\IT(D!
MSQ3)2WP"B QZB:DFP4,&H,* /,)H*N.MZWWIHQYW6.*N^Q%;LCMC(<(E.P \
MP!D%EK,\4TS M?3YHP51@$IG?84%@6' !=RRGT#60 UJ$*)C=[/JG'3) U$N
M !P6P.X?O,%:5I.0EP-?@BB, *86 (!4A,F!   PK!#_W49H0@"24#+.-1&
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M1"=P"B=W=ME9C0-V%L%N="=YEJ?^>98G<3KG=JKG<I8 XH2AC*PG9%[ 2]X
M!CA .ZJG?AJG8.Y4:!@!;@VA S@$8] E/J*&"QACZ:SG:?# .Z:G;VZG<<AG
M=HK !-!.?[8FA;I$A57H 4$HA-J!)OYG#/R #D$H"0PA:J (!Z"E?"[,A'IH
M$"S ;OXG8I*H<8;#@1[@#5Q )KEH7D6H$S1$=B8H)S0 = IIA.["<CY NIAE
M?2+H!N$H<\K#:_IF>#I @X3G>79I$>A#WN0,#%0 412 @.0  Y 9@5%H$G@
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MA=Y7N$9#'=0">I5XA3T(BF1L):  #596XI!Q%VAS(&@S RQP03A -3!,9?=
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M%2P@$ L(!-"!,Q+PL8$_V6&P PL&C+. 3Q14(,$P#7BZ@9H?9 #/*@R<P8
MNZU  0."W!9N=VE 8,!A#BQP#1=EZ,6 AN')2L4'I>#3DA076&!!/_+FXL!A
M&Y1Q!P8.V,$! ANRRG###C\,<<32&6!, %+0:K$$!-3S@ <$B#8"Q1$08.('
M"0C@00,"4'" % 5X@T#)!VRR8*P3)/  !P \4$$!:A*PS<W>"$!2 ^9L# ')
M!QRB9LL7K/S  70>H(<  $^ 0 0VI++ !@5\(04O& " !0(>BZ'' PAD@.@C
M(U.P *+^*/3\P<P$=2" -<1(S'???O\->*!D9##  A@H (.RPJ 2Z@8T?$"
M,;PTT-X"6OR2 0 **$# 8;QDO> *3)FR]N,%B.& 0U(<7@$!+&@@"LJ@FIP"
MGK+ZA\!4COMZ00)F,3 !  LD( /E#I1L00$LO'# /GI<<( "C.P1P0+7KAU
M @IX&\$!(WS @ &&!TY^^>:?CSYZ&B200$@,Q(/H!P;$<X7U4%C0'N1A?T"Y
MIL8\4A\.?(L(W2-",!#'A:\-H0- LY=#XG+ ^!Q :YVZ *+^<:GZ',I7GK(!
M"Q2 @06LH (,D( *L%6F:EG/=H. P1T>D+,-9( I>6B ]3+^D( -D$PR&<@
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M  +&82E2?: <!@C5#,2D @6(P9D?L)04NLF !5#-$L!80%P?D("U)2RO14"
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M$ ,"9#\/!/#>'P@0@&9QWP!_X#0%MK=)$Z   5!%Y1$ D/)^5!,%W2,!"S
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M!+$%   0  #@@V91"]$V 1"G! H0D(7 !/+BCT]B%@"P0 ,  !2@,]?0 0!
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MLV=*-##^FB,_A<4!KG<R"N!]X)"4 ,"8;FD=AV1I$B"4[#   4 J'/E9 S
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M&G>^ZVLJO(!YU\!0[!L@KG@C.\*,1:"U&SI7X6N_]UM2N4D= "R_)S+ !6S
M!XS JB+ "<S #>S #PS!$2S!$TS!%?S "PS!&,PB;&+!'>S!U($.2J*:]/8@
MW:$DX+B_2*"-QM@@#A*,E@ =*P -T7>HTY&. ;P/Z^2]Z;&6VM$1@,I8K1C#
M(ID$9TD=4Z&SK:*_=[+$F57#HXL.8ID>3?P=&T#$T@$F_!L=7%8DC;##T+$;
MF26L03(D2.0 .2D"EN!]/ F7 F"1>G I)[EE'KF34<NU%L/^%SLI $+)$CL9
M )WUF)["0'5,$I:&!_L6  +0<0(ID/:2B'!ZQ40@:07 8Z?SMT[0;IUJ/^A1
M$;1B'1I[FS;W'XQ@--6Q#/=172&9!+&5'>;KA4[ 62!L'H$014],3$;P2=#A
M02X2#]'19POB<^#Q7//1 *%2'0QP;M[!0&5G%HBB=$W%5S>+4DNJ!707103
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MZV(Y9 0!;.,0AV!I7[:!<W9+"W9Q1( %Y;H""5 >G. _\5%M>34_=7," \,
M/N !IM9,U0I$NS=G2<&1SA06R]-9!;  VG4'U7,PP7*1>Q \Z-(4#0!5$7X,
M,:X%NI8 RC-5#5!%FE+,3@FY*6E)_NR< ]!9"H!?RF,!#V"E',= /<TH(<X
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M.JB#60<![* 6$!D,; "GA:8P'P(%9,6  6'0\L4$ 2CP4R7^!A@@U !J2$"
M @9,T$'*#5R@S&L;6*".6&RZ"D0-%RCA@P/2VDD" OL@\ 4'"UR4@6.ON"S"
M!>0@H+4""^S"FIF_[=   Q]T(697$D4003 O"##Y#?\<\.[4):UH+BT*D/Q!
ML'. :UX*!C#J0E/%^K#'$0X\0::=!;!!TA6]<T"; 8_#H  # 0.!Z4$'3%TK
M;9/7\D$%+C0P=@T6C#UYC"]0$,:]-GPF!E_"[X! F1(XF\($B1\QX)^5$)"
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MU*(:%5I&K=G1@ I-G][\Z$9+6LV2KM(&9>0,20N6T9;64IS2;&9)MVG2BD9
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M@5^T11%'?L(# #!DQKFN!P(X' L0(X8=Y)1QO)+KRPS @0=5H+U$50! *\"
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MJA4#_0!=@!$ ;X5=%)&=G+2#_G5?7)Q!'+2% >S"H*@"#BQ0FZ"73F!+!F"
M%T0?%MA(*S! 8!A HW6.DRW9*IP;K>0$V\P,!0P"622 B>3("XB?>"6$SS19
MHS@ *"S:#8 <*=@"051!-!" .XC:#;C)G4"!E+Q -:2#!E "A 08435'V+B
MI<A2X1#)D?Q*E+"&)R#7"Q@/$ P% 436E%3  \3 ).S 6Z3")(P8@[@ E F
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M/(X+MEF 2NI4#ISA2 +1H0A%OHB*+>#'&CD(KV!  Y#G_DW %09/3'Z Q'3
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M!\4>[@#:<:B#S!EVT_1&.MCC@= &9PW" 9C%)J; %"@-OHR-"[#!*%9@ 3B
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M,@ -6-L/?$4!)<67NM,,1+,F;D@4U@'O E'_B->T&T=M;$Z0:"@H4&&Z;**
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M8PC 2XUN=F=IE!@$D(*'U>GZWM#^1!?MQ%T2["'K @.D.0 #4NP7P!B>!*6
M '/$-(P!CN:T 0'6<)!M!0!8T(<BSS#@"0'8C0 V-5 #<B0"EB !&PD%&'#7
M4]%M:H\"7$60$@SO@B( !?4PX$U7!0 2S0&^38BQ!D(F=0 & Z0 T-<*#&$$
M!P*<1P<NP*2'0)#6=)!- UQ[8  #>D>(  %9(!Q()@5T@)TVE%!6 4U/?XZ
M-&#3K%-3H8SR  $+''Z$!@,<H$  -GBEP $=J!$J -J,X( T5WK7BB&267SY
M*!$,/PH$GD@0@R_Y/@.! &< '2-/?J^E@ DS:&$'P6=(E@J"X3X'"*!-!%!
M 1*2@C#^R(HG":",$1#  /9=JB@+$,H )@&$B)&( .]"0 )"IXS$ ($.['A
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M>Z/P.@32 %_C':?#71\0 *I&%D;'A9C(%<GR'7 '(;<B!H:R ?,C3A&0-B,
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M:3'\* ,OG)_LJ. 1 GXL2 $!X-E+4'#NF0 *9 6;OW#$4!L*;!H<0JMC!?;
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M:VAXD_,?#P#T09NL;2" .@@X1P5 0Y&/V!:G/.R6!K-'AH'^&M&1DAP"V=D
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M-I?*20 \= J'^04"'0C $Q#Q 0"@XP(&0(!&/5 @ \ I?P=@')FH^+\-B,
M!*@: I.J5&9= &^,>UYS4&@BMX2(%/B@W10$:**-;=2E8:D' ^)%C T\P0.U
M\VH$<)+^$1LX3"RM;,N0HBD60S*!,39(IQS-,A,76( *C> #!"A B!/6K ,8
M0)K)2F4C-Q!"8^1;K U$=($+;,"O.(D.4!4250;1C*U8<X!5+UL,"DRA9K,2
M3@,4, $;;8 F!B,M^U)E ZH]0#CTT!>1+FL'MX!6F;.U5NX\( $@K$(.KHD
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MH,B42B[MF8_% 0.@"YJ5>H1?7!DAT9R *L^B/4Y;P0':D8'$58&CI09J+ N
M&%J(5BAP8=DI1#N+$6E>C+O0&DZ?+I$.K9QJLQ EK\ZR0II>R@TX*]&WM+ W
M!!93CLR*16)?_P$+8J2L8B 1-3F?ZX'2@K^S%$"T;.Z2T >0E@L0Q0&#UCKD
M#6@+=>3^@1C/E3&Z-O!M$]S5 FC' $\\0-Y@Z>*R1;[KAP=M%%45N<8D.(4A
M2:RJ$'.@ @9#L6J*;(4#DT4" &C+*_EK^-GRI!05;FX'4ESD#0Q88SF^L02<
M?=W3[",Y'   $)14@3!@8 )5?I!UKI9\8ABV<QK00 46>P'=6A/("I/#0M?
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MBJ",8 SB#511*;32E*B79_*'SY"$HW5'L52, Z#<%8Q)SBB1.VX"E #-!\P
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MKH706,_>^0:?8H!,YH$<X,;<IHG0>)T-B.A%J=E]%2XD1 I[/$&0I(ERX(&
M&,,2O-3>,%"+, $1: M@I*.)UJF0R0<+(%0.,Y^:!-]\!7$_!,\D6$'7(*-R
MK,!Z1$MFD(9NV(('O-(&V-UL"=HW,,\CF&T"I"4'M*L<^)R)!O*9;8$<;**V
M%%+A318/"(?P/FL>O0X4> ,G=9).V9JP  DTI=&TL(>4M @5S!<O/(@P&&T#
MH$L_$)0!7*(TEX(%! ]_, F+A(W^$\Q$# AG!1014- *-ZR  OQ:^T8>8*3M
M]=S+?FR46PQ 'CD&OCP!#*>R$93.POB  ,G2$T")6Z 92@1)VT&!>2V%&]L
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M/*])HO<>@'K GU6"#]EY P!  -R"3O!\/<XMT,]#  0   "  ?0@>P!]_P
M,;R0!Q<)!/P>#@B T1=]9J"# P"]1 # QD"R&SQ T>NP3AT]$V   +C :)Q)
MT7OEU0, G/"\T1/%!.S$"Q"%9NP\:3 3#A@ S]OP: $]*2"3T3\<T$]$7R[
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M)1! ]@$!P,7PP!0454%#]^!(X"!4%.C9D%3@>$"6H$-',4#C(+6W\<%A\ B
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M 0E8@(8RO@9  7//U+* BJVMS'+++I_&8;$X&D   "(P D  "'&@[#=Z- "
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MP04+/ "!)RU8I\P&"=#$E05P;S-V48 '!M ^ !T#%\BP0!8R0(8#;.!,'2B
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MX$ $N%*L'3CE EW5@6*JF,;(J# "!<#%7)D' P,X $,3F("*[D@##=3B3IA
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M P8L((UP/(X!0B_&2R R0L<H2@<=6*H#*+*%>ML%W@J@A$[+@G,&T*'J4]
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MN#B,@=0 _@B(2"2.6D$Q6M"&(X")J"$4=V@:'$ !$5 =]A!#[C((25@,!^
M%<!5B%**D>%8OX@#R)$/BI!,HU>2=D-H;+09SL$>)C%[KR(44V W/C"4YS$"
M7:@>FZ$!_V82'9 ](3,"6JF, 8&543E;2*1'O]B5[XB0;F!S.D<5#W$H5U%O
M"8E?4. +R#4*R6  9V 3:7017=$AIE%U][*,;F$G)R !9,7^%:NUEA6)#PE1
MCS$V%?@R"Q/B(8A#,28 >7U"4S$P'/;$*%8C#<R#=L9@/P9 "3)R !BG* 7P
M*@L#/*\R9P]!*SM$"U,P.%P!1GWQ$+B2#5"  .:E""[0 @^0  8B%O!6/!M
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M)JGWT@7^:P$!01!%72 J;! !"TDM5EIL7E 0." N,5%E:F0M)P!5NX,'M=
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MH3@7#P7W<3L9$EH0$MU$<]/ #.)!0^T2N%) 5B, 9M!"1+/S6D7@#1BB%O@
M+>Q!M3^2 EIA@1W0,Q*4 ?00*LO2!1Y20=[P ,P0*ZCT4^YB, 9B9?@3K%]+
M#"Q:!UVQ6K-9 P'@#0I 6-KG/6JK20[@JHKF %KY"& K CYK!PEFE?_71\)
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M98*5@#$["\&I+JP>>E2L8[1],!P0_*9"*HLBU9("U1"7294!'< *E1$#Y$,
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M*Y+U*".U0GLAK>7"4E&1)1@P+4_ 6!Z@S"P!):BJ@6S0#@:P55NR)A3@JA+
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M19 _D\E(=-"@)I"0X; 31V\7Y7@!/E($*1^N2ET,:8QS)!>\^$,'I&D3CM8
M1C%2:94I(9-H 6$UDXGUX/<1IB?-F/#>4&!\)#4%1T>2.M'^AQ70VTX@K<==
M!R]G#^6[6LRP&>SH#15@<>$ O$\E DN$!XG_<B;MUK.P+IO1$%0 M>IPL31@
M >P1K.]] >&W1>U#?'U8#!30ARE;6@^%#N;7H#70AQBP&1UP ;2O?R S!T50
MEL+.@'!$@$OM^]I&+"Q# 5K,@#.B@$XNB5K]L( __*S!1=%/_=5O_8\(AJ#
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M!TB @#STR/N! <N 2T(# 2A 0*W^#,Z#0 &).'!M !\X($$$3A8J;P+%'(
M L\D9\"ZI04P*&@$1("F!%\F((H$#6!@<3 1.-#BF02@F<$&8OJK#@8'V*LG
M0B5P0  # X@B@ ())&"BCO*,4 "^":3Y058??Q!GNQ%\("8"-&< KZ43"$ 2
M"0A #>LH%Q  ;P ;6$# !7V.$U4!,\MB0 ,./+.-!0=4<$$P' C @:YV9[!
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MI_^8E+N@T@A2W)$5-"#+#JA*%Q7^@%K'O+@CC1!#8VRI!:+NA'2)?A'._GB
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MX%M(2$7_H$!_C$3*%".+49\?J$7^]?&."1B83!A;:P" 6A1?7KI0:HQ!:Q"
M]QDC6V" #^1%<NC%G=1"&@B"![!6(; %&VA$7H*C$#(  ! $F'7 7I( FYC
M ,A#!T#-MZB$Y^C,.K@%M=C0! ! $+";DH3%:]I+JQA"!K!F9Z:,'_0 NX$:
M$."C% 2!Q/A.:ECD"]Q3QW42.2I,),Z#-WB *'@(YS3'H#S2U/6AK915)3F
M!3R !=#8)T7 31U*9<U#!$ 6H"P FDC! ER >RZ. PU"K=18XYF6Q:&,1W&
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M$ HS& P+1J#^_P #"AQ(<&"!!2XZ=- @@%H7 !P.$!#0 4$#%P(0?DB H$.
M81\,1+@ X$R% !T$7,@ @,"!D.X*'.G@\$@!$@L,N$#P(('^ A<$HK@(H*&!
M !<8 &1X$,#%!@!<. AX,"">P"((^%#(:  A 6B^*"F \."E 0((=$8P("&
ME2L*"BA \.% !P-TD :@4&!2@E\() "@<,& A0*<CHA<@#! D (3!'=HT%<F
MA@$2#DB0JB"" @L6)C0 \.&!I&D<"#PP< TN 3(9R'3164# K%\$/A#@,R'-
M@ D0$G08D" "@14[KD#8H8' /0(ICK",8 $ %9T+?B2X /E*!L<;-O2M"\'!
MA Z(_WY 4$7F 0X(>"V@,"% !@*NV!*M'SR!V*P(R"( &11L\!H"&AU!P&\%
MK+3; M<,<  $!"@P60(-T!:  WS^4>#(!'UE$-\#"#U0#U%7/*7 91DL=\L
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M%C08X.QCF^F4 "X&=+  "9,92$T"G!CF406I25#%KWFE@&%I2^26@5FX-*
M![PT.' <$FQ@P0$>$/E!9W=1LH%.LKIP*"41/R"3!P)LX$ Y"%R  232 6#
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M*CLN@(D^\P $7B(-662@ Q+(D5"Z@!*O(2D"".A-"RZ Q0EX$D>6@X]\P*:
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M$-WGHP?;U5W"@20"ZM*#*\VRED'Q  ! E1KJ\K(XE!>'I]#!O'5Y%35(XDT
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M.( !LN4S/";  Q[8Q\,R#FZM*,!?^KP!$RAP#<O%*%#7"%N.XNV4Z3&F;+C
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MY_9G+49QH%#-*I0*3/9Q"J4VS!(C=B&G*S, OBFO03(A@Z0_#D 4!R@^(G
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MPS;\T@4CT8:W<S5\"7BX<)D5< <&^S^B_D&,0&2X#DEW8COI%V\;%"UA,.,
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MI318>,>Q;V:DP ,!&(-! <J0., #!8CB5(]  ""!P@4,M.$ 6C20@* FS)F
M*7PZ$, ,!S2P:"@?1 ! !QX<@+"N9)40JX(0?"" 4Z(\ "Y2!)BQ0 81(!!K
M:Q;TI6F&A APP *)4&" !0@^0 =PFBJ [0<#+&!O"A,D<,$ &"!<*B,)LXG!
MG1E(H, %"WAPT8Y&S&' !PP\( $AKYV< @/LM<@L!0+@TXH)E&( #9L*?N
MVXU2T H"%6 @0+/, #"!PVQ:H,'^3)1V0( 'G]<U(.FW"  #41D0\)/@D9?X
M 0&,."#!3!\<, ,*#'AB*@6$R"N/SGU-ED("4*"4CP%_"H* IQ]L (W)B_<G
M!-QW!/&T( '8+J@#K35 " P%D% A!WH@3(^SWGCM9Z-ZJ&Z[!1TH(+ICFQ4
MA0,;&^_ >A] X$#*,&"*5U#" J*X"!".(H$)C&D BYM A8P ACMDX%G V0!S
M'/.N#_0/9"4PE0HJ8 8(,. "HG",580@ &,\  83H-L%$J"! %3B 180U 1
M9[ %V@X5+0D !F= K]10I .">X%CS#"M:BVN+WP900L&< @A%( #":!#!"80
M@8Z9X##^0*"#J)9G QO!C@EZ:( $'$ (#4!/6P'H3U]0H$8/6  >M/G '")
M"+B4[R=T,P C!/"S!H2" R I  6<D0(K9< ,#/K/_\)P@ N88@$ R$ %F$>"
ME"TI#HSJ@"?@ "--Z2-O;)1 !A0@+95%Z(0S(6,79W*!#CB #B7R%!=FZ:-#
ME.4"&*1  TS"@ FTJ@637-T'[H<!H"U+,(L#X#!XUZ8#H#)%-*B* J"C +'Q
M@'#.^Q(&H#8U364R#A,H$0 9X(7-Q(-NN3("#/SQ  <F8"^>*!T^;2& &40
M @V0) <0T!.DT,T0!3B AI3HF+- ( *]2P%ZFM>!!1"@"L3^,P.5-"2HE\TN
M GH@9P*\T;:19=%Z&0AF.S;PM?_\(#5XHD/R\D&"!^BNBO,I4PF &8^^3"!,
MHNBI!=@0 (1"306CI, "%,"C D"03TPMI@8^) A!:0 I TB B6)(*#T$@3F3
MZEL&%@"#=47  ;CQ1$E,T%--(8$!FV'" 9@65#Y8  %<&"6(A)"AK=GP#ER(
M6OY:M$(+"(F0ITN=DC)@,V8<39 8M$H*_EFX _QO C$J0;"4=  .*,!N0H*
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MCJ8L4.)NL[II"NBX%UKLQ\7!@ $0B$T^M&=K6.RXZVK8I\KT0.,G_<=&CX@
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M"FP*&MS729$(<B$$_ZR @LC&'-1%!+Q1,YC%(!A2Y0@" R#!<4U!JYB9!DR
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MP$6+Z6T%5$  P $#7%'8K,P6G<X"H."T_9H#'0"I$,#]D!$@J1-$O0S M9
M@$.=!@TFT:'H4<LC! I?6,&K$8%U058,'D"C[BD,!=CSS-R8]"X01$YP!$#^
M().*()+Z)9/5#8 &' \ET$XXR4_PME@%,<''!< -D8!U6< ]4 RPT@  ')<#
M80"I+)D]2-WR&4T#%%=T\-UC:2'^ZUR .NDM/)CO21D VC24CXA;V_F)J3R*
M$HB;. I 0%41Q]3-XQJP"7C0:?W:Y-I.$,S3234*PSP#S-X.2G2 [GB J<R0
M!RC [ C. P! )Y2;,KA &I ):#P"TRA/^CE;*\2.!V, &&2-0P4 Q= --4U1
MA@"'!+#1H#")$R!(IA' (B0"^QD&)?1*NW#P50P Z,GB)=V>8NGG(Z#(!DQ,
MNSR!X7*% 3<J: C*:_1:_A"/$4!#@;["(\%!XC&$&M_!SB3=YZ!"&$WO%FE0
M"IR? +3OLW )^[C?]V!0,KF-[1U.W51=&OB<90F !P3*(S] RN0!@]$ <TA1
MU-SM@*#^@A4H@'KX#&\)YP^4E4?]A,WX" J=BJ+LPSV RP2=@BA4@(T] PKT
M#M94@ -)Z+30#>@<@,720:[@LF9T'G2QEB9<JE'T!01L0*9Q7LM$L<PA$>=9
MJ?/L4P: W<31BZ 43T10D^14E9_,C\%]1!QIB:8(HJ2\5V8&8"C\0#ZB"*)P
M42I-@!D@$;R)33AE1*YL$ 5(FX]<D?,TRE6<UM72RG@D$Q[=C@&=E,WPPU$$
M)SUGD@%%D0=0#)>JP )<1K!@ )4)@B@H6U YRP5H@)5Q03:I0.@H6S)Q5J#9
M$L@<\W8YS^..0Y5.!%R,Y<>9PEI!K6<0)3%M43C1'9']0([^Q$@6P8C2$=G-
MT0""V$@%-(";SH")HH+_,  %6-.I+0X&*8;JJ0#(U0L&F)EU#0I2_8<I!)60
M,H<0WQ W! '#R)>P",I#3U*]U!)$N(V9K4\M.U>@=,H]O,T&:,UQ)<!)I4#>
M[>2?08"-22GL0(&X;1.M$(7FFM7K5!Z)ML*;. "UG8+!V([?ENM#NY5\G 0!
M_$_M:/(M8- $ E/[6F(Q1!5T_$]WV8P!H, DQ<5$L?(A=,HM[B3=4  .G9";
M8BD@FZ<).$!?_/.J==QL,4 Q&&,Q.X9_E'(R^X\&^!;K5$,0Y,M<(('1XH"D
M'%B85.GBZ$%LB"A"O(0R/+2O5,W^3R#*"2B)BIB$/VGV>P$-'<"(F&E&HSC#
M"H.$D(R3"3'!N67$B:I /[=#0#%"B2CU&00'=@C*0---WW3#!,B/260$(7NU
M=?*77W7VUG3LR99 MW'T:8D""()!8&^),6!/,O1-;3 '<<X.-[PTW?F6D9A&
M)]1TOG191H]36?M)&\B7"K3;MR#RXA 91D&!V,B:GRCUVS UQOE)6$FUA=$-
M(P"<0JGTF,AW.^SK;$G223&"E7DS^)PU%E<I7$P5@+%1)7#J0QFY.S "D*J(
MW'#04_!%3OE2 &0<F>BL:6C" K3* )'"'01.O=1G:0TT9(>!;QQW^WY@') H
M);R&GZ#^J,_%0;)!08R$MD/I 0>_T E8)VH'"+B$6& @17C)<GSX5OO>#[W4
M]N/-A 8DS >\4:#(SU-0-2Y'$4;HKC+00)Y]U&(\"P0>@$F8F1Z1R9Z"#B3H
M[Q)74(L%]@90QP2XSW?5MAAJP0PPF <PAF@BB D0  7D5H%F !T.P>^NR]&M
MAPL+R>V4<R6@P$EO46#?3=B0]+[0@P+0SO.4UZ*H0 7U3@64F'*IU)X&P'4?
M>+'/2)W$CI@F$[%/C@QP#5M (%S,JN \0[0TC0"TF.PZ0 %D4@O4&MO=ZNBN
M3ET%IXZN%,E32@2(F0D<"-X D0')7:*@RW](R:04EUEE3%K^X=B)V XA]7EG
M*8BCT$'_J RYB[ P%L -V1BM8 V*\,?]E+81$0495X,H6("-)57@M(U4AT\,
ME<3_FN__; $J^Q=3>8ON/LJTD?D5.M29 R(X%PB7LG75,,[I/2\)<-FTS40!
M4 NQ3UL$0H&H>PR-68P&  !_: ^7T XAH 3;W8<,SLS(,X"-;2"=.F\&D1HJ
M, Y9!*$.]X5E.[8S&( 69DJFV\Y =$EP;,NND0"H1,^$[%:I!\A]Y$I[F!D'
MV?,LNL>NX=$$.L-L/8!)@#M1L.LKP$"D1.N!WL9/$ *1IL #X.JW"P'6Z8,@
MY$$X4HP@'!<[^8\$&!T]]A$MM<#^_Y1;?V4'"SRO^]%S(N&1='1V"@"3 ] N
M?,F&'M%%,%P)"'PBE7W89#+,)3K9U'W14G(.(XGZM3R?A?EP(A\*@S+)9"Z6
MDN@EDL0L"Y3)X=%9& Z+Q /[2#\;E>;9>,0H$)TGPO!F*J+PA*'3,B(<(27_
M@T&Q\0'U <'@Y&;TT)<"$1-V$Y'ST8%8<N'TT' !PS'!\><!T4!($32WX_"7
MQW8Q6*&1T=!!$4/&*L+QX- !9HDB6@>16;)$5C(Q09BW$0%C"TA&04=MT8=1
M4M%WL<%A41BD@=$1!+YQ'M01;L)=2-AQQOY;P>)6\FT9E'=1$5^B@Y,-%?A]
M\(=+6Y[^.;,\L,NR@X.&+!EBL+L 40>&#80TQ-@08V %14^>9.$P4L0L#GTZ
M%-1B<)K,F31KVKR),Z=."@DR/""B,ZC0H41S&KA7M(,"/$6;.GT*-:J(!P=P
M277: .A5HAT(1)CQ-"--L5O+FCV+-JW:M6<A9GSK)@M/K8#$DL5Y=ZS3O&YT
M9L'@PVF99G7SD.5;$W%AO(9OPM6K6*B'NQ/H&HYLMLD'S)@3ZW5)P9'GM)$[
MLPUJ^K3JU:Q;NWX-.[;LV;1KV[Z-.[?NW65=])UIH4UJWL2+&S^./+GRY<R;
MYY30S&IC$ZU$N+7K/+OV[=R[>_\.GK:'!1XP+$BP((^& PC^$%"X($&" R$)
M/#Q < "C @<# H?_#V"  @Y(8(&U&> ! D0H0-@!/B @006F%%#( Q80\ ,!
M'020 P%6& ABB"*.2&*)X!7  08$)%"=!@-,$6%Z!V00@4\$''!  1@<D$4!
M;9@(9)!"#DEDD5<= $X'&PS0#@<$]%%!!%1\P$EZ##1@R2 \?F  $<,9"6:8
M8HY)YG(>&*!4(@6PD(4$!D!0P 05I,<! .FI&%P!&R#X00%$&"!:F8(.2FBA
MAK8600P21(!4(198\( $*(D@RQ,10+#!&R-DX$$#7QX*:JBBCDKJ!PX@H$ "
MTI7*:JNNOCKJ71I<L.ITL-Z*:Z[^NN[*:Z^^_@ILL,(.2VRQQAZ+;++*+LML
ML\X^&VIGG!'W*;367HNM3'<%:I-5M4J%V&1#58O3JK_LQ6UVF:)&F$X=I&L6
M!]6VF].Y "KI%[QI<=1!HSC]0],M3F$0$R":B; !2:/E@8$UX,I$0I@]].E#
M!@)8A8$ !1@P0 %*$4"   B(0<  "-@B  $<5S7C!@2DMV<!)5A00,<L=&!
M/@9L@)X("XPL @0CN]R&! I@ #0G.(,\0%4)@$R IQ0,P/3,5.]L L@")# -
M!P&T(\( /Q;5 -!1>5#=4)(6Y4$ #MLD%P!?.G# 9C+9H.A-P0$" 0H"O T(
M$GRG P#^O9[M%U0'EH55BUD,"%#$XF[@80'DJS$P  8!D 4!V(!T ,#8@&P
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MR01*   *"(",N#L2S](A"QM(&5JYA( !9, !6T,KZ#H0T">28  +L-X')CD
MTX$(FP:P )-:VA?-Q:!.N , ED@*  (XH4[\>)Y?"[H "E"R 1C*0@)DV1^9
M[:X#(*47 >;T  5D8 $7P   .L9AT*$92Z'5& OIM]8Q+L7^;@%X@/D&4.<$
MZD"C>0#K<!? @7+ZR4GC98#7-K  T3'@GP)HA  TL  ,.   S#A !1B@  ^
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M3"R*#R+-HU+J(/  D#/] BKVK@0T:YT/+*!N"(!U!.#M  QY;>$*V% 6\3F
M'# I R/^HZH00KIGYV*)/16/M%B9#LQ/@\X"S/<:4MKV!S]UH &31@(>XH1R
M&R<=1A!=;0,*!= V)5!P"X$ X440D)-@3%=@YQ%H9^8#<@4('J)$=-!TTG=9
M8"<ZI+,! ,82N=,><_<VZ^-A'] 3DR0$TM,3WJ<!Z%%2<W=W0&=: " #VY1J
M>X8])Z, )M,E-)017E,"7R8!%$(%I!,# F !3]5VXX5<'Z!WL_4 9I8 M.8*
M)25X%( A3)4CC<)<LX4E2_%)Z_,!_L,E$O  'E8 @7%>FF,"SL4UX_<[#_
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M.:  L94V/G8 F?9['%,.*Y('+"*6#@E<0.4!8[B74Y, ;T@!EH4EX294,J0
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MA$*Z:(X5->)C5 - V0@3 /;E"P"0A;%^$-:C,N/%I*GC6^7I)@$U8-Y) &<
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M(#"<#& $>'  ./1P' 0<;!1.&#24?DR(!F!\8$ $0(AL<!18"&B.2=@T0"$
M*)!004=+3U-76U]C9V^*FG!4BG T&$386!PH+$0M+#1T4#7^(-P ,"Q$>" X
M,!Q$")3T"6$@ *%  P@(/ S0-(2%!@\!@@4H=(#>,QHINA"Y<,0(AC,/GF30
MD.3" 0 1?G 0 .$# P4;;#R(UZ.%$(=D,J18\L52N@-M#$B@X 44@'14&"1P
M.".! 2?!'@@8L($ ": 5"J#:\&-2$@84*-UQ1$!3 (W1$$!@D,* $0)?;5R
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M FT42$&&75)0EPD-)&$&!P]\8L &"40P(TX'3) G!3! ,@$0.'C0P 0BD+,
MI%9>086&%SA@"%M1C N$ [I:XH40$5280 5"X80!@.-ED,\/].2@@$99+%!
M)A(D)4 '(@"@"Q4&&)9#>1,\$H$! B@"9!$$(/#GDE^:("D<*K)C@Y;2)I"
M"+>E0, ,5)@QD,J:"O''!@OTH_'+K^Z$1P,,(+F!@ @@D.H0! 30!01X.&"
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M  0<( ,4, *JE& #:*" (A$@ P-F8) '&,4N!4A !SK 1PTH@$][$4<00'&
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MN]!4!C;')^K!-*9H>JD0:DK)*D"#IA[@$QK410.<2H.2RZ'IIG:B@FCP8:=
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MN<&FK5+3!$#[9< "L "0Z1LH2)+#5,'W<4 8$,*7Y((YB,#>6 "J] $+8,
M&($O. L51 X>)%'$%, $^,8"[ 7^ $S C' 3=GA0U/S  3P6*EC> . 2(!@&
M/V0 +9A91:0/;0B(",@.OI"$ SQ"$Y & %8 (*65:\0>>QP<_ 1 Z/V(%.S#
M%M))Y !2%56"ECS@C%C!A11 1P0,:13 .'6  "A U>P7])P   3 W6G$&:6$
M*B#)!QP CV%B+WC:C#! 5J &&,+)J[6$RP#@!BA3EDPCDGB":<S,$&A=35&
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M%4$%:@#!.<; -R$)5'C &M <H=Q/ZPG>Q2$)@$""$6I?'EE=*=( 3:0*E)F
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M.C10U@86&&3$, J0 <\#2!'"3V$3<3-#!!AI- ,JT'F0GP;^9'BAAPFX2%
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M0/JU<HE_'3!R0JHS^"!( %(4< W^*A[84"D'^**B0PK("L(3$$+8M@(%JB!
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MO% A*0RP(F^284 [,C!7,.(-%1#^R0<!4+& L_R29'_,K&;EP,)>4& $-=1
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M='6-,,.$ P+ 7M"NN(M-\YK;_.8XSWEF)S&IP)JU&)(3 !@[L <"=/((U,P
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M;9"! 2V0VTP T J4= ,-O2"L69U;AKH4@2;B,5[.DPC;E0SZX Y>8!O'@#F
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MH: K%J<-AB(5'"@ AV 2"J0B[D(L"E !!8!_;*,50F@L]&!04D") Z,.&:@
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M*Q#@ /"   @@*>UP/5]@$PYP RYA*49P%_A6)Q:8=4E2%?0PF<1G-:_E#8D
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M%;%G=X%/FI[K&HF,@UX'1;OG\H$,Z>%I]5P-Q< @?=0?9QW7Q)O>=X)-MS4
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M*DA P%A!K4 :<0,8T$ $&,1G@@:K;49" E*M4F  ?0"P%%\'-+=4 9'L@ $
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M!0((8)8L)   ]]$H MR2)00D4B@ >, $OC$2! !  P$4# :2)2<"=+, $1"
M.D@P &G^V"," 7A"!(S83 HHR !:D (ZG#H"M5T@J725PFYZ<@H&>(V6WT #
M*Z@$@&]^ # ](%28%' H@'E I0F0'P#"Q)H%A*MG$F@)"0S@@PXX9PL?*$ "
M%& C [PE7.A8Q7T"H  "?< ("BV "U&ZUP D8"0?R$C6I"K=Z5(7$^0A!ZQ0
M:J-!;8"NM'0 !8AD@ S,B*.UF&1J]V!9MYC/+*>12A1(8P -S($>O="D/5QG
MCPK,4RI(J)E9I[ &P9#1 $:T  >4&H ,/" 6'! &H;1#RPA8($M%F<H$%
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M,$# !N2*,IF ):! ;1R)&VG#!""A!NP*!,QD!K!@,&R !" A"6B FY5 4)[
M!@@E2GI?.Z"=/9G &Q$?XLB !1BE"5# 1?* 5C*"!4R -B@,C+2 @-S+^=T
M'Z5 -Z5 D*2D"U"-"RC"3JH P5B !!@D=43 F6P $\G"7_8D35X TM5#5_3
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MT3%86,#&!#17 4@ PE; <B ":39%1 CL"5[ OFKGT8H<E"+5?BD C2+;:XW
M+DS _03^EJW$&3)<DF@E@ 8<0.LDP%)93P7D1(?-9JH\ $OAC@:L5)AZG1*A
M!0_LE: ("@*<S77B5 :P[E*9Z6)MGIOEC^!JP^'0Z!'ISI\,3*!,0 1<0(\B
M%8T^U 4XP 7 +=H)RKKJSF)1VSDL  50&@/@:3"1C Z^5KY(E,:H@@$DKOC
MVG42C-$.2!>8A5/0* _U:%*]%N45#56X58.9:<<&'F34TLV8  8H@**0 &_
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MWRN;RX3$,)"//O^]W6]DX5\<)_!0F-J"O^9>5Z*+2UH*C<9%9#3C[B68_IE
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M/NRQTQ[[^>&S#COZ[J^>/NVOVR[^O_KLL3%$6+6S$1:1QAOF "(!*(#LP0E
M-L0 !2P  0G04"XR@0!/)  !"TB !2^(009B<(,7U& '/<C!#'8PA!P$(0D1
M8$(-FC"$#%SA"$EH00^J,(8OG& -86A!!2@ ABG$(0US2"4=_J@!&MJ,#@^H
M $TDT0$MV,P"7+ 22#4J$TQ$B1$!$D ?>8*)+> B$ZFX12Z&HP5$S 1"O!A
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MBXWUK&MJ ^Y  ZV6-6^3*) "+%W5L0+1  T0BUA]*!6+%L(+,2B@$QWQ@$W
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?S,1-[,1/#,51+,533,55;,57C,59K,5;S,7S&@( .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>g160222nk03i001.gif
<DESCRIPTION>G160222NK03I001.GIF
<TEXT>
begin 644 g160222nk03i001.gif
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M]?479!\L,( 'E@%6P5%\91# :1-$X,Y:4@F@P4,&?L!;!P(\%AP$'E10W 0
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M*Q>><@<N.\>FA];&9;,V=CVP :B5^=7S!S\CJ6"Y@YZ;6G/^_SS8='&G01V
M.6:+9D !0'_++Z9!;FJ7.V4O8)O!8P> *'!H^_@POPTI5]FLST7W5Z)*[:IJ
MQ\!^(&QYQ09NLIB&5V\FFO,QH'!;C<N9@0"0IY97G@*&BCG0^4Q00:"+0?B
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M&_O9%1:-EGVI)15_>._'+5K ?_C^^RW_9NXAMRUB7Y:<CP,'Z<D1B  F X"
M*D/ED&:!#M PP#_B=IFG_A@4> J0 <52ES<"*PY?Q'<B+7'7NVP\S67A^)@$
MRWECGAWA46(\ 3U_Z8@^^;.R4X%CC.[X+<[LZ%W*T4AJ#OF_"X:K@-GV@$H[
M.0 *EK( $N!;J% FU!M^$/\*/%B%\31K!RQQ/AA;W0L]]HQI7C"NX687%!]/
MLW&.4G""[;&C8)5+$'WO&I:Q[(9K84:"WAFA[Y?('YNM'$$6J:.!EJY]Q97
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M6ILW?B18":T6<<QT+6B5&PR@5HXD8G842=VF$^PS*-22&[5W:0D&*;E7=PD
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M>UF<>/ Q$?"*C.,8SK0! H",D>&/7H.82N1?! E>PU4K+F.#33*,<#:';1@
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M%6!-&K"6& T>*)8N^^S5=J$?UPPK03O /,LJ*J8P@YC):KT(M"T-\A2A%F
M6D(M$5  69P>D/( %&"+OM%JH'JS@.L!Q%U ^C!WL&,Y9D,"0',!!\"A[&>T
M*C4 D3L=][O"#^&T B"6CR'9W&&CUP$, ^#'+^6*?:$82"3^EE<MFX?D&8I\
M2X(*'@/ *BZCM=Y#-V'M*_/;3?)@/U HJ/!5VY'  0G^'A[@$W<R=E(B)1QP
M)Q_P"Q?^X%3G$QZ@ <:P ;]P)UWU$LA0X4L#%B9^$AP XA_@ 9^RXB<^.=>
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M\PIS9-&A1(9*<=*T9!X8E (*,H&7, J=3F#2!P;%*$)(3F<  ,B&JJ2!1V$
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MJ#K6LZ[UK7.]ZU%O@-3!GO4&2  "#0B"#!=0.[,+,P(04, #%*!V!D!  @V
MP *H/L.A]UR&#L!!U&6H  A P $0 )_;)T"!""@P[B)\P P38':C+^#P#I#
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M))<<1"8_;H5'B-$$5,"=$,:6- '^ @2 '53 2X:$1B0D%B2,1O$!!TA ?Y
M0#:;=EBC%M!E*TCG4?%C #01 -Q @RC W: C4F@0!G"'>Q0 81@ C63&C-G$
M5C2F&YQD2*@DB0U( *!DF4R' >#.1,[(?Z94!^Q7#GD > #4!1"' (PH%E C
M%Q0/A!H)%WT%7 4,K& -<G3%=P@ >%R W#D2B?"5>G0%45(!ZZRG3-Y @#:)
M:"# 0+1HM;C'X1E1/AE%<$B-47S2 MRE4\;6&,Q8<W1+3@1 !EC 4?Y SY6+
MB)&'F7Z']7 2/7X)0FJ@>M7+63C+BPD''PS,"*R  0A!!NC03<7, *@ >@3
M_6GD#7C^8O%0U%1@E@$DDL>P@+-(P%2LB*86P&N\6 0,P(;]@%EF0<(X0 <<
M0 6$#6VB4=B,AMFM@!81 $X(P%YD@&H8 )-6 5U:92<<!9B* <Y$R%;\A-8
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MT3*GW(8CU:XF">PS>-A!'I7@F0S%.'_&H"32(G7!9;."([(!!Z!9-^;$0'3
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M@I$S[E;^,%ZKV7#EH!6 , $AY$8& TKD# 0BH\46"  <A G0P4,  QL(0/S
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MW/BW8:LN<$"0#%LH$,!]$V2@95.=:5&%!_XIX)H+&"SI08I1Y!!M6; F+$M
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M<  /D+'^UR!O&_ )!3"Y?A (<3$6 ["O3V%-_M0 68  .RL ^UJX&1 !>'$
M"8 !6RL.L4M>C#(!&=NV )$ '(  %/0,#O )Q>D N<:K,3-NQ4$\K#NV8Y$
M'=("!% 5"GRV#$D /.MM'58/!].V%F  XW  <=:Z=7)\2W4!.K5O$(  ')
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MYW*  $3N DHKXOUBIA9Z&NRA0($BLRD93+#!UWU!8P5 66SQ"9K;-![@V,#
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M"2Q P"_+<O)  09(06RT'U! @ (&>-  6A#0 $R60NKAA2L$:)!! 7,JH0
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M>ARLCY(&Q7FX 2O?<& [!?P5XB822,  #W6PXFBL P&P +,XD0</&* !Y^.
M!02P 6-]( !BH $"8F" "GC @MK^$H8!.($ "FS =@P014!VMH8!#,H^'[!3
MB'*0M>)@ &,A.]1_!- !-_UE J^Z"6O.)X7)R<L<K(#1!NYE 8>E %Y"D-X&
M*N"2#*BOA R81_A*1X&[M6("&!  !0.0KX<DX &].U1N1.=&OW2N0K2BPJ[>
M:$>A*&,!8/O";@R$APGP*06:D  &I'<  Q0 /C2HP!$FP*@:!"$ !4$+,TZ
M'RB$*APO*X :J!"%%,BP$!, !P(T8+TEM,  %HC  SI00CP49'M*8$$$#J0
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MF  1%K!-J1U6C!Z:@@7<@(H)C%9C'Q! !5:!!'*E8  :6.@2'/I5',3N% 5
M(?FPQP#PA"\!1$#7T3B CI,BER=Q=&,=D^O<E"C AA^,QZ&RE(!6:<,Y%4!
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M@]CM ':SHYWL:E\$"R06@2 LCK$WR$H#HH"014!@$+EC9[\>@(-)3( "%)
M*Z\I/OCD?1(T_E_>.=6O"7 O GI_/.$K$ H)"#[S@:? YCFO><%WGO,5\'SF
M2?_YTG<^]*8'/><WSRG74V"EFJ_ Z&,O>\&/?J4O: &7:%_^JG3'OO2XIWWN
M?Y]NXOO^^,@W/O*5W_SD0__YSF=^]*5O?>=7/_O-I_[S2V5\YG.?^.&7?G;\
M>J?EH[_[Y[^^]:D__O:+/_[R_SW]NP_][T>?^_6??O[EC_W[]Q__;5\ 'A_^
M#:#R&6"Z64#:N!$%'  !^ $$"@"U+  "E)T=4$M%'$#1"$ '#L $/F !Y,,U
MO($!', &U@D!T$D'LB 'NJ '>N '?F#1R& ,NJ ,J@D-WF -SB /YJ":_. .
MXB -]B 1&N$/#B$0VB 2 F$3.N$30F$42N$44F$4$B$0!H  !, ';F$.9B$'
M @"= $   $ 9FF$ 9*&:;&$'CB'^  P &9*A&<KA'-)A'=KA'>)A'NKA'O)A
M'_KA'P)B( KB(!)B(1KB(2*B(.*2TC%B(X:.?%#!L 4<E.S:KBF;KV4::HP(
MKR'!!O#:PBU<AH B*(KB*(:BKYEBAI2B*:+B*9(B*X[B*OJ:+,XB++IB++*B
M+*JB+<*B+N)B*KXB+P8C,/9B*[XB+>:B,2(C,OYB,39C,@XC,3KC+3YC-3[C
M*BZC,#(C,QJC!MB;23V:(XKC.))C.9KC.:)C.JKC.K)C.^[9T+EC/,KC/-)C
M/=KC/>)C/NKC/O)C/_KC/P)D0 KD0!)D0<*<02)D0BKD0C)D0SKD0T)D1.J9
M!XR>^&#^FT2R'$;RRC?FQ*@Q(CQJI$0V$0T"0#Z%Y$F&3@/4B$Z@#4>BY$N.
MHZV\A 3<4PE8 )"H1RQX@<&A0!CT9'6LVTWUY+Q-@1=@  E,24Y80 #0P0 ,
MQ$K$0I@AG4I83 "HRDIHA$]01 ,XP &TT5:@"TW<3U+J1%8Q&41209JT7,Q]
M@5#1'&!0%I4TP$4^A0;4155@3@.XY%^4%TP^9!.5!E:4R:&8(5&)BY[X 0!$
M0(B4X0G8RX4 P$-<0RN480G=30,   ,T$5G.A#7I"P/,E$J,SX7<P0DI1ITL
M)8&LA (M(DU$0+/4B>ZH1 -8DDR<#[XIEP9II%K* AG.5'G^O,E)2 \+N"4$
MP(D7&(ARD(?7"(45/8$518K]P-!.J G %,!<0(#M^&5#-I$<SD,3)0!YD,_X
MN)D&;&%'V$L&6!$#7(">Y(F(  #$N$0'P$@'  ",H!!L\80=\)A5HD $B$R^
MQ&<#(5@K!( -+4':7( &^-V%:)1*(A6<O,,$7H@=:%3-V (#% !W840=I,!U
MZ<X$#( 2.( !0$!BL8%RY$!VSH-]$H$#6 L5U-D 35,L>,-=2 )7#H!K:,P
M?&5!\J92K(D#I$T!@,V;N,8 1% 9U@  P.A-6%$ E)"XQ(63XH%E@N8:%(.%
MF4-\SM:%S ,E/,!-?A(GL-8:U%3^N3" &CC ]L3 B4K-56YG0381 W">'FD$
M !"!]%@ !=04$@" $M0I"GA6$PW>&&; WQ!I4;%.9@I%0J" QM D10: <E
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MV"3/89*"5@RD'J%A&#;'*P# '7Q6>\;" R8 &7J /2' &^:NW ; @3 % P"
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M%ZB@&A2 *\0-:S6'*=B!4>%,&HV/[2A' 11R5HRVTU2Y$@. "6HA!J2"*QG
MF4( G/MUAFOP<F5-C&^"!>Q+9D0L)]R-' "Q/Q2K =R2B*PQ6U!82=J*778N
M<?P*=#OPXO+,7]R !'!+F].Y7PDWC"+6$<Q+>QK6$8!)$-BG <!J!M6UIR-
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M##I3.)#D90 ,'A\4 3IHB8J+C(V.CY"1DI.4E9:.'(<  C( $1X"  0;'PP
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M'$09(@,2EJN#,!X8P$  &F0@ )+%WG<  %T$H,"$##20P80(&#"! :)R, #
MR@B 'P$22MO?(KX8LP,36 K1093^FJ:A00(*4EE$C@DWW=7""$Q)P0$)2"$1
M #<H$-^,:2%Y J>"GLI(+"Q<T,P!%S AC!H+ " '&D@^0TK;"UAPR@-F#U"
M!R$.0( +FT2T,BD5,9/=50S0NF*Y!0,HZ@>,(B"#P1_(HD #,PKPJ@ ?[X%
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M &S14('DG$D!]_JK;L4AOD1(X P-^ $:*(#)UFX' 9):#P]BF0C9I@,""F#
M<BS I@IXB0+T0L.K$! EF2C 3=G=  ,6\ DD*. !R7A &Q+A (9EA0&Z4<"D
MF&2"!Y2H=SN@03X:4,9D$-<]3A'"! Z@@7L&,U<X:L!39*)%-(1THQM80 )H
MNML*4P5)34R$@BW,X83=H\.1 !2(1]Q1HV:8'B1.,7F* PFFG=@2%%F'4MAA
MG1@-YPK^,5*QCG?,XQ[[^,= #K*0AXS(#22@ 4XB1,/N4@D'=#/',LFM/>Q8
MM61<SP0'*)$'5L"(#2"9 3\P7P,:S(,+!"LE#2 F#QB:LL<1^<UPCK.<[0@
M YQ,"040;D'NH.=&2$!LZQC"*5A@BF#8:& 4)H3=%)" (^0@#@I"T A-JC<@
M"& !0YFSIC?-:2$'0 80: 46XQE>!*#M!-!UD@V00 $-,."3+%!!!!; BM;%
M\UP*H &%,76('>CG!J=0 O48$;^$X,$D:-A%2[O0 :[EAP$NZ;2TITUM"U<)
M9T^U@04$D#XOJ=55!N"A  03G^A2"GZG*H #;B5))"3 1^C^1<4#)F0B U3@
MF 18E[/,<#Q&,+"$7O*;&G3A !^J%  C,<*N<%7MACO\X:0Z48D>!KD*I P'
MN)W2\5P(.0]@8$*7RP!^)& 'K%1.4'9 0%8:D(!8>&!ED++I ;Z+@!_((J:[
M3DD]7&60*6 %%0KH$"&88(+E5$F3$$^ZTI=NEA,=I@+Q,8 %(N"E!QQ@1!LP
MF)WRPS>0,P\_$"CY:<W$ #LD0 BO</G'/7Z0$&5@9.4(A@Q&MNLR3'R;IU[
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MM$([M$1;M$9[M$B;M%H!L2RKLDK[&3,[;5'[M(I $E1[M3[[ $@3JZV%#A=
M ,-!$6: LN&373$"9FZ6LAF+!K7A""KP3D91 5KD9A>P #0U3!#0#MPS@#.
M6\W5C"V!FP,8& ^0%AZPDEBK$QWPCNGW"%9["8OK+C&2-@SQL.F0MHH0+O[
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M #S?$]3-=R ?2?)Q_":!@J#P:0 TN(!G,P!@2!81%NL1)(: BP8P^2 "AT4
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M C<208<_( ;,J0&VK"0;%@10R(/^VHL]#%@6"USTZ2P8H'<2N"XC">1I-SR
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MO$9D?>.0_(#%A5+!D DZ2$4#% S^3Y&!$&S >MG"39Q<T!U+P7R?ZXG?77A
M2!69DS  049?AR42\2B51C# %=C?!5# I3P OB3 L## I=B? !";MR1,4&4?
M(P "!S#4AU1 3"F ^SC M,B5NP "UMG8L;!BB:T*#I"8I]%$)V)!A^F9-HQ0
M!G@:(?  B T (=#+VQ""(4B:Q!6E "R !P#, )Q< ]Q "0$2(Q"""3@ (102
MSQ2"D^@5)52 AWG,3RW #A7,Z+5 V46 I$44;YS!T9P!2NT:%MQ5)$A:/#1
MA4$4E6 7LFB+PKG!9950%ER URWCCPF;;6%!!/0.\QE  D3$HZF?Y!1 ^RC
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MT"S6 ]R)[.@*)J&&*&_+U_FA*BATU:;' 8[2!#!))P; N;2P +!8$$$?W1V
M(7B5\ZS '41S)%S A?4.Z^$6%KA-*&  H@AQ"T1&-D%/!Z@<U0*DFPE'5PFB
M8^Y'3Y]&6V%M^[1!ZC6 !Y  #X!E82(R!(P$!"R &D1 .ZFI"ZT!(+2,6GK
M7]E<RV$ 6N_Q!!BU*7T"7".RC6 :!XR!*9D8' B(S8+KI7 (HXC "RZ!0%"
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MN,B(V#% <"# ]@!@8$!0L0%)4+#QP= Y</$!0., L-$@\"% NB= \U'P !K
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M35K@.B)=A"$!-[##"D16  [00P,4N(%1%-*. %C4 !EX B@^I@ :\" ?&PC
M SS0&@KT@@49(( &GK('!/!DGAD00"VZT "VWM1853BEXCBPC,: YJR>6((8
M0O@!!X"C"P>PE4[/BUYV\706*M&%BJJ@HPB 4!V"O(#^(M ,T$CCE IHP&^C
M^H;=R28,#OC,9 1@.:4(9TL'J$;^1671!D5R!P/(N%,OPLH. -@J+@< 9#72
MX #"L<4 (JA?&R8#0J:,@@_8K 'C*#0'=.#U&9T:X@*$684@):"/&GN+2)03
M '#4D&T/@  #QG<#,TW + BXPF[3@("]T6 L4,2 -\+["9]29*H6X$5XVT$
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M R\P)8Y$'\## UWF)6SS3 I2;9]@ 1UA7QY  O(3!'Q  1,!$L>C@0_T 11
M/005!D&R QWX@3"P1E'@&'N0!&'^@&P*LFVZAX,YJ(-;HTG4LX,_"(1!F#0A
M1S(3,PA7HC$M0X1"R(1-Z(1/"(51*(532(55:(57B(59J(5;R(5=Z(5?"(9
MLX1A2(8H8X1E*$DZ GQPH".]]S7%=B \<'UKJ(9K2!!=("5M>#5^("5?XPZ
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M,7?@!RR@51%P;(<P&N72!QYD )M2ELW(!V$EBX#0%7^ 282P0"'% YEIAG^
M5A$ (2U@&'\)-0Y$0L'A'\>@+ .A1)K4"^'4+!&D#=!R!3SG 6_5!U)U#+)
M!ZX87@/A6[[@>A"B  : #8/P4E3P!*L(%IA4#9/!.!5$#<044@L :AT@*E(E
M 14A#231/\74 )6S';3P%@^P>@ZU6'Q@2NZ0#K(070FQ!OBE 5=! 05@*QW
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MR+,0 1X[G=$)H0Z]?/QZ2A!F&&ZC X?\*]*,0$<!#O3%U<?P";MF/9?\#,<
M%^79 SSAKPH04ZA+3&J=0R[I@.T,/)EUUZ<T'*#$( P1+3R "]2P&)QE4C&Q
M:F'U,2R F L$(_*0QVF0KMF7E<7L&?DARV+0N!%DN&R3Q2/9"SA6!)YAS?2H
MSM)\8PRQ3<NPH=?2"\AR3PK<6Z 1 $Z1OCU0& \ #@ D<YZ'B$>C<T#2P7C3
M&9"&1&  CS"[**];!7A5:M# :7##(W'V"AX RIY N:CK:<F\3!JZ):'<!VVF
M$,+0>4H' +V0 ._\T7L1  -@D5C^8$7B] GR92M@BC8A)$Z81@ !\(')%%W0
M0$\F3@ #^=L XFOE@&D#4 ]AR0TX,,W4\#;[B[< $:]95@"2T!YXU1XZ)\2L
M%4%A91% 1=VH"\@"FU=#&0]!Q0%XZQD?DQ5!U0N,%E8\$0]$=:60[20?&FL!
M$$[L(\N(%Z^Q @X@)$+-Y9:32.,,@3BXP6EM%U8.\ X"$ "A@QQ97!M\Q  !
M4$RTH<!_]<F^IAC 4%3@T@G\2F$JX*]ON4!X];"AN$ [AKDC6>(EGA5/U0$H
M5 KN6$QM$080$,0C"41]1)-R%I;)VPS$H -TCD/&W0=$Q&/SX#8@!*9\@ KQ
M"@V><P?^.]8!?.1ZLS!EH<@#SHU/+CM5F($.D4!V/!$ "3$!K!!6G%Q,.]X3
MU5 #)YL&(;[HU?3(/#%,-MQ#U+0'D3Y,D;T'U":9*#R^@Z.1..,NS#.'_NB4
M<. >UR<?B$B(.G(US,,>2J$?$)^4?["&*:("[=$!"#H8<S!],?F9'L ><E@)
MV!$B6(!_$_^''?]5((*(&^!W#.L>0U(%[#L18&#QJB4?_H& #_@MT\O$)Q%3
MP$#RH?T*3= >&D ]R9@L)V#Q5; D'$ C/K\#>=$%EE:";=(DW-$'?+,' 4<K
M'C!&=[)^_2$:(=)X45!M (+1G^(N0PLB<$)6%H E!$4*E<;^!Q32'AD DG5D
M]=ZC\S3R?DA0 UV&H&,D'=1#]B9B7X/Q*_:% <$V'V#@?.L> ,Q#]AR2*K]"
M#?OW,1YP)1<P$4@"!ALPF'L@PBP7+1J @JA?1R@X^00!9W96 TT"@5E1'S2?
M@5/$BA,Q%N[K),#/OJ\@0,+O(4IAYGF_710 )Z0?!6!P7!_BQ%^Y("*2^C8R
M)*%-(V,Q\$2CB%EY+M]/'NY"5"$5'N2O"$_G14<"5*&M -^O 8M=,+;8<?U;
M->$A #Q.8%"E_@H# @?TD:5YHJE:7L W-:L\JU1"X[F>/P"R X/"(;%H/"*3
M.\Y&Z0QZ-!S29NJL6)\IS\I#.77^.D.ND6S"-%.9B?G4_KS=I3A<CJ/G-)?B
M&T_*6)#X 0T*"K450LEX<*V):4%&)GE 9)!(I)E@?F2A;$2<9#Q /':0F87-
M 54X(*(1?F@$PEIH$-4N9@Q>=!JJ2GI@6$5E:!@';=ARZG8T:7@TQQ+R"EFD
M/?]FFV2F,'UL)';_Q42&XV1A2^IPJYM$F4MZ*[>7I-/?3P*,? A4H!!DN%!@
M!08 CSY4 & @@(!F!'I].#!A2 <"" Y^Z$$.B (%=7)<8,!OXA ##F10 ,#.
M1 < )"%AV*A" 0!_WP($ *!SY8P# /8LJ#FA@(>:$@RTF&(N@8 ?)S@4(&#
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MJ8(WC+!Q#$".!YG<.R@G5@@P40#^A:+S2*JJ[:9;4?O\JQ$ "7A@0,/Z9"
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M@ )$#Q0): !IE,.&"7!  >]!P1KY$0,#/. "[V% KDC J0\X "#+$\$%$.>
M!$0/$!6HP)L0< .P:( "W?'47TA0M5,.H!)@6X "BH))E3#@/>597_1B54JL
M^&-.(_F'5CHP1CXM8 '1NT!!;$("!JBN NF;P% ^0#,)6 X 'EC 0!2PNM>U
ML@U3#%,Q3&" $30 B[ 2T4E$ISM+]$ YR 0;'N< .DIY  $$ @ %((- #F!
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MI>H#-A+D6*#A871E#_!U00!DKF_^(H"R6AVI/K4P!OT0704>4"N;<,%ULV(
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M<H(#N-]]C"T:.NP"],VKR 8&SL+^JDQ 0YC "T6 9C+@I4 @G'"5("&F"7"
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M0.1(8"'^S@%X1'Y1@$=LGS5=B_:9AS)1SL%*!IA00JXU@>5L=040 '3 20.
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M ""/0&#-3T1C2PR-6!5-5$AD0LP-PQ0-FK4?LB%/&T0**DV;6$1UZZE-^Y[
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M 1Y8F\$"4X]D  <3+":SLEK$JT&Y)43+P 8,E&N !=$6L RZ"_27PMIHT V
M$G"J\F>)Y0KP!=2W#A#J !D04$TC$JCV]>JLM^[ZZWIY@,#^#1XX8 !AQK+L
M1L00*%"#EB0@,$2;$W1Y 0((2.!! D4PP,$&!;39T@&.AX&GBQ$CT 'T#"
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M%SKR@)!UX8 ?]P)("X;&D&C4C1_M"(/U1+ ''<@CBB#)%TK&CI,(8Y@ _"2
M+GC 3ETH&AC6Q@0 C$19!8@2 &8)@ Q P&@0,("W9ODF3=0% P!X$P"*($C#
M> L5Z ( @)P3J@?<J@0"@((W+   00Z * 3: #:],2=I'E)J"@C57B3 DI:
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M!6INEZ+^$6!.=Y"4>1>PMH,,H$TFJ@2U?I7?"^RM8PTH5P#<;9H+Q#)>%2"
MMSK@$B^),,#F(EDU&.7G#R! >H5CU[0XL( N$6 #:G+*:K+K@0*@@T5=I)/M
MVK7,R 0[8CQ  +L>P*X D)%:34,\'*<6DWAMX %EXH "NG3-!4CMQGVB.Z8(
ML ^V]4K1T;GF!H0%KVZ4 *[JY'@')+L:!<A] #O)6+\<Q2P+5(.:&$ <,.5"
M)QO!RA3+4H VABF!Q>2Y3& PS;1L# $*.&IYNZY^N2+!@&8O:P$+T(  -."4
M"1RKA!KE0)X-H(TQ36#[DO!09H!3'Q!-&  H1;$ &9  \E+^2Q @/ &@ 4U3
M-%@4-\B';?%C"-^"-:M!/1]P0-YR 0J +FHB)MJT"CD5&=/'*[,0 *UP(HZW
M 8MQ =JE  M 30^P 1Y65<PR"6!P33Q09#(X$/'B8SQP ::S !-@  > !?$W
M?L*R;.C5!1(0<5U@A'?1*#"#);=$!@TP)C+C,GJQ8&OV3@[6 .F0 I6&-0NU
M!)U5"2 6*R;&<7-A 3OC)X RARCF-QF +G'S  Q(.)'A=X0!+Q[@7 YP+E>
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M#*.9"6"&?B*4[&( ;:)+B>,!?!!1+N8P"$0"7DF#RG-2QT LF"A\Q+=NZ1@
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M B@00 8'D'+#!34D\10!O(@2B$$M+D#  :"4D4UT_T1Q@ L4,!+ !1T0@
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M %,:"/U"/AXD5$$ADS3@=K."L'[/'6U]0 D._T:Q#@4,\,T [FZ7"P,$#3E
M87@1+*!#S(;HP!,2#(0FQ00+Q-/! W8_YWW?%VSP% \9,/  !';%1KD$UP]/
M*@4+X*Z.J$1HP( $(( N#BR@ 0_P@ 0*X14)<"0! *D  QHSB6@X( (30%?J
MN&:#"-S!-AUP'^8.-Z\',& "T(M@#!+@#AXX(%)\$)T!U>$]= 7D ! H'P9
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M\<\TPL!@[3M ![3J0,=R  9+E0\"@#DP*OQ75_ZU#P'X %$]0.&>GN"L%!1
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M@@J^.8"(#YP!""!C-8A^'1!I( $Z>,!,H(L !1RT PSH!\ 9X("TT"8"9$#
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MM45*N A4LE1*!TB  \28-*18MK#'"2+"X>W0-'G@JZB !QB(8Y )D1B T*B
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M# 2 .WB./M ,XB&:P#R :YW!'1 >+YX1-JR-0)[)OPQ>A32(W-! V[R'$3"
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MV*TS$IJ*)BT>J<  R$G[;8-O<:#M3D.,E0*C? 73XDZ8*$$]8"Z2N8> \%L
M6.$"'$(,G-.>Z>T S()_)*I2>>W^"H G.W'7M+V%!S! QX5"@%";=/;0#+P%
M7]INY\E BQS  +C#]T;!5R#) U1FG,1JF$2MM2FL"4 )[W( CC"*$!#$4P1C
MK! N9C$L"8>56>S6O!R7W!!!K<T+$00.$7A &LWPULR+@[E-@KW KKKP?)F/
MV;S 09'DW:R4KWF1G]T-#&R @^F*$K\ $5S8A'F-5FW1;FV .Q&!%8_I4EEQ
M!\0PA00.?UF8KM@732EQ&C7Q5>63!LP8!V" #'M1-'2,W?A"+,7!%NDP6\#
M$2>3W4R8FK3-"UA O^!P?:D#0/SPW"#!X[A-P;(2$7Q-0/C6$S>Q 7\-A9C-
M"_K/C,W^5A3\9 YOT2,;E-NT1>.LF!HI$=K@0;]T#+_IBF'=S02LV%2,!MX$
M!/4],@7XCRJU34WA !8?GZY(@#52@$$-SR %P@XUU@NTCBN+021U@.-$U/&H
MD1N_ -W(R0;X%T T6#:OU 481M]TL\,HT6(E8KA5LMN,%J/-P!W1<A>#8A[C
M "]W,33KR@M7<PGG<S<1)>EQ53U-@) >3\<MK#X7-'T4A6(8M$(OM'VX1P($
MXUD9#2XA@:[U4PF4'QS0$T-O-$?/DCZ9<D<S+&])<4@SM(F%%51%4F"%\7V<
MM!JY-!:@LA7<UYAJ#4R7]!0P0+Z%EU-9 >$H$A2R4Y-&%HC^S139K'-7<4<L
MX=Y*P%4N55B61;59_2!+1[4^$<X-9,!.0_)RW?059#&+P5511X$X5\&,58%(
MW1-]C35*:_1QO54.*U55 ]5]-5@6V#5S2?4SM7%'T5Q9C3#6B%18X[1]@$*5
MRE4*U,<I"FY/\( *@/1]C((03P$-')2B2 1:2@$C=C)UZ?-YR%+;QH#-.0R"
M20'SW$?^4 'G6IU]=,5]@"F(@<%.1\$#9/;C9<"#U$=9R!7CQ8#V:H%V2 -!
M!X0+*( UOE/1:4WT8>TW+U-]-,!0RY+4T?:3$79A(TVEZ-6XU<P+?DZ:XFL"
M1(.  ,$!V,!&PE 8M5\I0!8_ D+^LWA(' 2B8.%%CP9#!%P<8SNW(=@? FQS
M4CP9'B[ "S[ =OI6&2' 4W!:>]Y-&;A-;47  .R0L/@!;'S$1HI6?H((TJR4
MU]*$,OU,%+#=@L6/=<6179R2P\CWO$#&\AAW'L4C%$B #8#F 5:=!8"=#,1C
M$%  !F", C1$&;&V!]SG$CC ]I!0M^;OF;16>(N .[22"<&&X>! *'G !%3&
M&:0":G!4H.$":AT!; "$1!S#07V%&7!'JX1XZW"&+53 'PA0(L7JO$B$VR@
M?>$.2-Z-/YZ).US1NWI23PJS0/&%]@QL%$B+.LAX3EFY!%!(;_3X\.@ $LF-
M!M!$;DS^1;B^$/21R@7,HB%  0= CEYQU.H43BP'02 83P7<@F]'3V=D@P,T
MQ*3P0>EH *%SE!&ED5V-QL "A("$KHP#! 8D]YPW$OKAPQ'@WN#)1Q(D(TZB
M0PSHQ1+@C@7LM@PD@19QQYZ3>F+[7@:8W3',P *8#V25#F?X0+ 8@@E9=WV
M:E2@(^]-8B@XW4F! MK50/[D )MF!A>P0G[VPAL4@ZTG"P.<Q@]TP*E(@$T>
M358BPE*,#DLT]@T82"%Z";*@BV><BGN BTBBS+](7HE&11EHT=14B_EH,*-L
M5XM$1,11@%;^QT,)2"/5VENHR0"<T:^,2*KTKC/UA.?$4=_^8HG=G0R"8,4K
M^HS4D5NE5&FR57 2C%,@^ ?*B58"'B0EV R.?$<S^AOA)8$A6F$8VHRPO,NJ
M0,QK/.]/THRP* &OQ<E530TB$**WR8 01!K*O8E^0HG_F9""/( <0:.?'$O6
MHQBJ9$(%.$$N",ZY)K<0), 9QHDAM4,KG B>-"FJQ)P O(LO0EP!*(!K@*&4
M?(7<J(6^%44@GH*L)0L8^!\"M8+.*@U%^1]!H-_,M (GO@.U=FPR8$ Z@:Z$
M;,0:_T"M<4$"U!EM5V"DZ:P!X)C=?4$!, JW) "=PJ0,?-WDM2&26+F_[:S<
M. 90V(SQY\2)#'FM#<"*<,%EZ6S^M22$0:P,WY* +":;B+RD?$ 6:/21"*CB
MP4P>N],'-O !"$R/<7S'M #.^;6N%UQ?4CX.,'5"%G!2,8-\!A5&('*D #X7
MP4=@^2@"!XRKA9@8!AE!AU"9+!N(ZR3PX7 %BTM@<KU,!) '6@/8(**#R411
M48!7X=#GQ!&PT>(AE? A<7 !D/$! 9 0Y6!P]?$ Y #4 6#E<D%QX%A@)8!Q
M 83 Z,)AT2"P,2#3T=7QH6$B0_;! "&&\4# (< Q).0RH##CX/8Q,?!A(/$!
M4.%Q$0%T0 $!-'[5L;G@"#'@D8<1@-&0(!FE4"")H4!7\;$ W:'HB@)H"/@!
MX*!)@X#^"16<0-CT D"$#9.$E7 1P5J%!.UD+& @80D$ 1YV;(@2((,#!U(8
M/,)@ ,.?7LM<B+J0X6 [#@KF'51@S8:Y37-:#%CP(5:&"B-GE&%@H$, #PN0
MNK#@9 *!#_"T=8B =$$9"UA]&*!XTLF+'1XFP. WP (% NTT&&C3HP&<; A<
MGM7TH4+*@QH"\&JQH2L%2;X(^!$0(4HY! 4DR/ 0T 4&6@;J<@!@(8%+"6B2
M?J#(88,3'E(*\) @F-K6*U H^BIT95:U#PV 4+!FJP$T%P6$6," H,2 ; ,<
MB*G)*;KTZ=2K6[^./7K'"@ Z6"AQYH!@NIBOM*-PC8&",@3^A S<.ED(@7P%
M.$#@(.8#UB=1-E18,,!A+9SA  ,'; (&=[PY$DM1'AA@@4070$#*!Q@ <$$"
M#SQ@S6<<8/)! 7X4=,\V#.V&2&920!.! 8RE\1\ &JS R3$?X"85)2TT1(@C
M9_%W#00-<)) '<C$T$L%UNCG00)6&$B- R/)44$&2])AVA $.5 !>%NY.(0%
M#QQ@ 31DIE,)$"]LH@!2$A @%7X!6"#!!'@L0P "%S"000>@8*C>= /-$,5/
M!E300 9:Z5=&1!#4Q=MLC$"P508(2.7+1QD],L &<'Y R0X-9!.! [=(8$ &
MPDE'$0:L2;4!@ PPX($"6VV890?^0$BP) &.N* >AS.X5(X!%!QZA05HS,5!
M 1[$"8%+*W!@@"=FY:1+=R_4=UI),E16P28I^<I  [7*H$A?)FR0P) 8[& 8
M#XPP$J$O&_S6@FB=#.#%0[TP((  OD270)L'[/39=\:IU0(B'6A0PC1Y4B!-
M$[)Q(@!.!U6R9 LC3 "$/!=C V&6Q7TA00/*P<'&!0] EUW,,L],<W2B2'"A
M)UM]!@0 T$0H( P%W'!!<C<8IT*:(4:@#5D 0!" !I;HYT0! V P@(:?V@2
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M'0[(AA9:.0'I,2 *+O!43RI  :3^7&!(OO*EA0K0K@XH0 8.(, "Y+@(ES3
M.$AI@&%.83KD'&8!!1B2!0QP1 _D!&>1:T&$F$*)*E"P.8] "@5^Y0(Q=*"4
M!G! +%H B03TH(/+D!OVM- + L3% YWJW]TZ< X2T DI!H!HO@AP@1+<@@/G
MP-(NG4FD3;RI#YRH1L$\(+].0",GL'.!]A#P "L]BRY"VL(R#E" *M2.&@)0
MP %6> $"1!!4!@#  OWV 0)L  ,%B&-2$G"VP.R0$IWK5$,.6A->8.UICR@
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MA#\0<(H#,!JN<$B5Q20 C=[PHT &: 8#6+* !>J) 3G(0U5,L[S>6.$"LK/
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MO/($@B4C E!\4*1>W)%/6U$N@($YVV :\6,:X_ <#G $&"(5GF -ZK8"DJ
ML*,R8L!HN753\\8(7(0$'C 26N$2<8, 3M ;?B0 ';4,FC#^A7N&<&\" 9(P
M#DO  *$U"9)P#]42 "^' PWX#D6S:I40 !N!'T\S!<;C5RB$=,C3$;%U Y0P
M*66W#=QA"2Z! $VU%5PE "G4%V5C J#C.3>0 (=Q"QG!)\'W/T?4<16Q'$-P
M QB@!/.S9R802"2! 'ZE %US%!2T $TG"M_8 MW8.1. @Y#@1PQ0 -XV:,:U
M+:"0>$\#<K$0%S%U1"5  $WG<A$R/T"@(43 B1#E;>N .TL ,A;$7'$U2P$
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M6"WP.Y)%A!FP&)P@%U+;"P.;7U*$FAN07_B!9)]&"N!J >:E*#(@-4F1 [U
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MIT "*0\64-W"T6!"KC85*NBJX*U ' :-%"@XP&H(V;)FSZ)-JW9MV:,2[-0
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M8D,"X)0'5SQ@'1G#0![.XX   ($ #B  30RA'ADXLE'9 AV>_$:1!:QJ -R
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M;9ZJ;_T!93P7 O5LZ_X0^2SN^(S=M6[R&+[X C30;1DL !XPTG("8T" CR2
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M0-P&)6F.(:11!6 .@5"&,?Q1CVQ* +P*&OD#,H0($^9"!C7 MU#+P%P !2
M!."==@D  Y@,/-B<WB1 8Z21$#"(WZ45=\"&@*S*<'3 JG 57V27+K4=5?A3
MV9V):3"5L#B !QR&"VX &PC "U@4*@2 >WS$!1S ,-Z/5I$*DGU+'K535#5.
M'N5)=EC4;@S >>2)YBA)'=@)&(E( 32  4S!'SPA[!R)<EAD3I5& GQ*#B1
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MH\:-<A& LL#<J-"-.=  #=0/!WC81WQC'<1 ^6" 1KQ"GTHB*N!#_[P#%&2
M;OHFH'U),)3/E J4'N!/;LP"?$5ERV6 &9Q&JTCG#122+0T"^4R38SU"ED#$
M2E2&(7! !/!2.+2C2,"-G/S2:PGG:#) </4&U2# &_!/H3SE4,6+.!3 &#9
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MAX:TA)$TD86X1,AR4AN0C%@0 #3XETO@2$#AP#Y^1A=<RUO^9,*]'BN@10
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M (Y 8%(@0$SE0%(,J$W_9)>8*$'^>,BEF0F$[L#=9XQ!@<@)Q*3 /ZU<N-0
M;E1'26D T7'$G?9$94SHVDQ8 5 ,#13+XR*9 ='A6?#2!4W/B;4+$]I0)0@I
M'5< ^33"%KP4H&0J>\5!!-!)*HA#EIAM;I"JW5DO!IS#-<B!-<1  \CB8E
M>&U ';A#]V%2,EQ#\.Z%2Z)"4ESKFCB#-96([I"OZ3TO6Z#RA\("?]G> "EC
MI71!#/N"2P0$(*B&PHP!?M+R5^*5FK*"_.Z(C4&,2V0;++S*C88$2L3)#B@$
M<:;1;JC',.HO_Y@8<,1=&B"2(-$<R-#(+-QM&F D;J0E&?@'KBQ(&;''&,YD
M @ (\(W^Y#5PP$?L@<3&P#4 \/V0#(8<\ &<QQ DQ<J9P;$T4C(E00)DEW;\
M*R0@YKUXQ]1(&%:.E6 8QQ8,@#DM0 %8+Q\A]4> ))\DP5;!V[]*TU[4:9A\
MR>X^A @@=8(-#-5(4R&-9GB8@H@2 11AZG6,BJY8:5=*0@$H<RSXH0%H%<1
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M1O3,XOT\MXG\W3+(7H&F[HZYPR-@  482>Y)1,BBY;"I R[@AF@$\R.=_4"
M#1IHF.ZUS/5=!:O?SVRP5XC)7FZXPQC4G8*!4< 8(:-80, X5MUL?EN!%_ -
M00:@JT]<AD04E8;Y[ZXR#$] "\HL@"[ 0"FG$%!D4@6\2RO^R-YER!Z_7 !!
M_)WEM_KG4\!SX\"<J -/:.8-_%[VF0"]J W4Y(; T$ G80O *3Q*]D$2(-]C
M=#^G3-GF8T(#9%;E6\#UP,>\E"A1:CNT%.??.Y\[K T-7 !V@8#3919T?5[U
M4-\%5&TU=5^-5E#$V75521_?9^/XK"R3FH:2O 1(%TB@([$,9P.(IS.99'C@
ML'A,+IO/:##'\"DD*8X)XD,H< X=P@R2F @R&%8&&S4>'Q!S44$$'08<& 0<
M&0,:/ ,2'@T; C "%Q(G"PX7"A\1;!, &@,6'046#45N*#4) ARK')H;!(8U
M RPU<A\3"RZ'#QD%'QAV!!@?!S_^!SLV?!\,#!T %Q@'8 T?"0L?"%K:/ <:
M!# )$!Q)$*4!%Q4''@0:' R^8QL 'AZPZ:? 0ZH.&@1T>,#@T!P;&M@\F-,G
M5X,$;4X4N.!@00-R-CB\X$ @0Y\/!B:L^;!@ H0%'!)HD## @X,_S^R98N#@
M6P-H2MB@7",B'X0'**.0<X"A01)W&2I$@+!A3@41 "AX*( !@8]O%Q[6P#
M X-OZHB5*!GQ@P*F SKPT5  J2\&;!;86?!@ZX8\7VILH*1ASC $"3Q R,=
M@ 8&,$(BN&"!;=E"V# 2:+!.0H9G 7 AH&$(0A$]$]@PT (3@JH&0L%@@!#R
MF3<ZR0C^;'"7!X,*;!,P!&AE@X'N S++3BB(@,*U"45L>,S K:N1'!@9:'!@
MHD &FBPYZS[:" .'N!F^2<!H0P*_;#P0F7))F\.R!:7X"C="8;!B"*F)8P4I
M=%AQP#N4I*'@@@PV2,8:C1AB$@<(6,"72\(]X( #!4TDS5 \B/(!!PX@H%<C
M'SA@0 ((I*7$%$'5H( %&S#P0!87/$6;.!$,<( !&R4 #0- V'#2!ZP * %2
M-@R0A"&-X<< !:5$\$ $I; 400 +G!5%=#:\PDP"*UG'0S@)-$0! 5[QX$$"
M#31$#$80,) F2B.R <$!"UA1QC^'Q%9#..O58, %FSWP0 '^-,3H %)U1E!$
M!0IL\@ $!=!6@*!#]/)! P(U ($!W$7G%S'<8;1<.1B4R,<!RBB B0T;?!--
M3%\P$(\#!53@ 1X&=+"!!"K^A -2)2C P ;+I/@1!1(08&<!_<3"#%I?3!!%
M?6PX0$@"%AQ B&D\,#"' K2Y-$$6#5QB@P=Z#N   P#-*$ZZA@536K,0A$/M
MF0T-\"UG<;'H0"760!!N#5Y1,0$C_7[@2C\VS$8+!@(LD$ OXKHE 1Z'M"HM
M 0J#5%Q#"\" 0 3$5&! 7P2(DT0-]M%P@ 5X-:#  VLD $0#[IT030:CE'."
M>V6YDF(!)=I: Q<-$%"$!X9<L"+^! MQF^(7&;"!  ) K#25!7,TUP)&@YSW
M: $L.^CVVW"'<0<=)V" D0)N5/#')H1L #0,%]3D" ]OB5/$9_ Z6P-5(24(
MX$.R/F/* SD>TM :U[2@00(L$,F#S[]<P*P!"-= 0#!&E*+!!)1.3C8*!TSP
M;P49\/1N-"S87>8<U8K3T 0>; *#(6].)$P#< 11$!M5<6#%)('Y T"@X'P@
M03@H57:"![,J\<V&*;9$3@4+:&!K!1AL-3BM0C5PD1(:*/K!ZAU/<.D<%) C
MY ) 9*"2:':9GZVHD8!<5> C+$D"3\AA *Q=SS<1B$!Z,- 4\]6 )PK  0,X
M\ GBL:3^"-:!%3&VE2<C?.L"(B07U3*3P$.89@X<H-V[V* SB26A0FV@300P
M0@'464\H[D$)Q1K ,H%AHP$D0<A,(D$+""CL(152U@9@\H!P=. >8<! VUK@
M'0Q(X(J$4( <:/" 5GEK AH@'RT, ;1/G< K$5@ $<*Q@#U58PC_2ID[/* !
M\TC"#0]83F2$1#EQ-*4!'4  !E"4)@]@8&:&< "9W,>##5AR 0BX%!Y-*,#@
M[68!*'+BPMIT@88XHFL]B%[<5LG*--"%& ;0V DJ ( ,)*0T!%A %H2C,7(L
MP&2&2Y$!&G  A12 3'Q2@  (88.'*>  &! * E(# 9J,(@G^C5!  @! H050
MP#%VHT!6"!< 8CT$.6#8%'YX=@ *N,,"&(E 0^K2& _L3 *.R2087$8!MFV
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M( )XW4 &@'H(IU2  ]6T5W!:H  D[K..87/? S9@ 3#3ACATYJ"%F%0(!U@
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M C!TAV#Y2W.05.HG!AV3!WI1!#&1BSP@B:M!,BPQ3F>!%!5@)P((7T#0 0T
M-G20("B@+&1BC9\" +VF *2R3S1I?@/ (I%$C1;@ 6#S(X1P%MAH.3)A Q=
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M#@WP)BTB)%$JD[A(C4WK2,C1QU(<#;.,2;/P#\ # %; 7K;  0H'!@8P9'.
M(NR%-X7G%E?K+PD0N[7[ ?"+'[QR""=@)W1P<QRU#$$90R\# !O@#8X%'6CA
MDCNI4G,JO@Y V/*$*:7C!ZZA"0# $ VA4IAB3PVAI6&RKT#B>*1"KT.C/#*2
M24RXD@@ 40?"F70 !(9 $^%7>*O^XA9\P2AA0=E(<A8880\?Z:1.LL$>L$P1
M,P8=PP%QR!GVL-.&=<E(LEHB(4$IP0H)*".T10ERD!HL-E6?!24I<PE!J6^(
MU<>'=1$*4PJFT37+$2SI[&[P@C>T82=9# 89PQ+?%;[B0!FSFZ*P*@'VX2&'
M +#"0"KB>(<D@SF(E0<KP@@=H\\.#C<(70,=48<CDM]:<GWOLD@H0!INEP$N
M]30A<0'LZPL8.@8PZ,$T0S/L^P6^X.$HP'C,9(5],R(4(RQC@3"V3(<[0#&.
MA#! V"@!6#HX;G@7D()^)PD))A@T8V\&&!@!F*@^^.*%0$$C/B)]DWLWJ 0L
MS:.&T(#^E2!A$A,]/"H8FQ7EYA%B?F=^'M[#B@81#KCCHJ5H]I?AZ3,$[%LZ
M\P:$+U@-KBP8=.CE;L+G>:X$-8(1#=AW2C!E9!X8@(8+9 #FS,#2- #HM%()
M0J,!DUX):CXBT3-OC<)II''F_(4"%(3B;=Z ;D?J7^#H*GCH@Q?E3:PM+B0Q
M A@&B8KH-CYX20X17;[CM>Y_6<:!%8/G0,%!B)[J#]YS18>N"L+'G'@[J;%J
MS+YU*#?M-&?MR:YQKY/M2%=#V.Z('*=X68=XL*07S3>'S\Y*W\[M[*[NZ=[N
M\.YQZPYV)6?C:]@@\PXW*@AW\:YR:?3N=4?+"K+N^0[O7UC^=UFG<(GZB$YW
M<0 O=?D5=LSPUA@N!D@ "H8HA_85S<]^\)&7=/N%X8:@X;5W[G^"[W7G-A0/
M?]\7>"Y.[95D\F GIAJ/B0QO<I@>@.OG@Q-V>"^?\I'>9"M?\ SO/(]^?^\2
M@D37=U18X@G6#QRF!--']/U.7]##!&A0&BS#NALG'%0G/Y07E' 22WD7E$@?
MP]1J!O\F!LZ1QF10<9A1P8&'#C1'%UEW)#??>''H-H4"\2GEG ^?!E^7<FZ0
M'F3@ @&0^-S03F;@G!T8!A*@5"N7#.()=V4E!GD  )H)!@@  (G?Q 0  *Z[
M"0"0( [@([UEE%5O7V[+;X'0<)#^9ETBZ@ LPV^ZU@$1H EWX :8M />/$(N
MX78&0 V3 2!C81J']V>#;P,94$TW* $SA@(3T!_,$@BI3D$E%@A?( 0M,)59
M)A0TS=(68 5F;0%_UA3",OZCU;=CS0+U4 GS5@$#UFO,P 6+YBLCPIM-.EH5
M8&5(\ @@4&'?1'2>96D?=F'5]W5BXW76U<7>MR0?HE)9?3B5R>;S$'!B/8B3
M5<G(,I<*SW/9.'375>?*^WA:V R%QZ%@M3%,DIS!6#H92VP&^R@Z&NK,2-3"
M1%%%D\S$18S&3!)*FE,'P54<Q@15T02B!L7BA\;E3Y1&A8Y&J6#4A07/@<.'
M@89%W$;^11)'Z*<,1RO*YL= 0TQ&YL<%A8Z3U@11!I+3']F(!Q4D3X$$QT%4
MM\?&!(#*Q\'%!9'66)Z)!L=&)@>&!( .1ST,2K<%X"**'4>.#!M&L'IS8P4%
M !)*N/E@ =$'"E X8(J204"'!P#4=0@089:2 1P&_'!P@(. 'P(P#+A3H-N'
M#:CPQ+@2X]TNF#IW\NSI\R?0GAU66A" !@F!=P8J!)#PP<$/"%!N#C!GHD$-
M" _(.44PH40O)DX2P!KPP$-5"PL^5-@*X $' A2<8"# (0,L!%0.9'@@04-2
M A4H$(@R00%:"1FX.9# ,L;2G1T&($A@0 &)I! 0;!@0(0/^@@,6*A3 $.'
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M $04(!X &&RG  %$R%#8 @$\,$!_ BQP   ?-*# *Q\<",%:8U0V@'#T?!#
M!08,H,!%!]Z'P%H$T K !A  H( $S@4@$ #6I'< ;!!PMTQZ+D8!IJN8H?H!
M P$$4T@" GA*0 $:#*"*$^$LH"P""H :RZM!F7LNNNGRQ,%JA;(P 05K>>K
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M +NP&\H3HG$44$C74F=@J1.1)_## Q#P@)<8RP/U:8"U-A#^@$0Y 4Q:4$$
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MH/PF/0DD((V0NZPNE>"=1GH  0W(@,4P0Q^:#A!$28#. ]0$ <2(#%KND5P
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MIE'1HYO_-@0JV=BI,-OC+(<2<(!A0"X 5>Q#?>91EPKB:E42>0DK5Q5E[U;
M6BBI:Q12QA*M;F5,EF( KD2W   LME&ZFD  HI+C ,B+0\-8R4KH%@X)?,J
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MW<P4$(P'I#2! )$*KCQ#DM$CL24  0A 97E< 'A'!!2  @3 !E@0'HA,"1T
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MA00(P*=TCX606WP500=PJU34TE#IS=4$" ,XQ990ZP^TU)7^86^42L5B5$\
M6&J@8L9+<)9ZI@>CI: $2,4W4!"7OL<"?'$$Z  #'L ]J2FR/$">!N"4A(-,
M4(RQ$B01Q0%G+'$ 9IS/\(L%^:E+ EI+I*L"* ^R("L7H0P4R)TB$\%#Y<&/
M1(#Z+=TJ1I2DNI#Q=>ZP.5#:<@<194!G;M 0B8.]0(N\;DBPV(%0N.Z&>$\L
M&$%5>4 :)3$)N$<K8, ,  ?OMA6C?1&_"(#PO@%P%-P@58V83A9D^,P(/"\L
M% I:OH!VX"P5T+ >RDMMP 4Y<"PLJ(44$8F&^$>^\0? ,0 H=\/$]>VGNDV8
M#=$5#0=LP*\R2\XA-@#C'/,5Q4#^8_QP-RR-_U:'+ T$CJ90D*@L"0R-/+W8
MU3U1<.K3>,)*Y&!H2UJ4Y#0,.8]G"DF1%!3O O>,$X)"09$PBG*#5]2%IWP%
M7VP-P#D%/:TGA C.BZZ0/5.!5F"2%4R '=!(P*Q%:%Z45/0M);6*")@"ZK"%
MO2YPZ_1 ,$>$O,* 0R7''#3#&F*QZ]R/<3*:XLH56QD >@5S-W((3=RS/I0E
M%[>*.;Q"KM@P33!3,%A#8=QD'MR/*Q)+$8!FXK"%6!.-3WF.Y7T'3ZD5TEW4
MQ3+:A#I!NOI0@^G==&DRL:D(Q,%/I!C0,\#)D+D(-\B=K8F*(HIU$C*!5"F3
M\,7',;[^A#<='@/\CZ><DRME,B3[P$<8B@T]W=0DP @@ !2T;*AT@V5\IIA!
MBR?H\/V@A(:\:DN0A@-4,;* "0,LVE/H (3P&EMXAT7)F"%]P*ZH!N'FY6F=
MK_JIQRR@5!&N:U8Z !,@T8)U%4NQPH_\612@I590K3 AB_IME%/HCN@(C?0D
M)P98"WCD".EHI] DM&2!7IL9D'?H3<7^D:%6L>[ AEK8*VQHV>#X*ZQAB 8
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M%9Y!2%/ P[P+*CLX</#A@(4' CP,2&"A7(X.$_(N  ;  H0JUW!]()#A ;!
M"2ZPQM!@S8 )M7=%:>!!P0T:%P(\F'#@"[L#319(X%!<& (.$.0DT*!@B -"
MV1\XR* DO @&+C0@B,"@\8@* CY$(##! @M\H,!W"CAGC!4(3(!+!@4>  5L
M%K@#@1@$6!,3 <EA4. 5*GW0D08!2.  .PXT0,$ &&CP  <+W)$ ! P\,\(%
M!8!R7P,#CJ#  1XDX%T!R2!0@0.(C1!! 0RNP0 $+WZP@)&-.6   QN\N, -
M"5#0P&?^ .A1P@4"A#&@ Q!@0$]GT"WX  /@D?9# 0](  4$ E0V'W-08&!
M+Q6@]P%1'Q@@FAT'!K#2 Y^A!@$"O: V0@*"#& 2' -(\," %BQ@P4H9&&#!
MEA4\<$%C$$1 P0+1!== !P> 82H!$!QPQ@2D@%A 3PM<D, :"!RPTBI$2K#2
MKQ,@D,$!6#C VZ#%)=" ! ,6EP$ $2BP!CL*$(F D5!,8(Y['@C@9 *8_L"C
M&PIXP( #%-"# 6P#U+)' 1?D=RP&@""WDI(5T..CG _XH !J/EH!P;@0)*!
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M6 4V7_21"0-  0J@0"$'*H!2 P?&4U<@;RE8!"5'!/FG 1$ =2900CPS,LC
M/T! 943@55N0@SI#95-! K:2 GS^T8,141.#5X1&N ,Y: D:L0I&P11':!82
MD8.QD1;7L M;$1GCL (TH!BV<"O,L(5[L4W>,Q)> 868H!,!00)9.'@B<0T'
M=@V3(0DDH D<@ 1L\1!DX0RHD(>O) (YLP*O\ (B00@U:(<TX(1)$1"Y< I8
M0!";\!BA0 -CD L8$@H:00P6(0U/L0H!T8C(0 @C$1([ 117$1$Y@19HD1#Q
M(!--N () 11.&!)P< H.\1!N>!*;@!)+L8LJ"(P[$!PF (0G\"_!9SI/40=$
MD(0CT"945 0_R -6-(3!J 46D07-" /2.'C6N .;\HN740TRL $" &_>2$D.
M  #TLC/^"Q UO;B-Z"B/\TB/]6B/]XB.VHB/^\B/_<@#;N&/7("'Q<40 6F0
M!XF0]K@ @@B/O3@>'6$Z5+8 9K48YD"$-.!OQ,@#^MB&B/$"X!*.*" !)I&$
M1'@",N2)I; &C,A*O90V)S 5#E&--2(I@V<'5'8!S-$2,3$_9B%WPX,N&8!V
M75"2R1@#^I*22=F-=@A#,!F2/JB1ES"1)6 !DS1: S@"=I4"?2 #' D/HQ42
MAA2(8% !$K !&; +4F,2K& '6*D"&@ 3%B"+(Y !E<*172E'2JD".2@1-B%O
MF#!#A22(U# &"8F.N'27MD @$8@"-D "=I<"0**7E<0RA +^!CP  :73!0U
M%RQ2/$] 9?<TF22  8P) Q$S ?'004P0AH'"'0KP D!2('MP<(>1$ALG%J)E
MD&:R!0 &C(DY HA'+QZ  +8W4+B5 (+B=GYGDEL$G"GP>R) ;-LT &@U( N#
M<XZ"=VQ  (G7&!8@ (V')R8P#^[%D//Q>I0$CIBA0L!H 7( !010&4IS)H9I
MC>%$'YZ0 -/&.=,F&HRV 26"*::!5NA2 0U@)6QP8_,"5UTR<$?&F]NY 9 S
M"0-"#AHA=250!@^01$> # AJ#B"X!W5%1;EA5_!S&KG + -V$F>B"-*"(1X
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M>%(W3JJ5? .#)G\2  >@F8OQ._-2'6N'ID13*M>"&)C;0U";=-KE$42"/1_
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M:"J0 =CC)HO!V1:W6N:0.Y*B^CIW"O_%8)3?ABXN8EU+#$D7;-W2*J11"DW
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M=@H<L  &$*C7Z <.M*=<16^E)T$+"3#P(%<?,!" !PP48$$#/G5(@44D,*
M!0XX,*@'&BB@GI2@&74!!!P0,&,E/'Z@@ H(W%$ !9,RR%>*P:8JP00>#$"9
M?9;.D$%\"F1PP3>@7=# !/U H$(!,B2 P0,5<.1H# ,\YE$ $3!XVTZ.D8#!
MN$1)R^58VK9@9@/[I,K--MAL)(#^CQEL8 4$$O@H1ZJL3A I/D4P^<$!$Y%7
MLLE1?.8! 2)$H($%Q1QP !<+;&#;!P@P($$!"XUA!5V%/.<"!1L\8%L 4@IP
M 08"8/>! ?M4$&\Q\\V   ;G^=3;Q1C F %?V&A0XP$19"!# 9M2EN9<H&4
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MD[.J;B<),*0EHNH2 Z!R8@.=WI<.D) "<,8:%F#H_BP!O7505!Q3@( JBJ"
M%O"(&+3^5:!/L/2H WPDC(G:")6L0-8^VHQ["N$CKE3AF/TXRFIWG!63KL>
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MP .#]P!YVU$!#!C !DCK@ 21( , 8$ ]1E#$72; T _@0  :D"<)2KR!XS
M#SO9!33^!^ !R#(TK &/!0R@P'&JP 6LV*J=% !FBQ69:-K@FA\C/1-!@*4J
M3:.80&B@"*JT!0W*T@JN2'T#3V_%E*)I=># ,C9:L8OBZF*+M[#E,(XJ.X^O
M7@(-[&0V7*=!!S)P]=D(!>Y.V4#^U/$RD?-^@ )PXH<&FM:!O@.&+13S"G;L
M?G@7O#(#?6_4U59 @QU.@0/.*($J4F$+1DCD*5PG&PTJ#G<7^.0"$]"\YJ.C
M.*U#91X^\4 $P^43#$P! SX1T^$W4&"*%>4I)6#(=7 2^JY+*9I,P,#JO9 "
MCTC 'Q=(XEM$P 3-R4T$? ]$O5NA@0J$/J-\VY:P&X2:'!5>S"@H:*8E$)U?
M^60E.^% CJ8R)0DDQ# CF("'PK63'5:<3V2 ]F''GB3= 2)@ BI@&G" -2W@
M SJ1.CT=#5"1C4 "!&)@!FK@!H)!CW%@$WD@&F# X-G 4-3!YBG=!ZK@"K)@
M"[K@"\+^8 S*X S28 W:X WB8 [JX [R8 _ZX \"81 *X1 281$:X1$B81+J
M0@@J81/VX!VX0 %R@.])Q-54G'X\D^\-H-3IAW[,WO.IA.1MH20D'VIXREW8
M7D8YA5^4(%+<0EQ,G0N<X1N@H2W4 E7TCFK8A:.HH5U,!"BPW2K0P03^A@P2
MHA,B(A%J    $ "H@L1(@ $(P "T" $,P$:M3P 8@*<M4+9M5*S<C %<(JL8
M  # %U\H40%T2RLH   PP2-%B2@*P#+$S&*T  $4G2I.0:,EP  00 $HT!2T
M8@"L%UO-$KRAQ@ $@-810 #\3@!\F<3 "IA9U ?Y1 4<#H?^"( F6D(&" !\
M$8 N@8?$U$#'-($#D,P.^,]6W9&%D" ))( G_0"^K0'YV8 $S%(4*$>W%=0"
M=)H*T$@#'( ,C(5_@!D$- ^?X8VB*%L0;<X.3$ ^WD '^-426)4#R$$C'=T,
MD L6"%EUY)\0=&,[ @$4CI /[(XX>L0#H: -<,EP0$ @JF-W7$/1"6%5;( $
M ,"7X**%($< Y$M58(>V?<X,Z*0M?!<',*)Q$%$+;5')C8! E@(R1H"\P==B
M( /&D8 %    Z-(M5( K_DHQQ)L((-H'!   6 %Z%,)Y ( %<"4C<F7<N8 '
M--H4A&7JD>5;;@$(+2(%>( $!!K^#AR-5L#6%'3:-/F&!7R6HPS-*A'81@!
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M?1#_(:33((\X;HS6"28'1.NNR,#CS .7*L0E"FK,""NAV08$<,(FKDR/A@\
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MH6D<WP0/=SX.7,K!?WQF*<5)O#CB(F;  S" 4GK-6R+C 4"7O,7N,1G5-"A
M.P:J6+@L,L (ME&0%=' TCBC9AI 59Z*DBCG )0G!3AL20  JKRE9JZ *Q:"
MH8':%B@E!2B!ZBD$@6AJ?4Y +6PK0K@B5P[%L?SIMC:-5G6+,JP*9"#D6S(.
MFI9G06W^D[P%W6U$0%5.D3."!O*@94?)Q_N8F?9^T"O!K.:!4 0<C@#$9/R0
M "=!7U7P7*0QIUJ**%TF &4XP&*-8OAPPH"@9;V!D)MPI+'(FP*X#_M>!^,F
MCP\% #UTP;:4+W.IP 1<0%C>1CD90* VS;9>Q#2T4$1*T 4\3N#0I 96!0=P
M<141JM,\!%"BQF2BI9Q9$V+Y$T':;1U #J1=C=.FY;'IE LX9;4UBS$-$NMV
M1*\&0%HV2+;]9RA=JD=\B1J]R,:AQA@;0 &0W)R"D##=$?!,P06 AN!6!: :
M,AP7:ME@Q-(*LE)>$<VPTP=0HJE@9*L8ZN$<L&UD@*L80$+^D&.>'DX^;)C3
M8( "!3 A! DP?Q!G+( _<LT\W.[-(,/%D62H49TZ^TFO_HJ\F8I23H&^_9GX
MJM"O)D TTP6>FL7['--'K.4)3Q?.0<<J%4',<"7#@$:CT ?)E46C +%F^H0
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M'*2%C;L&[@4,5SBH"I3%,X^GZ*6%"1K_*I7%T_$-6_PG.5#,KUQ>Y;'%C8Y
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MN,')J@X5_J 0TLJ&TU5(KTH10ZF#A44<@D7"X-6DI0L\9^ZSJLGGV7R Z64
M($%/!P$%" CHTD!  @ 3/I0@,",1!@!BM268H '!AP<!$BE@H&& ) \!Y&H
MD#31!0,?()A^%2%!H@0E+Q$@B/D5ZKJ)9%<Z  '%:IM2%"P8MSJ( \D<P03(
MX,!$I [3C0=H#2:#YP//77FO-(%UV0\(=K12 (!!(@3A4RU(!B#9J@61)UD(
M/:D#@)P?5   52<48!LL![BG"@<+@&)! YAL,%T P 5FX0D3$*" !2@\X!X'
M (%XH'<+(*6 ! 6 U$ #$7CPF$7^G;%$V <"< B!"@#0 0"'*%#0  3;Q;9
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M,=,&4X'^D1]T2E8;N!Z0P1>_XH 3%%*T^\-A#<&#@4#/65J%!0LG@T$%-ED
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M5X"[;4 ")L" M8XP@!TUH (1T-XSIM, V_BN %4@  %*AP,;K&9W#MB >0+
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M>X9_8& #V44A-4CT#T_\N:703*"BVRL/C]9&QP98+0S;20#P#/" %L'.2@U
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MP $+(,%JTE6RL:4F=KU!A@9:<" ;A'9+IHG  W"[ 5:%XF83. @ 5L":)=_
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M)D8L\: 6K& E>G$2H5"@S->@5\&?#2H!_V43%5 2SZD2,03^=AJ:#:- +/)
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M X8I2N7XT@# KI./#$#P(,L! 6W^%23 :+!+P" )7TXM":/ X(*'#E#(2""
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M$K$RY"(+F,6MW!"PP?*WO_[][\,VP#D.M88!H2N1W!K 'PBP[@#%B #L[/<
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M9)7-4%@NB1Z(V4%:'41,U&%%B2;^;4;C (!G$][CK_R%9N+ !2@ !3R"8D9
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M#31)K$H+A0;(%JV"&]@"FYBK!VG T-Z=[$G= =2 55[+'8AAT^:9)[18"C3
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M#0(036CT80$!#@@0DIM"3Y*"!<(PA"(Q9;@'" :<P7)0E W^V U(8($&3L%
M 0E@4)0*O_SP00731: 0=TT8(. E;4WA0 ,4<<;!(/T@Q<$ "!Q   0:V-(=
M,0R<(QP9P'!W0Q&=$!-!!4AU@!%P%,0@PP(R%,%!  U(@("',#A@SATA!O(
M*47@0(%%&@R2P0,/U(/!($@E8,$E+ARPXI$-U&0++\1DF(,%,G1P 'L(2*
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M)7ZT0\D.5Y&*N1(T!-B DT1TIBI4"!=V$AA5GG7-UJV/6(.!0 (<T!<5#&*
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M, <0@8 +]F.%"41  CVX@"IL, ;KX2J\&&LDCX17N_Y6X XUUL"5L5*^#7A
M"38@\&&,(8&Z'%BS5IX S$:@HBJ8N9%CT8J C\.9_#8@3!/^2$Y/(Y0"#L@@
MQU4%,>BFP &.9(4(O%' '3!FOJ\EMY ]G  .@O#H4B6!(R&KPJ$Q;>*-I6 #
M1-@;=KJLB@Z8[EDB4$(*.G V%P@$?S*$6!$HX(2L!+K#$0)P#]IW@R"3RK?,
M;O85Y*%99S,[ K]J=@(,2 4'1#LF ' A;]TA[7!7H0,+$,"2Q8WN=!O!(G&&
MY %8J^YX0V"CO.WB^^)-(%/@>]_\-A#L^@W)#D!W:S6FTK)SX-UC3B'56RCD
MCJ_@ 4]WH> 03_?#]W/PK#W<< 2J[\:U]G$L>'SA(0\.%^I+@8'S4X4G5SC+
M6_YR JTCYHVIPL=Q8 ^52YOB(O?^,(.Q4W* "WT+ISUW%CZ> <X$787*U8#M
M.@[)I3^2 U#QP-/3K7,L=  '4A]Z%:C^=:^#/.M8Z($'NJX"?U^![,'Y[H%N
M[G:QV_P&9T?[V^..=;GC&P$),'J!"M7Q 1!@E+K4>[-G^,1_=,$!OMZ:RBH@
M@J73ZM#I1O-U#B2!??QZNIZ2-]N[4+<!D4YR6HA7( ?T&C!/X2UXST'U#H3/
MO]25"HB;.&]'02#)ELL"L^6"!*Z>!50!O"BM-WPD+Q" 55?  F>W0,$V]APF
MFZ_(:E1UI#4P ?@"$M[-<8'0A)O5',",$5[K %#"T!;E6J\'&^" #9Q>@6)I
MP.G8E=G^2:JR_K'$D ,J8>YQ/6!^)Y$A&& #U*4"&Y!TU.!TFZ-FP3%_%=8#
M'< 9%;-Z&V"!11 /.&>! L(PS$44X6-UXE=.&M #TT)Y7T6"0<,!+A4/MM-^
MQ!4<%H@# L<!KO0U;=$!*>@!*PB#(P@,=J)+!;0W!Y"#A<0!/3@Y, B )&AU
MR<$P3A@<=>=TQU$#WY!P)H&%-_" )W$I]*:%3KB% @<GRZ-_3MB C>)D1.A_
M\0 , .A^-5:#)J 112!Q3K=C'; "'I*%9=AS'6)U#7B$3H!=$*"'-[ J.WB&
M.6AVA;1UBB@\8+B(1P@,J\&'7X6%,_@UCW,P*O2'#C>%9+7^<F.!72N(94C1
MB1W1@+ S</-G=A:(73MX;"FH?VMX)79G? >B 4Q1,QH@ 6<1 +) 1AM1$ 4#
M!KC1%Q#@!MJP51(4 >_&=U8P$B$A"7F@(VH@  A0"]CH$5T6+ E@"S_ ,SKE
M  '  $]F!+"! +R3"$B"!AKF(85C1]V&).D1)5=1 "G >/5R#: T @T@'F/#
M(  0)6! !IWP5R)0&]%0>!40 -+A">!D"RPU 7H '1PPCYN3!M?37S42/H.!
M:U]Q5?(" 040 44"8R:#C7LQ!010 ':!709P1M<@#2=0 [Q3% ]@--KP$G&2
M'X:!(0K1 @@G (=A)+CA!6CT;AS^D@HK-91\MPH94 [,H@C T!Z"( $$P C5
M44A#P0"_T#8_P L>L!V )RC\06]B"07QMP]' 0>4L0%_4QM&9 %OH0#T4@ ,
M$ VK$9%STA\;\(L)X%C_110(<'DW<!8O40Q%X!%;(AA@0$3R8D09%Q,-P']M
MT8RUH&$!$&00<#=&4&U_42LNEB*212-NUI3A$R>Q@0$(P!=5LT ?LYI7,C_0
M@0-#>0E=8F8,(%(E\P5,8 L=(!!&4R3-4R\N  /:4% P PBK 6Y"(@%$Z(Q8
MTR@,\)P:<$9S1 H" #/OE@B7@#'7L "KD0RW&&YSD!X6\1;48 ,&@(U')##"
M0SH:<0'^A%([=^( :I-(]/51VY$@Z4%F9*(OK=,A\-,EJ/ +XS$ V1>>)ZD<
M)1 ^)L 5@!0+UCDI.: V.; @)A8M@I0>DQ,K!0 &.B4>MW <QZ(R">!M"0 .
M(N 1V3(%(ZH+!=0,SM&+7E 2644!5S$(+1(K<E,$SZ$V>W8!"I8#%*@+\N!2
M@-1%C)4#"?H(\[@&0L,9A@4'%B WSI0!Y;$&OE8B-G C J M.$ F0K,Q9),P
M&O ,=H-0&%"C3)(>%A !2!$;O- #@4%.1O06]848/= >G40P%Y  66IB;,$[
MS_(/./"4P!1I8: RS70)770P?_,']D %": N*F,=Z60#[1'^#1LSG@=6#1GQ
M4;?2% B2.+(P#.UR '_SFE@  0*0 /R894("61!:0&N00?VQ!KTC @< ;,.0
M1P_@"8"0$W&Z <UH%S?P$!! (:Z1J\H% !G3$K#5!YM82'1R RTA$QNC,J?!
M<D[V..1Q."V % EZ 6!J&!L ,]&!?W1H=8'!DPI )];"+C*A5JZ$'GE*GM)F
MGMN1 P>@G@)E.:0@ [-0,^)'*(TI0VH38/>F K 5%95"!*R) %3)&?(J+%,D
M,)^0?2TY ;F +37R "ZP .JR!/*".&_@ (Y3/B(R!//%$MFU/O?V"JJP._>B
M)NUR">RQ(2556AOC"$GY:^HR"T7^L40C6ST54&A)L@IAV2+<@49\,%*Q4A>'
M-H/G<@,ZU1(OF@8I,@5L<3C^@C44LCEA(!*HHBV<B10.]*,B(EL?H)U3,*:#
MH( "H  ),!U<>UD%<P<!M0!CYD)= 2=:I"N14K$X\U:N-[*LR0!NDA4% %!7
M @RZT#('@!L90UH+0!28"@^!,BB V4B%-P,E\!YDLE<?\23D 168<3COPPL"
M9TG-4ZA+T*)Y$ U'$;)6D+=%8%@%18@E0&TS &X<@@.QP!Y,PE<8,!.*XY^X
MR@0U2T_EP"-OL#L<Q"&J(&2UUY#BL9MT^"IQTCIP,KA6 *YR@4#<FPT#L$!Y
M,AH&H ;^@%J8@7!$]U2QQ- )88( :8$\FG,4@C$[F+JOS=8<YL=3<6H&-C!8
MM]$ PXA/ES >J>,&!TL,9-%W_.A!P8$.^D.M@_"<8>FBNV,YUS!'"B4"/!6V
M%Y0?;=&=W#$G<W4XU;%+]5 4241U5S$#%%A?/C4*OP2A<""!(J(RK]D5+AP1
MWFDW2/&<F9H>&5 ]%G WM.&54#(6!."ZDH4]-'."QN =[W8LP6'%#UH$^C:6
M:3(3.$2EK@(JQW&?_^ L.' .QGD-<4L_3F<+8X,683)F7]60<' !P>NW!2,)
M*U(.-E Q0[ QY&##'2$ /2 6!M"0"D VN!4(;W$T8* <UX#^?<)G%4_RJ'79
MPA; &L2Y'9: /?KT" T".&T8(:':Q3F (0VP=1HA7QXR+9W:+FVC0/]F!7VS
M=7!0 MUQ0?3$D)%7!";$!BB*)V_ $K;0 "[T"MGR !:1)6\;#?O!F<J<)EUC
M*Q"0?!_0D'W0O3@@ 1"C,F=4HH.<77)4 GA[OC2C%NL1"#/#R&YR.*:X,1)T
M"3B9 A_QM_3X+"JB!AW $[%B)[88P /B,?Y0)Y-\ S@)(.:7%8-P6JMZ.QP0
M*BEG J"RCR[U!WSW*F34=VN  W\C0PL4)E="=;UPR*FR J*;9R/U-5I!  MT
M2P# @K."C28P*&#K4S/5&E87 )S^,2UK, W $:AX4@"!$09)?0"T8&X_NDDD
M9@!4; +*?!X&@%BPP1S(YP+^6E\.( T<5%I+!&FQV@L_C2!'5!%?2TGO@1LP
M#<\E$A+,EP8A0T0S,#]>@ E@.P"-MP E!0A)E%WNJT3CDSK1 7C A">*D#L.
MB@ +8 @,\ 8V")B<L*J8"@'#D  IM$!INIH%Y85\=T]PLA.N<A;&P &!@AA,
M<ABBFQ>,41 ;D+(&4))UK*5M,@S4L+8WL O\P:#'@0FV>;?IR*BE=-57P"T'
M,-5)D H)PS/5\Q;0E=3+80)>40 >TD\R<$%&&05P<B;C'-"_@*_7[:NH,0BO
MVJ09  /^&? ^$Z!@/% 'C9T>>[&UI3+3 KF)A9+?EP0(. E9<,( .5T$>&O<
M(;( "6K([*$ >9, L?H&"OT>!SUT8.,!%+#;6@#3:4R$XG9V'#=W)E=?*\ R
MP.(((4XDDGUT',=U)G<2'H=='OXUZN)Q<0> *LXP)D0%O=SA+J<"#O=U R<
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M>'QT/)QX5&"47D.4<CS4C%CL.>A]6%[S]_O_ PPH< N' 1O^/ 3)($ 5"@X
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M!A($08!DQBQ@!@04>,#<6RDJT$  /^H#@ T)5(   >+-,D $)*Z%HD;N*2"
M.<%Y99-H&URV#$?D%$3 +0=00,!%DSG   8!?/./=Q-40($ G=!U@)\!] &
M>R=,]@",!!2 E"(>#+@ $02(]11]$W"EU0<2V#B0J:>BFJH*)$U@(P/6B%B
M.:]R8,#^!K+*, $OYI26P ($7'" #@5L@$ 2$PBY0 ($> 3<3&F@9Q2L5$ U
MP <*<$:19"FFX=(#O%1DP0$V7&"I(A T,"H!%D#PP 4PPAB:!044V@(#!0V5
M0%4I&,  !0R01.,'M>*41 ,4"?R! >]&B=X!J R54@7@RE &"HN=UDLUEU$T
MW@@<J5G1%Y2AT,"(2@&000,61## '@($:X,Y#23 R!:WFE,! \CN8"URD^K0
M  3@=' !6')DH, C*"#@0[H24"3# LU8>\:^*.A9! 8$)%&=KB*"A4 G&AD
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M 4Z$A_)BA8*)M'(V%'&7L7(HFY&534_M\D#-SN );5@" 5?;P=L4@Q+1U8A
MU=')G\S!B72%"PP:0 SC)("!M^U,!C@1P=02D(0J8;$(+0A/E08CQC-@B6:2
M<QXC.N;^1%)H3D0 R)N$=O B!VP/(/DQQP/,("X(,, EO*  1;!X@2^A@0KN
M,X>"Y"@'!0BI6#;08AE. L"3HG0@!S! !Q1P% 5T<"[Z*N,.=B<##   1P(P
M'6N*(I4/P&Q>H&E ?G36  _@2IUIP!6*,O.0TJ -:DJ($'H0T$("-FT[$RB
M8!@@AA3(<0=ERUL%:',MUV#H \T!A+Z"=1$9' "7"3 (*BJ0%I"@@ $MF)==
M>=&<#6B *8>K#H@$TT%"4D!'ZV@!]S03 4EIQ(7)48V-U!BK"60L X[Z0(]D
M8ZOD>.1'>?,>6Z354LXPD69&\:-)+& G92E! .B8 .LZX#+^_T EDH3+:V)<
MICEK+,^*"W@ !UIS0H%Z0 $2D(^2%%:TB.A(@,$PRQ80(S=7I :61$"#PLHB
M@2C!+@W&8!PQ?A! YW@D6$3 Y1AL,@*DW$)=MWM7%,] @8)L0+D%<98 [YL
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M>D #+L)CL8@@# C=0 2"F :Q<*7+#Z )CU4"!B94X*TIP$!BP"RT:Q#[(J.
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MPDQ$Q5!$9=#;!1B$&U*BNI #)'$%,92!1O!/6!T KRW@>"0 6WR2!>#4"?U
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M7>2U\JG^6!:[*($]R@8!N9%6T$W^D)P M83.MRI,Y'C)!JAL6,A-:;'&J#A
M62E!2E8%-XP!2N@ >TREA5GC/45J0PV,2\@@7%F"I3#EFH1!B@2+&;T=$YP&
M%2C!-'$1P I&4*;0.3CGK@!( AR"!F3NK/R ')&,W(A(7.P&VCQ8TH".;)3
M3 *8Q,9 2M(0VGP;B2C 102+SY*#%STR9D48M_##$:&+RN*5<V*KA=&91?X
M_VY$EX&+$PEL.[;B-40%CW6E6F$ ]8!L7\*H6B4&N  (!,/F#N!*#4 Q8[1D
M$SP,KHP7$)N!5G ;P-(9-D6-T(@?"J-4K: &$4P,\*6! ,6 UX'!=@&" J!N
M#X&3._G^AIKBB+9%QF\@Q F\"XR2 @V!TW)P51$<Q8FJCT^@C8 H238<0(U5
MUX:TP#F5!'UH,K(*@ *PU.<*D!?+TK4<-3),R/>D[@( 9@"@I4P;S4</!F R
MG!<)1YK@F3;\R1D80&V 1(MH8*V 9LY2A9ANS:]\P1M?0V,@@%P30XX0"Q1_
M14D7@,4R 0=K)#.QADNXS!8L1ZL@1;I:[N=.IPM=]D)0@'HP40KPR,60!A#U
M=+IV4%S0M6AL'!@0P%6@ PF+PYO1UU^(+BP10%SXR&'3"Y0N%(,HP+1>171E
M;LE4 \84P 4Q55' 21&0Q(B@*P201=X$MK@*H>_,W2]ALWC^/7&K+ P!"0O.
ME"YZ. "*"1;\HIB,O0904&Q#^]T"Y)T, $OL4-,6> Q5/("C?+8 [R7M/0!8
MA(/#ZL!>;,M@?,%O.@#7B*LN4>Q7),\OS;/;D,54V$<%7-2+4(1;.("6?(L2
M?$GT*HI>0 85.$M^P-B!D25'JTJ(H%X)"*/A35\(]N+ZI8 <!A =F@/]C*+\
MW0 A$@F1-($4<$":51<,) &,GP./;Z*3S:$2R!AP=,0@YF$D=MFVX2$>FD/F
M#*(^5$)DB &2NV*;W< &2"(M[2$S]E )1L94#HP4:,":?((4P/B3*X$JH.$9
M]O.D_D*YH%L >>%,W%<3\  MXD[^"7["'>0Y-KB!D^6!(O  )C"&#;SCP*A"
M,]#9P)3YH2>ZC>_ (MB!""RZB-1B25B/&&A0OW4J+H@"(*Q#$^!0U*F:#OSX
M#G@Y*69 $DQJ$:"9%WHA[F39"(B ?6("!10D^QG%"TB!;52AC?(SD*= EGW"
MP(S?"PY!QN*A&Q"8@(DICHD:D(_@I )6CL_$GI_#%8'BCW-/MT=&/ZL *C:$
MQ4F:Q1W$+*3[KF\ANLL "U88#IE#!ORCB2M"1?]?8^@BO_?>J6!<_S"AP/O?
M!@R  E 8PC]>U%Y#-C0IPO_4_.V#PZ.*!Y0JQG,\Q[]BJA!YQ^L?!W@"W>U[
MXYV\/@#^L@> N_Z=WYJ[;,IO(._AHLCO'YO;LZS_0#_FXPS,6XL/O*I )*YM
MF6UX >T!?=U-WZ[_3T.FRC]6'_6]7LU'AK!+(2]*XPV(VCF4^#]@7]??E-77
MGJJ,8']PGQ)8/=C?S G3>TI=@ !2^C2V?3\H>]:[W_^PO,T+?=HA6D+] U#,
M'W>YE"X.*LT0"_\YZ_:19.B-XU#0X^H.1'U0_=@7'G%-@6S-*T#X3HJ\5\_W
M RFO@J7R@X4\'NU88W>=RH",7F<;+G=U4 &87B[TCR %!#YLE0QPQS\X1, /
M'@^H2I0 LMXK OZ@3;SA@+L=@=%A@%T84G@3@9I2'"E2U!C^ !\3/,>MC< ;
M+<,7H,,@$MT=&#T3L (, (3D:A825CRYS<XC@@@6B.*JZ=ONCM2Q0,D82 0$
MOAWN=($9K .(2($]@$"Q?=6D?2C:497W1=QW81\WT9%S96G:3:U>)Z,QH8J5
MVHC$V6PFGF?L@Z&X-)N,!65H]%*7@$LUL5*?2\P%L?7</AL-9OGQ8#J6CN:2
MRB0[-' \/1H98QX7'2@<AHN#&WHC' -)/DD0 X,H=Q]8-1T710.@"1^-FR=4
M,8P>!A$]'@XJD"@79A8:'1P8J:8<O3X7,1UQ?("U8RER+JT/7P=T=1HQ47IC
M,0T0=;1#Q 8<45.$@$2+>A\+$\3^5 BK%M&F(QJYD!IC&1FE']9P6=$$%2 X
M\&#!1:A.$C3U@&!@@0\*3CQDV$!#0P5%*"KPH>*!PHE$BRJL@J3N0P,&7U)@
MF,"# P<+!6ME.) LI<V;.'/JW,DSIP4"Z%@6P !@@@, $!I(L## 0X$/#AY@
M&*#! H &="8X-%!!PE,"!R (^""!:X )$U!N$-#AP ,+ C9<&! !@,,#$W+L
M;! A X"!/0PP@" !P04/!""X18R@; $&,R$0>""A5 ()'PQL6/! \0<% PS7
MD4%@#0P#%A8,#-!@02D&""  Z+! *=L>JB6@+!"C<X< #_!6H$L V ;!!IPI
M X!@P@#^N0,:%)" P:&' QH&*#A (($" Q\L*(!02H* !@0D=!!P &./"V-3
M+%"00!;[!4 G/ [ (\&" EH 4$ E=82V'0./H9. ?^N=H%H/"2# 0"D8%""=
M!A$0P !X%AS0V@OG'6"!7PTDD\$H"@2@30KU?6#A!Q (),$# (P(  ,*.*3!
M8PM^("()"G2@74U>5'"  P1L0 $"Z'F0S@0"(,D# P<<($!-5#Y0VEK2F? 4
M!P2(0X*%21*%@'L^BG/< PE0%( #$<)(P%&8U7? 1 (8H  ,",#I$ HN)$"
M 8VA(R$ &CA0@%@S%#5! @]0 N@'#'A1FP:L26C2 0@\E0'^ PX@0-8  VCC
M HD1G%> 0\U98("B*P9V@0.*K*5  09X($ !".SH #0?(+# @P0@\%VH!\C@
ME@%%" "; L$6@"8*2#8P  89L)88I0@@<&5/X(8K[K@X::"A%1P@4(&H'("7
M@01S=0">7!0\1P&T/5#@T Z2?3:!CQ<80(,%0*@UBAHGIO;O21@0D,$%R>+D
M@@/::/:% 6XM   &2=4@L#Y#??  2N9F4,!U#6@ 36E3::  2CW I1%M"U@D
MP!IU&)#!-RYRH$#*A_50@ .%M*+( Q&<9(H%$D#+60\94""R/BD4P$<$$G#
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MI14N0!H#VO "+PQ&=#Y[@)Z@%@!%:  "&N#,=_S%@'^!YY '2)>Q:&<!45'
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MV"XNG# "8: -!<#$U<]88"H=F$QV)!#8#3S@=RB!U*1")3+0-?)-'ICD#%\
ME)HFJ[9*_89+D^F9='Y&&Q-8PJD", -\2*L#YE3$ <#ZKP+D[REHF8 7A!"
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M8T"4',5:X74EZ50W># 63>4B&2 E&Z@! . D\2:0O<4?-.(!3&(F;1%> *
MQR$JS-9?%98!ZM8#$4!> _D N3, D%$C!T!>B44!,Y8G%8 HBD(I"L !1?$
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M,!7 K8DRIO[Q AWD$"@T&@;[6TP;)^H\IDP=Q% MP![ ;>&1"35" IL!.AF
M)E^;+'$,.GZ4.YWD%]<1U2:QQU3@UAYL?(%L5D)2  7@+.%!  W ++75('X+
MV=+#M$C"C@>@D&[T!?\H:;(@U"X"5@?M0.'1!8DQ/>M" D%&V0GP')DKP&XS
MI1;W JS!+)3APJ[AE4/&)+5DL"S^8"$FYA2NX76=    ]1@B":F[#<X>M0#U
M)3+*#163]!A.40<",$PEMS\5,QX!H%CX(AB'=#)S84R(41,1D&=U(9[72P.
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M.34,%P Q!TE8G@ *!(#*  @$4 \ C 0 RP@3!#   1\@4, !KW$00 %]>4!
MBQ!44 !M!1$W@ $ C"(  .B,H($ !0S 07<#7"#  0!T-H&0\@AIER4") "
M/(0<,  & @ 1  8%&!"  AIB0X$  LB#  ($&/ B  :<(($O!R19X@4HXL6C
M Q8$0( $6'[P805J L! BTL0 $#^980@X,D"  # D@0 \/8; +X<64  &C0
M@ "2?-"G,0H,\$T!9:(B@!$:%@ 4CP98X"A*!1 @D 0("  -"1<X>H$$!WS)
M@H8#<.(HB'4 H $#"%QI! ,#*-"#!0DX<.$'% 0@P ,P?9+ !I0Y&T$ P51@
M  $7>## ! :XJ0  AS5'  )L+* F6@/ J4P&ZKJY:$4,U-4I BP04,&F\B0
M+QN$&H"+! U8\, %!%Q2F08&%."O70\@T"NA#QQ0 !!I*G/! 1$((,>AN(K
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MIP$T<(!@DH JT8S? :ZY 0DP8 +UX)(Q)R"XDSF )@@X#(285 6=W@45Q^+
MHI01Q$N.@$MFTY^38D>!TD4  1;0)?,6<+R8=8(1"N7-+QM K6.=0((**$E5
M%  - QBU S^]#Q<[M8GC-0 ""." =@+@+KS)HZXFZDP%DH6)648#7<8(QB:0
MY@UH1JS^!KSA0 ,64(@&-"",FCSE6O8YJ/>9-!OV-*,]T(0W.5P@ <DKR4>/
M)*4.[- 8G4G *-CHV4[,L $$0!P!'F<@$L $"+SCXBWUM $!;""DI7-B!!*@
MQJ/-\0-Z^L!R>J?$$EWC! _4)%,54!GO1&,.$2B1S*Z:.FNXJ97&: !,$I"
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M"M(\8%4(N"FBDLY&!2(0 3)1,'6V-=%:)9"\SX*R *2#6 ." QD4T$;<'5+
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M@H(LXL=26$4G@IA PN,Q;D4]JD'^(JC!@%2!1%JB)=H. WQ!'_@3%F@D#E!
M#)H$O) !1S*B19ZDC9F 9;G ]H6C$*!D.N@**!)B_1C"/Y4D3%X!3N:D%>PD
M3_XD4 :E4 ZE&_BD&.RD1^HD42XE4S:E4X;!8_0$"]"(#F3 )\B6)YKD$#Q
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M4N2!'!!.A,#:,11AN^R'=K7#E,J  PB "! 8THV"!L2G A2@ )2+ Q!#'KR
M0EB&WJ# F4%7'+)0,^C.BP5G;?BK.D;2I\PG8O1<G767!"$7B"V  WB !4 #
M[#G2"Y8(!5R@8\W9=IV*F UI%@2'V1@HMT#-\3B0EJU(RVT**''I#%:(:Q#)
MPA"$K/SF@VG) <3GHQ0 -E!)Y=U%P%!#NM2% ]0%/870F=4%/=27YSB G0$?
M!:C1_[&$%GE 'NA*Y6).;61/NX7#UD0 3%P 3$Q%?/7%$D' DL68*AR&2@)
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MD$58?\I  506^S:?_I68!&WHGZ"""OD16B#*-/R7E\3T$4:S-S"<J[V*DLC
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MXL6,&SM^#%FD!0 $^!$@\.&2T9K^N#X(^.E1 H![!P!DP "@# 8!=$-9*&"
MS#S8!#"4(%#D@P,#"(@A(3#%"(<$!9:50!"!!(8#I'PI&+ CLO3IU*M;OXX]
MN\G) #9PH&QB'P8T5S+(M5UG[1$,MCK8W;CWPP(!\D_EI?I!=  .'0  Z) !
M91YLT!U'"1Q P0/F!;  1"/(!T 1%0R0P0 ]*%"  P4F(T $ ZCA 00 Q/#!
MAQ4  (HP(CZH78LNO@ACC#+.^)$% LB"6@$?(/  :@L H ("!A2 X@<&#$#
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M!0C !OPPTYDYA>L&?<M-SI1"QC@@ 39.(-$*>!QQBD4@!/3^1P%@JT &@#,
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M@>0 =@!0)/"$&" )VP!8D5A6ZP9.C$ /%B /W/-H+A8M34#^#!=W,2L (@6
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M66=A^!!^]X1WQ!"2\Z4):_*,6\*7 452N@D;1A$@98!U\U8HR8%SER%ANP:
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M(546)"&X(<6HK>&Z((&Y -]9EY1 [*[O(,&[6. =;8XTD[%3[)I(0L8[ZC<
MF[(%WX$"$M.UER4DGM)L/>TMP_U!>T0HC:2RRSX =:-GWA(;+S,GW=,:HE$
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M00H=\%0="5L>DZIAB81U0 &8-  9 IOR]X$! U"53PYU?4 !7@(D(($"610
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M0GH@,"]I2UL&S8@9AUBR@@3D8U .F$<%7(H$$N!H#PZ D0\>LP CC/='#X#
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MB9PRT@8JIL\>-$C$;LHTF ./AL/^, DDQM" TTP5PTIL: HB0RC&P3!*=[C
MZM32:XB" &!$"P45$I3-'#A<(EQ3=TZ.S:A2!;!6UP&( @ %4 R ")0&&;B/
M4F%KJ>::$CS9EZGK7" C4%35$NQ(Z& <7I20)CRMZ&1&H47/M01<@/04OC#I
M,%C)*+S ). %(C&)%&C3W,P 85SN991G]XR"WQ*7J43/ ]1GZNP&!K"6J+#,
M,%PL']S)R12'>JB7^VB59]A+0-Y(S#:!:CG<66P ;Q*+%O&0.@VL7FV FN@)
MPF(,ZS11! C')WF&:"0:-%R  &G.8[@ X:@?Y#(),A7#?/;0/%3-T@D OAG
MN;89_I#^P-?]$MXX 'Y $'%Q<&Q.QTDY@(;AK,D<2KYRP'KP\* \ .THG!'$
M@R_&B&!8DBZ<Q8D)00T;3 J04\ E ')<<6#4 3,QA9%V1]9B5"#NZ&L0"=*A
M3C$FA]J6;3J<+0%8:?1P'LQ 0*3 [10D!8VNA%5 @%UY3A:,#1Y" S:0<=#D
M3@1XQ']P((^>9LT=KH+@SM3H"@)8Z82% Y5H@ !L*6P(4@TXP+-T7:*%)L]H
M+C@E"\QT@@($4RWU4\8\!& NXQ1L"#"H1XAJ@!O]C*-2P*V84QUL[64VT [K
M00G%1R3X(I_84T\JCZ3A!C#F3\A('82 SP1PD,!,K1O\1XW^6$(68\)( 0B5
M[H4>\(=TY!,?P(4HY#$RS:H240-FBH)JX:%2>,;:*L6MX #>6(!@*)'-6/-)
MY4C?V,(']U !<*E@X(6"'*N0C6@'^-2E,'%.L)86,327-NX$X]"\"0(F$5,K
M60*R1$\8E)I2D9/,'I(T0 @/[08%1%,W .HT=-7(\,%VZ((T1&1 PDWPK=PZ
MI4.\T4^ "-<Z9MNPO,!#%0=!5332;!4\3@U.N !@2(DNZ*'\YL^?,-%6/<)_
M- W&#,-)?-"%%<!4X, S7?'X9FP;6,K +8X;ZB@6KHOH'H$(N!$#0 8FH?&Z
M= ?&=+0Y3P._)0G"EHTZ,$$B"4'^PZ9) S!=!;S<$1!+2 B":-CO'D'R"U"F
M)=#-2TPU)>.LD\R%7,CI2=CN5*0 ]0A2*;'5]<I,7K#RI05Q_)Y,)8"N$P3H
M10C! R";CW03MK(F!X009-32P!7SE8V!';7!0R" 661!(3NS)#,I(@."QDS5
MSXA !$AWBK (!I#<.@B,R$R5L%S:]0J)P=R5*AV!.4V+/"1)(820&AO03^D1
M3/E7.N0301$'"8S7S#B"!"A.C%2 0N_1B70'CO0O29N3J%7I#[QVTBC!"61
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MZ0C\H(/!.!D(^,$!9S'SCR/_?3& 1R1DJ1@E&PA @0,.7 ! !B#5:@$$C@'
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ME0%LX  72)\"7K4  G! "LYP&0$:,,&^$:4:$T @[XAB,F<<@ $(Z, #!B"
M#8"E,9QAEP'LL#H=0 V!\"' ,P!0  \\X''=FU4E-/8%#TP@+!#PB 4F )8.
MU! E4UO?!"9@  HH8"1]J O+'O<![&P  4S:6QT*MBL%:& J7P"? ^UB@9<Q
M<32&2<M'YH,!#T  :QS< ,^,F*HO4. 5!-"="\"W@+I P \-\  ""A<# L#$
M$)FSQ<QZ\@\[,.9)^M/! 00#/KO^7$ 1]?%9&_Y6 0\HP#7]29GZ"%"<JA5@
M I[4R&KJ^(& /:8"%&C#YNC1+V<0Y93N<P '&E8!+\#M5%X#6TX"H(T?:
M!C#  0!0FZ!L((^"8 U0.' L03'@AU=9XDC\(A;$\*!/%P#7LI:0.PX(0)!>
MB"0+#M#)F5Q $)D[G04&%16UA0L9+&" # # P:FY+R<MU($@4)8"@:U  771
M00#8,Q)\B0\FN^E8 6XFQ-5YY3@H\1,*VE;%G#!,4.OIF >&I@-NZLV6>JE
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M2(KKD51W>*B1  2 ?96<_'*2'_E53N;ZF%B$" X(E]C$[0P K+F.:UG1B*
M\"0(=(O0TL8 T5 2H+!4>(LF^C:JKO*D:*@O7#F9  !D4U;&/>#GN7-X?P?0
M,0<LG6N+A=(.$K84"O%<4$5G1M1EX]F@CH2:*A-!M<.C@3;HZF>B"?"I/,+Q
M!QQ#BPC^P,M)17P5+>=J;YF!K* @D 82+,R %B/:3=UWOZ8,8$A'QW7#_M:!
M?]N!J!88+@3"TN><[,L938UFKH@R3O<A&N$0.D!M!%.(5N+$,8V; 8"QP*\%
ML#)YP_-(!I'ZU[FJ;>>DML1IG<.XK)P:.;@9@7TN\)^[MG<R2W# $%=  >.W
M)P+WNW5_&N""V/Y) =Q/0=UFVDO&<6$!1//  IZ _@,N0%\F@MP7D"<:U,%'
M 29D&M/+Y_%!U65J:=(!;--=.@ <(V N%#!1"[ :&/,A=((4X2<! Q<XAI!8
MR^)A4;(]^%=%;8,:P/%<;-9*K#0!;.4%IZ9</-  W^41',#^!EBT6U4T,?E#
M P@ 0AH@-N&"%&5C3*&#$F07/(*A,EB@>BE0/E5C(@DS @ T$RCQ!&;F9 OP
M'RPX.J(C)X_')WT4#!G4-UX20G*"4'IQ9TA5 EVS TU# 6,40L!R*L' /3M!
M T$1'IVS<WGT #'G$0\0,?GS)&E&5GTC&WW#/:W$6RPP!8_A.0HP%I#!%/Z3
M &1@<YD#$P-10A!@ "F1@W$F*$\D&#8G-!4S%0X@ C('6=6F9D$A;O- %),C
M.Y"%!7J!?PL@&]KQ&#G!702P<6$A4TJX Q/6:OGV"DAQ 1]4-0Z0&Y+S)'##
M+;LQ  :A1D.!,W[D%1G0-F$7?-;^R#4/@ &M=XV4H$LL<(G<^ C)0!+,X U)
M\ D7 0O6P M%4XT]5!3]  ?\50U   >Z,(]+4 U.H0PL ! QTH\'$0W*P 3J
MZ .U8"+G86'%5 <H,!"@@@+%5$P'^8X^,"3]P0P+>9%R<I$[,ACTV)#L.!@A
MV0OC" 7X&(Z*P8_]B!,&<1'QP!?+D!A.9BHH@#4H>9,X201!DI,\V9,^^9-
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M<$YC'   @!H4,,\$8%9T!L6F/!@#0!2K &QLHUXYL3D<L!VX<49XF@J&RC4
M-9014!=A9A=U42$<T#LL8%QOA@)B%I5!,72+ $$#, :/IWJ,L#/7PZ,?4CBM
M=!R"4 $2<*YH8KY\XB<[]CIGU)YBX='L41>-)G$1X!&"@!7B!TPCQ2((QP(X
MV!@8  !#,F.@DZ.JZ 5YEX1Z(8B-H)E'T%@JNZ9<,57H8$[O) +\<F%WD4UH
M+"=]5JC^*W&CI_(D7L%#,U$!@O!.'R$!VN#* 3T\$K !8SD6H0L&P9@39+8>
M/34[<QD4!.H"><=1S[(  1*'5?-R!: !%E 7-6O/0MPZ.<"@CJ,#'>VOX0(
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M('T"0X#-7G?S_@!VA((!C D$V/" P <*!,0J$/ @P8 L$ 84X, A (0"<@\
M>("B0X L&@!@T"B@ZD;,!08,*$^W@_ '!SH  " QD(8#)R8H.-&@  (DF"3!
M PA X $"!"C@ 0,F&-## AI<H%T,#20PWPD+ -!@ MI!P0!)3USH'0H;A<8
M A'^H\#^<15(<$ 6$B!P@& (]'$ ,BF^=<$"#O3'8P0+2E#5!P[DY,$"#S!@
MP0<<.-  B D$Y8$#%C#@@ ,98#G"!%!FP<"0$C$ @!422+2! 3, !::*&330
M@$060/#  CG=QF(!&CP018.^!2;%! [$%H$&#4S 0 L<P/G@!Y5)I"4"3/X
MP (4'' H!?LQ<%^)'DP  01UDK  !(Q" &=LEW:R 0#]5>; "(HN(!P$%D!I
M0F<D5I"D#$H*UANP_4P @ '<>1<9 0YP $ '%F( @ 41 $ 8!!L4]^0' $CP
M; 8+$& G?31X$$ &H=)W 0702E G 60!, %]'SP 4@$X";+^[ $(!!## JI
MZ8$ 3!+0@ <)5(7  Q,$U=T'!DQ@  <4=:"  1>HP<%*#PCZ7,,=@+1 58@6
M$^H'!U3EP&PH.+?L!$IJ9$*>"EQP ),(:%!! ;LD(%$">TW[)&$_6"9# %4*
M\ $#F28@@28?6*# PQT< #%B&,@%@7X(*+#! !M,H-\)%R WK-<.5"! L_T1
MT%%A&0B  0-#=T  #@%T &O)'$30R6O%^)@<HN]6@-(!#V00WM=(1^#! -NZ
MH.VS$V0P0 <6",JB% 9TD&X%6'Y 0 05 & <2@C< , %$/0W@ 4:]%=@PZCH
M-X!+.YO!8 ,<D,7 !; O8%NPP<O^(_J;@GGPY@!5#9!=:@!P0,'1!DB0[@(&
M*$!?"_LZ #9/X<E 'HH4#!#!LW@T,*M^ < +@&_L-_ K?@]B $& U8EHQ@D'
M1"R7B%UB4,"2%" 6!"1H P;+2)H\ *H.248N$Y*2%(;T@9R=8#DHJ YC8D,6
M6TUG PL(@"HH BH")$5/$2B !2K0'Q5^P&85X-3<6H" #'  5 ;Z')4DT*4B
M'0M,E\K.!(.2  Q8P#,G*, &&C" SEC@ 8*Y@ +.QK0#9$DB%4#."2R5/SV-
MP"4*6,#70A.%5,2& 1G0#P=> S:S??%0"9#:'P20F@"UL%"!J5[FY*6?#41@
M72>8H0/^P&2@"@3(8QUPR(LDX(#&!(@#^BE,HYZTM'E-C $=H4 !'  &X7&2
M'F#9Q8NX=C(!Z"<OSYN- 6K%$0<<R'GTF9]POB, "! R-PJP6<7*YRT.%,L#
MVLI+^Y!6%0QT)"O\RP!(6E.!!%0@92[Q6 N^]I+1.&!M%T" !SIP$040R05I
M0IAOTC0?_4$@ ZZ35*.4EP4.1,>;>)!+H-!T 0[D"3-19.<&./" I.SL U&,
M@%R6V2@&+*"8,K ? C"@  FXR3NI"% $3N:="L IA M@7$<2RD)/T E1,T):
M4'@$/0Y 9ENA40X**L _ QAG!-5)@* :0*(BD65O&6ADI$#^XIN9Q4E9_%/9
M!:#X1PV L0-[DT)UY%,#'7IFAN][P014>M TDJX&65HI29BDR!X] 5$6R "+
MOI !!@1E,IT\JSFB()M<8,P  ^@/?025E\T%8()B D  +$ ?#KQ2=*NI 0$$
M((#&M$0 PGE6#0&0@ 0!!H1UE0#[P-*EH_V!59M87J,(()\-B.\$9_#-*9;8
MPME(2S,F>X!P$(- #W#S81#37)H<X+ $)$5T$Y!  5[438W@86P+H.>GPE,;
M#@C 20R(2RX,UDPS!70U!M"I"P+PQ?X8P%"9O 4 !'6J(E5%=;RD7X#HTD(J
M!.P[E"H92KA)@@!],0(!B]8'FBG^A9-XJT@+&%/E4BD C+CM >>Y:9/DD@!2
MA><"TBO  WCYAPOQQ[,9 *N,NCE!?>[1.P?HT>@B@ #<7B O!2K=UA0 7G\N
M0 &Y(4"FAD28" S8# ^+P,,F\)J'H;7&[/C%0SB@$#"T00Z>2(,7HI 3ZTQ%
M,U+HB2>$H($6:$ SZY1!&]+0 3M)H0H8R,476H ,+Z!@ _-T08]Y@H'R_(#*
M3Y#!F#M0'AI804)O>8(<*O#F"D3! MEDTLW04+DD2 =^7I#<5[]P"ST<@%.W
M,("+A.Q$<U8P"QGH 09B\.@F.;'.(UA"?-$9&SBT  /K+&:@\"P>@\J@5DQ2
MH 4L1H+^+/TA=:GAP*DS P$)?%E+07G>'SHP@:">P F=RY04*."!,=^B!QZ
M,17BZX!,:2 #GQ*R1#3@  EX0H<Q<(*$:I"P*&#  4'YP 4:T)$-:-K&YG:'
M7W5S;E9L@ !T_$>:!#$! ?QUW?:^][W5C>^^9,+,-1A$1,R:$5CH.QR]*/C
M]ZWPA3.\X0Y_.,0C+O&)4[SB%K\XQC.N\8USO.,>_SC(0R[RD;>B WP%!%\,
MH9:3"T(MA<##,611E"@(G.3PV$#-;:[S/[BM/I;)':LZLAGNX%4!*7]" 'XJ
MB )(Q 'J9L F'*:+/R! Z?$]@&JPTI=R0^+@12*U(0A9 R;^,6"3BN@ ;!RA
M 0),"1;SM,$BP* 8F^SB4_^@;0-LLPMS>@!#6E\$PETPF*,K0C$411HR</Y&
M0 3^'W)' 054\8M@V$H*NQH$K(O4E R]N;()V,7D5<Z(M!MD #:R[;.63":L
MN/P':ME% ; NK?[<0@@-\%[KL\F3V)T-S#DW0(/$EA.8:R8*QA^"\9,O@\<(
M_@\4T)P,+D8!J?[]!!FPNE'H#IBV:]W(6L^ 8!Y0%4B*/H*2]\5^'A"3QB>\
M$ .8IX0-@;]+'+5$6@(>"E#E]$^P_P-#',4U^8;_]0"(7(+5 (*<($*#H8#E
M5%^OD<6 28'(#$)>D)XE](+8> 7^V9P  YP$L63 AA1 ?[P$@$S01AB4@IS
M7T   9P"P&@+6!A FES ;'Q$PT2  P# ?%P6L D"C>1/#V2'_LQ,)CG 8B&-
M#.J3*JR-/UU MRP-7&R"&LQ- *Q  928FB6 !<#3 O03"B0  "S.<274D<7-
MUC!(%_;$ 72@!2P6%/0(J0 &TT2!V/E'5;C-E&%&@]B% 37 ]GP;"F#-&W&
M A3B%ZI/HR  ;1W9?2E :/B)=WA0!_92!EP(DY#*[T   R@ 6"4 7QQ&X7Q
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M%  %H!,S-HL%,*,&(,9X3( I&$?^G5P(7#1,4.0)F&! <K**Y1@18%2+)R9
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M:SKB$Z"+*D0 V2J,9U";S<1&WD$75^@. #@'\2)1 /2 ?G!I !  +\5?@@P
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M02@)!R#^;/*7X,*! PL*_"I 1H6#, E$%%N H(,@#P50I- P0-"O"<HB &"
M 2F# @D:$. 0Q4$""&$Z")B %!2%)1D*D$U*X,'0#S[@=&C[( &&#%<=%  +
MQ1^%KQ(,,!# Z<$'&1H,9(7@0< O963S99#S ($$5@T,I5"@BH"'K0CV!'6
M( )0!Z_.+1"0;X\!50(V%,AP[\,?"I$(6-@ VP#!'!+<TIN0X$%M"0 >T*,
MX$)C"0H^Z94PP'*' LA=,$A>.Y8$!WP?,%!&O$!A#1<08=P@:*33%)7U,!@
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M8%L2#$"0@9.K?(?! UP8:< &OB(P0;4?1#E(@P^VZ8!<O'R*6*]M.?'.*XU
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MU <\5 H.*@8"*8$" @"P@0H40S<$\= $",@ 0=Y@$W/SP/ER4+((,K,@[*#
M I713B"DR"6@2%$$(A U,.Q/-[S^"@#*6C9 C7' -@= TZ4H@"5[6: P$NR
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M48+9&^P8(RAU!@(<4#$%9J !2?"7!6IS@ D\,%3M.4$I-MC (EIFA!040@+
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MFU919F"A  * !H5X :^1$!40 +08%#6"H<T( *80  . !A(1 (M9KB\Q  8
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M)D+*/@[2JB/+"[W<"@8&%?U:E5;A&3(1%7( "$S]"11@K4=& P4    P.&?
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M2 #@@H_^M>\#!L@"QS*0J7U:P%5M:=L#_O8!!V1HE4E#@0$P(*0*N$HNH*K
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MX0<X.&?//*!#$Y"S?[Y9)\ )]$;![!WV8G+/CF+5 H)X 0:L-<T&X,^R&Y:
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MI)/FXIQ#%#"-R(B1! @H> -*9^JK!L\%$Z!3!I'P0?6^X"-S41FSTI 5NG:
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MV62!-OQ5)CK@IS 9%KR:43D8!0Q6GN&#&Z@($G'/XI 0YQ31 '"#&@Z  VA
M)0G #/C+!7!-L[2-*QR) QJ!*RU  +2!"SP%"4"($414V$B44+". NQ3)$H1
M D#!QS&7V/S/\.U@VS#"JQE GJFA&TR8*XW/Z]2C#T&1&S2 ^@1 ?* AW4Q
M,ZV0[ %>M2C  ,@!VVF2/#*$B@0* ;B!N7U'K@!*K2T;B/W/-;T=F(B<Z=C
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M.,FS@(5]+55]4"<2:%9C8@&Q"*A]Z8%SZ & +()FFLSX(.<O2$HN@$QL2J9
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M<C0. >08 + ?(<X(!714,'WBE>6"BC[ )O35I D# LC"WRRI+KB08%';"&Q
M42E?XQPD!0G"#<X" !A# U5"5^F,/@2.H&)KMFKKMH:I>:4#$6YA)>G5<7)
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M/(W).A#8/D&)47S4@4$/?B6:%5#ET:)LKLI2:=6K5S3C?R776_52^&1>C6#
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M01T&Z&#)?XY58(@.!?UUVD-42,#" Z<Q8U47#&Q P0\J?(" $ [0!]$&%G3
M%%(F/# ,"M(<H% PW540EUU26.$+, ]@L<4%$D#P@ 1+="*!?A9H89$$D$TQ
M8@,+G"1!@2:<9T%.7?C"U@ M;I#-!YVHP(%=!-S3"V .=#!F!P50@)P&$]33
M1$+3% #.&!) = (&M3! D4> !BKHH(3" L '!@R30&$ -%  , 1$VDH"=5P
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M0'TI$,+^=8:@O0R8Q 1G(>$"&>B!# 20 \_R%Q6>I8&S# $E)=C LS($D30
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M!Z7\76E\Y^L1 D- 9=GA)Z<\4HCP_0=OOAWK! )0@'$@ !^/,  #B@4*6DW
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MAR>(: H_8X4M5%IO#"3/2=HH1<B3*@$!G$P:#R'#Y0A0Q7')H1-" !==++*
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M\0*#]Z@,)L ,8^(5<Q4#@$$(&?!@*X8HEF4"(-<9:O" 7TC^"<O@7#L!#8K
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M"%\-@!;^B78#"[ (!/ ?&@ 3L%@ PQD3<D@(%] !(<$$KQ-KJ4DYGU$K.FH
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M:V7B"A5@KF;P&MDQ-7XRIV#"(G]Q@,DS$G.S ,]2*K)@#W1G"D>1'0@@>3X
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M(7Y$T&C^89%S9!$ ^]&V/E((&9XBIG$#AZ@-6# !$:#7=J0L#VHS4W,R.J$
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MX&K!. P]$ JDL07YL'0%,0.XD'RO04&4L!)W0X2"TP,D&_?(D1UD,139\(=
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C.RVUU5I[+;;9:KLMM]UZ^RVXX8H[+KGEFGLNNNFJBV ( #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>g160222nk03i002.gif
<DESCRIPTION>G160222NK03I002.GIF
<TEXT>
begin 644 g160222nk03i002.gif
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M/F PK1DR@0\-(#,H(2$R IV0O^8M\*$"@-LE"NS]^A4R;Z#( 36(/-1RB00
M*ICP2O(#4@"%2W" O%4U@-D?)GPMT/Q!B0-V!U@54-%?7GR:%WRPA^#X"05H
M 1 8@,"#9JOJ#5 1 ?KMQ]T'60'^D)I N554V0 -_&7>"EX)L! $D3D '0 -
M>$>450=>P!R ">@T8@$#I';=@A%\E9H&8"FPP $"S.5;4B48,%<""61F60,3
M)B>D'C!>A:!F%4$G77  ;-1!5$29T$%N:GG6X0<'!-">!0J>!Q@+'ICVDGX
M4%!"?2ML8)<)'OR%T0<$"/!4ES!^59%X  1 CFDD7%! B2IXYM5D'ZAI0#ZK
MO28H5P"4Z!EP)ZAYY0DM1D9"971^EP(%+MHCW D(-#GDJ'HL1RA ]B@Y'YP
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MX:*"&:7?\M4&>>0FJ"FG"9KM@L)0N!G 1F!T@?.UR (8<L@%"':C@RP%+ E
MCX7B I@.-(!T:8$1;S8P "UUIGPI4-/I3" >QP2  03P %A,!)X3^$8L?!'
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MZW@JT-\NQ),8Z'1HIMY1B]\"X)WN0,?2P.%43TQ7@N44$CRA@B?=2*O:*0G
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M"X"7Q:D R;.6O0.6Q?F&$;1DAW, &'@ TGD ";  X7, B".=B#.=VHDX<H$
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M/-*?AON>ATN?_XF?_LFX ?JXCANY^XFXBEN? IJX\6F=R8, .FJ-#! ^"L
MU(D[Q2F=NJ=_!A"ZX-F7?FF:"_":HLNRR$F98+N:76F[7.N5L,FULHF:8&N;
M)EJA7UN;K0F8E*F:8RF94#NA.+J7=/F\T!N]TCN]U$N7MZD%$=$1*V&J2&D2
M7D25LKJ]2=FOX&N4*/&JIIJ4PSJJ60FPZLN^[TNJZTN5)_'^B_&[ONJ;O_*K
M$35)$1%1J_@+OK:JE""1JRPQ5TKS5@GQ$J"UDR.!#V_%DA(LP34QP19LP=2'
MDBU#?=28DAG<DB7)P1D,D@R1D".3CQN9PBK<"R09C!BICQ89PPSICRY<P_\8
MD22\D!^IPSDLD2O\PT <Q$(\Q$1<Q$9\Q$B<Q$J\Q$S<Q$[\Q% <Q5*,#!M
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MC,TLHOS+AK@ ERP=I-@;NO<:3.,!Q6DF1@$K?OD!#E#/$V#^.2MAM^:H  4
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MJ,#$ X)#1W*H(82B P>4"'Q,L!)#PR\+'#!HP&##G Q""CJ 1>LA7XDP7%1
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MC4JMA '@=%+R:L<P,( '.S3 R@+^)Q1 5@$I$\X( 10Y\&$!G.*B@"I 5&#
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M60@8(!%JJ<.PFH#64'P,/PR85#85$"H+S>L#DS/ 4(/75PD\!D,S4QX >)&
MU*EB YG^VJ)KF P-!>!,"0S8(@+2[$$&)  _!ZB+6$ 6@=["L+C&=$!M_>(O
M%5SK &0(U0$$8I8%)*("#0C 7'537.@-HQ1A<&,.67&![\2@L[45FA<4<&@M
M-P$KK(!  1: %4ZQ I$$B%R_#M",!_8C>PV10:A_X+UC_,8! &,#%BW0/H$1
M !-%64"NJY"(B@;;6#_>0@.$=NL"(*  %)B%"HK+!-8F($A3>$T!Y.=9&!)
M%N 06@%2@ ;VB ;;_(H"YM!<$W1"!1-D8!T"\)4+!T^  X3[B3@\F #O+>P;
M8?!&.C 2@'24X\'="(,\,.;!*.0 63);.*3UH),(/< N7./^TP.8W"L,_V#)
M>M[<QX+YO2W\R6?^(,":;""+!1 @ PX1&LT/ H!_#>X/3DD HUU\U$9=8#Q_
M_(.I:*4!*F<@ 6R^' =J%(ZPQZ @R&J(N2D5#M%XIW#E25,85(<%(\?LIFAP
M5KT6%ZK)Y3#IN1"L #9  5PL8 ]S1M,%1B :!#P3")GB0 #2\(T*8-F)GHI
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M)I1$*S";8%&0)]1-9SC (:B?:>!?:Y $A(P(.&C-;(5!E<4!XE4!R1A)!5"
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M90C+&IX.3$P;76 79>ABZ)C(#< &,&AC68;CG9B9%5[!>R[H6*!0%A  .-!
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M#2Y0!X3.YLAOY_U +ST0%^!*YJR&BU"89E3O#.$'!XP21=2O!X7F6=&E'4@
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MS*FH#@Q X54! )0#U$56OQ@ DT<+ Q  ,# +/85= K!"RN2G41@B1 /#')H
MF!]$J%0;N2G&XV4//WM0"D  EN>(L#Q 9SH"Q0$!I$6<XQGY.A0 ]M1$Y'7.
M_4Q"&X3^F]C5VP'DB(,9W**[,K52!CZTVXB&I*MD@ %DF@L2@-; 4.74PL(T
MT)."0@(,=9?#G]#L:_)<ANH%&P&0@0$(P.T:PP5@P<=\@4'<I"$U!FK@@O?4
M77^9!!"D2LDD@IDCSD\ P\!D"DFVQA\P.2;DQP4PP,SXG;/3BH,YG;[LP1O2
M;#@D0JYIC/>M!Y]T SXH-S\)LSB46VLP60Y$0);HZ)L, +C719[@Q,;I.6J
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M< DV>4-13( 8'L*PSJ$,_$$ T$3^Z]<!+"S_^I)!"MS"GN!'GG3[3I2 #<#
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M6<U!@ ,65#  !1<(P($& W" P(!PFC  -=(8$( 7T6I 0 W[G&$$!CIHI,4
M%CC:22))DF&!H-K*41M!'_2*!%3M4/&-![3^^EX5#N2D61D'.. ! ;>*=4,
M](4R ;^H(7!4 V\%8($#QAAA02@2E(&,:!K%X\!F'D"P4:YI; ;*7O)^B\ %
M%6QDAS\X*$"! 1O(\L$ ./&@S@XQ0V"! 1E(,.B<1\SPE , R.'#!;0V"54I
M)A"P9\:?6C+!!%2@TH8%#1QU!P8$["&'!3KH\DDF+*=6P<G?'J"# %1@ ,?$
MF3PPM!_^E7P!LA\%%5$! !HTT(D$F862@ 05!# @80#HM, W'P"@PHDG28+2
M 6P3D6/EEE]^([4'GO/ !<@RP"X$""101@,&*" #$D<=H,!0![;>  <$<+'
M!1J<OO4&"BR0@ <4''"U'V'2@=D\]>@^7P$*[.439>X5< %\"A1U #4(* "
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M( &=<(%1B?/$.3KP@@HDH /;JT3,$%@$"*#%0GZH@38P\"TS*,T&"4 =-1R
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M"EW +=)@! 7B*)F!"JD2'@<P P,R/7"4&9E A()R2I#4)3)2 YGP+T08@.A
M"]_B#W$& UGH$3X!89$P+&)A@A>$#)G ?460+ O@:EFS+M00#8P2(W H22<3
M9WCW-D>!!)MA._?%"*\B 3(S&.C &A=G JGC$3 T <HW"]<S!;=P)T=P3?QQ
M!@7P?B%6!@GP'166"8NH<( RD8+^8P#R5@1) ")F9@@;$0&XE @9^4PS^1">
M4 8D60U%\&D/ $D7T FF@Q]U8@$5TH>/P@^?PF<G Q6 M13AP#*.$FFX%  *
M8$:0( XO(@#7DS6G8Q8$( )'0!)%L!'A@11\<R#XXREJ@P#A\'$.%!4>(&<%
M"#+9,0!<L!)&(&T8(#"?,#N@ "!P"&+KP@_("'I :0 '\%&:DP-F)H,"X !K
MMB'#&!4.Y4D/ 43_@ CT8 JOIR9" HE090"0]GY/52%=0 ]MU(_K(14'T&.A
M('U>4'=(,$Y3$ 5+ @%/<#T\DQJW@T _09MWH1UJDB([F) GL71*E N<5CNM
M$%"V,H7^[P"/5J<"2^$ T/  %  .-4![2U%8R*(9B;$1MA(X3+5KOC:'19 !
MMDA V?176?A%G321,/44JO2 7&%M?% $0;8D=N$M[!$-NW(:&S,&-X #0D8:
M6- 72V$<TI0 ,&-FF])FG2":9V !_\4;4R>"FW4;@A=?]# 9)]!G" 2&$$%!
MC=<33:0M:+<!_@%)@2 3S_ B<@$()U%_C, -2/(UHI%I15 SC' &RQ=0?<("
M]'$0?ID!/X"*D<9G4B./.?%,+K,D"O,'(-(!F 00EI@S&; !^J<!7^H#[& H
M9#0 7G$ &Y @M2:';-ED&L!%<9E: /<C$C8!MN ',=(8CUC^!-JR/%S760%Q
M!V^H4@,2 5YSF :"#K^U =#Q B59!@0& [028QOP6-.!!"MW#H?@.6J""[:1
M#(JR K2R<\XXFD.5G5#Q%JCI,FKZ%)/A#9DZDS 0+<B@![6W+H32:^LA9GL$
M/,AV@V6A!_/V-?$Q4EYS#%F0"23 %3GC"+<"'2Q1)U7J!DC!+9L'6X*W )F1
M"D"@&=]  U[@"&L::+/0&80GC]\B1YKF:G?"?GZ0$T?A:9-0!0:Y*1R@?.C'
MAUX@"0$A0B6Y-;)#D/O@!Q W: A@#\X(-T!HKL5" #;49X)Q@^M"+/4" 8Q)
M I6P-5  %Q7:GQ&@)CUT.*=Q%+C^JDS%-P<)\ ((LR2U82+'<C)=0@#I(YX(
M "H^@"4/H0(I(@ Z('*:02LS"2Q(\&3?D H7@@Z,$V);PS:%\4[P90?M<  Y
M4P5Z SU\0"VY,;69ID0(L '<MG))<"RA9"YR(BA<\ #(<1W08Q7&LAF=8JJ1
M-!0-('CD^C8WR$.81RT%TWUF=AT'\0^!<W<2H#$E0!WTM)=&0 #&]Q2WZ"^$
MBG8\ UZ):AP1,+4'8&VG@1!EL*^@)#5W PHZ004B.0'5YP %0 8#$7D-L#TI
MD@,@<A3N<:I"57N<8&;6E@P%@#9!UA%8:3VGV$;.& 8*<"R>QJ]&L'+*8P,W
M\2 1^BC^F $H2E,\-M!#H.29NX.\<=0 !R UZS,@!8!%?$($$X :1P!'?L /
M*8*Y"6$%C@)TG96F)I!]A7ELFO %1\ 0G+!)M'"Z*Y!])= !.L$>?$-QF(B/
MX.L1/T&CWS&5V8)%:0H_(/%S1(B5E'2ZA00%&, 0!H"[!9( G.:33_1&!G U
M)C>AI9D,71,6R))B0*H"8Z9Q%H(O(78 +S$!(($,M88JHR-;-%%F![89I9).
M7_1"$,$ )G/#\B!EUQ,@U'")?KE\HZ)$GK!)A8 W/EBO")&E#?  7#!K#E L
M OE;GI(1NN( 1YP>RO:H2)(,T(1D&Y.'A:%MYOL VB8!C6?^ KY"N&]D7#\2
MQ14 ;%7@ ;L1 =GTI<E@ E54!7.@#&_D&K$46X(, VQ6!34 3!#39C T!_^A
M*YH12\V NYY@ 7.V IG")6\T9N5R3&O'R)I\'K/[51B&% 553Q%%/)D@5NUD
M3S9641$E5A/%4$]04)'"$9D@B[O%4*255,/0"I<FPAPE5'*!.4&\7[",4T:C
M8M:LS=O,S6,ER]R<6^^122G2,&O%*&R,.=]\4GRAK'XU8A6DS#/56NJ,6)_U
M)P+ISE65S\"P4[7\621U(P>5S #=5\N\STBE4_3<S36ET&;5T#?UT#;RRPLV
MFM\<T1']39:3@W205],L3H&5(^W^V0NX(6,Y-@P8'6(>H $@[5<'96=T@ 'S
M9",<$,7!@%E=D*4+W57.XAK_+%'GM#%>P$4QQ<_0[!O?PPL80 @=) =$G<ZL
M10</LGE G2.G5&O+QGA=L  _!YM"E4SZ#%KH4,V\()Z54V+$90$F;2/R$3-J
M[0M"LY]282K<5 9K5AA]12V5.0<6$ #XC#>$R-(XQ4.=0M$XLA7HHPOAA2-"
M$,!0+4E>@ X&J=,NE8*L"U+:TX4L:3FUU]%&P)CIA!99B%)>16<:["661=7U
M@L:P1035:@1B< '/T'BI[5D3M4X8A<NKV '%S 6Z;$X<TE3S9,LFH!WOT=O@
M!!M\1<O^&U!0'?#"\N"RA/$>[4P,O_T>6Z$N<:I. @7,ZQ1 9,F=+\!/!R56
M[% *$\T!OQ';N\+=Z2T5,E89Z0U)/488I9#>C2J2)5DX'1#;<. !M9(%E%(*
MIVQ8<T$YF%4#4L!0K A9Y!Q3GG,0C7H!6:HT:<W@(1;)F.56OB$?<6MEFU$#
MU90%62K2A$$*?7KB<"4!U6%F-78$;#T$*Y#6$MN>3/58DXU2V&,!HF,84)9]
M+(8<,J$['^PH7,P7"5=)V!-E"[!Y%[#5CU4!;61)#9"7?0H  91,S_9"M:<V
MGO C7' ="S"&=P$RHA,*B<&[6K>]1/#!SLAU\O8["S @HB/^S9]B$W\503[@
M*PTS<M $/$51/@8 BB/'P9IQ  B KES:  # 'IE08,<;%P3P BWS!\0K! ?@
M+^&#N!V@2'XP<NVINW[M #3T!!(0 _WI6-=S% P12O8$ 3:$+-EG!ILVFXGS
M0Q.*B@<2 )?01*U2E:CC-VV@,TP  Q[IC%H#<2N5";) O'-N *<#"AM1+6+Q
MP8"E$R \;@2@O!$  .L@30#@M1#12;X1H;(G304@A;N!0T28G><0%POP% K#
M;04).AH\  0P/"(GDGY  -UW.U% !@R0*\"B/ "T,M,S1]QV?R#:! @P +0B
M.@H'6P# =8X <NM@1EOC! >0L]?^TSM>0&#GH  $T #&P 8= N_6(T1Q8P0S
M! N'<#@S)Q8])P#GM ";AAK:$A?%XGZRGBJ@([.(X*%PHP%,8;E'<+&OLQAO
MP6T4H '9$U0X/ENAX  W>*C40M,'I 5WH#M/?QRXJAI/CTF<N ?^9PT0L0%C
MV,Z&D@^A$'$;34$O$#@2=A0"\$R2TP9?6P8N U^DD9^HV!PJ]*.^ 0 0MAWN
M!Z=S!OAUPAO_TD:)<DUW$F1/[U#"$I)@3 -@:PK\X)3>4G/C]WFL\G?.=P0(
MT)4'$*Y1(2@50 %UNQ'&4F-;\UU/?V5G0 6IH-2GS(UU\@R%T2_@E"N5T"^6
M ++") G^\Z "W]4A5; I96 H!U(#,_M0=8 -.]DP-7\[18X$@*7U':+4/=35
M1O"S+Z(U7" :;":$Q[8M42ZO?MT&WJD"+G,$9?'[X! /+#)AL%K(WB86_( (
M8 @"'/$Q3N9\!?1)R35PG_QA1&Q@S33+5.4%,!_(HB+P?!22#T*3DEP('L.G
M,I E/ <&C:#)!)PRS<#C(70(R\-RHG D/I9+8^%)2"0%#B6A*2 5=$AH."A\
MP$T@?' ,B,E4"!%)+'RX<1Q\3'7,8 ">=4! ># P; 28"6C@R45(&'!8?%!<
M7&0R+&A4\&S %EPE6$1$<%!Y,@+R*"\S-SL_0T=+3T-#4#'^1%A>/"1D7##(
M(OUU9J9$5#Q8/*!\-'P87+A-R5PH:"SR)%!H&G0</,IP0*Q<KPX&D/R;\$_"
MH0,<,F1JD*W8AP<Q$CBPH(Z3C%Y($%S80X+3-@CN$$:P0,&D @L2&MB2T43)
MA241($0XQ*' AAD>'JSL=Z"#E@V"6,B:(9$# "0S\&C0 $'!-AD/)%#@XN"!
M)7P,<#Z8D""G!@,*'NBH4&X&MH"%DKAB@&D= PQ2':S@ >'1@08.%IS(MD%!
MVPU#5:#MT)*'E@L(#L1D<*C7!XP?'"K,D ?"A2-#V,E@L$0"!@=<*M:Y\"$,
M/$TB*EBHD&W&@T-=W_5\>J&#N\O^92%@4,?#00PDBP7,N4 ! [Z(#3!8!,!I
M0X(*MI7VCO" F+()%C!0^9!!P833#"AH6*!QN95Y%*Y4UI+M@8$*%23$Z!%>
M085N[V)HH, "^YA10 032)!!*1-$@($$IR'  2$*N#.5!.P8 % $,#4@&@H6
MV)/))C,\&)H&V.1Q 7,R\(= 3^EYD(<"&,!VC(13Y1;0=E?% <$$%*UHD%/4
M$%FDD4<BJ4E%5$BD301Q?)#2#&6QZ)@,]<DAS"&D7.8@%P@@8=T]RB"P0@>"
M-*%, Q)H@80M4WRT 26,<.401.VLD$$![<2  %>6##G.%&\FX40%#I1716U+
MR,F-)B;^]./; A=8L(-V%U"1P0 <1<F5%2)XX(\'!62 B&IL$2,=#R#)H$@&
M^)"7Z#H?8(K0CP4DP $"5!3 E0846!">4G%0MP$*&A"@BJY(/*#! QL 42IM
M0CB!P!(/E"88'HL<$R$)NB8U P0 W 0 "@H02P4"[AB000U(9/! 9\R"1L)H
M\>Q9&26R ,"!97FP@D%>D(S 1"49KFI!!^SLD8 [WPR7C4 ,[%+ $LS=T4$:
M)#2@X#O96(" &\I4D$PP$.380P4=""!$3B.3,,$=,3"03AD\81! !QID AFM
M5YSIA)ME(.N/$P=PQ5 $B^ $ 1=K5K"(LQLX,JH&$[KS  +^->BB"@\#[+.
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MW"QG.^O9SX(VM,J(@FA]<D(#+*&THHU"\ :FVM?"-K:R]6P%)#D-S-ZV 05
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MH  .)5"FT1*&$R&;43NZ&?&6SR!J#+&$R]9%#PKM?#$/$.4'%O V8%4!(YR
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M%$ !6( :8 H-",L9Y AXA(0% ![^!-0&$R@ !0! /&0( J"'X\79 = " $A
M[MF/+4&/5"B  :H5J>#$JU4 !>R!D!D $;4&1H%- W @?]3 *<%- *@#511A
M>C2+*?B0!^A 6=!!"T)&ZRP#&72 !53'"-3,E*3.&")3!31"$I1,B7F!(D8!
MF.6=<&U1)U!!"[R:&?0#P@0#UW4(:4T)!_;B@]2 &7X &ED;&BP %[Q!2.Q,
MA!T#"0@,/M##+G =$DA YIT./J@'!L2!)[@5 =R'.R@!"0S)*UA"B<%'+@R
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MKO0']=!,[K'<S5$.9< .=5X !Z9$FM@/S"5!.L28Y] -!H:&6)P#L(0,,QR
M2G"!"/C19>*2P""-3VR U#D .ZS)S8'-?0CF8@8$">S#K_"6 RS!G5' #AB%
M?>3:J\3, PBF4#C!(_% E<(&3W1 U)P$G@8$!3!D3;!0L.Q"2S =4"UG<=$9
M)ZR(LZS()C >2+ *+%TF.;0#"E!  Z@%(PPC)Q#''G =4#$9RO6 5UP >SI%
M.UJ+L+5J&(6' <S!(K2 53@(.P!0:B%!J\E!,08$H8A&!$S>"CC%+S9'/9B9
M IP?0FS^0 DX$SL@@6E>Q9H@0E U )6LPA-0A.?]0;PH Y;$)#?:'0IXBQ($
M$@+91;Z8@DF. /I4P1'D* G8*87>#YJ5& <611), ,V&13!8 H?N  8PP!_D
MU BH!WN6AY[\1"6<SI0,1?5('*UD0CAR*:<T5K#XQG\\8UED@ZBEP2YM7@"4
MBIIV*(M\B7UV$P-L#,VZ0J+<J>+PUB(0@(ZJA4WHZI[XD$\$0#8X)CCI(&.\
M7VS\93L$W)X@YEX"P3=PQ4T$R2C,P*5F!2,@3M0=0MY24Y1 )K(XUW/L0276
M'.V<P3(IH@>,87TJ1)1\F10H0J7(@#)5A$'-T01<0"5,P$'^$.,N6 1C98*?
M[@D$H"@/16>&Z -X=$ 18$]E7$ 3OD"<16ML20 #:A +(0 6X:K\**("!$%(
M*!^-Z%&5M@,74$!#O(\/'@5QY*T()("%_H'T*.<0($ "5,+V\4"U#0!72)H(
M.MEE3)#A[6L2X$H8%*HLW%\M%9X"%, T79X=',1EX,< + "L*<F9<(+TT)\Q
M=0<F=I%57LZG3LD)I>4N2-$"R" BE X5>!ZL_<$2L<D1<=H!($]4*%F4H, K
M+!&N-6R4<$XF($ V?%#[M9 4Y(HF7,[E#0>,IN"[R,$+&B8B,-$7O&"&K (#
M9P-#%, <B9&4<@'H&4 EL(*D90'^XUW2\R03V6X>GU MKF3!S:;@95C:"W61
M!!; -0U J5Q%(RBG>V[0+EA?\VY.)^D?<&D"5]2#,\T(VPT%:OH# 2PE$/WO
M\W".6= 5)BH# UR.YPG3(H#((=/ Y;E8)^U65-C&$[%%!5P "CP3ITP.(EP3
MNB G8YF%$+@!540)#0B(#!NE@ R!:M2! _3$@PPBBH'3-&Y)=;!<.SAFFKJ,
M$)CB\ZS=3?R$@#S"_DF&+ 0(US5(LT2)$/@ ODXO<;G5G4'"GXF!WXR42CE3
MH)6:)CA!."45)/B-.HL'$O"!KI4;@@6:I2'8;KA4!P"+4WS'5OD1OLE IE40
M:SY/(CW^ @:<BCIS@K.=&J+- $*SLS*8P4S]$SVX%Z49E0=,+>SP5U@!U'E!
M%DI?&E%UP%4YFD]<6F#%M%:IR1C)%5BU)TZAM#.E5WH@K3O !#64E7$M%32P
M$E'AUU'[EV])F#,<=3.<E618V#/4DF1Y,Y(,67===6<]2!]$V3B#=5A#PP5Y
M5E:+=6A)$VPI N7.]%G+%Z).;U6[]>/41%O/]5UC=7\A%U[S=5_[]5\#=F +
M-H=!@P1 &E,3MCEOEP=$0%H=5YA@6""AYS,X 13D5SE10 51%V9U]&![]F>#
M=FB+]G9MS9&XB1Y9E]5LF7+&344]@P4 PX9%@]V8-=R.]FW^XW9NZS9NX]@
M[8Q _.Z4C&I2Y(&+T<J32AJL>D^-(D)EBT9%S"$+,"0/I 3<.HLW'TH$)#=S
MIX2X6E,'&,O\VAU8RL%VG(I!6( #U//=.%=8=.PAM\"1=5+JT,"3NA6B''$[
M ,",0H $L'4$R%S^H@50BX=O(V8?7@NZ[<7PH4-P[_:#0WB$2[AXO4(%R04
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MP\Q8P,&^#BQ3Y_N(N "!K,1YD!M+'@BJZ)=S^Q? !U1ZR0I.@8$!G&H#;--
MS1+@L 3^R PB'=B1RCX @+/4+ *CPP0#J"8"D7V 9OMREZN@@):/5>!5WZD
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M7QIPCPJHY!8 )$P\6":3(1RW7!?X$P,+6 !'FNTJL^1E=T;^@\.KV?2IRR3
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MT>)/PH1.@.)3<F($H34#:4=:7N,L8:@O7^4].=4W:6<X#-1CO60Z]\8,<V4
M.:4R9 ).0=!+D6()6$,OER VOH0GD4"LB+8"LQ8J//-;HX/^ *;"0 64?* '
M 0?@4QX0#@_S $ED+YTEBQCP)YS@ 0$P.2O %1S69!-P69K L-I  .T$%'R6
MJT4G'D<R7!%CL./$);Q0L0Q *XIR*'L12@33*1PFJ(3T!UCC,+;16.)!K!\
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M !<)#".@:+)5 4+4#\243AU/T>TL$$> -2SS  \P:G(04  W_ 7#R?G%@@^
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M19/9P??)RDQ4$T'97B&8@3H%E 3800NL ]1=0"0(01F<5>[P# .<3 I4S@)
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M6&5 :1F ISR ,4 5M=03!B6 ?AW 'AT RIQ!G S'YI +I*B=)JG/>VS'7@!
M.9U"?0E$+ P ?#3%>2A YB1"!K (.RI 1 P+U!D02I:,+HS)=&# 5$7(K,E%
M+H9*Y?%)"\!.I?V4 V3(75&3 33)Y(R ML">(EUA=P =?ZA%V$'+&@T1!3S;
M!-",57#3DY36<PD1K[&1-)*<W9Q**AP3/1D#&$50I\P&,^BB!E1)SS1 CB0(
M\AC%>4@ XMD,,,P"!-A! *Q1_)"C4>A)YI1..1U"CL3)K.V'""A*)YX!CI3$
M+2; *3S^BH5=4OG%C=I]"+F<PG04C!ZD7"A&4X1]6H,\@2MRPP/<D\,(409\
MD#ITA!":APG<XCZU4-UAI$K5RML(0*UTA 'H24=T"/88$[0Y@(K(@ #,@@!0
MD"P^9PNAG0N 1SW,@@/XE$R:"CX8P \X1*T@SU8,A5S0VD@]C:UH4V"&C[1X
M482HPU+&2RQ@3CD-"_F\72*8 D?4B! > %08#P3(WGZ,22+  :!)B_% WFP<
MSY.P3(*]RP4("Y-T2#1^@P$AJ*1$B)+DS@7(HFN9A1I$ &6-U(#PXO&P!0&\
MB"HL@"B E5$QA(72 S6U";(90)2USU'\0 5(R.(4S 78"%/^9-1[2L-"P-$J
M]%T _(#)I. /_2!U@,(FS(D0U</'78D"0H;!5.A*T%7989D-HHG@^$;W48(.
M=H4]\ E*;-Y>+!MMT%8+Y!0O- *?J=0 J$6EX58'Y=%^,&)_X*0L\4CN#)I!
M[H5J!&;WO>8%! \Q'L  ($[7G>8T<5AD=I0Q4, ]B8EY=  ">,P&*-=-9HSI
M#$'\7 V+\:)'/HD!O8Y^3-D'Q-.K;D"9Z8?Z < _<  $%("'G 5U. "+!,"5
M\!0-&$!P(8 !%2IV.=+TB  F"@$DM0!; )8JT!\U24#WF2 $^ IR. %\G@)#
M2<OZY( >%$J9W)[>E<U&15V0M:#^87C*S@!ITL1!+131Y.B=!B#>*'A"8%JK
ME4 =4DT O%23.F0H5/A+ELIA WRH;^G"<Y6"$#X=/E!"JPQ3-RS&=^&60TP-
M33A"=NU%FY3D!_#-DW242K5 LQY+!!U0+,2F4<&'P2#*?4&%)@A1 B;%?)RJ
MFSF$(XP )1W*IV:&$+B7*'SJ=K1$WDB+.K7#!#!(4Y@--9%I V# *9#-CI /
MY+&8>[EI0OB/+;(++XS4H&&&WBVJ(@04N43.IS7B7SB N+39,B5%KE(3+U#0
M&S1 8<D@)4(&PB";I*+6,J#,F6@=IE+6 WPF0$(,ILY78/A)!(A=_$R M]8=
M-<G'-OK^UZ(,XS- X*LJAH<4R[.!B;#D%5D!P@,8D #0 ^UTDPIP9%Q$P+?\
M@:ST$%,&@MV2+%NPQ $%$X^QA%KP93*E0*&\IP4$PP1D"=3$ 4,4S'F<+A=B
M32*<E 7PBMS2R;N.2=)<"9N:[ !00+S$B(.V$*)TRY400($TB!+4BGJI@RJJ
M1@+@ZPCL9HA2UAHTB&4T4EAXI 5(R)%H&-)(PRKE1P7PH?%P!"@E2BWV':9^
M1P-P '')&9<@RM5$30<MVWQI0./BR#XH@,S^ )%DS:=:ZQKTB@X<)>3Q"E^J
MTC%H0 JN3RI,RED\B7Z-F-Y!DB$)3B*4Z0W/ @6<9;ATA#W^4M.RD0$'E*Y9
M4&BUT ,BB 2='E!)]LJYT,&9CD)T/L!9O$N<)-,/%&HR0< .2X-UO*I*GDH#
M0 I 'L3I]2V^K DKPL I_,&L]<979.D.%E%JR"(5DR1:?,4R_87/2>,+TT;>
MX*G-&$RD (!NCN=*>H<0/<.=:$Z&.&J7>(H*X)8?N.@LK$=DRB*D31D3\0A\
M/@X<E =O'DNVEL*).%;./-R59(T)R!D3=H5VV@&IY(,^$9<;X"Z6>= 19%8#
MS&:DZ!:*F("/6)L&S%T[T)8N4)5JB 0[#EX&K$&$.."R5<4:E,J3($$]&(#D
M"N2NC,.4N1<2Y(J&G%'Y41,:/(#^)I6!TXPI<7G97AA 8N6,&GY0[GV%"52'
MAM2?"1@3-:6 ^#Q!?>6#?=6#S=RS;OFSD[R=^K6#<5@*KVE)EQ81,K3#,X@R
M"4K2$X@"X+5#8&HC!(%L59%H._Q8!CS /ZM#C>2#S8)L!@2F28!LD%*0)+3)
MY_Q%+&  ?&Q 8"*!4:C##I0T.C\!4>P1&D<3S,4:HPD!O:C><QDOO23U"Y@F
M#7C:U%F:"@!KJI6:17@)$!04&C(K4L>:"EC12RWE,['9<TR95%O!"5W# D2J
M5@.!K%AC4=>U73_1$@W;_4@ R'*!28O!HL*"%-B/!:RU-10N&/SH-8#%RWWU
M7;/!8T?^MF1/-F57MF5?-F9GMF9O-F=WMF=_-FB'MFB/-FF7MFF?-FJGMFJO
M=EV?\<)-=58KVFIY!FNOT$,+ ;P0714LZFNT#A>XMNKH-1L(=PN!X#X;=BI;
MPP)C 7!7 L#&]@@L$>Q8G!@@-@U,E0-P'!8PL H$'G-+6M=T4$(P#\E.PS-C
M05#SP") =QDX -]N@5C8BKX@U%0? ,QJ0P9LH<&MXBK, 75OP;-AW2P$M#9P
M%EU7@0M!]P0L6Y^,WB3#]1<4@VI1 %&S0@"LH%T2-QBL( UX4^45';;-I0H8
MEA<\#1,5 -[MW6_KFMA5]:)YK!!P@*F= $JBVE&SA4^L +W^P,00R+@*O X9
M4;5>F^P^-%J/<[5#H(5"H,6M2K"F&0*7^;@4P)IGQ$('O .F"0$:" 80V(Z,
M9SFZ//GM3,&^]0H@D$ TG >?D0G6\$4+T1^JF/26E\JPL:.Q',ES5]\S],]<
MQH&2\#4%>C<JO(EV_]-(V0$%3<5.(X^$S.4+Y4/W+9_UA-GC"3,E)D4'E(DB
M";:U/JTTE,ZU>'5DPI8+6,Y- (F$<8#D/(/?5 SL990GG%72L@):P8>U4.1.
M_-@"G#,4%)=B8":K6:L%?Q#?^K<0'*74EK,#-, "] ^:/,)$9[<NI,"S_ >"
M6A0CW,")7,LM1,VRY YQ4>$E8*G^C:BS-_2'U+10<?E7+0H!A3"%05[+#^4)
MY&&FGI#'%TJ-V=$[&8 >=?M"&:R'CQV"V/D"J6%"0*>'*1I5C+6$ =RB"4S
M<[I24_P(\AY'!KQ! 1@#<F"-,6RG#&K8QBL'QO#-2B17"S2 ;<E//2G9!!2#
M*9Z5;16! ACKT^E6DVU.S:? ([R.ZD%F/WS04I@%K*) AA#7/]DWV:UDR][6
M4L"/*%@+ EQ)<2$ BS0 .]QS 02TD+7XO=W9:(9L)]Z3JT*7&5"QA@& KQR
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M%@7,3A!Z$0 &;,0 , @%B!3P2VHB(( MPN(!!.+C&"YF*H@HHDXIB*,%,#
M"!AP!L?^J<BJ'M&;?\W@ 0&(!+_>EQCT7$PB&_(=(T>HAW^MXH1[L<QM5IA
MZIE" P'8VA9JL+7#@6,IY7C">&QD "G@R0(4((<=9!"RSDEM<]2LIC6KX:G(
MZ(<LU."  QR$*21,  F*8("(/L"!M:RG&A\A)RV<!@?P3.,,KO* 2SB @/RH
M@!H-P$LU/-" .1DB C?YVS L\(CK96$!.=& !YKI*@-BP#L6&,8$QD)0GHE'
M7]Z1  0J,">@>"1 \\*+!00#E&&P$YX2L$)+NU*!"V3@ MZYF 8NL 'L/)2D
MIN# !+#VMZ!840)5\2E+--"!'E2K#=78 %*)8X':;>JG-_'^*05,TTU_+D>@
MFD(G7C;PTYH6="DE,T7 EI*=]705*!=+*C6<BLX)#$,5V9D84N':4YYR0*BY
M^-N<-#"!7M0B$Q:X55#7PP%_T%5*>:V*8:N!U%Q0 P/!<6AVK*"I3%AE@G<8
M:PPXT $+K/,R>*D"4N]PVL]V)+6W,I\,.G"5SU(C8*X](%=B4% /I%:WWH&
M% 2*6FB=M;/6\((5-.N#PVT #_BX@P=8AA<\2!>W#D*N%3I0.ZM4]YK<[:YW
MOYNE!@@ $2H%KWG/FR5@0,!YZ&VO>]][7CW!=[[53(J5(@!"[OH"&^2H(GW_
M"^  7R.[,\CN<:D4'$:9E\#69##^?#%;+@%+>,(4KK"%JX%=*R$7O)XUJX,O
M#.(0BWC$)"ZQB4^,XA2K>,4LWMR'98 > 7-HM.N1ZS;@"<W!4,D4'B"G(4:+
MS6=J20-KL(:\KN1);1BGQ>:U+).?#.4H2WG*_S0%!6AXW.UD[L74T6BU!.$
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M &$8 U1R10-01?^!  0 9L"9'RNB%PK0.5N 66_B38Q' !QPA!<  'M % >
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M@Q=RJA?+LU9D*@:P!HC+<$9(0Z52;3CI-,3">:64+[%@+# @#J/U(]7F4 <
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M<VSY= !OL "<!P.@DX-_+0 .A!,\P6\#8"A0L#LI8R][40;U'4'&0'LL4A"
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M#*TK![ 0"4!!$Q=0(XP08=[!/TF.3E^1'7&Z&(GEI_OQO!+@0N-HS$!1$U"
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M(TR&! <R+#%@"680#A^N7U " 7_,1 D'&0C@ 2.J?("!.I<8P($'XBA  1&
M7.8-!PYT,)5?D/!T27Q88*"2)P@XQ@-:'U!0@A)O7++5 ?[^02;+ !1\X, "
M&NSR0E>/X'.(#'04D)P' DRP3 8(_ &!#1D8H)(&6XBE@0\^?)!7-R,XHXP,
M2EC@QQX.F-)'!!-&@  %"&J@DPJ6/&!#&D24:!@D$TS"PQH<;,#= B(X$,&4
M&HS"A$.#$6"!=0P40L$&">"YT04JY2/- 0]\0  "1ZHD" <Z8; <0X*TD0"9
M'3Z1 *$XM<%>$R4FM04G2"3A7%(2>-!<11XH, $];OP1@8<*%+1:G)?H=DD"
M;DF@035D\;"  AH,(((2!FS0E06A4L!)3@QH8,H4%109:'WJS+# !1!LL6Q0
M2B& 6 \ZQ2.!8SNM.\AJ%F2'@0+^*8V1PE9+,," 0E\\D]\VJ'FC0%$'0'&;
MQ!-37+'%2T 00 ";=B4  ^PX;(("!!0 "A0E,W2%30=()P9R04R W0$%< "!
M-Q ($, ?#3SD, 8#'& # P/ UH (92HQ"@,)1% 150GPD(!%2H1K@,<7%6"
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MRA!:&M1BYJ\!HP$'*/A2D#$ $ +@6L)<--(!#X0%4XNQ1 4 Z*L]1.]>'7T
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M$6?EE0UXK98*H/*')QA !#LZP 5Z[$=?K[(!$MSHO@E@#>*R!?4'6 4J>CX
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MCWU"$/S^@3-F1K*$B3(V 2/\3 <,YTO:%10,B')8(*'%#DMH !NT@J)] Q9
MP>QE00X00/L%  8\ (X@90>XW!R(0'P(4)9X0S9BP9)TP!'@(5KQ 0&D(@(
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M8UP 6Q FB8UG&_Q! U$%0K %!!'#!Q:8I1'"']P!6XB6)6" 9EX$JY79\J7
M!8C 0,E$Y5&%!+A9X?%!S?S3 _B'A61&"ES&MO!9(EX"*%@ CFS :-!J&^20
M<4Q ?X'^0@?8T -1A;7@KW2=DP7H"1/YA04\U,@N*.Y)4S,Y"Y\4"0I3C,HM
MDH4^2"(50)V]QCXXIR ])3;%!H+Y,#$%\6RT%PP;\1$+\2O%QG@A\6MH!$7
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MCB;59 L>0Q%77T!'H$X!@4*VZ)#^ \UJZU"",)!?9B /)',U*KO&*W $LMY
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MAL3.5 /$6P$JZ$^<103E: ^<>"TPYA040*\50C$0@+IRU0"%&^$8 +'0UTV
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M@Z"()EQN*(QE^56'!>)5$S 6$BUU$KA@N" ((:<!&-!Y'3 S4KHZ'_0HCG.
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M!G=X!DT?$!4">"8(7$@W@$T)! /Q4."!(%4< 1@NF.$ D4"9!/ABK"N!3-4
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M*%!D003%&>*.!ADHH!4&&R2P7U B[&)! AX\X<@&JWV ')#HE# !7):"AL$
M&\3(00+-J#-=2""%949F%2"P0:H<0!"!!Q! H$$ 'G 9QU[<=NOMM]PJ(\$+
M]J1@@@3^ !Q@0 #-/- 0-PD80LU@F15@9 $L)&#@/0VIAX<G!<"EZ )AL='
M%,1*8, $?T8PQ3GY/2" &05@D$ 3*T&(P)0E<,!G,2<P$, "F)4003$5MS%!
M,0+<(!T.?(JHF@$("-#!!@488._%48BRAP$'##!0 P847<])""A@P 4[UH!
M!]S(V8F/;6R5PP,9/0%0@9.$E+,A0N>A-"<XT]Q<.G9 R8AK.F?8PQ8&#(-9
M#0-Q4F U/$2@!78,:&* N=,1X.'?_+!!F<5U8.B =CDD<(,)"'@08SW-,(!&
M+0OPS  --QQ0K& E"#[= 49&D0"<)8AIPG?J=B"1 YE]H$S^$Y@!LQOH]5CE
M5E< 474" OJRX,-^QW['S^/G>GY'!\YZ;40;NAPPA04'+$ 24JD7L&@;#A@$
M00$)E+)0&3'P65F#():_/8N$ ZB I*)8(.KIFO2CJ[IX*KG&3+O= %]-'8
M2"SP'PEH0A3%$4'\+-<<Y#2  QTP@P>" :X*6O""X.) $SR0@5*T07(:V,"J
M!*2DIY1.!QEX2@=RX $5HJEC>#"1!DQ(PA4J*0='^, &,J"!%AI)@TIJQR4X
MX('27>(L'VH1"'LPPR&:@ ,8(%X/.@A#-_#0!$<P80YM:,,VF,B#.MB'#3D8
MCB"VL U$S-9< M4#(9R'+B;"H@K^XS!#.<90C3@00AWQ(,*G2$X(I>. D80
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ML*(.J#80%J( P($#BS&V@_%O.@# \MD\E7 9_+ 6.H1JAD"^,"==@O%6?YH
M\ZP5,L,:!]D$/M&L)G"IQ)*\.N%UA/!UWF4;"-"G[S&_1QG^!3EB6'%3.AN@
MVDP6F/\< V02MP:0 -RW6BXF(B77)6SR;MASE\1#@VO3+'_!)=" D\-UE"S
M=W3F&EMP!TD#,B%YE"K5WSYR$W$#)!MC?P_'V$73#$ '-!.4<P516#3##<!@
M /@<&$0.-6P2& > :4  #5! -)&C"P1W P^0,T% <'+87= YOFVU  RF? Q
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M%HQ@1'#N&7(86H-#7  28D?D?6% $T&%1/-+0Y!SG(AG%ME", "1Z9MAS"4
M<W 5/:H*_D[W$N=;3]&NZ>C=/4P-@3X6PR*4DH@\60D[M*7^]%#1%2 05<CG
M"9U&%MI'.<\D.9^U*,EWL%!U?+^F@% @++_/!>$8/#R'PN1(*^@LBE\"LOAA
M%(I94BJQ"3 50L'XZQA*A(/!8%0T#%<(U:.0?#@'"XD'C@5#0X"&@]'%0P7#
MAP&' 0M65(Y&TP=&PT+" P9.R4>"$4!&P<611L+"T 2!%&RL["QMK>TM;J[N
M+F_O;(< :L9% JJ#@\05QY8"Q2/'C&@&P]W#Q8J&1 <&AT1 QII!Q$9!A0+&
MA\)BQ(>$XP\$J(4$J$+,# 2X0<<!>C&,! 0<,$#PP*!"$ W9,&30<$' I \-
M% B:8.& 'RD%-G H@"%;!P<*.B3^:.!! X9^*SXTLA EP@,+!#9(\!$ 70,,
M*Y1TF(#.PX<(!SHP8""A#8=./CH4 /J!38='$1HXX*"A K$/&@A5M6!A6X<&
M"3Q@V##@PH(''11DD/'C08(KJ2YH&("! @X$++!6P(%AP(8+'OH>\4!AL(!'
MZ" X0MHF @1 3QM<B'"A#4L,#AJ4,.!A7BA1%VK^J%#@"(97'Q",X)".3R-S
M6#@@0(>@@03.&"8D8+?[R 4"'C@TF$#B X0+2P5PR.#C%/(&,"!7&,"2A*0/
MU@0BK[ @*H2(!"JLCOE1 +@2[&IB(,&F_89VU" @"?0APX .' 9X1:+ZJ6<?
ME!.4!@K^.!(!6\[0X0Y+YP12FP#Q%3#- Q)%=@4#MTFAP!:1A 24 ; ]P %$
MZ<3V 0 ;T/$!,B%^D*%,6J'C"XTUVG@CCCGN4H$!$Q0@ 8\1$- !!&UT0$(#
M!?BQ#% )?!0 ! )4F( #0@FB@&F3>/!C! ",P,("%? CP0". +7E W4PQ< #
MB4$P@R>/L"%.&PVP@T":IT$ 0 </,. *<3T:$-\/7CP4 2"1:,3")A-X!H$]
M / @ &]$'B ! 6V]Y  &!ESF&0 *P.7! %<5\,!*/QA7@0!&&;E/ @<H(%PX
M41T0020,%.#( @44 ($?NDI@%B<.:&   SHX<, #!-QSQ #^Y*%&@*X:9 "
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MZ@!@;,8"UCG 'PVT 0#4ZQ6L;6FRT_MFV@\/*%V2*&=JTX#$($("X&!L Q@
MZ0T(WAL B"LMP@L/:P3  QH^5I^PL_J-2 '(&PB&"2C JK ]7C _PD  ^B#P
M"V1@IU*P4R@<VX4'9. $BV#^ ='^X_,-$$#\[A<%S$E*!P!&3  #!DQ%#OP4
M/7C >/"?&?@  ? ! U@ !/Q8!U" =5 %<BC)SQR!4<R>]4!$;BV#6OV  8R(
M.&@ <^B$*'C%%0@ 'V#*!B"6% B ,R#@D(2!U0D(04  4_1%!4 *2X!":0#
M%'R  !@!:DU;.C0 2=R'G0S%"3"@!D2 !'! T^26%.#8'DR 6C  !%!  VP
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MOFR ?J0C;$G+[+'#$O3,:5!6A=3&HV%" 9B$HZ5=I"$E'UQ VEG++$"?=%B
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M@PX0GED027CX2X&)04Z 0LL8QR/0!RGBR=QI  4(1*;417!,&#%U2P $@)=
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M.D69%?4>#V/8"[^./B'!ZQP7]D08"M!"![!?IYW#C- $H0B&5K31,$08$F
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M:X]:?T8WH$+7&+1+/S9D*U.WZHNGWD8$7@L#+$U(2J -S(!TBJQ$:,.OB-X
MO@PUX-20:///6([/ 0 %4*IV((GH$>&&B(H/_-FRD,6IY!Y0<$#"-2FJ\,'2
M&$TZ_IS:'0#PF(;Z[*X!<,;=L,D '.<->*0/. P-&)\X>$1=E.8/I-7!963:
MAO2)6I$ P-[-YAE$,$([$&&]& 3^ 2Q!]-*!RTD;Z,@$JE1(J^C:[6Y!#RQ
M '# W-"  LR>@90* D1(9"<X+3FV@MM";JSBNM3B*RAJTYK%2>2''+S(;58:
M'\04E@ #2D"$6^>%!#UFV4X !< F192( 9BT8 /%"BP .^@ <4\ !Y<M2OB
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M:@@0  !6 P( :!7@(8)6  8\=/":U<"'"@ BK 7PX8'6K!H4!"AQH.R!L=0
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MJZ(Z (T"E4:)VP/PZ%F< @),E.&7!5  [0<-S/G G28HP$"4(WQ:KJ*R5OJ
M,AX\P$!Q%KBJD:LKO"EB!PQ8X(!P"6SKBP0<### =HTVA\&"3E8F9DX20"!?
M!0HX()"-.<%6 50+%#>!! NXQ($"#1  S0,&*)#"! DDD$($"(CA"ZXM8G@
MS <+X!,&#,PDJ,H&8#"!?.+:Z ,&S6V@E@<-%+# / VDZ"I-#B10A@/R$??!
M 7TJD,".^!6 M,@C$, !!PE8H( ':BE@[B84; L /!ST*$(#I'T @0 F.. 8
M  QH(-;^-0",!]J# =AYZ00"4,;A 1!DL *=)AC04W$0+$Z!< 4T@$$$E ]
M0 0Q6WDW9IV+8$!H'UQPUUD39"?!!:93&$ $%:B%0  +Y$B@ ;9;A   < <!
M <TS'"!! @8#<'74"@3KM\P3#(U! $U=SL "ES6PF0$-/## 9,2[M<MY"##@
M6]<(2% ! A<4D.N#!S! P&)0"[>"7170;YX)H$L#49N?"2XP@ R8C$ /0 "I
M ' 4 Z1',>]S4M<4D!XQ"2 ];CF HM0E @P8 #=-:8\ % @!$6X  ;DRC!C
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M:@",RH$"!&Q>+)R>#CP(R'*\\@/.^P "-  A"T2  1L@C0<-BSZ<P2 "S4D
M 2\P-0X8@ (50%D19] !"2A/!-)!T S4HIP*;- ](I@ 6@_0QQ0T"R:P.8 %
M)K"X!93^ZP#6B<D"*::D>Y6%9Q_@*01R(P(*;&:QW]D@']M6 &7@A@PB$$!Q
M$, EEA;*AQHX*@& ^2W*ZB"7'QB9<D:P*$D"KF11_4X =HJEJ'U3 Q33@6I)
MZQ8)^"I*'F0;?8 T <H*J 0=L*U\K2NN7K@M QX<(,PN0[XV(9=U])76 R9@
M 6U^<Y^8V!4!$$#04#6(G'LS#3<8,*"J#*87]^6*WY[& P8,(".,4MD+6">?
M$KQ(!S8T0458YYJ5W%4'&_#G9K)7"S*=R!?Y8XQ\]H0AOTDR((5Z"V]DXIW*
M+4!5$C#J" YP@<W$Y8NNLI8%QGG3#3AS!,9=@))LE #F3E'^/DI#J@<VLRL'
MC$IA&"A?7!8;-ZYAH'8'6"QI( "3CU2J ,V237!B8A.S<O)3A YA BX6G@:0
M<50R8$ZR(-#8GBIW8MC]E0M&:($9CP Z*TA <0Y 0.L0K;&3*8'61K(9LS1@
M/:MD &:C8EGZ,DTX&KCD:+_YD %IEK V&K2,=(  8)Y, S"+"P1LR;<M9D C
M"WA&!=#D6XM03&_$8$<"N\:L"5LL+H-5VN7FEP(.-&MO/28 T@S @04T( )8
M4FD",G!)^J)4!=&E35V*0]\(L&S0'C"'7EF0O1+$F:,Q>E-N5I#J&!'JL!50
MC&BY1A O0]18-PB.:Q)&&QL9I@/^FUR \XJ< H,=MR,0<("TFI=#GH+1$S+.
MZ:ZB=C>5VZ\%AU' 7H1SH07XY0)^NTH\C9< !,!#6[!\7P"FRKK*K$ LCXP:
M < YQKLI@ ( J( %]A9" ( 3 5&JZEDT @ 9L(7MMN7B")A$H  X:4 %T%[4
MN7@>KA!VACL8#04B0 $,1.T!T"+-RA&0PO(%BS85N(!-6<<!8ZG@AQS80 "$
M8V(=X*8;1RW# 5HMAI_IP&099CG2: A$#!Y%7 .2T M$R*PRC&>3I"EK!6*R
MV8X75].;70"=3^]!" QV=X-F'ZQMZ\J&A=E<;'?;QS"X^E<7R;;\_F)QPX93
M$_A&^;#^CJMXI95$!5S[]-?;':)/J ,"L$_9 Y)Z\T08636: )ADN"'\HB9"
M%" !:,-'9W=)FX%IC%=@%B,&*X)O; $-E1,3RG=[ C ]*\,W!E !8)8>U54<
M ^@R42(7AM,+Z')#;S)8?%-H)V(>%. UAN4K*@5FS.,+[V58WI$B#+ 9$L!.
M4^0[#;084F=SI"5FU<8#H'%IL%4:[S, LF0T/2A"#&  E0$95@8;;"<=X[,#
M=U,94-(KA8$VMN4)OY)<4>(!:[,F\J4"+\( ^3 9_/,S(G<?9N5*/2$"<O8Z
M!U  H,(#V!="=2@&BY4N=&8 C+86R%$.^M8]#; !#J ,HE7^,M]A,OA1 7(H
M!I\T  E@(X*8+M;P2)@A+ASF,XLH$.FR 67E2//@  [  &;! 'J&(:\G DH5
M:7'1*_N60MU@4L-0'-$D*O/2 LI790%11S9"$CJP #\C'S9A*2?'3?=!*O/
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M69C#29S%:9S'B0C"Z0J0N0&VH1*A-1NSB1!75A L$3H2(( :L1W-(!\$(0'
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M N/UI5R AIW 1_W8*#@Q 5"A2=?1D7^C>@K'4?)H%%G@ 3=12 J ;P%1  6
M5(RG4BE5I88% .")6;6*)0[09<;7##25#PW $0]0 5=U'UT2(D1 (:'":+,G
M :!"4R&Y>I=4<YSI,][QBN"1BALP/N?!-T>A#!G5'DFC (2T&-#0)AR%8BD
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M^C^"D2C* 20WIAP30UM\) $#0 VKQ#(#R0D0*$:+D4,"X!NZ\!LFP"DL0 '
M=Y5,U$ ;P#,9XA3D@3*L*@SG(@:781ATTA09 !;D PZ:VU)@6S(C9 "FLSAK
M:U@6D1/^9->(XS)40W 5*= !B40AGL**+]2AJ74B[],!/%,TSWH!U.)8A1(
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M!0L$". '72S(@(?*Q&7! AWH^\$#N3#P  )'''&! EI%L';^%\<HP!4& R
MJY,=.,"AQ TH$, !,BS@0%-S'R!$!%6.69H'"3B  !WWYFV6 X@KD.5[!"C
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MI0O8PW,P64 14)<#*7U1BQR@@/\(4)T "L 7]BA /'IR %0T@ (#$ D'"B"
M<@S@>DGP6]BR ( &.( KM\M H"H   C Y0/2(X"^!D Z]U&"205P1*P84  /
M*& E!3( 8CBHA < @'-Q$4 !,, W"?3 +3CB5A8IA %[)" ) VA;C'0$@ 50
M( #J*$ 9&S A#*QD%*=\1;WR&+HFK<UQ"U!@#.XE 0-<  $'T(#N$."E&$$
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MC9,!\)L*M)>MU1CGS(>?(0 %L$C^(M70%S"3#V%= ;P*&9R/ 7C=_:B'E#!
M%^B(R6 ".*&=%/%5FR6BO7@/CX'2W,D%5!P/>3!)!"S X_D0/< *\@R8"?R1
MLQD UAQ/C#346X@-H,5 8G' \(G9!U1*%8W2$ 1 ?4%!%BF?C)V @ZP 6R&/
MV!S6"H!1D[R' AP/5YB%,5[  % )8CP 5S1  1"C>9P! H@4#Z7=!>C=\S2%
M!;R%+#[*WT2%YD@)W.45%BQ5W&C$IS&.<U6,+1')"FQ4TKW3U8R11Z5 ##;
M'Z%2YZB! EQ6[=5+=.&&CR0" G#%!H 6QED4 V"8V-RC!<3%RBQ;WJ#A JR-
MV"0!WZC^X!4&3B U2>15 5SHB_>P7!_<B@B($P- @JN=04%FI!=TPA" X\?
MB(O!B#PUB6MH@ ]I@0QZS\8U@)?$0%1P!06(VGI$18I\$UJLB $DR1>D0!-(
M)#LT4CL163/R! FP05=^CA!LD^#$@!A!@$NQT" $W,'1!\B8VI#1T*R! @N(
M9"I @+A=30,T3 ,T0"[X61( !UM*84" "XNLS)>HP % 00I "W(8@0MT"A1(
MWP2$ Q$\ 9)\P0YD@T-40,;=FQ/L0$4@Q!G0 !9L C'44P6$0A1LP-A\ 00P
M!B?*!6DPQQ#M% L,0W%(P7F8!'!F08T,AW"R0W%$!,%@!V_^/H->!*=5*.<9
MO,1'5<6;@$5Q:H@0=,".L,!&:,@^"(%R0D=34,8K>4AR'HI,1.=UL!Q7*,#;
MZ.98(!<MA@7-_<B3U&=-W-=,2 #N10'3A0:1A1-^*@$?L@78(<#^]>>#7H4%
MK.=5<">$%D;BV$=,C,I0R$:>&, R=D=1\,=01!9;<$83\&=S ,6(2D$&U02P
MS(036(4OJ"B'RH0$BB-,E-93 (6.&4B+=L9X6NB0$FF1&NF1(FF2*NF2,FF3
MF@983 4'( 9LO.95H$=@D(AC"(>88&EW!(B4'H<2T"B7I@4R$ =\F@ED9FB-
M'DKGR40+$,.LM2>0QL":JF@^I(7^%@@"Q6!!A=Z;04Q!BF+';+0 E [-#K!*
M3%#+4%Q )$E8F ZJ4)1'4?3,9$$%>K"H6+PG,=#)36C"3%A4ICHI4"AHC. 2
M@K*%,Q6HFWZ&=:&J%PP>A6*/$I3H3XR3_<A$4PFJ/KS?<SAHK@* 8C4 9F!<
M4&32"FR3TSP*BR .3  AQ4A%6'#)?\9$8:X 9\8$NPF%#X'8-)5&(8W'E<&+
M[A!I M GCZX.J$[HJ-[(GTE+/;&#F1G75BV:G_"6TT!!(T1!!2 8+3Q *JR(
M0B2!!,@!;&85<A0L_:%%;2(GR*"F,@#5=V;(Q,!F$'@ S_%!OOC!*4 )9^*"
M"RB$*3S^%@!D0 ZTB#&L29HE2@"\1W!U@@;X"-]5A1.L 1^Z0IY\ 044 27,
M6M@,*Q#FP!UL  V4 P!40&F* &I*4?QE2&JUQIEQA000&9<LE,.1EO@EQ*(9
MH"[^Y2"D4X;P! *80-<D@/CDAPTI0/%)0<#%#3&PT!C0$F/\P)_T0=[HQ#=Q
M!7B%$!;HR)^ EID( @ P";(EP$!(&H>P /($D_]-*:#-DPA=C=1V#R=,3MV"
M#<&(40I@P*>MA\IE$K9*VKI25%=)9@9@Y=82I=MIA=#%X.(2)H^!%Q\D0#"M
MB BP2.T.D0$NSI\4!UPH9(?E+A0@W!7%1Q]$#24<;4' "U/^K$F#(MP9(%P"
M*$.N3>B<\0V4,,X""$P7!*P2$%F4B95"PID0A )<V L?O=(4I< 4":-L2LI\
M2,5;UEEKZ LDC22[WH0E48  81):3!L$V-$#$, $"(!.2(\!8(+N>,\K>4XM
M 5!)1682X$"62%D*+-8"A%:SF2L'!$ $:%LX)<DW'1R3"("Y%<[G!=P*4!)R
M<87NQ($+O<<814 /8$ LF5)D20GRT%\+T S-CLL840SX&)T]38 +%<L!<,#K
M$)D2G%" O@("&Q?<'8 &!Q<2CU;\ L %/*\ 0  %P )*\9@]\9V4!( \#9/G
MQ=5[!-,"*%/\_%'PX814R$ZSX=+^?/R4!THO/4&3O$B) \36!E  51V7JTU
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MD *E1E8LK8[UV>)\R8/Q0)0,E@E0B5'?(IQI %I5S#B/DP4<$S2*R!U,2UJ
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M%.&-K5')JS@;#OE"(.<4B\3%)F!A7V@  '3 TS6%V0;2)'+)8K4H7O- ?9D
M^AZE(IR!#6$XXDKF>XS34I$!MD1K!? 0U=7+,P85Q11 #1Q221V!;Z8B;OY-
M$AHB!9"3T3S7$Q!!!=0%<HX3Z%C!B$R  6UNGN'9Q$I@\O@9U8C-O11<G]7
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M@4*%#-9$>^!=1L-E(>:WM[@@86P%#N-U ]HFR[$0YF_RZ]_/OW\;#\+AY]^
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M]MILM^UV&K!^8$$.8G$PP%-S&*!C"05PH-@'!+Q60 <%_'& 9!H,C@$!O@4
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M@ /$@(&[J", E#C L5%+ 2&_@ *O2@>Q8*&;\HJ&GA8@18NM\XX,J$=N+H?
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M$^!JA&82D1"&2N0 0X1'T^0 S08['] ]W&-5 2 0!9!M6I@-(H$-YO=TK#0
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MZT$-UH L")#,PH='E1!F,M ,R/('Q$HK8:&M9;!!<_%S^E3^!M-$!PLP"BG
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M;7" R^UMM@5-H92>)<"=;O!A[QL(Q7,&W)/<=1W#1Y=$BS./K3$E58<3)O%
MA#<"Z6!J8NP"JND!MUE>J^%E,0D$WF<TUB/2$ZJ=9S4"&WXP.F&"R>2(GQ!P
M&I !1N?@;N<9?D,K=< <%/#@?9C2 Z0.S4#<56 !].1Y-O/K0Q(5$9YVTV$P
M>O14%' !7,"L:E$9%Y .!T$(\& G&S _2S;-/C!5IR)DE&N"+T&.93 !$  F
M!Y$.<B1VH@EXL7 JGQ&@0P  PO  (#S->$L&V0 L&W!R=K3^#:4A" C?0_/]
MU2(%2D9#$<U0*1Y0.F M&V"]"F1P 9$R$8C: *20(1.T!N6 HX)Q$\CB"PZ
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M@T%"1\#^P 4@W@)"0I4# @$' 4:#0V"#4$'O  5"P\= @X&$QA?R1J"!P\+
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MM ]X,#R(T.,'(QYT8,$% RRPP0%Q".!! 8?]LP$'101@603=.+#$ /Q)P$$
MPA  @0=X>&#%!P_T!$ ',6%@ & %(>6"(7\XYD$ C B@@(L_P&-! U)L]D$-
M4UR4F08*1 !! 7'1)@"02V24  (^@5$(/%-(,10>'63PAP7-!)#!  0\H$$@
M"KP@04_'R1(3!5N(I@&-V "2@03^"'P4W@=Q2#=%?7LHT,L!!R@R8$A<*/>#
M ??%H4$<'O2H02\#(5%- @H4D 4/!IC7FP9K%'   @>(=A(@!43 R&3&#+5
M+Q5^$%=,?=CE0P<"4B##9"]P(-%H8Z65T:?[V$4! 1<LR!2RR2J[[%$5,/G
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M%@:,$8$%1, !V.C/9"Y2@00\@#.!N(#_*J&!9P3" BI@Q614XP8&B"T0 F4
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M_C?  R[P@1.\X 9GBAGR\9=N3#32I-CQP2,N\8E3O.(6O_C!X?&*:IC%/@D
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M\9.__.8_/_K3K_[UL[_][G\__../?G(SB]?$IK_]KTI_^>N?__[_/P ZWGR
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M0EPTG$3= B! 0&\H0:VLUB9]$W8  IJ1S@5YS@T9!,2AB1_%3 #@W<;PXP_
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MF:YL6Q".,73::O$HH_0$4/9'/_XC=%G-CQF '"5($)5);V0 BKW <&7!7Q$
MD:F&%/+^A&OF24\ 03&<+LVYQ>M<TD6T(SJTQ8?)E@"X$!)D@  H!R#5R *@
MA0\,ZQ!H3Z1$PX#@ M/B1WZ& 39$"!:$39?BPC1XX%BAC7I.PX21X6D@SL:E
MX+==RP9((=XY0*\"#S^E+@& !8)$R)$)AR>X;0P<F;-1D@$)9WU@++LZ(U ^
M*.% 2R' $9T(@@4X (D C-:1PKP8@ ;@ ]_@A%U50C#@A[.MIVFX38]0P/#<
MA;X]@P7XT$8]"H>*BVVJ:U&,CJM0+7X=02#0U0\\@ -,@,G6%8"@16,( @?P
M$R,\$YEPP&KQ3IQ5057V<%88'01([6(870-<:9XDBKS@PJG^K(A6<$#2441&
MP9G10<IFW*&]68H !T;H;(E6M(ZHT (.+6[.A-*[F%G9%,*8",(!D G;=# )
M"H)7%B2*Z8C 6"@DO%(/% &.T%4%O "HO(M>]D**3D " ,0*(S)Z]48?&"L3
MPVD@J-:%;, "@$47R2D,W"'8I06B\'!]0 Q;<HL4 <%:G$R$W7!'LD&1"0+_
MMHQP4B'-F0$V+- 1M (EL8]UE$!&18I#=DBG[$$0-&]-],A=T 5J!@(;X0%!
M1M?B^"J-.)MB."I9(1N!!6:[A@$$SF-1U&8O6D -F8;YFH;R'(!JM%("4$4:
M$-X/P,$E$X6/K8Y*<8#SP@];"17^Z:[0$L AC3E CF  W03((F_ $FA,!W!5
MG@3. T/#[TGH?QSL]Y )!E, #Z#5=4Y",.G(,]44 0>FJ$QD.P>N,:C %>0$
M&J2N^N"K09R*NUPIQGKS? V"O8'%'JU(>.J#-T57+R1 L81"4C&Q6"0Q3!9!
MR;3,BKR% E,#SI()^VA$6&0#UQ3T?XR5:>!$ZL:MAV9K\ K$ 2"(94RAE2UQ
MB=3485U+0K3,U/X 0A<D&>859_2"KUK7ZZ!%#5! \_B%"A#.\)Q2!1@#X.JO
M%56"NM1P!A@##ED-5>429 RB RS2OS[F?ZB%#/E DKA!=(&T#/5&;8:UP*JH
M/AQ(3I?^56&TJ"!L9S$HZLV909A<PE\D50FA5 ]:AU[HTJ>\@FA@@UXTF,>.
M </QTQA$2!.5$!G:*@ (2EM1D:]6@P"TX@N8RC+I'57]B EVIP DB>EE HWE
M*\XYJ0>BA<"V)\:^"5KOT3/4 %Y0D?^PD'TI,2CFX@O<9OY2%3>X503T"XT-
M*JI!EZA=A75(IZBJG:@4(MQ<"L# 0^E$"Y0(PA: 3L5H@]'B@KTY#L%X XD"
M2DV-B-KY$<9J6JB0*(5KQ440 D]70C*#J=QL!B]$Z1+4,#=RX@'0*K$@ O0,
M:KV^DS3X!^Y$%TF%@H<1P^FV@#[0QF30& -8108?@5LA YW^..DX2N<"P"=T
M74#83 W7(0,& @ V!&X35T&=8L*>/4,'O !?I.&P*C!:M8PA^H!>!$IQE C8
MF3E<0X)/R (NH-T<-%B_[(UOG9*H3<3YD$M !HKRY<!,G3@I(P8!'(  R!98
M^)@ZH)PAMO,M_/"/7H^=$H4LX-V#U; 7-L*K0(XG4(35WJ%/S$(5-)+-(0P,
MG\0$]*H$Y&$&?,?A1M>K/R6D(0PV0.4UZL,4)@%H&0\4A- )O .I:8!_#HA7
M8# 44 !4DDFK2U7 NDCI+'L'8!<,GP9@RLZKO[H^Z#J4?::UM7.1>H6UD0\6
MO#K)L:$ Y^136MM?A2\=OS 2G #^5'PVRP)(?0,F!LB)F0G6Y$":("3'JRQ2
ML4?% 54,[O7J4X(6&[+"6^RE(&A8@PF?!^TN(+""0&@)UO0>'.1)A(T-#$<;
M#R@?44C.!NPAN;]%\Y%*XIQ$B@0F&1'MZQRCQ@ (-OS>*"#./0K$5HI;Z3AB
M!7 7=%E1[?4 ?- SFO^ 4$27/@B6QGMC= $(J=%.MW?[,;9C?'R42'YCGHP-
MH]AK$HQ-!E1]+94KM W%U^=)@W4DUT=I-PX%KNE'W-=2W-]'VA,%A/1 BL+]
MCAT8U\.CU[=] $+?(');G=QAU#':]1G/45  U@V^^4VC!MW:MVGCM"5; EJ^
MI4D;N67^FSM2H^UEFN0G11-B/K=!/NJ/'^>/C2.6_'T8&\DCX5QJ_K+D95OY
M&J]5>\RXR%" 9=EC@$X^X[!5/B"0Y<_JQ_Q"_5*XA 3I6@]>/B.>_BBD/O6+
MWWM])E)LV%)4@':?%2Q26I@SP2/-/E&XE5W=<Q)$L"#$!*@4B[PI *K'S O
M/1$BBP"]FI+=3Z5]7/7W?^1Q%PA@UN==%O:)WI=:W,==7X=Y@CEM%?MMVHKA
M8#:="L5R07$R+U*FDN"Q-)J/1=')L#R:3.=#W<4XU4\&Q>.,/I<-6_<I,#Z#
M#'7%4I-0'@Q%X5'QE2'3TG/ (8'&<E' ,F' DB'QA:&!88?^9!;1X3'B0;%B
MX=$1L<-FPN,S@>8A =&A47AQ"5'VB&(!4<B"@< BP?EQ@+!"$>&&<2'(TR'Q
MH/#1 !,QT4,P>8JQ"T-Q(<QF^U'Q724Q@4=1H4 AY?X.'R\_3U]O?X^?K[_/
MW^__#S"@P($$"Q:L  #"@3D$".PZ\.# APD%)!!(\DN# 0T")%P8$*&BM 0*
M)"8@H #") 81!#SPD #" !0)%AR(PB," P4-,@" !F%8 P<$/C H@  #@0<&
MIB%HH&#.% $O#C@8=@$!!P(&. Q0( '!KSQ4/QCPL,& A0 .%!25,(T!24 "
M%#A \*7710P-IEGX&@F"  ,4#H#^I$"@@0 +!31T ""C<0*XOPP8P,*"0D(#
M.PPP8/! @Z-A%AI@X$P"*\4,!-H!^45R : "!CHX>("A0 ?-"LIXD(,TC@8$
M$Q[\"D \@ ;&3"70:8! 8H2F!#A0"+  PP,*83]$(.  P!J#Y,N;/X\^O?KU
M[-N[KT?!48<#&"1Z(" !IDJ:$3)$X7! !Y%4\(!W#FPPV@%7! 4!&A1$\D $
M'RS@P 11=(='8QY,\!$85W'2P0 :,+## @52,(%H'6P@(@]@?9#0!L5$DL <
M <B@00!Y#5.!!@!H  4& *P@P 82.*#! "1(P($ 5328&D<()!" A :@T, #
M$LAW5AS^*$BP  ,I_C2<! 9<<)TOBTSDB 6_H*-!- =<HE52M/" @ 81S&G!
M+1E()$B'#CAW (<'[#(6,!*Y*9P!#F#BY0=@(3!"!K5%(R 'C7WP  17P*!@
M!01H5$6AJ;V':JJJKLIJJZZ^VL\$"[! J40;+/5  Q)4@( #!;#R7X #6A/!
M Q?@-.@"(T3P98 ?(,"2KA%<90%.*03 0[5@% @! A&(^, +",A@ 8H&1 "!
M HM,T, %6D(0E"-1?>#D-4UXQT!8$30 [ P#<%"<MB2D]<4#I[ AT0Q7=FD!
M2P4*Z $'D;"Q@ 3Y0G ;! PD!A4&"=SR@<5F2/29 U%$\$S^@5 4<'!2'D2P
M  +.]?(+ WTYHJM7#K1EP:=X0##-L7'X$ &T'"CWP6T%O-!!4M%P0.G$\%HP
M:P8%4$"!P0DOT ZL7G\-=MABCSVVJ'W,F;"I"DQ Z;,0;-6!3'&8X!Q<-M!2
MI (CV-+ 61<D(N$#H5%U%P^_67( %& TZ,@&RH7V@4(<Y)O;"@=HP8,! 7@
M 0 <_";I<2APM&,' BP-0)MC#; !NW180D!]+.#& P8"' %!40D4J%:Q)'0)
MT0<DT5O4 @!TT @I!620IQ03$."! PWPF@).!Q1UP:PFII:4]$E;ZXM7,0#
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MSR938I$+BC"UNDZ$N&$M'R" -0C^D)$ 9,!Q7P#0'F[;C,NR 0"3*,H,I"
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M!.KS -;0OBL0OW;A<N>2-"B :R'C'#"$1E;  "4ED&9BOLOU5H8#,_?F<NX
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M\K "_3P0'4#0 LW.I-3-[@ YPTFJ^>S/-I308X.7IF305*4/?2 IV.QV#9D
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M 1Q5R7D (+PP, '=%?%VJTFU"%2@"F@PVS-0!3_@G.+9"UL<?GI!:J,P V1
M!4+ "*-3O$M7O,S@&!B0%P1]W'<" RF5 J#\3.FT;WRF=Z(&RI^Q!AH3%"ZS
ME4^D$RX)&BCM//E3!3ZG-]BU O>&PT/Q(B8D&^V@,06\8&*$)8F[(PW#9^.
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M?(DP"!\)Q2(R?!25JH81^4 >'</^0M*Y64#,)& TR-0H'$C$S74H- 15&&E
M3 Q$1!!8T"0<.G 0R!3\"6B,230H8+S4=$0X*"!H'-!4B RQS#@X$&"L= V
M"6!04#4\".E SD!T72B(?304?-;T'@A2,&#<#3502"!S9=#N>104(!1(:! D
M1 S5-J1=('# T7B$+Q1@=,UH" #FPP5::TXLNK)GQ@$.$EX\/+ )H( +&#(4
MF&! Q8<!DK(PD)%@C@8!]Y#TLR? P($!X%C-\$!@@XE7&1AB(%!0EX99!>XD
M8Z!  [X,$EAD",!P RH8%:+U2W8OPX($% 3%@.'!PC\#R&@\<+?&5P>)(AZ4
MF- @P@#^%@ZXSI EQP2$!EX;'/AS)$"#>10:+$JSP(,"( H$T7!PP,& # S^
M(+"0U\2A&1$0,!C5,,% (0P2,#!@;L:$+D,F+- 5X2C!%P,628!PP<@&!=1:
M_?MPX$J6#)SA! 1#8,Z&4@@FG)@004F" U82-*@1* [L!AP>$0@R4K2/[MZ_
M@^].YD.'"Q1H:4A@04 '#Q,Z$/K  0,"28LB-]126L@7&Q[FXU7! 17DM $'
M:"P"1WUT+' '!$%H@,$"N=4"%"'?U. !!M<YP$ CT E2!$$00&"$*UG$Q=$G
M&7TPB@>-%5"!!QMH8(D-"B20@8!(S("!!*EU8,$NNCQ0@ K^#H@0S ?#<#'#
M U\ID]H'$43W# <#T/A! B+0H!,V'_QUQ@<94.# !.%\P$4T'HAF@"\98(!!
M!^T(,D0%_=QCP6\U3*AA/U1(8(&2$ES&#$(?6-#F$%@\A&B:2GZ04SP-E#B'
M3$C<U,<'#"Q2TB\/7!8= 5E4H$&C-+CPAP-H;"(&!L-P]T!/''0P@ Q#"'7E
M$#XRP$!20QS 5 D_Q0&+#4)%(&!TMGZ@QFQ>(#.$>28L,($,&21Q%BUJ32!"
M!K+=XL2 -3TI7W0S=# J0148,H$O?2V0!06WK@&< -@".\LF"7!$4'2F[%$6
MBIMV@8$!+_IRID&&!+&I!!(888'^4J\100%]>&1A9#XES%! >HMT>\]>-"F
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MWI'')*&9VCP.N0,1_>$ J?%>C-ZFI1(<X.%DF%H"D)$N#!A&$ @XP/]L@ $
M." @0A$!$,XF1 3KJ9&%I8:;-M4A"+20 :A:]!3 S=R!$-E&-@% U35+VQQ
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M6!J$-Z0,J$U=P>K6W8#/)CA'5ES!XFF)+XRL?!"B3-+7-& HEB9F 5 ,\XC
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MW;A!4B8#->J&G-"I"+"P- @RVCF$$TP T>'"U]^)K!#1V6)#!J2,*4P "'E
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M8,&'"K(J'"!13<$%"0 P(%F@@,*# L1>P+B (58'!((J4-" #4<UB2083&!
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MR 47$*#L1"E*$(Y4$WS;'*:R8,+! HPTE"B=[SQ7P%:1P1"QL1)0:)%4'"C
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MYYS<WHX8[> '"3;@W6V).&'R37QQVV6!;:VVIPD&/%\A41TV';KR2@@%@"_
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M+0/0+2S@)7F8$47#>[E2 \$A&WC12%L1!GMA  + 3KF1"0OH37"8 %<  0L
MA^9%'D 0(HBG>PHP-WC@%2SS 3]B -P@  TP  OW<6MH+ 90AL '3T'B(%RX
M 1=@!E:&BG/3%1,  %\3'%VC15+^A!4(, "^I40(06&A)0KC] ]EU C==2HE
M,!3"< M4((-<2$&.$ "2$0$_L4>_8HSV90 ), !2>  &8 D -3<.8 AWR P
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MS&1=PV "O9 L&: Z7& #D90$!V !.()5!A JH^! +:A%I',J,98LPL@ +2
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M*(+P5 O@$,&(+X2PB7?3"3A0A_0)29$@%:(5!%UCAY&JE5U4-#)0#I35 !T
M9J!)$CB'MD7&)I^P&U]J!@+'  27AT2CC,]Y2YRACD3S US("@C%$=#TILGF
M) 2P"VM!!1P1@ &5 #L '@J0$;$I938@$ <PD/0S3>-0APM O6^:'],3# -
M91#P*QSL 17P!T8) 'G@&0*' ++^4#A7N!:^/(('P$_U-1("< #BH02C.!@\
M8 !&Z $$#!I4D <9N"6% Z(PL $!L"PAB(?(8 ""_,+_,!&QW B],( 04 T[
M,('#P(!)<! LC!/N$0"U2 $#]KA\E0 XF DI<H?M$ 46T"MW&(L%M!90\"-=
M8PDA^#YP< .1X3P/1YP<<38,T+.YT07G%@ZDD4U'TC01F*-L^&I?^ *AQ,EY
M^ )N4$ 3T,-LZ,$%T 2<272B:#Q6.4#MG #91#@U\)QWQHXX:$S\K Q[80/
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M H!A%0 $"&H 0]"J$+ &J"KQ P< -#YH."!$@P $"03XN(/@X5FS+"@D.'+
MPX6Z)!3 =-$ @,<J&/2:</G&P8,3%@C7B   VP,('100^]  @80' X:UP#!6
M"=:V/S(0B'( P3^Y4ACT*L% HCP%#3@\, ##%"T)&C#8CA500X %+%B.(.Z.
M!(2E+!;D7%>@=;VOG02$D2#@@P(":!(0" OPPP, )A0 2(QFZC , 6)1&#!B
M@E/P  H *RLD P)?I3]@B- +@P478""," ,9H]L'%/2"RP80:!&-:"5HT!,V
M%SPP# +^&'@000<5I##.A.98T$L[%U"0WP<3.-!-BA%(0%D'#UCPX ,/6?"
M<B5T(( $%[S5@#H/6#/! S.=L($""[3E04D26* !&$A! $$ONLA(%@052!9!
M!&AH4-(Z%SJ "P0 P$5"!-9 4",+-VIA89=@1?! 32IH@$,$$RA03 -+5="
M C[08@$"%O3Y 0->?G92DL)],"5M*S"@10.WB'#G!Q=@T8$M&C"P@ +==.#
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M=6?CV9X.< $Y\H@"!9!  G8@ 09,P#9;^X#=&K9, O2H528P #-L0S>/K<X
M%,#("A 0*@*H@S)1K$#?*F"^"20S4!98@+;Z]J)')4!3%HC >GQ%MVHLJP0)
MB(;9I.=+ ^!*63DTWU<XD!>RT,< TVA C<8WJ5PE)A>9VL_^E#! F6&>( $'
M:$]B(A.I$]!N A-(P 0D0 ,?(<H QLB 3,SBO1UQ#P$<X-:5(( 9O%6R '2A
M##X9EJL"0& '!4" _N1HF\IM9048>XF*!K  [O TGO= @P>> Q94Y<=[+ZD
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MH*2=@-?)M,:@98&^- 2H4,"WT([^C(S%&'2#I_0"!ZP,J$# A!P#3F3?<CW
M!@#*M R$Q,V#!*[(",Q &&! 23T />P-IKU$&,!5<:V,.2"(Z-S FEC#9U7'
M-*2;!F9*+U  0Z!#8@",OH2!!E#>.D  2)D##>$3&D1 VXS@Z9 ,>PF)%@A;
M!73# RB)%"((&DQ WSV)?_U#R0#*0[Q(8F0<6!&3,221FO0"@DB ^J3!,)3+
M!P)56ZC4;( %MOP'D*@#E;R']&7*+-F$OJC: G &!NS'"7"(.P"(@+R$OT5:
M.Q#3A> "FNT$!_2=,00;>Z5)(4[ ,&P CN!#I+E#)H(5+G3(!+#(07$&OG@
M!4SB>$3^0 5P!@=0P$ZPGPL4W4&43,VAP# P@[YH@##H2RIRAJK]1S"T0S<@
MQ!5N0$VP )K!!0> XC'06<D@V31HP#:BPPY4CC2"0P=LP),D2'Z 0S6"@P7<
M R*B@8: Q2J"!6<\ UA(XT[X E)8P^' 8VLP P=(X2L$I!ML308XFAQH#&]\
MH"@@7+^M0C8)9 W]@++L#FL)Y!S,PDFDGB*AU3K( RUPI$:V@''<P4@^@8^
MVAS\0X\D0DD*02Q:Y(#804NVP=@$P080HT7FI$[N)$_VI$\*I$IRH?])@$?
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MA5XHAF:HAFXHAW:HAQ9'$LRD(GTHB99H:(IH'WCD(M "0)(D/K1HZH$D$6P
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MQ"6*V8$3!D4I!01 GO9-YI'%B;M)O3V+$.%"X>4GW9Q,0\#+JL"%Y* !4B^
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M&#LJ,)B0@ ,'!1*DJ-FI8:(7#&#T%*ME=$,N"*$:/(BBZEPN1EY8?EOPQ4T
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M@06936)#UD)<=G 1BVR,@0253IJ*!A.85Q ;=590A@85V 9%1PCH<8$%MET
MA;0A28#^@M$2R!P!!'H$$,,$&*  =SSFZ.$UQJ&,W@-?$["$1!&K9C#!!8,<
M,  24?4=P2@5B)L2*Q046>L.$OS*0)%[V!#! T' +6X%QR?B_ <!X:6'(QH\
M$+@$6$S8?! 3"*89!0E8X)?U*%B@/'@00$!:#Q!8JTKG*TA0#@85 +#3,YO'
M 0&Z:8Q[P7H !8SE!@@<# , @5DO**# ?G!/%8*90 =04@8.= X%66# QAIS
M A"I(Q47D 8#]#"1!M1@(6OH2YCR X$)&* @J(B#,AJPA3I)(1X>$$ Z!G%
MYG%@  4X#P,>< #E/0 !Z_*"6)H" 0+DY@(.0-(F-J"  ^#^0@$ R)L9S,$
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M>%P#P*O.@BRY0$G-DZ;H42/7Z@;I9@B76B@RDR=>JPKR. K@*AFS)QN+H17
MRAB(Q!Y;N;6UD1_#(1T PAP>,+=]H0,;8!N)\QF>8GP% ALIDC5=!'5BP[6(
M,S!]"QZOHHJK$2D@<BE7)3-3N@/+P0&7P@5N(!JRB@*:$AIO<RG2X!ZA>Z)&
M,[ S&P]4A$#6< X.X!49EBHVT GG4$XV= R(HP-?X $ 44:_:P"T.'ZL,H-=
M8 ._.Q9<P*(.L A"\ 9%XHO24P$;8$J)$0%4^0;OR7,',P&^A(LD\3L34&7]
MA )98E7^;U%%:0  A6"=:-"4'3-+F9HGEF9>*Z F435F=,&/DF)LDE("]3>
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M*= P)^\AH9&(A*X/< P'^'$)QQ[^(R3@!&4\^;$ =2S0P!3T03H**J%YPK5
M3,1 &W78BF:4T8G26"(A9NF9=^C#'@AT!@\2H. ."*B,"3#G A>H  -,I!DX
M2@$##FC)THZ@*P\, %D-J #E$F(:"3" +_%@@*\6) $'3."$#Y@ 01I@'I\@
MAP-KI)P&%M"9"3# -/8A) X*X#0/-6 Q*RA \F32 /U,<C$<H,HK45<L#R3
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MDO!IH <3ZL0#G."7B3@@ XOU2 D28!414-8-!>U-)WJ1A-\.  *^XIQ07V
M"D0 !2P]45V_X0$!-.!]:LL 6>YFRUEIDH3U:$ R$ &!!UPC&=7 (@0:P)CP
M-F4A0K#/ ')*%EV)< 4R6< &$D";3EC &"TIAVUQ0H,N6$XO-?"##R*5#-K4
M@ $1*,!34OPI ;1$.#SA <V^D8&%-(US&=A )PCP &TJP )CT)[EZN&7%"Q9
M!7W00%DP4(\8/^% /4O& Y;%V6?^D*RMDNA$:\B A%K P:9V<6B'@T.41T9
M /$$0#Y=D(P& "%$W:G !NAP@7H0+S%D>$U0YB"$%$S5IA:X0S5J)8$<"<6%
MIDP'!*P+@(2@HP!22O&/51'2G512)"DP1ES+J8 -A$XR&X@A6N2W@@THP).)
M)(US$1L!+O/ ,6 63@2&_)H(.$(ZBZO LNJ2CQ+$P;9FL6D4>E,!* ^@ QF
MP 0$(!/2"8(]]0A.8>;0F&;', (^<.(C'Z621YI-!;_XP4NF(@(%7$(#1P#S
M3C@#B<F9I@,0&/@/BA:Y)R2##Q$H 0*0HF@>!  PXY#0(W&<.P/,@&<!D&C&
MA^ !1'C^(G<'4$ !$H"0'_3%51RYPJDO+*D/4, *13A ,D2X&D0^F%B.*<<=
M'-!SA4.UVL4P L#OP!L@#L 6H#2+$]$!.-+X@)TI[8T$,N 'B["% P4(2B]
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M_,46'F#/0FB!BH@=IIG%':"9V.G8::" 4N7'Y@F "V&  (Q;)UQ"5'7;/!"
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MS"V\D&30K*-<CJU&W?O]P[[J2R?PJ+0 7<+" :7X7ZR$DAW*7*QPUK.HC:Q
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M0C8/N2OOO'MQ\( ;].:K[[Z<16  #<CQ*[ $ 5PA\,$(YUN!> G_F(Y%[3X
M  STOD,O!/,TK/'&''?L,6=(@#EO@YJ17&$+)N^5LBH>(&"PRO2NW)G,+'^,
MLJ</K#BSS9E50.7-6NVL,<TQ;R8ST?(B72\&(H>;F2F<*>U'JO)V<"[/6&>M
M]=9<=^T9U1M+#?381G<M[FY7[Q7^7 ?;@CTUOV)[;0:]SFHV[=QVIXU-($0W
M#5J7GW&P%M?6[ 68EYT)#O/B):?K=MQR(WQ8T.Y"K@!#-D2PP0%*!U(1NH>K
M"\$5*T.^EP($B-V )J8'O=/7UQQ ^AYS<98*Y"FW7H$T+#2@P"("8)X9!JF[
M4 8VG&?6 0$&&%" ;I&?[/%P3ONAP."J7.\9 ZS[X<M-FVD &4#J:M"'9W69
M_YD#Q;1>?0L2$ !^DK^O;H9=>K<P 0!$YJMT8=&3FSQ*UB"BY8\S"@A8#A;8
MF1&D9B_Y<P#%TM4 S*V'9:VS .?89@.BR$P"C; ;B3J(MSUDC&3K294%;F(/
M,VS '$;^*T -Z'1!;BD/2=+B%LF$90.V+2-G?K  I@@PB[ME9B#'*D"\L##!
M41A@ P%:8J_$Y2PQ<<M1S" 1461%$U9U@&H>R "2A'4N4LG&5(Y:U+%T8ZI2
MO4%.J,&4#:S51?IX8 .7*L 9LS7'7K$@34Q3A7N8H$95C*DV:R0* G[7Q5F=
MD6E$2( "2&:!+6Y 3AD(#I!FN*AAM:I!-;'/ >KT(SGZ@0 A#!U@F+8H<S#!
M6PM3VPYH4H#C"0( PWE !JYA(P]P8V4*$$9#A(C'"TR #D"9DP8@P+<+?"=.
M!K-0!)"Y 0D$0@("Z(X&'M F'S L@ VK@/SP$00&+$ "&B#^0LO8HX %O.P#
M"6!  5BG@ (PX%P'L><YY%>*12!%7 I(P ',P9($$ @ .OB=!A1P@&L,@@&3
MI!,!DJ&!!!C@GG[(0#MO0@IY+H0.#VB 3!A@!#X\X #%P, "$O@;!7"!1(^Q
M ">\,X$-%. BFJBH"&ZB ,4$9W/ X( "> *$'"P 8A<8:C$0T( !S(D! >"
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M4' Y"&SD!BH/ %!0X:F%F^ ;$C31Q@)\\9WH>B  PNJ#^N:I4M'684/'J,
M-H" 8C3@)A=1KT@#D(_@9. 5W@$"$EN0$?7^;@)FA4PPK:D*!ORD .Y!":,[
M]6OM!L!W=I#+$+Q3@\U-PM$ R$/]^+.D0R_T 4L$<L,*88,G4L B NA !12
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M#2,!\] RJ(<J$$$$+X@%\+"!ND05M"-1L" #9: $]B* !5!=SG$32C 51Z
MDT 45)$*!A4TCNA4>W ^+$!Q6\  U^!2\#1?;18(+?&"J:@(M7$\! @_<Y$.
M03 6BJ 6HN@ '%$,C/ C?1!LT-A])X8-3H@2$(( Y\(/SY<D1#0'(?039M
M&<,(6B8FL'8%AI8!=7$^CA=RY@=/3M$(@2).?T =5$(4*[4!QH8-3?-_?_8&
M* @1(B-5'' $4;5X(&0!#P% Y 8;-V$  I #QH9P_9$%H^3^&IH "<W0/S\X
M"%9X<RB +W  7U 05>*S%($P5. 6)T#P9V_Q.R/19N?0"#\@@-93 ?QA%O!0
M@PI%90@  SJ!/^I%"L/P"[A!'4! ?[XP'C9G !F237H1/^(0:4#0<_RH?'@C
M !1@>#4Q9\5 EM.0!<DP%4LQ"\^QCSU% 4 P.2T >R28:PL&%01V#FX155
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M?7-6G;"W%_^G%;(#D/%%,)@R %ZQ5!% >)NX #)#%B^'8NWE9B:0 -4T<$3
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MQ\ %AH!AW$Y%?4: #@FJ#*@!00 =54]B.-B PD&2 54:4,"$ 4(8" \PC.!
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MP!6S\)T"J+1G6= , G(FQ0,4P" )&,#FK."!!"@@ :RZ9 9X&AH5&.  B]A
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M":6<IN!*G,@($,@ !>B0!)0R1Q,_'DC_%$59N/9$)6CQRU99  P.!  3-'Y
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M*<$[5,JI+(*%$)L*=!BR,0<1-$\,C(DAQ O:6,C++%X%T$*IO0)+<%)QV(
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MTP#1_$C^P=D,C08@C]1 C=,$21.@I]>.UN'2+<#X7A?@$.\D@90$K^M";2%
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M23S/_T3^F"'3TL*L+'RN@0S-SVB<-@3,7@UB@^R?0! 5@/W2,=R11<AO!I6
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M:"B+L(+Q]O8 .G"/$4-*"#U@  $^LG"&C&QD"+V@&G UX@$BX(03+#";15Q
M.1\<QB$*X  "-G(;Z@"@(X"2 #U"@BT1,"7V)+"&<C0")1L*E!,R\$=%)*5#
MG\E>!_3^D8! E-$</W+".SK$EEF>!H(; IG5$((("62 ,RN@0R+"ITNO/6X4
M]#O$;3S@AD;TY@[!R$ W'4$&!#+%B(YL9]\R$ $_0<96=<  <B30@1JHP *K
M,DF=>/$M@4D@ "K(@P%>T"L(Y&T !=C  WJ%4)M<8$I&$M*A'F"!GED +!YI
M0-5VI8<55, &%G# P7ZU@J)$3  Z*H0# """E0VD%Q-X:"[88U.;7J "1X"
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M-P.!! (2@$,90CE  #O8S$$OD)3MX(4. AC)<R$@FCD(Q0),)B !%I ,7:@
MEA$PP+<&L"X=)2 ET>B)&TEU@8A &"7!$%(%3@ @Y.QD!N9(I%L@L%>V\8<-
M!IC'!*KRT\X<(,!2<L($.B.?31!BKXXB72BGP"0%<<]1YZI/Q#QA!=OX9@1=
M2H!/T6Q1>X+R)3K>@ ,6T W&7@$#Z.D$!S#0&<I6+A];&&P[2#46TS!&2F@!
M[ $N($DGU&D/U") 7%U4"R<]P*-=8!XBPN>![W0"L C(-@46XZEH%> V32A
M!&)UAP_^" !"IK;L 3SUF(TAB#5_@%-Y9) =#42$ [!.A@>8U $!;  M:PE
MY0Z B;F0#@R*'E%"()1<!ZS!$J_N!)'<LIQQC P3#/"N(!RPD0@(0!CRJB\,
M(I $?>P  P"8!@8\T!]]:V "4:C )GAA:@1M(-MZL,J$?]X\"LR&25@6R-0P
MD8R1E?@#%$"ZGXKS*-DTA;6",&X9N!=A PP%(+[(]B<Z>*/R#$$ 2IG6'KI
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M,"N>(1.95!$2=R.+PPO3PA/RL%C((1I8=AD<<!:4 "\FP $SYS5YAPG'! ,
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M/QT",(,#4.UJ/@-I61'D 0QPM'(EJ1L@ BD2"?_1A)CK(>)Q""C'4>O#"Q1
MM'H3J&_40-:+M%,08'N#')NPMQ; 4 /PES<@  4@ 'EG86US"M<7  5@!O3
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MFK%VB- 4$L!>;" -HR7!PM &3Z@/O1+0B3!ME;<M\^4*!8$']S-&>'%,>W$
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M$R4+O.!JD:$ V@6/ ,:/&#$DVJ$"1BV&BL '#GP#" X=.F'^$Z;&+]@("]P
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M!0%T2"#^ (("MA\ .*D*.)8I<-MPZ@R$P0*G#PHV%*AP8=F#"!$8?)# (,,
M.. 4V E"3(4"!!C8'>,2+;"$#0(T%.C@('<2"H),2("A$61F!SDD"?#00<"]
M)2@S/$B@8!@)>1N6;G7TH$,6# <:6#"@ >'68X:6> B 0$.]#Q, B*SXH0&[
M U 8U!:P(:%"5+4"4&0&;A(X8%0"+4AP#0,0;## !!8,4,$ VA1@1S2O:6 /
M!Z )480 NHFS1 8 F(&(#15B0$!\0,BA@0,L*,7/#P<,](, %SS@&@%0+''
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MCE6?P)S$"_#>"M >%*!&/NU  0@"?I"1#; 3)%P3&8P!P/P.F)A"Y?A !R@
M*AA*9LA!";'55EP 25A&#2%#R+#+'GR( ]3%*1A$%K4)J/  2"",3DC<NQ2
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M!*PB;,T'*A1 *>&31X3& (#&DXB=>P .APA) J#">K3%?'R&(SR$NK#'$AB
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MO50=WFP)W'0$@14!OA8!?C TB D+/."(/PCG#4&.WJ#$M6B'Z3P+!5"<'6!
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M.#H:6P;#O-A*,BHDW-!0\@ 'I&ZA.=-;2?@88P3F/[5S1V'K;;2E#H3GU?P
M*.!&&,P([7&'=V2"K0(.O.E/-HP"+]H :DNH 5P$120 ,\E2I!<8S(@12/*
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M@9X*8@5?$:F%D8$!IG4DGP-PQ;5-!+T)00*3&(29TB!\8..!<AF1\,8'' A
MFVDZ-'5! "E--5 #26P09@"IQ)  4CDT<(- .W[ QP,T0#:#*1T]H-H(78B#
M06\$S/ **1P)P5X-6PP@Q)FC=3K' @MH$(8&@\& 0!@J<9":!@3HU4$$&BQ@
MTP%67+N2K,.B<$%G\PVS"PGT;,!! D7U0P^G R!F7 !(P>"@'Q(LL)  X&[3
M4%\P2!'^BG@7[*C 4P-0%T 5"\'@0:5LG>5! A!T)X8"0$7@'  8M$G0QA-$
MJH$""VR@R4-F+>"! 8"4DY$ %!AA 5L4M+9&!R[(]P"I-K2Y02(Q:"! Q!=/
MH EZ[MTPA#9QU8>-KVCX%$,&6%Q H3@RW&"C/#$,\$H]$@"PP4D=<E1  Q.^
MPX "'N#:- $7F.7A R(DT4 >TUG:P $56$5/!0^,%0,$<!#@@5@M2C#+W18P
M0*.S-;P@8P(7/%# /UT0T*(8")Q7P!H:4E! = )D<.0ONC@P3!@(1*!.E[SW
M[KLRTN$P@0?;&K"-!-DN!P M KQS1P/AZEQ#P( C@"]Z!1S^8  )$QR00#:O
M2$!I0O3"O$8"7? @70.@QT!?"16_;+Z+IG00Z8$8#  !:NR?*17['3F  TI1
MA%0LH"'!PEL,K$>R$MPM >,:C*^$ (7A240!2)' "QR0,OLDX $8J @"-H",
M!"1!+]830]S^X(:,S:,DMP@$'R!  (6H4 &MV$ '1E& G(U+ QJ @%3V9P #
M-" U&##8%@ZPCD"\(CDH>$>=_,,IO,! )6#8QO>659.YV:HC$*3'Q""0.1CH
M9SX50, K(#"W=UC  */86!@TAA'Y!$(]7(D%!!#0  YT@#XX*\)!XJ2+)-2.
M 1>P#6<8@"XQ8$!S#.##$99T@2#^=" ,/ME#"?*SD#[" G(?F("&#B2#)X8/
M QR0%5B.(X,P9,XY8@@:.S9@A0_0$@>)8@E2'BF!"*3"=APPEP2&!P<81& /
MIWND32CP @MLPQ&]'-<<(N !#43L?9,,& P*X8%[K$@,E^P(0FYPRY2\@YJA
M?($$DI4WFHAA>//PRFC8(X$+2.!$'+@ !J(C@PIXH +5H<;O!DI0+4VA [YI
M1ENF4,W)E8"AX#S=,JH)@PWP0#&/Z8/&0N+.#K3%(&T)4@/>A1!P&F2B*(6%
M.Y]!-V8P%*(J9<9'>;?2@C9C""\K4I> $ M,Q:*FOVL 0 W@PF5,0*<VA85&
MK(61I#K^U:5/E0 CGCI0!;#(JE1-*E"SI!<-'#.K8 VK6,?J# WLH9ADK8TR
MD)K6MD)5&2N20%%Y]X#3$:2M'J" !M.Z53'8DY0U[:M&W6H0F SV&7WUP 1F
MZ@S!^@ZH&.#,27OG6+6ZM9J,):QF-\M9:%2VLZ -+6<YT-&L^(ZTB,WL1#^K
MT(%JP*ZJ=:EIW:HG@M9VMK9LD;ULVH%6=8FT')"H9W$[6=]I0)NB3>M2G)$!
M#R!FHU@5[)@(2T)H&",N&IC 7%/JC(ZDL0>9Y0 IDWJ!#+Q1K1@0 %O%0)W.
M';89*\T?*7/DA_%REP<,<&$OH2+89R:/&09 +@=(] Q5<8C^K;-C1A?  8T'
M;&BCU7D&!?29C-[)I"(P8$Z6."!09T2,=P12:H<M#$''B0%1&<IE[X(P@36P
M%A9"90>7O 96%"77K1EHZC(4L($*H.1Q7%Q& <S@5K!  P/W"%<$[,L[#G^@
M"FRPKP76:U#+UF"Q*F8#E:<0FY0(][,\\&DC@E X*S>#A3PPV;@VBM"-/CD/
M&/ *3=J<$8G0I,70*(.M*AR#Q;H9%F@8UF$AJP.'UF2.)0C).Z:@A0[T8P<\
M"-*3WTH.1,- .#1!+4*K^Q@LV3*1G'(N+ ZH,>*2]K6<:M7[>D ;#@""0T%N
MF@7:HL]87( $KY !!L(,@0VDHLO^.0IOD):%@7?9<@,9H(#I,J"O95F3T'/8
MAXS]N@%4$N(\':CUK9^<L0N\P-$DS#:3K=D1($;V,1?0Y(W3BN2XZ$[%&YC3
M25!TC_S*<$FQJ (#X/+(B!R'AOHN)FR0XR(@/$4!<*%W*S5" 9D5P+?U+0(?
MN/)()=!RO*G$JL0?,#G;\9%3#1C%B@ @5PAD  !"O4%0[J6)'3HELU)A@$1+
M&(:@%& ZGT! !<+08N-9  !HZ%X]8# 2""( "RT5'=ZDT[@SS0,!V\LGT&>J
M %99#P'%"@0#=!Z+"121"(=PP"R(4?&[+*!BD&$ W]HF 4'?FHHPV]X[#H"4
M!J@C8V7^5B@:CC[7$38%?;#  "C 1I\E'LZW/(#<-!P D#)<3'8,N$WW&'F#
M 1@O"3-0QW8$  'UP,);.%R% %@@!EO$H ,)V'ID Z  (KE(>RNA@ $.D(2J
M=[A3\3N [B7Z@ $ 0+O6N\T! -9BJ/^S/CBLU,CXR!;61 86MZX; [:WAMZS
M\2)Q =Q<(P" B&QD]A0)@ D!H-<\Z,0!><B) ] 6@X0PP R[D/%%_3  !1C@
M;H-(7 0,P$$2A.ECEC-K R! Z), RI=A!>!U(20 $=!#2O   H!AZR96W?,!
M =!'J0,+\B%X-5(QZ%(**/9)Y44-)3$!SI( !] 3>,,^-<#^(IH /42S !Q&
M'5*@ ,;Q>^+A+1+H!S>P "C1#E]2 !P0 <N"7S9A !@@"!YP-PN"-ZDQ."XB
M 1O@+):##1C@"+BA)GX0!"8$"QE0>P=(#GR 05/V>DHP 7WA 6C7"[/F(R:0
M-]4'.3<@!7M$#B?C;?_%!MNP?G[P:%<4! 00!@ZV+T.23*:S 2>@ )K2%0]@
M ;<Q'C92%_<P$FT22FN0.K^!?C5 !BL1165(#E0&3LY2A[5Q @!1%[%@ !R@
M 3<2!P(2#DK5&H,0*3*$#0N! !J4!^ ")X)& /=  1 @-AS"*K"P+1^@;'&!
M5)AF*WSP1N?5 I2S+Z17+5K04W/^" A,&$N#P %\4P8Y%@004"$ =8DO@!D&
M45<UT (7@(I^A2]8X ZV"$H+( %"5'%Z(P80X"R9P$U*D(3', CZ(!U^]#HE
M=4^P0$T>0) Y=@.H$P3/=P(6\ K=0P_JX3KC(CE"*!:HY(<?H"-N8'!%,"\N
M8FD3"%:E((0N$F1\0 &<$R:YDP5CDED"% &QXS5.]A$I87([!R#ZU!HH1G (
MD %V%T3A2 V$(A"PD$8=<@ 4UQU"" %^B!H7A0(=80(FH$[>-C$:Y&3BPP;9
M52F$$F=J6 %B0I*+P0O*QP-'\ #;L")],PBI\3-:]Q11%DHMPQ9TIP=$< (I
M^&0Z)P_^:+5-$H$-EY1K?78/2!A*#G 60&!',U(IY*(SB$&/%M  M!AEB^$
MHP 9@/(E2=%EFB%H+B(.[#$$T) 'I"@&)[ 4'@(+IR%H:N@$0* Y2L5!J3((
M[,"-C;ED1& "<1$=/!8 4S F-4=@(7$Q_?$L29DM"?!!FL,<&_ '-(!Z'5
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M\E$ J13I"1&AV0%!#8:(&,&-&D2Q06'1N'*%! O\0@,','<IB([2^&#83I7
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M-"02LFFMS'I9RY7UWJ[ A0EZ6LFMK@HSG?5 /@\'H-MZ$J#M\(##CN9W5,$
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M@]P@%$B!*K5!DY2&)ZS ^>5)1 I!"? *#$S*:#K9])V1KO"+RPB#R'0!'AQ
M,2@ OS!>T%3*OF7&"V@("^5)\?W :,Y+$CC!(U32P_V%XK%"JRP<) 21#=
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M#%T0?(+BH9L0Q$,G1H _BB>X04 *#0 <9)$=>$Z%"D P#$ &0@<>&,]V-$F
M'$$M)$'WO ['9,#(?$+T6H K6"/^R I% /X!)PV, 1S$9"QL@8(E@B*&'M
M('F RQ@,G5+ NJE28$KL9K;@ )A"!40!ATY?R2),$51"8:B/O*631AP'0NAD
MK;CJ3\'$ &*,! @ !1R$$.3D#?H"$3H3V2# 27JH&='N(N@C,+'JX9G!!@C
MHP@ !XD  R0#.>8)#8RQ"%1*GW[%4^4 'IP2)$5*2?:E!6!">+S?40W)-1UI
MFZ!#YJCI&F!!G(C%&'0*&(&-E750)6UF =CB'7[;$43C2C33-Q67@WRQDR&
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M8:$0$4&!<+/ D74# 3!A(+%1(('PP$& 06#A45 !H<!AZ< 6I$'0<""A >!
ME341YS P)H%FX9#GV.O["QPL/"Q\L61QD-+Q,:"Q\/!Q8)% T=:(4P&@07'P
M0>#P$>BMD550_9#"H1+-$#'@84& X]%F\+$ Q(HAX('@H0$DRP5[#: M4""F
M (8:*31X4/!A2S@$&P)T6)@A P-O-A)(N##@@P5[AN9]0"!%09X!&#P,X.!
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MMUF="G.F;,51!SGD&4"/ A-D]4$#"DCU@61M0(#&%!8T (3^!PFD<A0$"71
MAP<]8+" !- 4X $&BF1!SP/@5. /!ATH^$<%6/11P00*7-4@@4$\\\$&"X;T
M00%8X)"! &UL%8$#&@Q0000"7$-,E%).2:4C$VSDP0,9+)&@!%\\<(",!2"
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M A(P@C9X)'X"S10 .$4X%3"I$)[^L8<#Y'$J6TSB)+\* $!P$;]ZP2L $ '
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M: 0&N%5D;FD@KYGBI@TV4!E'<&#/EFN)3-*45WK IT$ENH'^!CI  0OP*B
MN@B>,=!G>#6B1*%N4",V0$[R=8 #O2LSJTW]$TKW<4B>H<<U'&*Y4M/DTFN4
M3L7@A0$\!Z%$G+H!!Y:A@0M$1M*HT\!/EA$9S_11V);F4X ]Q:8)%'O:W52V
MJ2VWC-L!^\3<0H'EWA3M73OB5?  ![>VW:,A7</<CL UN(T]ZMI(9X $I+>_
MZ5'L9;/' ]$.UHE1I6@^86[A?#KFL-,L)8)O>.(4KWB5HG <;EE\CYCPR,8W
M3NV/XZ"T(N_%;!%##!;]U:$E;SG!+"9$EZ>.8L65N3#RYP 2KP[B-H>7Z&[
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M(=;A !'61%T4 1!P;&YD*GG2 /V6 /10$.%5--  #OYG.082'N3@.ROU  #
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M!@+P9CAHD(06RY8N7\*,*7,FS9HV;^+,^=(#@ @<"&!P0([)C0(8?K5[*:'
M#0\$)E08L,I")R0X2GZ8 * #A@<3-D8P (5#/#<2'# Q8.$/A%DT*$"SPA2M
M!0 :+A3H\$"#6 08.BR YN&"#QP'"&1P8D\"A@(6)@C$L2E#@S8#&EP@\&%!
MA0IB&^R0V"B2K @"TMQ0P$2!A@<"-*CD *DQCAX#'7@PP.$LM \0(/#]H(&
M'K>V$1 S\+4";<\O'F0 <.$G7R8).@1B $E)AP$=*D2F)4!"!P%'-2?PD2R#
M1SCV*&@0^(!#A384&%R8$=6-!0S^;<1$PL)6HS7%S@<-=)6 !AQP,< &U&W
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M;!PS 7;^W7  =$ ,NHZ@&0X(@& W>&CE0O8N\_Q&$JW92B"@N!1_^>0T#GC
M'RJ0&41 X ($PT,R-)"%-TC D A0P+>.(!#\-65B%1/+ SKQMNZ<)9OP(:H&
M2K(\KUPH 0# T\#<8#>_+(MZ5(6,!RJ*@\RD1CODW,J3EHF!95)%$0-0D@@*
MH+@Z78,"0Z"7!R2@S0*T02%&+("FMM*WI9R-&JR A&04NA0('* PPOD" P2P
MO!$9Y@#PZ$ C&P!.FPH##HO(*10M( !-L> ROK('&\3B  *8H0-+H=?'4%N-
M_#%@0 P)0"O%\BQJ:#0^#E  */S5 "M-P"/8:R0N-% !(OC^:P04\<$";.?+
MYT(WNH12K1*T\!5:/& 1%+A.,EL2E&>,H:MU/<H5_G2#[/IF#"^RE0.^T[8=
MD,$)._ A+90D 0@ IGC)RE=!_$",#L2@#E0J*0[(*1PF'#)Q-SC6%I[J 0\0
M PH>F #;&$:+"##A:0T@EDR]PH&9":=F0V+$#"(,EPM4P@(0. J>&$ !"#R0
MC:=C@@28X(%*M%(X.O! F^A8D)4N@L(R6X(IQD!9'L"7# 9FVQA^ ($F]V[%
M6>$ A(]0D+-.X,$38(PG/&"!#+1#BSVTP7?JFTP,7*X#E2##ELE0 8FX*T44
M>(@%/'#6)JNV'9;$EG$E,+56FN_^(EF^BI\O8&<;M1(U<W84#EP:/ ZY*@(6
M,%\>#+T%0-]@5!E@T /'@ $4EBW$W+J !*8GG+,Z2HL,.@+XC#@!JK#Y AI(
MPV[JP($42<&]DO'S7TSQD!MXHM<HIC5 1]T.#!!+NLI>-K-I$@&"--MU=BNC
M<Z-=ER03B@"$C?:@D,WM;[/$$^ >MTT(1.YSHSO=K!--J O%:.B^6P,V@O,U
M6O)N0MW;5893W:#)G>]UN^[?ZAYXWL"]:H(C/.$*7SC#&^[PAT,\XA*?.,4K
M;O&+8SSC&M\XQSON\8^#/.0B'SG)2V[RDZ,\Y2I?.<M;[G*%_UO@+I%Y4UYN
M\YOC/.?^.M\YSWMN$P]PBN;/#070GX%+EOB(=0>'B8QITH&E)UMI"]+)!C@G
MJ YP*ND^WWD9+@<' : !!Q]<L(T)C(/*,.(PJI"1=E3S <(L0",6F)7 YH$=
M9S7 (H@06)$BK( 64$0E:V:)8F@AD?L 2N@XT,#@WXZ0O"QH%5:G!<M8\D,$
MY513];:W,P)%(J7E1 $1?NZ':<&/EX6G)AJHV0TBP,$"-)XFZK*(*V#X -;C
M0'LTJ7R=8<+/R;-$92]K]Q9@,P)<"<<[+H$   J @&O91%F%DD  '*6_+5R@
MR5M?>9C*YH$!7&8 VB+# .R2F@#<8#RT*(!T;@"1-0"@% #^\-4D*A =5F"M
M//B'3_./  "3_58XB(!4%81C+8\V2!]+B _&M,2DM,Z[G<T62 D4\("A"4#3
M;0$%Q%XD@$&F-$ '3("LW%#-;8&:F4),T)QGP02C"1P_-0HMT-K1D9$"WI!$
M )_1.8H#XH ,T5$6X  'L%$&L%'5O0PSW4 #E X!H$:@41.G<$7!+<NR0$ #
MC-Y7%<0&Y %+;-H-& !+L089F-HS7-G-<$ZO-6%X7 P ;<#E\ #Z+4 #%!T/
MP%D6GEV,'$@I/!VMS4+53=VLR8R-8.&J-96C<(5$^,@:2H27U08 $!9H@&&*
M[(/[T>'VE=PGV  3M8@IK( :\-7^@@W!8F"?K\Q4S!S10$38+62 R2Q>ZOW"
M:6A%BS   *6&'%Q3A(W+2XS+%-87*;2!!V!!V#U- F3 =U6*;TP*!%"  33-
M;D&"GCS 4WQ ^7%+=&Q$N.R!325*>MA(?"3 GE$>!!U4IQB70'# E[ !$T0
MWV@*QUQ!CU 5.EQ/0["1"HI=.#!! PB,19S-DFR!5\3B>;&"=\3"1E $]OR
MP! !/J@&,Q3$K72"^#C YU0+ (37%QD1!A4&!!2"%"@  A# #"C!3HT .$&1
M.&6 6'2!SQ"!Y-Q#$: .&72D $!";MQ%C;&$\6!$ [P@%W#" $Q#  R :SP
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M(?R,'W#"SYSD#%! 8:2"O;E!)>Q!YYW7V=@FD<27&30#QY !QE3.68I! \R
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M&/S= \!1$LC)!,!(>\$&+'A J#:%^M4&?.D!.J:$/*N9"8B J+XPR&4 '%W
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M#P4=" )D4WHL# 6/#GJS#@X'/-C^0W!AP@4<;Q(,\/!EP09J!B1\.$&A700
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MQ<S%DF+1:QH?5-?/3&0M:8#*-N;^,@!3H70H@SA  2*1HXG]1*]SD(.LGC
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M]!$)"O 7)_ [IY(9T9@N]4,.'C<!"4 :[Z, GB0#4R5^$"!&[G@+@C1I#O!
M%"A7(]"01Z(RCP /!Z$,@. 17-(&!! K\Q4 *6)2D%83AZ7^ ,LA$Z&B!Z3
M7D[R!&-@& RT RB@ + 5!-"B!MT *.[@$704=*&2?$B&(.2A88/A%4^Q $[W
M('M"4+)G,$XG5;WQ!!XQ!Q]U7)63 ?QA 67FDGZP6TBV'4L6! ?0 $]!D^&
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MV680U2*L*/E 3S-01-6B)^F8">_\( $F8UN@81UBOM"*5J$=3S,@1 !6-":
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MCVD'?%(%!P$@$,\=^W PB@<!>%$ 21?HX0!7=V1!F@8&D(- !Q0,@,&!3>V
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M@P%=28900H:)PI6L!@CH!CEXH($7$.V#-C@ .,IP$C+5 &=/8 8'FB89##
M%_/:P++&5#3OD*-13'$+5)R6@!S58 :9@\$$K'89"\E' I88T#FVE0"FY B
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MH#0*&.?H4Z_ZT"^>B8LG9NLA'WO0SQX3LZ\]ZS%O ;NO_O*X[[T3?P]\R'=
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ME 3_29VV5< SV$$SL@X%N!L&G,,?N.(?!  $1%U.O>(T2F+#<=W!D8:GD(@
M6(< D!0S7 !3X-H XJ"**1T!?9V2X,X[1N,K AW+B$R5G)K3P2( 4->R>($N
M5 FC/ $LR)0+E8 %\)!XL4 '+(#^50 ) &#5W+4/PM' N9V;!I1/"77%"X#/
M$/H5HW@$"BP*VIB "T7@$VZ&MY#),91!!)Q(TZ2 Y3Q  50""\3$1Z9%-2
M <S/6A1 +ES$74B@*FS:;%5!)S  W1!20!F%'V3961R89$3 2F0A@N& *,0
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M2NQ ]&!$%V&#N+0")R!8:!F53H22T#*++H1.6SB"U5[K8$"D=A@<)BF9(ZV
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M9@B?3KXYRC_1R=STQ !8':<\S%O?R4?,2HC(S,>\Q%1I%]S\\*U&ZO(\]$W
M @ ]SB<?T4O?9FB ^,7?TF,>[AU]T4>]U$\]U5>]U7>&N%V&^/P&!+Z>05\]
MV(>]V(\]V9>]V4>,^%K&SPK)A]C  KS\)9V]W,\]W=>]W=]]\GV1Q^@Q'DQ
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M_*;2K7T%$?9W'A#7E0?'09& ]BQ@($#+%< ' 0 %'+"YO2D)6 X8$0+\48
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M)S^&Q\P,)70!L*,WV;@6"Y - ANX7PX^8P7G.>$!".C !0Z'"")H( <YE%_
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M%[W'2220)HSW$XK2B0- /:I!=P7DA*JRN'/HIU%P!)GS3/:B>PAP (: (P0
MHP6P ,GFMK=""$"PMXJWM8S7FD_2%V[K3Z"CN1S@11$@ !OA(MNT>8G["PC0
M?6PC* /0!'QG*?]*!'!RA_JD"+V7&A*#1[>[(ANP-U6D3FGW! _P?_#E MC4
M6N;U  <B9:#%4X)!)_=V*Q+P(3C0G]; *HQ!7WUT0&N1&O[@0EW15!R *+1(
M4%L)!(&@I3JT4L)@  .9;'/XKGC^@%?6YP'XHD["A,)[B$T:H!B3T C\N#1
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MV$#^$+#^4G $&6 7_*85GO:"%; =]59L.: AZD1$)EP=[8A+J?D+"=8EAW%
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M-3,8. ,P:R5D"3R[P;RUP=4F/S/05(I3$:Q4&8%0Q*?"I Z@''GS)*>6+W@
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M%8WR3%[VM"SP*#A("8#G&$*"2;PCLYMS0'B! +G3%2O0%= C(A"FY8PS_$!
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MZ@(+R(  TO-#"9A" J@RP&#T-!@"("Y.%?Q/ ";P&Q:PJGN,8<  Q(0K$7
M4 @87ED>=D!K': #$)B3 6R5B#D58 0&F$ $G%4!#AX@ PB02  R 0 ,,,
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MQ&#0*,Y*H-'&$LP7>/0/$5 %H#2' =]H8#D$>)L@-!@F4RA%D!^@  .\2E)
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M4V&.YE K6DD!,A!F_A8GTD7B2;\%&ZD)*  !14#O6FZ]CP,N&E!$F&\!P'!
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MW"T@*YB$^41&!$##1*V3,: '')" PI5 !?@*2; "ZIS /1F.<=Z31-@,"V
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M LRM6#80!R2C'FF 0=%/D.3= 9F#,B#D<_W!!!AC:2+*'0A*,%W-;;F#!&R
MCCD-W5RE5WG8J2C =A04Z%)$%<P! E1*<!8 /S) J>D&)[GK$I04$]B;*M@
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MT1/\#J!PF/0Y2AES8RTF14NN@2I7G_E$2DM*H59]5B#8%43E1L%V;)$]7"F
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M/)#A,QH-1-W2 FC!Z#Q@*,F RJ5$T\M&\C# T4N0'C;P=%1._.![0?7N H#
M\%$#,V2-LA&55'!&]T'.QPG1I^L3LA@81V[WN1P4!8VQ8:A@#CJ')V-8%#"6
M @,'^U0,.HJ!8;A8$KK%AW' @#](SWI(M T,AL-@X[AT? @,:PD("A\%$ L5
M'4<)#AS^!3I).QH "PH,<A0!'$04 @<%!QL+#@HU+X<>$P8-!!X6"! &&A 3
M=1$O%+((%$0: 0P*.15:!QD0#44%$0D6'H$*AA ,#@DR.AJR#P@>!Q8?$5#
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M0<A,U(B9<@53 ^J2FTB8D8H.>, [#AHI!YQLF95B (UD4(\9.#("%A9*.2P
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M:N;7<=I&="XP* -R Q@!!7,G210!,1X2>39P#=IU5F%#2-<P /T 48.7.E
M"6:T6%! 9#/@=PI$"H=P"P<P 8@Q?Z)(-!9F R08%88@ +>@9:3B6U]P 7+C
M8W)1AA/P J/6<1IV>JXG&<0U-(O6);O&3!R%9O^!,%0A$1D@/S-'?]#@3&C
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M8+!8WG4!#D,TEE-(EA$@* %R(\![AN!$ECD"D<>U0Z8!FY @!6 Y))<]\M/
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M\;\E.S 8I@YU\1)_.W4"T4CA^ U#$'S/J8)N%#H3X.2()0SW %DSH6G-@UU
MH! DH7LO4;0NT@Q.]'7'J0P2EW.#!PXV1Y.Q1"U5F(JI8@$'Y2D(FM8)TD%
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M1!4"!F5$!8%'@@,L1\.#%0584X"$!X!A1,.(EF0$0M?N0P/%@49"A<9!A(.
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(^_VWU"$  #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>g160222nk03i003.gif
<DESCRIPTION>G160222NK03I003.GIF
<TEXT>
begin 644 g160222nk03i003.gif
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M-.O=;'K^FL:J9WQ.=X*M $3@'U ]85OHN'F@V6 \H1V@0 )@)9D;<'1J>T
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M '0@A\$2-D%H8I,R[L)V,P@(0(SU *=THL ! B# 2R*0*V_Y1'P%,'!KQ%0
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M79&8Q/C^&NFYHP"Q$8#(L:$O>O[&S/DZ6 [)(^/I=-P=*0?X2X63$57G,XJ
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M*R*1 9$1&QTQ'TSQ?-Q ;ZPR %(#)4OF2D65)F!#;-@21;W1@[/G/2)1*0Y
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M&H  $<.6*.&60M.6<OF6<QF7=!DQ=EF7<ZD "\"6;EF(#;  D=*!"\  6]$
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MD+71^7(!J/+$7>T.0E@ V[/3]@,0[GP1/?$26?T6YU77#*  [T#4.I$;$@U
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M"A,O@$!C"HSDS4LG4TC !Q M4:$3'7!P!21"(;# %8QD $ WWI!@*8PD">H
M#R:#B$*Q='VJX $+'!"!!)4HP%4/5&VC @)PGZ '4Q)Q=?=:6LU> *A8<XB
M%:F?4$$0#"A@ !=8@(%!!P5$)1HCH2:PG <* -2!4134U&Z.I@(!]/T%*@=0
M ,-*U:8K<$5G*YB *Q1 )WT=(!($N$,]>G "W<SM%0KBP9+P0 1Z"2$4!J
MQZ15 @0 !"V,N  GR& D!,CO \N;  ]F1II&T- P07("BD(F$!1L8"T%D, F
M0I: X,3^ @7&H)7R-+ !,DRQ#*!P1 /<YCX6J*0<9."  &CGB XP8(D>R* %
M$D.,ER1  49211::@185., E.2K-#MXQNP5$[@,*0!1.$G '@!0@8K60#2%$
M4[1%,K*1CGRD"U!S1C5!L@4/"$HCEU+)%GA DT+SI Q40D)WL*D%P0@E*#G)
M EAHJY-"\20L8Q ==PBE!3?0%@KVE)):MK(:G70A"^;H@E2NS!&:="7Q"I %
M9/*2F"H8 A>#!$IFIF PSORD++EXS6OB4FA&BB;1.H"3[#@3:@_(UB;3J<Y0
M=I.6O 1G.[GY FJVH'EB@R<[8Y !>3HRE?Q<IW48\8  D&K^:&0S&M$&!U#M
M9"!W[FSG0E4P 47ND@(J6V0X5)G.?U:2HT/CX"Z+QI92$LT"![@<R"*JTI6R
MM*4N?2E,8QI1C\ITIMFL*4YSNE":SH">.OUI"G09 9+.4Z,A?:=&1>!#D'&
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M6( "$   >*2Q@>#A0AH6*$WE$@ !%E>#Q0XEGBP(+(H=$ 1P!;//@U9P 0!
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M%>SD F3&4< '(:".#Y#C,1'4T=U.+1#$+U8:0%Q!HU#A2&1%O^C!9;@%>%
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M+2[3LG;D,F69<CZMDSGWDTZ%<SIK<S?#\Q+NFDT=LRHM1;0)15"H!R0I *Z
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M+' *Y'J ;@0 06A2@1W0&35);NWU_UZ+OF@?9ZV%H;T$:\2#$I317Y]HX"%
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M$6 Z5P+^;AVU0 2D8.$ "15JW$N5I"PT !ZSR8W.!MY^T'4O4+7DP7=90S#
MT $DT$!3$CR 130:0*!D7"A0+IA%*OAKQ <$+)Y"!@,TH$@'D1L S03TNF2
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M#(V!B[>(X* B)38#H$!W-I WAXK^X$P/ .0++-4!&D"(E@3 P*9,5R4;1'D
MMF/"YP IJ@8 P&3;GDDZ_HDP#?3D 17W0  . -Q>G*X KBJ;!?-EM3UPD^B;
M@$_U9& &F9L8  $J60#R:PP<8  # 7"0"A8FGR25:6,,,)'A(G  +6"JQP"8
MP#,^,8GY\)8D%WV!-3>FDP%((((64,4!<I8"=YBL LD]'3 6T W/V&>4G_%6
M%:2P=PUT00%P*%,C/I($::D( &_Q2E,VHP<4/&#FZCO D9K"+Z"S"$6"(X*E
M#& +E*1)!:<Y #0J+JMM$P "I\/  $02K@2\X%T*"(#;9RZK YRL<0Y+7?/T
M;CI^$6'^ 0KP1D4(4+*CU!D.0)""(,X4 2B<@($#\)"W-OB+ E!370> @P':
M(HN/90!K!V@;*@"@B!P18.\'4D#CA&]39!,@ B !<K,9J1!Z<Q$ #^ !QN -
M9)$! ,!R5<( )% 5=L$.$E 3$S 9VE,;/P&!1Z!^/L!SBD4P', Y"3  @&<2
M!6  !4!+$I@>LK*"!% %K ,YVR0 0/=[&[ *?.,Z"#0C#S5')X!*!0$O/& ]
M.3( #_ 8>Z$(O-()J,  ,J$6$;=3)D G0T O%W :7X$"::<*6. EXB0] 2$W
M0N  /V(""1(;=W I1<!72K ;GC !=> QXP$+IF,6VD( R#3^9_V@.BEP31!@
M.!\! 1KP$QK0=U(5(R<0)O/@&910!SF1.@(0$150$J"B BAB.!X  (HD#:83
M+[;P +.1=J,3 #HQ"6<&% Q 1^3A'5I '!A #QVG(640.+,0&L3Q%RF@ (%
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MI!JNLR<D($YL0 0#EP9#@"I- 1,7)"L^,Q9<ISJ!U H/@H4_M0%&N!UIX 8
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M#!CP!P,9!@$9"O*%9/ 1$5DPEQ< %4D7@7B@!\]XEJR7<0-B"Z5)'/- "6U
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M%='SC3P@ .FD ,<3!?^8%K?S&O.Q(M9&P!2P! A13@H0'Q#P,0]@2#_!7AF
M7@AU"4TD [#1!4QP9);!L!S5$-UX"4P@8"^^H5<;&U58#L1;CN-!5-5R"4.P
M;.NY)S6)2EY@$Z(1&]MM#FI.!CD@!OUP;J6",^N)2HV@!1V@%+$T<YAN$A68
M%!.@FDY% :SS!7M"Z3#0$,"BYAE $_2 <34!!FKZAR.NF@&#'@&S!'5P*PSP
M1GR@&8K8C>P9W\7AN(A3DY+2#.&0,\OFLBPX(W>09-!Q1SA!Y3VRN4E6LXM"
M)WV(,CX( !A0'%&@0[5;#O$M >+^! !WL$(#P!DS ;:]P+#0-1E=1!1(P!.L
M3ETEKX'T0 $B,#08@'S!P 9UT%]J4S?O<1.)'!PSHD,:.#$ P"!Z8 %<8 ^@
MT00=7 8TT%$X4<<%*%*X<-9&6A'!8BLP< D&M0U:<=9I4&>L[0$1T "WB+2!
MD/1X2 <*BN;FDAJ<]+*TF(A(9NV<6;L<D&%&/ G(,10@7Q$G4/$4  T+4#&*
MI!H.H%R82H^,DL?!.'V!,  6+RZB%S@/@(G1(PAG@SI-J$&IP""98 N#D#AT
M@"E-)%^7-P#&M7^;@2 ;)#:>X4@$F1N]HB-L&I#_R),<,/D^L]ILLP$*X'*4
M-#*B\WO^&)B.<[%<:<"K)9$ 0NL,-N 93H%+,[<X.H(S9T(OOJ<A;@ '-;-W
MYV!MM#8V4D$#J:$!D@!ZSY@!TF+G#R M,N(9B^*G-FI=FU(2DOXEMO08VT$#
M&@("WL)@R%=<TJ(-%'1\2#(1US=_WG<!$N1P!IQ;)/=Y/#Y*32$3:6@$E(?A
MMJ (/A"$YQ'! " ;Y6=@"S2.EUH%P*$,,(_!AT*8'!9EBK;1 ?"1$:0)7!'4
M'71$2)!]9 A<'$!D#$PD2&P ,$0,;!A0:%1%(&P<:%  6#)*-28D4!Q$=,3J
MZ%PH4!CH!2S8*/%$,, T&%@43%P(>$ D'60H.$1^7#7.?4C^$% L')+E3D=D
M]."Q#"58/%P2;$@ 6#!(>-0DCS763S]XF'P05$P4*.EPL*#4!P83KC'(5*$!
M@W 5%BBP)W$BQ8H6+V+,Z,! @@SQ'CA(X"6-$B0?'FH@H"/!A0L)/D1X24 #
MF0@&.E3Y8*!+A'@R*CDP\4" *P$6(!1H8.'#@4!*%LC2PR&G$J33($Q;P$$
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MZ7EE40H'<#F2P+$/Q/SB*5YK\ !)G^FQJ9E\Z" ! Q7TZQ*'A]SRS@ER;;E
M&GC"L@$'#BQU>B,1Q +U2P9 _NIGO":B_%X.%/'&@MA<FK[ZZTO400$R1#2=
M @7,N$ "QVQ 0 ($K$#?*W_S 17TZ(^KE "7"8R( 0R @  T@"TK0, R"'B'
MAR @.!V$K5@<PDLX,-  K-AO&KC^*,!@E(" !O3F,C^0315,X0 %7*  +Q(
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MKH2-B) O."I$?S2B 0CX509H(($ /" E*KC"2_C$OI?"]%(3(H.O5NF((G7
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ME(&E< M#G\/0]9:"HP?$1ZAVDNL&]-9;!9*!.&FQ0%HV8-?0IH587^40(SP
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M0%Q"]T&A'2G B"C@ 1R ?KA2<'$$RD# B-2% AC%-!C  .B!)1B VBA! P#
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M[ -BO CWQ-#%N #!+(_Q=(IL.   %&)*+ME4!$1MY<$!*$ '8-1??$Y*N-)
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M76P#%J#5_(DD ;1*"0W)&V*%!2C#&?H'J.X$&13 ^VP11"S ,'+/VI#'4&2
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M0 $EO80S)]@<JPB^.JFZ@< GCF1IGFBJKFSKOG LSW1MWWBNCYWQ+8F'A83
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M"4.B@0*V (1K.]L%2; !!GI @RY$7D@>   $ $ "'0    (0 "#51XA>\"$
M! " ,86! 4L$0'&:&(Q#\&H  ,!B&Q+P%P@,40",D)H0^Y" <[ L $)$ "V\
M& !%6:(2$Q# ((J8149@D8ET.8$T##   [CQ!$Z2V@TZ )<59* -+E!820J1
M@G?5QC4KJ   ^G""(K@ 9 !15_QBL*G1]$I&*(C(# SP*QH Y )FI($66&
M*])A18:S <!24)0!#( ;9SF!L4K 2.(Y0 !]A&'\)-"' N3^, 6,*<#.)$"
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M$7))T @]Q ,1: D8<@!'X&5>L$ZJP $\-P(74%GH=1R#  "J,!8-]2(?T$P
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M0+Y1% #T!/'C !3G&^DT/9PV+@50"0X@ 4<P"G5!*,! 'Q=Q=O0P A*&>,?
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M 5("2-(DB7&#&@!*DTD;'C('!I  ).@0!P"8$9DU_-D>BH :/BJJ[I$F4](
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M0^ !ZD*?+P$<+1('AO%34K<81P,1J1$&M(J78&#)TE07$4'^$<^(!;O"$%C
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M%+M1/UTFT"*#5'H^<O H*C;6[I=%I2$5Y] $)B#F8N!Q&0*4T:H'JQR'J$8
M2O #$:<:Y(4Q1%Z9^B-/-^A?%F#G62!O1NXUI0%0)Z"2(J 8010&Y.4 &"#E
M:!TD:F!.LL!?U,4!TR!).$D5B 1-86#=2;5.Y%5WL2X"?M<82\!?OU1"8)ZN
M 0Y/A*);;[U)N@V4"B%$&>CFA>B$Y*5"^94!IAUD66DO%G<,87![KE%-[L-J
M.NA%MR5)[U5%).#C 1P6(@ <>\ -4W4"<B8 F/#E<E3;?6[^(\NV(9BR35)
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M\$[+T40I[%VGA35MPE_-5C7[DM040:6E* QVJNORI-O6K1#Z]@:_?>AAD=-
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M100!P"T(-S$!\^:4O1P890(_;"$#/- !"*RB#4,CQ1;^X2(7$$\]%5",30Z
M@0G,"  1D$ ) H  !5 #,A ,P #$,0AQ<'!,(L,#$1I@D38X@"?1B<S -!F!
MH*!A" 180@ :@(+_, 6 A>H876S^T,EIM4T"D#F 6NBFRUTV*2PR&\T).K"-
M9610+K#0 # 5-TSS4&"9,JL !2SA@;!TP (4N( X**0#4& 3F2;P)GV@:8&G
MF6 "V]A 6"CPGV@V) +NTD&2*O /#@"EF!,8C08D@$YYJI.9%IC S>XB 6S>
MH1/RE("Q$CA0N4! '$2!&C]]20$%Y,X\.9/)\=Q% 5QLH $+N)=YNN !"##D
M A20)PVN:0)H"F5I[II !2X S0I X'B%L, #-A !:*[O50U(CCHSD#,*9$(J
M '6F>1K@@+M)SZ+@D0 T[R:!"4"@ 17P0 /<]8 P0" QV\C 76P0 20,LT%3
MH\_0!AK^K@XTH!!@O0 #]-* Z$1@K 5ASP0@<E(3(&0H%9!'XEH#$7%<X [T
M84!)]9(D#3P@+!>HQD@5D(D-A)4#$6#)2GT!@7]$-@+D'&G^BN!+*@!4+F'=
MCFTXVM4<'A:8-%C& Q1 CJ6N] +'DR=,LW;0Y>""!L<#STF)ZH$'6**P-IA
M.5@DI0(Q) [X!-04-&#-U613J6'H@$Q5:AML/B"ZC]!$!7"(5),J+F<2Z,+K
M*C !UO*RO>Y]+WSC*]_YQLUH]+TO?O,;-W+JM[_^_2^ AT&_ !.XP 9VKP?X
M*PQQ?#8("<Y/@X7"X%_P]VD3EK"#,2PS"V.8PT+Y\(4_3 7^UD%89@M.6X8U
M\> 2.SC"&DXQBC^[8AB;N,8F5G"(R\$>!N\8Q3:V,(<KK.,9^WC#$ XQBY^D
M8A';>,DU3C"0D]SC#4^YQ<%0,-VP; @M-YG"&>;REL',)#'+E\P'CB^6/>SE
M(C?)S&=^,YSC+.<YT[G.=KXSGO,L#.><P#0["(LG@E,"#! @N>XYF2(54(,%
MD,,+!X )O8021 (PY'(<8)Q-JI)I#-(/)@NHP0-,0H0.+*!-X/%!J2%[ I/X
M"*XZ6&2IS9D,]307/,E80!@PP#O#?D#7"*A&!A(P&J(2DCX-H(8XM.,I!'QZ
M6@PA=1@Z#=(G66#6J;// K;1@&3^^$XF,-G/JVSRCPJ4AP%<A>:L$^"!RR(
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M%<S%L*#0,NY++G0>>3"!2<+! ZXAF]"47F ,Z?UD#M0!1S""B;U=2\X%!VC
MM=@2%"0 *7 *L=P%1OH#0+P#^U$!3/0@8<"&Y_1@-5S-3[+AB1!+H3D8(6B!
M2:)&<, $-$! H62  _P=7!3':!G K2 A)/5>R;G(:#!%S7 &)1 +[B$<8:S>
M&G1,MJ7^"N,$ %?4 ;'@0EF$)1X00"F,Y%#\I+,TP R\P+1\43N^)FS&V04T
M S". !1 DFTL%>A!X7O 3PJ,X<E,(TC%#).IP1:DGW@(CKJ\2!A4@'%PA#@8
M0$&@Q#( 4 '4AD5"C3]\9?F80<[,Q10X S*-ACBTP=3A@@04) :^#?LPQ !
MP"PAP"JPSI3$!1FD0GFR(2%<2P!D@K&<C'O\0@44@+',VS*ZD1C045T6P-N]
M""%NQ@9DPXU R!+D!C*!0A.@ 07>H!E02$9L  ,,!JOD@;AD&Q]\X@]B@"1M
M /"H8S)8"]+\!0VV#R1\&AH )-]1X"WBY0-HP'+@06Q%R;;^18 )=@OQK82D
M,,%W(":$>%80,.8W)  ',,^)V!8VF9A;U((W:$5K/ $&T!$EX,D\HM,4O&>L
MO) 1MEL%+$%ZQ@HH%,T6&ER0E&-LUJF=!I@',$4)H$ $K%=&(%+CK4M)K(8
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M:79!HPB%#](@UC1.!BQ![%3E;A@&0. $.-TIR[:L?+7!?X2=#13  _"@!Q2
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M*@I #%3F&EB&>0@ ("@" <2444R''YXT41>U41L"\%B#A/ 5U@0 *"R*R@R
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M9(4]LL(3&&$5X <"Z&87X,@41 #^L1R )2C 19T K!M6!Z##YEV I4 A*&]
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M_P_@?OE]D-,3OG1 1P&I!%A+!P^,!XD"[+V0@0,%%-  A+*@D( !&I:"P@,
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MW&8K#GOLLD/W-<%@&3Z,!3HLD+4L L!90P= V()V+#DQ_4$"H9%B@ NK.#V
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M@,;LX  3V$ ';E4#=:CN \>2Q>F<:)X,_ 95Z7G!K&I@ 05P"0+:<X4&)("
M\E30C)S^[*2K.@!*+[I"'3-8#)FH $5>#* !%,! I.+ (_*](@-?"<#<>.1"
M5]!A!O(Y0OU6D8"HN4)*,(! 'GDYB@R,*0T7^ $7T0<+#PB$+@EPHR>OB4T
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MU=D@];&K?>QS$_O:WP[WN,M][FZW.HE3CO?K>: #&N#727K^ ZL1UJ"Z'N0
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M 52P)\Y#81NX!VBD/WMU'-T$E<E3%P8  1,P$13) $GP#J4V"FUA!+^3%A[
M)V28!*$0!25@$22  !&P*$/P D:U +WQFI(&,53IFXEC7T<0 ;#4"+HA-@30
M +"AFF"T L+3"2BPF'\ ,7+2 &G93AJ  +VQ#GK(!W- ?<G6%C#R1%$P >'S
M1.DD 7,U OG$'@&@AW+P" ^X'NX4#2Q09P#PD1^P!*2#D<CS ZS!C!)1"! P
M:07@!Q-Q)S900X)P/W,@ ?C@(('S"'@3 Y-&"0>0GD]T &4P#Z]9 ;S#'M
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M#NV$<;.+O%JE*.IR1PT@ 9]1%D1:*X; !%20#.7A #*5"76P!72;O-\+.XH
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M!!-@IAXN (^F'@O121%YB&N[T0OOK0ISW=V_GMW<3>RQ5NS?+=[,,7'D'>S
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M[]S3[D0=]4),K1LYU,M _'ATSRG^#-BURTP.0/!I07N:^M8FJ! LZ$'OF*G
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M\)D&N,!%NND #6"$! UAA5@V4( /T".3//CE!<3!2IG<9C@Y^8 #<+/'!E2
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MF@&O?H"&)"!L/1@0G0\H8 [D%.T'8-("77 U%;'L  /H$%NYPCC&,IYQ( Z
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2IX;!:9W:Z9WB:9[J*8V&   [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>g160222nk05i001.gif
<DESCRIPTION>G160222NK05I001.GIF
<TEXT>
begin 644 g160222nk05i001.gif
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M(DC@=B! YPFJ*33X$ % A@(*"#](4#5 @P<!+"R0L+<=9@D0!#A@$,%@Z<$
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M#3CIEJ?1C<M-JKH6D.JO78*G 0)C/E#>AA@PX(!Q:2)P977.3&OSS7**Q4
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M/ ILYAS-4U5A-(:W.H*'&[O<E6'X2*4)$0QE8#E<RVXHEAQ>B4V*C&8UUJ<
M_7@'-AE0P&A*<T2#@0YWY0(,_^)8K[!PDD6+&V" ,.> OAUP,UJL7= N \:
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M;Q#@ :]QA45E%ZWQ)%1(@23V78#^QG@!ISSB00$ZP0!HJ(9X]CZU8D>NLB"
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MM-$W[>0P9+F$9SD.;I$J/0B.*N*6F\B2YQ@;D04><T$8\M5\+K, VZ2!JF@
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MJ6, &8 7I0<@KHZ]_6H"NY$!1M\7_&X"F2X 0 ]H:TZ/)G !OFX $F^!=\X
MH%Y-<L+H&&  *?&V55_X<$ DMF4 &%"&[=XC;-)L'D*7650MUE%Z*6$\'3
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M/R\-^_C^<Q_,CV_WH;7OV;9%-+?@@@5RP&PW6FTB)(#<=+/=I !WSF6 PP;
M_?=!!;2=Y0%VMV$WW6@!^*>#; #@=8)L[<A@7CN!P3>  -A=T!H!)TAPV0B]
M3<?B; J@X-ET+>IG0FX'6="CCP! Y\YL!1A3@6"Y&1D8!1[,IM4#^BVP&&D"
M13#;;O=]!AN8=S3G@ 894.#9B 5TE]%T%'60   %B##< AI@H($#LU$D7G(C
M;&><>09D<.<$GK736@!C:7.9"7DV8"<&D3XX(  &B( :<N&U&2FG)@RW)H
M6-#!>AA@]X &%UPE0FZH7J !@W(*MQFD&*CZ 0:S6?7!D,O^\2>J"K^E4.$
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M!MAK($YON>'5LM@/1ST#WQ_C&N><  1O_H-P$\P"U6'3\%O92E(^[&GH,@W
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M:,#*3&'=%;5&UC!/  2'YHT@$@R*I*!!<&% 3Y#* T  (>$0LL2@,9U !D2
M TP ]0P*]2#6"RK/ SS !VZ I,0@LK# J\S9"W+ G;B "9I$#*: G<P!J?3@
MG,E!#@@7( @A2]2*"6( !&Y !3S 3<Q(S7" !3R M$FAL73AH/26F5C 5KF
M"N( 8FT M0S*H!6A"I0/(/B6DI$ :4G#-+#,$W[?+YP #%S%"]C H/".#73
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M2H!VVB $0 !QHF$#7,D"1, ",.7^ RQ 6EY)53;E E#E4[XG?,:G?,ZG?"8
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ML00R*0![#, $,$C,\D !=,D-1,!.G<!BX K7?$  8-=3Q>T/I.T;$ #D+D$
M/( %Y EH",S&SL %,.^LO=T3?"S^Y@Z/!R'!,AG !!2-N9%CA5R1RX80#D3/
M@T1/^-$@L(BB#>(>7@4!0"#!"O1&PQ*!;%Q+14W!"ES)^/: !TQ  LB/;_'&
M!@@6T+Q/!S1  XC#%5S 0UAO OM SR8!:@B<-* @(!PB,>0J"K/LYS+!P7;4
ML@17 "2%!X:&]SU+KEV!";L LL7AOBGLX\1(--@*"E $:B2;."AA6-$2M?8
M]+H! 7CO$8#OOCE5 ^1##<8$ U3 -@2'!GA#8^C(#^J%?%0 4[C  +9N#XAO
M#BP$7"F &J'# "0 -4! !4C  (@@J4D9%"412#! "C0/14C P]8L#A0 YMT
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M5(,@\^AMA1B  OP&EFLV#O1V#M#NEH"MCFS#^9E  .Q#!NAG/67W<)2&4-M
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M^L29WX"<XT!";+0)F#PI;<E85&_^Z4B >#A5'%_WT<4X$45W&QBR8UM!>H^
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MP4*%#A+PE>SC0%:?"A$D2(!P(<:# T5Y)%# L\,$.!VPVGK@-$*M&A8,/-#
MH-8# G F&$@0592 88$J(.A@ <(>!L/*)M#P@ F$ E%C3:@P\(+7#Q(:U(AP
M8(\& -Z0&3AVM$8%L$^'=7A@=H\'4AAB7@#U  Y)!G ^<(C0&O""N)F??"!5
MTL.1"?@R/(! @>@&#:T_8,!L S $E+YIE':96<&?S!8DD-S^4&'/:9\Q8)-T
MNC)&]@U1,V" D@%=A>*UV["CLB&^Q@[H.*P<7H/^!J,Q--P/3T4! _71P1[T
MU; !0O'EM\=^XO@70PSW02B*# "VAZ$3!#B688<UM.*A*% X0$F()A(CP!0G
M>D3!,W01\]8')*U(8X>XS5ACCGQ(IV./($$QP7LVX*BC *#XB(P(%R))# &9
M, F(1E!8D%$?1&*8E(Q6:BD(%5=Z62,!58KXHR@,/?!E'P5P"&6;@4#!0&4A
MIED%G9E!80R7)N+()YA,KN.F#1T <&2@?6P0P)*&\N'DHHXBI=2C&*8HZ5$"
M5OHH;IB>F.>F;0:9&X8![&"GFXC^*KKI (Z5>A2KGF;IZ5$#J/AFI41>&JN;
M-^::X56\(@DHAJY2,4"AFY[Z:PTB!2+!=$-:0R".T#[!'Q73-M$!G]4ZD:T@
MVR)5(K>VU>#!E]U2:^6VYV+;9T"TBC.CG5!\^RVVUGI9;Q5AK.C!M_T^<>6Z
M_>8K[&VE)*MG.GC^,2P59=A"6PT:7""E-0,+:D%'%EN#$GP5-,Q'L*%HU7$'
M%U00SRPH(^,!H0E7BFRR!!B++3A%T#5!$"X[L8$6 G!'"*4UN!$  DO^<HA1
M&2A!P$I=%<$$%0X4X8!&#QBB )TC1EH#!^ <8%0%!R" P  1VR#"JC:4784[
M/D3]P=3^ [!W"TY=HX( >TW,FM\F47= -@*X4A$! &-I1D85$Q00@ +H=$"(
MT>0REN@'[B P-@+&[@NR*0<@5\,!<\0 3@ , #C9@!<T U&-<2+<'H\EN<&=
MS088J$41-&AAR A[0$!- 7A $T2X3H"#JBE "AG(U.A<H(0A U*@\Y.B[!QK
MS+\NR\<# DS"N >3#7#<#$YH44$=^" Q 3AP3*: ,@?7< $ 5+F,0@ 1!*#4
M,Q%H48O5   "*QB&! XQ-39!2D\E$$-EKE   _P,/LU@TS7L9RT"!& PYCM@
M TK@DPU\P@82O!H 4J8A%8&# 1K$QSA(@ DOF3 J4$!:2V;^5+\? &  ^' $
M \A1 PQ X@[34$,S!L0,)';( ^  7>%&MP('@$-.'5@#AQ@' 2V\*T2:6A1Y
MT.!""Z#09!W9P,-,T2F/>  ) (C+%1J0AS],S0&\P,+_'!"!-9 ''H4K0P-^
M,S5GV2 #K$L>,1S /#Y@8 T!0$<SBJ*%EE0#'' +A0"4N*G)&%)2"!C(E1)@
M  JL B$:&  ->J# R5!B!4Q@' \.\8'"X4,)*QE1&Z,@B_KM8&H),L$-C@2%
M [1@,M[0PAUHV3RN$6$52(@'\L!T0$ADX@I*6(647CD%-SBF  T!  S, 0E0
MF ,.&5")OG R#N'5CPGFH $?6'?^RWQ XH:3N]I> . ?RFCBEKS#9WY"9SPH
M7*IS@$#4&)!#!#9\ P8>&,-*;.88&<! !C2ST?P"]40RW,(0#%U$ %IB 0$8
MPIVAX%'G5E""N#3C#JZ4@ +P<1"T62(#"HC*. KEO"'58  %:,8F10&J0/ T
MIAV(P( *5X')?',+Q!C5RR35@Y\ZZ@ 738DA#F#.)A#"G37T9BQGT#)9I#,?
M,)U'$PH@ 'RLX0-(J,4!+Z#4G<[/ _R340#F(+@/^9,/6VM"X:: A%;ZP$C;
MHH $)L,A"S@ ?H @1'!\*0+AE28/=DO@V+CC!+ZY80>(_8 R&'> P]G@+,J(
MRP-*DSC^,'&@A<K "1*BT@ +$.(.5MOK62N:F0TTH ,1E*D#"-""R9F#AYH0
MAE<]T  C*6  */00G!!!T XEH $:J(5=V!J. WK  =X8 "(P%PH\@8X8-3E@
M+60P "AH@3\; "Y_1$<%]HFC' .TUC_,FAD))-)+4RA<Q^A'RRO (0]5Y:M3
M<V6AIV**>WS8P )Z%QY"E$(C!_R#,B;0LE6, Z_+6 & !I#6#ZRUK:^\P!4&
M5  YB4.?'Q# ' X@O&_8E@^PJ@$A +N$G#B  _[#@P4R)C&OS@( Q\C CX,C
MHV<@@@@E JX-ZF<W"6=@#:)E!DZFQEDB>Q8!%N %)X)R :/^D'BTJ34R!3KB
M"!K<&+M,@!-^=THJ)PPN1 2(5 (0D8*4X* E]<N ##CT#!@+H",FZF*@-IR"
M\,@A"BV8P!Q<5N- I/$C)#9##Y?Q@0N,H<WR8 \''(&<7-B @ O(6AS>7!(Q
MF$(9A"[<&QB3XSRH.! 'SE[E9!9G0<2# K-AZ@4%68,K_,$-&/8E72E1 GQX
M."0!0$@)L!L5-US #0P- '3SHT\/N+@1HP-'/-*4I7+%C:E(P*P,%@N-3'16
M(X@Z1NYB_ P.?8$2Z+6!&RI[0LL!0($VX)LN]0UL('B@&7JHP6O_V<?0X0 G
MGS:?%<A]2S=WQ!R*FK.'ZDP6$R#^8 1W&;?9%)Z 9A 6?T"<TVUF[::3C",C
MCHB*DQW] 4A3HE0F52-VS[M#*#@"(=04;0*$,(L*-L$<5>*=+O0JU2T59-4
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ML!)"H' #4.C(LC,CLD HPR@'_.@&)!!F8+![+Q((-\4KFI1U!.@$5S!8<W!
M16 (CA$ ,38U6G  4V(_8W!>=^4(B" #.$$$ U "GM$,*U *$C8&\0 $._ ,
M@@, PY ':@  F%0%),(E': $#$ "-R  "@!<BK)N"*)E3I!0(C6##\< :\!I
M4Z,B'#  $-$,558#0J,%)+(,)4@(N#4U 50#N4<%%Z$SM; &*T  '?,,'4$
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M!)1:IRX6!"*E0740J47@CT&@09J:J)OJJH^:"YCJ"?Z8 KE@J[D@JYX0!"E
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M^0N6WEN]9((ITKLE7<+ R8LA]>.7GAF\F<$!9/>:?! 4K@C!_/O!"!(*#B+
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M)EBA&/I'@U2@ *KA(1NP PG Q&V2!S ,)=';'C7D$Z+D&A,0 7> >N7 HWO
M%.<Q 1!0"],F 5%S 1%P0]+LD#LJ6M81>Q+ 'A80 (KQS<*(!_!L<'=;'%0B
M#ERA#4V!$$21DC%@SG&S !,0%WG!!-DA#NP$ 8F9 ==<#A+0$MLL6LG5$AL
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M ?3(7!&@8@:@R<"0%/SMR2A=BXB@TA^@/U<P :]3 (>ET:+#W[*8QUGRZV)
M$@>@%P<Y-;(5&:N@:?;61HFW1JM\.EN@ :%$ 8@@)AL@ !D -I[U?P\@CVT
M-H1R.$"Q#1H0"]>P'Z9\9PEQ)$NSN 2P.@I@ <RQ"@191;,W ,0L ![ C$I)
MRQC"BG#<(4&""N%)D9J6 5\.BR?^O>X"((84@ $'T-:U !00,!#5I8\C'P%Q
M(D9-H-%'V097+@["HP [4(P<?@%GH"4,, 7E3DAJM:'%I]@"KVF;X0!++"A#
ML?.^,1"P$>-MX "$Y +AC!6(E!Q0+ %@0PDHH+>?HR5BO@ ^(?#3=8,:34*N
MV0"L'&*W\U()027[,)"K5=VF-#&SH!0(4.OPM^H<'2X;X&[*[1BHG.*)X#7
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M A %@07R>'! !1%8E)@#3P7@00<"7$/5 QC,944L].3QWWE-;.-29#((@$$
M&3PY&3;@R:-/,4IXE0,1'P"07IP(1%"5!6404(D% %!DW*$$:*J2,V3=(!D"
M1UP 3X<MI;-!!@,$%X,"X.W4Z 4$8!B#::W Y6<']R*0!&@'B(4*P@@P<$&
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M$ 7DV#K_\:(DKZ-4E0BP@ =X(#(!Z%YP"!24ATZ-C,!J P3:907ZU&%\;=C
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MBY$P]($.88T>OX!"+\"F@:1S .>4\C7=&4I:7R>U[GI7T @MD( _6" J-]B
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M@@E2"#V]6@8P)2]:91O<7:_Y%RV=35=1U6Q8E4W5E#N5TT]=98&T5" 1'A.
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MA$I/&K,@.MTE SL#!<RQ@F3'!.-PJ]W4',0M!H^6 \S+ +'!BCFP+AG2.CC
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M;UP:N!U1:@B%!$#N"6G6@9M*6X+^/)2R0E/.E<\":,A9T0E6*YR-M3%X93=
M GB 0F,#&]LP56>RP;(+N*A"R6"(6\7MKP1LZPCY0C48N/U IX0X4/+>9M3T
MG+.<0H>X^VV&<8^@U&2Q%TY $0")@9CRP*9WA]?P%^/2EJS'6Z+9(_A".:MU
M.-Q $KQK=_3K3SCWV1W2E;N$@H -'0V/ 4P &!9(T?T$#L $V&1D ]S&]+G?
M%RJ 4E#'?L_%?P3B HR ?5#?VYF,[>794ZV+A_V/8$D+$^2>X+7"P/SB)PY
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M,  4.E">@X8!',QV(0T8 (#("Q)<-H%X"F3@   (?!"!:D[^=>" 1@4T\ $
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M_VTPHP9JOOKG!">%R(1X#+"KYG/^AH!,0+?)S@!!DL42T($!'> ,E<S[::%
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MRTA <LFZ0"=E1H&5[6A)X7% NS*(R!'H2)53LQ#E#% $RW#^@  "D"-&("D
M)!5J92Y)IOWV")<$ "!<=;+4VYB4%]TX,P%^P@X%J$6;!=RD4\X[@(]"A!W2
M],5(1I$9#2(F )APH"1O7 [,+-F4#:@R+=0,J$ SX4:,D$T$&1'+06D %5<E
M34KKT$@',G",J&G@(HPXX PT8 %2&((4=,!(+#HPT@Z)H$$8L@!)17"!+6A
M<VPCD$8$%(N0OH08%6BI" (VNA%LX0(OJ&%V)NI&$XB $*2H87,&*I*,'+0#
M0XG#40QY%!YJQ -#D>@6MI"!.CG@,AD1 0>JNH6IGF*A%ZDJ0A\#5::Z]:W!
ML.9-T@>*^<#UKJ90   $@$=+N.7^!W_%JV %*R6[GB>P@[TK8L>0G<0Z]K&;
M<.-6-6"11_2C$C.U[ V<*M8FQ,$,C<6(-+:*T#P]YK,(]1!D5[N#0!WK!:,[
MD"AWVM@)V*4#4;Q"7YUZH"U$12T6X8)GAS,!", T:N%PAAF\-8(WA($,A1-'
M!-@1D"H4LA@84 =S:W !<^1N+4EBVP,F0(H3!(:U@[4F3&)3&U+Z=3B]FE8.
M:@0 L.D( SA[@08"8%9P$.9(5GB%*IM#@%:M)6EVO&8AT<M@+H!L!B,J96$
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M<].:CJ[FE!<'$$"!7T/;V88=&F?+V@!R*$G0!L!CYUE("^'^RIB(]]1F&Q1
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MD72LQFS^": ?<^  A;1?*U,8<[490Q$!U((ZQC(GAL6!7!,%^T,;ZX<\1:
M%0!_#(=N$A!&)  ?T[9 X]4X#X <Z/8 NJ0@S:9+,\!$Z9(L=:& RT$YSJ=,
M!(!&,H,S$=!=#L K)T8XLA!H2<2&<*5V#Z!7/+(\.J(.BH<4.Q(;EB4=>=$;
MT_$M.+9?:I$ ?"5RW#) G4%*RT$ %4 :24$MN$<<%X=_#_  \/$I=A$%O;$:
M);0;B_$!^W6,N]$YZG$K+^4GK<%NR/0VLT ;L>$\/_0=C-(<!_  C$(#L_%3
M #( ER$OH$%PH$A$#A!%!Z !$2 !BB$++Z!K.)@'4",5"/#^ C,RA!\PB0U
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M'( 77R4"!V !\!DB$* K1H("C1,!!80<M%AWDJ9V0K,"$U  Z8@7RQ">_<8
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MUWJ]UWS=UW[]UX =V(*]PSH\V(9=V "<P [<UFDMQ(0XA+5)1P+,UFE-V4B
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M%50@@D="=> 3(AI(-=D.!7@P$ >W6&!   F\M,, 9(!#!QLQWN7 *(<M\-I
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MTD=7& &D#@ W5&9Q I5S2:Z&,)$<-( &\5E4]3K@G4ZD1(FBB$(*-%"EU%A
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M5PD#("$!#>@  +;!XB'HH(00: 4]FZ'B=QQ"I,@I !+08!\%..(A"3B (BH
M #T2@,B'V*P""D!>L?CCO0Z0!P <?(T<("([*Q4Q'2B$"/V=IP.YK(5J Z"(
MOZS** 4&%$BJ%8, ($!=5GC//LK  5H]=EHQ/"J@ \T5#UQ C<$UB.+&P0;F
M$5HT, A2F[?P&NH<)BO0F, %+H"QL\ E6"<@BR@Z0 U1*& "^A)-<<706QG>
M;\ILL Y#-A6!#G@: C74Q01$/)H[*($/I68A\_#C =!-X!F@(O6DXS@,88J"
M>T"X@A4RT(#W;& "")&($H)$M,_^#!=^5[A!M*<M@0RH1")K60.,&( :*6P%
M5<]5IPQ? B$F?B15D%SK#JQPVZYQ!1FZJ#:MJ=>)CAS&*!XYMW(\\>]\GT #
MDZE'10=F 3E$8-URU8,.)M >*6R*&G:"-E<HL <&?(8K&M>>ODY0 6^LKRP,
MN)BFEC@+@MK: R.9@O80<MB@Q, FN7H&JA>A# WD*XZWH(5[K= !"^#KL"I
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M14"-EFC,3$"6<(6('J#MO44DU1X?P,!M&JB6OL5_$( !+)5B"< !#,"Y0
M+,%Q@<1281-Z),1E!$"6 =B<Z4M2P6D&G(<.4 %).$:,L0&?P@.<@I40+$
M9,8&_$4 P&F;40:<F@"C L"73,"Y'$@QP.FR%(,R($!9V55;4($ #, !2,#R
M7)"#K%Z6<MXE2D$8Q5\\G9VH)!M=Y(%;B)2&;JFM9M!_6($$@$@ U$,/?)4'
M?*DB%  ^B JD)L0J:8$_>,L:A(+T+($(]*H1>HL5#$JUJ<AY((V1Q <.M2EG
MR4T"*=DS2)4&A(O) 88]9%ES]=K^IT)* CB7 LA96XC-1NA!/8A&FXG:;0W"
MG9);'+E&<<%:IJU%X65 A7T:\[2&U*6 ?S"$F1EL!A!=P;4&EEIH0&3:VVE
MB.9*R82"9312 M31P/F1 ZR:0FZ T-#":5P!WJ5*&9!F#'B:_=T,UTU !#!L
M!@2+:-XJS[;%?]C:5G[ U:!( ##(F8JA()"I$F@"EW3" ]R'KO08<V )(@C
M,]B!N%05&GP+N;5"4Q07 "C987P5!H15G!37MW1>&5RA5T! C!!=)[#ADI4!
M*M*M(E;(I"(  ;P7I]Z>LYS.25!A8WF/GJE9>"5& %S*(0B B_5 LWREO<3
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M0/$@3@'0&>W2LP0H:7']C .4K=#B'8   G65CI^;>OE>/""XBU0=F1:<%SW
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M :>\5A$"'E3PED])/&7)KN2FPX4^B.140 T1)R1G1GJFPK*P#?3S\ <'J,R
M(!T$!9:55GCI! %(2W"Q8A%0LD("-$>6P  H57"Q=$($4 <)*1%PSP.!:B!!
M 5=\$('"&F! P$&+:-!('<(VT8 (!#"@P%P)\,&! $8-8"<<!U EBU,O# [!
MF!\0$@!*)RT0!@<!#.)NY31B;>:1>52D   .L,"V!7-$\,0%A<'3P!0=7+PF
MZ=_LK44N4PP @!<N)O - !(\<"@ %V2@@CB+""M$U1OT"\8)0YP1I@RD9&#
M/?E8TD&_%2Q"@"$!>.   C%@ $;^3%X$D %$%A @0F-@*1#  S&,]$$ !FA0
MT?$U<*U 4DY)@ &I&A10 0DL  /=$,(#R#< '    KVR2N<F@ &_): !T:*
M!7P'@2@ X'H%N"!AJ! !'0W  W/[P )$T A+4* 5';B#"@\BE D0!B0ZD=J:
M7K*:<K @@*MA@"H:8KD@Q@A>IIG@O!# @"!,H"0=+)L0&@   A"E!21TP2)"
MDA(':&027Q("JG8@'0L\H  +D,4'+."%Z%A !0JX!0QDT@=V1& =4A%"#"*
M@0M6X107V-Y0<N"!!P!@ !+(@97(YX!3(/(>L(C?!A: DK05BP;OZ.- ^!
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M7S<JC !V2WSIML:<D3@E!*"&] ,02$"T+- *+_%3$&/-4Q ^K Z0Z." (VA
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M1TZY<#[^$M$SOY !2)2?W'H/JT)P2/"H]"$+2V .$,$$Q848O!%9BY.7S6<
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ME."["9G401A0D_W7-PW@-6[[MMY&O+Z#4C.H"I1* %?2-K.A.?(#-CT(E;L
M!@H#2F,E!)!D76(B+5. 7*HP=9'^ (\I=PHU.#A@N(R<:W<;\WI2,$(_=ZO]
M$Q0@D0%OYP+'@A+ZP)]"T0YF)Q6<V7U=LB;P.'1UH'CT0S&9VF <H!B80@B2
MRU!"()%&_ ;[&$-H$W1:2158F =)874V((%/(9$>:G!#T +U&F&^$ 'OV #[
M0 @@(1 2\(XB0+H(\ YL0YH^DP&^J\82<6WJ&5$=5'5XP@JQ\A'K)S!?D:<-
M7!X8X!.O!SQKBC8%!!*<PEB-/*^: ;BWA!,%M$8:8"X3(%EXLTPH];NQ8(<(
M< IGA%,X@ IX<%TD:@-U0&!+D$$,H&#5"!I2<JN UPY$LG$L""QT8U<F=Q*Z
MP,?.RY/^6\  $_!3<% '2@%R7G0/K^HFXR28D(#,]2@4D $!B\"L<%!&H!26
M A892<$RYHPI(3%T>O PDO,=.W.MNM"M.)((;R<4NY)0>P 'E+ (3^ F=!%S
M^2 G[W!ZO1E5_T224F1+<-!!D"R\"H $#&S)[8%2[YA6#^6+!* CL$H*5#4(
MJ3K*UJ=H[1-!,_<%DA5USN1A:<0.#D %IOP&/(!U Z 379 BB!  :PR2#9 F
M MT!3QO,IX !Y!0!;4$!MR,$^9"/AU%A X&<[" "$Y1A3-!&./&XZ7"K0C%T
MBH$Y+N!*'\&?BC;078DV--;-1PP2W@(!5\(*!THJ0+ UMQG^"\<K)];[#ON(
M1MR2S[D+D3# J+L@2HJAT_5R $\1 2S(!SP@%$Q+ %.<"!F@#28$T54M$F7C
M5#[#!CI1QX7L,^YHV%_A 7GTT>YQ/@*0!>D%9_R0 -?EFGB7$E[ P$9T![63
M!SR9"ZY9%KLB12L02Q.0R"E1GEF0-*C(U3.H2P2KN<.Z F5-.ETBS+>Y@'B#
M=25A1.C@0_5" _,CT/?0V7BC"'90U.HK)['D.W#=1Y DV4B$!!" 1'SP!!S=
M14*9$=\!;DY07"R()T'G6?Q@,*!Q*!Q05P%E;:X:NT[@;UQ4-B57>+I02J^2
M<=V:!G;YN<5[45Y"KC\U#P#U*-S^@A0:L00TD!$F.P#CA(-\( $V00)'0#_:
M$GRO[1X<XAJ#5J+3L@N!-AK5$AJN86Y$+@QMJN0VT$M9AF>F 1[A,BQ>$!M0
M9AO1^"6+O0)S"L"ZP %9/BU(#B=:;D<$-:<151H$Q2J<$5&OX2="WBJ%.N1/
MYJX,Y'-%SAI2WB+PI^:XH>,[#@S:%FI5FA>T8*+&H%*_D.@:P@'C5,O#\'=_
M+NF3/J.$3NF7CNF9KNF;SNF=SB"6[NFA;@PEBV49$&0D)K_T)01?NSBPL06+
M)EC<TA@]UA@=P 'M.00?@2B++1Y=M 3[BJ9#T%A(GAEL*K[NMGAQBNR%)F.!
M[BG$,:?^T*"YG3+MR0">OC&XPJ"H19?GE;SJL($HC?'ES>"FSCX0K7WM0A 7
M$^,+*?(EPD@,TM0+0LLAJ[@+%*"E K$%3KB,@3Z\]S9H_5YB(VM U1X:6S !
M!J\?EC!(,LE3:%.>Q"0+ 7 &[ "J7/#=!# Y^GV*3V&!IU@%I6(#89 #J>B$
MMR7:J$@[B9R[4[ $T5A*-9A5IA@HSC0'->C',E%*'Q$MJ(A4@T0[K! 1[(.*
MTF%0<E+9V66#O.!*8+$5PW$ TC$>_!X,<!WDE:29NL  Q>@+D\#U@)$ S@D,
M)T%@FYT'#"#VOA",RIUH)YX,R!P,)2L4'3!1R'$H$/#9I^'^$%B&-,1@T+R@
M #(L:2/P"A 0EC[C7\6P,\&:#++T*PJO[B*PDP4B"$_A0XD0!!L4ETE0+R)<
M5WTP9AN$5* DF2G1FX*R-BON%" 1!@2F#XA9CJ&J!]W#[F]  #L0^W&U7._
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MI#D(74A())AHLF!07"BL131PD5!$/$DXO%%D!+-L.%0@(%(X!&1,I%PT1,!
M#(H&0Y94""AL>$ T,'$X/(BR-4@\<%0TO&4\.# Y5"=L/-19/%0;F6^68!!
M200)_2Z8*U5F(<.&#A]"C"AQX08 :S@,\("@P0<!!-*P 0 ADZ,#"D@(& ,
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MPP C"8!!\J:>:?B("<&X!0D>1X'=*6EV, !GG:B6 74NSP'QF@T' L@^A3!
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M.@40!RA%(7K)]7@ Y(V<E*1E>W" 7X!B')S %&2$0RQ38=X#N?3(G0P.U7!
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ML,[R- VB3 !'$-,F*84'Z(T#.";^,MQ)&[ (#>B0>/2/$'@'"_3-ZYS>]FP
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M!MP 4JCD&J!E&D@E&4AE*62 H@F'4*A>FJ1 &FR>%>A SN".'K# T)QWJ"W
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M BLR! "X+8"# @ NFKAP@*2*"1%>=!" [E=&1!(45$A@@(/^!0(:+"3HLF$
MAHH?(G1C0 )"3P?14#1P5H#"!P(/%C(9,(%# 6TGBF;  '("R H$;JKE% '
MR),%%1@0EP! @@X7###(\B$#@A,")%18H.#"/@@4&$1]4(!$!0H=%DP8^*'"
M 03:#&RP$'5M(A,/%B1^=]$C7ZA] WQ X$Z#@:ON-G3^4.#8@P9%34B8< 'D
MAP>='22H,H #@P<G_GE>7ND!@08-?EX=& ## P!9 T"(6*+OU[88VC;0$("#
M @ 1!FRH$$!"  L32 !0P&#DM7@= G0PRUP1AP0%%*!!"A+\U1T"%91P@ 9
M?<"! 1U 6 (#6Y#'A 0.8##<!Q?^4#!! ^]$8\("R*TFVSP/N-3?BHE(,, '
M"22PP 8 # A!AJI1@!T#!BH46 /B."" @_8Q\$%+"H!(Q8T?!# @ 1-,P,
M!WPPP(!\L4@(%1$HD(!5'?B3I0+(>;!@-P4=T &:'RB0!0?J?1"?AB=<,,%H
ME8G8)@E'R@96BEH&FDAZ'T@PGP< 6)7 !!@ P$$& !@3TPE^I<# <!8 T$$"
M(+:4@)$,4(#A!RE]($ $ FR@E)4;>,"!H(0H $$%T-%58A4#YO0!6:N)D\%K
M",55$!4%!.G 3%0\P&A:'RQ@)#KP5"% !Z%5<<"KL&8KB(O2#GG=  -$$<"T
M!Q@0P*W^&%39W0+#7: I IUJT.@  ,!'0@ ('*"> #P5D%\'ZV@;2 94#@#2
M P'P5&4%+YH)8$<:%,!  >Y@\%RP2/7V$1,/(-#Q"0T<<-*C IB0@ (+=-0!
M @R(+/#+?@1%*5@90'8"!F RFD('I5%Z40<)8C @!E1DP)M"&W1 0,VO:D!!
M4'@M 1;,?J!6A1,;,,$-"A4,>(4$Z)S@$[81\(D7M@5!@4+66?"5=0IO4RWW
M*1K4.'<B3K10<W<OW-+UW8"#8I,N.R>H1."()Z[XXHPWDF7CD$<N^1J#3V[Y
MY9AGKOGFG'?N^>>@AR[ZZ*27;OKIJ*>N^NJLM^[ZZ[#'+OO^[+37;OOMN.>N
M^^Z\]^[[[\ '+_SP?1-O_/'()S\WT*5I$+;S85FPQ5A)=\%!!1>4PW8&3'A@
M0<]A)9WE!E-CP(3XCV^ COF4>MW$-#NC72<U'F1/Z>-P)\U!Y3;8%/;A.=
MVHC&@PPX@0KRNT'<=-"!_X%A%Q?($A4PD,!>=$@%/%/(+7J1 ??Q;QP6P)\7
MOJ$%Y1&B*"(P4@(,Q*Z) ,!P" #  0@@@(ML1 15ZL   L .Y!Q !!LZ@0,"
M0*\X-2M2)TB  ^I&@ "TYP0F8,"0"! 5 G0$!6T1@<J2@ITKL", KVD4.FA$
M$!8H@$H$6, ,/N@"!K%Q!;O # K^$.# -Z+  !5X  3"M ,&&,D7+9A $,]
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MF.>,;-7^%.0>'!B7 A+V 0AH0VE+1&)^/+N"69\ )@](2 (@\E;D-&!2"<A
MND,CE C%Z$L&1P$W0.,3>^C%(V;E2P(2Q'(.2*EEJV'[:GJ63QCY!2#02#L#
MTG65"DC@NP95" %,D)A-"42%EJ&""0J3]C1QC5E5&'"5CF* FD6#Y"G@[DFB
M<) $H"TG#V  1%X%X0M*@(I*S #P_X&  9F[.TA!;E(TP"X'N+@FL15'@U -
MX[@*Z)-^66W:'9!'S)\@*PBJ M CA 48V89122+,BG]3HEE'  )1BHD%^NM
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M+I$1("2@@VMEO6J1%U0R#WC4'0*Q*RXLCQ? J2*6%W\':Z.92$E1HP<ZPJ#
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M+F^O[R]PL/ PB4>" $, PB' Q(1"'=^  H*"1\"M2%-!\L4&@$?&0$; 0T*
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MA2-D<,6-9AUB2'LRRSTWW75C@H<!?M0PP )#?M-@ 90^-:X"<C#8FQ -%*"
M '>1H($ "2 P#J0G";!A 1='" W^ 0] \)8!A>=1Z0"!$Q"EP@84"- Z!8.*
M;80'' !-T#7:?3ONN>N.0@)SZDS!:8]X?9>6K3B5;#8:4-!EI15PV3P'&GC
M$@8N<(!J!Z14KX&,CW?@ ?>/]/0#.XJ5UD&'A>W[N^.[N_\^_._2L4%ZG,0]
M"0%OW!\___W[_[]M[@7  1*P@._+0'\.XQ2I?.H%%&C?!RY @6SX('UJB\YS
M,"@J"_B@?AD$3PF4-)T3F*%X(@@/!WQ0@086PX N?"$,O?.!8.4 &G1HB!ER
M$#!63*  RO((7A P 0& 1B>+V)=SI,8)AE%@$!#TQ9Y,T &>2.! DI!  BCP
M "+%L(O^7OQB"AC FK1HHP!\2(<<4+>%#SQM!$XR@P,8T($!F$$"XRJ&$BNE
M%_W8C!44@  $X-(G$311!"WZU 4<\ 8'[ L"R^M! S90 :V(H&I"8(L=JB
M@E2M*A+HAP\.T8"J;  "%A"D/MA"@@HT #1L;  0P2C+6?JO @08P&\V5 KT
MV:D#!WA%*P;@E!X2$@%& A4L\(@J$>@D%&#)$%0:$( +! 4?GP++!V8G 0[9
MTB<3,-0")O"-"$1@(@G@20,4R8<$$  #OPQ#!VKE 00\D  <@.4%!J RP@C
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M@#(4((0.<( .&!# +3;@ BC0Q0( "*L&TK85EE=*+/KYGE/^OE<I\7'E)0P
MP+Y83H=55"H)I3$4T$L @9<48'1*;SI+#;%,>9_9N)/DR3\G,(;<(  600)+
M530@3<=U@(A(0]^3,"#,DG]1'8$= *]Y"H!((2# '9@!70;PH*9@0,D\J(/%
M(6<2./"8)RRP%P(,X#.U]0-(#O# KF/DH"KL/0@C4  $&*N  )PO /MJ4PT
M,(!E7+6?V3Q  @! OQ9TFAH,<.4I9-&KSS^D4H1D!00R $L2- H0$WBM$=I-
M=P,* &X"X)R'8Z1V^UZ '!J:)@DP (]RXH"Q"_B&(<Q!CR)C@V8*V0"T1J#]
MJY">*DT(F1Q)_TDAT&%0<]P0*^C^< %I$=\"VO?E JQ!-I45K0 $UY59/!6
M /S(P4"$<,V".Y$ !<#<"(33"57!N!3 !"R 1RA +"V?"[E>$B2.REV!!\Q"
M 51?%%2*Z046=2Q#6TR2 $02 * *R<D4!03 YUA) =S<7<" YX#&!G"8&A"
M ^2@?I">/O@3C*V,^@4 ]E#!!3Q$#2)$ /R(K42(FWB:"Y 3'267"%P*A+T$
M&[C)(!3'19! !/3*D"10A(@6"+J0X"7A8Q1.% Q"+5B ]8T B/1$HH2*3\'#
MB#6!"_2.%+@8-D +!GA!V>E#M+A2%2Q#.QFA]OGA7?C3S@!)_NE'HC"#I?P
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MRLFK%-"".""KRJ* 1/3&&,"4.7P  .26''63!20 [TI8A"S*.B"<6F5DI1"
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MU4(.Z*D! Z#3F!J &GX<0( ;B$ F%. E#;)C 'Q# ,,^ ('^!/3O PH  *"
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MC@R@'P?W6( '="  H$0$IHYGBI[^[8\"W+Q  >Z7 P-,( *I&4 ^(W/0!R"
M WC<Y@<BX,( 9" "P'+:!PX@ #M)H0 -X"@3>[:#!@A 3YU[YZB 9QL- * ,
MN3E &8"(@4&9D8E[0\P#8#<H5WH  %_ Q$<M\%(1[" ">/"641(VOP \<4PQ
M0%8$ ' (4P$ #:A"3 :(^@$'.@".VHL,((WGOX\J"GDX3($"-J"NW!0@!P7P
M E0_D,-/XK53#$"#\1CPI6]PP%9OF@*<4AE)!UCA&WI\UJ!T\%6:8J 8'W"
M SI V 3XD@D D*&B#I"#2 7P [*BJA!.1@&/&@!-&OU  6Z F.+Q0'HGNT
MQ%<Y3CW^(#4)G%]8PJ<#!5@@ [?M" ]R0]QF#>J=>(4C7.I5  WL[@.F6, (
M&J"!U<X/!W \'L]R]8T,=!<N*+   5R+!@+0-!)$O*IR)\<%)43WHKF! 3LJ
M*X$)**H#>4S .#D!.E.- 3'C.ZX;4O92'8P6%0K DP9ZAA@'.$*]=NK 2GEP
M!M)F0+83@"82G4L1;N+W G[-50LJP":;>0 Q:I(!40C@A4%I (["L1QB7#$
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M;> L'(,$ M.??M$Q(:<C^_(QD2&<5N&>%1,9LVE\%%(M_-D8#?H9)R(:$&
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M1H;R!!0   F@%TKD=!)P0%( +@Y0 .+%"1881::'1"3C ,0".DEQ2[/2  '
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MQ?(!%U8L!N!E-09QB20(G,O:,1 !&?!YCTMGH,D+YR"!-==ND3N4I48"LS<
MWU!21D8 !U".$[U"N3%6A'(!_3A\]*=?+/ 37^(M_D72F?$Y,<  .%0&%+!U
ME'8E+<T!#-,!#]  -R #A)"I(]>K5F$S.AS:F(-14S<#;I=I941GS]0Y"@>:
M,P<!E?,/3E8'93AC4VAU79<KH1(JA["-#3&SK@E'H 5G-=G%4U-D;Y;"7Y)M
M+1%XLW+6+:W"]N8XQ_E1+4+%Y9-=5@ O)B8%@G?G],,,WZS^SS/'E=01BRT^
MVT[E'(++4HD-1U%.!C[28AMJ;!4@?)C@0%6N,HX@8;3F):-Z/)Z=6_!0$/;&
M YX$"K S#K3WX8$9%?V70E>Q 4GD H,2(K=T.;J' 3"FVSVPC2?!)60B1L']
MQ]PG")\E83A$F=VE!P+0%$6G$M.,&()SNTB@D\D@7,WJ5 O%N2=1$N,M/?X=
M*F)4&=!. @1P=UZB/!Z0.X<1.^T\*!4NOR=G4+6'5U^ 9I*HY*XR!DEG*&<
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MH0$0^(8GG)  CR@3#NF8@S\XL <)4,T(!RA GQ#Q@ 0XZ &Q 240MCD"17
M ?R(@ '^:). <  !'4E P $,4(!W0,  ]31 :20B3[#%@H,0(  "$%  FSA@
M &%8Q+3H20!T9,   '#EFR1@AT<20)\!4 P,!#85 FRS 39@@P$(Z@$#E-0
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MP/#![AU" J#>JYR>*JH>66G! O"9Y*F:3$D /]&> )0&$0X;.X16!OP LPG
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M1&"5D$&G;.R49F6E&;3,1&4C9]U"7!%+F4%!C7P7C:6"6'F"D_' M+T).E+
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MJ55?W99.64%<+>+5*J71"( -7&4BU)TT7)5.V8%JKBO#W2$$>(!."2)?Y!0
MV(%8H;?A9)].U4P@/*%@>*,TU)UUM?1M 8  ],>0Z=1P>X-XOA04&*('@/0=
MGLL0W*&H]O>0O4,@$B(4B!6$TU@<8!6-V<M0IQ:-[52'MY*J]9E:&HS6ZDO
MN!T=^%ED#,(!P&].@D$P8=:"#%DXH%AA#K40W%E9J<0CLD"764!)&2LZ9-.J
M%!W#]2=GG( 1\&?+M=#!CF1*SE3HV42D.70XK)D%O&B+TIHJ6 C#W4)E5D K
MAIX-.$ !G'<H@<(7:*WCL$;RV8#^!IS#[:EN6@,,XMG;Q$26;MP&VD:$O@0
M!YPW>/351;+I[N&B -C! DP>DJ;&J8SA'%@=!K@V&$P$3Q1H!:SH $>627#Y
MP TU!_@61E!6]K$IYN8D@/B?2#Z6JB'M&^$6@-S &SDH>XQUKW(-"%I <:@F
M"XGG !K:A6!!.$Q+O+Z48-"3./RL#6!![AI OQS#5@C9R85#%6Q%JU?B'$CD
M \!(Z'64#5"W<;#W(_4WUQW! O1&/L;KA=9 5:H:%!BF?Z[?FRQ 6T&!K=(=
M3!%8#"2E,;ZR;_^M>#( #&@Y'9!K%A?6.QBDUTC#:9U42XT1/'[?.LY3<2 G
MJ[1KC9#^7VX]H1@X3D$3 $$(%A'$@).! 3KHRP0?[&Y5  04@439T#$"APT0
M0F$!!#CY=P55T;? 6AX$P;O8S-;Y3=0-N*KQ@C$:&H!1$2SRP[!@TX!)VA($
MK6&-&@&$@AKX3^6M*'S5!<-Y4$1D= ($3*5#P!)@I[/R@*A+=4=Q'(*40(RR
M]&]8/<EO6L 0@(W-G 1PP%ZD'KL=P 0;28T"1:[Y4JX*!LUU7F]8@!ASD\BP
MU3M@U6ZU F9ZG'G-AJPZ" 9FQ//5#*VE."$H!P@CIZBOJX"-U@,@6PV@E01*
M'_W578PM7;XO".K#>SO=H[P1W4$,"S 5@6L?]+ Y &B)5G;^&2]B4R8VD2O$
MF $44.OWUH9D]:)-$!0H*0=;'D(5G(U_0\E*TES!&2*I=\DZ^DM<7936%OD:
MR)-J-01&')G;D1\41.3"ZPO>BN0 &",_X.4"].?!@8)DG;E^@,#@1$S078'8
M?1+P(,SW>5]#R'@S/ T0L8-- /.9& :3UT<P^6 TG U@<'S@6(!/P5&P)!I7
M0^ H^% &N ,# Q@5;H5!I+=1H&4&109P24P6%V@' E4? P41"P 9'QL?!P $
M%U>4E9:7F)F:FYR4 Q4: Q@)%#<M @ 6$P K'Q  'F*H$D4%%&L5!!H? 1,<
M ZT.!S((!1\ $#(< !0.#Q(\"3C^'0(! 0"^ -<"/P$.,A9E% $; \D/Q@>,
M4AL]!  *'P8&'QT!8#0LZ3$5 07:'R(86]& 7@,&RW8-T : " X"M#! &D*)
M0ID/>ZX-L"#/2H<"'1Y,N<8(AP56".)I")#!P,H-%0#LNM 0!P)\,OK4JZ&
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MQ 00&1H4Q$,A Q<8(P,#QE30DYL"Z$A)F!:XM4"7."0H@U7^'D"@IP%6>$
M!PX$< D# !SP72,F,% -D8Z<Q @-*<E P00;Z-D9 Q$\ %P,]E3PP%A(X+ '
M$>VL<%)3.*!(Q@I#3%"-!_ZML(HC^2S!WY>+CD7   A$@I9ZR<H@@%L'[,)L
M E/*4( $&PBPBP)V4K('1Q+<<%(*7W5&!$V"[L&(55H8!XX R1[P@!1CR;"
M D+(J<5XQ>+P63\'8%8#0P($5=MX Y3KRC?0SD#/NM<\D%:)7 & 2F[D>FN%
M! ,DD!N].&Q CT_+3;+,!1.H*@,-QW[ P9 .' EIE 944T0,_ZPYP)HU()"6
M6SC0X)\6M&B73#[?XH%4PS($\(#^D%XJ14 R N3FWU8$Q #)#__\D.T5-QW3
MFQEV1N?BVW#';<DG27UP$CT0Q(9'?3&!4:7=)L2T 209!,!!5!MH4)D,PLA@
MU\(38""7 C>(M#8U)4JQ"XVN\"&$G8IT"0$]!D0@T0T*'("!!1R%A8%_]GZ0
M% 16\F&! 1A<0 !]5OADQ4I,*KNZ0X*=BLU<:]-P1K/ QI#  1XHV@/K%G"6
ME@(13!!<6AA0 \ &)TU@ 0%)*J]4C5#%X%,&\)DQ(9,%#!,V!L(]8B.^=LMT
M15(-9&\U+Q>0 BQ:0(% 2*P> * -LYQ@J7[DSB?&2<L/*A& "9[)(A1"P 4J
M< $/<./^+7,YP 4H8"\:G.L\CQC3!E;1$DF\@@@TL <$,-"  $P%3S%B@_@B
MT %N=885Y)&&2+S&#)\T9T\*6 8@XF&U#6P@--8:#P$($ %R<4 ",:!),HQA
ML@UP@ %!@,=G)JB8 %0O V-2@  :$"U&=& A17$0N2*@,AG0A0,-$( $4+1"
M 'Q& ;R2%!,*8((&'.E;NI.!%"I @36=)!ZK4 "F\ ,  _PKB6M96@&L<!+^
M>*L #$ 1+?+(!0%T(!S$X)$T3B(B*<7!$3V8!%T84://& V414B1[ (0G0G)
M[9? 7)$!+) ! M#@>35PDS(:(P '>$!217EC@SI5@%1A@ #^;K$ 1930F6%T
MP#N\9$3JZH%+M!!@5)R:1.%H 0$!#.  K3B)O1K'3 (XPCO5,.4"OO,_',0L
M#0XH7#4DXX1JM"$- =A%!WJ&"HG5"IP)74IL,F!*PS@1+[28E0!FL1;M;04L
M1^L<![0Y %YR9D_:J.8NKP$&'M@1,5VA"0;PZ8]&+,2,7CFI#LA3  Y0Y$"Z
M*2D"3FJM)(U/!H7[IMXL68^_5:(K'ABJ8@;@@4H-= -A*F,&() "7NXO ),(
M)34\N;6/I,"3C2# 1@.0C 1\!QE"6.L7OY&@Q#A@31_IDD@$L(#$D 4_W*!A
MX9HB(!GHRW&@T<X&CR2!GB9Q:SG^L2=H4K>VQAEV A5( &C<XH$';*81Y%(
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M$ A /H'&Q_,Y8#4 RZ<CF (&GF@ P(!E A\&($.X0 "NK4#KK<P>]I?%@(D
M3 + &$ '1<!  -A(25B! ,##!T'DD^8F9Z?G)VBHZ"AIJ6E3RT9'F.I+BTC&
MZL?&!H?^;1@';8P'F(>JQL>MR :&;(5LC 8&3,?R1Z#K12Y'\8>&Q :,Q<4+
MAP3W<\;I.'FY^3EZNOHZ>WM3PX2.ECM]O?T]?K[^/K_-?/N_?@('$BQH\"#"
MA H7,FSH\"'$B!(G4JQH\2+&C!HW<NSH\2/(D")'DBQI\B3*E"I7LFSI\B7,
MF#)GTJQI\R;.G#IW\NSI\R?0H$*'$BUJ]"C2I$J7,FWJ]"G4J%*G4JUJ]2K6
MK%JW<NWJ]2O8L&+'DBUK]BS:M&K7LFWK]BW<N'+GTJUK]R[>O'KW\NWK]R_@
MP(('$RYL^##BQ(H7,V[L^#'DR)(G4ZYL^3+4@#LT8^[L^3/^Z-#I*DB04&&>
MH@CB/I".8&'5M0C27F!P+8(", SQGA'3H*%"!@\8:&43;9QQ@0 % "@0<: ,
M@ @?&A$0,*"#"@(#OGR( (! @ ,?%*R!HRK !0$"JC/@ ,# =@K'YR,F$$]#
M@?$$M%00-.#1 *3E]P$"6 C 30<#/(!!"5$<$P &$&;Q00;B=2=(!,[0M^%?
MDR P  H!2"!"!P@D>, ## 1P3240!)"A 2\HL, 9&"3 P ,6$+"!<@<,<,$&
M CPP 0'-)2 ?ATGR5>0%#^0W@'1AF#B  @H P,<# \"!!07-K<* &0=$H$ &
M"4RP@!4+/-" !D%:V5P8R"@YIUW^]HE@@ 8*H$!A?@*  >('#\3X0  =;+"C
M" CD1P  $(@1P 1>  -+"=ZM1B>F=2IGW2P!&.!  "'*5P$ %$20GQAK'" D
M @'P8:5\RVF0 7,/)." !C%^8$",#/"1*;!O85>:;"+8^.DJ#CRR)@4.P)+
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MP(OQ=,!HE! 8,$$=%F#P@  (C%B !%G"T,"1E<,@ +2@<@#F,W&D1\$$5&
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M4"H#0 %^4HH!&RA<U8Y@@5"]*PPO4BA8&%I! F#@ J :3P$T<+\J3 =)W*.
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M1*XZH( !%(" !X@8"1B<:8ZM<8#JPADQFLG !+H$G@"LYV\)4$ $9CD!"5A
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M&FCAYB)"0@?.!)X,-@&]]?QY#=H P@(\ ,LOT'G$=8"?V.K #URH]A!4  7
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M2&('., J3)&3!4&NM6'R88  ?)_^#O!1#$Q>!K @5?G#,\"?SWD)$-) %"3
MI*0'&L+ !N[0!CS'$-T&F*P'!0S4*D  FO *&TQ"J"2 @7G-Q%5 "L5C4Q1)
M_Y1 +*U1_PC!_5Q*D-"5SQ5!O7'#/$R?2#';,$Q TVQ+!&S'^>7 &XV!=!Q
MV?U@3I5@HHG !#0"?VW 5DF [A'  C1 1H;!2GU4_147(R2 EEV9!:P82T9%
MD8R)<H%/@B!@#U!;+04;8$6?#U0'5?4-'&@9"PK)+PB*,P@'!)BD ,A.0.D
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MM$JN"1*..D!&/@\PM $&J(D58"4BN>O^? 'E*)48;T%S1,?03H<XO4@$$$(
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MS\_?_RX@/7_U"L[3]V\@0@0'#M [D"_? 0;W%"B@V #!Q076'%AL9TV!1U_
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FM*ZUK6^-ZUSK>M>\[K6O?PWL8 M[V,0NMK&/C>QD*WO9E@X! #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>g160222nk07i001.gif
<DESCRIPTION>G160222NK07I001.GIF
<TEXT>
begin 644 g160222nk07i001.gif
M1TE&.#EASP*C _0   $! 0P,#!04%!P<'"0D)"PL+#0T-#L[.T1$1$Q,3%-3
M4UM;6V-C8VQL;'1T='Q\?(.#@XR,C)24E)N;FZ.CHZRLK+2TM+N[N\/#P\O+
MR]/3T]O;V^3DY.SL[/3T]/[^_B'Y!       (?XU($EM86=E(&=E;F5R871E
M9"!B>2!!1E!,($=H;W-T<V-R:7!T("AD979I8V4]<&YM<F%W*0H +     #/
M J,#  7^8(5]9&F>:*JN;.N^<"S/=&W?>*[O?.__P*!P2"P:C\BD<LEL.I_0
MJ'1*K5JOV*QVR^UZO^"P>$PNF\_HM'K-;KO?\+A\3J_;[_B\?L_O^_^ @8*#
MA(6&AXB)BHN,C8Z/D)&2DY25EI>8F9J;G)V>GZ"AHJ.DI::GJ*FJJZRMKJ^P
ML;*SM+6V0!XHN;HDN[LGO[\?P< FPL+&O26^RL/)SL7+S\K(Q,W0V-?7S-;8
MS+?@X>+CY.7F31D='1@:%AX3&!ORZ>\9&149'!47&Q<?'1DT4(BG+\,'#?,H
M=)@0<,,'"AGD;<@ T2"&"1PT=-C P5T]"Q4R;HCW\,+"#!?^+&08<;$#!0WV
M.&#PP$'"Q D=+D3D\ &DRYP9,!I4F<&"!9D.*6K < &?O0D?1LJSV<]AA:,;
M+,2;,/(@AY?V1E38((%#4WOGTJHMD\M!OP42#G@ P(#"! D4.&P \ ""@ <8
M$""@ .$#A@@6 "R@<&% @P\2)DR $$ #  <21@BH*_D!  @2/C0 8 %"!@D5
M$FR\?&" A<@.H 8X@ $ !@<''BSXX#D#@ @/'%!XX"$Q8=L,).#]4  !AP 7
M%B0N_2%!@PD+#%BX_L$!= 8)#%3H"^#K [P *$A@8'!VA0H%D@/(P.!#A L
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M!#1$@,$!"WR%22$&FK4X[US <0<83I?:)RWUL"=^[YG?CS)@/V])1E;DRY6
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M?3IG>5=3SAKP0+8JR"CN9$=RI-2=E9U\*5Z<[0= M24$":<-*EH99.( ."/
M -)U2MABTLD&5WWY9G;  U[KBE. -]_@Z)&3-4!84U>3&( !"_RD K$5(!>
M1>-#4X6CU'%@7:XJ&B!!XHE#TYX \2>.X@?8"]!P@!"HC3,"(A _QJ4'>(?[
M@'7^!H/ ?8EP#FQ)>=QC%,,!;SX!^,G#E (6_NCC/HNA@84&T#D-#L NW?+
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M_8W?_44@5$V@33T@!X9@!Y)?!D;>\YT@"KH>%)V5!)P5"T; 63U  S0  R@
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MRM34!"13VE6!52" 9O$G?L*"=1S58_[G!]Y2U4@%A9)H6RJ>54" ]-RG0NJ
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M  +L20U(G @\S&)DF%*4JUU8F)\I1?*H@(*R +HXB@>P183^T,I=P,B""-0
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MKC*$!$!%J>2N+<D![_+T++5#LM30P8H+-W' PSS PW#-D:)L3 3<DY")E02
M??:NJCBW"1PN%!X-[7C ="? CABLGL!)AARH!W1=!6" C)!TM*DU4\$)!B"
M6%N!@GY!@70-1]VU \B-=;_+AJ"+8""'8=A$PE3+9\S/)_D !6?>J43 $PJ-
MEGUW!9S*E=!FEXI="?!%#W'.J7@P8<PO+Y3M$%N(1/R)B_J9!V#X?EA%V-R
M=:1) 50G1V<*;0/QBO\ -R&*!UC'!)RIKG3 G6@ <E@ <M#F9'! @$0 9QGW
MI0H'&[_^]1!P\0P(1XC?"4X$B0BD[I5 ATUPP'1+.BRS\>")0 *@=&D=Z63
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M@.?JR5F$D-%S?4  <R#V' C1\%J?&FEOVI0#_9UG6Y[3#@NLMAX$94," 8@
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M&?!:] <!Y@*!]Z=[#Y A&^  RS0"\O(-%6!2D# !YB46$A@!ZR<(\4<"%>
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ME@(A0SI0:@T$^(=AD0!5=:2/5 #59PT&8(6@0#K62 <. (83D0L\^[ =(CE
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MW(>]YO>$!(, MY<!DK4M$[!^ 8@'E(6%"T@Z!M!_#I  3D,YYO89&)P! Q0
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MZ H9D #^PSP"P>KS!-F"DDWO>U4BEMSYQJ4 FZ$IS--_(@U/;C'C3+#8Y\X
M]B?M>%#W;0)$W <!"\!%T%<VK?7M]&Y'2>]ROVX!#<"V&S3ER?O+'&E')<7:
M"P\"V_%9R>>1R/=!4%.M*V82WJ.2'3-]4?,]#+$AL6@\Q@8/)+/I?!(] 0RT
MNEA^)(,/@@$1?!J2CV'".' &G8^"81ED%K $9".@("R-Q1L#66# G7PD>"18
M  FA; !@3$1\4( I- 3RH$P4;$@4?!PX!'+0121D$&1D"&0@1&@4H'QD%$X
M;"P0;!!<3!AP-)A4 ,!,''@@. SZ>!@L:(Q@%'18&,!Z0A;^U U(K ZN',A%
M7% <2,,A:'PX.%P,<" T> Q8>!#,(*,D++$..AQD#$R8L,"3A0D(#$%"X:%
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M_/-_74E\@'B@Y=,-#.^Z[J2?KQL'(\+$.$<!M^P.=1I8@ <DH"$'>* #'?!
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M12#02 B1 &4I!7@/<MC!@M=,8P@)F& GJ)..&2V!%POI@!FF$<,QK6 \']F
M/,AP'!/ B TD6 (TA,.%@03)#!^@[0(X,-4-FH!L'##-  _V22UI@&Z%% ^A
M8&">"0CE 9=*P \JY2?UA"8+&WE.1H8 L6E*[5CM6*@!M .#5RSF0T)@E%JH
M@ *P)& ":*D*=U$FFA@DB0W(<.CB*@P71 "+#!$X0 4Z$  M90<9PR7$ S
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MD&\Z@!JU &&>("* :9Q]9V0X@ *YV11*2-0_(7U  (APN5&$8(%.D  1$B#
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M4,_M3(\*D6$89H_Y+(X93H\:MH[^,-6."KDAYR#/',)AXK#A&193.74 !FA
M3<W#2)3.R2 *"=1*+)P(#]R,Y^#+!5@ !_!0!/C(+G#2"MC,+4F !+AAP4@6
MJCR%A#!,\,Q#!5#(22 "D05/!FP (DPB)_%0!GS5"<0A&>$A')K/Y<1;#LQ<
M6CU%07Q/,5&  ]37Y.E,S=C)>U"7"A7$P22-!SQ%(D[*!.!(&LE,\2@*- I0
MS=!7S0P/!:1&Z1A+\!2B(EJC**KB !W+QJ10#$U:(:8B@LP#!?!AU3&,"<5"
M_SAB#AQ1/F* !Z"#!NP0B%S Y<!$!JS!+GR/.9J&!93,"?SA';8A+5(/1$JD
M&\HB1*K^H43.HD7*81J.3O7@3AL^9.G$(1?6ENQIX4E"T97\'DK6AP0(V)&P
M9$Q6S0/43(#(Y$V^UF?$G@ PPU1)1P0H0#L9E*,195$.I5 :Y50AI5$B)0.T
MDXXX0 M(90/ BK,H#(PT  0\AL)D3,9<XE>"Y25ZI5>&95F*I00$Q%AVY5F"
MY5JBY5NFY01P(S<&!%W&)5FV921UY5W>I5BF)5KR)3=^Y5_&)6#RI6'*I5WR
MI5P69D"P)6(Z)E["99&L!@6\Y6 "9F;VI6(")EW27V$*YEAB)F$NIF(NYFG&
MY6>BYFJFI64Z)EM*9FB.YE[.)6R.9EN:I6A>(@4D!5WB)F;^FF5N J=P!F=8
MZJ9N%B=R)F=;:F57ED@+ (=;2J9DWN99/@)K"-UCYF8$M, C^(6"R(I+4J4+
M_ *!10N,M L=[ %39N6CJ8.S",E[NI0$#!GK>9,Q$$!^#@ ![&=^^N=_\J=^
M%L!_!E2  BB !M0 ).B!]F=_,BA_-JA^.BB!,NB$^J>%0JB" H""$D  [">'
M6JB"BNB("D  F"@ H"B*!D"*KJB)!H  B"B,#D  !.B,FJ@  ,"* @".[NB,
MYJB'NJB."JF&JJB'YBB/EJB*;FB*,FF3.JF*)ND " ",PJB.YB@ $(",BBB-
MKJB$2FF"QNA^3JF4[NB+#L".3BG^D#XIE*+HC$XIE98HF5ZIDJXIB^XHG=8I
MD_)HG5KIE>(HCW)HG(ZIB*(H?\JHFLHICBJHF<IHAA9HA'KIB#JJFX+HAU[H
MI5(HB-:HI1HHA^JGA&(JIXHJ@E;H@1HHIH;JA$+JJ;+JIW+JIG8JJC[HASIH
MB'[J@Y)J 3PJ@BZHI_8?3@)KY$00+YTA\,CBL&K3?"FKLFJ3!,T1&\610CBK
M!&F1@,Q7=J#,'SGK!J",L/P1LTZ0@'3 M2;KN$80M\X7NBJKNJ:KLD:0@$3K
MN<[7N,)B%O'2']DA+.IKO?;1'&GK!(WKNJ[K! G+L&81P%X.MP:LL"QKNRZK
MN3*LP$K^K+IJD;JR:[<Z;!]=J[1F$>[,U[X"[!9Q:Q_M4KURI.-09+T^Z[XB
M3K"Z[,NNC_6@FO-TD_M,3NHX3\YRT__\31<RW._H; W!;*IE3<O>3?H0+<_:
MI]+B;/(([?,DK= :3]32+!3U#M/"CL\.[=;N+-9:K0A=K=-.+1RYCM9R3>[4
M4 !];0!%I$>Z#=*^;=!^;==P;=W:[=WB;=[J[=[R;=_Z[=\";N *[N 2;N$:
M[N$B;N(J[N(R;MLR[N-";N1*[N12;N5:[N5B;N:6C:(8BS2I61R.D-."C=E&
MC>AZ+=AJ;MC0ZWY\K!<^[=6T%NFF[N3B@Y(>'M;>; *IS^S^\N[?E!;PD$X'
M $"*Y*[L]N[QUAX"U  ^=1499H[FE!'5LBPWT5\%6*;D@(\-X @8%L$&1( U
MCFT2E='Y1"]U^0?] :T&&,[XE$[J36\W*89'.B[M"@#@V8?P:M#@<( IDD!=
MO<XP2>U;6&_/7*V_(.\!-QO@,0)S#!XSK(%W'  KL4(M)$C]SL,!\$ F'(SL
MI ,!E &=T0(&Z @W&<"**J@L%0$"C(%H\!42_ ,!-"\3",<;6:V/_6D\.>W@
M01$Y[0<*O-<!BT>3[8T[L8@<N)G/_)T-@@FR&(>= $4>S)CQ$H%S0(*-"8P1
M9.72VMZ&PC!]&,$-:C$05VX";.C^F=9") P9!@ 6%U1$K0# F:3! (B)[_VN
M @SO>ID+ /BC"]*G B1';NUL*A21)*!!I!G';@V (5P -V" 1H39 @3 !&F=
MG<F.!IP5(L#P$C@?(3A B($1F'1+ N3O[DW: <Q:";B%%N!!(SJ;NQC6DN@=
MO16()>N$)4=;Q"C7 G@6!:@;[_'@2DZNKA)!# 8##P!  0S>G%D  /P" *SP
M6@# !5"$ . 97TDQ$8@?"9SQJ_% 4F@!PZ"HB\!=!+2; ZB 0ZW*( 0:%PA%
M7D2%'"26>.A4_(AQZC8;6EGF&W,!<^R6,0#>,MN:, R*,R^S,3"S<>DJ-V8;
M?0*S?63^0"3+5&V "20E6S"X!:.HE7BX9/(5TXJ2U?S=6R,#1R$@0"-@WY9!
MLY(\Q\SXU1N1<NE5P!U(01#X!P 88(4!@)_XGAI_@5O@6P8X\P"H0 $@P (\
MAT:P ?/@ P,XQTK4@@- G =C[H!NB7/  .&M5[\ 0#JXH-1L@S.+!U.+6]F
MQSV]6AALTBO8TX8<7OW2@PGD T5HP]\M<Z, =0&LZ'N\0$=)S<91 SD=0SWW
M;OZIA ORX JTH#'@0# PU1E+P4X$@$'P0@0,!(PBP&63QG-4#5 7D:K<X!O
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M7C490#@'/_H>O_"P.K]&+&B#-@AO Q@ ;3BY'NLQ<B_S ?AY2'N;/PV$ 10
M&2."/?W  L Z/;47:M<"?3Y  "! !Z <Y<:#GB[#KC'S>E%!>5,$JQMZ !B
M,[/W"MC^TS43P3)+&D%)@ !T@ ( VE&;=0#TGF*(NA8L-]7<]<$?Q'A4E-1,
M.DY3"*%C>J8G+@:DWLK<T,VT F+[B%8DT04 !RQ!8O"$RW@E>?!@(B4V2GT
M#2SHQ)0,2@L<3)KL[P:P3!S8SQ!\'@/X#$') &;;";0A2ZWU0!IYA"C,5_XQ
MSZ'%0)7;Y 44E@B3  1M! 4=##1DRP8=#">DLRA>0 "@0S @ B^(2QJY&]R/
M1(HP0'<_+G=* +2 R0:@5CHWP%/8?(B[AR,-S0=[5KR\U=E*P']$B:%-2YA
MT-_M8Z7HU,3@WO0- H.T0 2L 9 $Q(!,4+Q)R%2H/!"3+L/^SP_:3#P8TW[M
M2P8$J(&6P;I?+&WNQ_YK"3_Z#/_BJBWOT"S<.F_XE"Y'LJV^T@XL+/+_L)'U
M=V36.O\+56WB,(SB'8OH%J_<AFW*!VLL!G]$0B\ZF:[S,JWZ1__T'O_\3Y'Z
M+<X;4:L<_=ZX3BOV0.W]@T#G?61IGN98>N+'HNNJPG2]<C,YLKO]M26@2^@K
M&H_(I'+);)(Z'-RSP^Q0G;2.9K:Q?#88'G9,+IO/Z+1ZS78B#J1- 8"@6@*
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M#$0*V%9MG=6K2 HD\( Q6<H-(W4T!%M1*+ )D+8 <\$B(K:1,ZEXP/ EAP4
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M 0!*>-RQ 1R $H#;)EEBDKGX1":T2T>0VPFY&(?771V4!(P"#&@P  8/3#J
M8?N, (%/]/A$ *%VQDE":O%D3,DQ-]%S 9@5(("!7QE  ,<#4/,2@#<-9%1
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M(""!$:@I%KEK+PH"([(IP2<0%]C63$OPM->2  $5D,*0J-0D 3C8!>'X0 !
M@=T*&R$#> A+BY81%U=M0P!]F.X(H&6M%2%CDM&PPC=._*D,U&9*$" O3 "%
M#,E<2EO^$*#  B@@*P=081J_0 \ 8C&"%M&E 770%@4@8"\/E&8D!?C'!![@
M!134+7V><&\%,-" 2P6I ^Q=*C\,$+@5<< !"R*!IJ9DGF#=!;(6EJQV$4 G
M(%&C#\L!A 4\58 ',6!6?7A*CP!%'6I$2 "=2,ID"H>Q;TJ  0:@@('JP0'R
M0.R\ !'.;X22V@%T(FPR"B$&8(28% $VSJ@V9X\P$Y^&S0!?_LH33U+B@H19
MX  6 Y0]8' _$D1 .\M(40*FY.DA)Z(6^&"(:O8Y10QPQ@!P4-<#Z(0'"C.@
M,H5AV[!@EBU\Z?K7:+:136PA&B\<  +3^88KIHV_$51I4J/^41D'+/F#>D@X
M?6QKQ8!3[58%3$ !%7  YCPAX6T,CP+(\<L&O @CE>E86P! Q-@>H(D*(&<U
M#5B /C2X[P@LB0$/B$ X*C7O-^T[?$VMAP>DA U8% DS)$ B8F#T:7[;7%U3
M>HA.-'<%B\3:6J&*8 (D@.#R " BHBA E9/6N1ZZ D\?AH<.B"X<0R #Q!^<
M<E(B?IPS$R*#H,CV"'TB!X8<1@ 5L-@=/&@".P+@'V@_(J*0<P!(&&Q86DT:
M4>I+ JSKX^KT95N+]FUSFBX@M\>HEZQHY@4#E&89&@A2_T+N 5SKW=C]<  <
M A8D*#I[--'X7BM^ZSUH?3<0;'W^@I#P\06AY$DUC! 2D%PP 6"0NO"II@=T
M!#&LW5O**W' "WI\XH?5^G@ W:&!TT:\CP/(ADK(HME"OI  .[ - ?:@-ST8
MT( 'N H!#RC3 [ =0DUP%L/)@,8%..R% F K >&O<A ., X%,?Z(Z*8[W$/S
M@"M8H@"J,0"[1F^%(V$10 \=H&_#A7L*E2X6H$"'L'(2UG@1, '(@8 &T$&$
M<0D+ '$P\P9W,0'J(F$N=GB? S0;X%DC@%SZ4 #ZD"P#$QPS563U8 DP: '4
M4U1W01^9\B1XHC3R<5T,V% 0P0&68 %:P $E\541YP<&4 "!\44?0 _-UX3M
MX4L#E!+^'D  Y6$_K>  ^I!]4K<M16, P;8+6$<4$S ZZ*$ ''(?]C8"KL(
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MEF1I#@K@8####U]WE#30'#U0#7V!!*+C&2X@(=/P6U/H/"@@ 0?  /G2)@Q
M !WY*]1%!VLQ&>IB2F6YF(S9F'E3 /07%1]@( <E;E] &#DY @/ =J14 X"@
M"<2&0HBP->P40EYT0.A! --69</^H@>!,35ZT &!\P"7Y)BV>9NX>2H$4%LN
M\C9MXQI$-A%Z4 &[B0\'<"PIZ $+$ &&104340!7(@@;H#F>9@@*T2HHH Q!
M<A>:$$J7X %GDQ,+(!TN,!H2("3'\79?8&YPH \-, &*F9OR.9_T65!'9 QP
MH#Z[>1<94!) U"(3  @8EF NPBRMP!['\(1XXA\-0#\*-!_?A#D,0 %$!PT(
MT  DXP&-. M35 M;1@?!82V/=0"YE OV<!?<2'SUN:(LVJ)I )V)(0 7T _+
MERD3L !],'[Z\%T/4F!/(C@TPSE/(@'+D!1FHYD5,#;W<)(E@#D1H! 4X"79
M\AV:14W^%_4?4]AW$( -*%$>$O$797$7&^6B9%JF9NH#F@(ZQD$1,JH/%C 1
M83,E/'H/>L(V$&H__!ET 5!?F_,-%A !/B& >E$(AS E-2( RKD,&R8*QU$!
MV\([JS$E$H !I:$;N9,1>\$!?NED^W"FGOJI9[I8JK$+OHD->? #>_5;@=$D
M#^(>KI(I4(-H(01MFI B?1$(=P0'^2*;M71M$F8AAF!^)N))WOE89]0(,+&;
M_@@ 7>,O!  =# 2JTCJM\PE<4! '-S,7.P 7(Q$%'M"M<I@<U0<!FA! <B@D
M+[ 1'>!9.C 2'U$6U^H"TE@"%@52Z%H8P)0!-J*OU-JO_BK^GT;)ED50:<\Z
MIC:  3SXKPJ[L PK+C-FE<T E%<94 U;L1;KHF!YL1J[L1S;L1[[L2 ;LB([
MLB1;LOY*4%5Y5Z4)E5BIE";[LB^;L4<0L#!;LS9[LXMQ5!F  2*E%E8P%ZR!
M 1=P 4'+&D1KM$7+&CN;M$RKM#MK5CS+ AWP6E(+!C^E 2( %C@0!3C $%[[
MM6 ;MF([MF1;MF9[MFB;MFJ[MFS;MF[[MG ;MW([MW1;MW9[MWB;MWJ+MEVK
MMEH@4D4%N&H1%SC05$VE 185!1J@M#(E4J_0N&O5N#P[N:_ &F#QLS,1(!1
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M\1S?\1[_\2 ?\MCEVB+OW!;?327?&">/WBN?\MN3 5=L'&"!V\8-3MDJL%O
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M)1ML9@Z5&2@PY0/:?#!!86F6<]&R#_#X30$6+->. Q5L1LL%#V! 0 D'7-!
M*A%0!W39+AQ00030N<( 'PXTL '%'/#1!P* ILD PB7P]D%HB'& 680+N0$=
M!A0/ )CC"0!FP0$6I G! ]IQ$% ?MC"BP-(1)&!!<0PDX &A]?DQ  9N$X"5
M QTHUXX%>YX] 01\(0B?QM*0M@$"?9YAP 8M4JGEKL$/1LC^D#44UH - 6S@
MP:X$\ W"..\# K!&\!#PC0> "0P B!KD@(<8&W"M#QEH$P<F( $'H(@&L$H
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MQV*(C#1M <L,@'B8R\LI"GE4R+<<CKJAD&(9Q*E=T(,X!DS^L8T$D-T+K%,
M@ YK/-@GAJP!'>GW]<&%&4S-G@R54 (!: "O%L*;*4J;7)&D?D/.NMHZ?92F
M[%TGS(O_08V00*S\SAS3D,_*LD>ZJH4+J*8: M/.G&HEW!6O\M?9O$8?K1D*
M 8#IG,[S/5<I"$"1$8!Z$4 Q"4_D7,!.[H)6"(!PZ695@0Y0*$!A.-486*!Q
M/$\G9(!J\!08.D#K;07DR!OQV!A^>H@!: EJ0MU]L%'.P$?()J(2V$"V0 U-
MW4LI(  '&DRGS5O\F =)-E%!Y0X)\!(AX.!X1: 2J$4WC*8NS9 $0(YZH0AP
MJ!M_H=9"2!7Y6$FIA!PSM]\/,_/^#^Q,8,!ABJK=L23 83:  (Q'GJ'$S3J@
M?-@'E((!M9: 9AU'<XW')*A 5Q')?+"-?9BK?YR!<24 J3""UXC1+ZN$SBG
M?4ZP#(*..DV=3]YJ+5@.0/A98$C &?BL]Q"=%]R"5/T((=C1C0K7J:Y8AMC7
M"YSO0K2>+7PH;1@0";S12;_BJ5T =9Q 8'#;B7G:U_%%&-C"1=MR)Q  $\-$
M_A@2O'$32XM,"'H!D+U !+P9TA&%<;W8.KF,1/!2-E;F+0B)<&3!5_P B?5
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M$GHI/FZAP>F!6LY6G@L@S\FGO'%(L+:!&F'O#5QH'4"0=$L T[E,GA<<*2%
MB:>1  8$<1V Z@;,5!9X4?8D?U8# :&<@7R^**B.?!!# 6"@0R@JX02P?0\!
M@36<KZ+P23XP"5FT*-/+1/8P^3)+</L-@1]XI!\PKA*2!!,,/1 4?23D'PA<
MWSABVZ=A7Q95WM=)T^M-TLM.W8=!U7B):"R>R^X#09"6&\CL8SDNI]2J]8K-
M:K=<ZRO[G288D$/8VC!0$I!/^-R-RZL6B7N>M20.<3C$0 +^AS>X%4% B)@X
M*#@2T^4!,9!Q5\6H>,FU@$!A\$")>64).KHDB@5G*D<!H!)*^@H[^I8E@9'Z
M0O$P&>B%6OHEZC'["?P[8EK,^':&X[!+17,\BT/Q>7Q])XSMIGS:3?PA82'-
M6PS-NVU,;*E]C1S<F^X^]2)1[046S8[.;5V972H=LQ$4'+3Z1TY@*H !T9GC
MYRIB0H@"RVU!UM#:L SC\%&,!3*1!PZGG@7L(&7DE0[#J'!8"$I0NT8+6<Z<
M<W/.RT PET@)F1&&J)]<>A(2EA,HSJ1%E2XBJH412Q(=2%(UND@>(91==J[<
M(=7FJ25>SSD]*^>%!CXR/W!0 O'^@:<7&)0\]%# Y)0,;0Z8Q+H0'@4&=SH8
MN'78P3AXZ%0DF%N1WA(+ -J\8-" TD($)[)PQ.;+G[4%)UXLJ,9HP,&/@2!C
M,2%:ZQT($2P VL?O5M2& QN@OO20A(;?%R4&?!%!@>9K%?3^,_"CGO([9#3*
MOE-A\?788]-!V!#!DP.K6 JH:-N \+D&/NQ>?X$@0NP.\M':![/! ML-S_B[
ME:^!?_R1Y, #57UP@5T;=$;"!!R@Q &#+SPPP =^/4@"!^0=4]4+"V:HP1<?
MCJ A30>ZL0%)$S"@T@: ?# B-(==0-)-1[QP(PD+=(#!:HUPM\0!$$23P *?
M; ",2C3^':"!&S<B1<(#ZG&WDS GNH7D!\Y,U8!\'(18B@ B4)4E4E)4E1F6
MTOSDP \D5M$!@T)]\$ +%5;R4Y56.DF.-AX\":>$6:)HV@1N$54CE']FN*8;
M8"*UTP0(+#HG$T^F]&>-#,9)PPX4&.E!9X,>X":(7W0 9@4DL52!<E] X("C
M891X!X9!V@&#G&0F&B<,5@UZS#/"; !67AEDP $ &7"U@B W/$@L"1]*D%F-
M3<*@I00;5'-"M(3*F4 4->ZB00<4%(#5?;%L,, #!A3PP:<,$.8  PM P,%A
M @3P0!J1>!"!  \4P)\2$## QA*)(:#  (:2H   >B!PP #^)$&@ '243!"
M7PX@8("A$!1P +H2%$" )Q,08$"L#!"P0  6:,!R 1U4$$ "!!@!""<%/*SC
M @E4^, &&"2P!XQ[Q)H  I..P5D% %# GI8*)+!LRIJ<H4&1"GBPR@$,*F!D
M(YH<8 L!0\=:00$+"* A DT#/(  ]U@80+D)7-T1B0B0_$$% R10P \,_)T
MG04P_ $#$V1@P $)@.5& "+@<( !B5,PP ($3.+  9+':P !F440  %?<#
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M]NC'E!LP P4[D)<[3 !>8>2?!A80*P>DTE!8*\"0'J,E)1 & 1,0I0?TX $
M&*H =Y.E)^QE(9.0[0X.2)QMDI6V?(F@ !S0'YT:( &+1<,!3#,G'^Z@/OY!
M@ *'J, G747)!Q@*;0)MP0?L2 DQX;,:")! !0[AQ UX,0,[BJ4!@A"!'$5
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MB;0;*B#126P"29#3 !8;ZAL>4,L3[)'VQC4 2:@BX1G0A&(J+6 !8A6 I9.
M0%U.\.8,&,I(-&5 ]FI\F6NSBR2[A.\=FMMB+TE@+2#=["3\8IX52$#  -GQ
M!R;;."DH(%9 QQ]B,;B#^ %\I0^0@#.@L+\WBYK76R3, Q#^<$,8%"V 6X^
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M'J(8KT8".?L#6D:L4\"U$? GD<=C4W #,E0!U>"M%# )2]3^&9%W G_#$A8
MARMP ?\5$!^X!-:Z"QB05>-P 8JQ HJX6H_66A5[# 20MGK@%D!7N)EQ#QQ!
M=<-CMZ&[EQLU&0 PBY1A&4#77; Z-#NP;*R9'[PZ;(L["4,@E_3 0O4!'JG;
M > Z.ZI"(N=C <O9 DBR.&#37:S9 <YC(**A .87M@X0@$X0 "=0!]Y;!S4
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MP6,(R$08)K@&)L%=C= R(Z,!9, Q&_  !" !G],/*_(]_A< G82'-F, #L0
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MDK(V58>%!$9'6+S)6Y)!8HB;2_?+!M=8B2V58$62/:EZ9;0<"/ BAHECK13
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MGLJ@0_HL&B//PE+H7 2:!,=B^!#^)IO>Q,")-!@122)8L+4-G49KL<@$/A[
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M\($!$FJ $WS @!I$X"L5>%8!7H"Q\=0"3$#0Q@'*!0 &L&49N8%  \XWA7Z
MX@3*8D K'. 9:@H&(HUY %T,T(,U;,,:OHF '3Q0B0<L40,!,,,G,D"D&CP
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MD"M.4( '^$ *G [*<+BDYU(C/>E*QZ_'][U,B&RH,R3?@#;8< $N5B "YX%
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MQ)P,/JK&*  "9OG'V6V58HI/_RT; @Z J]Q?=RK.?@)F3J&81 01 ES/4QS
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MD,,>0,""^8<"6 1$_(=$ @DS: ]DU,"5LD*:I8*/D0E!;)!+[.L,=-M9>H
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M!R#4:.Q2 %P 6[3<%]C#"CR 2B)F,[V!.GA=$^0J_U4>*V0+SQ6%S-A !%2
M//35-Y  $PA&.$A<*S".GTG71-3 G_D9D"E 0B2<;!!"!$3&%20"!N I3$2
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M/:\R"G#1GP#T13#,CB9(+2@K$?159LT + Q((T1 %8W KV44L*FJ+5""!Q"
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M'[F:Q-1/6&5D[&>5"+;"O2&0!F3_Y..@]QO$B#K!^_0!)!8" D)_PHE LI#
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M,PT-;G98Q@!080C+X,7V%Y66A@+&/TC@RQS#@-3,\SV0(%J@U7<H%!B!EX&
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M)@/8)T$#)PB9[ D;.# ?$!PP_>'7SU0@0 8-'."!  \P0.@W% #PWP,!3#
MF094T," !:S&+P0%/%  !P8PP  "'S#P0 ()!Q .:T)VL$ #!'\ ]P1CB_@!
M C2*T\D!&#PP0 1SI]*V QP X$ "K$6 N-DHM/V  N$8T.G^YP5,-T X-3Y
M*,P...#!  AT( "<A"=0Y0 4(!_D JAU0, $B*>2P6P'(* [,! $T $# BB@
M_.,.:(D"BQS<?MT'!D#PN 4 Q%F ^J$1D  "!<SP?@%&C@I?"@0C$,"7 %A
M)RX   T5  $8, "2BH>V 4A@ \@[0 0R(( %7.X!D2.8 0IQ@P<@0&X=B, "
M0/B E!E  M!1Q/P(8$$&%(!?1^B; /0$IP$0*  NG""_?K<!YB&P CU+  0.
M,($#)(@ @^-7!0P0@28=#@($P$T" *"["T2 <!X@@! P4"XK8&YP03* YX#
MQ+%Y@(D*:$ ' $" T-R  @3(GNW^#H"; I#-/ I8@ 0&\(4/3,""40/'Y6S8
M  9(8$B@.\ &A'@X#\");X6R82KH&(':I9 ,!6@9X03 @+))#@$1&%LJ)E#
M#K1'2,!HP (>8)X#E+  'K#>!! @ 2HJB%^H2T!H$N" /3HRC@78&GOX-H#"
M*8!@58. ["(0G(V9ZG7O.P!K'+" "FBI 0*0 .I,R8!8ZE%+5D/-!]Z'  ;=
MC@&2!)LZ<\$I-!V@ ZSCG %HH*+/,,A$0PQ1<#Z1! L,J0 BP ^A>"6 1@V
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MBOF5@4E;TV=#ZEB0'IV& UB3"S('P'SL6&A39F*TJSDIKPO\4.ID-#4YWT0
M$$7G (ST!#D:I9J#$R/(>M#2#UUWG IF8D.E5@0$6&1MQ2$BW(HU1FGH9JFH
M=X+SW< "C';T"=6:H,]4>C;(UH#F9FBV!\Q&^.-$0]U8=-).B@.PJ<  #"MY
MN>AL(  I=9,G/3#K%PDH-/ ^HP941UG +H-3P%  (!)@(B(@5K&AL8 %;\"\
MR';.4W!ODB$1D-G%6IM09*9$A/)?/O-")R8.8G-&3/%/1K#^.DPW:2XG=2\R
M 'L6!E'4!L?P'M,S'\#E,@\P 4N5!G<%,<W& S;D2@5W< FR &C  /-77AX
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M7N &5<*>8*+58IW7>@VK;<.S6)(&!;"VLU$Z &"S#+( A0T K,,^/&L#?PT
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MZ9[^Z: >ZJ(^ZJ2>W4]=ZJ@>T&[^<-^IWNHDW0F+) !K:RRN7NL,?6@$  "
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M&S'@H++^UC3B'U8).T4+T.-',J)>*178G+03K?9.E"%(IR[Q1 V"\J/"/
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M"/@%1TV4*4"*!@2X(( "'TBPAW,:R #!@8E8$  ""   7S($#8 !&NUU4,
M'$0C@ 03_%=  1QD8%L2'BR@674^B( !).1Y^26888HYIED<].$!5)UL<(\%
MUWBP43V2<=!!!QJ\M,$%%L!)0D #=9!F)Q8 :H]#& 1D2 8=T";91!G,5%8]
MOK&4)U0;"'H/G _1-@>A'5QP 50=8/"I0))14.H('5A 09J>DG" = 0!2 D
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ML  #'N !&!A(!8,HQ"'2:R\R1$(MO!#![0"@?6X100,"  $*1" !^GL< 0@
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M&A)P<PU\,(B#4!6"!0)H'XI6%:O2<BQD:Z HHB)!'VS82PDUH!0;.D$JM>)
M"FX7%0!\H@Z,P-M^$N" "EB@ JZM0 ?J:;>60! *[SQL! S  0]$(P N1(*4
MQAH;ZD @A5#AEF3'D)\'D#2RW6G^K'.%B!!6'$!@WX2'"'I5 P[@;2.JLY0F
MKY00(C&$ 1$@* '_5+:'A.VI.'#%[79 4:"^0%C(G0R/=E9=/-[@ 8R(7-(.
M\"'TC8 #%Z@G A* +?Y&M\$./@?K%H( 575B&A;(J0T&0)P,U"HY0/LI-C"P
M"*TA@ )$6<I<:8> FF[@ 0)89 Y(TZRO90E\[E7"1(^A$@1 (!H&\%%$K<,
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MZ3<G 0^X@)(($ C,=VB^Q+\__H'^2A $K*S "KC8Q;Q#]'%&'* "  Z@ #X
M!%09 RK@;D# Q30 !&",6V7,3B7 *K05 ^S46RT 7/D<7(5@;$1.IGF@!S:'
M"9Y@;, 5/_!#"B" "L;&"9Y@Y)A@"#+ 7#$ "T8."\;&!LI@"%Y@A5A"?G@$
M!X(/2K3@)5S@"O+#"C8A^/%@$SZA$P8A$%ZA$X)?#TYA"K+@#$(A%"8 \N4?
M&<)/09C)9-&)D\C#3MS)0VQ 0;SA&\:A'(J>F8"*H5S !F1$!E@*GEP :V%
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MU]X%@G^=:8^84K91JK^>BPB(W5&ZQB?80J;Y"%7]1P!H0+X2AJH5U<->!RB
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M>MXP$ =QN>S""4!E:G!8!DQ ^ DQ$S?QF'B0121":IB!$U>Q%9/)!+P!1WY
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M]C9!YY8(D@$%%K1#(IA)$@2S6FR"=B< ;5X.&JOE%W0  6S$9)!9NQ2 3#-
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M^*#@ +C^#@MRC(-PH,. "!H"0!!P8<$Z= ?,+4! H8"& 1H:%,  8%V7* [
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MFL(\VZ:=Q:()+;"OTO)  0$:  P"#3"@0)3?'8"  <8I\%T"]Y3+K;FD<8O
M/>XFH&ZY##2@T0(+3,: 1@T0LD "]SKP+0,&-X OOU\(C)[!!U-F4I903+K2
M X<61N<'&!BPK[[]?@QNOPZLHA$ Y'Q," ,)** O:_@&'.YWWA+B@,H*%-P
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M*P,2Z% &!MF&#&#@ @PX!P1UIX%3,@N:.G/ \"@5D*H4(%?"Z-&]&'!..%1
M OTZ3A\8L"T]]*$O\0( E]Z #6#^;*,/'AA @ 8P  +P$9@,S>$B O8="R2.
M.$]H0  ,0( U1/-UUSQ  1#*+4[^26,2&(# )L"$PW$A+?.!B0-9*0P.F/(
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M^3-^^G 8:B"X(9=#XAQ I'D>>@,2HK(^Y)'38G>IY/SYP 1ZH1L8<. !0%^
M-^):B2W0P-E)[<(%N#Z&$F@,-I]Q0(T<35BL)^\#9EF+PKG @@ELH)KG$<!"
M-P"! L0SZ"GD:S:\$0AX/F"4'%@/!G[M3*!NDP<.L( O'#Z+DG,E#%@WS@=T
ML5V+8V%G_3%'&\"A 3R4'A@ T,"/).$+=08@ QZ(;,D(,'C&7#MO8/R, ((L
M*S=@P._IZ\8Q"5]XNF\ELA.7 P]TE@%*#J ( &#"&I(@&P_$:@'?$#N91"$<
MV)@+##3^&4(8/( 9C=U@0[(NJGF!(Y4!4(!>!P@"./1"+B'X AL);\S5/TH)
M710)*Y-M=J O&2(!#U!UC4%-R-<_5,)@BA6 <8!2&B!X&+!JE20 &M -$P .
MZQ$N&2!_'G!("] !@Y$:?"4&8K  ??$#Z]  FC4&B_ $-[ ;>\(! @!RWC0
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M/J%'Q-$#"; ,#& ,8%MLQ9$9Y\03 .F^R;)U%BD!,YO [X/^$HOE6$'8#PE
M 1Z0"!'@A(]QITT)6.0[;Y^P#=57 PYD;\_X%5A\#H*$!C_"!287P[HA' ?
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M DP$ 0'^$%B@ *5GO)0/$(P^0($$&02Q$Q$34(#!0K=Y86D& #AQP$ BQ&;
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M/SOJPG_^-("]24*AAAF @,@PPP'*K>P#Y_( \S(P DPNH (9.,!K9*0V:4T
M RZXP&+2]!('2:U9#@NHZ(1I#0?8)@X6", 5+>K1C[J0$NN (/ R<(%>>, !
M#H@,6,R @58]((C22L)]XG8M3*CH,E(P !P:\,.6/,$!CD0$ AC @95ZI'(+
MB$ "/%!$"AC+ GU48G4\8"$^G$Z-%1!J!AA@ 'FMH2T;^L"F4 29#DQ'' 18
M@ )*1 ' !: !+Y5(:CCS <$X0",/P"H4TE4U 6".#Q5Z@L>D^ XVWBE:('T&
M$=+4$"*T HB+G2QEBY>6N]TBHU-@0G7(:@%UR($R$I#J92K^<!/,)$<#$YA
M!YK*@(I"(22Q =CS2& _II*!3GG!P (.0  J/: "$K@*XI@R 08@@ (-T-L(
M+'8IR!#,2Y=P0 2JZY%2P2L.$SA "390H07LD+K46ZU)(;  NW&@+4](4QG
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MD((!_(,>O8!7$1-Q:($ M!55/  LE!$X 4!."L /\4@OM$(-!!Q5G.<]P,(
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M$,#!#;W!$<:]Q\G(RLS-SL_*$M#^T=/5UL82#[P.R0_7W]C'O+S0O!+CQL'
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M#004?/ Z Q_0_H$(I5O P 4<(  (3%'#/B0'4M?L@1,8/+WSYA%PH(D&"TR
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M8 />K-T&;M&!7E0@?!Z(P (RD(5>?*"'O<"="!PP-;\\L0$;"-W- '&$TR'
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5D1JYD1S9D1[YD2 9DB(YDBH8 @ [

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
